PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Schmitz, L; Motani, R				Schmitz, Lars; Motani, Ryosuke			Nocturnality in Dinosaurs Inferred from Scleral Ring and Orbit Morphology	SCIENCE			English	Article							ACTIVITY PATTERNS; EVOLUTION; CATHEMERALITY; EYEBALLS; FEATURES; MAMMALS; BRAIN; SIZE	Variation in daily activity patterns facilitates temporal partitioning of habitat and resources among species. Knowledge of temporal niche partitioning in paleobiological systems has been limited by the difficulty of obtaining reliable information about activity patterns from fossils. On the basis of an analysis of scleral ring and orbit morphology in 33 archosaurs, including dinosaurs and pterosaurs, we show that the eyes of Mesozoic archosaurs were adapted to all major types of dig activity (that is, nocturnal, diurnal, and cathemeral) and provide concrete evidence of temporal niche partitioning in the Mesozoic. Similar to extant amniotes, flyers were predominantly diurnal; terrestrial predators, at least partially, nocturnal; and large herbivores, cathemeral. These similarities suggest that ecology drives the evolution of diet activity patterns.	[Schmitz, Lars] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Schmitz, Lars; Motani, Ryosuke] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Schmitz, L (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	lschmitz@ucdavis.edu	Schmitz, Lars/G-2928-2010; Motani, Ryosuke/K-2607-2015	Schmitz, Lars/0000-0003-0210-4383; Motani, Ryosuke/0000-0001-5022-1053	NSF [EAR 0551024]; Department of Geology, University of California Davis; Royal Ontario Museum; German Academic Exchange Service; German Research Foundation	NSF(National Science Foundation (NSF)); Department of Geology, University of California Davis; Royal Ontario Museum; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation(German Research Foundation (DFG))	We thank D. Brinkmann, S. Carlson, I. Schwab, G. Vermeij, and P. Wainwright for comments. C. Cicero, A. Engilis, I. Engilis, D. Evans, M. Flannery, P. Holroyd, M. Koelbl-Ebert, J. McGuire., C. Mehling, M. Norell, R. Papendieck, O. Rauhut, M. Sander, K. Seymour, B. Shaffer, D. Unwin, X. Xu, and Z. Zhou granted specimen access. The project was supported by NSF grant EAR 0551024 to R.M. and Darrell Funds of the Department of Geology, University of California Davis, an M. A. Fritz Award of Royal Ontario Museum, a doctoral stipend of German Academic Exchange Service, and a postdoctoral fellowship of German Research Foundation to L.S.	Bennett SC, 2007, PALAEONTOL Z, V81, P376, DOI 10.1007/BF02990250; Carpenter Kenneth, 2000, Gaia (Lisboa), V15, P135; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; Chure Daniel J., 2000, Gaia (Lisboa), V15, P233; CROMPTON AW, 1978, NATURE, V272, P333, DOI 10.1038/272333a0; Curtis DJ, 2006, FOLIA PRIMATOL, V77, P178, DOI 10.1159/000089703; GITTLEMAN JL, 1986, J MAMMAL, V67, P23, DOI 10.2307/1380998; Hall MI, 2009, ANAT REC, V292, P798, DOI 10.1002/ar.20889; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P769, DOI 10.1007/s00114-007-0258-7; Kurochkin EN, 2007, BIOL LETTERS, V3, P309, DOI 10.1098/rsbl.2006.0617; Lee MSY, 2004, ASSEMBLING THE TREE OF LIFE, P451; Longrich Nick, 2010, P308; Maloney SK, 2005, J COMP PHYSIOL A, V191, P1055, DOI 10.1007/s00359-005-0030-4; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; MCNEIL R, 1992, BIOL REV, V67, P381, DOI 10.1111/j.1469-185X.1992.tb01188.x; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; MOTANI R, EVOLUTION, DOI DOI 10.1111/J.1558-5646.2011.01271; Mougeot F, 2000, J AVIAN BIOL, V31, P376, DOI 10.1034/j.1600-048X.2000.310314.x; OWENSMITH RN, 1988, MEGULLERBIVORES INFL; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schmitz L, 2010, VISION RES, V50, P936, DOI 10.1016/j.visres.2010.03.009; Schmitz L, 2009, J MORPHOL, V270, P759, DOI 10.1002/jmor.10720; Seebacher F, 1999, J EXP BIOL, V202, P77; Sellwood BW, 2006, SEDIMENT GEOL, V190, P269, DOI 10.1016/j.sedgeo.2006.05.013; Swingland I. R., 1979, HDB BIOTELEMETRY RAD, P611; Tattersall I, 2006, FOLIA PRIMATOL, V77, P7, DOI 10.1159/000089692; Weishampel DB., 2004, DINOSAURIA; WIENS JA, 1961, COMMUNITY ECOLOGY, P145	30	101	102	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					705	708		10.1126/science.1200043	http://dx.doi.org/10.1126/science.1200043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21493820				2022-12-24	WOS:000290265800039
J	Buyx, A; Tait, J				Buyx, Alena; Tait, Joyce			Ethical Framework for Biofuels	SCIENCE			English	Editorial Material									[Buyx, Alena] Nuffield Council Bioeth, London WC1B 3JS, England; [Tait, Joyce] Univ Edinburgh, Econ & Social Res Council, Innogen Ctr, Edinburgh EH1 1LZ, Midlothian, Scotland	Innogenetics NV; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Edinburgh	Buyx, A (corresponding author), Nuffield Council Bioeth, London WC1B 3JS, England.	abuyx@nuffieldbio-ethics.org			ESRC [ES/F028180/1] Funding Source: UKRI; Economic and Social Research Council [ES/F028180/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Amnesty International, 2008, BRAZ AMN INT REP 200; Dobson A., 1998, JUSTICE ENV; *EC, 2010, COMM COMM VOL SCHEM; *FOEI, 2008, MAL PALM OIL GREEN G; Humphreys S., 2009, AHRCRES104 UN; IEA International Energy Agency, 2010, WORLD EN OUTL 2010; Kaswan A., 2003, N CAROLINA LAW REV, V81, P1031; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Lapola DM, 2010, P NATL ACAD SCI USA, V107, P3388, DOI 10.1073/pnas.0907318107; Nuffield Council on Bioethics, 2011, BIOF ETH ISS; *OECD, 2006, GUID LIC GEN INV; POGGE T., 2008, WORLD POVERTY HUMAN; Rawls J., 1971, THEORY JUSTICE; Rawls John, 1993, POLITICAL LIBERALISM, pxviii; *REN FUELS AG, 2010, GALL REV IND EFF BIO; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; US Environmental Protection Agency, 2011, REN FUEL STAND RFS; World Bank, 2010, RISING GLOBAL INTERE	18	46	46	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					540	541		10.1126/science.1206064	http://dx.doi.org/10.1126/science.1206064			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756DE	21487119				2022-12-24	WOS:000289991100029
J	Chafe, R; Born, KB; Slutsky, AS; Laupacis, A				Chafe, Roger; Born, Karen B.; Slutsky, Arthur S.; Laupacis, Andreas			The rise of people power	NATURE			English	Editorial Material							CEREBROSPINAL VENOUS INSUFFICIENCY; MULTIPLE-SCLEROSIS		[Chafe, Roger] Mem Univ Newfoundland, St John, NF A1B 3V6, Canada; [Born, Karen B.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada; [Slutsky, Arthur S.; Laupacis, Andreas] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Slutsky, Arthur S.; Laupacis, Andreas] King Saud Univ, Riyadh, Saudi Arabia	Memorial University Newfoundland; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; King Saud University	Chafe, R (corresponding author), Mem Univ Newfoundland, St John, NF A1B 3V6, Canada.	roger.chafe@med.mun.ca	Slutsky, Arthur/M-3325-2019					[Anonymous], 2009, CTV NEWS        1121; Canadian Institute of Health Research, 2010, JOINT INV M MULT SCL; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; LERNER IJ, 1984, CANCER, V53, P815, DOI 10.1002/1097-0142(19840201)53:3+<815::AID-CNCR2820531334>3.0.CO;2-U; Rudick RA, 2010, NAT REV NEUROL, V6, P472, DOI 10.1038/nrneurol.2010.117; Sundstrom P, 2010, ANN NEUROL, V68, P255, DOI 10.1002/ana.22132; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2009, J VASC SURG, V50, P1348, DOI 10.1016/j.jvs.2009.07.096	8	48	49	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					410	411		10.1038/472410a	http://dx.doi.org/10.1038/472410a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	755QC	21525907	Bronze			2022-12-24	WOS:000289949600010
J	Brennan, DF; Dar, AC; Hertz, NT; Chao, WCH; Burlingame, AL; Shokat, KM; Barford, D				Brennan, Damian F.; Dar, Arvin C.; Hertz, Nicholas T.; Chao, William C. H.; Burlingame, Alma L.; Shokat, Kevan M.; Barford, David			A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK	NATURE			English	Article							KINASE SUPPRESSOR; GENE ENCODES; WEB SERVER; PROTEIN; ACTIVATION; INHIBITOR; MECHANISM; DOMAIN; SCAFFOLDS; PATHWAY	In metazoans, the Ras-Raf-MEK (mitogen-activated protein-kinase kinase)-ERK (extracellular signal-regulated kinase) signalling pathway relays extracellular stimuli to elicit changes in cellular function and gene expression. Aberrant activation of this pathway through oncogenic mutations is responsible for a large proportion of human cancer. Kinase suppressor of Ras (KSR)(1-3) functions as an essential scaffolding protein to coordinate the assembly of Raf-MEK-ERK complexes(4,5). Here we integrate structural and biochemical studies to understand how KSR promotes stimulatory Raf phosphorylation of MEK (refs 6, 7). We show, from the crystal structure of the kinase domain of human KSR2 (KSR2(KD)) in complex with rabbit MEK1, that interactions between KSR2(KD) and MEK1 are mediated by their respective activation segments and C-lobe alpha G helices. Analogous to BRAF (refs 8, 9), KSR2 self-associates through a side-to-side interface involving Arg 718, a residue identified in a genetic screen as a suppressor of Ras signalling(1-3). ATP is bound to the KSR2(KD) catalytic site, and we demonstrate KSR2 kinase activity towards MEK1 by in vitro assays and chemical genetics. In the KSR2(KD)-MEK1 complex, the activation segments of both kinases are mutually constrained, and KSR2 adopts an inactive conformation. BRAF allosterically stimulates the kinase activity of KSR2, which is dependent on formation of a side-to-side KSR2-BRAF heterodimer. Furthermore, KSR2-BRAF heterodimerization results in an increase of BRAF-induced MEK phosphorylation via the KSR2-mediated relay of a signal from BRAF to release the activation segment of MEK for phosphorylation. We propose that KSR interacts with a regulatory Raf molecule in cis to induce a conformational switch of MEK, facilitating MEK's phosphorylation by a separate catalytic Raf molecule in trans.	[Brennan, Damian F.; Chao, William C. H.; Barford, David] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; [Dar, Arvin C.; Hertz, Nicholas T.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA; [Dar, Arvin C.; Hertz, Nicholas T.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94107 USA; [Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94107 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	shokat@cmp.ucsf.edu; david.barford@ic.ac.uk		Hertz, Nicholas/0000-0002-6527-6898	Cancer Research UK; ICR; HHMI; NIH [NCRR RR015804, NCRR RR001614]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015804, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); ICR; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Cancer Research UK grant to D. B., ICR studentships to D. F. B. and W. C. H. C. and HHMI grant to K. M. S. We thank staff at the ESRF for help with data collection and K. Wood and V. Good for help with protein production and Z. Zhang for assistance with cloning. Mass spectrometry was made possible by NIH grants NCRR RR015804 and NCRR RR001614. The MEK1/p50<SUP>Cdc37</SUP> baculovirus was a gift from C. Vaughan. We thank Cell Signaling Technologies for help with phosphospecific MEK antibodies.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bankston D, 2002, ORG PROCESS RES DEV, V6, P777, DOI 10.1021/op020205n; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai Z, 2009, MOL CELL, V35, P818, DOI 10.1016/j.molcel.2009.09.007; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Claude JB, 2004, NUCLEIC ACIDS RES, V32, pW606, DOI 10.1093/nar/gkh400; Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Douziech M, 2006, GENE DEV, V20, P807, DOI 10.1101/gad.1390406; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hertz Nicholas T, 2010, Curr Protoc Chem Biol, V2, P15, DOI 10.1002/9780470559277.ch090201; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Statsuk AV, 2008, J AM CHEM SOC, V130, P17568, DOI 10.1021/ja807066f; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	39	185	189	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					366	U134		10.1038/nature09860	http://dx.doi.org/10.1038/nature09860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21441910				2022-12-24	WOS:000289724600043
J	Perencevich, EN; Lautenbach, E				Perencevich, Eli N.; Lautenbach, Ebbing			Infection Prevention and Comparative Effectiveness Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTERVENTION; RESISTANCE; STATEMENT		[Perencevich, Eli N.] Iowa City VA Med Ctr, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City, IA 52246 USA; [Perencevich, Eli N.] Univ Iowa, Carver Coll Med, Div Gen Internal Med, Iowa City, IA USA; [Lautenbach, Ebbing] Univ Penn, Sch Med, Dept Med & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Pennsylvania; Pennsylvania Medicine	Perencevich, EN (corresponding author), Iowa City VA Med Ctr, Ctr Comprehens Access & Delivery Res & Evaluat, 601 Hwy 6 W 3E21, Iowa City, IA 52246 USA.	eli-perencevich@uiowa.edu		Perencevich, Eli/0000-0002-3721-3355	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI080942] Funding Source: NIH RePORTER; NIAID NIH HHS [K24AI080942] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cook TD, 2008, J POLICY ANAL MANAG, V27, P724, DOI 10.1002/pam.20375; Harris AD, 2005, CLIN INFECT DIS, V41, P77, DOI 10.1086/430713; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Lautenbach E, 2010, CLIN INFECT DIS, V50, P523, DOI 10.1086/650169; McGinnis JM., 2010, REDESIGNING CLIN EFF; Platt R, 2010, MED CARE, V48, pS52, DOI 10.1097/MLR.0b013e3181dbebcf; Saginur R, 2009, CLIN INFECT DIS, V49, P1254, DOI 10.1086/605666; Shardell M, 2007, CLIN INFECT DIS, V45, P901, DOI 10.1086/521255; Stone SP, 2007, LANCET INFECT DIS, V7, P282, DOI 10.1016/S1473-3099(07)70082-8; Weber SG, 2007, INFECT CONT HOSP EP, V28, P249, DOI 10.1086/512261	10	16	18	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1482	1483		10.1001/jama.2011.450	http://dx.doi.org/10.1001/jama.2011.450			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486981				2022-12-24	WOS:000289424100027
J	Hopson, J; Holmes, J				Hopson, Jackie; Holmes, Jeremy			Through the wasteland: chronic depression	BRITISH MEDICAL JOURNAL			English	Editorial Material												jh@byfleet.org							0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 11	2011	342								d93	10.1136/bmj.d93	http://dx.doi.org/10.1136/bmj.d93			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UT	21482596	Bronze			2022-12-24	WOS:000289721100016
J	Smith, J				Smith, Jim			A long shadow over Fukushima	NATURE			English	Editorial Material									Univ Portsmouth, Portsmouth PO1 2UP, Hants, England	University of Portsmouth	Smith, J (corresponding author), Univ Portsmouth, Portsmouth PO1 2UP, Hants, England.	jim.smith@port.ac.uk	Smith, Jim T/G-7716-2011	Smith, Jim T/0000-0002-0808-2739					0	11	11	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					7	7		10.1038/472007a	http://dx.doi.org/10.1038/472007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745VV	21475152	Green Submitted			2022-12-24	WOS:000289199400006
J	Volkow, ND; McLellan, TA				Volkow, Nora D.; McLellan, Thomas A.			Curtailing Diversion and Abuse of Opioid Analgesics Without Jeopardizing Pain Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC NONCANCER PAIN		[Volkow, Nora D.] NIDA, NIH, Bethesda, MD 20892 USA; [McLellan, Thomas A.] Univ Penn, Sch Med, Ctr Subst Abuse Solut, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Pennsylvania	Volkow, ND (corresponding author), NIDA, NIH, 6001 Execut Blvd,Room 5274,MSC 9581, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		*AM MED ASS, 2011, ASS TREAT PAIN PAT S; Centers for Disease Control and Prevention, 2010, UN DRUG POIS US; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Halperin EC, 2010, ACAD MED, V85, P203, DOI 10.1097/ACM.0b013e3181c88506; Inciardi JA, 2007, PAIN MED, V8, P171, DOI 10.1111/j.1526-4637.2006.00255.x; JOHNSTON LD, NIH PUBLICATION, V1; Manchikanti L, 2010, PAIN PHYSICIAN, V13, P401; Reid MC, 2002, J GEN INTERN MED, V17, P173, DOI 10.1046/j.1525-1497.2002.10435.x; *SAMHSA, TRENDS EM DEP VIS IN; *SAMHSA DRUG ALC S, 2008, SUBST AB TREATM ADM	10	160	162	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1346	1347		10.1001/jama.2011.369	http://dx.doi.org/10.1001/jama.2011.369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745JT	21467287				2022-12-24	WOS:000289162400024
J	Standfuss, J; Edwards, PC; D'Antona, A; Fransen, M; Xie, GF; Oprian, DD; Schertler, GFX				Standfuss, Jorg; Edwards, Patricia C.; D'Antona, Aaron; Fransen, Maikel; Xie, Guifu; Oprian, Daniel D.; Schertler, Gebhard F.X.			The structural basis of agonist-induced activation in constitutively active rhodopsin	NATURE			English	Article							CRYSTAL-STRUCTURE; OPSIN; BINDING; INTERMEDIATE; COUNTERION; MECHANISM; MOVEMENT; REVEALS; FAMILY; ROD	G-protein-coupled receptors (GPCRs) comprise the largest family of membrane proteins in the human genome and mediate cellular responses to an extensive array of hormones, neurotransmitters and sensory stimuli. Although some crystal structures have been determined for GPCRs, most are for modified forms, showing little basal activity, and are bound to inverse agonists or antagonists. Consequently, these structures correspond to receptors in their inactive states. The visual pigment rhodopsin is the only GPCR for which structures exist that are thought to be in the active state(1),(2). However, these structures are for the apoprotein, or opsin, form that does not contain the agonist all-trans retinal. Here we present a crystal structure at a resolution of 3 angstrom for the constitutively active rhodopsin mutant Glu 113 Gln(3-5) in complex with a peptide derived from the carboxy terminus of the alpha-subunit of the G protein transducin. The protein is in an active conformation that retains retinal in the binding pocket after photoactivation. Comparison with the structure of ground-state rhodopsin(6) suggests how translocation of the retinal beta-ionone ring leads to a rotation of transmembrane helix 6, which is the critical conformational change on activation(7). A key feature of this conformational change is a reorganization of water-mediated hydrogen-bond networks between the retinal-binding pocket and three of the most conserved GPCR sequence motifs. We thus show how an agonist ligand can activate its GPCR.	[Standfuss, Jorg; Fransen, Maikel; Schertler, Gebhard F.X.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Standfuss, Jorg; Edwards, Patricia C.; Schertler, Gebhard F.X.] MRC, Lab Mol Biol, Cambridge CB2 0QH, England; [D'Antona, Aaron; Xie, Guifu; Oprian, Daniel D.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [D'Antona, Aaron; Xie, Guifu; Oprian, Daniel D.] Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; MRC Laboratory Molecular Biology; Brandeis University; Brandeis University	Standfuss, J (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.		Schertler, Gebhard/M-9512-2014; Standfuss, Joerg/G-5126-2011	Schertler, Gebhard F.X./0000-0002-5846-6810	Medical Research Council [MC_U105197215, MC_U105178937] Funding Source: Medline; NEI NIH HHS [R01 EY007965, EY007965] Funding Source: Medline; NINDS NIH HHS [T32 NS007292] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER; MRC [MC_U105197215, MC_U105178937] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahuja S, 2009, J BIOL CHEM, V284, P10190, DOI 10.1074/jbc.M805725200; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; GROENENDIJK GWT, 1980, EUR J BIOCHEM, V106, P119; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kono M, 2008, BIOCHEMISTRY-US, V47, P7567, DOI 10.1021/bi800357b; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Standfuss J, 2008, J MOL BIOL, V380, P145, DOI 10.1016/j.jmb.2008.04.055; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	30	366	373	5	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					656	660		10.1038/nature09795	http://dx.doi.org/10.1038/nature09795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21389983	Green Accepted			2022-12-24	WOS:000288951200049
J	Schrag, SJ				Schrag, Stephanie J.		Global Grp B Streptococcal Vaccine	Group B streptococcal vaccine for resource-poor countries	LANCET			English	Editorial Material							CONJUGATE VACCINE; DISEASE; MORTALITY; INFANTS		[Schrag, Stephanie J.; Global Grp B Streptococcal Vaccine] Ctr Dis Control & Prevent CDC, Div Bacterial Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Schrag, SJ (corresponding author), Ctr Dis Control & Prevent CDC, Div Bacterial Dis, Atlanta, GA 30333 USA.	sschrag@cdc.gov						Baker CJ, 2003, VACCINE, V21, P3468, DOI 10.1016/S0264-410X(03)00353-0; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8; DEVANI, 2010, VACC NEON INF DES VA; Gray KJ, 2007, EMERG INFECT DIS, V13, P223, DOI 10.3201/eid1302.060680; Hillier S, 2009, INFECT DIS SOC AM, P186; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; Lee CH, 2009, VACCINE, V27, P726, DOI 10.1016/j.vaccine.2008.11.065; Lin FYC, 2004, J INFECT DIS, V190, P928, DOI 10.1086/422756; Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814; Moore MR, 2003, LANCET INFECT DIS, V3, P201, DOI 10.1016/S1473-3099(03)00577-2; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Saleem S, 2010, OBSTET GYNECOL, V115, P1225, DOI 10.1097/AOG.0b013e3181e00ff0	14	12	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 2	2011	378	9785					11	12		10.1016/S0140-6736(10)61932-0	http://dx.doi.org/10.1016/S0140-6736(10)61932-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791IU	21377722				2022-12-24	WOS:000292659700008
J	Beasley, BN; Unger, EF; Temple, R				Beasley, B. Nhi; Unger, Ellis F.; Temple, Robert			Anticoagulant Options - Why the FDA Approved a Higher but Not a Lower Dose of Dabigatran	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ATRIAL-FIBRILLATION; WARFARIN		[Beasley, B. Nhi] US FDA, Div Cardiovasc & Renal Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Unger, Ellis F.; Temple, Robert] US FDA, Off Drug Evaluat 1, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Beasley, BN (corresponding author), US FDA, Div Cardiovasc & Renal Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], 2010, GUIDANCE IND NONINFE; Birman-Deych E, 2006, STROKE, V37, P1070, DOI 10.1161/01.STR.0000208294.46968.a4; Connolly SJ, 2010, NEW ENGL J MED, V363, P1877; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; fda, FDA APPR DRUG PROD; *FOOD DRUG ADM CTR, DAB PROP IND PREV ST	6	190	200	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2011	364	19					1788	1790		10.1056/NEJMp1103050	http://dx.doi.org/10.1056/NEJMp1103050			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MM	21488759				2022-12-24	WOS:000290483000003
J	Darmstadt, GL				Darmstadt, Gary L.			Stillbirths: missing from the family and from family health	LANCET			English	Editorial Material							SURVIVAL; NEWBORN; INTERVENTIONS; STRATEGIES; MORTALITY; IMPACT		Bill & Melinda Gates Fdn, Global Hlth Program, Family Hlth Div, Seattle, WA 98102 USA	Bill & Melinda Gates Foundation	Darmstadt, GL (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Family Hlth Div, Seattle, WA 98102 USA.	gary.darmstadt@gatesfoundation.org	Darmstadt, Gary/AAU-7488-2020	Darmstadt, Gary/0000-0002-7522-5824				BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Haws RA, 2010, SOC SCI MED, V71, P1764, DOI 10.1016/j.socscimed.2010.03.051; Kumar V, 2010, SEMIN PERINATOL, V34, P446, DOI 10.1053/j.semperi.2010.09.006; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lee ACC, 2008, PEDIATRICS, V121, pE1381, DOI 10.1542/peds.2007-1966; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Rubens CE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S7; Yakoob MY, 2010, SEMIN PERINATOL, V34, P387, DOI 10.1053/j.semperi.2010.09.010	14	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 7	2011	377	9777					1550	1551		10.1016/S0140-6736(11)60099-8	http://dx.doi.org/10.1016/S0140-6736(11)60099-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	763IJ	21496909				2022-12-24	WOS:000290549700007
J	Turner, MR; Camacho, X; Fischer, HD; Austin, PC; Anderson, GM; Rochon, PA; Lipscombe, LL				Turner, Marci R.; Camacho, Ximena; Fischer, Hadas D.; Austin, Peter C.; Anderson, Geoff M.; Rochon, Paula A.; Lipscombe, Lorraine L.			Levothyroxine dose and risk of fractures in older adults: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							THYROID-STIMULATING HORMONE; BONE-MINERAL DENSITY; SEROTONIN-REUPTAKE INHIBITORS; SUBCLINICAL HYPERTHYROIDISM; HIP-FRACTURES; ADMINISTRATIVE DATA; HYPOTHYROID PATIENTS; SUBSEQUENT FRACTURE; ATRIAL-FIBRILLATION; LONG-TERM	Objective To quantify the effect of levothyroxine dose on risk of fractures in older adults. Design Nested case-control study. Setting Population based health databases, Ontario, Canada. Participants Adults aged 70 or more prescribed levothyroxine between 1 April 2002 and 31 March 2007 and followed for fractures until 31 March 2008. Cases were cohort members admitted to hospital for any fracture, matched with up to five controls from within the cohort who had not yet had a fracture. Main outcome measure Primary outcome was fracture (wrist or forearm, shoulder or upper arm, thoracic spine, lumbar spine and pelvis, hip or femur, or lower leg or ankle) in relation to levothyroxine use (current, recent past, remote). Risk among current users was compared between those prescribed high, medium, and low cumulative levothyroxine doses in the year before fracture. Results Of 213 511 prevalent levothyroxine users identified, 22 236 (10.4%) experienced a fracture over a mean 3.8 years of follow-up, 18 108 (88%) of whom were women. Compared with remote levothyroxine use, current use was associated with a significantly higher risk of fracture (adjusted odds ratio 1.88, 95% confidence interval 1.71 to 2.05), despite adjustment for numerous risk factors. Among current users, high and medium cumulative doses (>0.093 mg/day and 0.044-0.093 mg/day) were associated with a significantly increased risk of fracture compared with low cumulative doses (<0.044 mg/day): 3.45 (3.27 to 3.65) and 2.62 (2.50 to 2.76), respectively. Conclusion Among adults aged 70 or more, current levothyroxine treatment was associated with a significantly increased risk of fracture, with a strong dose-response relation. Ongoing monitoring of levothyroxine dose is important to avoid overtreatment in this population.	[Rochon, Paula A.; Lipscombe, Lorraine L.] Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada; [Turner, Marci R.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Camacho, Ximena; Fischer, Hadas D.; Austin, Peter C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Anderson, Geoff M.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Toronto	Lipscombe, LL (corresponding author), Womens Coll Res Inst, 790 Bay St, Toronto, ON M5G 1N8, Canada.	lorraine.lipscombe@wchospital.ca	Rochon, Paula A/J-2918-2016	Rochon, Paula A/0000-0002-5973-4151	Canadian Institutes of Health Research (CIHR) [OTG-88591, HOA-80075]; Canadian Diabetes Association/CIHR; Heart and Stroke Foundation of Ontario; University of Toronto	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association/CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); University of Toronto(University of Toronto)	This work was supported by a team grant (OTG-88591) from the Canadian Institutes of Health Research (CIHR) and by a CIHR interdisciplinary capacity enhancement grant (HOA-80075). LLL is supported by a Canadian Diabetes Association/CIHR clinician scientist award. PCA is supported by a career investigator award from the Heart and Stroke Foundation of Ontario. GMA is supported by the University of Toronto chair in health management strategies.	Acotto CG, 1998, OSTEOPOROSIS INT, V8, P455, DOI 10.1007/s001980050091; Alibhai SMH, 2010, J UROLOGY, V184, P918, DOI 10.1016/j.juro.2010.04.068; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Auer J, 2001, AM HEART J, V142, P838, DOI 10.1067/mhj.2001.119370; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Bauer DC, 2001, ANN INTERN MED, V134, P561, DOI 10.7326/0003-4819-134-7-200104030-00009; Brennan MD, 2006, THYROID, V16, P375, DOI 10.1089/thy.2006.16.375; Canadian Institute of Health Information, 2010, DRUG US SEN PUBL DRU; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Dennis MS, 2002, STROKE, V33, P728, DOI 10.1161/hs0302.103621; DEWHALLEY P, 1995, BRIT J GEN PRACT, V45, P93; DUNCAN WE, 1994, THYROID, V4, P183, DOI 10.1089/thy.1994.4.183; ERIKSEN EF, 1985, BONE, V6, P421, DOI 10.1016/8756-3282(85)90218-2; ERNSTER VL, 1994, PREV MED, V23, P587, DOI 10.1006/pmed.1994.1093; Essebag V, 2003, AM HEART J, V146, P581, DOI 10.1016/S0002-8703(03)00512-X; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Flynn RW, 2010, J CLIN ENDOCR METAB, V95, P186, DOI 10.1210/jc.2009-1625; GRANT DJ, 1993, CLIN ENDOCRINOL, V39, P529, DOI 10.1111/j.1365-2265.1993.tb02404.x; Guidelines and Protocols Advisory Committee, 2010, THYR FUNCT TESTS DIA; Hadji P, 2000, EUR J ENDOCRINOL, V142, P445, DOI 10.1530/eje.0.1420445; HALL R, 1979, CLIN ENDOCRINOL META, V8, P29, DOI 10.1016/S0300-595X(79)80007-9; Hall S, 2006, J CLIN EPIDEMIOL, V59, P67, DOI 10.1016/j.jclinepi.2005.05.001; Hawker GA, 1997, J CLIN EPIDEMIOL, V50, P265, DOI 10.1016/S0895-4356(96)00368-X; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hoogendoorn EH, 2004, POSTGRAD MED J, V80, P394, DOI 10.1136/pgmj.2003.017095; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; KOPEC JA, 1990, J EPIDEMIOL COMMUN H, V44, P179, DOI 10.1136/jech.44.3.179; Lee JS, 2010, ARCH INTERN MED, V170, P1876, DOI 10.1001/archinternmed.2010.424; Leslie WD, 2007, BONE, V40, P991, DOI 10.1016/j.bone.2006.11.008; Leslie WD, 2009, JAMA-J AM MED ASSOC, V302, P883, DOI 10.1001/jama.2009.1231; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Liu B, 1998, LANCET, V351, P1303, DOI 10.1016/S0140-6736(97)09528-7; Mamdani M, 2007, OSTEOPOROSIS INT, V18, P1595, DOI 10.1007/s00198-007-0446-5; MANDEL SJ, 1993, ANN INTERN MED, V119, P492, DOI 10.7326/0003-4819-119-6-199309150-00009; Mazziotti G, 2010, BONE, V46, P747, DOI 10.1016/j.bone.2009.10.031; Meier C, 2004, OSTEOPOROSIS INT, V15, P209, DOI 10.1007/s00198-003-1527-8; MOORADIAN AD, 1995, CLIN GERIATR MED, V11, P159, DOI 10.1016/S0749-0690(18)30288-X; OKOSIEME OE, 2010, QJM; Pouwels S, 2009, STROKE, V40, P3281, DOI 10.1161/STROKEAHA.109.554055; Rejnmark L, 2007, OSTEOPOROSIS INT, V18, P409, DOI 10.1007/s00198-006-0250-7; RICHARDS J, 2001, P STAT CAN S STAT CA; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; RIGGS BL, 1982, J CLIN INVEST, V70, P716, DOI 10.1172/JCI110667; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; ROBBINS J, 1981, ENVIRON HEALTH PERSP, V38, P65, DOI 10.2307/3429363; Roberts CGP, 2004, LANCET, V363, P793, DOI 10.1016/S0140-6736(04)15696-1; ROSS DS, 1989, J CLIN ENDOCR METAB, V69, P684, DOI 10.1210/jcem-69-3-684; SAWIN CT, 1989, JAMA-J AM MED ASSOC, V261, P2653, DOI 10.1001/jama.261.18.2653; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; SAWIN CT, 1983, AM J MED, V75, P206, DOI 10.1016/0002-9343(83)91192-0; SCHNEIDER DL, 1994, JAMA-J AM MED ASSOC, V271, P1245, DOI 10.1001/jama.271.16.1245; Sheppard MC, 2002, ARCH INTERN MED, V162, P338, DOI 10.1001/archinte.162.3.338; Somwaru LL, 2009, J CLIN ENDOCR METAB, V94, P1342, DOI 10.1210/jc.2008-1696; STALL GM, 1990, ANN INTERN MED, V113, P265, DOI 10.7326/0003-4819-113-4-265; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Surks MI, 2010, J CLIN ENDOCR METAB, V95, P496, DOI 10.1210/jc.2009-1845; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Trimpou P, 2010, OSTEOPOROSIS INT, V21, P409, DOI 10.1007/s00198-009-0961-7; *US THYR FUNCT TES, 2006, UK GUID US THYR FUNC; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P139, DOI 10.1007/s00223-005-0068-x; Vestergaard P, 2000, THYROID, V10, P335, DOI 10.1089/thy.2000.10.335; WEJDA B, 1995, J INTERN MED, V237, P241, DOI 10.1111/j.1365-2796.1995.tb01172.x; Weller I, 2004, ANN EPIDEMIOL, V14, P319, DOI 10.1016/j.annepidem.2003.08.005	70	77	79	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2011	342								d2238	10.1136/bmj.d2238	http://dx.doi.org/10.1136/bmj.d2238			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759BV	21527461	Green Published, hybrid			2022-12-24	WOS:000290215900002
J	Hochberg, T				Hochberg, Todd			Moments held-photographing perinatal loss	LANCET			English	Editorial Material												todd@toddhochberg.com							0	4	5	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1310	1311		10.1016/S0140-6736(11)60528-X	http://dx.doi.org/10.1016/S0140-6736(11)60528-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21504088				2022-12-24	WOS:000289962900017
J	Tsutakawa, SE; Classen, S; Chapados, BR; Arvai, AS; Finger, LD; Guenther, G; Tomlinson, CG; Thompson, P; Sarker, AH; Shen, BH; Cooper, PK; Grasby, JA; Tainer, JA				Tsutakawa, Susan E.; Classen, Scott; Chapados, Brian R.; Arvai, Andrew S.; Finger, L. David; Guenther, Grant; Tomlinson, Christopher G.; Thompson, Peter; Sarker, Altaf H.; Shen, Binghui; Cooper, Priscilla K.; Grasby, Jane A.; Tainer, John A.			Human Flap Endonuclease Structures, DNA Double-Base Flipping, and a Unified Understanding of the FEN1 Superfamily	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; POLYMERASE-BETA; 3'-FLAP POCKET; BINDING; REPLICATION; EXONUCLEASE; CATALYSIS; PCNA	Flap endonuclease (FEN1), essential for DNA replication and repair, removes RNA and DNA 5' flaps. FEN1 5' nuclease superfamily members acting in nucleotide excision repair (XPG), mismatch repair (EXO1), and homologous recombination (GEN1) paradoxically incise structurally distinct bubbles, ends, or Holliday junctions, respectively. Here, structural and functional analyses of human FEN1: DNA complexes show structure-specific, sequence-independent recognition for nicked dsDNA bent 100 degrees with unpaired 3' and 5' flaps. Above the active site, a helical cap over a gateway formed by two helices enforces ssDNA threading and specificity for free 5' ends. Crystallographic analyses of product and substrate complexes reveal that dsDNA binding and bending, the ssDNA gateway, and double-base unpairing flanking the scissile phosphate control precise flap incision by the two-metal-ion active site. Superfamily conserved motifs bind and open dsDNA; direct the target region into the helical gateway, permitting only nonbase-paired oligonucleotides active site access; and support a unified understanding of superfamily substrate specificity.	[Tomlinson, Christopher G.; Thompson, Peter; Grasby, Jane A.] Univ Sheffield, Dept Chem, Ctr Chem Biol, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England; [Tsutakawa, Susan E.; Finger, L. David; Sarker, Altaf H.; Cooper, Priscilla K.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Classen, Scott] Scripps Res Inst, Phys Biosci Div, La Jolla, CA 92037 USA; [Chapados, Brian R.; Arvai, Andrew S.; Guenther, Grant; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Chapados, Brian R.; Arvai, Andrew S.; Guenther, Grant; Tainer, John A.] Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Finger, L. David; Shen, Binghui] City Hope Natl Med Ctr, Div Radiat Biol, Duarte, CA 91010 USA; [Finger, L. David; Shen, Binghui] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Shen, Binghui] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	University of Sheffield; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; City of Hope; City of Hope; Beckman Research Institute of City of Hope; Zhejiang University	Grasby, JA (corresponding author), Univ Sheffield, Dept Chem, Ctr Chem Biol, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England.	j.a.grasby@sheffield.ac.uk; jat@scripps.edu	Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429; Shen, Binghui/0000-0002-4408-407X; Finger, L. David/0000-0002-2342-9569; Thompson, Peter/0000-0002-4688-3414; Tsutakawa, Susan/0000-0002-4918-4571	NIH/NCI [RO1CA081967, R01CA073764, P01 CA092584]; BBSRC [BBF0147321]; ALS [DE-AC02-05CH11231]; DOE; DOE, OBER; NIH; NCRR; Biomedical Technology Program; NIGMS; NATIONAL CANCER INSTITUTE [R01CA073764, R01CA081967, P01CA092584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F014732/1, B19316] Funding Source: researchfish; BBSRC [BB/F014732/1] Funding Source: UKRI	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ALS; DOE(United States Department of Energy (DOE)); DOE, OBER(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work on FEN1 is supported by the NIH/NCI through RO1CA081967, R01CA073764, and P01 CA092584 (SBDR) and by BBSRC (BBF0147321). Crystal data was collected at the SIBYLS beamline 12.3.1 (ALS, Contract DE-AC02-05CH11231) and beamline 11-1 (SSRL, supported by DOE, OBER, NIH, NCRR, Biomedical Technology Program, and the NIGMS). Morphing movies were produced with CHIMERA (NIH P41 RR-01081). We thank Hong Xu and Chiharu Hitomi for technical assistance and Gareth Williams, James Holton, Mike Pique, Elizabeth Getzoff, David Moiani, Cliff Ng, and Peter Burgers for contributing to the analyses.	Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; FINGER LD, 2010, FEN1 FLAP STRUCTURE; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Friedrich-Heineken E, 2004, NUCLEIC ACIDS RES, V32, P2520, DOI 10.1093/nar/gkh576; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Hohl M, 2003, J BIOL CHEM, V278, P19500, DOI 10.1074/jbc.M213155200; Hohl M, 2007, NUCLEIC ACIDS RES, V35, P3053, DOI 10.1093/nar/gkm092; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Ivanov I, 2007, P NATL ACAD SCI USA, V104, P1465, DOI 10.1073/pnas.0603468104; Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008; Kim CY, 2001, BIOCHEMISTRY-US, V40, P3208, DOI 10.1021/bi002100n; Krahn JM, 2004, STRUCTURE, V12, P1823, DOI 10.1016/j.str.2004.08.001; Kuppuraj G, 2009, J PHYS CHEM B, V113, P2952, DOI 10.1021/jp807972e; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lyamichev V, 1999, P NATL ACAD SCI USA, V96, P6143, DOI 10.1073/pnas.96.11.6143; Matsuzaki Y, 2002, NUCLEIC ACIDS RES, V30, P3273, DOI 10.1093/nar/gkf440; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Navarro MS, 2007, GENETICS, V176, P1391, DOI 10.1534/genetics.107.073056; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Qiu JZ, 2002, J BIOL CHEM, V277, P24659, DOI 10.1074/jbc.M111941200; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; ROBERTS VA, 1991, J BIOL CHEM, V266, P13431; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Schroeder GK, 2006, P NATL ACAD SCI USA, V103, P4052, DOI 10.1073/pnas.0510879103; Sengerova B, 2010, BIOCHEMISTRY-US, V49, P8085, DOI 10.1021/bi100895j; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Singh P, 2007, J BIOL CHEM, V282, P3465, DOI 10.1074/jbc.M606582200; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Tumey LN, 2005, BIOORG MED CHEM LETT, V15, P277, DOI 10.1016/j.bmcl.2004.10.086; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xu Y, 2001, J BIOL CHEM, V276, P30167, DOI 10.1074/jbc.M100985200; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	50	195	201	9	144	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					198	211		10.1016/j.cell.2011.03.004	http://dx.doi.org/10.1016/j.cell.2011.03.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496641	Green Accepted, Bronze			2022-12-24	WOS:000289549900010
J	Cooper, MA; Shlaes, D				Cooper, Matthew A.; Shlaes, David			Fix the antibiotics pipeline	NATURE			English	Editorial Material									[Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Queensland	Cooper, MA (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	m.cooper@imb.uq.edu.au; shlaes.david@earthlink.net	Cooper, Matthew A./C-7988-2009	Cooper, Matthew A./0000-0003-3147-3460				[Anonymous], REPORT EUROPEAN COMM; Morel Chantal M, 2010, BMJ, V340, pc2115, DOI 10.1136/bmj.c2115; Mossialos E, 2009, POLICIES INCENTIVES	3	345	353	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					32	32		10.1038/472032a	http://dx.doi.org/10.1038/472032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745VV	21475175	Bronze			2022-12-24	WOS:000289199400018
J	Mozaffarian, D; Shi, PL; Morris, JS; Spiegelman, D; Grandjean, P; Siscovick, DS; Willett, WC; Rimm, EB				Mozaffarian, Dariush; Shi, Peilin; Morris, J. Steven; Spiegelman, Donna; Grandjean, Philippe; Siscovick, David S.; Willett, Walter C.; Rimm, Eric B.			Mercury Exposure and Risk of Cardiovascular Disease in Two U.S. Cohorts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; FOOD FREQUENCY QUESTIONNAIRE; POLYUNSATURATED FATTY-ACIDS; MYOCARDIAL-INFARCTION; FISH INTAKE; SELENIUM INTAKE; SERUM SELENIUM; DIETARY-INTAKE; WHOLE-BLOOD; WOMEN	BACKGROUND Exposure to methylmercury from fish consumption has been linked to a potentially increased risk of cardiovascular disease, but evidence from prior studies is equivocal. Beneficial effects of the ingestion of fish and selenium may also modify such effects. METHODS Among subjects from two U. S. cohorts (a total of 51,529 men and 121,700 women) whose toenail clippings had been stored, we prospectively identified incident cases of cardiovascular disease (coronary heart disease and stroke) in 3427 participants and matched them to risk-set-sampled controls according to age, sex, race, and smoking status. Toenail mercury and selenium concentrations were assessed with the use of neutron-activation analysis. Other demographic characteristics, cardiovascular risk factors, fish consumption, and lifestyle habits were assessed by means of validated questionnaires. Associations between mercury exposure and incident cardiovascular disease were evaluated with the use of conditional logistic regression. RESULTS Median toenail mercury concentrations were 0.23 mu g per gram (interdecile range, 0.06 to 0.94) in the case participants and 0.25 mu g per gram (interdecile range, 0.07 to 0.97) in the controls. In multivariate analyses, participants with higher mercury exposures did not have a higher risk of cardiovascular disease. For comparisons of the fifth quintile of mercury exposure with the first quintile, the relative risks were as follows: coronary heart disease, 0.85 (95% confidence interval [CI], 0.69 to 1.04; P = 0.10 for trend); stroke, 0.84 (95% CI, 0.62 to 1.14; P = 0.27 for trend); and total cardiovascular disease, 0.85 (95% CI, 0.72 to 1.01; P = 0.06 for trend). Findings were similar in analyses of participants with low selenium concentrations or low overall fish consumption and in several additional sensitivity analyses. CONCLUSIONS We found no evidence of any clinically relevant adverse effects of mercury exposure on coronary heart disease, stroke, or total cardiovascular disease in U. S. adults at the exposure levels seen in this study.	[Mozaffarian, Dariush] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Mozaffarian, Dariush; Willett, Walter C.; Rimm, Eric B.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Mozaffarian, Dariush; Shi, Peilin; Spiegelman, Donna; Willett, Walter C.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mozaffarian, Dariush; Willett, Walter C.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Grandjean, Philippe] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Morris, J. Steven] Univ Missouri, Columbia, MO 65211 USA; [Siscovick, David S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Siscovick, David S.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Missouri System; University of Missouri Columbia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mozaffarian, D (corresponding author), 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008; Grandjean, Philippe/I-2962-2014	Grandjean, Philippe/0000-0003-4046-9658	National Institute of Environmental Health Sciences [R01-ES014433, ES013692]; National Heart, Lung, and Blood Institute [HL34594, HL088521, HL35464]; National Cancer Institute [CA87969, CA55075]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA087969, P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL035464, R01HL088521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014433, R01ES013692] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by grants from the National Institute of Environmental Health Sciences (R01-ES014433 and ES013692), the National Heart, Lung, and Blood Institute (HL34594, HL088521, and HL35464), and the National Cancer Institute (CA87969 and CA55075).; Funded by the National Institutes of Health.	Ahlqwist M, 1999, ACTA ODONTOL SCAND, V57, P168; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; [Anonymous], 1997, MERC STUD REP C; [Anonymous], 2010, JOINT FAO WHO EXP CO; [Anonymous], 2004, WHAT YOU NEED KNOW M; Bleys J, 2009, AM J EPIDEMIOL, V169, P996, DOI 10.1093/aje/kwn414; Chan HM, 2004, NUTR REV, V62, P68, DOI 10.1301/nr.2004.janr.68-72; Choi AL, 2009, ENVIRON HEALTH PERSP, V117, P367, DOI 10.1289/ehp.11608; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fillion Myriam, 2006, Environ Health, V5, P29, DOI 10.1186/1476-069X-5-29; GARLAND M, 1993, CANCER EPIDEM BIOMAR, V2, P493; Groth E, 2010, ENVIRON RES, V110, P226, DOI 10.1016/j.envres.2009.12.006; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Hallgren CG, 2001, BRIT J NUTR, V86, P397, DOI 10.1079/BJN2001415; HARRIS M, 1979, DIABETES, V28, P1039; Hu FB, 2000, JAMA-J AM MED ASSOC, V283, P2961, DOI 10.1001/jama.283.22.2961; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; Joshi A, 2003, J PUBLIC HEALTH DENT, V63, P52, DOI 10.1111/j.1752-7325.2003.tb03474.x; Konig A, 2005, AM J PREV MED, V29, P335, DOI 10.1016/j.amepre.2005.07.001; Lim S, 2010, NEUROTOXICOLOGY, V31, P10, DOI 10.1016/j.neuro.2009.10.001; Longnecker MP, 1996, EPIDEMIOLOGY, V7, P384, DOI 10.1097/00001648-199607000-00008; LONGNECKER MP, 1993, AM J CLIN NUTR, V57, P408, DOI 10.1093/ajcn/57.3.408; MacIntosh DL, 1997, CANCER EPIDEM BIOMAR, V6, P1043; Mason MM, 1998, J RADIOANAL NUCL CH, V236, P29, DOI 10.1007/BF02386313; McDowell MA, 2004, ENVIRON HEALTH PERSP, V112, P1165, DOI 10.1289/ehp.7046; Morton J, 2004, BIOMARKERS, V9, P47, DOI 10.1080/13547500410001670312; Mozaffarian D, 2005, CIRCULATION, V111, P157, DOI 10.1161/01.CIR.0000152099.87287.83; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mozaffarian D, 2009, INT J ENV RES PUB HE, V6, P1894, DOI 10.3390/ijerph6061894; Ohno T, 2007, ENVIRON RES, V103, P191, DOI 10.1016/j.envres.2006.06.009; Rice DC, 2004, ENVIRON RES, V95, P406, DOI 10.1016/j.envres.2003.08.013; Rose GA, 1982, WHO MONOGRAPH SERIES, V56; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Suzuki T, 1989, Sangyo Igaku, V31, P235; VARO P, 1988, AM J CLIN NUTR, V48, P324, DOI 10.1093/ajcn/48.2.324; Virtanen JK, 2005, ARTERIOSCL THROM VAS, V25, P228, DOI 10.1161/01.ATV.0000150040.20950.61; Walker A E, 1981, Stroke, V12, pI13; Wennberg M, 2007, BRIT J NUTR, V98, P1038, DOI 10.1017/S0007114507756519; Yaginuma-Sakurai K, 2010, NEUROTOXICOL TERATOL, V32, P240, DOI 10.1016/j.ntt.2009.08.009; Yorifuji T, 2010, ENVIRON RES, V110, P40, DOI 10.1016/j.envres.2009.10.011; Yoshizawa K, 2002, NEW ENGL J MED, V347, P1755, DOI 10.1056/NEJMoa021437	43	130	132	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1116	1125		10.1056/NEJMoa1006876	http://dx.doi.org/10.1056/NEJMoa1006876			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428767	Green Accepted, Green Published			2022-12-24	WOS:000288701100006
J	Shema, R; Haramati, S; Ron, S; Hazvi, S; Chen, A; Sacktor, TC; Dudai, Y				Shema, Reut; Haramati, Sharon; Ron, Shiri; Hazvi, Shoshi; Chen, Alon; Sacktor, Todd Charlton; Dudai, Yadin			Enhancement of Consolidated Long-Term Memory by Overexpression of Protein Kinase M zeta in the Neocortex	SCIENCE			English	Article							PKM-ZETA; FACILITATION; MAINTENANCE; POTENTIATION; STORAGE; CORTEX; LTP	Memories are more easily disrupted than improved. Many agents can impair memories during encoding and consolidation. In contrast, the armamentarium of potential memory enhancers is so far rather modest. Moreover, the effect of the latter appears to be limited to enhancing new memories during encoding and the initial period of cellular consolidation, which can last from a few minutes to hours after learning. Here, we report that overexpression in the rat neocortex of the protein kinase C isozyme protein kinase M zeta (PKM zeta) enhances long-term memory, whereas a dominant negative PKM zeta disrupts memory, even long after memory has been formed.	[Shema, Reut; Haramati, Sharon; Ron, Shiri; Hazvi, Shoshi; Chen, Alon; Dudai, Yadin] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Physiol, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Pharmacol, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Neurol, Brooklyn, NY 11203 USA	Weizmann Institute of Science; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Dudai, Y (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	yadin.dudai@weizmann.ac.il		Haramati, Sharon/0000-0002-7496-5214; Chen, Alon/0000-0003-3625-8233	Israel-U.S. Binational Science Foundation; Nella and Leon Benoziyo Center for Neurologica Diseases; NIH [R01 MH53576, MH57068]; Israeli Academy of Sciences and Humanities; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057068, R01MH057068, R01MH053576] Funding Source: NIH RePORTER	Israel-U.S. Binational Science Foundation(US-Israel Binational Science Foundation); Nella and Leon Benoziyo Center for Neurologica Diseases; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli Academy of Sciences and Humanities; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The support of the Israel-U.S. Binational Science Foundation (Y.D and T.C.S), the Nella and Leon Benoziyo Center for Neurologica Diseases (Y.D.), and of NIH R01 MH53576 and MH57068 (T.C.S.) is gratefully acknowledged. R.S. is supported by the Adams Fellowship program of the Israeli Academy of Sciences and Humanities. We thank R. Eilam for providing invaluable assistance in histochemistry.	[Anonymous], 1983, CANADIAN PSYCHOL; Aydin A, 1997, ANIM LEARN BEHAV, V25, P108, DOI 10.3758/BF03199029; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Berman DE, 2003, LEARN MEMORY, V10, P16, DOI 10.1101/lm.53703; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y., 2002, MEMORY KEYWORDS CONC; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GIURGEA C, 1973, Conditional Reflex, V8, P108; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shema R, 2009, LEARN MEMORY, V16, P122, DOI 10.1101/lm.1183309; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; STERNBERG DB, 1985, BEHAV NEURAL BIOL, V44, P447, DOI 10.1016/S0163-1047(85)90856-8; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935	24	139	151	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1207	1210		10.1126/science.1200215	http://dx.doi.org/10.1126/science.1200215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385716				2022-12-24	WOS:000287971200046
J	Inuzuka, H; Shaik, S; Onoyama, I; Gao, DM; Tseng, A; Maser, RS; Zhai, B; Wan, LX; Gutierrez, A; Lau, AW; Xiao, YH; Christie, AL; Aster, J; Settleman, J; Gygi, SP; Kung, AL; Look, T; Nakayama, KI; DePinho, RA; Wei, WY				Inuzuka, Hiroyuki; Shaik, Shavali; Onoyama, Ichiro; Gao, Daming; Tseng, Alan; Maser, Richard S.; Zhai, Bo; Wan, Lixin; Gutierrez, Alejandro; Lau, Alan W.; Xiao, Yonghong; Christie, Amanda L.; Aster, Jon; Settleman, Jeffrey; Gygi, Steven P.; Kung, Andrew L.; Look, Thomas; Nakayama, Keiichi I.; DePinho, Ronald A.; Wei, Wenyi			SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction	NATURE			English	Article							FBW7 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; PHOSPHORYLATION; DEGRADATION; DIFFERENTIATION; COMPLEX; CANCERS; PROTEIN	The effective use of targeted therapy is highly dependent on the identification of responder patient populations. Loss of FBW7, which encodes a tumour-suppressor protein, is frequently found in various types of human cancer, including breast cancer, colon cancer(1) and T-cell acute lymphoblastic leukaemia (T-ALL)(2). In line with these genomic data, engineered deletion of Fbw7 in mouse T cells results in T-ALL(3-5), validating FBW7 as a T-ALL tumour suppressor. Determining the precise molecular mechanisms by which FBW7 exerts antitumour activity is an area of intensive investigation. These mechanisms are thought to relate in part to FBW7-mediated destruction of key proteins relevant to cancer, including Jun(6), Myc(7), cyclin E-8 and notch 1 (ref. 9), all of which have oncoprotein activity and are overexpressed in various human cancers, including leukaemia. In addition to accelerating cell growth(10), overexpression of Jun, Myc or notch 1 can also induce programmed cell death(11). Thus, considerable uncertainty surrounds how FBW7-deficient cells evade cell death in the setting of upregulated Jun, Myc and/or notch 1. Here we show that the E3 ubiquitin ligase SCFFBW7 (a SKP1-cullin-1-F-box complex that contains FBW7 as the F-box protein) governs cellular apoptosis by targeting MCL1, a pro-survival BCL2 family member, for ubiquitylation and destruction in a manner that depends on phosphorylation by glycogen synthase kinase 3. Human T-ALL cell lines showed a close relationship between FBW7 loss and MCL1 overexpression. Correspondingly, T-ALL cell lines with defective FBW7 are particularly sensitive to the multi-kinase inhibitor sorafenib but resistant to the BCL2 antagonist ABT-737. On the genetic level, FBW7 reconstitution or MCL1 depletion restores sensitivity to ABT-737, establishing MCL1 as a therapeutically relevant bypass survival mechanism that enables FBW7-deficient cells to evade apoptosis. Therefore, our work provides insight into the molecular mechanism of direct tumour suppression by FBW7 and has implications for the targeted treatment of patients with FBW7-deficient T-ALL.	[Inuzuka, Hiroyuki; Shaik, Shavali; Gao, Daming; Tseng, Alan; Wan, Lixin; Lau, Alan W.; Wei, Wenyi] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Onoyama, Ichiro; Nakayama, Keiichi I.] Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Maser, Richard S.; Xiao, Yonghong; DePinho, Ronald A.] Harvard Univ, Belfer Inst Appl Canc Sci, Dana Farber Canc Inst, Dept Med Oncol,Sch Med, Boston, MA 02115 USA; [Maser, Richard S.] Jackson Lab, Bar Harbor, ME 04609 USA; [Zhai, Bo; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Gutierrez, Alejandro; Christie, Amanda L.; Kung, Andrew L.; Look, Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Christie, Amanda L.; Kung, Andrew L.] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Aster, Jon] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Settleman, Jeffrey] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc,Dept Med, Boston, MA 02129 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Jackson Laboratory; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wei, WY (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	wwei2@bidmc.harvard.edu	Wan, Lixin/F-2124-2011; Maser, Richard/B-2970-2012; Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; Gao, Daming/0000-0003-4374-1055; Gutierrez, Alejandro/0000-0002-0249-9007; DePinho, Ronald/0000-0002-5625-577X	Emerald Foundation; Leukemia and Lymphoma Society; National Institutes of Health [GM089763]; Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089763] Funding Source: NIH RePORTER	Emerald Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lawler, C. Schorl, Q. Zhang and S. Glueck for critical reading of the manuscript, J. DeCaprio, M.-C. Hung, M. A. Kelliher, W. Harper and W. Hahn for providing reagents, L. Cantley and A. Toker for suggestions, I. Wertz and V. Dixit for sharing unpublished data, and members of the Wei and DePinho labs for useful discussions. W.W. is a Kimmel Scholar and V Scholar. This work was supported in part by the Emerald Foundation New Investigator award (W.W.), the Leukemia and Lymphoma Society Special Fellow award (W.W.) and a grant from the National Institutes of Health (W.W.; GM089763). R.A.D. is an American Cancer Society Research Professor and is supported by the Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science.	Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Konopleva M, 2008, CANCER RES, V68, P3413, DOI 10.1158/0008-5472.CAN-07-1919; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Panka DJ, 2008, J BIOL CHEM, V283, P726, DOI 10.1074/jbc.M705343200; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Sanchez I, 2001, NEURON, V29, P563, DOI 10.1016/S0896-6273(01)00232-X; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	29	485	503	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					104	U128		10.1038/nature09732	http://dx.doi.org/10.1038/nature09732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368833	Green Accepted			2022-12-24	WOS:000287924100043
J	Morikawa, T; Kuchiba, A; Yamauchi, M; Meyerhardt, JA; Shima, K; Nosho, K; Chan, AT; Giovannucci, E; Fuchs, CS; Ogino, S				Morikawa, Teppei; Kuchiba, Aya; Yamauchi, Mai; Meyerhardt, Jeffrey A.; Shima, Kaori; Nosho, Katsuhiko; Chan, Andrew T.; Giovannucci, Edward; Fuchs, Charles S.; Ogino, Shuji			Association of CTNNB1 (beta-Catenin) Alterations, Body Mass Index, and Physical Activity With Survival in Patients With Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISLAND METHYLATOR PHENOTYPE; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; COLON-CANCER; MICROSATELLITE INSTABILITY; E-CADHERIN; PROGNOSTIC-SIGNIFICANCE; ACTIVITY QUESTIONNAIRE; NUCLEAR ACCUMULATION; PIK3CA MUTATION; RECTAL-CANCER	Context Alterations of the WNT signaling pathway and cadherin-associated protein beta 1 (CTNNB1 or beta-catenin) have been implicated in colorectal carcinogenesis and metabolic diseases. Objective To test the hypothesis that CTNNB1 activation in colorectal cancer modifies prognostic associations of body mass index (BMI) and level of postdiagnosis physical activity. Design, Setting, and Patients Two US prospective cohort studies (Nurses' Health Study and the Health Professionals Follow-up Study) were used to evaluate CTNNB1 localization by immunohistochemistry in 955 patients with stage I, II, III, or IV colon and rectal cancer from 1980 through 2004. A Cox proportional hazards model was used to compute the hazard ratio (HR) for mortality, adjusting for clinical and tumor features, including microsatellite instability, CpG island methylator phenotype, level of long interspersed nucleotide element 1 methylation, mutations in KRAS, BRAF, or PIK3CA, and tumor protein p53. Main Outcome Measures Colorectal cancer-specific mortality and overall mortality through June 30, 2009. Results In obese patients (BMI >= 30), positive status for nuclear CTNNB1 was associated with significantly better colorectal cancer-specific survival (adjusted HR, 0.24 [95% confidence interval {CI}, 0.12-0.49], P<.001 for interaction; 5-year survival: 0.85 for patients with positive nuclear CTNNB1 status vs 0.78 for those with negative status) and overall survival (adjusted HR, 0.56 [95% CI, 0.35-0.90], P=.03 for interaction; 5-year survival: 0.77 for patients with positive nuclear CTNNB1 status vs 0.74 for those with negative status), while CTNNB1 status was not associated with prognosis among nonobese patients (BMI <30). Among patients with negative status for nuclear CTNNB1 and cancer in stages I, II, or III, postdiagnosis physical activity was associated with better colorectal cancer-specific survival (adjusted HR, 0.33 [95% CI, 0.13-0.81], P=.05 for interaction; 5-year survival: 0.97 for >= 18 vs 0.89 for <18 metabolic equivalent task hours/week), while postdiagnosis physical activity was not associated with colorectal cancer-specific survival among patients with positive status for nuclear CTNNB1 (adjusted HR, 1.07 [95% CI, 0.50-2.30]). Conclusions Among obese patients only, activation of CTNNB1 was associated with better colorectal cancer-specific survival and overall survival. Postdiagnosis physical activity was associated with better colorectal cancer-specific survival only among patients with negative status for nuclear CTNNB1. These molecular pathological epidemiology findings suggest that the effects of alterations in the WNT-CTNNB1 pathway on outcome are modified by BMI and physical activity. JAMA. 2011;305(16):1685-1694 www.jama.com	[Ogino, Shuji] Harvard Univ, Sch Med, Brigham & Womens Hosp,Dept Med Oncol, Dana Farber Canc Inst,Ctr Mol Oncol Pathol, Boston, MA 02215 USA; [Chan, Andrew T.; Giovannucci, Edward; Fuchs, Charles S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02215 USA; [Ogino, Shuji] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02215 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Ogino, S (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp,Dept Med Oncol, Dana Farber Canc Inst,Ctr Mol Oncol Pathol, 450 Brookline Ave,Room JF-215C, Boston, MA 02215 USA.	shuji_ogino@dfci.harvard.edu	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767; Ogino, Shuji/0000-0002-3909-2323	US National Institute of Health [P01CA87969, P01CA55075, P50CA127003, K07CA122826, R01CA151993, R01CA137178]; Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Japan Society for Promotion of Science; NATIONAL CANCER INSTITUTE [R01CA151993, R01CA137178, K07CA122826, P50CA127003, R01CA050385, P01CA087969, P01CA055075] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institute of Health grants P01CA87969, P01CA55075, P50CA127003, K07CA122826, R01CA151993, and R01CA137178 and by grants from the Bennett Family Fund and the Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance. Dr Morikawa was supported by a fellowship grant from the Japan Society for Promotion of Science. Dr Chan is a Damon Runyon Clinical Investigator.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Arango NA, 2005, DEV BIOL, V288, P276, DOI 10.1016/j.ydbio.2005.09.045; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Cheah PY, 2002, CANCER-AM CANCER SOC, V95, P2479, DOI 10.1002/cncr.10986; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Chung GG, 2001, CLIN CANCER RES, V7, P4013; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Doria-Rose VP, 2006, CANCER CAUSE CONTROL, V17, P63, DOI 10.1007/s10552-005-0360-0; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Elzagheid A, 2008, WORLD J GASTROENTERO, V14, P3866, DOI 10.3748/wjg.14.3866; Fang QX, 2010, J SURG ONCOL, V102, P433, DOI 10.1002/jso.21537; Filiz AI, 2010, COLORECTAL DIS, V12, P1223, DOI 10.1111/j.1463-1318.2009.01994.x; Gunther K, 1998, DIS COLON RECTUM, V41, P1256, DOI 10.1007/BF02258226; Han QF, 2006, CANCER LETT, V231, P129, DOI 10.1016/j.canlet.2005.01.026; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hugh TJ, 1999, BRIT J CANCER, V80, P1046, DOI 10.1038/sj.bjc.6690461; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Kawada M, 2006, CANCER RES, V66, P2913, DOI 10.1158/0008-5472.CAN-05-3460; Kawasaki T, 2007, NEOPLASIA, V9, P569, DOI 10.1593/neo.07334; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Lugli A, 2007, HISTOPATHOLOGY, V50, P453, DOI 10.1111/j.1365-2559.2007.02620.x; Martensson A, 2007, ONCOL REP, V17, P447; Maruyama K, 2000, ONCOLOGY-BASEL, V59, P302, DOI 10.1159/000012187; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Meyerhardt JA, 2009, ARCH INTERN MED, V169, P2102, DOI 10.1001/archinternmed.2009.412; Meyerhardt JA, 2009, CLIN CANCER RES, V15, P5931, DOI 10.1158/1078-0432.CCR-09-0496; Miyamoto S, 2004, ONCOL REP, V12, P245; Norwood MGA, 2010, HISTOPATHOLOGY, V57, P101, DOI 10.1111/j.1365-2559.2010.03587.x; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2006, NEOPLASIA, V8, P458, DOI 10.1593/neo.06247; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Ogino S, 2008, J CLIN ONCOL, V26, P5713, DOI [10.1200/JCO.2008.18.2675, 10.1200/JCO.2009.22.8858]; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Roca F, 2006, J SURG ONCOL, V93, P151, DOI 10.1002/jso.20413; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Sinicrope FA, 2010, CLIN CANCER RES, V16, P1884, DOI 10.1158/1078-0432.CCR-09-2636; Waldman SA, 2009, JAMA-J AM MED ASSOC, V301, P745, DOI 10.1001/jama.2009.141; Wanitsuwan W, 2008, WORLD J GASTROENTERO, V14, P6052, DOI 10.3748/wjg.14.6052; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wong SCC, 2004, CLIN CANCER RES, V10, P1401, DOI 10.1158/1078-0432.CCR-0157-03; Wong SCC, 2003, J CLIN PATHOL-MOL PA, V56, P347, DOI 10.1136/mp.56.6.347; Zhang W, 2008, ONCOL REP, V20, P1013, DOI 10.3892/or_00000103; Zhao JX, 2010, BIOCHEM BIOPH RES CO, V395, P146, DOI 10.1016/j.bbrc.2010.03.161	58	147	149	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1685	1694		10.1001/jama.2011.513	http://dx.doi.org/10.1001/jama.2011.513			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521850	Bronze, Green Accepted			2022-12-24	WOS:000289890500022
J	[Anonymous]				[Anonymous]			PERSONAL VIEW Private alcohol detox clinics should be regulated	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 20	2011	342								d2399	10.1136/bmj.d2399	http://dx.doi.org/10.1136/bmj.d2399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755ON	21508046				2022-12-24	WOS:000289942900007
J	Alavez, S; Vantipalli, MC; Zucker, DJS; Klang, IM; Lithgow, GJ				Alavez, Silvestre; Vantipalli, Maithili C.; Zucker, David J. S.; Klang, Ida M.; Lithgow, Gordon J.			Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan	NATURE			English	Article							CAENORHABDITIS-ELEGANS; DISEASE; STRESS; DAF-16; PROTEOSTASIS; INHIBITION; ALZHEIMER; LONGEVITY; SELECTION	Genetic studies indicate that protein homeostasis is a major contributor to metazoan longevity(1). Collapse of protein homeostasis results in protein misfolding cascades and the accumulation of insoluble protein fibrils and aggregates, such as amyloids(2). A group of small molecules, traditionally used in histopathology to stain amyloid in tissues, bind protein fibrils and slow aggregationin vitro and in cell culture(3,4). We proposed that treating animals with such compounds would promote protein homeostasis in vivo and increase longevity. Here we show that exposure of adult Caenorhabditis elegans to the amyloid-binding dye Thioflavin T (ThT) resulted in a profoundly extended lifespan and slowed ageing. ThT also suppressed pathological features of mutant metastable proteins and human beta-amyloid-associated toxicity. These beneficial effects of ThT depend on the protein homeostasis network regulator heat shock factor 1 (HSF-1), the stress resistance and longevity transcription factor SKN-1, molecular chaperones, autophagy and proteosomal functions. Our results demonstrate that pharmacological maintenance of the protein homeostatic network has a profound impact on ageing rates, prompting the development of novel therapeutic interventions against ageing and age-related diseases.	[Alavez, Silvestre; Vantipalli, Maithili C.; Zucker, David J. S.; Klang, Ida M.; Lithgow, Gordon J.] Buck Inst Res Aging, Novato, CA 94945 USA; [Zucker, David J. S.] Dominican Univ Calif, Dept Nat Sci & Math, San Rafael, CA 94901 USA; [Klang, Ida M.] Karolinska Inst, Ctr Biosci, Novum, Dept Biosci & Nutr, S-14183 Huddinge, Sweden	Buck Institute for Research on Aging; Karolinska Institutet	Lithgow, GJ (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	salavez@buckinstitute.org; glithgow@buckinstitute.org	Alavez, Silvestre/AAM-4894-2021	Alavez, Silvestre/0000-0002-9220-0696; Zucker, David/0000-0001-7476-8299	National Institutes of Health (NIH) National Center for Research Resources; Larry L. Hillblom Foundation; NIH [UL1024917, 1R01AG029631-01A1, AG21069, AG22868, AG029631-01A1, ES016655]; Larry L. Hillblom Foundation [UL1 RR024917]; Longevity Consortium [U19AGO231222]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RL1ES016655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022868, R01AG029631, R01AG021069] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Larry L. Hillblom Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; Longevity Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. A. Gerencser for expert assistance with the confocal microscopy; A. M. Cuervo, M. S. Gill, M. Lucanic, J. Campisi, S. Melov, V. Lunyak and P. Kapahi for suggestions on the manuscript, members of the G.J.L. and P. Kapahi laboratories for helpful discussion and members of the Paper Polishing Club. Nematode strains were provided by the Ceanorhabditis Genetics Center, funded by the National Institutes of Health (NIH) National Center for Research Resources. CF2189 was a gift from C. Kenyon's laboratory. This work was supported by grants from the Larry L. Hillblom Foundation and the NIH (UL1024917, supporting the Interdisciplinary Research Consortium on Geroscience and 1R01AG029631-01A1). G.J.L. is supported by the NIH AG21069, AG22868, AG029631-01A1, ES016655, the Larry L. Hillblom Foundation and UL1 RR024917. S.A. was supported by the U19AGO231222 from the Longevity Consortium.	ANDERSON P, 1984, P NATL ACAD SCI-BIOL, V81, P4470, DOI 10.1073/pnas.81.14.4470; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7; Frid P, 2007, BRAIN RES REV, V53, P135, DOI 10.1016/j.brainresrev.2006.08.001; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Li WS, 2007, DEV CELL, V12, P235, DOI 10.1016/j.devcel.2006.12.002; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Rodriguez-Rodriguez C, 2009, J AM CHEM SOC, V131, P1436, DOI 10.1021/ja806062g; Temussi PA, 2003, EMBO J, V22, P355, DOI 10.1093/emboj/cdg044; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; ZENGEL JM, 1980, CELL MOTIL CYTOSKEL, V1, P73, DOI 10.1002/cm.970010107	26	274	284	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					226	229		10.1038/nature09873	http://dx.doi.org/10.1038/nature09873			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21451522	Green Accepted			2022-12-24	WOS:000289469100044
J	Howard, GCW; Nairn, M				Howard, G. C. W.; Nairn, M.			GUIDELINES Management of adult testicular germ cell tumours: summary of updated SIGN guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; TESTIS		[Nairn, M.] Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland; [Howard, G. C. W.] Western Gen Hosp, Edinburgh Canc Ctr, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Nairn, M (corresponding author), Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland.	moray.nairn@nhs.net		Nairn, Moray/0000-0001-6474-4410				ALBERS P, 2009, GUIDELINES TESTICULA; CHILVERS CED, 1989, BRIT J CANCER, V59, P126, DOI 10.1038/bjc.1989.25; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; GIWERCMAN A, 1993, EUR UROL, V23, P104; Harland SJ, 1998, J UROLOGY, V160, P1353, DOI 10.1016/S0022-5347(01)62535-7; Howard GCW, 2005, CLIN ONCOL-UK, V17, P435, DOI 10.1016/j.clon.2005.03.011; HOWARD GCW, 1995, BRIT J CANCER, V72, P1307, DOI 10.1038/bjc.1995.506; *INF STAT DIV SCOT, MAL GEN ORG CANC; *INF STAT DIV SCOT, CANC MAL GEN ORG; *INF STAT DIV SCOT, CHILDH AD YOUNG AD C; Mead GM, 1997, J CLIN ONCOL, V15, P594; *SCOTT INT GUID NE, 2011, SIGN PUBL, V124	12	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2011	342								d2005	10.1136/bmj.d2005	http://dx.doi.org/10.1136/bmj.d2005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UZ	21493673				2022-12-24	WOS:000289721700004
J	Manson, JE; Mayne, ST; Clinton, SK				Manson, JoAnn E.; Mayne, Susan T.; Clinton, Steven K.			Vitamin D and Prevention of Cancer - Ready for Prime Time?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Manson, JoAnn E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Mayne, Susan T.] Yale Univ, Sch Publ Hlth, Dept Epidemiol & Publ Hlth, New Haven, CT USA; [Mayne, Susan T.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Clinton, Steven K.] Ohio State Univ, Div Med Oncol, Columbus, OH 43210 USA; [Manson, JoAnn E.; Mayne, Susan T.; Clinton, Steven K.] Comm Dietary Reference Intakes Vitamin D & Calciu, Inst Med, Washington, DC USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; Yale University; University System of Ohio; Ohio State University	Manson, JE (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.							Byers T, 2010, AM J EPIDEMIOL, V172, P1, DOI 10.1093/aje/kwq112; Chung M., 2009, AHRQ PUBLICATION; Helzlsouer KJ, 2010, AM J EPIDEMIOL, V172, P4, DOI 10.1093/aje/kwq119; Institute of Medicine, 2011, DIETARY REFERENCE IN; International Agency for Research on Cancer, 2008, VIT D CANC REP IARC	5	112	119	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1385	1387		10.1056/NEJMp1102022	http://dx.doi.org/10.1056/NEJMp1102022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21428761				2022-12-24	WOS:000289467200001
J	Loewenberg, S				Loewenberg, Samuel			Profile Mitch Besser-helping mothers with HIV become mentors	LANCET			English	Biographical-Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1145	1145		10.1016/S0140-6736(11)60452-2	http://dx.doi.org/10.1016/S0140-6736(11)60452-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750IH	21459200				2022-12-24	WOS:000289539300015
J	Lazzaro, BP; Rolff, J				Lazzaro, Brian P.; Rolff, Jens			Danger, Microbes, and Homeostasis	SCIENCE			English	Editorial Material							INNATE IMMUNE-SYSTEM; ANTIMICROBIAL PEPTIDE; BACTERIAL-INFECTION; HOST-DEFENSE; DROSOPHILA; SELF; PATTERNS; INSECTS; GENES; SENSE		[Lazzaro, Brian P.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Rolff, Jens] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Cornell University; University of Sheffield	Lazzaro, BP (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	jor@sheffield.ac.uk	hongbo, yi/G-9615-2011	Rolff, Jens/0000-0002-1529-5409				Anselme C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-43; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Gambaryan S, 2010, J BIOL CHEM, V285, P18352, DOI 10.1074/jbc.M109.077602; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; OTTI O, UNPUB; Ragan Emily J., 2009, P34; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vilcinskas A, 2010, VIRULENCE, V1, P206, DOI 10.4161/viru.1.3.12072; Wang JW, 2009, P NATL ACAD SCI USA, V106, P12133, DOI 10.1073/pnas.0901226106; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	20	43	48	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					43	44		10.1126/science.1200486	http://dx.doi.org/10.1126/science.1200486			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454776				2022-12-24	WOS:000289000000030
J	Moszynski, P				Moszynski, Peter			RESPIRATORY DISEASES Tuberculosis: a clear and present danger	BRITISH MEDICAL JOURNAL			English	Editorial Material												globewisecom@hotmail.com						LAWN SD, 2011, LANCET          0317; Moszynski P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1937; *PUBL HLTH ACT SUP, 2010, LOND TB SERV REV HLT; STOP TB Partnership, GLOB PLAN STOP TB 20	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 1	2011	342								d2089	10.1136/bmj.d2089	http://dx.doi.org/10.1136/bmj.d2089			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WJ	21459967				2022-12-24	WOS:000289201700007
J	Greving, JP; Visseren, FLJ; de Wit, GA; Algra, A				Greving, J. P.; Visseren, F. L. J.; de Wit, G. A.; Algra, A.			Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; LONG-TERM SURVIVAL; CARDIOVASCULAR-DISEASE; LOWERING MEDICATIONS; DRUG-TREATMENT; RISK; STROKE; METAANALYSIS	Objective To assess the cost-effectiveness of low dose statins for primary prevention of vascular disease, incorporating current prices, non-adherence (reduced clinical efficacy while maintaining healthcare costs), and the results of the recently published JUPITER trial. Design Cost-effectiveness analysis using a Markov model. Sensitivity analyses and Monte Carlo simulation evaluated the robustness of the results. Setting Primary care in The Netherlands. Participants Hypothetical populations of men and women aged 45 to 75 years without a history of vascular disease at different levels of risk for vascular disease (myocardial infarction and stroke) over 10 years. Interventions Low dose statin treatment daily versus no treatment for 10 years. Main outcome measures Number of fatal and nonfatal vascular events prevented, quality-adjusted life-years (QALYs), costs, and incremental cost-effectiveness ratios over 10 years. Results Over a 10-year period, statin treatment cost (sic)35 000 (30 pound 000, $49 000) per QALY gained for men aged 55 years with a 10-year vascular risk of 10%. The incremental cost-effectiveness ratio improved as risk for vascular disease increased. The cost per QALY ranged from approximately (sic)5000 to (sic)125 000 when the 10-year vascular risk for men aged 55 years was varied from 25% to 5%. The incremental cost-effectiveness ratio slightly decreased with age after the level of vascular risk was specified. Results were sensitive to the costs of statin treatment, statin effectiveness, non-adherence, disutility of taking medication daily, and the time horizon of the model. Conclusions In daily practice, statin treatment seemed not to be cost-effective for primary prevention in populations at low risk of vascular disease, despite low costs of generic drug pills. Adherence to statin treatment needs to be improved to enhance the cost-effectiveness of the use of statins for primary prevention.	[Greving, J. P.; de Wit, G. A.; Algra, A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands; [Visseren, F. L. J.] Univ Med Ctr Utrecht, Dept Vasc Med, NL-3584 CX Utrecht, Netherlands; [de Wit, G. A.] Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands; [Algra, A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosc, Dept Neurol & Neurosurg, Utrecht Stroke Ctr, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Greving, JP (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands.	J.P.Greving@umcutrecht.nl	Visseren, Frank LJ/I-4855-2013	Visseren, Frank/0000-0003-3951-5223; de Wit, G. Ardine/0000-0002-1375-7657	Netherlands Organisation for Health Research and Development (ZonMW) [6120.0019]; Merck; Catharijne foundation Utrecht; AstraZeneca	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Merck(Merck & Company); Catharijne foundation Utrecht; AstraZeneca(AstraZeneca)	This study was supported by an unconditional grant from the Netherlands Organisation for Health Research and Development (ZonMW, project number 6120.0019). The funding source had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit an article for publication.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that: the submitted work was supported only by ZonMW; JPG, GAdW, and AA have no relationships with companies that might have an interest in the submitted work in the previous three years; the department of FLV has received research grants from Merck, the Netherlands Organisation for Health research and Development and from the Catharijne foundation Utrecht and speaker fees from Merck and AstraZeneca; none of the authors has non-financial interests that may be relevant to the submitted work.	American Heart Association, 2008, HEART DIS STROK STAT; Augustovski FA, 1998, J GEN INTERN MED, V13, P824, DOI 10.1046/j.1525-1497.1998.00246.x; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bates TR, 2009, EXPERT OPIN PHARMACO, V10, P2973, DOI 10.1517/14656560903376186; Bronnum-Hansen H, 2001, J CLIN EPIDEMIOL, V54, P1244, DOI 10.1016/S0895-4356(01)00405-X; Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Buskens E, 2004, RADIOLOGY, V233, P101, DOI 10.1148/radiol.2331030863; Christie Bryan, 2006, BMJ, V333, P988, DOI 10.1136/bmj.39024.405602.DB; DEBOER MJ, 1995, AM J CARDIOL, V76, P830, DOI 10.1016/S0002-9149(99)80238-0; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; Dutch Health Care Insurance Board, 2009, DRUG COSTS; Dutch Healthcare Authority, 2009, RAT VAR PROF VAR LAB; Greving JP, 2008, CIRCULATION, V117, P2875, DOI 10.1161/CIRCULATIONAHA.107.735340; Grover SA, 2003, ARCH INTERN MED, V163, P333, DOI 10.1001/archinte.163.3.333; Helin-Salmivaara A, 2008, CLIN THER, V30, P2228, DOI 10.1016/j.clinthera.2008.12.003; Hiatt JG, 1999, AM J MANAG CARE, V5, P437; Huse DM, 1998, AM J CARDIOL, V82, P1357, DOI 10.1016/S0002-9149(98)00641-9; JAGERGEURTS MH, 2006, CARDIOVASCULAR DIS N; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; Johannesson M, 2001, EUR HEART J, V22, P919, DOI 10.1053/euhj.2000.2484; Koek HL, 2007, NETH J MED, V65, P434; Koek HL, 2006, AM J CARDIOL, V98, P993, DOI 10.1016/j.amjcard.2006.05.016; Lampe FC, 2000, EUR HEART J, V21, P1052, DOI 10.1053/euhj.1999.1866; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; NAGLIE IG, 1992, MED DECIS MAKING, V12, P239, DOI 10.1177/0272989X9201200401; OOSTENBRINK JB, 2004, GUIDELINE COSTING RE; Perreault S, 2009, AM J MED, V122, P647, DOI 10.1016/j.amjmed.2009.01.032; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; Pignone M, 2006, ANN INTERN MED, V144, P326, DOI 10.7326/0003-4819-144-5-200603070-00007; Post PN, 2001, STROKE, V32, P1425, DOI 10.1161/01.STR.32.6.1425; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Statistics Netherlands, 2002, LIF DUTCH POP AG SEX; Stolk E, 2007, P PLEN M EUROQOL GRO, V153, P65; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; Vaartjes I, 2008, EUR J NEUROL, V15, P1315, DOI 10.1111/j.1468-1331.2008.02309.x; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	45	75	75	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2011	342								d1672	10.1136/bmj.d1672	http://dx.doi.org/10.1136/bmj.d1672			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WF	21450800	hybrid			2022-12-24	WOS:000289201200002
J	Cisneros, JC; Abdala, F; Rubidge, BS; Dentzien-Dias, PC; Bueno, AD				Cisneros, Juan Carlos; Abdala, Fernando; Rubidge, Bruce S.; Dentzien-Dias, Paula Camboim; Bueno, Ana de Oliveira			Dental Occlusion in a 260-Million-Year-Old Therapsid with Saber Canines from the Permian of Brazil	SCIENCE			English	Article							EVOLUTION; ORIGIN	Anomodonts, a group of herbivorous therapsid "mammal-like reptiles," were the most abundant tetrapods of the Permian. We present a basal anomodont from South America, a new taxon that has transversally expanded palatal teeth and long saber canines. The function of the saber teeth is unknown, but probable uses include deterring attack from predators and intraspecific display or combat. The complex palatal teeth were used to process high-fiber food and represent early evidence of dental occlusion in a therapsid. This discovery provides new insight into the evolution of heterogeneous dentition in therapsids and broadens our understanding of ecological interactions at the end of the Paleozoic.	[Cisneros, Juan Carlos] Univ Fed Piaui, Ctr Ciencias Nat, BR-64049550 Teresina, Piaui, Brazil; [Cisneros, Juan Carlos; Bueno, Ana de Oliveira] Univ Fed Rio Grande do Sul, Dept Paleontol & Estratig, Porto Alegre, RS, Brazil; [Abdala, Fernando; Rubidge, Bruce S.] Univ Witwatersrand, Bernard Price Inst Palaeontol Res, ZA-2050 Johannesburg, Johannesburg, South Africa; [Dentzien-Dias, Paula Camboim] Univ Fed Piaui, Picos, Piaui, Brazil	Universidade Federal do Piaui; Universidade Federal do Rio Grande do Sul; University of Witwatersrand; Universidade Federal do Piaui	Cisneros, JC (corresponding author), Univ Fed Piaui, Ctr Ciencias Nat, BR-64049550 Teresina, Piaui, Brazil.		Dentzien-Dias, Paula/AAZ-3945-2020; Abdala, Fernando/I-8054-2019; Rubidge, Bruce/AAE-7021-2019	Rubidge, Bruce/0000-0003-2477-1873; Cisneros, Juan Carlos/0000-0001-6159-1981	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478914/2006-77]; Department of Science and Technology; National Research Foundation; Palaeontological Scientific Trust	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Department of Science and Technology(Department of Science & Technology (India)); National Research Foundation; Palaeontological Scientific Trust	We thank A. E. Figueiredo, M. A. Franca, T. P. Melo, and W. Velasques-Alves for field support. V. Abdala, K. Angielczyk, L. Backwell, P. Backwell, M. Jennions, T. Kemp, and R. Reisz, are acknowledged for discussion and valuable comments. J.C.C., P. C. D. D., and A.O.B. were funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); F. A. and B. S. R. were funded by the Department of Science and Technology, National Research Foundation, and Palaeontological Scientific Trust. Fieldwork was funded by a CNPq grant (478914/2006-77) awarded to C. L. Schultz.	Angielczyk KD, 2004, PALEOBIOLOGY, V30, P268, DOI 10.1666/0094-8373(2004)030<0268:PEFAIO>2.0.CO;2; BARGHUSEN H R, 1975, Paleobiology, V1, P295; Caro Tim, 2005, pXIII; Cisneros Juan Carlos, 2005, Revista Brasileira de Paleontologia, V8, P13; Darwin G., 1871, P423; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Frobisch J, 2009, P ROY SOC B-BIOL SCI, V276, P3611, DOI 10.1098/rspb.2009.0911; Frobisch J, 2009, EARTH-SCI REV, V95, P119, DOI 10.1016/j.earscirev.2009.04.001; Geist V., 1998, DEER WORLD THEIR EVO; Ivakhnenko M.F., 2005, Paleontological Journal, V39, pS393; Ivakhnenko M, 2008, PALEONTOL J+, V42, P859, DOI 10.1134/S0031030108090013; Kemp TS, 2006, J EVOLUTION BIOL, V19, P1231, DOI 10.1111/j.1420-9101.2005.01076.x; KING GM, 1981, PHILOS T R SOC B, V291, P244; Liu J, 2010, P ROY SOC B-BIOL SCI, V277, P285, DOI 10.1098/rspb.2009.0883; Liu J, 2009, ACTA PALAEONTOL POL, V54, P393, DOI 10.4202/app.2008.0071; Modesto S, 1999, P ROY SOC B-BIOL SCI, V266, P331, DOI 10.1098/rspb.1999.0642; Modesto S. P., 2000, AGE DINOSAURS RUSSIA; MODESTO SP, 1995, PALAEONTOLOGY, V38, P213; Ogg G.J., 2008, CONCISE GEOLOGIC TIM; POOLE DFG, 1956, Q J MICROSC SCI, V97, P303; Reisz RR, 2006, J EXP ZOOL PART B, V306B, P261, DOI 10.1002/jez.b.21115; ROSE KD, 2006, BEGINNING AGE MAMMAL; Rubidge BS, 2001, ANNU REV ECOL SYST, V32, P449, DOI 10.1146/annurev.ecolsys.32.081501.114113; Rybczynski N, 2001, NATURE, V411, P684, DOI 10.1038/35079567; Sues H.-D., 2000, EVOLUTION HERBIVORY, P9; Sullivan C, 2003, P ROY SOC B-BIOL SCI, V270, P173, DOI 10.1098/rspb.2002.2189	26	38	39	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1603	1605		10.1126/science.1200305	http://dx.doi.org/10.1126/science.1200305			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436452				2022-12-24	WOS:000288754500055
J	Brower, V				Brower, Vicki			BIOMARKERS Portents of malignancy	NATURE			English	Editorial Material																		Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Gustafson AM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000251; Lam S, 2006, CANCER EPIDEM BIOMAR, V15, P1526, DOI 10.1158/1055-9965.EPI-06-0128; Paz-Elizur T, 2006, CANCER RES, V66, P11683, DOI 10.1158/0008-5472.CAN-06-2294; Qui J., 2008, J CLIN ONCOL, V26, P5060; Zhang XL, 2010, PHYSIOL GENOMICS, V41, P1, DOI 10.1152/physiolgenomics.00167.2009	6	33	33	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S19	S21		10.1038/471S19a	http://dx.doi.org/10.1038/471S19a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430715	Bronze			2022-12-24	WOS:000288702200016
J	Meek, SJ; O'Brien, RV; Llaveria, J; Schrock, RR; Hoveyda, AH				Meek, Simon J.; O'Brien, Robert V.; Llaveria, Josep; Schrock, Richard R.; Hoveyda, Amir H.			Catalytic Z-selective olefin cross-metathesis for natural product synthesis	NATURE			English	Article							RING-CLOSING METATHESIS; EFFICIENT; COMPLEXES; PLASMALOGEN; MOLYBDENUM; KRN7000	Alkenes are found in many biologically active molecules, and there are a large number of chemical transformations in which alkenes act as the reactants or products (or both) of the reaction. Many alkenes exist as either the E or the higher-energy Z stereoisomer. Catalytic procedures for the stereoselective formation of alkenes are valuable, yet methods enabling the synthesis of 1,2-disubstituted Z alkenes are scarce. Here we report catalytic Z-selective cross-metathesis reactions of terminal enol ethers, which have not been reported previously, and of allylic amides, used until now only in E-selective processes. The corresponding disubstituted alkenes are formed in up to >98% Z selectivity and 97% yield. These transformations, promoted by catalysts that contain the highly abundant and inexpensive metal molybdenum, are amenable to gram-scale operations. Use of reduced pressure is introduced as a simple and effective strategy for achieving high stereoselectivity. The utility of this method is demonstrated by its use in syntheses of an anti-oxidant plasmalogen phospholipid, found in electrically active tissues and implicated in Alzheimer's disease, and the potent immunostimulant KRN7000.	[Meek, Simon J.; O'Brien, Robert V.; Llaveria, Josep; Hoveyda, Amir H.] Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA; [Schrock, Richard R.] MIT, Dept Chem, Cambridge, MA 02139 USA	Boston College; Massachusetts Institute of Technology (MIT)	Hoveyda, AH (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Cros, Josep Llaveria/W-1021-2019	Cros, Josep Llaveria/0000-0003-2260-3657	US National Institutes of Health, Institute of General Medical Sciences [GM-59426]; National Science Foundation [CHE-0715138]; US National Science Foundation [DBI-0619576]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059426] Funding Source: NIH RePORTER; Division Of Chemistry [1111074] Funding Source: National Science Foundation	US National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by the US National Institutes of Health, Institute of General Medical Sciences (GM-59426 to A.H.H. and R.R.S.) and the National Science Foundation (CHE-0715138 to A.H.H.). R.V.O. and J.L. were LaMattina and Spanish government Visiting Scholar Fellows, respectively. We thank S. Castillon, S. J. Malcolmson and M. Yu for discussions. Mass spectrometry facilities at Boston College are supported by the US National Science Foundation (DBI-0619576).	Alexander JB, 1998, J AM CHEM SOC, V120, P4041, DOI 10.1021/ja974353i; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; CHATTERJEE AK, 2003, HDB METATHESIS, V2, P246, DOI DOI 10.1002/9783527619481.CH20; CROWE WE, 1995, J AM CHEM SOC, V117, P5162, DOI 10.1021/ja00123a023; Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g; Hansen EC, 2004, ORG LETT, V6, P2035, DOI 10.1021/ol049378i; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Hoveyda AH, 2010, ANGEW CHEM INT EDIT, V49, P34, DOI 10.1002/anie.200904491; Ibrahem I, 2009, J AM CHEM SOC, V131, P3844, DOI 10.1021/ja900097n; Jiang AJ, 2009, J AM CHEM SOC, V131, P16630, DOI 10.1021/ja908098t; Kim S, 2004, SYNTHESIS-STUTTGART, P847, DOI 10.1055/s-2004-822315; La DS, 2001, J AM CHEM SOC, V123, P7767, DOI 10.1021/ja010684q; Lankalapalli RS, 2009, ORG LETT, V11, P2784, DOI 10.1021/ol9009078; Lee YJ, 2009, J AM CHEM SOC, V131, P10652, DOI 10.1021/ja904098h; Lee Y, 2009, J AM CHEM SOC, V131, P18234, DOI 10.1021/ja9089928; Llaveria J, 2009, ORG LETT, V11, P205, DOI 10.1021/ol802379b; Malcolmson SJ, 2008, NATURE, V456, P933, DOI 10.1038/nature07594; Meek SJ, 2009, J AM CHEM SOC, V131, P16407, DOI 10.1021/ja907805f; Michieletti M, 2008, J ORG CHEM, V73, P9192, DOI 10.1021/jo8019994; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Negishi EI, 2008, ACCOUNTS CHEM RES, V41, P1474, DOI 10.1021/ar800038e; Nicolaou K. C., 1997, LIEBIGS ANN CHEM, P1283; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4490, DOI 10.1002/anie.200500369; Prunet J., 2010, METATHESIS NATURAL P, P287; Qin DH, 1999, J AM CHEM SOC, V121, P662, DOI 10.1021/ja982837o; SCHRADER TO, 2003, HDB METATHESIS, V2, P205; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; Solans-Monfort X, 2005, J AM CHEM SOC, V127, P14015, DOI 10.1021/ja053528i; Trappeniers M, 2008, CHEMMEDCHEM, V3, P1061, DOI 10.1002/cmdc.200800021	30	285	305	3	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					461	466		10.1038/nature09957	http://dx.doi.org/10.1038/nature09957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430774	Green Accepted			2022-12-24	WOS:000288702200052
J	Welch, HG; Sharp, SM; Gottlieb, DJ; Skinner, JS; Wennberg, JE				Welch, H. Gilbert; Sharp, Sandra M.; Gottlieb, Dan J.; Skinner, Jonathan S.; Wennberg, John E.			Geographic Variation in Diagnosis Frequency and Risk of Death Among Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADJUSTMENT	Context Because diagnosis is typically thought of as purely a patient attribute, it is considered a critical factor in risk-adjustment policies designed to reward efficient and high-quality care. Objective To determine the association between frequency of diagnoses for chronic conditions in geographic areas and case-fatality rate among Medicare beneficiaries. Design, Setting, and Participants Cross-sectional analysis of the mean number of 9 serious chronic conditions (cancer, chronic obstructive pulmonary disease, coronary artery disease, congestive heart failure, peripheral artery disease, severe liver disease, diabetes with end-organ disease, chronic renal failure, and dementia) diagnosed in 306 hospital referral regions (HRRs) in the United States; HRRs were divided into quintiles of diagnosis frequency. Participants were 5 153 877 fee-for-service Medicare beneficiaries in 2007. Main Outcome Measures Age/sex/race-adjusted case-fatality rates. Results Diagnosis frequency ranged across HRRs from 0.58 chronic conditions in Grand Junction, Colorado, to 1.23 in Miami, Florida (mean, 0.90 [95% confidence interval {CI}, 0.89-0.91]; median, 0.87 [interquartile range, 0.80-0.96]). The number of conditions diagnosed was related to risk of death: among patients diagnosed with 0, 1, 2, and 3 conditions the case-fatality rate was 16, 45, 93, and 154 per 1000, respectively. As regional diagnosis frequency increased, however, the case fatality associated with a chronic condition became progressively less. Among patients diagnosed with 1 condition, the case-fatality rate decreased in a stepwise fashion across quintiles of diagnosis frequency, from 51 per 1000 in the lowest quintile to 38 per 1000 in the highest quintile (relative rate, 0.74 [95% CI, 0.72-0.76]). For patients diagnosed with 3 conditions, the corresponding case-fatality rates were 168 and 137 per 1000 (relative rate, 0.81 [95% CI, 0.79-0.84]). Conclusion Among fee-for-service Medicare beneficiaries, there is an inverse relationship between the regional frequency of diagnoses and the case-fatality rate for chronic conditions. JAMA. 2011;305(11):1113-1118 www.jama.com	[Welch, H. Gilbert; Sharp, Sandra M.; Gottlieb, Dan J.; Skinner, Jonathan S.; Wennberg, John E.] Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Welch, H. Gilbert] Dept Vet Affairs Med Ctr, White River Jct, VT USA; [Skinner, Jonathan S.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Welch, HG (corresponding author), Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, 35 Centerra Pkwy,Ste 202, Lebanon, NH 03766 USA.	h.gilbert.welch@dartmouth.edu			National Institute on Aging [PO1-AG19783]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by grant PO1-AG19783 from the National Institute on Aging.	Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; IEZZONI LI, 1994, HEALTH SERV RES, V29, P435; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; MedPAC (Medicare Payment Advisory Commission), 2011, REG VAR MED SERV US; MORREIM EH, 1991, ARCH INTERN MED, V151, P443, DOI 10.1001/archinte.151.3.443; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Pine M, 2009, MED DECIS MAKING, V29, P69, DOI 10.1177/0272989X08323297; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Welch WP, 1995, HEALTH AFFAIR, V14, P104, DOI 10.1377/hlthaff.14.4.104	10	111	112	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1113	1118		10.1001/jama.2011.307	http://dx.doi.org/10.1001/jama.2011.307			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	734ZF	21406648	Green Accepted, Bronze			2022-12-24	WOS:000288381900023
J	Gao, YK; Katyal, S; Lee, YS; Zhao, JF; Rehg, JE; Russell, HR; McKinnon, PJ				Gao, Yankun; Katyal, Sachin; Lee, Youngsoo; Zhao, Jingfeng; Rehg, Jerold E.; Russell, Helen R.; McKinnon, Peter J.			DNA ligase III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair	NATURE			English	Article							BASE EXCISION-REPAIR; STRAND BREAK REPAIR; MITOCHONDRIAL-DNA; MOUSE CELLS; DISEASE; XRCC1; DAMAGE; INACTIVATION; POLYMERASE; EXPRESSION	DNA replication and repair in mammalian cells involves three distinct DNA ligases: ligase I (Lig1), ligase III (Lig3) and ligase IV (Lig4)(1). Lig3 is considered a key ligase during base excision repair because its stability depends upon its nuclear binding partner Xrcc1, a critical factor for this DNA repair pathway(2,3). Lig3 is also present in the mitochondria, where its role in mitochondrial DNA (mtDNA) maintenance is independent of Xrcc1 (ref. 4). However, the biological role of Lig3 is unclear as inactivation of murine Lig3 results in early embryonic lethality(5). Here we report that Lig3 is essential for mtDNA integrity but dispensable for nuclear DNA repair. Inactivation of Lig3 in the mouse nervous system resulted in mtDNA loss leading to profound mitochondrial dysfunction, disruption of cellular homeostasis and incapacitating ataxia. Similarly, inactivation of Lig3 in cardiac muscle resulted in mitochondrial dysfunction and defective heart-pump function leading to heart failure. However, Lig3 inactivation did not result in nuclear DNA repair deficiency, indicating essential DNA repair functions of Xrcc1 can occur in the absence of Lig3. Instead, we found that Lig1 was critical for DNA repair, but acted in a cooperative manner with Lig3. Additionally, Lig3 deficiency did not recapitulate the hallmark features of neural Xrcc1 inactivation such as DNA damage-induced cerebellar interneuron loss(6), further underscoring functional separation of these DNA repair factors. Therefore, our data reveal that the critical biological role of Lig3 is to maintain mtDNA integrity and not Xrcc1-dependent DNA repair.	[Gao, Yankun; Katyal, Sachin; Lee, Youngsoo; Zhao, Jingfeng; Russell, Helen R.; McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet, Memphis, TN 38105 USA; [Rehg, Jerold E.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	McKinnon, PJ (corresponding author), St Jude Childrens Hosp, Dept Genet, Memphis, TN 38105 USA.	peter.mckinnon@stjude.org	Rehg, Jerold E/N-8111-2018	Lee, Youngsoo/0000-0003-4773-6464; Katyal, Sachin/0000-0002-7790-4054	National Institutes of Health [NS-37956, CA-21765]; Cancer Center [P30 CA21765]; American Lebanese and Syrian Associated Charities of St Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956, R56NS037956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese and Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Hartwell Center for biotechnology support, the Transgenic Core Facility for blastocyst injections and the Animal Resources Center for animal husbandry. We also acknowledge the Light Microscopy Core, the Electron Microscopy Core and C. Calabrese and the Animal Imaging Core for magnetic resonance imaging and echocardiography analysis. P.J.M. is supported by the National Institutes of Health (NS-37956, CA-21765), a Cancer Center Support Grant (P30 CA21765) and the American Lebanese and Syrian Associated Charities of St Jude Children's Research Hospital. S.K. is a Neoma Boadway AP Endowed Fellow.	Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Bentley DJ, 2002, J CELL SCI, V115, P1551; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040; Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668; LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; LJUNGQUIST S, 1994, MUTAT RES, V314, P177, DOI 10.1016/0921-8777(94)90081-7; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Nakai A, 2000, DEV BRAIN RES, V121, P67, DOI 10.1016/S0165-3806(00)00025-0; Pinz KG, 1998, MOL CELL BIOL, V18, P1257, DOI 10.1128/MCB.18.3.1257; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Reynolds JJ, 2009, MOL CELL BIOL, V29, P1354, DOI 10.1128/MCB.01471-08; Sleeth KM, 2004, BIOCHEMISTRY-US, V43, P12924, DOI 10.1021/bi0492612; TOMKINSON AE, 1988, J BIOL CHEM, V263, P12532; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089	30	134	135	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					240	U134		10.1038/nature09773	http://dx.doi.org/10.1038/nature09773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390131	Green Accepted			2022-12-24	WOS:000288170200042
J	Graham, WJ; Varghese, B				Graham, Wendy J.; Varghese, Beena			Quality, quality, quality: gaps in the continuum of care	LANCET			English	Editorial Material							HEALTH		[Graham, Wendy J.] Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland; [Varghese, Beena] Publ Hlth Fdn India, New Delhi, India	University of Aberdeen; Public Health Foundation of India	Graham, WJ (corresponding author), Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland.	w.graham@abdn.ac.uk		Graham, Wendy/0000-0003-1473-5342				Bell JS., 2003, TRENDS DELIVERY CARE; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Godlee F, 2009, BMJ-BRIT MED J, V339, pb4346, DOI DOI 10.1136/bmj.b4346; Institute of Medicine, 2001, CROSS QUAL CHASM; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Neal S, 2010, WHITE RIBBON ALLIANC; Nehru, 1962, GLIMPSES WORLD HIST; Pan American Health Organization/WHO, 2003, MON RED MAT MORB MOR; The Earth Institute Columbia University, 2010, BARR GAPS AFF MHEALT; United Nations, 2010, GLOB STRAT WOM CHILD; United Nations Population Fund, 2009, CONC ASS JAN SUR YOJ; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; WHO, 2010, WOR HEALT REP, P1; WHO, 2008, FACTSH SKILL ATT; COUNTDOWN 2015 MATER; 2010, PARTNERSHIP MATERNAL	16	56	56	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					E5	E6		10.1016/S0140-6736(10)62267-2	http://dx.doi.org/10.1016/S0140-6736(10)62267-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	21474173				2022-12-24	WOS:000299317700001
J	Selmi, C; Bowlus, CL; Gershwin, ME; Coppel, RL				Selmi, Carlo; Bowlus, Christopher L.; Gershwin, M. Eric; Coppel, Ross L.			Primary biliary cirrhosis	LANCET			English	Article							URSODEOXYCHOLIC-ACID THERAPY; RANDOMIZED CONTROLLED-TRIALS; LONG-TERM SURVIVAL; REGULATORY T-CELLS; ANTIMITOCHONDRIAL ANTIBODIES; CLINICAL-FEATURES; ANTINUCLEAR ANTIBODIES; BIOCHEMICAL RESPONSE; NATURAL-HISTORY; LIVER-DISEASE	Primary biliary cirrhosis is a chronic liver disease characterised by intrahepatic bile-duct destruction, cholestasis, and, in some cases, cirrhosis. Evidence supporting the autoimmune nature of this disorder includes the appearance of highly specific antimitochondrial antibodies (AMAs) and autoreactive T cells. Concordance rates in monozygotic twins, familial prevalence, and genetic associations underscore the importance of genetic factors, whereas findings of epidemiological studies and murine models suggest a possible role for exogenous chemicals and infectious agents through molecular mimicry. The incidence of primary biliary cirrhosis has increased over recent decades, possibly attributable to augmented testing of liver biochemistry rather than a rise in disease incidence. AMAs remain the hallmark of diagnosis in most cases and allow detection of asymptomatic patients. Symptomatic individuals usually present with either pruritus or fatigue and, more rarely, with either jaundice or complications of cirrhosis. The prognosis of primary biliary cirrhosis has improved because of early diagnosis and use of ursodeoxycholic acid, the only established medical treatment for this disorder. Although not a cure, treatment can slow disease progression and delay the need for liver transplantation. However, some patients do not respond adequately to ursodeoxycholic acid and might need alternative therapeutic approaches.	[Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Selmi, Carlo] Univ Milan, Dept Translat Med, IRCCS Ist Clin Humanitas, Milan, Italy; [Bowlus, Christopher L.] Univ Calif Davis, Div Gastroenterol & Hepatol, Davis, CA 95616 USA; [Gershwin, M. Eric] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA	Monash University; Humanitas University; IRCCS Humanitas Research Hospital; University of Milan; University of California System; University of California Davis; University of California System; University of California Davis	Coppel, RL (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	ross.coppel@monash.edu	Selmi, Carlo/ABG-4899-2021; Bowlus, Christopher/N-9276-2016; Coppel, Ross L/A-6626-2008	Selmi, Carlo/0000-0002-0323-0376; Bowlus, Christopher/0000-0002-3906-6811; Coppel, Ross L/0000-0002-4476-9124	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067003] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK090019, R01 DK067003] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHRENS EH, 1950, MEDICINE, V29, P299, DOI 10.1097/00005792-195012000-00002; Al-Harthy N, 2010, HEPATOLOGY, V52, P562, DOI 10.1002/hep.23683; Ala A, 2006, HEPATOLOGY, V43, P525, DOI 10.1002/hep.21076; Allocca M, 2006, GUT, V55, P1795, DOI 10.1136/gut.2005.079814; Benetti A, 2008, J CLIN GASTROENTEROL, V42, P306, DOI 10.1097/01.mcg.0000248017.31386.39; Berg CP, 2009, LIVER INT, V29, P797, DOI 10.1111/j.1478-3231.2008.01942.x; Bergasa NV, 2008, CLIN LIVER DIS, V12, P385, DOI 10.1016/j.cld.2008.02.013; Bergasa NV, 1998, HEPATOLOGY, V27, P679, DOI 10.1002/hep.510270307; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Bogdanos DP, 2009, CLIN REV ALLERG IMMU, V36, P30, DOI 10.1007/s12016-008-8087-9; Bruggraber SFA, 2003, GASTROENTEROLOGY, V125, P1705, DOI 10.1053/j.gastro.2003.09.034; BURROUGHS AK, 1984, GUT, V25, P133, DOI 10.1136/gut.25.2.133; Cerri G, 2010, CLIN NEUROPHYSIOL, V121, P1321, DOI 10.1016/j.clinph.2009.12.040; CHA S, 1993, P NATL ACAD SCI USA, V90, P2527, DOI 10.1073/pnas.90.6.2527; Charatcharoenwitthaya P, 2007, LIVER TRANSPLANT, V13, P1236, DOI 10.1002/lt.21124; Chazouilleres O, 1998, HEPATOLOGY, V28, P296, DOI 10.1002/hep.510280203; Chuang YH, 2006, J AUTOIMMUN, V26, P232, DOI 10.1016/j.jaut.2006.04.001; Corpechot C, 2005, GASTROENTEROLOGY, V128, P297, DOI 10.1053/j.gastro.2004.11.009; CROSIGNANI A, 1991, HEPATOLOGY, V14, P1000, DOI 10.1016/0270-9139(91)90119-G; Dahlan Y, 2003, GASTROENTEROLOGY, V125, P1476, DOI 10.1016/j.gastro.2003.08.022; DATTA DV, 1966, GASTROENTEROLOGY, V50, P323; de Rave S, 2005, TRANSPL INT, V18, P937, DOI 10.1111/j.1432-2277.2005.00161.x; DICKSON ER, 1989, HEPATOLOGY, V10, P1, DOI 10.1002/hep.1840100102; Fukushima N, 2002, HEPATOLOGY, V36, P1383, DOI 10.1053/jhep.2002.37140; FUSSEY SPM, 1988, P NATL ACAD SCI USA, V85, P8654, DOI 10.1073/pnas.85.22.8654; Garcia RFL, 2001, HEPATOLOGY, V33, P22, DOI 10.1053/jhep.2001.20894; Garrido MC, 1996, J CLIN PATHOL, V49, P556, DOI 10.1136/jcp.49.7.556; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; GLUUD C, 2002, COCHRANE DB SYST REV, V1; Goldblatt J, 2002, GASTROENTEROLOGY, V122, P1235, DOI 10.1053/gast.2002.32993; Gong Y, 2008, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000551.PUB2; Gong Y, 2007, AM J GASTROENTEROL, V102, P1799, DOI 10.1111/j.1572-0241.2007.01235.x; Goulis J, 1999, LANCET, V354, P1053, DOI 10.1016/S0140-6736(98)11293-X; Granito A, 2007, ALIMENT PHARM THER, V26, P831, DOI 10.1111/j.1365-2036.2007.03433.x; Granito A, 2006, ALIMENT PHARM THER, V24, P1575, DOI 10.1111/j.1365-2036.2006.03172.x; Guanabens N, 2005, J HEPATOL, V42, P573, DOI 10.1016/j.jhep.2004.11.035; Hardy T, 2010, LIVER INT, V30, P1551, DOI 10.1111/j.1478-3231.2010.02288.x; Heathcote EJ, 2000, HEPATOLOGY, V31, P1005, DOI 10.1053/he.2000.5984; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hollingsworth KG, 2008, CLIN GASTROENTEROL H, V6, P1041, DOI 10.1016/j.cgh.2008.04.013; Hollingsworth KG, 2009, J MAGN RESON IMAGING, V29, P780, DOI 10.1002/jmri.21555; Holtmeier J, 2001, DIGESTION, V64, P137, DOI 10.1159/000048854; Huet PM, 2008, GASTROENTEROLOGY, V135, P1552, DOI 10.1053/j.gastro.2008.07.019; Invernizzi P, 2005, SEMIN LIVER DIS, V25, P298, DOI 10.1055/s-2005-916321; Invernizzi P, 1997, HEPATOLOGY, V25, P1090, DOI 10.1002/hep.510250507; James OFW, 1999, HEPATOLOGY, V30, P390, DOI 10.1002/hep.510300213; Jones DEJ, 2007, ALIMENT PHARM THER, V25, P471, DOI 10.1111/j.1365-2036.2006.03223.x; Jones DE, 2010, J HEPATOL, V53, P911, DOI 10.1016/j.jhep.2010.05.026; Jones DEJ, 2007, GUT, V56, P1615, DOI 10.1136/gut.2007.122150; Jones DEJ, 2006, GUT, V55, P536, DOI 10.1136/gut.2005.080317; Kikuchi K, 2005, GASTROENTEROLOGY, V128, P304, DOI 10.1053/j.gastro.2004.11.005; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; Kita H, 2002, GASTROENTEROLOGY, V123, P1031, DOI 10.1053/gast.2002.36020; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Kuiper EMM, 2009, GASTROENTEROLOGY, V136, P1281, DOI 10.1053/j.gastro.2009.01.003; Lan RY, 2006, HEPATOLOGY, V43, P729, DOI 10.1002/hep.21123; Lee J, 2007, CLIN GASTROENTEROL H, V5, P1313, DOI 10.1016/j.cgh.2007.07.015; Leslie WD, 2003, GASTROENTEROLOGY, V125, P941, DOI 10.1016/S0016-5085(03)01062-X; Leung PSC, 2007, J IMMUNOL, V179, P2651, DOI 10.4049/jimmunol.179.4.2651; LEUSCHNER U, 1994, J HEPATOL, V21, P624, DOI 10.1016/S0168-8278(94)80111-8; Lindor KD, 1996, GASTROENTEROLOGY, V110, P1515, DOI 10.1053/gast.1996.v110.pm8613058; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Lleo A, 2008, AUTOIMMUN REV, V7, P626, DOI 10.1016/j.autrev.2008.06.009; Lleo A, 2010, HEPATOLOGY, V52, P987, DOI 10.1002/hep.23783; Lleo A, 2009, HEPATOLOGY, V49, P871, DOI 10.1002/hep.22736; Lleo A, 2008, J AUTOIMMUN, V31, P257, DOI 10.1016/j.jaut.2008.04.009; Locke GR, 1996, HEPATOLOGY, V23, P52, DOI 10.1002/hep.510230108; Longhi MS, 2008, HEPATOLOGY, V47, P581, DOI 10.1002/hep.22071; Longo M, 2002, GUT, V51, P265, DOI 10.1136/gut.51.2.265; LOZANO F, 1988, HEPATOLOGY, V8, P930, DOI 10.1002/hep.1840080438; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; Mackay IR, 2009, J AUTOIMMUN, V33, P170, DOI 10.1016/j.jaut.2009.09.006; MacQuillan Gerry C, 2003, Clin Liver Dis, V7, P941, DOI 10.1016/S1089-3261(03)00099-0; Mao TK, 2005, HEPATOLOGY, V42, P802, DOI 10.1002/hep.20859; Marasini B, 2001, ANN RHEUM DIS, V60, P1046, DOI 10.1136/ard.60.11.1046; Marzioni M, 2007, J HEPATOL, V46, P583, DOI 10.1016/j.jhep.2007.01.006; Mason A, 2010, J HEPATOL, V52, pS1, DOI 10.1016/S0168-8278(10)60004-9; Mattalia A, 1998, HEPATOLOGY, V27, P656, DOI 10.1002/hep.510270303; Mayo MJ, 2008, HEPATOLOGY, V48, P1549, DOI 10.1002/hep.22517; McNally RJQ, 2009, HEPATOLOGY, V50, P1169, DOI 10.1002/hep.23139; Metcalf JV, 1996, LANCET, V348, P1399, DOI 10.1016/S0140-6736(96)04410-8; Miyachi K, 1996, MOL BIOL REP, V23, P227, DOI 10.1007/BF00351173; Miyakawa H, 1999, AUTOIMMUNITY, V30, P11, DOI 10.3109/08916939908994755; Miyakawa H, 2001, HEPATOLOGY, V34, P243, DOI 10.1053/jhep.2001.26514; Moteki S, 1996, HEPATOLOGY, V24, P97; Muratori P, 2004, CLIN EXP IMMUNOL, V135, P154, DOI 10.1111/j.1365-2249.2004.02332.x; Muratori P, 2003, AM J GASTROENTEROL, V98, P431, DOI 10.1016/S0002-9270(02)05925-7; MUTIMER DJ, 1989, HEPATOLOGY, V10, P403, DOI 10.1002/hep.1840100402; MYSZOR M, 1990, Q J MED, V75, P377; Nakamura M, 2005, J HEPATOL, V42, P386, DOI 10.1016/j.jhep.2004.11.016; Nakamura M, 2007, HEPATOLOGY, V45, P118, DOI 10.1002/hep.21472; Newton JL, 2007, HEPATOLOGY, V45, P1496, DOI 10.1002/hep.21609; Newton JL, 2006, HEPATOLOGY, V44, P91, DOI 10.1002/hep.21230; Odin JA, 2001, J CLIN INVEST, V108, P223, DOI 10.1172/JCI200110716; Oertelt S, 2007, HEPATOLOGY, V45, P659, DOI 10.1002/hep.21583; Padgett KA, 2005, J AUTOIMMUN, V24, P209, DOI 10.1016/j.jaut.2005.01.012; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; Pla X, 2007, EUR J GASTROEN HEPAT, V19, P859, DOI 10.1097/MEG.0b013e328277594a; Poupon RE, 1997, GASTROENTEROLOGY, V113, P884, DOI 10.1016/S0016-5085(97)70183-5; Prince M, 2002, GASTROENTEROLOGY, V123, P1044, DOI 10.1053/gast.2002.36027; PRINCE M, 2005, COCHRANE DB SYST REV, V2; Prince MI, 2010, GUT, V59, P508, DOI 10.1136/gut.2009.184218; Prince MI, 2004, GUT, V53, P865, DOI 10.1136/gut.2003.023937; Ramos-Casals M, 2005, J VIRAL HEPATITIS, V12, P648, DOI 10.1111/j.1365-2893.2005.00642.x; Ray-Chadhuri D, 2001, GUT, V48, P42; Reuben A, 2003, HEPATOLOGY, V37, P225, DOI 10.1002/hep.510370134; Rieger R, 2007, J AUTOIMMUN, V28, P76, DOI 10.1016/j.jaut.2007.02.003; Rieger R, 2006, J AUTOIMMUN, V27, P7, DOI 10.1016/j.jaut.2006.06.002; Rigamonti C, 2006, GUT, V55, P388, DOI 10.1136/gut.2005.075002; ROLL J, 1983, NEW ENGL J MED, V308, P1, DOI 10.1056/NEJM198301063080101; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257, DOI 10.1177/003591576706001205; Selmi C, 2005, SEMIN LIVER DIS, V25, P265, DOI 10.1055/s-2005-916319; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; Selmi C, 2004, GASTROENTEROLOGY, V127, P493, DOI 10.1053/j.gastro.2004.05.033; Selmi C, 2003, HEPATOLOGY, V38, P1250, DOI 10.1053/jhep.2003.50446; SHERLOCK S, 1968, Acta Gastro-Enterologica Belgica, V31, P416; Shimoda S, 2003, GASTROENTEROLOGY, V124, P1915, DOI 10.1016/S0016-5085(03)00387-1; Shimoda S, 2008, J AUTOIMMUN, V31, P110, DOI 10.1016/j.jaut.2008.05.003; Silveira MG, 2008, HEPATOLOGY, V48, P1149, DOI 10.1002/hep.22458; Silveira MG, 2007, AM J GASTROENTEROL, V102, P1244, DOI 10.1111/j.1572-0241.2007.01136.x; Sood S, 2004, GASTROENTEROLOGY, V127, P470, DOI 10.1053/j.gastro.2004.04.064; Springer J, 1999, AM J GASTROENTEROL, V94, P47; Stojakovic T, 2007, HEPATOLOGY, V46, P776, DOI 10.1002/hep.21741; Sylvestre PB, 2003, LIVER TRANSPLANT, V9, P1086, DOI 10.1053/jlts.2003.50213; Tanaka A, 2007, ANN NY ACAD SCI, V1107, P259, DOI 10.1196/annals.1381.028; Telesca D, 2008, BIOMETRICS, V64, P10, DOI 10.1111/j.1541-0420.2007.00825.x; TRIGER DR, 1980, BRIT MED J, V281, P772, DOI 10.1136/bmj.281.6243.772; van Hoogstraten HJE, 1999, J HEPATOL, V31, P256, DOI 10.1016/S0168-8278(99)80222-0; Wakabayashi K, 2009, CLIN EXP IMMUNOL, V155, P577, DOI 10.1111/j.1365-2249.2008.03837.x; Wakabayashi K, 2008, HEPATOLOGY, V48, P531, DOI 10.1002/hep.22390; Walden HR, 2008, HEPATOLOGY, V48, P1874, DOI 10.1002/hep.22540; WALKER JG, 1965, LANCET, V1, P827; Wesierska-Gadek J, 2006, HEPATOLOGY, V43, P1135, DOI 10.1002/hep.21172; Xu LZ, 2003, P NATL ACAD SCI USA, V100, P8454, DOI 10.1073/pnas.1433063100; Yang GX, 2008, HEPATOLOGY, V47, P1974, DOI 10.1002/hep.22226; Zuchner D, 1997, HEPATOLOGY, V26, P1123	139	216	239	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1600	1609		10.1016/S0140-6736(10)61965-4	http://dx.doi.org/10.1016/S0140-6736(10)61965-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21529926				2022-12-24	WOS:000290549700034
J	Dunn, M; Greenhill, SJ; Levinson, SC; Gray, RD				Dunn, Michael; Greenhill, Simon J.; Levinson, Stephen C.; Gray, Russell D.			Evolved structure of language shows lineage-specific trends in word-order universals	NATURE			English	Article								Languages vary widely but not without limit. The central goal of linguistics is to describe the diversity of human languages and explain the constraints on that diversity. Generative linguists following Chomsky have claimed that linguistic diversity must be constrained by innate parameters that are set as a child learns a language(1,2). In contrast, other linguists following Greenberg have claimed that there are statistical tendencies for co-occurrence of traits reflecting universal systems biases(3-5), rather than absolute constraints or parametric variation. Here we use computational phylogenetic methods to address the nature of constraints on linguistic diversity in an evolutionary framework(6). First, contrary to the generative account of parameter setting, we show that the evolution of only a few word-order features of languages are strongly correlated. Second, contrary to the Greenbergian generalizations, we show that most observed functional dependencies between traits are lineage-specific rather than universal tendencies. These findings support the view that-at least with respect to word order-cultural evolution is the primary factor that determines linguistic structure, with the current state of a linguistic system shaping and constraining future states.	[Dunn, Michael; Levinson, Stephen C.] Max Planck Inst Psycholinguist, NL-6500 AH Nijmegen, Netherlands; [Dunn, Michael; Levinson, Stephen C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands; [Greenhill, Simon J.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland 1142, New Zealand; [Greenhill, Simon J.] Univ Auckland, Computat Evolut Grp, Auckland 1142, New Zealand	Max Planck Society; Radboud University Nijmegen; University of Auckland; University of Auckland	Dunn, M (corresponding author), Max Planck Inst Psycholinguist, POB 310, NL-6500 AH Nijmegen, Netherlands.	michael.dunn@mpi.nl	Dunn, Michael/F-1077-2012; Greenhill, Simon/I-3554-2019; Gray, Russell/H-2078-2015; Galantucci, Bruno/E-5770-2010; Greenhill, Simon J/B-3114-2011	Dunn, Michael/0000-0001-5349-5252; Greenhill, Simon/0000-0001-7832-6156; Gray, Russell/0000-0002-9858-0191; Greenhill, Simon J/0000-0001-7832-6156				Baker M., 2001, ATOMS LANGUAGE; BAKKER P, 2010, OXFORD HDB LINGUISTI; CAMPBELL L, 1997, AM INDIAN LANGUAGES, P133; Cela-Conde C. J., 1998, SYNTAX, V1, P19, DOI DOI 10.1111/1467-9612.00002; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky Noam, 1981, LECT GOVT BINDING; Croft W, 2008, ANNU REV ANTHROPOL, V37, P219, DOI 10.1146/annurev.anthro.37.081407.085156; Cysouw M, 2005, HANDB SPRACH KOMMUN, V27, P554; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Dryer M.S., 2007, LANGUAGE TYPOLOGY AN, P61, DOI DOI 10  1017/CBO9780511619427.002; Dryer Matthew S., 2008, WORLD ATLAS LANGUAGE; DYEN I, 1992, T AM PHILOS SOC, V82, P1; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; Guthrie M., 1971, COMP BANTU, V2; Hawkins J. A., 2009, LANGUAGE UNIVERSALS, P54, DOI DOI 10.1093/ACPROF:OSO/9780195305432.003.0004; Holden CJ, 2002, P ROY SOC B-BIOL SCI, V269, P793, DOI 10.1098/rspb.2002.1955; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; LIGHTFOOT DW, 1989, BEHAV BRAIN SCI, V12, P321, DOI 10.1017/S0140525X00048883; MACE R, 1994, CURR ANTHROPOL, V35, P549, DOI 10.1086/204317; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Raftery AE, 1996, BIOMETRIKA, V83, P251, DOI 10.1093/biomet/83.2.251; Reesink G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000241	29	252	255	6	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					79	82		10.1038/nature09923	http://dx.doi.org/10.1038/nature09923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	759CQ	21490599	Green Published			2022-12-24	WOS:000290218300034
J	Plikus, MV; Baker, RE; Chen, CC; Fare, C; de la Cruz, D; Andl, T; Maini, PK; Millar, SE; Widelitz, R; Chuong, CM				Plikus, Maksim V.; Baker, Ruth E.; Chen, Chih-Chiang; Fare, Clyde; de la Cruz, Damon; Andl, Thomas; Maini, Philip K.; Millar, Sarah E.; Widelitz, Randall; Chuong, Cheng-Ming			Self-Organizing and Stochastic Behaviors During the Regeneration of Hair Stem Cells	SCIENCE			English	Article							SKIN; MORPHOGENESIS; FOLLICLES; PATTERNS; WNT	Stem cells cycle through active and quiescent states. Large populations of stem cells in an organ may cycle randomly or in a coordinated manner. Although stem cell cycling within single hair follicles has been studied, less is known about regenerative behavior in a hair follicle population. By combining predictive mathematical modeling with in vivo studies in mice and rabbits, we show that a follicle progresses through cycling stages by continuous integration of inputs from intrinsic follicular and extrinsic environmental signals based on universal patterning principles. Signaling from the WNT/bone morphogenetic protein activator/inhibitor pair is coopted to mediate interactions among follicles in the population. This regenerative strategy is robust and versatile because relative activator/inhibitor strengths can be modulated easily, adapting the organism to different physiological and evolutionary needs.	[Plikus, Maksim V.; Chen, Chih-Chiang; de la Cruz, Damon; Widelitz, Randall; Chuong, Cheng-Ming] Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA; [Baker, Ruth E.; Maini, Philip K.] Math Inst, Ctr Math Biol, Oxford OX1 3LB, England; [Chen, Chih-Chiang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Chih-Chiang] Natl Yang Ming Univ, Dept Dermatol, Taipei 112, Taiwan; [Chen, Chih-Chiang] Taipei Vet Gen Hosp, Dept Dermatol, Taipei, Taiwan; [Fare, Clyde] Life Sci Interface Doctoral Training Ctr, Oxford OX1 3QD, England; [Andl, Thomas] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Maini, Philip K.] Oxford Ctr Integrat Syst Biol, Dept Biochem, Oxford OX1 3QU, England; [Millar, Sarah E.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Chuong, Cheng-Ming] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan	University of Southern California; University of Oxford; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; University of Oxford; Vanderbilt University; University of Oxford; University of Pennsylvania; National Taiwan University	Chuong, CM (corresponding author), Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA.	cmchuong@usc.edu		Millar, Sarah/0000-0001-8792-6890; Baker, Ruth/0000-0002-6304-9333; Plikus, Maksim/0000-0002-8845-2559; Andl, Thomas/0000-0002-5555-468X	National Institute of Arthritis and Musculoskeletal and Skin Diseases [RO1-AR42177, AR60306, AR47364]; UK Engineering and Physical Sciences Research Council; Royal Society; California Institute for Regenerative Medicine;  [RO1-AR47709]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047364, R01AR060306, R01AR042177, R01AR047709] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	C.-M.C. is supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases RO1-AR42177, AR60306, and AR47364; S.E.M. by RO1-AR47709; R.E.B. by a UK Engineering and Physical Sciences Research Council First grant; P.K.M. by a Royal Society Wolfson Research Merit Award; and M.V.P. by a California Institute for Regenerative Medicine postdoctoral grant. There is a USC patent application partially based on the work in this study on the compositions and methods to modulate hair growth.	Antaya RJ, 2005, J AM ACAD DERMATOL, V53, pS130, DOI 10.1016/j.jaad.2004.12.029; Chuong CM, 2009, INT J DEV BIOL, V53, P653, DOI 10.1387/ijdb.082594cc; Cutrone M, 2005, EUR J PEDIATR, V164, P630, DOI 10.1007/s00431-005-1707-y; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Halloy J, 2000, P NATL ACAD SCI USA, V97, P8328, DOI 10.1073/pnas.97.15.8328; Jiang TX, 1999, DEVELOPMENT, V126, P4997; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Plikus MV, 2008, J INVEST DERMATOL, V128, P1071, DOI 10.1038/sj.jid.5701180; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P9680, DOI 10.1073/pnas.1731184100; WHITELEY HJ, 1958, NATURE, V181, P850, DOI 10.1038/181850a0; Wolfram S., 2002, NEW KIND SCI	17	144	151	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					586	589		10.1126/science.1201647	http://dx.doi.org/10.1126/science.1201647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527712	Green Accepted			2022-12-24	WOS:000289991100048
J	Truman, RW; Singh, P; Sharma, R; Busso, P; Rougemont, J; Paniz-Mondolfi, A; Kapopoulou, A; Brisse, S; Scollard, DM; Gillis, TP; Cole, ST				Truman, Richard W.; Singh, Pushpendra; Sharma, Rahul; Busso, Philippe; Rougemont, Jacques; Paniz-Mondolfi, Alberto; Kapopoulou, Adamandia; Brisse, Sylvain; Scollard, David M.; Gillis, Thomas P.; Cole, Stewart T.			Probable Zoonotic Leprosy in the Southern United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYCOBACTERIUM-LEPRAE; ARMADILLO EXPOSURE; DASYPUS-NOVEMCINCTUS; 9-BANDED ARMADILLO; HANSENS-DISEASE; WILD ARMADILLOS; CONTACT; ASSOCIATION; ORIGIN	BACKGROUND In the southern region of the United States, such as in Louisiana and Texas, there are autochthonous cases of leprosy among native-born Americans with no history of foreign exposure. In the same region, as well as in Mexico, wild armadillos are infected with Mycobacterium leprae. METHODS Whole-genome resequencing of M. leprae from one wild armadillo and three U. S. patients with leprosy revealed that the infective strains were essentially identical. Comparative genomic analysis of these strains and M. leprae strains from Asia and Brazil identified 51 single-nucleotide polymorphisms and an 11-bp insertion-deletion. We genotyped these polymorphic sites, in combination with 10 variable-number tandem repeats, in M. leprae strains obtained from 33 wild armadillos from five southern states, 50 U. S. outpatients seen at a clinic in Louisiana, and 64 Venezuelan patients, as well as in four foreign reference strains. RESULTS The M. leprae genotype of patients with foreign exposure generally reflected their country of origin or travel history. However, a unique M. leprae genotype (3I-2-v1) was found in 28 of the 33 wild armadillos and 25 of the 39 U. S. patients who resided in areas where exposure to armadillo-borne M. leprae was possible. This genotype has not been reported elsewhere in the world. CONCLUSIONS Wild armadillos and many patients with leprosy in the southern United States are infected with the same strain of M. leprae. Armadillos are a large natural reservoir for M. leprae, and leprosy may be a zoonosis in the region.	[Truman, Richard W.; Sharma, Rahul; Scollard, David M.; Gillis, Thomas P.] Louisiana State Univ, Sch Vet Med, Bur Primary Hlth Care,Natl Hansens Dis Program, Hlth Resources & Serv Adm,Dept Hlth & Human Serv, Baton Rouge, LA 70803 USA; [Singh, Pushpendra; Busso, Philippe; Rougemont, Jacques; Kapopoulou, Adamandia; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland; [Rougemont, Jacques; Kapopoulou, Adamandia] Swiss Inst Bioinformat, Lausanne, Switzerland; [Paniz-Mondolfi, Alberto] Inst Biomed, Caracas, Venezuela; [Brisse, Sylvain] Inst Pasteur, Paris, France	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; United States Health Resources & Service Administration (HRSA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Truman, RW (corresponding author), Louisiana State Univ, Sch Vet Med, Bur Primary Hlth Care,Natl Hansens Dis Program, Hlth Resources & Serv Adm,Dept Hlth & Human Serv, Skip Bertman Dr, Baton Rouge, LA 70803 USA.	rtruman@hrsa.gov	SHARMA, RAHUL/F-2691-2013; Singh, Pushpendra/J-6484-2015; Brisse, Sylvain/M-8723-2013; Truman, Richard/E-3025-2013	Singh, Pushpendra/0000-0001-9453-8669; Brisse, Sylvain/0000-0002-2516-2108; 	Fondation Raoul Follereau; American Leprosy Missions; Society of Saint Lazarus; IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) Consortium; Health Resources and Services Administration; National Institutes of Health, National Institute of Allergy and Infectious Diseases [RO1-AI47197-01A1, NIAID IAA-2646]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047197] Funding Source: NIH RePORTER	Fondation Raoul Follereau; American Leprosy Missions; Society of Saint Lazarus; IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) Consortium; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Fondation Raoul Follereau, the American Leprosy Missions, the Society of Saint Lazarus, the IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) Consortium, the Health Resources and Services Administration, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases (grants RO1-AI47197-01A1 and NIAID IAA-2646).; Funded by the National Institute of Allergy and Infectious Diseases and others	Abide JM, 2008, SOUTH MED J, V101, P635, DOI 10.1097/SMJ.0b013e31816f8610; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMEZCUA ME, 1984, INT J LEPROSY, V52, P254; Badger LF, 1955, PUBLIC HEALTH REP, V70, P525, DOI 10.2307/4589124; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Bruce S, 2000, J AM ACAD DERMATOL, V43, P223, DOI 10.1067/mjd.2000.106368; Clark BM, 2008, AM J TROP MED HYG, V78, P962, DOI 10.4269/ajtmh.2008.78.962; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; *DEP HLTH HUM SERV, 2009, SUMM HANS DIS US 200; Deps PD, 2008, INDIAN J DERMATOL VE, V74, P338, DOI 10.4103/0378-6323.42897; FILICE GA, 1977, AM J TROP MED HYG, V26, P137, DOI 10.4269/ajtmh.1977.26.137; Gillis T, 2009, LEPROSY REV, V80, P250; Hall BG, 2010, J CLIN MICROBIOL, V48, P1997, DOI 10.1128/JCM.00149-10; Hamilton HK, 2008, INT J DERMATOL, V47, P545, DOI 10.1111/j.1365-4632.2008.03722.x; KIRCHHEIMER W F, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P693; Lane JE, 2006, J AM ACAD DERMATOL, V55, P714, DOI 10.1016/j.jaad.2006.02.070; Li HT, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/2/025006; Loughry WJ, 2009, J WILDLIFE DIS, V45, P144, DOI 10.7589/0090-3558-45.1.144; LUMPKIN LR, 1983, J AM ACAD DERMATOL, V9, P899, DOI 10.1016/S0190-9622(83)70206-9; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Taulman JF, 1996, J BIOGEOGR, V23, P635, DOI 10.1111/j.1365-2699.1996.tb00024.x; THOMAS DA, 1987, J INFECT DIS, V156, P990, DOI 10.1093/infdis/156.6.990; Truman R, 2005, LEPROSY REV, V76, P198; TRUMAN RW, 1986, AM J TROP MED HYG, V35, P588, DOI 10.4269/ajtmh.1986.35.588; TRUMAN RW, 1991, EPIDEMIOL INFECT, V106, P549, DOI 10.1017/S0950268800067613; WALSH GP, 1986, J LEUKOCYTE BIOL, V40, P645, DOI 10.1002/jlb.40.5.645; Weir BS., 1996, GENETIC DATA ANAL; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P333; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	34	208	218	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1626	1633		10.1056/NEJMoa1010536	http://dx.doi.org/10.1056/NEJMoa1010536			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755NW	21524213	Green Accepted, Bronze			2022-12-24	WOS:000289940400009
J	Jernberg, T; Johanson, P; Held, C; Svennblad, B; Lindback, J; Wallentin, L				Jernberg, Tomas; Johanson, Per; Held, Claes; Svennblad, Bodil; Lindback, Johan; Wallentin, Lars		SWEDEHEART RIKS-HIA	Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							THERAPY; METAANALYSIS; REPERFUSION; OUTCOMES; DISEASE; TRENDS; STATIN	Context Only limited information is available on the speed of implementation of new evidence-based and guideline-recommended treatments and its association with survival in real life health care of patients with ST-elevation myocardial infarction (STEMI). Objective To describe the adoption of new treatments and the related chances of short-and long-term survival in consecutive patients with STEMI in a single country over a 12-year period. Design, Setting, and Participants The Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA) records baseline characteristics, treatments, and outcome of consecutive patients with acute coronary syndrome admitted to almost all hospitals in Sweden. This study includes 61 238 patients with a first-time diagnosis of STEMI between 1996 and 2007. Main Outcome Measures Estimated and crude proportions of patients treated with different medications and invasive procedures and mortality over time. Results Of evidence based-treatments, reperfusion increased from 66% (95%, confidence interval [CI], 52%-79%) to 79% (95% CI, 69%-89%; P<.001), primary percutaneous coronary intervention from 12% (95% CI, 11%-14%) to 61% (95% CI, 45%-77%; P<.001), and revascularization from 10% (96% CI, 6%-14%) to 84% (95% CI, 73%-95%; P<.001). The use of aspirin, clopidogrel, beta-blockers, statins, and angiotensin-converting enzyme (ACE) inhibitors all increased: clopidogrel from 0% to 82% (95% CI, 69%-95%; P<.001), statins from 23% (95% CI, 12%-33%) to 83% (95% CI, 75%-91%; P<.001), and ACE inhibitor or angiotensin II receptor blockers from 39% (95% CI, 26%-52%) to 69% (95% CI, 58%-70%; P<.001). The estimated in-hospital, 30-day and 1-year mortality decreased from 12.5% (95% CI, 4.3%-20.6%) to 7.2% (95% CI, 1.7%-12.6%; P<.001); from 15.0% (95% CI, 6.2%-23.7%) to 8.6% (95% CI, 2.7%-14.5%; P<.001); and from 21.0% (95% CI, 11.0%-30.9%) to 13.3% (95% CI, 6.0%-20.4%; P<.001), respectively. After adjustment, there was still a consistent trend with lower standardized mortality over the years. The 12-year survival analyses showed that the decrease of mortality was sustained over time. Conclusion In a Swedish registry of patients with STEMI, between 1996 and 2007, there was an increase in the prevalence of evidence-based treatments. During this same time, there was a decrease in 30-day and 1-year mortality that was sustained during long-term follow-up. JAMA. 2011;305(16):1677-1684 www.jama.com	[Jernberg, Tomas] Dept Med, Cardiol Sect, Huddinge, Sweden; [Jernberg, Tomas] Karolinska Inst, Karolinska Univ Hosp, S-14186 Huddinge, Sweden; [Johanson, Per] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Held, Claes; Svennblad, Bodil; Lindback, Johan; Wallentin, Lars] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Uppsala University	Jernberg, T (corresponding author), Karolinska Univ Hosp, Dept Cardiol, Huddinge, Sweden.	tomas.jernberg@karolinska.se	Lindbäck, Johan/R-2900-2017; Held, Claes/AAA-3973-2021	Lindbäck, Johan/0000-0002-6473-8798; Held, Claes/0000-0001-9402-7404; Johanson, Per/0000-0001-9802-4147; Jernberg, Tomas/0000-0003-1695-379X	Swedish Heart Lung Foundation; Swedish Association of Local Authorities and Regions	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Association of Local Authorities and Regions	This study was supported by the Swedish Heart Lung Foundation. Financial support for the registry is provided by the Swedish Association of Local Authorities and Regions.	Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; De Luca G, 2005, JAMA-J AM MED ASSOC, V293, P1759, DOI 10.1001/jama.293.14.1759; Fang J, 2010, AM J MED, V123, P259, DOI 10.1016/j.amjmed.2009.08.018; Floyd KC, 2009, CIRC-CARDIOVASC QUAL, V2, P88, DOI 10.1161/CIRCOUTCOMES.108.811828; Flynn MR, 2005, EUR HEART J, V26, P308, DOI 10.1093/eurheartj/ehi079; Franzosi MG, 1998, CIRCULATION, V97, P2202, DOI 10.1161/01.CIR.97.22.2202; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Go AS, 2006, ANN INTERN MED, V144, P229, DOI 10.7326/0003-4819-144-4-200602210-00004; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kushner, 2010, CIRCULATION, V121, pE257, DOI 10.1161/CIR.0b013e3181d7a65e; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Peterson ED, 2010, HEART, V96, P1798, DOI 10.1136/hrt.2010.200261; R Development Core Team, 2009, R FDN STAT COMP; Roger VL, 2010, CIRCULATION, V121, P863, DOI 10.1161/CIRCULATIONAHA.109.897249; Stenestrand U, 2005, AM HEART J, V149, P82, DOI 10.1016/j.ahj.2004.07.018; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430; Thygesen K, 2007, EUR HEART J, V28, P2525; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 2000, EUR HEART J, V21, P1502, DOI 10.1053/eurj.2000.2305	30	279	292	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1677	1684		10.1001/jama.2011.522	http://dx.doi.org/10.1001/jama.2011.522			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521849	Bronze			2022-12-24	WOS:000289890500021
J	Xu, GZ; Lo, YC; Li, QB; Napolitano, G; Wu, XF; Jiang, XL; Dreano, M; Karin, M; Wu, H				Xu, Guozhou; Lo, Yu-Chih; Li, Qiubai; Napolitano, Gennaro; Wu, Xuefeng; Jiang, Xuliang; Dreano, Michel; Karin, Michael; Wu, Hao			Crystal structure of inhibitor of kappa B kinase beta	NATURE			English	Article							UBIQUITIN-LIKE DOMAIN; PROTEIN-KINASE; CATALYTIC SUBUNIT; IKK-BETA; DOCKING INTERACTIONS; COMPLEX; PHOSPHORYLATION; ACTIVATION; ALPHA; BINDING	Inhibitor of kappa B (I kappa B) kinase (IKK) phosphorylates I kappa B proteins, leading to their degradation and the liberation of nuclear factor kappa B for gene transcription. Here we report the crystal structure of IKK beta in complex with an inhibitor, at a resolution of 3.6 angstrom. The structure reveals a trimodular architecture comprising the kinase domain, a ubiquitin-like domain (ULD) and an elongated, alpha-helical scaffold/dimerization domain (SDD). Unexpectedly, the predicted leucine zipper and helix-loop-helix motifs do not form these structures but are part of the SDD. The ULD and SDD mediate a critical interaction with I kappa B alpha that restricts substrate specificity, and the ULD is also required for catalytic activity. The SDD mediates IKK beta dimerization, but dimerization per se is not important for maintaining IKK beta activity and instead is required for IKK beta activation. Other IKK family members, IKK alpha, TBK1 and IKK-i, may have a similar trimodular architecture and function.	[Xu, Guozhou; Lo, Yu-Chih; Li, Qiubai; Wu, Hao] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA; [Napolitano, Gennaro; Wu, Xuefeng; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Jiang, Xuliang] EMD Serono Res Inst, Billerica, MA 01821 USA; [Dreano, Michel] Merck Serono, CH-1211 Geneva, Switzerland	Cornell University; University of California System; University of California San Diego; Merck KGaA; EMD Serono Inc.	Wu, H (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA.	haowu@med.cornell.edu	Napolitano, Gennaro/O-5377-2016; Wu, Xuefeng/F-5003-2011	Napolitano, Gennaro/0000-0002-8615-4654	National Institutes of Health; American Heart Association; Cancer Research Institute; American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079260, R01AI050872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Cancer Research Institute; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Rajashankar and N. Sukumar for data collection at the NE-CAT of APS, B. Schwer for help with the kinase assay, P. Gaillard for help with the chemistry and G. Ahlsen, L. Shapiro and B. Honig for the ultracentrifugation experiments. This work was supported by the National Institutes of Health (H. W. and M. K.), the American Heart Association (G. X. and Y.-C.L.) and the Cancer Research Institute (Y.-C.L.). M. K. is an American Cancer Society Research Professor.	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARROGA CF, 1995, P NATL ACAD SCI USA, V92, P7637, DOI 10.1073/pnas.92.17.7637; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; DeLano W.L., 2002, PYMOL MOL VIEWER; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; May MJ, 2004, J BIOL CHEM, V279, P45528, DOI 10.1074/jbc.M408579200; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shaul JD, 2008, BIOCHEM BIOPH RES CO, V374, P592, DOI 10.1016/j.bbrc.2008.07.082; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Tang ED, 2003, J BIOL CHEM, V278, P49661; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xu RM, 1996, P NATL ACAD SCI USA, V93, P6308, DOI 10.1073/pnas.93.13.6308; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	50	141	145	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					325	U222		10.1038/nature09853	http://dx.doi.org/10.1038/nature09853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21423167	Green Accepted			2022-12-24	WOS:000289724600034
J	Herr, HW				Herr, Harry W.			Intravesical Bacille Calmette-Guerin in Patients With Asymptomatic Bacteriuria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Herr, HW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Urol, 1275 York Ave, New York, NY 10021 USA.	herrh@mskcc.org						Billips BK, 2007, INFECT IMMUN, V75, P5353, DOI 10.1128/IAI.00922-07; Gross PA, 2007, CLIN INFECT DIS, V45, P1335, DOI 10.1086/522183; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Schaeffer EM, 2006, NAT CLIN PRACT UROL, V3, P24, DOI 10.1038/ncpuro0357	4	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1413	1414		10.1001/jama.2011.428	http://dx.doi.org/10.1001/jama.2011.428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486973	Bronze			2022-12-24	WOS:000289424100016
J	Buiting, HM; Rurup, ML; Wijsbek, H; van Zuylen, L; den Hartogh, G				Buiting, Hilde M.; Rurup, Mette L.; Wijsbek, Henri; van Zuylen, Lia; den Hartogh, Govert			Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To examine health professionals' experiences of and attitudes towards the provision of chemotherapy to patients with end stage cancer. Design Purposive, qualitative design based on in-depth interviews. Setting Oncology departments at university hospitals and general hospitals in the Netherlands. Participants 14 physicians and 13 nurses who cared for patients with metastatic cancer. Results Physicians and nurses reported trying to inform patients fully about their poor prognosis and treatment options. They would carefully consider the (side) effects of chemotherapy and sometimes doubted whether further treatment would contribute to patients' quality of life. Both groups considered the patients' wellbeing to be important, and physicians seemed inclined to try to preserve this by offering further chemotherapy, often followed by the patient. Nurses were more often inclined to express their doubts about further treatment, preferring to allow patients to make the best use of the time that is left. When confronted with a treatment dilemma and a patient's wish for treatment, physicians preferred to make compromises, such as by "trying out one dose." Discussing death or dying with patients while at the same time administering chemotherapy was considered contradictory as this could diminish the patients' hope. Conclusions The trend to greater use of chemotherapy at the end of life could be explained by patients' and physicians' mutually reinforcing attitudes of "not giving up" and by physicians' broad interpretation of patients' quality of life, in which taking away patients' hope by withholding treatment is considered harmful. To rebalance the ratio of quantity of life to quality of life, input from other health professionals, notably nurses, may be necessary.	[Buiting, Hilde M.; Rurup, Mette L.; Wijsbek, Henri; den Hartogh, Govert] Univ Amsterdam, Dept Philosophy, Oude Turfmarkt 141-147, NL-1012 GC Amsterdam, Netherlands; [van Zuylen, Lia] Univ Med Ctr, Erasmus MC, Dept Med Oncol, POB 2040, NL-3000 CA Rotterdam, Netherlands	University of Amsterdam; Erasmus University Rotterdam; Erasmus MC	Buiting, HM (corresponding author), Univ Amsterdam, Dept Philosophy, Oude Turfmarkt 141-147, NL-1012 GC Amsterdam, Netherlands.	h.m.buiting@uva.nl			ZonMw, the Netherlands Organization for Health Research and Development [70-71300-98-048]	ZonMw, the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This study was supported by a grant from ZonMw, the Netherlands Organization for Health Research and Development ( grant No 70-71300-98-048). The study sponsor had no role in the study design; collection, analysis, and interpretation of the data; or in the writing of the article and decision to submit the article for publication.	Ablin RJ, 2010, ARCH INTERN MED, V170, P1397, DOI 10.1001/archinternmed.2010.290; Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA, Vseventh; Braga S, 2007, PSYCHO-ONCOL, V16, P863, DOI 10.1002/pon.1140; Breier-Mackie S, 2001, NURS ETHICS, V8, P510, DOI 10.1191/096973301682553805; Buiting HM, 2008, EUR J PUBLIC HEALTH, V18, P681, DOI 10.1093/eurpub/ckn084; de Kort SJ, 2010, HEALTH CARE ANAL, V18, P164, DOI 10.1007/s10728-009-0121-4; Dreyer A, 2009, J MED ETHICS, V35, P672, DOI 10.1136/jme.2009.030668; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Fishman J, 2010, ARCH INTERN MED, V170, P515, DOI 10.1001/archinternmed.2010.11; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Grant L, 2010, BMJ-BRIT MED J, V341, pc4859; Kirk P, 2004, BMJ-BRIT MED J, V328, P1343, DOI 10.1136/bmj.38103.423576.55; LANTOS JD, 1989, AM J MED, V87, P81; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Punt CJA, 1998, CANCER-AM CANCER SOC, V83, P679, DOI 10.1002/(SICI)1097-0142(19980815)83:4<679::AID-CNCR8>3.0.CO;2-F; Ritchie J, 2007, QUALITATIVE RES PRAC; SCHNEIDERMAN LJ, 1993, ARCH INTERN MED, V153, P437, DOI 10.1001/archinte.153.4.437; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Spencer L, 2007, QUALITATIVE RES PRAC; STEWARD WP, 1995, ANN ONCOL, V6, P49; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; van Leeunven AF, 2004, J PAIN SYMPTOM MANAG, V28, P351, DOI 10.1016/j.jpainsymman.2004.01.005; Vos T, 2009, THESIS U AMSTERDAM; Zanchetta Margareth S, 2006, Clin J Oncol Nurs, V10, P803, DOI 10.1188/06.CJON.803-807	28	70	70	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2011	342								d1933	10.1136/bmj.d1933	http://dx.doi.org/10.1136/bmj.d1933			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44GZ	21464103	Green Published			2022-12-24	WOS:000209738800001
J	Hocking, MD; Reynolds, JD				Hocking, Morgan D.; Reynolds, John D.			Impacts of Salmon on Riparian Plant Diversity	SCIENCE			English	Article							PACIFIC SALMON; MYCORRHIZAL FUNGI; FRESH-WATER; NITROGEN; NUTRIENT; FORESTS; PRODUCTIVITY; ECOSYSTEMS; ABUNDANCE; DYNAMICS	The study of natural gradients in nutrient subsidies between ecosystems allows for predictions of how changes in one system can affect biodiversity in another. We performed a large-scale empirical test of the role of Pacific salmon (Oncorhynchus spp.) in structuring riparian plant communities. A comparison of 50 watersheds in the remote Great Bear Rainforest of British Columbia's central coast in Canada shows that salmon influence nutrient loading to plants, shifting plant communities toward nutrient-rich species, which in turn decreases plant diversity. These effects are mediated by interactions between salmon density and the physical characteristics of watersheds. Predicting how salmon affect terrestrial ecosystems is central to conservation plans that aim to better integrate ecosystem values into resource management.	[Hocking, Morgan D.; Reynolds, John D.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Hocking, MD (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	mhocking@sfu.ca	Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074	Simon Fraser University (SFU); Natural Science and Engineering Research Council of Canada (NSERC); B.C. Leading Edge Endowment Fund; Pacific Salmon Foundation; B.C. Pacific Salmon Forum; Mountain Equipment Co-op	Simon Fraser University (SFU); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); B.C. Leading Edge Endowment Fund; Pacific Salmon Foundation; B.C. Pacific Salmon Forum; Mountain Equipment Co-op	Supported by the Tom Buell Endowment Fund at Simon Fraser University (SFU), a Natural Science and Engineering Research Council of Canada (NSERC) postdoctoral fellowship (M. D. H.), NSERC Discovery and Accelerator grants (J.D.R.), the B.C. Leading Edge Endowment Fund, the Pacific Salmon Foundation, the B.C. Pacific Salmon Forum, and Mountain Equipment Co-op. We thank C. Aries for plant surveys; D. Braun, A. Cooper, E. Darling, N. Dulvy, R. Field, J. Harding, J. Linton, M. Stubbs, W. Palen, J. Verspoor, and the Earth<INF>2</INF>Ocean Research Group at SFU for discussions and analytical support; A. Albright, J. Barlow, J. Beaudin, J. Gordon-Walker, I. Jansma, E. Nelson, M. Spoljaric, J. Wilson, and the Raincoast Conservation Foundation for field support; R. Carpenter, M. Reid, and others at the Heiltsuk Integrated Resource Management Department; L. Jorgenson from Qqs Projects Society in Bella Bella; and the Heiltsuk Nation for research partnerships in their traditional territory.	ALABACK PB, 1982, ECOLOGY, V63, P1932, DOI 10.2307/1940131; Bartz KK, 2005, ECOSYSTEMS, V8, P529, DOI 10.1007/s10021-005-0064-z; Bilby RE, 1996, CAN J FISH AQUAT SCI, V53, P164, DOI 10.1139/cjfas-53-1-164; Bilby RE, 2001, FISHERIES, V26, P6, DOI 10.1577/1548-8446(2001)026<0006:PEOTUO>2.0.CO;2; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Darimont CT, 2010, CONSERV LETT, V3, P379, DOI 10.1111/j.1755-263X.2010.00145.x; Darimont Chris T., 2008, BMC Ecology, V8, P14, DOI 10.1186/1472-6785-8-14; DFO, 2005, FISH OC CAN; Diez JM, 2007, ECOLOGY, V88, P3144, DOI 10.1890/07-0047.1; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Helfield JM, 2002, OECOLOGIA, V133, P573, DOI 10.1007/s00442-002-1070-x; Hobbie EA, 2008, ECOSYSTEMS, V11, P815, DOI 10.1007/s10021-008-9159-7; Hocking MD, 2009, OIKOS, V118, P1307, DOI 10.1111/j.1600-0706.2009.17302.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Janetski DJ, 2009, OECOLOGIA, V159, P583, DOI 10.1007/s00442-008-1249-x; Klinka K., 1989, INDICATOR PLANTS COA; Kranabetter JM, 2010, ECOSYSTEMS, V13, P108, DOI 10.1007/s10021-009-9304-y; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; Maron JL, 2006, ECOL MONOGR, V76, P3, DOI 10.1890/05-0496; Moore JW, 2007, ECOLOGY, V88, P1278, DOI 10.1890/06-0782; Moore JW, 2004, CAN J FISH AQUAT SCI, V61, P1582, DOI [10.1139/f04-103, 10.1139/F04-103]; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Pinay G, 2003, ECOSYSTEMS, V6, P336, DOI 10.1007/s10021-002-0169-6; POJAR J, 1987, FOREST ECOL MANAG, V22, P119, DOI 10.1016/0378-1127(87)90100-9; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Price MHH, 2008, CAN J FISH AQUAT SCI, V65, P2712, DOI 10.1139/F08-174; Reimchen TE, 2000, CAN J ZOOL, V78, P448, DOI 10.1139/cjz-78-3-448; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Tiegs SD, 2008, ECOL APPL, V18, P4, DOI 10.1890/07-0655.1; Verspoor JJ, 2010, ECOSYSTEMS, V13, P1020, DOI 10.1007/s10021-010-9371-0; Wilkinson CE, 2005, OIKOS, V108, P85, DOI 10.1111/j.0030-1299.2005.13277.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zuur Alain F., 2009, P1	35	134	139	4	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1609	1612		10.1126/science.1201079	http://dx.doi.org/10.1126/science.1201079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21442794				2022-12-24	WOS:000288754500057
J	Chabner, BA				Chabner, Bruce A.			Early Accelerated Approval for Highly Targeted Cancer Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INHIBITION		Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Chabner, BA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.							Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Kwak EL, 2011, NEW ENGL J MED, V364, P588; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; McClellan M, 2011, NAT REV DRUG DISCOV, V10, P79, DOI 10.1038/nrd3360; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Sequist, 2008, J CLIN ONCOL, V26, P3472, DOI 10.1200/JCO.2008.18.4747; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494	7	64	65	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1087	1089		10.1056/NEJMp1100548	http://dx.doi.org/10.1056/NEJMp1100548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FY	21428763				2022-12-24	WOS:000288701100002
J	Janssens, ACJW; Ioannidis, JPA; van Duijn, CM; Little, J; Khoury, MJ				Janssens, A. Cecile J. W.; Ioannidis, John P. A.; van Duijn, Cornelia M.; Little, Julian; Khoury, Muin J.		GRIPS Grp	Strengthening the Reporting of Genetic Risk Prediction Studies: The GRIPS Statement	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER; EPIDEMIOLOGY; ASSOCIATION; MARKER; CURVE		[Janssens, A. Cecile J. W.; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Little, Julian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; [Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA 30333 USA	Erasmus University Rotterdam; Erasmus MC; University of Ioannina; University of Ottawa; Centers for Disease Control & Prevention - USA	Janssens, ACJW (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.janssens@erasmusmc.nl	Little, Julian/AAR-6117-2020; Ioannidis, John P. A./G-9836-2011; janssens, cecile c/L-1075-2015	Little, Julian/0000-0001-5026-5531; Van Duijn, Cornelia/0000-0002-2374-9204; Dolan, Siobhan/0000-0001-8890-8045; Janssens, A Cecile/0000-0002-6153-4976	Centers for Disease Control and Prevention; Erasmus University Medical Center; Center for Medical Systems Biology in the framework of the Netherlands Genomics Initiative; Netherlands Organisation for Scientific Research; Tufts Clinical and Translational Science Institute; National Institutes of Health, National Center for Research Resources [UL1 RR025752]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Erasmus University Medical Center; Center for Medical Systems Biology in the framework of the Netherlands Genomics Initiative; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Tufts Clinical and Translational Science Institute; National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The Centers for Disease Control and Prevention sponsored the workshop on behalf of the Human Genome Epidemiology Network. Dr. Janssens is supported by grants from Erasmus University Medical Center, the Center for Medical Systems Biology in the framework of the Netherlands Genomics Initiative, and the VIDI grant of the Netherlands Organisation for Scientific Research. Dr. Ioannidis is supported by Tufts Clinical and Translational Science Institute, which is supported by the National Institutes of Health, National Center for Research Resources (UL1 RR025752). Dr. Little holds a Canada Research Chair in Human Genome Epidemiology. The funding sources had no role in the study design, data collection, analysis, preparation of the manuscript, or decision to submit the manuscript for publication.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Freedman AN, 2005, JNCI-J NATL CANCER I, V97, P715, DOI 10.1093/jnci/dji128; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Janssens ACJW, 2010, CIRC-CARDIOVASC GENE, V3, P3, DOI 10.1161/CIRCGENETICS.110.938092; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Khoury MJ, 1998, AM J EPIDEMIOL, V148, P1; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Khoury MJ, 2010, AM J EPIDEMIOL, V172, P517, DOI 10.1093/aje/kwq211; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Kyzas PA, 2007, JNCI-J NATL CANCER I, V99, P236, DOI 10.1093/jnci/djk032; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2700, 10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Vandenbrouke JP, 2009, J CLIN EPIDEMIOL, V62, P594, DOI 10.1016/j.jclinepi.2008.12.003; von Elm E, 2004, BMJ-BRIT MED J, V329, P868, DOI 10.1136/bmj.329.7471.868; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	24	16	16	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6					421	+		10.7326/0003-4819-154-6-201103150-00008	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734WA	21403077				2022-12-24	WOS:000288370000006
J	Rex, DK				Rex, Douglas K.			Effect of the Centers for Medicare & Medicaid Services Policy About Deep Sedation on Use of Propofol	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OUTPATIENT COLONOSCOPY; ENDOSCOPY; NURSES; GASTROENTEROLOGY	On 11 December 2009, the Centers for Medicare & Medicaid Services issued a policy stating that deep sedation can only be administered by an anesthesiologist, a certified registered nurse anesthetist, or a trained medical doctor or a doctor of osteopathy not involved in the performance of a medical procedure. Propofol is a popular sedation agent that is usually administered by anesthesia specialists in a service termed monitored anesthesia care (MAC). Monitored anesthesia care adds substantial new fees to procedural sedation. However, available evidence shows that propofol can be used safely by nonanesthesiologists for procedural sedation. The American Society of Anesthesiologists considers that propofol implies deep sedation and should only be administered by anesthesia specialists. The Centers for Medicare & Medicaid Services policy on deep sedation can be viewed as supporting an ongoing conversion to MAC to deliver propofol for procedural sedation. However, the absence of an evidence base supporting a need for MAC to deliver propofol, combined with its high cost, suggests that alternatives to MAC to deliver propofol deserve fair and balanced evaluation.	[Rex, Douglas K.] Indiana Univ Hosp, Indianapolis, IN 46202 USA	Indiana University System	Rex, DK (corresponding author), Indiana Univ Hosp, 4100,550 N Univ Blvd, Indianapolis, IN 46202 USA.	drex@iupui.edu						*AM ASS NURS AN FE, 2009, CMS REPL AN INT GUID; *AM MED ASS, 2010, CPT STAND ED 2010, P416; *AM SOC AN, STAT GRANT PRIV NON; *AM SOC AN, POL PROC GOV AN PRIV; American Society of Anesthesiologists, STAT SAF US PROP; Bhananker SM, 2006, ANESTHESIOLOGY, V104, P228, DOI 10.1097/00000542-200602000-00005; Brill Joel V, 2008, Gastrointest Endosc Clin N Am, V18, P665, DOI 10.1016/j.giec.2008.06.012; Byrne MF, 2008, CAN J GASTROENTEROL, V22, P457, DOI 10.1155/2008/268320; Chutkan R, 2004, GASTROINTEST ENDOSC, V60, P167, DOI 10.1016/S0016-5107(04)01699-2; *CMS, CMS PUBL; Cohen LB, 2006, AM J GASTROENTEROL, V101, P967, DOI 10.1111/j.1572-0241.2006.00500.x; Cohen LB, 2004, GASTROINTEST ENDOSC, V59, P795, DOI 10.1016/S0016-5107(04)00349-9; Cote GA, 2010, CLIN GASTROENTEROL H, V8, P137, DOI 10.1016/j.cgh.2009.07.008; Dumonceau JM, 2010, ENDOSCOPY, V42, P960, DOI 10.1055/s-0030-1255728; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; Inadomi JM, 2010, GASTROINTEST ENDOSC, V72, P580, DOI 10.1016/j.gie.2010.04.040; Jain R, 2010, GASTROINTEST ENDOSC, V72, P469, DOI 10.1016/j.gie.2010.02.017; KAYE JM, 2005, SURGISTRATEGIES; Knape JTA, 2007, EUR J ANAESTH, V24, P563, DOI 10.1017/S0265021506002092; Pambianco DJ, 2011, GASTROINTEST ENDOSC, V73, P765, DOI 10.1016/j.gie.2010.10.031; Patel S, 2005, AM J GASTROENTEROL, V100, P2689, DOI 10.1111/j.1572-0241.2005.00320.x; Rex DK, 2009, GASTROENTEROLOGY, V137, P1229, DOI 10.1053/j.gastro.2009.06.042; Riphaus A, 2009, ENDOSCOPY, V41, P787, DOI 10.1055/s-0029-1215035; Sharma VK, 2007, GASTROINTEST ENDOSC, V66, P27, DOI 10.1016/j.gie.2006.12.040; Sipe BW, 2002, GASTROINTEST ENDOSC, V55, P815, DOI 10.1067/mge.2002.124636; Symington L, 2006, EMERG MED J, V23, P89, DOI 10.1136/emj.2005.023713; Ulmer BJ, 2003, CLIN GASTROENTEROL H, V1, P425, DOI 10.1016/S1542-3565(03)00226-X; VanNatta ME, 2006, AM J GASTROENTEROL, V101, P2209, DOI 10.1111/j.1572-0241.2006.00760.x; Vargo JJ, 2009, GASTROENTEROLOGY, V137, P2161, DOI 10.1053/j.gastro.2009.09.050	29	36	36	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					622	626		10.7326/0003-4819-154-9-201105030-00007	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21536938				2022-12-24	WOS:000290112300005
J	Peralta, CA; Shlipak, MG; Judd, S; Cushman, M; McClellan, W; Zakai, NA; Safford, MM; Zhang, XA; Muntner, P; Warnock, D				Peralta, Carmen A.; Shlipak, Michael G.; Judd, Suzanne; Cushman, Mary; McClellan, William; Zakai, Neil A.; Safford, Monika M.; Zhang, Xiao; Muntner, Paul; Warnock, David			Detection of Chronic Kidney Disease With Creatinine, Cystatin C, and Urine Albumin-to-Creatinine Ratio and Association With Progression to End-Stage Renal Disease and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; RACIAL-DIFFERENCES; CARDIOVASCULAR EVENTS; US ADULTS; ALL-CAUSE; REASONS; STROKE; RISK; GFR; POPULATION	Context A triple-marker approach for chronic kidney disease (CKD) evaluation has not been well studied. Objective To evaluate whether combining creatinine, cystatin C, and urine albumin-to-creatinine ratio (ACR) would improve identification of risks associated with CKD compared with creatinine alone. Design, Setting, and Participants Prospective cohort study involving 26 643 US adults enrolled in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study from January 2003 to June 2010. Participants were categorized into 8 groups defined by estimated glomerular filtration rate (GFR) determined by creatinine and by cystatin C of either <60 or >= 60 mL/min/1.73 m(2) and ACR of either <30 or >= 30 mg/g. Main Outcome Measures All-cause mortality and incident end-stage renal disease with median follow-up of 4.6 years. Results Participants had a mean age of 65 years, 40% were black, and 54% were women. Of 26 643 participants, 1940 died and 177 developed end-stage renal disease. Among participants without CKD defined by creatinine, 24% did not have CKD by either ACR or cystatin C. Compared with those with CKD defined by creatinine alone, the hazard ratio for death in multivariable-adjusted models was 3.3 (95% confidence interval [CI], 2.0-5.6) for participants with CKD defined by creatinine and ACR; 3.2 (95% CI, 2.2-4.7) for those with CKD defined by creatinine and cystatin C, and 5.6 (95% CI, 3.9-8.2) for those with CKD defined by all biomarkers. Among participants without CKD defined by creatinine, 3863 (16%) had CKD detected by ACR or cystatin C. Compared with participants who did not have CKD by any measure, the HRs for mortality were 1.7 (95% CI, 1.4-1.9) for participants with CKD defined by ACR alone, 2.2 (95% CI, 1.9-2.7) for participants with CKD defined by cystatin C alone, and 3.0 (95% CI, 2.4-3.7) for participants with CKD defined by both measures. Risk of incident end-stage renal disease was higher among those with CKD defined by all markers (34.1 per 1000 person-years; 95% CI, 28.7-40.5 vs 0.33 per 1000 person-years; 95% CI, 0.05-2.3) for those with CKD defined by creatinine alone. The second highest end-stage renal disease rate was among persons missed by the creatinine measure but detected by both ACR and cystatin C (rate per 1000 person-years, 6.4; 95% CI, 3.6-11.3). Net reclassification improvement for death was 13.3% (P<.001) and for end-stage renal disease was 6.4% (P<.001) after adding estimated GFR cystatin C in fully adjusted models with estimated GFR creatinine and ACR. Conclusion Adding cystatin C to the combination of creatinine and ACR measures improved the predictive accuracy for all-cause mortality and end-stage renal disease.	[Peralta, Carmen A.; Shlipak, Michael G.] San Francisco VA Med Ctr, Dept Med, San Francisco, CA USA; [Peralta, Carmen A.; Shlipak, Michael G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Judd, Suzanne; Zhang, Xiao] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL USA; [Muntner, Paul] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL USA; [Safford, Monika M.; Warnock, David] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Cushman, Mary; Zakai, Neil A.] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Cushman, Mary; Zakai, Neil A.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [McClellan, William] Emory Univ, Dept Med, Atlanta, GA 30322 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Vermont; University of Vermont; Emory University	Peralta, CA (corresponding author), 4150 Clement St,111A1, San Francisco, CA 94121 USA.	carmenalicia.peralta@ucsf.edu		Cushman, Mary/0000-0002-7871-6143	Amgen; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services [U01 NS041588]; Amgen Corp.; National Institutes of Diabetes and Digestive and Kidney Diseases [1K23SK082793-01]; Robert Wood Johnson Harold Amos award; American Heart Association [0640012N];  [R01AG034853];  [R01DK066488];  [R01HL085757];  [R01DK078124];  [R21HL091217]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091217, R01HL085757, R01HL080477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK095877, R01DK078124, R01DK066488, K23DK082793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034853] Funding Source: NIH RePORTER	Amgen(Amgen); National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Amgen Corp.; National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Robert Wood Johnson Harold Amos award; American Heart Association(American Heart Association); ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Warnock reported that he is a consultant for Amgen Corp and has received research support from Amgen. Dr Cushman reported receiving research support from Amgen. Dr McClellen reported receiving research support from Amgen. Otherwise, no other conflicts of interest were reported.; This research project is supported by cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services. Additional funding was provided by an investigator-initiated grant-in-aid from Amgen Corp. Dr Peralta is funded by the National Institutes of Diabetes and Digestive and Kidney Diseases grant 1K23SK082793-01 and a Robert Wood Johnson Harold Amos award. Dr Shlipak is funded by grants R01AG034853 (PI), R01DK066488 (PI), R01HL085757 (Co-Investigator), R01DK078124 (Co-Investigator), and R21HL091217 (Co-Investigator) and by an American Heart Association Established Investigator Award (0640012N; PI)	Bakris GL, 2010, LANCET, V375, P1173, DOI 10.1016/S0140-6736(09)62100-0; Bauer C, 2008, J AM SOC NEPHROL, V19, P844, DOI 10.1681/ASN.2008010110; Couser WG, 2007, J AM SOC NEPHROL, V18, P2803, DOI 10.1681/ASN.2007080964; de Jong PE, 2008, NEPHROL DIAL TRANSPL, V23, P1092, DOI 10.1093/ndt/gfn028; den Hartog JR, 2009, CLIN J AM SOC NEPHRO, V4, P419, DOI 10.2215/CJN.04080808; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foley RN, 2009, CLIN J AM SOC NEPHRO, V4, P965, DOI 10.2215/CJN.05281008; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Jaar BG, 2008, CLIN J AM SOC NEPHRO, V3, P601, DOI 10.2215/CJN.02540607; Kwong YT, 2010, AM J KIDNEY DIS, V56, P39, DOI 10.1053/j.ajkd.2010.02.347; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, AM J KIDNEY DIS, V53, pS4, DOI 10.1053/j.ajkd.2008.07.048; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McClellan W, 2007, J AM SOC NEPHROL, V18, P1344, DOI 10.1681/ASN.2006090952; Menon V, 2008, KIDNEY INT, V73, P1310, DOI 10.1038/ki.2008.67; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Peralta CA, 2011, J AM SOC NEPHROL, V22, P147, DOI 10.1681/ASN.2010050483; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak MG, 2006, ANN INTERN MED, V145, P237, DOI 10.7326/0003-4819-145-4-200608150-00003; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Tamura MK, 2008, AM J KIDNEY DIS, V52, P227, DOI 10.1053/j.ajkd.2008.05.004; Tonelli M, 2011, ANN INTERN MED, V154, P12, DOI 10.7326/0003-4819-154-1-201101040-00003; Warnock DG, 2010, AM J KIDNEY DIS, V56, P861, DOI 10.1053/j.ajkd.2010.05.017; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	32	320	330	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1545	1552		10.1001/jama.2011.468	http://dx.doi.org/10.1001/jama.2011.468			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21482744	Green Accepted, Bronze			2022-12-24	WOS:000289683000023
J	Staton, TL; Lazarevic, V; Jones, DC; Lanser, AJ; Takagi, T; Ishii, S; Glimcher, LH				Staton, Tracy L.; Lazarevic, Vanja; Jones, Dallas C.; Lanser, Amanda J.; Takagi, Tsuyoshi; Ishii, Shunsuke; Glimcher, Laurie H.			Dampening of death pathways by schnurri-2 is essential for T-cell development	NATURE			English	Article							NEGATIVE SELECTION; POSITIVE SELECTION; THYMOCYTE DEVELOPMENT; BH3-ONLY PROTEINS; MURINE SCHNURRI-2; TRANSGENIC MICE; BCL-2 FAMILY; APOPTOSIS; ANTIGEN; BIM	Generation of a diverse and self-tolerant T-cell repertoire requires appropriate interpretation of T-cell antigen receptor (TCR) signals by CD4(+)CD8(+) double-positive thymocytes. Thymocyte cell fate is dictated by the nature of TCR-major-histocompatibility-complex (MHC)-peptide interactions, with signals of higher strength leading to death (negative selection) and signals of intermediate strength leading to differentiation (positive selection)(1). Molecules that regulate T-cell development by modulating TCR signal strength have been described but components that specifically define the boundaries between positive and negative selection remain unknown. Here we show in mice that repression of TCR-induced death pathways is critical for proper interpretation of positive selecting signals in vivo, and identify schnurri-2 (Shn2; also known as Hivep2) as a crucial death dampener. Our results indicate that Shn2(-/-) double-positive thymocytes inappropriately undergo negative selection in response to positive selecting signals, thus leading to disrupted T-cell development. Shn2(-/-) double-positive thymocytes are more sensitive to TCR-induced death in vitro and die in response to positive selection interactions in vivo. However, Shn2-deficient thymocytes can be positively selected when TCR-induced death is genetically ablated. Shn2 levels increase after TCR stimulation, indicating that integration of multiple TCR-MHC-peptide interactions may fine-tune the death threshold. Mechanistically, Shn2 functions downstream of TCR proximal signalling compenents to dampen Bax activation and the mitochondrial death pathway. Our findings uncover a critical regulator of T-cell development that controls the balance between death and differentiation.	[Staton, Tracy L.; Lazarevic, Vanja; Jones, Dallas C.; Lanser, Amanda J.; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Takagi, Tsuyoshi; Ishii, Shunsuke] RIKEN Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan; [Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Glimcher, Laurie H.] Ragon Inst MGH MIT & Harvard, Charlestown, MA 02129 USA	Harvard University; Harvard T.H. Chan School of Public Health; RIKEN; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu	Ishii, Shunsuke/A-5271-2016; Lazarevic, Vanja/B-1160-2009	Ishii, Shunsuke/0000-0002-6530-2478; Lazarevic, Vanja/0000-0002-5783-7130	National Institutes of Health [AI29673, K99AR055668]; NATIONAL CANCER INSTITUTE [ZIABC011431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, R01AI029673, P30AI060354, R37AI029673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR055668] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23370079, 23659244] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank R. Davis for providing Bim phospho-Thr-112 specific antibody; R. Germain for providing DAP3 and P139 cell lines; M. Winslow and E. Gallo for critical reading of the manuscript and valuable comments. T.L.S. is a Fellow of the Leukemia and Lymphoma Society and V.L. was a Fellow of the Irvington Institute. Supported by the National Institutes of Health grant AI29673 (L.H.G.) and K99AR055668 (D.C.J.).	ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Cainan B. J., 1995, IMMUNITY, V3, P273, DOI DOI 10.1016/1074-7613(95)90113-2; Cante-Barrett K, 2006, J IMMUNOL, V176, P2299, DOI 10.4049/jimmunol.176.4.2299; Ebert PJR, 2008, IMMUNITY, V29, P734, DOI 10.1016/j.immuni.2008.09.014; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; GLIMCHER LH, 1982, NATURE, V298, P283, DOI 10.1038/298283a0; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Jones DC, 2010, P NATL ACAD SCI USA, V107, P8254, DOI 10.1073/pnas.1003727107; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kimura MY, 2007, J IMMUNOL, V178, P4926, DOI 10.4049/jimmunol.178.8.4926; Kimura MY, 2005, J EXP MED, V201, P397, DOI 10.1084/jem.20040733; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Liang J, 2003, DEVELOPMENT, V130, P6453, DOI 10.1242/dev.00863; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Naeher D, 2007, J EXP MED, V204, P2553, DOI 10.1084/jem.20070254; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Takagi T, 2001, NAT IMMUNOL, V2, P1048, DOI 10.1038/ni728; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001	30	31	31	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					105	U138		10.1038/nature09848	http://dx.doi.org/10.1038/nature09848			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475200	Green Accepted			2022-12-24	WOS:000289199400046
J	Brower, V				Brower, Vicki			EPIGENETICS Unravelling the cancer code	NATURE			English	Editorial Material							METHYLATION; CARCINOMA; GENE											Brait M, 2009, CANCER EPIDEM BIOMAR, V18, P2984, DOI 10.1158/1055-9965.EPI-08-1245; Christensen BC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001043; Frank B., 2010, CANC GENETICS, V127, P2822; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366; Slattery ML, 2011, CANCER EPIDEM BIOMAR, V20, P57, DOI 10.1158/1055-9965.EPI-10-0843	7	48	49	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S12	S13		10.1038/471S12a	http://dx.doi.org/10.1038/471S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430711	Bronze			2022-12-24	WOS:000288702200012
J	Lord, C; Bhandari, D; Menon, S; Ghassemian, M; Nycz, D; Hay, J; Ghosh, P; Ferro-Novick, S				Lord, Christopher; Bhandari, Deepali; Menon, Shekar; Ghassemian, Majid; Nycz, Deborah; Hay, Jesse; Ghosh, Pradipta; Ferro-Novick, Susan			Sequential interactions with Sec23 control the direction of vesicle traffic	NATURE			English	Article							CASEIN KINASE-I; ENDOPLASMIC-RETICULUM; COPII VESICLE; INTERMEDIATE COMPARTMENT; NEGATIVE REGULATION; PROTEIN-TRANSPORT; GOLGI TRANSPORT; COAT; COMPLEX; BINDING	How the directionality of vesicle traffic is achieved remains an important unanswered question in cell biology. The Sec23p/Sec24p coat complex sorts the fusion machinery (SNAREs) into vesicles as they bud from the endoplasmic reticulum (ER). Vesicle tethering to the Golgi begins when the tethering factor TRAPPI binds to Sec23p. Where the coat is released and how this event relates to membrane fusion is unknown. Here we use a yeast transport assay to demonstrate that an ER-derived vesicle retains its coat until it reaches the Golgi. A Golgi-associated kinase, Hrr25p (CK1 delta orthologue), then phosphorylates the Sec23p/Sec24p complex. Coat phosphorylation and dephosphorylation are needed for vesicle fusion and budding, respectively. Additionally, we show that Sec23p interacts in a sequential manner with different binding partners, including TRAPPI and Hrr25p, to ensure the directionality of ER-Golgi traffic and prevent the back-fusion of a COPII vesicle with the ER. These events are conserved in mammalian cells.	[Lord, Christopher; Bhandari, Deepali; Menon, Shekar; Ferro-Novick, Susan] Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, Biomol & Prote Mass Spectrometry Facil, La Jolla, CA 92093 USA; [Nycz, Deborah; Hay, Jesse] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Ghosh, Pradipta] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Montana System; University of Montana; University of California System; University of California San Diego	Ferro-Novick, S (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	sfnovick@ucsd.edu	Lord, Christopher/AAX-7130-2021; Lord, Christopher/B-3295-2012	Lord, Christopher/0000-0003-0820-8298; Lord, Christopher/0000-0002-3226-0515	Howard Hughes Medical Institute; Burroughs Wellcome Fund; SRP Super Fund Research Program; National Institutes of Health [GM-059378, RR-015583]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059378] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); SRP Super Fund Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Schekman, M. Cyert, L. Miller, B. Glick, M. Lowe and E. Mizuno-Yamasaki for strains, constructs, purified protein and antibody; K. Reinisch for discussions; S. Chen, H. Cai and M. Garcia-Marcos for advice; W. Zhou and A. Lougheed for technical assistance. This work was supported by the Howard Hughes Medical Institute. Salary support for S.F.-N., D.B. and S.M. was provided by the Howard Hughes Medical Institute, P.G. was funded by the Burroughs Wellcome Fund and M.G. by the SRP Super Fund Research Program. Work at the University of Montana was supported by National Institutes of Health grant GM-059378 (to J.C.H.) and the National Institutes of Health COBRE Center grant RR-015583.	BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Chin HF, 2009, J MOL BIOL, V389, P275, DOI 10.1016/j.jmb.2009.03.068; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Dudognon P, 2004, FEBS LETT, V561, P44, DOI 10.1016/S0014-5793(04)00109-7; Flanagan JJ, 2006, J BIOL CHEM, V281, P2281, DOI 10.1074/jbc.M511695200; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Gimeno RE, 1996, MOL BIOL CELL, V7, P1815, DOI 10.1091/mbc.7.11.1815; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Lusk CP, 2007, TRAFFIC, V8, P647, DOI 10.1111/j.1600-0854.2007.00559.x; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; Milne DM, 2001, EXP CELL RES, V263, P43, DOI 10.1006/excr.2000.5100; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Murakami A, 1999, J BIOL CHEM, V274, P3804, DOI 10.1074/jbc.274.6.3804; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; SARASTE J, 1991, J CELL SCI, V100, P415; SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185; Whyte JRC, 2002, J CELL SCI, V115, P2627; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189	29	129	131	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					181	+		10.1038/nature09969	http://dx.doi.org/10.1038/nature09969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21532587	Bronze, Green Accepted			2022-12-24	WOS:000290487200031
J	Ji, AL; Wang, F; Luo, WJ; Yang, RH; Chen, JY; Cai, TJ				Ji, Ailing; Wang, Feng; Luo, Wenjing; Yang, Ruihua; Chen, Jingyuan; Cai, Tongjian			Lead poisoning in China: a nightmare from industrialisation	LANCET			English	Editorial Material							EXPOSURE		[Luo, Wenjing; Chen, Jingyuan; Cai, Tongjian] Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Peoples R China; [Ji, Ailing; Wang, Feng; Yang, Ruihua] Fourth Mil Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Cai, TJ (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Peoples R China.	ctjcsl@netease.com	Cai, Tong-Jian/AAX-6338-2021	Cai, Tong-Jian/0000-0003-3188-6265				Barbosa F, 2005, ENVIRON HEALTH PERSP, V113, P1669, DOI 10.1289/ehp.7917; CHEN G, 2009, CHINA NEWS AGEN 0815; Cheng HF, 2010, ENVIRON POLLUT, V158, P1134, DOI 10.1016/j.envpol.2009.12.028; CUI M, 2009, BEIJING NEWS    0823; GUO H, 2009, LEGAL DAILY     1021; He KM, 2009, SCI TOTAL ENVIRON, V407, P3986, DOI 10.1016/j.scitotenv.2009.03.018; JIA H, 2009, CHEM WORLD      0825; LE Y, 2009, MORE PARENTS PROTEST; Meyer PA, 2008, MUTAT RES-REV MUTAT, V659, P166, DOI 10.1016/j.mrrev.2008.03.003; *NAT DEV REF COMM, 2007, ACC COND LEAD ZINC I; *PEOPL REP CHIN NA, 2007, NEC ID RESP GOV DIFF; QIAN W, 2010, CHINA DAILY     0317; RAN J, 2010, SO WEEKLY       0324; Watts J, 2009, LANCET, V374, P868, DOI 10.1016/S0140-6736(09)61612-3; Zhang SM, 2009, BIOMED ENVIRON SCI, V22, P288, DOI 10.1016/S0895-3988(09)60058-1; 2010, SHENZHEN DAILY  0318	16	51	60	3	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2011	377	9776					1474	1476		10.1016/S0140-6736(10)60623-X	http://dx.doi.org/10.1016/S0140-6736(10)60623-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761RX	21492927				2022-12-24	WOS:000290419400009
J	Wechsler, T; Newman, S; West, SC				Wechsler, Thomas; Newman, Scott; West, Stephen C.			Aberrant chromosome morphology in human cells defective for Holliday junction resolution	NATURE			English	Article							STRUCTURE-SPECIFIC NUCLEASES; MUS81-EME1; MECHANISM; BLM; HELICASE; REPAIR; IDENTIFICATION; REPLICATION; RESOLVASE; COMPLEX	In somatic cells, Holliday junctions can be formed between sister chromatids during the recombinational repair of DNA breaks or after replication fork demise. A variety of processes act upon Holliday junctions to remove them from DNA, in events that are critical for proper chromosome segregation. In human cells, the BLM protein, inactivated in individuals with Bloom's syndrome, acts in combination with topoisomerase III alpha, RMI1 and RMI2 (BTR complex) to promote the dissolution of double Holliday junctions(1,2). Cells defective for BLM exhibit elevated levels of sister chromatid exchanges (SCEs) and patients with Bloom's syndrome develop a broad spectrum of early-onset cancers caused by chromosome instability(3). MUS81-EME1 (refs 4-7), SLX1-SLX4 (refs 8-11) and GEN1 (refs 12, 13) also process Holliday junctions but, in contrast to the BTR complex, do so by endonucleolytic cleavage. Here we deplete these nucleases from Bloom's syndrome cells to analyse human cells compromised for the known Holliday junction dissolution/resolution pathways. We show that depletion of MUS81 and GEN1, or SLX4 and GEN1, from Bloom's syndrome cells results in severe chromosome abnormalities, such that sister chromatids remain interlinked in a side-by-side arrangement and the chromosomes are elongated and segmented. Our results indicate that normally replicating human cells require Holliday junction processing activities to prevent sister chromatid entanglements and thereby ensure accurate chromosome condensation. This phenotype was not apparent when both MUS81 and SLX4 were depleted from Bloom's syndrome cells, suggesting that GEN1 can compensate for their absence. Additionally, we show that depletion of MUS81 or SLX4 reduces the high frequency of SCEs in Bloom's syndrome cells, indicating that MUS81 and SLX4 promote SCE formation, in events that may ultimately drive the chromosome instabilities that underpin early-onset cancers associated with Bloom's syndrome.	[Wechsler, Thomas; West, Stephen C.] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK, London Res Inst, S Mimms EN6 3LD, Herts, England; [Newman, Scott] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	Cancer Research UK; University of Cambridge	West, SC (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK, London Res Inst, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk	Newman, Scott/B-4843-2012	West, Stephen/0000-0001-8848-9418	Cancer Research UK; Louis-Jeantet Foundation; European Research Council; Swiss Bridge Foundation; Breast Cancer Campaign; UK Medical Research Council; Cancer Research UK [11582] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Louis-Jeantet Foundation; European Research Council(European Research Council (ERC)European Commission); Swiss Bridge Foundation; Breast Cancer Campaign; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	We thank I. Hickson for providing the Bloom's syndrome cell lines and advice, P. Edwards for help and providing facilities for chromosome painting, S. Horswell for the statistical analysis, S. Ip for the GEN1 antibody, M.G. Blanco for assistance with SCE scoring and our laboratory colleagues for their encouragement and suggestions. We further thank K. Cimprich, the Cimprich laboratory members, and C. Wang, W. Johnson and A. Straight. This work was supported by Cancer Research UK, the Louis-Jeantet Foundation, the European Research Council, the Swiss Bridge Foundation and the Breast Cancer Campaign. S.N. was supported by a studentship from the UK Medical Research Council.	Alsop AE, 2006, CANCER GENET CYTOGEN, V164, P97, DOI 10.1016/j.cancergencyto.2005.09.011; Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bayani J., 2005, CURR PROTOC CELL BIO, P7; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Blanco MG, 2010, DNA REPAIR, V9, P394, DOI 10.1016/j.dnarep.2009.12.017; Breger KS, 2004, CANCER RES, V64, P8231, DOI 10.1158/0008-5472.CAN-04-0879; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Ellis NA, 1999, AM J HUM GENET, V65, P1368, DOI 10.1086/302616; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Gaymes TJ, 2002, ONCOGENE, V21, P2525, DOI 10.1038/sj.onc.1205331; Hearst JE, 1998, TRENDS GENET, V14, P244, DOI 10.1016/S0168-9525(98)01481-4; Ho CK, 2010, MOL CELL, V40, P988, DOI 10.1016/j.molcel.2010.11.016; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tay YD, 2010, J BIOL CHEM, V285, P11427, DOI 10.1074/jbc.M110.108399; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	30	161	165	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					642	U126		10.1038/nature09790	http://dx.doi.org/10.1038/nature09790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21399624	Green Accepted			2022-12-24	WOS:000288951200044
J	Hecht, SS				Hecht, Stephen S.			PERSPECTIVE Tackling the real issues	NATURE			English	Editorial Material									Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hecht, SS (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	hecht002@umn.edu		Hecht, Stephen/0000-0001-7228-1356				Boyle P., 2008, World Cancer Report 2008; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; United States Department of Health and Human Services, 2010, TOB SMOK CAUS DIS, P221	4	0	0	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S18	S18		10.1038/471S18a	http://dx.doi.org/10.1038/471S18a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430714	Bronze			2022-12-24	WOS:000288702200015
J	Rubinow, KB; Hirsch, IB				Rubinow, Katya B.; Hirsch, Irl B.			Reexamining Metrics for Glucose Control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ESTIMATED AVERAGE GLUCOSE; BLOOD-GLUCOSE; 1,5-ANHYDROGLUCITOL; RISK		[Rubinow, Katya B.; Hirsch, Irl B.] Univ Washington, Dept Internal Med, Div Metab Endocrinol & Nutr, Seattle, WA 98095 USA	University of Washington; University of Washington Seattle	Hirsch, IB (corresponding author), Univ Washington, Dept Internal Med, Div Metab Endocrinol & Nutr, 4225 Roosevelt Ave NE,Ste 101, Seattle, WA 98095 USA.	ihirsch@uw.edu						Cohen RM, 2008, DIABETES CARE, V31, P151, DOI 10.2337/dc07-1465; Hempe JM, 2010, DIABETES CARE, V33, P1449, DOI 10.2337/dc09-1498; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Lachin JM, 2007, DIABETES, V56, P1913, DOI 10.2337/db07-0028; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Roohk H Vernon, 2008, J Diabetes Sci Technol, V2, P1114; Saudek CD, 2006, JAMA-J AM MED ASSOC, V295, P1688, DOI 10.1001/jama.295.14.1688; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; YAMANOUCHI T, 1991, DIABETES, V40, P52, DOI 10.2337/diabetes.40.1.52	10	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1132	1133		10.1001/jama.2011.314	http://dx.doi.org/10.1001/jama.2011.314			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734ZF	21406652				2022-12-24	WOS:000288381900027
J	Sun, TT; Aceto, N; Meerbrey, KL; Kessler, JD; Zhou, CS; Migliaccio, I; Nguyen, DX; Pavlova, NN; Botero, M; Huang, JA; Bernardi, RJ; Schmitt, E; Hu, GA; Li, MZ; Dephoure, N; Gygi, SP; Rao, M; Creighton, CJ; Hilsenbeck, SG; Shaw, CA; Muzny, D; Gibbs, RA; Wheeler, DA; Osborne, CK; Schiff, R; Bentires-Alj, M; Elledge, SJ; Westbrook, TF				Sun, Tingting; Aceto, Nicola; Meerbrey, Kristen L.; Kessler, Jessica D.; Zhou, Chunshui; Migliaccio, Ilenia; Nguyen, Don X.; Pavlova, Natalya N.; Botero, Maria; Huang, Jian; Bernardi, Ronald J.; Schmitt, Earlene; Hu, Guang; Li, Mamie Z.; Dephoure, Noah; Gygi, Steven P.; Rao, Mitchell; Creighton, Chad J.; Hilsenbeck, Susan G.; Shaw, Chad A.; Muzny, Donna; Gibbs, Richard A.; Wheeler, David A.; Osborne, C. Kent; Schiff, Rachel; Bentires-Alj, Mohamed; Elledge, Stephen J.; Westbrook, Thomas F.			Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase	CELL			English	Article							PHOSPHOTYROSINE INTERACTION DOMAIN; PROTEIN; PEST; DIFFERENTIATION; SUBSTRATE; ONCOGENE; RECEPTOR; IDENTIFICATION; ASSOCIATION; EXPRESSION	Among breast cancers, triple-negative breast cancer (TNBC) is the most poorly understood and is refractory to current targeted therapies. Using a genetic screen, we identify the PTPN12 tyrosine phosphatase as a tumor suppressor in TNBC. PTPN12 potently suppresses mammary epithelial cell proliferation and transformation. PTPN12 is frequently compromised in human TNBCs, and we identify an upstream tumor-suppressor network that posttranscriptionally controls PTPN12. PTPN12 suppresses transformation by interacting with and inhibiting multiple oncogenic tyrosine kinases, including HER2 and EGFR. The tumorigenic and metastatic potential of PTPN12-deficient TNBC cells is severely impaired upon restoration of PTPN12 function or combined inhibition of PTPN12-regulated tyrosine kinases, suggesting that TNBCs are dependent on the proto-oncogenic tyrosine kinases constrained by PTPN12. Collectively, these data identify PTPN12 as a commonly inactivated tumor suppressor and provide a rationale for combinatorially targeting proto-oncogenic tyrosine kinases in TNBC and other cancers based on their profile of tyrosine-phosphatase activity.	[Sun, Tingting; Meerbrey, Kristen L.; Kessler, Jessica D.; Schmitt, Earlene; Westbrook, Thomas F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Meerbrey, Kristen L.; Kessler, Jessica D.; Schmitt, Earlene; Rao, Mitchell; Shaw, Chad A.; Gibbs, Richard A.; Westbrook, Thomas F.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bernardi, Ronald J.; Westbrook, Thomas F.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Creighton, Chad J.; Hilsenbeck, Susan G.] Baylor Coll Med, Div Biostat, Houston, TX 77030 USA; [Creighton, Chad J.; Hilsenbeck, Susan G.; Gibbs, Richard A.; Wheeler, David A.; Osborne, C. Kent; Schiff, Rachel; Westbrook, Thomas F.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Migliaccio, Ilenia; Botero, Maria; Huang, Jian; Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Muzny, Donna; Gibbs, Richard A.; Wheeler, David A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Aceto, Nicola; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland; [Zhou, Chunshui; Pavlova, Natalya N.; Hu, Guang; Li, Mamie Z.; Elledge, Stephen J.] Harvard Univ, Howard Hughes Med Inst, Dept Genet, Sch Med,Div Genet,Brigham & Womens Hosp, Boston, MA 02115 USA; [Dephoure, Noah; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Nguyen, Don X.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Friedrich Miescher Institute for Biomedical Research; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Yale University	Westbrook, TF (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	thomasw@bcm.edu	Hu, Guang/E-7474-2016; Mohamed, Bentires-Alj/F-4484-2015; Wheeler, David A/M-9740-2018; Dephoure, Noah/N-7818-2014; Aceto, Nicola/O-2484-2014	Hu, Guang/0000-0003-0437-4723; Mohamed, Bentires-Alj/0000-0001-6344-1127; Wheeler, David A/0000-0002-9056-6299; Dephoure, Noah/0000-0001-5802-2657; Aceto, Nicola/0000-0001-9579-6918; Shaw, Chad/0000-0001-7267-5398; Hartman, Jessica/0000-0003-1578-3389	Susan G. Komen for the Cure [KG090355, P50 CA058183, HG3456]; U.S. Army [W81XWH0410197]; Novartis Research Foundation; European Research Council (ERC); Swiss Cancer League; Krebsliga Beider Basel; NATIONAL CANCER INSTITUTE [P50CA058183, P30CA125123] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102745] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); U.S. Army(United States Department of DefenseUnited States Army); Novartis Research Foundation; European Research Council (ERC)(European Research Council (ERC)); Swiss Cancer League; Krebsliga Beider Basel; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J. Luo, J. Rosen, and A. Lee for suggestions and critical reading of the manuscript. We are grateful to A. Lee, J. LaBaer, O. Lee, Z. Songyang, and J. Qin for providing reagents, and A. Elia for help with phosphopeptide analysis. This work was supported by a Susan G. Komen for the Cure Career Catalyst Award (KG090355) to T. F. W., S. P. O. R. E developmental grant (P50 CA058183) to T. F. W., S. P. O. R. E. grant (P50 CA058183) to R. S. and C. K. O., grant HG3456 to S. P. G., and a U.S. Army Innovator Award (W81XWH0410197) to S. J. E. Research in the laboratory of M.B.-A. is supported by the Novartis Research Foundation, the European Research Council (ERC starting grant), the Swiss Cancer League, and the Krebsliga Beider Basel. S. J. E. is an Investigator with the Howard Hughes Medical Institute. T. F. W. is a scholar of The V Foundation and Mary Kay Ash Foundation for Cancer Research.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; BATZER AG, 1995, MOL CELL BIOL, V15, P4403; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Brandt R, 2000, ONCOGENE, V19, P2129, DOI 10.1038/sj.onc.1203520; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Hurvitz SA, 2009, FUTURE ONCOL, V5, P1015, DOI 10.2217/FON.09.68; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Markova B, 2003, BIOCHEMISTRY-US, V42, P2691, DOI 10.1021/bi0265574; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SONGYANG Z, 1995, J BIOL CHEM, V270, P14863, DOI 10.1074/jbc.270.25.14863; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; YANG Q, 1993, J BIOL CHEM, V268, P6622; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	41	212	222	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					703	718		10.1016/j.cell.2011.02.003	http://dx.doi.org/10.1016/j.cell.2011.02.003			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376233	Bronze, Green Accepted			2022-12-24	WOS:000288007100010
J	Christiani, DC				Christiani, David C.			Combating Environmental Causes of Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Christiani, David C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Christiani, DC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009; Hiatt, Robert/AAQ-1537-2021	Colditz, Graham/0000-0002-7307-0291; 				*IARC, IARC MON EV CARC RIS; *NAT CANC I PRES C, 2010, RED ENV CANC RISK WH; THOMAS DB, 1987, CANCER RES, V47, P5771; Tomatis L, 1997, CARCINOGENESIS, V18, P97, DOI 10.1093/carcin/18.1.97; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055	5	17	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					791	793		10.1056/NEJMp1006634	http://dx.doi.org/10.1056/NEJMp1006634			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366471				2022-12-24	WOS:000287928400002
J	McGilchrist, I				McGilchrist, Iain			The Art of Medicine Paying attention to the bipartite brain	LANCET			English	Editorial Material												iain.mcgilchrist@all-souls.ox.ac.uk						MCGILCHRIST I, 2010, DIALOG CLIN NEUROSCI, V12, P317; McGilchrist I., 2009, MASTER HIS EMISSARY; McNeill D., 1992, HAND MIND WHAT GESTU; Rogers LJ., 2002, COMP VERTEBRATE LATE; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303	5	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1068	1069		10.1016/S0140-6736(11)60422-4	http://dx.doi.org/10.1016/S0140-6736(11)60422-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	743QY	21449085				2022-12-24	WOS:000289035000015
J	Lerman, L				Lerman, Liz			The Genome Dances	SCIENCE			English	Editorial Material											Lerman, L (corresponding author), Liz Lerman Dance Exchange, Takoma Pk, MD USA.								0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1027	1027		10.1126/science.1203459	http://dx.doi.org/10.1126/science.1203459			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350168				2022-12-24	WOS:000287699000051
J	Schilcher, J; Michaelsson, K; Aspenberg, P				Schilcher, Jorg; Michaelsson, Karl; Aspenberg, Per			Bisphosphonate Use and Atypical Fractures of the Femoral Shaft	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIAPHYSEAL FEMUR FRACTURES; SUPPRESSED BONE TURNOVER; STRESS-FRACTURES; ALENDRONATE; COMPLICATION; WOMEN	BACKGROUND Studies show conflicting results regarding the possible excess risk of atypical fractures of the femoral shaft associated with bisphosphonate use. METHODS In Sweden, 12,777 women 55 years of age or older sustained a fracture of the femur in 2008. We reviewed radiographs of 1234 of the 1271 women who had a subtrochanteric or shaft fracture and identified 59 patients with atypical fractures. Data on medications and coexisting conditions were obtained from national registries. The relative and absolute risk of atypical fractures associated with bisphosphonate use was estimated by means of a nationwide cohort analysis. The 59 case patients were also compared with 263 control patients who had ordinary subtrochanteric or shaft fractures. RESULTS The age-adjusted relative risk of atypical fracture was 47.3 (95% confidence interval [CI], 25.6 to 87.3) in the cohort analysis. The increase in absolute risk was 5 cases per 10,000 patient-years (95% CI, 4 to 7). A total of 78% of the case patients and 10% of the controls had received bisphosphonates, corresponding to a multivariable-adjusted odds ratio of 33.3 (95% CI, 14.3 to 77.8). The risk was independent of coexisting conditions and of concurrent use of other drugs with known effects on bone. The duration of use influenced the risk (odds ratio per 100 daily doses, 1.3; 95% CI, 1.1 to 1.6). After drug withdrawal, the risk diminished by 70% per year since the last use (odds ratio, 0.28; 95% CI, 0.21 to 0.38). CONCLUSIONS These population-based nationwide analyses may be reassuring for patients who receive bisphosphonates. Although there was a high prevalence of current bisphosphonate use among patients with atypical fractures, the absolute risk was small.	[Schilcher, Jorg; Aspenberg, Per] Linkoping Univ, Fac Hlth Sci, Dept Expt & Clin Med, SE-58185 Linkoping, Sweden; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Sect Orthoped, Uppsala, Sweden; [Michaelsson, Karl] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Linkoping University; Uppsala University; Uppsala University	Aspenberg, P (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Expt & Clin Med, SE-58185 Linkoping, Sweden.	per.aspenberg@liu.se	Michaelsson, Karl/AAM-9094-2021	Michaelsson, Karl/0000-0003-2815-1217	Eli Lilly; Amgen; Swedish Research Council	Eli Lilly(Eli Lilly); Amgen(Amgen); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Dr. Aspenberg reports receiving consulting fees from Eli Lilly and Amgen and grant support to his institution, Linkoping University, from Eli Lilly and Amgen, as well as holding stock in AddBIO, a company trying to commercialize a method for bisphosphonate coating of implants to be inserted in bone, and holding a patent for this method. No other potential conflict of interest relevant to this article was reported.; Funded by the Swedish Research Council.	Abrahamsen B, 2010, J CLIN ENDOCR METAB, V95, P5258, DOI 10.1210/jc.2010-1571; Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Calltorp J, 1996, LANCET, V347, P587, DOI 10.1016/S0140-6736(96)91278-7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Girgis CM, 2010, NEW ENGL J MED, V362, P1848, DOI 10.1056/NEJMc0910389; Ing-Lorenzini K, 2009, DRUG SAFETY, V32, P775, DOI 10.2165/00002018-200932090-00002; Kwek EBK, 2008, INJURY, V39, P224, DOI 10.1016/j.injury.2007.08.036; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; Lenart BA, 2008, NEW ENGL J MED, V358, P1304, DOI 10.1056/NEJMc0707493; NEER RM, 1995, BONE, V17, pS501, DOI 10.1016/8756-3282(95)00343-7; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Odvina CV, 2010, CLIN ENDOCRINOL, V72, P161, DOI 10.1111/j.1365-2265.2009.03581.x; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; ROTHMAN KJ, 2008, MODERN EPIDEMIOLOGY; Schilcher J, 2009, ACTA ORTHOP, V80, P413, DOI 10.3109/17453670903139914; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Visekruna M, 2008, J CLIN ENDOCR METAB, V93, P2948, DOI 10.1210/jc.2007-2803	19	482	496	2	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1728	1737		10.1056/NEJMoa1010650	http://dx.doi.org/10.1056/NEJMoa1010650			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542743				2022-12-24	WOS:000290219800009
J	Lowden, MR; Flibotte, S; Moerman, DG; Ahmed, S				Lowden, Mia Rochelle; Flibotte, Stephane; Moerman, Donald G.; Ahmed, Shawn			DNA Synthesis Generates Terminal Duplications That Seal End-to-End Chromosome Fusions	SCIENCE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; GENE AMPLIFICATION; CANCER GENOMES; COPY-NUMBER; HUMAN-CELLS; TELOMERES; REARRANGEMENTS; REPLICATION; DELETION	End-to-end chromosome fusions that occur in the context of telomerase deficiency can trigger genomic duplications. For more than 70 years, these duplications have been attributed solely to breakage-fusion-bridge cycles. To test this hypothesis, we examined end-to-end fusions isolated from Caenorhabditis elegans telomere replication mutants. Genome-level rearrangements revealed fused chromosome ends having interrupted terminal duplications accompanied by template-switching events. These features are very similar to disease-associated duplications of interstitial segments of the human genome. A model termed Fork Stalling and Template Switching has been proposed previously to explain such duplications, where promiscuous replication of large, noncontiguous segments of the genome occurs. Thus, a DNA synthesis-based process may create duplications that seal end-to-end fusions, in the absence of breakage-fusion-bridge cycles.	[Lowden, Mia Rochelle; Ahmed, Shawn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Lowden, Mia Rochelle; Ahmed, Shawn] Univ N Carolina, Dept Biol, Chapel Hill, NC 27514 USA; [Flibotte, Stephane; Moerman, Donald G.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of British Columbia	Ahmed, S (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	shawn@med.unc.edu		Flibotte, Stephane/0000-0001-9613-7666	NIH [GM066228, GM072150]; Genome Canada; Genome British Columbia; Michael Smith Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066228, R01GM066228, F31GM072150] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Canada(Genome Canada); Genome British Columbia; Michael Smith Research Foundation(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Maydan for technical assistance; D. Reiner, J. Sekelsky, L. Shtessel, D. Shippen, and T. Petes for comments on the manuscript; and D. Ramsden for discussion. S. A. and M. L. were supported by NIH grants GM066228 and GM072150. D. G. M. was supported by funds from Genome Canada and Genome British Columbia and the Michael Smith Research Foundation. D. G. M. is a fellow of the Canadian Institute for Advanced Research.	Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Bailey SM, 2006, NUCLEIC ACIDS RES, V34, P2408, DOI 10.1093/nar/gkl303; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bosco G, 1998, GENETICS, V150, P1037; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Cheung I, 2006, NUCLEIC ACIDS RES, V34, P96, DOI 10.1093/nar/gkj417; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Letsolo BT, 2010, NUCLEIC ACIDS RES, V38, P1841, DOI 10.1093/nar/gkp1183; Lowden MR, 2008, GENETICS, V180, P741, DOI 10.1534/genetics.108.089920; Mantripragada KK, 2004, INT J MOL MED, V13, P273; McClintock B, 1941, GENETICS, V26, P234; McVey M, 2004, GENETICS, V168, P2067, DOI 10.1534/genetics.104.033902; Meier B, 2006, PLOS GENET, V2, P187, DOI 10.1371/journal.pgen.0020018; MOERMAN DG, 1991, NUCLEIC ACIDS RES, V19, P5669, DOI 10.1093/nar/19.20.5669; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Raices M, 2008, CELL, V132, P745, DOI 10.1016/j.cell.2007.12.039; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stansel RM, 2001, EMBO J, V20, P5532; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645	26	39	39	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					468	471		10.1126/science.1199022	http://dx.doi.org/10.1126/science.1199022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512032	Green Accepted, Green Submitted			2022-12-24	WOS:000289784900044
J	Quagliarello, V				Quagliarello, Vincent			Dissemination of Neisseria meningitidis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA	Yale University	Quagliarello, V (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.							Butler D, 2010, NATURE, V468, P143, DOI 10.1038/468143a; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Murray CJL, 2001, GLOBAL BURDEN DIS 20; Sutherland TC, 2010, INFECT IMMUN, V78, P3832, DOI 10.1128/IAI.01377-09; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056/NEJMra0906357	5	9	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1573	1575		10.1056/NEJMcibr1101564	http://dx.doi.org/10.1056/NEJMcibr1101564			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21506747				2022-12-24	WOS:000289722700019
J	Hargrove, LJ; Simon, AM; Lipschutz, RD; Finucane, SB; Kuiken, TA				Hargrove, Levi J.; Simon, Ann M.; Lipschutz, Robert D.; Finucane, Suzanne B.; Kuiken, Todd A.			Real-Time Myoelectric Control of Knee and Ankle Motions for Transfemoral Amputees	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Hargrove, Levi J.; Simon, Ann M.; Lipschutz, Robert D.; Finucane, Suzanne B.; Kuiken, Todd A.] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA	Shirley Ryan AbilityLab	Hargrove, LJ (corresponding author), Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA.	l-hargrove@northwestern.edu		Simon, Ann/0000-0002-6431-0329				Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Ha KH, 2011, IEEE T BIO-MED ENG, V58, P144, DOI 10.1109/TBME.2010.2070840; Hitt JK, 2010, J MED DEVICES, V4, DOI 10.1115/1.4001139; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Netter FH, 2010, ATLAS HUMAN ANATOMY, P511; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	6	47	57	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1542	1544		10.1001/jama.2011.465	http://dx.doi.org/10.1001/jama.2011.465			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21505133				2022-12-24	WOS:000289683000021
J	Savage, N				Savage, Neil			EARLY DETECTION Spotting the first signs	NATURE			English	Editorial Material																		Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Wax A, 2011, GASTROENTEROLOGY, V141, P443, DOI 10.1053/j.gastro.2011.06.020; Willmann JK, 2010, J NUCL MED, V51, P433, DOI 10.2967/jnumed.109.068007	4	26	27	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S14	S15		10.1038/471S14a	http://dx.doi.org/10.1038/471S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430712				2022-12-24	WOS:000288702200013
J	Nabel, GJ; Wei, CJ; Ledgerwood, JE				Nabel, Gary J.; Wei, Chih-Jen; Ledgerwood, Julie E.			Vaccinate for the next H2N2 pandemic now	NATURE			English	Editorial Material							INFLUENZA-VIRUSES		[Nabel, Gary J.; Wei, Chih-Jen; Ledgerwood, Julie E.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Nabel, GJ (corresponding author), NIH, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA.	gnabel@nih.gov	Wei, Chih/GVT-5734-2022		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005047] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen GL, 2010, J VIROL, V84, P7695, DOI 10.1128/JVI.00511-10; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; Kaverin NV, 2000, ARCH VIROL, V145, P1059, DOI 10.1007/s007050070109; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; Stohr K, 2010, NATURE, V465, P161, DOI 10.1038/465161a; Webster Robert G., 1997, Journal of Infectious Diseases, V176, pS14, DOI 10.1086/514168; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	10	53	55	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					157	158		10.1038/471157a	http://dx.doi.org/10.1038/471157a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FK	21390107	Bronze			2022-12-24	WOS:000288170200013
J	Ruan, YJ				Ruan, Yijun			Presenting the Human Genome: Now in 3D!	SCIENCE			English	Editorial Material									Genome Inst Singapore, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ruan, YJ (corresponding author), Genome Inst Singapore, Singapore, Singapore.								0	1	3	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1025	1026		10.1126/science.1203602	http://dx.doi.org/10.1126/science.1203602			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350163				2022-12-24	WOS:000287699000047
J	Sillesen, H; Falk, E				Sillesen, Henrik; Falk, Erling			Why not screen for subclinical atherosclerosis?	LANCET			English	Editorial Material							PRIMARY PREVENTION; TASK-FORCE; DISEASE; RISK; INTERVENTIONS; ASSOCIATION		[Sillesen, Henrik] Rigshosp, Dept Vasc Surg, DK-2100 Copenhagen, Denmark; [Sillesen, Henrik] Univ Copenhagen, DK-2100 Copenhagen, Denmark; [Falk, Erling] Aarhus Univ Hosp, Dept Cardiol, Skejby, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University	Sillesen, H (corresponding author), Rigshosp, Dept Vasc Surg, DK-2100 Copenhagen, Denmark.	sillesen@mac.com	Sillesen, Henrik/ABB-5668-2020					Fuster V, 2009, NAT REV CARDIOL, V6, P669, DOI 10.1038/nrcardio.2009.187; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Hecht HS, 2008, AM J CARDIOL, V101, P1805, DOI 10.1016/j.amjcard.2008.02.086; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Muntendam P, 2010, AM HEART J, V160, P49, DOI 10.1016/j.ahj.2010.02.021; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Naghavi M, 2006, AM J CARDIOL, V98, p2H, DOI 10.1016/j.amjcard.2006.03.002; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shah PK, 2010, J AM COLL CARDIOL, V56, P98, DOI 10.1016/j.jacc.2009.09.081; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; WISLOFF T, 2008, COSTS LIFE YEAR GAIN	12	44	44	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					645	646		10.1016/S0140-6736(11)60059-7	http://dx.doi.org/10.1016/S0140-6736(11)60059-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815EW	21440933				2022-12-24	WOS:000294509900007
J	Neff, S; Goldschmidt, R				Neff, Sarah; Goldschmidt, Ronald			Centers for Disease Control and Prevention 2006 Human Immunodeficiency Virus Testing Recommendations and State Testing Laws	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Neff, Sarah; Goldschmidt, Ronald] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Neff, S (corresponding author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.	neffs@nccc.ucsf.edu						[Anonymous], 2011 COMP STAT HIV T; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1	2	28	28	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1767	1768		10.1001/jama.2011.564	http://dx.doi.org/10.1001/jama.2011.564			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758HZ	21540419	Bronze			2022-12-24	WOS:000290156200016
J	Jarvinen, TLN; Sievanen, H; Kannus, P; Jokihaara, J; Khan, KM				Jarvinen, Teppo L. N.; Sievanen, Harri; Kannus, Pekka; Jokihaara, Jarkko; Khan, Karim M.			The true cost of pharmacological disease prevention	BRITISH MEDICAL JOURNAL			English	Editorial Material							OSTEOPOROTIC FRACTURES; CONTROLLED-TRIAL; FALLS; RISK		[Jarvinen, Teppo L. N.] Univ Tampere, Dept Orthopaed Surg, Tampere 33014, Finland; [Sievanen, Harri] Cent Finland Cent Hosp, Dept Surg, Jyvaskyla 40620, Finland; [Sievanen, Harri] UKK Inst, Bone Res Grp, Tampere 33500, Finland; [Kannus, Pekka] Tampere Univ Hosp, Div Orthopaed & Traumatol, Tampere 33520, Finland; [Jokihaara, Jarkko; Khan, Karim M.] Univ British Columbia, Ctr Hip Hlth & Mobil, Vancouver, BC V5Z 1M9, Canada	Tampere University; Central Finland Central Hospital; UKK Institute; Tampere University; Tampere University Hospital; University of British Columbia	Jarvinen, TLN (corresponding author), Univ Tampere, Dept Orthopaed Surg, Tampere 33014, Finland.	teppo.jarvinen@uta.fi	Jokihaara, Jarkko/C-5817-2017; Järvinen, Teppo/B-8189-2013	Jokihaara, Jarkko/0000-0001-6153-2180; Järvinen, Teppo/0000-0003-3713-956X				Borgstrom F, 2010, OSTEOPOROSIS INT, V21, P495, DOI 10.1007/s00198-009-0989-8; Compston JE, 2006, LANCET, V368, P973, DOI 10.1016/S0140-6736(06)69394-X; Cooper A, 2008, CLIN GUIDELINES EVID; Dawson J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c186; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Inderjeeth CA, 2009, BONE, V44, P744, DOI 10.1016/j.bone.2008.12.003; Jarvinen TLN, 2008, BRIT MED J, V336, P124, DOI 10.1136/bmj.39428.470752.AD; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kannus P, 2006, J BONE MINER RES, V21, P1836, DOI 10.1359/JBMR.060815; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V299, P1651, DOI 10.1001/jama.299.14.1651; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; *NAT I HLTH CLIN E, 2006, NICE CLIN GUID, V34; *NICE, 2010, NICE TECHN APPR GUID, V160; Parikh S, 2009, J AM GERIATR SOC, V57, P327, DOI 10.1111/j.1532-5415.2008.02119.x; Relton C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1066; Robertson MC, 2001, BRIT MED J, V322, P701, DOI 10.1136/bmj.322.7288.701; Sawka AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009515; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; van Staa TP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000194; Yeaw J, 2009, J MANAGE CARE PHARM, V15, P728, DOI 10.18553/jmcp.2009.15.9.728	21	39	39	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2011	342								d2175	10.1136/bmj.d2175	http://dx.doi.org/10.1136/bmj.d2175			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OI	21505222				2022-12-24	WOS:000289942200004
J	Ferguson, CD				Ferguson, Charles D.			Do not phase out nuclear power - yet	NATURE			English	Editorial Material									Federat Amer Scientists, Washington, DC 20036 USA		Ferguson, CD (corresponding author), Federat Amer Scientists, Washington, DC 20036 USA.	cferguson@fas.org							0	8	8	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					411	411		10.1038/471411a	http://dx.doi.org/10.1038/471411a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430730				2022-12-24	WOS:000288702200022
J	Kegel, A; Betts-Lindroos, H; Kanno, T; Jeppsson, K; Strom, L; Katou, Y; Itoh, T; Shirahige, K; Sjogren, C				Kegel, Andreas; Betts-Lindroos, Hanna; Kanno, Takaharu; Jeppsson, Kristian; Strom, Lena; Katou, Yuki; Itoh, Takehiko; Shirahige, Katsuhiko; Sjogren, Camilla			Chromosome length influences replication-induced topological stress	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; TOPOISOMERASE-I; RECQ HELICASE; BUDDING YEAST; REPAIR; PROTEINS; COMPLEX; FORKS; DAMAGE	During chromosome duplication the parental DNA molecule becomes overwound, or positively supercoiled, in the region ahead of the advancing replication fork. To allow fork progression, this superhelical tension has to be removed by topoisomerases, which operate by introducing transient DNA breaks(1). Positive supercoiling can also be diminished if the advancing fork rotates along the DNA helix, but then sister chromatid intertwinings form in its wake(1,2). Despite these insights it remains largely unknown how replication-induced superhelical stress is dealt with on linear, eukaryotic chromosomes. Here we show that this stress increases with the length of Saccharomyces cerevisiae chromosomes. This highlights the possibility that superhelical tension is handled on a chromosome scale and not only within topologically closed chromosomal domains as the current view predicts. We found that inhibition of type I topoisomerases leads to a late replication delay of longer, but not shorter, chromosomes. This phenotype is also displayed by cells expressing mutated versions of the cohesin-and condensin-related Smc5/6 complex. The frequency of chromosomal association sites of the Smc5/6 complex increases in response to chromosome lengthening, chromosome circularization, or inactivation of topoisomerase 2, all having the potential to increase the number of sister chromatid intertwinings(3). Furthermore, nonfunctional Smc6 reduces the accumulation of intertwined sister plasmids after one round of replication in the absence of topoisomerase 2 function. Our results demonstrate that the length of a chromosome influences the need of superhelical tension release in Saccharomyces cerevisiae, and allow us to propose a model where the Smc5/6 complex facilitates fork rotation by sequestering nascent chromatid intertwinings that form behind the replication machinery.	[Kegel, Andreas; Betts-Lindroos, Hanna; Kanno, Takaharu; Jeppsson, Kristian; Strom, Lena; Sjogren, Camilla] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Katou, Yuki; Itoh, Takehiko] Tokyo Inst Technol, Grad Sch Biosci, Lab Silico Funct Genom, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Bunkyo Ku, Tokyo 1130032, Japan	Karolinska Institutet; Tokyo Institute of Technology; University of Tokyo	Sjogren, C (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Eulersvag 3, S-17177 Stockholm, Sweden.	camilla.sjogren@ki.se	Ström, Lena/AAJ-9025-2020; Itoh, Takehiko/E-8873-2014	Itoh, Takehiko/0000-0002-6113-557X; Lindroos, Hanna/0000-0002-8455-8452; Strom, Lena/0000-0002-8898-3675; Bjorkegren, Camilla/0000-0001-7354-9270; Shirahige, Katsuhiko/0000-0002-7862-1144	JST; SSF; Vinnova	JST(Japan Science & Technology Agency (JST)); SSF(Swedish Foundation for Strategic Research); Vinnova(Vinnova)	We thank K. Nasmyth, J. Haber, E. Green and X. Zhao for yeast strains and the BEA core facility at Karolinska Institutet for help with ChIP on chip. Financial support: Strategic Japanese-Swedish Cooperative Program from JST, SSF and Vinnova (C. S. and K. S.); please see Supplementary Information for additional support.	Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; HAMER L, 1995, P NATL ACAD SCI USA, V92, P11706, DOI 10.1073/pnas.92.25.11706; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; HIASA H, 1994, J BIOL CHEM, V269, P2093; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; KIM RA, 1989, J MOL BIOL, V208, P257, DOI 10.1016/0022-2836(89)90387-2; KJELDSEN E, 1992, J MOL BIOL, V228, P1025, DOI 10.1016/0022-2836(92)90310-G; KOSHLAND D, 1987, SCIENCE, V238, P1713, DOI 10.1126/science.3317838; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Outwin EA, 2009, MOL CELL BIOL, V29, P4363, DOI 10.1128/MCB.00377-09; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Rosenfeld S, 2009, GENE REGUL SYST BIO, V3, P159; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; SPELL RM, 1994, MOL CELL BIOL, V14, P1465, DOI 10.1128/MCB.14.2.1465; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	36	79	79	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					392	+		10.1038/nature09791	http://dx.doi.org/10.1038/nature09791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368764				2022-12-24	WOS:000288444000048
J	Watts, G				Watts, Geoff			Genetics The hunt for the mystery genes	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]	1	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2011	342								d1463	10.1136/bmj.d1463	http://dx.doi.org/10.1136/bmj.d1463			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735VA	21393321				2022-12-24	WOS:000288447000009
J	Cardenas, ML; Gosling, WD; Sherlock, SC; Poole, I; Pennington, RT; Mothes, P				Cardenas, Macarena L.; Gosling, William D.; Sherlock, Sarah C.; Poole, Imogen; Pennington, R. Toby; Mothes, Patricia			The Response of Vegetation on the Andean Flank in Western Amazonia to Pleistocene Climate Change	SCIENCE			English	Article								A reconstruction of past environmental change from Ecuador reveals the response of lower montane forest on the Andean flank in western Amazonia to glacial-interglacial global climate change. Radiometric dating of volcanic ash indicates that deposition occurred similar to 324,000 to 193,000 years ago during parts of Marine Isotope Stages 9, 7, and 6. Fossil pollen and wood preserved within organic sediments suggest that the composition of the forest altered radically in response to glacial-interglacial climate change. The presence of Podocarpus macrofossils similar to 1000 meters below the lower limit of their modern distribution indicates a relative cooling of at least 5 degrees C during glacials and persistence of wet conditions. Interglacial deposits contain thermophilic palms suggesting warm and wet climates. Hence, global temperature change can radically alter vegetation communities and biodiversity in this region.	[Cardenas, Macarena L.; Gosling, William D.; Sherlock, Sarah C.] Open Univ, Dept Earth & Environm Sci, CEPSAR, Milton Keynes MK7 6AA, Bucks, England; [Poole, Imogen] Univ Aberdeen, Dept Geol & Petr Geol, Kings Coll, Aberdeen AB24 3UE, Scotland; [Pennington, R. Toby] Royal Bot Garden Edinburgh, Trop Biol Grp, Edinburgh EH3 5LR, Midlothian, Scotland; [Mothes, Patricia] Escuela Politec Nacl, Inst Geofis, Quito, Ecuador	Open University - UK; University of Aberdeen; Escuela Politecnica Nacional Ecuador	Cardenas, ML (corresponding author), Open Univ, Dept Earth & Environm Sci, CEPSAR, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	m.l.cardenas@open.ac.uk	Gosling, William/D-2459-2009; Gosling, William/AAB-2761-2020	Gosling, William/0000-0001-9903-8401; Gosling, William/0000-0001-9903-8401; Cardenas, Macarena/0000-0002-6500-2352; Pennington, Toby/0000-0002-8196-288X; Sherlock, Sarah/0000-0003-0494-6760	Open University; Royal Botanical Garden Edinburgh; Santander; British Ecological Society; University Utrecht	Open University; Royal Botanical Garden Edinburgh; Santander; British Ecological Society; University Utrecht	We thank M. Hall (Instituto Geofisico, Quito, Ecuador), A. Correa-Metrio and M. Bush (Florida Institute of Technology), and Erazo residents. We also thank the reviewers for their valuable comments. This work was supported by funding from The Open University, Royal Botanical Garden Edinburgh, Santander, British Ecological Society, and University Utrecht.	BUSH MB, 1990, QUATERNARY RES, V34, P330, DOI 10.1016/0033-5894(90)90045-M; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Faegri K., 1898, J BIOGEOGR, V12, P238; Gosling WD, 2008, PALAEOGEOGR PALAEOCL, V259, P35, DOI 10.1016/j.palaeo.2007.02.050; Gosling WD, 2009, J VEG SCI, V20, P1041, DOI 10.1111/j.1654-1103.2009.01102.x; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hooghiemstra H., 1984, VEGETATIONAL CLIMATI; Jorgensen P. M., 1999, CATALOGUE VASCULAR P; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kelley S. P., 2002, NOBLE GASES GEOCHEMI; Long CJ, 1998, CAN J FOREST RES, V28, P774, DOI 10.1139/cjfr-28-5-774; Moraes M, 1995, BIODIVERSITY AND CONSERVATION OF NEOTROPICAL MONTANE FORESTS, P473; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Niemann H, 2008, J QUATERNARY SCI, V23, P203, DOI 10.1002/jqs.1134; Pennington T. D., 2004, ILLUSTRATED GUIDE TR; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Schwerdtfeger W., 1976, CLIMATES CENTRAL S A; Torres-Romero J. H., 1988, FLORA COLOMBIA; Weng CY, 2004, J TROP ECOL, V20, P113, DOI 10.1017/S0266467403001068	20	45	49	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1055	1058		10.1126/science.1197947	http://dx.doi.org/10.1126/science.1197947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350174				2022-12-24	WOS:000287699000060
J	Capewell, S; O'Flaherty, M				Capewell, Simon; O'Flaherty, Martin			Rapid mortality falls after risk-factor changes in populations	LANCET			English	Editorial Material							HEART-DISEASE		[Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Capewell, S (corresponding author), Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England.	capewell@liverpool.ac.uk		O'Flaherty, Martin/0000-0001-8944-4131				Capewell S, 2011, EUR HEART J, V32, P1187, DOI 10.1093/eurheartj/ehr049; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Franco M, 2007, AM J EPIDEMIOL, V166, P1374, DOI 10.1093/aje/kwm226; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE; STROM A, 1951, LANCET, V260, P126, DOI 10.1016/S0140-6736(51)91210-X; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; *WHO, EUR HLTH ALL DAT HFA; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187	11	108	112	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2011	378	9793					752	753		10.1016/S0140-6736(10)62302-1	http://dx.doi.org/10.1016/S0140-6736(10)62302-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21414659				2022-12-24	WOS:000294585300010
J	Lee, H; Chah, OK; Sheen, J				Lee, Horim; Chah, Ok-Kyong; Sheen, Jen			Stem-cell-triggered immunity through CLV3p-FLS2 signalling	NATURE			English	Article							RECEPTOR-LIKE KINASE; BACTERIAL ELICITOR FLAGELLIN; RICH REPEAT DOMAIN; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; PERCEPTION; FLS2; CLAVATA1; MERISTEM; RESISTANCE	Stem cells in the shoot apical meristem (SAM) of plants are the self-renewable reservoir for leaf, stem and flower organogenesis(1,2). In nature, disease-free plants can be regenerated from SAM despite infections elsewhere, which underlies a horticultural practice for decades(3). However, the molecular basis of the SAM immunity remains unclear. Here we show that the CLAVATA3 peptide (CLV3p), expressed and secreted from stem cells and functioning as a key regulator of stem-cell homeostasis in the SAM of Arabidopsis(1,2,4), can trigger immune signalling and pathogen resistance via the flagellin receptor kinase FLS2 (refs 5, 6). CLV3p-FLS2 signalling acts independently from the stem-cell signalling pathway mediated through CLV1 and CLV2 receptors(1,2,4), and is uncoupled from FLS2-mediated growth suppression(5,6). Endogenous CLV3p perception in the SAM by a pattern recognition receptor for bacterial flagellin, FLS2, breaks the previously defined self and non-self discrimination in innate immunity(6,7). The dual perception of CLV3p illustrates co-evolution of plant peptide and receptor kinase signalling for both development and immunity. The enhanced immunity in SAM or germ lines may represent a common strategy towards immortal fate in plants and animals(1,2,8).	[Lee, Horim; Chah, Ok-Kyong; Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lee, Horim; Chah, Ok-Kyong; Sheen, Jen] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Lee, Horim; Chah, Ok-Kyong; Sheen, Jen] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, H (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	hrlee@molbio.mgh.harvard.edu; sheen@molbio.mgh.harvard.edu	Lee, Horim/I-6180-2019		NSF; NIH; MGH CCIB fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060493, R01GM070567] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH CCIB fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Laux for the pWUS::GUS line, Y. Matsubayashi for the purified Ara-CLV3 peptide and advice, A. Collmer for the GFP-labelled P. syringae pv. tomato DC3000, L. Shan and P. He for constructs, G. Tena, F. Ausubel, J. Bush, J. Plotnikova and ABRC for mutant seeds and bacterial strains, and Y. Xiong, M. McCormack, Y. Niu, M. Ramon and J. Li for critically reading of the manuscript. Funding was provided by the NSF, NIH and the MGH CCIB fund to J.S.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; Baurle I, 2005, PLANT CELL, V17, P2271, DOI 10.1105/tpc.105.032623; Baurle I, 2003, BIOESSAYS, V25, P961, DOI 10.1002/bies.10341; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Butenko MA, 2009, TRENDS PLANT SCI, V14, P255, DOI 10.1016/j.tplants.2009.02.002; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; Dievart A, 2003, PLANT CELL, V15, P1198, DOI 10.1105/tpc.010504; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fiers M, 2006, PLANT PHYSIOL, V141, P1284, DOI 10.1104/pp.106.080671; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Goldsby RA, 2006, KUBY IMMUNOLOGY; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; HOLLINGS M, 1965, ANNU REV PHYTOPATHOL, V3, P367, DOI 10.1146/annurev.py.03.090165.002055; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Jun JH, 2008, CELL MOL LIFE SCI, V65, P743, DOI 10.1007/s00018-007-7411-5; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; KOORNNEEF M, 1983, J HERED, V74, P265, DOI 10.1093/oxfordjournals.jhered.a109781; Miwa H, 2008, PLANT CELL PHYSIOL, V49, P1752, DOI 10.1093/pcp/pcn148; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Scheres B, 2005, CELL, V122, P499, DOI 10.1016/j.cell.2005.08.006; Schreiber K, 2008, PLANT J, V54, P522, DOI 10.1111/j.1365-313X.2008.03425.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yamamizo C, 2006, PLANT PHYSIOL, V140, P681, DOI 10.1104/pp.105.074906; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	40	57	61	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					376	U559		10.1038/nature09958	http://dx.doi.org/10.1038/nature09958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21499263	Green Accepted			2022-12-24	WOS:000290722400049
J	Gheorghiade, M; Braunwald, E				Gheorghiade, Mihai; Braunwald, Eugene			A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OUTCOMES; ASSOCIATION; CARDIOLOGY; SOCIETY; LUNG		[Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Med, Chicago, IL 60611 USA; [Braunwald, Eugene] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc Med, Sch Med,Dept Med,TIMI Study Grp, Boston, MA 02115 USA	Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Med, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu						Flaherty JD, 2009, J AM COLL CARDIOL, V53, P254, DOI 10.1016/j.jacc.2008.08.072; Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2010, EUR J HEART FAIL, V12, P423, DOI 10.1093/eurjhf/hfq045; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Peacock WF, 2010, J AM COLL CARDIOL, V56, P343, DOI 10.1016/j.jacc.2010.03.051	10	42	44	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1702	1703		10.1001/jama.2011.515	http://dx.doi.org/10.1001/jama.2011.515			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521852				2022-12-24	WOS:000289890500024
J	Quraishi, NA; Esler, C				Quraishi, Nasir A.; Esler, Claire			EASILY MISSED? Metastatic spinal cord compression	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SURGICAL-MANAGEMENT; CANCER; DISEASE; RADIOTHERAPY; DIAGNOSIS; RESECTION		[Quraishi, Nasir A.] Queens Med Ctr, Ctr Spine Studies & Surg, Nottingham NG7 2UH, England; [Esler, Claire] Leicester Royal Infirm, Dept Oncol, Leicester, Leics, England	University of Nottingham; University of Leicester	Quraishi, NA (corresponding author), Queens Med Ctr, Ctr Spine Studies & Surg, Nottingham NG7 2UH, England.	nasquraishi@hotmail.com						AARON AD, 1994, JAMA-J AM MED ASSOC, V272, P1206, DOI 10.1001/jama.272.15.1206; Baur A, 2002, RADIOLOGY, V225, P730, DOI 10.1148/radiol.2253011413; Chen YJ, 2007, SPINE, V32, pE413, DOI 10.1097/BRS.0b013e318074d6c7; Fung HS, 2003, RADIOGRAPHICS, V23, P179, DOI 10.1148/rg.231025043; Graham PH, 2006, CLIN ONCOL-UK, V18, P70, DOI 10.1016/j.clon.2005.08.015; HELWEGLARSEN S, 1994, EUR J CANCER, V30A, P396, DOI 10.1016/0959-8049(94)90263-1; Klimo PJ, 2003, NEUROSURG FOCUS, V15, P1; Kwok Y, 2006, HEMATOL ONCOL CLIN N, V20, P1297, DOI 10.1016/j.hoc.2006.09.008; Levack P, 2002, CLIN ONCOL-UK, V14, P472, DOI 10.1053/clon.2002.0098; Levack P, 2001, 9708 CRAG; Loblaw DA, 2003, CLIN ONCOL, V14, P472; Mannion RJ, 2007, BRIT J NEUROSURG, V21, P593, DOI 10.1080/02688690701593579; National Institute for Health and Clinical Excellence, 2008, CLIN GUID NAT I HLTH; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; Prewett S, 2010, CLIN ONCOL-UK, V22, P222, DOI 10.1016/j.clon.2010.01.006; Quraishi NA, 2010, J BONE JOINT SURG BR, V92B, P1054, DOI 10.1302/0301-620X.92B8.22296; SCHABERG J, 1985, SPINE, V10, P19, DOI 10.1097/00007632-198501000-00003; Schiff D, 2003, NEUROL CLIN, V21, P67, DOI 10.1016/S0733-8619(02)00033-6; Sciubba DM, 2006, SURG ONCOL, V15, P141, DOI 10.1016/j.suronc.2006.11.002; Senel A, 2007, NEUROSURG REV, V30, P131, DOI 10.1007/s10143-007-0067-7; Shehadi JA, 2007, EUR SPINE J, V16, P1179, DOI 10.1007/s00586-007-0357-3; SORENSEN PS, 1994, EUR J CANCER, V30A, P22, DOI 10.1016/S0959-8049(05)80011-5; White BD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2538; Witham TF, 2006, NAT CLIN PRACT NEURO, V2, P87, DOI 10.1038/ncpneuro0116	24	14	15	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2011	342								d2402	10.1136/bmj.d2402	http://dx.doi.org/10.1136/bmj.d2402			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759BT	21525095				2022-12-24	WOS:000290215600004
J	Coles, CH; Shen, YJ; Tenney, AP; Siebold, C; Sutton, GC; Lu, WX; Gallagher, JT; Jones, EY; Flanagan, JG; Aricescu, AR				Coles, Charlotte H.; Shen, Yingjie; Tenney, Alan P.; Siebold, Christian; Sutton, Geoffrey C.; Lu, Weixian; Gallagher, John T.; Jones, E. Yvonne; Flanagan, John G.; Aricescu, A. Radu			Proteoglycan-Specific Molecular Switch for RPTP sigma Clustering and Neuronal Extension	SCIENCE			English	Article							TYROSINE-PHOSPHATASE-SIGMA; HEPARAN-SULFATE PROTEOGLYCANS; MICE LACKING; PTP-SIGMA; RECEPTOR; REGENERATION; LAR; SYNDECAN; SYSTEM; INJURY	Heparan and chondroitin sulfate proteoglycans (HSPGs and CSPGs, respectively) regulate numerous cell surface signaling events, with typically opposite effects on cell function. CSPGs inhibit nerve regeneration through receptor protein tyrosine phosphatase sigma (RPTP sigma). Here we report that RPTPs acts bimodally in sensory neuron extension, mediating CSPG inhibition and HSPG growth promotion. Crystallographic analyses of a shared HSPG-CSPG binding site reveal a conformational plasticity that can accommodate diverse glycosaminoglycans with comparable affinities. Heparan sulfate and analogs induced RPTPs ectodomain oligomerization in solution, which was inhibited by chondroitin sulfate. RPTPs and HSPGs colocalize in puncta on sensory neurons in culture, whereas CSPGs occupy the extracellular matrix. These results lead to a model where proteoglycans can exert opposing effects on neuronal extension by competing to control the oligomerization of a common receptor.	[Coles, Charlotte H.; Siebold, Christian; Sutton, Geoffrey C.; Lu, Weixian; Jones, E. Yvonne; Aricescu, A. Radu] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Shen, Yingjie; Tenney, Alan P.; Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Shen, Yingjie; Tenney, Alan P.; Flanagan, John G.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Tenney, Alan P.] Columbia Univ, Motor Neuron Ctr, New York, NY 10032 USA; [Gallagher, John T.] Univ Manchester, Paterson Inst Canc Res, Fac Med & Hlth Sci, Sch Canc & Imaging Sci, Manchester M20 4BX, Lancs, England	University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Columbia University; Paterson Institute for Cancer Research; University of Manchester	Jones, EY (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	yvonne@strubi.ox.ac.uk; flanagan@hms.harvard.edu; radu@strubi.ox.ac.uk	Jones, Yvonne/N-8111-2019; Aricescu, Alexandru/L-3891-2013; Jones, Yvonne/J-2293-2016; Flanagan, John/AAM-2995-2020	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Coles, Charlotte/0000-0003-4525-7144; Siebold, Christian/0000-0002-6635-3621; Aricescu, Alexandru ARadu/0000-0003-3783-1388	Wellcome Trust; European Research Community Fund [MRTN-CT-2006-035830]; NIH [EY11559, HD29417]; Cancer Research UK; UK Medical Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD029417, R01HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; Cancer Research UK [10976] Funding Source: researchfish; Medical Research Council [G0700232, G0900084] Funding Source: researchfish; MRC [G0700232, G0900084] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Community Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Coordinates and structure factors are deposited in the Protein Data Bank (see table S2). We thank K. Harlos, T. Walter, and staff of the European Synchrotron Radiation Facility and Diamond Light Source for assistance; the Harvard Medical School Nikon Imaging Center for resources and advice; C. Serra-Pages and A. W. Stoker for RPTP sigma cDNAs; M. Tremblay and N. Uetani (McGill Univ.) for the RPTP sigma<SUP>-/-</SUP> mouse; R. J. Gilbert and R. T. Aplin for analytical ultracentrifugation and mass spectrometry; and J. Silver, B. Lang, and A. W. Stoker for advice and discussions. This work was funded by the Wellcome Trust, the European Research Community Fund (MRTN-CT-2006-035830), the NIH (grants EY11559 and HD29417), Cancer Research UK, and the UK Medical Research Council. C. H. C. was the recipient of a Wellcome Trust D. Phil. studentship, C. S. is a Wellcome Trust Research Career Development Fellow, E.Y.J. is a Cancer Research UK Principal Research Fellow, and A. R. A. is a UK Medical Research Council Career Development Award Fellow. Current patent applications related to this work have been filed by Harvard Univ. A provisional patent filed by the University College London, related to the discovery of HSPGs as RPTP sigma ligands, expired in 2001. J. T. G. is the founder, director, and majority shareholder of Iduron, Paterson Institute for Cancer Research, Univ. of Manchester (Manchester, UK).	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Duan YT, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3110pe6; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Elchebly M, 1999, NAT GENET, V21, P330, DOI 10.1038/6859; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Harmer NJ, 2006, BIOCHEM J, V393, P741, DOI 10.1042/BJ20050985; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Ledig MM, 1999, J CELL BIOL, V147, P375, DOI 10.1083/jcb.147.2.375; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; McLean J, 2002, J NEUROSCI, V22, P5481; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Rashid-Doubell F, 2002, J NEUROSCI, V22, P5024, DOI 10.1523/JNEUROSCI.22-12-05024.2002; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Thompson KM, 2003, MOL CELL NEUROSCI, V23, P681, DOI 10.1016/S1044-7431(03)00120-9; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Uetani N, 2006, J NEUROSCI, V26, P5872, DOI 10.1523/JNEUROSCI.0386-06.2006; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Wallace MJ, 1999, NAT GENET, V21, P334, DOI 10.1038/6866; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279	33	234	247	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					484	488		10.1126/science.1200840	http://dx.doi.org/10.1126/science.1200840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21454754	Green Accepted			2022-12-24	WOS:000289784900048
J	Kagaya, K; Takahata, M				Kagaya, Katsushi; Takahata, Masakazu			Sequential Synaptic Excitation and Inhibition Shape Readiness Discharge for Voluntary Behavior	SCIENCE			English	Article							CENTRAL NERVOUS SYSTEM; PROCAMBARUS-CLARKII; NEURAL ACTIVITY; CENTRAL COMPLEX; FRONTAL-CORTEX; MOTOR CORTEX; CRAYFISH; INITIATION; MOVEMENTS; WALKING	How do animals initiate voluntary behavior? A key phenomenon in neuroscience is the readiness or preparatory neural activity in specific regions of the animal brain. The neurons and synaptic mechanisms mediating this activity are unknown. We found that the readiness discharge is shaped by sequential synaptic excitation and inhibition in the brain of crayfish (Procambarus clarkii). The readiness discharge neurons extended axon collaterals that appeared to activate recurring local interneurons. Therefore, we propose that the readiness discharge is formed by sequential synaptic events within the brain without feedback signals from downstream ganglia. The circuit involved is suited for signal processing for self-generated voluntary initiation of behavior.	[Kagaya, Katsushi; Takahata, Masakazu] Hokkaido Univ, Dept Biol Sci, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University	Kagaya, K (corresponding author), Hokkaido Univ, Dept Biol Sci, Fac Sci, Sapporo, Hokkaido 0600810, Japan.	kagaya@sci.hokudai.ac.jp		Kagaya, Katsushi/0000-0003-3001-7690	Ministry of Education, Culture, Sports, Science and Technology, Japan [18657025, 20370028]; Grants-in-Aid for Scientific Research [23370031] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (18657025 and 20370028).	ATWOOD HL, 1967, J EXP BIOL, V46, P249; Bender JA, 2010, CURR BIOL, V20, P921, DOI 10.1016/j.cub.2010.03.054; BOWERMAN RF, 1974, J EXP BIOL, V60, P119; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chikamoto K, 2008, ZOOL SCI, V25, P783, DOI 10.2108/zsj.25.783; CHRACHRI A, 1990, J NEUROSCI, V10, P707; Hyland B, 1998, BEHAV BRAIN RES, V94, P255, DOI 10.1016/S0166-4328(97)00157-5; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Kagaya K, 2010, J NEUROSCI, V30, P1348, DOI 10.1523/JNEUROSCI.4885-09.2010; Maimon G, 2006, J NEUROSCI, V26, P2487, DOI 10.1523/JNEUROSCI.3590-05.2006; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; OKANO K, 1987, EXP BRAIN RES, V66, P155; Roskies AL, 2010, ANNU REV NEUROSCI, V33, P109, DOI 10.1146/annurev-neuro-060909-153151; SANDEMAN D, 1992, BIOL BULL, V183, P304, DOI 10.2307/1542217; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; WIERSMA CAG, 1958, J COMP NEUROL, V110, P421, DOI 10.1002/cne.901100306	16	12	12	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					365	368		10.1126/science.1202244	http://dx.doi.org/10.1126/science.1202244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493864				2022-12-24	WOS:000289516600049
J	Ritter, JM				Ritter, J. M.			Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE CONTROL; HEART-FAILURE; RENIN; SYSTEM; TRIAL; BLOCKADE; DRUGS		[Ritter, J. M.] St Thomas Hosp, Dept Clin Pharmacol, London SE1 7EH, England; [Ritter, J. M.] Kings Coll London, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Ritter, JM (corresponding author), St Thomas Hosp, Dept Clin Pharmacol, London SE1 7EH, England.	james.ritter@kcl.ac.uk						BROWN JJ, 1965, BMJ-BRIT MED J, V2, P144, DOI 10.1136/bmj.2.5454.144; Brown MJ, 2003, J HUM HYPERTENS, V17, P81, DOI 10.1038/sj.jhh.1001511; Coleman JJ, 2010, BRIT J CLIN PHARMACO, V70, P109, DOI 10.1111/j.1365-2125.2010.03654.x; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dickerson JEC, 1999, LANCET, V353, P2008, DOI 10.1016/S0140-6736(98)07614-4; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Hermida RC, 2009, HYPERTENSION, V54, P40, DOI 10.1161/HYPERTENSIONAHA.109.130203; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; MACGREGOR GA, 1981, NATURE, V291, P329, DOI 10.1038/291329a0; MACGREGOR GA, 1985, J CARDIOVASC PHARM, V7, pS82, DOI 10.1097/00005344-198507001-00016; McDowell SE, 2006, BMJ-BRIT MED J, V332, P1177, DOI 10.1136/bmj.38803.528113.55; Medical Research Party Working Party, 1985, BMJ-BRIT MED J, V291, P99; Menard J, 1997, CIRCULATION, V96, P3072, DOI 10.1161/01.CIR.96.9.3072; Messerli FH, 2009, J AM COLL CARDIOL, V53, P468, DOI 10.1016/j.jacc.2008.10.036; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; Nakao N, 2009, LANCET, V374, P1226; National Institute for Health and Clinical Excellence, 2006, HYP MAN HYP AD PRIM; Okin PM, 2007, ANN INTERN MED, V147, P311, DOI 10.7326/0003-4819-147-5-200709040-00006; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Ritter JM, 2008, TXB CLIN PHARM, P185; Salvetti A, 1999, DRUGS, V57, P665, DOI 10.2165/00003495-199957050-00002; Sciarretta S, 2011, ARCH INTERN MED, V171, P384, DOI 10.1001/archinternmed.2010.427; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; The Seventh Report of the Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure, 2004, 7 JOINT NAT COMM PRE; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	26	10	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2011	342								d1673	10.1136/bmj.d1673	http://dx.doi.org/10.1136/bmj.d1673			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749JT	21474511				2022-12-24	WOS:000289462400002
J	Gousseff, M; Arnaud, L; Lambert, M; Hot, A; Hamidou, M; Duhaut, P; Papo, T; Soubrier, M; Ruivard, M; Malizia, G; Tieulie, N; Riviere, S; Ninet, J; Hatron, PY; Amoura, Z				Gousseff, Marie; Arnaud, Laurent; Lambert, Marc; Hot, Arnaud; Hamidou, Mohamed; Duhaut, Pierre; Papo, Thomas; Soubrier, Martin; Ruivard, Marc; Malizia, Giuseppe; Tieulie, Nathalie; Riviere, Sophie; Ninet, Jacques; Hatron, Pierre-Yves; Amoura, Zahir		Capillary Leak Syndrome Registry	The Systemic Capillary Leak Syndrome: A Case Series of 28 Patients From a European Registry	ANNALS OF INTERNAL MEDICINE			English	Article							HYPOVOLEMIC SHOCK; COMPARTMENT SYNDROME; MONOCLONAL GAMMOPATHY; CLARKSONS-DISEASE; MULTIPLE-MYELOMA; RECURRENT SHOCK; RARE CAUSE; PERMEABILITY; EDEMA; TERBUTALINE	Background: The systemic capillary leak syndrome (SCLS) is a rare disease characterized by life-threatening attacks of capillary hyperpermeability. Objective: To describe the clinical characteristics, laboratory findings, treatments, and outcomes of patients with SCLS who were not previously reported in the literature. Design: Case series. Setting: Patients referred to a European multicenter SCLS registry between January 1997 and July 2010. Patients: 28 patients with SCLS. Measurements: Frequency, severity of attacks, and vital status were assessed every 6 months, from diagnosis to the end of the study. Results: 13 men and 15 women referred to the registry who were not previously reported in the literature had 252 attacks. Median age at disease onset was 49.1 years (range, 5.4 to 77.7 years), and median annual frequency of attacks was 1.23 (range, 0.13 to 21.18) per patient. Monoclonal IgG gammopathy was observed in 25 patients (89%). Preventive treatment included intravenous immunoglobulin (n = 18), terbutaline (n = 9), and aminophylline (n = 10). Eight patients died (29%); 1-year survival was 89%, and 5-year survival was 73%. Death was directly related to SCLS attacks in 6 of 8 cases (75%). In 10 patients with a prediagnosis period greater than 6 months who received preventive treatment, the annual frequency of attacks after diagnosis decreased by a median of 1.55 (range, 0.14 to 8.84) per patient. Five years after diagnosis, survival was 85% in 23 patients who had received prophylactic treatment and 20% in 5 patients who had not. Limitation: The benefits of preventive treatment could not be precisely ascertained because of the small sample size and because most patients received several treatments. Conclusion: Clinical experience with these 28 patients with SCLS suggests that prophylactic treatment with beta(2)-agonists or intravenous immunoglobulin may reduce the frequency and severity of attacks and may improve survival.	Hop Bichat Claude Bernard, AP HP, Pitie Salpetriere Hosp, INSERM, F-75877 Paris 18, France; Univ Paris 06, Paris, France; Univ Nord France, Lille, France; Univ Lyon 1, Hop Edouard Herriot, F-69365 Lyon, France; CHU Nantes, Hotel Dieu, F-44035 Nantes 01, France; Hop Nord Amiens, Amiens, France; Ctr Hosp Univ Clermont Ferrand, F-63058 Clermont Ferrand 01, France; Ctr Hosp Univ Estaing, Clermont Ferrand, France; Osped Riuniti Villa Sofia Osped Cervello, Palermo, Italy; Hop Archet, F-06202 Nice 3, France; CHU Montpellier, F-34295 Montpellier 5, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Nantes Universite; CHU de Nantes; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Nice; Universite de Montpellier; CHU de Montpellier	Amoura, Z (corresponding author), Grp Hosp Pitie Salpetriere, Serv Med Interne 2, 47-83 Blvd Hop, F-75013 Paris, France.	zahir.amoura@psl.aphp.fr	lambert, marc/V-7380-2017; AMOURA, Zahir/P-5324-2017; Amoura, Zahir/P-5325-2017	lambert, marc/0000-0002-3485-8238; AMOURA, Zahir/0000-0003-0292-9043; Malizia, Giuseppe/0000-0002-0995-8755; ARNAUD, Laurent/0000-0002-8077-8394	Universite Pierre et Marie Curie, Paris, France; Laboratoire Francais du Fractionnement et des Biotechnologies (Les Ulis, France)	Universite Pierre et Marie Curie, Paris, France; Laboratoire Francais du Fractionnement et des Biotechnologies (Les Ulis, France)	Universite Pierre et Marie Curie, Paris, France.r Primarily by Universite Pierre et Marie Curie (Paris, France) and in part by Laboratoire Francais du Fractionnement et des Biotechnologies (Les Ulis, France).	ALEXANIAN R, 1995, SEMIN HEMATOL, V32, P20; Amoura Z, 1997, AM J MED, V103, P514, DOI 10.1016/S0002-9343(97)00272-6; Assaly R, 2001, CHEST, V120, P1301, DOI 10.1378/chest.120.4.1301; ATKINSON JP, 1977, MEDICINE, V56, P225, DOI 10.1097/00005792-197705000-00004; BALASCH J, 1994, ANN INTERN MED, V121, P27, DOI 10.7326/0003-4819-121-1-199407010-00005; BARNADAS MA, 1995, J AM ACAD DERMATOL, V32, P364, DOI 10.1016/0190-9622(95)90405-0; Bayry J, 2006, INT IMMUNOPHARMACOL, V6, P528, DOI 10.1016/j.intimp.2005.11.013; Bonadies N, 2006, EUR J INTERN MED, V17, P363, DOI 10.1016/j.ejim.2005.12.011; BOUHAJA B, 1994, INTENS CARE MED, V20, P307, DOI 10.1007/BF01708975; CAIN JR, 1986, KIDNEY INT, V29, P181; Chihara R, 2002, INTERNAL MED, V41, P953, DOI 10.2169/internalmedicine.41.953; CICARDI M, 1990, ANN INTERN MED, V113, P475, DOI 10.7326/0003-4819-113-6-475; CLARKSON B, 1960, AM J MED, V29, P193, DOI 10.1016/0002-9343(60)90018-8; Crenier L, 1997, ACTA CLIN BELG, V52, P401, DOI 10.1080/17843286.1997.11718607; Dams K, 2007, CHEST, V132, P1393, DOI 10.1378/chest.07-0456; de Barros R T, 1983, Rev Hosp Clin Fac Med Sao Paulo, V38, P170; Deeren DH, 2005, ANN HEMATOL, V84, P89, DOI 10.1007/s00277-004-0946-8; DEREURE O, 1994, DERMATOLOGY, V188, P152, DOI 10.1159/000247123; Dhir V, 2007, INTERNAL MED, V46, P899, DOI 10.2169/internalmedicine.46.6129; DOLBERGSTOLIK OC, 1993, CHEST, V104, P123, DOI 10.1378/chest.104.1.123; DOORENBOS CJ, 1988, NETH J MED, V32, P178; DRODER RM, 1992, AM J MED, V92, P523, DOI 10.1016/0002-9343(92)90749-2; Druey KM, 2010, ANN INTERN MED, V153, P90, DOI 10.7326/0003-4819-153-2-201007200-00005; Elias AD, 2001, BONE MARROW TRANSPL, V27, P269, DOI 10.1038/sj.bmt.1702780; EWAN PW, 1988, LANCET, V2, P1496; FELLOWS IW, 1988, LANCET, V2, P1143; FISHBEIN MC, 1974, AM J SURG, V127, P740, DOI 10.1016/0002-9610(74)90361-4; FOELDVARI I, 1995, J PEDIATR-US, V127, P739, DOI 10.1016/S0022-3476(95)70163-X; GARCIABRAGADO F, 1987, MED CLIN-BARCELONA, V89, P426; Gauvin F, 2000, CRIT CARE MED, V28, P3341, DOI 10.1097/00003246-200009000-00038; GEORGE C, 1978, INTENS CARE MED, V4, P159, DOI 10.1007/BF01700259; Gleich GJ, 2009, BRIT J HAEMATOL, V145, P271, DOI 10.1111/j.1365-2141.2009.07599.x; Gousseff M, 2009, REV MED INTERNE, V30, P754, DOI 10.1016/j.revmed.2009.01.005; GUIDET B, 1990, INTENS CARE MED, V16, P332, DOI 10.1007/BF01706361; Gyger M, 2005, BONE MARROW TRANSPL, V35, P201, DOI 10.1038/sj.bmt.1704730; Hamada Yoshihiro, 2004, Asian Cardiovasc Thorac Ann, V12, P193; Hiraoka E, 1995, INTERNAL MED, V34, P1220, DOI 10.2169/internalmedicine.34.1220; HORWITH M, 1967, J AMER MED ASSOC, V200, P101, DOI 10.1001/jama.200.2.101; JANINMANIFICAT L, 1982, NOUV PRESSE MED, V11, P2716; Jillella AP, 2000, LEUKEMIA LYMPHOMA, V38, P419, DOI 10.3109/10428190009087034; KANG PM, 1995, RENAL FAILURE, V17, P615, DOI 10.3109/08860229509037627; KAO NL, 1993, CHEST, V104, P1637, DOI 10.1378/chest.104.5.1637c; Kaplan MJ, 1999, ARCH DERMATOL, V135, P553, DOI 10.1001/archderm.135.5.553; Kapoor P, 2010, MAYO CLIN PROC, V85, P905, DOI 10.4065/mcp.2010.0159; Karatzios C, 2006, PEDIATR CRIT CARE ME, V7, P377, DOI 10.1097/01.PCC.0000227120.61949.FB; Kawabe S, 2002, INTERNAL MED, V41, P211, DOI 10.2169/internalmedicine.41.211; LAGRUE G, 1986, PRESSE MED, V15, P1554; Lambert M, 2008, CRIT CARE MED, V36, P2184, DOI 10.1097/CCM.0b013e31817d7c71; LARCAN A, 1975, BIBL ANAT, P343; Lassoued K, 1998, INTENS CARE MED, V24, P981, DOI 10.1007/s001340050700; Lee Young Seok, 2007, Korean Journal of Internal Medicine, V22, P130; LOFDAHL CG, 1979, ACTA MED SCAND, V206, P405; LUQUEL L, 1989, REV MED INTERNE, V10, P359, DOI 10.1016/S0248-8663(89)80037-2; Marasini B, 1979, Bibl Anat, P41; Marx G, 2000, INTENS CARE MED, V26, P1252, DOI 10.1007/s001340000601; Matsumura M, 2007, INTERNAL MED, V46, P1585, DOI 10.2169/internalmedicine.46.0254; MCGREGOR JM, 1991, BRIT J DERMATOL, V125, P472, DOI 10.1111/j.1365-2133.1991.tb14777.x; Michiels JJ, 2006, SEMIN THROMB HEMOST, V32, P577, DOI 10.1055/s-2006-949663; Muller M, 2004, INTERNIST, V45, P587, DOI 10.1007/s00108-004-1162-2; OHTA H, 1994, ACTA PAEDIATR, V83, P1113, DOI 10.1111/j.1651-2227.1994.tb13000.x; Onal H, 2007, ANN TROP PAEDIATR, V27, P81, DOI 10.1179/146532807X170556; PURI RK, 1989, CANCER IMMUNOL IMMUN, V28, P267; RONDEAU E, 1987, EUR J CLIN INVEST, V17, P53, DOI 10.1111/j.1365-2362.1987.tb01225.x; Sabbadini D D, 2002, Minerva Anestesiol, V68, P929; SABBADINI DD, 2002, MINERVA ANESTESIOL, V68, P933; Sahnoun I, 2005, REV MED INTERNE, V26, P409, DOI 10.1016/j.revmed.2004.12.009; Sanghavi R, 2006, ANAESTH INTENS CARE, V34, P388, DOI 10.1177/0310057X0603400308; Schmidt S, 1999, NEUROLOGY, V53, P220, DOI 10.1212/WNL.53.1.220; Shimura H, 1999, EUR SURG RES, V31, P390, DOI 10.1159/000008717; Sion-Sarid R, 2010, PEDIATRICS, V125, pE687, DOI 10.1542/peds.2009-1691; Staak JO, 2003, AM J MED, V115, P332, DOI 10.1016/S0002-9343(03)00349-8; SVENSJO E, 1982, ACTA PHYSIOL SCAND, V116, P265, DOI 10.1111/j.1748-1716.1982.tb07140.x; Tahirkheli NK, 1999, ANN INTERN MED, V130, P905, DOI 10.7326/0003-4819-130-11-199906010-00015; TEELUCKSINGH S, 1990, Q J MED, V75, P515; TEELUCKSINGH S, 1989, LANCET, V1, P330; Tieulie N, 2005, REV MED INTERNE, V26, pS223, DOI 10.1016/S0248-8663(05)80032-3; Valderrey FP, 1999, AM J EMERG MED, V17, P743, DOI 10.1016/S0735-6757(99)90179-1; Vigneau U, 2002, NEPHROL DIAL TRANSPL, V17, P492, DOI 10.1093/ndt/17.3.492; Wiest GH, 2001, MED KLIN, V96, P365, DOI 10.1007/PL00002217	79	96	103	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2011	154	7							464	10.7326/0003-4819-154-7-201104050-00004	http://dx.doi.org/10.7326/0003-4819-154-7-201104050-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744EX	21464348				2022-12-24	WOS:000289078700003
J	Kir, S; Beddow, SA; Samuel, VT; Miller, P; Previs, SF; Suino-Powell, K; Xu, HE; Shulman, GI; Kliewer, SA; Mangelsdorf, DJ				Kir, Serkan; Beddow, Sara A.; Samuel, Varman T.; Miller, Paul; Previs, Stephen F.; Suino-Powell, Kelly; Xu, H. Eric; Shulman, Gerald I.; Kliewer, Steven A.; Mangelsdorf, David J.			FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis	SCIENCE			English	Article							SYNTHASE KINASE-3-BETA; GLUCOSE-HOMEOSTASIS; GROWTH; PHOSPHORYLATION; FIBROBLAST-GROWTH-FACTOR-19; INACTIVATION; KLOTHO; MTORC1; SIGNAL; RSK	Fibroblast growth factor (FGF) 19 is an enterokine synthesized and released when bile acids are taken up into the ileum. We show that FGF19 stimulates hepatic protein and glycogen synthesis but does not induce lipogenesis. The effects of FGF19 are independent of the activity of either insulin or the protein kinase Akt and, instead, are mediated through a mitogen-activated protein kinase signaling pathway that activates components of the protein translation machinery and stimulates glycogen synthase activity. Mice lacking FGF15 (the mouse FGF19 ortholog) fail to properly maintain blood concentrations of glucose and normal postprandial amounts of liver glycogen. FGF19 treatment restored the loss of glycogen in diabetic animals lacking insulin. Thus, FGF19 activates a physiologically important, insulin-independent endocrine pathway that regulates hepatic protein and glycogen metabolism.	[Kir, Serkan; Kliewer, Steven A.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Beddow, Sara A.; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Miller, Paul; Previs, Stephen F.] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Suino-Powell, Kelly; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Case Western Reserve University; Van Andel Institute; Howard Hughes Medical Institute; Yale University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kliewer, SA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	steven.kliewer@utsouthwestern.edu; davo.mango@utsouthwestern.edu	Xu, H. Eric/ABD-7487-2021; Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Mangelsdorf, David/0000-0002-4355-0796; Xu, H. Eric/0000-0002-6829-8144	Howard Hughes Medical Institute; NIH [DK67158, DK62434, DK40936, U24 DK076169]; Robert A. Welch Foundation [I-1275, I-558]; Yale and Case Western Reserve University Mouse Metabolic Phenotyping Centers; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076169, U19DK062434, R01DK067158, R01DK040936, U24DK059635, R24DK085638] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Yale and Case Western Reserve University Mouse Metabolic Phenotyping Centers; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Inagaki, X. Ding, and A. Bookout for their help with animal experiments and M. Cobb and P. Scherer (University of Texas Southwestern Medical Center) for discussion and comments. This research was supported by the Howard Hughes Medical Institute (G. I. S., D.J.M.), the NIH (DK67158 and DK62434 to S. A. K. and D.J.M., DK40936 and U24 DK076169 to G. I. S.), the Robert A. Welch Foundation (I-1275 to D.J.M. and I-558 to S. A. K.), and the Yale and Case Western Reserve University Mouse Metabolic Phenotyping Centers. A Materials Transfer Agreement is required for sharing materials from the Van Andel Institute.	Anderson SR, 2008, METABOLISM, V57, P347, DOI 10.1016/j.metabol.2007.10.009; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Dufner DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE1277, DOI 10.1152/ajpendo.00580.2004; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rachdaoui N, 2009, MOL CELL PROTEOMICS, V8, P2653, DOI 10.1074/mcp.M900026-MCP200; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004	26	418	445	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1621	1624		10.1126/science.1198363	http://dx.doi.org/10.1126/science.1198363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436455	Green Accepted			2022-12-24	WOS:000288754500060
J	Iheanacho, I				Iheanacho, Ike			Drug Tales and Other Stories Prescription charges: a tax on the English	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2011	342								d1790	10.1136/bmj.d1790	http://dx.doi.org/10.1136/bmj.d1790			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MJ	21429994				2022-12-24	WOS:000288948000020
J	Ferrell, JE; Tsai, TYC; Yang, QO				Ferrell, James E., Jr.; Tsai, Tony Yu-Chen; Yang, Qiong			Modeling the Cell Cycle: Why Do Certain Circuits Oscillate?	CELL			English	Article							POSITIVE FEEDBACK; FISSION YEAST; MATHEMATICAL-MODEL; MITOTIC OSCILLATOR; DIVISION CYCLE; BUDDING YEAST; KAIC PHOSPHORYLATION; NEGATIVE FEEDBACK; RESTRICTION POINT; CIRCADIAN CLOCKS	Computational modeling and the theory of nonlinear dynamical systems allow one to not simply describe the events of the cell cycle, but also to understand why these events occur, just as the theory of gravitation allows one to understand why cannonballs fly in parabolic arcs. The simplest examples of the eukaryotic cell cycle operate like autonomous oscillators. Here, we present the basic theory of oscillatory biochemical circuits in the context of the Xenopus embryonic cell cycle. We examine Boolean models, delay differential equation models, and especially ordinary differential equation (ODE) models. For ODE models, we explore what it takes to get oscillations out of two simple types of circuits (negative feedback loops and coupled positive and negative feedback loops). Finally, we review the procedures of linear stability analysis, which allow one to determine whether a given ODE model and a particular set of kinetic parameters will produce oscillations.	[Ferrell, James E., Jr.; Tsai, Tony Yu-Chen; Yang, Qiong] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Ferrell, James E., Jr.; Tsai, Tony Yu-Chen] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	james.ferrell@stanford.edu	; Yang, Qiong/G-9630-2016	Tsai, Tony/0000-0003-1121-9406; Yang, Qiong/0000-0002-2442-2094	NIH [GM077544]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077544] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Markus Covert for the idea of starting this tutorial with a Boolean analysis instead of plunging right into ODEs and David Dill for helpful discussions. This work was supported by NIH GM077544.	Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Alfieri R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S16; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; Borisuk MT, 1998, J THEOR BIOL, V195, P69, DOI 10.1006/jtbi.1998.0781; Braunewell S, 2007, J THEOR BIOL, V245, P638, DOI 10.1016/j.jtbi.2006.11.012; BUSENBERG S, 1994, J MATH BIOL, V32, P573, DOI 10.1007/BF00573462; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Ciliberto A, 2003, J CELL BIOL, V163, P1243, DOI 10.1083/jcb.200306139; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Ge H, 2008, MATH BIOSCI, V211, P132, DOI 10.1016/j.mbs.2007.10.003; Gilbert D A, 1974, Curr Mod Biol, V5, P197; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A, 1996, EXPERIENTIA, V52, P212, DOI 10.1007/BF01920708; Haase SB, 1999, NATURE, V401, P394, DOI 10.1038/43930; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; KAUFFMAN S, 1975, J THEOR BIOL, V55, P47, DOI 10.1016/S0022-5193(75)80108-1; Li B, 2010, J THEOR BIOL, V264, P771, DOI 10.1016/j.jtbi.2010.03.023; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Mangla K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008906; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Mura I, 2008, J THEOR BIOL, V254, P850, DOI 10.1016/j.jtbi.2008.07.019; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; NOREL R, 1991, SCIENCE, V251, P1076, DOI 10.1126/science.1825521; NOVAK B, 1993, J THEOR BIOL, V165, P101, DOI 10.1006/jtbi.1993.1179; NOVAK B, 1993, J CELL SCI, V106, P1153; Novak B, 1998, BIOPHYS CHEM, V72, P185, DOI 10.1016/S0301-4622(98)00133-1; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; OBEYESEKERE MN, 1992, BIOCHEM BIOPH RES CO, V184, P782, DOI 10.1016/0006-291X(92)90658-8; Okabe Y, 2007, BIOPHYS J, V93, P3451, DOI 10.1529/biophysj.107.109991; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Sel'kov E E, 1970, Biofizika, V15, P1065; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Srividhya J, 2006, J THEOR BIOL, V241, P617, DOI 10.1016/j.jtbi.2005.12.020; Steuer R, 2004, J THEOR BIOL, V228, P293, DOI 10.1016/j.jtbi.2004.01.012; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; TYSON J, 1975, J MATH BIOL, V1, P289, DOI 10.1007/BF00279848; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang YP, 2006, PHYSICA D, V219, P35, DOI 10.1016/j.physd.2006.05.009; Zwicker D, 2010, P NATL ACAD SCI USA, V107, P22540, DOI 10.1073/pnas.1007613107	69	221	222	2	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					874	885		10.1016/j.cell.2011.03.006	http://dx.doi.org/10.1016/j.cell.2011.03.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414480	Bronze			2022-12-24	WOS:000288543500007
J	Struijs, JN; Baan, CA				Struijs, Jeroen N.; Baan, Caroline A.			Integrating Care through Bundled Payments - Lessons from the Netherlands	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Struijs, Jeroen N.; Baan, Caroline A.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Struijs, JN (corresponding author), Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.		Struijs, Jeroen/AAA-8057-2022; Struijs, Jeroen/AAX-6827-2020; Struijs, Jeroen/AAQ-9872-2020	Struijs, Jeroen/0000-0002-7493-6720; 				COORDINATINGCAR.BT, 2008, NEW ENGL J MED, V358, P1064; de Brantes F, 2009, NEW ENGL J MED, V361, P1033, DOI 10.1056/NEJMp0906121; Devers K, 2009, CAN ACCOUNTABLE CARE; Luft HS, 2010, NEW ENGL J MED, V363, P1389, DOI 10.1056/NEJMp1009380; STRUIJS JN, 2010, EXPT BUNDLED PAYMENT	5	104	104	3	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					990	991		10.1056/NEJMp1011849	http://dx.doi.org/10.1056/NEJMp1011849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735SX	21410368				2022-12-24	WOS:000288439000003
J	Davidson, GH; Hamlat, CA; Rivara, FP; Koepsell, TD; Jurkovich, GJ; Arbabi, S				Davidson, Giana H.; Hamlat, Christian A.; Rivara, Frederick P.; Koepsell, Thomas D.; Jurkovich, Gregory J.; Arbabi, Saman			Long-term Survival of Adult Trauma Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTIPLE IMPUTATION; NATIONAL EVALUATION; GERIATRIC-PATIENTS; INJURED PATIENTS; LATE DEATH; OUTCOMES; CARE; MORTALITY; SYSTEMS; DISCHARGE	Context Inpatient trauma case fatality rates may provide an incomplete assessment for overall trauma care effectiveness. To date, there have been few large studies evaluating long-term mortality in trauma patients and identifying predictors that increase risk for death following hospital discharge. Objectives To determine the long-term mortality of patients following trauma admission and to evaluate survivorship in relationship with discharge disposition. Design, Setting, and Patients Retrospective cohort study of 124 421 injured adult patients during January 1995 to December 2008 using the Washington State Trauma Registry linked to death certificate data. Main Outcome Measures Kaplan-Meier and Cox proportional hazards models were used to evaluate long-term mortality following hospital admission for trauma. Results Of the 124 421 trauma patients, 7243 died before hospital discharge and 21 045 died following hospital discharge. Cumulative mortality at 3 years postinjury was 16% (95% confidence interval [CI], 15.8%-16.2%) compared with the expected population cumulative mortality of 5.9% (95% CI, 5.9%-5.9%). In-hospital mortality improved during the 14-year study period from 8% (n=362) to 4.9% (n=600), whereas long-term cumulative mortality increased from 4.7% (95% CI, 4.1%-5.4%) to 7.4% (95% CI, 6.8%-8.1%). After adjustments for confounders, patients who were older and those who were discharged to a skilled nursing facility had the highest risk of death. The adjusted hazard ratios (HRs) for death after discharge to a skilled nursing facility compared with that after discharge home were 1.41 (95% CI, 0.72-2.76) for patients aged 18 to 30 years, 1.92 (95% CI, 1.36-2.73) for patients aged 31 to 45 years, 2.02 (95% CI, 1.39-2.93) for patients aged 46 to 55 years, 1.93 (95% CI, 1.40-2.64) for patients aged 56 to 65 years, 1.49 (95% CI, 1.14-1.94) for patients aged 66 to 75 years, 1.54 (95% CI, 1.27-1.87) for patients aged 76 to 80 years, and 1.38 (95% CI, 1.09-1.74) for patients older than 80 years. Other significant predictors of mortality after discharge included maximum head injury score on Abbreviated Injury Score scale (HR, 1.20; 95% CI, 1.13-1.26), Injury Severity Score (HR, 0.98; 95% CI, 0.97-0.98), Functional Independence Measure (HR, 0.89; 95% CI, 0.88-0.91), mechanism of injury being a fall (HR, 1.43; 95% CI, 1.30-1.58), and having Medicare (HR, 1.28; 95% CI, 1.15-1.43) or other government insurance (HR, 1.65; 95% CI, 1.47-1.85). Conclusions Among adults admitted for trauma in Washington State, 3-year cumulative mortality was 16% despite a decline in in-hospital deaths. Discharge to a skilled nursing facility at any age following trauma admission was associated with a higher risk of subsequent mortality. JAMA. 2011;305(10):1001-1007 www.jama.com	[Davidson, Giana H.; Hamlat, Christian A.; Jurkovich, Gregory J.; Arbabi, Saman] Univ Washington, Dept Surg, Seattle, WA 98104 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Rivara, Frederick P.; Koepsell, Thomas D.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Arbabi, Saman] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle	Arbabi, S (corresponding author), Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, 325 9th Ave,Box 359796, Seattle, WA 98104 USA.	sarbabi@uw.edu			National Institute of Child Health and Human Development [1T32HD057822-01AZ]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057822] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institute of Child Health and Human Development grant 1T32HD057822-01AZ that was awarded to the Pediatric Injury Research Training Program.	Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Battistella FD, 1998, J TRAUMA, V44, P618, DOI 10.1097/00005373-199804000-00010; Claridge JA, 2010, J AM COLL SURGEONS, V210, P788, DOI 10.1016/j.jamcollsurg.2009.12.035; Clark DE, 2004, J AM GERIATR SOC, V52, P2023, DOI 10.1111/j.1532-5415.2004.52560.x; DEMARIA EJ, 1987, ANN SURG, V206, P738, DOI 10.1097/00000658-198712000-00009; FINELLI FC, 1989, J TRAUMA, V29, P541, DOI 10.1097/00005373-198905000-00001; Gubler KD, 1996, J TRAUMA, V41, P952, DOI 10.1097/00005373-199612000-00002; Gubler KD, 1997, ARCH SURG-CHICAGO, V132, P1010; Legner VJ, 2009, ANN SURG, V249, P250, DOI 10.1097/SLA.0b013e318195e12f; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mullins RJ, 1998, JAMA-J AM MED ASSOC, V279, P1727, DOI 10.1001/jama.279.21.1727; Munin MC, 2010, AM J PHYS MED REHAB, V89, P530, DOI 10.1097/PHM.0b013e3181e29f54; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Olson CJ, 2003, J TRAUMA, V55, P45, DOI 10.1097/01.TA.0000071291.17287.57; ORESKOVICH MR, 1984, J TRAUMA, V24, P565, DOI 10.1097/00005373-198407000-00003; Probst C, 2009, J TRAUMA, V66, P1212, DOI 10.1097/TA.0b013e318197b97c; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Skaga NO, 2008, INJURY, V39, P612, DOI 10.1016/j.injury.2007.11.426; *US CDCP, MULT CAUS DEATH 2005; Utter GH, 2006, J TRAUMA, V60, P529, DOI 10.1097/01.ta.0000204022.36214.9e; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Winzelberg GS, 2003, ARCH INTERN MED, V163, P2552, DOI 10.1001/archinte.163.21.2552; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; ZIETLOW SP, 1994, J TRAUMA, V37, P985, DOI 10.1097/00005373-199412000-00020	26	186	188	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1001	1007		10.1001/jama.2011.259	http://dx.doi.org/10.1001/jama.2011.259			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386078	Bronze			2022-12-24	WOS:000288129600019
J	King, MC				King, Mary-Claire			A Healthy Son	SCIENCE			English	Editorial Material									Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	King, MC (corresponding author), Univ Washington, Seattle, WA 98195 USA.			King, Mary-Claire/0000-0001-9426-1743					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1026	1026		10.1126/science.1204088	http://dx.doi.org/10.1126/science.1204088			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350166	Bronze			2022-12-24	WOS:000287699000049
J	Boal, AK; Grove, TL; McLaughlin, MI; Yennawar, NH; Booker, SJ; Rosenzweig, AC				Boal, Amie K.; Grove, Tyler L.; McLaughlin, Monica I.; Yennawar, Neela H.; Booker, Squire J.; Rosenzweig, Amy C.			Structural Basis for Methyl Transfer by a Radical SAM Enzyme	SCIENCE			English	Article							23S RIBOSOMAL-RNA; CONFERS ANTIBIOTIC-RESISTANCE; CATECHOL O-METHYLTRANSFERASE; PYRUVATE FORMATE-LYASE; CRYSTAL-STRUCTURE; 5'-DEOXYADENOSYL RADICALS; FES CLUSTER; ADENOSYLMETHIONINE; MECHANISM; CFR	The radical S-adenosyl-L-methionine (SAM) enzymes RlmN and Cfr methylate 23S ribosomal RNA, modifying the C2 or C8 position of adenosine 2503. The methyl groups are installed by a two-step sequence involving initial methylation of a conserved Cys residue (RlmN Cys(355)) by SAM. Methyl transfer to the substrate requires reductive cleavage of a second equivalent of SAM. Crystal structures of RlmN and RlmN with SAM show that a single molecule of SAM coordinates the [4Fe-4S] cluster. Residue Cys(355) is S-methylated and located proximal to the SAM methyl group, suggesting the SAM that is involved in the initial methyl transfer binds at the same site. Thus, RlmN accomplishes its complex reaction with structural economy, harnessing the two most important reactivities of SAM within a single site.	[Grove, Tyler L.; McLaughlin, Monica I.; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Grove, Tyler L.; McLaughlin, Monica I.; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Yennawar, Neela H.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Northwestern University; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	squire@psu.edu; amyr@northwestern.edu		McLaughlin, Martin/0000-0003-4410-0786	NIH [GM58518, GM63847]; National Research Service Award; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM100011, R01GM058518, R01GM063847] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by NIH grants GM58518 (A. C. R.) and GM63847 (S.J.B.) and a National Research Service Award fellowship to A. K. B. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). GM/CA CAT has been funded in whole or in part with Federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3RF9 (RlmN) and 3RFA (RlmN+SAM).	Allen BD, 2003, J AM CHEM SOC, V125, P9018, DOI 10.1021/ja034242l; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Cosper NJ, 2000, BIOCHEMISTRY-US, V39, P15668, DOI 10.1021/bi0022184; Fontecave M, 2001, CURR OPIN CHEM BIOL, V5, P506, DOI 10.1016/S1367-5931(00)00237-4; Frey P. A., 2007, ENZYMATIC REACTION M; Frey P. A., 1992, ENZYMES, V20, P142; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hardin JW, 2010, J MOL BIOL, V402, P412, DOI 10.1016/j.jmb.2010.07.040; HEGAZI MF, 1979, J AM CHEM SOC, V101, P4359, DOI 10.1021/ja00509a052; Iwig DF, 2004, BIOCHEMISTRY-US, V43, P13510, DOI 10.1021/bi048692h; Jarrett JT, 2003, CURR OPIN CHEM BIOL, V7, P174, DOI 10.1016/S1367-5931(03)00022-X; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Kampmeier JA, 2010, BIOCHEMISTRY-US, V49, P10770, DOI 10.1021/bi101509u; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; Kimura S, 2010, NUCLEIC ACIDS RES, V38, P1341, DOI 10.1093/nar/gkp1073; KOWALAK JA, 1995, J BIOL CHEM, V270, P17758, DOI 10.1074/jbc.270.30.17758; LaMarre JM, 2011, ANTIMICROB AGENTS CH, V55, P2989, DOI 10.1128/AAC.00183-11; Larsson KM, 2001, STRUCTURE, V9, P739, DOI 10.1016/S0969-2126(01)00627-X; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Markham G. D., 2010, ENCY LIFE SCIENCES; Miller DJ, 2003, PROTEIN SCI, V12, P1432, DOI 10.1110/ps.0302403; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Nicolet Y, 2009, P NATL ACAD SCI USA, V106, P14867, DOI 10.1073/pnas.0904385106; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Westler WM, 2011, J AM CHEM SOC, V133, P1310, DOI 10.1021/ja1049059; WOODARD RW, 1980, J BIOL CHEM, V255, P9124; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y	48	125	127	0	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1089	1092		10.1126/science.1205358	http://dx.doi.org/10.1126/science.1205358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21527678	Green Accepted			2022-12-24	WOS:000290996700046
J	Sackett, B; Sakel, M				Sackett, Brian; Sakel, Mohamed			A PATIENT'S JOURNEY Motor neurone disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sakel, Mohamed] E Kent Hosp Univ NHS Fdn Trust, Kent & Canterbury Hosp, Canterbury CT1 3NG, Kent, England	University of Kent		brian@sackett.go-plus.net							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 3	2011	342								d1661	10.1136/bmj.d1661	http://dx.doi.org/10.1136/bmj.d1661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762MA	21540256	Green Submitted, Bronze			2022-12-24	WOS:000290481600005
J	Ratcliff, WC; Denison, RF				Ratcliff, William Croft; Denison, Robert Ford			Alternative Actions for Antibiotics	SCIENCE			English	Editorial Material									[Ratcliff, William Croft; Denison, Robert Ford] Univ Minnesota, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Ratcliff, WC (corresponding author), Univ Minnesota, St Paul, MN 55108 USA.	denis036@umn.edu						Berleman JE, 2006, J BACTERIOL, V188, P5888, DOI 10.1128/JB.00559-06; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; Diggle SP, 2007, PHILOS T R SOC B, V362, P1241, DOI 10.1098/rstb.2007.2049; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Gilg O, 2010, SCIENCE, V327, P276, DOI 10.1126/science.1184964; Jousset A, 2008, FUNCT ECOL, V22, P714, DOI 10.1111/j.1365-2435.2008.01411.x; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Nizak C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000212; Ratcliff WC, 2009, ISME J, V3, P870, DOI 10.1038/ismej.2009.38; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; SMITH J. M., 1964, Nature, V201, P1145, DOI 10.1038/2011145a0; Ward J., 2008, CONTROL BIOFILM INFE, P79; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	16	43	43	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					547	548		10.1126/science.1205970	http://dx.doi.org/10.1126/science.1205970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527704				2022-12-24	WOS:000289991100034
J	van den Elsen, JMH; Isenman, DE				van den Elsen, Jean M. H.; Isenman, David E.			A Crystal Structure of the Complex Between Human Complement Receptor 2 and Its Ligand C3d	SCIENCE			English	Article							EPSTEIN-BARR-VIRUS; STAPHYLOCOCCUS-AUREUS; BINDING-SITE; COMPONENT C3; CR-2; CD21; RESIDUES; ARTHRITIS; CR2/CD21; IMMUNITY	The interaction of complement receptor 2 (CR2)-which is present on B cells and follicular dendritic cells-with its antigen-bound ligand C3d results in an enhanced antibody response, thus providing an important link between the innate and adaptive immune systems. Although a cocrystal structure of a complex between C3d and the ligand-binding domains of CR2 has been published, several aspects of this structure, including the position in C3d of the binding interface, remained controversial because of disagreement with biochemical data. We now report a cocrystal structure of a CR2(SCR1-2):C3d complex at 3.2 angstrom resolution in which the interaction interfaces differ markedly from the previously published structure and are consistent with the biochemical data. It is likely that, in the previous structure, the interaction was influenced by the presence of zinc acetate additive in the crystallization buffer, leading to a nonphysiological complex. Detailed knowledge of the binding interface now at hand gives the potential to exploit the interaction in vaccine design or in therapeutics directed against autoreactive B cells.	[van den Elsen, Jean M. H.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Isenman, David E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Bath; University of Toronto	van den Elsen, JMH (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssjmhve@bath.ac.uk; d.isenman@utoronto.ca	van den Elsen, Jean/D-9274-2011	van den Elsen, Jean/0000-0002-0367-1956				Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; CAREL JC, 1990, J BIOL CHEM, V265, P12293; Clark EA, 2011, MOL IMMUNOL, V48, P452, DOI 10.1016/j.molimm.2010.09.017; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; Del Nagro CJ, 2005, J IMMUNOL, V175, P5379, DOI 10.4049/jimmunol.175.8.5379; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DIEFENBACH RJ, 1995, J IMMUNOL, V154, P2303; Fang YF, 1998, J IMMUNOL, V160, P5273; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Hannan JP, 2005, J MOL BIOL, V346, P845, DOI 10.1016/j.jmb.2004.12.007; Isenman DE, 2010, J IMMUNOL, V184, P1946, DOI 10.4049/jimmunol.0902919; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; KALLI KR, 1991, J IMMUNOL, V147, P590; Kovacs JM, 2009, J BIOL CHEM, V284, P9513, DOI 10.1074/jbc.M808404200; Kuhn KA, 2008, MOL IMMUNOL, V45, P2808, DOI 10.1016/j.molimm.2008.01.036; LAMBRIS JD, 1985, P NATL ACAD SCI USA, V82, P4235, DOI 10.1073/pnas.82.12.4235; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; MOORE MD, 1989, J BIOL CHEM, V264, P20576; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Prota AE, 2002, P NATL ACAD SCI USA, V99, P10641, DOI 10.1073/pnas.162360499; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Shaw CD, 2010, J MOL BIOL, V404, P697, DOI 10.1016/j.jmb.2010.10.005; Szakonyi G, 2001, SCIENCE, V292, P1725, DOI 10.1126/science.1059118	26	56	64	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					608	611		10.1126/science.1201954	http://dx.doi.org/10.1126/science.1201954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527715				2022-12-24	WOS:000289991100054
J	Oh, JS; Susor, A; Conti, M				Oh, Jeong Su; Susor, Andrej; Conti, Marco			Protein Tyrosine Kinase Wee1B Is Essential for Metaphase II Exit in Mouse Oocytes	SCIENCE			English	Article							ACTIVATION; EGG; PHOSPHORYLATION; RESUMPTION; ARREST; CDC20	Waves of cyclin synthesis and degradation regulate the activity of Cdc2 protein kinase during the cell cycle. Cdc2 inactivation by Wee1B-mediated phosphorylation is necessary for arrest of the oocyte at G2-prophase, but it is unclear whether this regulation functions later during the metaphase-to-anaphase transition. We show that reactivation of a Wee1B pathway triggers the decrease in Cdc2 activity during egg activation. When Wee1B is down-regulated, oocytes fail to form a pronucleus in response to Ca2+ signals. Calcium-calmodulin-dependent kinase II (CaMKII) activates Wee1B, and CaMKII-driven exit from metaphase II is inhibited by Wee1B down-regulation, demonstrating that exit from metaphase requires not only a proteolytic degradation of cyclin B but also the inhibitory phosphorylation of Cdc2 by Wee1B.	[Conti, Marco] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Conti, M (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA.	contim@obgyn.ucsf.edu			NIH [GM080527-05, HD052909]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080527] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. J. Han for Wee1B plasmids, K. T. Jones for cyclin B plasmids, and T. Lorca for the CaMKII plasmid. This work was supported by NIH grants GM080527-05 and HD052909. J.O. designed, performed, and analyzed most of the experiments in this study. A. S. performed immunostaining. M.C. conceived the project and supervised the study. J.O. and M.C. wrote the manuscript.	BACHVAROVA R, 1985, DEV BIOL, V108, P325, DOI 10.1016/0012-1606(85)90036-3; D'Angiolella V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000247; Han SJ, 2005, CURR BIOL, V15, P1670, DOI 10.1016/j.cub.2005.07.056; Hutchins JRA, 2003, MOL BIOL CELL, V14, P4003, DOI 10.1091/mbc.E03-02-0061; Jones KT, 2005, REPRODUCTION, V130, P813, DOI 10.1530/rep.1.00710; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Madgwick S, 2005, J CELL SCI, V118, P3849, DOI 10.1242/jcs.02506; Oh JS, 2010, J CELL BIOL, V188, P199, DOI 10.1083/jcb.200907161; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Sveiczer A, 1999, J CELL SCI, V112, P1085; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Yin S, 2007, CELL CYCLE, V6, P2990, DOI 10.4161/cc.6.23.4993	15	77	90	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					462	465		10.1126/science.1199211	http://dx.doi.org/10.1126/science.1199211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21454751	Green Accepted			2022-12-24	WOS:000289784900042
J	Durand, S; Lykke-Andersen, J				Durand, Sebastien; Lykke-Andersen, Jens			SnapShot: Nonsense-Mediated mRNA Decay	CELL			English	Editorial Material									[Durand, Sebastien; Lykke-Andersen, Jens] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Durand, S (corresponding author), Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA.		Durand, Sebastien/Q-2138-2019	Durand, Sebastien/0000-0002-9960-9099; Lykke-Andersen, Jens/0000-0003-1821-0754				Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Kashima I, 2010, GENE DEV, V24, P2440, DOI 10.1101/gad.604610; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007	10	11	15	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					324	U2		10.1016/j.cell.2011.03.038	http://dx.doi.org/10.1016/j.cell.2011.03.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496649	Bronze			2022-12-24	WOS:000289549900020
J	Baker, M				Baker, Monya			A LIVING SYSTEM ON A CHIP	NATURE			English	Editorial Material																		Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; Gunther A, 2010, LAB CHIP, V10, P2341, DOI 10.1039/c004675b; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Imura Y, 2010, ANAL CHEM, V82, P9983, DOI 10.1021/ac100806x; Mahler GJ, 2009, BIOTECHNOL BIOENG, V104, P193, DOI 10.1002/bit.22366; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sonntag F, 2010, J BIOTECHNOL, V148, P70, DOI 10.1016/j.jbiotec.2010.02.001; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Sung JH, 2011, LAB CHIP, V11, P389, DOI [10.1039/c0lc00273a, 10.1039/c01c00273a]; Sung JH, 2010, LAB CHIP, V10, P446, DOI 10.1039/b917763a	10	153	165	0	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					661	665		10.1038/471661a	http://dx.doi.org/10.1038/471661a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455183	Bronze			2022-12-24	WOS:000288951200047
J	Fine, DR				Fine, David R.			Personal View We need a simple test for prosopagnosia	BRITISH MEDICAL JOURNAL			English	Editorial Material									Southampton Univ Hosp NHS Trust, Southampton, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust	Fine, DR (corresponding author), Southampton Univ Hosp NHS Trust, Southampton, Hants, England.	davidrfine@gmail.com		Fine, David/0000-0001-8041-3275					0	6	6	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2011	342								d1736	10.1136/bmj.d1736	http://dx.doi.org/10.1136/bmj.d1736			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742MJ	21429993				2022-12-24	WOS:000288948000030
J	Yanovski, SZ; Yanovski, JA				Yanovski, Susan Z.; Yanovski, Jack A.			Obesity Prevalence in the United States - Up, Down, or Sideways?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADULTS		[Yanovski, Susan Z.] NIDDKD, Off Obes Res, Bethesda, MD 20892 USA; [Yanovski, Jack A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Obes, Program Dev Endocrinol & Genet, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yanovski, SZ (corresponding author), NIDDKD, Off Obes Res, Bethesda, MD 20892 USA.			Yanovski, Jack/0000-0001-8542-1637	Intramural NIH HHS [Z99 HD999999, ZIA HD000641-16] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000641] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P951; EATON DK, 2007, OBES REV, V8, P307; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012	4	114	121	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					987	989		10.1056/NEJMp1009229	http://dx.doi.org/10.1056/NEJMp1009229			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735SX	21410367	Green Accepted, Bronze			2022-12-24	WOS:000288439000002
J	Simsek, D; Furda, A; Gao, Y; Artus, J; Brunet, E; Hadjantonakis, AK; Van Houten, B; Shuman, S; McKinnon, PJ; Jasin, M				Simsek, Deniz; Furda, Amy; Gao, Yankun; Artus, Jerome; Brunet, Erika; Hadjantonakis, Anna-Katerina; Van Houten, Bennett; Shuman, Stewart; McKinnon, Peter J.; Jasin, Maria			Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair	NATURE			English	Article							STRAND BREAK REPAIR; EMBRYONIC LETHALITY; GENE ENCODES; XRCC1; NUCLEAR; PROTEINS; BINDING; ALPHA; CELLS; CYCLE	Mammalian cells have three ATP-dependent DNA ligases, which are required for DNA replication and repair(1). Homologues of ligase I (Lig1) and ligase IV (Lig4) are ubiquitous in Eukarya, whereas ligase III (Lig3), which has nuclear and mitochondrial forms, appears to be restricted to vertebrates. Lig3 is implicated in various DNA repair pathways with its partner protein Xrcc1 (ref. 1). Deletion of Lig3 results in early embryonic lethality in mice, as well as apparent cellular lethality(2), which has precluded definitive characterization of Lig3 function. Here we used pre-emptive complementation to determine the viability requirement for Lig3 in mammalian cells and its requirement in DNA repair. Various forms of Lig3 were introduced stably into mouse embryonic stem (mES) cells containing a conditional allele of Lig3 that could be deleted with Cre recombinase. With this approach, we find that the mitochondrial, but not nuclear, Lig3 is required for cellular viability. Although the catalytic function of Lig3 is required, the zinc finger (ZnF) and BRCA1 carboxy (C)-terminal-related (BRCT) domains of Lig3 are not. Remarkably, the viability requirement for Lig3 can be circumvented by targeting Lig1 to the mitochondria or expressing Chlorella virus DNA ligase, the minimal eukaryal nick-sealing enzyme(3), or Escherichia coli LigA, an NAD(+)-dependent ligase(1). Lig3-null cells are not sensitive to several DNA-damaging agents that sensitize Xrcc1-deficient cells(4-6). Our results establish a role for Lig3 in mitochondria, but distinguish it from its interacting protein Xrcc1.	[Simsek, Deniz; Artus, Jerome; Brunet, Erika; Hadjantonakis, Anna-Katerina; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Simsek, Deniz; Hadjantonakis, Anna-Katerina; Shuman, Stewart; Jasin, Maria] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Furda, Amy; Van Houten, Bennett] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Furda, Amy; Van Houten, Bennett] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Gao, Yankun; McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Brunet, Erika] Museum Natl Hist Nat, F-75005 Paris, France; [Brunet, Erika] CNRS, UMR7196, F-75005 Paris, France; [Brunet, Erika] INSERM, U565, F-75005 Paris, France; [Shuman, Stewart] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Jude Children's Research Hospital; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Memorial Sloan Kettering Cancer Center	Jasin, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA.	m-jasin@ski.mskcc.org	BRUNET, ERIKA/H-9297-2017; BRUNET, ERIKA/K-7154-2016; Van Houten, Bennett/K-2284-2019	BRUNET, ERIKA/0000-0002-1726-4673; BRUNET, ERIKA/0000-0002-1726-4673; Artus, Jerome/0000-0003-3423-8634; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124	PA CURE; National Institutes of Health [ES019566, NS37956, CA21765, GM54668]; NATIONAL CANCER INSTITUTE [P30CA021765, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS037956, R01NS037956] Funding Source: NIH RePORTER	PA CURE; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Caldecott for the gift of the Lig3 expression vector, and M. Sanz for initial assistance with the SCE analysis. We also thank the members of Jasin laboratory, especially Y. Akamatsu, J. LaRocque, E. Kass and F. Vanoli, for discussions. This work was supported by PA CURE (to B.V.H.) and by National Institutes of Health grants ES019566 (to B.V.H.), NS37956 and CA21765 (to P.J.M.), and GM54668 (to M.J.).	BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bentley DJ, 1996, NAT GENET, V13, P489, DOI 10.1038/ng0896-489; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Chen X, 2009, DNA REPAIR, V8, P961, DOI 10.1016/j.dnarep.2009.06.002; Cotner-Gohara E, 2008, J BIOL CHEM, V283, P10764, DOI 10.1074/jbc.M708175200; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; PARK UE, 1989, J BACTERIOL, V171, P2173, DOI 10.1128/jb.171.4.2173-2180.1989; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Willer M, 1999, CURR BIOL, V9, P1085, DOI 10.1016/S0960-9822(99)80477-1	26	165	167	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					245	U139		10.1038/nature09794	http://dx.doi.org/10.1038/nature09794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390132	Green Accepted			2022-12-24	WOS:000288170200043
J	Bhutta, MF; Williamson, IG; Sudhoff, HH				Bhutta, Mahmood F.; Williamson, Ian G.; Sudhoff, Holger H.			Easily Missed? Cholesteatoma	BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC OTITIS-MEDIA; MIDDLE-EAR CHOLESTEATOMA; PREDICTORS; MANAGEMENT; PALSY					m.bhutta@doctors.org.uk	Sudhoff, Holger/AAV-9741-2020	Sudhoff, Holger/0000-0002-9274-5645; Bhutta, Mahmood/0000-0002-4688-1670				BAIN J, 1988, BRIT MED J, V296, P1617, DOI 10.1136/bmj.296.6637.1617; Browning GG., 2008, SCOTT BROWNS OTORHIN, P3396; Ikeda M, 2006, ACTA OTO-LARYNGOL, V126, P95, DOI 10.1080/00016480500265950; Jung JY, 2002, ORL-J OTO-RHIN-LARYN, V64, P95, DOI 10.1159/000057787; Kemppainen HO, 1999, ACTA OTO-LARYNGOL, V119, P568; Lemmerling MM, 2008, EUR J RADIOL, V66, P363, DOI 10.1016/j.ejrad.2008.01.020; MILROY CM, 1989, J CLIN PATHOL, V42, P460, DOI 10.1136/jcp.42.5.460; NUNEZ DA, 1990, J LARYNGOL OTOL, V104, P468, DOI 10.1017/S0022215100112903; Olszewska E, 2004, EUR ARCH OTO-RHINO-L, V261, P6, DOI 10.1007/s00405-003-0623-x; Omran A, 2006, LARYNGOSCOPE, V116, P619, DOI 10.1097/01.mlg.0000208367.03963.ca; OREILLY BJ, 1991, J LARYNGOL OTOL, V105, P990, DOI 10.1017/S0022215100118031; ROSENFELD RM, 1992, ARCH OTOLARYNGOL, V118, P384; Sheahan P, 2001, J LARYNGOL OTOL, V115, P962; Siddiq MA, 2007, J LARYNGOL OTOL, V121, P114, DOI 10.1017/S0022215106003227; Smith JA, 2006, OTOLARYNG CLIN N AM, V39, P1237, DOI 10.1016/j.otc.2006.09.001; Syed I, 2008, BRIT J HOSP MED, V69, pM34, DOI 10.12968/hmed.2008.69.Sup3.28764; Vercruysse JP, 2009, B-ENT, V5, P233; WETMORE RF, 1987, INT J PEDIATR OTORHI, V14, P101, DOI 10.1016/0165-5876(87)90020-6	18	21	21	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 3	2011	342								d1088	10.1136/bmj.d1088	http://dx.doi.org/10.1136/bmj.d1088			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732EQ	21372073				2022-12-24	WOS:000288168200003
J	Chiefari, E; Tanyolac, S; Paonessa, F; Pullinger, CR; Capula, C; Iiritano, S; Mazza, T; Forlin, M; Fusco, A; Durlach, V; Durlach, A; Malloy, MJ; Kane, JP; Heiner, SW; Filocamo, M; Foti, DP; Goldfine, ID; Brunetti, A				Chiefari, Eusebio; Tanyolac, Sinan; Paonessa, Francesco; Pullinger, Clive R.; Capula, Carmelo; Iiritano, Stefania; Mazza, Tommaso; Forlin, Michele; Fusco, Alfredo; Durlach, Vincent; Durlach, Anne; Malloy, Mary J.; Kane, John P.; Heiner, Steven W.; Filocamo, Mirella; Foti, Daniela P.; Goldfine, Ira D.; Brunetti, Antonio			Functional Variants of the HMGA1 Gene and Type 2 Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context High-mobility group A1 (HMGA1) protein is a key regulator of insulin receptor (INSR) gene expression. We previously identified a functional HMGA1 gene variant in 2 insulin-resistant patients with decreased INSR expression and type 2 diabetes mellitus (DM). Objective To examine the association of HMGA1 gene variants with type 2 DM. Design, Settings, and Participants Case-control study that analyzed the HMGA1 gene in patients with type 2 DM and controls from 3 populations of white European ancestry. Italian patients with type 2 DM(n=3278) and 2 groups of controls (n=3328) were attending the University of Catanzaro outpatient clinics and other health care sites in Calabria, Italy, during 2003-2009; US patients with type 2 DM (n=970) were recruited in Northern California clinics between 1994 and 2005 and controls (n=958) were senior athletes without DM collected in 2004 and 2009; and French patients with type 2 DM (n=354) and healthy controls (n=50) were enrolled at the University of Reims in 1992. Genomic DNA was either directly sequenced or analyzed for specific HMGA1 mutations. Messenger RNA and protein expression for HMGA1 and INSR were measured in both peripheral lymphomonocytes and cultured Epstein-Barr virus-transformed lymphoblasts from patients with type 2 DM and controls. Main Outcome Measures The frequency of HMGA1 gene variants among cases and controls. Odds ratios (ORs) for type 2 DM were estimated by logistic regression analysis. Results The most frequent functional HMGA1 variant, IVS5-13insC, was present in 7% to 8% of patients with type 2 DM in all 3 populations. The prevalence of IVS5-13insC variant was higher among patients with type 2 DM than among controls in the Italian population (7.23% vs 0.43% in one control group; OR, 15.77 [95% confidence interval {CI}, 8.57-29.03]; P<.001 and 7.23% vs 3.32% in the other control group; OR, 2.03 [95% CI, 1.51-3.43]; P<.001). In the US population, the prevalence of IVS5-13insC variant was 7.7% among patients with type 2 DM vs 4.7% among controls (OR, 1.64 [95% CI, 1.05-2.57]; P=.03). In the French population, the prevalence of IVS5-13insC variant was 7.6% among patients with type 2 DM and 0% among controls (P=.046). In the Italian population, 3 other functional variants were observed. When all 4 variants were analyzed, HMGA1 defects were present in 9.8% of Italian patients with type 2 DM and 0.6% of controls. In addition to the IVS5 C-insertion, the c. 310G>T (p.E104X) variant was found in 14 patients and no controls (Bonferroni-adjusted P=.01); the c.*82G>A variant (rs2780219) was found in 46 patients and 5 controls (Bonferroni-adjusted P<.001); the c.*369del variant was found in 24 patients and no controls (Bonferroni-adjusted P<.001). In circulating monocytes and Epstein-Barr virus-transformed lymphoblasts from patients with type 2 DM and the IVS5-13insC variant, the messenger RNA levels and protein content of both HMGA1 and the INSR were decreased by 40% to 50%, and these defects were corrected by transfection with HMGA1 complementary DNA. Conclusions Compared with healthy controls, the presence of functional HMGA1 gene variants in individuals of white European ancestry was associated with type 2 DM. JAMA. 2011;305(9):903-912 www.jama.com	[Chiefari, Eusebio; Paonessa, Francesco; Capula, Carmelo; Iiritano, Stefania; Foti, Daniela P.; Brunetti, Antonio] Univ Catanzaro Magna Graecia, Dipartimento Med Sperimentale & Clin G Salvatore, Catanzaro, Italy; [Brunetti, Antonio] Univ Catanzaro Magna Graecia, Cattedra Endocrinol, Catanzaro, Italy; [Tanyolac, Sinan; Malloy, Mary J.; Goldfine, Ira D.] Univ Calif San Francisco, Sch Nursing, Dept Med, San Francisco, CA 94143 USA; [Kane, John P.] Univ Calif San Francisco, Sch Nursing, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Pullinger, Clive R.] Univ Calif San Francisco, Sch Nursing, Dept Physiol Nursing, San Francisco, CA 94143 USA; [Tanyolac, Sinan; Goldfine, Ira D.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Pullinger, Clive R.; Malloy, Mary J.; Kane, John P.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Mazza, Tommaso; Forlin, Michele] Microsoft Res Univ Trento, Ctr Computat & Syst Biol, Trento, Italy; [Fusco, Alfredo] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Durlach, Vincent] Ctr Hosp Univ, Hop Robert Debre, Reims, France; [Durlach, Anne] Ctr Hosp Univ, Hop Maison Blanche, Lab Pol Bouin, Reims, France; [Heiner, Steven W.] Brigham Young Univ, Dept Hlth Sci, Provo, UT 84602 USA; [Filocamo, Mirella] Ist Giannina Gaslini, Lab Diagnosi Prepostnatale Malattie Metab, I-16148 Genoa, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Microsoft; University of Trento; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); CHU de Reims; CHU de Reims; Universite de Reims Champagne-Ardenne; Brigham Young University; University of Genoa; IRCCS Istituto Giannina Gaslini	Brunetti, A (corresponding author), Univ Catanzaro Magna Graecia, Viale Europa, I-88100 Germaneto Catanzaro, Italy.	brunetti@unicz.it	Chiefari, Eusebio/Y-2558-2019; Filocamo, Mirella/AAG-3948-2021; Brunetti, Antonio/K-7756-2016; Foti, Daniela P/K-8038-2016; Tanyolac, Sinan/AAP-5966-2021; Mazza, Tommaso/I-4531-2019; Mazza, Tommaso/H-6414-2016	Chiefari, Eusebio/0000-0001-5329-3124; Filocamo, Mirella/0000-0001-5505-8507; Mazza, Tommaso/0000-0003-0434-8533; Mazza, Tommaso/0000-0003-0434-8533; Fusco, Alfredo/0000-0003-3332-5197; Foti, Daniela/0000-0002-9536-5736; Paonessa, Francesco/0000-0002-4729-0928	Telethon-Italy [GGP04245]; MIUR Italy [2004062059-002]; National Institutes of Health [RO1DK056933]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056933] Funding Source: NIH RePORTER	Telethon-Italy(Fondazione Telethon); MIUR Italy(Ministry of Education, Universities and Research (MIUR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Brunetti received research funding from Telethon-Italy (grant GGP04245) and from MIUR Italy (protocol 2004062059-002). Dr Goldfine received research funding from National Institutes of Health grant RO1DK056933.	Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Borrmann L, 2001, ONCOGENE, V20, P4537, DOI 10.1038/sj.onc.1204577; Brunetti A, 1996, J CLIN INVEST, V97, P258, DOI 10.1172/JCI118400; Brunetti A, 2001, FASEB J, V15, P492, DOI 10.1096/fj.00-0190com; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Chiefari E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1040; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; Foti D, 2003, MOL CELL BIOL, V23, P2720, DOI 10.1128/MCB.23.8.2720-2732.2003; GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84; GOLDFINE ID, 1987, ENDOCR REV, V8, P235, DOI 10.1210/edrv-8-3-235; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groop L, 2008, CURR DIABETES REP, V8, P192, DOI 10.1007/s11892-008-0033-y; HARRIS M, 1979, DIABETES, V28, P1039; HOLLENBECK C, 1987, J CLIN ENDOCR METAB, V64, P1169, DOI 10.1210/jcem-64-6-1169; International Diabetes Federation, IDF DIAB ATL; Krolewski AS, 2005, JOSLINS DIABETES MEL; Lakka TA, 2004, DIABETES, V53, P1603, DOI 10.2337/diabetes.53.6.1603; Liu J, 2003, MOL REPROD DEV, V66, P81, DOI 10.1002/mrd.10323; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; O'Rahilly S, 2007, BIOCHEM SOC T, V35, P33, DOI 10.1042/BST0350033; OLEFSKY JM, 1977, DIABETES, V26, P680, DOI 10.2337/diab.26.7.680; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Roth J, 1975, Recent Prog Horm Res, V31, P95; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Smith RJ, 2010, J CLIN ENDOCR METAB, V95, P1566, DOI 10.1210/jc.2009-1966; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Tan K, 2007, DIABETES, V56, P714, DOI 10.2337/db06-0921; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TAYLOR SI, 1992, ENDOCR REV, V13, P566, DOI 10.1210/er.13.3.566; Unger RH, 2008, JAMA-J AM MED ASSOC, V299, P1185, DOI 10.1001/jama.299.10.1185; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171	43	69	71	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					903	912		10.1001/jama.2011.207	http://dx.doi.org/10.1001/jama.2011.207			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	728DP	21364139	Bronze			2022-12-24	WOS:000287854700023
J	Sugg, R				Sugg, Richard			The art of medicine Prescientific death rites, vampires, and the human soul	LANCET			English	Editorial Material									Univ Durham, Dept English Studies, Durham DH1 3LZ, England	Durham University	Sugg, R (corresponding author), Univ Durham, Dept English Studies, Durham DH1 3LZ, England.	richard.sugg@durham.ac.uk						Barley N., 1997, DANCING GRAVE ENCOUN; BLUM R, 1970, DANGEROUS HOUR LORE; DUBOULAY J, 1982, MAN, V17, P219, DOI 10.2307/2801810; Merridale C., 2000, NIGHT STONE DEATH ME; Sugg R., 2011, MUMMIES CANNIBALS VA; Warner EA, 2000, FOLKLORE, V111, P67, DOI 10.1080/001558700360898; WARNER EA, 2000, FOLKLORE, V111, P255	7	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2011	377	9767					712	713		10.1016/S0140-6736(11)60259-6	http://dx.doi.org/10.1016/S0140-6736(11)60259-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	729JQ	21374901				2022-12-24	WOS:000287946000014
J	Leung, AKW; Nagai, K; Li, J				Leung, Adelaine K. W.; Nagai, Kiyoshi; Li, Jade			Structure of the spliceosomal U4 snRNP core domain and its implication for snRNP biogenesis	NATURE			English	Article							AUTOMATED STRUCTURE SOLUTION; CRYSTAL-STRUCTURE; SM PROTEINS; U1 SNRNP; ELECTRON-MICROSCOPY; RNA-BINDING; COMPLEX; U5; U2; U6	The spliceosome is a dynamic macromolecular machine that assembles on pre-messenger RNA substrates and catalyses the excision of non-coding intervening sequences (introns)(1-3). Four of the five major components of the spliceosome, U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), contain seven Sm proteins (SmB/B9, SmD1, SmD2, SmD3, SmE, SmF and SmG) in common(4,5). Following export of the U1, U2, U4 and U5 snRNAs to the cytoplasm(6,7), the seven Sm proteins, chaperoned by the survival of motor neurons (SMN) complex, assemble around a single-stranded, U-rich sequence called the Sm site in each small nuclear RNA (snRNA), to form the core domain of the respective snRNP particle(8,9). Core domain formation is a prerequisite for re-import into the nucleus(10), where these snRNPs mature via addition of their particle-specific proteins. Here we present a crystal structure of the U4 snRNP core domain at 3.6 angstrom resolution, detailing how the Sm site heptad (AUUUUUG) binds inside the central hole of the heptameric ring of Sm proteins, interacting one-to-one with SmE-SmG-SmD3-SmB-SmD1-SmD2-SmF. An irregular backbone conformation of the Sm site sequence combined with the asymmetric structure of the heteromeric protein ring allows each base to interact in a distinct manner with four key residues at equivalent positions in the L3 and L5 loops of the Sm fold. A comparison of this structure with the U1 snRNP at 5.5 angstrom resolution(11,12) reveals snRNA-dependent structural changes outside the Sm fold, which may facilitate the binding of particle-specific proteins that are crucial to biogenesis of spliceosomal snRNPs.	[Leung, Adelaine K. W.; Nagai, Kiyoshi; Li, Jade] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Nagai, K (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	kn@mrc-lmb.cam.ac.uk; jl@mrc-lmb.cam.ac.uk	Leung, Adelaine/F-4132-2011; Leung, Adelaine/AAV-3357-2021	Leung, Adelaine/0000-0002-2849-4474; 	Medical Research Council of the UK; HFSP; NSERC; Sidney Sussex College, Cambridge University; Medical Research Council [MC_U105184330] Funding Source: researchfish; MRC [MC_U105184330] Funding Source: UKRI	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HFSP(Human Frontier Science Program); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sidney Sussex College, Cambridge University(University of Cambridge); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council of the UK and a HFSP grant. A.K.W.L. was supported by the Overseas Research Students Awards Scheme, Canada-Cambridge Commonwealth studentship, a postgraduate scholarship from NSERC and a Junior Research Fellowship from Sidney Sussex College, Cambridge University. We thank the European Synchrotron Radiation Facility and Daresbury beamline staff for their support. We thank M. Jinek, M. Kampmann and Y. Kondo for their help with crystallization. We also thank C. Kambach, J. Avis, R. Young, S. Walke and H. Teo for laying the foundation of this project, C. Oubridge and D. Pomeranz Krummel for sharing Sm proteins and providing help and advice throughout the project, and P. Zwart for advice on twinning.	Arnold E., 2001, INT TABLES CRYSTALLO, VF, P705; BRINGMANN P, 1986, EMBO J, V5, P3509, DOI 10.1002/j.1460-2075.1986.tb04676.x; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burge CB, 1999, RNA WORLD, P525; Collins BM, 2003, J BIOL CHEM, V278, P17291, DOI 10.1074/jbc.M211826200; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DIAMOND R, 1992, PROTEIN SCI, V1, P1279, DOI 10.1002/pro.5560011006; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Draper DE, 2008, BIOPHYS J, V95, P5489, DOI 10.1529/biophysj.108.131813; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FISCHER U, 1993, EMBO J, V12, P573, DOI 10.1002/j.1460-2075.1993.tb05689.x; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Guthrie C., 2003, RNA, V9, P193; Hartmuth K, 1999, J MOL BIOL, V285, P133, DOI 10.1006/jmbi.1998.2300; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; HERMANN H, 1995, EMBO J, V14, P2076, DOI 10.1002/j.1460-2075.1995.tb07199.x; HINTERBERGER M, 1983, J BIOL CHEM, V258, P2604; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; KASTNER B, 1990, P NATL ACAD SCI USA, V87, P1710, DOI 10.1073/pnas.87.5.1710; KASTNER B, 1989, EMBO J, V8, P277, DOI 10.1002/j.1460-2075.1989.tb03374.x; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Leung AKW, 2010, J MOL BIOL, V402, P154, DOI 10.1016/j.jmb.2010.07.017; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; McConnell TS, 2003, RNA, V9, P193, DOI 10.1261/rna.2136103; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NELISSEN RLH, 1994, EMBO J, V13, P4113, DOI 10.1002/j.1460-2075.1994.tb06729.x; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Oubridge C, 2009, STRUCTURE, V17, P930, DOI 10.1016/j.str.2009.05.009; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Sauter C, 1999, J CRYST GROWTH, V196, P365, DOI 10.1016/S0022-0248(98)00852-5; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; Toro I, 2002, J MOL BIOL, V320, P129, DOI 10.1016/S0022-2836(02)00406-0; Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Will CL, 2006, COLD SPRING HARB MON, V43, P369; YU YT, 1999, RNA WORLD, V2, P487	56	94	103	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					536	U285		10.1038/nature09956	http://dx.doi.org/10.1038/nature09956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21516107	Green Accepted			2022-12-24	WOS:000290951300046
J	Masui, O; Bonnet, I; Le Baccon, P; Brito, I; Pollex, T; Murphy, N; Hupe, P; Barillot, E; Belmont, AS; Heard, E				Masui, Osamu; Bonnet, Isabelle; Le Baccon, Patricia; Brito, Isabel; Pollex, Tim; Murphy, Niall; Hupe, Philippe; Barillot, Emmanuel; Belmont, Andrew S.; Heard, Edith			Live-Cell Chromosome Dynamics and Outcome of X Chromosome Pairing Events during ES Cell Differentiation	CELL			English	Article							WIDESPREAD MONOALLELIC EXPRESSION; XIST EXPRESSION; INACTIVATION CENTER; NONCODING RNA; HISTONE H3; STEM-CELLS; REGION; TSIX; CHOICE; TRANSCRIPTION	Random X inactivation represents a paradigm for monoallelic gene regulation during early ES cell differentiation. In mice, the choice of X chromosome to inactivate in XX cells is ensured by monoallelic regulation of Xist RNA via its antisense transcription unit Tsix/Xite. Homologous pairing events have been proposed to underlie asymmetric Tsix expression, but direct evidence has been lacking owing to their dynamic and transient nature. Here we investigate the live-cell dynamics and outcome of Tsix pairing in differentiating mouse ES cells. We find an overall increase in genome dynamics including the Xics during early differentiation. During pairing, however, Xic loci show markedly reduced movements. Upon separation, Tsix expression becomes transiently monoallelic, providing a window of opportunity for monoallelic Xist upregulation. Our findings reveal the spatiotemporal choreography of the X chromosomes during early differentiation and indicate a direct role for pairing in facilitating symmetry-breaking and monoallelic regulation of Xist during random X inactivation.	[Masui, Osamu; Bonnet, Isabelle; Le Baccon, Patricia; Brito, Isabel; Pollex, Tim; Murphy, Niall; Hupe, Philippe; Barillot, Emmanuel; Heard, Edith] Inst Curie, F-75248 Paris, France; [Masui, Osamu; Bonnet, Isabelle; Pollex, Tim; Murphy, Niall; Heard, Edith] CNRS, UMR3215, F-75248 Paris, France; [Masui, Osamu; Bonnet, Isabelle; Pollex, Tim; Murphy, Niall; Heard, Edith] INSERM, U934, F-75248 Paris, France; [Le Baccon, Patricia] CNRS, UMR218, F-75248 Paris, France; [Brito, Isabel; Hupe, Philippe; Barillot, Emmanuel] INSERM, U900, F-75248 Paris, France; [Brito, Isabel; Hupe, Philippe; Barillot, Emmanuel] Mines ParisTech, F-77300 Fontainebleau, France; [Hupe, Philippe] CNRS, UMR144, F-75248 Paris, France; [Belmont, Andrew S.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Illinois System; University of Illinois Urbana-Champaign	Heard, E (corresponding author), Inst Curie, 26 Rue Ulm, F-75248 Paris, France.	edith.heard@curie.fr	Hupe, Philippe/T-8793-2017; Heard, Edith/D-7197-2017; Masui, Osamu/AAH-4111-2019	Hupe, Philippe/0000-0001-8468-3424; Heard, Edith/0000-0001-8052-7117; Pollex, Tim/0000-0001-5669-3940; Bonnet, Isabelle/0000-0003-2343-3784; BARILLOT, Emmanuel/0000-0003-2724-2002	Human Frontier Science Program; EU; ANR; FRM [SPF20080512397]; ERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058460] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); EU(European Commission); ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Heard laboratory and John Sedat for helpful discussions; Michele Guggiari, Christel Picard, Matt Plutz, and Patricia Diabangouaya for technical assistance; Yohanns Bellaiche, Francois Graner, and Jennifer Chow for helpful advice and for critical reading of the manuscript. We thank Olivier Renaud and Olivier Leroy (PICT@BDD imaging facility), as well as Sebastian Huart for assistance with image analysis. This work was supported by the Human Frontier Science Program to E.H. and A.S.B.; the EU FP7 program HEROIC IP; ANR and FRM funding, and an ERC Advanced Investigator Award to E.H.; and the FRM to I. Bonnet (postdoc grant n degrees SPF20080512397).	Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Carmo-Fonseca M, 2002, TRENDS CELL BIOL, V12, P491, DOI 10.1016/S0962-8924(02)02387-5; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Chureau C, 2011, HUM MOL GENET, V20, P705, DOI 10.1093/hmg/ddq516; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Debrand E, 1999, MOL CELL BIOL, V19, P8513; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2010, BIOESSAYS, V32, P581, DOI 10.1002/bies.201000019; Nicodemi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108104; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ohlsson R, 2007, SCIENCE, V318, P1077, DOI 10.1126/science.1150705; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Okamoto I, 2009, CHROMOSOME RES, V17, P659, DOI 10.1007/s10577-009-9057-7; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rajapakse I, 2009, P NATL ACAD SCI USA, V106, P6679, DOI 10.1073/pnas.0900986106; ROUGEULLE C, 1994, MAMM GENOME, V5, P416, DOI 10.1007/BF00357001; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Sado T, 2001, DEVELOPMENT, V128, P1275; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Scialdone A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000244; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5	44	101	103	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					447	458		10.1016/j.cell.2011.03.032	http://dx.doi.org/10.1016/j.cell.2011.03.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529716	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000290022900013
J	Elshaug, AG; Garber, AM				Elshaug, Adam G.; Garber, Alan M.			How CER Could Pay for Itself - Insights from Vertebral Fracture Treatments	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RANDOMIZED-TRIAL; VERTEBROPLASTY		[Elshaug, Adam G.] Commonwealth Fund, Int Program Hlth Policy & Practice, New York, NY 10021 USA; [Elshaug, Adam G.] Univ Adelaide, Sch Populat Hlth & Clin Practice, Adelaide, SA, Australia; [Garber, Alan M.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Garber, Alan M.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Garber, Alan M.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Commonwealth Fund; University of Adelaide; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Elshaug, AG (corresponding author), Commonwealth Fund, Int Program Hlth Policy & Practice, New York, NY 10021 USA.		Elshaug, Adam G/A-5714-2008	Elshaug, Adam/0000-0002-4939-5379				Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Food and Drug Administration, MAN US FAC DEV EXP D; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Weinstein JN, 2009, NEW ENGL J MED, V361, P619, DOI 10.1056/NEJMe0905889	4	19	20	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1390	1393		10.1056/NEJMp1101475	http://dx.doi.org/10.1056/NEJMp1101475			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	749LD	21488762	Green Published			2022-12-24	WOS:000289467200003
J	Sims, RJ; Rojas, LA; Beck, D; Bonasio, R; Schuller, R; Drury, WJ; Eick, D; Reinberg, D				Sims, Robert J., III; Rojas, Luis Alejandro; Beck, David; Bonasio, Roberto; Schueller, Roland; Drury, William J., III; Eick, Dirk; Reinberg, Danny			The C-Terminal Domain of RNA Polymerase II Is Modified by Site-Specific Methylation	SCIENCE			English	Article							TRANSCRIPTION; CARM1; INTEGRATOR; EXPRESSION; IICTD	The carboxy-terminal domain (CTD) of RNA polymerase II (RNAPII) in mammals undergoes extensive posttranslational modification, which is essential for transcriptional initiation and elongation. Here, we show that the CTD of RNAPII is methylated at a single arginine (R1810) by the coactivator-associated arginine methyltransferase 1 (CARM1). Although methylation at R1810 is present on the hyperphosphorylated form of RNAPII in vivo, Ser2 or Ser5 phosphorylation inhibits CARM1 activity toward this site in vitro, suggesting that methylation occurs before transcription initiation. Mutation of R1810 results in the misexpression of a variety of small nuclear RNAs and small nucleolar RNAs, an effect that is also observed in Carm1(-/-) mouse embryo fibroblasts. These results demonstrate that CTD methylation facilitates the expression of select RNAs, perhaps serving to discriminate the RNAPII-associated machinery recruited to distinct gene types.	[Sims, Robert J., III; Rojas, Luis Alejandro; Beck, David; Bonasio, Roberto; Drury, William J., III; Reinberg, Danny] NYU, Sch Med, HHMI, Dept Biochem, New York, NY 10016 USA; [Schueller, Roland; Eick, Dirk] CIPSM, Dept Mol Epigenet, Helmholtz Ctr Munich, D-81377 Munich, Germany	Howard Hughes Medical Institute; New York University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Reinberg, D (corresponding author), NYU, Sch Med, HHMI, Dept Biochem, 522 1st Ave,Smilow 211, New York, NY 10016 USA.	danny.reinberg@nyumc.org	Bonasio, Roberto/P-1356-2014; Rojas, Luis/C-2204-2011	Bonasio, Roberto/0000-0002-0767-0889; Reinberg, Danny/0000-0003-4288-2016; Rojas, Luis Alejandro/0000-0001-6445-1562	HHMI; NIH [GM-37120, GM-71166]; Deutsche Forschungsgemeinschaft [SFB/Transregio-5, SFB684]; Jose Carreras Leukmiestiftung eV; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071166, R01GM037120, R37GM037120] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Jose Carreras Leukmiestiftung eV; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by the HHMI (to D. R.) and grants from NIH (GM-37120 to D. R. and GM-71166 to R.J.S.). R. B. is a fellow of the Helen Hay Whitney foundation. D. E. was supported by Deutsche Forschungsgemeinschaft (SFB/Transregio-5, SFB684) and Jose Carreras Leukmiestiftung eV. We thank L. Vales, E. Lecona, and P. Voigt for careful reading of the manuscript; R. D. Chapman and K. Burger for technical support; and members of the Reinberg lab for critical commentaries during the development of this project. RNA-seq data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus as GEO series GSE27315.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2010, J BIOL CHEM, V285, P20564, DOI 10.1074/jbc.M110.132530; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; Meininghaus M, 2000, J BIOL CHEM, V275, P24375, DOI 10.1074/jbc.M001883200; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; Ryan K, 2002, MOL CELL BIOL, V22, P1684, DOI 10.1128/MCB.22.6.1684-1692.2002; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024	16	150	152	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					99	103		10.1126/science.1202663	http://dx.doi.org/10.1126/science.1202663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454787	Green Accepted			2022-12-24	WOS:000289000000046
J	Fang, WG; Vega-Rodriguez, J; Ghosh, AK; Jacobs-Lorena, M; Kang, A; St Leger, RJ				Fang, Weiguo; Vega-Rodriguez, Joel; Ghosh, Anil K.; Jacobs-Lorena, Marcelo; Kang, Angray; St Leger, Raymond J.			Development of Transgenic Fungi That Kill Human Malaria Parasites in Mosquitoes	SCIENCE			English	Article							ENTOMOPATHOGENIC FUNGUS; METARHIZIUM-ANISOPLIAE; ANOPHELINE MOSQUITOS; TRANSMISSION; SPOROZOITES; STRATEGIES; SCORPINE; DISEASE; VECTOR	Metarhizium anisopliae infects mosquitoes through the cuticle and proliferates in the hemolymph. To allow M. anisopliae to combat malaria in mosquitoes with advanced malaria infections, we produced recombinant strains expressing molecules that target sporozoites as they travel through the hemolymph to the salivary glands. Eleven days after a Plasmodium-infected blood meal, mosquitoes were treated with M. anisopliae expressing salivary gland and midgut peptide 1 (SM1), which blocks attachment of sporozoites to salivary glands; a single-chain antibody that agglutinates sporozoites; or scorpine, which is an antimicrobial toxin. These reduced sporozoite counts by 71%, 85%, and 90%, respectively. M. anisopliae expressing scorpine and an [SM1](8):scorpine fusion protein reduced sporozoite counts by 98%, suggesting that Metarhizium-mediated inhibition of Plasmodium development could be a powerful weapon for combating malaria.	[Fang, Weiguo; St Leger, Raymond J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Vega-Rodriguez, Joel; Ghosh, Anil K.; Jacobs-Lorena, Marcelo] Johns Hopkins Sch Publ Hlth, Dept Mol Microbiol & Immunol, Malaria Res Inst, Baltimore, MD 21205 USA; [Kang, Angray] Univ Westminster, Sch Life Sci, Dept Mol & Appl Biosci, Antibody Technol Grp, London W1W 6UW, England	University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Roehampton University; University of Westminster	St Leger, RJ (corresponding author), Univ Maryland, Dept Entomol, 4112 Plant Sci Bldg, College Pk, MD 20742 USA.	stleger@umd.edu	hongbo, yi/G-9615-2011; St. Leger, Raymond/N-3219-2013; Fang, Weiguo/G-6680-2012; weiguo, fang/F-5933-2010	Fang, Weiguo/0000-0002-8431-8256; Kang, Angray/0000-0002-4672-4114	NIH [5R21A1079429-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079429, R21AI088033, R01AI031478] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant 5R21A1079429-02. The GenBank accession numbers of the sequences used in the study are P56972 (scorpine) and HQ833020 (PfNPNA-1).	Alves SB, 2002, J APPL ENTOMOL, V126, P504, DOI 10.1046/j.1439-0418.2002.00674.x; BEIER JC, 1991, MED VET ENTOMOL, V5, P71, DOI 10.1111/j.1365-2915.1991.tb00523.x; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Boyd MF, 1933, AM J HYG, V17, P666, DOI 10.1093/oxfordjournals.aje.a117932; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; Chappel JA, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-28; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Farenhorst M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012081; Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265; Hancock PA, 2009, P ROY SOC B-BIOL SCI, V276, P71, DOI 10.1098/rspb.2008.0689; Hancock PA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000525; Howard AFV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-168; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; James AA, 2003, J EXP BIOL, V206, P3817, DOI 10.1242/jeb.00616; James S. P., 1936, Proceedings of the Royal Society of Medicine London, V29; Knols BGJ, 2010, FUTURE MICROBIOL, V5, P339, DOI 10.2217/FMB.10.11; Koella JC, 2009, EVOL APPL, V2, P469, DOI 10.1111/j.1752-4571.2009.00072.x; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; Maniania NK, 2002, BIOCONTROL SCI TECHN, V12, P59, DOI 10.1080/09583150120110662; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Riehle MA, 2005, INSECT BIOCHEM MOLEC, V35, P699, DOI 10.1016/j.ibmb.2005.02.008; Rio RVM, 2004, TRENDS MICROBIOL, V12, P325, DOI 10.1016/j.tim.2004.05.001; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Thomson R, 2009, P NATL ACAD SCI USA, V106, P19509, DOI 10.1073/pnas.0905669106; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; *WHO, 2009, WORLD MAL REP; Zhioua E, 1997, J PARASITOL, V83, P815, DOI 10.2307/3284273	30	185	199	8	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1074	1077		10.1126/science.1199115	http://dx.doi.org/10.1126/science.1199115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350178	Green Accepted			2022-12-24	WOS:000287699000066
J	Nevo-Dinur, K; Nussbaum-Shochat, A; Ben-Yehuda, S; Amster-Choder, O				Nevo-Dinur, Keren; Nussbaum-Shochat, Anat; Ben-Yehuda, Sigal; Amster-Choder, Orna			Translation-Independent Localization of mRNA in E. coli	SCIENCE			English	Article							ESCHERICHIA-COLI; INTRACELLULAR-LOCALIZATION; BACILLUS-SUBTILIS; GLOBAL ANALYSIS; MEMBRANE; TRANSCRIPTION; PROTEINS; BINDING; CELLS; CHLORAMPHENICOL	Understanding the organization of a bacterial cell requires the elucidation of the mechanisms by which proteins localize to particular subcellular sites. Thus far, such mechanisms have been suggested to rely on embedded features of the localized proteins. Here, we report that certain messenger RNAs (mRNAs) in Escherichia coli are targeted to the future destination of their encoded proteins, cytoplasm, poles, or inner membrane in a translation-independent manner. Cis-acting sequences within the transmembrane-coding sequence of the membrane proteins are necessary and sufficient for mRNA targeting to the membrane. In contrast to the view that transcription and translation are coupled in bacteria, our results show that, subsequent to their synthesis, certain mRNAs are capable of migrating to particular domains in the cell where their future protein products are required.	[Nevo-Dinur, Keren; Nussbaum-Shochat, Anat; Ben-Yehuda, Sigal; Amster-Choder, Orna] Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Amster-Choder, O (corresponding author), Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, POB 12272, IL-91120 Jerusalem, Israel.	amster@cc.huji.ac.il			Israel Science Foundation; European Research Council [209130]	Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission)	We acknowledge members of S.B.-Y.'s group for help with fluorescence microscopy, members of O.A.-C.'s group for stimulating discussions, and E. Bibi and E.S. Bochkareva for technical advice on cell fractionation. We thank the following individuals for their gifts: I. Golding for pIG-K33, R. H. Singer for pSL-MS2 6, and Z. Livneh for purified single-stranded DNA binding protein (SSB) and anti-SSB serum. We are grateful to A. Wright, E. Bibi, and R. Losick for critically reading our manuscript. This research was supported by a research grant (awarded to O.A.-C.) by the Israel Science Foundation founded by the Israel Academy of Sciences and Humanities. S.B.-Y. is supported by the European Research Council starting grant (209130).	Amster-Choder O, 2005, CURR OPIN MICROBIOL, V8, P127, DOI 10.1016/j.mib.2005.02.014; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; CHEN MW, 1993, J BACTERIOL, V175, P5697, DOI 10.1128/JB.175.17.5697-5700.1993; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Ebersbach G, 2007, TRENDS MICROBIOL, V15, P101, DOI 10.1016/j.tim.2007.01.004; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; GOLDMAN E, 1995, J MOL BIOL, V245, P467, DOI 10.1006/jmbi.1994.0038; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; Janakiraman A, 2004, TRENDS MICROBIOL, V12, P518, DOI 10.1016/j.tim.2004.09.003; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Lopian L, 2003, P NATL ACAD SCI USA, V100, P7099, DOI 10.1073/pnas.1037608100; Lopian L, 2010, EMBO J, V29, P3630, DOI 10.1038/emboj.2010.240; LUNDBERG U, 1988, GENE, V72, P141, DOI 10.1016/0378-1119(88)90136-9; Palacios IM, 2007, SEMIN CELL DEV BIOL, V18, P163, DOI 10.1016/j.semcdb.2007.01.008; Prilusky J, 2009, P NATL ACAD SCI USA, V106, P6662, DOI 10.1073/pnas.0902029106; Schluenzen F, 2006, NAT STRUCT MOL BIOL, V13, P871, DOI 10.1038/nsmb1145; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Sorg JA, 2005, CELL MICROBIOL, V7, P1217, DOI 10.1111/j.1462-5822.2005.00563.x; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Valencia-Burton M, 2009, P NATL ACAD SCI USA, V106, P16399, DOI 10.1073/pnas.0907495106; WEISBERGER AS, 1967, ANNU REV MED, V18, P483, DOI 10.1146/annurev.me.18.020167.002411	29	187	191	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1081	1084		10.1126/science.1195691	http://dx.doi.org/10.1126/science.1195691			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350180				2022-12-24	WOS:000287699000068
J	Liu, JN; Steiner, M; Dunlop, JA; Keupp, H; Shu, DG; Ou, QA; Han, JA; Zhang, ZF; Zhang, XL				Liu, Jianni; Steiner, Michael; Dunlop, Jason A.; Keupp, Helmut; Shu, Degan; Ou, Qiang; Han, Jian; Zhang, Zhifei; Zhang, Xingliang			An armoured Cambrian lobopodian from China with arthropod-like appendages	NATURE			English	Article							CHENGJIANG LAGERSTATTE; ANOMALOCARIS; EVOLUTION; ORIGIN; FAUNA	Cambrian fossil Lagerstatten preserving soft-bodied organisms have contributed much towards our understanding of metazoan origins(1-3). Lobopodians are a particularly interesting group that diversified and flourished in the Cambrian seas. Resembling 'worms with legs', they have long attracted much attention in that they may have given rise to both Onychophora (velvet worms)(4-6) and Tardigrada (water bears)(7,8), as well as to arthropods in general(9-12). Here we describe Diania cactiformis gen. et sp. nov. as an 'armoured' lobopodian from the Chengjiang fossil Lagerstatte (Cambrian Stage 3), Yunnan, southwestern China. Although sharing features with other typical lobopodians, it is remarkable for possessing robust and probably sclerotized appendages, with what appear to be articulated elements. In terms of limb morphology it is therefore closer to the arthropod condition, to our knowledge, than any lobopodian recorded until now. Phylogenetic analysis recovers it in a derived position, close to Arthropoda; thus, it seems to belong to a grade of organization close to the point of becoming a true arthropod. Further, D. cactiformis could imply that arthropodization (sclerotization of the limbs) preceded arthrodization (sclerotization of the body). Comparing our fossils with other lobopodian appendage morphologies-see Kerygmachela(9,10), Jianshanopodia(13) and Megadictyon(12)-reinforces the hypothesis that the group as a whole is paraphyletic, with different taxa expressing different grades of arthropodization.	[Liu, Jianni; Shu, Degan; Han, Jian; Zhang, Zhifei; Zhang, Xingliang] NW Univ Xian, Dept Geol, State Key Lab Continental Dynam, Early Life Inst, Xian 710069, Peoples R China; [Liu, Jianni; Steiner, Michael; Keupp, Helmut] Free Univ Berlin, Dept Earth Sci, D-12249 Berlin, Germany; [Dunlop, Jason A.] Humboldt Univ, Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, D-10115 Berlin, Germany; [Shu, Degan; Ou, Qiang] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China	Northwest University Xi'an; Free University of Berlin; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; China University of Geosciences	Liu, JN (corresponding author), NW Univ Xian, Dept Geol, State Key Lab Continental Dynam, Early Life Inst, Xian 710069, Peoples R China.	liujianni@126.com	Dunlop, Jason A./AAC-8042-2019; Han, Jian/AAU-4500-2021	Han, Jian/0000-0002-2134-4078; Ou, Qiang/0000-0002-1142-5114; Dunlop, Jason/0000-0002-0179-6640	Alexander von Humboldt Foundation at the Freie Universitat Berlin; National Science Foundation of China [40802011, 40830208]; State Key Laboratory of Continental Dynamics, Northwest University; DFG [Forschergruppe 736]	Alexander von Humboldt Foundation at the Freie Universitat Berlin(Alexander von Humboldt Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Continental Dynamics, Northwest University; DFG(German Research Foundation (DFG))	This work was supported by a Research Scholarship from the Alexander von Humboldt Foundation at the Freie Universitat Berlin, the National Science Foundation of China (grants 40802011 and 40830208) and the MOST Special Fund from the State Key Laboratory of Continental Dynamics, Northwest University (to J.L.), and a DFG grant within the Forschergruppe 736 (to H. K. and M. S.). We thank M. G. Chi for the reconstruction, J. Evers and M. Y. Sun for photography and table, and local workers for their strenuous field work.	Bergstrom J, 2008, GFF, V130, P189; BUDD G, 1993, NATURE, V364, P709, DOI 10.1038/364709a0; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; Budd GE, 2001, ZOOL ANZ, V240, P265, DOI 10.1078/0044-5231-00034; Chen Junyuan, 1997, Bulletin of the National Museum of Natural Science (Taichung), V10, P11; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; Delle Cave L., 1975, Monitore Zoologico Italiano (NS), V9, P67; DZIK J, 1989, LETHAIA, V22, P169, DOI 10.1111/j.1502-3931.1989.tb01679.x; Edgecombe GD, 2010, ARTHROPOD STRUCT DEV, V39, P74, DOI 10.1016/j.asd.2009.10.002; HOU XG, 1995, ZOOL J LINN SOC-LOND, V114, P3, DOI 10.1006/zjls.1995.0014; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; HOU XG, 1991, ZOOL SCR, V20, P395; Kuhl G, 2009, SCIENCE, V323, P771, DOI 10.1126/science.1166586; Liu JN, 2007, ACTA ZOOL-STOCKHOLM, V88, P279, DOI 10.1111/j.1463-6395.2007.00281.x; Liu JN, 2006, ACTA PALAEONTOL POL, V51, P215; Liu JN, 2004, CHINESE SCI BULL, V49, P1063, DOI 10.1360/04wd0052; Ma XY, 2009, ARTHROPOD STRUCT DEV, V38, P271, DOI 10.1016/j.asd.2009.03.001; Maas A, 2007, CHINESE SCI BULL, V52, P3385, DOI 10.1007/s11434-007-0515-3; Ramskold L, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P107; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Wang XQ, 2004, CHINESE SCI BULL, V49, P49, DOI 10.1360/03wd0329; WHITTINGTON HB, 1978, PHILOS T R SOC B, V284, P165, DOI 10.1098/rstb.1978.0061; Willmer P., 1991, INVERTEBRATE RELATIO, P273	24	50	59	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					526	530		10.1038/nature09704	http://dx.doi.org/10.1038/nature09704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350485				2022-12-24	WOS:000287652900040
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: bipolar II disorder	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	8	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2011	342								d2767	10.1136/bmj.d2767	http://dx.doi.org/10.1136/bmj.d2767			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MB	21543400				2022-12-24	WOS:000290481700009
J	Van Allen, EM				Van Allen, Eliezer M.			Paracentesis by Moonlight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												evanallen@partners.org		Van Allen, Eliezer/0000-0002-0201-4444					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1635	1636		10.1001/jama.2011.472	http://dx.doi.org/10.1001/jama.2011.472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521838				2022-12-24	WOS:000289890500001
J	Oleksiuk, O; Jakovljevic, V; Vladimirov, N; Carvalho, R; Paster, E; Ryu, WS; Meir, Y; Wingreen, NS; Kollmann, M; Sourjik, V				Oleksiuk, Olga; Jakovljevic, Vladimir; Vladimirov, Nikita; Carvalho, Ricardo; Paster, Eli; Ryu, William S.; Meir, Yigal; Wingreen, Ned S.; Kollmann, Markus; Sourjik, Victor			Thermal Robustness of Signaling in Bacterial Chemotaxis	CELL			English	Article							ESCHERICHIA-COLI; COVALENT MODIFICATION; RECEPTOR COMPLEXES; TEMPERATURE; MECHANISM; BINDING; PRECISION; MOTOR; MODEL; TAR	Temperature is a global factor that affects the performance of all intracellular networks. Robustness against temperature variations is thus expected to be an essential network property, particularly in organisms without inherent temperature control. Here, we combine experimental analyses with computational modeling to investigate thermal robustness of signaling in chemotaxis of Escherichia coli, a relatively simple and well-established model for systems biology. We show that steady-state and kinetic pathway parameters that are essential for chemotactic performance are indeed temperature-compensated in the entire physiological range. Thermal robustness of steady-state pathway output is ensured at several levels by mutual compensation of temperature effects on activities of individual pathway components. Moreover, the effect of temperature on adaptation kinetics is counterbalanced by preprogrammed temperature dependence of enzyme synthesis and stability to achieve nearly optimal performance at the growth temperature. Similar compensatory mechanisms are expected to ensure thermal robustness in other systems.	[Oleksiuk, Olga; Jakovljevic, Vladimir; Vladimirov, Nikita; Carvalho, Ricardo; Sourjik, Victor] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Paster, Eli; Ryu, William S.; Wingreen, Ned S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Meir, Yigal] Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel; [Kollmann, Markus] Univ Dusseldorf, Dept Biol, D-40225 Dusseldorf, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Princeton University; Princeton University; Ben Gurion University; Heinrich Heine University Dusseldorf	Sourjik, V (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	v.sourjik@zmbh.uni-heidelberg.de	MEIR, YIGAL/F-1888-2012	Carvalho, Ricardo/0000-0002-5994-0094; Oleksiuk, Olga/0000-0002-6100-107X; Jakovljevic, Vladimir/0000-0002-6082-4867; Meir, Yigal/0000-0003-1606-8969	National Institutes of Health [GM082938]; Deutsche Forschungsgemeinschaft [SO 421/3-3, KO3442/3-1]; C.H.S.-Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); C.H.S.-Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Schwarz und A. Muller for help with cloning, L. Turner for sharing data, and R. Endres and M. Mayer for valuable discussions. This work was supported by grant GM082938 from the National Institutes of Health and in parts by grants SO 421/3-3 and KO3442/3-1 from the Deutsche Forschungsgemeinschaft and by the C.H.S.-Foundation.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; Andrews BW, 2006, PLOS COMPUT BIOL, V2, P1407, DOI 10.1371/journal.pcbi.0020154; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Endres RG, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.49; HASTINGS JW, 1957, P NATL ACAD SCI USA, V43, P804, DOI 10.1073/pnas.43.9.804; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; Jiang LL, 2009, BIOPHYS J, V97, P74, DOI 10.1016/j.bpj.2009.04.029; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Li GY, 2000, CELL, V100, P357, DOI 10.1016/S0092-8674(00)80671-6; Lovdok L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000171; LOWE G, 1987, NATURE, V325, P637, DOI 10.1038/325637a0; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; MAEDA K, 1976, J BACTERIOL, V127, P1039, DOI 10.1128/JB.127.3.1039-1046.1976; Mehra A, 2009, CELL, V137, P749, DOI 10.1016/j.cell.2009.03.019; Meir Y, 2010, BIOPHYS J, V99, P2766, DOI 10.1016/j.bpj.2010.08.051; Mello BA, 2005, P NATL ACAD SCI USA, V102, P17354, DOI 10.1073/pnas.0506961102; MIZUNO T, 1984, J BACTERIOL, V159, P360, DOI 10.1128/JB.159.1.360-367.1984; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; Nara T, 1996, J BIOL CHEM, V271, P17932, DOI 10.1074/jbc.271.30.17932; Neumann S, 2010, EMBO J, V29, P3484, DOI 10.1038/emboj.2010.224; Nishiyama SI, 1997, J BACTERIOL, V179, P6573, DOI 10.1128/jb.179.21.6573-6580.1997; Paster E, 2008, P NATL ACAD SCI USA, V105, P5373, DOI 10.1073/pnas.0709903105; Rajan K, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.022902; Salman H, 2007, NAT CELL BIOL, V9, P1098, DOI 10.1038/ncb1632; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Sourjik V, 2010, EMBO J, V29, P2724, DOI 10.1038/emboj.2010.178; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Turner L, 1999, BIOPHYS J, V77, P597, DOI 10.1016/S0006-3495(99)76916-X; Virshup DM, 2009, CELL, V137, P602, DOI 10.1016/j.cell.2009.04.051; Vladimirov N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000717; Vladimirov N, 2009, BIOL CHEM, V390, P1097, DOI 10.1515/BC.2009.130; Vladimirov N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000242	46	57	62	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					312	321		10.1016/j.cell.2011.03.013	http://dx.doi.org/10.1016/j.cell.2011.03.013			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496648	Bronze, Green Accepted			2022-12-24	WOS:000289549900018
J	Short, J; Murray, S				Short, Jeffrey; Murray, Susan			A frozen hell	NATURE			English	Editorial Material									[Short, Jeffrey] JWS Consulting Out Juneau, Juneau, AK USA; [Murray, Susan] Advocacy Grp Oceana, Juneau, AK 99801 USA		Short, J (corresponding author), JWS Consulting Out Juneau, Juneau, AK USA.	jwsosc@gmail.com; smurray@oceana.org	Short, Jeffrey/AAZ-9241-2021						0	7	7	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					162	163		10.1038/472162a	http://dx.doi.org/10.1038/472162a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21490650				2022-12-24	WOS:000289469100017
J	Bartelds, GM; Krieckaert, CLM; Nurmohamed, MT; van Schouwenburg, PA; Lems, WF; Twisk, JWR; Dijkmans, AC; Aarden, L; Wolbink, GJ				Bartelds, Geertje M.; Krieckaert, Charlotte L. M.; Nurmohamed, Michael T.; van Schouwenburg, Pauline A.; Lems, Willem F.; Twisk, Jos W. R.; Dijkmans, A. C.; Aarden, Lucien; Wolbink, Gerrit Jan			Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; CLINICAL-RESPONSE; CROHNS-DISEASE; IMMUNOGENICITY; INFLIXIMAB; THERAPY; COHORT	Context Short-term data on the immunogenicity of monoclonal antibodies showed associations between the development of antidrug antibodies and diminished serum drug levels, and a diminished treatment response. Little is known about the clinical relevance of antidrug antibodies against these drugs during long-term follow-up. Objective To examine the course of antidrug antibody formation against fully human monoclonal antibody adalimumab and its clinical relevance during long-term (3-year) follow-up of patients with rheumatoid arthritis (RA). Design, Setting, and Patients Prospective cohort study February 2004-September 2008; end of follow-up was September 2010. All 272 patients were diagnosed with RA and started treatment with adalimumab in an outpatient clinic. Main Outcome Measures Disease activity was monitored and trough serum samples were obtained at baseline and 8 time points to 156 weeks. Serum adalimumab concentrations and antiadalimumab antibody titers were determined after follow-up. Treatment discontinuation, minimal disease activity, and clinical remission were compared for patients with and without antiadalimumab antibodies. Results After 3 years, 76 of 272 patients (28%) developed antiadalimumab antibodies-51 of these (67%) during the first 28 weeks of treatment. Patients without antiadalimumab antibodies had much higher adalimumab concentrations (median, 12 mg/L; IQR, 9-16 mg/L) compared with patients with antibody titers from 13 to 100 AU/mL (median, 5 mg/L; IQR, 3-9 mg/L; regression coefficient, -4.5; 95% CI, -6.0 to -2.9; P < .001) and also those greater than 100 AU/mL (median, 0 mg/L; IQR, 0-3 mg/L; regression coefficient, -7.1; 95% CI, -8.4 to -5.8; P < .001). Patients with antiadalimumab antibodies more often discontinued participation due to treatment failure (n=29 [38%]; hazard ratio [HR], 3.0; 95% CI, 1.6-5.5; P < .001) compared with antiadalimumab antibody-negative ones (n=28 [14%]). Ninety-five of 196 patients (48%) without antiadalimumab antibodies had minimal disease activity vs 10 of 76 patients (13%) with antiadalimumab antibodies; patients with antiadalimumab antibodies less often had sustained minimal disease activity score in 28 joints (DAS28) (<3.2; HR, 3.6; 95% CI, 1.8-7.2; P < .001) compared with antiadalimumab antibody-negative ones. Three of 76 patients (4%) with antiadalimumab antibodies achieved sustained remission compared with 67 of 196 (34%) antiadalimumab antibody-negative ones; patients with antiadalimumab antibodies less often achieved remission (DAS28 <2.6; HR, -7.1; 95% CI, 2.1-23.4; P < .001) compared with antiadalimumab antibody-negative ones. Conclusion Among outpatients with RA in whom adalimumab was started over 3 years, the development of antidrug antibodies was associated with lower adalimumab concentration and lower likelihood of minimal disease activity or clinical remission. JAMA. 2011;305(14):1460-1468 www.jama.com	[Bartelds, Geertje M.; Krieckaert, Charlotte L. M.; Nurmohamed, Michael T.; Wolbink, Gerrit Jan] Jan van Breemen Res Inst, Amsterdam, Netherlands; [Nurmohamed, Michael T.; Lems, Willem F.; Twisk, Jos W. R.; Dijkmans, A. C.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [van Schouwenburg, Pauline A.; Aarden, Lucien; Wolbink, Gerrit Jan] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	Wolbink, GJ (corresponding author), Reade Ctr Rehabil & Rheumatol, Div Rheumatol, Dr Jan van Breemenstr 2, NL-1056 AB Amsterdam, Netherlands.	g.wolbink@reade.nl		van Schouwenburg, Pauline/0000-0003-2779-1415; Nurmohamed, Michael/0000-0002-6274-1934; Wolbink, Gerrit Jan/0000-0003-1924-7460	Abbott; Roche; Pfizer; MSD; UCB; BMS; Wyeth; Schering-Plough; Wyeth Pharmaceuticals; Abbott Laboratories; Dutch Arthritis Foundation	Abbott(Abbott Laboratories); Roche(Roche Holding); Pfizer(Pfizer); MSD; UCB(UCB Pharma SA); BMS(Bristol-Myers Squibb); Wyeth(Wyeth); Schering-Plough(Merck & CompanySchering Plough Corporation); Wyeth Pharmaceuticals(Wyeth); Abbott Laboratories(Abbott Laboratories); Dutch Arthritis Foundation	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Nurmohamed reports having received consultancy fees from Abbott, Roche, Pfizer, MSD, UCB, BMS, and Wyeth; payment for lectures from Abbott, Roche, and Pfizer; and research grants from Abbott, Roche, and Pfizer. Dr Lems reports having received honoraria for lectures from Abbott, Roche, and Schering-Plough. Dr Dijkmans reports having received research grants from Schering-Plough, Abbott, and Wyeth. Dr Wolbink reports having received a research grant from Wyeth Pharmaceuticals and honoraria for lectures from Amgen and Pfizer. No other disclosures were reported.; Funding was provided by Abbott Laboratories and Wyeth Pharmaceuticals.; We are grateful to the Clinical Research Bureau of Reade, formerly the Jan van Breemen Institute, which receives support from the Dutch Arthritis Foundation, for help in the practical aspects of the cohort study. We thank the following research nurses for performing clinical assessments: Marga Kammeijer-Rippen, Anne-Marie Abrahams, Astrid Twisk, and Martine Kos, Department of Rheumatology, Jan van Breemen Research Institute; and for preparation and performing the assays, we thank Henk de Vrieze, MSc, and Kim van Houten, MSc, Sanquin Research; and Margret de Koning, MSc, Department of the Clinical Laboratory, Jan van Breemen Research Institute. None of the individuals listed in this acknowledgment received compensation for their work in association with this study.	Allez M, 2010, J CROHNS COLITIS, V4, P355, DOI 10.1016/j.crohns.2010.04.004; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Bartelds GM, 2010, ANN RHEUM DIS, V69, P817, DOI 10.1136/ard.2009.112847; Bartelds GM, 2009, ARTHRITIS RHEUM, V60, P2541, DOI 10.1002/art.24709; Bartelds GM, 2007, ANN RHEUM DIS, V66, P921, DOI 10.1136/ard.2006.065615; Bartelds GM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3208; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Blom M, 2010, ARTHRIT CARE RES, V62, P1335, DOI 10.1002/acr.20211; Calabresi PA, 2007, NEUROLOGY, V69, P1391, DOI 10.1212/01.wnl.0000277457.17420.b5; Furst DE, 2007, ANN RHEUM DIS, V66, P2, DOI 10.1136/ard.2007.081430; Jamnitski A, 2011, ANN RHEUM DIS, V70, P284, DOI 10.1136/ard.2010.135111; Karmiris K, 2009, GASTROENTEROLOGY, V137, P1628, DOI 10.1053/j.gastro.2009.07.062; Krieckaert CLM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3147; Lecluse LLA, 2010, ARCH DERMATOL, V146, P127, DOI 10.1001/archdermatol.2009.347; Miyasaka N, 2008, MOD RHEUMATOL, V18, P252, DOI 10.1007/s10165-008-0045-0; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P624, DOI 10.1136/ard.2009.108787; van Schouwenburg PA, 2010, J IMMUNOL METHODS, V362, P82, DOI 10.1016/j.jim.2010.09.005; Vermeire S, 2007, GUT, V56, P1226, DOI 10.1136/gut.2006.099978; West RL, 2008, ALIMENT PHARM THER, V28, P1122, DOI 10.1111/j.1365-2036.2008.03828.x; Wolbink GJ, 2005, ANN RHEUM DIS, V64, P704, DOI 10.1136/ard.2004.030452; Wolbink GJ, 2006, ARTHRITIS RHEUM-US, V54, P711, DOI 10.1002/art.21671	23	568	608	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1460	1468		10.1001/jama.2011.406	http://dx.doi.org/10.1001/jama.2011.406			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486979	Bronze			2022-12-24	WOS:000289424100023
J	Parolini, O				Parolini, Ornella			In Utero Hematopoietic Stem-Cell Transplantation - A Match for Mom	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEVERE COMBINED IMMUNODEFICIENCY		Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy		Parolini, O (corresponding author), Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy.		PAROLINI, ORNELLA/C-7946-2013; PAROLINI, ORNELLA/ABI-7862-2020	PAROLINI, ORNELLA/0000-0002-5211-6430; PAROLINI, ORNELLA/0000-0002-5211-6430				Flake AW, 1996, NEW ENGL J MED, V335, P1806, DOI 10.1056/NEJM199612123352404; Nijagal A, 2011, J CLIN INVEST, V121, P582, DOI 10.1172/JCI44907; Peranteau WH, 2007, BLOOD, V109, P1331, DOI 10.1182/blood-2006-04-018606; Wengler GS, 1996, LANCET, V348, P1484, DOI 10.1016/S0140-6736(96)09392-0	4	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1174	1175		10.1056/NEJMcibr1100692	http://dx.doi.org/10.1056/NEJMcibr1100692			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428775				2022-12-24	WOS:000288701100015
J	Takeuchi, D; Hirabayashi, T; Tamura, K; Miyashita, Y				Takeuchi, Daigo; Hirabayashi, Toshiyuki; Tamura, Keita; Miyashita, Yasushi			Reversal of Interlaminar Signal Between Sensory and Memory Processing in Monkey Temporal Cortex	SCIENCE			English	Article							AUDITORY-CORTEX; MACAQUE MONKEY; OSCILLATIONS; NETWORK; LOBE; ORGANIZATION; RECOGNITION; INFORMATION; PERCEPTION; MECHANISMS	The primate temporal cortex implements visual long-term memory. However, how its interlaminar circuitry executes cognitive computations is poorly understood. Using linear-array multicontact electrodes, we simultaneously recorded unit activities across cortical layers in the perirhinal cortex of macaques performing a pair-association memory task. Cortical layers were estimated on the basis of current source density profiles with histological verifications, and the interlaminar signal flow was determined with cross-correlation analysis between spike trains. During the cue period, canonical "feed-forward" signals flowed from granular to supragranular layers and from supragranular to infragranular layers. During the delay period, however, the signal flow reversed to the "feed-back" direction: from infragranular to supragranular layers. This reversal of signal flow highlights how the temporal cortex differentially recruits its laminar circuits for sensory and mnemonic processing.	[Takeuchi, Daigo; Hirabayashi, Toshiyuki; Tamura, Keita; Miyashita, Yasushi] Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Tamura, Keita/I-2931-2012; Miyashita, Yasushi/B-7171-2019	Tamura, Keita/0000-0003-2697-1510; Miyashita, Yasushi/0000-0003-3496-8637	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19002010, 18700378]; Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS) [1811234, 211438]; Grants-in-Aid for Scientific Research [19002010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to Y.M. (19002010) and Grant-in-Aid for Young Scientists from MEXT to T. H. (18700378); a grant from Takeda Science Foundation to Y.M.; and Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists to D. T. (1811234) and K. T. (211438). This work was also supported in part by Global Center of Excellence Program from MEXT. We thank M. Takeda for discussions and comments and H. Kasahara, R. Fujimichi, T. Matsui, and K. W. Koyano for advice and help with experiments.	Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Hirabayashi T, 2005, J NEUROSCI, V25, P10299, DOI 10.1523/JNEUROSCI.3036-05.2005; Hirabayashi T, 2010, J NEUROSCI, V30, P10407, DOI 10.1523/JNEUROSCI.0135-10.2010; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Naya Y, 2003, J NEUROSCI, V23, P2861; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Saleem KS, 1996, J NEUROSCI, V16, P4757; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Suzuki WA, 2003, J COMP NEUROL, V463, P67, DOI 10.1002/cne.10744; Suzuki WA, 2009, NEURON, V61, P657, DOI 10.1016/j.neuron.2009.02.008; Tomita M, 2005, J NEUROPHYSIOL, V93, P378, DOI 10.1152/jn.00643.2004; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003	28	91	92	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1443	1447		10.1126/science.1199967	http://dx.doi.org/10.1126/science.1199967			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415353				2022-12-24	WOS:000288504000043
J	Narita, M; Young, ARJ; Arakawa, S; Samarajiwa, SA; Nakashima, T; Yoshida, S; Hong, SK; Berry, LS; Reichelt, S; Ferreira, M; Tavare, S; Inoki, K; Shimizu, S; Narita, M				Narita, Masako; Young, Andrew R. J.; Arakawa, Satoko; Samarajiwa, Shamith A.; Nakashima, Takayuki; Yoshida, Sei; Hong, Sungki; Berry, Lorraine S.; Reichelt, Stefanie; Ferreira, Manuela; Tavare, Simon; Inoki, Ken; Shimizu, Shigeomi; Narita, Masashi			Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes	SCIENCE			English	Article							RAG GTPASES; PROTEIN; COMPLEX	Protein synthesis and autophagic degradation are regulated in an opposite manner by mammalian target of rapamycin (mTOR), whereas under certain conditions it would be beneficial if they occurred in unison to handle rapid protein turnover. We observed a distinct cellular compartment at the trans side of the Golgi apparatus, the TOR-autophagy spatial coupling compartment (TASCC), where (auto)lysosomes and mTOR accumulated during Ras-induced senescence. mTOR recruitment to the TASCC was amino acid-and Rag guanosine triphosphatase-dependent, and disruption of mTOR localization to the TASCC suppressed interleukin-6/8 synthesis. TASCC formation was observed during macrophage differentiation and in glomerular podocytes; both displayed increased protein secretion. The spatial coupling of cells' catabolic and anabolic machinery could augment their respective functions and facilitate the mass synthesis of secretory proteins.	[Narita, Masako; Young, Andrew R. J.; Samarajiwa, Shamith A.; Nakashima, Takayuki; Berry, Lorraine S.; Reichelt, Stefanie; Ferreira, Manuela; Tavare, Simon; Narita, Masashi] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Arakawa, Satoko; Shimizu, Shigeomi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol & Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Samarajiwa, Shamith A.; Tavare, Simon] Univ Cambridge, Dept Oncol, Cambridge CB2 0RE, England; [Yoshida, Sei; Hong, Sungki; Inoki, Ken] Univ Michigan, Dept Mol & Integrat Physiol & Internal Med, Inst Life Sci, Ann Arbor, MI 48109 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Tokyo Medical & Dental University (TMDU); University of Cambridge; University of Michigan System; University of Michigan	Narita, M (corresponding author), Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	masashi.narita@cancer.org.uk; masashi.narita@cancer.org.uk	Arakawa, Satoko/AAM-9638-2020; Samarajiwa, Shamith/B-1601-2013; Ferreira, Manuela/AAF-5299-2020; Ferreira, Manuela/I-7904-2018	Arakawa, Satoko/0000-0002-4375-1643; Samarajiwa, Shamith/0000-0003-1046-0601; Ferreira, Manuela/0000-0001-9498-8061; Ferreira, Manuela/0000-0001-9498-8061; Ferreira, Manuela/0000-0002-0075-2400; Young, Andrew/0000-0002-7522-5525; Narita, Masako/0000-0002-9774-4908; Narita, Masashi/0000-0001-7764-577X; Yoshida, Sei/0000-0002-4771-3900; Reichelt, Stefanie/0000-0003-4151-0712	Univ. of Cambridge; Cancer Research UK; Hutchison Whampoa; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation; Juvenile Diabetes Research Foundation; NIH [DK083491]; Grants-in-Aid for Scientific Research [23657084, 22770054] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083491] Funding Source: NIH RePORTER; Cancer Research UK [19556] Funding Source: researchfish	Univ. of Cambridge; Cancer Research UK(Cancer Research UK); Hutchison Whampoa; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Research UK(Cancer Research UK)	We thank K. Ryan, N. Mizushima, F. Watt, and R. Rios for reagents; R. Rios, D. Tuveson, T. Kanaseki, I. Mills, N. Dolman, and members of Narita lab for helpful discussion; L. Blackburn for editing; CRI's Genomics, Bioinformatics, Microscopy (J. Harris), and Histopathology facilities for technical support; and the Gurdon Institute's microscopy facility (A. Sossick) for optical microscopy experimental. This work was supported by the Univ. of Cambridge; Cancer Research UK; Hutchison Whampoa; Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology of Japan; the Program for Promotion of Fundamental Studies in the National Institute of Biomedical Innovation (S.A. and S.S.); and Juvenile Diabetes Research Foundation Award and NIH grant DK083491 (K.I.). Expression data are available at the National Center for Biotechnology Information Gene Expression Omnibus under accession number GSE28464.	Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	13	370	381	4	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					966	970		10.1126/science.1205407	http://dx.doi.org/10.1126/science.1205407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21512002	Green Accepted			2022-12-24	WOS:000290766600044
J	Green, RA; Kao, HL; Audhya, A; Arur, S; Mayers, JR; Fridolfsson, HN; Schulman, M; Schloissnig, S; Niessen, S; Laband, K; Wang, SH; Starr, DA; Hyman, AA; Schedl, T; Desai, A; Piano, F; Gunsalus, KC; Oegema, K				Green, Rebecca A.; Kao, Huey-Ling; Audhya, Anjon; Arur, Swathi; Mayers, Jonathan R.; Fridolfsson, Heidi N.; Schulman, Monty; Schloissnig, Siegfried; Niessen, Sherry; Laband, Kimberley; Wang, Shaohe; Starr, Daniel A.; Hyman, Anthony A.; Schedl, Tim; Desai, Arshad; Piano, Fabio; Gunsalus, Kristin C.; Oegema, Karen			A High-Resolution C. elegans Essential Gene Network Based on Phenotypic Profiling of a Complex Tissue	CELL			English	Article							FUNCTIONAL GENOMIC ANALYSIS; WIDE RNAI SCREENS; NUCLEAR-ENVELOPE; INTERACTOME NETWORK; CELL-DIVISION; CHROMOSOME-I; KINETOCHORE; MICROSCOPY; OVARY; MAP	High-content screening for gene profiling has generally been limited to single cells. Here, we explore an alternative approach-profiling gene function by analyzing effects of gene knockdowns on the architecture of a complex tissue in a multicellular organism. We profile 554 essential C. elegans genes by imaging gonad architecture and scoring 94 phenotypic features. To generate a reference for evaluating methods for network construction, genes were manually partitioned into 102 phenotypic classes, predicting functions for uncharacterized genes across diverse cellular processes. Using this classification as a benchmark, we developed a robust computational method for constructing gene networks from high-content profiles based on a network context-dependent measure that ranks the significance of links between genes. Our analysis reveals that multi-parametric profiling in a complex tissue yields functional maps with a resolution similar to genetic interaction-based profiling in unicellular eukaryotes-pinpointing subunits of macromolecular complexes and components functioning in common cellular processes.	[Kao, Huey-Ling; Schulman, Monty; Piano, Fabio; Gunsalus, Kristin C.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Green, Rebecca A.; Laband, Kimberley; Wang, Shaohe; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Green, Rebecca A.; Laband, Kimberley; Wang, Shaohe; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Audhya, Anjon; Mayers, Jonathan R.] Univ Wisconsin, Dept Biomol Chem, Madison Med Sch, Madison, WI 53706 USA; [Arur, Swathi] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Fridolfsson, Heidi N.; Starr, Daniel A.] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA; [Schedl, Tim] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Schloissnig, Siegfried; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Niessen, Sherry] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Niessen, Sherry] Scripps Res Inst, Dept Physiol Chem, Ctr Physiol Prote, La Jolla, CA 92037 USA; [Piano, Fabio; Gunsalus, Kristin C.] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates	New York University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis; Washington University (WUSTL); Max Planck Society; Scripps Research Institute; Scripps Research Institute	Gunsalus, KC (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, 12 Waverly Pl,8th Floor, New York, NY 10003 USA.	kcg1@nyu.edu; koegema@ucsd.edu	Hyman, Tony/F-1923-2011; Wang, Shaohe/J-6456-2019; Hyman, Anthony A/B-3917-2017	Wang, Shaohe/0000-0001-9522-2359; Hyman, Anthony A/0000-0003-3664-154X; Schloissnig, Siegfried/0000-0003-4574-8330; Laband, Kimberley/0000-0002-8535-2050; Starr, Daniel/0000-0001-7339-6606; Green, Rebecca/0000-0002-4528-011X	American Cancer Society [PF-06-254-01-CCG]; Helen Hay Whitney Foundation; NIH [R01 GM074207, R01 HD046236, R01 GM085503, R01 GM085150, R01 GM088151, R01 GM073874]; Ludwig Institute for Cancer Research; NIH National Center for Research Resources, for strains; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085503, R01GM088151, R01GM074207, R01GM085150, R01GM073874] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NIH National Center for Research Resources, for strains(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the American Cancer Society (PF-06-254-01-CCG, to RG), the Helen Hay Whitney Foundation (to A. A.), and the NIH R01 GM074207 to K.O., R01 HD046236 to K.C.G. and FP; R01 GM085503 to K.C.G.; R01 GM085150 to TS; R01 GM088151 to A.A.; R01 GM073874 to D.A.S.) and by funding from the Ludwig Institute for Cancer Research to KO and AD. We thank Kahn Rhrissorrakrai for the MINE algorithm, Michael Volkmer for movie formatting, and the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, for strains. Author Contributions: Conceived and designed the experiments: KO, AD, RG, AA. Performed the experiments: RG, AA, SN, SA, TS, SW, HF, DS, JM. Scored the data: AA, RG, KO. Manually partitioned the genes into classes: RG, KO. Reworked Phenobank to include the gonad morphology data: SS, RG, KO, AH. Developed N-Browse: HK, MS, FP, KG. Developed CSI: KO, RG, HK, MS, FP, KG. Conceptualized and performed network analysis: HK, FP, KG. Contributed reagents/materials/analysis tools: KO, RG, AA, SN, KL, SA, TS, AD, HK, MS, KG, FP, HF, DS.	[Anonymous], 2008, CURR PROTOC BIOINFOR; [Anonymous], WORMBOOK C ELEGANS R; Arur S, 2009, P NATL ACAD SCI USA, V106, P4776, DOI 10.1073/pnas.0812285106; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2009, NAT METHODS, V6, P721, DOI 10.1038/nmeth1009-721; Conrad C, 2010, J CELL BIOL, V188, P453, DOI 10.1083/jcb.200910105; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Essex A, 2009, MOL BIOL CELL, V20, P1252, DOI 10.1091/mbc.E08-10-1047; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fridolfsson HN, 2010, J CELL BIOL, V191, P115, DOI 10.1083/jcb.201004118; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Gunsalus Kristin C, 2008, J Biol, V7, P8, DOI 10.1186/jbiol70; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Kimble Judith, 2005, WormBook, P1; Kops GJPL, 2010, J CELL SCI, V123, P1623, DOI 10.1242/jcs.061549; Lee MH, 2007, GENETICS, V177, P2039, DOI 10.1534/genetics.107.081356; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r26; MADURO M, 1995, GENETICS, V141, P977; Mathey-Prevot B, 2006, COLD SPRING HARB SYM, V71, P141, DOI 10.1101/sqb.2006.71.027; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Praitis V, 2001, GENETICS, V157, P1217; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Starr DA, 2001, DEVELOPMENT, V128, P5039; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Zhou K, 2009, J CELL BIOL, V186, P229, DOI 10.1083/jcb.200902101; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	49	142	144	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					470	482		10.1016/j.cell.2011.03.037	http://dx.doi.org/10.1016/j.cell.2011.03.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529718	Green Accepted, Bronze			2022-12-24	WOS:000290022900015
J	Orans, J; McSweeney, EA; Iyer, RR; Hast, MA; Hellinga, HW; Modrich, P; Beese, LS				Orans, Jillian; McSweeney, Elizabeth A.; Iyer, Ravi R.; Hast, Michael A.; Hellinga, Homme W.; Modrich, Paul; Beese, Lorena S.			Structures of Human Exonuclease 1 DNA Complexes Suggest a Unified Mechanism for Nuclease Family	CELL			English	Article							HUMAN FLAP ENDONUCLEASE-1; HUMAN MISMATCH REPAIR; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; POLYMERASE-I; CANCER SUSCEPTIBILITY; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; ACTIVE-SITE; RESECT DNA	Human exonuclease 1 (hExo1) plays important roles in DNA repair and recombination processes that maintain genomic integrity. It is a member of the 50 structure-specific nuclease family of exonucleases and endonucleases that includes FEN-1, XPG, and GEN1. We present structures of hExo1 in complex with a DNA substrate, followed by mutagenesis studies, and propose a common mechanism by which this nuclease family recognizes and processes diverse DNA structures. hExo1 induces a sharp bend in the DNA at nicks or gaps. Frayed 50 ends of nicked duplexes resemble flap junctions, unifying the mechanisms of endo- and exonucleolytic processing. Conformational control of a mobile region in the catalytic site suggests a mechanism for allosteric regulation by binding to protein partners. The relative arrangement of substrate binding sites in these enzymes provides an elegant solution to a complex geometrical puzzle of substrate recognition and processing.	[Orans, Jillian; McSweeney, Elizabeth A.; Iyer, Ravi R.; Hast, Michael A.; Hellinga, Homme W.; Modrich, Paul; Beese, Lorena S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Beese, LS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	lb12@duke.edu	Classen, Scott/AAY-8176-2020	Modrich, Paul/0000-0001-8708-9885	National Institutes of Health [R01 GM091487, R01 GM45190, P01 CA092584]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; DOE with the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091487, R01GM045190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE with the U.S. Department of Energy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anita Changela, Shannon Kelly, and Miaw-Sheue Tsai for assistance with cloning and purification. This work was supported by National Institutes of Health grants R01 GM091487 to L.S.B., R01 GM45190 to P.M., and P01 CA092584 to L.S.B. and P.M. P.M. is an Investigator of the Howard Hughes Medical Institute. Use of the Advanced Photon Source was supported, in part, by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number W-31-109-Eng-38. Use of the SIBYLS beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, was supported, in part, by the DOE program Integrated Diffraction Analysis Technologies (IDAT) and the DOE program Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) under contract number DE-AC02-05CH11231 with the U.S. Department of Energy.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Barnes CJ, 1996, J BIOL CHEM, V271, P29624, DOI 10.1074/jbc.271.47.29624; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Brautigam CA, 1998, J MOL BIOL, V277, P363, DOI 10.1006/jmbi.1997.1586; Brautigam CA, 1999, BIOCHEMISTRY-US, V38, P696, DOI 10.1021/bi981537g; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dervan JJ, 2002, P NATL ACAD SCI USA, V99, P8542, DOI 10.1073/pnas.082241699; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Doherty KM, 2005, J BIOL CHEM, V280, P28085, DOI 10.1074/jbc.M500265200; Dore AS, 2006, NUCLEIC ACIDS RES, V34, P4515, DOI 10.1093/nar/gkl623; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FANG WH, 1993, J BIOL CHEM, V268, P11838; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Genschel J, 2009, J BIOL CHEM, V284, P21536, DOI 10.1074/jbc.M109.021287; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hohl M, 2007, NUCLEIC ACIDS RES, V35, P3053, DOI 10.1093/nar/gkm092; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; KOLODNER RD, 1995, TRENDS BIOCHEM SCI, V20, P397, DOI 10.1016/S0968-0004(00)89087-8; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Liberti SE, 2011, DNA REPAIR, V10, P73, DOI 10.1016/j.dnarep.2010.09.023; Matsui E, 2002, J BIOL CHEM, V277, P37840, DOI 10.1074/jbc.M205235200; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; OTWINOWSKI Z, 1998, DENZO SCALEPACK PROG; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Schmutte C, 1998, CANCER RES, V58, P4537; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Sengerova B, 2010, BIOCHEMISTRY-US, V49, P8085, DOI 10.1021/bi100895j; Sharma S, 2003, J BIOL CHEM, V278, P23487, DOI 10.1074/jbc.M212798200; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Vallur AC, 2010, J BIOL CHEM, V285, P28514, DOI 10.1074/jbc.M110.132738; Vallur AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008908; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	63	121	123	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					212	223		10.1016/j.cell.2011.03.005	http://dx.doi.org/10.1016/j.cell.2011.03.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496642	Bronze, Green Accepted			2022-12-24	WOS:000289549900011
J	Lee, SJ; Eng, C				Lee, Sei J.; Eng, Catherine			Goals of Glycemic Control in Frail Older Patients With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISABILITY; CARE		[Lee, Sei J.] San Francisco VA Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; [Lee, Sei J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Eng, Catherine] On Lok Lifeways, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Lee, SJ (corresponding author), San Francisco VA Med Ctr, Div Geriatr, 4150 Clement St,Bldg 1,Room 211A, San Francisco, CA 94121 USA.	sei.lee@ucsf.edu			NCRR NIH HHS [KL2 RR024130] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Araki A, 2009, GERIATR GERONTOL INT, V9, P105, DOI 10.1111/j.1447-0594.2008.00495.x; Berlie HD, 2010, ANN PHARMACOTHER, V44, P712, DOI 10.1345/aph.1M551; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Flacker JM, 2003, J AM GERIATR SOC, V51, P213, DOI 10.1046/j.1532-5415.2003.51060.x; Guralnik JM, 1996, ANNU REV PUBL HEALTH, V17, P25, DOI 10.1146/annurev.pu.17.050196.000325; Hobbs C, 2010, VA DOD CLIN PRACTICE; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; MANTON KG, 1993, J GERONTOL, V48, pS153, DOI 10.1093/geronj/48.4.S153; Resnick HE, 2008, DIABETES CARE, V31, P287, DOI 10.2337/dc07-1425	10	35	44	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1350	1351		10.1001/jama.2011.404	http://dx.doi.org/10.1001/jama.2011.404			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745JT	21467289	Green Accepted			2022-12-24	WOS:000289162400026
J	Raya-Rivera, A; Esquiliano, DR; Yoo, JJ; Lopez-Bayghen, E; Soker, S; Atala, A				Raya-Rivera, Atlantida; Esquiliano, Diego R.; Yoo, James J.; Lopez-Bayghen, Esther; Soker, Shay; Atala, Anthony			Tissue-engineered autologous urethras for patients who need reconstruction: an observational study	LANCET			English	Article							COLLAGEN MATRIX; BUCCAL MUCOSAL; GRAFTS; VASCULARIZATION; REPLACEMENT; MANAGEMENT; ANTERIOR; STENOSIS; BLADDER	Background Complex urethral problems can occur as a result of injury, disease, or congenital defects and treatment options are often limited. Urethras, similar to other long tubularised tissues, can stricture after reconstruction. We aimed to assess the effectiveness of tissue-engineered urethras using patients' own cells in patients who needed urethral reconstruction. Methods Five boys who had urethral defects were included in the study. A tissue biopsy was taken from each patient, and the muscle and epithelial cells were expanded and seeded onto tubularised polyglycolic acid:poly(lactide-co-glycolide acid) scaffolds. Patients then underwent urethral reconstruction with the tissue-engineered tubularised urethras. We took patient history, asked patients to complete questionnaires from the International Continence Society (ICS), and did urine analyses, cystourethroscopy, cystourethrography, and flow measurements at 3, 6, 12, 24, 36, 48, 60, and 72 months after surgery. We did serial endoscopic cup biopsies at 3, 12, and 36 months, each time in a different area of the engineered urethras. Findings Patients had surgery between March 19, 2004, and July 20, 2007. Follow-up was completed by July 31, 2010. Median age was 11 years (range 10-14) at time of surgery and median follow-up was 71 months (range 36-76 months). AE1/AE3, alpha actin, desmin, and myosin antibodies confirmed the presence of cells of epithelial and muscle lineages on all cultures. The median end maximum urinary flow rate was 27.1 mL/s (range 16-28), and serial radiographic and endoscopic studies showed the maintenance of wide urethral calibres without strictures. Urethral biopsies showed that the engineered grafts had developed a normal appearing architecture by 3 months after implantation. Interpretation Tubularised urethras can be engineered and remain functional in a clinical setting for up to 6 years. These engineered urethras can be used in patients who need complex urethral reconstruction.	[Raya-Rivera, Atlantida; Yoo, James J.; Lopez-Bayghen, Esther; Soker, Shay; Atala, Anthony] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA; [Raya-Rivera, Atlantida; Yoo, James J.; Lopez-Bayghen, Esther; Soker, Shay; Atala, Anthony] Wake Forest Univ, Sch Med, Dept Urol, Winston Salem, NC 27157 USA; [Raya-Rivera, Atlantida; Esquiliano, Diego R.; Lopez-Bayghen, Esther] Metropolitan Autonomous Univ, HIMFG Tissue Engn Lab, Mexico City, DF, Mexico; [Raya-Rivera, Atlantida; Esquiliano, Diego R.; Lopez-Bayghen, Esther] IPN, CINVESTAV, Mexico City 07738, DF, Mexico	Wake Forest University; Wake Forest University; Universidad Autonoma Metropolitana - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Atala, A (corresponding author), Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.	aatala@wfubmc.edu	Yoo, James J./L-4850-2017; Lopez-Bayghen, Esther/A-8006-2008	Lopez-Bayghen, Esther/0000-0002-2849-7587; Atala, Anthony/0000-0001-8186-2160	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [AA- P50DKO65289]; Conacyt; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065298] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (AA- P50DKO65289). ARR and DE were recipients of a Conacyt Doctoral Fellowship. We thank R Fierro-Pastrana and P Valencia for their scientific expertise and contributions, and J Olson for editorial assistance.	Al-Qudah Hosam S., 2005, Int. braz j urol., V31, P459, DOI 10.1590/S1677-55382005000500007; Asif A, 2005, KIDNEY INT, V67, P1986, DOI 10.1111/j.1523-1755.2005.00299.x; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9; ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5; Bhargava S, 2008, EUR UROL, V53, P1263, DOI 10.1016/j.eururo.2008.01.061; Brandes S, 2006, UROL CLIN N AM, V33, P87, DOI 10.1016/j.ucl.2005.10.001; Caldamone AA, 1998, UROLOGY, V51, P15, DOI 10.1016/S0090-4295(98)00088-0; Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X; De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1016/S0022-5347(05)64414-X; Dorin RP, 2008, WORLD J UROL, V26, P323, DOI 10.1007/s00345-008-0316-6; El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101; El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8; Joseph D., 2009, AM UR ASS ANN M CHIC; Kajbafzadeh Abdol-Mohammad, 2005, BMC Urol, V5, P3, DOI 10.1186/1471-2490-5-3; Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006; KANTERMAN RY, 1995, RADIOLOGY, V195, P135, DOI 10.1148/radiology.195.1.7892454; Koraitim MM, 2004, UROLOGY, V64, P228, DOI 10.1016/j.urology.2004.03.019; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mundy AR, 2006, POSTGRAD MED J, V82, P489, DOI 10.1136/pgmj.2005.042945; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Pansadoro Vito, 2002, Curr Opin Urol, V12, P223, DOI 10.1097/00042307-200205000-00008; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Sander EA, 2004, J BIOMED MATER RES A, V70A, P506, DOI 10.1002/jbm.a.30109; Sarkar S, 2007, MED BIOL ENG COMPUT, V45, P327, DOI 10.1007/s11517-007-0176-z; Zinman L, 2000, Curr Urol Rep, V1, P180, DOI 10.1007/s11934-000-0017-1	26	322	349	1	87	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1175	1182		10.1016/S0140-6736(10)62354-9	http://dx.doi.org/10.1016/S0140-6736(10)62354-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750IH	21388673	Green Accepted			2022-12-24	WOS:000289539300033
J	Sarafoglou, K; Rodgers, J; Hietala, A; Matern, D; Bentler, K				Sarafoglou, Kyriakie; Rodgers, John; Hietala, Amy; Matern, Dietrich; Bentler, Kristi			Expanded Newborn Screening for Detection of Vitamin B-12 Deficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							METHYLMALONIC ACID; TOTAL HOMOCYSTEINE; COBALAMIN		[Sarafoglou, Kyriakie; Rodgers, John; Bentler, Kristi] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Hietala, Amy] Minnesota Dept Hlth, St Paul, MN USA; [Matern, Dietrich] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Minnesota Department of Health (MHD); Mayo Clinic	Sarafoglou, K (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA.	saraf010@umn.edu		Sarafoglou, Kyriakie/0000-0002-5741-3629				Campbell C D, 2005, Haematologica, V90, pECR45; Hinton CF, 2010, J PEDIATR-US, V157, P162, DOI 10.1016/j.jpeds.2010.03.006; Monsen ALB, 2001, PEDIATRICS, V108, P624, DOI 10.1542/peds.108.3.624; Rasmussen SA, 2001, J PEDIATR-US, V138, P10, DOI 10.1067/mpd.2001.112160; SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X; Turgeon CT, 2010, CLIN CHEM, V56, P1686, DOI 10.1373/clinchem.2010.148957	6	36	37	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1198	1200		10.1001/jama.2011.310	http://dx.doi.org/10.1001/jama.2011.310			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427371	Bronze			2022-12-24	WOS:000288652100013
J	Janssens, ACJW; Ioannidis, JPA; van Duijn, CM; Little, J; Khoury, MJ				Janssens, A. Cecile J. W.; Ioannidis, John P. A.; van Duijn, Cornelia M.; Little, Julian; Khoury, Muin J.		GRIPS Grp	Research Methods & Reporting Strengthening the reporting of genetic risk prediction studies: the GRIPS statement	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EPIDEMIOLOGY; ASSOCIATION; MODELS; MARKER; CURVE					a.janssens@erasmusmc.nl	Little, Julian/AAR-6117-2020; Ioannidis, John P. A./G-9836-2011	Little, Julian/0000-0001-5026-5531; Janssens, A Cecile/0000-0002-6153-4976; Dolan, Siobhan/0000-0001-8890-8045; Van Duijn, Cornelia/0000-0002-2374-9204	Centers for Disease Control and Prevention on behalf of Human Genome Epidemiology Network; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention on behalf of Human Genome Epidemiology Network; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The workshop was sponsored by the Centers for Disease Control and Prevention on behalf of the Human Genome Epidemiology Network. Opinions in this paper do not necessarily represent the official position or policies of the authors' employers, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Freedman AN, 2005, JNCI-J NATL CANCER I, V97, P715, DOI 10.1093/jnci/dji128; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Janssens ACJW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000420; Janssens ACJW, 2010, CIRC-CARDIOVASC GENE, V3, P3, DOI 10.1161/CIRCGENETICS.110.938092; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Khoury MJ, 1998, AM J EPIDEMIOL, V148, P1; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Khoury MJ, 2010, AM J EPIDEMIOL, V172, P517, DOI 10.1093/aje/kwq211; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Kyzas PA, 2007, JNCI-J NATL CANCER I, V99, P236, DOI 10.1093/jnci/djk032; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2700, 10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297; Vandenbrouke JP, 2009, J CLIN EPIDEMIOL, V62, P594, DOI 10.1016/j.jclinepi.2008.12.003; von Elm E, 2004, BMJ-BRIT MED J, V329, P868, DOI 10.1136/bmj.329.7471.868; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	26	15	15	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2011	342								d631	10.1136/bmj.d631	http://dx.doi.org/10.1136/bmj.d631			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KW	21411493	Green Published, Green Submitted			2022-12-24	WOS:000209546100001
J	Mackin, P; Thomas, SHL				Mackin, Paul; Thomas, Simon H. L.			Therapeutics Atypical antipsychotic drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; 2ND-GENERATION; SCHIZOPHRENIA					paul.mackin@ncl.ac.uk	Thomas, Simon/AAK-9674-2021					Agid O, 2007, NEUROPSYCHOPHARMACOL, V32, P1209, DOI 10.1038/sj.npp.1301242; Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; Bushe Chris, 2008, J Psychopharmacol, V22, P46, DOI 10.1177/0269881107088435; Citrome L, 2006, INT J CLIN PRACT, V60, P933, DOI 10.1111/j.1742-1241.2006.01044.x; Douglas IJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1227; FARAH A, 2005, J CLIN PSYCHIAT, V7, P268, DOI DOI 10.4088/PCC.V07N0602; Grunder G, 2009, NAT REV DRUG DISCOV, V8, P197, DOI 10.1038/nrd2806; Hedges D, 2003, DRUG TODAY, V39, P551, DOI 10.1358/dot.2003.39.7.799445; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; Kesselheim AS, 2007, JAMA-J AM MED ASSOC, V297, P308, DOI 10.1001/jama.297.3.308; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lewis SW, 2006, SCHIZOPHRENIA BULL, V32, P715, DOI 10.1093/schbul/sbj067; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Mackin P, 2008, HUM PSYCHOPHARM CLIN, V23, P3, DOI 10.1002/hup.915; *NAT HLTH SERV BUS, PRESCR REV APR JUN 2; Newham JJ, 2008, BRIT J PSYCHIAT, V192, P333, DOI 10.1192/bjp.bp.107.041541; *NIH CLIN EXC, 2009, 82 NIH CLIN EXC; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Stanniland C, 2000, DRUG SAFETY, V22, P195, DOI 10.2165/00002018-200022030-00004; Tanne JH, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4422; Verdoux H, 2010, ACTA PSYCHIAT SCAND, V121, P4, DOI 10.1111/j.1600-0447.2009.01425.x	21	14	15	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2011	342								d1126	10.1136/bmj.d1126	http://dx.doi.org/10.1136/bmj.d1126			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732EU	21378070				2022-12-24	WOS:000288168600002
J	Pattinson, R; Kerber, K; Buchmann, E; Friberg, IK; Belizan, M; Lansky, S; Weissman, E; Mathai, M; Rudan, I; Walker, N; Lawn, JE				Pattinson, Robert; Kerber, Kate; Buchmann, Eckhart; Friberg, Ingrid K.; Belizan, Maria; Lansky, Sonia; Weissman, Eva; Mathai, Matthews; Rudan, Igor; Walker, Neff; Lawn, Joy E.		Lancet's Stillbirths Series Steeri	Stillbirths 4 Stillbirths: how can health systems deliver for mothers and babies?	LANCET			English	Article							MATERNAL MORTALITY; CHILD HEALTH; OBSTETRIC CARE; GLOBAL HEALTH; PRETERM BIRTH; NEWBORN; INTERVENTIONS; CHALLENGES; FACILITIES; CONTINUUM	The causes of stillbirths are inseparable from the causes of maternal and neonatal deaths. This report focuses on prevention of stillbirths by scale-up of care for mothers and babies at the health-system level, with consideration for effects and cost. In countries with high mortality rates, emergency obstetric care has the greatest effect on maternal and neonatal deaths, and on stillbirths. Syphilis detection and treatment is of moderate effect but of lower cost and is highly feasible. Advanced antenatal care, including induction for post-term pregnancies, and detection and management of hypertensive disease, fetal growth restriction, and gestational diabetes, will further reduce mortality, but at higher cost. These interventions are best packaged and provided through linked service delivery methods tailored to suit existing health-care systems. If 99% coverage is reached in 68 priority countries by 2015, up to 1.1 million (45%) third-trimester stillbirths, 201000 (54%) maternal deaths, and 1.4 million (43%) neonatal deaths could be saved per year at an additional total cost of US$10.9 billion or $2.32 per person, which is in the range of $0.96-2.32 for other ingredients-based intervention packages with only recurrent costs.	[Pattinson, Robert; Belizan, Maria] Univ Pretoria, Dept Obstet & Gynaecol, Med Res Council Maternal & Infant Hlth Care Strat, ZA-0001 Pretoria, South Africa; [Kerber, Kate; Lawn, Joy E.] Saving Newborn Lives Save Children, Cape Town, South Africa; [Buchmann, Eckhart] Chris Hani Baragwanath Hosp, Dept Obstet & Gynaecol, Johannesburg, South Africa; [Buchmann, Eckhart] Univ Witwatersrand, Johannesburg, South Africa; [Friberg, Ingrid K.; Walker, Neff] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Belizan, Maria] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Lansky, Sonia] Univ Fed Minas Gerais, Belo Horizonte Hlth Dept, Belo Horizonte, MG, Brazil; [Weissman, Eva] Futures Inst, New York, NY USA; [Mathai, Matthews] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Lawn, Joy E.] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Lawn, Joy E.] Inst Child Hlth, London, England	University of Pretoria; Save the Children; University of Witwatersrand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Minas Gerais; World Health Organization; University of Split; University of Edinburgh; University of London; University College London	Pattinson, R (corresponding author), Univ Pretoria, Dept Obstet & Gynaecol, Med Res Council Maternal & Infant Hlth Care Strat, POB 667, ZA-0001 Pretoria, South Africa.	robert.pattinson@up.ac.za	Lawn, Joy/ABE-6382-2020; Rudan, Igor/I-1467-2012; Flenady, Vicki Jane/O-9609-2014	Lawn, Joy/0000-0002-4573-1443; Rudan, Igor/0000-0001-6993-6884; Flenady, Vicki Jane/0000-0001-8114-7677; Belizan, Maria/0000-0002-8739-5249; Froen Froen, Jahn Frederik/0000-0001-9390-8509	Bill & Melinda Gates Foundation; Global Alliance to Prevent Prematurity and Stillbirth; Partnership for Maternal, Newborn and Child Health	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Global Alliance to Prevent Prematurity and Stillbirth; Partnership for Maternal, Newborn and Child Health	Some technical work and travel for this report during 2010 were funded through a grant for The Lancet's Series from the Bill & Melinda Gates Foundation to the International Stillbirth Alliance secretariat. JEL and KK are funded by the Bill & Melinda Gates Foundation through Saving Newborn Lives/Save the Children. Some meetings and travel were partially funded by the Global Alliance to Prevent Prematurity and Stillbirth and the Partnership for Maternal, Newborn and Child Health. The funding organisations had no role in the drafting or direction of this report. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their employers. We thank Robert Goldenberg for helpful insights and thoughtful review of this paper; and scorers for the Child Health and Nutrition Research Initiative research priority setting exercise (in alphabetical order): Hassan Baaqeel, Zulfiqar A Bhutta, Betty Chacko, Evita Fernandez, Rajshree Jha, Ruby Jose, James Machoki M'Imunya, Suneeta Mittal, Nafissa Bique Osman, Zahida Qureshi, Gary L Darmstadt, Louise Day, Nighat Shah, Nilofer Babar, Shabnam Khowaja, and Sidrah Nausheen for low-income countries; and Hany Abdel-Aleem, Jose M Belizan, Jackie Ho, Ravindran Jegasothy, Tippawan Liabsuetrakul, Deepika Attygalle, Eckhart Buchmann, Jose Guilherme Cecatti, Yolanda Contreras Garcia, Glen Mola, Neil Moran, Metin Gulmezoglu, Matthews Mathai, Jose Ortiz-Segarra, Robert Pattinson, Alejandro Vargas, Paulino Vigil-De Gracia, and Juan Carlos Vazquez for middle-income countries.	Althabe F, 2008, PAEDIATR PERINAT EP, V22, P42, DOI 10.1111/j.1365-3016.2007.00912.x; Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; [Anonymous], INT DRUG PRIC IND GU; Bala M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub2; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; BLENCOWE H, INT J EPIDEMIOL S1, V39, P110; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Chivu CM, 2008, AM J HEALTH PROMOT, V22, P237, DOI 10.4278/06051566R2.1; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; Darmstadt GL, 2009, INT J GYNECOL OBSTET, V107, pS89, DOI 10.1016/j.ijgo.2009.07.010; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; *GUTTM I, FACTS INV FAM PLANN; Hodnett ED, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003766.pub2; Hofmeyr GJ, 2009, INT J GYNECOL OBSTET, V107, pS21, DOI 10.1016/j.ijgo.2009.07.017; Hounton S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1947; *INT HLTH PARTN, 2009, TASKF INN INT FIN HL; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008137; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; LAWN J, 2005, TRACKING PROGR CHILD; LAWN J, 2005, DIS CONTROL PRIORITI; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Lee ACC, 2009, INT J GYNECOL OBSTET, V107, pS65, DOI 10.1016/j.ijgo.2009.07.012; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; McClure EM, 2007, INT J GYNECOL OBSTET, V96, P139, DOI 10.1016/j.ijgo.2006.10.010; MEADS CA, 2008, HEALTH TECHNOL ASSES, V12, pR3, DOI DOI 10.3310/hta12060; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; OPIYO N, 2010, COCHRANE DB SYST REV, V4; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; Rudan I, 2008, CROAT MED J, V49, P720, DOI 10.3325/cmj.2008.49.720; Shiffman J, 2007, AM J PUBLIC HEALTH, V97, P796, DOI 10.2105/AJPH.2006.095455; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Shiffman J, 2009, B WORLD HEALTH ORGAN, V87, P608, DOI 10.2471/BLT.08.060749; Singh S, 2009, ADDING IT COSTS BENE; *SKILL CAR IN, 2007, TEST APPR INCR SKILL; SOWDEN A, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001291; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; UNICEF, SUPPL CAT; Victora CG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S4; Vidanapathirana J, 2005, COCHRANE DB SYST REV, V3; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; *WHO, 2009, REC INT IMPR MAT NEW; *WHO, 2010, CHOOSING INT AR COST; WHO, 2010, TRENDS MAT MORT 1990; *WHO COMM MACR HLT, 2002, IMPR HLTH OUTC POOR; World Health Organization, 2005, WORLD HLTH REP 2005	62	122	122	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1610	1623		10.1016/S0140-6736(10)62306-9	http://dx.doi.org/10.1016/S0140-6736(10)62306-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21496910	Green Submitted			2022-12-24	WOS:000290549700035
J	Bader, M; Benjamin, S; Wapinski, OL; Smith, DM; Goldberg, AL; Steller, H				Bader, Maya; Benjamin, Sigi; Wapinski, Orly L.; Smith, David M.; Goldberg, Alfred L.; Steller, Hermann			A Conserved F Box Regulatory Complex Controls Proteasome Activity in Drosophila	CELL			English	Article							MEIOTIC CELL-CYCLE; CASPASE ACTIVITY; 20S PROTEASOMES; SPERMATID DIFFERENTIATION; PROTEIN-DEGRADATION; 26S PROTEASOMES; ACTIVATOR PA28; BETA-TUBULIN; CYTOCHROME-C; MELANOGASTER	The ubiquitin-proteasome system catalyzes the degradation of intracellular proteins. Although ubiquitination of proteins determines their stabilities, there is growing evidence that proteasome function is also regulated. We report the functional characterization of a conserved proteasomal regulatory complex. We identified DmPI31 as a binding partner of the F box protein Nutcracker, a component of an SCF ubiquitin ligase (E3) required for caspase activation during sperm differentiation in Drosophila. DmPI31 binds Nutcracker via a conserved mechanism that is also used by mammalian FBXO7 and PI31. Nutcracker promotes DmPI31 stability, which is necessary for caspase activation, proteasome function, and sperm differentiation. DmPI31 can activate 26S proteasomes in vitro, and increasing DmPI31 levels suppresses defects caused by diminished proteasome activity in vivo. Furthermore, loss of DmPI31 function causes lethality, cell-cycle abnormalities, and defects in protein degradation, demonstrating that DmPI31 is physiologically required for normal proteasome activity.	[Bader, Maya; Benjamin, Sigi; Wapinski, Orly L.; Steller, Hermann] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Smith, David M.; Goldberg, Alfred L.] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA	Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard Medical School	Steller, H (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	steller@rockefeller.edu	Smith, David/AAL-7662-2020	Smith, David/0000-0002-1502-676X	Rockefeller University; NIH [RO1GM60124]; NIGMS; Multiple Myeloma Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060124] Funding Source: NIH RePORTER	Rockefeller University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Multiple Myeloma Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to C. Zucker, R. Lehmann, HD, Ryoo, L. Vosshall, and J. Belote for fly strains. R. Lehmann generously shared the Vasa antibody. B. Chait and M. Sekedat were a tremendous help in setting up the proteomic screen. E. Arama devised the original male-sterile screen. Members of the Vosshall lab consulted on generating homologous recombination mutants and provided materials. K. Sobczyk participated in the proteasome-activity experiments. We thank M. Garcia-Fernandez and M. Pratt for critically reading this manuscript. O. Wapinski was supported by The Rockefeller University SURF Program. H. Steller is an investigator of the Howard Hughes Medical Institute. This work was supported by NIH grant RO1GM60124 to H.S. and by grants from the NIGMS and the Multiple Myeloma Foundation to A.L.G.	Alessandrini A, 1997, LEUKEMIA, V11, P342, DOI 10.1038/sj.leu.2400581; Arama E, 2006, EMBO J, V25, P232, DOI 10.1038/sj.emboj.7600920; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bader M, 2010, DEVELOPMENT, V137, P1679, DOI 10.1242/dev.050088; Baker CC, 2007, DEVELOPMENT, V134, P2863, DOI 10.1242/dev.003764; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Belote JM, 2002, GENESIS, V34, P80, DOI 10.1002/gene.10131; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fujimuro M, 1997, EUR J BIOCHEM, V249, P427, DOI 10.1111/j.1432-1033.1997.00427.x; Fuller MT, 1998, SEMIN CELL DEV BIOL, V9, P433, DOI 10.1006/scdb.1998.0227; Fuller MT., 1993, DEV DROSOPHILA MELAN, VI; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; GAUHAR Z, 2008, DROSOPHILA MELANOGAS; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Haas KF, 2007, BIOL CELL, V99, P615, DOI 10.1042/BC20070019; Hime GR, 1996, J CELL SCI, V109, P2779; HOYLE HD, 1995, DEV GENET, V16, P148, DOI 10.1002/dvg.1020160208; Jin ZG, 2005, DEVELOPMENT, V132, P4075, DOI 10.1242/dev.01965; KEMPHUES KJ, 1980, CELL, V21, P445, DOI 10.1016/0092-8674(80)90481-X; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lin TY, 1996, DEVELOPMENT, V122, P1331; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; MA CP, 1992, J BIOL CHEM, V267, P10515; Masson P, 2001, J BIOL CHEM, V276, P1383, DOI 10.1074/jbc.M007379200; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Noguchi T, 2003, DEVELOPMENT, V130, P1805, DOI 10.1242/dev.00406; ORRWEAVER TL, 1994, TRENDS GENET, V10, P321, DOI 10.1016/0168-9525(94)90035-3; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tanahashi N, 1997, GENES CELLS, V2, P195, DOI 10.1046/j.1365-2443.1997.d01-308.x; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Zaiss DMW, 1999, FEBS LETT, V457, P333, DOI 10.1016/S0014-5793(99)01072-8; Zaiss DMW, 2002, P NATL ACAD SCI USA, V99, P14344, DOI 10.1073/pnas.212257299; Zhong L, 2007, DEVELOPMENT, V134, P3517, DOI 10.1242/dev.004770	52	66	72	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					371	382		10.1016/j.cell.2011.03.021	http://dx.doi.org/10.1016/j.cell.2011.03.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529711	Bronze, Green Accepted			2022-12-24	WOS:000290022900007
J	Geller, RJ				Geller, Robert J.			Shake-up time for Japanese seismology	NATURE			English	Editorial Material							EARTHQUAKE		Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 1130033, Japan	University of Tokyo	Geller, RJ (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 1130033, Japan.	bob@eps.s.u-tokyo.ac.jp	Geller, Robert J/A-1753-2009	Geller, Robert J/0000-0001-6628-9431				ANDO M, 1975, TECTONOPHYSICS, V25, P69, DOI 10.1016/0040-1951(75)90011-6; ANDO M, 1975, TECTONOPHYSICS, V27, P119, DOI 10.1016/0040-1951(75)90102-X; Geller RJ, 1997, GEOPHYS J INT, V131, P425, DOI 10.1111/j.1365-246X.1997.tb06588.x; Headquarters for Earthquake Research Promotion, 2005, NAT SEISM HAZ MAPS J; Kagan YY, 1996, B SEISMOL SOC AM, V86, P274; KAGAN YY, 1991, J GEOPHYS RES-SOL EA, V96, P21419, DOI 10.1029/91JB02210; Kanamori H., 1995, SEISMOL RES LETT, V66, P7; McCaffrey R, 2008, GEOLOGY, V36, P263, DOI 10.1130/G24402A.1; Newman A., 2001, SEISMOLOGICAL RES LE, V72, P647; 1973, NATURE, V245, P174	10	133	136	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					407	409		10.1038/nature10105	http://dx.doi.org/10.1038/nature10105			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	755QC	21490595	Bronze			2022-12-24	WOS:000289949600009
J	Morris, K				Morris, Kelly			Shershah Syed: improving maternal care in Pakistan	LANCET			English	Editorial Material												kellyvitalwriter@gmail.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1309	1309		10.1016/S0140-6736(11)60527-8	http://dx.doi.org/10.1016/S0140-6736(11)60527-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21497689	Bronze			2022-12-24	WOS:000289962900016
J	Mullan, Z; Horton, R				Mullan, Zoe; Horton, Richard			Bringing stillbirths out of the shadows	LANCET			English	Editorial Material									[Mullan, Zoe; Horton, Richard] The Lancet, London NW1 7BY, England		Mullan, Z (corresponding author), The Lancet, London NW1 7BY, England.	zoe.mullan@lancet.com						BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; *STILLB NEON DEATH, WHAT IS WHY 17; World Health Organization, GLOB BURD DIS GBD	10	43	46	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1291	1292		10.1016/S0140-6736(11)60098-6	http://dx.doi.org/10.1016/S0140-6736(11)60098-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21496920				2022-12-24	WOS:000289962900004
J	Lu, FR; Li, S; Jiang, Y; Jiang, J; Fan, H; Lu, GF; Deng, D; Dang, SY; Zhang, X; Wang, JW; Yan, NE				Lu, Feiran; Li, Shuo; Jiang, Yang; Jiang, Jing; Fan, He; Lu, Guifeng; Deng, Dong; Dang, Shangyu; Zhang, Xu; Wang, Jiawei; Yan, Nieng			Structure and mechanism of the uracil transporter UraA	NATURE			English	Article							SIGNATURE MOTIF; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE RECOGNITION; XANTHINE PERMEASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MOLECULAR-BASIS; FAMILY; CLONING; PROTEINS	The nucleobase/ascorbate transporter (NAT) proteins, also known as nucleobase/cation symporter 2 (NCS2) proteins, are responsible for the uptake of nucleobases in all kingdoms of life and for the transport of vitamin C in mammals(1,2). Despite functional characterization of the NAT family members in bacteria, fungi and mammals, detailed structural information remains unavailable. Here we report the crystal structure of a representative NAT protein, the Escherichia coli uracil/H+ symporter UraA, in complex with uracil at a resolution of 2.8 angstrom. UraA has a novel structural fold, with 14 transmembrane segments (TMs) divided into two inverted repeats. A pair of antiparallel beta-strands is located between TM3 and TM10 and has an important role in structural organization and substrate recognition. The structure is spatially arranged into a core domain and a gate domain. Uracil, located at the interface between the two domains, is coordinated mainly by residues from the core domain. Structural analysis suggests that alternating access of the substrate may be achieved through conformational changes of the gate domain.	[Lu, Feiran; Li, Shuo; Jiang, Yang; Jiang, Jing; Fan, He; Lu, Guifeng; Deng, Dong; Dang, Shangyu; Zhang, Xu; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Lu, Feiran; Li, Shuo; Jiang, Yang; Jiang, Jing; Fan, He; Lu, Guifeng; Deng, Dong; Dang, Shangyu; Zhang, Xu; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Yan, NE (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Lu, Feiran/0000-0002-1757-2895; Dang, Shangyu/0000-0001-9141-1865	Ministry of Science and Technology [2009CB918802, 2011CB910501]; Tsinghua University; National Natural Science Foundation of China [91017011]; Yuyuan Foundation; Li Foundation	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yuyuan Foundation; Li Foundation	We thank N. Shimizu at the Spring-8 beamline BL41XU, and J. He and S. Huang at the Shanghai Synchrotron Radiation Facility for on-site assistance. We thank Y. Shi and Y. Yan for critical discussions. This work was supported by funds from the Ministry of Science and Technology (grant numbers 2009CB918802 and 2011CB910501), Tsinghua University 985 Phase II funds and Project 91017011 supported by the National Natural Science Foundation of China. N.Y. acknowledges support from the Yuyuan Foundation and the Li Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSEN PS, 1995, J BACTERIOL, V177, P2008, DOI 10.1128/jb.177.8.2008-2013.1995; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; de Koning H, 2000, MOL MEMBR BIOL, V17, P75; DeLano W.L., 2002, PYMOL MOL VIEWER; DIALLINAS G, 1989, GENETICS, V122, P341; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Georgopoulou E, 2010, J BIOL CHEM, V285, P19422, DOI 10.1074/jbc.M110.120543; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Wang YX, 2000, BIOCHEM BIOPH RES CO, V267, P488, DOI 10.1006/bbrc.1999.1929; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	35	140	141	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					243	246		10.1038/nature09885	http://dx.doi.org/10.1038/nature09885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21423164				2022-12-24	WOS:000289469100048
J	Persha, L; Agrawal, A; Chhatre, A				Persha, Lauren; Agrawal, Arun; Chhatre, Ashwini			Social and Ecological Synergy: Local Rulemaking, Forest Livelihoods, and Biodiversity Conservation	SCIENCE			English	Article							HUMAN-MODIFIED WORLD; DECENTRALIZATION; GOVERNANCE; POVERTY; MANAGEMENT	Causal pathways to achieve social and ecological benefits from forests are unclear, because there are few systematic multicountry empirical analyses that identify important factors and their complex relationships with social and ecological outcomes. This study examines biodiversity conservation and forest-based livelihood outcomes using a data set on 84 sites from six countries in East Africa and South Asia. We find both positive and negative relationships, leading to joint wins, losses, and trade-offs depending on specific contextual factors; participation in forest governance institutions by local forest users is strongly associated with jointly positive outcomes for forests in our study.	[Persha, Lauren; Agrawal, Arun] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Chhatre, Ashwini] Univ Illinois, Dept Geog, Urbana, IL 61801 USA	University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Urbana-Champaign	Persha, L (corresponding author), Univ Michigan, Sch Nat Resources & Environm, 440 Church St, Ann Arbor, MI 48109 USA.	lpersha@umich.edu	Agrawal, Arun/A-4257-2009	Agrawal, Arun/0000-0001-6796-2958; Persha, Lauren/0000-0002-4956-0442; Chhatre, Ashwini/0000-0002-5374-7867	Ford Foundation; MacArthur Foundation; National Science Foundation [BCS-0703073, CNH-0709545]; University of Michigan	Ford Foundation; MacArthur Foundation; National Science Foundation(National Science Foundation (NSF)); University of Michigan(University of Michigan System)	We thank E. Ostrom, T. Hayes, two anonymous reviewers, and members of the Development, Sustainable Livelihoods and Conservation (DESULICO) group for comments on an earlier draft of this paper, and R. Kornak and J. England for assistance with data cleaning. We gratefully acknowledge the many researchers affiliated with IFRI as Collaborating Research Centers for their data contributions and ongoing involvement with the IFRI network. This work was funded by the Ford Foundation, the MacArthur Foundation, National Science Foundation grants BCS-0703073 and CNH-0709545, and a University of Michigan OVPR/Rackham grant for an Annual Institute on Joint Outcomes related to Sustainability.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Agrawal A, 2001, POLIT SOC, V29, P485, DOI 10.1177/0032329201029004002; Agrawal A, 2008, SCIENCE, V320, P1460, DOI 10.1126/science.1155369; Andersson KP, 2006, WORLD DEV, V34, P576, DOI 10.1016/j.worlddev.2005.08.009; BARROW E, 2009, CUTOMARY PRACTICES F; Belcher B, 2005, WORLD DEV, V33, P1435, DOI 10.1016/j.worlddev.2004.10.007; Belcher BM, 2005, INT FOREST REV, V7, P82, DOI 10.1505/ifor.2005.7.2.82; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Gardner TA, 2010, BIOL CONSERV, V143, P2293, DOI 10.1016/j.biocon.2010.05.017; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Hill JL, 2003, J BIOGEOGR, V30, P1391, DOI 10.1046/j.1365-2699.2003.00930.x; Larson AM, 2008, ANNU REV ENV RESOUR, V33, P213, DOI 10.1146/annurev.environ.33.020607.095522; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Putz FE, 2001, CONSERV BIOL, V15, P7, DOI 10.1046/j.1523-1739.2001.00018.x; Ribot JC, 2006, WORLD DEV, V34, P1864, DOI 10.1016/j.worlddev.2005.11.020; Sunderlin WD, 2005, WORLD DEV, V33, P1383, DOI 10.1016/j.worlddev.2004.10.004; Wollenberg E, 2007, INT FOREST REV, V9, P670, DOI 10.1505/ifor.9.2.670; Wunder S, 2001, WORLD DEV, V29, P1817, DOI 10.1016/S0305-750X(01)00070-5	20	365	372	6	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1606	1608		10.1126/science.1199343	http://dx.doi.org/10.1126/science.1199343			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739XH	21436453				2022-12-24	WOS:000288754500056
J	Hirnschall, G; Schwartlander, B				Hirnschall, Gottfried; Schwartlaender, Bernhard			Treatment 2.0: catalysing the next phase of scale-up	LANCET			English	Editorial Material									[Schwartlaender, Bernhard] Joint United Nations Programme HIV AIDS, Evidence Strategy & Results Dept, CH-1211 Geneva, Switzerland; [Hirnschall, Gottfried] WHO, HIV Dept, CH-1211 Geneva, Switzerland	World Health Organization	Schwartlander, B (corresponding author), Joint United Nations Programme HIV AIDS, Evidence Strategy & Results Dept, CH-1211 Geneva, Switzerland.	schwartlanderb@unaids.org						GRUBB I, 2003, PUBLIC HLTH APPROACH; Kates J, 2010, FINANCING RESPONSE A; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; MIDDELKOOP K, 2009, 5 IAS C HIV PATH TRE; Siegfried N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008272.pub2; *UN GEN ASS, 2006, 2006 HIGH LEV M AIDS; *UNAIDS, 2007, RES NEEDS AIDS LOW M; UNAIDS, 2010, TREATM 2 0 IS THIS F; UNAIDS, 2010, GLOB REP UNAIDS REP; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2010, ANT THER HIV INF INF	12	34	34	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					209	211		10.1016/S0140-6736(11)60247-X	http://dx.doi.org/10.1016/S0140-6736(11)60247-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21353697				2022-12-24	WOS:000293201100009
J	Ishizuka, K; Kamiya, A; Oh, EC; Kanki, H; Seshadri, S; Robinson, JF; Murdoch, H; Dunlop, AJ; Kubo, K; Furukori, K; Huang, B; Zeledon, M; Hayashi-Takagi, A; Okano, H; Nakajima, K; Houslay, MD; Katsanis, N; Sawa, A				Ishizuka, Koko; Kamiya, Atsushi; Oh, Edwin C.; Kanki, Hiroaki; Seshadri, Saurav; Robinson, Jon F.; Murdoch, Hannah; Dunlop, Allan J.; Kubo, Ken-ichiro; Furukori, Keiko; Huang, Beverly; Zeledon, Mariela; Hayashi-Takagi, Akiko; Okano, Hideyuki; Nakajima, Kazunori; Houslay, Miles D.; Katsanis, Nicholas; Sawa, Akira			DISC1-dependent switch from progenitor proliferation to migration in the developing cortex	NATURE			English	Article							DEVELOPING MOUSE-BRAIN; NEURONAL MIGRATION; DISC1; PROTEIN; ADULT; GENE; MICE; DIFFERENTIATION; VISUALIZATION; DEFECTS	Regulatory mechanisms governing the sequence from progenitor cell proliferation to neuronal migration during corticogenesis are poorly understood(1-10). Here we report that phosphorylation of DISC1, a major susceptibility factor for several mental disorders, acts as a molecular switch from maintaining proliferation of mitotic progenitor cells to activating migration of postmitotic neurons in mice. Unphosphorylated DISC1 regulates canonical Wnt signalling via an interaction with GSK3 beta, whereas specific phosphorylation at serine 710 (S710) triggers the recruitment of Bardet-Biedl syndrome (BBS) proteins to the centrosome. In support of this model, loss of BBS1 leads to defects in migration, but not proliferation, whereas DISC1 knockdown leads to deficits in both. A phospho-dead mutant can only rescue proliferation, whereas a phospho-mimic mutant rescues exclusively migration defects. These data highlight a dual role for DISC1 in corticogenesis and indicate that phosphorylation of this protein at S710 activates a key developmental switch.	[Ishizuka, Koko; Kamiya, Atsushi; Seshadri, Saurav; Furukori, Keiko; Huang, Beverly; Zeledon, Mariela; Hayashi-Takagi, Akiko; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA; [Oh, Edwin C.; Robinson, Jon F.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Oh, Edwin C.; Robinson, Jon F.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Oh, Edwin C.; Robinson, Jon F.; Katsanis, Nicholas] Duke Univ, Dept Pediat, Durham, NC 27710 USA; [Kanki, Hiroaki; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Kubo, Ken-ichiro; Nakajima, Kazunori] Keio Univ, Sch Med, Dept Anat, Tokyo 1608582, Japan; [Murdoch, Hannah; Dunlop, Allan J.; Houslay, Miles D.] Univ Glasgow, CMVLS, Inst Neurosci & Psychol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Johns Hopkins University; Duke University; Duke University; Duke University; Keio University; Keio University; University of Glasgow; Johns Hopkins University	Sawa, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA.	katsanis@cellbio.duke.edu; asawa1@jhmi.edu	Houslay, Miles D/A-6825-2011; Okano, Hideyuki/I-7584-2019; Kubo, Ken-ichiro/B-2520-2015; Katsanis, Nicholas/E-1837-2012; Nakajima, Kazunori/L-3396-2013; Houslay, Miles/AAM-5281-2020; kamiya, atsushi/L-8550-2016	Kubo, Ken-ichiro/0000-0003-4023-5069; Nakajima, Kazunori/0000-0003-1864-9425; kamiya, atsushi/0000-0002-4274-5567; Katsanis, Nicholas/0000-0002-2480-0171; Houslay, Miles/0000-0002-3826-8091	USPHS [MH-084018, MH-069853, MH-085226, MH-088753, MH-091230, HD-04260, DK-072301, DK-075972]; Stanley foundation; RUSK foundation; Maryland Stem Cell Research Fund; NARSAD; Macular Vision Research Foundation; Foundation for Fighting Blindness; Health Labor Sciences; MEXT; Takeda; PMAC-PSJ; Fight for Sight Postdoctoral Fellowship; Medical Research Council, UK [G0600765]; Strategic Research Program for Brain Sciences; Medical Research Council [G0600765] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301, R01DK075972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092443, R01MH069853, P20MH084018, R21MH085226, RC1MH088753, R01MH091230] Funding Source: NIH RePORTER; MRC [G0600765] Funding Source: UKRI	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Stanley foundation; RUSK foundation; Maryland Stem Cell Research Fund; NARSAD(NARSAD); Macular Vision Research Foundation; Foundation for Fighting Blindness; Health Labor Sciences; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda(Takeda Pharmaceutical Company Ltd); PMAC-PSJ; Fight for Sight Postdoctoral Fellowship; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Y. Y. Lema for preparing figures and organizing the manuscript and P. Talalay for critical reading of this manuscript. We appreciate J. M. Gerdes, A. K. Mustafa, N. Shahani, T. Boronina, D. Chen and R. N. Cole for scientific discussions and technical support. We thank T. Tomoda, N. Sugiyama, M. Hasegawa, Q. Lu, E. S. Anton and A. Chenn for providing us with constructs. This work was supported by USPHS grants of MH-084018 Silvo O. Conte center (A. S.), MH-069853 (A.S.), MH-085226 (A.S.), MH-088753 (A.S.), MH-091230 (A.K.), HD-04260 (N.K.), DK-072301 (N.K.), and DK-075972 (N.K.); grants from Stanley and RUSK foundations and from Maryland Stem Cell Research Fund (A.S.); grants from NARSAD and S-R foundations (A.S. and A.K.); grants from the Macular Vision Research Foundation and the Foundation for Fighting Blindness as well as the Distinguished George W. Brumley Professorship (N.K.); a grant from Health Labor Sciences (K.-i.K.); grants from Strategic Research Program for Brain Sciences (K.N.), MEXT (K.N.), Takeda (K.N.) and PMAC-PSJ (K.N.); Fight for Sight Postdoctoral Fellowship (E.O.); grant from the Medical Research Council, UK (G0600765; M.D.H.).	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Greengard P, 1998, BRAIN RES REV, V26, P274, DOI 10.1016/S0165-0173(97)00057-X; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Ishizuka K, 2007, MOL PSYCHIATR, V12, P897, DOI 10.1038/sj.mp.4002024; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2008, ARCH GEN PSYCHIAT, V65, P996, DOI 10.1001/archpsyc.65.9.996; Kanki H, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-5; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Mochida GH, 2004, ARCH NEUROL-CHICAGO, V61, P637, DOI 10.1001/archneur.61.5.637; Moudjou M, 1996, J CELL SCI, V109, P875; Niwa M, 2010, NEURON, V65, P480, DOI 10.1016/j.neuron.2010.01.019; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tan PL, 2007, P NATL ACAD SCI USA, V104, P17524, DOI 10.1073/pnas.0706618104; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang X, 2007, J NEUROSCI RES, V85, P3567, DOI 10.1002/jnr.21440; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	38	145	157	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					92	U107		10.1038/nature09859	http://dx.doi.org/10.1038/nature09859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21471969	Green Accepted			2022-12-24	WOS:000290218300037
J	Clementz, MT; Sewall, JO				Clementz, Mark T.; Sewall, Jacob O.			Latitudinal Gradients in Greenhouse Seawater delta O-18: Evidence from Eocene Sirenian Tooth Enamel	SCIENCE			English	Article							PALAEOCENE/EOCENE THERMAL MAXIMUM; STABLE-ISOTOPE ANALYSIS; MIDDLE EOCENE; TEMPERATURES; REGION; WATER	The Eocene greenhouse climate state has been linked to a more vigorous hydrologic cycle at mid-and high latitudes; similar information on precipitation levels at low latitudes is, however, limited. Oxygen isotopic fluxes track moisture fluxes and, thus, the delta O-18 values of ocean surface waters can provide insight into hydrologic cycle changes. The offset between tropical d18O values from sampled Eocene sirenian tooth enamel and modern surface waters is greater than the expected 1.0 per mil increase due to increased continental ice volume. This increased offset could result from suppression of surface-water delta O-18 values by a tropical, annual moisture balance substantially wetter than that of today. Results from an atmospheric general circulation model support this interpretation and suggest that Eocene low latitudes were extremely wet.	[Clementz, Mark T.] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; [Clementz, Mark T.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Sewall, Jacob O.] Kutztown State Univ, Dept Phys Sci, Kutztown, PA 19530 USA	University of Wyoming; University of Wyoming; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania	Clementz, MT (corresponding author), Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA.	mclemen1@uwyo.edu; sewall@kutztown.edu			American Chemical Society; NSF; Directorate For Geosciences [0847413] Funding Source: National Science Foundation	American Chemical Society(American Chemical Society); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank S. Bajpai, D. P. Domning, S. Sorbi, and the museums and institutions that made fossil specimens available for this study (a list of all institutions is provided in the SOM); P. Haselhorst and S. L. Peek for assistance with sample preparation; the University of Wyoming Stable Isotope Facility for stable isotope analyses; and E. Speelman. Funding for travel and analyses was provided by the American Chemical Society Petroleum Research Fund (M. T. C.) and the NSF (M. T. C.). Computation was supported by Virginia Tech Advanced Research Computing and the Department of Geosciences. We also thank two anonymous reviewers for critical and thoughtful comments that improved this manuscript.	[Anonymous], 1965, U RHODE ISLAND OCC P; Bice KL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000678; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Bowen GJ, 2004, NATURE, V432, P495, DOI 10.1038/nature03115; Clementz MT, 2008, PALAIOS, V23, P574, DOI 10.2110/palo.2007.p07-054r; Clementz MT, 2009, GEOLOGY, V37, P307, DOI 10.1130/G25533A.1; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; Jahren AH, 2003, GEOLOGY, V31, P463, DOI 10.1130/0091-7613(2003)031<0463:HEFTME>2.0.CO;2; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Manabe S, 1997, AMBIO, V26, P47; McConnell MC, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002035; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; Schmidt G. A., 1999, GLOBAL SEAWATER OXYG; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Sluijs A, 2009, NAT GEOSCI, V2, P777, DOI 10.1038/NGEO668; Speelman EN, 2010, EARTH PLANET SC LETT, V298, P57, DOI 10.1016/j.epsl.2010.07.026; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; YOSHIDA N, 1991, J GEOPHYS RES-OCEANS, V96, P815, DOI 10.1029/90JC01580; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551	23	29	30	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					455	458		10.1126/science.1201182	http://dx.doi.org/10.1126/science.1201182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512030				2022-12-24	WOS:000289784900040
J	Biton, S; Ashkenazi, A				Biton, Sharon; Ashkenazi, Avi			NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-alpha Feedforward Signaling	CELL			English	Article							NF-KAPPA-B; DOMAIN KINASE RIP; IONIZING-RADIATION; IKK ACTIVATION; DEATH; CANCER; ATM; EXPRESSION; APOPTOSIS; NECROSIS	Upon DNA damage, ataxia telangiectasia mutated (ATM) kinase triggers multiple events to promote cell survival and facilitate repair. If damage is excessive, ATM stimulates cytokine secretion to alert neighboring cells and apoptosis to eliminate the afflicted cell. ATM augments cell survival by activating nuclear factor (NF)-kappa B; however, how ATM induces cytokine production and apoptosis remains elusive. Here we uncover a p53-independent mechanism that transmits ATM-driven cytokine and caspase signals upon strong genotoxic damage. Extensive DNA lesions stimulated two sequential NF-kappa B activation phases, requiring ATM and NEMO/IKK-gamma: The first phase induced TNF-alpha-TNFR1 feedforward signaling, promoting the second phase and driving RIP1 phosphorylation. In turn, RIP1 kinase triggered JNK3/MAPK10-dependent interleukin-8 secretion and FADD-mediated proapoptotic caspase-8 activation. Thus, in the context of excessive DNA damage, ATM employs NEMO and RIP1 kinase through autocrine TNF-alpha signaling to switch on cytokine production and caspase activation. These results shed light on cell-fate regulation by ATM.	[Biton, Sharon; Ashkenazi, Avi] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bartek J, 2006, SCIENCE, V311, P1110, DOI 10.1126/science.1124540; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Fumagalli M, 2009, NAT CELL BIOL, V11, P921, DOI 10.1038/ncb0809-921; HANDE KR, 1984, CANCER RES, V44, P379; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Jones DT, 2001, BLOOD, V98, P2800, DOI 10.1182/blood.V98.9.2800; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Piret B, 1999, ONCOGENE, V18, P2261, DOI 10.1038/sj.onc.1202541; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wesselborg S, 1999, BLOOD, V93, P3053, DOI 10.1182/blood.V93.9.3053; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Zhou DH, 2001, INT J RADIAT BIOL, V77, P763, DOI 10.1080/09553000110050047	61	210	214	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					92	103		10.1016/j.cell.2011.02.023	http://dx.doi.org/10.1016/j.cell.2011.02.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458669	Bronze			2022-12-24	WOS:000289053900012
J	Septimus, EJ; Perlin, JB; Cormier, SB; Moody, JA; Hickok, JD				Septimus, Edward J.; Perlin, Jonathan B.; Cormier, Scott B.; Moody, Julia A.; Hickok, Jason D.			A Multifaceted Mandatory Patient Safety Program and Seasonal Influenza Vaccination of Health Care Workers in Community Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Septimus, Edward J.; Perlin, Jonathan B.; Cormier, Scott B.; Moody, Julia A.; Hickok, Jason D.] HCA Inc, Clin Serv Grp, Nashville, TN USA	Hospital Corporation of America	Septimus, EJ (corresponding author), HCA Inc, Clin Serv Grp, Nashville, TN USA.	jonathan.perlin@hcahealthcare.com						Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; *CDCP, SEAS INFL FREE RES; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Harris K. M., 2010, Morbidity and Mortality Weekly Report, V59, P357; Rakita RM, 2010, INFECT CONT HOSP EP, V31, P881, DOI 10.1086/656210	5	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					999	1000		10.1001/jama.2011.244	http://dx.doi.org/10.1001/jama.2011.244			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386077				2022-12-24	WOS:000288129600018
J	Arpaia, N; Godec, J; Lau, L; Sivick, KE; McLaughlin, LM; Jones, MB; Dracheva, T; Peterson, SN; Monack, DM; Barton, GM				Arpaia, Nicholas; Godec, Jernej; Lau, Laura; Sivick, Kelsey E.; McLaughlin, Laura M.; Jones, Marcus B.; Dracheva, Tatiana; Peterson, Scott N.; Monack, Denise M.; Barton, Gregory M.			TLR Signaling Is Required for Salmonella typhimurium Virulence	CELL			English	Article							TOLL-LIKE RECEPTORS; III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; PHAGOSOME MATURATION; SEROVAR TYPHIMURIUM; NATURAL-RESISTANCE; DENDRITIC CELLS; INTRACELLULAR PARASITES; ANTIMICROBIAL PEPTIDES; MACROPHAGE APOPTOSIS	Toll-like receptors (TLRs) contribute to host resistance to microbial pathogens and can drive the evolution of virulence mechanisms. We have examined the relationship between host resistance and pathogen virulence using mice with a functional allele of the nramp-1 gene and lacking combinations of TLRs. Mice deficient in both TLR2 and TLR4 were highly susceptible to the intracellular bacterial pathogen Salmonella typhimurium, consistent with reduced innate immune function. However, mice lacking additional TLRs involved in S. typhimurium recognition were less susceptible to infection. In these TLR-deficient cells, bacteria failed to upregulate Salmonella pathogenicity island 2 (SPI-2) genes and did not form a replicative compartment. We demonstrate that TLR signaling enhances the rate of acidification of the Salmonella-containing phagosome, and inhibition of this acidification prevents SPI-2 induction. Our results indicate that S. typhimurium requires cues from the innate immune system to regulate virulence genes necessary for intracellular survival, growth, and systemic infection.	[Arpaia, Nicholas; Godec, Jernej; Lau, Laura; Sivick, Kelsey E.; Barton, Gregory M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [McLaughlin, Laura M.; Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Jones, Marcus B.; Dracheva, Tatiana; Peterson, Scott N.] J Craig Venter Inst, Pathogen Funct Genom Resource Ctr, Rockville, MD 20850 USA	University of California System; University of California Berkeley; Stanford University; J. Craig Venter Institute	Barton, GM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	barton@berkeley.edu	hongbo, yi/G-9615-2011; Arpaia, Nicholas/R-2549-2018	Barton, Gregory/0000-0002-3793-0100; Arpaia, Nicholas/0000-0002-0657-0528; Monack, Denise/0000-0003-3804-2209	NIH [P01-AI063302, Y1-AI-8401, T32-GM007232]; Burroughs Wellcome Fund; University of California Cancer Research Coordinating Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, R01AI008401, R01AI072429, R22AI008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); University of California Cancer Research Coordinating Committee(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Machen, P. Herzmark, J. Ross, and E. Peled for assistance with ratiometric imaging; members of the Barton lab, J. Ayres, and R. Vance for critical reading of this manuscript; C. Rae and N. Meyer-Morse for assistance with L. monocytogenes; M. Fontana and K. Monroe for assistance with L. pneumophila; R. Zalpuri and K. McDonald for assistance with EM; and H. Nolla for assistance with flow cytometry. This work was supported in part by grants from the NIH (P01-AI063302 to D. M. M. and G. M. B.; Y1-AI-8401 to S. N. P.), the Burroughs Wellcome Fund (D. M. M.), and the University of California Cancer Research Coordinating Committee (G. M. B.) and an NIH NRSA Trainee appointment on grant T32-GM007232 (N. A.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Cook P, 2007, IMMUNOLOGY, V122, P222, DOI 10.1111/j.1365-2567.2007.02631.x; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Detweiler CS, 2003, MOL MICROBIOL, V48, P385, DOI 10.1046/j.1365-2958.2003.03455.x; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hedrick SM, 2004, IMMUNITY, V21, P607, DOI 10.1016/j.immuni.2004.08.020; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kim CC, 2004, J BACTERIOL, V186, P4694, DOI 10.1128/JB.186.14.4694-4704.2004; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pfeifer CG, 1999, INFECT IMMUN, V67, P5690, DOI 10.1128/IAI.67.11.5690-5698.1999; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rappl C, 2003, FEMS MICROBIOL LETT, V226, P363, DOI 10.1016/S0378-1097(03)00638-4; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Royle MCJ, 2003, J IMMUNOL, V170, P5445, DOI 10.4049/jimmunol.170.11.5445; Russell DG, 2007, NAT IMMUNOL, V8, P217, DOI 10.1038/ni0307-217a; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Silphaduang U, 2007, J BACTERIOL, V189, P3669, DOI 10.1128/JB.00002-07; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Valdez Y, 2008, CELL MICROBIOL, V10, P1646, DOI 10.1111/j.1462-5822.2008.01155.x; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Vidal SM, 1996, J IMMUNOL, V157, P3559; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Vijay-Kumar M, 2008, INFECT IMMUN, V76, P1276, DOI 10.1128/IAI.01491-07; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wong CE, 2009, INFECT IMMUN, V77, P4750, DOI 10.1128/IAI.00545-09; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Zaharik ML, 2002, P NATL ACAD SCI USA, V99, P15705, DOI 10.1073/pnas.252415599	72	167	171	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					675	688		10.1016/j.cell.2011.01.031	http://dx.doi.org/10.1016/j.cell.2011.01.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376231	Green Accepted, Bronze			2022-12-24	WOS:000288007100008
J	Cao, Y; Jin, XS; Levin, EJ; Huang, H; Zong, YN; Quick, M; Weng, J; Pan, YP; Love, J; Punta, M; Rost, B; Hendrickson, WA; Javitch, JA; Rajashankar, KR; Zhou, M				Cao, Yu; Jin, Xiangshu; Levin, Elena J.; Huang, Hua; Zong, Yinong; Quick, Matthias; Weng, Jun; Pan, Yaping; Love, James; Punta, Marco; Rost, Burkhard; Hendrickson, Wayne A.; Javitch, Jonathan A.; Rajashankar, Kanagalaghatta R.; Zhou, Ming			Crystal structure of a phosphorylation-coupled saccharide transporter	NATURE			English	Article							COLI MANNITOL PERMEASE; BACTERIAL PHOSPHOTRANSFERASE SYSTEM; ESCHERICHIA-COLI; MEMBRANE TOPOLOGY; CARBOHYDRATE TRANSPORTERS; CHITIN DISACCHARIDE; SUBSTRATE-BINDING; PHOSPHOENOLPYRUVATE; PROTEIN; N,N'-DIACETYLCHITOBIOSE	Saccharides have a central role in the nutrition of all living organisms. Whereas several saccharide uptake systems are shared between the different phylogenetic kingdoms, the phosphoenolpyruvate-dependent phosphotransferase system exists almost exclusively in bacteria. This multi-component system includes an integral membrane protein EIIC that transports saccharides and assists in their phosphorylation. Here we present the crystal structure of an EIIC from Bacillus cereus that transports diacetylchitobiose. The EIIC is a homodimer, with an expansive interface formed between the amino-terminal halves of the two protomers. The carboxy-terminal half of each protomer has a large binding pocket that contains a diacetylchitobiose, which is occluded from both sides of the membrane with its site of phosphorylation near the conserved His 250 and Glu 334 residues. The structure shows the architecture of this important class of transporters, identifies the determinants of substrate binding and phosphorylation, and provides a framework for understanding the mechanism of sugar translocation.	[Cao, Yu; Levin, Elena J.; Huang, Hua; Weng, Jun; Pan, Yaping; Zhou, Ming] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Jin, Xiangshu] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Zong, Yinong] Sanford Burnham Inst, La Jolla, CA 92037 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Love, James; Punta, Marco; Rost, Burkhard; Hendrickson, Wayne A.] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Dept Comp Sci, D-85748 Munich, Germany; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Inst Adv Study, D-85748 Munich, Germany; [Javitch, Jonathan A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, NE CAT, Adv Photon Source, Argonne, IL 60439 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Sanford Burnham Prebys Medical Discovery Institute; Columbia University; Columbia University; New York State Psychiatry Institute; Technical University of Munich; Technical University of Munich; Columbia University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Zhou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	mz2140@columbia.edu	Rost, Burkhard/A-1908-2016; Punta, Marco/ABH-4698-2020; Cao, Yu/GNP-6653-2022	Rost, Burkhard/0000-0003-0179-8424; Punta, Marco/0000-0002-0050-0676; Cao, Yu/0000-0003-1409-2068; Jin, Xiangshu/0000-0002-6551-8850; Javitch, Jonathan/0000-0001-7395-2967	US National Institutes of Health [DK088057, GM098878, GM05026-sub0007, T32HL087745];  [GM05026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL087745, R01HL086392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Data for this study were measured at beamlines X4A, X4C, X25 and X29 of the National Synchrotron Light Source and the NE-CAT 24ID-C and E at the Advanced Photon Source. This work was supported by the US National Institutes of Health (DK088057, GM098878 and GM05026-sub0007 to M.Z., and T32HL087745 to E.J.L.). M.Z. is a Pew Scholar in Biomedical Sciences. The NYCOMPS central facility was supported by GM05026 to W.A.H. as part of the Protein Structure Initiative (PSI-2) established by the National Institute of General Medical Sciences. The authors would like to thank B. Honig for support and M. Saier, B. Erni, R. Kaback and D.-N. Wang for comments on the manuscript and helpful discussions. M.Z. is grateful to R. MacKinnon for advice and encouragement.	Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BUHR A, 1993, J BIOL CHEM, V268, P11599; Chen Q, 1998, BIOCHEMISTRY-US, V37, P8714, DOI 10.1021/bi9731652; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNI B, 1986, BIOCHEMISTRY-US, V25, P305, DOI 10.1021/bi00350a004; Keyhani NO, 2000, J BIOL CHEM, V275, P33084, DOI 10.1074/jbc.M001043200; Keyhani NO, 1997, P NATL ACAD SCI USA, V94, P14367, DOI 10.1073/pnas.94.26.14367; KHANDEKAR SS, 1989, J CELL BIOCHEM, V39, P207, DOI 10.1002/jcb.240390212; Koning RI, 1999, J MOL BIOL, V287, P845, DOI 10.1006/jmbi.1999.2650; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; KUNDIG W, 1964, P NATL ACAD SCI USA, V52, P1067, DOI 10.1073/pnas.52.4.1067; Lemieux MJ, 2004, CURR OPIN STRUC BIOL, V14, P405, DOI 10.1016/j.sbi.2004.06.003; Levin EJ, 2009, NATURE, V462, P757, DOI 10.1038/nature08558; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Nguyen TX, 2006, J MOL MICROB BIOTECH, V11, P345, DOI 10.1159/000095636; Opacic M, 2010, J BIOL CHEM, V285, P25324, DOI 10.1074/jbc.M110.122523; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAS HH, 1987, BIOCHEMISTRY-US, V26, P6689, DOI 10.1021/bi00395a019; POSTMA PW, 1985, MICROBIOL REV, V49, P232, DOI 10.1128/MMBR.49.3.232-269.1985; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; REPHAELI AW, 1980, J BACTERIOL, V141, P658, DOI 10.1128/JB.141.2.658-663.1980; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Saier MH, 2005, BIOCHEM SOC T, V33, P220, DOI 10.1042/BST0330220; SaraceniRichards CA, 1997, J BACTERIOL, V179, P1135, DOI 10.1128/jb.179.4.1135-1142.1997; SaraceniRichards CA, 1997, J BACTERIOL, V179, P5171, DOI 10.1128/jb.179.16.5171-5177.1997; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Siebold C, 2001, FEBS LETT, V504, P104, DOI 10.1016/S0014-5793(01)02705-3; SUGIYAMA JE, 1991, P NATL ACAD SCI USA, V88, P9603, DOI 10.1073/pnas.88.21.9603; van Montfort BA, 2002, J BIOL CHEM, V277, P14717, DOI 10.1074/jbc.M201533200; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; WENG QP, 1992, J BIOL CHEM, V267, P19529; WENG QP, 1993, BIOCHEMISTRY-US, V32, P11211, DOI 10.1021/bi00092a034; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Yagur-Kroll S, 2005, J BIOL CHEM, V280, P19306, DOI 10.1074/jbc.M410896200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhou M, 2004, J MOL BIOL, V338, P839, DOI 10.1016/j.jmb.2004.03.020	50	67	67	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					50	U58		10.1038/nature09939	http://dx.doi.org/10.1038/nature09939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21471968	Green Accepted			2022-12-24	WOS:000290218300028
J	Summerfield, D				Summerfield, Derek			FIRST PERSON Metropolitan Police blues: protracted sickness absence, ill health retirement, and the occupational psychiatrist	BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTTRAUMATIC-STRESS; DEPRESSION; STILL		Kings Coll London, Inst Psychiat, London SE5 8BB, England	University of London; King's College London	Summerfield, D (corresponding author), Kings Coll London, Inst Psychiat, London SE5 8BB, England.	derek.summerfield@slam.nhs.uk						BIGOS S, 1991, SPINE, V1, P1; Black C., 2008, WORKING HLTH TOMORRO; Brugha TS, 2004, BRIT J PSYCHIAT, V185, P378, DOI 10.1192/bjp.185.5.378; CANNING EC, 2003, THESIS U HULL; Cole J, 2008, BRIT J PSYCHIAT, V192, P83, DOI 10.1192/bjp.bp.107.039826; Dobson R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5688; Harvey SB, 2009, BRIT J PSYCHIAT, V194, P201, DOI 10.1192/bjp.bp.108.055111; Healthcare Commission, 2007, NO VOIC NO CHOIC JOI; Horton R, 2006, LANCET, V368, P1750, DOI 10.1016/S0140-6736(06)69641-4; Hussey S, 2004, BRIT MED J, V328, P88, DOI 10.1136/bmj.37949.656389.EE; Neal LA, 2004, BRIT J PSYCHIAT, V184, P247, DOI 10.1192/bjp.184.3.247; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Rosen GM, 2008, BRIT J PSYCHIAT, V192, P3, DOI 10.1192/bjp.bp.107.043083; Summerfield D, 2006, J ROY SOC MED, V99, P161, DOI 10.1258/jrsm.99.3.161; Summerfield D., 2004, POSTTRAUMATIC STRESS, P233, DOI [DOI 10.1002/9780470713570, 10.1002/9780470713570.ch12]; Waddell G., 2006, IS WORK GOOD YOUR HL; Waddell G., 2004, CONCEPTS REHABILITAT; Wainwright D., 2002, WORK STRESS MAKING M	18	20	20	1	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2011	342								d2127	10.1136/bmj.d2127	http://dx.doi.org/10.1136/bmj.d2127			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OI	21505221				2022-12-24	WOS:000289942200003
J	Oliver, A				Oliver, Adam			Is nudge an effective public health strategy to tackle obesity? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England	University of London; London School Economics & Political Science	Oliver, A (corresponding author), Univ London London Sch Econ & Polit Sci, LSE Hlth, Houghton St, London WC2A 2AE, England.	a.j.oliver@lse.ac.uk	Oliver, Adam/CAG-2031-2022					Cabinet Office, 2010, APPL BEH INS HLTH; Cassidy J, 2011, BMJ-BRIT MED J, V342, pd1648; Paul-Ebhohimhen V, 2008, OBES REV, V9, P355, DOI 10.1111/j.1467-789X.2007.00409.x; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; PIANO STAIRS THEFUNT	5	21	21	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2011	342								d2168	10.1136/bmj.d2168	http://dx.doi.org/10.1136/bmj.d2168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UZ	21493667				2022-12-24	WOS:000289721700005
J	Foster, CB; Sabella, C				Foster, Charles B.; Sabella, Camille			Health Care-Associated Infections in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-STREAM INFECTIONS; INFANTS		[Foster, Charles B.; Sabella, Camille] Cleveland Clin Childrens Hosp, Ctr Pediat Infect Dis, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Sabella, C (corresponding author), Cleveland Clin Childrens Hosp, Ctr Pediat Infect Dis, 9500 Euclid Ave,Desk S-25, Cleveland, OH 44195 USA.	sabellc@ccf.org						Aly H, 2005, PEDIATRICS, V115, P1513, DOI 10.1542/peds.2004-1785; Bernstein HH, 2010, PEDIATRICS, V126, P809, DOI 10.1542/peds.2010-2376; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Grohskopf LA, 2002, J PEDIATR-US, V140, P432, DOI 10.1067/mpd.2002.122499; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Ingraham AM, 2010, J AM COLL SURGEONS, V211, P705, DOI 10.1016/j.jamcollsurg.2010.09.006; MACDONALD NE, 1982, NEW ENGL J MED, V307, P397, DOI 10.1056/NEJM198208123070702; Miller MR, 2010, PEDIATRICS, V125, P206, DOI 10.1542/peds.2009-1382; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841	10	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1480	1481		10.1001/jama.2011.449	http://dx.doi.org/10.1001/jama.2011.449			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486980				2022-12-24	WOS:000289424100026
J	Choe, HW; Kim, YJ; Park, JH; Morizumi, T; Pai, EF; Krauss, N; Hofmann, KP; Scheerer, P; Ernst, OP				Choe, Hui-Woog; Kim, Yong Ju; Park, Jung Hee; Morizumi, Takefumi; Pai, Emil F.; Krauss, Norbert; Hofmann, Klaus Peter; Scheerer, Patrick; Ernst, Oliver P.			Crystal structure of metarhodopsin II	NATURE			English	Article							HELIX MOVEMENT; RHODOPSIN; ACTIVATION; TRANSDUCIN; LIGAND; DISPLACEMENT; CONFORMATION; SPECTROSCOPY; OPSIN; LIGHT	G-protein-coupled receptors (GPCRs) are seven transmembrane helix (TM) proteins that transduce signals into living cells by binding extracellular ligands and coupling to intracellular heterotrimeric Gproteins (G alpha beta gamma)(1). The photoreceptor rhodopsin couples to transducin and bears its ligand 11-cis-retinal covalently bound via a protonated Schiff base to the opsin apoprotein(2). Absorption of a photon causes retinal cis/trans isomerization and generates the agonist all-trans-retinal in situ. After early photoproducts, the active G-protein-binding intermediate metarhodopsin II (Meta II) is formed, in which the retinal Schiff base is still intact but deprotonated. Dissociation of the proton from the Schiff base breaks a major constraint in the protein and enables further activating steps, including an outward tilt of TM6 and formation of a large cytoplasmic crevice for uptake of the interacting C terminus of the G alpha subunit(3-5). Owing to Schiff base hydrolysis, Meta II is short-lived and notoriously difficult to crystallize. We therefore soaked opsin crystals with all-trans-retinal to form Meta II, presuming that the crystal's high concentration of opsin in an active conformation (Ops*)(6,7) may facilitate all-trans-retinal uptake and Schiff base formation. Here we present the 3.0 angstrom and 2.85 angstrom crystal structures, respectively, of Meta II alone or in complex with an 11-amino-acid C-terminal fragment derived from G alpha (G alpha CT2). G alpha CT2 binds in a large crevice at the cytoplasmic side, akin to the binding of a similar G alpha-derived peptide to Ops* (ref. 7). In the Meta II structures, the electron density from the retinal ligand seamlessly continues into the Lys 296 side chain, reflecting proper formation of the Schiff base linkage. The retinal is in a relaxed conformation and almost undistorted compared with pure crystalline all-trans-retinal. By comparison with early photoproducts we propose how retinal translocation and rotation induce the gross conformational changes characteristic for Meta II. The structures can now serve as models for the large GPCR family.	[Choe, Hui-Woog; Kim, Yong Ju; Park, Jung Hee; Morizumi, Takefumi; Hofmann, Klaus Peter; Scheerer, Patrick; Ernst, Oliver P.] Charite, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Choe, Hui-Woog] Chonbuk Natl Univ, Coll Nat Sci, Dept Chem, Chonju 561756, South Korea; [Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Pai, Emil F.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Krauss, Norbert] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jeonbuk National University; University of Toronto; University of Toronto; University of Toronto; University of London; Queen Mary University London; Humboldt University of Berlin	Choe, HW (corresponding author), Charite, Inst Med Phys & Biophys CC2, Charite Pl 1, D-10117 Berlin, Germany.	hwchoe@jbnu.ac.kr; klaus_peter.hofmann@charite.de; oliver.ernst@utoronto.ca	Pai, Emil/R-8908-2019; Pai, Emil F/D-2526-2013; Morizumi, Takefumi/AAA-2063-2021	Pai, Emil/0000-0002-1162-7242; Morizumi, Takefumi/0000-0002-2785-209X; Krauss, Norbert/0000-0002-7128-4632; Scheerer, Patrick/0000-0001-5028-2075	DFG [Sfb449, Sfb740]; ERC; Canada Research Chairs Program; Ministry of Education, Science and Technology [2010-0002738]; CBNU; Leibniz Graduate School of Molecular Biophysics, Berlin	DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); Canada Research Chairs Program(Canada Research Chairs); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); CBNU; Leibniz Graduate School of Molecular Biophysics, Berlin	We thank J. Engelmann, C. Koch and B. Bauer for technical assistance, and F. Siebert and W. Hubbell for critically reading the manuscript. We are grateful to the European Synchrotron Radiation Facility (ESRF, Grenoble), D. von Stetten and A. Royant of the ID29S-Cryobench (ESRF, Grenoble) and U. Muller and the scientific staff of the BESSY-MX/Helmholtz Zentrum Berlin fur Materialien und Energie at beamlines BL 14.1 and BL 14.2, where the data were collected, for continuous support. This work was supported by the DFG Sfb449 (to O.P.E.), Sfb740 (to O.P.E. and K.P.H.) and an Advanced Investigator ERC grant (to K.P.H.) and by the Canada Research Chairs Program (to E.F.P.). H.-W.C. gratefully acknowledges the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0002738) and CBNU funds for overseas research 2009. Y.J.K. thanks the Leibniz Graduate School of Molecular Biophysics, Berlin, for a scholarship.	Ahuja S, 2009, J AM CHEM SOC, V131, P15160, DOI 10.1021/ja9034768; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Brown MF, 2010, BBA-BIOMEMBRANES, V1798, P177, DOI 10.1016/j.bbamem.2009.08.013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe HW, 2011, NEUROPHARMACOLOGY, V60, P52, DOI 10.1016/j.neuropharm.2010.07.018; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Ernst OP, 2000, METHOD ENZYMOL, V315, P471; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Fujimoto Y, 2001, CHEM-EUR J, V7, P4198, DOI 10.1002/1521-3765(20011001)7:19<4198::AID-CHEM4198>3.0.CO;2-X; Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knierim B, 2008, J BIOL CHEM, V283, P4967, DOI 10.1074/jbc.M703059200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau PW, 2007, J MOL BIOL, V372, P906, DOI 10.1016/j.jmb.2007.06.047; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Ludeke S, 2005, J MOL BIOL, V353, P345, DOI 10.1016/j.jmb.2005.08.039; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nakamichi H, 2006, ANGEW CHEM INT EDIT, V45, P4270, DOI 10.1002/anie.200600595; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Salgado GFJ, 2006, J AM CHEM SOC, V128, P11067, DOI 10.1021/ja058738+; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Siebert F, 1995, ISRAEL J CHEM, V35, P309; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948	43	521	525	4	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					651	U137		10.1038/nature09789	http://dx.doi.org/10.1038/nature09789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21389988				2022-12-24	WOS:000288951200046
J	Deweerdt, S				Deweerdt, Sarah			FOOD The omnivore's labyrinth	NATURE			English	Editorial Material							CANCER INCIDENCE; RISK											ARMSTRONG B, 1975, INT J CANCER, V15, P617, DOI 10.1002/ijc.2910150411; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Key TJ, 2011, BRIT J CANCER, V104, P6, DOI 10.1038/sj.bjc.6606032; Lampe JW, 2009, AM J CLIN NUTR, V89, pS1553, DOI 10.3945/ajcn.2009.26736D; Maskarinec G, 2004, ETHNIC DIS, V14, P431; Navarro SL, 2009, CANCER PREV RES, V2, P345, DOI 10.1158/1940-6207.CAPR-08-0178; Wu AH, 2008, BRIT J CANCER, V98, P9, DOI 10.1038/sj.bjc.6604145; ZHANG Y, 1994, P NATL ACAD SCI USA, V12; ZHANG Y, 1992, P NATL ACAD SCI USA, V15, P2399	10	18	18	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S22	S24		10.1038/471S22a	http://dx.doi.org/10.1038/471S22a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430718				2022-12-24	WOS:000288702200018
J	Curry, LA; Spatz, E; Cherlin, E; Thompson, JW; Berg, D; Ting, HH; Decker, C; Krumholz, HM; Bradley, EH				Curry, Leslie A.; Spatz, Erica; Cherlin, Emily; Thompson, Jennifer W.; Berg, David; Ting, Henry H.; Decker, Carole; Krumholz, Harlan M.; Bradley, Elizabeth H.			What Distinguishes Top-Performing Hospitals in Acute Myocardial Infarction Mortality Rates? A Qualitative Study	ANNALS OF INTERNAL MEDICINE			English	Article							ELDERLY-PATIENTS; OF-CARE; UNITED-STATES; OUTCOMES; CONSEQUENCES; ALLIANCE; FAILURE; IMPROVE; CULTURE; PROJECT	Background: Mortality rates for patients with acute myocardial infarction (AMI) vary substantially across hospitals, even when adjusted for patient severity; however, little is known about hospital factors that may influence this variation. Objective: To identify factors that may be related to better performance in AMI care, as measured by risk-standardized mortality rates. Design: Qualitative study that used site visits and in-depth interviews. Setting: Eleven U.S. hospitals that ranked in either the top or the bottom 5% in risk-standardized mortality rates for 2 recent years of data from the Centers for Medicare & Medicaid Services (2005 to 2006 and 2006 to 2007), with diversity among hospitals in key characteristics. Participants: 158 members of hospital staff, all of whom were involved with AMI care at the 11 hospitals. Measurements: Site visits and in-depth interviews conducted with hospital staff during 2009. A multidisciplinary team performed analyses by using the constant comparative method. Results: Hospitals in the high-performing and low-performing groups differed substantially in the domains of organizational values and goals, senior management involvement, broad staff presence and expertise in AMI care, communication and coordination among groups, and problem solving and learning. Participants described diverse protocols or processes for AMI care (such as rapid response teams, clinical guidelines, use of hospitalists, and medication reconciliation); however, these did not systematically differentiate high-performing from low-performing hospitals. Limitation: The qualitative design informed the generation of hypotheses, and statistical associations could not be assessed. Conclusion: High-performing hospitals were characterized by an organizational culture that supported efforts to improve AMI care across the hospital. Evidence-based protocols and processes, although important, may not be sufficient for achieving high hospital performance in care for patients with AMI.			Curry, LA (corresponding author), 60 Coll St,Box 208034, New Haven, CT 06520 USA.	leslie.curry@yale.edu	curry, leslie/AAA-6100-2022; , Harlan/AAI-2875-2020	curry, leslie/0000-0002-3419-4654; 	Agency for Healthcare Research and Quality [R01-HS-016929]; United Health Foundation; Commonwealth Fund [20090565]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS016929] Funding Source: NIH RePORTER; FOOD AND DRUG ADMINISTRATION [U01FD004585] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); United Health Foundation; Commonwealth Fund; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	Grant Support: By the Agency for Healthcare Research and Quality (R01-HS-016929), United Health Foundation, and the Commonwealth Fund (20090565).	Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; Baldwin LM, 2004, J RURAL HEALTH, V20, P99, DOI 10.1111/j.1748-0361.2004.tb00015.x; Bradley EH, 2005, MED CARE, V43, P282, DOI 10.1097/00005650-200503000-00011; Bradley Elizabeth H, 2007, Crit Pathw Cardiol, V6, P91, DOI 10.1097/HPC.0b013e31812da7bc; Bradley EH, 2010, AM J CARDIOL, V106, P1108, DOI 10.1016/j.amjcard.2010.06.014; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; Bradley EH, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-25; CLARITAS N, 2009, POPULATION FACTS 200; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Glaser B, 1978, DISCOV GROUNDED THEO; GORDON GG, 1992, J MANAGE STUD, V29, P783, DOI 10.1111/j.1467-6486.1992.tb00689.x; Horwitz LI, 2008, ARCH INTERN MED, V168, P1755, DOI 10.1001/archinte.168.16.1755; Inui TS, 1996, ANN INTERN MED, V125, P770, DOI 10.7326/0003-4819-125-9-199611010-00012; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Marsh DR, 2004, BMJ-BRIT MED J, V329, P1177, DOI 10.1136/bmj.329.7475.1177; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Normand SLT, 1996, JAMA-J AM MED ASSOC, V275, P1322, DOI 10.1001/jama.275.17.1322; Patterson ES, 2004, INT J QUAL HEALTH C, V16, P125, DOI 10.1093/intqhc/mzh026; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Popescu I, 2009, CIRC-CARDIOVASC QUAL, V2, P221, DOI 10.1161/CIRCOUTCOMES.108.813790; Rathore SS, 2006, AM HEART J, V152, P371, DOI 10.1016/j.ahj.2005.12.002; Ross JS, 2007, HEALTH AFFAIR, V26, P238, DOI 10.1377/hlthaff.26.1.238; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Sofaer S, 1999, HEALTH SERV RES, V34, P1101; SPEAR SJ, 1999, HARVARD BUS REV, P96; Sternin J, 2000, HARVARD BUS REV, V78, P14; SUDMAN S., 1996, THINKING ANSWERS APP; Sutcliffe KM, 2004, ACAD MED, V79, P186, DOI 10.1097/00001888-200402000-00019; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; van Dyck C, 2005, J APPL PSYCHOL, V90, P1228, DOI 10.1037/0021-9010.90.6.1228	39	225	225	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6					384	+		10.7326/0003-4819-154-6-201103150-00003	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	734WA	21403074	Green Accepted			2022-12-24	WOS:000288370000002
J	Fuller, J; Wright, A				Fuller, John; Wright, Andrew			A Patient's Journey Adult atopic eczema	BRITISH MEDICAL JOURNAL			English	Editorial Material												somersettalk@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 14	2011	342								d644	10.1136/bmj.d644	http://dx.doi.org/10.1136/bmj.d644			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739EZ	21402667				2022-12-24	WOS:000288697700004
J	Wertz, IE; Kusam, S; Lam, C; Okamoto, T; Sandoval, W; Anderson, DJ; Helgason, E; Ernst, JA; Eby, M; Liu, JF; Belmont, LD; Kaminker, JS; O'Rourke, KM; Pujara, K; Kohli, PB; Johnson, AR; Chiu, ML; Lill, JR; Jackson, PK; Fairbrother, WJ; Seshagiri, S; Ludlam, MJC; Leong, KG; Dueber, EC; Maecker, H; Huang, DCS; Dixit, VM				Wertz, Ingrid E.; Kusam, Saritha; Lam, Cynthia; Okamoto, Toru; Sandoval, Wendy; Anderson, Daniel J.; Helgason, Elizabeth; Ernst, James A.; Eby, Mike; Liu, Jinfeng; Belmont, Lisa D.; Kaminker, Josh S.; O'Rourke, Karen M.; Pujara, Kanan; Kohli, Pawan Bir; Johnson, Adam R.; Chiu, Mark L.; Lill, Jennie R.; Jackson, Peter K.; Fairbrother, Wayne J.; Seshagiri, Somasekar; Ludlam, Mary J. C.; Leong, Kevin G.; Dueber, Erin C.; Maecker, Heather; Huang, David C. S.; Dixit, Vishva M.			Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7	NATURE			English	Article							UBIQUITIN LIGASE; MITOTIC EXIT; CANCER; CELLS; APOPTOSIS; RESISTANCE; CATALYZES; PROTEINS; DIVISION	Microtubules have pivotal roles in fundamental cellular processes and are targets of antitubulin chemotherapeutics(1). Microtubule-targeted agents such as Taxol and vincristine are prescribed widely for various malignancies, including ovarian and breast adenocarcinomas, non-small-cell lung cancer, leukaemias and lymphomas(1). These agents arrest cells in mitosis and subsequently induce cell death through poorly defined mechanisms(2). The strategies that resistant tumour cells use to evade death induced by antitubulin agents are also unclear(2). Here we show that the pro-survival protein MCL1 (ref. 3) is a crucial regulator of apoptosis triggered by antitubulin chemotherapeutics. During mitotic arrest, MCL1 protein levels decline markedly, through a post-translational mechanism, potentiating cell death. Phosphorylation of MCL1 directs its interaction with the tumour-suppressor protein FBW7, which is the substrate-binding component of a ubiquitin ligase complex. The polyubiquitylation of MCL1 then targets it for proteasomal degradation. The degradation of MCL1 was blocked in patient-derived tumour cells that lacked FBW7 or had loss-of-function mutations in FBW7, conferring resistance to antitubulin agents and promoting chemotherapeutic-induced polyploidy. Additionally, primary tumour samples were enriched for FBW7 inactivation and elevated MCL1 levels, underscoring the prominent roles of these proteins in oncogenesis. Our findings suggest that profiling the FBW7 and MCL1 status of tumours, in terms of protein levels, messenger RNA levels and genetic status, could be useful to predict the response of patients to antitubulin chemotherapeutics.	[Wertz, Ingrid E.; Kusam, Saritha; Lam, Cynthia; Helgason, Elizabeth; Ernst, James A.; Fairbrother, Wayne J.; Dueber, Erin C.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Okamoto, Toru; Huang, David C. S.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Sandoval, Wendy; Ernst, James A.; Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Anderson, Daniel J.; Eby, Mike; Belmont, Lisa D.; Jackson, Peter K.; Ludlam, Mary J. C.; Leong, Kevin G.; Maecker, Heather] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Liu, Jinfeng; Kaminker, Josh S.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [O'Rourke, Karen M.; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Pujara, Kanan; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Kohli, Pawan Bir; Johnson, Adam R.] Genentech Inc, Dept Biochem Pharmacol, San Francisco, CA 94080 USA; [Chiu, Mark L.] Abbott Labs, Dept Biol Struct, Abbott Pk, IL 60064 USA; [Huang, David C. S.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Roche Holding; Genentech; Walter & Eliza Hall Institute; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Abbott Laboratories; University of Melbourne	Wertz, IE (corresponding author), Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA.	ingrid@gene.com	chiu, mark/AAK-2756-2021; dixit, vishva m/A-4496-2012; Huang, David C. S./C-7586-2013	dixit, vishva m/0000-0001-6983-0326; Huang, David C. S./0000-0002-3101-4873; Helgason, Elizabeth/0000-0002-0397-9125; Seshagiri, Somasekar/0000-0003-4272-6443; Jackson, Peter/0000-0002-1742-2539; Chiu, Mark/0000-0001-6300-404X; Liu, Jinfeng/0000-0002-0343-8222; Anderson, Daniel/0000-0002-3249-2439; Maecker, Heather/0000-0002-5378-1141	National Health and Medical Research Council [461221, 361646]; Leukemia and Lymphoma Society [SCOR 7413]; National Institutes of Health [CA043540, CA80188]; Australian Cancer Research Foundation; Australian Research Council; NATIONAL CANCER INSTITUTE [R01CA043540, R01CA080188] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Cancer Research Foundation; Australian Research Council(Australian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Ekert for FDM cell lines, J. Stinson for sequencing assistance, S. Johnson and C. Santos for assistance with obtaining patient samples, P. Haverty for bioinformatics analysis, C. Grimaldi for cloning assistance, J. Dynek for TaqMan advice, D. French for tumour analysis, C. Quan and J. Tom for peptide synthesis, I. Zilberleyb and the Baculovirus Expression Group for cloning and protein production, S. Charuvu for generating MCL1 point mutants, A. Bruce for graphics assistance, the Genentech Cancer Genome Project Team, Z. Modrusan, R. Soriano and the microarray lab for ovarian tumour data sets, K. Newton for editorial assistance, W. Wei for sharing unpublished results, and A. Eldridge, D. Kirkpatrick, D. Vucic, E. Varfolomeev, T. Goncharov, A. Cochran, O. Huang, A. Huang, Y. Pereg, A. Loktev, D. Phillips, J. Wu, M. van Delft, D. Eaton, E. Shaulian, T. Hunter, S. Cory, J. Adams, A. Strasser, R. Deshaies and G. Evan for discussions. Work in the Huang laboratory is supported by the National Health and Medical Research Council (program grant #461221, IRIISS grant #361646 and a fellowship to D.C.S.H.), the Leukemia and Lymphoma Society (SCOR 7413), the National Institutes of Health (grants CA043540 and CA80188), the Australian Cancer Research Foundation, and an Australian Research Council Australian Postdoctoral fellowship to T.O. We apologize to our colleagues whose primary work could not be cited owing to space constraints.	Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Finkin S, 2008, ONCOGENE, V27, P4411, DOI 10.1038/onc.2008.77; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Mesquita B, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-101; Ozalp SS, 2002, EUR J GYNAECOL ONCOL, V23, P337; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	20	594	619	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					110	114		10.1038/nature09779	http://dx.doi.org/10.1038/nature09779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368834				2022-12-24	WOS:000287924100044
J	Kuepper, R; van Os, J; Lieb, R; Wittchen, HU; Hofler, M; Henquet, C				Kuepper, Rebecca; van Os, Jim; Lieb, Roselind; Wittchen, Hans-Ulrich; Hoefler, Michael; Henquet, Cecile			Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study	BRITISH MEDICAL JOURNAL			English	Article							INTERNATIONAL DIAGNOSTIC INTERVIEW; EARLY DEVELOPMENTAL-STAGES; BEHAVIORAL SENSITIZATION; GENERAL-POPULATION; CROSS-SENSITIZATION; SWEDISH CONSCRIPTS; USE DISORDERS; SCHIZOPHRENIA; PSYCHOPATHOLOGY; RELIABILITY	Objective To determine whether use of cannabis in adolescence increases the risk for psychotic outcomes by affecting the incidence and persistence of subclinical expression of psychosis in the general population (that is, expression of psychosis below the level required for a clinical diagnosis). Design Analysis of data from a prospective population based cohort study in Germany (early developmental stages of psychopathology study). Setting Population based cohort study in Germany. Participants 1923 individuals from the general population, aged 14-24 at baseline. Main outcome measure Incidence and persistence of subthreshold psychotic symptoms after use of cannabis in adolescence. Cannabis use and psychotic symptoms were assessed at three time points (baseline, T2 (3.5 years), T3 (8.4 years)) over a 10 year follow-up period with the Munich version of the composite international diagnostic interview (M-CIDI). Results In individuals who had no reported lifetime psychotic symptoms and no reported lifetime cannabis use at baseline, incident cannabis use over the period from baseline to T2 increased the risk of later incident psychotic symptoms over the period from T2 to T3 (adjusted odds ratio 1.9, 95% confidence interval 1.1 to 3.1; P=0.021). Furthermore, continued use of cannabis increased the risk of persistent psychotic symptoms over the period from T2 to T3 (2.2, 1.2 to 4.2; P=0.016). The incidence rate of psychotic symptoms over the period from baseline to T2 was 31% (152) in exposed individuals versus 20% (284) in non-exposed individuals; over the period from T2 to T3 these rates were 14% (108) and 8% (49), respectively. Conclusion Cannabis use is a risk factor for the development of incident psychotic symptoms. Continued cannabis use might increase the risk for psychotic disorder by impacting on the persistence of symptoms.	[Kuepper, Rebecca; van Os, Jim; Henquet, Cecile] Maastricht Univ, Med Ctr, Dept Psychiat & Neuropsychol,EURON, S Limburg Mental Hlth Res & Teaching Network, NL-6200 MD Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England; [Lieb, Roselind] Univ Basel, Dept Psychol, Div Epidemiol & Hlth Psychol, CH-4003 Basel, Switzerland; [Lieb, Roselind; Wittchen, Hans-Ulrich] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wittchen, Hans-Ulrich; Hoefler, Michael] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany	Maastricht University; University of London; King's College London; University of Basel; Max Planck Society; Technische Universitat Dresden	van Os, J (corresponding author), Maastricht Univ, Med Ctr, Dept Psychiat & Neuropsychol,EURON, S Limburg Mental Hlth Res & Teaching Network, POB 616, NL-6200 MD Maastricht, Netherlands.	j.vanos@sp.unimaas.nl	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Wittchen, Hans-Ulrich/A-8507-2014; van Os, Jim/I-9496-2012; van Os, Jim/C-2113-2014; van Os, Jim/V-8884-2019; Wittchen, Hans-Ulrich/ABA-8901-2020; Hofler, Michael/A-8153-2014	van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586; Wittchen, Hans-Ulrich/0000-0002-6311-7711; Hofler, Michael/0000-0001-7646-8265	German Ministry of Research, Education and Technology [01EB9405/6, 01EB9901/6]; Deutsche Forschungsgemeinschaft (DFG); NIH [RO1DA016977-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016977] Funding Source: NIH RePORTER	German Ministry of Research, Education and Technology; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The EDSP study is funded by grants of the German Ministry of Research, Education and Technology (01EB9405/6 and 01EB9901/6) and the Deutsche Forschungsgemeinschaft (DFG), and this paper is part of NIH grant RO1DA016977-01, PL.	ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; Arseneault L, 2004, BRIT J PSYCHIAT, V184, P110, DOI 10.1192/bjp.184.2.110; Cadoni C, 2001, PSYCHOPHARMACOLOGY, V158, P259, DOI 10.1007/s002130100875; Cadoni C, 2008, J NEUROCHEM, V106, P1586, DOI 10.1111/j.1471-4159.2008.05503.x; Collip D, 2008, SCHIZOPHRENIA BULL, V34, P220, DOI 10.1093/schbul/sbm163; COTTLER LB, 1991, DRUG ALCOHOL DEPEN, V29, P17, DOI 10.1016/0376-8716(91)90018-T; Cougnard A, 2007, PSYCHOL MED, V37, P513, DOI 10.1017/S0033291706009731; Degenhardt L, 2003, DRUG ALCOHOL DEPEN, V71, P37, DOI 10.1016/S0376-8716(03)00064-4; Degenhardt L, 2006, CAN J PSYCHIAT, V51, P556, DOI 10.1177/070674370605100903; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Ferdinand RF, 2005, ADDICTION, V100, P612, DOI 10.1111/j.1360-0443.2005.01070.x; Fisher HL, 2009, SCHIZOPHR B     1007; Grech A, 2005, EUR PSYCHIAT, V20, P349, DOI 10.1016/j.eurpsy.2004.09.013; *GROUP INV, 2010, ARCH GEN PSYCHI 1004; Hanssen M, 2005, BRIT J CLIN PSYCHOL, V44, P181, DOI 10.1348/014466505X29611; Henquet C, 2005, BMJ-BRIT MED J, V330, P11, DOI 10.1136/bmj.38267.664086.63; Howes OD, 2004, INT J NEUROPSYCHOPH, V7, pS7, DOI 10.1017/S1461145704004122; Johns LC, 2001, CLIN PSYCHOL REV, V21, P1125, DOI 10.1016/S0272-7358(01)00103-9; Keshavan M, 2008, SCHIZOPHR RES, V103, P114, DOI 10.1016/j.schres.2008.03.006; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Lieb R, 2000, EUR ADDICT RES, V6, P170, DOI 10.1159/000052043; McGrath J, 2010, ARCH GEN PSYCHIAT, V67, P440, DOI 10.1001/archgenpsychiatry.2010.6; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179; Niemi LT, 2003, SCHIZOPHR RES, V60, P239, DOI 10.1016/S0920-9964(02)00234-7; O'Daly O. G., 2005, J DUAL DIAGN, V1, P11; Perkonigg A, 2008, ADDICTION, V103, P439, DOI 10.1111/j.1360-0443.2007.02064.x; Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rossler W, 2007, SCHIZOPHR RES, V92, P1, DOI 10.1016/j.schres.2007.01.002; Semple DM, 2005, J PSYCHOPHARMACOL, V19, P187, DOI 10.1177/0269881105049040; Spauwen J, 2006, PSYCHOL MED, V36, P407, DOI 10.1017/S0033291705006902; van Os J, 2002, AM J EPIDEMIOL, V156, P319, DOI 10.1093/aje/kwf043; van Os J, 2005, CURR OPIN PSYCHIATR, V18, P141, DOI 10.1097/00001504-200503000-00006; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Van Rossum I, 2009, SCHIZOPHR B     0930, DOI 101093/schbul/sbp101; Verdoux H, 2002, SCHIZOPHR RES, V54, P59, DOI 10.1016/S0920-9964(01)00352-8; Wittchen HU, 2007, DRUG ALCOHOL DEPEN, V88, pS60, DOI 10.1016/j.drugalcdep.2006.12.013; Wittchen HU, 2009, DRUG ALCOHOL DEPEN, V102, P151, DOI 10.1016/j.drugalcdep.2009.02.012; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Wittchen HU, 1998, EUR ADDICT RES, V4, P18, DOI 10.1159/000018921; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Zammit S, 2002, BRIT MED J, V325, P1199, DOI 10.1136/bmj.325.7374.1199	46	183	186	0	45	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 1	2011	342								d738	10.1136/bmj.d738	http://dx.doi.org/10.1136/bmj.d738			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732ED	21363868	Green Submitted, hybrid, Green Published			2022-12-24	WOS:000288166600010
J	Rabeharisoa, V				Rabeharisoa, Vololona			Socializing Genetic Diseases	SCIENCE			English	Editorial Material									MINES ParisTech, Ctr Sociol Innovat, Paris, France	UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech	Rabeharisoa, V (corresponding author), MINES ParisTech, Ctr Sociol Innovat, Paris, France.								0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1026	1027		10.1126/science.1203631	http://dx.doi.org/10.1126/science.1203631			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350165				2022-12-24	WOS:000287699000050
J	Buchanan, JA; Heard, K; Burbach, C; Wilson, ML; Dart, R				Buchanan, Jennie A.; Heard, Kennon; Burbach, Cynthia; Wilson, Michael L.; Dart, Richard			Prevalence of Levamisole in Urine Toxicology Screens Positive for Cocaine in an Inner-City Hospital	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Buchanan, Jennie A.] Denver Hlth & Hosp Author, Dept Emergency Med, Denver, CO USA; [Buchanan, Jennie A.; Heard, Kennon; Dart, Richard] Rocky Mt Poison & Drug Ctr, Denver, CO USA; [Burbach, Cynthia] Dept Publ Hlth, Denver, CO USA; [Wilson, Michael L.] Denver Hlth & Hosp Author, Dept Pathol, Denver, CO USA	Denver Health Medical Center; Denver Health Medical Center	Buchanan, JA (corresponding author), Denver Hlth & Hosp Author, Dept Emergency Med, Denver, CO USA.	jennie.buchanan3@dhha.org			NATIONAL INSTITUTE ON DRUG ABUSE [K08DA020573] Funding Source: NIH RePORTER; NIDA NIH HHS [K08 DA020573-05, K08DA020573, K08 DA020573] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		AMERY WKP, 1992, INT J IMMUNOPHARMACO, V14, P481, DOI 10.1016/0192-0561(92)90179-O; Chang A, 2010, CLIN PHARMACOL THER, V88, P408, DOI 10.1038/clpt.2010.156; *DRUG ENF ADM INT, 2010, DRUG INT BRIEF COC C; Rongioletti F, 1999, BRIT J DERMATOL, V140, P948, DOI 10.1046/j.1365-2133.1999.02833.x; Spector S, 1998, NEUROPSYCHOPHARMACOL, V19, P417, DOI 10.1016/S0893-133X(98)00034-7; Valentino AMM., 2005, MICROGRAM J, V3, P134	6	51	52	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1657	1658		10.1001/jama.2011.531	http://dx.doi.org/10.1001/jama.2011.531			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521846				2022-12-24	WOS:000289890500018
J	Spence, D				Spence, Des			FROM THE FRONTLINE The importance of mistrust: drugs of diversion	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 20	2011	342								d2465	10.1136/bmj.d2465	http://dx.doi.org/10.1136/bmj.d2465			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755ON	21508049				2022-12-24	WOS:000289942900011
J	Amato, S; Liu, XX; Zheng, B; Cantley, L; Rakic, P; Man, HY				Amato, Stephen; Liu, Xiuxin; Zheng, Bin; Cantley, Lewis; Rakic, Pasko; Man, Heng-Ye			AMP-Activated Protein Kinase Regulates Neuronal Polarization by Interfering with PI 3-Kinase Localization	SCIENCE			English	Article							HIPPOCAMPAL-NEURONS; BRAIN-DEVELOPMENT; AXONAL-TRANSPORT; POLARITY; TRANSLOCATION; KINESIN-1; MIGRATION; CULTURE; GROWTH; ENERGY	Axon-dendrite polarization is crucial for neural network wiring and information processing in the brain. Polarization begins with the transformation of a single neurite into an axon and its subsequent rapid extension, which requires coordination of cellular energy status to allow for transport of building materials to support axon growth. We found that activation of the energy-sensing adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) pathway suppressed axon initiation and neuronal polarization. Phosphorylation of the kinesin light chain of the Kif5 motor protein by AMPK disrupted the association of the motor with phosphatidylinositol 3-kinase (PI3K), preventing PI3K targeting to the axonal tip and inhibiting polarization and axon growth.	[Amato, Stephen; Man, Heng-Ye] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Liu, Xiuxin; Rakic, Pasko] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Liu, Xiuxin; Rakic, Pasko] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Zheng, Bin; Cantley, Lewis] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Zheng, Bin; Cantley, Lewis] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Boston University; Yale University; Yale University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Man, HY (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	hman@bu.edu	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Zheng, Bin/0000-0002-0998-7177	Kavli Institute; NAAR/Autism Speaks fellowship;  [MH07907];  [GM56203];  [GM41890];  [K99CA133245]; NATIONAL CANCER INSTITUTE [R00CA133245, K99CA133245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041890, R01GM056203, R01GM041890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014841] Funding Source: NIH RePORTER	Kavli Institute; NAAR/Autism Speaks fellowship; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. R. Luo for providing EGFP-PH, K. Hasimoto-Torii for GFP virus, and J. Asara for assistance with mass spectrometry. This research was supported by MH07907 (H.-Y.M), GM56203 and GM41890 (L. C. C.), K99CA133245 (B.Z.), the Kavli Institute (P. R.), and a NAAR/Autism Speaks fellowship (X.L.).	Ageta-Ishihara N, 2009, J NEUROSCI, V29, P13720, DOI 10.1523/JNEUROSCI.3018-09.2009; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jareb M, 1997, J NEUROSCI, V17, P8955; Jia YH, 2007, IMMUNITY, V27, P453, DOI 10.1016/j.immuni.2007.07.016; Katagiri H, 1996, J BIOL CHEM, V271, P16987, DOI 10.1074/jbc.271.29.16987; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; NAKATA T, 2007, SCI STKE, pPE6; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Tabata H, 2003, J NEUROSCI, V23, P9996; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010	29	102	104	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					247	251		10.1126/science.1201678	http://dx.doi.org/10.1126/science.1201678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21436401	Green Accepted			2022-12-24	WOS:000289251100055
J	Kivimaki, M; Batty, GD; Hamer, M; Ferrie, JE; Vahtera, J; Virtanen, M; Marmot, MG; Singh-Manoux, A; Shipley, MJ				Kivimaeki, Mika; Batty, G. David; Hamer, Mark; Ferrie, Jane E.; Vahtera, Jussi; Virtanen, Marianna; Marmot, Michael G.; Singh-Manoux, Archana; Shipley, Martin J.			Using Additional Information on Working Hours to Predict Coronary Heart Disease	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; JAPANESE WORKERS; OVERTIME WORK; RISK-FACTOR; PREVENTION; STATEMENT; CURVE; SCORE; AREA	Background: Long working hours are associated with increased risk for coronary heart disease (CHD). Adding information on long hours to traditional risk factors for CHD may help to improve risk prediction for this condition. Objective: To examine whether information on long working hours improves the ability of the Framingham risk model to predict CHD in a low-risk, employed population. Design: Cohort study with baseline medical examination performed between 1991 and 1993 and prospective follow-up for incident CHD performed until 2004. Setting: Civil service departments in London (the Whitehall II study). Participants: 7095 adults (2109 women and 4986 men) aged 39 to 62 years working full-time without CHD at baseline. Measurements: Working hours and the Framingham risk score were measured at baseline. Coronary death and nonfatal myocardial infarction were ascertained from medical screenings every 5 years, hospital data, and registry linkage. Results: 192 participants had incident CHD during a median 12.3-year follow-up. After adjustment for their Framingham risk score, participants working 11 hours or more per day had a 1.67-fold (95% CI, 1.10-to 2.55-fold) increased risk for CHD compared with participants working 7 to 8 hours per day. Adding working hours to the Framingham risk score led to a net reclassification improvement of 4.7% (P = 0.034) due to better identification of persons who later developed CHD (sensitivity gain). Limitation: The findings may not be generalizable to populations with a larger proportion of high-risk persons and were not validated in an independent cohort. Conclusion: Information on working hours may improve risk prediction of CHD on the basis of the Framingham risk score in low-risk, working populations.	[Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Univ Turku, FI-20520 Turku, Finland; Turku Univ Hosp, FI-20520 Turku, Finland; Finnish Inst Occupat Hlth, FI-00250 Helsinki, Finland; Univ Helsinki, FI-00250 Helsinki, Finland; INSERM, F-75654 Paris 13, France	University of London; University College London; University of Turku; University of Turku; Finnish Institute of Occupational Health; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	m.kivimaki@ucl.ac.uk	Marmot, M G/Y-3920-2019; Ferrie, Jane/AAZ-2009-2020; Hamer, Mark/C-1602-2008; Hamer, Mark/AAJ-6814-2021; Vahtera, Jussi/J-3271-2013; Singh-Manoux, Archana/F-6804-2013; Kivimaki, Mika/B-3607-2012; Batty, GD/Y-4401-2018	Marmot, M G/0000-0002-2431-6419; Hamer, Mark/0000-0002-8726-7992; Hamer, Mark/0000-0002-8726-7992; Singh-Manoux, Archana/0000-0002-1244-5037; Kivimaki, Mika/0000-0002-4699-5627; Batty, GD/0000-0003-1822-5753; Vahtera, Jussi/0000-0002-6036-061X	Medical Research Council; British Heart Foundation; Bupa Foundation; National Heart, Lung, and Blood Institute and National Institute on Aging of the National Institutes of Health; Wellcome Trust; Health and Safety Executive; Department of Health; Agency for Health Care Policy and Research; John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health; Academy of Finland; NEW OSH ERA; European Science Foundation; MRC [G0902037] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R01AG034454] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0902037, G8802774, G0100222, G19/35] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Bupa Foundation; National Heart, Lung, and Blood Institute and National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome Trust); Health and Safety Executive; Department of Health; Agency for Health Care Policy and Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health; Academy of Finland(Academy of Finland); NEW OSH ERA; European Science Foundation(European Science Foundation (ESF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council; British Heart Foundation; Bupa Foundation; and the National Heart, Lung, and Blood Institute and National Institute on Aging of the National Institutes of Health.r By the Medical Research Council; British Heart Foundation; Wellcome Trust; Health and Safety Executive; Department of Health; Agency for Health Care Policy and Research; John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health; National Heart, Lung, and Blood Institute and National Institute on Aging of the National Institutes of Health; Academy of Finland; NEW OSH ERA Research Programme; and European Science Foundation. Drs. Kivimaki and Vahtera are supported by the Academy of Finland, Dr. Batty is a Wellcome Trust Fellow, Dr. Ferrie is supported by the Medical Research Council, Dr. Marmot is a Medical Research Council professor, Dr. Singh-Manoux is supported by a European Young Investigator Award from the European Science Foundation, and Mr. Shipley is supported by the British Heart Foundation.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; ARMITAGE P, 1977, STAT METHODS MED RES; BRESLOW NE, 1980, STATISTICAL METHODS, V1, P1; BUELL P, 1960, J Chronic Dis, V11, P615, DOI 10.1016/0021-9681(60)90060-6; Caruso CC, 2004, DHHS NIOSH PUBLICATI, DOI 10.26616/NIOSHPUB2004143; Cook NR, 2010, CURR CARDIOVASC RISK, V4, P112, DOI 10.1007/s12170-010-0084-x; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Eller NH, 2009, CARDIOL REV, V17, P83, DOI 10.1097/CRD.0b013e318198c8e9; FALGER PRJ, 1992, J PSYCHOSOM RES, V36, P777, DOI 10.1016/0022-3999(92)90136-P; Fukuoka Y, 2005, INT J CARDIOL, V100, P29, DOI 10.1016/j.ijcard.2004.04.003; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Holtermann A, 2010, HEART, V96, P1638, DOI 10.1136/hrt.2010.197145; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kim HC, 2010, J AM COLL CARDIOL, V55, P2080, DOI 10.1016/j.jacc.2009.12.047; LIU L, 2009, SAS GLOB FOR 2009 WA; Liu Y, 2002, OCCUP ENVIRON MED, V59, P447, DOI 10.1136/oem.59.7.447; Mannan H, 2010, J EVAL CLIN PRACT, V16, P756, DOI 10.1111/j.1365-2753.2009.01190.x; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; *ORG EC COOP DEV, 2004, OECD EMPL OUTL REC L; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pignone M, 2010, DIABETES CARE, V33, P1395, DOI 10.2337/dc10-0555; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Rose G, 1982, CARDIOVASCULAR SURVE; *SAS I, JACKKN BOOTSTR AN; SHAFER JL, 1997, ANAL INCOMPLETE MULT; Sokejima S, 1998, BRIT MED J, V317, P775, DOI 10.1136/bmj.317.7161.775; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Tarumi K, 2003, IND HEALTH, V41, P101, DOI 10.2486/indhealth.41.101; THEORELL T, 1972, J CHRON DIS, V25, P139, DOI 10.1016/0021-9681(72)90170-1; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Uchiyama S, 2005, J OCCUP HEALTH, V47, P102, DOI 10.1539/joh.47.102; Virtanen M, 2010, EUR HEART J, V31, P1737, DOI 10.1093/eurheartj/ehq124; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	43	60	61	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2011	154	7							457	10.7326/0003-4819-154-7-201104050-00003	http://dx.doi.org/10.7326/0003-4819-154-7-201104050-00003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744EX	21464347	Green Accepted			2022-12-24	WOS:000289078700002
J	Lammens, K; Bemeleit, DJ; Mockel, C; Clausing, E; Schele, A; Hartung, S; Schiller, CB; Lucas, M; Angermuller, C; Soding, J; Strasser, K; Hopfner, KP				Lammens, Katja; Bemeleit, Derk J.; Moeckel, Carolin; Clausing, Emanuel; Schele, Alexandra; Hartung, Sophia; Schiller, Christian B.; Lucas, Maria; Angermueller, Christof; Soeding, Johannes; Straesser, Katja; Hopfner, Karl-Peter			The Mre11:Rad50 Structure Shows an ATP-Dependent Molecular Clamp in DNA Double-Strand Break Repair	CELL			English	Article							MRE11 COMPLEX; ESCHERICHIA-COLI; DAMAGE RESPONSE; PROTEIN COMPLEX; KINASE-ACTIVITY; RECOMBINATION; CHROMOSOME; RAD50; SBCCD; MECHANISMS	The MR (Mre11 nuclease and Rad50 ABC ATPase) complex is an evolutionarily conserved sensor for DNA double-strand breaks, highly genotoxic lesions linked to cancer development. MR can recognize and process DNA ends even if they are blocked and mis-folded. To reveal its mechanism, we determined the crystal structure of the catalytic head of Thermotoga maritima MR and analyzed ATP-dependent conformational changes. MR adopts an open form with a central Mre11 nuclease dimer and two peripheral Rad50 molecules, a form suited for sensing obstructed breaks. The Mre11 C-terminal helix-loophelix domain binds Rad50 and attaches flexibly to the nuclease domain, enabling large conformational changes. ATP binding to the two Rad50 subunits induces a rotation of the Mre11 helix-loop-helix and Rad50 coiled-coil domains, creating a clamp conformation with increased DNA-binding activity. The results suggest that MR is an ATP-controlled transient molecular clamp at DNA double-strand breaks.	[Lammens, Katja; Straesser, Katja; Hopfner, Karl-Peter] Univ Munich, CIPSM, D-81377 Munich, Germany; [Lammens, Katja; Bemeleit, Derk J.; Moeckel, Carolin; Clausing, Emanuel; Schele, Alexandra; Hartung, Sophia; Schiller, Christian B.; Lucas, Maria; Angermueller, Christof; Soeding, Johannes; Straesser, Katja; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Lammens, Katja; Bemeleit, Derk J.; Moeckel, Carolin; Clausing, Emanuel; Schele, Alexandra; Hartung, Sophia; Schiller, Christian B.; Lucas, Maria; Angermueller, Christof; Soeding, Johannes; Straesser, Katja; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Hopfner, Karl-Peter] Univ Munich, Munich Ctr Adv Photon, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Hopfner, KP (corresponding author), Univ Munich, CIPSM, Feodor Lynen Str 25, D-81377 Munich, Germany.	hopfner@lmb.uni-muenchen.de	Hopfner, Karl-Peter/B-6864-2014; Lucas, Maria/G-9788-2012; Söding, Johannes/A-3341-2013	Hopfner, Karl-Peter/0000-0002-4528-8357; Lucas, Maria/0000-0002-7854-4249; Söding, Johannes/0000-0001-9642-8244; Strasser, Katja/0000-0003-3533-5516	German Research Council [SFBs 684, 646, TR5]; German Excellence Initiative (CIPSM); European Commission; NIH [U19AI83025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	German Research Council(German Research Foundation (DFG)); German Excellence Initiative (CIPSM); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank John Petrini for his gift of an alpha-Mre11 antibody. We thank Britta Coordes for help with the yeast work and members of the Hopfner lab, especially Matthew Bennett, Gregor Witte, and Alfred Lammens, for discussions. We thank the staffs of the Swiss Light Source (Villingen), European Synchrotron Radiation Facility (Grenoble), German Electron Synchrotron (Hamburg), and Advanced Light Source (Berkeley) for technical support. We thank the Max-Planck-Crystallization Facility (Martinsried) for crystallization trials. This work was funded by grants from the German Research Council (SFBs 684, 646, and TR5), the German Excellence Initiative (CIPSM), European Commission (IP DNA repair), and NIH U19AI83025.	Bentchikou E, 2007, J BACTERIOL, V189, P4784, DOI 10.1128/JB.00452-07; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chamankhah M, 1999, NUCLEIC ACIDS RES, V27, P2072, DOI 10.1093/nar/27.10.2072; Connelly JC, 2003, DNA REPAIR, V2, P795, DOI 10.1016/S1568-7864(03)00063-6; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Leach DRF, 1997, MOL MICROBIOL, V26, P597, DOI 10.1046/j.1365-2958.1997.6071957.x; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee K, 2008, NATURE, V454, P543, DOI 10.1038/nature07054; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Mascarenhas J, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-20; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; RAYMOND WE, 1993, NUCLEIC ACIDS RES, V21, P3851, DOI 10.1093/nar/21.16.3851; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Zahradka K, 2009, J BACTERIOL, V191, P1677, DOI 10.1128/JB.01877-07; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	47	157	160	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					54	66		10.1016/j.cell.2011.02.038	http://dx.doi.org/10.1016/j.cell.2011.02.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458667	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-24	WOS:000289053900009
J	Tsaytler, P; Harding, HP; Ron, D; Bertolotti, A				Tsaytler, Pavel; Harding, Heather P.; Ron, David; Bertolotti, Anne			Selective Inhibition of a Regulatory Subunit of Protein Phosphatase 1 Restores Proteostasis	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; STRESS; DEPHOSPHORYLATION; EIF2-ALPHA; GUANABENZ; DEATH	Many biological processes are regulated through the selective dephosphorylation of proteins. Protein serine-threonine phosphatases are assembled from catalytic subunits bound to diverse regulatory subunits that provide substrate specificity and subcellular localization. We describe a small molecule, guanabenz, that bound to a regulatory subunit of protein phosphatase 1, PPP1R15A/GADD34, selectively disrupting the stress-induced dephosphorylation of the a subunit of translation initiation factor 2 (eIF2 alpha). Without affecting the related PPP1R15B-phosphatase complex and constitutive protein synthesis, guanabenz prolonged eIF2 alpha phosphorylation in human stressed cells, adjusting the protein production rates to levels manageable by available chaperones. This favored protein folding and thereby rescued cells from protein misfolding stress. Thus, regulatory subunits of phosphatases are drug targets, a property used here to restore proteostasis in stressed cells.	[Tsaytler, Pavel; Bertolotti, Anne] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Harding, Heather P.; Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; University of Cambridge	Bertolotti, A (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	aberto@mrc-lmb.cam.ac.uk		Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636	UK Medical Research Council; MRC [MC_U105185860] Funding Source: UKRI; Medical Research Council [G0600717B, MC_U105185860] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Merritt and C. Wallace for biotinylated guanabenz, J. Hastie for purified recombinant PP1c, anonymous reviewers for suggestions, and M. Goedert for advice on the manuscript. Supported by the UK Medical Research Council. D. R. is a Wellcome Trust Principal Research Fellow. A. B. is a co-inventor on patent WO/2008/041133.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; HOLMES B, 1983, DRUGS, V26, P212, DOI 10.2165/00003495-198326030-00003; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431	15	374	392	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					91	94		10.1126/science.1201396	http://dx.doi.org/10.1126/science.1201396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21385720				2022-12-24	WOS:000289000000044
J	Buchen, L				Buchen, Lizzie			MISSING THE MARK	NATURE			English	News Item							DIAGNOSTIC MARKERS; BIOMARKERS; READY											Berg AO, 2009, GENET MED, V11, P66, DOI 10.1097/GIM.0b013e3181928f56; Coates RJ, 2008, CLIN CANCER RES, V14, P7575, DOI 10.1158/1078-0432.CCR-08-2296; Cramer DW, 2011, CANCER PREV RES, V4, P365, DOI 10.1158/1940-6207.CAPR-10-0195; Greene MH, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-2232; Mai PL, 2011, CANCER PREV RES, V4, P303, DOI 10.1158/1940-6207.CAPR-11-0053; McIntosh M, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-0623; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Mor G., 2009, P AM ASS CANC RES AA; Mor G, 2008, CLIN CANCER RES, V14, P7577, DOI 10.1158/1078-0432.CCR-08-2621; Schweitzer B, 2000, P NATL ACAD SCI USA, V97, P10113, DOI 10.1073/pnas.170237197; Thorpe JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001281; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	13	56	56	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					428	432		10.1038/471428a	http://dx.doi.org/10.1038/471428a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430749	Bronze			2022-12-24	WOS:000288702200030
J	Dillner, L				Dillner, Luisa			Long term conditions How services for long term conditions could be reborn	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Department of Health, 2011, FUNCT GP COMM CONS W	1	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 22	2011	342								d1730	10.1136/bmj.d1730	http://dx.doi.org/10.1136/bmj.d1730			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MF	21427039				2022-12-24	WOS:000288947500008
J	Pe'er, D; Hacohen, N				Pe'er, Dana; Hacohen, Nir			Principles and Strategies for Developing Network Models in Cancer	CELL			English	Article							TRANSCRIPTIONAL NETWORK; IDENTIFICATION; INHIBITION; GENE; MAP; ACTIVATION; REGULATORS; DYNAMICS; GENOME; MODULE	The flood of genome-wide data generated by high-throughput technologies currently provides biologists with an unprecedented opportunity: to manipulate, query, and reconstruct functional molecular networks of cells. Here, we outline three underlying principles and six strategies to infer network models from genomic data. Then, using cancer as an example, we describe experimental and computational approaches to infer "differential" networks that can identify genes and processes driving disease phenotypes. In conclusion, we discuss how a network-level understanding of cancer can be used to predict drug response and guide therapeutics.	[Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Pe'er, Dana] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Hacohen, Nir] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Columbia University; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pe'er, D (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	dpeer@biology.columbia.edu	Califano, Andrea/F-7239-2012	Pe'er, Dana/0000-0002-9259-8817	NIH [DP2-OD002414-01, DP2 OD002230]; NIAID [U54 AI057159]; Burroughs Wellcome Fund; Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002414, DP2OD002230] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank Arnon Arazi, Andrea Califano, William Hahn, Andreja Jovic, Oren Litvin, Neal Rosen, Sagi Shapira, and Cathy Wu for valuable comments. The authors would like to thank Oren Litvin for help with the illustrations. This research was supported by the NIH Director's New Innovator Award Program through grant numbers DP2-OD002414-01 (D.P.) and DP2 OD002230 (N.H.), as well as NIAID U54 AI057159 (N.H.). D.P. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and Packard Fellowship for Science and Engineering.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Chen BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.69; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Litvin O, 2009, P NATL ACAD SCI USA, V106, P6441, DOI 10.1073/pnas.0810208106; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ornatsky OI, 2008, ANAL CHEM, V80, P2539, DOI 10.1021/ac702128m; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sachs K, 2009, J COMPUT BIOL, V16, P201, DOI 10.1089/cmb.2008.07TT; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697	48	132	133	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					864	873		10.1016/j.cell.2011.03.001	http://dx.doi.org/10.1016/j.cell.2011.03.001			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414479	Green Accepted, Bronze			2022-12-24	WOS:000288543500006
J	Sinnott, M; Shaban, RZ				Sinnott, Michael; Shaban, Ramon Z.			Personal View Can we have a culture of patient safety without one of staff safety?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sinnott, Michael; Shaban, Ramon Z.] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Sinnott, Michael] Univ Queensland, Brisbane, Qld, Australia; [Shaban, Ramon Z.] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia	University of Queensland; Griffith University; Menzies Health Institute Queensland	Sinnott, M (corresponding author), Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.	michael_sinnott@health.qld.gov.au	Sinnott, Michael/D-1155-2012	Sinnott, Michael/0000-0002-2338-3126; Shaban, Ramon/0000-0002-5203-0557				Occupational Safety and Health Administration, 2008, OCC SAF HLTH STAND; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; SINNOTT M, 2010, PERIOPERAT NURS CLIN, V5, P59; *SOC THOR SURG, 2009, HIST PAT SAF PAT SAF; Tseng D, 2005, INFECT DIS HEALTH, V10, P89, DOI 10.1071/HI05089	5	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2011	342								c6171	10.1136/bmj.c6171	http://dx.doi.org/10.1136/bmj.c6171			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732EU	21378073	Green Published			2022-12-24	WOS:000288168600001
J	Peterson, PN; Shetterly, SM; Clarke, CL; Bekelman, DB; Chan, PS; Allen, LA; Matlock, DD; Magid, DJ; Masoudi, FA				Peterson, Pamela N.; Shetterly, Susan M.; Clarke, Christina L.; Bekelman, David B.; Chan, Paul S.; Allen, Larry A.; Matlock, Daniel D.; Magid, David J.; Masoudi, Frederick A.			Health Literacy and Outcomes Among Patients With Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIMITED LITERACY; CONTROLLED-TRIAL; HOSPITAL ADMISSION; IDENTIFY PATIENTS; SKILLS; RISK; POPULATION; QUESTIONS; ENROLLEES; MORTALITY	Context Little is known about the effects of low health literacy among patients with heart failure, a condition that requires self-management and frequent interactions with the health care system. Objective To evaluate the association between low health literacy and all-cause mortality and hospitalization among outpatients with heart failure. Design, Setting, and Patients Retrospective cohort study conducted at Kaiser Permanente Colorado, an integrated managed care organization. Outpatients with heart failure were identified between January 2001 and May 2008, were surveyed by mail, and underwent follow-up for a median of 1.2 years. Health literacy was assessed using 3 established screening questions and categorized as adequate or low. Responders were excluded if they did not complete at least 1 health literacy question or if they did not have at least 1 year of enrollment prior to the survey date. Main Outcome Measures All-cause mortality and all-cause hospitalization. Results Of the 2156 patients surveyed, 1547 responded (72% response rate). Of 1494 included responders, 262 (17.5%) had low health literacy. Patients with low health literacy were older, of lower socioeconomic status, less likely to have at least a high school education, and had higher rates of coexisting illnesses. In multivariable Cox regression, low health literacy was independently associated with higher mortality (unadjusted rate, 17.6% vs 6.3%; adjusted hazard ratio, 1.97 [95% confidence interval, 1.3-2.97]; P=.001) but not hospitalization (unadjusted rate, 30.5% vs 23.2%; adjusted hazard ratio, 1.05 [95% confidence interval, 0.8-1.37]; P=.73). Conclusion Among patients with heart failure in an integrated managed care organization, low health literacy was significantly associated with higher all-cause mortality. JAMA. 2011;305(16):1695-1701 www.jama.com	[Peterson, Pamela N.] Denver Hlth Med Ctr, Div Cardiol, Denver, CO 80204 USA; [Peterson, Pamela N.; Shetterly, Susan M.; Clarke, Christina L.; Magid, David J.; Masoudi, Frederick A.] Kaiser Permanente Colorado Inst Hlth Res, Denver, CO USA; [Peterson, Pamela N.; Bekelman, David B.; Allen, Larry A.; Matlock, Daniel D.; Magid, David J.; Masoudi, Frederick A.] Univ Colorado Denver, Aurora, CO USA; [Bekelman, David B.] Denver VA Med Ctr, Denver, CO USA; [Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Chan, Paul S.] Univ Missouri, Kansas City, MO 64110 USA	Denver Health Medical Center; Kaiser Permanente; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City	Peterson, PN (corresponding author), Denver Hlth Med Ctr, Div Cardiol, Mail Code 0960,777 Bannock St, Denver, CO 80204 USA.	pamela.peterson@ucdenver.edu	Masoudi, Frederick/Q-7467-2019; Allen, Larry/AAI-1323-2020	Matlock, Dan/0000-0001-9597-9642	American Heart Association [067001N]; National Heart, Lung, and Blood Institute [K23HL102224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Peterson is supported by American Heart Association Pharmaceutical Roundtable grant 067001N. Dr Chan is supported by a Career Development Grant Award (K23HL102224) from the National Heart, Lung, and Blood Institute. Dr Allen is supported by an American Heart Association Scientist Development Award.	Baker DW, 2007, ARCH INTERN MED, V167, P1503, DOI 10.1001/archinte.167.14.1503; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Baker DW, 1998, J GEN INTERN MED, V13, P791, DOI 10.1046/j.1525-1497.1998.00242.x; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Cavanaugh K, 2009, DIABETES CARE, V32, P2149, DOI 10.2337/dc09-0563; Chew LD, 2004, FAM MED, V36, P588; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; COX DR, 1972, J R STAT SOC B, V34, P187; Davis T C, 1993, Fam Med, V25, P391; Davis TC, 2006, ANN INTERN MED, V145, P887, DOI 10.7326/0003-4819-145-12-200612190-00144; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; DeWalt DA, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-30; Eichler K, 2009, INT J PUBLIC HEALTH, V54, P313, DOI 10.1007/s00038-009-0058-2; Evangelista LS, 2010, J CARD FAIL, V16, P9, DOI 10.1016/j.cardfail.2009.10.026; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Institute of Medicine, 2004, PRESCR END CONF; Kripalani S, 2006, J GEN INTERN MED, V21, P852, DOI 10.1111/j.1525-1497.2006.00536.x; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Murray MD, 2009, CLIN PHARMACOL THER, V85, P651, DOI 10.1038/clpt.2009.7; Paasche-Orlow MK, 2006, J GEN INTERN MED, V21, P884, DOI 10.1111/j.1525-1497.2006.00544.x; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Powers BJ, 2010, JAMA-J AM MED ASSOC, V304, P76, DOI 10.1001/jama.2010.896; Riegel B, 2009, CIRCULATION, V120, P1141, DOI 10.1161/CIRCULATIONAHA.109.192628; Seligman HK, 2005, J GEN INTERN MED, V20, P1001, DOI 10.1111/j.1525-1497.2005.00189.x; Sudore RL, 2006, J GEN INTERN MED, V21, P806, DOI 10.1111/j.1525-1497.2006.00539.x; von Wagner C, 2009, HEALTH EDUC BEHAV, V36, P860, DOI 10.1177/1090198108322819; Wallace LS, 2007, J SURG RES, V140, P208, DOI 10.1016/j.jss.2007.01.029; Wallace LS, 2006, J GEN INTERN MED, V21, P874, DOI 10.1111/j.1525-1497.2006.00532.x; Weiss BD, 2006, J GEN INTERN MED, V21, P823, DOI 10.1111/j.1525-1497.2006.00531.x; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166	32	269	276	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1695	1701		10.1001/jama.2011.512	http://dx.doi.org/10.1001/jama.2011.512			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521851	Bronze, Green Accepted			2022-12-24	WOS:000289890500023
J	Redman, C; Duffy, S; Bromham, N; Francis, K				Redman, C.; Duffy, S.; Bromham, N.; Francis, K.			GUIDELINES Recognition and initial management of ovarian cancer: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Redman, C.] Univ Hosp N Staffordshire, Stoke On Trent ST4 6QG, Staffs, England; [Duffy, S.] Yorkshire Canc Network, Harrogate HG2 7RY, England; [Bromham, N.; Francis, K.] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales	Keele University	Redman, C (corresponding author), Univ Hosp N Staffordshire, Stoke On Trent ST4 6QG, Staffs, England.			Bromham, Nathan/0000-0003-2165-4188				JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Kirwan JMJ, 2002, BRIT MED J, V324, P148, DOI 10.1136/bmj.324.7330.148; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V61; *NAT I HLTH CLIN E, 2005, CLIN GUID NAT I HLTH, V27; *NAT I HLTH CLIN E, 2011, CLIN GUID NAT I HLTH, V122; National Institute for Health and Clinical Excellence, 2009, GUID MAN; Neilson JP, 2009, OBSTET GYNECOL, V113, P1157, DOI [10.1002/14651858.CD004706.pub2, 10.1097/AOG.0b013e3181a4b7e8]; Office for National Statistics, 2007, SURV RAT ENGL PAT DI; WALSH P, 2005, CANC ATLAS UK IRELAN, P193	9	17	17	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2011	342								d2073	10.1136/bmj.d2073	http://dx.doi.org/10.1136/bmj.d2073			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OR	21511784				2022-12-24	WOS:000289943400004
J	Smagulova, F; Gregoretti, IV; Brick, K; Khil, P; Camerini-Otero, RD; Petukhova, GV				Smagulova, Fatima; Gregoretti, Ivan V.; Brick, Kevin; Khil, Pavel; Camerini-Otero, R. Daniel; Petukhova, Galina V.			Genome-wide analysis reveals novel molecular features of mouse recombination hotspots	NATURE			English	Article							MEIOTIC RECOMBINATION; HOT-SPOT; PRDM9; GENE; MAP; INSTABILITY	Meiotic recombination predominantly occurs at discrete genomic loci called recombination hotspots, but the features defining these areas are still largely unknown (reviewed in refs 1-5). To allow a comprehensive analysis of hotspot-associated DNA and chromatin characteristics, we developed a direct molecular approach for mapping meiotic DNA double-strand breaks that initiate recombination. Here we present the genome-wide distribution of recombination initiation sites in the mouse genome. Hotspot centres are mapped with approximately 200-nucleotide precision, which allows analysis of the fine structural details of the preferred recombination sites. We determine that hotspots share a centrally distributed consensus motif, possess a nucleotide skew that changes polarity at the centres of hotspots and have an intrinsic preference to be occupied by a nucleosome. Furthermore, we find that the vast majority of recombination initiation sites in mouse males are associated with testis-specific trimethylation of lysine 4 on histone H3 that is distinct from histone H3 lysine 4 trimethylation marks associated with transcription. The recombination map presented here has been derived from a homogeneous mouse population with a defined genetic background and therefore lends itself to extensive future experimental exploration. We note that the mapping technique developed here does not depend on the availability of genetic markers and hence can be easily adapted to other species with complex genomes. Our findings uncover several fundamental features of mammalian recombination hotspots and underline the power of the new recombination map for future studies of genetic recombination, genome stability and evolution.	[Smagulova, Fatima; Petukhova, Galina V.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Gregoretti, Ivan V.; Brick, Kevin; Khil, Pavel; Camerini-Otero, R. Daniel] NIDDKD, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Petukhova, GV (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	rdcamerini@mail.nih.gov; gpetukhova@usuhs.mil	Brick, Kevin/N-1156-2019; Smagulova, Fatima/K-5459-2015	Brick, Kevin/0000-0002-9596-6400; Khil, Pavel/0000-0002-4903-8777; Smagulova, Fatima/0000-0001-6883-1968; Mott, Richard/0000-0002-1022-9330	March of Dimes Foundation [5-FY07-667]; NIGMS, NIH [1R01GM084104-01A1]; USUHS [FS71HU, R071HU, CS71HU]; NIDDK (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084104] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USUHS; NIDDK (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Lichten (NCI, NIH) and P. Hsieh (NIDDK, NIH) for comments and discussion. We are grateful to S. Sharmeen for her help with high-throughput sequencing. This work was supported in part by Basil O'Connor Starter Scholar Research Award Grant No. 5-FY07-667 from the March of Dimes Foundation (G. V. P.); NIH grant 1R01GM084104-01A1 from NIGMS (G. V. P.); New Investigator Start-up Grants FS71HU, R071HU and CS71HU from USUHS (G. V. P.); and the NIDDK (NIH) Intramural Research Program (R.D.C.-O.).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnheim N, 2007, ANNU REV GENET, V41, P369, DOI 10.1146/annurev.genet.41.110306.130301; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buard J, 2007, TRENDS GENET, V23, P301, DOI 10.1016/j.tig.2007.03.014; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; Clark AG, 2010, ANNU REV GENOM HUM G, V11, P45, DOI 10.1146/annurev-genom-082908-150031; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kauppi L, 2009, METHODS MOL BIOL, V557, P323, DOI 10.1007/978-1-59745-527-5_20; Khambata S, 1996, GENOME RES, V6, P195, DOI 10.1101/gr.6.3.195; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Qin J, 2004, MOL CELL BIOL, V24, P1655, DOI 10.1128/MCB.24.4.1655-1666.2004; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001	30	235	237	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					375	378		10.1038/nature09869	http://dx.doi.org/10.1038/nature09869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21460839	Green Accepted			2022-12-24	WOS:000289724600045
J	Douglas, I; Evans, S; Smeeth, L				Douglas, Ian; Evans, Stephen; Smeeth, Liam			Effect of statin treatment on short term mortality after pneumonia episode: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; THERAPY	Objective To determine whether statins protect against all cause mortality after a diagnosis of pneumonia. Design Cohort study using propensity score based method to control for differences between people prescribed and not prescribed statins. Setting United Kingdom Health Improvement Network database, which contains electronic primary care medical records of more than six million patients. Participants Every patient starting a statin between 1995 and 2006 (129 288) matched with up to five non-statin users (n=600 241); 9073 patients had a recorded diagnosis of pneumonia, of whom 1398 were using a statin. Main outcome measure All cause mortality within six months of diagnosis of pneumonia. Results Among users and non-users of statins with comparable propensity scores, 95/942 users and 686/ 3615 non-users died on the day that pneumonia was diagnosed. In the following six month period, 109/847 statin users died compared with 578/2927 non-users, giving an adjusted hazard ratio of 0.67 (0.49 to 0.91). If these observed benefits translated into clinical practice, 15 patients would need to be treated with a statin for six months after pneumonia to prevent one death. Conclusions Compared with people who were not taking statins, the risk of dying in the six month period after pneumonia was substantially lower among people who were already established on long term statin treatment when the pneumonia occurred. Whether some or all of this protective effect would be obtained if statin treatment begins when a patient first develops pneumonia is not known. However, given that statins are cheap, safe, and well tolerated, a clinical trial in which people with pneumonia are randomised to a short period of statin treatment is warranted.	[Douglas, Ian; Evans, Stephen; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Douglas, I (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	ian.douglas@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Evans, Stephen/0000-0002-1474-2596; Smeeth, Liam/0000-0002-9168-6022	Wellcome Trust; Medical Research Council; MRC [G0802403] Funding Source: UKRI; Medical Research Council [G0802403] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	During this work, ID was funded by grants from the Wellcome Trust and the Medical Research Council paid to the London School of Hygiene and Tropical Medicine. LS was funded by a grant from the Wellcome Trust. Sponsors played no role in the study design; the collection, analysis, and interpretation of data; the writing of the article; or the decision to submit it for publication	Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Bourke Alison, 2004, Inform Prim Care, V12, P171; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Laufs U, 2001, AM J CARDIOL, V88, P1306, DOI 10.1016/S0002-9149(01)02095-1; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P1195, DOI 10.1002/pds.1441; Li JJ, 2006, ANGIOLOGY, V57, P1, DOI 10.1177/000331970605700101; Liao JK, 2005, AM J CARDIOL, V96, p24F, DOI 10.1016/j.amjcard.2005.06.009; Lodi S, 2010, BRIT J CLIN PHARMACO, V69, P85, DOI 10.1111/j.1365-2125.2009.03560.x; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P697, DOI 10.1002/pds.1769; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Office for National Statistics, 2008, GUID DOCT COMPL MED; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Terblanche M, 2006, LANCET INFECT DIS, V6, P242, DOI 10.1016/S1473-3099(06)70439-X; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286	22	61	61	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 6	2011	342								d1642	10.1136/bmj.d1642	http://dx.doi.org/10.1136/bmj.d1642			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749JR	21471172	Green Accepted, hybrid, Green Published			2022-12-24	WOS:000289462100001
J	Kim, S; Grant, RA; Sauer, RT				Kim, Seokhee; Grant, Robert A.; Sauer, Robert T.			Covalent Linkage of Distinct Substrate Degrons Controls Assembly and Disassembly of DegP Proteolytic Cages	CELL			English	Article							ESCHERICHIA-COLI; SERINE-PROTEASE; HTRA GENE; CHAPERONE; PDZ; TRANSCRIPTION; ACTIVATION; PROTEINS; ENVELOPE; TEMPERATURES	Protein quality control requires careful regulation of intracellular proteolysis. For DegP, a periplasmic protease, substrates promote assembly of inactive hexamers into proteolytically active cages with 12, 18, 24, or 30 subunits. Here, we show that sensitive activation and cage assembly require covalent linkage of distinct substrate sequences that affect degradation (degrons). One degron binds the DegP active site, and another degron binds a separate tethering site in PDZ1 in the crystal structure of a substrate-bound DegP dodecamer. FRET experiments demonstrate that active cages assemble rapidly in a reaction that is positively cooperative in substrate concentration, remain stably assembled while uncleaved substrate is present, and dissociate once degradation is complete. Thus, the energy of binding of linked substrate degrons drives assembly of the proteolytic machine responsible for subsequent degradation. Substrate cleavage and depletion results in disassembly, ensuring that DegP is proteolytically active only when sufficient quantities of protein substrates are present.	[Kim, Seokhee; Grant, Robert A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu	Kim, Seokhee/C-2303-2018	Kim, Seokhee/0000-0003-0806-583X; Sauer, Robert/0000-0002-1719-5399	NIH [AI-16892]; NIH-NCRR [RR-15301]; DOE Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Cezairliyan, A. de Regt, S. Glynn, D. Kahne, H. Kim, I. Levchenko, S. Lima, A. Olivares, I. Papayannopoulos, D. Pheasant, K. Schmitz, T. Schwartz, J. Sohn, and S. F. Sui for help, information, and discussions. Supported by NIH-grant AI-16892. Studies at the NE-CAT beamlines of the Advanced Photon Source were supported by NIH-NCRR award RR-15301 and by the DOE Office of Basic Energy Sciences under contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Iwanczyk J, 2007, J BACTERIOL, V189, P3176, DOI 10.1128/JB.01788-06; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jomaa A, 2007, J BACTERIOL, V189, P706, DOI 10.1128/JB.01334-06; Kolmar H, 1996, J BACTERIOL, V178, P5925, DOI 10.1128/jb.178.20.5925-5929.1996; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Sohn J, 2009, MOL CELL, V33, P64, DOI 10.1016/j.molcel.2008.12.017; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; SWAMY KHS, 1983, ARCH BIOCHEM BIOPHYS, V224, P543, DOI 10.1016/0003-9861(83)90242-4; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4	35	60	63	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					67	78		10.1016/j.cell.2011.02.024	http://dx.doi.org/10.1016/j.cell.2011.02.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458668	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000289053900010
J	Jackevicius, CA; Tu, JV; Ross, JS; Ko, DT; Carreon, D; Krumholz, HM				Jackevicius, Cynthia A.; Tu, Jack V.; Ross, Joseph S.; Ko, Dennis T.; Carreon, Daniel; Krumholz, Harlan M.			Use of Fibrates in the United States and Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR OUTCOMES; GEMFIBROZIL; RHABDOMYOLYSIS; PREVENTION; EVENTS; TRENDS; TRIAL; RISK; MEN	Context Interest in the role of fibrates intensified after the publication of the negative results from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, which assessed therapy with fenofibrate plus statins. The evidence for clinical benefit in outcomes with the use of fibrates is heavily weighted on the use of the older fibrates such as gemfibrozil and clofibrate. Objectives To examine trends in the current use of fibrates and to examine the relationship between differences in the availability and use of brand-name vs generic formulations of fenofibrate and the economic implications in the United States compared with Canada. Design, Setting, and Patients Population-level, observational cohort study using IMS Health data from the United States and Canada of patients prescribed fibrates between January 2002 and December 2009. Main Outcome Measures Fibrate prescriptions dispensed and expenditures. Results In the United States, fibrate prescriptions dispensed increased from 336 prescriptions/100 000 population in January 2002 to 730 prescriptions/100 000 population in December 2009, an increase of 117.1% (95% confidence interval [CI], 116.0%-117.9%), whereas in Canada, fibrate prescriptions increased from 402 prescriptions/100 000 population in January 2002 to 474 prescriptions/100 000 population in December 2009, an increase of 18.1% (95% CI, 17.9%-18.3%) (P<.001). In the United States, fenofibrate prescriptions dispensed increased from 150 prescriptions/100 000 population in January 2002 to 440 prescriptions/100 000 population in December 2009, an increase of 159.3% (95% CI, 157.7%-161.0%), comprising 47.9% of total fibrate prescriptions in 2002 and 65.2% in 2009. In Canada, fenofibrate prescriptions increased from 321 prescriptions/100 000 population in January 2002 to 429 prescriptions/100 000 population in December 2009. The annual ratio of generic to brand-name fenofibrate use in the United States ranged from 0:1 to 0.09:1 between 2002 and 2008, while the ratio in Canada steadily increased from 0.51:1 to 1.89:1 between 2005 and 2008. In the United States, crude fenofibrate expenditures increased from $11 535/100 000 population/month in 2002 to $44 975/100 000 population/month in 2009, while the rates in Canada declined from $17 695/100 000 population/month in 2002 to $16 112/100 000 population/month in 2009. Fibrate expenditures per 100 000 population were 3-fold higher in 2009 in the United States compared with Canada. Conclusion During the past decade, prescriptions for fibrates (particularly fenofibrate) increased in the United States, while prescriptions for fibrates in Canada remained stable. JAMA. 2011; 305(12): 1217-1224	[Jackevicius, Cynthia A.; Carreon, Daniel] Western Univ Hlth Sci, Coll Pharm, Dept Pharm Practice & Adm, Pomona, CA 91766 USA; [Jackevicius, Cynthia A.; Tu, Jack V.; Ko, Dennis T.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Jackevicius, Cynthia A.; Tu, Jack V.] Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Tu, Jack V.; Ko, Dennis T.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Jackevicius, Cynthia A.] Univ Hlth Network, Toronto, ON, Canada; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Med,Sect Gen Internal Med, Ctr Outcomes Res & Evaluat,Yale New Haven Hosp, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth,Sect Hlth Policy & Adm, Ctr Outcomes Res & Evaluat,Yale New Haven Hosp, New Haven, CT 06510 USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, Ctr Outcomes Res & Evaluat,Yale New Haven Hosp, New Haven, CT USA; [Krumholz, Harlan M.] Robert Wood Johnson Clin Scholars Program, New Haven, CT USA	Western University of Health Sciences; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Yale University; Yale University; Yale University	Jackevicius, CA (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharm Practice & Adm, 309 E 2nd St, Pomona, CA 91766 USA.	cjackevicius@westernu.edu	, Harlan/AAI-2875-2020	Ko, Dennis/0000-0001-6840-8051; Ross, Joseph/0000-0002-9218-3320; Tu, Jack/0000-0003-0111-722X	College of Pharmacy of Western University of Health Sciences, Pomona, California; Canadian Institutes of Health Research; Canada Research Chair in Health Services Research; Heart and Stroke Foundation of Ontario, Toronto; National Institute on Aging [K08 AG032886]; American Federation of Aging Research; National Heart, Lung, and Blood Institute [U01-HL105270]; Ontario Ministry of Health and Long-Term Care, Toronto; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	College of Pharmacy of Western University of Health Sciences, Pomona, California; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Health Services Research(Canada Research Chairs); Heart and Stroke Foundation of Ontario, Toronto(Heart & Stroke Foundation of Ontario); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation of Aging Research; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ontario Ministry of Health and Long-Term Care, Toronto(Ministry of Health and Long-Term Care, Ontario); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded in part by the College of Pharmacy of Western University of Health Sciences, Pomona, California, and in part by a Canadian Institutes of Health Research team grant in cardiovascular outcomes research awarded to the Canadian Cardiovascular Outcomes Research Team. Dr Tu is supported by a Canada Research Chair in Health Services Research and by a Career Investigator award of the Heart and Stroke Foundation of Ontario, Toronto. Dr Ross is currently supported by the National Institute on Aging grant K08 AG032886 and by the American Federation of Aging Research through the Paul B. Beeson Career Development Award Program. Dr Ko is supported by a new investigator award from the Canadian Institutes of Health Research. Dr Krumholz is supported by grant U01-HL105270 (awarded to the Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. The Institute for Clinical Evaluative Sciences is supported by an operating grant from the Ontario Ministry of Health and Long-Term Care, Toronto.	Abourbih S, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.03.030; Alsheikh-Ali AA, 2004, AM J CARDIOL, V94, P935, DOI 10.1016/j.amjcard.2004.06.033; [Anonymous], ABB SUES LUP AMD APP; [Anonymous], WALL STREET J; Backman JT, 2000, CLIN PHARMACOL THER, V68, P122, DOI 10.1067/mcp.2000.108507; Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Danzon PM, 2008, HEALTH AFFAIR, V27, P221, DOI 10.1377/hlthaff.27.1.221; Drugs@FDA, APPR DRUG PROD; Fischer MA, 2003, HEALTH SERV RES, V38, P1051, DOI 10.1111/1475-6773.00162; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Health Canada, NOT COMPL; IMS Health Inc, IMS DAT ASS DAT INF; Institute of Medicine, 2010, EV BIOM SURR ENDP CH; Jackevicius CA, 2008, NEW ENGL J MED, V358, P1819, DOI 10.1056/NEJMsa0801461; Jackevicius CA, 2009, CAN MED ASSOC J, V181, pE19, DOI 10.1503/cmaj.081913; Jones PH, 2005, AM J CARDIOL, V95, P120, DOI 10.1016/j.amjcard.2004.08.076; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Majumdar SR, 2003, AM J MED, V115, P467, DOI 10.1016/S0002-9343(03)00422-4; Office of the Attorney General State of California, TRICOR SETTL AGR; Office of the Attorney General State of New York, ATT GEN CUOM ANN SET; Omar MA, 2002, ANN PHARMACOTHER, V36, P288, DOI 10.1345/aph.1A289; Orange Book Blog, ANT CAS ABB MOV FORW; Redberg RF, 2010, ARCH INTERN MED, V170, P384, DOI 10.1001/archinternmed.2010.48; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stafford RS, 2004, JAMA-J AM MED ASSOC, V291, P54, DOI 10.1001/jama.291.1.54; *STAT CAN, 2001 CENS CAN; US Census Bureau, TABL 1 POP EST; Vachris MA, 1999, MON LABOR REV, V122, P3; VHA Pharmacy Benefits Management, STAT REP	35	63	64	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1217	1224		10.1001/jama.2011.353	http://dx.doi.org/10.1001/jama.2011.353			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427374	Green Accepted, Bronze			2022-12-24	WOS:000288652100017
J	Shah, SM; Carey, IM; Harris, T; DeWilde, S; Cook, DG				Shah, Sunil M.; Carey, Iain M.; Harris, Tess; DeWilde, Stephen; Cook, Derek G.			Quality of chronic disease care for older people in care homes and the community in a primary care pay for performance system: retrospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-FAILURE; NURSING-HOMES; OF-CARE; RESIDENTS; MANAGEMENT; HEALTH	Objective To describe the quality of care for chronic diseases among older people in care homes (nursing and residential) compared with the community in a pay for performance system. Design Retrospective analysis of The Health Improvement Network (THIN), a large primary care database. Setting 326 English and Welsh general practices, 2008-9. Participants 10 387 residents of care homes and 403 259 residents in the community aged 65 to 104 and registered for 90 or more days with their general practitioner. Main outcome measure 16 process quality indicators for chronic disease management appropriate for vulnerable older people for conditions included in the UK Quality and Outcomes Framework. Results After adjustment for age, sex, dementia, and length of registration, attainment of quality indicators was significantly lower for residents of care homes than for those in the community for 14 of 16 indicators. The largest differences were for prescribing in heart disease (beta blockers in coronary heart disease, relative risk 0.70, 95% confidence interval 0.65 to 0.75) and monitoring of diabetes (retinal screening, 0.75, 0.71 to 0.80). Monitoring hypothyroidism (0.93, 0.90 to 0.95), blood pressure in people with stroke (0.92, 0.90 to 0.95), and electrolytes for those receiving loop diuretics (0.89, 0.87 to 0.92) showed smaller differences. Attainment was lower in nursing homes than in residential homes. Residents of care homes were more likely to be identified by their doctor as unsuitable or non-consenting for all Quality and Outcomes Framework indicators for a condition allowing their exclusion from targets; 33.7% for stroke and 34.5% for diabetes. Conclusion There is scope for improving the management of chronic diseases in care homes, but high attainment of some indicators shows that pay for performance systems do not invariably disadvantage residents of care homes compared with those living in the community. High use of exception reporting may compromise care for vulnerable patient groups. The Quality and Outcomes Framework, and other pay for performance systems, should monitor attainment and exception reporting in vulnerable populations such as residents of care homes and consider measures that deal with the specific needs of older people.	[Shah, Sunil M.; Carey, Iain M.; Harris, Tess; DeWilde, Stephen; Cook, Derek G.] Univ London, Div Populat Hlth Sci & Educ, London SW17 0RE, England	University of London	Shah, SM (corresponding author), Univ London, Div Populat Hlth Sci & Educ, London SW17 0RE, England.	sushah@sgul.ac.uk	Carey, Iain/O-6973-2014	Carey, Iain/0000-0003-1099-8460; Harris, Tess/0000-0002-8671-1553; Cook, Derek/0000-0002-9723-5759; DeWilde, Stephen/0000-0002-4238-4474	BUPA Foundation	BUPA Foundation	This study was funded by a grant from the BUPA Foundation, an independent medical research charity. The funder had no involvement in the study design; collection, analysis, and interpretation of the data; writing of the article; or decision to submit the article for publication.	[Anonymous], 2007, J AM GERIATR SOC, V55, pS464; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bourke Alison, 2004, Inform Prim Care, V12, P171; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Fahey T, 2003, BRIT MED J, V326, P580, DOI 10.1136/bmj.326.7389.580; Feldman SM, 2009, J AM MED DIR ASSOC, V10, P354, DOI 10.1016/j.jamda.2009.02.010; Heckman GA, 2004, CAN J CARDIOL, V20, P963; Lester Helen, 2010, Qual Prim Care, V18, P103; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Litaker JR, 2003, CLIN THER, V25, P1918, DOI 10.1016/S0149-2918(03)80196-0; McMurdo MET, 2007, BRIT MED J, V334, P913, DOI 10.1136/bmj.39191.405833.80; NHS Employers, 2006, GUID EXC REC; Petrovic M, 2010, BRIT J CLIN PHARMACO, V69, P713; Resnick HE, 2008, DIABETES CARE, V31, P287, DOI 10.2337/dc07-1425; Rochon PA, 1999, JAMA-J AM MED ASSOC, V282, P113, DOI 10.1001/jama.282.2.113; Saliba Debra, 2004, J Am Med Dir Assoc, V5, P297, DOI 10.1016/S1525-8610(04)70019-5; Shah SM, 2010, AGE AGEING, V39, P617, DOI 10.1093/ageing/afq086; Shah SM, 2008, BRIT J GEN PRACT, V58, P862, DOI 10.3399/bjgp08X376195; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Steel N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a957; Steel N, 2007, BRIT J GEN PRACT, V57, P449; Wenger NS, 2007, J AM GERIATR SOC, V55, pS457, DOI 10.1111/j.1532-5415.2007.01375.x; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Zingmond DS, 2009, MED CARE, V47, P536, DOI 10.1097/MLR.0b013e318190cd8b	25	40	40	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2011	342								d912	10.1136/bmj.d912	http://dx.doi.org/10.1136/bmj.d912			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UY	21385803	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000288446800007
J	Maxmen, A				Maxmen, Amy			Exome Sequencing Deciphers Rare Diseases	CELL			English	News Item																			0	26	29	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					635	637		10.1016/j.cell.2011.02.033	http://dx.doi.org/10.1016/j.cell.2011.02.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376225	Bronze			2022-12-24	WOS:000288007100002
J	George, PM; Banya, W; Pareek, N; Bilton, D; Cullinan, P; Hodson, ME; Simmonds, NJ				George, P. M.; Banya, W.; Pareek, N.; Bilton, D.; Cullinan, P.; Hodson, M. E.; Simmonds, N. J.			Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RECOMBINANT HUMAN DNASE; PSEUDOMONAS-AERUGINOSA; CONTROLLED-TRIAL; DORNASE-ALPHA; MORTALITY; TRANSPLANTATION; CF	Objectives To evaluate the survival of patients with cystic fibrosis whose lung function has deteriorated to a forced expiratory volume in one second (FEV1) below 30% predicted in the recent treatment era and to explore factors associated with any change in survival. Design Cohort study. Setting Adult cystic fibrosis unit in London. Participants 276 patients (147 (53%) male) whose FEV1 was first observed to be less than 30% predicted between 1 January 1990 and 31 December 2003. Main outcome measure Survival during follow-up to 31 December 2007 in two year sub-cohorts. Results Median survival improved from 1.2 years in the 1990-1 group to 5.3 years in the 2002-3 group, with a marked improvement in survival from 1994. The use of nebulised recombinant human DNase was significantly associated with a reduced risk of death (hazard ratio 0.59, 95% confidence interval 0.44 to 0.79). Significantly increased risks were associated with a body mass index under 19 (hazard ratio 1.52, 1.10 to 2.10), long term oxygen therapy (3.52, 2.49 to 4.99), and nebulised antibiotics (1.84, 1.05 to 3.22). Conclusion A marked improvement has occurred in the survival of patients with cystic fibrosis with an FEV1 less than 30% predicted. Secondary analyses suggest that some of this improvement may be due to use of recombinant human DNase.	[George, P. M.; Pareek, N.; Bilton, D.; Hodson, M. E.; Simmonds, N. J.] Royal Brompton Hosp, Dept Cyst Fibrosis, London SW3 6NP, England; [Banya, W.] Royal Brompton Hosp, Dept Res & Dev, London SW3 6NP, England; [Bilton, D.; Cullinan, P.; Hodson, M. E.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Royal Brompton Hospital; Royal Brompton Hospital; Imperial College London	Simmonds, NJ (corresponding author), Royal Brompton Hosp, Dept Cyst Fibrosis, London SW3 6NP, England.	n.simmonds@rbht.nhs.uk		Bilton, Diana/0000-0002-1913-9171	Respiratory Biomedical Research Unit (BRU) at the Royal Brompton Hospital; National Institute for Health Research [CL-2008-16-001] Funding Source: researchfish	Respiratory Biomedical Research Unit (BRU) at the Royal Brompton Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by the Respiratory Biomedical Research Unit (BRU) at the Royal Brompton Hospital; MEH, DB, and NJS are part of the Chronic Suppurative Lung Disease (CSLD) research consortium of the Respiratory BRU. We acknowledge the input of Khin Gyi for supporting the data collection process that proved invaluable to the study.	Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; Doershuk CF, 1999, CHEST, V115, P782, DOI 10.1378/chest.115.3.782; ELBORN JS, 1991, THORAX, V46, P881, DOI 10.1136/thx.46.12.881; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; FINKELSTEIN SM, 1988, J PEDIATR-US, V112, P373, DOI 10.1016/S0022-3476(88)80315-9; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; GIBSON GJ, 1993, EUR RESPIR J, V6, P155; Hodson ME, 2008, J CYST FIBROS, V7, P537, DOI 10.1016/j.jcf.2008.06.003; Jones AP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001127.pub2; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Liou TG, 2001, JAMA-J AM MED ASSOC, V286, P2683, DOI 10.1001/jama.286.21.2683; Madden BP, 2002, EUR RESPIR J, V19, P310, DOI 10.1183/09031936.02.00218502; Mahadeva R, 1998, BMJ-BRIT MED J, V316, P1771, DOI 10.1136/bmj.316.7147.1771; Milla CE, 2005, DIABETES CARE, V28, P2141, DOI 10.2337/diacare.28.9.2141; Milla CE, 1998, CHEST, V113, P1230, DOI 10.1378/chest.113.5.1230; MISCHLER EH, 1982, AM J DIS CHILD, V136, P1060, DOI 10.1001/archpedi.1982.03970480026006; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; Paul K, 2004, AM J RESP CRIT CARE, V169, P719, DOI 10.1164/rccm.200307-959OC; Quan JM, 2001, J PEDIATR-US, V139, P813, DOI 10.1067/mpd.2001.118570; RAMSEY BW, 1993, NEW ENGL J MED, V328, P1740, DOI 10.1056/NEJM199306173282403; Rosenfeld M, 1997, AM J EPIDEMIOL, V145, P794; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; SHAH PL, 1995, THORAX, V50, P333, DOI 10.1136/thx.50.4.333; Steinkamp G, 2002, THORAX, V57, P596, DOI 10.1136/thorax.57.7.596; UK Cystic Fibrosis Trust Nutrition Working Group, 2002, NUTR MAN CYST FIBR; Wark P, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001506.pub3	28	77	81	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2011	342								d1008	10.1136/bmj.d1008	http://dx.doi.org/10.1136/bmj.d1008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732DK	21357627	Green Published, hybrid			2022-12-24	WOS:000288164200003
J	Su, CC; Long, F; Zimmermann, MT; Rajashankar, KR; Jernigan, RL; Yu, EW				Su, Chih-Chia; Long, Feng; Zimmermann, Michael T.; Rajashankar, Kanagalaghatta R.; Jernigan, Robert L.; Yu, Edward W.			Crystal structure of the CusBA heavy-metal efflux complex of Escherichia coli	NATURE			English	Article							MEMBRANE-FUSION PROTEIN; MULTIDRUG EFFLUX; PSEUDOMONAS-AERUGINOSA; PERIPLASMIC COMPONENT; PUMP; ACRB; SYSTEM; TRANSPORTER; SOFTWARE; CRYSTALLOGRAPHY	Gram-negative bacteria, such as Escherichia coli, expel toxic chemicals through tripartite efflux pumps that span both the inner and outer membrane. The three parts are an inner membrane, substrate-binding transporter; a membrane fusion protein; and an outer-membrane-anchored channel. The fusion protein connects the transporter to the channel within the periplasmic space. A crystallographic model of this tripartite efflux complex has been unavailable because co-crystallization of the various components of the system has proven to be extremely difficult. We previously described the crystal structures of both the inner membrane transporter CusA(1) and the membrane fusion protein CusB(2) of the CusCBA efflux system(3,4) of E. coli. Here we report the co-crystal structure of the CusBA efflux complex, showing that the transporter (or pump) CusA, which is present as a trimer, interacts with six CusB protomers and that the periplasmic domain of CusA is involved in these interactions. The six CusB molecules seem to form a continuous channel. The affinity of the CusA and CusB interaction was found to be in the micromolar range. Finally, we have predicted a three-dimensional structure for the trimeric CusC outer membrane channel and developed a model of the tripartite efflux assemblage. This CusC(3)-CusB(6)-CusA(3) model shows a 750-kilodalton efflux complex that spans the entire bacterial cell envelope and exports Cu I and Ag I ions.	[Su, Chih-Chia; Long, Feng; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Zimmermann, Michael T.; Jernigan, Robert L.; Yu, Edward W.] Iowa State Univ, Bioinformat & Computat Biol Interdept Grad Progra, Ames, IA 50011 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, NE CAT, Argonne, IL 60439 USA; [Jernigan, Robert L.; Yu, Edward W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA	Iowa State University; Iowa State University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Iowa State University; Iowa State University	Yu, EW (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	ewyu@iastate.edu	Long, Feng/F-5475-2011; Jernigan, Robert L/A-5421-2012	Long, Feng/0000-0001-6313-8558; Jernigan, Robert L/0000-0003-0996-8360; Zimmermann, Michael/0000-0001-7073-0525	National Institutes of Health [R01GM074027, R01GM086431, R01GM081680, R01GM072014]; National Center for Research Resources at the National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086431, R01GM072014, R01GM074027, R01GM081680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grants R01GM074027 (E.W.Y.), R01GM086431 (E.W.Y.), R01GM081680 (R.L.J.) and R01GM072014 (R.L.J.). This work is based on research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; Bagai I, 2007, J BIOL CHEM, V282, P35695, DOI 10.1074/jbc.M703937200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Gerken H, 2004, MOL MICROBIOL, V54, P620, DOI 10.1111/j.1365-2958.2004.04301.x; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Su CC, 2006, J BACTERIOL, V188, P7290, DOI 10.1128/JB.00684-06; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Xue Y, 2008, NAT CHEM BIOL, V4, P107, DOI 10.1038/nchembio.2007.57	33	160	161	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					558	U153		10.1038/nature09743	http://dx.doi.org/10.1038/nature09743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350490	Green Accepted, Green Submitted			2022-12-24	WOS:000287652900047
J	DESMET, J; DEMAEYER, M; HAZES, B; LASTERS, I				DESMET, J; DEMAEYER, M; HAZES, B; LASTERS, I			THE DEAD-END ELIMINATION THEOREM AND ITS USE IN PROTEIN SIDE-CHAIN POSITIONING	NATURE			English	Article							CONFORMATION	THE prediction of a protein's tertiary structure is still a considerable problem because the huge amount of possible conformational space' makes it computationally difficult. With regard to side-chain modelling, a solution has been attempted by the grouping of side-chain conformations into representative sets of rotamers 2-5. Nonetheless, an exhaustive combinatorial search is still limited to carefully identified packing units 5,6 containing a limited number of residues. For larger systems other strategies had to be developed, such as the Monte Carlo Procedure 6,7 and the genetic algorithm and clustering approach 8. Here we present a theorem, referred to as the 'dead-end elimination' theorem, which imposes a suitable condition to identify rotamers that cannot be members of the global minimum energy conformation. Application of this theorem effectively controls the computational explosion of the rotamer combinatorial problem, thereby allowing the determination of the global minimum energy conformation of a large collection of side chains.	CORVAS INT NV,B-9000 GHENT,BELGIUM; UNIV GRONINGEN,BIOSON RES INST,DEPT CHEM,9747 AG GRONINGEN,NETHERLANDS	University of Groningen	DESMET, J (corresponding author), KATHOLIEKE UNIV LEUVEN,INTERDISCIPLINARY RES CTR,CAMPUS KORTRIJK,B-8500 KORTRIJK,BELGIUM.							BERENSTEIN FC, 1977, J MOL BIOL, V112, P535; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; DELHAISE P, 1984, J MOL GRAPHICS, V2, P103, DOI 10.1016/0263-7855(84)80002-8; JAMES MNG, 1983, J MOL BIOL, V163, P299, DOI 10.1016/0022-2836(83)90008-6; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; LEE C, 1991, NATURE, V352, P448, DOI 10.1038/352448a0; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; MCGREGOR MJ, 1987, J MOL BIOL, V198, P295, DOI 10.1016/0022-2836(87)90314-7; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; TUFFERY P, 1991, J BIOMOL STRUCT DYN, V8, P1267, DOI 10.1080/07391102.1991.10507882	12	557	587	2	36	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 9	1992	356	6369					539	542		10.1038/356539a0	http://dx.doi.org/10.1038/356539a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN231	21488406				2022-12-24	WOS:A1992HN23100065
J	Heuser, RG; Osborne, M; Hall, J				Heuser, Rose G.; Osborne, Molly L.; Hall, Jesse			Update in Pulmonary and Critical Care Medicine: Evidence Published in 2010	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DISEASE; RISK	This Update summarizes studies published in 2010 that the authors consider highly relevant to the practice of pulmonary and critical care medicine. Topics include anticholinergic therapy in asthma, identification of patients with chronic obstructive pulmonary disease who are at risk for exacerbations, pulmonary vasodilator therapy in idiopathic pulmonary fibrosis, tuberculosis testing, tyrosine kinase inhibitors in non-small cell lung cancer, early palliative care and cancer survival, outcomes of critical illness, sedatives and neuromuscular blockade in critically ill patients, interventions and monitoring in patients with shock, and management of acute hypoxemic respiratory failure.	Oregon Hlth & Sci Univ, Dept Med, Pulm & Crit Care, Portland, OR 97239 USA; Univ Chicago Hosp & Clin, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA	Oregon Health & Science University; University of Chicago; University of Illinois System	Osborne, M (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Pulm & Crit Care, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.							Au DH, 2009, J GEN INTERN MED, V24, P457, DOI 10.1007/s11606-009-0907-y; Collard HR, 2007, CHEST, V131, P897, DOI 10.1378/chest.06-2101; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800	5	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					614	621		10.7326/0003-4819-154-9-201105030-00339	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00339			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21464338				2022-12-24	WOS:000290112300014
J	Rappaport, B; Mellon, RD; Simone, A; Woodcock, J				Rappaport, Bob; Mellon, R. Daniel; Simone, Arthur; Woodcock, Janet			Defining Safe Use of Anesthesia in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COHORT		[Rappaport, Bob; Mellon, R. Daniel; Simone, Arthur] US FDA, Off New Drugs, Div Anesthesia & Analgesia Prod, Silver Spring, MD 20993 USA; [Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Rappaport, B (corresponding author), US FDA, Off New Drugs, Div Anesthesia & Analgesia Prod, Silver Spring, MD 20993 USA.							Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; JR SW, 2007, TOXICOL SCI, V98, P145; PAULE MG, 2011, NEUROTOXICOL TE 0115; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d	5	153	156	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1387	1390		10.1056/NEJMp1102155	http://dx.doi.org/10.1056/NEJMp1102155			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	749LD	21388302	Bronze			2022-12-24	WOS:000289467200002
J	Haber, DA; Gray, NS; Baselga, J				Haber, Daniel A.; Gray, Nathanael S.; Baselga, Jose			The Evolving War on Cancer	CELL			English	Article							CELL LUNG-CANCER; KINASE INHIBITORS; MUTATIONS; EGFR; GEFITINIB; IMATINIB; GENE; IDENTIFICATION; CHROMOSOME; RESISTANCE	Building on years of basic scientific discovery, recent advances in the fields of cancer genetics and medicinal chemistry are now converging to revolutionize the treatment of cancer. Starting with serendipitous observations in rare subsets of cancer, a paradigm shift in clinical research is poised to ensure that new molecular insights are rapidly applied to shape emerging cancer therapies. Could this mark a turning point in the "War on Cancer''?	[Haber, Daniel A.; Baselga, Jose] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Haber, DA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Baselga J, 2010, SAN ANT BREAST CANC, pS3; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Cosimo S, 2010, ASCO M, V28, P3008; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Furman RR, 2010, ASCO MEET ABSTR, V28, P3032; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leaf C., 2004, FORTUNE MAGAZIN 0322; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Marsden BD, 2008, CURR OPIN CHEM BIOL, V12, P40, DOI 10.1016/j.cbpa.2008.01.042; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; NOWELL PC, 1960, SCIENCE, V132, P1497; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; ODAY S, 2010, ASCO M, V28, P4; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	39	165	172	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					19	24		10.1016/j.cell.2011.03.026	http://dx.doi.org/10.1016/j.cell.2011.03.026			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458664	Bronze			2022-12-24	WOS:000289053900005
J	Chen, P; Lin, JJ; Lu, CS; Ong, CT; Hsieh, PF; Yang, CC; Tai, CT; Wu, SL; Lu, CH; Hsu, YC; Yu, HY; Ro, LS; Lu, CT; Chu, CC; Tsai, JJ; Su, YH; Lan, SH; Sung, SF; Lin, SY; Chuang, HP; Huang, LC; Chen, YJ; Tsai, PJ; Liao, HT; Lin, YH; Chen, CH; Chung, WH; Hung, SI; Wu, JY; Chang, CF; Chen, L; Chen, YT; Shen, CY				Chen, Pei; Lin, Juei-Jueng; Lu, Chin-Song; Ong, Cheung-Ter; Hsieh, Peiyuan F.; Yang, Chih-Chao; Tai, Chih-Ta; Wu, Shey-Lin; Lu, Cheng-Hsien; Hsu, Yung-Chu; Yu, Hsiang-Yu; Ro, Long-Sun; Lu, Chung-Ta; Chu, Chun-Che; Tsai, Jing-Jane; Su, Yu-Hsiang; Lan, Sheng-Hsing; Sung, Sheng-Feng; Lin, Shu-Yi; Chuang, Hui-Ping; Huang, Li-Chen; Chen, Ying-Ju; Tsai, Pei-Joung; Liao, Hung-Ting; Lin, Yu-Hsuan; Chen, Chien-Hsiun; Chung, Wen-Hung; Hung, Shuen-Iu; Wu, Jer-Yuarn; Chang, Chi-Feng; Chen, Luke; Chen, Yuan-Tsong; Shen, Chen-Yang		Taiwan SJS Consortium	Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEVENS-JOHNSON-SYNDROME; ADVERSE DRUG-REACTIONS; EPIDERMAL NECROLYSIS; ASSOCIATION; ALLELE; POPULATION; MARKER; DEATH	BACKGROUND Carbamazepine, an anticonvulsant and a mood-stabilizing drug, is the main cause of the Stevens-Johnson syndrome (SJS) and its related disease, toxic epidermal necrolysis (TEN), in Southeast Asian countries. Carbamazepine-induced SJS-TEN is strongly associated with the HLA B* 1502 allele. We sought to prevent carbamazepine- induced SJS-TEN by using HLA-B*1502 screening to prospectively identify subjects at genetic risk for the condition. METHODS From 23 hospitals in Taiwan, we recruited 4877 candidate subjects who had not taken carbamazepine. We genotyped DNA purified from the subjects' peripheral blood to determine whether they carried the HLA-B*1502 allele. Those testing positive for HLA-B*1502 (7.7% of the total) were advised not to take carbamazepine and were given an alternative medication or advised to continue taking their prestudy medication; those testing negative (92.3%) were advised to take carbamazepine. We interviewed the subjects by telephone once a week for 2 months to monitor them for symptoms. We used the estimated historical incidence of SJS-TEN as a control. RESULTS Mild, transient rash developed in 4.3% of subjects; more widespread rash developed in 0.1% of subjects, who were hospitalized. SJS-TEN did not develop in any of the HLA-B*1502-negative subjects receiving carbamazepine. In contrast, the estimated historical incidence of carbamazepine-induced SJS-TEN (0.23%) would translate into approximately 10 cases among study subjects (P<0.001). CONCLUSIONS The identification of subjects carrying the HLA-B* 1502 allele and the avoidance of carbamazepine therapy in these subjects was strongly associated with a decrease in the incidence of carbamazepine-induced SJS-TEN.	[Chen, Pei; Wu, Shey-Lin; Chuang, Hui-Ping; Huang, Li-Chen; Chen, Ying-Ju; Tsai, Pei-Joung; Liao, Hung-Ting; Lin, Yu-Hsuan; Chen, Chien-Hsiun; Hung, Shuen-Iu; Wu, Jer-Yuarn; Chen, Yuan-Tsong; Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Lin, Juei-Jueng] Chu Shang Show Chwan Hosp, Nantou, Taiwan; [Lu, Chin-Song; Ro, Long-Sun; Chu, Chun-Che] Chang Gung Mem Hosp Linkou, Dept Neurol, Kweishan, Taiwan; [Chung, Wen-Hung] Chang Gung Mem Hosp Linkou, Dept Dermatol, Kweishan, Taiwan; Chang Gung Univ, Coll Med, Kweishan, Taiwan; [Ong, Cheung-Ter; Hsu, Yung-Chu; Su, Yu-Hsiang; Sung, Sheng-Feng] Chia Yi Christian Hosp, Chiayi, Taiwan; [Hsieh, Peiyuan F.] Taichung Vet Gen Hosp, Taichung, Taiwan; [Hsieh, Peiyuan F.] Natl Chi Nan Univ, Nantou, Taiwan; [Yang, Chih-Chao] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Tai, Chih-Ta; Lan, Sheng-Hsing] Kaohsiung Med Univ, Chung Ho Mem Hosp, Kaohsiung, Taiwan; [Tai, Chih-Ta; Lan, Sheng-Hsing] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Wu, Shey-Lin] Changhua Christian Hosp, Changhua, Taiwan; [Lu, Cheng-Hsien] Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Yu, Hsiang-Yu] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Yu, Hsiang-Yu] Natl Yang Ming Univ, Taipei 112, Taiwan; [Shen, Chen-Yang] China Med Univ, Coll Publ Hlth, Taichung, Taiwan; [Lu, Chung-Ta] China Med Univ, China Med Univ Hosp, Taichung, Taiwan; [Tsai, Jing-Jane] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; [Chen, Yuan-Tsong] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA	Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Taichung Veterans General Hospital; National Chi Nan University; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Changhua Christian Hospital; Chang Gung Memorial Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Duke University	Chen, P (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd, Taipei 115, Taiwan.	chen0010@ibms.sinica.edu.tw; bmcys@ibms.sinica.edu.tw	Wu, Jer-Yuarn/S-7010-2018; Hung, Shuen-Iu/ABB-2139-2021; Hung, Shuen-Iu/HHS-9012-2022; Shen, CY/F-6271-2010; Chen, Chien Hsiun/Q-3826-2018	Hung, Shuen-Iu/0000-0001-6531-5538; Yang, Chih-Chao/0000-0002-0352-3144; Huang, Ying-Zu/0000-0002-8666-4013; Chen, Pei-Jer/0000-0001-8316-3785; Yu, Hsiang-Yu/0000-0002-8183-1863	National Science Council of Taiwan; Taiwan Drug Relief Foundation; National Science Council, Taiwan; Academy-Industry Collaboration Program [NSC95-3112- B-001-023, NSC97-3112-B-001-007]; Taiwan Drug Relief Foundation [TDRF9707, TDRF9809]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Drug Relief Foundation; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academy-Industry Collaboration Program; Taiwan Drug Relief Foundation	Funded by the National Science Council of Taiwan and the Taiwan Drug Relief Foundation; Supported by grants from the National Research Program for Genomic Medicine, National Science Council, Taiwan (for the National Clinical Core and the National Genotyping Core) and from the Academy-Industry Collaboration Program (NSC95-3112- B-001-023 and NSC97-3112-B-001-007); and the Taiwan Drug Relief Foundation (TDRF9707 and TDRF9809).	Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Flockhart DA, 2009, CLIN PHARMACOL THER, V86, P109, DOI 10.1038/clpt.2009.39; Fritsch P O, 2000, Am J Clin Dermatol, V1, P349, DOI 10.2165/00128071-200001060-00003; Garcia-Doval I, 2000, ARCH DERMATOL, V136, P323, DOI 10.1001/archderm.136.3.323; Hung Shuen-Iu, 2005, Per Med, V2, P225, DOI 10.2217/17410541.2.3.225; Hung SL, 2006, PHARMACOGENET GENOM, V16, P297, DOI 10.1097/01.fpc.0000199500.46842.4a; JC R, 1994, NEW ENGL J MED, V331, P1272; Lim KS, 2008, NEUROL ASIA, V13, P15; Locharernkul C, 2009, EPILEPSIA, V50, P971, DOI 10.1111/j.1528-1167.2009.02138_2.x; Lonjou C, 2006, PHARMACOGENOMICS J, V6, P265, DOI 10.1038/sj.tpj.6500356; Man CBL, 2008, EPILEPSIA, V49, P941; Man CBL, 2007, EPILEPSIA, V48, P1015, DOI 10.1111/j.1528-1167.2007.01022.x; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Mehta TY, 2009, INDIAN J DERMATOL VE, V75, P579, DOI 10.4103/0378-6323.57718; Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537; Tassaneeyakul W, 2010, EPILEPSIA, V51, P926, DOI 10.1111/j.1528-1167.2010.02533.x; WEI CY, 2010, TAIW ACGA 2010 INT C; Yang CWO, 2007, J ALLERGY CLIN IMMUN, V120, P870, DOI 10.1016/j.jaci.2007.06.017	19	472	505	0	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1126	1133		10.1056/NEJMoa1009717	http://dx.doi.org/10.1056/NEJMoa1009717			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428768				2022-12-24	WOS:000288701100007
J	Sporn, MB				Sporn, Michael B.			PERSPECTIVE The big C - for Chemoprevention	NATURE			English	Editorial Material							TRIAL		Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA	Dartmouth College	Sporn, MB (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA.	michael.b.sporn@dartmouth.edu						Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Issa JPJ, 2011, CANCER PREV RES, V4, P6, DOI 10.1158/1940-6207.CAPR-10-0348; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; LaCroix AZ, 2010, JNCI-J NATL CANCER I, V102, P1706, DOI 10.1093/jnci/djq415; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Schmidt C, 2010, J NATL CANCER I, V102, P1690, DOI 10.1093/jnci/djq477; Sporn MB, 2006, NAT CLIN PRACT ONCOL, V3, P364, DOI 10.1038/ncponc0536; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047	10	31	32	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S10	S11		10.1038/471S10a	http://dx.doi.org/10.1038/471S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430710				2022-12-24	WOS:000288702200011
J	Spence, D				Spence, Des			From The Frontline Bad medicine: gynaecological examinations	BRITISH MEDICAL JOURNAL			English	Editorial Material							NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS					destwo@yahoo.co.uk						Chernesky MA, 2005, SEX TRANSM DIS, V32, P729, DOI 10.1097/01.olq.0000190057.61633.8d; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; Fang JY, 2008, J PEDIATR ADOL GYNEC, V21, P355, DOI 10.1016/j.jpag.2008.03.010; Padilla LA, 2005, INT J GYNECOL OBSTET, V88, P84, DOI 10.1016/j.ijgo.2004.09.015; Simms I, 2003, SEX TRANSM INFECT, V79, P491, DOI 10.1136/sti.79.6.491	5	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2011	342								d1342	10.1136/bmj.d1342	http://dx.doi.org/10.1136/bmj.d1342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732EO	21367841				2022-12-24	WOS:000288167900003
J	Ang, YS; Tsai, SY; Lee, DF; Monk, J; Su, J; Ratnakumar, K; Ding, JJ; Ge, YC; Darr, H; Chang, B; Wang, JL; Rendl, M; Bernstein, E; Schaniel, C; Lemischka, IR				Ang, Yen-Sin; Tsai, Su-Yi; Lee, Dung-Fang; Monk, Jonathan; Su, Jie; Ratnakumar, Kajan; Ding, Junjun; Ge, Yongchao; Darr, Henia; Chang, Betty; Wang, Jianlong; Rendl, Michael; Bernstein, Emily; Schaniel, Christoph; Lemischka, Ihor R.			Wdr5 Mediates Self-Renewal and Reprogramming via the Embryonic Stem Cell Core Transcriptional Network	CELL			English	Article							CHROMATIN-STRUCTURE; DEVELOPMENTAL REGULATORS; HISTONE H3; POLYCOMB; GENES; PLURIPOTENT; BINDING; GENOME; RECOGNITION; METHYLATION	The embryonic stem (ES) cell transcriptional and chromatin-modifying networks are critical for self-renewal maintenance. However, it remains unclear whether these networks functionally interact and, if so, what factors mediate such interactions. Here, we show that WD repeat domain 5 (Wdr5), a core member of the mammalian Trithorax (trxG) complex, positively correlates with the undifferentiated state and is a regulator of ES cell self-renewal. We demonstrate that Wdr5, an "effector" of H3K4 methylation, interacts with the pluripotency transcription factor Oct4. Genome-wide protein localization and transcriptome analyses demonstrate overlapping gene regulatory functions between Oct4 and Wdr5. The Oct4-Sox2-Nanog circuitry and trxG cooperate in activating transcription of key self-renewal regulators, and furthermore, Wdr5 expression is required for the efficient formation of induced pluripotent stem (iPS) cells. We propose an integrated model of transcriptional and epigenetic control, mediated by select trxG members, for the maintenance of ES cell self-renewal and somatic cell reprogramming.	[Ang, Yen-Sin; Tsai, Su-Yi; Lee, Dung-Fang; Monk, Jonathan; Su, Jie; Ratnakumar, Kajan; Ding, Junjun; Darr, Henia; Chang, Betty; Wang, Jianlong; Rendl, Michael; Bernstein, Emily; Schaniel, Christoph; Lemischka, Ihor R.] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA; [Ang, Yen-Sin; Lee, Dung-Fang; Monk, Jonathan; Su, Jie; Darr, Henia; Chang, Betty; Schaniel, Christoph; Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Ang, Yen-Sin; Tsai, Su-Yi; Lee, Dung-Fang; Su, Jie; Ding, Junjun; Darr, Henia; Chang, Betty; Wang, Jianlong; Rendl, Michael; Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Ratnakumar, Kajan; Bernstein, Emily] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Tsai, Su-Yi; Ratnakumar, Kajan; Rendl, Michael; Bernstein, Emily] Mt Sinai Sch Med, Dept Dermatol, New York, NY 10029 USA; [Ge, Yongchao] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ang, YS (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA.	yen-sin.ang@mssm.edu; ihor.lemischka@mssm.edu	Schaniel, Chrisoph/C-9655-2012; Ding, Junjun/C-4098-2012; Wang, Jianlong/GQR-1191-2022; Ge, Yongchao/AAG-9317-2021; Ding, Junjun/F-8618-2015; Wang, Jianlong/AAG-9425-2020; Schaniel, Christoph/P-3836-2019	Wang, Jianlong/0000-0002-1317-6457; Ge, Yongchao/0000-0001-6448-5703; Schaniel, Christoph/0000-0002-1343-4858; TSAI, SU-YI/0000-0002-7423-645X; Lee, Dung-Fang/0000-0003-2387-597X; Rendl, Michael/0000-0001-6326-620X; Monk, Jonathan M./0000-0002-3895-8949; Ding, Junjun/0000-0002-9936-882X; Su, Jie/0000-0002-3071-7139	NIH [R01GM078465]; NYSTEM [C024410, C024285]; Dermatology Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; Dermatology Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C.D. Allis, C. Hughes, J. Wysocka, A. Sevilla, X. Carvajal-Vergara, F. Pereira, A. Waghray, S. Pardo, S. Mendez-Ferrer, W.L. Tam, B. Lim, C. Ren, H.A. Wu, J. Gingold, and V. Nair for technical assistance, materials, and advice. This work was supported by NIH (R01GM078465) to I.R.L.; NYSTEM (C024410) to I.R.L and C.S.; and NYSTEM (C024285) to E.B.D.F.L. is a NYSCF Fellow. M.R. is supported by a Dermatology Foundation Career Development Award.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Lairmore TC, 2009, ADV EXP MED BIOL, V668, P87; Landeira D, 2011, TRENDS CELL BIOL, V21, P74, DOI 10.1016/j.tcb.2010.10.004; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Pullirsch D, 2010, DEVELOPMENT, V137, P935, DOI 10.1242/dev.035956; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Taylor MD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000813; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tsai SY, 2010, STEM CELLS, V28, P221, DOI 10.1002/stem.281; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhu ED, 2008, J BIOL CHEM, V283, P7361, DOI 10.1074/jbc.M703304200	44	419	439	1	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					183	197		10.1016/j.cell.2011.03.003	http://dx.doi.org/10.1016/j.cell.2011.03.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21477851	Green Accepted, Bronze			2022-12-24	WOS:000289549900009
J	Ghosh, S; Larson, SD; Hefzi, H; Marnoy, Z; Cutforth, T; Dokka, K; Baldwin, KK				Ghosh, Sulagna; Larson, Stephen D.; Hefzi, Hooman; Marnoy, Zachary; Cutforth, Tyler; Dokka, Kartheek; Baldwin, Kristin K.			Sensory maps in the olfactory cortex defined by long-range viral tracing of single neurons	NATURE			English	Article							ODOR REPRESENTATIONS; MONOMERIC RED; MITRAL CELLS; BULB; NUCLEUS; PROJECTIONS; ORGANIZATION; INFORMATION; RECEPTORS; CIRCUITRY	Sensory information may be represented in the brain by stereotyped mapping of axonal inputs or by patterning that varies between individuals. In olfaction, a stereotyped map is evident in the first sensory processing centre, the olfactory bulb (OB), where different odours elicit activity in unique combinatorial patterns of spatially invariant glomeruli(1,2). Activation of each glomerulus is relayed to higher cortical processing centres by a set of similar to 20-50 'homotypic' mitral and tufted (MT) neurons(3). In the cortex, target neurons integrate information from multiple glomeruli to detect distinct features of chemically diverse odours(4-6). How this is accomplished remains unclear, perhaps because the cortical mapping of glomerular information by individual MT neurons has not been described. Here we use new viral tracing and three-dimensional brain reconstruction methods to compare the cortical projections of defined sets of MT neurons. We show that the gross-scale organization of the OB is preserved in the patterns of axonal projections to one processing centre yet reordered in another, suggesting that distinct coding strategies may operate in different targets. However, at the level of individual neurons neither glomerular order nor stereotypy is preserved in either region. Rather, homotypic MT neurons from the same glomerulus innervate broad regions that differ between individuals. Strikingly, even in the same animal, MT neurons exhibit extensive diversity in wiring; axons of homotypic MT pairs diverge from each other, emit primary branches at distinct locations and 70-90% of branches of homotypic and heterotypic pairs are non-overlapping. This pronounced reorganization of sensory maps in the cortex offers an anatomic substrate for expanded combinatorial integration of information from spatially distinct glomeruli and predicts an unanticipated role for diversification of otherwise similar output neurons.	[Ghosh, Sulagna; Hefzi, Hooman; Marnoy, Zachary; Dokka, Kartheek; Baldwin, Kristin K.] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Larson, Stephen D.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Program Neurosci, La Jolla, CA 92037 USA; [Cutforth, Tyler] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California Santa Cruz	Baldwin, KK (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	kbaldwin@scripps.edu		Baldwin, Kristin/0000-0002-6137-030X	Pew Scholars Award; California Institute of Regenerative Medicine; Whitehall Foundation; O'Keefe Foundation; Shapiro Family Foundation; Dorris Neuroscience Center	Pew Scholars Award; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Whitehall Foundation; O'Keefe Foundation; Shapiro Family Foundation; Dorris Neuroscience Center	We wish to thank G. Patrick for the gift of pSin2gene virus and S. Djakovic for help with viral production. We thank O. Kwon and K. Spencer for assistance with imaging. We thank A. Maximov and J. Hazen for critical reading of the manuscript. We thank T. Cutforth for generating and R. Axel for supporting the generation of the ORT mouse strain, which was a gift. We thank the NCMIR, the Waitt Foundation and M. Ellisman for providing access to state-of-the-art imaging equipment and image processing tools. We thank the Baldwin and Cline lab members for providing laboratory support and advice. This work was supported by a Pew Scholars Award (K.K.B.) and support from the California Institute of Regenerative Medicine, the Whitehall Foundation, the O'Keefe Foundation, the Shapiro Family Foundation and the Dorris Neuroscience Center.	Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Brunjes PC, 2010, J COMP NEUROL, V518, P1603, DOI 10.1002/cne.22293; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUONVISO N, 1991, EUR J NEUROSCI, V3, P493, DOI 10.1111/j.1460-9568.1991.tb00836.x; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; Khan AG, 2010, WIRES SYST BIOL MED, V2, P603, DOI 10.1002/wsbm.85; Kikuta S, 2010, P NATL ACAD SCI USA, V107, P12363, DOI 10.1073/pnas.1003999107; Lei HM, 2006, J NEUROSCI, V26, P12023, DOI 10.1523/JNEUROSCI.2598-06.2006; LUSKIN MB, 1982, J COMP NEUROL, V209, P249, DOI 10.1002/cne.902090304; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nagayama S, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00120; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; SCOTT JW, 1985, J COMP NEUROL, V242, P415, DOI 10.1002/cne.902420309; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012	33	182	187	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					217	220		10.1038/nature09945	http://dx.doi.org/10.1038/nature09945			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21451523				2022-12-24	WOS:000289469100042
J	Gott, M; Ingleton, C; Bennett, MI; Gardiner, C				Gott, Merryn; Ingleton, Christine; Bennett, Michael I.; Gardiner, Clare			Transitions to palliative care in acute hospitals in England: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OF-LIFE CARE; HEART-FAILURE; CANCER; END; SPOTLIGHT; PEOPLE	Objective To explore how transitions to a palliative care approach are perceived to be managed in acute hospital settings in England. Design Qualitative study. Setting Secondary or primary care settings in two contrasting areas of England. Participants 58 health professionals involved in the provision of palliative care in secondary or primary care. Results Participants identified that a structured transition to a palliative care approach of the type advocated in UK policy guidance is seldom evident in acute hospital settings. In particular they reported that prognosis is not routinely discussed with inpatients. Achieving consensus among the clinical team about transition to palliative care was seen as fundamental to the transition being effected; however, this was thought to be insufficiently achieved in practice. Secondary care professionals reported that discussions about adopting a palliative care approach to patient management were not often held with patients; primary care professionals confirmed that patients were often discharged from hospital with "false hope" of cure because this information had not been conveyed. Key barriers to ensuring a smooth transition to palliative care included the difficulty of "standing back" in an acute hospital situation, professional hierarchies that limited the ability of junior medical and nursing staff to input into decisions on care, and poor communication. Conclusion Significant barriers to implementing a policy of structured transitions to palliative care in acute hospitals were identified by health professionals in both primary and secondary care. These need to be addressed if current UK policy on management of palliative care in acute hospitals is to be established.	[Gott, Merryn] Univ Auckland, Fac Med & Hlth Sci, Sch Nursing, Auckland 1, New Zealand; [Ingleton, Christine] Univ Sheffield, No Gen Hosp, Sch Nursing & Midwifery, Sheffield S10 2TN, S Yorkshire, England; [Bennett, Michael I.] Univ Lancaster, Sch Hlth & Med, Int Observ End Life Care, Lancaster LA1 4YW, England; [Gardiner, Clare] Univ Sheffield, St Lukes Hosp, Sch Nursing & Midwifery, Sheffield S10 2TN, S Yorkshire, England	University of Auckland; Northern General Hospital; University of Sheffield; Lancaster University; University of Sheffield	Gott, M (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Nursing, Auckland 1, New Zealand.	m.gott@auckland.ac.nz	Harding, Richard/G-9729-2012; Bennett, Michael I/A-1620-2009	Bennett, Michael I/0000-0002-8369-8349; Gott, Merryn/0000-0003-4399-962X; Gardiner, Clare/0000-0003-1785-7054	National Institute of Health Research; National Institute for Health Research [08/1809/233] Funding Source: researchfish	National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the National Institute of Health Research under the Service Delivery and Organisation programme. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Department of Health. All authors declare independence from the study funders.	Barclay S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4862; Barnes S, 2006, HEALTH SOC CARE COMM, V14, P482, DOI 10.1111/j.1365-2524.2006.00636.x; Bell D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3231; Bennett MI, 2010, PALLIATIVE MED, V24, P456, DOI 10.1177/0269216310366064; Boyd K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4863; Burt RS, 2005, BROKERAGE CLOSURE IN; Department of Health, 2008, END LIF CAR STRAT EN; Department of Health, 2010, ROUT SUCC END LIF CA; Doug M, 2009, ARCH DIS CHILD; General Medical Council, 2010, TREATM CAR END LIF G; Gold Standards Framework, 2010, GSF AC HOSP; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gott M, 2009, PALLIATIVE MED, V23, P642, DOI 10.1177/0269216309106790; Gott M, 2007, PALLIATIVE MED, V21, P95, DOI 10.1177/0269216307076348; Grande G, 2009, PALLIATIVE MED, V23, P187, DOI 10.1177/0269216309102697; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Murray SA, 2008, BRIT MED J, V336, P958, DOI 10.1136/bmj.39535.491238.94; National Audit Office, 2008, END LIF CAR; O'Leary N, 2009, EUR J HEART FAIL, V11, P406, DOI 10.1093/eurjhf/hfp007; Schofield P, 2006, PALLIATIVE MED, V20, P397, DOI 10.1191/0269216306pm1156oa; Selman L, 2007, HEART, V93, P963, DOI 10.1136/hrt.2006.106518; Seymour J, 2011, LIVING AGEING DYING; The Gold Standards Framework, 2010, GSF PROGN IND GUID; van Walraven C, 2004, J GEN INTERN MED, V19, P624, DOI 10.1111/j.1525-1497.2004.30082.x	25	91	91	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2011	342								d1773	10.1136/bmj.d1773	http://dx.doi.org/10.1136/bmj.d1773			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WE	21447572	hybrid, Green Submitted, Green Published			2022-12-24	WOS:000289200800004
J	Kendall, T; Tyrer, P; Whittington, C; Taylor, C				Kendall, Tim; Tyrer, Peter; Whittington, Craig; Taylor, Clare		Guideline Dev Grp	Guidelines Assessment and management of psychosis with coexisting substance misuse: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISORDERS; ALCOHOL					tim2.kendall@virgin.net	Whittington, Craig/B-1380-2008	Whittington, Craig/0000-0002-1950-0334				[Anonymous], 2007, CLIN GUID NAT I HLTH; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Cerullo MA, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-29; Gregg L, 2007, CLIN PSYCHOL REV, V27, P494, DOI 10.1016/j.cpr.2006.09.004; Jackson CT, 2007, PSYCHIAT SERV, V58, P270, DOI 10.1176/appi.ps.58.2.270; Kavanagh DJ, 2004, SCHIZOPHR RES, V66, P115, DOI 10.1016/S0920-9964(03)00130-0; Loubser I., 2009, J PSYCHIAT INTENSIVE, V5, P33, DOI [https://doi.org/10.1017/S1742646408001386, DOI 10.1017/S1742646408001386]; McCreadie RG, 2002, BRIT J PSYCHIAT, V181, P321, DOI 10.1192/bjp.181.4.321; Moolchan ET, 2001, J ADDICT DIS, V20, P55, DOI 10.1300/J069v20n02_05; National Institute for Health and Clinical Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2011, CLIN GUID NAT I HLTH; National Institute for Health and Clinical Excellence, 2009, CLIN GUID NAT I HLTH; National Institute for Health and Clinical Excellence, 2006, CLIN GUID NAT I HLTH; Noordsy DL, 2003, SUBSTANCE MISUSE PSY, P159; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Ries RK, 2004, PSYCHIAT SERV, V55, P445, DOI 10.1176/appi.ps.55.4.445; Tracy K, 2007, AM J DRUG ALCOHOL AB, V33, P253, DOI 10.1080/00952990601174931; Urichuk L, 2008, CURR DRUG METAB, V9, P410, DOI 10.2174/138920008784746373	18	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2011	342								d1351	10.1136/bmj.d1351	http://dx.doi.org/10.1136/bmj.d1351			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MJ	21430003				2022-12-24	WOS:000288948000003
J	Tan, T; Shaw, EJ; Siddiqui, F; Kandaswamy, P; Barry, PW; Baker, M				Tan, T.; Shaw, E. J.; Siddiqui, F.; Kandaswamy, P.; Barry, P. W.; Baker, M.		Guideline Dev Grp	Guidelines Inpatient management of diabetic foot problems: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material												pwb1@leicester.ac.uk						Diabetes UK, 2009, PUTT FEET 1 COMM SPE; *NAT I HLTH CLIN E, 2011, CLIN GUID NAT I HLTH, V114; *NAT I HLTH CLIN E, 2011, CLIN GUID NAT I HLTH, V119; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V73; *NAT I HLTH CLIN E, 2004, CLIN GUID NAT I HLTH, V10; Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157	6	19	25	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2011	342								d1280	10.1136/bmj.d1280	http://dx.doi.org/10.1136/bmj.d1280			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MJ	21430002				2022-12-24	WOS:000288948000014
J	Zakar, T; Mesiano, S				Zakar, Tamas; Mesiano, Sam			How Does Progesterone Relax the Uterus in Pregnancy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zakar, Tamas] John Hunter Hosp, Dept Obstet & Gynaecol, Newcastle, NSW, Australia; [Zakar, Tamas] Univ Newcastle, Mothers & Babies Res Ctr, Newcastle, NSW 2308, Australia; [Mesiano, Sam] Case Western Reserve Univ, Dept Reprod Biol, Cleveland, OH 44106 USA	John Hunter Hospital; University of Newcastle; Case Western Reserve University	Zakar, T (corresponding author), John Hunter Hosp, Dept Obstet & Gynaecol, Newcastle, NSW, Australia.		Zakar, Tamas/G-7507-2013	Zakar, Tamas/0000-0002-1690-1159				Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107	2	49	51	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					972	973		10.1056/NEJMcibr1100071	http://dx.doi.org/10.1056/NEJMcibr1100071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21388317	Green Published			2022-12-24	WOS:000288170300017
J	Carlet, J; Collignon, P; Goldmann, D; Goossens, H; Gyssens, IC; Harbarth, S; Jarlier, V; Levy, SB; N'Doye, B; Pittet, D; Richtmann, R; Seto, WH; van der Meer, JWM; Voss, A				Carlet, Jean; Collignon, Peter; Goldmann, Don; Goossens, Herman; Gyssens, Inge C.; Harbarth, Stephan; Jarlier, Vincent; Levy, Stuart B.; N'Doye, Babacar; Pittet, Didier; Richtmann, Rosana; Seto, Wing H.; van der Meer, Jos W. M.; Voss, Andreas			Society's failure to protect a precious resource: antibiotics	LANCET			English	Editorial Material							RESISTANCE; EMERGENCE		[Carlet, Jean] WHO, African Partnership Patient Safety Programme, Paris, France; [Collignon, Peter] Canberra Hosp, Infect Dis Unit, Woden, ACT, Australia; [Collignon, Peter] Canberra Hosp, Dept Microbiol, Woden, ACT, Australia; [Collignon, Peter] Australian Natl Univ, Sch Clin Med, Woden, ACT, Australia; [Goldmann, Don] Inst Healthcare Improvement, Cambridge, MA USA; [Goldmann, Don] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Goldmann, Don] Harvard Univ, Sch Med, Boston, MA USA; [Goossens, Herman] Univ Antwerp, Lab Med Microbiol, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium; [Gyssens, Inge C.; van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med & Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Gyssens, Inge C.; Voss, Andreas] Hasselt Univ, Diepenbeek, Belgium; [Harbarth, Stephan; Pittet, Didier] Univ Hosp Geneva, Infect Control Program, Geneva, Switzerland; [Harbarth, Stephan; Pittet, Didier] Univ Hosp Geneva, WHO Collaborating Ctr Patient Safety, Geneva, Switzerland; [Harbarth, Stephan; Pittet, Didier] Univ Geneva, Fac Med, Geneva, Switzerland; [Jarlier, Vincent] UPMC Univ Paris, Bacteriol Hyg Pitie Salpetriere Hosp, AP HP, Paris, France; [Levy, Stuart B.] Tufts Univ, Sch Med, Ctr Adaptat Genet & Drug Resistance, Boston, MA 02111 USA; [Levy, Stuart B.] Tufts Univ, Sch Med, Dept Mol Biol Microbiol, Boston, MA 02111 USA; [Levy, Stuart B.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [N'Doye, Babacar] Minist Sante & Prevent, Programme Natl Lutte Infect Nosocomiales PRONALIN, Dakar, Senegal; [Richtmann, Rosana] Emilio Ribas Infect Dis Inst, Dept Infect Dis, Sao Paulo, Brazil; [Seto, Wing H.] Hong Kong Hosp Author, Dept Qual & Safety, Hong Kong, Hong Kong, Peoples R China	World Health Organization; Australian National University; Canberra Hospital; Australian National University; Canberra Hospital; Australian National University; Institute for Healthcare Improvement; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Antwerp; Radboud University Nijmegen; Hasselt University; University of Geneva; University of Geneva; World Health Organization; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Tufts University; Tufts University; Tufts University	Carlet, J (corresponding author), 9 Rue Terrasse, F-94000 Creteil, France.	jeancarlet@gmail.com	van der Meer, Jos W.M./C-8521-2013; Gyssens, Inge C.J./L-4343-2015; Voss, A./H-8111-2014; Gyssens, Inge/ABB-9031-2021; Collignon, Peter/U-4846-2019	van der Meer, Jos W.M./0000-0001-5120-3690; Gyssens, Inge/0000-0002-9226-0752; Collignon, Peter/0000-0001-8648-9203; Seto, Wing Hong/0000-0002-1139-9200				Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Chisholm SA, 2010, J ANTIMICROB CHEMOTH, V65, P2141, DOI 10.1093/jac/dkq289; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Earnshaw S, 2010, EUROSURVEILLANCE, V14, P23; European Centre for Disease Prevention and Control, ECDC EMEA JOINT TECH; European Centre for Disease Prevention and Control, EARS NET DAT; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grave K, 2010, J ANTIMICROB CHEMOTH, V65, P2037, DOI 10.1093/jac/dkq247; Hughes JM, 2011, JAMA-J AM MED ASSOC, V305, P1027, DOI 10.1001/jama.2011.279; Hulscher MEJL, 2010, LANCET INFECT DIS, V10, P167, DOI 10.1016/S1473-3099(10)70027-X; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; *INF DIS SOC AM, BAD BUGS NO DRUGS; Jajoo M, 2011, PEDIATR INFECT DIS J, V30, P218, DOI 10.1097/INF.0b013e3182064bfe; Johnson PDR, 2010, J INFECT DIS, V202, P1278, DOI 10.1086/656319; Kennedy K, 2010, EUR J CLIN MICROBIOL, V29, P1501, DOI 10.1007/s10096-010-1031-y; Koo SH, 2010, KOREAN J LAB MED, V30, P498, DOI 10.3343/kjlm.2010.30.5.498; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; KUNIN CM, 1973, ANN INTERN MED, V79, P555, DOI 10.7326/0003-4819-79-4-555; Li JY, 2010, FOODBORNE PATHOG DIS, V7, P1387, DOI 10.1089/fpd.2010.0581; Ofner-Agostini M., 2009, CAN J INFECT DIS MED, V20, P43; Seto WH, 2010, INFECT CONT HOSP EP, V31, P948, DOI 10.1086/655833; Uma B, 2010, INDIAN J GASTROENTER, V29, P201, DOI 10.1007/s12664-010-0044-x; Union. CotE, 2002, OJ L, V45, P13; United States Centers for Disease Prevention and Control, GET SMART PROGR; van Hal SJ, 2011, EUR J CLIN MICROBIOL, V30, P603, DOI 10.1007/s10096-010-1128-3	26	210	226	2	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					369	371		10.1016/S0140-6736(11)60401-7	http://dx.doi.org/10.1016/S0140-6736(11)60401-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21477855				2022-12-24	WOS:000293615800035
J	Fitzpatrick, K				Fitzpatrick, Kevin			Should the law on assisted dying be changed? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									Not Dead Yet UK, Reynoldston, Wales		Fitzpatrick, K (corresponding author), Not Dead Yet UK, Reynoldston, Wales.	kevin@inclusion21.org						CAMPBELL J, 2006, HMV UK M ST THOM HOS; O'Neill O, 2010, AUTONOMY ASSISTED SU; Tiernan E, 2002, J ROY SOC MED, V95, P386, DOI 10.1258/jrsm.95.8.386; Wittgenstein Ludwig., 1974, TRACTATUS LOGICO PHI	4	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2011	342								d1883	10.1136/bmj.d1883	http://dx.doi.org/10.1136/bmj.d1883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OR	21511803				2022-12-24	WOS:000289943400001
J	Lu, W; Du, JA; Wacker, T; Gerbig-Smentek, E; Andrade, SLA; Einsle, O				Lue, Wei; Du, Juan; Wacker, Tobias; Gerbig-Smentek, Elke; Andrade, Susana L. A.; Einsle, Oliver			pH-Dependent Gating in a FocA Formate Channel	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; NUCLEOTIDE-SEQUENCE; MEMBRANE-PROTEINS; NITRATE; IDENTIFICATION; DEHYDROGENASE; TRANSPORTER; METABOLISM; MECHANISM; BACTERIA	The formate transporter FocA was described to switch its mode of operation from a passive export channel at high external pH to a secondary active formate/H+ importer at low pH. The crystal structure of Salmonella typhimurium FocA at pH 4.0 shows that this switch involves a major rearrangement of the amino termini of individual protomers in the pentameric channel. The amino-terminal helices open or block transport in a concerted, cooperative action that indicates how FocA is gated in a pH-dependent way. Electrophysiological studies show that the protein acts as a specific formate channel at pH 7.0 and that it closes upon a shift of pH to 5.1.	[Lue, Wei; Du, Juan; Wacker, Tobias; Gerbig-Smentek, Elke; Andrade, Susana L. A.; Einsle, Oliver] Univ Freiburg, Lehrstuhl Biochem, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Freiburg	Einsle, O (corresponding author), Univ Freiburg, Lehrstuhl Biochem, Inst Organ Chem & Biochem, Albertstr 21, D-79104 Freiburg, Germany.	einsle@biochemie.uni-freiburg.de	Andrade, Susana L. A./D-5119-2012; Du, Juan/AAQ-5466-2020	Andrade, Susana L. A./0000-0003-2267-8499; Einsle, Oliver/0000-0001-8722-2893	Deutsche Forschungsgemeinschaft [Ei-520/3, An-676/1, IRTG 1478]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the staff at beamline X06SA at the Swiss Light Source, in particular T. Tomizaki, for assistance with data collection and W. Hardt (ETH Zurich) for genomic DNA of S. typhimurium. R. Dutzler (University of Zurich) is acknowledged for helpful discussions. This work was supported by Deutsche Forschungsgemeinschaft (Ei-520/3 to O.E., An-676/1 to S. L. A. A., and IRTG 1478). The structural model and structure factors have been deposited with the Protein Data Bank (accession code 3Q7K).	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Aveyard R., 1973, INTRO PRINCIPLES SUR; BERG BL, 1991, J BIOL CHEM, V266, P22380; Clegg S, 2002, MOL MICROBIOL, V44, P143, DOI 10.1046/j.1365-2958.2002.02858.x; Cole J, 1996, FEMS MICROBIOL LETT, V136, P1; Hakobyan M, 2005, BIOPHYS CHEM, V118, P135, DOI 10.1016/j.bpc.2005.09.012; KNAPPE J, 1990, FEMS MICROBIOL LETT, V75, P383, DOI 10.1111/j.1574-6968.1990.tb04108.x; Leonhartsberger S, 2002, J MOL MICROB BIOTECH, V4, P269; MACY J, 1976, J BACTERIOL, V125, P423, DOI 10.1128/JB.125.2.423-428.1976; ROSSMANN R, 1991, MOL MICROBIOL, V5, P2807, DOI 10.1111/j.1365-2958.1991.tb01989.x; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; Sawers RG, 1994, ANTON LEEUW INT J G, V66, P57; STANKOWSKI S, 1991, BIOPHYS J, V60, P341, DOI 10.1016/S0006-3495(91)82059-8; Stroud RM, 2003, ADV PROTEIN CHEM, V63, P291; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Waight AB, 2010, NAT STRUCT MOL BIOL, V17, P31, DOI 10.1038/nsmb.1740; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; WHITE WB, 1992, J BACTERIOL, V174, P4997, DOI 10.1128/JB.174.15.4997-5004.1992; WIMPENNY JW, 1967, BIOCHIM BIOPHYS ACTA, V148, P233, DOI 10.1016/0304-4165(67)90298-X	21	60	60	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					352	354		10.1126/science.1199098	http://dx.doi.org/10.1126/science.1199098			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493860				2022-12-24	WOS:000289516600045
J	Murakoshi, H; Wang, H; Yasuda, R				Murakoshi, Hideji; Wang, Hong; Yasuda, Ryohei			Local, persistent activation of Rho GTPases during plasticity of single dendritic spines	NATURE			English	Article							LONG-TERM POTENTIATION; KINASE; PROTEINS; DYNAMICS; ACTIN; CULTURES; BINDING	The Rho family of GTPases have important roles in the morphogenesis of the dendritic spines(1-3) of neurons in the brain and synaptic plasticity(4-9) by modulating the organization of the actin cytoskeleton(10). Here we used two-photon fluorescence lifetime imaging microscopy(11-13) to monitor the activity of two Rho GTPases-RhoA and Cdc42-in single dendritic spines undergoing structural plasticity associated with long-term potentiation in CA1 pyramidal neurons in cultured slices of rat hippocampus. When long-term volume increase was induced in a single spine using two-photon glutamate uncaging(14,15), RhoA and Cdc42 were rapidly activated in the stimulated spine. These activities decayed over about five minutes, and were then followed by a phase of persistent activation lasting more than half an hour. Although active RhoA and Cdc42 were similarly mobile, their activity patterns were different. RhoA activation diffused out of the stimulated spine and spread over about 5 mm along the dendrite. In contrast, Cdc42 activation was restricted to the stimulated spine, and exhibited a steep gradient at the spine necks. Inhibition of the Rho-Rock pathway preferentially inhibited the initial spine growth, whereas the inhibition of the Cdc42-Pak pathway blocked the maintenance of sustained structural plasticity. RhoA and Cdc42 activation depended on Ca2+/calmodulin-dependent kinase (CaMKII). Thus, RhoA and Cdc42 relay transient CaMKII activation(13) to synapse-specific, long-term signalling required for spine structural plasticity.	[Murakoshi, Hideji; Wang, Hong; Yasuda, Ryohei] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Yasuda, Ryohei] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	yasuda@neuro.duke.edu	Murakoshi, Hideji/W-9266-2018; Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297	Howard Hughes Medical Institute; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Institute of Drug Abuse; Alzheimer's Association; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027807] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Alzheimer's Association(Alzheimer's Association); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Hahn, G. Bokock, A. Aplin, S. Soderling, M. Matsuda and Y. Hayashi for plasmids and reagents, S.-J. Lee for CaMKII activation data, S. Soderling, S. Raghavachari, L. van Aelst, Y. Hayashi, H. Kasai and M. Ehlers for discussion, and H. Hedrick and M. Patterson for comments on the manuscript. We also thank A. Wan for preparing cultured slices and D. Kloetzer for laboratory management. This study was funded by the Howard Hughes Medical Institute, the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the National Institute of Drug Abuse, the Alzheimer's Association and the Japan Society for the Promotion of Science (H.M.).	Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Kasri NN, 2008, PFLUG ARCH EUR J PHY, V455, P787, DOI 10.1007/s00424-007-0385-1; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; LAKOWICZ JR, 2006, PRINCIPLES FLUORESCE, pCH8, DOI DOI 10.1007/978-0-387-46312-4; Lee S. J., 2010, CAMKII RAS OPEN NEUR, V3, P117; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McAllister A K, 2000, Sci STKE, V2000, ppl1, DOI 10.1126/stke.2000.51.pl1; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nikolic M, 2008, MOL NEUROBIOL, V37, P187, DOI 10.1007/s12035-008-8032-1; O'Brien JA, 2006, NAT PROTOC, V1, P977, DOI 10.1038/nprot.2006.145; O'Kane EM, 2003, J NEUROCHEM, V87, P1309, DOI 10.1046/j.1471-4159.2003.02102.x; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tamura M, 2005, BBA-PROTEINS PROTEOM, V1754, P245, DOI 10.1016/j.bbapap.2005.06.015; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wilde C, 2000, J BIOL CHEM, V275, P16478, DOI 10.1074/jbc.M910362199; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhao J, 2002, BIOCHEM BIOPH RES CO, V297, P653, DOI 10.1016/S0006-291X(02)02257-X	40	380	388	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					100	U132		10.1038/nature09823	http://dx.doi.org/10.1038/nature09823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21423166	Green Accepted			2022-12-24	WOS:000289199400045
J	Malik, FI; Hartman, JJ; Elias, KA; Morgan, BP; Rodriguez, H; Brejc, K; Anderson, RL; Sueoka, SH; Lee, KH; Finer, JT; Sakowicz, R; Baliga, R; Cox, DR; Garard, M; Godinez, G; Kawas, R; Kraynack, E; Lenzi, D; Lu, PP; Muci, A; Niu, CR; Qian, XP; Pierce, DW; Pokrovskii, M; Suehiro, I; Sylvester, S; Tochimoto, T; Valdez, C; Wang, WY; Katori, T; Kass, DA; Shen, YT; Vatner, SF; Morgans, DJ				Malik, Fady I.; Hartman, James J.; Elias, Kathleen A.; Morgan, Bradley P.; Rodriguez, Hector; Brejc, Katjusa; Anderson, Robert L.; Sueoka, Sandra H.; Lee, Kenneth H.; Finer, Jeffrey T.; Sakowicz, Roman; Baliga, Ramesh; Cox, David R.; Garard, Marc; Godinez, Guillermo; Kawas, Raja; Kraynack, Erica; Lenzi, David; Lu, Pu Ping; Muci, Alexander; Niu, Congrong; Qian, Xiangping; Pierce, Daniel W.; Pokrovskii, Maria; Suehiro, Ion; Sylvester, Sheila; Tochimoto, Todd; Valdez, Corey; Wang, Wenyue; Katori, Tatsuo; Kass, David A.; Shen, You-Tang; Vatner, Stephen F.; Morgans, David J.			Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure	SCIENCE			English	Article							CONSCIOUS DOGS; SUBFRAGMENT-1; ACTOMYOSIN; MECHANISM; ATPASE; MOTOR; 1ST	Decreased cardiac contractility is a central feature of systolic heart failure. Existing drugs increase cardiac contractility indirectly through signaling cascades but are limited by their mechanism-related adverse effects. To avoid these limitations, we previously developed omecamtiv mecarbil, a small-molecule, direct activator of cardiac myosin. Here, we show that it binds to the myosin catalytic domain and operates by an allosteric mechanism to increase the transition rate of myosin into the strongly actin-bound force-generating state. Paradoxically, it inhibits adenosine 5'-triphosphate turnover in the absence of actin, which suggests that it stabilizes an actin-bound conformation of myosin. In animal models, omecamtiv mecarbil increases cardiac function by increasing the duration of ejection without changing the rates of contraction. Cardiac myosin activation may provide a new therapeutic approach for systolic heart failure.	[Malik, Fady I.; Hartman, James J.; Elias, Kathleen A.; Morgan, Bradley P.; Rodriguez, Hector; Brejc, Katjusa; Anderson, Robert L.; Sueoka, Sandra H.; Lee, Kenneth H.; Finer, Jeffrey T.; Sakowicz, Roman; Baliga, Ramesh; Cox, David R.; Garard, Marc; Godinez, Guillermo; Kawas, Raja; Kraynack, Erica; Lenzi, David; Lu, Pu Ping; Muci, Alexander; Niu, Congrong; Qian, Xiangping; Pierce, Daniel W.; Pokrovskii, Maria; Suehiro, Ion; Sylvester, Sheila; Tochimoto, Todd; Valdez, Corey; Wang, Wenyue; Morgans, David J.] Cytokinetics Inc, Preclin Res & Dev, San Francisco, CA 94080 USA; [Katori, Tatsuo; Kass, David A.] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Shen, You-Tang; Vatner, Stephen F.] CV Dynam, N Brunswick, NJ 08902 USA; [Vatner, Stephen F.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Vatner, Stephen F.] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Newark, NJ 07103 USA; [Shen, You-Tang] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Shen, You-Tang] Univ Penn, Sch Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; University of Pennsylvania	Malik, FI (corresponding author), Cytokinetics Inc, Preclin Res & Dev, San Francisco, CA 94080 USA.	fmalik@cytokinetics.com		Brejc, Katjusa/0000-0002-4562-6109	Cytokinetics; NIH [1-R43-HL-66647-1]; Cytokinetics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL066647, R01HL106511] Funding Source: NIH RePORTER	Cytokinetics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytokinetics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Chabala, C. Homcy, T. A. Pollard, J. H. Sabry, R. J. Solaro, J. A. Spudich, J. R. Teerlink, and R. D. Vale for their advice over the course of this work; A. Franklin and S. Hollenbach for their contributions to the conduct of some of these studies; and M. Rowley and J. Goldstein for assistance in preparing the manuscript. Y.-T.S., D. A. K., and S. F. V. are members of the Scientific Advisory Board and received research support, compensation, and stock options (D. A. K. and S. F. V.) from Cytokinetics. Cytokinetics holds a patent on omecamtiv mecarbil (U. S. Patent no. 7,507,735); Amgen is a licensee of this patent. Support provided by Small Business Innovation Research grant, NIH (1-R43-HL-66647-1) and Cytokinetics, Inc.	Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Banfor PN, 2008, AM J PHYSIOL-HEART C, V294, pH238, DOI 10.1152/ajpheart.01181.2007; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CLEEMANN L, 1991, J PHYSIOL-LONDON, V432, P283, DOI 10.1113/jphysiol.1991.sp018385; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; KOMAMURA K, 1992, J CLIN INVEST, V89, P1825, DOI 10.1172/JCI115787; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; McMurray JJV, 2010, NEW ENGL J MED, V362, P228, DOI 10.1056/NEJMcp0909392; Morgan BP, 2010, ACS MED CHEM LETT, V1, P472, DOI 10.1021/ml100138q; Petersen John W, 2008, Crit Care Med, V36, pS106, DOI 10.1097/01.CCM.0000296273.72952.39; Pollard TD, 2008, CELL BIOL, V2nd, P705; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Shen YT, 2010, CIRC-HEART FAIL, V3, P522, DOI 10.1161/CIRCHEARTFAILURE.109.930321; Shen YT, 1999, AM J PHYSIOL-HEART C, V277, pH388, DOI 10.1152/ajpheart.1999.277.1.H388; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; Suzuki T, 2009, CIRC-HEART FAIL, V2, P334, DOI 10.1161/CIRCHEARTFAILURE.108.802298; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	24	364	376	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1439	1443		10.1126/science.1200113	http://dx.doi.org/10.1126/science.1200113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415352	Green Accepted			2022-12-24	WOS:000288504000042
J	Wu, H; D'Alessio, AC; Ito, S; Xia, K; Wang, ZB; Cui, KR; Zhao, KJ; Sun, YE; Zhang, Y				Wu, Hao; D'Alessio, Ana C.; Ito, Shinsuke; Xia, Kai; Wang, Zhibin; Cui, Kairong; Zhao, Keji; Sun, Yi Eve; Zhang, Yi			Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells	NATURE			English	Article							DNA METHYLATION; HISTONE H3; DEVELOPMENTAL REGULATORS; CHROMATIN-STRUCTURE; POLYCOMB; GENOME; GENES; COMPLEX; BINDING; PROTEIN	Epigenetic modification of the mammalian genome by DNA methylation (5-methylcytosine) has a profound impact on chromatin structure, gene expression and maintenance of cellular identity(1). The recent demonstration that members of the Ten-eleven translocation (Tet) family of proteins can convert 5-methylcytosine to 5-hydroxymethylcytosine raised the possibility that Tet proteins are capable of establishing a distinct epigenetic state(2,3). We have recently demonstrated that Tet1 is specifically expressed in murine embryonic stem (ES) cells and is required for ES cell maintenance(2). Using chromatin immunoprecipitation coupled with high-throughput DNA sequencing, here we show in mouse ES cells that Tet1 is preferentially bound to CpG-rich sequences at promoters of both transcriptionally active and Polycomb-repressed genes. Despite an increase in levels of DNA methylation at many Tet1-binding sites, Tet1 depletion does not lead to downregulation of all the Tet1 targets. Interestingly, although Tet1-mediated promoter hypomethylation is required for maintaining the expression of a group of transcriptionally active genes, it is also involved in repression of Polycomb-targeted developmental regulators. Tet1 contributes to silencing of this group of genes by facilitating recruitment of PRC2 to CpG-rich gene promoters. Thus, our study not only establishes a role for Tet1 in modulating DNA methylation levels at CpG-rich promoters, but also reveals a dual function of Tet1 in promoting transcription of pluripotency factors as well as participating in the repression of Polycomb-targeted developmental regulators.	[D'Alessio, Ana C.; Ito, Shinsuke; Xia, Kai; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Howard Hughes Med Inst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wu, Hao; Sun, Yi Eve] Univ Calif Los Angeles, David Geffen Sch Med, IDDRC Semel Inst Neurosci & Human Behav, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wu, Hao; Sun, Yi Eve] Univ Calif Los Angeles, David Geffen Sch Med, IDDRC Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Wang, Zhibin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Lab Human Environm Epigenomes, Baltimore, MD 21025 USA; [Cui, Kairong; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zhang, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Howard Hughes Med Inst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Xia, Kai/B-7214-2014; Wu, Hao/G-4145-2013	Wu, Hao/0000-0002-1256-6891; Zhang, Yi/0000-0002-2789-0811; Xia, Kai/0000-0003-1326-0891; Wu, Hao/0000-0003-4395-6929	NIH [GM68804, R56MH082068]; Division of Intramural Research of National Heart, Lung and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH082068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of National Heart, Lung and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Abraham and I. Chepelev for Illumina sequencing and data transfer; J. He and A. T. Nguyen for FACS sorting; O. Taranova for discussion; S. Wu for critical reading of the manuscript. This work was supported by NIH grants GM68804 (to Y.Z.), R56MH082068 (to Y.E.S.) and support from the Division of Intramural Research Program of National Heart, Lung and Blood Institute, NIH (K.Z.). S. I. is a research fellow of the Japan Society for the Promotion of Science. Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pelizzola M, 2008, GENOME RES, V18, P1652, DOI 10.1101/gr.080721.108; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu SC, 2010, CELL RES, V20, P1109, DOI 10.1038/cr.2010.114; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	30	488	507	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					389	U578		10.1038/nature09934	http://dx.doi.org/10.1038/nature09934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21451524	Green Accepted, Green Published			2022-12-24	WOS:000290722400052
J	Cleland, K; Peipert, JF; Westhoff, C; Spear, S; Trussell, J				Cleland, Kelly; Peipert, Jeffrey F.; Westhoff, Carolyn; Spear, Scott; Trussell, James			Family Planning as a Cost-Saving Preventive Health Service	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cleland, Kelly; Trussell, James] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Peipert, Jeffrey F.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Westhoff, Carolyn] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; [Westhoff, Carolyn] Columbia Univ, Dept Epidemiol, New York, NY USA; [Westhoff, Carolyn] Columbia Univ, Dept Populat & Family Hlth, New York, NY USA; [Spear, Scott] Planned Parenthood Texas Capital Reg, Austin, TX USA; [Spear, Scott] Planned Parenthood Cent Texas, Austin, TX USA; [Trussell, James] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England	Princeton University; Washington University (WUSTL); Columbia University; Columbia University; Columbia University; University of Hull; University of York - UK	Cleland, K (corresponding author), Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.		Potter, Joseph E/A-3122-2008	Cleland, Kelly/0000-0001-9966-1260	NICHD NIH HHS [R24 HD047879] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Brown S.S., 1995, BEST INTENTIONS UNIN; Frost JJ, 2008, PERSPECT SEX REPRO H, V40, P94, DOI 10.1363/4009408; Postlethwaite D, 2007, CONTRACEPTION, V76, P360, DOI 10.1016/j.contraception.2007.07.006; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Trussell J, 2010, CONTRACEPTION, V82, P391, DOI 10.1016/j.contraception.2010.04.008	5	66	69	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18								10.1056/NEJMp1104373	http://dx.doi.org/10.1056/NEJMp1104373			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759DC	21506736				2022-12-24	WOS:000290219800005
J	Colquhoun, D				Colquhoun, David			WELLBEING The A to Z of the wellbeing industry: from angelic reiki to patient centred care	BRITISH MEDICAL JOURNAL			English	Editorial Material							SURVIVAL		UCL, London WC1E 6BT, England	University of London; University College London	Colquhoun, D (corresponding author), UCL, London WC1E 6BT, England.	d.colquhoun@ucl.ac.uk	Colquhoun, David/C-1664-2008	Colquhoun, David/0000-0002-4263-017X				Coyne JC, 2007, PSYCHOL BULL, V133, P367, DOI 10.1037/0033-2909.133.3.367; Cumberlege J., 2010, FAIR SOC HEARLY LIVE; *DEP BUS INN SKILL, MENT CAP WELLB PROJ; Epstein RM, 2011, ANN FAM MED, V9, P100, DOI 10.1370/afm.1239; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; MARMOT M, WORK STRESS HLTH WHI; Schofield P, 2004, CANCER-AM CANCER SOC, V100, P1276, DOI 10.1002/cncr.20076; Wilkinson R., 2009, SPIRIT LEVEL	8	1	1	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2011	342								d2711	10.1136/bmj.d2711	http://dx.doi.org/10.1136/bmj.d2711			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MB	21543407				2022-12-24	WOS:000290481700007
J	Bivona, TG; Hieronymus, H; Parker, J; Chang, K; Taron, M; Rosell, R; Moonsamy, P; Dahlman, K; Miller, VA; Costa, C; Hannon, G; Sawyers, CL				Bivona, Trever G.; Hieronymus, Haley; Parker, Joel; Chang, Kenneth; Taron, Miquel; Rosell, Rafael; Moonsamy, Philicia; Dahlman, Kimberly; Miller, Vincent A.; Costa, Carlota; Hannon, Gregory; Sawyers, Charles L.			FAS and NF-kappa B signalling modulate dependence of lung cancers on mutant EGFR	NATURE			English	Article							ACQUIRED-RESISTANCE; MET AMPLIFICATION; ERLOTINIB; MUTATIONS; KINASE; CELLS; ADENOCARCINOMA; INHIBITION; GEFITINIB; APOPTOSIS	Human lung adenocarcinomas with activating mutations in EGFR (epidermal growth factor receptor) often respond to treatment with EGFR tyrosine kinase inhibitors (TKIs), but the magnitude of tumour regression is variable and transient(1,2). This heterogeneity in treatment response could result from genetic modifiers that regulate the degree to which tumour cells are dependent on mutant EGFR. Through a pooled RNA interference screen, we show that knockdown of FAS and several components of the NF-kappa B pathway specifically enhanced cell death induced by the EGFR TKI erlotinib in EGFR-mutant lung cancer cells. Activation of NF-kappa B through overexpression of c-FLIP or IKK (also known as CFLAR and IKBKB, respectively), or silencing of I kappa B (also known as NFKBIA), rescued EGFR-mutant lung cancer cells from EGFR TKI treatment. Genetic or pharmacologic inhibition of NF-kappa B enhanced erlotinib-induced apoptosis in erlotinib-sensitive and erlotinib-resistant EGFR-mutant lung cancer models. Increased expression of the NF-kappa B inhibitor I kappa B predicted for improved response and survival in EGFR-mutant lung cancer patients treated with EGFR TKI. These data identify NF-kappa B as a potential companion drug target, together with EGFR, in EGFR-mutant lung cancers and provide insight into the mechanisms by which tumour cells escape from oncogene dependence.	[Bivona, Trever G.; Hieronymus, Haley; Moonsamy, Philicia; Dahlman, Kimberly; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Parker, Joel] Express Anal Inc, Durham, NC 27713 USA; [Chang, Kenneth; Hannon, Gregory] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Taron, Miquel; Rosell, Rafael; Costa, Carlota] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona 08916, Spain; [Taron, Miquel; Rosell, Rafael; Costa, Carlota] USP Dexeus Univ Inst, Barcelona 08028, Spain; [Hannon, Gregory; Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave,Box 20, New York, NY 10065 USA.	sawyersc@mskcc.org	Parker, Joel/AAG-1108-2019; Sawyers, Charles/G-5327-2016; Hannon, Gregory/AAB-3568-2019		Charles A. Dana Foundation; ASCO YIA; Caine Halter Lung Cancer Research Fund/Uniting Against Lung Cancer; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	Charles A. Dana Foundation; ASCO YIA; Caine Halter Lung Cancer Research Fund/Uniting Against Lung Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Pao, H. Varmus and members of the MSKCC Lung Cancer Oncogenome group for intellectual support. We thank J. Javier Sanchez for analysing human lung cancer gene expression data. We thank J. Wongvipat and E. Philips for technical assistance and W. Polkinghorn and members of the Sawyers Laboratory for critique of the manuscript. T.G.B. is supported by the MSKCC Clinical Scholars Fellowship funded by the Charles A. Dana Foundation, an ASCO YIA, and the Caine Halter Lung Cancer Research Fund/Uniting Against Lung Cancer Research Grant. C.L.S. and G.H. are Investigators of the Howard Hughes Medical Institute.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; Green DR, 2010, NATURE, V465, P433, DOI 10.1038/465433a; Haber DA, 2005, COLD SH Q B, V70, P419, DOI 10.1101/sqb.2005.70.043; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Miller VA, 2008, J CLIN ONCOL, V26, P1472, DOI 10.1200/JCO.2007.13.0062; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Yang JM, 2006, CLIN CANCER RES, V12, P950, DOI 10.1158/1078-0432.CCR-05-1220	23	314	331	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					523	526		10.1038/nature09870	http://dx.doi.org/10.1038/nature09870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430781	Green Published, Green Accepted			2022-12-24	WOS:000288702200064
J	Gravitz, L				Gravitz, Lauren			CHEMOPREVENTION First line of defence	NATURE			English	Editorial Material							CANCER PREVENTION; CELLS											Bode AM, 2009, NAT REV CANCER, V9, P508, DOI 10.1038/nrc2646; Gerner EW, 2009, CLIN CANCER RES, V15, P758, DOI 10.1158/1078-0432.CCR-08-2235; Lippman SM, 2009, CANCER RES, V69, P5269, DOI 10.1158/0008-5472.CAN-09-1750; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Xu L, 2009, JNCI-J NATL CANCER I, V101, P1141, DOI 10.1093/jnci/djp227; Zhang L, 2010, NATURE, V464, P1058, DOI 10.1038/nature08871	6	29	31	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S5	S7		10.1038/471S5a	http://dx.doi.org/10.1038/471S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430719				2022-12-24	WOS:000288702200009
J	Mateen, FJ; Brook, RD				Mateen, Farrah J.; Brook, Robert D.			Air Pollution as an Emerging Global Risk Factor for Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASES		[Mateen, Farrah J.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; [Mateen, Farrah J.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD 21287 USA; [Brook, Robert D.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA	Johns Hopkins University; Johns Hopkins University; University of Michigan System; University of Michigan	Mateen, FJ (corresponding author), Johns Hopkins Univ, Dept Neurol, 600 N Wolfe St,Pathol Bldg,Room 627, Baltimore, MD 21287 USA.	fmateen@jhsph.edu		Mateen, Farrah/0000-0002-4293-8115				[Anonymous], 2009, REUTERS         0217; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187; LOGAN WPD, 1953, LANCET, V264, P336; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Oudin A, 2010, NEUROEPIDEMIOLOGY, V34, P131, DOI 10.1159/000274807; *WHO, 2008, 310 WHO; Zhou PP, 2005, CLIMATE CHANGE AFRIC, P140	10	57	60	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1240	1241		10.1001/jama.2011.352	http://dx.doi.org/10.1001/jama.2011.352			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427378				2022-12-24	WOS:000288652100022
J	Steidl, C; Shah, SP; Woolcock, BW; Rui, LX; Kawahara, M; Farinha, P; Johnson, NA; Zhao, YJ; Telenius, A; Ben Neriah, S; McPherson, A; Meissner, B; Okoye, UC; Diepstra, A; van den Berg, A; Sun, M; Leung, G; Jones, SJ; Connors, JM; Huntsman, DG; Savage, KJ; Rimsza, LM; Horsman, DE; Staudt, LM; Steidl, U; Marra, MA; Gascoyne, RD				Steidl, Christian; Shah, Sohrab P.; Woolcock, Bruce W.; Rui, Lixin; Kawahara, Masahiro; Farinha, Pedro; Johnson, Nathalie A.; Zhao, Yongjun; Telenius, Adele; Ben Neriah, Susana; McPherson, Andrew; Meissner, Barbara; Okoye, Ujunwa C.; Diepstra, Arjan; van den Berg, Anke; Sun, Mark; Leung, Gillian; Jones, Steven J.; Connors, Joseph M.; Huntsman, David G.; Savage, Kerry J.; Rimsza, Lisa M.; Horsman, Douglas E.; Staudt, Louis M.; Steidl, Ulrich; Marra, Marco A.; Gascoyne, Randy D.			MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers	NATURE			English	Article							B-CELL LYMPHOMA; POOR PATIENT SURVIVAL; REED-STERNBERG CELLS; HODGKIN LYMPHOMA; PROTEIN EXPRESSION; LINE; JAK2; TRANSLOCATION; ABERRATIONS; RESOLUTION	Chromosomal translocations are critically involved in the molecular pathogenesis of B-cell lymphomas, and highly recurrent and specific rearrangements have defined distinct molecular subtypes linked to unique clinicopathological features(1,2). In contrast, several well-characterized lymphoma entities still lack disease-defining translocation events. To identify novel fusion transcripts resulting from translocations, we investigated two Hodgkin lymphoma cell lines by whole-transcriptome paired-end sequencing (RNA-seq). Here we show a highly expressed gene fusion involving the major histocompatibility complex (MHC) class II transactivator CIITA (MHC2TA) in KM-H2 cells. In a subsequent evaluation of 263 B-cell lymphomas, we also demonstrate that genomic CIITA breaks are highly recurrent in primary mediastinal B-cell lymphoma (38%) and classical Hodgkin lymphoma (cHL) (15%). Furthermore, we find that CIITA is a promiscuous partner of various in-frame gene fusions, and we report that CIITA gene alterations impact survival in primary mediastinal B-cell lymphoma (PMBCL). As functional consequences of CIITA gene fusions, we identify downregulation of surface HLA class II expression and overexpression of ligands of the receptor molecule programmed cell death 1 (CD274/PDL1 and CD273/PDL2). These receptor-ligand interactions have been shown to impact anti-tumour immune responses in several cancers(3), whereas decreased MHC class II expression has been linked to reduced tumour cell immunogenicity(4). Thus, our findings suggest that recurrent rearrangements of CIITA may represent a novel genetic mechanism underlying tumour-microenvironment interactions across a spectrum of lymphoid cancers.	[Steidl, Christian; Shah, Sohrab P.; Woolcock, Bruce W.; Farinha, Pedro; Johnson, Nathalie A.; Telenius, Adele; Ben Neriah, Susana; McPherson, Andrew; Meissner, Barbara; Sun, Mark; Leung, Gillian; Huntsman, David G.; Horsman, Douglas E.; Gascoyne, Randy D.] Ctr Lymphoid Cancers, Dept Pathol & Lab Med, Vancouver, BC V5Z 4E6, Canada; [Steidl, Christian; Shah, Sohrab P.; Woolcock, Bruce W.; Farinha, Pedro; Johnson, Nathalie A.; Telenius, Adele; Ben Neriah, Susana; McPherson, Andrew; Meissner, Barbara; Sun, Mark; Leung, Gillian; Huntsman, David G.; Horsman, Douglas E.; Gascoyne, Randy D.] Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; [Rui, Lixin; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Kawahara, Masahiro; Okoye, Ujunwa C.; Steidl, Ulrich] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Kawahara, Masahiro; Okoye, Ujunwa C.; Steidl, Ulrich] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; [Zhao, Yongjun; Jones, Steven J.; Marra, Marco A.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Diepstra, Arjan; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9700 AB Groningen, Netherlands; [Connors, Joseph M.; Savage, Kerry J.] BC Canc Agcy Ctr Lymphoid Canc, Div Med Oncol, Vancouver, BC V5Z 4E6, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; British Columbia Cancer Agency; University of Groningen; University of Arizona; University of British Columbia	Gascoyne, RD (corresponding author), Ctr Lymphoid Cancers, Dept Pathol & Lab Med, Vancouver, BC V5Z 4E6, Canada.	rgascoyn@bccancer.bc.ca	Staudt, Louis/AAC-5324-2019; li, rui/GSD-4367-2022; Huntsman, David/ABE-6082-2020; Jones, Steven J/C-3621-2009; Marra, Marco A/B-5987-2008; rui, li/GYR-3791-2022; Gascoyne, Randy D/A-6009-2013; Connors, Joseph/AAF-5284-2019; Savage, Kerry/HCH-5539-2022; van den Berg, Anke/H-1718-2011	Jones, Steven J/0000-0003-3394-2208; Marra, Marco A/0000-0001-7146-7175; Gascoyne, Randy D/0000-0002-2610-5690; Connors, Joseph/0000-0002-1361-7531; van den Berg, Anke/0000-0002-8894-2638; Diepstra, Arjan/0000-0001-9239-1050; Okoye-Okafor, Ujunwa/0000-0001-8824-1666; Farinha, Pedro/0000-0001-9364-9391	Cancer Research Society; Michael Smith Foundation for Health Research; Lymphoma Research Foundation; Canadian Breast Cancer Foundation; Canadian Institutes of Health Research [178536]; Terry Fox Foundation [019001]; Genome Canada/Genome BC; National Institutes of Health/National Cancer Institute [R00CA131503]; Leukemia Research Foundation; National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [ZIABC011008, ZIABC011006, R00CA131503] Funding Source: NIH RePORTER	Cancer Research Society; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Lymphoma Research Foundation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation; Genome Canada/Genome BC(Genome Canada); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Research Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by a postdoctoral fellowship of the Cancer Research Society (Steven E. Drabin Fellowship) to C. S., the Michael Smith Foundation for Health Research to C. S. and S. P. S., the Lymphoma Research Foundation to C. S. and the Canadian Breast Cancer Foundation to S. P. S. Operational funds were available through the Canadian Institutes of Health Research, grant number 178536 to R. D. G. R. D. G., J.M.C., M. A. M. and D. E. H. are also supported by the Terry Fox Foundation ( number 019001). This work was in part supported by an infrastructure grant of Genome Canada/Genome BC. U. S. is the recipient of a Howard Temin Award of the National Institutes of Health/National Cancer Institute (R00CA131503), a new investigator award of the Leukemia Research Foundation, and is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research of the Albert Einstein College of Medicine. We thank G. Simkin, C. Polumbo and T. Vogler for technical support. L. R. is the recipient of a CJ Martin Fellowship from the National Health and Medical Research Council of Australia.	Amini RM, 2002, LEUKEMIA LYMPHOMA, V43, P2179, DOI 10.1080/1042819021000032917; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Blank C, 2005, CANCER IMMUNOL IMMUN, V54, P307, DOI 10.1007/s00262-004-0593-x; Chin KC, 1997, J IMMUNOL, V159, P2789; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; Diepstra A, 2007, J CLIN ONCOL, V25, P3101, DOI 10.1200/JCO.2006.10.0917; Dyer MJS, 2003, INT J HEMATOL, V77, P315, DOI 10.1007/BF02982637; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Joos S, 2003, INT J CANCER, V103, P489, DOI 10.1002/ijc.10845; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lennon AM, 1997, IMMUNOGENETICS, V45, P266, DOI 10.1007/s002510050202; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lestou VS, 2003, BRIT J HAEMATOL, V122, P745, DOI 10.1046/j.1365-2141.2003.04502.x; Martin-Subero JI, 2006, CANCER RES, V66, P10332, DOI 10.1158/0008-5472.CAN-06-1992; Martinez-Ramirez A, 2004, LEUKEMIA, V18, P348, DOI 10.1038/sj.leu.2403230; Masternak K, 2000, GENE DEV, V14, P1156; Melzner I, 2006, INT J CANCER, V118, P1941, DOI 10.1002/ijc.21485; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Roberts RA, 2006, BLOOD, V108, P311, DOI 10.1182/blood-2005-11-4742; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Sambade C, 2006, INT J CANCER, V118, P555, DOI 10.1002/ijc.21417; Savage KJ, 2006, ANN ONCOL, V17, P123, DOI 10.1093/annonc/mdj030; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Shah SP, 2006, BIOINFORMATICS, V22, pE431, DOI 10.1093/bioinformatics/btl238; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Shustik J, 2010, HAEMATOL-HEMATOL J, V95, P96, DOI 10.3324/haematol.2009.007203; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Yamamoto R, 2008, BLOOD, V111, P3220, DOI 10.1182/blood-2007-05-085159; Zhou H, 1997, J IMMUNOL, V158, P4741	41	408	425	5	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					377	+		10.1038/nature09754	http://dx.doi.org/10.1038/nature09754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368758	Green Accepted			2022-12-24	WOS:000288444000045
J	Mirza, DM; Hashim, MJ; Sheikh, A				Mirza, Deen M.; Hashim, Muhammad Jawad; Sheikh, Aziz			10-Minute Consultation Malaria	BRITISH MEDICAL JOURNAL			English	Editorial Material												deenmirza@doctors.org.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Hashim, Muhammad Jawad/0000-0002-9280-9709				Chiodini P, 2007, GUIDELINES MALARIA P	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 15	2011	342								d1149	10.1136/bmj.d1149	http://dx.doi.org/10.1136/bmj.d1149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FA	21406530	Green Submitted			2022-12-24	WOS:000288698100016
J	Brown, RE				Brown, Raeford E., Jr.			A Door Closes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rbrow1@email.uky.edu	Brown, Raeford/I-1211-2019	Brown, Raeford/0000-0002-2295-2657					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					977	978		10.1001/jama.2011.254	http://dx.doi.org/10.1001/jama.2011.254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386070				2022-12-24	WOS:000288129600001
J	Ficz, G; Branco, MR; Seisenberger, S; Santos, F; Krueger, F; Hore, TA; Marques, CJ; Andrews, S; Reik, W				Ficz, Gabriella; Branco, Miguel R.; Seisenberger, Stefanie; Santos, Fatima; Krueger, Felix; Hore, Timothy A.; Marques, C. Joana; Andrews, Simon; Reik, Wolf			Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation	NATURE			English	Article							DNA METHYLATION; SELF-RENEWAL; STEM-CELLS; GENOME; WIDE; PLURIPOTENT; CONVERSION; PROTEINS	Methylation at the 59 position of cytosine in DNA has important roles in genome function and is dynamically reprogrammed during early embryonic and germ cell development(1). The mammalian genome also contains 5-hydroxymethylcytosine (5hmC), which seems to be generated by oxidation of 5-methylcytosine (5mC) by the TET family of enzymes that are highly expressed in embryonic stem(ES) cells(2-4). Here we use antibodies against 5hmC and 5mC together with high throughput sequencing to determine genome-wide patterns of methylation and hydroxymethylation in mouse wild-type and mutant ES cells and differentiating embryoid bodies. We find that 5hmC is mostly associated with euchromatin and that whereas 5mC is under-represented at gene promoters and CpG islands, 5hmC is enriched and is associated with increased transcriptional levels. Most, if not all, 5hmC in the genome depends on pre-existing 5mC and the balance between these two modifications is different between genomic regions. Knockdown of Tet1 and Tet2 causes downregulation of a group of genes that includes pluripotency-related genes (including Esrrb, Prdm14, Dppa3, Klf2, Tcl1 and Zfp42) and a concomitant increase in methylation of their promoters, together with an increased propensity of ES cells for extraembryonic lineage differentiation. Declining levels of TETs during differentiation are associated with decreased hydroxymethylation levels at the promoters of ES cell-specific genes together with increased methylation and gene silencing. We propose that the balance between hydroxymethylation and methylation in the genome is inextricably linked with the balance between pluripotency and lineage commitment.	[Ficz, Gabriella; Branco, Miguel R.; Seisenberger, Stefanie; Santos, Fatima; Hore, Timothy A.; Marques, C. Joana; Reik, Wolf] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Krueger, Felix; Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Reik, W (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England.	wolf.reik@bbsrc.ac.uk	Marques, Joana/B-5564-2008; Krueger, Felix/J-3340-2019; Ficz, Gabriella/HCH-3771-2022; Reik, Wolf/I-6794-2012; Branco, Miguel/H-9509-2019	Marques, Joana/0000-0002-5658-3773; Branco, Miguel/0000-0001-9447-1548; Ficz, Gabriella/0000-0001-9313-9578; Reik, Wolf/0000-0003-0216-9881; Santos, Fatima/0000-0002-3854-4084; Hore, Timothy/0000-0002-6735-225X; Krueger, Felix/0000-0002-5513-3324	BBSRC; MRC; EU NoE The Epigenome; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M236] Funding Source: researchfish; Medical Research Council [G0801156, G0801727] Funding Source: researchfish; BBSRC [BBS/E/B/0000M236] Funding Source: UKRI; MRC [G0801156, G0801727] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU NoE The Epigenome; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank A. Bird for discussions and input, K. Tabbada for help with epigenomics and transcriptomics sequencing, and M. Okano for providing the TKO ES cells. We would like to thank H. Stuart for her dedicated contribution to gene expression analyses, and all Reik lab members for advice and discussion. This work was funded by the BBSRC, MRC and the EU NoE The Epigenome.	Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Glover CH, 2006, PLOS COMPUT BIOL, V2, P1463, DOI 10.1371/journal.pcbi.0020158; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Iacovino M, 2009, STEM CELLS DEV, V18, P783, DOI 10.1089/scd.2008.0227; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Ting DT, 2004, METH MOLEC MED, V105, P23; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	37	846	905	4	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					398	U589		10.1038/nature10008	http://dx.doi.org/10.1038/nature10008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21460836				2022-12-24	WOS:000290722400054
J	Stolarz-Skrzypek, K; Kuznetsova, T; Thijs, L; Tikhonoff, V; Seidlerova, J; Richart, T; Jin, Y; Olszanecka, A; Malyutina, S; Casiglia, E; Filipovsky, J; Kawecka-Jaszcz, K; Nikitin, Y; Staessen, JA				Stolarz-Skrzypek, Katarzyna; Kuznetsova, Tatiana; Thijs, Lutgarde; Tikhonoff, Valerie; Seidlerova, Jitka; Richart, Tom; Jin, Yu; Olszanecka, Agnieszka; Malyutina, Sofia; Casiglia, Edoardo; Filipovsky, Jan; Kawecka-Jaszcz, Kalina; Nikitin, Yuri; Staessen, Jan A.		European Project Genes Hypertensio	Fatal and Nonfatal Outcomes, Incidence of Hypertension, and Blood Pressure Changes in Relation to Urinary Sodium Excretion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REDUCED DIETARY-SODIUM; CARDIOVASCULAR-DISEASE; SALT INTAKE; NATIONAL-HEALTH; POTASSIUM; MORTALITY; RISK; POPULATION; METAANALYSIS; CONSUMPTION	Context Extrapolations from observational studies and short-term intervention trials suggest that population-wide moderation of salt intake might reduce cardiovascular events. Objective To assess whether 24-hour urinary sodium excretion predicts blood pressure (BP) and health outcomes. Design, Setting, and Participants Prospective population study, involving 3681 participants without cardiovascular disease (CVD) who are members of families that were randomly enrolled in the Flemish Study on Genes, Environment, and Health Outcomes (1985-2004) or in the European Project on Genes in Hypertension (1999-2001). Of 3681 participants without CVD, 2096 were normotensive at baseline and 1499 had BP and sodium excretion measured at baseline and last follow-up (2005-2008). Main Outcome Measures Incidence of mortality and morbidity and association between changes in BP and sodium excretion. Multivariable-adjusted hazard ratios (HRs) express the risk in tertiles of sodium excretion relative to average risk in the whole study population. Results Among 3681 participants followed up for a median 7.9 years, CVD deaths decreased across increasing tertiles of 24-hour sodium excretion, from 50 deaths in the low (mean, 107 mmol), 24 in the medium (mean, 168 mmol), and 10 in the high excretion group (mean, 260 mmol; P<.001), resulting in respective death rates of 4.1% (95% confidence interval [CI], 3.5%-4.7%), 1.9% (95% CI, 1.5%-2.3%), and 0.8% (95% CI, 0.5%-1.1%). In multivariable-adjusted analyses, this inverse association retained significance (P=.02): the HR in the low tertile was 1.56 (95% CI, 1.02-2.36; P=.04). Baseline sodium excretion predicted neither total mortality (P=.10) nor fatal combined with nonfatal CVD events (P=.55). Among 2096 participants followed up for 6.5 years, the risk of hypertension did not increase across increasing tertiles (P=.93). Incident hypertension was 187 (27.0%; HR, 1.00; 95% CI, 0.87-1.16) in the low, 190 (26.6%; HR, 1.02; 95% CI, 0.89-1.16) in the medium, and 175 (25.4%; HR, 0.98; 95% CI, 0.86-1.12) in the high sodium excretion group. In 1499 participants followed up for 6.1 years, systolic blood pressure increased by 0.37 mm Hg per year (P<.001), whereas sodium excretion did not change (-0.45 mmol per year, P=.15). However, in multivariable-adjusted analyses, a 100-mmol increase in sodium excretion was associated with 1.71 mm Hg increase in systolic blood pressure (P.<001) but no change in diastolic BP. Conclusions In this population-based cohort, systolic blood pressure, but not diastolic pressure, changes over time aligned with change in sodium excretion, but this association did not translate into a higher risk of hypertension or CVD complications. Lower sodium excretion was associated with higher CVD mortality. JAMA. 2011;305(17):1777-1785 www.jama.com	[Staessen, Jan A.] Katholieke Univ Leuven, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, Dept Cardiovasc Dis,Lab Hypertens, BE-3000 Louvain, Belgium; [Stolarz-Skrzypek, Katarzyna; Olszanecka, Agnieszka; Kawecka-Jaszcz, Kalina] Jagiellonian Univ, Coll Med, Dept Cardiol & Hypertens 1, Krakow, Poland; [Tikhonoff, Valerie; Casiglia, Edoardo] Univ Padua, Dept Clin & Expt Med, Padua, Italy; [Seidlerova, Jitka; Filipovsky, Jan] Charles Univ Prague, Fac Med Pilsen, Plzen, Czech Republic; [Malyutina, Sofia; Nikitin, Yuri] Inst Internal Med, Novosibirsk, Russia; [Richart, Tom; Staessen, Jan A.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands	KU Leuven; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Padua; Charles University Prague; Maastricht University	Staessen, JA (corresponding author), Katholieke Univ Leuven, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, Dept Cardiovasc Dis,Lab Hypertens, Campus Sint Rafael,Kapucijnenvoer 35,Block D,POB, BE-3000 Louvain, Belgium.	jan.staessen@med.kuleuven.be	Seidlerova, Jitka/P-1188-2017; Malyutina, Sofia/J-1651-2018; Kuznetsova, Tatiana/ABI-5662-2020; Staessen, Jan A/A-1065-2011; Tikhonoff, Valerie/AAC-3728-2019; Nikitin, Yuri/D-2774-2018; Stolarz-Skrzypek, Katarzyna/E-1589-2011	Seidlerova, Jitka/0000-0002-2731-4961; Malyutina, Sofia/0000-0001-6539-0466; Kuznetsova, Tatiana/0000-0003-4293-4576; Staessen, Jan A/0000-0002-3026-1637; Tikhonoff, Valerie/0000-0001-7846-0101; Nikitin, Yuri/0000-0002-3932-2299; Thijs, Lutgarde/0000-0002-8108-2356; Casiglia, Edoardo/0000-0002-0003-3289; Olszanecka, Agnieszka/0000-0001-7020-9641	European Union [IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093]; Studies Coordinating Centre (Leuven, Belgium) [HEALTH-F4-2007-201550]; studies in Pilsen (Czech Republic); studies in Pilsen, Padova (Italy); studies in Pilsen, Krakow (Poland); Novosibirsk (Russian Federation); Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0575.06, G.0734.09]; Katholieke Universiteit Leuven, Belgium [OT/00/25, OT/05/49]; Polish Ministry for Science and Higher Education; Czech Society of Hypertension	European Union(European Commission); Studies Coordinating Centre (Leuven, Belgium); studies in Pilsen (Czech Republic)(Czech Republic Government); studies in Pilsen, Padova (Italy); studies in Pilsen, Krakow (Poland); Novosibirsk (Russian Federation)(Russian Federation); Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO); Katholieke Universiteit Leuven, Belgium(KU Leuven); Polish Ministry for Science and Higher Education(Ministry of Science and Higher Education, Poland); Czech Society of Hypertension	The European Union grants IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093. InGenious HyperCare, and HEALTH-F4-2007-201550 HyperGenes supported the Studies Coordinating Centre (Leuven, Belgium) and the studies in Pilsen (Czech Republic), Padova (Italy), Krakow (Poland), and Novosibirsk (Russian Federation). The Studies Coordinating Centre also received grants G.0575.06 and G.0734.09 from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium, and the grants OT/00/25 and OT/05/49 from the Katholieke Universiteit Leuven, Belgium. The Polish Ministry for Science and Higher Education supported the fellowship of Dr Stolarz-Skrzypek in Leuven. The Czech Society of Hypertension provided additional funding to Dr Seidlerova.	ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; Alderman MH, 1998, LANCET, V351, P781, DOI 10.1016/S0140-6736(97)09092-2; Alderman MH, 2010, JAMA-J AM MED ASSOC, V303, P448, DOI 10.1001/jama.2010.69; Bernstein AM, 2010, AM J CLIN NUTR, V92, P1172, DOI 10.3945/ajcn.2010.29367; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Campese VM, 1999, NUTR METAB CARDIOVAS, V9, P143; Chien KL, 2008, J HYPERTENS, V26, P1750, DOI 10.1097/HJH.0b013e328306a0a7; CLELAND JGF, 1987, BRIT HEART J, V58, P230; Cohen HW, 2008, J GEN INTERN MED, V23, P1297, DOI 10.1007/s11606-008-0645-6; Cohen HW, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.042; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Franklin SS, 1997, CIRCULATION, V96, P308; Gavin JR, 1999, DIABETES CARE, V22, pS5; GELEIJNSE JM, 1990, BMJ-BRIT MED J, V300, P899, DOI 10.1136/bmj.300.6729.899; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI [10.1161/HYPERTENSIONAHA.109.140798, 10.1161/HYP.0b013e3181dfc0ad]; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; He JA, 2000, HYPERTENSION, V35, P544, DOI 10.1161/01.HYP.35.2.544; He JA, 1999, JAMA-J AM MED ASSOC, V282, P2027, DOI 10.1001/jama.282.21.2027; HOSMER DW, 1989, APPL LOGISTIC REGRES; KAGAN A, 1985, STROKE, V16, P390, DOI 10.1161/01.STR.16.3.390; Kuznetsova T, 2002, BLOOD PRESS MONIT, V7, P215, DOI 10.1097/00126097-200208000-00003; LEVER AF, 1981, BRIT MED J, V283, P463, DOI 10.1136/bmj.283.6289.463; Li Y, 2007, HYPERTENSION, V49, P1291, DOI 10.1161/HYPERTENSIONAHA.106.085498; LUFT FC, 1982, HYPERTENSION, V4, P805, DOI 10.1161/01.HYP.4.6.805; McCarron DA, 2009, CLIN J AM SOC NEPHRO, V4, P1878, DOI 10.2215/CJN.04660709; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; Morris RC, 1999, HYPERTENSION, V33, P18, DOI 10.1161/01.HYP.33.1.18; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schmidlin O, 1999, HYPERTENSION, V33, P633, DOI 10.1161/01.HYP.33.2.633; SMITH WCS, 1988, BRIT MED J, V297, P329, DOI 10.1136/bmj.297.6644.329; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; STAESSEN J, 1983, AM J EPIDEMIOL, V117, P676, DOI 10.1093/oxfordjournals.aje.a113601; STAESSEN J, 1988, J HYPERTENS, V6, P965, DOI 10.1097/00004872-198812000-00003; Staessen JA, 2001, J HYPERTENS, V19, P1349, DOI 10.1097/00004872-200108000-00002; Staessen JA, 1997, AM J CLIN NUTR, V65, P661; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; TunstallPedoe H, 1997, BRIT MED J, V315, P722, DOI 10.1136/bmj.315.7110.722; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; Umesawa M, 2008, AM J CLIN NUTR, V88, P195, DOI 10.1093/ajcn/88.1.195; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038	45	417	429	0	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1777	1785		10.1001/jama.2011.574	http://dx.doi.org/10.1001/jama.2011.574			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758HZ	21540421	Green Published, Bronze			2022-12-24	WOS:000290156200018
J	Koenig, J; Linder, AN; Leutgeb, JK; Leutgeb, S				Koenig, Julie; Linder, Ashley N.; Leutgeb, Jill K.; Leutgeb, Stefan			The Spatial Periodicity of Grid Cells Is Not Sustained During Reduced Theta Oscillations	SCIENCE			English	Article							ENTORHINAL CORTEX; PLACE CELLS; UNIT-ACTIVITY; HIPPOCAMPUS; NEURONS; INTERFERENCE; NAVIGATION; FREQUENCY; SEPTUM; PHASE	Grid cells in parahippocampal cortices fire at vertices of a periodic triangular grid that spans the entire recording environment. Such precise neural computations in space have been proposed to emerge from equally precise temporal oscillations within cells or within the local neural circuitry. We found that grid-like firing patterns in the entorhinal cortex vanished when theta oscillations were reduced after intraseptal lidocaine infusions in rats. Other spatially modulated cells in the same cortical region and place cells in the hippocampus retained their spatial firing patterns to a larger extent during these periods without well-organized oscillatory neuronal activity. Precisely timed neural activity within single cells or local networks is thus required for periodic spatial firing but not for single place fields.	[Leutgeb, Stefan] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, San Diego, CA 92103 USA; Univ Calif San Diego, Ctr Neural Circuits & Behav, Div Biol Sci, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Leutgeb, S (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, San Diego, CA 92103 USA.	sleutgeb@ucsd.edu	koenig, julie/O-7865-2016	koenig, julie/0000-0003-0516-6627; Leutgeb, Jill/0000-0002-2014-842X	NSF/NIH/Bundesministerium fur Bildung und Forschung [1010463]; Ellison Medical Foundation [AG-NS-0724-10]; Alfred P. Sloan Foundation; Alzheimer's Association [NIRG-09-133414]	NSF/NIH/Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Alzheimer's Association(Alzheimer's Association)	The authors thank T. Solstad and E. Mankin for Matlab scripts and M. Hasselmo, L. Squire, and M. Scanziani for comments and discussions. Supported by the Walter F. Heiligenberg Professorship, NSF/NIH/Bundesministerium fur Bildung und Forschung grant 1010463, Ellison Medical Foundation grant AG-NS-0724-10, the Alfred P. Sloan Foundation, and Alzheimer's Association grant NIRG-09-133414.	Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brazhnik E, 2004, J NEUROSCI, V24, P9313, DOI 10.1523/JNEUROSCI.1618-04.2004; Burgess N, 1996, HIPPOCAMPUS, V6, P749; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Dickson CT, 2000, ANN NY ACAD SCI, V911, P127; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; JEFFERY KJ, 1995, NEUROREPORT, V6, P2166, DOI 10.1097/00001756-199511000-00017; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; MIZUMORI SJY, 1989, BRAIN RES, V500, P99, DOI 10.1016/0006-8993(89)90303-X; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	27	278	280	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					592	595		10.1126/science.1201685	http://dx.doi.org/10.1126/science.1201685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527713				2022-12-24	WOS:000289991100050
J	Neurohr, G; Naegeli, A; Titos, I; Theler, D; Greber, B; Diez, J; Gabaldon, T; Mendoza, M; Barral, Y				Neurohr, Gabriel; Naegeli, Andreas; Titos, Iris; Theler, Dominik; Greber, Basil; Diez, Javier; Gabaldon, Toni; Mendoza, Manuel; Barral, Yves			A Midzone-Based Ruler Adjusts Chromosome Compaction to Anaphase Spindle Length	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CONDENSATION; SEPARASE; PROTEIN; KINASE; ANEUPLOIDY; CANCER; CDC14; GENE	Partitioning of chromatids during mitosis requires that chromosome compaction and spindle length scale appropriately with each other. However, it is not clear whether chromosome condensation and spindle elongation are linked. Here, we find that yeast cells could cope with a 45% increase in the length of their longest chromosome arm by increasing its condensation. The spindle midzone, aurora/Ipl1 activity, and Ser10 of histone H3 mediated this response. Thus, the anaphase spindle may function as a ruler to adapt the condensation of chromatids, promoting their segregation regardless of chromosome or spindle length.	[Neurohr, Gabriel; Titos, Iris; Diez, Javier; Gabaldon, Toni; Mendoza, Manuel] Ctr Genom Regulat, Barcelona, Spain; [Neurohr, Gabriel; Titos, Iris; Diez, Javier; Gabaldon, Toni; Mendoza, Manuel] Univ Pompeu Fabra, Barcelona, Spain; [Neurohr, Gabriel; Naegeli, Andreas; Theler, Dominik; Greber, Basil; Mendoza, Manuel; Barral, Yves] ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mendoza, M (corresponding author), Ctr Genom Regulat, Barcelona, Spain.	manuel.mendoza@crg.es; yves.barral@bc.biol.ethz.ch	Mendoza, Manuel/M-9679-2015; Mendoza, Manuel/AAE-8987-2021; Gabaldón, Toni/A-7336-2008	Mendoza, Manuel/0000-0001-5522-4878; Gabaldón, Toni/0000-0003-0019-1735; Titos, Iris/0000-0002-5542-3794; Diez Perez, Javier/0000-0001-5032-4976; Naegeli, Andreas/0000-0002-5938-9124; Greber, Basil/0000-0001-9379-7159; Neurohr, Gabriel/0000-0003-1728-5498; Barral, Yves/0000-0002-0989-3373	La Caixa; Spanish Ministry of Science [BFU09-09168, BFU09-08213]; Swiss National Science Foundation	La Caixa(La Caixa Foundation); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank P. Meraldi, Z. Shcheprova, C. Weirich, and S. Buvelot for helpful comments and critical reading of the manuscript; D. Clarke (University of Minnesota) for reagents; C. Iannone and R. Tejedor for help with qPCR; F. Campelo for help with statistical analysis; the ETH Light Microscopy Center; the CRG Advanced Light Microscopy Unit; and the CRG Ultrasequencing Unit. This project was supported by grants from La Caixa to G. N., the Spanish Ministry of Science to T. G. (BFU09-09168) and M. M. (BFU09-08213), and the Swiss National Science Foundation to Y.B.	Bouck DC, 2008, ANNU REV GENET, V42, P335, DOI 10.1146/annurev.genet.42.110807.091620; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Harrison BD, 2009, CHROMOSOMA, V118, P633, DOI 10.1007/s00412-009-0224-6; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Nash RS, 2001, GENETICS, V157, P1469; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; SULLIVAN W, 1993, MOL BIOL CELL, V4, P885, DOI 10.1091/mbc.4.9.885; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Vas ACJ, 2007, MOL BIOL CELL, V18, P557, DOI 10.1091/mbc.E06-05-0454	20	69	70	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					465	468		10.1126/science.1201578	http://dx.doi.org/10.1126/science.1201578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21393511				2022-12-24	WOS:000289784900043
J	West-Eberhard, MJ; Smith, JAC; Winter, K				West-Eberhard, Mary Jane; Smith, J. Andrew C.; Winter, Klaus			Photosynthesis, Reorganized	SCIENCE			English	Editorial Material							CRASSULACEAN ACID METABOLISM; EVOLUTIONARY; EXPRESSION; ORIGINS		[West-Eberhard, Mary Jane] Univ Costa Rica, Smithsonian Trop Res Inst, Escuela Biol, San Pedro, Costa Rica; [Smith, J. Andrew C.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Winter, Klaus] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Costa Rica; University of Oxford; Smithsonian Institution; Smithsonian Tropical Research Institute	West-Eberhard, MJ (corresponding author), Univ Costa Rica, Smithsonian Trop Res Inst, Escuela Biol, San Pedro, Costa Rica.	mjwe@sent.com; andrew.smith@plants.ox.ac.uk; winterk@si.edu	Smith, J.A.C./M-3338-2014	Smith, J.A.C./0000-0001-9188-0258				Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Boxall SF, 2005, PLANT PHYSIOL, V137, P969, DOI 10.1104/pp.104.054577; Brown NJ, 2011, SCIENCE, V331, P1436, DOI 10.1126/science.1201248; Christin PA, 2010, TRENDS GENET, V26, P400, DOI 10.1016/j.tig.2010.06.005; Crayn DM, 2004, P NATL ACAD SCI USA, V101, P3703, DOI 10.1073/pnas.0400366101; Cushman JC, 1997, PLANT PHYSIOL, V113, P667, DOI 10.1104/pp.113.3.667; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Hibberd JM, 2010, ANNU REV PLANT BIOL, V61, P181, DOI 10.1146/annurev-arplant-042809-112238; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Silvera K, 2009, PLANT PHYSIOL, V149, P1838, DOI 10.1104/pp.108.132555; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; West-Eberhard Mary Jane, 2003, pi; Winter K, 1996, CRASSULACEAN ACID ME; Winter K, 2007, PLANT PHYSIOL, V143, P98, DOI 10.1104/pp.106.088922	15	43	49	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					311	312		10.1126/science.1205336	http://dx.doi.org/10.1126/science.1205336			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493847				2022-12-24	WOS:000289516600030
J	Misra, S; Hancock, M; Meeran, K; Dornhorst, A; Oliver, NS				Misra, Shivani; Hancock, Maggie; Meeran, Karim; Dornhorst, Anne; Oliver, Nick S.			HbA(1c): an old friend in new clothes	LANCET			English	Editorial Material							HEMOGLOBIN		[Misra, Shivani; Meeran, Karim; Dornhorst, Anne; Oliver, Nick S.] Imperial Healthcare NHS Trust, Dept Metab Med, London W6 8RF, England; [Misra, Shivani; Hancock, Maggie] Imperial Healthcare NHS Trust, Dept Clin Biochem, London W6 8RF, England		Misra, S (corresponding author), Imperial Healthcare NHS Trust, Dept Metab Med, London W6 8RF, England.	smisra@imperial.ac.uk	Oliver, Nick S/G-9109-2016	Oliver, Nick S/0000-0003-3525-3633; Misra, Shivani/0000-0003-2886-0726				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; *ASS CLIN BIOCH, HBA1C STAND LAB PROF; Barth JH, 2008, ANN CLIN BIOCHEM, V45, P343, DOI 10.1258/acb.2008.200815; Berg AH, 2008, J CLIN PATHOL, V61, P983, DOI 10.1136/jcp.2007.049205; Davidson MB, 2010, DIABETES RES CLIN PR, V87, P415, DOI 10.1016/j.diabres.2009.12.013; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; Kilpatrick ES, 2009, BMJ-BRIT MED J, V339, P1288; Little Randie R, 2003, Diabetes Technol Ther, V5, P979, DOI 10.1089/152091503322641024; Little RR, 2009, CURR OPIN ENDOCRINOL, V16, P113, DOI 10.1097/MED.0b013e328327728d; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Glycohemoglobin Standardization Program (NGSP), FACT INT HBA1C TEST; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Weykamp C, 2008, CLIN CHEM, V54, P240, DOI 10.1373/clinchem.2007.097402; World Health Organization, 2011, US GLYC HAEM HBA1C D	16	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2011	377	9776					1476	1477		10.1016/S0140-6736(10)61858-2	http://dx.doi.org/10.1016/S0140-6736(10)61858-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761RX	21354611				2022-12-24	WOS:000290419400010
J	Sun, G; Dilcher, DL; Wang, HS; Chen, ZD				Sun, Ge; Dilcher, David L.; Wang, Hongshan; Chen, Zhiduan			A eudicot from the Early Cretaceous of China	NATURE			English	Article							JURASSIC ANGIOSPERM; YIXIAN FORMATION; FOSSIL EVIDENCE; AGE; FLOWER; NOV.	The current molecular systematics of angiosperms(1) recognizes the basal angiosperms and five major angiosperm lineages: the Chloranthaceae, the magnoliids, the monocots, Ceratophyllum and the eudicots, which consist of the basal eudicots and the core eudicots(2). The eudicots form the majority of the angiosperms in the world today. The flowering plants are of exceptional evolutionary interest because of their diversity of over 250,000 species and their abundance as the dominant vegetation in most terrestrial ecosystems, but little is known of their very early history. In this report we document an early presence of eudicots during the Early Cretaceous Period. Diagnostic characters of the eudicot fossil Leefructus gen. nov. include simple and deeply trilobate leaves clustered at the nodes in threes or fours, basal palinactinodromous primary venation, pinnate secondary venation, and a long axillary reproductive axis terminating in a flattened receptacle bearing five long, narrow pseudo-syncarpous carpels. These morphological characters suggest that its affinities are with the Ranunculaceae, a basal eudicot family. The fossil co-occurs with Archaefructus sinensis(3) and Hyrcantha decussata(4) whereas Archaefructus liaoningensis(5) comes from more ancient sediments. Multiple radiometric dates of the Lower Cretaceous Yixian Formation place the bed yielding this fossil at 122.6-125.8 million years old(6-8). The earliest fossil records of eudicots are 127 to 125 million years old, on the basis of pollen(9,10). Thus, Leefructus gen. nov. suggests that the basal eudicots were already present and diverse by the latest Barremian and earliest Aptian.	[Sun, Ge; Dilcher, David L.; Wang, Hongshan] Shenyang Normal Univ, Inst Paleontol, Shenyang 110034, Peoples R China; [Sun, Ge; Dilcher, David L.] Jilin Univ, Res Ctr Paleontol, Changchun 130026, Peoples R China; [Dilcher, David L.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Wang, Hongshan] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Chen, Zhiduan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China	Shenyang Normal University; Jilin University; Indiana University System; Indiana University Bloomington; State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Botany, CAS	Sun, G (corresponding author), Shenyang Normal Univ, Inst Paleontol, Shenyang 110034, Peoples R China.	sunge@synu.edu.cn; dilcher@indiana.edu			Key Lab of Evolution of Past Life and Environment in Northeast Asia, Ministry of Education, China; Project "111'' of China; NSFC [40842002]	Key Lab of Evolution of Past Life and Environment in Northeast Asia, Ministry of Education, China(Ministry of Education, China); Project "111'' of China(Ministry of Education, China - 111 Project); NSFC(National Natural Science Foundation of China (NSFC))	We acknowledge the support of the Key Lab of Evolution of Past Life and Environment in Northeast Asia, Ministry of Education, China, and Project "111'' of China, NSFC project number 40842002, and the President Special Fund of Shenyang Normal University to carry out this research project during 2008-2009. Many thanks to S. M. Li and L. X. Wang for their help in collecting the fossil specimen. We thank Y. Duan, C. T. Li, Y. S. Liu, D. M. Jarzen, T. Lott, S. Trammel and W. Wang for their assistance in analysis, computer work, photography and artwork. We also thank P. and D. Soltis, K. Nixon, M. Moore and J. Doyle for suggestions.	Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; [Anonymous], 1991, POLLEN SPORES PATTER; Barrett PM, 2000, TRENDS ECOL EVOL, V15, P99, DOI 10.1016/S0169-5347(99)01782-6; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Chang M.M., 2001, JEHOL BIOTA; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Dilcher DL, 2007, P NATL ACAD SCI USA, V104, P9370, DOI 10.1073/pnas.0703497104; Doyle J., 1977, B CTR RECH EXPLOR PR, V1, P451; DOYLE JA, 1969, J ARNOLD ARBORETUM, V50, P1; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hughes NF., 1994, ENIGMA ANGIOSPERM OR; Leng Q, 2003, PLANT SYST EVOL, V241, P77, DOI 10.1007/s00606-003-0028-8; [孟凡雪 MENG Fanxue], 2008, [地质通报, Geological Bulletin of China], V27, P364; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Peng Y. D., 2003, GEOCHIMICA, V32, P427, DOI DOI 10.3321/J.ISSN:0379-1726.2003.05.003; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Ren D, 1998, SCIENCE, V280, P85, DOI 10.1126/science.280.5360.85; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Sun G, 2002, SCIENCE, V296, P899, DOI 10.1126/science.1069439; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Taylor T.N., 2008, PALEOBOTANY BIOL EVO; Wang SS, 2001, ACTA PETROL SIN, V17, P663; Wang W, 2009, PERSPECT PLANT ECOL, V11, P81, DOI 10.1016/j.ppees.2009.01.001; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; [张宏 Zhang Hong], 2006, [地质论评, Geological Review], V52, P63; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	30	92	105	3	83	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					625	628		10.1038/nature09811	http://dx.doi.org/10.1038/nature09811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455178				2022-12-24	WOS:000288951200040
J	Eisenstein, M				Eisenstein, Michael			VACCINES Know your enemy	NATURE			English	Editorial Material							CARCINOMA											Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; De Giovanni C, 2004, CANCER RES, V64, P4001, DOI 10.1158/0008-5472.CAN-03-2984; Gray A, 2009, VACCINE, V27, pG52, DOI 10.1016/j.vaccine.2009.09.106; Jaini R, 2010, NAT MED, V16, P799, DOI 10.1038/nm.2161; Malfertheiner P, 2008, GASTROENTEROLOGY, V135, P787, DOI 10.1053/j.gastro.2008.05.054	5	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S8	S9		10.1038/471S8a	http://dx.doi.org/10.1038/471S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430720	hybrid			2022-12-24	WOS:000288702200010
J	Seebacher, J; Gavin, AC				Seebacher, Jan; Gavin, Anne-Claude			SnapShot: Protein-Protein Interaction Networks	CELL			English	Editorial Material							ORGANIZATION; MAP		[Seebacher, Jan; Gavin, Anne-Claude] EMBL, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Seebacher, J (corresponding author), EMBL, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.			Gavin, Anne-Claude/0000-0003-4917-2340				Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Orchard S, 2007, NAT BIOTECHNOL, V25, P894, DOI 10.1038/nbt1324; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	8	47	49	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 18	2011	144	6					1000	U1		10.1016/j.cell.2011.02.025	http://dx.doi.org/10.1016/j.cell.2011.02.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414489	Bronze, Green Published			2022-12-24	WOS:000288543500016
J	Wakil, A; Ng, JM; Atkin, SL				Wakil, Ammar; Ng, Jen Min; Atkin, Stephen L.			Rational Testing Investigating hyponatraemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERNATREMIA; WATER					ammar.wakil@gmail.com	Atkin, stephen/ABE-7047-2020; atkin, stephen/D-7400-2014	atkin, stephen/0000-0002-5887-7257				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Clayton JA, 2006, QJM-INT J MED, V99, P505, DOI 10.1093/qjmed/hcl071; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Hawkins RC, 2003, CLIN CHIM ACTA, V337, P169, DOI 10.1016/j.cccn.2003.08.001; Milionis HJ, 2002, CAN MED ASSOC J, V166, P1056; Schrier RW, 2006, J AM SOC NEPHROL, V17, P1820, DOI 10.1681/ASN.2006030240; Verbalis JG, 2007, AM J MED, V120, pS1, DOI 10.1016/j.amjmed.2007.09.001; Yeates KE, 2004, CAN MED ASSOC J, V170, P365; Zenenberg Robert D, 2010, Hosp Pract (1995), V38, P89	9	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2011	342								d1118	10.1136/bmj.d1118	http://dx.doi.org/10.1136/bmj.d1118			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UV	21382929				2022-12-24	WOS:000288446500005
J	Pertel, T; Hausmann, S; Morger, D; Zuger, S; Guerra, J; Lascano, J; Reinhard, C; Santoni, FA; Uchil, PD; Chatel, L; Bisiaux, A; Albert, ML; Strambio-De-Castillia, C; Mothes, W; Pizzato, M; Grutter, MG; Luban, J				Pertel, Thomas; Hausmann, Stephane; Morger, Damien; Zueger, Sara; Guerra, Jessica; Lascano, Josefina; Reinhard, Christian; Santoni, Federico A.; Uchil, Pradeep D.; Chatel, Laurence; Bisiaux, Aurelie; Albert, Matthew L.; Strambio-De-Castillia, Caterina; Mothes, Walther; Pizzato, Massimo; Gruetter, Markus G.; Luban, Jeremy			TRIM5 is an innate immune sensor for the retrovirus capsid lattice	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; UNANCHORED POLYUBIQUITIN CHAINS; CYCLOPHILIN-A; TRIM5-ALPHA PROTEIN; HUMAN-CELLS; HIV-1; RESISTANCE; INFECTION; RESTRICTION; RECOGNITION	TRIM5 is a RING domain-E3 ubiquitin ligase that restricts infection by human immunodeficiency virus (HIV)-1 and other retroviruses immediately following virus invasion of the target cell cytoplasm(1,2). Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice(3,4) and several reports indicate that TRIM5 has a role in signal transduction(5-7), but the precise mechanism of restriction is unknown(8). Here we demonstrate that TRIM5 promotes innate immune signalling and that this activity is amplified by retroviral infection and interaction with the capsid lattice. Acting with the heterodimeric, ubiquitin-conjugating enzyme UBC13-UEV1A (also known as UBE2N-UBE2V1), TRIM5 catalyses the synthesis of unattached K63-linked ubiquitin chains that activate the TAK1 (also known as MAP3K7) kinase complex and stimulate AP-1 and NF kappa B signalling. Interaction with the HIV-1 capsid lattice greatly enhances the UBC13-UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NF-kappa B-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid. Finally, TAK1 and UBC13-UEV1A contribute to capsid-specific restriction by TRIM5. Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signalling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.	[Pertel, Thomas; Hausmann, Stephane; Guerra, Jessica; Lascano, Josefina; Reinhard, Christian; Santoni, Federico A.; Strambio-De-Castillia, Caterina; Pizzato, Massimo; Luban, Jeremy] Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Morger, Damien; Zueger, Sara; Gruetter, Markus G.] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Uchil, Pradeep D.; Mothes, Walther] Yale Univ, Sect Microbial Pathogenesis, Sch Med, New Haven, CT 06536 USA; [Chatel, Laurence] Novimmune SA, CH-1228 Geneva, Switzerland; [Bisiaux, Aurelie; Albert, Matthew L.] Inst Pasteur, INSERM, U818, F-75724 Paris, France	University of Geneva; University of Zurich; Yale University; NovImmune SA; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Luban, J (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland.	jeremy.luban@unige.ch	Albert, Matthew L/C-9782-2009; Pizzato, Massimo/AFL-0051-2022	Pizzato, Massimo/0000-0002-9491-1483; Santoni, Federico/0000-0002-3258-4747; Luban, Jeremy/0000-0001-5650-4054; Uchil, Pradeep/0000-0002-7236-858X; Strambio De Castillia, Caterina/0000-0002-1069-1816; Bisiaux, Aurelie/0000-0002-2447-3393; Pertel, Thomas/0000-0002-2286-6011	NIH [RO1AI59159, R21AI087467]; Swiss National Science Foundation [3100A0-128655, 3100A0-122342]; UZH Forschungskredit [54041402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087467, R01AI059159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UZH Forschungskredit; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Baltimore, M. J. Birrer, J. Brojatsch, A. Cimarelli, A. Delaco, S. Elledge, M. Emerman, W. Ferlin, D. Garcin, S. Ghosh, O. Haller, T. Hatziioannou, J. Hiscott, A. Iwasaki, D. Kolakofsky, M. Kosco-Vilbois, H. Malik, R. Medzhitov, M. R. Neagu, G. Napolitani, P. Palese, D. Pinschewer, O. Pornillos, L. Roux, O. Schwartz, M. Strubin, V. Studer, W. Sundquist, G. Towers, D. Trono, J. Tschopp, M. Yeager, M. Zufferey, and the Functional Genomics Center (Zurich), for ideas, technical assistance, and reagents. This work was supported by NIH grant RO1AI59159 to J. L., NIH grant R21AI087467 to W. M., Swiss National Science Foundation grant 3100A0-128655 to J. L. and 3100A0-122342 to M. G. and UZH Forschungskredit 54041402 to S.Z.	Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Berthoux L, 2003, J VIROL, V77, P3167, DOI 10.1128/JVI.77.5.3167-3180.2003; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; KORNBLUTH RS, 1989, J EXP MED, V169, P1137, DOI 10.1084/jem.169.3.1137; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Medzhitov R, 2008, NATURE, V455, P591, DOI 10.1038/455591a; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Sebastian S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-40; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tareen SU, 2011, VIROLOGY, V409, P113, DOI 10.1016/j.virol.2010.09.018; Ulm JW, 2007, VIROLOGY, V363, P245, DOI 10.1016/j.virol.2006.09.048; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	27	471	491	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					361	365		10.1038/nature09976	http://dx.doi.org/10.1038/nature09976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21512573	Green Accepted			2022-12-24	WOS:000289724600042
J	Claridge, LC; Armstrong, MJ; Booth, C; Gill, PS				Claridge, Lee C.; Armstrong, Matthew J.; Booth, Caroline; Gill, Paramjit S.			10-MINUTE CONSULTATION Gilbert's syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS		[Claridge, Lee C.; Armstrong, Matthew J.] Univ Birmingham, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England; [Booth, Caroline] York Hosp NHS Trust, York YO31 8HE, N Yorkshire, England; [Gill, Paramjit S.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Claridge, LC (corresponding author), Univ Birmingham, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England.	l.c.claridge@bham.ac.uk		Armstrong, Matthew/0000-0002-3425-1161				BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Esteban A, 1999, EUR J DRUG METAB PH, V24, P9, DOI 10.1007/BF03190005; FOULK WT, 1959, MEDICINE, V38, P25, DOI 10.1097/00005792-195902000-00002; OWENS D, 1975, J MED GENET, V12, P152, DOI 10.1136/jmg.12.2.152; Prueksaritanont T, 2002, DRUG METAB DISPOS, V30, P1280, DOI 10.1124/dmd.30.11.1280; Rotger M, 2005, J INFECT DIS, V192, P1381, DOI 10.1086/466531; SIEG A, 1987, DEUT MED WOCHENSCHR, V112, P1206, DOI 10.1055/s-2008-1068222; SIEG A, 1986, CLIN CHIM ACTA, V154, P41, DOI 10.1016/0009-8981(86)90086-0; THOMSEN HF, 1981, SCAND J GASTROENTERO, V16, P699, DOI 10.3109/00365528109182033	9	17	19	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2011	342								d2293	10.1136/bmj.d2293	http://dx.doi.org/10.1136/bmj.d2293			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755ON	21508045				2022-12-24	WOS:000289942900005
J	Shin, K; Lee, J; Guo, N; Kim, J; Lim, A; Qu, LS; Mysorekar, IU; Beachy, PA				Shin, Kunyoo; Lee, John; Guo, Nini; Kim, James; Lim, Agnes; Qu, Lishu; Mysorekar, Indira U.; Beachy, Philip A.			Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder	NATURE			English	Article							URINARY-TRACT-INFECTION; ESCHERICHIA-COLI; CANCER; DIFFERENTIATION; METASTASIS; NEOPLASIA; PATTERNS; AUTOPSY; RENEWAL; ORGAN	Epithelial integrity in metazoan organs is maintained through the regulated proliferation and differentiation of organ-specific stem and progenitor cells. Although the epithelia of organs such as the intestine regenerate constantly and thus remain continuously proliferative(1), other organs, such as the mammalian urinary bladder, shift from near-quiescence to a highly proliferative state in response to epithelial injury(2-4). The cellular and molecular mechanisms underlying this injury-induced mode of regenerative response are poorly defined. Here we show in mice that the proliferative response to bacterial infection or chemical injury within the bladder is regulated by signal feedback between basal cells of the urothelium and the stromal cells that underlie them. We demonstrate that these basal cells include stem cells capable of regenerating all cell types within the urothelium, and are marked by expression of the secreted protein signal Sonic hedgehog (Shh). On injury, Shh expression in these basal cells increases and elicits increased stromal expression of Wnt protein signals, which in turn stimulate the proliferation of both urothelial and stromal cells. The heightened activity of this signal feedback circuit and the associated increase in cell proliferation appear to be required for restoration of urothelial function and, in the case of bacterial injury, may help clear and prevent further spread of infection. Our findings provide a conceptual framework for injury-induced epithelial regeneration in endodermal organs, and may provide a basis for understanding the roles of signalling pathways in cancer growth and metastasis.	[Shin, Kunyoo; Lee, John; Kim, James; Lim, Agnes; Qu, Lishu; Beachy, Philip A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA; [Guo, Nini] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Stanford University; Johns Hopkins University; Washington University (WUSTL)	Beachy, PA (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA.	kunyoos@stanford.edu; pbeachy@stanford.edu	Mysorekar, Indira U./GRS-4574-2022	Mysorekar, Indira U./0000-0003-3917-8677; Lim, Agnes/0000-0002-6618-2500; Shin, Kunyoo/0000-0002-1519-9839	Department of Defense; National Institutes of Health; Pathway to Independence Award [K99/R00]	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Oro and J. Brooks for their critical reading of the manuscript, and the Stanford Center for Digestive Diseases for help with laser capture microdissection. This research was supported in part by grants from the Department of Defense and from the National Institutes of Health (P.A.B.) and a Pathway to Independence Award (K99/R00) to I.U.M. P.A.B. is an investigator of the Howard Hughes Medical Institute.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; HAGBERG L, 1983, INFECT IMMUN, V40, P273, DOI 10.1128/IAI.40.1.273-283.1983; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Ibla JC, 2006, METH MOL B, V341, P111; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Klumpp DJ, 2006, INFECT IMMUN, V74, P5106, DOI 10.1128/IAI.00376-06; Kurzrock EA, 2005, J UROLOGY, V173, P281, DOI 10.1097/01.ju.0000141585.17953.fa; Kurzrock EA, 2008, AM J PHYSIOL-RENAL, V294, pF1415, DOI 10.1152/ajprenal.00533.2007; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Mysorekar IU, 2009, CELL HOST MICROBE, V5, P463, DOI 10.1016/j.chom.2009.04.005; Nicolle LE, 2008, UROL CLIN N AM, V35, P1, DOI 10.1016/j.ucl.2007.09.004; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wallmeroth A, 1999, UROL INT, V62, P69, DOI 10.1159/000030361; WU XR, 1993, J CELL SCI, V106, P31; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	32	322	335	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					110	U145		10.1038/nature09851	http://dx.doi.org/10.1038/nature09851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21389986	Green Accepted			2022-12-24	WOS:000289199400047
J	Ludwig, DS				Ludwig, David S.			Technology, Diet, and the Burden of Chronic Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-HEART-DISEASE; PREVENTION		Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, Optimal Weight Life Program, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CNN Health, WE AR WHAT WE EAT AM; COHEN MN, 1984, PALEOPATHOLOGY ORIGI; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Pollan Michael, 2006, OMNIVORES DILEMMA NA; Rolls BJ, 2009, PHYSIOL BEHAV, V97, P609, DOI 10.1016/j.physbeh.2009.03.011; Rolls BJ, 2000, J AM DIET ASSOC, V100, P232, DOI 10.1016/S0002-8223(00)00070-5; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103	10	104	109	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1352	1353		10.1001/jama.2011.380	http://dx.doi.org/10.1001/jama.2011.380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467290				2022-12-24	WOS:000289162400027
J	Willyard, C				Willyard, Cassandra			LIFESTYLE Breaking the cancer habit	NATURE			English	Editorial Material							PHYSICAL-ACTIVITY; INTERVENTION; PREVENTION; MORTALITY; SURGERY; TRIAL											Adams TD, 2009, OBESITY, V17, P796, DOI 10.1038/oby.2008.610; Ashrafian H, 2010, CANCER          1129; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Epstein LH, 2010, PSYCHOL SCI, V21, P406, DOI 10.1177/0956797610361446; Friedenreich CM, 2010, EUR J CANCER, V46, P2593, DOI 10.1016/j.ejca.2010.07.028; Friedenreich CM, 2010, J CLIN ONCOL, V28, P1458, DOI 10.1200/JCO.2009.24.9557; Katz DL, 2010, AM J CLIN NUTR, V91, p1102S, DOI 10.3945/ajcn.2010.28450E; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7	9	4	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S16	S17		10.1038/471S16a	http://dx.doi.org/10.1038/471S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430713	Bronze			2022-12-24	WOS:000288702200014
J	Casarett, DJ				Casarett, David J.			Rethinking Hospice Eligibility Criteria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PALLIATIVE CARE; CANCER		[Casarett, David J.] Univ Penn, Sch Med, Ctr Bioeth, Philadelphia, PA 19104 USA; [Casarett, David J.] Univ Penn, Sch Med, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Casarett, DJ (corresponding author), Univ Penn, Sch Med, Ctr Bioeth, 3615 Chestnut St, Philadelphia, PA 19104 USA.	casarett@mail.med.upenn.edu						Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Casarett DJ, 2009, J CLIN ONCOL, V27, P953, DOI 10.1200/JCO.2008.17.8079; Fishman J, 2009, CANCER-AM CANCER SOC, V115, P689, DOI 10.1002/cncr.24046; Johnson KS, 2008, ARCH INTERN MED, V168, P218, DOI 10.1001/archinternmed.2007.36; National Hospice and Palliative Care Organization Facts and Figures, 2010, HOSP CAR AM; Rickerson E, 2005, J AM GERIATR SOC, V53, P819, DOI 10.1111/j.1532-5415.2005.53259.x; Schockett ER, 2005, J PAIN SYMPTOM MANAG, V30, P400, DOI 10.1016/j.jpainsymman.2005.04.013; Taylor DH, 2007, SOC SCI MED, V65, P1466, DOI 10.1016/j.socscimed.2007.05.028; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	9	28	28	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1031	1032		10.1001/jama.2011.271	http://dx.doi.org/10.1001/jama.2011.271			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	731SM	21386081				2022-12-24	WOS:000288129600024
J	Hyman, SE				Hyman, Steven E.			The Meaning of the Human Genome Project for Neuropsychiatric Disorders	SCIENCE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Hyman, SE (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.								0	6	6	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1026	1026		10.1126/science.1203544	http://dx.doi.org/10.1126/science.1203544			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350167				2022-12-24	WOS:000287699000048
J	Chambers, JD; Neumann, PJ				Chambers, James D.; Neumann, Peter J.			Listening to Provenge - What a Costly Cancer Treatment Says about Future Medicare Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chambers, James D.; Neumann, Peter J.] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Chambers, James D.] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England	Tufts Medical Center; Brunel University	Chambers, JD (corresponding author), Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA USA.							[Anonymous], 2010, FED REG, V75, P57045; *CTR MED MED SERV, 2010, CAG00422N CTR MED ME; Food and Drug Administration, 2010, SUMM REV SUMM BAS RE; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294	4	48	49	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1687	1689		10.1056/NEJMp1103057	http://dx.doi.org/10.1056/NEJMp1103057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759DC	21470004				2022-12-24	WOS:000290219800002
J	Yamada, K; Frouws, TD; Angst, B; Fitzgerald, DJ; DeLuca, C; Schimmele, K; Sargent, DF; Richmond, TJ				Yamada, Kazuhiro; Frouws, Timothy D.; Angst, Brigitte; Fitzgerald, Daniel J.; DeLuca, Carl; Schimmele, Kyoko; Sargent, David F.; Richmond, Timothy J.			Structure and mechanism of the chromatin remodelling factor ISW1a	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; HIGH-RESOLUTION; CRYSTAL-STRUCTURE; DNA COMPLEX; ORGANIZATION; EXPRESSION; POSITION; PROTEIN; DOMAIN; VISUALIZATION	Site-specific recognition of DNA in eukaryotic organisms depends on the arrangement of nucleosomes in chromatin. In the yeast Saccharomyces cerevisiae, ISW1a and related chromatin remodelling factors are implicated in establishing the nucleosome repeat during replication and altering nucleosome position to affect gene activity. Here we have solved the crystal structures of S. cerevisiae ISW1a lacking its ATPase domain both alone and with DNA bound at resolutions of 3.25 angstrom and 3.60 angstrom, respectively, and we have visualized two different nucleosome-containing remodelling complexes using cryo-electron microscopy. The composite X-ray and electron microscopy structures combined with site-directed photocrosslinking analyses of these complexes suggest that ISW1a uses a dinucleosome substrate for chromatin remodelling. Results from a remodelling assay corroborate the dinucleosome model. We show how a chromatin remodelling factor could set the spacing between two adjacent nucleosomes acting as a 'protein ruler'.	[Yamada, Kazuhiro; Frouws, Timothy D.; Angst, Brigitte; Fitzgerald, Daniel J.; DeLuca, Carl; Schimmele, Kyoko; Sargent, David F.; Richmond, Timothy J.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Richmond, TJ (corresponding author), ETH, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	richmond@mol.biol.ethz.ch						Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; BIENIOSSEK C, 2008, CURR PROT PROTEIN SC; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018; Cuperus G, 2002, GENETICS, V162, P633; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flaus A, 1996, P NATL ACAD SCI USA, V93, P1370, DOI 10.1073/pnas.93.4.1370; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Gangaraju VK, 2007, MOL CELL BIOL, V27, P3217, DOI 10.1128/MCB.01731-06; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horton JR, 2007, PROTEINS, V67, P1198, DOI 10.1002/prot.21352; Hu DL, 2000, J BIOL CHEM, V275, P2705, DOI 10.1074/jbc.275.4.2705; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mellor J, 2004, BBA-GENE STRUCT EXPR, V1677, P100, DOI 10.1016/j.bbaexp.2003.10.014; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinskaya M, 2009, MOL CELL BIOL, V29, P2419, DOI 10.1128/MCB.01050-08; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Unser M, 2005, J STRUCT BIOL, V149, P243, DOI 10.1016/j.jsb.2004.10.011; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Wang JP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000175	55	126	128	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					448	U536		10.1038/nature09947	http://dx.doi.org/10.1038/nature09947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525927				2022-12-24	WOS:000289949600029
J	Senturk, A; Pfennig, S; Weiss, A; Burk, K; Acker-Palmer, A				Sentuerk, Aycan; Pfennig, Sylvia; Weiss, Alexander; Burk, Katja; Acker-Palmer, Amparo			Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration	NATURE			English	Article							TYROSINE KINASES; PHOSPHORYLATION; SPECIFICATION; DISABLED-1; MECHANISMS; EXPRESSION; MUTATIONS; CASPASE-3; PREPLATE; RECEPTOR	Coordinated migration of neurons in the developing and adult brain is essential for its proper function. The secreted glycoprotein Reelin (also known as RELN) guides migration of neurons by binding to two lipoprotein receptors, the very-low-density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2, also known as LRP8)(1). Loss of Reelin function in humans results in the severe developmental disorder lissencephaly(2) and it has also been associated with other neurological disorders such as epilepsy, schizophrenia and Alzheimer's disease(3). The molecular mechanisms by which Reelin activates its receptors and controls cellular functions are largely unknown. Here we show that the neuronal guidance cues ephrin B proteins are essential for Reelin signalling during the development of laminated structures in the brain. We show that ephrin Bs genetically interact with Reelin. Notably, compound mouse mutants (Reln(+/-); Efnb3(-/-) or Reln(+/-); Efnb2(-/-)) and triple ephrin B1, B2, B3 knockouts show neuronal migration defects that recapitulate the ones observed in the neocortex, hippocampus and cerebellum of the reeler mouse. Mechanistically, we show that Reelin binds to the extracellular domain of ephrin Bs, which associate at the membrane with VLDLR and ApoER2 in neurons. Clustering of ephrin Bs leads to the recruitment and phosphorylation of Dab1 which is necessary for Reelin signalling. Conversely, loss of function of ephrin Bs severely impairs Reelin-induced Dab1 phosphorylation. Importantly, activation of ephrin Bs can rescue the reeler neuronal migration defects in the absence of Reelin protein. Together, our results identify ephrin Bs as essential components of the Reelin receptor/signalling pathway to control neuronal migration during the development of the nervous system.	[Sentuerk, Aycan; Pfennig, Sylvia; Weiss, Alexander; Burk, Katja; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci FMLS, D-60438 Frankfurt, Germany; [Sentuerk, Aycan; Pfennig, Sylvia; Weiss, Alexander; Burk, Katja; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Acker-Palmer, A (corresponding author), Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci FMLS, Max von Laue Str 9, D-60438 Frankfurt, Germany.	Acker-Palmer@bio.uni-frankfurt.de		Burk, Katja/0000-0001-6083-4152	Max Planck Institute of Neurobiology in Martinsried (Germany); Deutsche Forschungsgemeinschaft [AC180/2-1, 2-2]; University Frankfurt [EXC115, EXC147]	Max Planck Institute of Neurobiology in Martinsried (Germany); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Frankfurt	We would like to thank R. Klein for the ephrin B2<SUP>lox/lox</SUP> and ephrin B1<SUP>lox/lox</SUP> mice, N. Gale for the ephrin B3<SUP>-/-</SUP> mouse, J. Herz for the ApoER2<SUP>-/-</SUP> mouse, M. Goetz for 293-cells expressing Reelin or GFP, I. Segura for help with the ephrin B triple mutants, U. Bauer, O. Yildiz, C. Saygi, F. Kasikci, F. Voss and K. Happich for technical support, K. Hong and A. Griciuc for early contributions to this project, M. Frotscher for helpful discussions and I. Dikic and T. Acker for critically reading the manuscript. We acknowledge the Max Planck Institute of Neurobiology in Martinsried (Germany) for support and the use of equipment and animal facilities in the early stages of this project. This work was supported by grants from the Deutsche Forschungsgemeinschaft (AC180/2-1, 2-2 to A. A.-P.) and the Clusters of Excellence "Macromolecular Complexes (CEF)'' (EXC115) and ECCPS (EXC147) at the University Frankfurt.	Alifragis P, 2002, EXP NEUROL, V174, P259, DOI 10.1006/exnr.2002.7870; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Caviness V S Jr, 1982, Brain Res, V256, P293; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Costa E, 2002, Mol Interv, V2, P47, DOI 10.1124/mi.2.1.47; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Forster E, 2002, P NATL ACAD SCI USA, V99, P13178, DOI 10.1073/pnas.202035899; Ghoumari AM, 2000, EUR J NEUROSCI, V12, P2935, DOI 10.1046/j.1460-9568.2000.00186.x; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9; Zhang YM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-13	34	112	118	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					356	U123		10.1038/nature09874	http://dx.doi.org/10.1038/nature09874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21460838				2022-12-24	WOS:000289724600041
J	Lozano, AM				Lozano, Andres M.			Harnessing Plasticity to Reset Dysfunctional Neurons	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Toronto Western Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lozano, AM (corresponding author), Toronto Western Res Inst, Toronto, ON, Canada.		Lozano, Andres M/A-5058-2012	Lozano, Andres M./0000-0001-8257-3694				Davis KD, 1998, NATURE, V391, P385, DOI 10.1038/34905; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Moller AR, 2009, NEUROL RES, V31, P1023, DOI 10.1179/174313209X383303	5	17	22	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1367	1368		10.1056/NEJMcibr1100496	http://dx.doi.org/10.1056/NEJMcibr1100496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WS	21470016				2022-12-24	WOS:000289202800015
J	Thomson, MC; Connor, SJ; Zebiak, SE; Jancloes, M; Mihretie, A				Thomson, Madeleine C.; Connor, Stephen J.; Zebiak, Stephen E.; Jancloes, Michel; Mihretie, Abere			Africa needs climate data to fight disease	NATURE			English	Editorial Material									[Thomson, Madeleine C.; Connor, Stephen J.; Zebiak, Stephen E.] Columbia Univ, Int Res Inst Climate & Soc, Earth Inst, Palisades, NY 10964 USA; [Jancloes, Michel] Hlth & Climate Fdn, Washington, DC 20005 USA; [Mihretie, Abere] Antimalaria Assoc, Addis Ababa, Ethiopia	Columbia University	Thomson, MC (corresponding author), Columbia Univ, Int Res Inst Climate & Soc, Earth Inst, Palisades, NY 10964 USA.	mthomson@iri.columbia.edu						Alonso D, 2011, P ROY SOC B-BIOL SCI, V278, P1661, DOI 10.1098/rspb.2010.2020; Cibrelus L., 2010, 163 ITI; Connor SJ, 2010, PROCEDIA ENVIRON SCI, V1, P27, DOI 10.1016/j.proenv.2010.09.004; Dinku T, 2010, CLIM DEV, V2, P9, DOI 10.3763/cdev.2010.0029; Ghebreyesus TAZ., 2008, WMO B, V57, P256; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12; Parry M. L., 2007, CLIMATE CHANGE 2007; Reiter P, 2008, REV SCI TECH OIE, V27, P383, DOI 10.20506/rst.27.2.1804; Williams AP, 2011, CLIM DYNAM, V37, P2417, DOI 10.1007/s00382-010-0984-y	10	25	25	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					440	442		10.1038/471440a	http://dx.doi.org/10.1038/471440a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430752	Bronze, Green Submitted			2022-12-24	WOS:000288702200033
J	Brooks, MA; Tarini, BA				Brooks, M. Alison; Tarini, Beth A.			Genetic Testing and Youth Sports	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERFORMANCE; FITNESS		[Brooks, M. Alison] Univ Wisconsin, Dept Orthoped & Pediat, Madison, WI 53706 USA; [Tarini, Beth A.] Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA	University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Brooks, MA (corresponding author), 1685 Highland Ave, Madison, WI 53705 USA.	brooks@ortho.wisc.edu		Tarini, Beth/0000-0003-4272-8668	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD057994, K12HD055894] Funding Source: NIH RePORTER; NICHD NIH HHS [K23 HD057994, K12 HD055894, K23HD057994, K12HD055894] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		*ATL SPORTS GEN, ATL 1; Burdette HL, 2005, ARCH PEDIAT ADOL MED, V159, P46, DOI 10.1001/archpedi.159.1.46; Ciske DJ, 2001, PEDIATRICS, V107, P699, DOI 10.1542/peds.107.4.699; *CYGENE, OPT ATHL PERF DNA AN; National Collegiate Athletic Association, EST PROB COMP ATHL H; Rankinen T, 2010, MED SCI SPORT EXER, V42, P835, DOI 10.1249/MSS.0b013e3181d86cec; Small EW, 2007, PEDIATRICS, V119, P1242, DOI 10.1542/peds.2007-0887; Williams AG, 2009, MED SPORT SCI, V54, P176, DOI 10.1159/000235704; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Yang N, 2009, MED SPORT SCI, V54, P88, DOI 10.1159/000235698	10	8	9	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1033	1034		10.1001/jama.2011.286	http://dx.doi.org/10.1001/jama.2011.286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386082				2022-12-24	WOS:000288129600025
J	Scott, P				Scott, Phillip			Leishmania - A Parasitized Parasite	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Scott, P (corresponding author), Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA.							BARRAL A, 1992, AM J TROP MED HYG, V47, P587, DOI 10.4269/ajtmh.1992.47.587; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Liese J, 2008, IMMUNOBIOLOGY, V213, P377, DOI 10.1016/j.imbio.2007.12.005; Salinas G, 1996, AM J TROP MED HYG, V54, P425, DOI 10.4269/ajtmh.1996.54.425; STUART KD, 1992, P NATL ACAD SCI USA, V89, P8596, DOI 10.1073/pnas.89.18.8596	5	15	16	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1773	1774		10.1056/NEJMcibr1101694	http://dx.doi.org/10.1056/NEJMcibr1101694			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542750				2022-12-24	WOS:000290219800017
J	Scott, J				Scott, Janet			Stillbirths: breaking the silence of a hidden grief	LANCET			English	Editorial Material									Sands Stillbirth & Neonatal Death Charity, London W1B 1LY, England		Scott, J (corresponding author), Sands Stillbirth & Neonatal Death Charity, London W1B 1LY, England.	janet.scott@uk-sands.org							0	32	33	2	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 23	2011	377	9775					1386	1388		10.1016/S0140-6736(11)60107-4	http://dx.doi.org/10.1016/S0140-6736(11)60107-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	21496914				2022-12-24	WOS:000289963000007
J	Ochiai, M; Miyamoto, K; Kaneaki, T; Hayashi, S; Nakanishi, W				Ochiai, Masahito; Miyamoto, Kazunori; Kaneaki, Takao; Hayashi, Satoko; Nakanishi, Waro			Highly Regioselective Amination of Unactivated Alkanes by Hypervalent Sulfonylimino-lambda(3)-Bromane	SCIENCE			English	Article							SINGLE-ELECTRON TRANSFER; INTERMOLECULAR AMINATION; AMIDATION; OXYFUNCTIONALIZATION; FUNCTIONALIZATION; AZIRIDINATION; MECHANISM; BONDS	Amination of alkanes has generally required metal catalysts and/or high temperatures. Here we report that simple exposure of a broad range of alkanes to N-triflylimino-lambda(3)-bromane 1 at ambient temperature results in C-H insertion of the nitrogen functionality to afford triflyl-substituted amines in moderate to high yields. Marked selectivity for tertiary over secondary C-H bonds was observed; primary (methyl) C-H bonds were inert. Addition of hexafluoroisopropanol to inhibit decomposition of 1 dramatically improved the C-H amination efficiencies. Second-order kinetics, activation parameters (negative activation entropy), deuterium isotope effects, and theoretical calculations suggest a concerted asynchronous bimolecular transition state for the metal-free C-H amination event.	[Ochiai, Masahito; Miyamoto, Kazunori; Kaneaki, Takao] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Hayashi, Satoko; Nakanishi, Waro] Wakayama Univ, Fac Syst Engn, Dept Chem & Mat Sci, Wakayama 6408510, Japan	Tokushima University; Wakayama University	Ochiai, M (corresponding author), Univ Tokushima, Grad Sch Pharmaceut Sci, 1-78 Shomachi, Tokushima 7708505, Japan.	mochiai@ph.tokushima-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (B) (Japan Society for the Promotion of Science). We thank Central Glass Co., Japan, for a generous gift of BrF<INF>3</INF>.	Au SM, 1999, J AM CHEM SOC, V121, P9120, DOI 10.1021/ja9913481; Badiei YM, 2008, ANGEW CHEM INT EDIT, V47, P9961, DOI 10.1002/anie.200804304; BRESLOW DS, 1969, J AM CHEM SOC, V91, P2273, DOI 10.1021/ja01037a016; BRESLOW R, 1982, J CHEM SOC CHEM COMM, P1400, DOI 10.1039/c39820001400; Chen KH, 2009, OPT ENG, V48, DOI 10.1117/1.3121987; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; DESMARTEAU DD, 1993, J AM CHEM SOC, V115, P4897, DOI 10.1021/ja00064a063; Farooq U, 2009, ANGEW CHEM INT EDIT, V48, P1018, DOI 10.1002/anie.200805027; Fiori KW, 2007, J AM CHEM SOC, V129, P562, DOI 10.1021/ja0650450; Fokin AA, 2000, J AM CHEM SOC, V122, P7317, DOI 10.1021/ja000193q; Fructos MR, 2006, J AM CHEM SOC, V128, P11784, DOI 10.1021/ja0627850; Glukhovtsev MN, 1998, J AM CHEM SOC, V120, P10528, DOI 10.1021/ja9813156; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Gomez-Emeterio BP, 2008, ORGANOMETALLICS, V27, P4126, DOI 10.1021/om800218d; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Li ZG, 2007, ANGEW CHEM INT EDIT, V46, P5184, DOI 10.1002/anie.200700760; Liang CG, 2008, J AM CHEM SOC, V130, P343, DOI 10.1021/ja076519d; Lide D.R., 1992, CRC HDB CHEM PHYS, V73; Lin XF, 2007, CHEM-ASIAN J, V2, P1101, DOI 10.1002/asia.200700068; MELLO R, 1989, J AM CHEM SOC, V111, P6749, DOI 10.1021/ja00199a039; Nakamura E, 2002, J AM CHEM SOC, V124, P7181, DOI 10.1021/ja017823o; Ochiai M, 2008, J AM CHEM SOC, V130, P2118, DOI 10.1021/ja074624h; Ochiai M, 2007, J AM CHEM SOC, V129, P12938, DOI 10.1021/ja075811i; Ochiai M, 2010, CHEM COMMUN, V46, P511, DOI 10.1039/b922033j; Ochiai M, 2009, SYNLETT, P159, DOI 10.1055/s-0028-1087355; OKUYAMA T, 1995, J AM CHEM SOC, V117, P3360, DOI 10.1021/ja00117a006; Reichardt C., 2003, SOLVENTS SOLVENT EFF, V3rd; Schreiner PR, 2004, CHEM REC, V3, P247, DOI 10.1002/tcr.10070; Stang P. J., 1979, VINYL CATIONS	29	130	131	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					448	451		10.1126/science.1201686	http://dx.doi.org/10.1126/science.1201686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512029				2022-12-24	WOS:000289784900038
J	Giugliano, D; Esposito, K				Giugliano, Dario; Esposito, Katherine			Clinical Inertia as a Clinical Safeguard	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-PRESSURE CONTROL; PREVENTION		[Giugliano, Dario; Esposito, Katherine] Univ Naples 2, Dept Geriatr & Metab Dis, I-80138 Naples, Italy	Universita della Campania Vanvitelli	Giugliano, D (corresponding author), Univ Naples 2, Dept Geriatr & Metab Dis, Piazza L Miraglia 2, I-80138 Naples, Italy.	dario.giugliano@unina2.it	Esposito, Katherine/AHE-2564-2022; Maiorino, Maria Ida/AHE-9986-2022	Esposito, Katherine/0000-0002-3652-5154; Maiorino, Maria Ida/0000-0003-4659-7546; Giugliano, Dario/0000-0002-9377-873X				Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; National Center for Health Statistics, 2010, HLTH US 2009 SPEC FE; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Skyler JS, 2009, DIABETES CARE, V32, P187, DOI 10.2337/dc08-9026; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z	10	61	63	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1591	1592		10.1001/jama.2011.490	http://dx.doi.org/10.1001/jama.2011.490			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21505139				2022-12-24	WOS:000289683000031
J	Han, DR; Pal, S; Nangreave, J; Deng, ZT; Liu, Y; Yan, H				Han, Dongran; Pal, Suchetan; Nangreave, Jeanette; Deng, Zhengtao; Liu, Yan; Yan, Hao			DNA Origami with Complex Curvatures in Three-Dimensional Space	SCIENCE			English	Article							NANOSCALE SHAPES; FOLDING DNA; FLEXIBILITY; DESIGN	We present a strategy to design and construct self-assembling DNA nanostructures that define intricate curved surfaces in three-dimensional (3D) space using the DNA origami folding technique. Double-helical DNA is bent to follow the rounded contours of the target object, and potential strand crossovers are subsequently identified. Concentric rings of DNA are used to generate in-plane curvature, constrained to 2D by rationally designed geometries and crossover networks. Out-of-plane curvature is introduced by adjusting the particular position and pattern of crossovers between adjacent DNA double helices, whose conformation often deviates from the natural, B-form twist density. A series of DNA nanostructures with high curvature-such as 2D arrangements of concentric rings and 3D spherical shells, ellipsoidal shells, and a nanoflask-were assembled.	[Han, Dongran; Pal, Suchetan; Nangreave, Jeanette; Deng, Zhengtao; Liu, Yan; Yan, Hao] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Han, Dongran; Pal, Suchetan; Nangreave, Jeanette; Deng, Zhengtao; Liu, Yan; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Han, DR (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	dongran.han@asu.edu; yan_liu@asu.edu; hao.yan@asu.edu	Pal, Suchetan/R-5525-2019; Pal, Suchetan/D-3653-2012; Deng, Zhengtao/F-8581-2010; Liu, Yan/K-1999-2014	Pal, Suchetan/0000-0001-8291-2844; Deng, Zhengtao/0000-0002-8428-8982; Liu, Yan/0000-0003-0906-2606; Pal, Suchetan/0000-0002-6323-7502	Office of Naval Research; Army Research Office; National Science Foundation; Department of Energy; National Institutes of Health; Sloan Research Foundation; Arizona State University; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001016]	Office of Naval Research(Office of Naval Research); Army Research Office; National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Research Foundation; Arizona State University; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank the AFM applications group at Bruker Nanosurfaces for assistance in acquiring some of the high-resolution AFM images, using Peak Force Tapping with ScanAsyst on the MultiMode 8. This research was partly supported by grants from the Office of Naval Research, Army Research Office, National Science Foundation, Department of Energy, and National Institutes of Health to H.Y. and Y.L. and from the Sloan Research Foundation to H.Y. Y.L. and H.Y. were supported by the Technology and Research Initiative Fund from Arizona State University and as part of the Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0001016.	Aldaye FA, 2007, J AM CHEM SOC, V129, P13376, DOI 10.1021/ja075966q; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Lin C, 2009, BIOCHEMISTRY-US, V48, P1663, DOI 10.1021/bi802324w; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105	20	851	903	34	785	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					342	346		10.1126/science.1202998	http://dx.doi.org/10.1126/science.1202998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493857				2022-12-24	WOS:000289516600042
J	Liu, Y; Jiang, YA; Si, YX; Kim, JY; Chen, ZF; Rao, Y				Liu, Yan; Jiang, Yun'ai; Si, Yunxia; Kim, Ji-Young; Chen, Zhou-Feng; Rao, Yi			Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice	NATURE			English	Article							PARA-CHLOROPHENYLALANINE; COPULATORY-BEHAVIOR; SEROTONIN; LACKING; INNATE; RATS	Although the question of to whom a male directs his mating attempts(1,2) is a critical one in social interactions, little is known about the molecular and cellular mechanisms controlling mammalian sexual preference. Here we report that the neurotransmitter 5-hydroxytryptamine (5-HT) is required for male sexual preference. Wild-type male mice preferred females over males, but males lacking central serotonergic neurons lost sexual preference although they were not generally defective in olfaction or in pheromone sensing. A role for 5-HT was demonstrated by the phenotype of mice lacking tryptophan hydroxylase 2 (Tph2), which is required for the first step of 5-HT synthesis in the brain. Thirty-five minutes after the injection of the intermediate 5-hydroxytryptophan (5-HTP), which circumvented Tph2 to restore 5-HT to the wildtype level, adult Tph2 knockout mice also preferred females over males. These results indicate that 5-HT and serotonergic neurons in the adult brain regulate mammalian sexual preference.	[Liu, Yan; Jiang, Yun'ai; Si, Yunxia; Rao, Yi] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Liu, Yan] Chinese Acad Med Sci, Grad Sch, Beijing 100730, Peoples R China; [Liu, Yan] Peking Union Med Coll, Beijing 100730, Peoples R China; [Jiang, Yun'ai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Beijing 100864, Peoples R China; [Jiang, Yun'ai] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China; [Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Rao, Yi] Peking Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Peking University	Rao, Y (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	yrao@pku.edu.cn		Rao, Yi/0000-0002-0405-5426	Ministry of Science and Technology [2010CB833901]; Beijing Municipal Commission on Science and Technology; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056318] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Beijing Municipal Commission on Science and Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to E. S. Deneris for ePet1-Cre mice; to R. Johnson for Lmx1b<SUP>fl</SUP> mice; to M. Luo for discussions; to Z. Yan and Y. Lu for the operant conditioning apparatus; to X. Wang and Y. Wan for help with HPLC; to J. Lang and J. Yin for mouse breeding and genotyping; to P. Ding, P. Wang, H. Lu and X. Wang for technical assistance; to L. Zhao, Z. Qiu and H. Jing for animal caring; and to the Ministry of Science and Technology (973 program 2010CB833901) and Beijing Municipal Commission on Science and Technology for grant support (to Y.R.), and the NIH for grant support (to Z.-F.C.).	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Blanchard DC, 2003, BEHAV NEUROSCI, V117, P360, DOI 10.1037/0735-7044.117.2.360; Burwash MD, 1998, J CHEM ECOL, V24, P49, DOI 10.1023/A:1022384728170; Dailly E, 2006, J NEUROSCI METH, V150, P111, DOI 10.1016/j.jneumeth.2005.06.008; ERWIN J, 1976, ARCH SEX BEHAV, V5, P9, DOI 10.1007/BF01542236; FERGUSON J, 1970, SCIENCE, V168, P499, DOI 10.1126/science.168.3930.499; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferkin MH, 2005, PHYSIOL BEHAV, V85, P489, DOI 10.1016/j.physbeh.2005.05.014; GAWIENOWSKI AM, 1971, PHYSIOL BEHAV, V7, P551, DOI 10.1016/0031-9384(71)90108-9; Guo ZS, 2007, CHEM SENSES, V32, P463, DOI 10.1093/chemse/bjm015; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030; Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018; Kinnunen LH, 2004, BRAIN RES, V1024, P251, DOI 10.1016/j.brainres.2004.07.070; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; KOE BK, 1966, J PHARMACOL EXP THER, V154, P499; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; MALMNAS CO, 1971, NATURE, V232, P398, DOI 10.1038/232398a0; Moncho-Bogani J, 2002, PHYSIOL BEHAV, V77, P167, DOI 10.1016/S0031-9384(02)00842-9; Mustanski BS, 2005, HUM GENET, V116, P272, DOI 10.1007/s00439-004-1241-4; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; PRICE EO, 1991, J ANIM SCI, V69, P1019; SALIS PJ, 1971, NATURE, V232, P400, DOI 10.1038/232400a0; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Sommer V, 2006, HOMOSEXUAL BEHAV ANI; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wainberg ML, 2006, J CLIN PSYCHIAT, V67, P1968, DOI 10.4088/JCP.v67n1218; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006	30	99	106	8	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					95	U125		10.1038/nature09822	http://dx.doi.org/10.1038/nature09822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21441904	Green Accepted			2022-12-24	WOS:000289199400044
J	Morris, MC; Tangney, CC				Morris, Martha Clare; Tangney, Christine C.			A Potential Design Flaw of Randomized Trials of Vitamin Supplements	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COGNITIVE FUNCTION; ALZHEIMER-DISEASE; CARDIOVASCULAR-DISEASE; ACID SUPPLEMENTATION; DIETARY-INTAKE; RISK; ANTIOXIDANT; WOMEN		[Morris, Martha Clare] Rush Univ, Med Ctr, Sect Nutr & Nutr Epidemiol, Dept Internal Med, Oak Pk, IL 60304 USA; [Tangney, Christine C.] Rush Univ, Med Ctr, Dept Clin Nutr, Oak Pk, IL 60304 USA	Rush University; Rush University	Morris, MC (corresponding author), Rush Univ, Med Ctr, Sect Nutr & Nutr Epidemiol, Dept Internal Med, Rush Oak Pk Profess Off Bldg,610 S Maple,Ste 4700, Oak Pk, IL 60304 USA.	martha_c_morris@rush.edu			NIA NIH HHS [R01 AG021972] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG021972] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Durga J, 2007, LANCET, V369, P208, DOI 10.1016/S0140-6736(07)60109-3; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Kang JH, 2009, CIRCULATION, V119, P2772, DOI 10.1161/CIRCULATIONAHA.108.816900; Kang JH, 2008, AM J CLIN NUTR, V88, P1602, DOI 10.3945/ajcn.2008.26404; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Luchsinger JA, 2003, ARCH NEUROL-CHICAGO, V60, P203, DOI 10.1001/archneur.60.2.203; Morris MC, 2002, JAMA-J AM MED ASSOC, V287, P3230, DOI 10.1001/jama.287.24.3230; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86	10	80	83	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1348	1349		10.1001/jama.2011.383	http://dx.doi.org/10.1001/jama.2011.383			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467288	Green Accepted			2022-12-24	WOS:000289162400025
J	Pappu, S; Gunnell, Y; Akhilesh, K; Braucher, R; Taieb, M; Demory, F; Thouveny, N				Pappu, Shanti; Gunnell, Yanni; Akhilesh, Kumar; Braucher, Regis; Taieb, Maurice; Demory, Francois; Thouveny, Nicolas			Early Pleistocene Presence of Acheulian Hominins in South India	SCIENCE			English	Article							ATTIRAMPAKKAM; EXCAVATIONS; ARTIFACTS; BURIAL; SITE; AGE	South Asia is rich in Lower Paleolithic Acheulian sites. These have been attributed to the Middle Pleistocene on the basis of a small number of dates, with a few older but disputed age estimates. Here, we report new ages from the excavated site of Attirampakkam, where paleomagnetic measurements and direct Al-26/Be-10 burial dating of stone artifacts now position the earliest Acheulian levels as no younger than 1.07 million years ago (Ma), with a pooled average age of 1.51 +/- 0.07 Ma. These results reveal that, during the Early Pleistocene, India was already occupied by hominins fully conversant with an Acheulian technology including handaxes and cleavers among other artifacts. This implies that a spread of bifacial technologies across Asia occurred earlier than previously accepted.	[Pappu, Shanti; Akhilesh, Kumar] Sharma Ctr Heritage Educ, Madras 600004, Tamil Nadu, India; [Gunnell, Yanni] Univ Lyon 2, Dept Geog, CNRS UMR 5600, F-69676 Bron, France; [Braucher, Regis; Taieb, Maurice; Demory, Francois; Thouveny, Nicolas] CEREGE, F-13545 Aix En Provence 04, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Universite Jean Moulin Lyon 3; Universite Lyon 2; UDICE-French Research Universities; Aix-Marseille Universite	Pappu, S (corresponding author), Sharma Ctr Heritage Educ, 28 I Main Rd, Madras 600004, Tamil Nadu, India.	pappu.shanti@gmail.com	, Braucher/Q-5971-2017; DEMORY, FRANCOIS/AAC-6641-2019	, Braucher/0000-0002-4637-4302; Pappu, Shanti/0000-0003-4786-4968; THOUVENY, Nicolas/0000-0001-6601-856X; Demory, Francois/0000-0002-7526-9886	Homi Bhabha Fellowships Council; Leakey Foundation; Earthwatch Institute; Sharma Centre for Heritage Education; Indian Space Research Organisation, Regional Remote Sensing Centre, Bengaluru; Archaeological Survey of India, Delhi and Chennai Circle; Department of Archaeology, State Government of Tamil Nadu; Institut Universitaire de France; Institut National des Sciences de l'Univers/CNRS; French Ministry of Research; Institut de Recherche pour le Developpement; Commissariat a l'Energie Atomique	Homi Bhabha Fellowships Council; Leakey Foundation; Earthwatch Institute; Sharma Centre for Heritage Education; Indian Space Research Organisation, Regional Remote Sensing Centre, Bengaluru; Archaeological Survey of India, Delhi and Chennai Circle; Department of Archaeology, State Government of Tamil Nadu; Institut Universitaire de France; Institut National des Sciences de l'Univers/CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut de Recherche pour le Developpement; Commissariat a l'Energie Atomique(French Atomic Energy Commission)	Excavations at Attirampakkam were funded by the Homi Bhabha Fellowships Council, the Leakey Foundation, the Earthwatch Institute, and the Sharma Centre for Heritage Education. Ongoing studies are being funded by the Indian Space Research Organisation, Regional Remote Sensing Centre, Bengaluru, (Geosphere Biosphere Program). We thank Uday Raj, S. Ravindranath, C. B. S. Dutt, P. G. Diwakar, and R. Ramesh. We also thank the Archaeological Survey of India, Delhi and Chennai Circle, and the Department of Archaeology, State Government of Tamil Nadu, for licenses to excavate and support; the Institut Universitaire de France for field and analytical costs; M. Arnold and G. Aumaitre for assistance with <SUP>10</SUP>Be and <SUP>26</SUP>Al measurements; and the ASTER (Accelerateur pour les Sciences de la Terre, Environnement, Risques) national facility (CEREGE, Aix-en-Provence), which is supported by the Institut National des Sciences de l'Univers/CNRS, the French Ministry of Research, the Institut de Recherche pour le Developpement, and the Commissariat a l'Energie Atomique. All three reviewers contributed valuable comments.	Acharyya SK, 2003, CURR SCI INDIA, V84, P127; ASFAW B, 1992, NATURE, V360, P732, DOI 10.1038/360732a0; Bar-Yosef O, 1993, LITHIC ASSEMBLAGES U; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Chauhan PR, 2010, QUATERN INT, V223, P248, DOI 10.1016/j.quaint.2010.01.021; de la Torre I, 2008, J ANTHROPOL ARCHAEOL, V27, P244, DOI 10.1016/j.jaa.2007.12.001; DENNELL RW, 1988, CURR ANTHROPOL, V29, P495, DOI 10.1086/203666; DENNELL RW, 2004, BAR INT SERIES, V1265; Dennell RW, 2009, PALAEOLITHIC SETTLEM; Gaillard C, 2010, QUATERN INT, V223, P234, DOI 10.1016/j.quaint.2009.08.021; Gibbon RJ, 2009, J HUM EVOL, V56, P152, DOI 10.1016/j.jhevol.2008.09.006; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Granger DE, 2001, EARTH PLANET SC LETT, V188, P269, DOI 10.1016/S0012-821X(01)00309-0; Gunnell Y, 2006, CURR SCI INDIA, V91, P114; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Kailath AJ, 2000, RADIAT MEAS, V32, P371, DOI 10.1016/S1350-4487(99)00282-6; MISHRA S, 1995, CURR ANTHROPOL, V36, P847, DOI 10.1086/204442; MISHRA S, 1992, CURR ANTHROPOL, V33, P325, DOI 10.1086/204074; Paddayya K, 2002, CURR SCI INDIA, V83, P641; Pappu S, 2003, CURR ANTHROPOL, V44, P591, DOI 10.1086/377652; Pappu S., 2004, MAN ENV, VXXIX, P1; PAPPU S, 2001, BRIT ARCHAOLOGICAL R, V1003; Pappu S., 2006, AXE AGE ACHEULIAN TO, P155; Patnaik R, 2009, J HUM EVOL, V56, P114, DOI 10.1016/j.jhevol.2008.08.023; Petraglia MD, 2007, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/1-4020-5562-5_1; RENDELL H, 1985, CURR ANTHROPOL, V26, P393, DOI 10.1086/203287; Sangode S.J., 2007, GONDWANA GEOLOGICAL, V10, P111; Shen GJ, 2009, NATURE, V458, P198, DOI 10.1038/nature07741; Westgate JA, 1998, QUATERNARY RES, V50, P107, DOI 10.1006/qres.1998.1974	29	127	131	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1596	1599		10.1126/science.1200183	http://dx.doi.org/10.1126/science.1200183			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739XH	21436450				2022-12-24	WOS:000288754500053
J	Ostera, GR; Gostin, LO				Ostera, Graciela R.; Gostin, Lawrence O.			Biosafety Concerns Involving Genetically Modified Mosquitoes to Combat Malaria and Dengue in Developing Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Ostera, Graciela R.] Georgetown Univ, Dept Microbiol & Immunol, Washington, DC 20001 USA	Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Alsop Z, 2007, LANCET, V370, P925, DOI 10.1016/S0140-6736(07)61428-7; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Enserink M, 2010, SCIENCE, V330, P1460, DOI 10.1126/science.330.6010.1460; Enserink M, 2010, SCIENCE, V330, P1030, DOI 10.1126/science.330.6007.1030; Fang J, 2010, NATURE, V466, P432, DOI 10.1038/466432a; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Marshall JM, 2010, NAT BIOTECHNOL, V28, P896, DOI 10.1038/nbt0910-896; Secretariat of the Convention on Biological Diversity, CART PROT BIOS CONV; Taylor SM, 2010, JAMA-J AM MED ASSOC, V304, P2048, DOI 10.1001/jama.2010.1578; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3	10	19	21	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					930	931		10.1001/jama.2011.246	http://dx.doi.org/10.1001/jama.2011.246			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	728DP	21364141	Green Published			2022-12-24	WOS:000287854700026
J	Clase, CM; Gao, P; Tobe, SW; McQueen, MJ; Grosshennig, A; Teo, KK; Yusuf, S; Mann, JFE				Clase, Catherine M.; Gao, Peggy; Tobe, Sheldon W.; McQueen, Matthew J.; Grosshennig, Anja; Teo, Koon K.; Yusuf, Salim; Mann, Johannes F. E.		ONTARGET Investigators; TRANSCEND Investigators	Estimated Glomerular Filtration Rate and Albuminuria as Predictors of Outcomes in Patients With High Cardiovascular Risk A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; GENERAL-POPULATION; ADVERSE OUTCOMES; ALL-CAUSE; MORTALITY; EVENTS; MICROALBUMINURIA; CLASSIFICATION; INDIVIDUALS	Background: Glomerular filtration rate and albuminuria are risk factors for cardiovascular disease and markers of renal function. Objective: To examine the contribution of estimated glomerular filtration rate (eGFR) and urinary albumin-creatinine ratio beyond that of traditional cardiovascular risk factors to classification of patient risk for cardiovascular and renal outcomes. Design: Prospective cohort study that pooled all patients of ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and TRANSCEND (Telmisartan Randomized Assessment Study in Angiotensin-Converting-Enzyme-Inhibitor Intolerant Subjects with Cardiovascular Disease). Patients: 27 620 patients older than 55 years with documented cardiovascular disease, who were followed for a mean of 4.6 years. Measurements: Baseline eGFR, urinary albumin-creatinine ratio, and cardiovascular risk factors. Outcomes were all-cause mortality; a composite of cardiovascular death, myocardial infarction, stroke, and hospitalization for heart failure; long-term dialysis; and a composite of long-term dialysis and doubling of serum creatinine level. Results: Lower eGFRs and higher urinary albumin-creatinine ratios were associated with the primary cardiovascular composite outcome (for example, an adjusted hazard ratio of 2.53 [95% CI, 1.61 to 3.99] for an eGFR <30 mL/min per 1.73 m(2) and a very high urinary albumin-creatinine ratio). However, adding information about eGFR and urinary albumin-creatinine ratio to the risk reclassification analyses led to no meaningful decrease in the proportion of patients assigned to the intermediate-risk category (31% without vs. 32% with renal information). In contrast, eGFR and urinary albumin-creatinine ratio were strongly associated with risk for long-term dialysis and greatly improved both model calibration and risk stratification capacity when added to traditional cardiovascular risk factors (65% assigned to intermediate-risk categories without renal information vs. 18% with renal information). Limitation: Creatinine levels were not standardized. Conclusion: In patients with high vascular risk, eGFR and urinary albumin-creatinine ratio add little to traditional cardiovascular risk factors for stratifying cardiovascular risk but greatly improve risk stratification for renal outcomes.	McMaster Univ, Hamilton, ON, Canada; Populat Hlth Res Inst, Hamilton, ON, Canada; Univ Toronto, Toronto, ON, Canada; Schwabing Gen Hosp, Munich, Germany; KfH Kidney Ctr, Munich, Germany; Univ Erlangen Nurnberg, Erlangen, Germany	McMaster University; Population Health Research Institute; University of Toronto; University of Erlangen Nuremberg	Clase, CM (corresponding author), St Josephs Healthcare Hamilton, 50 Charlton Ave E, Hamilton, ON L8P 4A6, Canada.	clase@mcmaster.ca	Mann, Johannes/AAI-8803-2020	Clase, Catherine/0000-0002-4538-5958; Teo, Koon/0000-0002-3731-0956	Boehringer Ingelheim; Population Health Research Institute; European Commission [241544]	Boehringer Ingelheim(Boehringer Ingelheim); Population Health Research Institute; European Commission(European CommissionEuropean Commission Joint Research Centre)	Grant Support: By Boehringer Ingelheim, the Population Health Research Institute, and the European Commission (grant 241544, SysKid; Dr. Mann). Dr. Clase is supported by the clinical work of her colleagues.	Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Brantsma AH, 2008, J AM SOC NEPHROL, V19, P1785, DOI 10.1681/ASN.2007101065; *CAN ORG REPL REG, 2010, ANN REP 2008 CAN I H, P18853; Foster MC, 2007, ARCH INTERN MED, V167, P1386, DOI 10.1001/archinte.167.13.1386; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Levey AS, 2009, AM J KIDNEY DIS, V54, P205, DOI 10.1053/j.ajkd.2009.04.029; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Teo KK, 2004, AM HEART J, V148, P52, DOI 10.1016/j.ahj.2004.03.020; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Tonelli M, 2006, BMJ-BRIT MED J, V332, P1426, DOI 10.1136/bmj.38814.566019.2F; Vlek ALM, 2008, J INTERN MED, V264, P351, DOI 10.1111/j.1365-2796.2008.01970.x; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Warram JH, 1996, J AM SOC NEPHROL, V7, pA0606; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8	25	62	65	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5					310	318		10.7326/0003-4819-154-5-201103010-00005	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21357908				2022-12-24	WOS:000287799900003
J	DiMaio, F; Terwilliger, TC; Read, RJ; Wlodawer, A; Oberdorfer, G; Wagner, U; Valkov, E; Alon, A; Fass, D; Axelrod, HL; Das, D; Vorobiev, SM; Iwai, H; Pokkuluri, PR; Baker, D				DiMaio, Frank; Terwilliger, Thomas C.; Read, Randy J.; Wlodawer, Alexander; Oberdorfer, Gustav; Wagner, Ulrike; Valkov, Eugene; Alon, Assaf; Fass, Deborah; Axelrod, Herbert L.; Das, Debanu; Vorobiev, Sergey M.; Iwai, Hideo; Pokkuluri, P. Raj; Baker, David			Improved molecular replacement by density- and energy-guided protein structure optimization	NATURE			English	Article							CRYSTALLOGRAPHIC REFINEMENT; PREDICTION; ACCURACY; SOFTWARE	Molecular replacement(1-4) procedures, which search for placements of a starting model within the crystallographic unit cell that best account for the measured diffraction amplitudes, followed by automatic chain tracing methods(5-8), have allowed the rapid solution of large numbers of protein crystal structures. Despite extensive work(9-14), molecular replacement or the subsequent rebuilding usually fail with more divergent starting models based on remote homologues with less than 30% sequence identity. Here we show that this limitation can be substantially reduced by combining algorithms for protein structure modelling with those developed for crystallographic structure determination. An approach integrating Rosetta structure modelling with Autobuild chain tracing yielded high-resolution structures for 8 of 13 X-ray diffraction data sets that could not be solved in the laboratories of expert crystallographers and that remained unsolved after application of an extensive array of alternative approaches. We estimate that the new method should allow rapid structure determination without experimental phase information for over half the cases where current methods fail, given diffraction data sets of better than 3.2 angstrom resolution, four or fewer copies in the asymmetric unit, and the availability of structures of homologous proteins with >20% sequence identity.	[Terwilliger, Thomas C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [DiMaio, Frank; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [DiMaio, Frank; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Read, Randy J.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Wlodawer, Alexander] NCI, Macromol Crystallog Lab, Frederick, MD 21702 USA; [Oberdorfer, Gustav; Wagner, Ulrike] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Valkov, Eugene] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Alon, Assaf; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Axelrod, Herbert L.; Das, Debanu] SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Axelrod, Herbert L.; Das, Debanu] SLAC Natl Accelerator Lab, SSRL, Menlo Pk, CA 94025 USA; [Vorobiev, Sergey M.] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA; [Iwai, Hideo] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland; [Pokkuluri, P. Raj] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Graz; University of Cambridge; Weizmann Institute of Science; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Columbia University; University of Helsinki; United States Department of Energy (DOE); Argonne National Laboratory	Terwilliger, TC (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	terwilliger@lanl.gov; dabaker@u.washington.edu	Iwaï, Hideo/A-6416-2009; Read, Randy J/L-1418-2013; Terwilliger, Thomas/AAM-4079-2020; Valkov, Eugene/AAA-1735-2020; Terwilliger, Thomas/AEF-4827-2022; Baker, David/K-8941-2012; Valkov, Eugene/C-1554-2010; Terwilliger, Thomas C/K-4109-2012	Iwaï, Hideo/0000-0001-7376-5264; Read, Randy J/0000-0001-8273-0047; Terwilliger, Thomas/0000-0001-6384-0320; Valkov, Eugene/0000-0002-3721-1739; Baker, David/0000-0001-7896-6217; Terwilliger, Thomas C/0000-0001-6384-0320; Oberdorfer, Gustav/0000-0002-6144-9114; Alon, Assaf/0000-0001-8102-5290	NIH [5R01GM092802, P41RR002250]; Wellcome Trust; HHMI; Israel Science Foundation; DK Molecular Enzymology [W901]; Austrian Science Fund [P19858]; NIH, National Cancer Institute, Center for Cancer Research; academy of Finland [1131413]; Protein Structure Initiative of National Institute of General Medical Sciences [U54 GM074958]; US Department of Energy's Office of Science, Biological and Environmental Research [DE-AC02-06CH11357]; NIH, National Institutes of General Medical Sciences, Protein Structure Initiative [U54 GM094586, GM074898]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586, U54GM094597, U54GM074898, U54GM074958, P01GM063210, R01GM092802] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); HHMI(Howard Hughes Medical Institute); Israel Science Foundation(Israel Science Foundation); DK Molecular Enzymology(Austrian Science Fund (FWF)); Austrian Science Fund(Austrian Science Fund (FWF)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); academy of Finland(Academy of Finland); Protein Structure Initiative of National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy's Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Institutes of General Medical Sciences, Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.J.R., T.C.T. and D.B. thank the NIH (5R01GM092802), the Wellcome Trust (R.J.R.), and HHMI (D.B.) for funding this research. F.D. acknowledges the NIH (P41RR002250) and HHMI. D.F. and A.A. acknowledge support from the Israel Science Foundation. G.O. thanks DK Molecular Enzymology (FWF-project W901) and the Austrian Science Fund (FWF-project P19858). The work of A.W. was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. H.I. acknowledges support from the academy of Finland (1131413). S.M.V. was supported by a grant from the Protein Structure Initiative of National Institute of General Medical Sciences (U54 GM074958). The work of P.R.P. at Argonne National Laboratory was supported by the US Department of Energy's Office of Science, Biological and Environmental Research GTL programme under contract DE-AC02-06CH11357. We thank all members of the JCSG for their general contributions to the protein production and structural work. The JCSG is supported by the NIH, National Institutes of General Medical Sciences, Protein Structure Initiative (U54 GM094586 and GM074898).	ABE H, 1984, COMPUT CHEM, V8, P239, DOI 10.1016/0097-8485(84)85015-9; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; [Anonymous], 2006, CURRENT PROTOCOLS BI, DOI DOI 10.1002/0471250953.BI0506S15; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DePristo MA, 2005, STRUCTURE, V13, P1311, DOI 10.1016/j.str.2005.06.008; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rodriguez DD, 2009, NAT METHODS, V6, P651, DOI [10.1038/NMETH.1365, 10.1038/nmeth.1365]; Rossmann M. G., 1972, MOL REPLACEMENT METH; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Suhre K, 2004, ACTA CRYSTALLOGR D, V60, P796, DOI 10.1107/S0907444904001982; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640; WEIS WI, 1990, J MOL BIOL, V212, P737, DOI 10.1016/0022-2836(90)90234-D	29	188	189	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					540	U149		10.1038/nature09964	http://dx.doi.org/10.1038/nature09964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21532589	Green Accepted			2022-12-24	WOS:000290951300047
J	Mattison, MLP; Zeidel, M				Mattison, Melissa L. P.; Zeidel, Mark			Navigating the Challenges of In-flight Emergencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mattison, Melissa L. P.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Mattison, MLP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, 330 Brookline Ave, Boston, MA 02215 USA.	mmattiso@bidmc.harvard.edu						Gendreau MA, 2002, NEW ENGL J MED, V346, P1067, DOI 10.1056/NEJMra012774; Sand M, 2009, CRIT CARE, V13, DOI 10.1186/cc7690; Shaner DM, 2010, NEW ENGL J MED, V363, P1988, DOI 10.1056/NEJMp1006331; Silverman D, 2009, LANCET, V373, P2067, DOI 10.1016/S0140-6736(09)60209-9; *US FED AV ADM, 12133B US FED AV ADM; *US FED AV ADM, 12134B US FED AV ADM; *US FED AV ADM, COMM AIR CARR FAT RA; NO US AIRLINE FATALI; THERES DOCTOR BOARD	9	13	13	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2011	305	19					2003	2004		10.1001/jama.2011.618	http://dx.doi.org/10.1001/jama.2011.618			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764WO	21540410				2022-12-24	WOS:000290665500024
J	Bers, DM; Harris, SP				Bers, Donald M.; Harris, Samantha P.			TRANSLATIONAL MEDICINE To the rescue of the failing heart	NATURE			English	Editorial Material							FAILURE		[Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Harris, Samantha P.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	dmbers@ucdavis.edu	Bers, Donald M/C-4507-2012	Bers, Donald/0000-0002-2237-9483	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080367] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL080367] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; Kawase Y, 2011, J AM COLL CARDIOL, V57, P1169, DOI 10.1016/j.jacc.2010.11.023; Kushnir A, 2010, ADV PHARMACOL, V59, P1, DOI 10.1016/S1054-3589(10)59001-X; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Tang WHW, 2010, J AM COLL CARDIOL, V55, P688, DOI 10.1016/j.jacc.2009.10.028	6	10	11	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					36	39		10.1038/473036a	http://dx.doi.org/10.1038/473036a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544138				2022-12-24	WOS:000290218300024
J	Moynihan, R				Moynihan, Ray			MEDICALISATION A new deal on disease definition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ASSOCIATION; PANEL		Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Brotto L, 2009, ARCH SEXUAL BEHAV; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clayton A, 2009, J SEXUAL MED; Cosgrove L, 2006, PSYCHOTHER PSYCHOSOM, V75, P154, DOI 10.1159/000091772; Cosgrove L, 2009, NEW ENGL J MED, V360, P2035, DOI 10.1056/NEJMc0810237; Frances A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1168; Godlee F, 2010, BMJ-BRIT MED J, V341, pc4766; Institute of Medicine, 2009, CONFL INT MED RES ED; Kaplan RM, 2007, ANNU REV PUBL HEALTH, V28, P321, DOI 10.1146/annurev.publhealth.28.021406.144141; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Moynihan R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4442; *NIH, CONS DEV PROGR; NIH State of the Science Conference, 2009, NIH STAT SCI C DIAGN; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540; Ryan EA, 2011, DIABETOLOGIA, V54, P480, DOI 10.1007/s00125-010-2005-4; US Department of Health and Human Services Food and Drug Administration, 2008, FDA GUID; Welch G, 2011, DIAGNOSED MAKING PEO; WHO, REP WHO COMM SOC DET; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z	19	26	27	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2011	342								d2548	10.1136/bmj.d2548	http://dx.doi.org/10.1136/bmj.d2548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MA	21540259				2022-12-24	WOS:000290481600008
J	Tang, W; Lu, Y; Tian, QY; Zhang, Y; Guo, FJ; Liu, GY; Syed, NM; Lai, YJ; Lin, EA; Kong, L; Su, J; Yin, FF; Ding, AH; Zanin-Zhorov, A; Dustin, ML; Tao, J; Craft, J; Yin, ZN; Feng, JQ; Abramson, SB; Yu, XP; Liu, CJ				Tang, Wei; Lu, Yi; Tian, Qing-Yun; Zhang, Yan; Guo, Feng-Jin; Liu, Guang-Yi; Syed, Nabeel Muzaffar; Lai, Yongjie; Lin, Edward Alan; Kong, Li; Su, Jeffrey; Yin, Fangfang; Ding, Ai-Hao; Zanin-Zhorov, Alexandra; Dustin, Michael L.; Tao, Jian; Craft, Joseph; Yin, Zhinan; Feng, Jian Q.; Abramson, Steven B.; Yu, Xiu-Ping; Liu, Chuan-Ju			The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice	SCIENCE			English	Article							OLIGOMERIC MATRIX PROTEIN; GRANULIN-EPITHELIN PRECURSOR; TUMOR-NECROSIS-FACTOR; TRANSCRIPTION FACTOR; HOST-DEFENSE; ADAMTS-7; MUTATIONS; GENE; PSEUDOACHONDROPLASIA; DEGRADATION	The growth factor progranulin (PGRN) has been implicated in embryonic development, tissue repair, tumorigenesis, and inflammation, but its receptors remain unidentified. We report that PGRN bound directly to tumor necrosis factor receptors (TNFRs) and disturbed the TNF alpha-TNFR interaction. PGRN-deficient mice were susceptible to collagen-induced arthritis, and administration of PGRN reversed inflammatory arthritis. Atsttrin, an engineered protein composed of three PGRN fragments, exhibited selective TNFR binding. PGRN and Atsttrin prevented inflammation in multiple arthritis mouse models and inhibited TNF alpha-activated intracellular signaling. Collectively, these findings demonstrate that PGRN is a ligand of TNFR, an antagonist of TNF alpha signaling, and plays a critical role in the pathogenesis of inflammatory arthritis in mice. They also suggest new potential therapeutic interventions for various TNF alpha-mediated pathologies and conditions, including rheumatoid arthritis.	[Tang, Wei; Lu, Yi; Tian, Qing-Yun; Zhang, Yan; Guo, Feng-Jin; Liu, Guang-Yi; Syed, Nabeel Muzaffar; Lai, Yongjie; Lin, Edward Alan; Kong, Li; Liu, Chuan-Ju] NYU, Dept Orthopaed Surg, Sch Med, New York, NY 10003 USA; [Tang, Wei; Lu, Yi; Tian, Qing-Yun; Zhang, Yan; Guo, Feng-Jin; Liu, Guang-Yi; Syed, Nabeel Muzaffar; Lai, Yongjie; Lin, Edward Alan; Kong, Li; Abramson, Steven B.; Liu, Chuan-Ju] NYU, Hosp Joint Dis, New York, NY 10003 USA; [Tang, Wei; Lu, Yi; Yu, Xiu-Ping] Shandong Univ, Sch Med, Inst Pathogen Biol, Jinan 250012, Shandong, Peoples R China; [Su, Jeffrey] Cytovance Biol, Oklahoma City, OK 73104 USA; [Yin, Fangfang; Ding, Ai-Hao] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Zanin-Zhorov, Alexandra; Dustin, Michael L.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Tao, Jian; Craft, Joseph] Yale Univ, Sch Med, Dept Med, Rheumatol Sect, New Haven, CT 06520 USA; [Yin, Zhinan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Feng, Jian Q.] Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dallas, TX 75246 USA; [Abramson, Steven B.] NYU, Sch Med, Div Rheumatol, New York, NY 10003 USA; [Liu, Chuan-Ju] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Shandong University; Cornell University; New York University; Yale University; Nankai University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; New York University; New York University	Liu, CJ (corresponding author), NYU, Dept Orthopaed Surg, Sch Med, New York, NY 10003 USA.	chuanju.liu@med.nyu.edu	Dustin, Michael/AAM-4611-2020; Liu, Chuan-ju/AAT-8165-2021; Tian, Qingyun/L-7723-2014; Tang, Wei/A-6254-2016	Tang, Wei/0000-0002-4573-3502; liu, chuanju/0000-0002-7181-8032; Syed, Nabeel/0000-0001-8901-5601; Abramson, Steven/0000-0002-0668-6344; Dustin, Michael/0000-0003-4983-6389	NIH [AR050620, AR053210, GM061710, AI43542, AR040072]; Arthritis National Research Foundation; National Nature Science Foundation of China [30870121]; NSFC [30725015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043542, R01AI030165, R37AI043542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040072, K01AR053210, R37AR040072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061710] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis National Research Foundation(National Research Foundation of Korea); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Lengyel, J. Vilcek, and T. C. Caskey for critical reading and comments. We also thank G. Wisniewski for assisting with the CIA model, M. E. Dorf and A. Mukundan for reagents, and A. Martin and J. Quinn for assistance in Surface Plasmon Resonance assay. This work was funded by NIH grants AR050620 and AR053210 (to C.-J.L.), GM061710 (to A.-H. D), AI43542 (to M. L. D), and AR040072 (to J. C.); by a grant from Arthritis National Research Foundation (to C.-J.L.); by a National Nature Science Foundation of China Grant 30870121 (to X. P. Y); and by a National Outstanding Young Scientist Award of NSFC 30725015 (to Z.N.Y). Patents have been filed by NYU that claim peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods, and uses thereof [WO/2010/120374 (C.-J.L.) and PCT/US2010/001137 (C.-J.L.)]. TNFR2 (TNFRSF1B/CD120b) accession number: NM_130426. A full list of author contributions is available in the SOM.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bai XH, 2009, MOL CELL BIOL, V29, P4201, DOI 10.1128/MCB.00056-09; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Deng GM, 2005, NAT MED, V11, P1066, DOI 10.1038/nm1304; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Guo FJ, 2010, ARTHRITIS RHEUM-US, V62, P2023, DOI 10.1002/art.27491; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Liu CJ, 2006, FASEB J, V20, P988, DOI 10.1096/fj.05-3877fje; Liu CJ, 2006, J BIOL CHEM, V281, P15800, DOI 10.1074/jbc.M513433200; Liu CJ, 2009, NAT CLIN PRACT RHEUM, V5, P38, DOI 10.1038/ncprheum0961; Luan Y, 2008, OSTEOARTHR CARTILAGE, V16, P1413, DOI 10.1016/j.joca.2008.03.017; Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603; Netterwald James, 2009, Nat Biotechnol, V27, P495, DOI 10.1038/nbt0609-495; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Taylor PC, 2009, NAT CLIN PRACT RHEUM, V5, P126, DOI 10.1038/ncprheum1022; Thwin MM, 2004, ARTHRITIS RES THER, V6, pR282, DOI 10.1186/ar1179; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tolkatchev D, 2008, PROTEIN SCI, V17, P711, DOI 10.1110/ps.073295308; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	35	510	541	5	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					478	484		10.1126/science.1199214	http://dx.doi.org/10.1126/science.1199214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21393509	Green Accepted			2022-12-24	WOS:000289784900047
J	Habashi, JP; Doyle, JJ; Holm, TM; Aziz, H; Schoenhoff, F; Bedja, D; Chen, YC; Modiri, AN; Judge, DP; Dietz, HC				Habashi, Jennifer P.; Doyle, Jefferson J.; Holm, Tammy M.; Aziz, Hamza; Schoenhoff, Florian; Bedja, Djahida; Chen, YiChun; Modiri, Alexandra N.; Judge, Daniel P.; Dietz, Harry C.			Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism	SCIENCE			English	Article							SMOOTH-MUSCLE-CELLS; MARFAN-SYNDROME; MOUSE MODEL; BLOCKADE; GROWTH; PATHOGENESIS; CONTRIBUTES; MECHANISM; ACTIVATION; EXPRESSION	Angiotensin II (AngII) mediates progression of aortic aneurysm, but the relative contribution of its type 1 (AT1) and type 2 (AT2) receptors remains unknown. We show that loss of AT2 expression accelerates the aberrant growth and rupture of the aorta in a mouse model of Marfan syndrome (MFS). The selective AT1 receptor blocker (ARB) losartan abrogated aneurysm progression in the mice; full protection required intact AT2 signaling. The angiotensin-converting enzyme inhibitor (ACEi) enalapril, which limits signaling through both receptors, was less effective. Both drugs attenuated canonical transforming growth factor-beta (TGF beta) signaling in the aorta, but losartan uniquely inhibited TGF beta-mediated activation of extracellular signal-regulated kinase (ERK), by allowing continued signaling through AT2. These data highlight the protective nature of AT2 signaling and potentially inform the choice of therapies in MFS and related disorders.	[Habashi, Jennifer P.; Doyle, Jefferson J.; Holm, Tammy M.; Aziz, Hamza; Schoenhoff, Florian; Chen, YiChun; Modiri, Alexandra N.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Habashi, Jennifer P.; Doyle, Jefferson J.; Holm, Tammy M.; Aziz, Hamza; Schoenhoff, Florian; Chen, YiChun; Modiri, Alexandra N.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Habashi, Jennifer P.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Div Pediat Cardiol, Dept Pediat, Baltimore, MD 21205 USA; [Bedja, Djahida] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Judge, Daniel P.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	hdietz@jhmi.edu	Doyle, Jefferson/C-3156-2013; Chen, Yi-Chun/H-4468-2013; Chen, Yichun/AAI-3892-2020	Chen, Yichun/0000-0002-9092-7189; Schoenhoff, Florian/0000-0002-3311-4595; Judge, Daniel/0000-0002-3407-0248	NIH; Howard Hughes Medical Institute; National Marfan Foundation; Johns Hopkins School of Medicine; Smilow Center for Marfan Syndrome Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698, R01AR041135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Marfan Foundation; Johns Hopkins School of Medicine(Johns Hopkins University); Smilow Center for Marfan Syndrome Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the NIH (H. C. D., D.P.J.); Howard Hughes Medical Institute (H. C. D.); the National Marfan Foundation (H. C. D., J.P.H., J.J.D.); the Cellular and Molecular Medicine Training Program, Johns Hopkins School of Medicine (J.J.D.); and the Smilow Center for Marfan Syndrome Research (H. C. D.). We thank T. Inagami for the AT2KO mice. Johns Hopkins University and the authors (H. C. D., J.P.H., D.P.J.) have filed a patent relating to the use of TGF beta antagonists, including AT1 receptor blockers, for the treatment of Marfan syndrome.	Ahimastos AA, 2007, JAMA-J AM MED ASSOC, V298, P1539, DOI 10.1001/jama.298.13.1539; Akishita M, 1999, J CLIN INVEST, V103, P63, DOI 10.1172/JCI5182; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; Fukuda N, 2000, AM J HYPERTENS, V13, P191, DOI 10.1016/S0895-7061(99)00152-1; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Jones ES, 2004, J MOL CELL CARDIOL, V37, P1023, DOI 10.1016/j.yjmcc.2004.08.004; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Nagashima H, 2002, J VASC SURG, V36, P818, DOI 10.1067/mva.2002.126091; Nagashima H, 2001, CIRCULATION, V104, pI282; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Patten RD, 2003, CLIN SCI, V104, P109, DOI 10.1042/CS20020219; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Sakurabayashi-Kitade S, 2009, ATHEROSCLEROSIS, V206, P54, DOI 10.1016/j.atherosclerosis.2009.01.039; Siragy HM, 1999, P NATL ACAD SCI USA, V96, P6506, DOI 10.1073/pnas.96.11.6506; Ulmasov B, 2009, AM J PHYSIOL-GASTR L, V296, pG284, DOI 10.1152/ajpgi.90409.2008; Wolf G, 1999, J MOL MED-JMM, V77, P556, DOI 10.1007/s001099900028; Yetman AT, 2005, AM J CARDIOL, V95, P1125, DOI 10.1016/j.amjcard.2005.01.032	23	318	324	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					361	365		10.1126/science.1192152	http://dx.doi.org/10.1126/science.1192152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493863	Green Accepted			2022-12-24	WOS:000289516600048
J	Bonner, L				Bonner, Laura			The Walk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												bonnerlauram@gmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1393	1393		10.1001/jama.2011.368	http://dx.doi.org/10.1001/jama.2011.368			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486965				2022-12-24	WOS:000289424100030
J	Grumbine, RE; Xu, JC				Grumbine, R. Edward; Xu, Jianchu			Mekong Hydropower Development	SCIENCE			English	Editorial Material							BASIN		[Grumbine, R. Edward] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming 650204, Peoples R China; [Xu, Jianchu] World Agroforestry Ctr, Kunming 650204, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Grumbine, RE (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming 650204, Peoples R China.	ed.grumbine@gmail.com	Xu, Jianchu/Y-2890-2019					Baran E, 2009, AQUAT ECOSYST HEALTH, V12, P227, DOI 10.1080/14634980903149902; CIA, 2017, GHAN WORLD FACTB 201; Cruz RV, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P469; Dore J, 2010, ENVIRON MANAGE, V46, P60, DOI 10.1007/s00267-010-9527-x; Evans A, 2010, GLOBALIZATION SCARCI; Foran T., 2009, CONTESTED WATERSCAPE, P55; Friend R., 2009, CONTESTED WATERSCAPE, P307; Hirsch P., 2006, NATL INTERESTS TRANS; International Center for Environmental Management, 2010, MRC STRAT ENV ASS SE; Jensen JG, 2001, WATER SCI TECHNOL, V43, P157, DOI 10.2166/wst.2001.0529; Kummu M, 2010, GEOMORPHOLOGY, V119, P181, DOI 10.1016/j.geomorph.2010.03.018; Lebel L, 2010, INT ENVIRON AGREEM-P, V10, P355, DOI 10.1007/s10784-010-9141-7; Population Reference Bureau, 2010, 2010 WORLD POP DAT S; Shankleman J., 2009, GOING GLOBAL CHINESE; WANG JJ, 2009, RIVER RES APPL, V25, P33; WIPATAYOTIN A, 2011, BANGKOK POST    0217	16	161	168	3	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					178	179		10.1126/science.1200990	http://dx.doi.org/10.1126/science.1200990			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	746MM	21474740				2022-12-24	WOS:000289251100029
J	Zhang, K; Fischer, T; Porter, RL; Dhakshnamoorthy, J; Zofall, M; Zhou, M; Veenstra, T; Grewal, SIS				Zhang, Ke; Fischer, Tamas; Porter, Rebecca L.; Dhakshnamoorthy, Jothy; Zofall, Martin; Zhou, Ming; Veenstra, Timothy; Grewal, Shiv I. S.			Clr4/Suv39 and RNA Quality Control Factors Cooperate to Trigger RNAi and Suppress Antisense RNA	SCIENCE			English	Article							FISSION YEAST; CHROMOSOME SEGREGATION; LYSINE METHYLATION; MRNP FORMATION; HETEROCHROMATIN; COMPLEX; EXPORT; TRANSCRIPTION; PROTEINS; DEGRADATION	Pervasive transcription of eukaryotic genomes generates a plethora of noncoding RNAs. In fission yeast, the heterochromatin factor Clr4/Suv39 methyltransferase facilitates RNA interference (RNAi)-mediated processing of centromeric transcripts into small interfering RNAs (siRNAs). Clr4 also mediates degradation of antisense RNAs at euchromatic loci, but the underlying mechanism has remained elusive. We show that Clr4 and the RNAi effector RITS (RNA-induced transcriptional silencing) interact with Mlo3, a protein related to mRNA quality control and export factors. Loss of Clr4 impairs RITS interaction with Mlo3, which is required for centromeric siRNA production and antisense suppression. Mlo3 also interacts with the RNA surveillance factor TRAMP, which suppresses antisense RNAs targeted by Clr4 and RNAi. These findings link Clr4 to RNA quality control machinery and suggest a pathway for processing potentially deleterious RNAs through the coordinated actions of RNAi and other RNA processing activities.	[Zhang, Ke; Fischer, Tamas; Porter, Rebecca L.; Dhakshnamoorthy, Jothy; Zofall, Martin; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhou, Ming; Veenstra, Timothy] NCI, Lab Prote & Analyt Anal, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Fischer, Tamas/A-7729-2016	Fischer, Tamas/0000-0002-7996-4042	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011208, ZIABC010523] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Dhar and R. Allshire for antibody to Mlo3 and strains, E. Chen for helpful contributions, and F. Reyes-Turcu, N. Komissarova, and M. Lichten for comments on manuscripts and discussions. Microarray data are available at the National Center for Biotechnology Information's Gene Expression Omnibus repository under accession numbers GSE26999 and GSE17271. This work is supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute.	Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Djupedal I, 2009, EMBO J, V28, P3832, DOI 10.1038/emboj.2009.351; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Gerace EL, 2010, MOL CELL, V39, P360, DOI 10.1016/j.molcel.2010.07.017; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Javerzat JP, 1996, NUCLEIC ACIDS RES, V24, P4676, DOI 10.1093/nar/24.23.4676; Jensen TH, 2003, NAT STRUCT BIOL, V10, P10, DOI 10.1038/nsb0103-10; Kim VN, 2001, MOL CELLS, V12, P1; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Thakurta AG, 2005, EMBO J, V24, P2512, DOI 10.1038/sj.emboj.7600713; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	27	58	59	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1624	1627		10.1126/science.1198712	http://dx.doi.org/10.1126/science.1198712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436456	Green Accepted			2022-12-24	WOS:000288754500061
J	Jonietz, E				Jonietz, Erika			DESIGNING SMARTER CANCER PREVENTION TRIALS	NATURE			English	Editorial Material							PROSTATE-CANCER											Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660	2	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S20	S21		10.1038/471S20a	http://dx.doi.org/10.1038/471S20a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430717	Bronze			2022-12-24	WOS:000288702200017
J	Dickinson, DJ; Nelson, WJ; Weis, WI				Dickinson, Daniel J.; Nelson, W. James; Weis, William I.			A Polarized Epithelium Organized by beta- and alpha-Catenin Predates Cadherin and Metazoan Origins	SCIENCE			English	Article							CELL POLARITY; COMPLEX; DICTYOSTELIUM; ADHESION; EVOLUTION; MEMBRANE; ANCESTRY; ACTIN; GENE	A fundamental characteristic of metazoans is the formation of a simple, polarized epithelium. In higher animals, the structural integrity and functional polarization of simple epithelia require a cell-cell adhesion complex that contains a classical cadherin, the Wnt-signaling protein beta-catenin and the actin-binding protein alpha-catenin. We show that the non-metazoan Dictyostelium discoideum forms a polarized epithelium that is essential for multicellular development. Although D. discoideum lacks a cadherin homolog, we identify an alpha-catenin ortholog that binds a beta-catenin-related protein. Both proteins are essential for formation of the epithelium, polarized protein secretion, and proper multicellular morphogenesis. Thus, the organizational principles of metazoan multicellularity may be more ancient than previously recognized, and the role of the catenins in cell polarity predates the evolution of Wnt signaling and classical cadherins.	[Dickinson, Daniel J.; Nelson, W. James; Weis, William I.] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Nelson, W. James; Weis, William I.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Nelson, WJ (corresponding author), Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA.	wjnelson@stanford.edu; bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Dickinson, Daniel J./0000-0003-2651-2584	Stanford Graduate Fellowship; NSF; NIH [GM035527, GM56169]; U.S. Department of Energy; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035527, R01GM035527, R01GM056169] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank numerous colleagues for reagents (9); T. Soldati for sharing Sec15 antibodies before publication; C. Carswell-Crumpton, N. Ghori, J. Perrino, and T. Weiss for technical assistance; and D. Ehrhardt, N. King, D. N. Robinson, T. Soldati, J. A. Spudich, M. Tsujioka, H. Warrick, and members of the Nelson and Weis laboratories for discussions. This work was supported by a Stanford Graduate Fellowship and an NSF Graduate Research Fellowship (D. J. D.), NIH GM035527 (W. J. N.), and NIH GM56169 (W. I. W.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, supported by the U.S. Department of Energy and the National Institute of General Medical Sciences.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Blanton RL, 2000, P NATL ACAD SCI USA, V97, P2391, DOI 10.1073/pnas.040565697; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coates JC, 2002, MECH DEVELOP, V116, P117, DOI 10.1016/S0925-4773(02)00152-1; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; MCROBBIE SJ, 1988, DEV BIOL, V125, P59, DOI 10.1016/0012-1606(88)90058-9; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Urushihara H, 2008, DEV GROWTH DIFFER, V50, pS277, DOI 10.1111/j.1440-169X.2008.01013.x; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Williams HP, 2003, CURR OPIN MICROBIOL, V6, P621, DOI 10.1016/j.mib.2003.10.008; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893	22	98	99	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1336	1339		10.1126/science.1199633	http://dx.doi.org/10.1126/science.1199633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393547	Green Accepted			2022-12-24	WOS:000288215200050
J	Sandberg, MK; Al-Doujaily, H; Sharps, B; Clarke, AR; Collinge, J				Sandberg, Malin K.; Al-Doujaily, Huda; Sharps, Bernadette; Clarke, Anthony R.; Collinge, John			Prion propagation and toxicity in vivo occur in two distinct mechanistic phases	NATURE			English	Article							MOUSE SCRAPIE; MICE; DISEASE; PROTEIN; PRP; REPLICATION; PATHOGENESIS; INFECTIVITY; RESISTANT; STRAINS	Mammalian prions cause fatal neurodegenerative conditions including Creutzfeldt-Jakob disease in humans and scrapie and bovine spongiform encephalopathy in animals(1). Prion infections are typically associated with remarkably prolonged but highly consistent incubation periods followed by a rapid clinical phase. The relationship between prion propagation, generation of neurotoxic species and clinical onset has remained obscure. Prion incubation periods in experimental animals are known to vary inversely with expression level of cellular prion protein. Here we demonstrate that prion propagation in brain proceeds via two distinct phases: a clinically silent exponential phase not rate-limited by prion protein concentration which rapidly reaches a maximal prion titre, followed by a distinct switch to a plateau phase. The latter determines time to clinical onset in a manner inversely proportional to prion protein concentration. These findings demonstrate an uncoupling of infectivity and toxicity. We suggest that prions themselves are not neurotoxic but catalyse the formation of such species from PrPC. Production of neurotoxic species is triggered when prion propagation saturates, leading to a switch from autocatalytic production of infectivity (phase 1) to a toxic (phase 2) pathway.	[Sandberg, Malin K.; Al-Doujaily, Huda; Sharps, Bernadette; Clarke, Anthony R.; Collinge, John] UCL Inst Neurol, MRC Prion Unit, London WC1N 3BG, England; [Sandberg, Malin K.; Al-Doujaily, Huda; Sharps, Bernadette; Clarke, Anthony R.; Collinge, John] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Collinge, J (corresponding author), UCL Inst Neurol, MRC Prion Unit, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk			UK Medical Research Council; MRC [MC_U123192748, MC_U123160656] Funding Source: UKRI; Medical Research Council [MC_U123192748, MC_U123160656] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council. We thank J. Wadsworth for critical review of the manuscript, S. Walker for statistical advice, staff of our Biological Services Facility for animal care and technical assistance and R. Young for preparation of figures.	Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; CZUB M, 1986, J GEN VIROL, V67, P2005, DOI 10.1099/0022-1317-67-9-2005; DICKINSON AG, 1975, GENETICS, V79, P387; DICKINSON AG, 1972, NATURE-NEW BIOL, V237, P244, DOI 10.1038/newbio237244a0; DICKINSON AG, 1969, J COMP PATHOL, V79, P15, DOI 10.1016/0021-9975(69)90021-8; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; GAJDUSEK DC, 1988, J NEUROIMMUNOL, V20, P95; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hill AF, 2003, TRENDS MICROBIOL, V11, P578, DOI 10.1016/j.tim.2003.10.007; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Thackray AM, 2003, J VIROL, V77, P7991, DOI 10.1128/JVI.77.14.7991-7998.2003; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002	30	221	222	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					540	542		10.1038/nature09768	http://dx.doi.org/10.1038/nature09768			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350487				2022-12-24	WOS:000287652900043
J	Eddy, DM; Adler, J; Patterson, B; Lucas, D; Smith, KA; Morris, M				Eddy, David M.; Adler, Joshua; Patterson, Bradley; Lucas, Don; Smith, Kurt A.; Morris, Macdonald			Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINES; CARDIOVASCULAR-DISEASE; STATIN TREATMENT; PREVENTION; ARCHIMEDES; RISK; CARE; OUTCOMES; PROFILE; IMPACT	Background: Current guidelines focus on a particular risk factor and specify criteria for categorizing persons into a small number of treatment groups. Objective: To compare current guidelines with individualized guidelines (that use readily available characteristics from each person to calculate the risk reduction expected from treatment and to identify persons for treatment in ranked order of decreasing expected benefit), in the context of blood pressure management. Design: Analysis of person-specific, longitudinal data. Setting: The ARIC (Atherosclerosis Risk in Communities) Study. Participants: Persons aged 45 to 64 years without preexisting cardiovascular disease who currently do not receive antihypertensive treatment. Intervention: Treatment according to the criteria of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 guidelines); individualized guidelines, or treatment in decreasing order of expected benefit; and random care, or treatment of persons selected at random. Measurements: Number of myocardial infarctions (MIs) and strokes and medical costs. Results: Compared with treating people according to random care, individualized guidelines could prevent the same number of MIs and strokes as JNC 7 guidelines at savings that are 67% greater than using JNC 7 guidelines, or it could prevent 43% more MIs and strokes for the same cost as treatment according to JNC 7 guidelines. The superiority of individualized guidelines was not sensitive to a wide range of assumptions about costs, treatment effectiveness, level of risk for cardiovascular disease in the population, or effects on workflow. The degree of superiority was sensitive to the accuracy of the method used to rank patients and to its span (the proportion of the population for whom all of the outcomes of interest can be calculated). Limitations: Specific results apply to the effects of blood pressure management on MI and stroke in the ARIC Study population. The methods for calculating individual benefits require quantitative evidence about the relationships among risk factors, long-term outcomes, and treatment effects. Conclusion: Use of individualized guidelines can help to increase the quality and reduce the cost of care.	[Eddy, David M.; Adler, Joshua; Patterson, Bradley; Lucas, Don; Smith, Kurt A.; Morris, Macdonald] Archimedes, San Francisco, CA USA		Eddy, DM (corresponding author), 201 Mission St,29th Floor, San Francisco, CA 94105 USA.	author@archimedesmodel.com			National Heart, Lung, and Blood Institute; ARIC study investigators	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ARIC study investigators	The ARIC Study is conducted and supported by the National Heart, Lung, and Blood Institute in collaboration with the ARIC study investigators. This article was prepared using a limited-access data set and does not necessarily reflect the opinions or views of the ARIC Study investigators or the National Heart, Lung, and Blood Institute.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Bash LD, 2009, AM J EPIDEMIOL, V170, P414, DOI 10.1093/aje/kwp151; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Bundorf MK, 2004, HEALTH SERV RES, V39, P131; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Eddy DM, 2003, DIABETES CARE, V26, P3102, DOI 10.2337/diacare.26.11.3102; Eddy DM, 2003, DIABETES CARE, V26, P3093, DOI 10.2337/diacare.26.11.3093; EDDY DM, 1982, NEW ENGL J MED, V307, P343, DOI 10.1056/NEJM198208053070604; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P877; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; *FRAM HEART STUD, STORK; Framingham Heart Study, HARD COR HEART DIS 1; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Genest J, 2003, CAN MED ASSOC J, V169, P921; Halfhill TR, TOMS INFLATION CALCU; Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; *HEART FDN, QUICK REF GUID HLTH; Honaker J, AMELIA 2 PROGRAM MIS; Kahn R, 2008, CIRCULATION, V118, P576, DOI 10.1161/CIRCULATIONAHA.108.190186; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; Manuel DG, 2006, BMJ-BRIT MED J, V332, P1419, DOI 10.1136/bmj.38849.487546.DE; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; *NAT I HLTH CLIN E, STAT PREV CARD EV PA; National Heart Lung and Blood Institute, BIOL SPEC DAT REP IN; New Zealand Guidelines Group, ASS MAN CARD RISK; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Samsa GP, 1999, STROKE, V30, P338, DOI 10.1161/01.STR.30.2.338; Schlessinger L, 2002, J BIOMED INFORM, V35, P37, DOI 10.1016/S1532-0464(02)00006-0; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Tonkin Andrew, 2005, Heart Lung Circ, V14, P275; U.S. Department of Health and Human Services (National Heart Lung and Blood Institute, 7 US DEP HLTH HUM SE; U.S. Department of Health and Human Services National Institutes of Health, 3 US DEP HLTH HUM SE; *WIK, PERS MED; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; ARIC ATHEROSCLEROSIS	39	90	90	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					627	634		10.7326/0003-4819-154-9-201105030-00008	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21536939				2022-12-24	WOS:000290112300006
J	Modi, AC; Rausch, JR; Glauser, TA				Modi, Avani C.; Rausch, Joseph R.; Glauser, Tracy A.			Patterns of Nonadherence to Antiepileptic Drug Therapy in Children With Newly Diagnosed Epilepsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; TREATMENT ADHERENCE; REPORTED ADHERENCE; PEDIATRIC-PATIENTS; CYSTIC-FIBROSIS; ASTHMA; TRAJECTORIES; MEDICATION; ADOLESCENTS; DEFINITION	Context Because of epilepsy's common occurrence, the narrow therapeutic and safety margins of antiepileptic medications, and the recognized complications of medication nonadherence in adults with epilepsy, identifying the rates, patterns, and predictors of nonadherence in children with epilepsy is imperative. The onset and evolution of antiepileptic drug nonadherence in children with newly diagnosed epilepsy remains unknown. Objectives To identify and characterize trajectories of adherence in children with newly diagnosed epilepsy over the first 6 months of therapy and to determine sociodemographic and epilepsy-specific predictors of adherence trajectories. Design, Setting, and Patients Prospective, longitudinal observational study of antiepileptic drug adherence in a consecutive cohort of 124 children (2-12 years old) with newly diagnosed epilepsy at Cincinnati Children's Hospital Medical Center. Patients were recruited from April 2006 through March 2009, and final data collection occurred in September 2009. Main Outcome Measure Objective adherence measured using electronic monitors. Results Fifty-eight percent of children with newly diagnosed epilepsy demonstrated persistent nonadherence during the first 6 months of therapy. Group-based trajectory models identified 5 differential adherence patterns (Bayesian information criterion=-23611.8): severe early nonadherence (13%; 95% confidence interval [CI], 8%-20%), severe delayed nonadherence (7%; 95% CI, 3%-12%), moderate nonadherence (13%; 95% CI, 8%-20%), mild nonadherence (26%; 95% CI, 19%-34%), and near-perfect adherence (42%; 95% CI, 33%-50%). The adherence pattern of most patients was established by the first month of therapy. Socioeconomic status was the sole predictor of adherence trajectory group status (chi(2)(4)=19.3 [n=115]; P<.001; partial r(2)=0.25), with lower socioeconomic status associated with higher nonadherence. Conclusion Five trajectory patterns were identified that captured the spectrum of nonadherence to antiepileptic drugs among children with newly diagnosed epilepsy; the patterns were significantly associated with socioeconomic status. JAMA. 2011;305(16):1669-1676 www.jama.com	[Modi, Avani C.; Rausch, Joseph R.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Glauser, Tracy A.] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Modi, AC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, 3333 Burnet Ave,MLC 7039 Adherence Ctr, Cincinnati, OH 45229 USA.	avani.modi@cchmc.org	Rausch, Joseph R/E-8107-2018	Modi, Avani/0000-0002-7580-3751	National Institutes of Health [K23HD057333]; ucb Pharma; Eisai; Upsher-Smith; Lundbeck; Sunovion; Supernus; Questcor; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD057333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ucb Pharma(UCB Pharma SA); Eisai(Eisai Co Ltd); Upsher-Smith; Lundbeck(Lundbeck Corporation); Sunovion; Supernus; Questcor; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Modi reports that she has been a consultant for Novartis Pharmaceuticals Inc, which has an interest in antiepileptic drugs. Dr Glauser reports that he is an advisor to, a speaker for, and has received research grants from companies with interests in antiepileptic drugs, including ucb Pharma, Eisai, Upsher-Smith, Lundbeck, Sunovion, Supernus, and Questcor. No other disclosures were reported.; This research was funded by grant K23HD057333 from the National Institutes of Health awarded to Dr Modi.	Adams CD, 2004, CURR ALLERGY ASTHM R, V4, P425, DOI 10.1007/s11882-004-0007-3; Al-Faris EA, 2002, SAUDI MED J, V23, P969; Asadi-Pooya AA, 2005, SEIZURE-EUR J EPILEP, V14, P393, DOI 10.1016/j.seizure.2005.05.003; Asato MR, 2009, J CHILD NEUROL, V24, P562, DOI 10.1177/0883073809332396; Bassili A, 2002, INT J QUAL HEALTH C, V14, P277, DOI 10.1093/intqhc/14.4.277; Berquist RK, 2006, PEDIATR TRANSPLANT, V10, P304, DOI 10.1111/j.1399-3046.2005.00451.x; Cohen J., 2003, APPL MULTIPLE REGRES; Conklin CA, 2005, NICOTINE TOB RES, V7, P533, DOI 10.1080/14622200500185371; Ettinger AB, 2009, EPILEPSY BEHAV, V14, P324, DOI 10.1016/j.yebeh.2008.10.021; Faught E, 2008, NEUROLOGY, V71, P1572, DOI 10.1212/01.wnl.0000319693.10338.b9; Fiese BH, 2005, J PEDIATR-US, V146, P171, DOI 10.1016/j.jpeds.2004.08.083; Glass TR, 2010, JAIDS-J ACQ IMM DEF, V54, P197, DOI 10.1097/QAI.0b013e3181ca48bf; Glauser T, 2006, EPILEPSIA, V47, P1094, DOI 10.1111/j.1528-1167.2006.00585.x; Graves MM, 2007, CURR ALLERGY ASTHM R, V7, P427, DOI 10.1007/s11882-007-0065-4; HAYNES RB, 1976, LANCET, V1, P1265; Irvine L, 2002, EUR RESPIR J, V20, P1464, DOI 10.1183/09031936.02.00302102; Kahana S, 2008, J PEDIATR PSYCHOL, V33, P590, DOI 10.1093/jpepsy/jsm128; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Kyngas H, 2000, SEIZURE-EUR J EPILEP, V9, P598, DOI 10.1053/seiz.2000.0470; LEESTMA JE, 1989, ANN NEUROL, V26, P195, DOI 10.1002/ana.410260203; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; LUND L, 1974, ARCH NEUROL-CHICAGO, V31, P289, DOI 10.1001/archneur.1974.00490410037002; MATSUI D, 1994, J CLIN PHARMACOL, V34, P944, DOI 10.1002/j.1552-4604.1994.tb04009.x; Mitchell WG, 2000, EPILEPSIA, V41, P1616; Modi AC, 2011, SOC BEHAV EPILEPSY, P175; Modi AC, 2008, PEDIATRICS, V121, pE961, DOI 10.1542/peds.2007-1690; Modi AC, 2006, J PEDIATR PSYCHOL, V31, P846, DOI 10.1093/jpepsy/jsj096; Modi AC, 2011, J PEDIATR PSYCHOL, V36, P466, DOI 10.1093/jpepsy/jsq114; Modi AC, 2011, EPILEPSIA, V52, P370, DOI 10.1111/j.1528-1167.2010.02789.x; Modi AC, 2010, J PEDIATR PSYCHOL, V35, P1028, DOI 10.1093/jpepsy/jsq015; Modi AC, 2010, EPILEPSY BEHAV, V18, P94, DOI 10.1016/j.yebeh.2010.03.009; Modi AC, 2009, CHILD HEALTH CARE, V38, P107, DOI 10.1080/02739610902813245; MUELLER CW, 1981, CHILD DEV, V52, P13, DOI 10.2307/1129211; Mulvaney S, 2006, J AM ACAD CHILD PSY, V45, P737, DOI 10.1097/10.chi.0000214192.57993.06; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; NEUSPIEL DR, 1985, JAMA-J AM MED ASSOC, V254, P1321, DOI 10.1001/jama.254.10.1321; Pai ALH, 2010, PEDIATR TRANSPLANT, V14, P993, DOI 10.1111/j.1399-3046.2010.01391.x; Riekert KA, 2002, J CLIN PSYCHOL MED S, V9, P25, DOI 10.1023/A:1014131928789; Schurman JV, 2011, J PEDIATR PSYCHOL, V36, P116, DOI 10.1093/jpepsy/jsq046; Schwebel DC, 2007, J DEV BEHAV PEDIATR, V28, P245, DOI 10.1097/01.DBP.0000268561.80204.2a; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9	43	160	162	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1669	1676		10.1001/jama.2011.506	http://dx.doi.org/10.1001/jama.2011.506			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	754XG	21521848	Green Accepted			2022-12-24	WOS:000289890500020
J	Holm, TM; Habashi, JP; Doyle, JJ; Bedja, D; Chen, YC; van Erp, C; Lindsay, ME; Kim, D; Schoenhoff, F; Cohn, RD; Loeys, BL; Thomas, CJ; Patnaik, S; Marugan, JJ; Judge, DP; Dietz, HC				Holm, Tammy M.; Habashi, Jennifer P.; Doyle, Jefferson J.; Bedja, Djahida; Chen, YiChun; van Erp, Christel; Lindsay, Mark E.; Kim, David; Schoenhoff, Florian; Cohn, Ronald D.; Loeys, Bart L.; Thomas, Craig J.; Patnaik, Samarjit; Marugan, Juan J.; Judge, Daniel P.; Dietz, Harry C.			Noncanonical TGF beta Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice	SCIENCE			English	Article							N-TERMINAL KINASE; MOUSE MODEL; NOONANS-SYNDROME; ACTIVATION; RECEPTOR; CELLS; PATHOGENESIS; INHIBITOR; MUTATIONS; VALSALVA	Transforming growth factor-beta (TGF beta) signaling drives aneurysm progression in multiple disorders, including Marfan syndrome (MFS), and therapies that inhibit this signaling cascade are in clinical trials. TGF beta can stimulate multiple intracellular signaling pathways, but it is unclear which of these pathways drives aortic disease and, when inhibited, which result in disease amelioration. Here we show that extracellular signal-regulated kinase (ERK) 1 and 2 and Smad2 are activated in a mouse model of MFS, and both are inhibited by therapies directed against TGF beta. Whereas selective inhibition of ERK1/2 activation ameliorated aortic growth, Smad4 deficiency exacerbated aortic disease and caused premature death in MFS mice. Smad4-deficient MFS mice uniquely showed activation of Jun N-terminal kinase-1 (JNK1), and a JNK antagonist ameliorated aortic growth in MFS mice that lacked or retained full Smad4 expression. Thus, noncanonical (Smad-independent) TGF beta signaling is a prominent driver of aortic disease in MFS mice, and inhibition of the ERK1/2 or JNK1 pathways is a potential therapeutic strategy for the disease.	[Holm, Tammy M.; Habashi, Jennifer P.; Doyle, Jefferson J.; Chen, YiChun; van Erp, Christel; Lindsay, Mark E.; Kim, David; Schoenhoff, Florian; Cohn, Ronald D.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Holm, Tammy M.; Habashi, Jennifer P.; Doyle, Jefferson J.; Chen, YiChun; van Erp, Christel; Lindsay, Mark E.; Kim, David; Schoenhoff, Florian; Cohn, Ronald D.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Habashi, Jennifer P.; Lindsay, Mark E.; Cohn, Ronald D.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA; [Bedja, Djahida] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Loeys, Bart L.] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Thomas, Craig J.; Patnaik, Samarjit; Marugan, Juan J.] NIH, Chem Genom Ctr, Rockville, MD 20850 USA; [Judge, Daniel P.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Ghent University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Johns Hopkins University	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	hdietz@jhmi.edu	Cohn, Ronald/AAC-5835-2021; Chen, Yi-Chun/H-4468-2013; Loeys, Bart/B-3236-2017; Doyle, Jefferson/C-3156-2013	Loeys, Bart/0000-0003-3703-9518; Thomas, Craig/0000-0001-9386-9001; Judge, Daniel/0000-0002-3407-0248; Schoenhoff, Florian/0000-0002-3311-4595	National Institutes of Health; Howard Hughes Medical Institute; National Marfan Foundation; Cellular and Molecular Medicine Training Program; National Human Genome Research Institute; Smilow Center for Marfan Syndrome Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041135, P01AR049698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Marfan Foundation; Cellular and Molecular Medicine Training Program; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Smilow Center for Marfan Syndrome Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the National Institutes of Health (H. C. D. and D.P.J), Howard Hughes Medical Institute (H. C. D.), National Marfan Foundation (H. C. D., J.P.H., and J.J.D.), Cellular and Molecular Medicine Training Program (J.J.D.), National Human Genome Research Institute Intramural Research Program and the NIH Therapeutics for Rare and Neglected Diseases Program (C.J.T., S. P., and J.J.M.), and the Smilow Center for Marfan Syndrome Research (H. C. D.). We thank Dr. C. Deng for the Smad4-targeted mice. Johns Hopkins University and the authors (H. C. D., J.P.H., D.P.J., and R. C.) have filed a patent relating to the use of TGF beta antagonists, including angiotensin II type 1 receptor blockers, for the treatment of Marfan syndrome.	Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dietz HC, 2010, J CLIN INVEST, V120, P403, DOI 10.1172/JCI42014; Fukuda N, 2000, AM J HYPERTENS, V13, P191, DOI 10.1016/S0895-7061(99)00152-1; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Huang JB, 2010, CIRC RES, V106, P583, DOI 10.1161/CIRCRESAHA.109.207852; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; MORGAN JM, 1989, EUR HEART J, V10, P190, DOI 10.1093/oxfordjournals.eurheartj.a059462; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Purnell R, 2005, EUR J CARDIO-THORAC, V28, P346, DOI 10.1016/j.ejcts.2005.05.004; Wolf G, 1999, J MOL MED-JMM, V77, P556, DOI 10.1007/s001099900028; Xu XL, 2000, ONCOGENE, V19, P1868, DOI 10.1038/sj.onc.1203504; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	26	337	350	4	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					358	361		10.1126/science.1192149	http://dx.doi.org/10.1126/science.1192149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493862	Green Accepted			2022-12-24	WOS:000289516600047
J	Sosulski, DL; Bloom, ML; Cutforth, T; Axel, R; Datta, SR				Sosulski, Dara L.; Bloom, Maria Lissitsyna; Cutforth, Tyler; Axel, Richard; Datta, Sandeep Robert			Distinct representations of olfactory information in different cortical centres	NATURE			English	Article							TUFTED CELLS; BULB; PROJECTIONS; CORTEX; ODOR; ORGANIZATION; PATTERNS; SYSTEM; GENES; AXONS	Sensory information is transmitted to the brain where it must be processed to translate stimulus features into appropriate behavioural output. In the olfactory system, distributed neural activity in the nose is converted into a segregated map in the olfactory bulb(1-3). Here we investigate how this ordered representation is transformed in higher olfactory centres in mice. We have developed a tracing strategy to define the neural circuits that convey information from individual glomeruli in the olfactory bulb to the piriform cortex and the cortical amygdala. The spatial order in the bulb is discarded in the piriform cortex; axons from individual glomeruli project diffusely to the piriform without apparent spatial preference. In the cortical amygdala, we observe broad patches of projections that are spatially stereotyped for individual glomeruli. These projections to the amygdala are overlapping and afford the opportunity for spatially localized integration of information from multiple glomeruli. The identification of a distributive pattern of projections to the piriform and stereotyped projections to the amygdala provides an anatomical context for the generation of learned and innate behaviours.	[Sosulski, Dara L.; Bloom, Maria Lissitsyna; Cutforth, Tyler; Axel, Richard; Datta, Sandeep Robert] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Sosulski, Dara L.; Bloom, Maria Lissitsyna; Cutforth, Tyler; Axel, Richard; Datta, Sandeep Robert] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	ra27@columbia.edu		Axel, Richard/0000-0002-3141-4076; Datta, Sandeep/0000-0002-8068-3862	Burroughs Wellcome Fund; National Institutes of Health [DP2-OD-007109]; Howard Hughes Medical Institute; Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; Helen Hay Whitney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007109] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the R.A. and S.R.D. laboratories for comments and advice, B. Shykind for mice with GFP-labelled olfactory receptor neurons, S. X. Luo for image alignment advice, D. M. Bear for cross-correlation analysis advice, D. Padfield for Matlab code, R. Wilson for comments on the manuscript and P. Kisloff for manuscript preparation assistance. Financial support was provided by a Helen Hay Whitney Foundation Fellowship, a Career Award in the Medical Sciences grant from the Burroughs Wellcome Fund, and funding from the National Institutes of Health through the NIH Director's New Innovator Award Program (DP2-OD-007109) (S.R.D.), a Ruth L. Kirschstein National Research Service Award predoctoral fellowship from the National Institutes of Health (D.L.S.), and the Howard Hughes Medical Institute and a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative (R.A.).	BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; BUONVISO N, 1991, EUR J NEUROSCI, V3, P493, DOI 10.1111/j.1460-9568.1991.tb00836.x; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; DEOLMOS J, 1978, J COMP NEUROL, V181, P213, DOI 10.1002/cne.901810202; Emmenlauer M, 2009, J MICROSC-OXFORD, V233, P42, DOI 10.1111/j.1365-2818.2008.03094.x; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; LUSKIN MB, 1982, J COMP NEUROL, V209, P249, DOI 10.1002/cne.902090304; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Niimura Y, 2005, GENE, V346, P23, DOI 10.1016/j.gene.2004.09.027; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; PRICE JL, 1973, J COMP NEUROL, V150, P87, DOI 10.1002/cne.901500105; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SCHNEIDER SP, 1983, J NEUROPHYSIOL, V50, P358, DOI 10.1152/jn.1983.50.2.358; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; SCOTT JW, 1981, J NEUROPHYSIOL, V46, P918, DOI 10.1152/jn.1981.46.5.918; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; SKEEN LC, 1977, J COMP NEUROL, V172, P1, DOI 10.1002/cne.901720102; SLOTNICK BM, 1985, BEHAV NEUROSCI, V99, P956, DOI 10.1037/0735-7044.99.5.956; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306	31	301	308	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					213	216		10.1038/nature09868	http://dx.doi.org/10.1038/nature09868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21451525	Green Accepted			2022-12-24	WOS:000289469100041
J	Stein, RA				Stein, Richard A.			Epigenetics-The Link Between Infectious Diseases and Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELLS		Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Stein, RA (corresponding author), Princeton Univ, Dept Mol Biol, 1 Washington Rd,LTL 320, Princeton, NJ 08544 USA.	ras2@princeton.edu						DEBUSTROS A, 1988, P NATL ACAD SCI USA, V85, P5693; Fernandez AF, 2010, ONCOGENE, V29, P1405, DOI 10.1038/onc.2009.517; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Malfertheiner P, 2005, AM J GASTROENTEROL, V100, P2100, DOI 10.1111/j.1572-0241.2005.41688.x; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; Westra WH, 2009, HEAD NECK PATHOL, V3, P78, DOI 10.1007/s12105-009-0100-y; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	10	29	29	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1484	1485		10.1001/jama.2011.446	http://dx.doi.org/10.1001/jama.2011.446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486982				2022-12-24	WOS:000289424100028
J	Bhabha, G; Lee, J; Ekiert, DC; Gam, J; Wilson, IA; Dyson, HJ; Benkovic, SJ; Wright, PE				Bhabha, Gira; Lee, Jeeyeon; Ekiert, Damian C.; Gam, Jongsik; Wilson, Ian A.; Dyson, H. Jane; Benkovic, Stephen J.; Wright, Peter E.			A Dynamic Knockout Reveals That Conformational Fluctuations Influence the Chemical Step of Enzyme Catalysis	SCIENCE			English	Article							COLI DIHYDROFOLATE-REDUCTASE; ESCHERICHIA-COLI; LOOP; MOTIONS; COMPLEXES; MECHANISM	Conformational dynamics play a key role in enzyme catalysis. Although protein motions have clear implications for ligand flux, a role for dynamics in the chemical step of enzyme catalysis has not been clearly established. We generated a mutant of Escherichia coli dihydrofolate reductase that abrogates millisecond-time-scale fluctuations in the enzyme active site without perturbing its structural and electrostatic preorganization. This dynamic knockout severely impairs hydride transfer. Thus, we have found a link between conformational fluctuations on the millisecond time scale and the chemical step of an enzymatic reaction, with broad implications for our understanding of enzyme mechanisms and for design of novel protein catalysts.	[Bhabha, Gira; Ekiert, Damian C.; Wilson, Ian A.; Dyson, H. Jane; Wright, Peter E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Bhabha, Gira; Ekiert, Damian C.; Wilson, Ian A.; Dyson, H. Jane; Wright, Peter E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Lee, Jeeyeon; Gam, Jongsik; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Scripps Research Institute; Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wright, PE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wright@scripps.edu	Dyson, Jane/D-4160-2011	Dyson, Jane/0000-0001-6855-3398; Ekiert, Damian/0000-0002-2570-0404; Wright, Peter/0000-0002-1368-0223	National Institutes of Health (NIH) [GM75995, GM080209]; Skaggs Institute of Chemical Biology; NIH National Institute of General Medical Sciences (NIGMS) [U54 GM094586]; Achievement Rewards for College Scientists Foundation; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075995, U54GM094586, T32GM080209] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute of Chemical Biology; NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)General Electric); Achievement Rewards for College Scientists Foundation(General Electric); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge L. Tuttle for invaluable discussions, S. Bae for NMR data on the S148A mutant, H. Tien and D. Marciano of the Robotics Core at the Joint Center for Structural Genomics (JCSG) for automated crystal screening, and X. Dai for technical assistance with crystallographic data collection. This work was supported by the National Institutes of Health (NIH) grant GM75995 and the Skaggs Institute of Chemical Biology. The JCSG is supported by NIH National Institute of General Medical Sciences (NIGMS) (U54 GM094586). D. C. E. is supported by a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation and grant GM080209 from the NIH Molecular Evolution Training Program. The GM/CA CAT 23-ID-D has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the Advanced Photon Source (APS) was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or NIH. Coordinates and structure factors of N23PP/S148A ecDHFR and 1RX2-re-refined are deposited in PDB (code 3QL0 and 3QL3). G. B. and P. E. W. designed the research. G. B. performed NMR experiments. G. B. and D. C. E. performed crystallography experiments and structure refinement. I. A. W. supervised structure refinement. J.L. and J.G. performed kinetic experiments and analysis. G. B., P. E. W., and S.J.B. analyzed and interpreted the data. G. B., P. E. W., and J.L. wrote the manuscript. I. A. W., H.J.D., and S.J.B. edited the manuscript.	Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Cameron CE, 1997, BIOCHEMISTRY-US, V36, P15792, DOI 10.1021/bi9716231; DAVIES JF, 1990, BIOCHEMISTRY-US, V29, P9467, DOI 10.1021/bi00492a021; Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Khavrutskii IV, 2007, PROTEIN SCI, V16, P1087, DOI 10.1110/ps.062724307; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Miller GP, 2001, BIOCHEMISTRY-US, V40, P867, DOI 10.1021/bi001608n; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Nagel ZD, 2009, NAT CHEM BIOL, V5, P543, DOI 10.1038/nchembio.204; Osborne MJ, 2003, PROTEIN SCI, V12, P2230, DOI 10.1110/ps.03219603; Osborne MJ, 2001, BIOCHEMISTRY-US, V40, P9846, DOI 10.1021/bi010621k; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pisliakov AV, 2009, P NATL ACAD SCI USA, V106, P17359, DOI 10.1073/pnas.0909150106; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821	26	345	345	3	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					234	238		10.1126/science.1198542	http://dx.doi.org/10.1126/science.1198542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474759	Green Accepted			2022-12-24	WOS:000289251100051
J	Colson, JW; Woll, AR; Mukherjee, A; Levendorf, MP; Spitler, EL; Shields, VB; Spencer, MG; Park, J; Dichtel, WR				Colson, John W.; Woll, Arthur R.; Mukherjee, Arnab; Levendorf, Mark P.; Spitler, Eric L.; Shields, Virgil B.; Spencer, Michael G.; Park, Jiwoong; Dichtel, William R.			Oriented 2D Covalent Organic Framework Thin Films on Single-Layer Graphene	SCIENCE			English	Article							LARGE-AREA; CRYSTALLINE	Covalent organic frameworks (COFs), in which molecular building blocks form robust microporous networks, are usually synthesized as insoluble and unprocessable powders. We have grown two-dimensional (2D) COF films on single-layer graphene (SLG) under operationally simple solvothermal conditions. The layered films stack normal to the SLG surface and show improved crystallinity compared with COF powders. We used SLG surfaces supported on copper, silicon carbide, and transparent fused silica (SiO2) substrates, enabling optical spectroscopy of COFs in transmission mode. Three chemically distinct COF films grown on SLG exhibit similar vertical alignment and long-range order, and two of these are of interest for organic electronic devices for which thin-film formation is a prerequisite for characterizing their optoelectronic properties.	[Colson, John W.; Mukherjee, Arnab; Levendorf, Mark P.; Spitler, Eric L.; Park, Jiwoong; Dichtel, William R.] Cornell Univ, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA; [Shields, Virgil B.; Spencer, Michael G.] Cornell Univ, Dept Elect Engn, Ithaca, NY 14853 USA; [Woll, Arthur R.] Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; [Park, Jiwoong] Cornell Univ, Kavli Inst Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Dichtel, WR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA.	wdichtel@cornell.edu	Park, Jiwoong/C-2327-2013; Spencer, Michael/AAV-5283-2020; Dichtel, William R/A-5503-2009	Spencer, Michael/0000-0003-0914-9218; Dichtel, William R/0000-0002-3635-6119; Woll, Arthur/0000-0001-8925-2199	Cornell University; NSF [CHE-0847926, CHE-0936988]; NIH/National Institute of General Medical Sciences under NSF [DMR-0936384]; NSF Materials Research Science and Engineering Centers [DMR-0520404]	Cornell University; NSF(National Science Foundation (NSF)); NIH/National Institute of General Medical Sciences under NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF Materials Research Science and Engineering Centers(National Science Foundation (NSF))	This research was supported by startup funds provided by Cornell University and the NSF-funded CCI-I Center for Molecular Interfacing (CHE-0847926). This work is based on research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the NSF and the NIH/National Institute of General Medical Sciences under NSF award DMR-0936384. We also made use of the Cornell Center for Materials Research facilities with support from the NSF Materials Research Science and Engineering Centers program (DMR-0520404). J.W.C. thanks the NSF for the award of a Graduate Research Fellowship; E. L. S. thanks the NSF for the award of the American Competitiveness in Chemistry postdoctoral fellowship (CHE-0936988); and M. G. S. (FA9550-07-1-0332) and J.P. (FA9550-09-1-0691) thank the Air Force Office of Scientific Research. We thank D. Smilgies for helpful discussions and K. Cox for technical illustration assistance. A provisional patent application based on this work has been filed by Cornell University (USA 61/382,093).	Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/NNANO.2010.132, 10.1038/nnano.2010.132]; Baker JL, 2010, LANGMUIR, V26, P9146, DOI 10.1021/la904840q; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Cote AP, 2007, J AM CHEM SOC, V129, P12914, DOI 10.1021/ja0751781; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Ding XS, 2011, ANGEW CHEM INT EDIT, V50, P1289, DOI 10.1002/anie.201005919; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/NMAT2382, 10.1038/nmat2382]; Gourdon A, 2008, ANGEW CHEM INT EDIT, V47, P6950, DOI 10.1002/anie.200802229; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Kumar A, 2010, ACS NANO, V4, P11, DOI 10.1021/nn901903b; Levendorf MP, 2009, NANO LETT, V9, P4479, DOI 10.1021/nl902790r; Li XS, 2009, NANO LETT, V9, P4359, DOI 10.1021/nl902623y; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Lukose B, 2011, CHEM-EUR J, V17, P2388, DOI 10.1002/chem.201001290; Mayer AC, 2007, MATER TODAY, V10, P28, DOI 10.1016/S1369-7021(07)70276-6; Perepichka DF, 2009, SCIENCE, V323, P216, DOI 10.1126/science.1165429; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Smilgies DM, 2007, J APPL CRYSTALLOGR, V40, P716, DOI 10.1107/S0021889807023382; Smilgies DM, 2009, J APPL CRYSTALLOGR, V42, P1030, DOI [10.1107/S0021889809040126, 10.1107/S00218898090401]; Spitler EL, 2010, NAT CHEM, V2, P672, DOI [10.1038/NCHEM.695, 10.1038/nchem.695]; Tilford RW, 2006, CHEM MATER, V18, P5296, DOI 10.1021/cm061177g; Veld MI, 2008, CHEM COMMUN, P1536, DOI 10.1039/b718865j; Wan S, 2008, ANGEW CHEM INT EDIT, V47, P8826, DOI 10.1002/anie.200803826; Wan S, 2009, ANGEW CHEM INT EDIT, V48, P5439, DOI 10.1002/anie.200900881; Zwaneveld NAA, 2008, J AM CHEM SOC, V130, P6678, DOI 10.1021/ja800906f	27	828	850	77	1927	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					228	231		10.1126/science.1202747	http://dx.doi.org/10.1126/science.1202747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474758				2022-12-24	WOS:000289251100049
J	Shen, WL; Kwon, Y; Adegbola, AA; Luo, JJ; Chess, A; Montell, C				Shen, Wei L.; Kwon, Young; Adegbola, Abidemi A.; Luo, Junjie; Chess, Andrew; Montell, Craig			Function of Rhodopsin in Temperature Discrimination in Drosophila	SCIENCE			English	Article							NUCLEOTIDE-GATED CHANNEL; PHOSPHOLIPASE-C; G-PROTEIN; THERMOSENSATION; PHOTOTRANSDUCTION; RECEPTOR	Many animals, including the fruit fly, are sensitive to small differences in ambient temperature. The ability of Drosophila larvae to choose their ideal temperature (18 degrees C) over other comfortable temperatures (19 degrees to 24 degrees C) depends on a thermosensory signaling pathway that includes a heterotrimeric guanine nucleotide-binding protein (G protein), a phospholipase C, and the transient receptor potential TRPA1 channel. We report that mutation of the gene (ninaE) encoding a classical G protein-coupled receptor (GPCR), Drosophila rhodopsin, eliminates thermotactic discrimination in the comfortable temperature range. This role for rhodopsin in thermotaxis toward 18 degrees C was light-independent. Introduction of mouse melanopsin restored normal thermotactic behavior in ninaE mutant larvae. We propose that rhodopsins represent a class of evolutionarily conserved GPCRs that are required for initiating thermosensory signaling cascades.	[Shen, Wei L.; Kwon, Young; Luo, Junjie; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Shen, Wei L.; Kwon, Young; Luo, Junjie; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Adegbola, Abidemi A.; Chess, Andrew] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Adegbola, Abidemi A.; Chess, Andrew] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA; [Chess, Andrew] Broad Inst, Cambridge, MA 02142 USA; [Chess, Andrew] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Chess, Andrew] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Montell, Craig/AAH-3357-2021; Luo, Junjie/L-3285-2019; shen, wei/C-2311-2013	Montell, Craig/0000-0001-5637-1482; Kwon, Young/0000-0002-8937-3182	National Institute of General Medical Sciences, NIH [GM085335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085335] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Liu for advice with the statistical analyses, the Bloomington Stock Center, FlyBase, and the Harvard TRiP. A. A. A. received support from a NARSAD Young Investigator Award. This study was supported by a grant to C. M. from the National Institute of General Medical Sciences, NIH (GM085335).	Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; Filip M, 2009, PHARMACOL REP, V61, P761, DOI 10.1016/S1734-1140(09)70132-X; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Kwon Y, 2010, J NEUROSCI, V30, P10465, DOI 10.1523/JNEUROSCI.1631-10.2010; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; STRANGE PH, 1961, J EXP BIOL, V38, P237; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081	21	148	153	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1333	1336		10.1126/science.1198904	http://dx.doi.org/10.1126/science.1198904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393546				2022-12-24	WOS:000288215200049
J	Schraidt, O; Marlovits, TC				Schraidt, Oliver; Marlovits, Thomas C.			Three-Dimensional Model of Salmonella's Needle Complex at Subnanometer Resolution	SCIENCE			English	Article							III SECRETION SYSTEM; TRANSMISSION ELECTRON-MICROSCOPY; PHAGE PIV MULTIMER; STRUCTURAL INSIGHTS; SHIGELLA-FLEXNERI; APPARATUS; ORGANIZATION; TYPHIMURIUM; COMPONENT; REVEALS	Type III secretion systems (T3SSs) are essential virulence factors used by many Gram-negative bacteria to inject proteins that make eukaryotic host cells accessible to invasion. The T3SS core structure, the needle complex (NC), is a similar to 3.5 megadalton-sized, oligomeric, membrane-embedded complex. Analyzing cryo-electron microscopy images of top views of NCs or NC substructures from Salmonella typhimurium revealed a 24-fold symmetry for the inner rings and a 15-fold symmetry for the outer rings, giving an overall C3 symmetry. Local refinement and averaging showed the organization of the central core and allowed us to reconstruct a subnanometer composite structure of the NC, which together with confident docking of atomic structures reveal insights into its overall organization and structural requirements during assembly.	[Schraidt, Oliver; Marlovits, Thomas C.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Schraidt, Oliver; Marlovits, Thomas C.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Marlovits, TC (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	marlovits@imp.ac.at	Marlovits, Thomas/A-3568-2019; Schraidt, Oliver/ABE-3650-2020	Marlovits, Thomas/0000-0001-8106-4038; Schraidt, Oliver/0000-0001-8114-3713	Boehringer Ingelheim Fonds; Zentrum fur Innovation und Technologie (ZIT); Center for Molecular and Cellular Nanostructure Vienna (CMCN)	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Zentrum fur Innovation und Technologie (ZIT); Center for Molecular and Cellular Nanostructure Vienna (CMCN)	We would like to thank G. Resch for collaborating on the development of a semi-automated image acquisition software, the Institute of Molecular Pathology/Institute of Molecular Biotechnology/Gregor Mendel Institute (IMP/IMBA/GMI) EM and bioinformatics facility for technical support, W. Weber for generating and analyzing the mutational analysis, and all members of the Marlovits laboratory for critically reading the manuscript. We furthermore would like to thank J. E. Galan (Yale University) and members of his laboratory for continuous discussion, generous support, and materials. This work was supported by a Ph.D. fellowship from Boehringer Ingelheim Fonds (to O.S.) and a research grant from the Zentrum fur Innovation und Technologie (ZIT), Center for Molecular and Cellular Nanostructure Vienna (CMCN) (to T.C.M.). Accession numbers are EMD-1871, EMD-1874, EMD-1875, and PDB ID code 2Y9K and 2Y9J.	Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galkin VE, 2010, J MOL BIOL, V396, P1392, DOI 10.1016/j.jmb.2010.01.001; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Linderoth NA, 1997, SCIENCE, V278, P1635, DOI 10.1126/science.278.5343.1635; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Sani M, 2007, MICRON, V38, P291, DOI 10.1016/j.micron.2006.04.007; Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554	24	162	164	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1192	1195		10.1126/science.1199358	http://dx.doi.org/10.1126/science.1199358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385715				2022-12-24	WOS:000287971200042
J	Seshasai, SRK; Kaptoge, S; Thompson, A; Di Angelantonio, E; Gao, P; Sarwar, N; Whincup, PH; Mukamal, KJ; Gillum, RF; Holme, I; Njolstad, I; Fletcher, A; Nilsson, P; Lewington, S; Collins, R; Gudnason, V; Thompson, SG; Sattar, N; Selvin, E; Hu, FB; Danesh, J				Seshasai, Sreenivasa Rao Kondapally; Kaptoge, Stephen; Thompson, Alexander; Di Angelantonio, Emanuele; Gao, Pei; Sarwar, Nadeem; Whincup, Peter H.; Mukamal, Kenneth J.; Gillum, Richard F.; Holme, Ingar; Njolstad, Inger; Fletcher, Astrid; Nilsson, Peter; Lewington, Sarah; Collins, Rory; Gudnason, Vilmundur; Thompson, Simon G.; Sattar, Naveed; Selvin, Elizabeth; Hu, Frank B.; Danesh, John		Emerging Risk Factors Collabora	Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CANCER-MORTALITY; ASSOCIATION; METAANALYSIS; INSULIN	BACKGROUND The extent to which diabetes mellitus or hyperglycemia is related to risk of death from cancer or other nonvascular conditions is uncertain. METHODS We calculated hazard ratios for cause-specific death, according to baseline diabetes status or fasting glucose level, from individual-participant data on 123,205 deaths among 820,900 people in 97 prospective studies. RESULTS After adjustment for age, sex, smoking status, and body-mass index, hazard ratios among persons with diabetes as compared with persons without diabetes were as follows: 1.80 (95% confidence interval [CI], 1.71 to 1.90) for death from any cause, 1.25 (95% CI, 1.19 to 1.31) for death from cancer, 2.32 (95% CI, 2.11 to 2.56) for death from vascular causes, and 1.73 (95% CI, 1.62 to 1.85) for death from other causes. Diabetes (vs. no diabetes) was moderately associated with death from cancers of the liver, pancreas, ovary, colorectum, lung, bladder, and breast. Aside from cancer and vascular disease, diabetes (vs. no diabetes) was also associated with death from renal disease, liver disease, pneumonia and other infectious diseases, mental disorders, nonhepatic digestive diseases, external causes, intentional self-harm, nervous-system disorders, and chronic obstructive pulmonary disease. Hazard ratios were appreciably reduced after further adjustment for glycemia measures, but not after adjustment for systolic blood pressure, lipid levels, inflammation or renal markers. Fasting glucose levels exceeding 100 mg per deciliter (5.6 mmol per liter), but not levels of 70 to 100 mg per deciliter (3.9 to 5.6 mmol per liter), were associated with death. A 50-year-old with diabetes died, on average, 6 years earlier than a counterpart without diabetes, with about 40% of the difference in survival attributable to excess nonvascular deaths. CONCLUSIONS In addition to vascular disease, diabetes is associated with substantial premature death from several cancers, infectious diseases, external causes, intentional self-harm, and degenerative disorders, independent of several major risk factors. (Funded by the British Heart Foundation and others.)	[Whincup, Peter H.] St Georges Univ London, London, England; [Gillum, Richard F.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Holme, Ingar] Ullevaal Univ Hosp, Oslo, Norway; [Njolstad, Inger] Univ Tromso, Tromso, Norway; [Fletcher, Astrid] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Nilsson, Peter] Lund Univ, Lund, Sweden; [Lewington, Sarah; Collins, Rory] Univ Oxford, F Med Sci, Oxford, England; [Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Gudnason, Vilmundur] Iceland Heart Assoc, Reykjavik, Iceland; [Thompson, Simon G.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Sattar, Naveed] Univ Glasgow, Glasgow, Lanark, Scotland; [Selvin, Elizabeth] Johns Hopkins Univ, Baltimore, MD USA; [Hu, Frank B.] Harvard Univ, Boston, MA 02115 USA	St Georges University London; Centers for Disease Control & Prevention - USA; University of Oslo; UiT The Arctic University of Tromso; University of London; London School of Hygiene & Tropical Medicine; Lund University; University of Oxford; University of Iceland; Icelandic Heart Association; MRC Biostatistics Unit; University of Glasgow; Johns Hopkins University; Harvard University			Njolstad, Inger/X-3784-2019; Shaffer, Jonathan A/B-2783-2013; Gao, Pei/R-4794-2018; de la Camara, Agustin Gomez/S-7123-2018; Ulmer, Hanno/S-6615-2019; Rubio, Miguel Angel/GRJ-0134-2022; Mukamal, Kenneth/GVR-7978-2022; Benn, Marianne/O-4164-2019; Lennon, Lucy/ABB-9433-2020; Gudnason, Vilmundur/AAE-7126-2019; Dankner, Rachel/Q-5245-2019; Gudnason, Vilmundur/K-6885-2015; Bakker, Stephan J. L./J-4023-2015; Tanne, David/F-2560-2010; DiAngelantonio, Emanuele/ABE-6852-2020; Brunner, Eric/H-2114-2011; Marmot, M G/Y-3920-2019; vhmpp, aks/F-9756-2012; Gao, Pei/AAF-3065-2019; Meisinger, Christine/B-5358-2014; Stefanadis, Christodoulos/ABH-2232-2020	Gao, Pei/0000-0001-8649-1290; Ulmer, Hanno/0000-0001-5911-1002; Rubio, Miguel Angel/0000-0002-0495-6240; Benn, Marianne/0000-0002-1701-595X; Lennon, Lucy/0000-0002-1738-1351; Gudnason, Vilmundur/0000-0001-5696-0084; Dankner, Rachel/0000-0001-6454-6000; Gudnason, Vilmundur/0000-0001-5696-0084; Bakker, Stephan J. L./0000-0003-3356-6791; Tanne, David/0000-0002-6699-2220; Brunner, Eric/0000-0002-0595-4474; Marmot, M G/0000-0002-2431-6419; Gao, Pei/0000-0001-8649-1290; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Ramachandran, Vasan/0000-0001-7357-5970; Nordestgaard, Borge/0000-0002-1954-7220; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Engstrom, Gunnar/0000-0002-8618-9152; Whincup, Peter/0000-0002-5589-4107; Lawlor, Debbie A/0000-0002-6793-2262; Stefanadis, Christodoulos/0000-0001-5974-6454; Pennells, Lisa Anne/0000-0002-8594-3061; Rothenbacher, Dietrich/0000-0002-3563-2791; Stehouwer, Coen/0000-0001-8752-3223; Amouyel, Philippe/0000-0001-9088-234X; Di Angelantonio, Emanuele/0000-0001-8776-6719; Tiemeier, Henning/0000-0002-4395-1397; Lewington, Sarah/0000-0002-4496-4771; Woodward, Mark/0000-0001-9800-5296; Jorgensen, Torben/0000-0001-9453-2830; Jespersen, Jorgen/0000-0002-3059-2356; Bladbjerg, Else Marie/0000-0003-0912-2437	British Heart Foundation [RG/08/014]; U.K. Medical Research Council; Pfizer; Gates Cambridge Trust; Overseas Research Studentship Award; Addenbrooke's Charitable Trust; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [MC_U105260792, G0600705, G0902037] Funding Source: UKRI; British Heart Foundation [PG/09/002/26056, RG/08/014/24067, RG/07/008/23674, RG/08/013/25942] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [MC_U137686857, G0902037, MC_U105260792, G0100222, G19/35, G0401527, G1000143, G0600705, G8802774] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL085083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023629] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); Gates Cambridge Trust; Overseas Research Studentship Award; Addenbrooke's Charitable Trust; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the British Heart Foundation (RG/08/014), the U.K. Medical Research Council, and Pfizer (to the ERFC Coordinating Centre), as well as the Gates Cambridge Trust Scholarship, an Overseas Research Studentship Award, and an Addenbrooke's Charitable Trust Clinical Research Fellowship (to Dr. Kondapally Seshasai). Various sources have supported recruitment, follow-up, and laboratory measurements in the cohorts contributing to the ERFC. Investigators of several of these studies have contributed to a list (http://ceu.phpc.cam.ac.uk/research/erfc/studies) naming relevant funding sources.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Batty GD, 2004, CANCER CAUSE CONTROL, V15, P873, DOI 10.1007/s10552-004-1050-z; Chen SL, 2009, J UROLOGY, V182, pS51, DOI 10.1016/j.juro.2009.07.090; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dormandy J, 2009, DRUG SAFETY, V32, P187, DOI 10.2165/00002018-200932030-00002; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Emerging Risk Factors Collaboration, 2007, EUR J EPIDEMIOL, V22, P839, DOI DOI 10.1007/SL0654-007-9165-7; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gulliford MC, 2009, AM J EPIDEMIOL, V169, P455, DOI 10.1093/aje/kwn342; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Jawa A, 2004, MED CLIN N AM, V88, P1001, DOI 10.1016/j.mcna.2004.04.012; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Pannala R, 2009, AM J GASTROENTEROL, V104, P2318, DOI 10.1038/ajg.2009.253; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; UN Population Division, 2005, WORLD POP PROSP; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Waters KM, 2009, AM J EPIDEMIOL, V169, P937, DOI 10.1093/aje/kwp003; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; World Health Organization, 2007, WHO STAT INF SYST WH; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7	37	1756	1813	8	224	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					829	841		10.1056/NEJMoa1008862	http://dx.doi.org/10.1056/NEJMoa1008862			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366474	Bronze, Green Accepted			2022-12-24	WOS:000287928400008
J	Ioannou, GN				Ioannou, George N.			Hepatitis B Virus in the United States: Infection, Exposure, and Immunity Rates in a Nationally Representative Survey	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM IMMUNOGENICITY; VACCINATION; PREVENTION; DISEASES; BOOSTER; HEALTH	Background: Up-to-date estimates of the prevalence of hepatitis B virus (HBV) infection, exposure, and immunity are necessary to assess the effectiveness of ongoing programs aimed at preventing HBV transmission. Objective: To determine the prevalence and associations of chronic HBV infection, past exposure, and immunity in the United States from 1999 to 2008. Design: Nationally representative, cross-sectional household survey. Setting: U.S. civilian, noninstitutionalized population. Participants: 39 787 participants in the National Health and Nutrition Examination Survey (1999 to 2008) aged 2 years or older. Measurements: Chronic HBV infection was defined by presence of serum HBV surface antigen and past exposure by serum antibody to hepatitis B core antigen among persons aged 6 years or older. Infant immunity was defined by presence of serum antibody to hepatitis B surface antigen among children aged 2 years. Results: Among persons aged 6 years or older, 0.27% (95% CI, 0.20% to 0.34%) had chronic HBV infection (corresponding to approximately 704 000 persons nationwide), and 4.6% (CI, 4.1% to 5.0%) had been exposed to HBV (approximately 11 993 000 persons). These estimates are lower (P < 0.001) than estimates of HBV infection (0.42%) and exposure (5.1%) in the United States reported from 1988 to 1994. Infection and past exposure were very uncommon among persons aged 6 to 19 years. Children aged 2 years have high rates of immunity (68.6% [CI, 64.1% to 73.2%]). Adults, including those at high risk for infection, have much lower rates of immunity. Limitations: Incarcerated and homeless persons were not sampled. Categorization of race or ethnicity did not identify high-risk groups, such as persons of Asian and Pacific Islander descent. Conclusion: A cohort of children and adolescents is growing up in the United States with high rates of immunity against HBV and very low rates of infection. Vaccination of high-risk adults should continue to be emphasized.	[Ioannou, George N.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Ioannou, George N.] Univ Washington, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Ioannou, GN (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, S-111 Gastro,1660 S Columbian Way, Seattle, WA 98108 USA.	georgei@medicine.washington.edu			Veterans Affairs Research Enhancement Award Program	Veterans Affairs Research Enhancement Award Program	Grant Support: By the Veterans Affairs Research Enhancement Award Program.	Alter MJ, 2003, SEMIN LIVER DIS, V23, P39, DOI 10.1055/s-2003-37583; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; Bauer T, 2006, VACCINE, V24, P572, DOI 10.1016/j.vaccine.2005.08.058; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; *CDCP, 1995, MMWR-MORBID MORTAL W, V44, P574; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P997; Cheung RC, 2002, J CLIN GASTROENTEROL, V34, P476, DOI 10.1097/00004836-200204000-00021; Dorell C., 2010, Morbidity and Mortality Weekly Report, V59, P1018; Gabbuti A, 2007, VACCINE, V25, P3129, DOI 10.1016/j.vaccine.2007.01.045; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goldstein ST, 2002, J INFECT DIS, V185, P713, DOI 10.1086/339192; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hall AJ, 2010, HEPATOLOGY, V51, P1485, DOI 10.1002/hep.23674; Ioannou GN, 2007, CLIN GASTROENTEROL H, V5, P938, DOI 10.1016/j.cgh.2007.02.039; Kao JH, 2005, LANCET, V366, P1337, DOI 10.1016/S0140-6736(05)67544-7; Kaplan JE, 2009, MMWR RECOMM REP, V58, pCE1; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Lin YC, 2003, J INFECT DIS, V187, P134, DOI 10.1086/345871; Lu CY, 2008, J INFECT DIS, V197, P1419, DOI 10.1086/587695; McMahon BJ, 2005, ANN INTERN MED, V142, P333, DOI 10.7326/0003-4819-142-5-200503010-00008; McQuillan GM, 1999, AM J PUBLIC HEALTH, V89, P14, DOI 10.2105/AJPH.89.1.14; Molinari N. A., 2009, Morbidity and Mortality Weekly Report, V58, P921; *NHANES, LAB PROC MAN ANT HEP; Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053/j.gastro.2003.10.048; The National Health and Nutrition Examination Survey (NHANES), AN REP GUID; Urbani S, 2010, CLIN CHEM LAB MED, V48, P23, DOI 10.1515/CCLM.2010.002; US Census Bureau, US CENS 2000; Van Damme P, 2009, J MED VIROL, V81, P1710, DOI 10.1002/jmv.21568; Van Damme Pierre, 2007, Travel Med Infect Dis, V5, P79, DOI 10.1016/j.tmaid.2006.04.004; Wooten K. G., 2010, Morbidity and Mortality Weekly Report, V59, P1171; Zanetti AR, 2005, LANCET, V366, P1379, DOI 10.1016/S0140-6736(05)67568-X	32	122	124	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5					319	328		10.7326/0003-4819-154-5-201103010-00006	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21357909				2022-12-24	WOS:000287799900004
J	Sliwa, K; Stewart, S				Sliwa, Karen; Stewart, Simon			A low-cost solar-powered blood-pressure device	LANCET			English	Editorial Material							DISEASES CHRONIC DISEASES; HEART-DISEASE; SOWETO; HYPERTENSION; INSIGHTS		[Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Inst Cardiovasc Res Africa, ZA-7935 Cape Town, Western Cape, South Africa; [Stewart, Simon] Baker IDI, Melbourne, Vic, Australia	University of Cape Town; Baker Heart and Diabetes Institute	Sliwa, K (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Inst Cardiovasc Res Africa, ZA-7935 Cape Town, Western Cape, South Africa.	sliwa-hahnlek@mdh-africa.org	Stewart, Simon/M-3316-2016	Stewart, Simon/0000-0001-9032-8998; Sliwa, Karen/0000-0002-8272-0911				Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Lock K, 2010, LANCET, V376, P1699, DOI 10.1016/S0140-6736(10)61352-9; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mendis S, 2004, J HYPERTENS, V22, P59, DOI 10.1097/00004872-200401000-00013; Parati G, 2010, HYPERTENSION, V56, P1047, DOI 10.1161/HYPERTENSIONAHA.110.160408; Sliwa K, 2010, EUR HEART J, V31, P719, DOI 10.1093/eurheartj/ehp530; Stewart S, 2011, EUR HEART J, V32, P492, DOI 10.1093/eurheartj/ehq439; Stewart S, 2011, INT J CARDIOL, V146, P22, DOI 10.1016/j.ijcard.2009.05.061; Stewart S, 2009, NAT REV CARDIOL, V6, P489, DOI 10.1038/nrcardio.2009.79	9	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					647	648		10.1016/S0140-6736(11)60131-1	http://dx.doi.org/10.1016/S0140-6736(11)60131-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815EW	21513974				2022-12-24	WOS:000294509900008
J	Benowitz, NL; Samet, JM				Benowitz, Neal L.; Samet, Jonathan M.			The Threat of Menthol Cigarettes to U.S. Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Benowitz, Neal L.] San Francisco Gen Hosp, Med Ctr, Med Serv, Div Clin Pharmacol & Expt Therapeut, San Francisco, CA 94110 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Therapeut Sci, San Francisco, CA 94143 USA; [Samet, Jonathan M.] USC, Dept Prevent Med, Keck Sch Med, Los Angeles, CA USA; [Samet, Jonathan M.] Univ So Calif, USC Inst Global Hlth, Los Angeles, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; University of Southern California Keck Hospital; University of Southern California	Benowitz, NL (corresponding author), San Francisco Gen Hosp, Med Ctr, Med Serv, Div Clin Pharmacol & Expt Therapeut, San Francisco, CA 94110 USA.							Tobacco Products Scientific Advisory Committee (TPSAC), 2011, MENTH CIG PUBL HLTH; US Dep Health Educ Welfare (DHEW), 1964, DHEW PUBL	2	26	27	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2179	2181		10.1056/NEJMp1103610	http://dx.doi.org/10.1056/NEJMp1103610			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774NA	21542737				2022-12-24	WOS:000291392100002
J	Williams, K; Christensen, J; Pedersen, MT; Johansen, JV; Cloos, PAC; Rappsilber, J; Helin, K				Williams, Kristine; Christensen, Jesper; Pedersen, Marianne Terndrup; Johansen, Jens V.; Cloos, Paul A. C.; Rappsilber, Juri; Helin, Kristian			TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity	NATURE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; WIDE; PLURIPOTENT; CONVERSION; COMPLEX; GENES; MAPS	Enzymes catalysing the methylation of the 5-position of cytosine (mC) have essential roles in regulating gene expression and maintaining cellular identity. Recently, TET1 was found to hydroxylate the methyl group of mC, converting it to 5-hydroxymethyl cytosine (hmC). Here we show that TET1 binds throughout the genome of embryonic stem cells, with the majority of binding sites located at transcription start sites (TSSs) of CpG-rich promoters and within genes. The hmC modification is found in gene bodies and in contrast to mC is also enriched at CpG-rich TSSs. We provide evidence further that TET1 has a role in transcriptional repression. TET1 binds a significant proportion of Polycomb group target genes. Furthermore, TET1 associates and colocalizes with the SIN3A co-repressor complex. We propose that TET1 fine-tunes transcription, opposes aberrant DNA methylation at CpG-rich sequences and thereby contributes to the regulation of DNA methylation fidelity.	[Williams, Kristine; Christensen, Jesper; Pedersen, Marianne Terndrup; Johansen, Jens V.; Cloos, Paul A. C.; Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Williams, Kristine; Christensen, Jesper; Pedersen, Marianne Terndrup; Cloos, Paul A. C.; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Johansen, Jens V.] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Edinburgh	Helin, K (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	kristian.helin@bric.ku.dk	Rappsilber, Juri/ABF-3328-2020; Williams, Kristine/AAA-5662-2022; Rappsilber, Juri/B-7265-2015; Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Williams, Kristine/0000-0002-1198-6552; Rappsilber, Juri/0000-0001-5999-1310; Helin, Kristian/0000-0003-1975-6097; Vilstrup Johansen, Jens/0000-0001-7094-6801; Cloos, Paul/0000-0001-5863-0054; Pedersen, Marianne Terndrup/0000-0003-3808-0352	Danish Cancer Society; University of Copenhagen; Danish National Research Foundation; Lundbeck foundation; Novo Nordisk Foundation; Danish Medical Research Council	Danish Cancer Society(Danish Cancer Society); University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank U. Toftegaard for excellent technical help, M. Okano for the donation of TKO ES cells, and members of the Helin lab for discussions. M.T.P. was supported by a fellowship from the Danish Cancer Society. J.R. is a senior research fellow of the Wellcome Trust. The work in the Helin lab was supported by grants from the Excellence Program of the University of Copenhagen, the Danish National Research Foundation, the Danish Cancer Society, the Lundbeck foundation, the Novo Nordisk Foundation, and the Danish Medical Research Council.	Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; ERLANGER BF, 1964, P NATL ACAD SCI USA, V52, P68, DOI 10.1073/pnas.52.1.68; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohamedali AM, 2009, J CLIN ONCOL, V27, P4002, DOI 10.1200/JCO.2009.22.6985; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	29	760	798	1	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					343	U472		10.1038/nature10066	http://dx.doi.org/10.1038/nature10066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21490601	Green Accepted			2022-12-24	WOS:000290722400041
J	Badouel, C; McNeill, H				Badouel, Caroline; McNeill, Helen			SnapShot: The Hippo Signaling Pathway	CELL			English	Editorial Material							SIZE CONTROL		[Badouel, Caroline; McNeill, Helen] Univ Toronto, Samuel Lunenfeld Res Inst, Dept Mol Genet, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Badouel, C (corresponding author), Univ Toronto, Samuel Lunenfeld Res Inst, Dept Mol Genet, Mt Sinai Hosp, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		McNeill, Helen/E-4579-2013	McNeill, Helen/0000-0003-1126-5154				Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	6	71	75	3	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					484	U162	484.e1	10.1016/j.cell.2011.04.009	http://dx.doi.org/10.1016/j.cell.2011.04.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529719	Bronze			2022-12-24	WOS:000290022900017
J	Grove, TL; Benner, JS; Radle, MI; Ahlum, JH; Landgraf, BJ; Krebs, C; Booker, SJ				Grove, Tyler L.; Benner, Jack S.; Radle, Matthew I.; Ahlum, Jessica H.; Landgraf, Bradley J.; Krebs, Carsten; Booker, Squire J.			A Radically Different Mechanism for S-Adenosylmethionine-Dependent Methyltransferases	SCIENCE			English	Article							RIBOSOMAL-RNA METHYLTRANSFERASE; CONFERS ANTIBIOTIC-RESISTANCE; CATECHOL O-METHYLTRANSFERASE; BACTERIAL RIBOSOME; BIOTIN SYNTHASE; SAM; CFR; RESOLUTION; GENE; COLI	Methylation of small molecules and macromolecules is crucial in metabolism, cell signaling, and epigenetic programming and is most often achieved by S-adenosylmethionine (SAM)-dependent methyltransferases. Most employ an S(N)2 mechanism to methylate nucleophilic sites on their substrates, but recently, radical SAM enzymes have been identified that methylate carbon atoms that are not inherently nucleophilic via the intermediacy of a 5'-deoxyadenosyl 5'-radical. We have determined the mechanisms of two such reactions targeting the sp(2)-hybridized carbons at positions 2 and 8 of adenosine 2503 in 23S ribosomal RNA, catalyzed by RlmN and Cfr, respectively. In neither case is a methyl group transferred directly from SAM to the RNA; rather, both reactions proceed by a ping-pong mechanism involving intermediate methylation of a conserved cysteine residue.	[Grove, Tyler L.; Radle, Matthew I.; Ahlum, Jessica H.; Landgraf, Bradley J.; Krebs, Carsten; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Benner, Jack S.] New England Biolabs Inc, Div Chem Biol, Ipswich, MA 01938 USA; [Krebs, Carsten; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; New England Biolabs; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	squire@psu.edu	Squire, Jeremy A/A-9352-2012; Krebs, Carsten/D-4773-2009	Squire, Jeremy A/0000-0002-9863-468X; Krebs, Carsten/0000-0002-3302-7053	NIH [GM-63847]; American Chemical Society [46065-AC4]; Dreyfus Foundation; Beckman Foundation; New England Biolabs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063847, R01GM101957] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Chemical Society(American Chemical Society); Dreyfus Foundation; Beckman Foundation; New England Biolabs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Martin Bollinger Jr. for a critical reading of the manuscript and helpful discussions, L. Saleh for assistance, H. Noller and L. Lancaster for plasmid pKK3535, S. Tan for E. coli strain B834(DE3)pLysS, and P. Bevilacqua for a plasmid-encoding hexahistidine-tagged T7 RNA polymerase and his research group for sharing their expertise in RNA manipulation. This work was supported by NIH grant GM-63847 and American Chemical Society-Petroleum Research Fund grant 46065-AC4 (S. J. B.), the Dreyfus Foundation (Teacher Scholar Award to C. K.), the Beckman Foundation (Young Investigator Award to C. K.), and New England Biolabs (J.S.B).	Atta M, 2010, CURR OPIN STRUC BIOL, V20, P684, DOI 10.1016/j.sbi.2010.09.009; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Booth MPS, 2010, PROTEIN EXPRES PURIF, V74, P204, DOI 10.1016/j.pep.2010.07.010; Chow CS, 2007, ACS CHEM BIOL, V2, P610, DOI 10.1021/cb7001494; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Frey P. A., 2007, ENZYMATIC REACTION M; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2010, BIOCHEMISTRY-US, V49, P3783, DOI 10.1021/bi9022126; Guianvarc'h D, 1997, BIOCHEM BIOPH RES CO, V236, P402, DOI 10.1006/bbrc.1997.6952; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HEGAZI MF, 1979, J AM CHEM SOC, V101, P4359, DOI 10.1021/ja00509a052; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; KOWALAK JA, 1995, J BIOL CHEM, V270, P17758, DOI 10.1074/jbc.270.30.17758; Kudo F, 2007, J ANTIBIOT, V60, P492, DOI 10.1038/ja.2007.63; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Seto H, 1999, NAT PROD REP, V16, P589, DOI 10.1039/a809398i; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Steitz TA, 2010, ANGEW CHEM INT EDIT, V49, P4381, DOI 10.1002/anie.201000708; Taylor AM, 2008, BIOCHEMISTRY-US, V47, P9309, DOI 10.1021/bi801035b; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; van der Donk WA, 2006, J ORG CHEM, V71, P9561, DOI 10.1021/jo0614240; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; WOODARD RW, 1980, J BIOL CHEM, V255, P9124; WU WM, 1995, BIOCHEMISTRY-US, V34, P10532, DOI 10.1021/bi00033a027; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y	38	165	172	4	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					604	607		10.1126/science.1200877	http://dx.doi.org/10.1126/science.1200877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21415317				2022-12-24	WOS:000289991100053
J	Jain, R; Kralovic, SM; Evans, ME; Ambrose, M; Simbartl, LA; Obrosky, DS; Render, ML; Freyberg, RW; Jernigan, JA; Muder, RR; Miller, LJ; Roselle, GA				Jain, Rajiv; Kralovic, Stephen M.; Evans, Martin E.; Ambrose, Meredith; Simbartl, Loretta A.; Obrosky, D. Scott; Render, Marta L.; Freyberg, Ron W.; Jernigan, John A.; Muder, Robert R.; Miller, LaToya J.; Roselle, Gary A.			Veterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus aureus Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTIONS; NOSOCOMIAL TRANSMISSION; COLONIZATION PRESSURE; HOSPITAL ADMISSION; MRSA; SURVEILLANCE; RISK; PRECAUTIONS; PREVALENCE	BACKGROUND Health care-associated infections with methicillin-resistant Staphylococcus aureus (MRSA) have been an increasing concern in Veterans Affairs (VA) hospitals. METHODS A "MRSA bundle" was implemented in 2007 in acute care VA hospitals nationwide in an effort to decrease health care-associated infections with MRSA. The bundle consisted of universal nasal surveillance for MRSA, contact precautions for patients colonized or infected with MRSA, hand hygiene, and a change in the institutional culture whereby infection control would become the responsibility of everyone who had contact with patients. Each month, personnel at each facility entered into a central database aggregate data on adherence to surveillance practice, the prevalence of MRSA colonization or infection, and health care-associated transmissions of and infections with MRSA. We assessed the effect of the MRSA bundle on health care-associated MRSA infections. RESULTS From October 2007, when the bundle was fully implemented, through June 2010, there were 1,934,598 admissions to or transfers or discharges from intensive care units (ICUs) and non-ICUs (ICUs, 365,139; non-ICUs, 1,569,459) and 8,318,675 patient-days (ICUs, 1,312,840; and non-ICUs, 7,005,835). During this period, the percentage of patients who were screened at admission increased from 82% to 96%, and the percentage who were screened at transfer or discharge increased from 72% to 93%. The mean (+/- SD) prevalence of MRSA colonization or infection at the time of hospital admission was 13.6 +/- 3.7%. The rates of health care-associated MRSA infections in ICUs had not changed in the 2 years before October 2007 (P = 0.50 for trend) but declined with implementation of the bundle, from 1.64 infections per 1000 patient-days in October 2007 to 0.62 per 1000 patient-days in June 2010, a decrease of 62% (P<0.001 for trend). During this same period, the rates of health care-associated MRSA infections in non-ICUs fell from 0.47 per 1000 patient-days to 0.26 per 1000 patient-days, a decrease of 45% (P<0.001 for trend). CONCLUSIONS A program of universal surveillance, contact precautions, hand hygiene, and institutional culture change was associated with a decrease in health care-associated transmissions of and infections with MRSA in a large health care system.	[Jain, Rajiv; Evans, Martin E.; Ambrose, Meredith; Miller, LaToya J.] Vet Affairs Cent Off, Patient Care Serv, Vet Hlth Adm MRSA Program Off, Pittsburgh, PA USA; [Jain, Rajiv; Evans, Martin E.; Ambrose, Meredith; Miller, LaToya J.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Jain, Rajiv; Muder, Robert R.] VA Pittsburgh Healthcare Syst, Dept Internal Med, Pittsburgh, PA USA; [Jain, Rajiv; Muder, Robert R.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Obrosky, D. Scott] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA; [Kralovic, Stephen M.; Simbartl, Loretta A.; Roselle, Gary A.] VA Cent Off, Patient Care Serv, Natl Infect Dis Program Off, Cincinnati, OH USA; [Kralovic, Stephen M.; Simbartl, Loretta A.; Roselle, Gary A.] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Kralovic, Stephen M.; Render, Marta L.; Roselle, Gary A.] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH USA; [Render, Marta L.; Freyberg, Ron W.] VA Inpatient Evaluat Ctr, Cincinnati, OH USA; [Evans, Martin E.] Univ Kentucky, Sch Med, Dept Internal Med, Lexington, KY 40506 USA; [Jernigan, John A.] Ctr Dis Control & Prevent, Prevent & Response Branch, Div Healthcare Qual Promot, Atlanta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; University of Kentucky; Centers for Disease Control & Prevention - USA	Evans, ME (corresponding author), Lexington VAMC, VHA MDRO Program, 1101 Vet Dr,11I-CDD, Lexington, KY 40502 USA.	martin.evans@va.gov		Jernigan, John/0000-0001-8163-925X				[Anonymous], 2009, VHA HDB; [Anonymous], ID HEALTHC ASS INF H; Boyce JM, 2004, INFECT CONT HOSP EP, V25, P395, DOI 10.1086/502412; Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; Chang S, 2009, CLIN INFECT DIS, V48, P1423, DOI 10.1086/598505; Chowers MY, 2009, INFECT CONT HOSP EP, V30, P778, DOI 10.1086/599019; Clancy M, 2006, INFECT CONT HOSP EP, V27, P1009, DOI 10.1086/507915; Croft CA, 2009, AM SURGEON, V75, P458; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Harbarth S, 2000, J HOSP INFECT, V46, P43, DOI 10.1053/jhin.2000.0798; Hidron AI, 2009, INFECT CONT HOSP EP, V30, DOI 10.1086/595954; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lee BY, 2010, INFECT CONT HOSP EP, V31, P598, DOI 10.1086/652524; Lucet JC, 2003, ARCH INTERN MED, V163, P181, DOI 10.1001/archinte.163.2.181; Lucet JC, 2005, INTENS CARE MED, V31, P1051, DOI 10.1007/s00134-005-2679-0; Merrer J, 2000, INFECT CONT HOSP EP, V21, P718, DOI 10.1086/501721; Muder RR, 2008, INFECT CONT HOSP EP, V29, P702, DOI 10.1086/589981; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Nyman JA, 2011, AM J INFECT CONTROL, V39, P27, DOI 10.1016/j.ajic.2010.09.006; Pan A, 2005, INFECT CONT HOSP EP, V26, P127, DOI 10.1086/502515; Pujol M, 1996, AM J MED, V100, P509, DOI 10.1016/S0002-9343(96)00014-9; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Robicsek A, 2009, INFECT CONT HOSP EP, V30, P623, DOI 10.1086/597550; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Vos MC, 2009, INFECT CONT HOSP EP, V30, P977, DOI 10.1086/605921; Williams VR, 2009, AM J INFECT CONTROL, V37, P106, DOI 10.1016/j.ajic.2008.05.007; Wolk DM, 2009, J CLIN MICROBIOL, V47, P758, DOI 10.1128/JCM.01714-08; World Health Organization, 2009, WHO GUID HAND HYG HL	34	377	400	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1419	1430		10.1056/NEJMoa1007474	http://dx.doi.org/10.1056/NEJMoa1007474			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21488764				2022-12-24	WOS:000289467200006
J	Kim, KY; Levin, DE				Kim, Ki-Young; Levin, David E.			Mpk1 MAPK Association with the Paf1 Complex Blocks Sen1-Mediated Premature Transcription Termination	CELL			English	Article							RNA-POLYMERASE-II; ACTIVATED PROTEIN-KINASE; CELL-CYCLE REGULATOR; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; NONCATALYTIC MECHANISM; HISTONE METHYLATION; ELONGATION-FACTORS; 3'-END FORMATION; BINDING PROTEIN	The Mpk1 MAPK of the yeast cell wall integrity pathway uses a noncatalytic mechanism to activate transcription of stress-induced genes by recruitment of initiation factors to target promoters. We show here that Mpk1 additionally serves a function in transcription elongation that is also independent of its catalytic activity. This function is mediated by an interaction between Mpk1 and the Paf1 subunit of the Paf1C elongation complex. A mutation in Paf1 that blocks this interaction causes a specific defect in transcription elongation of an Mpk1-induced gene, which results from Sen1-dependent premature termination through a Nab3-binding site within the promoter-proximal region of the gene. Our findings reveal a regulatory mechanism in which Mpk1 overcomes transcriptional attenuation by blocking recruitment of the Sen1-Nrd1-Nab3 termination complex to the elongating polymerase. Finally, we demonstrate that this mechanism is conserved in an interaction between the human ERK5 MAPK and human Paf1.	[Kim, Ki-Young; Levin, David E.] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Levin, David E.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Boston University; Boston University	Levin, DE (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA.	delevin@bu.edu	Kim, Ki-Young/AAK-7142-2020	Levin, David/0000-0003-0696-2860	NIH [GM48533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102136, R01GM048533] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Judith Jaehning for comments on the manuscript; Steve Buratowski for helpful discussions; David Brow for the ACT1-CUP1 reporter system; Michael Culbertson for the sen1-1 mutant; Peter Piper for two-hybrid fusions; Elizabeth Yranski for assistance with strain construction; and two anonymous reviewers for insightful comments. This work was supported by a grant from the NIH (GM48533) to D.E.L.	Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; ANDREWS BJ, 1992, P NATL ACAD SCI USA, V89, P11852, DOI 10.1073/pnas.89.24.11852; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Baetz K, 2001, MOL CELL BIOL, V21, P6515, DOI 10.1128/MCB.21.19.6515-6528.2001; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Costa PJ, 2000, GENETICS, V156, P535; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; DICOMO CJ, 1995, MOL CELL BIOL, V15, P1835; Dodou E, 1997, MOL CELL BIOL, V17, P1848, DOI 10.1128/MCB.17.4.1848; Finkel JS, 2010, GENETICS, V184, P107, DOI 10.1534/genetics.109.110031; Gudipati RK, 2008, NAT STRUCT MOL BIOL, V15, P786, DOI 10.1038/nsmb.1460; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; Kim KY, 2010, YEAST, V27, P541, DOI 10.1002/yea.1782; KLIS FM, 1994, YEAST, V10, P851, DOI 10.1002/yea.320100702; Koch C, 1999, NUCLEIC ACIDS RES, V27, P2126, DOI 10.1093/nar/27.10.2126; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Morlando M, 2002, MOL CELL BIOL, V22, P1379, DOI 10.1128/MCB.22.5.1379-1389.2002; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sedgwick SG, 1998, J MOL BIOL, V281, P763, DOI 10.1006/jmbi.1998.1996; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; SIDOROVA J, 1993, MOL CELL BIOL, V13, P1069, DOI 10.1128/MCB.13.2.1069; Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Truman AW, 2006, EUKARYOT CELL, V5, P1914, DOI 10.1128/EC.00263-06; Truman AW, 2009, MOL CELL BIOL, V29, P6449, DOI 10.1128/MCB.00794-09; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013	59	74	75	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					745	756		10.1016/j.cell.2011.01.034	http://dx.doi.org/10.1016/j.cell.2011.01.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376235	Green Accepted, Bronze			2022-12-24	WOS:000288007100013
J	Arora, N; Chertow, GM				Arora, Neiha; Chertow, Glenn M.			Update in Nephrology: Evidence Published in 2010	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chertow, Glenn M.] Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94034 USA	Stanford University	Chertow, GM (corresponding author), Stanford Univ, Sch Med, Div Nephrol, 780 Welch Rd,Suite 106, Palo Alto, CA 94034 USA.	gchertow@stanford.edu		Chertow, Glenn/0000-0002-7599-0534					0	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					824	829		10.7326/0003-4819-154-12-201106210-00342	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00342			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21464341				2022-12-24	WOS:000291800500018
J	Armstrong, J				Armstrong, Joanne			Unintended Consequences - The Cost of Preventing Preterm Births after FDA Approval of a Branded Version of 17OHP	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Aetna, Womens Hlth Div, Sugar Land, TX USA		Armstrong, J (corresponding author), Aetna, Womens Hlth Div, Sugar Land, TX USA.							Behrman R.E, 2006, PRETERM BIRTH CAUSES; *FOOD DRUG ADM, 2002, FOOD DRUG ADM COMPL; Petrini JR, 2005, OBSTET GYNECOL, V105, P267, DOI 10.1097/01.AOG.0000150560.24297.4f; PJ MEIS, 2003, NEW ENGL J MED, V348, P2379; 2011, MAKENA WHOLESALE ACQ	5	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1689	1691		10.1056/NEJMp1102796	http://dx.doi.org/10.1056/NEJMp1102796			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759DC	21410391				2022-12-24	WOS:000290219800003
J	Burns, DM; D'Ambrogio, A; Nottrott, S; Richter, JD				Burns, David M.; D'Ambrogio, Andrea; Nottrott, Stephanie; Richter, Joel D.			CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation	NATURE			English	Article							MEDIATED CYTOPLASMIC POLYADENYLATION; RIBOSOMAL-PROTEIN L26; CELLULAR SENESCENCE; SYNAPTIC PLASTICITY; MICRORNAS; GLD-2; STABILIZATION; MOUSE; CELLS; MICE	Cytoplasmic polyadenylation-induced translation controls germ cell development(1,2), neuronal synaptic plasticity(3-5) and cellular senescence(6,7), a tumour-suppressor mechanism that limits the replicative lifespan of cells(8,9). The cytoplasmic polyadenylation element binding protein (CPEB) promotes polyadenylation by nucleating a group of factors including defective in germline development 2 (Gld2), a non-canonical poly(A) polymerase(10-12), on specific messenger RNA (mRNA) 3' untranslated regions (UTRs). Because CPEB regulation of p53 mRNA polyadenylation/translation is necessary for cellular senescence in primary human diploid fibroblasts(6), we surmised that Gld2 would be the enzyme responsible for poly(A) addition. Here we show that depletion of Gld2 surprisingly promotes rather than inhibits p53 mRNA polyadenylation/translation, induces premature senescence and enhances the stability of CPEB mRNA. The CPEB 3' UTR contains two miR-122 binding sites, which when deleted, elevate mRNA translation, as does an antagomir of miR-122. Although miR-122 is thought to be liver specific, it is present in primary fibroblasts and destabilized by Gld2 depletion. Gld4, a second non-canonical poly(A) polymerase, was found to regulate p53 mRNA polyadenylation/translation in a CPEB-dependent manner. Thus, translational regulation of p53 mRNA and cellular senescence is coordinated by Gld2/miR-122/CPEB/Gld4.	[Burns, David M.; D'Ambrogio, Andrea; Nottrott, Stephanie; Richter, Joel D.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	joel.richter@umassmed.edu	D'Ambrogio, Andrea/D-3729-2013		Max Planck Society; European Molecular Biology Organization [ALTF 995-2004]; National Institutes of Health [AG30323]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD037267] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030323] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank V. Ambros, J. Steitz, T. Kowalik and R. Davis for comments. S.N. was supported by a fellowship of the Max Planck Society and by European Molecular Biology Organization fellowship ALTF 995-2004. This work was supported by National Institutes of Health grant AG30323. Additional core support from the Diabetes Endocrinology Research Center (DK32520) is acknowledged.	Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Holst LM, 2010, EXP DERMATOL, V19, pE201, DOI 10.1111/j.1600-0625.2009.01049.x; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim JH, 2007, GENE DEV, V21, P2571, DOI 10.1101/gad.1593007; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Santos SDM, 2008, NATURE, V454, P288, DOI 10.1038/454288a; Schmid M, 2009, GENE DEV, V23, P824, DOI 10.1101/gad.494009; Schulte JH, 2009, CANCER LETT, V274, P10, DOI 10.1016/j.canlet.2008.06.010; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	27	145	153	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					105	U125		10.1038/nature09908	http://dx.doi.org/10.1038/nature09908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21478871	Green Accepted			2022-12-24	WOS:000290218300040
J	Shrank, WH				Shrank, William H.			Our Bulging Medicine Cabinets - The Other Side of Medication Nonadherence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shrank, William H.] Brigham & Womens Hosp, Dept Med, Div Pharmacoeidemiol & Pharmacoecon, Boston, MA 02115 USA; [Shrank, William H.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shrank, WH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoeidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.							Benotti MJ, 2009, ENVIRON SCI TECHNOL, V43, P597, DOI 10.1021/es801845a; Catalano RF, 2011, ADDICT BEHAV, V36, P79, DOI 10.1016/j.addbeh.2010.08.028; *FOOD DRUG ADM, DISP FLUSH CERT UN M; McCabe SE, 2009, ARCH PEDIAT ADOL MED, V163, P739, DOI 10.1001/archpediatrics.2009.120; Richman PB, 2001, AM J EMERG MED, V19, P57, DOI 10.1053/ajem.2001.20035	5	26	26	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1591	1593		10.1056/NEJMp1011624	http://dx.doi.org/10.1056/NEJMp1011624			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755NW	21524212				2022-12-24	WOS:000289940400004
J	Logan, AC; Yank, V; Stafford, RS				Logan, Aaron C.; Yank, Veronica; Stafford, Randall S.			Off-Label Use of Recombinant Factor VIIa in US Hospitals: Analysis of Hospital Records	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVATED FACTOR-VII; THROMBOEMBOLIC ADVERSE EVENTS; INTRACEREBRAL HEMORRHAGE; CONTROLLED-TRIALS; CARDIAC-SURGERY; CLINICAL-TRIALS; SAFETY; EFFICACY; HEMOPHILIA; TRANSFUSION	Background: Recombinant factor VIIa (rFVIIa) is approved for treatment of bleeding in patients who have hemophilia with inhibitors but has been applied to a wide range of off-label indications. Objective: To estimate patterns of off-label rFVIIa use in U. S. hospitals. Design: Retrospective database analysis. Setting: Data were extracted from the Premier Perspectives database (Premier, Charlotte, North Carolina), which contains discharge records from a sample of academic and nonacademic U. S. hospitals. Patients: 12 644 hospitalizations for patients who received rFVIIa during a hospital stay. Measurements: Hospital diagnoses and patient dispositions from 1 January 2000 to 31 December 2008. Statistical weights for each hospital were used to provide national estimates of rFVIIa use. Results: From 2000 to 2008, off-label use of rFVIIa in hospitals increased more than 140-fold, such that in 2008, 97% (95% CI, 96% to 98%) of 18 311 in-hospital uses were off-label. In contrast, in-hospital use for hemophilia increased less than 4-fold and accounted for 2.7% (CI, 1.9% to 3.5%) of use in 2008. Adult and pediatric cardiovascular surgery (29% [CI, 21% to 33%]), body and brain trauma (29% [CI, 19% to 38%]), and intracranial hemorrhage (11% [CI, 7.7% to 14%]) were the most common indications for rFVIIa use. Across all indications, in-hospital mortality was 27% (CI, 19% to 34%) and 43% (CI, 26% to 59%) of patients were discharged to home. Limitation: Accuracy and completeness of the discharge diagnoses and patient medication records in the database sample cannot be verified. Conclusion: Off-label use of rFVIIa in the hospital setting far exceeds use for approved indications. These patterns raise concern about the application of rFVIIa to conditions for which strong supporting evidence is lacking.	[Stafford, Randall S.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA	Stanford University	Stafford, RS (corresponding author), Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Off Bldg X312,251 Campus Dr, Palo Alto, CA 94304 USA.	rstafford@stanford.edu	Logan, Aaron C/ADJ-7526-2022; Stafford, Randall/F-3974-2017	Logan, Aaron C/0000-0002-1179-5879; Stafford, Randall/0000-0003-1805-1271	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [290-02-0017]; National Heart, Lung, and Blood Institute [K24HL086703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL086703] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, under contract 290-02-0017. Dr. Stafford also was supported by a National Heart, Lung, and Blood Institute mentoring award (RSS, K24HL086703).	Aledort LM, 2004, J THROMB HAEMOST, V2, P1700, DOI 10.1111/j.1538-7836.2004.00944.x; Aledort LM, 2010, NEW ENGL J MED, V363, P1853, DOI 10.1056/NEJMe1008857; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Carcao MD, 2008, SEMIN HEMATOL, V45, pS68, DOI 10.1053/j.seminhematol.2008.03.003; Diprose P, 2005, BRIT J ANAESTH, V95, P596, DOI 10.1093/bja/aei244; Diringer MN, 2008, STROKE, V39, P850, DOI 10.1161/STROKEAHA.107.493601; Diringer MN, 2010, STROKE, V41, P48, DOI 10.1161/STROKEAHA.109.561712; Ganguly S, 2006, CLIN LAB HAEMATOL, V28, P309, DOI 10.1111/j.1365-2257.2006.00815.x; Gill R, 2009, CIRCULATION, V120, P21, DOI 10.1161/CIRCULATIONAHA.108.834275; Goodnough LT, 2004, TRANSFUSION, V44, P1325, DOI 10.1111/j.1537-2995.2004.04052.x; Goodnough LT, 2002, INTENS CARE MED, V28, pS221, DOI 10.1007/s00134-002-1468-2; Hardy JF, 2008, ANN THORAC SURG, V86, P1038, DOI 10.1016/j.athoracsur.2008.05.013; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hedner U, 2008, THROMB HAEMOSTASIS, V100, P557, DOI 10.1160/TH08-07-0434; Heller M, 2008, PEDIATR BLOOD CANCER, V50, P1013, DOI 10.1002/pbc.21375; Howes Jeremy L, 2009, Am J Surg, V198, P895, DOI 10.1016/j.amjsurg.2009.05.026; Hsia CC, 2009, TRANSFUSION MED, V19, P43, DOI 10.1111/j.1365-3148.2009.00913.x; Hsia CC, 2008, ANN SURG, V248, P61, DOI 10.1097/SLA.0b013e318176c4ec; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; MacLaren R, 2005, TRANSFUSION, V45, P1434, DOI 10.1111/j.1537-2995.2005.00548.x; MAGNETTI S, 2007, P & T, V32, P218; Mayer SA, 2003, STROKE, V34, P224, DOI 10.1161/01.STR.0000046458.67968.E4; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; Roberts HR, 2004, BLOOD, V104, P3858, DOI 10.1182/blood-2004-06-2223; Roberts HR, 2004, SEMIN HEMATOL, V41, P101, DOI 10.1053/j.seminhematol.2003.11.019; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Thomas GOR, 2007, J TRAUMA, V62, P564, DOI 10.1097/TA.0b013e318031afc2; Webert KE, 2007, HAEMOPHILIA, V13, P518, DOI 10.1111/j.1365-2516.2007.01490.x; YANK V, 2010, COMP EFFECTIVENESS R; Yank V, 2011, ANN INTERN MED, V154, P529, DOI 10.7326/0003-4819-154-8-201104190-00004	31	99	104	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8					516	522		10.7326/0003-4819-154-8-201104190-00002	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-00002			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502649	Green Accepted			2022-12-24	WOS:000289622000014
J	O'Callaghan, T				O'Callaghan, Tiffany			The prevention agenda INTRODUCTION	NATURE			English	Editorial Material																		Boyle P, 2008, WORLD CANC REPORT 20; Niederdeppe J, 2010, J COMMUN, V60, P230, DOI 10.1111/j.1460-2466.2009.01474.x	2	22	23	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S2	S4		10.1038/471S2a	http://dx.doi.org/10.1038/471S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430716	Bronze			2022-12-24	WOS:000288702200008
J	Bendesky, A; Tsunozaki, M; Rockman, MV; Kruglyak, L; Bargmann, CI				Bendesky, Andres; Tsunozaki, Makoto; Rockman, Matthew V.; Kruglyak, Leonid; Bargmann, Cornelia I.			Catecholamine receptor polymorphisms affect decision-making in C. elegans	NATURE			English	Article							QUANTITATIVE TRAIT LOCUS; CARBON-DIOXIDE AVOIDANCE; DEPENDENT PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; PHEROMONE ATTRACTION; NATURAL VARIATION; SOCIAL-BEHAVIOR; OCTOPAMINE; TYRAMINE; NEURONS	Innate behaviours are flexible: they change rapidly in response to transient environmental conditions, and are modified slowly by changes in the genome. A classical flexible behaviour is the exploration-exploitation decision, which describes the time at which foraging animals choose to abandon a depleting food supply. We have used quantitative genetic analysis to examine the decision to leave a food patch in Caenorhabditis elegans. Here we show that patch-leaving is a multigenic trait regulated in part by naturally occurring non-coding polymorphisms in tyra-3 (tyramine receptor 3), which encodes a G-protein-coupled catecholamine receptor related to vertebrate adrenergic receptors. tyra-3 acts in sensory neurons that detect environmental cues, suggesting that the internal catecholamines detected by tyra-3 regulate responses to external conditions. These results indicate that genetic variation and environmental cues converge on common circuits to regulate behaviour, and suggest that catecholamines have an ancient role in regulating behavioural decisions.	[Bendesky, Andres; Tsunozaki, Makoto; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA; [Rockman, Matthew V.] New York Univ, Dept Biol, New York, NY 10003 USA; [Rockman, Matthew V.] New York Univ, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Carl Icahn Lab, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Rockefeller University; New York University; New York University; Howard Hughes Medical Institute; Princeton University; Princeton University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA.	cori@rockefeller.edu		Bendesky, Andres/0000-0002-4220-3653; Bargmann, Cornelia/0000-0002-8484-0618	Secretaria de Educacion Publica of Mexico; Rockefeller University; HHMI; NIH [GM089972]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089972] Funding Source: NIH RePORTER	Secretaria de Educacion Publica of Mexico; Rockefeller University; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Shingai for strains, and P. McGrath and members of the C. I. B. laboratory for discussions. A. B. was supported by the Secretaria de Educacion Publica of Mexico and by The Rockefeller University. C. I. B. and L. K. are Investigators of the Howard Hughes Medical Institute. This work was supported by HHMI and by NIH grant GM089972.	Ahringer J., 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.47.1, 10.1895/wormbook.1.47.1]; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Barrett HC, 2000, TRENDS COGN SCI, V4, P251, DOI 10.1016/S1364-6613(00)01495-9; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chelur DS, 2007, P NATL ACAD SCI USA, V104, P2283, DOI 10.1073/pnas.0610877104; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Edwards AC, 2009, GENETICS, V182, P889, DOI 10.1534/genetics.109.101691; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gerke J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001144; Gloria-Soria A, 2008, CURR BIOL, V18, P1694, DOI 10.1016/j.cub.2008.09.043; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Harvey SC, 2009, J EXP ZOOL PART B, V312B, P224, DOI 10.1002/jez.b.21287; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hong RL, 2008, P NATL ACAD SCI USA, V105, P7779, DOI 10.1073/pnas.0708406105; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Legare ME, 2000, GENOME RES, V10, P42; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Mello C, 1995, METHOD CELL BIOL, V48, P451; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Pirri JK, 2009, NEURON, V62, P526, DOI 10.1016/j.neuron.2009.04.013; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Reaume Christopher J., 2009, V191, P423, DOI 10.1007/978-3-540-68964-5_18; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stephens DW., 2007, FORAGING BEHAV ECOLO, DOI 10.7208/chicago/9780226772653.001.0001; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Suo S, 2006, J NEUROSCI, V26, P10082, DOI 10.1523/JNEUROSCI.0819-06.2006; Thomson MJ, 2006, GENETICS, V172, P2501, DOI 10.1534/genetics.105.050500; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	56	131	132	3	54	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					313	U207		10.1038/nature09821	http://dx.doi.org/10.1038/nature09821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21412235	Green Submitted, Green Accepted			2022-12-24	WOS:000289724600032
J	Garcia, NVD; Karayannis, T; Fishell, G				Garcia, Natalia V. De Marco; Karayannis, Theofanis; Fishell, Gord			Neuronal activity is required for the development of specific cortical interneuron subtypes	NATURE			English	Article							ELECTRICAL-ACTIVITY; IN-VIVO; GANGLIONIC EMINENCE; APOPTOTIC CELLS; CEREBRAL-CORTEX; MIGRATION; NETWORKS; MOUSE; PROJECTIONS; ENGULFMENT	Electrical activity has been shown to regulate development in a variety of species and in various structures(1), including the retina(2-4), spinal cord(5,6) and cortex(5). Within the mammalian cortex specifically, the development of dendrites and commissural axons in pyramidal cells is activity-dependent(7,8). However, little is known about the developmental role of activity in the other major cortical population of neurons, the GABA-producing interneurons. These neurons are morphologically and functionally heterogeneous and efforts over the past decade have focused on determining the mechanisms that contribute to this diversity(9-11). It was recently discovered that 30% of all cortical interneurons arise from a relatively novel source within the ventral telencephalon, the caudal ganglionic eminence (CGE)(11,12). Owing to their late birth date, these interneurons populate the cortex only after the majority of other interneurons and pyramidal cells are already in place and have started to functionally integrate. Here we demonstrate in mice that for CGE-derived reelin (Re)-positive and calretinin (Cr)-positive (but not vasoactive intestinal peptide (VIP)-positive) interneurons(12,13), activity is essential before postnatal day 3 for correct migration, and that after postnatal day 3, glutamate-mediated activity controls the development of their axons and dendrites. Furthermore, we show that the engulfment and cell motility 1 gene (Elmo1)(14), a target of the transcription factor distal-less homeobox 1 (Dlx1)(15), is selectively expressed in Re+ and Cr+ interneurons and is both necessary and sufficient for activity-dependent interneuron migration. Our findings reveal a selective requirement for activity in shaping the cortical integration of specific neuronal subtypes.	[Garcia, Natalia V. De Marco; Karayannis, Theofanis; Fishell, Gord] NYU, Langone Med Ctr, Smilow Neurosci Program, Dept Cell Biol, New York, NY 10016 USA; [Garcia, Natalia V. De Marco; Karayannis, Theofanis; Fishell, Gord] NYU, Langone Med Ctr, Dept Neural Sci, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Fishell, G (corresponding author), NYU, Langone Med Ctr, Smilow Neurosci Program, Dept Cell Biol, 550 1St Ave, New York, NY 10016 USA.	fisheg01@nyumc.org	Karayannis, Theofanis/GRR-3982-2022; Karayannis, Theofanis/O-5194-2014	Karayannis, Theofanis/0000-0002-3267-6254; Fishell, Gordon/0000-0002-9640-9278	Patterson Trust; National Institutes of Health, National Institute of Mental Health [5RO1MH068469-08, 2R01MH071679-09]; National Institute of Neurological Disorders and Stroke [5R01NS039007-1]; New York Stem Cell Science State [NGSG-130]; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039007, R01NS032993] Funding Source: NIH RePORTER	Patterson Trust; National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); New York Stem Cell Science State; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to R. Batista-Brito, E. Chiappe, R. Cossart, J. Dasen, J. Kaltschmidt, S. Lee, J. Hjerling Leffler, M. Long, D. Pisapia and B. Rudy for comments on the manuscript. We thank L. Yin for technical assistance. We are indebted to K. Ravichandran for providing the ELMO1 constructs. N.V.D.G. and T. K. are both supported by grants from The Patterson Trust. Research in the Fishell laboratory is supported by the National Institutes of Health, National Institute of Mental Health (5RO1MH068469-08 and 2R01MH071679-09), National Institute of Neurological Disorders and Stroke (5R01NS039007-1), New York Stem Cell Science State (NGSG-130) and the Simons Foundation.	Allene C, 2010, J PHYSIOL-LONDON, V588, P83, DOI 10.1113/jphysiol.2009.178798; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Manent JB, 2006, J NEUROSCI, V26, P5901, DOI 10.1523/JNEUROSCI.1033-06.2006; McCabe AK, 2006, J PHYSIOL-LONDON, V577, P155, DOI 10.1113/jphysiol.2006.117523; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Root CM, 2008, J NEUROSCI, V28, P4777, DOI 10.1523/JNEUROSCI.4873-07.2008; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stenman J, 2003, J NEUROSCI, V23, P167; STONE TW, 1993, PHARMACOL REV, V45, P309; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7	34	171	172	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					351	U116		10.1038/nature09865	http://dx.doi.org/10.1038/nature09865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21460837	Green Accepted			2022-12-24	WOS:000289724600040
J	Yu, XJ; Liang, MF; Zhang, SY; Liu, Y; Li, JD; Sun, YL; Zhang, LH; Zhang, QF; Popov, VL; Li, C; Qu, J; Li, Q; Zhang, YP; Hai, R; Wu, W; Wang, Q; Zhan, FX; Wang, XJ; Kan, B; Wang, SW; Wan, KL; Jing, HQ; Lu, JX; Yin, WW; Zhou, H; Guan, XH; Liu, JF; Bi, ZQ; Liu, GH; Ren, J; Wang, H; Zhao, Z; Song, JD; He, JR; Wan, T; Zhang, JS; Fu, XP; Sun, LN; Dong, XP; Feng, ZJ; Yang, WZ; Hong, T; Zhang, Y; Walker, DH; Wang, Y; Li, DX				Yu, Xue-Jie; Liang, Mi-Fang; Zhang, Shou-Yin; Liu, Yan; Li, Jian-Dong; Sun, Yu-Lan; Zhang, Lihong; Zhang, Quan-Fu; Popov, Vsevolod L.; Li, Chuan; Qu, Jing; Li, Qun; Zhang, Yan-Ping; Hai, Rong; Wu, Wei; Wang, Qin; Zhan, Fa-Xian; Wang, Xian-Jun; Kan, Biao; Wang, Shi-Wen; Wan, Kang-Lin; Jing, Huai-Qi; Lu, Jin-Xin; Yin, Wen-Wu; Zhou, Hang; Guan, Xu-Hua; Liu, Jia-Fa; Bi, Zhen-Qiang; Liu, Guo-Hua; Ren, Jun; Wang, Hua; Zhao, Zhuo; Song, Jing-Dong; He, Jin-Rong; Wan, Tao; Zhang, Jing-Shan; Fu, Xiu-Ping; Sun, Li-Na; Dong, Xiao-Ping; Feng, Zi-Jian; Yang, Wei-Zhong; Hong, Tao; Zhang, Yu; Walker, David H.; Wang, Yu; Li, De-Xin			Fever with Thrombocytopenia Associated with a Novel Bunyavirus in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS	BACKGROUND Heightened surveillance of acute febrile illness in China since 2009 has led to the identification of a severe fever with thrombocytopenia syndrome (SFTS) with an unknown cause. Infection with Anaplasma phagocytophilum has been suggested as a cause, but the pathogen has not been detected in most patients on laboratory testing. METHODS We obtained blood samples from patients with the case definition of SFTS in six provinces in China. The blood samples were used to isolate the causal pathogen by inoculation of cell culture and for detection of viral RNA on polymerase-chain-reaction assay. The pathogen was characterized on electron microscopy and nucleic acid sequencing. We used enzyme-linked immunosorbent assay, indirect immunofluorescence assay, and neutralization testing to analyze the level of virus-specific antibody in patients' serum samples. RESULTS We isolated a novel virus, designated SFTS bunyavirus, from patients who presented with fever, thrombocytopenia, leukocytopenia, and multiorgan dysfunction. RNA sequence analysis revealed that the virus was a newly identified member of the genus phlebovirus in the Bunyaviridae family. Electron-microscopical examination revealed virions with the morphologic characteristics of a bunyavirus. The presence of the virus was confirmed in 171 patients with SFTS from six provinces by detection of viral RNA, specific antibodies to the virus in blood, or both. Serologic assays showed a virus-specific immune response in all 35 pairs of serum samples collected from patients during the acute and convalescent phases of the illness. CONCLUSIONS A novel phlebovirus was identified in patients with a life-threatening illness associated with fever and thrombocytopenia in China.	[Liang, Mi-Fang; Li, Jian-Dong; Sun, Yu-Lan; Zhang, Quan-Fu; Li, Chuan; Qu, Jing; Zhang, Yan-Ping; Wu, Wei; Wang, Qin; Wang, Shi-Wen; Song, Jing-Dong; Wan, Tao; Sun, Li-Na; Hong, Tao; Li, De-Xin] Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing 102206, Peoples R China; [Yu, Xue-Jie; Li, Qun; Yin, Wen-Wu; Zhou, Hang; Dong, Xiao-Ping; Feng, Zi-Jian; Yang, Wei-Zhong; Wang, Yu] Chinese Ctr Dis Control & Prevent, Chinese CDC, Beijing 102206, Peoples R China; [Zhang, Shou-Yin; Hai, Rong; Kan, Biao; Wan, Kang-Lin; Jing, Huai-Qi; Lu, Jin-Xin; He, Jin-Rong; Zhang, Jing-Shan; Fu, Xiu-Ping] Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Control & Prevent, Beijing, Peoples R China; [Wang, Xian-Jun; Bi, Zhen-Qiang] Shandong Prov CDC, Jinan, Shandong, Peoples R China; [Zhan, Fa-Xian; Guan, Xu-Hua; Liu, Jia-Fa] Hubei Prov CDC, Wuhan, Hubei, Peoples R China; [Liu, Guo-Hua] Henan Prov CDC, Zhengzhou, Henan, Peoples R China; [Liu, Yan; Ren, Jun] Anhui Prov CDC, Hefei, Anhui, Peoples R China; [Wang, Hua] Jiangshu Prov CDC, Nanjing, Jiangshu, Peoples R China; [Zhao, Zhuo] Liaoning Prov CDC, Shenyang, Liaoning, Peoples R China; [Zhang, Yu] Hubei Prov Dept Hlth, Wuhan, Hubei, Peoples R China; [Yu, Xue-Jie; Liu, Yan; Zhang, Lihong; Popov, Vsevolod L.; Walker, David H.] Univ Texas Galveston, Med Branch, Dept Pathol, Galveston, TX 77550 USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Texas System; University of Texas Medical Branch Galveston	Li, DX (corresponding author), Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing 102206, Peoples R China.	wangyu@chinacdc.cn; lidx@chinacdc.cn	Yang, Wei/HIA-0360-2022; Wang, Tao/B-1331-2016; Yu, Xuejie/AAP-9246-2021		Ministry of Science and Technology [2008ZX10004-001, 2009ZX10004]; Ministry of Health; National Institute of Allergy and Infectious Diseases [U54 AI057156]; Chinese Center for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Chinese Center for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by China Mega-Project for Infectious Diseases grants (2008ZX10004-001 and 2009ZX10004) from the Ministry of Science and Technology and the Ministry of Health, by a Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases grant (U54 AI057156) from the National Institute of Allergy and Infectious Diseases, and by a grant from the Chinese Recruitment Program of Global Experts in the Chinese Center for Disease Control and Prevention (to Dr. Yu).	Depaquit J, 2010, EUROSURVEILLANCE, V15, P40; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Li CA, 2010, VACCINE, V28, P4294, DOI 10.1016/j.vaccine.2010.04.025; Nichol S. T., 2005, VIRUS TAXONOMY, P695; Peters CJ, 1999, ANNU REV MED, V50, P531, DOI 10.1146/annurev.med.50.1.531; POPOV VL, 1995, J MED MICROBIOL, V43, P411, DOI 10.1099/00222615-43-6-411; Pyrc Krzysztof, 2008, V454, P73, DOI 10.1007/978-1-59745-181-9_7; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Tenquist JD, 2001, J ROY SOC NEW ZEAL, V31, P481, DOI 10.1080/03014223.2001.9517666; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626; 2010, NATL GUIDELINE PREVE	14	970	1213	5	186	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1523	1532		10.1056/NEJMoa1010095	http://dx.doi.org/10.1056/NEJMoa1010095			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21410387	Green Accepted			2022-12-24	WOS:000289722700009
J	Cao, P; Maximov, A; Sudhof, TC				Cao, Peng; Maximov, Anton; Suedhof, Thomas C.			Activity-Dependent IGF-1 Exocytosis Is Controlled by the Ca2+-Sensor Synaptotagmin-10	CELL			English	Article							GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; RAT OLFACTORY-BULB; CA2+ SENSORS; PC12 CELLS; SYNAPTIC-TRANSMISSION; MESSENGER-RNA; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; DISTINCT CA2+	Synaptotagmins Syt1, Syt2, Syt7, and Syt9 act as Ca2+-sensors for synaptic and neuroendocrine exocytosis, but the function of other synaptotagmins remains unknown. Here, we show that olfactory bulb neurons secrete IGF-1 by an activity-dependent pathway of exocytosis, and that Syt10 functions as the Ca2+-sensor that triggers IGF-1 exocytosis in these neurons. Deletion of Syt10 impaired activity-dependent IGF-1 secretion in olfactory bulb neurons, resulting in smaller neurons and an overall decrease in synapse numbers. Exogenous IGF-1 completely reversed the Syt10 knockout phenotype. Syt10 colocalized with IGF-1 in somatodendritic vesicles of olfactory bulb neurons, and Ca2+-binding to Syt10 caused these vesicles to undergo exocytosis, thereby secreting IGF-1. Thus, Syt10 controls a previously unrecognized pathway of Ca2+-dependent exocytosis that is spatially and temporally distinct from Ca2+-dependent synaptic vesicle exocytosis controlled by Syt1. Our findings thereby reveal that two different synaptotagmins can regulate functionally distinct Ca2+-dependent membrane fusion reactions in the same neuron.	[Cao, Peng; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94305 USA; [Cao, Peng; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94305 USA; [Maximov, Anton; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci & Mol Genet, Dallas, TX 75390 USA; [Maximov, Anton; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, 1050 Arastradero Rd, Palo Alto, CA 94305 USA.	tcs1@stanford.edu	Karakhanov, Edward/P-1660-2015		Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01 MH085776] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085776] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGUADO F, 1993, J MOL ENDOCRINOL, V11, P231, DOI 10.1677/jme.0.0110231; Babity JM, 1997, P NATL ACAD SCI USA, V94, P2638, DOI 10.1073/pnas.94.6.2638; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BARTLETT WP, 1991, DEV BIOL, V147, P239, DOI 10.1016/S0012-1606(05)80021-1; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Bhalla A, 2008, J BIOL CHEM, V283, P21799, DOI 10.1074/jbc.M709628200; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Flannery AR, 2010, J CELL BIOL, V191, P599, DOI 10.1083/jcb.201003021; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GIACOBINI MMJ, 1995, DEV BRAIN RES, V84, P67, DOI 10.1016/0165-3806(94)00154-R; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; Li JL, 2009, SCI CHINA SER C, V52, P1156, DOI 10.1007/s11427-009-0160-y; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lynch KL, 2007, J CELL SCI, V120, P617, DOI 10.1242/jcs.03375; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mittelsteadt T, 2009, J COMP NEUROL, V512, P514, DOI 10.1002/cne.21908; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Scolnick JA, 2008, NEURON, V57, P847, DOI 10.1016/j.neuron.2008.01.027; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; Sorensen JB, 2003, J GEN PHYSIOL, V122, P265, DOI 10.1085/jgp.200308855; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; TROMBLEY PQ, 1990, J NEUROPHYSIOL, V64, P598, DOI 10.1152/jn.1990.64.2.598; Vicario-Abejon C, 2003, J NEUROSCI, V23, P895; Vrljic M, 2010, NAT STRUCT MOL BIOL, V17, P325, DOI 10.1038/nsmb.1764; Wang P, 2005, MOL CELL BIOL, V25, P8693, DOI 10.1128/MCB.25.19.8693-8702.2005; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004	47	99	104	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					300	311		10.1016/j.cell.2011.03.034	http://dx.doi.org/10.1016/j.cell.2011.03.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496647	Bronze, Green Accepted			2022-12-24	WOS:000289549900017
J	Volkow, ND; McLellan, TA; Cotto, JH; Karithanom, M; Weiss, SRB				Volkow, Nora D.; McLellan, Thomas A.; Cotto, Jessica H.; Karithanom, Meena; Weiss, Susan R. B.			Characteristics of Opioid Prescriptions in 2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ADOLESCENTS; DEPENDENCE; ADULTS; ABUSE		[Volkow, Nora D.; Cotto, Jessica H.; Karithanom, Meena; Weiss, Susan R. B.] NIDA, NIH, Bethesda, MD 20892 USA; [McLellan, Thomas A.] Univ Penn, Sch Med, Ctr Subst Abuse Solut, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Pennsylvania	Volkow, ND (corresponding author), NIDA, NIH, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			Intramural NIH HHS [Z99 DA999999] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		[Anonymous], CDCS ISS BRIEF UN DR; [Anonymous], VECT ON NAT VONA; Fortuna RJ, 2010, PEDIATRICS, V126, P1108, DOI 10.1542/peds.2010-0791; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Schramm-Sapyta NL, 2009, PSYCHOPHARMACOLOGY, V206, P1, DOI 10.1007/s00213-009-1585-5; Zacny J, 2003, DRUG ALCOHOL DEPEN, V69, P215, DOI 10.1016/S0376-8716(03)00003-6	6	550	553	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1299	1301		10.1001/jama.2011.401	http://dx.doi.org/10.1001/jama.2011.401			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467282	Bronze, Green Accepted			2022-12-24	WOS:000289162400016
J	Eliason, EJ; Clark, TD; Hague, MJ; Hanson, LM; Gallagher, ZS; Jeffries, KM; Gale, MK; Patterson, DA; Hinch, SG; Farrell, AP				Eliason, Erika J.; Clark, Timothy D.; Hague, Merran J.; Hanson, Linda M.; Gallagher, Zoe S.; Jeffries, Ken M.; Gale, Marika K.; Patterson, David A.; Hinch, Scott G.; Farrell, Anthony P.			Differences in Thermal Tolerance Among Sockeye Salmon Populations	SCIENCE			English	Article							CLIMATE-CHANGE; FRASER-RIVER; TEMPERATURE; MIGRATION; PACIFIC; PERFORMANCE; PHYSIOLOGY; WATER	Climate change-induced increases in summer water temperature have been associated with elevated mortality of adult sockeye salmon ( Oncorhynchus nerka) during river migration. We show that cardiorespiratory physiology varies at the population level among Fraser River sockeye salmon and relates to historical environmental conditions encountered while migrating. Fish from populations with more challenging migratory environments have greater aerobic scope, larger hearts, and better coronary supply. Furthermore, thermal optima for aerobic, cardiac, and heart rate scopes are consistent with the historic river temperature ranges for each population. This study suggests that physiological adaptation occurs at a very local scale, with population-specific thermal limits being set by physiological limitations in aerobic performance, possibly due to cardiac collapse at high temperatures.	[Eliason, Erika J.; Clark, Timothy D.; Gallagher, Zoe S.; Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Clark, Timothy D.; Hanson, Linda M.; Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V6T 1Z4, Canada; [Clark, Timothy D.; Jeffries, Ken M.; Gale, Marika K.; Hinch, Scott G.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1Z4, Canada; [Hague, Merran J.; Patterson, David A.] Simon Fraser Univ, Fisheries & Oceans Canada, Sci Branch, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Fisheries & Oceans Canada; Simon Fraser University	Eliason, EJ (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	eliason@zoology.ubc.ca	Clark, Timothy Darren/K-7129-2012	Clark, Timothy Darren/0000-0001-8738-3347; Eliason, Erika/0000-0002-0120-7498	Natural Sciences and Engineering Research Council of Canada (NSERC); Pacific Salmon Forum grants; Killam Postdoctoral Fellowship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Pacific Salmon Forum grants; Killam Postdoctoral Fellowship	We thank C. Whitney for assistance with the beta-adrenoceptors experiment and field assistance; A. Lotto, G. Cox, E. Sandblom, A. Collins, M. Drenner, C. Wilson, D. Roscoe, M. Donaldson, J. Burt, E. Martins, S. Pieperhoff, L. Thompson, J. Hills, V. Ives, S. Tang, B. Smith, M. Hamer, D. Eliason, G. Eliason, and P. Parsons for field assistance; S. Ballesta and S. Lague for assistance with the b-adrenoceptors experiment; D. Guo for assistance with heart dissection; S. Cooke for valuable discussions; S. Latham for scale analysis; K. Miller, N. Ginther, C. Wallace, and J. Candy for DNA analysis; and the Department of Fisheries and Oceans (DFO) Environmental Watch Program and the DFO Cultus Lake Salmon Research Laboratory. This research was funded by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grants to A. P. F. and S. G. H.; an NSERC Strategic grant to S. G. H. and A. P. F.; Pacific Salmon Forum grants to E. J. E., A. P. F., and S. G. H.; NSERC postgraduate scholarships to E. J. E., K. M. J., and M. K. G.; and a Killam Postdoctoral Fellowship to T. D. C.	Beacham TD, 2005, T AM FISH SOC, V134, P1124, DOI 10.1577/T05-005.1; Brander K, 2003, ICES MARINE SCI S, V219, P261; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Endler J.A., 1986, Monographs in Population Biology, pviii; English KK, 2005, T AM FISH SOC, V134, P1342, DOI 10.1577/T04-119.1; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Farrell AP, 2009, J EXP BIOL, V212, P3771, DOI 10.1242/jeb.023671; Ferrari MR, 2007, J HYDROL, V342, P336, DOI 10.1016/j.jhydrol.2007.06.002; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Hanson LM, 2007, J FISH BIOL, V71, P926, DOI 10.1111/j.1095-8649.2007.01533.x; Hinch SG, 2000, CAN J FISH AQUAT SCI, V57, P2470, DOI 10.1139/cjfas-57-12-2470; Hodgson S, 2002, CAN J ZOOL, V80, P542, DOI 10.1139/Z02-030; Hyatt K.D., 2003, CANADIAN WATER RESOU, V28, P689, DOI DOI 10.4296/CWRJ2804689; KEEN JE, 1993, J EXP BIOL, V181, P27; Lee CG, 2003, J EXP BIOL, V206, P3239, DOI 10.1242/jeb.00547; Mathes MT, 2010, CAN J FISH AQUAT SCI, V67, P70, DOI 10.1139/F09-158; Munday PL, 2008, CORAL REEFS, V27, P927, DOI 10.1007/s00338-008-0393-4; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Rodnick KJ, 2004, J FISH BIOL, V64, P310, DOI 10.1111/j.0022-1112.2004.00292.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Shiels HA, 1997, J EXP BIOL, V200, P1607; Steinhausen MF, 2008, J EXP BIOL, V211, P3915, DOI 10.1242/jeb.019281; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; Wang T, 2007, SCIENCE, V315, P49, DOI 10.1126/science.1137359	28	602	623	6	392	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					109	112		10.1126/science.1199158	http://dx.doi.org/10.1126/science.1199158			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454790				2022-12-24	WOS:000289000000049
J	Lishko, PV; Botchkina, IL; Kirichok, Y				Lishko, Polina V.; Botchkina, Inna L.; Kirichok, Yuriy			Progesterone activates the principal Ca2+ channel of human sperm	NATURE			English	Article							HUMAN SPERMATOZOA; STEROID-HORMONES; CALCIUM INFLUX; HYPERACTIVATED MOTILITY; MAMMALIAN SPERMATOZOA; NONGENOMIC ACTIONS; ACROSOME REACTION; CATSPER CHANNELS; MALE-FERTILITY; MOUSE SPERM	Steroid hormone progesterone released by cumulus cells surrounding the egg is a potent stimulator of human spermatozoa. It attracts spermatozoa towards the egg and helps them penetrate the egg's protective vestments(1). Progesterone induces Ca2+ influx into spermatozoa(1-3) and triggers multiple Ca2+-dependent physiological responses essential for successful fertilization, such as sperm hyperactivation, acrosome reaction and chemotaxis towards the egg(4-8). As an ovarian hormone, progesterone acts by regulating gene expression through a well-characterized progesterone nuclear receptor(9). However, the effect of progesterone upon transcriptionally silent spermatozoa remains unexplained and is believed to be mediated by a specialized, non-genomic membrane progesterone receptor(5,10). The identity of this non-genomic progesterone receptor and the mechanism by which it causes Ca2+ entry remain fundamental unresolved questions in human reproduction. Here we elucidate the mechanism of the non-genomic action of progesterone on human spermatozoa by identifying the Ca2+ channel activated by progesterone. By applying the patch-clamp technique to mature human spermatozoa, we found that nanomolar concentrations of progesterone dramatically potentiate CatSper, a pH-dependent Ca2+ channel of the sperm flagellum. We demonstrate that human CatSper is synergistically activated by elevation of intracellular pH and extracellular progesterone. Interestingly, human CatSper can be further potentiated by prostaglandins, but apparently through a binding site other than that of progesterone. Because our experimental conditions did not support second messenger signalling, CatSper or a directly associated protein serves as the elusive non-genomic progesterone receptor of sperm. Given that the CatSper-associated progesterone receptor is sperm specific and structurally different from the genomic progesterone receptor, it represents a promising target for the development of a new class of non-hormonal contraceptives.	[Lishko, Polina V.; Botchkina, Inna L.; Kirichok, Yuriy] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kirichok, Y (corresponding author), Univ Calif San Francisco, Dept Physiol, UCSF Mail Code 2140,Genentech Hall Room N272F,600, San Francisco, CA 94158 USA.	yuriy.kirichok@ucsf.edu	Lishko, Polina/GQH-9569-2022; Lishko, Polina/L-1191-2017		UCSF	UCSF	This work was funded by the UCSF Program for Breakthrough Biomedical Research.	AITKEN RJ, 1986, J REPROD FERTIL, V77, P451; Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; BAULIEU EE, 1989, SCIENCE, V245, P1351, DOI 10.1126/science.2781282; BLACKMORE PF, 1990, J BIOL CHEM, V265, P1376; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Huang LP, 2004, J PHARMACOL EXP THER, V309, P193, DOI 10.1124/jpet.103.060814; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Neri-Vidaurri PD, 2006, BIOCHEM BIOPH RES CO, V343, P105, DOI 10.1016/j.bbrc.2006.02.095; Olsona SD, 2010, B MATH BIOL, V72, P1925, DOI 10.1007/s11538-010-9516-5; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Ren DJ, 2010, PHYSIOLOGY, V25, P165, DOI 10.1152/physiol.00049.2009; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Revelli A, 1998, ENDOCR REV, V19, P3, DOI 10.1210/er.19.1.3; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; Schaefer M, 1998, P NATL ACAD SCI USA, V95, P3008, DOI 10.1073/pnas.95.6.3008; Shimizu Y, 1998, MOL HUM REPROD, V4, P555, DOI 10.1093/molehr/4.6.555; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; UHLER ML, 1992, FERTIL STERIL, V58, P1191; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xia JS, 2009, BIOL REPROD, V80, P1092, DOI 10.1095/biolreprod.108.074039	30	423	449	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2011	471	7338					387	+		10.1038/nature09767	http://dx.doi.org/10.1038/nature09767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412339				2022-12-24	WOS:000288444000047
J	Zhang, HM; Landmann, F; Zahreddine, H; Rodriguez, D; Koch, M; Labouesse, M				Zhang, Huimin; Landmann, Frederic; Zahreddine, Hala; Rodriguez, David; Koch, Marc; Labouesse, Michel			A tension-induced mechanotransduction pathway promotes epithelial morphogenesis	NATURE			English	Article							CYTOPLASMIC INTERMEDIATE-FILAMENT; CAENORHABDITIS-ELEGANS CUTICLE; MUSCLE DEVELOPMENT; C.-ELEGANS; IN-VIVO; GENE; ELONGATION; EMBRYO; MUTATIONS; EPIDERMIS	Mechanotransduction refers to the transformation of physical forces into chemical signals. It generally involves stretch-sensitive channels or conformational change of cytoskeleton-associated proteins(1). Mechanotransduction is crucial for the physiology of several organs and for cell migration(2,3). The extent to which mechanical inputs contribute to development, and how they do this, remains poorly defined. Here we show that a mechanotransduction pathway operates between the body-wall muscles of Caenorhabditis elegans and the epidermis. This pathway involves, in addition to a Rac GTPase, three signalling proteins found at the hemidesmosome: p21-activated kinase (PAK-1), the adaptor GIT-1 and its partner PIX-1. The phosphorylation of intermediate filaments is one output of this pathway. Tension exerted by adjacent muscles or externally exerted mechanical pressure maintains GIT-1 at hemidesmosomes and stimulates PAK-1 activity through PIX-1 and Rac. This pathway promotes the maturation of a hemidesmosome into a junction that can resist mechanical stress and contributes to coordinating the morphogenesis of epidermal and muscle tissues. Our findings suggest that the C. elegans hemidesmosome is not only an attachment structure, but also a mechanosensor that responds to tension by triggering signalling processes. We suggest that similar pathways could promote epithelial morphogenesis or wound healing in other organisms in which epithelial cells adhere to tension-generating contractile cells.	[Zhang, Huimin; Landmann, Frederic; Zahreddine, Hala; Rodriguez, David; Labouesse, Michel] Univ Strasbourg, Dev & Stem Cells Program, IGBMC, CNRS,INSERM,UMR7104,U964, F-67400 Illkirch Graffenstaden, France; [Koch, Marc] Univ Strasbourg, Imaging Ctr, IGBMC, CNRS,INSERM,UMR7104,U964, F-67400 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Labouesse, M (corresponding author), Univ Strasbourg, Dev & Stem Cells Program, IGBMC, CNRS,INSERM,UMR7104,U964, 1 Rue Laurent Fries,BP 10142, F-67400 Illkirch Graffenstaden, France.	lmichel@igbmc.fr		Koch, Marc/0000-0002-2678-235X; Zhang, Huimin/0000-0002-2167-9644; Zahreddine Fahs, Hala/0000-0003-0720-2484	ANR; ARC; EU; CNRS; INSERM	ANR(French National Research Agency (ANR)); ARC(Australian Research Council); EU(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We are grateful to H.-J. Cheng, the CGC and NBP-Japan, L. Lim, J. Nance, C. Gally and L. Broday for reagents, as well as M. Argentini for technical advice. We thank J. Ahringer for a discussion, and O. Pourquie, J.-L. Bessereau, S. Jarriault and members of the Labouesse laboratory (C. Gally, I. Kolotueva, N. Osmani and S. Quintin) for critical reading of the manuscript. This work was supported by grants from the ANR, ARC and EU (STREP-FP6 programme) (M. L.) and by institutional funds from the CNRS and INSERM.	Anderson DC, 2008, SCIENCE, V320, P1771, DOI 10.1126/science.1156063; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRENNER S, 1974, GENETICS, V77, P71; Chen WN, 1996, J BIOL CHEM, V271, P26362, DOI 10.1074/jbc.271.42.26362; CHISHOLM AD, 2005, WORMBOOK, DOI DOI 10.1895/WORMBOOK.1.7.1; Costa M, 1997, DEV BIOL, V184, P373, DOI 10.1006/dbio.1997.8530; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Gally C, 2009, DEVELOPMENT, V136, P3109, DOI 10.1242/dev.039412; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Gilleard JS, 1999, DEV BIOL, V208, P265, DOI 10.1006/dbio.1999.9202; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Goto H, 2002, GENES CELLS, V7, P91, DOI 10.1046/j.1356-9597.2001.00504.x; Hapiak V, 2003, DEV BIOL, V263, P330, DOI 10.1016/j.ydbio.2003.08.001; HODGKIN J, 1983, GENETICS, V103, P43; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; Iannuccelli E, 2010, BIOINFORMATICS, V26, P696, DOI 10.1093/bioinformatics/btq013; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaminsky R, 2009, DEV CELL, V17, P724, DOI 10.1016/j.devcel.2009.10.005; Karabinos A, 2003, J MOL BIOL, V333, P307, DOI 10.1016/j.jmb.2003.08.041; Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Lucanic M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000269; Orr AW, 2008, CIRC RES, V103, P671, DOI 10.1161/CIRCRESAHA.108.182097; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; SCHNABEL R, 1995, DEVELOPMENT, V121, P2219; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Woo WM, 2004, DEV BIOL, V267, P216, DOI 10.1016/j.ydbio.2003.11.007; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Zahreddine H, 2010, CURR BIOL, V20, P322, DOI 10.1016/j.cub.2009.12.061; Zhang HM, 2010, DEV DYNAM, V239, P1465, DOI 10.1002/dvdy.22255; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	41	183	205	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					99	U120		10.1038/nature09765	http://dx.doi.org/10.1038/nature09765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368832				2022-12-24	WOS:000287924100042
J	Siegel, M				Siegel, Michael			A Lost Opportunity for Public Health - The FDA Advisory Committee Report on Menthol	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02215 USA	Boston University	Siegel, M (corresponding author), Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02215 USA.			Siegel, Michael/0000-0002-2573-9616				MULLINS B, 2004, ROLL CALL       1005; SIEGEL M, 2007, REST STORY TOBACCO N; Tobacco Products Scientific Advisory Committee to the Food and Drug Administration, 2011, MENTH CIG PUBL HLTH; Young A., 2008, ATLANTA J CONST 0529	4	12	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2177	2179		10.1056/NEJMp1103403	http://dx.doi.org/10.1056/NEJMp1103403			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774NA	21542736				2022-12-24	WOS:000291392100001
J	Chiu, JC; Ko, HW; Edery, I				Chiu, Joanna C.; Ko, Hyuk Wan; Edery, Isaac			NEMO/NLK Phosphorylates PERIOD to Initiate a Time-Delay Phosphorylation Circuit that Sets Circadian Clock Speed	CELL			English	Article							SLEEP PHASE SYNDROME; DROSOPHILA CLOCK; PROTEIN; GENE; MELANOGASTER; MUTATION; KINASE; NEUROSPORA; DOUBLETIME; MUTANTS	The speed of circadian clocks in animals is tightly linked to complex phosphorylation programs that drive daily cycles in the levels of PERIOD (PER) proteins. Using Drosophila, we identify a time-delay circuit based on hierarchical phosphorylation that controls the daily downswing in PER abundance. Phosphorylation by the NEMO/NLK kinase at the "per-short" domain on PER stimulates phosphorylation by DOUBLETIME (DBT/CK1 delta/epsilon) at several nearby sites. This multisite phosphorylation operates in a spatially oriented and graded manner to delay progressive phosphorylation by DBT at other more distal sites on PER, including those required for recognition by the F box protein SLIMB/beta-TrCP and proteasomal degradation. Highly phosphorylated PER has a more open structure, suggesting that progressive increases in global phosphorylation contribute to the timing mechanism by slowly increasing PER susceptibility to degradation. Our findings identify NEMO as a clock kinase and demonstrate that long-range interactions between functionally distinct phospho-clusters collaborate to set clock speed.	[Chiu, Joanna C.; Ko, Hyuk Wan; Edery, Isaac] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Chiu, Joanna C.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Rutgers State University New Brunswick; University of California System; University of California Davis	Edery, I (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	edery@cabm.rutgers.edu		KO, HYUK WAN/0000-0003-1753-1900; Chiu, Joanna/0000-0001-7613-8127	NIH [R01NS03498, K99/R00NS061952]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS061952, K99NS061952, R01NS034958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Paul Hardin (Texas A&M, USA) for communicating unpublished results (Yu et al., 2011), Thomas Kusch (Rutgers University, USA) for Sfx cells, and the VDRC (Vienna, Austria) for RNAi lines. We thank Axel Diernfellner and Michael Brunner (Heidelberg University, Germany) for conditions for limited proteolysis. This work was supported by NIH grant (R01NS03498) to I. E. and NIH grant (K99/R00NS061952) to J.C.C.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Bae K, 2006, J BIOCHEM, V140, P609, DOI 10.1093/jb/mvj198; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BAYLIES MK, 1992, NEURON, V9, P575, DOI 10.1016/0896-6273(92)90194-I; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Hamblen MJ, 1998, GENETICS, V149, P165; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Kadener S, 2008, PLOS BIOL, V6, P965, DOI 10.1371/journal.pbio.0060119; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kim EY, 2007, MOL CELL BIOL, V27, P5014, DOI 10.1128/MCB.02339-06; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Ko HW, 2005, METHOD ENZYMOL, V393, P394, DOI 10.1016/S0076-6879(05)93018-8; Ko HW, 2007, J BIOL RHYTHM, V22, P488, DOI 10.1177/0748730407306929; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1994, J BIOL RHYTHM, V9, P189, DOI 10.1177/074873049400900303; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Marrus SB, 1996, EMBO J, V15, P6877, DOI 10.1002/j.1460-2075.1996.tb01080.x; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Nawathean P, 2007, MOL CELL BIOL, V27, P5002, DOI 10.1128/MCB.02338-06; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; RUTILA JE, 1992, J NEUROGENET, V8, P101, DOI 10.3109/01677069209084155; Schibler U, 2006, PROG BRAIN RES, V153, P271, DOI 10.1016/S0079-6123(06)53016-X; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784; Yu WJ, 2011, CURR BIOL, V21, P756, DOI 10.1016/j.cub.2011.02.037; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177	52	125	128	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					357	370		10.1016/j.cell.2011.04.002	http://dx.doi.org/10.1016/j.cell.2011.04.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21514639	Green Accepted, Bronze			2022-12-24	WOS:000290022900006
J	Maillard, RA; Chistol, G; Sen, M; Righini, M; Tan, JY; Kaiser, CM; Hodges, C; Martin, A; Bustamante, C				Maillard, Rodrigo A.; Chistol, Gheorghe; Sen, Maya; Righini, Maurizio; Tan, Jiongyi; Kaiser, Christian M.; Hodges, Courtney; Martin, Andreas; Bustamante, Carlos			ClpX(P) Generates Mechanical Force to Unfold and Translocate Its Protein Substrates	CELL			English	Article							GREEN FLUORESCENT PROTEIN; OPERATING PRINCIPLES; RNA-POLYMERASE; MOLECULE; DEGRADATION; MACHINE; THERMODYNAMICS; PROTEOLYSIS; RESOLUTION; PROTEASES	AAA(+) unfoldases denature and translocate polypeptides into associated peptidases. We report direct observations of mechanical, force-induced protein unfolding by the ClpX unfoldase from E. coli, alone, and in complex with the ClpP peptidase. ClpX hydrolyzes ATP to generate mechanical force and translocate polypeptides through its central pore. Threading is interrupted by pauses that are found to be off the main translocation pathway. ClpX's translocation velocity is force dependent, reaching a maximum of 80 aa/s near-zero force and vanishing at around 20 pN. ClpX takes 1, 2, or 3 nm steps, suggesting a fundamental step-size of 1 nm and a certain degree of intersubunit coordination. When ClpX encounters a folded protein, it either overcomes this mechanical barrier or slips on the polypeptide before making another unfolding attempt. Binding of ClpP decreases the slip probability and enhances the unfolding efficiency of ClpX. Under the action of ClpXP, GFP unravels cooperatively via a transient intermediate.	[Maillard, Rodrigo A.; Righini, Maurizio; Kaiser, Christian M.; Martin, Andreas; Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Maillard, Rodrigo A.; Chistol, Gheorghe; Sen, Maya; Righini, Maurizio; Tan, Jiongyi; Kaiser, Christian M.; Hodges, Courtney; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Maillard, Rodrigo A.; Chistol, Gheorghe; Kaiser, Christian M.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Sen, Maya; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Martin, Andreas; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Martin, A (corresponding author), Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA.	a.martin@berkeley.edu; carlos@alice.berkeley.edu		Chistol, Gheorghe/0000-0003-4868-3667; Hodges, H. Courtney/0000-0003-4441-497X; Bustamante, Carlos/0000-0002-2970-0073; Martin, Andreas/0000-0003-0923-3284; Righini, Maurizio/0000-0002-8454-8887	NSF; QB3 Institute; NIH [5K99GM086516, R01-GM0325543]; Searle Scholars Program; Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094497, K99GM086516, R01GM032543] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); QB3 Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lacramioara Bintu, Craig Hetherington, and Phillip Elms for helpful discussions. M.S. acknowledges support from the NSF Graduate Research Fellowship. C.M.K. acknowledges support from the QB3 Institute (Distinguished Postdoctoral Fellowship) and the NIH K99 Award (5K99GM086516). This research was supported in part by the Searle Scholars Program (A.M.), the NIH grant R01-GM0325543, the Lawrence Berkeley National Laboratory, and the Howard Hughes Medical Institute (C.B.).	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Bertz M, 2008, ANGEW CHEM INT EDIT, V47, P8192, DOI 10.1002/anie.200802987; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Bustamante C, 2001, ACCOUNTS CHEM RES, V34, P412, DOI 10.1021/ar0001719; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Horwich AL, 1999, P NATL ACAD SCI USA, V96, P11033, DOI 10.1073/pnas.96.20.11033; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Mickler M, 2007, P NATL ACAD SCI USA, V104, P20268, DOI 10.1073/pnas.0705458104; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Shin Y, 2009, P NATL ACAD SCI USA, V106, P19340, DOI 10.1073/pnas.0910484106; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yildiz A, 2005, TRENDS CELL BIOL, V15, P112, DOI 10.1016/j.tcb.2004.12.007; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102	35	196	201	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					459	469		10.1016/j.cell.2011.04.010	http://dx.doi.org/10.1016/j.cell.2011.04.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529717	Green Accepted, Bronze			2022-12-24	WOS:000290022900014
J	Beaglehole, R; Bonita, R; Horton, R; Adams, C; Alleyne, G; Asaria, P; Baugh, V; Bekedam, H; Billo, N; Casswell, S; Cecchini, M; Colagiuri, R; Colagiuri, S; Collins, T; Ebrahim, S; Engelgau, M; Galea, G; Gaziano, T; Geneau, R; Haines, A; Hospedales, J; Jha, P; Keeling, A; Leeder, S; Lincoln, P; McKee, M; Mackay, J; Magnusson, R; Moodie, R; Mwatsama, M; Nishtar, S; Norrving, B; Patterson, D; Piot, P; Ralston, J; Rani, M; Reddy, KS; Sassi, F; Sheron, N; Stuckler, D; Suh, I; Torode, J; Varghese, C; Watt, J				Beaglehole, Robert; Bonita, Ruth; Horton, Richard; Adams, Cary; Alleyne, George; Asaria, Perviz; Baugh, Vanessa; Bekedam, Henk; Billo, Nils; Casswell, Sally; Cecchini, Michele; Colagiuri, Ruth; Colagiuri, Stephen; Collins, Tea; Ebrahim, Shah; Engelgau, Michael; Galea, Gauden; Gaziano, Thomas; Geneau, Robert; Haines, Andy; Hospedales, James; Jha, Prabhat; Keeling, Ann; Leeder, Stephen; Lincoln, Paul; McKee, Martin; Mackay, Judith; Magnusson, Roger; Moodie, Rob; Mwatsama, Modi; Nishtar, Sonia; Norrving, Bo; Patterson, David; Piot, Peter; Ralston, Johanna; Rani, Manju; Reddy, K. Srinath; Sassi, Franco; Sheron, Nick; Stuckler, David; Suh, Il; Torode, Julie; Varghese, Cherian; Watt, Judith		Lancet NCD Action Grp; NCD Alliance	Priority actions for the non-communicable disease crisis	LANCET			English	Article							PREVENTING CHRONIC DISEASES; MIDDLE-INCOME COUNTRIES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HEALTH-BENEFITS; CLIMATE-CHANGE; GLOBAL BURDEN; RISK-FACTORS; ALCOHOL; SMOKING	The UN High-Level Meeting on Non-Communicable Diseases (NCDs) in September, 2011, is an unprecedented opportunity to create a sustained global movement against premature death and preventable morbidity and disability from NCDs, mainly heart disease, stroke, cancer, diabetes, and chronic respiratory disease. The increasing global crisis in NCDs is a barrier to development goals including poverty reduction, health equity, economic stability, and human security. The Lancet NCD Action Group and the NCD Alliance propose five overarching priority actions for the response to the crisis leadership, prevention, treatment, international cooperation, and monitoring and accountability and the delivery of five priority interventions tobacco control, salt reduction, improved diets and physical activity, reduction in hazardous alcohol intake, and essential drugs and technologies. The priority interventions were chosen for their health effects, cost-effectiveness, low costs of implementation, and political and financial feasibility. The most urgent and immediate priority is tobacco control. We propose as a goal for 2040, a world essentially free from tobacco where less than 5% of people use tobacco. Implementation of the priority interventions, at an estimated global commitment of about US$9 billion per year, will bring enormous benefits to social and economic development and to the health sector. If widely adopted, these interventions will achieve the global goal of reducing NCD death rates by 2% per year, averting tens of millions of premature deaths in this decade.	[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Horton, Richard] The Lancet, London, England; [Adams, Cary; Torode, Julie] NCD Alliance Union Int Canc Control, Geneva, Switzerland; [Alleyne, George; Hospedales, James] Pan Amer Hlth Org, Washington, DC USA; [Asaria, Perviz] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Baugh, Vanessa] Commonwealth Secretariat, London, England; [Bekedam, Henk; Rani, Manju; Varghese, Cherian] WHO Western Pacific Reg Off, Manila, Philippines; [Billo, Nils] NCD Alliance Int Union Against TB & Lung Dis, Paris, France; [Casswell, Sally] Massey Univ, Auckland, New Zealand; [Cecchini, Michele; Sassi, Franco] Org Econ Cooperat & Dev, Hlth Div, Paris, France; [Collins, Tea] NCD Alliance, Geneva, Switzerland; [Ebrahim, Shah] S Asia Network Chron Dis, New Delhi, India; [Engelgau, Michael] World Bank, Washington, DC 20433 USA; [Galea, Gauden] WHO European Reg Off, Copenhagen, Denmark; [Gaziano, Thomas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Geneau, Robert] Univ Ottawa, Ottawa, ON, Canada; [Haines, Andy; McKee, Martin; Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Jha, Prabhat] Ctr Global Hlth Res, Toronto, ON, Canada; [Colagiuri, Ruth; Colagiuri, Stephen; Keeling, Ann] NCD Alliance Int Diabet Federat, Brussels, Belgium; [Leeder, Stephen; Magnusson, Roger] Univ Sydney, Sydney, NSW 2006, Australia; [Lincoln, Paul; Mwatsama, Modi] Natl Heart Forum, London, England; [Mackay, Judith] World Lung Fdn, Hong Kong, Hong Kong, Peoples R China; [Moodie, Rob] Univ Melbourne, Melbourne, Vic, Australia; [Nishtar, Sonia] HeartFile, Islamabad, Pakistan; [Norrving, Bo] World Stroke Org, Geneva, Switzerland; [Patterson, David] Int Dev Law Org, Rome, Italy; [Ralston, Johanna] NCD Alliance World Heart Federat, Geneva, Switzerland; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Sheron, Nick] Univ Southampton, Southampton, Hants, England; [Stuckler, David] Harvard Univ, Boston, MA USA; [Suh, Il] Yonsei Univ, Coll Med, Seoul, South Korea	University of Auckland; Pan American Health Organization; Imperial College London; WHO Western Pacific Regional Office; Massey University; Organisation for Economic Co-operation & Development (OECD); The World Bank; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Ottawa; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; University of Melbourne; Public Health Foundation of India; University of Southampton; Harvard University; Yonsei University; Yonsei University Health System	Beaglehole, R (corresponding author), 42 Albert Rd, Auckland 0624, New Zealand.	r.beaglehole@auckland.ac.nz	Galea, Gauden/AAV-4335-2021; McKee, Marc D/E-2187-2011; Stuckler, David/H-2261-2012; McKee, Martin/E-6673-2018	Galea, Gauden/0000-0002-2257-6014; McKee, Marc D/0000-0001-8349-965X; Billo, Nils Eric/0000-0002-5735-5107; Asaria, Perviz/0000-0002-9037-0894; Moodie, Alan/0000-0002-8425-7975; Suh, Il/0000-0002-9689-7849; Reddy, K Srinath/0000-0003-3416-3548; Casswell, Sally/0000-0002-2211-7096; Norrving, Bo/0000-0002-8024-5096; Sheron, Nick/0000-0002-6156-8367; McKee, Martin/0000-0002-0121-9683; Geneau, Robert/0000-0001-6180-2515; Sassi, Franco/0000-0001-9773-2117; Sheron, Nick/0000-0001-5232-8292; Haines, Andy/0000-0002-8053-4605; Stuckler, David/0000-0002-1288-8401; Colagiuri, Stephen/0000-0002-2398-4781	Wellcome Trust; Family Health International; 19 Inter-American Development Bank; Bayer; Allergan; Syngis; Servier; 22 Photothera; Boehringer-Ingelheim; Pfizer; Wiley; Sanofi-Aventis; Varian Medical Systems; Roche; Boehringer Ingelheim; Novartis; Slender; 23 Merck; Eli Lilly; Heng Rui; Irmet; National Heart Forum	Wellcome Trust(Wellcome TrustEuropean Commission); Family Health International; 19 Inter-American Development Bank; Bayer(Bayer AG); Allergan(AbbVieAllergan); Syngis; Servier(Servier); 22 Photothera; Boehringer-Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer); Wiley; Sanofi-Aventis(Sanofi-Aventis); Varian Medical Systems; Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Novartis(Novartis); Slender; 23 Merck; Eli Lilly(Eli Lilly); Heng Rui; Irmet; National Heart Forum	PA has received grants from Wellcome Trust Clinical PhD Fellowship. SE has received grants from the Wellcome Trust, and royalties from 18 McGraw Hill for editing a book. RI-I is the editor of The Lancet. TG has received consultancy payments from Family Health International and 19 Inter-American Development Bank; and payment for lectures, including lectures on speakers bureaus, from Network for Continuing Medical 20 Education. BN has received consultancy payments from Bayer, payment for lectures including service on speakers bureaus from Allergan, and 21 royalties for a book published by Karolinska University Press. BN's institute has received money for consultancy from Syngis, Servier, Bayer, 22 Photothera, and Boehringer-Ingelheim. JT has received or has grants pending from Corporate Partners, Pfizer, Wiley, Sanofi-Aventis, Varian Medical Systems, Roche, Boehringer Ingelheim, Novartis, Slender, 23 Merck, Eli Lilly, Heng Rui, and Irmet. The other authors declare that they have no conflicts of interest.; We thank the National Heart Forum for providing financial, technical, and administrative support for the production of this report. The authors alone are responsible for the views expressed in this report and they do not necessarily represent the decisions, policy, or views of WHO, the World Bank, the OECD, or those of the member countries of these organisations.	Alleyne G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-15; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; [Anonymous], 2010, HLTH NUTR POPUL SER; [Anonymous], 2005, PREV CHRON DIS VIT I; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Balabanova D, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-22; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beaglehole R, 2010, LANCET, V376, P1619, DOI 10.1016/S0140-6736(10)61929-0; Beaglehole R, 2009, LANCET, V373, P2173, DOI 10.1016/S0140-6736(09)61168-5; Bhutta Z, 2011, LANCET, V377, P969, DOI 10.1016/S0140-6736(11)60169-4; Callaway M, 2007, J PAIN SYMPTOM MANAG, V33, P509, DOI 10.1016/j.jpainsymman.2007.02.003; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Casswell S, 2011, ADDICTION, V106, P1087, DOI 10.1111/j.1360-0443.2011.03361.x; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; ENGELAU MM, CAPITALIZING DEMOGRA; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; FIDLER DP, 2008, REVOLUTION GLOBAL HL; Freeman B, 2010, TOB CONTROL, V19, pE1, DOI 10.1136/tc.2009.032847; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Gill GV, 2011, DIABETOLOGIA, V54, P19, DOI 10.1007/s00125-010-1897-3; GLUCKMAN P, 2006, WHY OUR WORLD NO LON; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Horton R, 2007, LANCET, V370, P1881, DOI 10.1016/S0140-6736(07)61701-2; HOSPEDALES CJ, PAN AM J PU IN PRESS; Institute of Medicine, 2010, PROM CARD HLTH DEV W; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jha P., 1999, CURBING EPIDEMIC GOV; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; Knai C, 2010, LANCET, V376, P75, DOI 10.1016/S0140-6736(09)62063-8; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Li N, 2007, J HYPERTENS, V25, P2011, DOI 10.1097/HJH.0b013e3282b9714b; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lindholm LH, 2007, LANCET, V370, P720, DOI 10.1016/S0140-6736(07)61356-7; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Magnusson RS, 2009, PUBLIC HEALTH, V123, P265, DOI 10.1016/j.puhe.2008.12.023; MALONE R, 2010, BOTTOM LINE PUBLIC H; New Zealand Government, GOV RESP REP MAOR AF; Outterson K, 2008, HEALTH AFFAIR, V27, P130, DOI 10.1377/hlthaff.27.1.130; Piot Peter, 2010, BMJ, V341, pc4865, DOI 10.1136/bmj.c4865; Rayner G, 2006, HEALTH PROMOT INT, V21, P67, DOI 10.1093/heapro/dal053; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; *RGI CGHR, 2009, CAUS DEATH IND 2001; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; SRIDHAR D, 2011, GETTING POLITICS RIG; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Stuckler D, 2010, POLITICAL EC UNIVERS; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UN, 2010, PREV CONTR NONC DIS; *UN, 2008, COMPR FRAM ACT HIGH; *UN FRAM CONV CLIM, 2009, C PART 15 SESS COP A; Verkaik-Kloosterman J, 2010, BRIT J NUTR, V104, P1712, DOI 10.1017/S0007114510002722; WHO, 2010, WOR HEALT REP, P1; WHO, 2008, COMM SOC DET HLTH; World Economic Forum, 2011, GLOB RISKS 2011; World Health Organization, 2004, TOB POV VIC CYCL; World Health Organization, 2008, ACT PLAN GLOB STRAT; World Health Organization, 2007, PREV CARD DIS GUID A; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization, 2010, PACK ESS NONC PEN DI; World health organization, RISK FACT EST 2004; World Health Organization, 2009, MORT BURD DIS EST WH; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization (WHO), STEPWISE APPR SURV S; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Younger M, 2008, AM J PREV MED, V35, P517, DOI 10.1016/j.amepre.2008.08.017; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; 2011, LANCET, V377, P783	84	1093	1131	7	359	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2011	377	9775					1438	1447		10.1016/S0140-6736(11)60393-0	http://dx.doi.org/10.1016/S0140-6736(11)60393-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	21474174				2022-12-24	WOS:000289963000033
J	Robert, T; Vanoli, F; Chiolo, I; Shubassi, G; Bernstein, KA; Rothstein, R; Botrugno, OA; Parazzoli, D; Oldani, A; Minucci, S; Foiani, M				Robert, Thomas; Vanoli, Fabio; Chiolo, Irene; Shubassi, Ghadeer; Bernstein, Kara A.; Rothstein, Rodney; Botrugno, Oronza A.; Parazzoli, Dario; Oldani, Amanda; Minucci, Saverio; Foiani, Marco			HDACs link the DNA damage response, processing of double-strand breaks and autophagy	NATURE			English	Article							VALPROIC ACID; END RESECTION; CHECKPOINT; ACETYLATION; ACTIVATION; YEAST; SAE2; HELICASE; SGS1; SRS2	Protein acetylation is mediated by histone acetyltransferases (HATs) and deacetylases (HDACs), which influence chromatin dynamics, protein turnover and the DNA damage response. ATM and ATR mediate DNA damage checkpoints by sensing double-strand breaks and single-strand-DNA-RFA nucleofilaments, respectively. However, it is unclear how acetylation modulates the DNA damage response. Here we show that HDAC inhibition/ablation specifically counteracts yeast Mec1 (orthologue of human ATR) activation, double-strand-break processing and single-strand-DNA-RFA nucleofilament formation. Moreover, the recombination protein Sae2 (human CtIP) is acetylated and degraded after HDAC inhibition. Two HDACs, Hda1 and Rpd3, and one HAT, Gcn5, have key roles in these processes. We also find that HDAC inhibition triggers Sae2 degradation by promoting autophagy that affects the DNA damage sensitivity of hda1 and rpd3 mutants. Rapamycin, which stimulates autophagy by inhibiting Tor, also causes Sae2 degradation. We propose that Rpd3, Hda1 and Gcn5 control chromosome stability by coordinating the ATR checkpoint and double-strand-break processing with autophagy.	[Robert, Thomas; Vanoli, Fabio; Chiolo, Irene; Shubassi, Ghadeer; Foiani, Marco] Fdn IFOM, I-20139 Milan, Italy; [Chiolo, Irene] LBNL, Dept Genome Biol, Berkeley, CA 94710 USA; [Bernstein, Kara A.; Rothstein, Rodney] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10032 USA; [Botrugno, Oronza A.; Minucci, Saverio] European Inst Oncol, I-20139 Milan, Italy; [Parazzoli, Dario; Oldani, Amanda] Cogentech, I-20139 Milan, Italy; [Minucci, Saverio; Foiani, Marco] Univ Milan, DSBB, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Columbia University; IRCCS European Institute of Oncology (IEO); University of Milan	Foiani, M (corresponding author), Fdn IFOM, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	saverio.minucci@ifom-ieo-campus.it; marco.foiani@ifom-ieo-campus.it	Botrugno, Oronza Antonietta/P-2065-2017; Bernstein, Kara Anne/S-4943-2016; Foiani, Marco/M-8234-2014; Minucci, Saverio/J-9669-2012	Botrugno, Oronza Antonietta/0000-0002-2568-9815; Bernstein, Kara Anne/0000-0003-2247-6459; Foiani, Marco/0000-0003-4795-834X; Robert, Thomas/0000-0002-2458-7454; Rothstein, Rodney/0000-0002-4107-9654; Chiolo, Irene/0000-0002-3080-550X	Italian Association for Cancer Research; Telethon; European Community (GENICA); Italian Ministry of Health; FRM; EMBO; HFSP; FIRC;  [GM50237];  [GM67055];  [GM088413]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067055, R01GM050237, R00GM088413, K99GM088413, R37GM050237] Funding Source: NIH RePORTER	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); European Community (GENICA)(European Commission); Italian Ministry of Health(Ministry of Health, Italy); FRM(Fondation pour la Recherche Medicale); EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); FIRC(Fondazione AIRC per la ricerca sul cancro); ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Piatti, M. P. Longhese, M. Grunstein, J. K. Tyler, A. Pellicioli, M. Costanzo, R. Brost, M. Vogelauer, D. Klionsky, T. Roberts and C. Bertoli for reagents and technical suggestions, J. Barlow for DNA damage foci analysis, A. Sartori and S. Ferrari for communicating unpublished results, C. Lucca, D. Branzei, R. Bermejo and the members of our laboratories for comments. Work in M. F. laboratory was supported by grants from the Italian Association for Cancer Research and partially from Telethon, European Community (GENICA) and the Italian Ministry of Health. T. R. was supported by fellowships from FRM and EMBO and I.C. was supported by a short fellowship from HFSP and from FIRC. This work was also supported by GM50237 (to R.R.), GM67055 (to R.R.) and GM088413 (to K.B.).	Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Fiorani S, 2008, CELL CYCLE, V7, P493, DOI 10.4161/cc.7.4.5323; Fiorentino DF, 1997, MOL BIOL CELL, V8, P2519, DOI 10.1091/mbc.8.12.2519; Fu J, 2010, NEURO-ONCOLOGY, V12, P328, DOI 10.1093/neuonc/nop005; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lucca C, 2004, ONCOGENE, V23, P1206, DOI 10.1038/sj.onc.1207199; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Neecke H, 1999, EMBO J, V18, P4485, DOI 10.1093/emboj/18.16.4485; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Robert T, 2006, EMBO J, V25, P2837, DOI 10.1038/sj.emboj.7601158; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Scott KL, 2003, MOL CELL BIOL, V23, P4522, DOI 10.1128/MCB.23.13.4522-4531.2003; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shintani T, 2008, METHOD ENZYMOL, V451, P43, DOI 10.1016/S0076-6879(08)03204-7; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	47	301	312	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					74	79		10.1038/nature09803	http://dx.doi.org/10.1038/nature09803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368826	Green Accepted			2022-12-24	WOS:000287924100036
J	Zhou, Z; Feng, HQ; Zhou, BR; Ghirlando, R; Hu, KF; Zwolak, A; Jenkins, LMM; Xiao, H; Tjandra, N; Wu, C; Bai, YW				Zhou, Zheng; Feng, Hanqiao; Zhou, Bing-Rui; Ghirlando, Rodolfo; Hu, Kaifeng; Zwolak, Adam; Jenkins, Lisa M. Miller; Xiao, Hua; Tjandra, Nico; Wu, Carl; Bai, Yawen			Structural basis for recognition of centromere histone variant CenH3 by the chaperone Scm3	NATURE			English	Article							FISSION YEAST SCM3; SACCHAROMYCES-CEREVISIAE; SEDIMENTATION-VELOCITY; ANALYTICAL ULTRACENTRIFUGATION; PROTEIN; NMR; NUCLEOSOMES; CHROMATIN; HJURP; CSE4	The centromere is a unique chromosomal locus that ensures accurate segregation of chromosomes during cell division by directing the assembly of a multiprotein complex, the kinetochore(1). The centromere is marked by a conserved variant of conventional histone H3 termed CenH3 or CENP-A (ref. 2). A conserved motif of CenH3, the CATD, defined by loop 1 and helix 2 of the histone fold, is necessary and sufficient for specifying centromere functions of CenH3 (refs 3, 4). The structural basis of this specification is of particular interest. Yeast Scm3 and human HJURP are conserved non-histone proteins that interact physically with the (CenH3-H4) 2 heterotetramer and are required for the deposition of CenH3 at centromeres in vivo(5-13). Here we have elucidated the structural basis for recognition of budding yeast (Saccharomyces cerevisiae) CenH3 (called Cse4) by Scm3. We solved the structure of the Cse4-binding domain (CBD) of Scm3 in complex with Cse4 and H4 in a single chain model. An alpha-helix and an irregular loop at the conserved amino terminus and a shorter alpha-helix at the carboxy terminus of Scm3(CBD) wraps around the Cse4-H4 dimer. Four Cse4-specific residues in the N-terminal region of helix 2 are sufficient for specific recognition by conserved and functionally important residues in the N-terminal helix of Scm3 through formation of a hydrophobic cluster. Scm3(CBD) induces major conformational changes and sterically occludes DNA-binding sites in the structure of Cse4 and H4. These findings have implications for the assembly and architecture of the centromeric nucleosome.	[Zhou, Zheng; Feng, Hanqiao; Zhou, Bing-Rui; Xiao, Hua; Wu, Carl; Bai, Yawen] NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA; [Ghirlando, Rodolfo] NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA; [Hu, Kaifeng] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Zwolak, Adam; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Jenkins, Lisa M. Miller] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bai, YW (corresponding author), NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA.	yawen@helix.nih.gov	Jenkins, Lisa/AAI-2490-2021; Zhou, Bing-Rui/D-4766-2009; Ghirlando, Rodolfo/A-8880-2009	Zhou, Bing-Rui/0000-0002-5375-7977	NCI; NIDDK; NHLBI; NATIONAL CANCER INSTITUTE [ZIABC005263, ZIABC010808] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001048, ZIAHL006064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Ying, K. Varney, J. F. Ellena and J. Gruschus for help collecting NMR spectra, A. Bax for discussion, C. Klee and M. Lichten for comments on the manuscript, and D. Cleveland for plasmids of human CENP-A and H4 histones. This work is supported by the intramural research programs of NCI, NIDDK and NHLBI.	Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; COTTAREL G, 1989, MOL CELL BIOL, V9, P3342, DOI 10.1128/MCB.9.8.3342; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Houtman JCD, 2004, BIOCHEMISTRY-US, V43, P4170, DOI 10.1021/bi0357311; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Keith KC, 1999, MOL CELL BIOL, V19, P6130; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Wood CM, 2005, ACTA CRYSTALLOGR F, V61, P541, DOI 10.1107/S1744309105013813; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465	39	99	102	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					234	237		10.1038/nature09854	http://dx.doi.org/10.1038/nature09854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21412236	Green Accepted			2022-12-24	WOS:000289469100046
J	White, RM; Cech, J; Ratanasirintrawoot, S; Lin, CY; Rahl, PB; Burke, CJ; Langdon, E; Tomlinson, ML; Mosher, J; Kaufman, C; Chen, F; Long, HK; Kramer, M; Datta, S; Neuberg, D; Granter, S; Young, RA; Morrison, S; Wheeler, GN; Zon, LI				White, Richard Mark; Cech, Jennifer; Ratanasirintrawoot, Sutheera; Lin, Charles Y.; Rahl, Peter B.; Burke, Christopher J.; Langdon, Erin; Tomlinson, Matthew L.; Mosher, Jack; Kaufman, Charles; Chen, Frank; Long, Hannah K.; Kramer, Martin; Datta, Sumon; Neuberg, Donna; Granter, Scott; Young, Richard A.; Morrison, Sean; Wheeler, Grant N.; Zon, Leonard I.			DHODH modulates transcriptional elongation in the neural crest and melanoma	NATURE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; ZEBRAFISH; LEFLUNOMIDE; EXPRESSION; INHIBITOR; DISCOVERY; KINASE; CELLS; GENE	Melanoma is a tumour of transformed melanocytes, which are originally derived from the embryonic neural crest. It is unknown to what extent the programs that regulate neural crest development interact with mutations in the BRAF oncogene, which is the most commonly mutated gene in human melanoma(1). We have used zebrafish embryos to identify the initiating transcriptional events that occur on activation of human BRAF(V600E) (which encodes an amino acid substitution mutant of BRAF) in the neural crest lineage. Zebrafish embryos that are transgenic for mitfa:BRAF(V600E) and lack p53 (also known as tp53) have a gene signature that is enriched for markers of multipotent neural crest cells, and neural crest progenitors from these embryos fail to terminally differentiate. To determine whether these early transcriptional events are important for melanoma pathogenesis, we performed a chemical genetic screen to identify small-molecule suppressors of the neural crest lineage, which were then tested for their effects on melanoma. One class of compound, inhibitors of dihydroorotate dehydrogenase (DHODH), for example leflunomide, led to an almost complete abrogation of neural crest development in zebrafish and to a reduction in the self-renewal of mammalian neural crest stem cells. Leflunomide exerts these effects by inhibiting the transcriptional elongation of genes that are required for neural crest development and melanoma growth. When used alone or in combination with a specific inhibitor of the BRAF(V600E) oncogene, DHODH inhibition led to a marked decrease in melanoma growth both in vitro and in mouse xenograft studies. Taken together, these studies highlight developmental pathways in neural crest cells that have a direct bearing on melanoma formation.	[White, Richard Mark; Cech, Jennifer; Ratanasirintrawoot, Sutheera; Burke, Christopher J.; Langdon, Erin; Kaufman, Charles; Datta, Sumon; Zon, Leonard I.] Harvard Univ, Stem Cell Program & Hematol Oncol, Childrens Hosp Boston,Med Sch, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA; [White, Richard Mark; Kaufman, Charles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Lin, Charles Y.; Rahl, Peter B.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lin, Charles Y.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Tomlinson, Matthew L.; Wheeler, Grant N.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Mosher, Jack; Morrison, Sean] Univ Michigan, Howard Hughes Med Inst, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Chen, Frank] Harvard Univ, Cambridge, MA 02138 USA; [Long, Hannah K.] Univ Cambridge, Cambridge CB2 1TN, England; [Kramer, Martin] Genzyme Corp, Cambridge, MA 02142 USA; [Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Granter, Scott] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of East Anglia; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Harvard University; University of Cambridge; Sanofi-Aventis; Genzyme Corporation; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Zon, LI (corresponding author), Harvard Univ, Stem Cell Program & Hematol Oncol, Childrens Hosp Boston,Med Sch, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Long, Hannah/X-9731-2019; Young, Richard A/F-6495-2012; Wheeler, Grant N/D-3023-2009; Morrison, Sean/ABD-5326-2021; , Charles/ABC-8259-2020; Long, Hannah/A-6301-2013	Long, Hannah/0000-0002-5694-0398; Young, Richard A/0000-0001-8855-8647; Wheeler, Grant N/0000-0002-4335-8577; Long, Hannah/0000-0002-5694-0398; Morrison, Sean/0000-0003-1587-8329; Burke, Christopher/0000-0001-7609-1146; Kaufman, Charles/0000-0003-3122-1677; Ratanasirintrawoot, Sutheera/0000-0002-0641-5106	Howard Hughes Medical Institute; National Cancer Institute (National Institutes of Health); American Society for Clinical Oncology; National Institute of Arthritis and Musculoskeletal and SkinDiseases (National Institutes of Health); Biotechnology and Biological Sciences Research Council/Pfizer; NATIONAL CANCER INSTITUTE [R01CA103846, T32CA009172] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055368] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society for Clinical Oncology; National Institute of Arthritis and Musculoskeletal and SkinDiseases (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Biotechnology and Biological Sciences Research Council/Pfizer(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank G. Bollag and P. Lin for supplying PLX4720. The melanoma xenografts were performed with the assistance of T. Venezia-Bowman. In situ hybridization probes for crestin were supplied by P. Henion. We thank S. Lacadie, C. Ceol, Y. Houvras, T. Bowman, X. Bai and R. Field for discussions and/or comments on the manuscript. This work was supported by the Howard Hughes Medical Institute and the National Cancer Institute (National Institutes of Health) (L.I.Z.), Aid for Cancer Research, the American Society for Clinical Oncology and the National Institute of Arthritis and Musculoskeletal and SkinDiseases (National Institutes of Health) (R.M.W.). M.L.T. was a Biotechnology and Biological Sciences Research Council/Pfizer Industrial CASE award recipient.	AOKI T, 1982, J BIOL CHEM, V257, P432; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Bakos RM, 2010, EXP DERMATOL, V19, pE89, DOI 10.1111/j.1600-0625.2009.00991.x; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chen YL, 2007, PLOS COMPUT BIOL, V3, P602, DOI 10.1371/journal.pcbi.0030063; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Hong SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002029; Kaplan M J, 2001, Curr Opin Investig Drugs, V2, P222; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Krishnan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003621; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; McLean JE, 2001, BIOCHEMISTRY-US, V40, P2194, DOI 10.1021/bi001810q; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nguyen CT, 2010, DEV BIOL, V341, P167, DOI 10.1016/j.ydbio.2010.02.020; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rubinstein AL, 2000, GENESIS, V26, P86, DOI 10.1002/(SICI)1526-968X(200001)26:1<86::AID-GENE11>3.0.CO;2-Q; Schiff MH, 2000, DRUGS TODAY, V36, P383, DOI 10.1358/dot.2000.36.6.584259; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967	26	331	343	8	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					518	522		10.1038/nature09882	http://dx.doi.org/10.1038/nature09882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430780	Green Accepted, Green Submitted			2022-12-24	WOS:000288702200063
J	Fogle, KJ; Parson, KG; Dahm, NA; Holmes, TC				Fogle, Keri J.; Parson, Kelly G.; Dahm, Nicole A.; Holmes, Todd C.			CRYPTOCHROME Is a Blue-Light Sensor That Regulates Neuronal Firing Rate	SCIENCE			English	Article							DROSOPHILA CRYPTOCHROME; CIRCADIAN CLOCK; PDF CELLS; PHOTORECEPTOR; SLEEP; AROUSAL	Light-responsive neural activity in central brain neurons is generally conveyed through opsin-based signaling from external photoreceptors. Large lateral ventral arousal neurons (lLNvs) in Drosophila melanogaster increase action potential firing within seconds in response to light in the absence of all opsin-based photoreceptors. Light-evoked changes in membrane resting potential occur in about 100 milliseconds. The light response is selective for blue wavelengths corresponding to the spectral sensitivity of CRYPTOCHROME (CRY). cry-null lines are light-unresponsive, but restored CRY expression in the lLNv rescues responsiveness. Furthermore, expression of CRY in neurons that are normally unresponsive to light confers responsiveness. The CRY-mediated light response requires a flavin redox-based mechanism and depends on potassium channel conductance, but is independent of the classical circadian CRY-TIMELESS interaction.	[Fogle, Keri J.; Parson, Kelly G.; Dahm, Nicole A.; Holmes, Todd C.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine	Holmes, TC (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	tholmes@uci.edu		Holmes, Todd/0000-0001-8152-8832	NIH [NS046750]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107405, R01GM102965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank P. Hardin (anti-CRY), D. O'Dowd (gh146GAL4), J. Hall (cry<SUP>01</SUP> and cry<SUP>02</SUP>), S. Reppert (UAS-dpCRY1 and UAS-dpCRY2), P. Emery (UAS-cry<SUP>m</SUP>), and the Bloomington Stock Center for reagents; S. Vasu, M. Digman, and A. Starr for helpful discussion and technical advice; B. Horne for helpful comments on the manuscript and technical assistance; and S. DeGroot and D. Mumford for technical assistance. This work was funded by NIH grant NS046750 to T. C. H. The authors have no competing financial interests.	Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Helfrich-Forster C, 1998, CHRONOBIOL INT, V15, P567, DOI 10.3109/07420529808993195; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hirsh J, 2010, CURR BIOL, V20, P209, DOI 10.1016/j.cub.2009.11.037; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Park D, 2006, J NEUROPHYSIOL, V95, P3955, DOI 10.1152/jn.00117.2006; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011	23	140	143	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1409	1413		10.1126/science.1199702	http://dx.doi.org/10.1126/science.1199702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21385718	Green Accepted			2022-12-24	WOS:000288504000033
J	Suzuki, A; Stern, SA; Bozdagi, O; Huntley, GW; Walker, RH; Magistretti, PJ; Alberini, CM				Suzuki, Akinobu; Stern, Sarah A.; Bozdagi, Ozlem; Huntley, George W.; Walker, Ruth H.; Magistretti, Pierre J.; Alberini, Cristina M.			Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation	CELL			English	Article							ELEMENT-BINDING PROTEIN; IMMEDIATE-EARLY GENE; D-SERINE; RAT HIPPOCAMPUS; GLYCOGEN; GLUCOSE; POTENTIATION; PLASTICITY; ACTIN; CONSOLIDATION	We report that, in the rat hippocampus, learning leads to a significant increase in extracellular lactate levels that derive from glycogen, an energy reserve selectively localized in astrocytes. Astrocytic glycogen breakdown and lactate release are essential for long-term but not short-term memory formation, and for the maintenance of long-term potentiation (LTP) of synaptic strength elicited in vivo. Disrupting the expression of the astrocytic lactate transporters monocarboxylate transporter 4 (MCT4) or MCT1 causes amnesia, which, like LTP impairment, is rescued by L-lactate but not equicaloric glucose. Disrupting the expression of the neuronal lactate transporter MCT2 also leads to amnesia that is unaffected by either L-lactate or glucose, suggesting that lactate import into neurons is necessary for long-term memory. Glycogenolysis and astrocytic lactate transporters are also critical for the induction of molecular changes required for memory formation, including the induction of phospho-CREB, Arc, and phospho-cofilin. We conclude that astrocyte-neuron lactate transport is required for long-term memory formation.	[Magistretti, Pierre J.] Univ Lausanne CHUV, Lab Neuroenerget & Cellular Dynam, Brain Mind Inst, EPFL, Lausanne, Switzerland; [Magistretti, Pierre J.] Univ Lausanne CHUV, Ctr Psychiat Neurosci, Lausanne, Switzerland; [Suzuki, Akinobu; Stern, Sarah A.; Bozdagi, Ozlem; Huntley, George W.; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Bozdagi, Ozlem; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Walker, Ruth H.] James J Peters VAMC, Dept Neurol, Bronx, NY 10468 USA; [Walker, Ruth H.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai	Magistretti, PJ (corresponding author), Univ Lausanne CHUV, Lab Neuroenerget & Cellular Dynam, Brain Mind Inst, EPFL, Lausanne, Switzerland.	pierre.magistretti@epfl.ch; cristina.alberini@mssm.edu	Stern, Sarah/AAV-6019-2021	Stern, Sarah/0000-0002-3033-8251; Magistretti, Pierre Julius/0000-0002-6678-320X; Huntley, George W./0000-0003-3645-6192	Department of Veterans Affairs;  [R01-MH065635];  [R01-MH074736];  [T32-MH087004]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074736, R01MH065635, T32MH087004] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants R01-MH065635 and R01-MH074736 to C. M. A., Department of Veterans Affairs Merit Award to R. H. W. and T32-MH087004 to S. A. S. We thank Rick Koch, Dhananjay Bambah-Mukku, Dillon Chen, Gabriella Pollonini, and Virginia Gao for technical support; and Reginald Miller and the Center for Comparative Medicine and Surgery facility at Mount Sinai School of Medicine for technical support. P.J.M. is the recipient of the Asterion Chair at Ecole Polytechnique Federale de Lausanne (EPFL).	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Clarke Donald D., 1994, P645; DiNuzzo M, 2010, J CEREBR BLOOD F MET, V30, P1895, DOI 10.1038/jcbfm.2010.151; DRINGEN R, 1993, BRAIN RES, V623, P208, DOI 10.1016/0006-8993(93)91429-V; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fray AE, 1996, J PHYSIOL-LONDON, V496, P49, DOI 10.1113/jphysiol.1996.sp021664; Ghosh A, 2005, J BIOL CHEM, V280, P11114, DOI 10.1074/jbc.M410894200; Gibbs ME, 2007, J NEUROSCI RES, V85, P3326, DOI 10.1002/jnr.21307; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hamprecht B., 2005, NEUROGLIA, V2, P202, DOI [10.1093/acprof:oso/9780195152227.003.0015, DOI 10.1093/ACPROF:OSO/9780195152227.003.0015]; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Jahanshahi M, 2008, SINGAP MED J, V49, P388; Jahanshahi M., 2008, AM J ANIM VET SCI, V3, P28; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kettenmann H, 2005, NEUROGLIA, DOI Oxford University Press; Klann E, 2008, NEUROBIOL LEARN MEM, V89, P247, DOI 10.1016/j.nlm.2007.08.009; Leutgeb JK, 2005, NEUROSCIENCE, V131, P601, DOI 10.1016/j.neuroscience.2004.12.002; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; MAGISTRETTI PJ, 1988, NEUROSCIENCE, V24, P367, DOI 10.1016/0306-4522(88)90338-7; MAGISTRETTI PJ, 2008, FUNDAMENTAL NEUROSCI, P271; Mantzur L, 2009, NEUROBIOL LEARN MEM, V91, P85, DOI 10.1016/j.nlm.2008.09.001; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McKenna M.C., 2006, BASIC NEUROCHEMISTRY, P531; McNay Ewan C, 2002, Behav Cogn Neurosci Rev, V1, P264, DOI 10.1177/1534582302238337; Messier C, 2004, EUR J PHARMACOL, V490, P33, DOI 10.1016/j.ejphar.2004.02.043; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Rex A, 2009, PHYSIOL BEHAV, V98, P467, DOI 10.1016/j.physbeh.2009.07.015; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; SOTELO C, 1968, J CELL BIOL, V36, P151, DOI 10.1083/jcb.36.1.151; Swanson RA, 1992, CAN J PHYSIOL PHARM, V70, P138; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Urrila AS, 2004, J SLEEP RES, V13, P111, DOI 10.1111/j.1365-2869.2004.00401.x; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Waagepetersen HS, 2000, NEUROCHEM INT, V36, P435, DOI 10.1016/S0197-0186(99)00146-1; Walls AB, 2008, J NEUROCHEM, V105, P1462, DOI 10.1111/j.1471-4159.2008.05250.x; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008	64	938	970	13	134	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					810	823		10.1016/j.cell.2011.02.018	http://dx.doi.org/10.1016/j.cell.2011.02.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376239	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000288007100018
J	Li, B; Piriz, J; Mirrione, M; Chung, CH; Proulx, CD; Schulz, D; Henn, F; Malinow, R				Li, Bo; Piriz, Joaquin; Mirrione, Martine; Chung, ChiHye; Proulx, Christophe D.; Schulz, Daniela; Henn, Fritz; Malinow, Roberto			Synaptic potentiation onto habenula neurons in the learned helplessness model of depression	NATURE			English	Article							MIDBRAIN DOPAMINE NEURONS; DORSAL RAPHE NUCLEUS; LATERAL HABENULA; ANIMAL-MODEL; TRYPTOPHAN DEPLETION; RESPONSES; BEHAVIOR; STRESS; RAT; STIMULATION	The cellular basis of depressive disorders is poorly understood(1). Recent studies in monkeys indicate that neurons in the lateral habenula (LHb), a nucleus that mediates communication between forebrain and midbrain structures, can increase their activity when an animal fails to receive an expected positive reward or receives a stimulus that predicts aversive conditions (that is, disappointment or anticipation of a negative outcome)(2-4). LHb neurons project to, and modulate, dopamine-rich regions, such as the ventral tegmental area (VTA)(2,5), that control reward-seeking behaviour(6) and participate in depressive disorders(7). Here we show that in two learned helplessness models of depression, excitatory synapses onto LHb neurons projecting to the VTA are potentiated. Synaptic potentiation correlates with an animal's helplessness behaviour and is due to an enhanced presynaptic release probability. Depleting transmitter release by repeated electrical stimulation of LHb afferents, using a protocol that can be effective for patients who are depressed(8,9), markedly suppresses synaptic drive onto VTA-projecting LHb neurons in brain slices and can significantly reduce learned helplessness behaviour in rats. Our results indicate that increased presynaptic action onto LHb neurons contributes to the rodent learned helplessness model of depression.	[Li, Bo; Piriz, Joaquin; Chung, ChiHye; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Neurosci, La Jolla, CA 92093 USA; [Li, Bo; Piriz, Joaquin; Chung, ChiHye; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Biol Sci, La Jolla, CA 92093 USA; [Li, Bo; Mirrione, Martine; Henn, Fritz] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Mirrione, Martine; Schulz, Daniela; Henn, Fritz] Brookhaven Natl Lab, Upton, NY 11973 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory	Li, B (corresponding author), Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Neurosci, 9500 Gilman Dr 0634, La Jolla, CA 92093 USA.	bli@cshl.edu; rmalinow@ucsd.edu	Schulz, Daniela/H-5625-2011	Chung, ChiHye/0000-0002-3104-2399; Piriz, Joaquin/0000-0002-4588-6568; Proulx, Christophe/0000-0001-6484-9677; Li, Bo/0000-0002-0154-3088	Dana Foundation; National Institute of Mental Health, National Institutes of Health [1R01MH091903-01]; Shiley-Marcos Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091903, R01MH091119, R01MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER	Dana Foundation; National Institute of Mental Health, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Shiley-Marcos Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Deisseroth for help and suggestions, A. Gifford and A. Biegon for sharing equipment and laboratory space, and members of the Malinow Lab and Li Lab for discussions. This study was supported by the Dana Foundation (B. L.), the Biobehavioral Research Awards for Innovative New Scientists (BRAINS) from the National Institute of Mental Health, National Institutes of Health (1R01MH091903-01) (B. L.) and the Shiley-Marcos Endowment (R.M.).	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; CALDECOTTHAZARD S, 1988, J NEUROSCI, V8, P1951; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/S0278-5846(84)80032-9; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; Mill J, 2007, MOL PSYCHIATR, V12, P799, DOI 10.1038/sj.mp.4001992; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Roiser JP, 2009, BIOL PSYCHIAT, V66, P441, DOI 10.1016/j.biopsych.2009.05.002; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Schulz D, 2010, NEUROBIOL LEARN MEM, V93, P291, DOI 10.1016/j.nlm.2009.11.003; Shumake J, 2003, Behav Cogn Neurosci Rev, V2, P198, DOI 10.1177/1534582303259057; Vollmayr B, 2001, BRAIN RES PROTOC, V8, P1, DOI 10.1016/S1385-299X(01)00067-8; Winter C, 2011, BEHAV BRAIN RES, V216, P463, DOI 10.1016/j.bbr.2010.07.034; Yang LM, 2008, BEHAV BRAIN RES, V188, P84, DOI 10.1016/j.bbr.2007.10.022; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	34	400	422	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					535	U125		10.1038/nature09742	http://dx.doi.org/10.1038/nature09742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350486	Green Accepted			2022-12-24	WOS:000287652900042
J	Heallen, T; Zhang, M; Wang, J; Bonilla-Claudio, M; Klysik, E; Johnson, RL; Martin, JF				Heallen, Todd; Zhang, Min; Wang, Jun; Bonilla-Claudio, Margarita; Klysik, Ela; Johnson, Randy L.; Martin, James F.			Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size	SCIENCE			English	Article							GROWTH; EXPRESSION; REGULATOR; LIVER	Genetic regulation of mammalian heart size is poorly understood. Hippo signaling represents an organ-size control pathway in Drosophila, where it also inhibits cell proliferation and promotes apoptosis in imaginal discs. To determine whether Hippo signaling controls mammalian heart size, we inactivated Hippo pathway components in the developing mouse heart. Hippo-deficient embryos had overgrown hearts with elevated cardiomyocyte proliferation. Gene expression profiling and chromatin immunoprecipitation revealed that Hippo signaling negatively regulates a subset of Wnt target genes. Genetic interaction studies indicated that beta-catenin heterozygosity suppressed the Hippo cardiomyocyte overgrowth phenotype. Furthermore, the Hippo effector Yap interacts with b-catenin on Sox2 and Snai2 genes. These data uncover a nuclear interaction between Hippo and Wnt signaling that restricts cardiomyocyte proliferation and controls heart size.	[Heallen, Todd; Zhang, Min; Wang, Jun; Bonilla-Claudio, Margarita; Klysik, Ela; Martin, James F.] Texas A&M Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center	Martin, JF (corresponding author), Texas A&M Syst Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	jmartin@ibt.tamhsc.edu		Heallen, Todd/0000-0002-6003-8743; Zhang, Min/0000-0001-7055-6790	NIH [T32 DE15355-04, R01HD052785, R01HD060579, AHA09PRE2150024, AHA10POST4140029]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD060579, R01HD052785] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE015355] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Epstein, S. Sasakura, T. Gridley, M. Sudol, F. Long, and B. Amendt for reagents. Supported by NIH grants (J. F. M. and R. L. J.), T32 DE15355-04 (M. B. C.), R01HD052785 and R01HD060579 (R. L. J.), AHA09PRE2150024 (J. W.), and AHA10POST4140029 (T. H.). Microarray data (accession number GSE27259) can be accessed at the Gene Expression Omnibus (GEO) repository (www.ncbi.nlm.nih.gov/geo/).	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358; Koyanagi M, 2010, CIRC RES, V106, P1290, DOI 10.1161/CIRCRESAHA.109.206045; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Tzahor E, 2007, DEV CELL, V13, P10, DOI 10.1016/j.devcel.2007.06.006; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007	15	718	752	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					458	461		10.1126/science.1199010	http://dx.doi.org/10.1126/science.1199010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512031	Green Accepted			2022-12-24	WOS:000289784900041
J	Suter, DM; Molina, N; Gatfield, D; Schneider, K; Schibler, U; Naef, F				Suter, David M.; Molina, Nacho; Gatfield, David; Schneider, Kim; Schibler, Ueli; Naef, Felix			Mammalian Genes Are Transcribed with Widely Different Bursting Kinetics	SCIENCE			English	Article							EXPRESSION; CELLS; TIME	In prokaryotes and eukaryotes, most genes appear to be transcribed during short periods called transcriptional bursts, interspersed by silent intervals. We describe how such bursts generate gene-specific temporal patterns of messenger RNA (mRNA) synthesis in mammalian cells. To monitor transcription at high temporal resolution, we established various gene trap cell lines and transgenic cell lines expressing a short-lived luciferase protein from an unstable mRNA, and recorded bioluminescence in real time in single cells. Mathematical modeling identified gene-specific on-and off-switching rates in transcriptional activity and mean numbers of mRNAs produced during the bursts. Transcriptional kinetics were markedly altered by cis-regulatory DNA elements. Our analysis demonstrated that bursting kinetics are highly gene-specific, reflecting refractory periods during which genes stay inactive for a certain time before switching on again.	[Suter, David M.; Gatfield, David; Schneider, Kim; Schibler, Ueli] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Suter, David M.; Gatfield, David; Schneider, Kim; Schibler, Ueli] Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland; [Molina, Nacho; Naef, Felix] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Molina, Nacho; Naef, Felix] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Gatfield, David] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; University of Lausanne	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	ueli.schibler@unige.ch; felix.naef@epfl.ch	Gatfield, David/C-2354-2011; Naef, Felix/C-9527-2011; Suter, David/S-9210-2019; Molina, Nacho/F-2244-2010	Gatfield, David/0000-0001-5114-2824; Suter, David/0000-0001-5644-4899; Naef, Felix/0000-0001-9786-3037; Molina, Nacho/0000-0003-0233-3055	Swiss National Science Foundation [SNF 31-113565, SNF 31-128656/1, 3100A0-113617, 31-130714]; NCCR; European Research Council [ERC-2009-AdG 20090506]; State of Geneva; Louis Jeantet Foundation of Medicine; Ecole Polytechnique Federale de Lausanne (EPFL)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); State of Geneva; Louis Jeantet Foundation of Medicine; Ecole Polytechnique Federale de Lausanne (EPFL)	We thank A. Liani and Y.-A. Poget for building a bioluminescence reader, C. Bauer and J. Bosset for help with time-lapse imaging, P. Salmon and D. Trono for providing lentiviral constructs, A. Oates for critical reading of the manuscript, and N. Roggli for the artwork. The computations were performed at Vital-IT (www.vital-it.ch). The U.S.'s laboratory was supported by the Swiss National Science Foundation (SNF 31-113565, SNF 31-128656/1, and the NCCR program grant Frontiers in Genetics), the European Research Council (ERC-2009-AdG 20090506), the State of Geneva, and the Louis Jeantet Foundation of Medicine. F. N.'s laboratory was supported by the Swiss National Science Foundation (SNF grants 3100A0-113617 and 31-130714) and the Ecole Polytechnique Federale de Lausanne (EPFL).	Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Octavio LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000673; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Tan RZ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.14; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	24	571	583	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					472	474		10.1126/science.1198817	http://dx.doi.org/10.1126/science.1198817			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21415320				2022-12-24	WOS:000289784900045
J	Rizzini, L; Favory, JJ; Cloix, C; Faggionato, D; O'Hara, A; Kaiserli, E; Baumeister, R; Schafer, E; Nagy, F; Jenkins, GI; Ulm, R				Rizzini, Luca; Favory, Jean-Jacques; Cloix, Catherine; Faggionato, Davide; O'Hara, Andrew; Kaiserli, Eirini; Baumeister, Ralf; Schaefer, Eberhard; Nagy, Ferenc; Jenkins, Gareth I.; Ulm, Roman			Perception of UV-B by the Arabidopsis UVR8 Protein	SCIENCE			English	Article							CHROMOSOME CONDENSATION; SIGNAL-TRANSDUCTION; RADIATION; LIGHT; PHOTOMORPHOGENESIS; COMPLEMENTATION; TRANSCRIPTION; ACCUMULATION; PROTECTION; REGULATOR	To optimize their growth and survival, plants perceive and respond to ultraviolet-B ( UV-B) radiation. However, neither the molecular identity of the UV-B photoreceptor nor the photoperception mechanism is known. Here we show that dimers of the UVR8 protein perceive UV-B, probably by a tryptophan-based mechanism. Absorption of UV-B induces instant monomerization of the photoreceptor and interaction with COP1, the central regulator of light signaling. Thereby this signaling cascade controlled by UVR8 mediates UV-B photomorphogenic responses securing plant acclimation and thus promotes survival in sunlight.	[Rizzini, Luca; Favory, Jean-Jacques; Faggionato, Davide; Baumeister, Ralf; Schaefer, Eberhard; Ulm, Roman] Univ Freiburg, Fac Biol, Inst Biol 2, D-79104 Freiburg, Germany; [Cloix, Catherine; O'Hara, Andrew; Kaiserli, Eirini; Jenkins, Gareth I.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Faggionato, Davide; Baumeister, Ralf] Univ Freiburg, Fac Med, ZBMZ, D-79104 Freiburg, Germany; [Baumeister, Ralf; Schaefer, Eberhard; Ulm, Roman] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Nagy, Ferenc] Biol Res Ctr, Inst Plant Biol, H-6726 Szeged, Hungary; [Nagy, Ferenc] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Ulm, Roman] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva 4, Switzerland	University of Freiburg; University of Glasgow; University of Freiburg; University of Freiburg; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Edinburgh; University of Geneva	Ulm, R (corresponding author), Univ Freiburg, Fac Biol, Inst Biol 2, D-79104 Freiburg, Germany.	roman.ulm@unige.ch	Rizzini, Luca/AAV-4799-2020; Nagy, Ferenc/D-3532-2015; Jenkins, Gareth I/B-4785-2010	Rizzini, Luca/0000-0001-6950-0167; Nagy, Ferenc/0000-0002-6157-9269; Faggionato, Davide/0000-0003-1999-4706; Cloix, Catherine/0000-0001-5666-7558; KAISERLI, EIRINI/0000-0003-1517-4591; Faggionato, Davide/0000-0003-0877-5479	UK Biotechnology and Biological Sciences Research Council; Leverhulme Trust; Scottish Universities Life Science Alliance and the Hungarian Scientific Research Fund [OTKA-81399]; Excellence Initiative of the German Federal and State Governments [EXC 294]; Deutsche Forschungsgemeinschaft [UL341/1-1];  [Sonderforschungsbereich (SFB) 592];  [SFB 746]; Biotechnology and Biological Sciences Research Council [BB/F014961/1] Funding Source: researchfish; BBSRC [BB/F014961/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); Scottish Universities Life Science Alliance and the Hungarian Scientific Research Fund; Excellence Initiative of the German Federal and State Governments; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank L.-O. Essen, J. Paszkowski, and T. Kunkel for helpful comments and advice, and P. King for editing the manuscript. This research was supported by grants from the UK Biotechnology and Biological Sciences Research Council and the Leverhulme Trust to G. I. J.; the Scottish Universities Life Science Alliance and the Hungarian Scientific Research Fund (OTKA-81399) to F.N.; the Sonderforschungsbereich (SFB) 592 to R. B.; the Excellence Initiative of the German Federal and State Governments (EXC 294) and the SFB 746 to R. B., E. S., and R. U.; and the Emmy Noether Programme of the Deutsche Forschungsgemeinschaft (grant UL341/1-1) to R. U.	Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Brown BA, 2009, PHOTOCHEM PHOTOBIOL, V85, P1147, DOI 10.1111/j.1751-1097.2009.00579.x; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537; Favory JJ, 2009, EMBO J, V28, P591, DOI 10.1038/emboj.2009.4; FLEISCHMANN M, 1991, MOL GEN GENET, V227, P417, DOI 10.1007/BF00273932; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Frohnmeyer H, 2003, PLANT PHYSIOL, V133, P1420, DOI 10.1104/pp.103.030049; Hiltbrunner A, 2005, CURR BIOL, V15, P2125, DOI 10.1016/j.cub.2005.10.042; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Kaiserli E, 2007, PLANT CELL, V19, P2662, DOI 10.1105/tpc.107.053330; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Oravecz A, 2006, PLANT CELL, V18, P1975, DOI 10.1105/tpc.105.040097; Paul ND, 2003, TRENDS ECOL EVOL, V18, P48, DOI 10.1016/S0169-5347(02)00014-9; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Rozema J, 1997, TRENDS ECOL EVOL, V12, P22, DOI 10.1016/S0169-5347(96)10062-8; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Tong HY, 2008, P NATL ACAD SCI USA, V105, P21039, DOI 10.1073/pnas.0809942106; Ulm R, 2005, CURR OPIN PLANT BIOL, V8, P477, DOI 10.1016/j.pbi.2005.07.004; Ulm R, 2004, P NATL ACAD SCI USA, V101, P1397, DOI 10.1073/pnas.0308044100; Wargent JJ, 2009, NEW PHYTOL, V183, P315, DOI 10.1111/j.1469-8137.2009.02855.x; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007	24	735	803	21	374	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					103	106		10.1126/science.1200660	http://dx.doi.org/10.1126/science.1200660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454788				2022-12-24	WOS:000289000000047
J	Sleeman, JP; Thiery, JP				Sleeman, Jonathan P.; Thiery, Jean Paul			SnapShot: The Epithelial-Mesenchymal Transition	CELL			English	Editorial Material							PROGRESSION; CANCER		[Thiery, Jean Paul] Biopolis ASTAR, IMCB, Singapore 138673, Singapore; [Thiery, Jean Paul] Biopolis ASTAR, Expt Therapeut Ctr, Singapore 138673, Singapore; [Thiery, Jean Paul] Canc Sci Inst, Singapore 117456, Singapore; [Sleeman, Jonathan P.] Heidelberg Univ, Med Fac Mannheim, D-68167 Mannheim, Germany; [Sleeman, Jonathan P.] Karlsruhe Inst Technol, D-76021 Karlsruhe, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Sleeman, JP (corresponding author), Biopolis ASTAR, IMCB, Singapore 138673, Singapore.		Sleeman, Jonathan P/H-2515-2013; Thiery, Jean Paul/M-9387-2019; Thiery, Jean Paul/H-1550-2011	Sleeman, Jonathan P/0000-0003-1718-7687; Thiery, Jean Paul/0000-0003-0478-5020				Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Whipple RA, 2010, CANCER RES, V70, P8127, DOI 10.1158/0008-5472.CAN-09-4613; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	10	97	101	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1							162.e1	10.1016/j.cell.2011.03.029	http://dx.doi.org/10.1016/j.cell.2011.03.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458675	Bronze			2022-12-24	WOS:000289053900020
J	Gaston, MA; Zhang, LW; Green-Church, KB; Krzycki, JA				Gaston, Marsha A.; Zhang, Liwen; Green-Church, Kari B.; Krzycki, Joseph A.			The complete biosynthesis of the genetically encoded amino acid pyrrolysine from lysine	NATURE			English	Article							TRANSFER-RNA SYNTHETASE; M METHYL TRANSFER; METHANOSARCINA-BARKERI; CORRINOID PROTEIN; METHYLTRANSFERASES; CODE; RECONSTITUTION; UAG; EXPANSION; ANALOGS	Pyrrolysine, the twenty-second amino acid found to be encoded in the natural genetic code(1-4), is necessary for all of the known pathways by which methane is formed from methylamines(5,6). Pyrrolysine comprises a methylated pyrroline carboxylate in amide linkage to the e-amino group of L-lysine(2,7,8). In certain Archaea, three methyltransferases initiate methanogenesis from the various methylamines(9-11), and these enzymes are encoded by genes with an in-frame amber codon(12,13) that is translated as pyrrolysine(2,7,8). Escherichia coli that has been transformed with the pylTSBCD genes from methanogenic Archaea can incorporate endogenously biosynthesized pyrrolysine into proteins(14). The decoding of UAG as pyrrolysine requires pylT(1,6), which produces tRNA(Pyl) (also called tRNA(CUA)), and pylS(1), which encodes a pyrrolysyl-tRNA synthetase(4,15,16). The pylB, pylC and pylD genes(1) are each required for tRNA-independent pyrrolysine synthesis(14). Pyrrolysine is the last remaining genetically encoded amino acid with an unknown biosynthetic pathway. Here we provide genetic and mass spectrometric evidence for a pylBCD-dependent pathway in which pyrrolysine arises from two lysines. We show that a newly uncovered UAG-encoded amino acid, desmethylpyrrolysine, is made from lysine and exogenous D-ornithine in a pylC-dependent process followed by a pylD-dependent process, but it is not further converted to pyrrolysine. These results indicate that the radical S-adenosyl-L-methionine (SAM) protein PylB mediates a lysine mutase reaction that produces 3-methylornithine, which is then ligated to a second molecule of lysine by PylC before oxidation by PylD results in pyrrolysine. The discovery of lysine as the sole precursor to pyrrolysine will further inform discussions of the evolution of the genetic code and amino acid biosynthetic pathways. Furthermore, intermediates of the pathway may provide new avenues by which the pyl system can be exploited to produce recombinant proteins with useful modified residues.	[Gaston, Marsha A.; Krzycki, Joseph A.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Zhang, Liwen; Green-Church, Kari B.] Ohio State Univ, Mass Spectrometry & Prote Facil, CCIC, Columbus, OH 43210 USA; [Krzycki, Joseph A.] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Krzycki, JA (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	krzycki.1@osu.edu	Zhang, Liwen/P-1111-2016; Green, Kari B/H-3541-2011		National Institutes of Health; US Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health to K.B.G.-C. and by grants from the US Department of Energy and the National Institutes of Health to J.A.K. The authors are grateful to D. Longstaff for preparing the tagged mtmB1 version of pDLBAD.	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Atkins JF, 2002, SCIENCE, V296, P1409, DOI 10.1126/science.1073339; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; Burke SA, 1997, J BIOL CHEM, V272, P16570, DOI 10.1074/jbc.272.26.16570; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Fekner T, 2009, ANGEW CHEM INT EDIT, V48, P1633, DOI 10.1002/anie.200805420; Ferguson DJ, 1997, J BACTERIOL, V179, P846, DOI 10.1128/jb.179.3.846-852.1997; Ferguson DJ, 2000, J BIOL CHEM, V275, P29053, DOI 10.1074/jbc.M910218199; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Hao B, 2004, CHEM BIOL, V11, P1317, DOI 10.1016/j.chembiol.2004.07.011; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Krzycki JA, 2004, CURR OPIN CHEM BIOL, V8, P484, DOI 10.1016/j.cbpa.2004.08.012; Krzycki JA, 2005, CURR OPIN MICROBIOL, V8, P706, DOI 10.1016/j.mib.2005.10.009; Li WT, 2009, J MOL BIOL, V385, P1156, DOI 10.1016/j.jmb.2008.11.032; Longstaff DG, 2007, P NATL ACAD SCI USA, V104, P1021, DOI 10.1073/pnas.0610294104; Mahapatra A, 2006, MOL MICROBIOL, V59, P56, DOI 10.1111/j.1365-2958.2005.04927.x; Namy O, 2007, FEBS LETT, V581, P5282, DOI 10.1016/j.febslet.2007.10.022; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Rother M, 2010, ARCHAEA, V2010, DOI 10.1155/2010/453642; Soares JA, 2005, J BIOL CHEM, V280, P36962, DOI 10.1074/jbc.M506402200; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Wong JTF, 2005, BIOESSAYS, V27, P416, DOI 10.1002/bies.20208; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Yanagisawa T, 2008, CHEM BIOL, V15, P1187, DOI 10.1016/j.chembiol.2008.10.004	30	82	92	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					647	U131		10.1038/nature09918	http://dx.doi.org/10.1038/nature09918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455182	Green Accepted			2022-12-24	WOS:000288951200045
J	Brown, NJ; Newell, CA; Stanley, S; Chen, JE; Perrin, AJ; Kajala, K; Hibberd, JM				Brown, Naomi J.; Newell, Christine A.; Stanley, Susan; Chen, Jit E.; Perrin, Abigail J.; Kajala, Kaisa; Hibberd, Julian M.			Independent and Parallel Recruitment of Preexisting Mechanisms Underlying C-4 Photosynthesis	SCIENCE			English	Article							GENE-EXPRESSION; PHOSPHOENOLPYRUVATE CARBOXYLASE; MAIZE; FLAVERIA; PLANT; MESOPHYLL; EVOLUTION; PROMOTER; RICE; GRASSES	C-4 photosynthesis allows increased photosynthetic efficiency because carbon dioxide (CO2) is concentrated around the key enzyme RuBisCO. Leaves of C-4 plants exhibit modified biochemistry, cell biology, and leaf development, but despite this complexity, C-4 photosynthesis has evolved independently in at least 45 lineages of plants. We found that two independent lineages of C-4 plant, whose last common ancestor predates the divergence of monocotyledons and dicotyledons about 180 million years ago, show conserved mechanisms controlling the expression of genes important for release of CO2 around RuBisCO in bundle sheath (BS) cells. Orthologous genes from monocotyledonous and dicotyledonous C-3 species also contained conserved regulatory elements that conferred BS specificity when placed into C-4 species. We conclude that these conserved functional genetic elements likely facilitated the repeated evolution of C-4 photosynthesis.	[Brown, Naomi J.; Newell, Christine A.; Stanley, Susan; Chen, Jit E.; Perrin, Abigail J.; Kajala, Kaisa; Hibberd, Julian M.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge	Hibberd, JM (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	julian.hibberd@plantsci.cam.ac.uk	Kajala, Kaisa/E-8345-2011	Kajala, Kaisa/0000-0001-6483-7473; Perrin, Abigail/0000-0001-6682-4297; Chen, Jit Ern/0000-0003-4779-7275	Leverhulme Trust; BBSRC; Biotechnology and Biological Sciences Research Council [P19982, BB/I002243/1] Funding Source: researchfish; BBSRC [BB/I002243/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Leverhulme Trust and BBSRC for funding; C. Weil for B73; and M. Patel, J. Berry, S. Brockington, and D. Bradley for advice. N.J.B., J. E. C., and K. K. generated constructs; N.J.B., S. S., J. E. C., and A. J. P. performed microprojectile bombardment; C.A.N. and N.J.B. generated and analyzed stable transformants; N.J.B. and S. S. performed hybridization in situ; and N.J.B. and J. M. H. designed the experiments, analyzed the data, and wrote the paper. The complete study was supervised by J. M. H. All authors discussed the results and commented on the manuscript.	Akyildiz M, 2007, PLANT CELL, V19, P3391, DOI 10.1105/tpc.107.053322; BANSAL KC, 1992, P NATL ACAD SCI USA, V89, P3654, DOI 10.1073/pnas.89.8.3654; BOWES G, 1971, BIOCHEM BIOPH RES CO, V45, P716, DOI 10.1016/0006-291X(71)90475-X; Brown NJ, 2010, PLANT J, V61, P122, DOI 10.1111/j.1365-313X.2009.04040.x; Brown NJ, 2005, TRENDS PLANT SCI, V10, P215, DOI 10.1016/j.tplants.2005.03.003; Christin PA, 2007, CURR BIOL, V17, P1241, DOI 10.1016/j.cub.2007.06.036; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Hibberd JM, 2002, NATURE, V415, P451, DOI 10.1038/415451a; Hibberd JM, 2008, CURR OPIN PLANT BIOL, V11, P228, DOI 10.1016/j.pbi.2007.11.002; Hibberd JM, 2010, ANNU REV PLANT BIOL, V61, P181, DOI 10.1146/annurev-arplant-042809-112238; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Majeran W, 2009, TRENDS PLANT SCI, V14, P100, DOI 10.1016/j.tplants.2008.11.006; Matsuoka M, 2001, ANNU REV PLANT PHYS, V52, P297, DOI 10.1146/annurev.arplant.52.1.297; MATSUOKA M, 1991, MOL GEN GENET, V228, P143, DOI 10.1007/BF00282459; Nomura M, 2005, PLANT CELL PHYSIOL, V46, P754, DOI 10.1093/pcp/pci078; Nomura M, 2000, PLANT MOL BIOL, V44, P99, DOI 10.1023/A:1006461812053; Patel M, 2006, J BIOL CHEM, V281, P25485, DOI 10.1074/jbc.M604162200; PRENDERGAST HDV, 1987, AUST J PLANT PHYSIOL, V14, P403, DOI 10.1071/PP9870403; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sawers RJH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-12; Sheen J, 1999, ANNU REV PLANT PHYS, V50, P187, DOI 10.1146/annurev.arplant.50.1.187; Sinha NR, 1996, AM J BOT, V83, P1458, DOI 10.2307/2446101; Stockhaus J, 1997, PLANT CELL, V9, P479; Voznesenskaya EV, 2001, NATURE, V414, P543, DOI 10.1038/35107073; Westhoff P, 2004, ANN BOT-LONDON, V93, P13, DOI 10.1093/aob/mch003	25	96	97	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1436	1439		10.1126/science.1201248	http://dx.doi.org/10.1126/science.1201248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415351				2022-12-24	WOS:000288504000041
J	Struck, TH; Paul, C; Hill, N; Hartmann, S; Hosel, C; Kube, M; Lieb, B; Meyer, A; Tiedemann, R; Purschke, G; Bleidorn, C				Struck, Torsten H.; Paul, Christiane; Hill, Natascha; Hartmann, Stefanie; Hoesel, Christoph; Kube, Michael; Lieb, Bernhard; Meyer, Achim; Tiedemann, Ralph; Purschke, Guenter; Bleidorn, Christoph			Phylogenomic analyses unravel annelid evolution	NATURE			English	Article							POLYCHAETES ANNELIDA; CHARACTER LOSS; LOPHOTROCHOZOA; POSITION; MYZOSTOMIDA; RECONSTRUCTION; SEGMENTATION; CLITELLATA; ACCURACY; MODELS	Annelida, the ringed worms, is a highly diverse animal phylum that includes more than 15,000 described species and constitutes the dominant benthic macrofauna from the intertidal zone down to the deep sea. A robust annelid phylogeny would shape our understanding of animal body-plan evolution and shed light on the bilaterian ground pattern. Traditionally, Annelida has been split into two major groups: Clitellata (earthworms and leeches) and polychaetes (bristle worms), but recent evidence suggests that other taxa that were once considered to be separate phyla (Sipuncula, Echiura and Siboglinidae (also known as Pogonophora)) should be included in Annelida(1-4). However, the deep-level evolutionary relationships of Annelida are still poorly understood, and a robust reconstruction of annelid evolutionary history is needed. Here we show that phylogenomic analyses of 34 annelid taxa, using 47,953 amino acid positions, recovered a well-supported phylogeny with strong support for major splits. Our results recover chaetopterids, myzostomids and sipunculids in the basal part of the tree, although the position of Myzostomida remains uncertain owing to its long branch. The remaining taxa are split into two clades: Errantia (which includes the model annelid Platynereis), and Sedentaria (which includes Clitellata). Ancestral character trait reconstructions indicate that these clades show adaptation to either an errant or a sedentary lifestyle, with alteration of accompanying morphological traits such as peristaltic movement, parapodia and sensory perception. Finally, life history characters in Annelida seem to be phylogenetically informative.	[Struck, Torsten H.; Hoesel, Christoph; Purschke, Guenter] Univ Osnabruck, Biol Chem FB05, AG Zool, D-49069 Osnabruck, Germany; [Paul, Christiane; Tiedemann, Ralph; Bleidorn, Christoph] Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, D-14476 Potsdam, Germany; [Hill, Natascha; Hartmann, Stefanie] Univ Potsdam, Inst Biochem & Biol, Unit Bioinformat, D-14476 Potsdam, Germany; [Kube, Michael] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Lieb, Bernhard; Meyer, Achim] Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany; [Bleidorn, Christoph] Univ Leipzig, Inst Biol Mol Evolut & Systemat Anim 2, D-04103 Leipzig, Germany	University Osnabruck; University of Potsdam; University of Potsdam; Max Planck Society; Johannes Gutenberg University of Mainz; Leipzig University	Struck, TH (corresponding author), Univ Osnabruck, Biol Chem FB05, AG Zool, Barbarastr 11, D-49069 Osnabruck, Germany.	struck@biologie.uni-osnabrueck.de; bleidorn@uni-leipzig.de	Meyer, Achim/AAE-9061-2021; Lieb, Bernhard/AFT-2157-2022; Hartmann, Stefanie/H-4413-2011; Purschke, Guenter/AAU-9660-2021	Purschke, Guenter/0000-0002-2572-3390; Tiedemann, Ralph/0000-0002-2604-6336; Bleidorn, Christoph/0000-0001-7295-6616; Meyer, Achim/0000-0002-4345-274X	marine biological stations in Bamfield; Helgoland; List and Roscoff for collection of annelids; Deutsche Forschungsgemeinschaft [DFG-STR 683/5-2, DFG-Pu-84/5-1, DFG-TI-349/4-1, DFG Li 998/3-1, DFG-HA 5744/1-1, DFG-BL-787/2-1]	marine biological stations in Bamfield; Helgoland; List and Roscoff for collection of annelids; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to I. Ebersberger, S. Strauss and A. von Haeseler for the processing of our raw EST libraries. We also thank M. Aguado for species identification of Typosyllis pigmentata, as well as K. M. Halanych and P. A. Ramey-Balci for suggestions. T.H.S. and C.B. acknowledge support from the marine biological stations in Bamfield, Helgoland, List and Roscoff for collection of annelids. This work was funded by the priority programme 'Deep Metazoan Phylogeny' of the Deutsche Forschungsgemeinschaft by grants DFG-STR 683/5-2 (T.H.S.), DFG-Pu-84/5-1 (G.P. and T.H.S.), DFG-TI-349/4-1 (R.T.), DFG Li 998/3-1 (B.L.), DFG-HA 5744/1-1 (S.H.) and DFG-BL-787/2-1 (C.B.).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; [Anonymous], 1967, MONOGRAPH POLYCHAE 1; [Anonymous], 2010, NCBI DBEST EXPR SEQ; [Anonymous], 2010, RIBOSOMAL PROTEIN GE; [Anonymous], 2010, EUK ORTH GROUPS 100; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bleidorn C, 2007, J ZOOL SYST EVOL RES, V45, P299, DOI 10.1111/j.1439-0469.2007.00425.x; Bleidorn C, 2007, MOL BIOL EVOL, V24, P1690, DOI 10.1093/molbev/msm086; Bleidorn C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-150; Bleidorn C, 2009, MOL PHYLOGENET EVOL, V52, P57, DOI 10.1016/j.ympev.2009.03.022; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Dordel J, 2010, J ZOOL SYST EVOL RES, V48, P197, DOI 10.1111/j.1439-0469.2010.00567.x; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Eeckhaut I, 2003, J MORPHOL, V258, P269, DOI 10.1002/jmor.10160; Eibye-Jacobsen D, 2004, LETHAIA, V37, P317, DOI 10.1080/00241160410002027; Erseus C, 2005, HYDROBIOLOGIA, V535, P357, DOI 10.1007/s10750-004-4426-x; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Fauvel P., 1923, Faune de France Paris, V5, P1; FAUVEL PIERRE, 1927, FAUNE DE FRANCE, V16, P1; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Hartmann-Schru┬der, 1996, ANNELIDA BORSTENW 58; Hausdorf B, 2007, MOL BIOL EVOL, V24, P2723, DOI 10.1093/molbev/msm214; Helmkampf M, 2008, P ROY SOC B-BIOL SCI, V275, P1927, DOI 10.1098/rspb.2008.0372; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Maddison, 2019, MESQUITE MODULAR SYS; McHugh D, 2005, HYDROBIOLOGIA, V535, P309, DOI 10.1007/s10750-004-4414-1; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Pattengale ND, 2009, LECT NOTES COMPUT SC, V5541, P184, DOI 10.1007/978-3-642-02008-7_13; Purschke G, 2000, J ZOOL SYST EVOL RES, V38, P165, DOI 10.1046/j.1439-0469.2000.383146.x; Purschke G, 2006, ARTHROPOD STRUCT DEV, V35, P211, DOI 10.1016/j.asd.2006.07.005; Quatrefages A. de, 1866, HIST NATURELLE ANNEL, V1; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Rambaut A, 2014, TRACER V1 6; Rivera AS, 2009, DEV GENES EVOL, V219, P37, DOI 10.1007/s00427-008-0264-6; Rouse G. W., 2001, POLYCHAETES; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Rouse GW, 1999, BIOL J LINN SOC, V66, P411, DOI 10.1006/bijl.1998.0278; Shain DH, 2009, ANNELIDS IN MODERN BIOLOGY, P1, DOI 10.1002/9780470455203; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Struck TH, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-22; Struck TH, 2008, MOL PHYLOGENET EVOL, V48, P628, DOI 10.1016/j.ympev.2008.05.015; Struck TH, 2008, MOL BIOL EVOL, V25, P728, DOI 10.1093/molbev/msn019; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Struck TH, 2006, INTEGR COMP BIOL, V46, P558, DOI 10.1093/icb/icj055; Suschenko D, 2009, ZOOMORPHOLOGY, V128, P75, DOI 10.1007/s00435-008-0075-3; Tessmar-Raible K, 2003, CURR OPIN GENET DEV, V13, P331, DOI 10.1016/S0959-437X(03)00086-8; Westheide W, 1997, J NAT HIST, V31, P1, DOI 10.1080/00222939700770011; Westheide W., 1996, SPEZIELLE ZOOLOGIE E; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; Wiens JJ, 1998, SYST BIOL, V47, P625, DOI 10.1080/106351598260635; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59; Zrzavy J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-189	55	323	342	7	263	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					95	U113		10.1038/nature09864	http://dx.doi.org/10.1038/nature09864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368831				2022-12-24	WOS:000287924100041
J	Himler, AG; Adachi-Hagimori, T; Bergen, JE; Kozuch, A; Kelly, SE; Tabashnik, BE; Chiel, E; Duckworth, VE; Dennehy, TJ; Zchori-Fein, E; Hunter, MS				Himler, Anna G.; Adachi-Hagimori, Tetsuya; Bergen, Jacqueline E.; Kozuch, Amaranta; Kelly, Suzanne E.; Tabashnik, Bruce E.; Chiel, Elad; Duckworth, Victoria E.; Dennehy, Timothy J.; Zchori-Fein, Einat; Hunter, Martha S.			Rapid Spread of a Bacterial Symbiont in an Invasive Whitefly Is Driven by Fitness Benefits and Female Bias	SCIENCE			English	Article							BEMISIA-TABACI; HEMIPTERA ALEYRODIDAE; AEDES-AEGYPTI; INFECTION; WOLBACHIA; RICKETTSIA; POPULATIONS; DROSOPHILA; DIVERSITY; INCOMPATIBILITY	Maternally inherited bacterial symbionts of arthropods are common, yet symbiont invasions of host populations have rarely been observed. Here, we show that Rickettsia sp. nr. bellii swept into a population of an invasive agricultural pest, the sweet potato whitefly, Bemisia tabaci, in just 6 years. Compared with uninfected whiteflies, Rickettsia-infected whiteflies produced more offspring, had higher survival to adulthood, developed faster, and produced a higher proportion of daughters. The symbiont thus functions as both mutualist and reproductive manipulator. The observed increased performance and sex-ratio bias of infected whiteflies are sufficient to explain the spread of Rickettsia across the southwestern United States. Symbiont invasions such as this represent a sudden evolutionary shift for the host, with potentially large impacts on its ecology and invasiveness.	[Himler, Anna G.; Adachi-Hagimori, Tetsuya; Bergen, Jacqueline E.; Kozuch, Amaranta; Kelly, Suzanne E.; Tabashnik, Bruce E.; Chiel, Elad; Duckworth, Victoria E.; Dennehy, Timothy J.; Hunter, Martha S.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Himler, Anna G.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; [Chiel, Elad; Zchori-Fein, Einat] Agr Res Org, Newe Yaar Res Ctr, Entomol Lab, IL-30095 Ramat Yishay, Israel; [Adachi-Hagimori, Tetsuya] Osaka Prefectural Govt, Res Inst Environm Agr & Fisheries, Osaka 5830862, Japan; [Dennehy, Timothy J.] Bayer Crop Sci Ltd Partnership, Global Insecticide Resistance Management, Res Triangle Pk, NC 27709 USA	University of Arizona; University of Arizona; Bayer AG; Bayer CropScience	Hunter, MS (corresponding author), Univ Arizona, Dept Entomol, Forbes 410, Tucson, AZ 85721 USA.	mhunter@ag.arizona.edu	Hunter, Martha/AAF-5288-2020; Hunter, Martha/B-7307-2012	Hunter, Martha/0000-0002-6342-675X; Hunter, Martha/0000-0002-6342-675X; Chiel, Elad/0000-0002-7146-3219	NIH [1K 12 GM00708]; United States-Israel Binational Agricultural Research and Development fellowship [GS-1-2007]; Binational (US-Israel) Science Foundation [2004416]; U.S. Department of Agriculture National Research Initiative Cooperative State Research, Education, and Extension Service [2006-35302-17165]; NSF [DEB-1020460]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development fellowship; Binational (US-Israel) Science Foundation(US-Israel Binational Science Foundation); U.S. Department of Agriculture National Research Initiative Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Kim, N. Doidge, N. Dowdy, and J. Garcia for technical help and V. Corby-Harris and M. Torabi for advice on analyses. We are grateful to K. Oliver for helpful comments on an earlier version of the manuscript. A. G. H. was funded by NIH training grant 1K 12 GM00708, and E. C. was funded in part by the United States-Israel Binational Agricultural Research and Development fellowship (GS-1-2007). This research was supported by Binational (US-Israel) Science Foundation grant 2004416 and U.S. Department of Agriculture National Research Initiative Cooperative State Research, Education, and Extension Service grant 2006-35302-17165 to M. S. H. and E.Z.-F. and NSF grant DEB-1020460 to M. S. H. and A. G. H. Sequences have been deposited in GenBank under accession numbers HQ439024 to HQ439027, HQ997365, and JF288560.	Aksoy S, 2008, ADV EXP MED BIOL, V627, P35, DOI 10.1007/978-0-387-78225-6_3; Behar A, 2010, APPL ENVIRON MICROB, V76, P2280, DOI 10.1128/AEM.00026-10; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chiel E, 2009, ANN ENTOMOL SOC AM, V102, P413, DOI 10.1603/008.102.0309; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dobson SL, 2002, GENETICS, V160, P1087; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Giorgini M, 2010, APPL ENVIRON MICROB, V76, P2589, DOI 10.1128/AEM.03154-09; Goodacre SL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-32; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOFFMANN AA, 1994, GENETICS, V136, P993; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Palumbo JC, 2001, CROP PROT, V20, P739, DOI 10.1016/S0261-2194(01)00117-X; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Schulenburg JHGV, 2002, GENETICS, V160, P1075; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2	30	331	366	7	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					254	256		10.1126/science.1199410	http://dx.doi.org/10.1126/science.1199410			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474763				2022-12-24	WOS:000289251100057
J	Chen, CF; Park, CH; Boudouris, BW; Horng, J; Geng, BS; Girit, C; Zettl, A; Crommie, MF; Segalman, RA; Louie, SG; Wang, F				Chen, Chi-Fan; Park, Cheol-Hwan; Boudouris, Bryan W.; Horng, Jason; Geng, Baisong; Girit, Caglar; Zettl, Alex; Crommie, Michael F.; Segalman, Rachel A.; Louie, Steven G.; Wang, Feng			Controlling inelastic light scattering quantum pathways in graphene	NATURE			English	Article							GEL GATE DIELECTRICS; CARBON NANOTUBES; RAMAN-SPECTROSCOPY; TRANSISTORS; ELECTRONS	Inelastic light scattering spectroscopy has, since its first discovery(1,2), been an indispensable tool in physical science for probing elementary excitations, such as phonons(3), magnons(4) and plasmons(5) in both bulk and nanoscale materials. In the quantum mechanical picture of inelastic light scattering, incident photons first excite a set of intermediate electronic states, which then generate crystal elementary excitations and radiate energy-shifted photons(6). The intermediate electronic excitations therefore have a crucial role as quantum pathways in inelastic light scattering, and this is exemplified by resonant Raman scattering(6) and Raman interference(7,8). The ability to control these excitation pathways can open up new opportunities to probe, manipulate and utilize inelastic light scattering. Here we achieve excitation pathway control in graphene with electrostatic doping. Our study reveals quantum interference between different Raman pathways in graphene: when some of the pathways are blocked, the one-phonon Raman intensity does not diminish, as commonly expected, but increases dramatically. This discovery sheds new light on the understanding of resonance Raman scattering in graphene. In addition, we demonstrate hot-electron luminescence9 in graphene as the Fermi energy approaches half the laser excitation energy. This hot luminescence, which is another form of inelastic light scattering, results from excited-state relaxation channels that become available only in heavily doped graphene.	[Chen, Chi-Fan; Park, Cheol-Hwan; Horng, Jason; Geng, Baisong; Girit, Caglar; Zettl, Alex; Crommie, Michael F.; Louie, Steven G.; Wang, Feng] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Boudouris, Bryan W.; Segalman, Rachel A.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Boudouris, Bryan W.; Zettl, Alex; Crommie, Michael F.; Segalman, Rachel A.; Louie, Steven G.; Wang, Feng] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wang, F (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	fengwang76@berkeley.edu	Girit, Çağlar/AFT-1507-2022; Park, Cheol-Hwan/A-1543-2009; Girit, Çağlar/D-4845-2014; Zettl, Alex K/O-4925-2016; wang, Feng/I-5727-2015; 5.4, ALS Beamline/I-2863-2014; 1.4, ALS Beamline/I-1886-2014	Girit, Çağlar/0000-0001-8953-9261; Park, Cheol-Hwan/0000-0003-1584-6896; Girit, Çağlar/0000-0001-8953-9261; Zettl, Alex K/0000-0001-6330-136X; wang, Feng/0000-0001-8369-6194; Segalman, Rachel/0000-0002-4292-5103	US Department of Energy, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Office of Basic Energy Sciences [DE-AC02-05CH11231, DE-AC03-76SF0098]; ONR MURI [N00014-09-1-1066]; National Science Council; National Tsing Hua University, Taiwan [NSC98-2811-M-007-008, NSC98-2120-M-007-004]	US Department of Energy, Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); ONR MURI(MURIOffice of Naval Research); National Science Council(Ministry of Science and Technology, Taiwan); National Tsing Hua University, Taiwan	This work was supported by the US Department of Energy, Laboratory Directed Research and Development Program of Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231 (C.-F.C. and F.W.), by the Office of Basic Energy Sciences under contract nos DE-AC02-05CH11231 (B.W.B. and R.A.S.), DE-AC03-76SF0098 (Materials Science Division) (C.G., A.Z.) and DE-AC02-05CH11231 (Advanced Light Source), and by ONR MURI award N00014-09-1-1066 (J.H., C.-H.P., S.G.L., M.F.C.). C.-F.C. also acknowledges fellowship support from the National Science Council and National Tsing Hua University, Taiwan, under awards NSC98-2811-M-007-008 and NSC98-2120-M-007-004.	Basko DM, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165413; Basko DM, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/095011; CARDONA M, 1982, LIGHT SCATTERING SOL, V1; Cho JH, 2008, NAT MATER, V7, P900, DOI 10.1038/nmat2291; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Devereaux TP, 2007, REV MOD PHYS, V79, P175, DOI 10.1103/RevModPhys.79.175; Dresselhaus MS, 2010, NANO LETT, V10, P751, DOI 10.1021/nl904286r; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; ELSAESSER T, 1991, PHYS REV LETT, V66, P1757, DOI 10.1103/PhysRevLett.66.1757; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; GONI AR, 1991, PHYS REV LETT, V67, P3298, DOI 10.1103/PhysRevLett.67.3298; Ilani S, 2006, NAT PHYS, V2, P687, DOI 10.1038/nphys412; Kashuba O, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.241404; Kim BJ, 2010, NANO LETT, V10, P3464, DOI 10.1021/nl101559n; Landsberg G, 1928, NATURWISSENSCHAFTEN, V16, P557; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Li ZQ, 2008, NAT PHYS, V4, P532, DOI 10.1038/nphys989; LUI CH, 2010, ULTRAFAST PHOTOLUMIN; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Pimenta MA, 2007, PHYS CHEM CHEM PHYS, V9, P1276, DOI 10.1039/b613962k; Pisana S, 2007, NAT MATER, V6, P198, DOI 10.1038/nmat1846; RALSTON JM, 1970, PHYS REV LETT, V25, P814, DOI 10.1103/PhysRevLett.25.814; Raman CV, 1928, NATURE, V121, P619, DOI 10.1038/121619b0; Rao AM, 1997, SCIENCE, V275, P187, DOI 10.1126/science.275.5297.187; STOEHR RJ, 2010, FLUORESCENCE LASER C; Wang CJ, 2001, SCIENCE, V291, P2390, DOI 10.1126/science.291.5512.2390; Wang F, 2008, SCIENCE, V320, P206, DOI 10.1126/science.1152793; Yan J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.166802; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105	30	450	459	9	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					617	620		10.1038/nature09866	http://dx.doi.org/10.1038/nature09866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21412234				2022-12-24	WOS:000288951200038
J	Woods, RJ; Barrick, JE; Cooper, TF; Shrestha, U; Kauth, MR; Lenski, RE				Woods, Robert J.; Barrick, Jeffrey E.; Cooper, Tim F.; Shrestha, Utpala; Kauth, Mark R.; Lenski, Richard E.			Second-Order Selection for Evolvability in a Large Escherichia coli Population	SCIENCE			English	Article							TERM EXPERIMENTAL EVOLUTION; ASEXUAL POPULATIONS; CLONAL INTERFERENCE; BENEFICIAL MUTATIONS; ADAPTATION; GENERATIONS; EPISTASIS; VIRUS	In theory, competition between asexual lineages can lead to second-order selection for greater evolutionary potential. To test this hypothesis, we revived a frozen population of Escherichia coli from a long-term evolution experiment and compared the fitness and ultimate fates of four genetically distinct clones. Surprisingly, two clones with beneficial mutations that would eventually take over the population had significantly lower competitive fitness than two clones with mutations that later went extinct. By replaying evolution many times from these clones, we showed that the eventual winners likely prevailed because they had greater potential for further adaptation. Genetic interactions that reduce the benefit of certain regulatory mutations in the eventual losers appear to explain, at least in part, why they were outcompeted.	[Woods, Robert J.; Lenski, Richard E.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Barrick, Jeffrey E.; Kauth, Mark R.; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Cooper, Tim F.; Shrestha, Utpala] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	Michigan State University; Michigan State University; University of Houston System; University of Houston	Barrick, JE (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	jbarrick@cm.utexas.edu; lenski@msu.edu	Barrick, Jeffrey/A-3046-2012	Barrick, Jeffrey/0000-0003-0888-7358; Cooper, Timothy/0000-0001-5038-9366; Lenski, Richard/0000-0002-1064-8375; Woods, Robert/0000-0002-0679-9998	NSF [DEB1019989]; Defense Advanced Research Projects Agency [HR0011-09-1-0055]; NIH [K99GM087550]; McDonnell Foundation [220020174]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM087550, R00GM087550] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NSF (DEB1019989 to R. E. L.), Defense Advanced Research Projects Agency (HR0011-09-1-0055 to R. E. L. and T. F. C), the NIH (K99GM087550 to J.E.B.), and the McDonnell Foundation (220020174 to T. F. C). We thank N. Hajela for laboratory assistance, staff at the Michigan State University (MSU) Research Technology Support Facility for assistance with genome sequencing, and the MSU High-Performance Computing Cluster for computational support. Genome sequencing data have been deposited in the NCBI Short Read Archive (SRA024331).	Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick JE, 2010, MOL BIOL EVOL, V27, P1338, DOI 10.1093/molbev/msq024; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; CHAO L, 1983, EVOLUTION, V37, P125, DOI 10.1111/j.1558-5646.1983.tb05521.x; Colegrave N, 2008, HEREDITY, V100, P464, DOI 10.1038/sj.hdy.6801095; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper TF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040035; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Crozat E, 2005, GENETICS, V169, P523, DOI 10.1534/genetics.104.035717; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Elena SF, 1997, EVOLUTION, V51, P1058, DOI 10.1111/j.1558-5646.1997.tb03953.x; Fogle CA, 2008, GENETICS, V180, P2163, DOI 10.1534/genetics.108.090019; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Hansen TF, 2006, ANNU REV ECOL EVOL S, V37, P123, DOI 10.1146/annurev.ecolsys.37.091305.110224; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; McBride RC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-231; Park SC, 2007, P NATL ACAD SCI USA, V104, P18135, DOI 10.1073/pnas.0705778104; Philippe N, 2007, BIOESSAYS, V29, P846, DOI 10.1002/bies.20629; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Rozen DE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001715; Sniegowski PD, 2010, PHILOS T R SOC B, V365, P1255, DOI 10.1098/rstb.2009.0290; Stanek MT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-302; Tenaillon O, 1999, GENETICS, V152, P485; Weinreich DM, 2005, EVOLUTION, V59, P1165; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200	30	221	225	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1433	1436		10.1126/science.1198914	http://dx.doi.org/10.1126/science.1198914			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415350	Green Accepted, Green Submitted			2022-12-24	WOS:000288504000040
J	Wickliffe, KE; Lorenz, S; Wemmer, DE; Kuriyan, J; Rape, M				Wickliffe, Katherine E.; Lorenz, Sonja; Wemmer, David E.; Kuriyan, John; Rape, Michael			The Mechanism of Linkage-Specific Ubiquitin Chain Elongation by a Single-Subunit E2	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; DEGRADATION; INSIGHTS; REVEALS; POLYUBIQUITINATION; PERFORMANCE; ACTIVATION; TARGETS; ENZYMES	Ubiquitin chains of different topologies trigger distinct functional consequences, including protein degradation and reorganization of complexes. The assembly of most ubiquitin chains is promoted by E2s, yet how these enzymes achieve linkage specificity is poorly understood. We have discovered that the K11-specific Ube2S orients the donor ubiquitin through an essential noncovalent interaction that occurs in addition to the thioester bond at the E2 active site. The E2-donor ubiquitin complex transiently recognizes the acceptor ubiquitin, primarily through electrostatic interactions. The recognition of the acceptor ubiquitin surface around Lys11, but not around other lysines, generates a catalytically competent active site, which is composed of residues of both Ube2S and ubiquitin. Our studies suggest that monomeric E2s promote linkage-specific ubiquitin chain formation through substrate-assisted catalysis.	[Wickliffe, Katherine E.; Lorenz, Sonja; Wemmer, David E.; Kuriyan, John; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Lorenz, S (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	slorenz@berkeley.edu; mrape@berkeley.edu	Lorenz, Sonja/AAL-4499-2020	Lorenz, Sonja/0000-0002-9639-2381; Rape, Michael/0000-0003-4849-6343	NIH [GM 68933, GM68933, RR15756, GM83064]; NSF [BBS 0119304, BBS 8720134]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM068933, R01GM083064] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003088] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. J. Meyer for Ub-L-cycA; A. Williamson for golden extracts; members of the Rape and Kuriyan labs, J. Winger, S. Kassube, and J. Kirsch for discussions; J. Schaletzky for reading the manuscript and suggestions; J. Pelton for help with NMR experiments; D. King and T. Iavarone for mass spectrometry; and the staff at beamline 12.3.1 at LBNL for technical support. NMR instrumentation and operation were supported by NIH-GM 68933, NIH GM68933, NSF BBS 0119304 and NIH RR15756, and NSF BBS 8720134. S. L. is a fellow of The Leukemia & Lymphoma Society. M. R. is a Pew fellow and is supported by NIH GM83064 and an NIH New Innovator Award.	Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Jung CR, 2006, NAT MED, V12, P809, DOI 10.1038/nm1440; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Sheinerman FB, 2002, J MOL BIOL, V318, P161, DOI 10.1016/S0022-2836(02)00030-X; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	30	213	216	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					769	781		10.1016/j.cell.2011.01.035	http://dx.doi.org/10.1016/j.cell.2011.01.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376237	Green Accepted, Bronze			2022-12-24	WOS:000288007100015
J	Bester, AC; Roniger, M; Oren, YS; Im, MM; Sarni, D; Chaoat, M; Bensimon, A; Zamir, G; Shewach, DS; Kerem, B				Bester, Assaf C.; Roniger, Maayan; Oren, Yifat S.; Im, Michael M.; Sarni, Dan; Chaoat, Malka; Bensimon, Aaron; Zamir, Gideon; Shewach, Donna S.; Kerem, Batsheva			Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; PAPILLOMAVIRUS TYPE-16 E6; CELL-CYCLE CHECKPOINT; DNA-DAMAGE; CERVICAL-CANCER; REPLICATION STRESS; MAMMALIAN-CELLS; ORIGIN CHOICE; FRAGILE SITE; CARCINOGENESIS	Chromosomal instability in early cancer stages is caused by stress on DNA replication. The molecular basis for replication perturbation in this context is currently unknown. We studied the replication dynamics in cells in which a regulator of S phase entry and cell proliferation, the Rb-E2F pathway, is aberrantly activated. Aberrant activation of this pathway by HPV-16 E6/E7 or cyclin E oncogenes significantly decreased the cellular nucleotide levels in the newly transformed cells. Exogenously supplied nucleosides rescued the replication stress and DNA damage and dramatically decreased oncogene-induced transformation. Increased transcription of nucleotide biosynthesis genes, mediated by expressing the transcription factor c-myc, increased the nucleotide pool and also rescued the replication-induced DNA damage. Our results suggest a model for early oncogenesis in which uncoordinated activation of factors regulating cell proliferation leads to insufficient nucleotides that fail to support normal replication and genome stability.	[Bester, Assaf C.; Roniger, Maayan; Oren, Yifat S.; Sarni, Dan; Kerem, Batsheva] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91905 Jerusalem, Israel; [Chaoat, Malka; Zamir, Gideon] Hebrew Univ Jerusalem, Dept Surg, Hadassah Med Sch, IL-91905 Jerusalem, Israel; [Im, Michael M.; Shewach, Donna S.] Univ Michigan, Dept Pharmacol, Med Ctr, Ann Arbor, MI 48109 USA; [Bensimon, Aaron] Genom Vis, F-75014 Paris, France	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Michigan System; University of Michigan	Kerem, B (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, Edmond J Safra Campus, IL-91905 Jerusalem, Israel.	kerem@cc.huji.ac.il	Bester, Assaf/ABG-1707-2021		Nachmias Foundation of the Hebrew University; Israeli Ministry of Science; Israel Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA076581, R01CA083081] Funding Source: NIH RePORTER	Nachmias Foundation of the Hebrew University; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Israel Ministry of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Prof. Levana Sherman for the LXSN vectors and for helpful advice, Dr. Tzipora Shlomai for the F1 cells, and Prof. Jiri Bartek for the pbabe-puro-cyclin E vector. This work was partially supported by a grant from the Nachmias Foundation of the Hebrew University, France-Israel program of the Israeli Ministry of Science, and the Israel Ministry of Health.	Akli S, 2003, CANCER BIOL THER, V2, pS38; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Bartkova J, 2010, ONCOGENE, V29, P5095, DOI 10.1038/onc.2010.249; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Coquelle A, 1998, MOL CELL, V2, P259, DOI 10.1016/S1097-2765(00)80137-9; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Duensing S, 2003, CRIT REV EUKAR GENE, V13, P9, DOI 10.1615/CritRevEukaryotGeneExpr.v13.i1.20; Duensing S, 2002, CANCER RES, V62, P7075; Flanagan SA, 2007, MOL CANCER THER, V6, P1858, DOI 10.1158/1535-7163.MCT-07-0068; Frame FM, 2006, ONCOGENE, V25, P3258, DOI 10.1038/sj.onc.1209352; Garcia-Closas R, 2005, INT J CANCER, V117, P629, DOI 10.1002/ijc.21193; Garner-Hamrick PA, 2004, J VIROL, V78, P9041, DOI 10.1128/JVI.78.17.9041-9050.2004; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Gross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058, DOI 10.1073/pnas.95.14.8058; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harris CP, 2003, GENE CHROMOSOME CANC, V36, P233, DOI 10.1002/gcc.10158; Herrick J, 1999, BIOCHIMIE, V81, P859, DOI 10.1016/S0300-9084(00)87170-9; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Klausner RD, 2002, CANCER CELL, V1, P3, DOI 10.1016/S1535-6108(02)00020-X; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Narisawa-Saito M, 2008, CANCER RES, V68, P5699, DOI 10.1158/0008-5472.CAN-07-6862; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Plug-DeMaggio AW, 2004, ONCOGENE, V23, P3561, DOI 10.1038/sj.onc.1207388; Rampersaud GC, 2002, J AM DIET ASSOC, V102, P1273, DOI 10.1016/S0002-8223(02)90281-6; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; SHEWACH DS, 1992, ANAL BIOCHEM, V206, P178, DOI 10.1016/S0003-2697(05)80030-2; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Thompson DA, 1997, ONCOGENE, V15, P3025, DOI 10.1038/sj.onc.1201495; Tsantoulis PK, 2008, ONCOGENE, V27, P3256, DOI 10.1038/sj.onc.1210989; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; YAN ZA, 1987, J MED GENET, V24, P593, DOI 10.1136/jmg.24.10.593	44	576	587	4	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					435	446		10.1016/j.cell.2011.03.044	http://dx.doi.org/10.1016/j.cell.2011.03.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529715	Bronze, Green Accepted			2022-12-24	WOS:000290022900012
J	Gascoigne, KE; Takeuchi, K; Suzuki, A; Hori, T; Fukagawa, T; Cheeseman, IM				Gascoigne, Karen E.; Takeuchi, Kozo; Suzuki, Aussie; Hori, Tetsuya; Fukagawa, Tatsuo; Cheeseman, Iain M.			Induced Ectopic Kinetochore Assembly Bypasses the Requirement for CENP-A Nucleosomes	CELL			English	Article							OUTER KINETOCHORE; MICROTUBULE INTERFACE; DNA-BINDING; CENTROMERE; COMPLEX; PROTEIN; CHROMATIN; IDENTIFICATION; RECOGNITION; CHROMOSOME	Accurate chromosome segregation requires assembly of the multiprotein kinetochore complex at centromeres. Although prior work identified the centromeric histone H3-variant CENP-A as the important upstream factor necessary for centromere specification, in human cells CENP-A is not sufficient for kinetochore assembly. Here, we demonstrate that two constitutive DNA-binding kinetochore components, CENP-C and CENP-T, function to direct kinetochore formation. Replacing the DNA-binding regions of CENP-C and CENP-T with alternate chromosome-targeting domains recruits these proteins to ectopic loci, resulting in CENP-A-independent kinetochore assembly. These ectopic kinetochore-like foci are functional based on the stoichiometric assembly of multiple kinetochore components, including the microtubule-binding KMN network, the presence of microtubule attachments, the microtubule-sensitive recruitment of the spindle checkpoint protein Mad2, and the segregation behavior of foci-containing chromosomes. We additionally find that CENP-T phosphorylation regulates the mitotic assembly of both endogenous and ectopic kinetochores. Thus, CENP-C and CENP-T form a critical regulated platform for vertebrate kinetochore assembly.	[Gascoigne, Karen E.; Cheeseman, Iain M.] MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Gascoigne, Karen E.; Cheeseman, Iain M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Takeuchi, Kozo; Suzuki, Aussie; Hori, Tetsuya; Fukagawa, Tatsuo] Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; [Takeuchi, Kozo; Suzuki, Aussie; Hori, Tetsuya; Fukagawa, Tatsuo] Grad Univ Adv Studies, Mishima, Shizuoka 4118540, Japan	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Cheeseman, IM (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA.	icheese@wi.mit.edu	Fukagawa, Tatsuo/AAK-3922-2021; Suzuki, Aussie/ABF-4170-2021	Suzuki, Aussie/0000-0001-7390-5116; Cheeseman, Iain/0000-0002-3829-5612; Takeuchi, Kozo/0000-0003-2531-9264	Massachusetts Life Sciences Center; Searle Scholars Program; NIH/National Institute of General Medical Sciences [GM088313]; EMBO long-term fellowship; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088313] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22570008] Funding Source: KAKEN	Massachusetts Life Sciences Center; Searle Scholars Program; NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Mike Lampson, Rick Young, Terry Orr-Weaver, David Page, Stephen Taylor, and members of the Cheeseman and Hochwagen labs for helpful discussions and critical reading of the manuscript and the anonymous reviewers for constructive suggestions. This work was supported by awards to I.M.C. from the Massachusetts Life Sciences Center and the Searle Scholars Program and a grant from the NIH/National Institute of General Medical Sciences to I.M.C. (GM088313). I.M.C. is a Thomas D. and Virginia W. Cabot Career Development Professor of Biology. K.E.G. is supported by an EMBO long-term fellowship. Work in the Fukagawa Lab was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to T.F.	Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Gascoigne KE, 2011, CURR OPIN CELL BIOL, V23, P102, DOI 10.1016/j.ceb.2010.07.007; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Masumoto H, 1998, CHROMOSOMA, V107, P406, DOI 10.1007/s004120050324; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Shang WH, 2010, GENOME RES, V20, P1219, DOI 10.1101/gr.106245.110; SUGIMOTO K, 1994, J BIOCHEM-TOKYO, V116, P877, DOI 10.1093/oxfordjournals.jbchem.a124610; Suzuki A, 2011, J CELL BIOL, V193, P125, DOI 10.1083/jcb.201012050; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Yang CH, 1996, MOL CELL BIOL, V16, P3576	35	247	252	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					410	422		10.1016/j.cell.2011.03.031	http://dx.doi.org/10.1016/j.cell.2011.03.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529714	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000290022900010
J	Ashworth, A; Lord, CJ; Reis, JS				Ashworth, Alan; Lord, Christopher J.; Reis-Filho, Jorge S.			Genetic Interactions in Cancer Progression and Treatment	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; BREAST-CANCER; EXPRESSION PROFILES; STEM-CELLS; GENOME; TUMORS; RESISTANCE; MUTATIONS; THERAPY; INHIBITORS	As cancer cell genomes are unveiled at a breathtaking pace, the genetic principles at play in cancer are emerging in all their complexity, prompting the assessment of classical genetic interaction models. Here, we discuss the implications of these findings for cancer progression and heterogeneity and for the development of new therapeutic approaches.	[Ashworth, Alan; Lord, Christopher J.; Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Ashworth, A (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, Fulham Rd, London SW3 6JB, England.	alan.ashworth@icr.ac.uk; chris.lord@icr.ac.uk; jorge.reis-filho@icr.ac.uk	Lord, Christopher/AAX-7130-2021; Lord, Christopher J/B-3295-2012	Lord, Christopher J/0000-0002-3226-0515	NHS; CRUK	NHS; CRUK(Cancer Research UK)	We thank Breakthrough Breast Cancer, Cancer Research UK, The Breast Cancer Campaign, The Breast Cancer Research Foundation, AACR, and The Komen Foundation for their continued support. We acknowledge NHS funding to the NIHR Royal Marsden Hospital Biomedical Research Centre. J.S.R.-F. is the recipient of the 2010 CRUK Future Leaders Prize.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Ashworth A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003327; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Davies MA, 2010, ONCOGENE, V29, P5545, DOI 10.1038/onc.2010.323; Davies M, 2006, EXPERT OPIN PHARMACO, V7, P2243, DOI 10.1517/14656566.7.16.2243; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; DOBZHANSKY T, 1946, GENETICS, V31, P269; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foulkes WD, 2010, NAT REV CLIN ONCOL, V7, P348, DOI 10.1038/nrclinonc.2010.39; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lord CJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-38; LUCCHESI JC, 1968, GENETICS, V59, P37; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	61	292	299	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					30	38		10.1016/j.cell.2011.03.020	http://dx.doi.org/10.1016/j.cell.2011.03.020			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458666	Bronze			2022-12-24	WOS:000289053900007
J	Windbichler, N; Menichelli, M; Papathanos, PA; Thyme, SB; Li, H; Ulge, UY; Hovde, BT; Baker, D; Monnat, RJ; Burt, A; Crisanti, A				Windbichler, Nikolai; Menichelli, Miriam; Papathanos, Philippos Aris; Thyme, Summer B.; Li, Hui; Ulge, Umut Y.; Hovde, Blake T.; Baker, David; Monnat, Raymond J., Jr.; Burt, Austin; Crisanti, Andrea			A synthetic homing endonuclease-based gene drive system in the human malaria mosquito	NATURE			English	Article							SPECIFICITY; BINDING; TRANSMISSION; DERIVATIVES; GENERATION; CONVERSION; PROTEIN	Genetic methods of manipulating or eradicating disease vector populations have long been discussed as an attractive alternative to existing control measures because of their potential advantages in terms of effectiveness and species specificity(1-3). The development of genetically engineered malaria-resistant mosquitoes has shown, as a proof of principle, the possibility of targeting the mosquito's ability to serve as a disease vector(4-7). The translation of these achievements into control measures requires an effective technology to spread a genetic modification from laboratory mosquitoes to field populations(8). We have suggested previously that homing endonuclease genes (HEGs), a class of simple selfish genetic elements, could be exploited for this purpose(9). Here we demonstrate that a synthetic genetic element, consisting of mosquito regulatory regions(10) and the homing endonuclease gene I-SceI(11-13), can substantially increase its transmission to the progeny in transgenic mosquitoes of the human malaria vector Anopheles gambiae. We show that the I-SceI element is able to invade receptive mosquito cage populations rapidly, validating mathematical models for the transmission dynamics of HEGs. Molecular analyses confirm that expression of I-SceI in the male germline induces high rates of site-specific chromosomal cleavage and gene conversion, which results in the gain of the I-SceI gene, and underlies the observed genetic drive. These findings demonstrate a new mechanism by which genetic control measures can be implemented. Our results also show in principle how sequence-specific genetic drive elements like HEGs could be used to take the step from the genetic engineering of individuals to the genetic engineering of populations.	[Windbichler, Nikolai; Menichelli, Miriam; Papathanos, Philippos Aris; Burt, Austin; Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Thyme, Summer B.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Thyme, Summer B.; Baker, David] Univ Washington, Grad Program Biomol Struct & Design, Seattle, WA 98195 USA; [Li, Hui; Ulge, Umut Y.; Monnat, Raymond J., Jr.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Ulge, Umut Y.; Monnat, Raymond J., Jr.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Hovde, Blake T.; Monnat, Raymond J., Jr.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Burt, Austin] Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Crisanti, Andrea] Univ Perugia, Dept Expt Med, I-06122 Perugia, Italy	Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Imperial College London; University of Perugia	Crisanti, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, S Kensington Campus, London SW7 2AZ, England.	a.drcrisanti@imperial.ac.uk	Li, Hui/E-8866-2010; Papathanos, Philippos/ABE-4869-2021; Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Li, Hui/0000-0002-2980-2491; Ulge, Umut/0000-0002-3745-0668; Papathanos, Philippos Aris/0000-0001-8508-4554; Windbichler, Nikolai/0000-0001-9896-1165; Hovde, Blake/0000-0002-7112-3310; Thyme, Summer/0000-0003-3593-4148; Burt, Austin/0000-0001-5146-9640; Crisanti, Andrea/0000-0002-2406-4426	Foundation for the National Institutes of Health through Grand Challenges in Global Health initiative; NIH [GM084433, CA133831]; NATIONAL CANCER INSTITUTE [T32CA080416, RL1CA133831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084433] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Ashburner, S. Russell, D. Huen and S. Chan for comments, assistance and for plasmids. We thank M. P. Calos for providing the pET11phiC31polyA plasmid. We thank M. J. Fraser Jr for providing the pBSII-IFP2-orf plasmid. We thank J. Meredith and P. Eggleston for providing the docking strain. We thank A. Hall, T. Nolan, K. Magnusson, D. Rogers and S. Fuchs for assistance. We thank S. Arshiya Quadri and M. Szeto for experimental support and the members of the laboratories of D. Baker, R. Monnat, A. Scharenberg and B. Stoddard for their collective support of HEG engineering. A. F. M. Hackmann provided graphics support. Funded by a grant from the Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative and by NIH RL1 awards GM084433 to D.B. and CA133831 to R.J.M.	Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Bellaiche Y, 1999, GENETICS, V152, P1037; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Catteruccia F, 2005, NAT BIOTECHNOL, V23, P1414, DOI 10.1038/nbt1152; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Goddard MR, 2001, P ROY SOC B-BIOL SCI, V268, P2537, DOI 10.1098/rspb.2001.1830; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jarjour J, 2009, NUCLEIC ACIDS RES, V37, P6871, DOI 10.1093/nar/gkp726; Li FW, 2005, J INFECT DIS, V192, P878, DOI 10.1086/432552; Li H, 2009, NUCLEIC ACIDS RES, V37, P1650, DOI 10.1093/nar/gkp004; Lobo NF, 2006, NAT PROTOC, V1, P1312, DOI 10.1038/nprot.2006.221; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Munoz IG, 2011, NUCLEIC ACIDS RES, V39, P729, DOI 10.1093/nar/gkq801; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Rosen LE, 2006, NUCLEIC ACIDS RES, V34, P4791, DOI 10.1093/nar/gkl645; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thyme SB, 2009, NATURE, V461, P1300, DOI 10.1038/nature08508; Ulge UY, 2011, NUCLEIC ACIDS RES, V39, P4330, DOI 10.1093/nar/gkr022; Windbichler N, 2007, NUCLEIC ACIDS RES, V35, P5922, DOI 10.1093/nar/gkm632	40	237	254	1	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					212	+		10.1038/nature09937	http://dx.doi.org/10.1038/nature09937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21508956	Green Accepted, Green Submitted			2022-12-24	WOS:000290487200038
J	Esvelt, KM; Carlson, JC; Liu, DR				Esvelt, Kevin M.; Carlson, Jacob C.; Liu, David R.			A system for the continuous directed evolution of biomolecules	NATURE			English	Article							T7 RNA-POLYMERASE; START SITE SELECTION; PHAGE; TRANSCRIPTION; RECOGNITION; INITIATION; VECTORS; MUTANTS; YEAST; ASSAY	Laboratory evolution has generated many biomolecules with desired properties, but a single round of mutation, gene expression, screening or selection, and replication typically requires days or longer with frequent human intervention(1). Because evolutionary success is dependent on the total number of rounds performed(2), a means of performing laboratory evolution continuously and rapidly could dramatically enhance its effectiveness(3). Although researchers have accelerated individual steps in the evolutionary cycle(4-9), the only previous example of continuous directed evolution was the landmark study of Wright and Joyce(10), who continuously evolved RNA ligase ribozymes with an in vitro replication cycle that unfortunately cannot be easily adapted to other biomolecules. Here we describe a system that enables the continuous directed evolution of gene-encoded molecules that can be linked to protein production in Escherichia coli. During phage-assisted continuous evolution (PACE), evolving genes are transferred from host cell to host cell through a modified bacteriophage life cycle in a manner that is dependent on the activity of interest. Dozens of rounds of evolution can occur in a single day of PACE without human intervention. Using PACE, we evolved T7 RNA polymerase (RNAP) variants that recognize a distinct promoter, initiate transcripts with ATP instead of GTP, and initiate transcripts with CTP. In one example, PACE executed 200 rounds of protein evolution over the course of 8 days. Starting from undetectable activity levels in two of these cases, enzymes with each of the three target activities emerged in less than 1 week of PACE. In all three cases, PACE-evolved polymerase activities exceeded or were comparable to that of the wild-type T7 RNAP on its wild-type promoter, representing improvements of up to several hundred-fold. By greatly accelerating laboratory evolution, PACE may provide solutions to otherwise intractable directed evolution problems and address novel questions about molecular evolution.	[Carlson, Jacob C.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Esvelt, Kevin M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022	Esvelt, Kevin/0000-0001-8797-3945	National Institutes of Health/National Institute of General Medical Sciences [R01 GM065400]; HHMI; Hertz Foundation; National Science Foundation; Harvard Chemical Biology Graduate Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065400] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHMI(Howard Hughes Medical Institute); Hertz Foundation; National Science Foundation(National Science Foundation (NSF)); Harvard Chemical Biology Graduate Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences R01 GM065400 and by HHMI. K. M. E. acknowledges graduate research fellowships from the Hertz Foundation and the National Science Foundation. J.C.C. was supported by the Harvard Chemical Biology Graduate Program. We thank B. Dorr for assistance with phage generation modelling, E. Curtis for suggestions and V. D'Souza for plasmid pT7-911Q.	Baker K, 2002, P NATL ACAD SCI USA, V99, P16537, DOI 10.1073/pnas.262420099; Brieba LG, 2002, BIOCHEMISTRY-US, V41, P5144, DOI 10.1021/bi016057v; Calendar R., 2006, BACTERIOPHAGES; Camps M, 2003, P NATL ACAD SCI USA, V100, P9727, DOI 10.1073/pnas.1333928100; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis JN, 2010, J VIROL, V84, P1625, DOI 10.1128/JVI.01747-09; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Husimi Y, 1989, Adv Biophys, V25, P1, DOI 10.1016/0065-227X(89)90003-8; Ichetovkin IE, 1997, J BIOL CHEM, V272, P33009, DOI 10.1074/jbc.272.52.33009; IKEDA RA, 1993, BIOCHEMISTRY-US, V32, P9115, DOI 10.1021/bi00086a016; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Kuzmine I, 2003, J BIOL CHEM, V278, P2819, DOI 10.1074/jbc.M208405200; Makeyev EV, 2004, J VIROL, V78, P2114, DOI 10.1128/JVI.78.4.2114-2120.2004; MARTIN CT, 1987, BIOCHEMISTRY-US, V26, P2690, DOI 10.1021/bi00384a006; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; NELSON FK, 1981, VIROLOGY, V108, P338, DOI 10.1016/0042-6822(81)90442-6; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Rakonjac J, 1998, J MOL BIOL, V282, P25, DOI 10.1006/jmbi.1998.2006; RASKIN CA, 1993, P NATL ACAD SCI USA, V90, P3147, DOI 10.1073/pnas.90.8.3147; RASKIN CA, 1992, J MOL BIOL, V228, P506, DOI 10.1016/0022-2836(92)90838-B; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Vidal-Aroca F, 2006, BIOTECHNIQUES, V40, P433, DOI 10.2144/000112145; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wright MC, 1997, SCIENCE, V276, P614, DOI 10.1126/science.276.5312.614; Yuan L, 2005, MICROBIOL MOL BIOL R, V69, P373, DOI 10.1128/MMBR.69.3.373-392.2005	32	360	433	27	431	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					499	U550		10.1038/nature09929	http://dx.doi.org/10.1038/nature09929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21478873	Green Accepted			2022-12-24	WOS:000289949600040
J	Lawn, JE; Blencowe, H; Pattinson, R; Cousens, S; Kumar, R; Ibiebele, I; Gardosi, J; Day, LT; Stanton, C				Lawn, Joy E.; Blencowe, Hannah; Pattinson, Robert; Cousens, Simon; Kumar, Rajesh; Ibiebele, Ibinabo; Gardosi, Jason; Day, Louise T.; Stanton, Cynthia		Lancet's Stillbirths Series Steeri	Stillbirths 2 Stillbirths: Where? When? Why? How to make the data count?	LANCET			English	Article							4-MILLION NEONATAL DEATHS; PERINATAL-MORTALITY; INTRAPARTUM STILLBIRTHS; MATERNAL MORTALITY; PRETERM BIRTH; SURVIVAL 1; HEALTH; CARE; CLASSIFICATION; FETAL	Despite increasing attention and investment for maternal, neonatal, and child health, stillbirths remain invisible not counted in the Millennium Development Goals, nor tracked by the UN, nor in the Global Burden of Disease metrics. At least 2.65 million stillbirths (uncertainty range 2.08 million to 3.79 million) were estimated worldwide in 2008 (>= 1000 g birthweight or >= 28 weeks of gestation). 98% of stillbirths occur in low-income and middle-income countries, and numbers vary from 2.0 per 1000 total births in Finland to more than 40 per 1000 total births in Nigeria and Pakistan. Worldwide, 67% of stillbirths occur in rural families, 55% in rural sub-Saharan Africa and south Asia, where skilled birth attendance and caesarean sections are much lower than that for urban births. In total, an estimated 1.19 million (range 0.82 million to 1.97 million) intrapartum stillbirths occur yearly. Most intrapartum stillbirths are associated with obstetric emergencies, whereas antepartum stillbirths are associated with maternal infections and fetal growth restriction. National estimates of causes of stillbirths are scarce, and multiple (>35) classification systems impede international comparison. Immediate data improvements are feasible through household surveys and facility audit, and improvements in vital registration, including specific perinatal certificates and revised International Classification of Disease codes, are needed. A simple, programme-relevant stillbirth classification that can be used with verbal autopsy would provide a basis for comparable national estimates. A new focus on all deaths around the time of birth is crucial to inform programmatic investment.	[Lawn, Joy E.] Saving Newborn Lives Save Children, Cape Town, South Africa; [Lawn, Joy E.] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Lawn, Joy E.] Inst Child Hlth, London, England; [Blencowe, Hannah; Cousens, Simon] London Sch Hyg & Trop Med, London WC1, England; [Pattinson, Robert] Univ Pretoria, Dept Obstet & Gynaecol, MRC, Maternal & Infant Hlth Care Strategies Res Unit, ZA-0002 Pretoria, South Africa; [Kumar, Rajesh] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Ibiebele, Ibinabo] Mater Med Res Inst, Brisbane, Qld, Australia; [Gardosi, Jason] W Midlands Perinatal Inst, Birmingham, W Midlands, England; [Day, Louise T.] LAMB Hosp, Parbatipur, Bangladesh; [Stanton, Cynthia] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Save the Children; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Pretoria; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Mater Research; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lawn, JE (corresponding author), 11 South Way, ZA-7405 Cape Town, South Africa.	joylawn@yahoo.co.uk	Lawn, Joy/ABE-6382-2020; Flenady, Vicki Jane/O-9609-2014; Gardosi, Jason/GXN-1375-2022; Blencowe, Hannah/K-7415-2012	Lawn, Joy/0000-0002-4573-1443; Flenady, Vicki Jane/0000-0001-8114-7677; Froen Froen, Jahn Frederik/0000-0001-9390-8509; Gardosi, Jason/0000-0002-3230-1292; Blencowe, Hannah/0000-0003-1556-3159; Ibiebele, Ibinabo/0000-0001-6024-2958	Bill & Melinda Gates Foundation; Global Alliance to Prevent Prematurity and Stillbirths	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Global Alliance to Prevent Prematurity and Stillbirths	Some of the technical work for this paper during 2010 was funded through a grant from the Bill & Melinda Gates Foundation to the International Stillbirth Alliance secretariat for this series. JELLS funded by the Bill & Melinda Gates Foundation via Saving Newborn Lives/Save the Children. CS was partly funded by the Global Alliance to Prevent Prematurity and Stillbirths. The views expressed herein are solely those of the authors. We thank the team involved in the stillbirth rate estimates (Doris Chou, Saifuddin Ahmed, Laura Steinhardt, Andreea A Creanga, Ozge Tuncalp, Zohra Patel Balsara, Shivam Gupta, and Lale Say); Vicki Flenady, J Frederik Froen, and their team for the stillbirth cause and condition data from high-income countries; Felicity Mussell as the perinatal audit coordinator at LAMB Hospital, Bangladesh; Mikkel Oestergaard and Florence Rusciano at WHO for assistance with figure 2, the 20 scorers for the GHNRI research priority setting exercise (Romano Byaruhanga, Hannah Blencowe, Simon Cousens, Gary L Darmstadt, Louise T Day, Karen Edmond, Vincent Fauveau, Alfredo Fort, J Frederik Froen, Ron Gray, Rachel Haws, G Justus Hofmeyr, Jane Hirst, Mary Kamb, Anne C C Lee, Elizabeth M McClure, Nafissa Bique Osman, Robert Pattinson, Sonia Lansky, and Dave Woods);	AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; ACOLET D, 2008, 7 CONF ENQ MAT CHILD; Aggarwal AK, 2011, B WORLD HEALTH ORGAN, V89, P31, DOI 10.2471/BLT.10.076828; Aisien AO, 2000, INT J GYNECOL OBSTET, V71, P171, DOI 10.1016/S0020-7292(00)00214-9; AKPALA CO, 1993, J ROY SOC HEALTH, V113, P124, DOI 10.1177/146642409311300306; Ananth CV, 2009, INT J EPIDEMIOL, V38, P480, DOI 10.1093/ije/dyn194; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BARSON AJ, 1984, ARCH DIS CHILD, V59, P199, DOI 10.1136/adc.59.3.199; Bhutta Z, 2004, BRIT MED J, V328, P777, DOI 10.1136/bmj.328.7443.777; BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Campbell Oona, 2004, J Perinatol, V24, P284, DOI 10.1038/sj.jp.7211084; Costeloe K, 2006, BJOG-INT J OBSTET GY, V113, P10, DOI 10.1111/j.1471-0528.2006.01118.x; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; *CTR MAT CHILD ENQ, PER MORT 2008; DAVID RJ, 1983, PEDIATRICS, V71, P531; Doyal L, 2004, B WORLD HEALTH ORGAN, V82, P162; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P430, DOI 10.1111/j.1365-3016.2008.00961.x; Edouard L, 1985, World Health Stat Q, V38, P289; Fauveau V, 2007, LANCET, V370, P1310, DOI 10.1016/S0140-6736(07)61571-2; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Froen JF, 2001, AM J OBSTET GYNECOL, V184, P694, DOI 10.1067/mob.2001.110697; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gissler M, 2010, INFORM HEALTH SOC CA, V35, P64, DOI 10.3109/17538157.2010.492923; *GLOB ALL PREV PRE, 2010, BMC PREGNANCY CHI S1, V10, pS7; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Goldenberg RL, 2009, INT J GYNECOL OBSTET, V107, pS1, DOI 10.1016/j.ijgo.2009.07.014; Harvey SA, 2004, INT J GYNECOL OBSTET, V87, P203, DOI 10.1016/j.ijgo.2004.06.017; Harvey SA, 2007, B WORLD HEALTH ORGAN, V85, P783, DOI 10.2471/BLT.06.038455; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Huang DY, 2000, OBSTET GYNECOL, V95, P215, DOI 10.1016/S0029-7844(99)00536-0; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Korteweg FJ, 2006, BJOG-INT J OBSTET GY, V113, P393, DOI 10.1111/j.1471-0528.2006.00881.x; Kramer MS, 2002, AM J EPIDEMIOL, V156, P493, DOI 10.1093/aje/kwf077; LanghoffRoos J, 1996, ACTA OBSTET GYN SCAN, V75, P820, DOI 10.3109/00016349609054710; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn Joy, OPPORTUNITIES AFRICA; Lawn JE, 2008, PAEDIATR PERINAT EP, V22, P410, DOI 10.1111/j.1365-3016.2008.00960.x; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031; Lawn JE, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S2; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Luo ZC, 2006, CAN MED ASSOC J, V174, P1415, DOI 10.1503/cmaj.051096; MacDorman Marian F, 2009, Natl Vital Stat Rep, V57, P1; Macfarlane A, 2003, EUR J OBSTET GYN R B, V111, pS15, DOI 10.1016/j.ejogrb.2003.09.003; *MAT CHILD HLTH RE, 1999, 7 MAT CHILD HLTH RES; *MRC MAT INF HLTH, SAV BAB 200 IN PRESS; Nuffield Council on Bioethics, 2006, CRIT CAR DEC FET NEO; Oyelese KO, 1998, AUST NZ J OBSTET GYN, V38, P391, DOI 10.1111/j.1479-828X.1998.tb03094.x; PARSONS L, 1990, BRIT J OBSTET GYNAEC, V97, P237, DOI 10.1111/j.1471-0528.1990.tb01788.x; PATTINSON RC, 1995, S AFR MED J, V85, P145; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Petersson K, 2002, ACTA OBSTET GYN SCAN, V81, P284; PITT C, 2010, LANCET, V371, P1268; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rani M, 2008, INT J QUAL HEALTH C, V20, P62, DOI 10.1093/intqhc/mzm052; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; ROSENFIELD A, 1985, LANCET, V2, P83; Rudan I, 2007, CROAT MED J, V48, P595; Say Lale, 2006, Reprod Health, V3, P1, DOI 10.1186/1742-4755-3-1; Shankar A, 2008, LANCET, V371, P1223, DOI 10.1016/S0140-6736(08)60536-X; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Shiffman Jeremy, 2004, Afr J Reprod Health, V8, P6, DOI 10.2307/3583389; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Spector JM, 2008, B WORLD HEALTH ORGAN, V86, P315, DOI 10.2471/BLT.07.049924; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; *STILLB RES CONS, 2010, GLOB RES AG RED STIL; Ticconi C, 2003, JAIDS-J ACQ IMM DEF, V34, P289, DOI 10.1097/00126334-200311010-00005; Vergani P, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.098; Wang H, 2001, Zhonghua Yi Xue Za Zhi, V81, P1424; WARD HRG, 1995, S AFR MED J, V85, P147; WHO, 2006, PER NEON MORT YEAR 2 PER NEON MORT YEAR 2; WHO, 1993, INT STAT CLASS DIS R, V2; WHO UNICEF, 2010, COUNTD 2015 DEC REP; Winbo IGB, 1998, INT J EPIDEMIOL, V27, P499, DOI 10.1093/ije/27.3.499; Winbo IGB, 1997, INT J EPIDEMIOL, V26, P1298, DOI 10.1093/ije/26.6.1298; Wood NS, 2003, ARCH DIS CHILD-FETAL, V88, pF492, DOI 10.1136/fn.88.6.F492; WOODS R, 2009, DEATH BIRTH 2009, P294; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471; World Health Organization, TRENDS MAT MORT 1990; World Health Organization, 1996, WHOFRHMSM967; Wu ZC, 2003, BRIT MED J, V327, P1319, DOI 10.1136/bmj.327.7427.1319; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608	101	489	505	1	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2011	377	9775					1448	1463		10.1016/S0140-6736(10)62187-3	http://dx.doi.org/10.1016/S0140-6736(10)62187-3			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UF	21496911	Green Accepted, Green Submitted			2022-12-24	WOS:000289963000034
J	Michard, E; Lima, PT; Borges, F; Silva, AC; Portes, MT; Carvalho, JE; Gilliham, M; Liu, LH; Obermeyer, G; Feijo, JA				Michard, Erwan; Lima, Pedro T.; Borges, Filipe; Silva, Ana Catarina; Portes, Maria Teresa; Carvalho, Joao E.; Gilliham, Matthew; Liu, Lai-Hua; Obermeyer, Gerhard; Feijo, Jose A.			Glutamate Receptor-Like Genes Form Ca2+ Channels in Pollen Tubes and Are Regulated by Pistil D-Serine	SCIENCE			English	Article							D-AMINO ACIDS; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; CALCIUM-CHANNELS; ROOT HAIRS; GROWTH; PLANTS; REVEALS; GLR3.3; CELLS	Elevations in cytosolic free calcium concentration ([Ca2+](cyt)) constitute a fundamental signal transduction mechanism in eukaryotic cells, but the molecular identity of Ca2+ channels initiating this signal in plants is still under debate. Here, we show by pharmacology and loss-of-function mutants that in tobacco and Arabidopsis, glutamate receptor-like channels (GLRs) facilitate Ca2+ influx across the plasma membrane, modulate apical [Ca2+] cyt gradient, and consequently affect pollen tube growth and morphogenesis. Additionally, wild-type pollen tubes grown in pistils of knock-out mutants for serine-racemase (SR1) displayed growth defects consistent with a decrease in GLR activity. Our findings reveal a novel plant signaling mechanism between male gametophyte and pistil tissue similar to amino acid-mediated communication commonly observed in animal nervous systems.	[Michard, Erwan; Lima, Pedro T.; Borges, Filipe; Silva, Ana Catarina; Portes, Maria Teresa; Carvalho, Joao E.; Feijo, Jose A.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Gilliham, Matthew] Univ Adelaide, Waite Res Inst, Glen Osmond, SA 5064, Australia; [Gilliham, Matthew] Univ Adelaide, Sch Agr Food & Wine, Glen Osmond, SA 5064, Australia; [Liu, Lai-Hua] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant & Soil Interact, Beijing 100193, Peoples R China; [Obermeyer, Gerhard] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Feijo, Jose A.] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, P-1749016 Lisbon, Portugal	Instituto Gulbenkian de Ciencia; University of Adelaide; University of Adelaide; China Agricultural University; Salzburg University; Universidade de Lisboa	Feijo, JA (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	jfeijo@fc.ul.pt	Obermeyer, Gerhard/G-4061-2013; Gilliham, Matthew/Y-4403-2019; michard, erwan/GXH-1685-2022; Gilliham, Matthew/C-1998-2013; Portes, Maria Teresa/AAC-1353-2019; Carvalho, João E/AAQ-1456-2020; Feijo, Jose A./ADM-0262-2022; Obermeyer, Gerhard/M-5942-2019	Obermeyer, Gerhard/0000-0001-8102-6322; Gilliham, Matthew/0000-0003-0666-3078; Gilliham, Matthew/0000-0003-0666-3078; Portes, Maria Teresa/0000-0001-5668-0605; Carvalho, João E/0000-0002-7770-4351; Feijo, Jose A./0000-0002-1100-5478; Obermeyer, Gerhard/0000-0001-8102-6322; Borges, Filipe/0000-0002-7388-2118; Michard, Erwan/0000-0001-7997-3822	Fundacao para a Ciencia e a Tecnologia [SFRH/BPD 21056/2004]; European Molecular Biology Organization [ASTF 193-2007]; Agropolis fellowships; Centro de Biologia do Desenvolvimento [FCT U664]; FCT [BIA-BCM/108044/2008, QUI/64339/2006]; Austrian Science Fund [P21298]; China National Science Foundation [30771288]; Austrian Science Fund (FWF) [P 21298] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Agropolis fellowships; Centro de Biologia do Desenvolvimento; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Austrian Science Fund(Austrian Science Fund (FWF)); China National Science Foundation(National Natural Science Foundation of China (NSFC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	E. M. acknowledges Fundacao para a Ciencia e a Tecnologia (SFRH/BPD 21056/2004), European Molecular Biology Organization (ASTF 193-2007), and Agropolis fellowships. We thank M. Watahiki (University of Hokkaido) for the YC3.1 construct and M. Iwano (Nara Institute of Science and Technology, Japan) for the YC3.6C Arabidopsis line. glr1.2-1 and glr3.7-1 insertion lines were originally characterized by P. Walch-Liu, X. Q. Qu, and Y. Y. Gong in L.-H. L.'s laboratory, in collaboration with M. Tester (University of Adelaide) and B. Forde (University of Lancaster). We thank N. Moreno and P. Almada for imaging support, A. Sommer for protoplast preparation, C. E. Tadokoro for immunofluorescence advice, J. Becker for helpful discussions on the genetic design of the experiments, P. Dias for help in oscillation analysis, and J. B. Thibaud (Institut National de la Recherche Agronomique-Supagro, Montpellier) for other institutional support to E. M. J.A.F.' s laboratory is supported by the Centro de Biologia do Desenvolvimento (FCT U664) and FCT grants BIA-BCM/108044/2008 and QUI/64339/2006. G.O.'s laboratory is supported by Austrian Science Fund grant P21298. L.-H. L. was supported by China National Science Foundation grant 30771288.	Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; BOAVIDA LC, 2011, PLANT PHYSL; Bruckner H, 2003, AMINO ACIDS, V24, P43, DOI 10.1007/s00726-002-0322-8; Davenport R, 2002, ANN BOT-LONDON, V90, P549, DOI 10.1093/aob/mcf228; Demidchik V, 2004, PLANTA, V219, P167, DOI 10.1007/s00425-004-1207-8; Dennison KL, 2000, PLANT PHYSIOL, V124, P1511, DOI 10.1104/pp.124.4.1511; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dubos C, 2003, PLANT J, V35, P800, DOI 10.1046/j.1365-313X.2003.01849.x; Feijo JA, 2001, BIOESSAYS, V23, P86, DOI 10.1002/1521-1878(200101)23:1&lt;86::AID-BIES1011&gt;3.0.CO;2-D; Feijo Jose A., 2010, Journal of Biology (London), V9, P18, DOI 10.1186/jbiol233; Frietsch S, 2007, P NATL ACAD SCI USA, V104, P14531, DOI 10.1073/pnas.0701781104; Fujitani Y, 2006, PHYTOCHEMISTRY, V67, P668, DOI 10.1016/j.phytochem.2006.01.003; Iwano M, 2009, PLANT PHYSIOL, V150, P1322, DOI 10.1104/pp.109.139329; MALHO R, 1995, PLANT CELL, V7, P1173, DOI 10.1105/tpc.7.8.1173; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Meyerhoff O, 2005, PLANTA, V222, P418, DOI 10.1007/s00425-005-1551-3; Michard E, 2008, SEX PLANT REPROD, V21, P169, DOI 10.1007/s00497-008-0076-x; Michard E, 2009, INT J DEV BIOL, V53, P1609, DOI 10.1387/ijdb.072296em; Miedema H, 2008, NEW PHYTOL, V179, P378, DOI 10.1111/j.1469-8137.2008.02465.x; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; Moreno N., 2007, Rhythms in plants: phenomenology, mechanisms, and adaptive significance, P39, DOI 10.1007/978-3-540-68071-0_2; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Pierson ES, 1996, DEV BIOL, V174, P160, DOI 10.1006/dbio.1996.0060; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Prado AM, 2008, MOL PLANT, V1, P703, DOI 10.1093/mp/ssn034; Qi Z, 2006, PLANT PHYSIOL, V142, P963, DOI 10.1104/pp.106.088989; Qu HY, 2007, NEW PHYTOL, V174, P524, DOI 10.1111/j.1469-8137.2007.02069.x; ROBINSON T, 1976, LIFE SCI, V19, P1097, DOI 10.1016/0024-3205(76)90244-7; Roy SJ, 2008, PLANT CELL ENVIRON, V31, P861, DOI 10.1111/j.1365-3040.2008.01801.x; Shang ZL, 2005, PLANT CELL PHYSIOL, V46, P598, DOI 10.1093/pcp/pci063; Stephens NR, 2008, PLANT PHYSIOL, V146, P529, DOI 10.1104/pp.107.108134; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Wu JY, 2010, PLANT J, V63, P1042, DOI 10.1111/j.1365-313X.2010.04301.x	35	282	304	4	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					434	437		10.1126/science.1201101	http://dx.doi.org/10.1126/science.1201101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21415319				2022-12-24	WOS:000289784900034
J	Surjit, M; Ganti, KP; Mukherji, A; Ye, T; Hua, G; Metzger, D; Li, M; Chambon, P				Surjit, Milan; Ganti, Krishna Priya; Mukherji, Atish; Ye, Tao; Hua, Guoqiang; Metzger, Daniel; Li, Mei; Chambon, Pierre			Widespread Negative Response Elements Mediate Direct Repression by Agonist-Liganded Glucocorticoid Receptor	CELL			English	Article							REV-ERB-ALPHA; MOUSE KERATINOCYTES; GENE PROMOTER; BINDING; MICE; MECHANISMS; GROWTH; TRANSACTIVATION; TRANSREPRESSION; TRANSCRIPTION	The glucocorticoid (GC) receptor (GR), when liganded to GC, activates transcription through direct binding to simple (+)GRE DNA binding sequences (DBS). GC-induced direct repression via GR binding to complex "negative" GREs (nGREs) has been reported. However, GR-mediated transrepression was generally ascribed to indirect "tethered" interaction with other DNA-bound factors. We report that GC-induces direct transrepression via the binding of GR to simple DBS (IR nGREs) unrelated to (+) GRE. These DBS act on agonist-liganded GR, promoting the assembly of cis-acting GR-SMRT/NCoR repressing complexes. IR nGREs are present in over 1000 mouse/human ortho-log genes, which are repressed by GC in vivo. Thus variations in the levels of a single ligand can coordinately turn genes on or off depending in their response element DBS, allowing an additional level of regulation in GR signaling. This mechanism suits GR signaling remarkably well, given that adrenal secretion of GC fluctuates in a circadian and stress-related fashion.	[Surjit, Milan; Ganti, Krishna Priya; Mukherji, Atish; Ye, Tao; Hua, Guoqiang; Metzger, Daniel; Li, Mei; Chambon, Pierre] Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire, Coll France,Inserm U964,UMR7104, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chambon, P (corresponding author), Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire, Coll France,Inserm U964,UMR7104, F-67404 Illkirch Graffenstaden, France.	chambon@igbmc.fr	Ye, Tao/D-8026-2011; Ganti, Krishna Priya/AAV-2106-2021	Metzger, Daniel/0000-0002-5555-046X; Li, Mei/0000-0003-4225-6699	CNRS; INSERM; ANR [ANR 07-Physio 002-01]; Association pour la Recherche a l'IGBMC (ARI)	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Association pour la Recherche a l'IGBMC (ARI)	This study is dedicated to the memory of Dr. Regine Losson, who died last year. She was a wonderful colleague and an outstanding scientist. We thank the staff of the animal and cell culture facilities of the IGBMC/ICS; Dr. H. Gronemeyer and Leo Pharmaceutical for kind gifts of RU24858 and MC903, respectively; Dr. S. Kato for floxed VDR mice; Dr. G. Richards for a critical reading of the manuscript; and Estelle Meyer for secretarial help. This work was supported by the CNRS, the INSERM, the ANR (No. ANR 07-Physio 002-01), and the Association pour la Recherche a l'IGBMC (ARI). M.S., A.M., G.H., and K.G. were supported by ARI fellowships.	Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Belvisi MG, 2001, J IMMUNOL, V166, P1975, DOI 10.4049/jimmunol.166.3.1975; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; BOAM DSW, 1990, J BIOL CHEM, V265, P8285; Carey M, 2001, TRANSCRIPTIONAL REGU, DOI Cold Spring Harbor Laboratory Pr; CARO JF, 1982, J CLIN INVEST, V69, P866, DOI 10.1172/JCI110526; Chen A, 2004, ENDOCRINOLOGY, V145, P2445, DOI 10.1210/en.2003-1570; Chen A, 2006, J NEUROSCI, V26, P5500, DOI 10.1523/JNEUROSCI.3955-05.2006; Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O; Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; Chida D, 2007, P NATL ACAD SCI USA, V104, P18205, DOI 10.1073/pnas.0706953104; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743; Dostert A, 2004, CURR PHARM DESIGN, V10, P2807; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; Fassler R, 1996, EXP CELL RES, V222, P111, DOI 10.1006/excr.1996.0014; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Goodman PA, 1996, MOL CELL ENDOCRINOL, V120, P139, DOI 10.1016/0303-7207(96)03830-0; Gross KL, 2008, TRENDS ENDOCRIN MET, V19, P331, DOI 10.1016/j.tem.2008.07.009; Karin M, 1998, CELL, V93, P487, DOI 10.1016/S0092-8674(00)81177-0; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li SW, 2001, DEV DYNAM, V222, P141, DOI 10.1002/dvdy.1178; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Mocetti P, 2001, TISSUE CELL, V33, P1, DOI 10.1054/tice.2000.0144; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Neufeld-Cohen A, 2010, P NATL ACAD SCI USA, V107, P19020, DOI 10.1073/pnas.1013761107; Ochala J, 2007, J PHYSIOL-LONDON, V581, P1283, DOI 10.1113/jphysiol.2007.129759; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramot Y, 2009, BIOESSAYS, V31, P389, DOI 10.1002/bies.200800121; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Rogatsky I, 1999, MOL CELL BIOL, V19, P5036; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sasaki N, 2001, NEPHROL DIAL TRANSPL, V16, P479, DOI 10.1093/ndt/16.3.479; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schakman O, 2008, ENDOCRINOLOGY, V149, P3900, DOI 10.1210/en.2008-0439; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Stewart PM, 1996, LANCET, V347, P88, DOI 10.1016/S0140-6736(96)90211-1; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; Torra IP, 2000, ENDOCRINOLOGY, V141, P3799, DOI 10.1210/en.141.10.3799; Tuckermann JP, 1999, J CELL BIOL, V147, P1365, DOI 10.1083/jcb.147.7.1365; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; Vayssiere BM, 1997, MOL ENDOCRINOL, V11, P1245, DOI 10.1210/me.11.9.1245; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; WRANGE O, 1989, J BIOL CHEM, V264, P5253; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324	60	369	375	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					224	241		10.1016/j.cell.2011.03.027	http://dx.doi.org/10.1016/j.cell.2011.03.027			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496643	Bronze			2022-12-24	WOS:000289549900012
J	He, HL; Liyanarachchi, S; Akagi, K; Nagy, R; Li, JF; Dietrich, RC; Li, W; Sebastian, N; Wen, B; Xin, BZ; Singh, J; Yan, P; Alder, H; Haan, E; Wieczorek, D; Albrecht, B; Puffenberger, E; Wang, H; Westman, JA; Padgett, RA; Symer, DE; de la Chapelle, A				He, Huiling; Liyanarachchi, Sandya; Akagi, Keiko; Nagy, Rebecca; Li, Jingfeng; Dietrich, Rosemary C.; Li, Wei; Sebastian, Nikhil; Wen, Bernard; Xin, Baozhong; Singh, Jarnail; Yan, Pearlly; Alder, Hansjuerg; Haan, Eric; Wieczorek, Dagmar; Albrecht, Beate; Puffenberger, Erik; Wang, Heng; Westman, Judith A.; Padgett, Richard A.; Symer, David E.; de la Chapelle, Albert			Mutations in U4atac snRNA, a Component of the Minor Spliceosome, in the Developmental Disorder MOPD I	SCIENCE			English	Article							PRIMORDIAL DWARFISM; INTRONS; RNA; U4; PROTEIN; VIVO; PCNT	Small nuclear RNAs (snRNAs) are essential factors in messenger RNA splicing. By means of homozygosity mapping and deep sequencing, we show that a gene encoding U4atac snRNA, a component of the minor U12-dependent spliceosome, is mutated in individuals with microcephalic osteodysplastic primordial dwarfism type I (MOPD I), a severe developmental disorder characterized by extreme intrauterine growth retardation and multiple organ abnormalities. Functional assays showed that mutations (30G>A, 51G>A, 55G>A, and 111G>A) associated with MOPD I cause defective U12-dependent splicing. Endogenous U12-dependent but not U2-dependent introns were found to be poorly spliced in MOPD I patient fibroblast cells. The introduction of wild-type U4atac snRNA into MOPD I cells enhanced U12-dependent splicing. These results illustrate the critical role of minor intron splicing in human development.	[He, Huiling; Liyanarachchi, Sandya; Akagi, Keiko; Nagy, Rebecca; Li, Jingfeng; Li, Wei; Sebastian, Nikhil; Wen, Bernard; Yan, Pearlly; Alder, Hansjuerg; Westman, Judith A.; Symer, David E.; de la Chapelle, Albert] Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; [He, Huiling; Liyanarachchi, Sandya; Akagi, Keiko; Li, Jingfeng; Li, Wei; Sebastian, Nikhil; Wen, Bernard; Yan, Pearlly; Alder, Hansjuerg; Symer, David E.; de la Chapelle, Albert] Ohio State Univ, Sch Biomed Sci, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Nagy, Rebecca; Westman, Judith A.; Symer, David E.] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Columbus, OH 43210 USA; [Dietrich, Rosemary C.; Singh, Jarnail; Padgett, Richard A.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; [Xin, Baozhong; Wang, Heng] DDC Clin Special Needs Children, Middlefield, OH 44062 USA; [Haan, Eric] SA Pathol Womens & Childrens Hosp, S Australian Clin Genet Serv, Adelaide, SA 5006, Australia; [Haan, Eric] Univ Adelaide, Dept Pediat, Adelaide, SA 5005, Australia; [Wieczorek, Dagmar; Albrecht, Beate] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Puffenberger, Erik] Clin Special Children, Strasburg, PA 17579 USA; [Symer, David E.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; SA Pathology; University of Adelaide; University of Duisburg Essen; University System of Ohio; Ohio State University	de la Chapelle, A (corresponding author), Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA.	albert.delachapelle@osumc.edu	Yan, Pearlly S/E-4339-2011; Nagy, Rebecca Shrigley/E-4088-2011; Symer, David E./E-4173-2011; Wieczorek, Dagmar/AAU-6008-2021; Westman, Judith/E-4294-2011	Yan, Pearlly S/0000-0003-1965-4920; Wieczorek, Dagmar/0000-0003-2812-6492; Puffenberger, Erik/0000-0002-6388-9148	Ohio Supercomputing Center [PAS0425-2]; Cleveland Foundation [L2009-0078]; NIH [GM093074, GM079527]; National Cancer Institute [P30 CA16058]; OSU Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093074, R01GM079527] Funding Source: NIH RePORTER	Ohio Supercomputing Center; Cleveland Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OSU Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Mehlen and M.-M. Coissieux for the French control sample set, P. Meinecke for information on patients, J. Palatini for sharing equipment and advice, J. Lockman for technical support, and the Microarray Shared Resource and Nucleic Acid Shared Resource of the OSU Comprehensive Cancer Center for genotyping and sequencing. Supported by Ohio Supercomputing Center grant PAS0425-2 for computational resources (K. A. and D. E. S.), Leonard Krieger Fund of the Cleveland Foundation grant L2009-0078 (H. W.), NIH grants GM093074 and GM079527 (R. A. P.), National Cancer Institute grant P30 CA16058 (H. H., S. L., K. A., J. L., R.N., W. L., N.S., B. W., P.Y., H. W., D. E. S., J. A. W., and A.dlC.), and the OSU Comprehensive Cancer Center.	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Boulisfane N, 2011, HUM MOL GENET, V20, P641, DOI 10.1093/hmg/ddq508; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; MAJEWSKI F, 1982, AM J MED GENET, V12, P37, DOI 10.1002/ajmg.1320120105; MAJEWSKI F, 1976, MONATSSCHR KINDERH, V124, P499; Matter N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni041; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Pessa HKJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013215; Piane M, 2009, AM J MED GENET A, V149A, P2452, DOI 10.1002/ajmg.a.33035; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Shukla GC, 2002, NUCLEIC ACIDS RES, V30, P4650, DOI 10.1093/nar/gkf609; Sigaudy S, 1998, AM J MED GENET, V80, P16, DOI 10.1002/(SICI)1096-8628(19981102)80:1<16::AID-AJMG4>3.3.CO;2-X; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; TAYBI H, 1967, RADIOLOGY, V89, P275, DOI 10.1148/89.2.275; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Willems M, 2010, J MED GENET, V47, P797, DOI 10.1136/jmg.2009.067298; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	21	155	159	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					238	240		10.1126/science.1200587	http://dx.doi.org/10.1126/science.1200587			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474760	Green Accepted			2022-12-24	WOS:000289251100052
J	Pasqualucci, L; Dominguez-Sola, D; Chiarenza, A; Fabbri, G; Grunn, A; Trifonov, V; Kasper, LH; Lerach, S; Tang, HY; Ma, J; Rossi, D; Chadburn, A; Murty, VV; Mullighan, CG; Gaidano, G; Rabadan, R; Brindle, PK; Dalla-Favera, R				Pasqualucci, Laura; Dominguez-Sola, David; Chiarenza, Annalisa; Fabbri, Giulia; Grunn, Adina; Trifonov, Vladimir; Kasper, Lawryn H.; Lerach, Stephanie; Tang, Hongyan; Ma, Jing; Rossi, Davide; Chadburn, Amy; Murty, Vundavalli V.; Mullighan, Charles G.; Gaidano, Gianluca; Rabadan, Raul; Brindle, Paul K.; Dalla-Favera, Riccardo			Inactivating mutations of acetyltransferase genes in B-cell lymphoma	NATURE			English	Article							CREB-BINDING-PROTEIN; ACUTE MYELOID-LEUKEMIA; CYCLE ARREST; CBP; P300; P53; TRANSCRIPTION; COACTIVATOR; ACETYLATION; HEMATOPOIESIS	B-cell non-Hodgkin's lymphoma comprises biologically and clinically distinct diseases the pathogenesis of which is associated with genetic lesions affecting oncogenes and tumour-suppressor genes. We report here that the two most common types-follicular lymphoma and diffuse large B-cell lymphoma-harbour frequent structural alterations inactivating CREBBP and, more rarely, EP300, two highly related histone and non-histone acetyltransferases (HATs) that act as transcriptional co-activators in multiple signalling pathways. Overall, about 39% of diffuse large B-cell lymphoma and 41% of follicular lymphoma cases display genomic deletions and/or somatic mutations that remove or inactivate the HAT coding domain of these two genes. These lesions usually affect one allele, suggesting that reduction in HAT dosage is important for lymphomagenesis. We demonstrate specific defects in acetylation-mediated inactivation of the BCL6 oncoprotein and activation of the p53 tumour suppressor. These results identify CREBBP/EP300 mutations as a major pathogenetic mechanism shared by common forms of B-cell non-Hodgkin's lymphoma, with direct implications for the use of drugs targeting acetylation/deacetylation mechanisms.	[Pasqualucci, Laura; Dominguez-Sola, David; Chiarenza, Annalisa; Fabbri, Giulia; Grunn, Adina; Tang, Hongyan; Murty, Vundavalli V.; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Pasqualucci, Laura; Dominguez-Sola, David; Chiarenza, Annalisa; Fabbri, Giulia; Grunn, Adina; Tang, Hongyan; Murty, Vundavalli V.; Dalla-Favera, Riccardo] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Pasqualucci, Laura; Murty, Vundavalli V.; Dalla-Favera, Riccardo] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Trifonov, Vladimir; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Trifonov, Vladimir; Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Kasper, Lawryn H.; Lerach, Stephanie; Brindle, Paul K.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Rossi, Davide; Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, Div Hematol, Dept Clin & Expt Med, I-28100 Novara, Italy; [Rossi, Davide; Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, IRCAD, I-28100 Novara, Italy; [Chadburn, Amy] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Northwestern University; Feinberg School of Medicine; St Jude Children's Research Hospital; Columbia University	Pasqualucci, L (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	lp171@columbia.edu; rd10@columbia.edu	Chiarenza, Annalisa/AAC-2013-2019; Mullighan, Charles/H-3253-2011; Gaidano, Gianluca/AAW-2773-2021; Rabadan, Raul/AAZ-7367-2020; Kasper, Lawryn/GWV-5700-2022	Chiarenza, Annalisa/0000-0002-8759-4854; Mullighan, Charles/0000-0002-1871-1850; Gaidano, Gianluca/0000-0002-4681-0151; Brindle, Paul/0000-0001-7172-8478; Rabadan, Raul/0000-0001-7946-9255; Dominguez-Sola, David/0000-0001-9569-8402	NIH [PO1-CA092625, RO1-CA37295, DE018183]; Leukemia and Lymphoma Society; Cancer Center (CORE) [P30 CA021765]; American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital; Northeast Biodefence Center [U54-AI057158]; National Library of Medicine [1R01LM010140-01]; AIRC [10007]; NATIONAL CANCER INSTITUTE [P01CA092625, R01CA037295, P30CA021765, R37CA037295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018183] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Cancer Center (CORE); American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Northeast Biodefence Center; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Q. Shen and the Molecular Pathology Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University for histology service; W. Gu for discussions and reagents; Y. Tang, M. Li and D. Chao for suggestions; V. Bardwell for the Bcl6 reporter construct; and R. S. K. Chaganti for sharing unpublished information. Whole-exome capture and sequencing were conducted at Roche NimbleGen and 454 Life Sciences. Automated DNA sequencing was performed at Genewiz Inc. This work was supported by NIH grants PO1-CA092625 and RO1-CA37295 (to R.D.-F.), a Specialized Center of Research grant from the Leukemia and Lymphoma Society (to R.D.-F.), NIH grant DE018183, a Cancer Center (CORE) support grant P30 CA021765, and the American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital (to P.K.B.), the Northeast Biodefence Center (U54-AI057158) and the National Library of Medicine(1R01LM010140-01) (to R.R.), and the AIRC Special Program Molecular Clinical Oncology-5 per mille (contract number 10007, Milan) (to G.G.). A. Chiarenza is on leave from the Division of Hematology, Ospedale Ferrarotto, University of Catania, Catania, Italy. L.P. is on leave from the University of Perugia Medical School, Perugia, Italy.	Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bieber T, 2001, BIOTECHNIQUES, V30, P74, DOI 10.2144/01301st03; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Bordoli L, 2001, NUCLEIC ACIDS RES, V29, P4462, DOI 10.1093/nar/29.21.4462; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Downing JR, 2009, NEW ENGL J MED, V361, P1111, DOI 10.1056/NEJMe0906090; Garbati MR, 2010, CANCER LETT, V291, P237, DOI 10.1016/j.canlet.2009.10.018; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Goodman RH, 2000, GENE DEV, V14, P1553; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Huynh KD, 2000, GENE DEV, V14, P1810; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kung AL, 2000, GENE DEV, V14, P272; Kuninger D, 2007, J BIOTECHNOL, V131, P253, DOI 10.1016/j.jbiotec.2007.07.498; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; MILLER RW, 1995, AM J MED GENET, V56, P112, DOI 10.1002/ajmg.1320560125; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oike Y, 1999, BLOOD, V93, P2771; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Roelfsema Jeroen H., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000415; Rowley JD, 1997, BLOOD, V90, P535; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Shigeno K, 2004, CANCER LETT, V213, P11, DOI 10.1016/S0304-3835(03)00442-7; Sobulo OM, 1997, P NATL ACAD SCI USA, V94, P8732, DOI 10.1073/pnas.94.16.8732; Stimson L, 2009, ANN ONCOL, V20, P1293, DOI 10.1093/annonc/mdn792; Swerdlow E., 2008, WHO CLASSIFICATION T; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Ward R, 2005, J MED GENET, V42, P514, DOI 10.1136/jmg.2004.025080; Xu W, 2006, BLOOD, V107, P4407, DOI 10.1182/blood-2005-08-3263; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	49	631	658	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					189	U75		10.1038/nature09730	http://dx.doi.org/10.1038/nature09730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390126	Green Accepted, Green Published			2022-12-24	WOS:000288170200031
J	Nuesch, E; Dieppe, P; Reichenbach, S; Williams, S; Iff, S; Juni, P				Nueesch, Eveline; Dieppe, Paul; Reichenbach, Stephan; Williams, Susan; Iff, Samuel; Jueni, Peter			All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RHEUMATOID-ARTHRITIS; CARDIOVASCULAR-DISEASE; MULTIPLE IMPUTATION; REPLACEMENT SURGERY; ASSOCIATION; PAIN; PREVALENCE; DISABILITY; INFLAMMATION; REQUIREMENT	Objective To examine all cause and disease specific mortality in patients with osteoarthritis of the knee or hip. Design Population based cohort study. Setting General practices in the southwest of England. Participants 1163 patients aged 35 years or over with symptoms and radiological confirmation of osteoarthritis of the knee or hip. Main outcome measures Age and sex standardised mortality ratios and multivariable hazard ratios of death after a median of 14 years' follow-up. Results Patients with osteoarthritis had excess all cause mortality compared with the general population (standardised mortality ratio 1.55, 95% confidence interval 1.41 to 1.70). Excess mortality was observed for all disease specific causes of death but was particularly pronounced for cardiovascular (standardised mortality ratio 1.71, 1.49 to 1.98) and dementia associated mortality (1.99, 1.22 to 3.25). Mortality increased with increasing age (P for trend <0.001), male sex (adjusted hazard ratio 1.59, 1.30 to 1.96), self reported history of diabetes (1.95, 1.31 to 2.90), cancer (2.28, 1.50 to 3.47), cardiovascular disease (1.38, 1.12 to 1.71), and walking disability (1.48, 1.17 to 1.86). However, little evidence existed for increased mortality associated with previous joint replacement, obesity, depression, chronic inflammatory disease, eye disease, or presence of pain at baseline. The more severe the walking disability, the higher was the risk of death (P for trend <0.001). Conclusion Patients with osteoarthritis are at higher risk of death compared with the general population. History of diabetes, cancer, or cardiovascular disease and the presence of walking disability are major risk factors. Management of patients with osteoarthritis and walking disability should focus on effective treatment of cardiovascular risk factors and comorbidities, as well as on increasing physical activity.	[Nueesch, Eveline; Reichenbach, Stephan; Iff, Samuel; Jueni, Peter] Univ Bern, ISPM, CH-3012 Bern, Switzerland; [Nueesch, Eveline; Iff, Samuel; Jueni, Peter] Univ Hosp Bern, CTU Bern, CH-3010 Bern, Switzerland; [Dieppe, Paul] Univ Exeter, Peninsula Med Sch, Inst Clin Educ, Exeter EX4 4QJ, Devon, England; [Dieppe, Paul] Univ Plymouth, Peninsula Med Sch, Inst Clin Educ, Plymouth PL4 8AA, Devon, England; [Reichenbach, Stephan] Univ Hosp Bern, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland; [Williams, Susan] Univ Bristol, Dept Social Med, Bristol, Avon, England	University of Bern; University of Bern; University Hospital of Bern; University of Exeter; University of Plymouth; University of Bern; University Hospital of Bern; University of Bristol	Juni, P (corresponding author), Univ Bern, ISPM, CH-3012 Bern, Switzerland.	juni@ispm.unibe.ch	Juni, Peter/Q-8700-2016; Iff, Samuel/AAJ-4998-2020; Hug, Balthasar L./G-1568-2010	Juni, Peter/0000-0002-5985-0670; Iff, Samuel/0000-0002-4441-5465; Reichenbach, Stephan/0000-0001-8098-6567	Department of Health; South and West NHS Research and Development Directorate; Swiss National Science Foundation [3233-066377, 3200-066378]; Arthritis Research UK	Department of Health; South and West NHS Research and Development Directorate; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Arthritis Research UK(Versus Arthritis)	The Somerset and Avon Survey of Health was originally funded by the Department of Health and the South and West NHS Research and Development Directorate. This work was funded by the Swiss National Science Foundation (grant numbers 3233-066377 and 3200-066378) and by Arthritis Research UK. The funding bodies had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bellocco R, 2010, EUR J EPIDEMIOL, V25, P777, DOI 10.1007/s10654-010-9497-6; CERHAN JR, 1995, AM J EPIDEMIOL, V141, P225, DOI 10.1093/oxfordjournals.aje.a117424; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Cisternas MG, 2009, ARTHRIT RHEUM-ARTHR, V61, P1694, DOI 10.1002/art.24897; Couzin-Frankel J, 2010, SCIENCE, V330, P1621, DOI 10.1126/science.330.6011.1621; Eachus J, 1996, BMJ-BRIT MED J, V312, P287; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Frankel S, 1999, LANCET, V353, P1304, DOI 10.1016/S0140-6736(98)06451-4; Fransen M, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004376.PUB2; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Haara MM, 2004, J BONE JOINT SURG AM, V86A, P1452, DOI 10.2106/00004623-200407000-00013; Haara MM, 2003, ANN RHEUM DIS, V62, P151, DOI 10.1136/ard.62.2.151; Hernandez-Molina G, 2008, ARTHRIT RHEUM-ARTHR, V59, P1221, DOI 10.1002/art.24010; Hochber MC, 2008, CLIN EXP RHEUMATOL, V26, pS120; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P366, DOI 10.5271/sjweh.2914; Jenkinson CM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3170; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Juni P, 2010, OSTEOARTHR CARTILAGE, V18, P640, DOI 10.1016/j.joca.2009.12.010; Juni P, 2006, BEST PRACT RES CL RH, V20, P721, DOI 10.1016/j.berh.2006.05.002; Juni P, 2003, RHEUMATOLOGY, V42, P516, DOI 10.1093/rheumatology/keg196; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kumar N, 2007, J RHEUMATOL, V34, P1695; Landi F, 2010, J CLIN EPIDEMIOL, V63, P752, DOI 10.1016/j.jclinepi.2009.09.007; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lawrence RC, 1990, HLTH STATUS WELL BEI, P136; MCALINDON TE, 1992, BRIT J RHEUMATOL, V31, P189; MONSON RR, 1976, J CHRON DIS, V29, P459, DOI 10.1016/0021-9681(76)90086-2; Myasoedova Elena, 2010, Curr Rheumatol Rep, V12, P379, DOI 10.1007/s11926-010-0117-y; Penninx BWJH, 2002, J GERONTOL B-PSYCHOL, V57, pP124, DOI 10.1093/geronb/57.2.P124; Reichenbach S, 2011, ANN RHEUM DIS, V70, P293, DOI 10.1136/ard.2010.132985; Robertsson O, 2007, J BONE JOINT SURG BR, V89B, P599, DOI 10.1302/0301-620X.89B5.18355; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Snow MH, 2005, CURR OPIN RHEUMATOL, V17, P234; Stannus O, 2010, OSTEOARTHR CARTILAGE, V18, P1441, DOI 10.1016/j.joca.2010.08.016; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Wagenmakers R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-141; Wagner P, 2011, EUR J CANC      0110; Watson DJ, 2003, J RHEUMATOL, V30, P1196; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	45	426	432	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2011	342								d1165	10.1136/bmj.d1165	http://dx.doi.org/10.1136/bmj.d1165			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UY	21385807	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-24	WOS:000288446800005
J	Fu, SN; Yang, L; Li, P; Hofmann, O; Dicker, L; Hide, W; Lin, XH; Watkins, SM; Ivanov, AR; Hotamisligil, GS				Fu, Suneng; Yang, Ling; Li, Ping; Hofmann, Oliver; Dicker, Lee; Hide, Winston; Lin, Xihong; Watkins, Steven M.; Ivanov, Alexander R.; Hotamisligil, Goekhan S.			Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity	NATURE			English	Article							GLUCOSE-HOMEOSTASIS; MASS-SPECTROMETRY; ADIPOSE-TISSUE; ER STRESS; MICE; CA2+-ATPASE; INSULIN; PHOSPHATIDYLETHANOLAMINE; CHOLESTEROL; ACTIVATION	The endoplasmic reticulum (ER) is the main site of protein and lipid synthesis, membrane biogenesis, xenobiotic detoxification and cellular calcium storage, and perturbation of ER homeostasis leads to stress and the activation of the unfolded protein response(1). Chronic activation of ER stress has been shown to have an important role in the development of insulin resistance and diabetes in obesity(2). However, the mechanisms that lead to chronic ER stress in a metabolic context in general, and in obesity in particular, are not understood. Here we comparatively examined the proteomic and lipidomic landscape of hepatic ER purified from lean and obese mice to explore the mechanisms of chronic ER stress in obesity. We found suppression of protein but stimulation of lipid synthesis in the obese ER without significant alterations in chaperone content. Alterations in ER fatty acid and lipid composition result in the inhibition of sarco/endoplasmic reticulum calcium ATPase (SERCA) activity and ER stress. Correcting the obesity-induced alteration of ER phospholipid composition or hepatic Serca overexpression in vivo both reduced chronic ER stress and improved glucose homeostasis. Hence, we established that abnormal lipid and calcium metabolism are important contributors to hepatic ER stress in obesity.	[Fu, Suneng; Yang, Ling; Li, Ping; Ivanov, Alexander R.; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Fu, Suneng; Yang, Ling; Li, Ping; Ivanov, Alexander R.; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hofmann, Oliver; Dicker, Lee; Hide, Winston; Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Watkins, Steven M.] Lip Technol Inc, W Sacramento, CA 95691 USA; [Hotamisligil, Goekhan S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Hofmann, Oliver M/F-1800-2013; Hide, Winston A/V-2727-2017; Hide, Winston/R-3815-2019; Yang, Ling/C-8000-2011; Hide, Winston Hide/C-7217-2009	Hofmann, Oliver M/0000-0002-7738-1513; Hide, Winston A/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Yang, Ling/0000-0002-3105-3063	National Institutes of Health [DK52539, 1RC4-DK090942]; Syndexa Pharmaceuticals; NIH/NIEHS [T32ES007155]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090942, R01DK052539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Syndexa Pharmaceuticals; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Porter, E. Freeman and R. Davis for technical assistance. The anti-HERP antibody is a gift of Y. Hirabayashi. We thank the members of the G.S.H. laboratory for scientific discussions and critical reading of the manuscript. This work was supported in part by the National Institutes of Health (DK52539 and 1RC4-DK090942) and a research grant from Syndexa Pharmaceuticals to G.S.H. S.F. was supported in part by the NIH/NIEHS postdoctoral training grant (T32ES007155).	Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; CHENG KH, 1986, J BIOL CHEM, V261, P5081; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kim SJ, 2010, NEUROSCI LETT, V479, P292, DOI 10.1016/j.neulet.2010.05.083; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li SY, 2006, DIABETOLOGIA, V49, P1434, DOI 10.1007/s00125-006-0229-0; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; LODISH HF, 1990, J BIOL CHEM, V265, P10893; Miyauchi Y, 2006, J BIOL CHEM, V281, P22882, DOI 10.1074/jbc.M601966200; MOORE L, 1975, J BIOL CHEM, V250, P4562; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schiller J, 2001, J LIPID RES, V42, P1501	24	682	705	11	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2011	473	7348					528	531		10.1038/nature09968	http://dx.doi.org/10.1038/nature09968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21532591	Green Accepted			2022-12-24	WOS:000290951300044
J	Kulkarni, S; Savan, R; Qi, Y; Gao, XJ; Yuki, Y; Bass, SE; Martin, MP; Hunt, P; Deeks, SG; Telenti, A; Pereyra, F; Goldstein, D; Wolinsky, S; Walker, B; Young, HA; Carrington, M				Kulkarni, Smita; Savan, Ram; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Bass, Sara E.; Martin, Maureen P.; Hunt, Peter; Deeks, Steven G.; Telenti, Amalio; Pereyra, Florencia; Goldstein, David; Wolinsky, Steven; Walker, Bruce; Young, Howard A.; Carrington, Mary			Differential microRNA regulation of HLA-C expression and its association with HIV control	NATURE			English	Article							SURFACE EXPRESSION; DEADENYLATION; ANTIGENS; GENOME; GENES	The HLA-C locus is distinct relative to the other classical HLA class I loci in that it has relatively limited polymorphism(1), lower expression on the cell surface(2,3), and more extensive ligand-receptor interactions with killer-cell immunoglobulin-like receptors(4). A single nucleotide polymorphism (SNP) 35 kb upstream of HLA-C (rs9264942; termed -35) associates with control of HIV5-7, and with levels of HLA-C messenger RNA transcripts(8) and cell-surface expression(7), but the mechanism underlying its varied expression is unknown. We proposed that the -35 SNP is not the causal variant for differential HLA-C expression, but rather is marking another polymorphism that directly affects levels of HLA-C-7. Here we show that variation within the 3' untranslated region (UTR) of HLA-C regulates binding of the microRNA hsa-miR-148 to its target site, resulting in relatively low surface expression of alleles that bind this microRNA and high expression of HLA-C alleles that escape post-transcriptional regulation. The 3' UTR variant associates strongly with control of HIV, potentially adding to the effects of genetic variation encoding the peptide-binding region of the HLA class I loci. Variation in HLA-C expression adds another layer of diversity to this highly polymorphic locus that must be considered when deciphering the function of these molecules in health and disease.	[Kulkarni, Smita; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Bass, Sara E.; Martin, Maureen P.; Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA; [Kulkarni, Smita; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Martin, Maureen P.; Pereyra, Florencia; Walker, Bruce; Carrington, Mary] Harvard Univ, Boston, MA 02114 USA; [Kulkarni, Smita; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Martin, Maureen P.; Pereyra, Florencia; Walker, Bruce; Carrington, Mary] MIT, Ragon Inst, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hunt, Peter; Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Aids, San Francisco, CA 94110 USA; [Telenti, Amalio] Univ Lausanne, Inst Microbiol, CH-1011 Lausanne, Switzerland; [Goldstein, David] Duke Univ, Inst Genome Sci & Policy, Ctr Human Genome Variat, Durham, NC 27708 USA; [Wolinsky, Steven] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Lausanne; Duke University; Northwestern University; Feinberg School of Medicine	Carrington, M (corresponding author), NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA.	carringm@mail.nih.gov	Wolinsky, Steven/B-2893-2012; Young, Howard/R-5140-2019; Telenti, Amalio/AAY-1674-2021; Goldstein, David/AAY-8125-2020; Hunt, Peter W./P-2976-2017; Young, Howard/A-6350-2008	Hunt, Peter W./0000-0002-4571-4870; Wolinsky, Steven/0000-0002-9625-6697; Young, Howard/0000-0002-3118-5111; Savan, Ram/0000-0002-3087-1355	National Cancer Institute, National Institutes of Health (NIH) [HHSN261200800001E, N02-CP-55504, R01-DA04334, R01-DA12568]; NIH, National Cancer Institute, Center for Cancer Research; Cancer Inflammation Program Project Award; Bill & Melinda Gates Foundation; Mark and Lisa Schwartz Foundation; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung and Blood Institute [UO1-AI-35042, 5-MO1-RR-00722, UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041]; Swiss HIV Cohort Study; Swiss National Science Foundation [33CSC0-108787];  [UL1 RR024131];  [P30 AI27763]; NATIONAL CANCER INSTITUTE [ZIABC010791] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Inflammation Program Project Award; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Mark and Lisa Schwartz Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swiss HIV Cohort Study; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under contracts HHSN261200800001E, N02-CP-55504, R01-DA04334 and R01-DA12568. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research and the Cancer Inflammation Program Project Award for the year 2009, a grant from the Bill & Melinda Gates Foundation as part of the Collaboration for AIDS Vaccine Discovery, and the Mark and Lisa Schwartz Foundation. We would also like to thank the patients and investigators involved in the Multicenter AIDS Cohort Study (the MACS is funded by the National Institute of Allergy and Infectious Diseases, with supplemental funding from the National Cancer Institute and the National Heart, Lung and Blood Institute (grants UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613 and UO1-AI-35041), the Swiss HIV Cohort Study (see Supplementary Note 4 for the list of members), supported by the Swiss National Science Foundation grant number 33CSC0-108787, and the SCOPE study, which was funded by the UL1 RR024131 (Clinical and Translational Sciences Award) and P30 AI27763 (Center for AIDS Research) grants. We thank S. Anderson, G. O'Connor and R. Thomas for advice, A. Kronfli and K. Ramakrishnan for assistance in plasmid and genomic DNA preparations, A. McFarland for western blots, V. Braud for the DT9 antibody, R. Johnson and G. Nelson for statistical advice and T. Covell for administrative assistance.	Apps R, 2008, TRENDS IMMUNOL, V29, P313, DOI 10.1016/j.it.2008.02.012; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Kralovicova J, 2006, J IMMUNOL, V176, P2381, DOI 10.4049/jimmunol.176.4.2381; KRANGEL MS, 1986, J EXP MED, V163, P1173, DOI 10.1084/jem.163.5.1173; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HC, 2010, METHODS MOL BIOL, V612, P377, DOI 10.1007/978-1-60761-362-6_26; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; MCCUTCHEON JA, 1995, J EXP MED, V181, P2085, DOI 10.1084/jem.181.6.2085; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490; Schaefer MR, 2008, J IMMUNOL, V180, P7804, DOI 10.4049/jimmunol.180.12.7804; Setini A, 1996, HUM IMMUNOL, V46, P69, DOI 10.1016/0198-8859(96)00011-0; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; TILANUS MGJ, 2002, IMMUNOBIOLOGY HUMAN, V1, P304; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; ZEMMOUR J, 1992, J EXP MED, V176, P937, DOI 10.1084/jem.176.4.937	27	267	280	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					495	U548		10.1038/nature09914	http://dx.doi.org/10.1038/nature09914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21499264	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000289949600039
J	Solt, LA; Kumar, N; Nuhant, P; Wang, YJ; Lauer, JL; Liu, J; Istrate, MA; Kamenecka, TM; Roush, WR; Vidovic, D; Schurer, SC; Xu, JH; Wagoner, G; Drew, PD; Griffin, PR; Burris, TP				Solt, Laura A.; Kumar, Naresh; Nuhant, Philippe; Wang, Yongjun; Lauer, Janelle L.; Liu, Jin; Istrate, Monica A.; Kamenecka, Theodore M.; Roush, William R.; Vidovic, Dusica; Schuerer, Stephan C.; Xu, Jihong; Wagoner, Gail; Drew, Paul D.; Griffin, Patrick R.; Burris, Thomas P.			Suppression of T(H)17 differentiation and autoimmunity by a synthetic ROR ligand	NATURE			English	Article							TH17 CELL-DIFFERENTIATION; ORPHAN RECEPTOR-ALPHA; REV-ERB-ALPHA; GAMMA-T; NUCLEAR RECEPTORS; MASS-SPECTROMETRY; TARGET GENE; IDENTIFICATION; EXCHANGE; AGONIST	T-helper cells that produce interleukin-17 (T(H)17 cells) are a recently identified CD4(+) T-cell subset with characterized pathological roles in autoimmune diseases(1-3). The nuclear receptors retinoic-acid-receptor-related orphan receptors alpha and gamma t (ROR alpha and ROR gamma t, respectively) have indispensible roles in the development of this cell type(4-7). Here we present SR1001, a high-affinity synthetic ligand-the first in a new class of compound-that is specific to both ROR alpha and ROR gamma t and which inhibits T(H)17 cell differentiation and function. SR1001 binds specifically to the ligand-binding domains of ROR alpha and ROR gamma t, inducing a conformational change within the ligand-binding domain that encompasses the repositioning of helix 12 and leads to diminished affinity for co-activators and increased affinity for co-repressors, resulting in suppression of the receptors' transcriptional activity. SR1001 inhibited the development of murine T(H)17 cells, as demonstrated by inhibition of interleukin-17A gene expression and protein production. Furthermore, SR1001 inhibited the expression of cytokines when added to differentiated murine or human T(H)17 cells. Finally, SR1001 effectively suppressed the clinical severity of autoimmune disease in mice. Our data demonstrate the feasibility of targeting the orphan receptors ROR alpha and ROR gamma t to inhibit specifically T(H)17 cell differentiation and function, and indicate that this novel class of compound has potential utility in the treatment of autoimmune diseases.	[Solt, Laura A.; Kumar, Naresh; Wang, Yongjun; Lauer, Janelle L.; Liu, Jin; Istrate, Monica A.; Griffin, Patrick R.; Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Kumar, Naresh; Istrate, Monica A.; Vidovic, Dusica; Schuerer, Stephan C.; Griffin, Patrick R.] Scripps Res Inst, Scripps Res Inst Mol Screening Ctr, Jupiter, FL 33458 USA; [Nuhant, Philippe; Roush, William R.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Kamenecka, Theodore M.; Griffin, Patrick R.] Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA; [Vidovic, Dusica; Schuerer, Stephan C.] Univ Miami, Ctr Computat Sci, Miami, FL 33136 USA; [Xu, Jihong; Wagoner, Gail; Drew, Paul D.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Miami; University of Arkansas System; University of Arkansas Medical Sciences	Burris, TP (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	NIH [DK080201, DK089984, MH084512, DK088499, GM084041]; National Multiple Sclerosis Society [RG389A2/1]; NIH Molecular Library Screening Center Network (MLSCN) [U54MH074404]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201, F32DK088499, R24DK089984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769, U54MH084512, U54MH074404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH Molecular Library Screening Center Network (MLSCN); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants to T. P. B. (DK080201, DK089984 and MH084512), to L. A. S. (DK088499) and P. R. G. (GM084041) and a grant from the National Multiple Sclerosis Society to P. D. D. (RG389A2/1). Additionally, the efforts of P. R. G. and W. R. R. were supported by the NIH Molecular Library Screening Center Network (MLSCN) grant U54MH074404 (Hugh Rosen, Principal Investigator).	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Delerive P, 2002, J BIOL CHEM, V277, P35013, DOI 10.1074/jbc.M202979200; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Pascal BD, 2009, J AM SOC MASS SPECTR, V20, P601, DOI 10.1016/j.jasms.2008.11.019; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Tamauchi H, 2004, INT IMMUNOL, V16, P179, DOI 10.1093/intimm/dxh026; Wada T, 2008, MOL PHARMACOL, V73, P891, DOI 10.1124/mol.107.040741; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Xu JH, 2007, J NEUROCHEM, V103, P1801, DOI 10.1111/j.1471-4159.2007.04875.x; Xu JH, 2009, J LEUKOCYTE BIOL, V86, P401, DOI 10.1189/jlb.1008600; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	25	371	418	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					491	U547		10.1038/nature10075	http://dx.doi.org/10.1038/nature10075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21499262	Green Accepted			2022-12-24	WOS:000289949600038
J	Roy, S; Hsiung, F; Kornberg, TB				Roy, Sougata; Hsiung, Frank; Kornberg, Thomas B.			Specificity of Drosophila Cytonemes for Distinct Signaling Pathways	SCIENCE			English	Article							EGF RECEPTOR; EYE; PATTERN; INHIBITION; TRIGGERS; SPITZ; DISC	Cytonemes are types of filopodia in the Drosophila wing imaginal disc that are proposed to serve as conduits in which morphogen signaling proteins move between producing and target cells. We investigated the specificity of cytonemes that are made by target cells. Cells in wing discs made cytonemes that responded specifically to Decapentaplegic (Dpp) and cells in eye discs made cytonemes that responded specifically to Spitz (the Drosophila epidermal growth factor protein). Tracheal cells had at least two types: one made in response to Branchless (a Drosophila fibroblast growth factor protein, Bnl), to which they segregate the Bnl receptor, and another to which they segregate the Dpp receptor. We conclude that cells can make several types of cytonemes, each of which responds specifically to a signaling pathway by means of the selective presence of a particular signaling protein receptor that has been localized to that cytoneme.	[Kornberg, Thomas B.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kornberg, TB (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	tkornberg@ucsf.edu	Roy, Sougaya/I-5341-2019	Roy, Sougaya/0000-0002-2236-9277	Herbert Boyer Postdoctoral Fellowship; National Institute of General Medical Studies; National Heart, Lung, and Blood Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030637] Funding Source: NIH RePORTER	Herbert Boyer Postdoctoral Fellowship; National Institute of General Medical Studies(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Li and K. Kechris for help with data analysis; S. Liu for technical help; the Bloomington Drosophila Stock Center, I. Guerrero, E. Bier, M. Krasnow, J. Duffy, M. Sato, and K. Wharton for fly stocks; and T. Wunderlich for hCre*PR*. This work was supported in part by a Herbert Boyer Postdoctoral Fellowship (to S. R.) and by grants from the National Institute of General Medical Studies and the National Heart, Lung, and Blood Institute to T.B.K.	Alvarado D, 2004, GENETICS, V167, P187, DOI 10.1534/genetics.167.1.187; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Guha A, 2009, DEV BIOL, V335, P317, DOI 10.1016/j.ydbio.2009.09.005; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Jones C, 2004, SEMIN CELL DEV BIOL, V15, P75, DOI 10.1016/j.semcdb.2003.09.002; Kornberg TB, 2007, CURR OPIN GENET DEV, V17, P264, DOI 10.1016/j.gde.2007.05.010; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Reifegerste R, 1999, BIOESSAYS, V21, P275, DOI 10.1002/(SICI)1521-1878(199904)21:4<275::AID-BIES3>3.0.CO;2-5; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592	16	175	177	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					354	358		10.1126/science.1198949	http://dx.doi.org/10.1126/science.1198949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493861	Green Accepted			2022-12-24	WOS:000289516600046
J	Xu, F; Wu, HX; Katritch, V; Han, GW; Jacobson, KA; Gao, ZG; Cherezov, V; Stevens, RC				Xu, Fei; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Jacobson, Kenneth A.; Gao, Zhan-Guo; Cherezov, Vadim; Stevens, Raymond C.			Structure of an Agonist-Bound Human A(2A) Adenosine Receptor	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ALLOSTERIC MODULATION; SUBTYPE-SELECTIVITY; BINDING-SITE; IDENTIFICATION; DOMAINS; GPCR	Activation of G protein-coupled receptors upon agonist binding is a critical step in the signaling cascade for this family of cell surface proteins. We report the crystal structure of the A(2A) adenosine receptor (A(2A)AR) bound to an agonist UK-432097 at 2.7 angstrom resolution. Relative to inactive, antagonist-bound A(2A)AR, the agonist-bound structure displays an outward tilt and rotation of the cytoplasmic half of helix VI, a movement of helix V, and an axial shift of helix III, resembling the changes associated with the active-state opsin structure. Additionally, a seesaw movement of helix VII and a shift of extracellular loop 3 are likely specific to A(2A)AR and its ligand. The results define the molecule UK-432097 as a "conformationally selective agonist" capable of receptor stabilization in a specific active-state configuration.	[Xu, Fei; Wu, Huixian; Han, Gye Won; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Katritch, Vsevolod] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Katritch, Vsevolod] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Jacobson, Kenneth A.; Gao, Zhan-Guo] NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Han, Gye Won/GLQ-8724-2022; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8673-2022; Wu, Huixian/N-6353-2014; Han, Gye Won/GLT-1531-2022; Jacobson, Kenneth Alan/A-1530-2009; Katritch, Vsevolod/Q-8357-2016; soler, martha maricel m gomez/L-6025-2014; Stevens, Raymond/K-7272-2015; Katritch, Vsevolod/Y-2721-2019	Han, Gye Won/0000-0003-4107-835X; Cherezov, Vadim/0000-0002-5265-3914; Wu, Huixian/0000-0003-1357-9747; Jacobson, Kenneth Alan/0000-0001-8104-1493; Katritch, Vsevolod/0000-0003-3883-4505; soler, martha maricel m gomez/0000-0002-4412-8108; Stevens, Raymond/0000-0002-4522-8725; 	National Institute of Diabetes and Digestive and Kidney Diseases; NIH Roadmap Initiative [P50 GM073197]; NIH [GM075915]; NSF [IIS0308078]; Science Foundation Ireland [02-IN1-B266]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104];  [U54 GM094618]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089857, U54GM094618, P50GM073197, R01GM075915] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (K.A.J. and Z.-G.G.), PSI: Biology grant U54 GM094618 for structure production, and NIH Roadmap Initiative grant P50 GM073197 for technology development. R. C. S. thanks N. Dekker at AstraZeneca for suggesting the UK-432097 compound for biochemical and structural studies. We thank J. Velasquez for help on molecular biology; C. Cornillez-Ty, T. Trinh, and K. Allin for help on baculovirus expression; E. Chien and W. Liu for advice on protein purification and LCP crystallization; I. Wilson, M. Hanson, and A. IJzerman for careful review and scientific feedback on the manuscript; K. Kadyshevskaya for assistance with figure preparation; A. Walker for assistance with manuscript preparation; L. Heitman for A<INF>2A</INF>AR compounds used in thermal stability studies; Y. Zheng and M. Caffrey for use of an in meso robot (built with support from NIH grant GM075915, NSF grant IIS0308078, and Science Foundation Ireland grant 02-IN1-B266); and J. Smith, R. Fischetti, and N. Sanishvili for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104. R. C. S. is a founder and member of the board of directors of Receptos, a GPCR structure-based drug discovery company. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification code 3QAK.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Cristalli Gloria, 2009, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-540-89615-9_3; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gao ZG, 2003, MOL PHARMACOL, V63, P1021, DOI 10.1124/mol.63.5.1021; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Ivanov AA, 2009, J MED CHEM, V52, P3284, DOI 10.1021/jm801533x; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jaakola VP, 2010, J BIOL CHEM, V285, P13032, DOI 10.1074/jbc.M109.096974; Jiang QL, 1996, MOL PHARMACOL, V50, P512; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Katritch V, 2011, NEUROPHARMACOLOGY, V60, P108, DOI 10.1016/j.neuropharm.2010.07.009; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; Mantell SJ, 2009, BIOORG MED CHEM LETT, V19, P4471, DOI 10.1016/j.bmcl.2009.05.027; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rieger JM, 2001, J MED CHEM, V44, P531, DOI 10.1021/jm0003642; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Tchilibon S, 2004, BIOORGAN MED CHEM, V12, P2021, DOI 10.1016/j.bmc.2004.02.037; Vanni S, 2010, J MOL BIOL, V397, P1339, DOI 10.1016/j.jmb.2010.01.060; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	36	638	655	0	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					322	327		10.1126/science.1202793	http://dx.doi.org/10.1126/science.1202793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21393508	Green Accepted			2022-12-24	WOS:000289516600036
J	Boyles, JG; Cryan, PM; McCracken, GF; Kunz, TH				Boyles, Justin G.; Cryan, Paul M.; McCracken, Gary F.; Kunz, Thomas H.			Economic Importance of Bats in Agriculture	SCIENCE			English	Editorial Material							WHITE-NOSE SYNDROME; FREE-TAILED BATS; POLLINATION ECOLOGY; SOUTHERN THAILAND; MYOTIS-LUCIFUGUS; WIND TURBINES; BROWN BAT; HYPOTHESES; FATALITIES; DISEASE		[Boyles, Justin G.] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Cryan, Paul M.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [McCracken, Gary F.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA	University of Pretoria; United States Department of the Interior; United States Geological Survey; University of Tennessee System; University of Tennessee Knoxville; Boston University	Boyles, JG (corresponding author), Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	jgboyles@zoology.up.ac.za	Boyles, Justin G/A-5152-2010	McCracken, Gary/0000-0002-2493-8103; Cryan, Paul/0000-0002-2915-8894				ANTHONY ELP, 1977, ECOLOGY, V58, P775, DOI 10.2307/1936213; Arnett EB, 2011, FRONT ECOL ENVIRON, V9, P209, DOI 10.1890/100103; Baerwald EF, 2009, J WILDLIFE MANAGE, V73, P1077, DOI 10.2193/2008-233; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; Bumrungsri S, 2008, J TROP ECOL, V24, P467, DOI 10.1017/S0266467408005191; Bumrungsri S, 2009, J TROP ECOL, V25, P85, DOI 10.1017/S0266467408005531; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Elliot D. L., 1986, WIND ENERGY RESOURCE; Federico P, 2008, ECOL APPL, V18, P826, DOI 10.1890/07-0556.1; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Hallam TG, 2011, CONSERV BIOL, V25, P189, DOI 10.1111/j.1523-1739.2010.01603.x; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; KURTA A, 1989, PHYSIOL ZOOL, V62, P804, DOI 10.1086/physzool.62.3.30157928; Pimentel David, 2009, P89, DOI 10.1007/978-1-4020-8992-3_4; Rydell J, 2010, ACTA CHIROPTEROL, V12, P261, DOI 10.3161/150811010X537846; *USDA, 2009, GEOGR AR SER USDA, V1; WHITAKER JO, 1995, AM MIDL NAT, V134, P346, DOI 10.2307/2426304; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944	23	430	468	11	469	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					41	42		10.1126/science.1201366	http://dx.doi.org/10.1126/science.1201366			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743EJ	21454775				2022-12-24	WOS:000289000000029
J	Oberst, A; Dillon, CP; Weinlich, R; McCormick, LL; Fitzgerald, P; Pop, C; Hakem, R; Salvesen, GS; Green, DR				Oberst, Andrew; Dillon, Christopher P.; Weinlich, Ricardo; McCormick, Laura L.; Fitzgerald, Patrick; Pop, Cristina; Hakem, Razq; Salvesen, Guy S.; Green, Douglas R.			Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis	NATURE			English	Article							CELL-DEATH; RIP1 KINASE; ACTIVATION; REQUIREMENT; APOPTOSIS; HOMEOSTASIS; EXPRESSION; RECEPTORS; REGULATOR; CLEAVAGE	Caspase-8 has two opposing biological functions-it promotes cell death by triggering the extrinsic pathway of apoptosis, but also has a survival activity, as it is required for embryonic development(1), T-lymphocyte activation(2), and resistance to necrosis induced by tumour necrosis factor-alpha (TNF-alpha) and related family ligands(3,4). Here we show that development of caspase-8-deficient mice is completely rescued by ablation of receptor interacting protein kinase-3 (RIPK3). Adult animals lacking both caspase-8 and RIPK3 display a progressive lymphoaccumulative disease resembling that seen with defects in CD95 or CD95-ligand (also known as FAS and FASLG, respectively), and resist the lethal effects of CD95 ligation in vivo. We have found that caspase-8 prevents RIPK3-dependent necrosis without inducing apoptosis by functioning in a proteolytically active complex with FLICE-like inhibitory protein long (FLIPL, also known as CFLAR), and this complex is required for the protective function.	[Oberst, Andrew; Dillon, Christopher P.; Weinlich, Ricardo; McCormick, Laura L.; Fitzgerald, Patrick; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Pop, Cristina; Salvesen, Guy S.] Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; [Hakem, Razq] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	St Jude Children's Research Hospital; Sanford Burnham Prebys Medical Discovery Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Weinlich, Ricardo/G-9028-2013; Weinlich, Ricardo/AAW-3154-2020; Green, Douglas R/N-8083-2018; Dillon, Christopher/P-4457-2014; Weinlich, Ricardo/S-7495-2016	Weinlich, Ricardo/0000-0001-6822-7330; Green, Douglas R/0000-0002-7332-1417; Dillon, Christopher/0000-0002-9458-0266; Hakem, Razqallah/0000-0001-5948-7931	NIH [AI44828, CA69381]; CIHR [MOP 36537]; Sass Foundation for Medical Research; ALSAC; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Sass Foundation for Medical Research; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank W. J. Kaiser and E. S. Mocarski for their discussions and material support. We thank Ariad Pharmaceutical for providing the homo- and heterodimerization reagents. We thank the members of the St. Jude Immunology FACS core facility, as well as M. Johnson, L. Janke and the St. Jude Veterinary Pathology Core. We also thank the St. Jude Hartwell Center. This work was supported by NIH grant AI44828 to D. R. G. and CA69381 to G. S. S., as well as CIHR grant MOP 36537 to R. H. C. P. D. was supported by a fellowship grant from the Sass Foundation for Medical Research. This work was also supported by ALSAC.	Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chang David W, 2003, Sci STKE, V2003, pPL1, DOI 10.1126/stke.2003.167.pl1; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; QUAN LT, 1995, J BIOL CHEM, V270, P10377, DOI 10.1074/jbc.270.18.10377; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scharner D, 2009, ARTERIOSCL THROM VAS, V29, P571, DOI 10.1161/ATVBAHA.108.182006; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	32	875	885	8	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					363	+		10.1038/nature09852	http://dx.doi.org/10.1038/nature09852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368763	Green Accepted			2022-12-24	WOS:000288444000042
J	Hussein, SM; Batada, NN; Vuoristo, S; Ching, RW; Autio, R; Narva, E; Ng, S; Sourour, M; Hamalainen, R; Olsson, C; Lundin, K; Mikkola, M; Trokovic, R; Peitz, M; Brustle, O; Bazett-Jones, DP; Alitalo, K; Lahesmaa, R; Nagy, A; Otonkoski, T				Hussein, Samer M.; Batada, Nizar N.; Vuoristo, Sanna; Ching, Reagan W.; Autio, Reija; Narva, Elisa; Ng, Siemon; Sourour, Michel; Hamalainen, Riikka; Olsson, Cia; Lundin, Karolina; Mikkola, Milla; Trokovic, Ras; Peitz, Michael; Bruestle, Oliver; Bazett-Jones, David P.; Alitalo, Kari; Lahesmaa, Riitta; Nagy, Andras; Otonkoski, Timo			Copy number variation and selection during reprogramming to pluripotency	NATURE			English	Article							EMBRYONIC STEM-CELLS; DNA-DAMAGE RESPONSE; SELF-RENEWAL; FRAGILE SITES; DIFFERENTIATION; FIBROBLASTS; SUPPRESSION; ACTIVATION; INDUCTION; CULTURE	The mechanisms underlying the low efficiency of reprogramming somatic cells into induced pluripotent stem (iPS) cells are poorly understood. There is a clear need to study whether the reprogramming process itself compromises genomic integrity and, through this, the efficiency of iPS cell establishment. Using a high-resolution single nucleotide polymorphism array, we compared copy number variations (CNVs) of different passages of human iPS cells with their fibroblast cell origins and with human embryonic stem (ES) cells. Here we show that significantly more CNVs are present in early-passage human iPS cells than intermediate passage human iPS cells, fibroblasts or human ES cells. Most CNVs are formed de novo and generate genetic mosaicism in early-passage human iPS cells. Most of these novel CNVs rendered the affected cells at a selective disadvantage. Remarkably, expansion of human iPS cells in culture selects rapidly against mutated cells, driving the lines towards a genetic state resembling human ES cells.	[Hussein, Samer M.; Vuoristo, Sanna; Hamalainen, Riikka; Olsson, Cia; Lundin, Karolina; Mikkola, Milla; Trokovic, Ras; Otonkoski, Timo] Univ Helsinki, Biomedicum Stem Cell Ctr, Res Program Unit, FI-00014 Helsinki, Finland; [Hussein, Samer M.; Sourour, Michel; Hamalainen, Riikka; Nagy, Andras] Samuel Lunenfeld Res Inst, Toronto, ON M5T 3H7, Canada; [Batada, Nizar N.; Ng, Siemon] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Ching, Reagan W.; Bazett-Jones, David P.] Hosp Sick Children, Dept Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Autio, Reija; Narva, Elisa; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Autio, Reija; Narva, Elisa; Lahesmaa, Riitta] Abo Akad Univ, FIN-20520 Turku, Finland; [Autio, Reija] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Peitz, Michael; Bruestle, Oliver] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany; [Peitz, Michael; Bruestle, Oliver] Hertie Fdn, D-53127 Bonn, Germany; [Alitalo, Kari] Univ Helsinki, Lab Mol Canc Biol, FI-00014 Helsinki, Finland; [Alitalo, Kari] Univ Helsinki, Cent Hosp, FI-00014 Helsinki, Finland; [Nagy, Andras] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Otonkoski, Timo] Univ Helsinki, Childrens Hosp, FI-00029 Helsinki, Finland	University of Helsinki; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Turku; Abo Akademi University; Tampere University; University of Bonn; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Toronto; University of Helsinki	Otonkoski, T (corresponding author), Univ Helsinki, Biomedicum Stem Cell Ctr, Res Program Unit, FI-00014 Helsinki, Finland.	nagy@lunenfeld.ca; timo.otonkoski@helsinki.fi	Autio, Reija/D-2037-2014; Alitalo, Kari K/J-5013-2014; Närvä, Elisa Maarit/AAA-4885-2022; Martikainen, Riikka/AAR-8397-2020; Peitz, Michael/AHB-0741-2022; Nagy, Andras/G-6465-2013; Otonkoski, Timo/F-1189-2011; Trokovic, Ras/AAC-7309-2022	Alitalo, Kari K/0000-0002-7331-0902; Närvä, Elisa Maarit/0000-0003-0517-9436; Martikainen, Riikka/0000-0002-5102-0672; Nagy, Andras/0000-0003-4311-0413; Trokovic, Ras/0000-0002-3065-6663; Autio, Reija/0000-0002-6519-2715; Batada, Nizar/0000-0002-8007-1487	EU; Academy of Finland; Finnish Cancer Organizations; Helsinki University Hospital; Sigrid Juselius Foundation; Stem Cell Network Canada; GL2; CIHR; McEwen Centre for Regenerative Medicine; Ontario Institute for Cancer Research through the Ontario Ministry of Research and Innovation	EU(European Commission); Academy of Finland(Academy of Finland); Finnish Cancer Organizations; Helsinki University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Stem Cell Network Canada; GL2; CIHR(Canadian Institutes of Health Research (CIHR)); McEwen Centre for Regenerative Medicine; Ontario Institute for Cancer Research through the Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by funding for the ESTOOLS consortium under the Sixth RFP of the EU (S.M.H., T.O., R.L. and O.B.), the Academy of Finland (T.O. and R.A.), the Finnish Cancer Organizations (R.L.), the Research Funds of the Helsinki University Hospital (T.O.), the Sigrid Juselius Foundation (T.O.), the Stem Cell Network Canada, GL2 and CIHR (A.N.). S.M.H. is a recipient of a McEwen Post-doctoral Fellowship from the McEwen Centre for Regenerative Medicine. N.N.B. is the recipient of a New Investigator Award from the Ontario Institute for Cancer Research, through the Ontario Ministry of Research and Innovation. A.N. is Tier 1 Canada Research Chair in Stem Cells and Regeneration. We are grateful to I. Rogers, M. Faiz and K. Nagy for critically reading and editing the manuscript, and J. Ustinov, H. Sariola and J. Palgi for skilled assistance in the characterization of human iPS cells. We thank N. Rahkonen for sample processing, as well as the Finnish Microarray and Sequencing Centre (http://www.btk.fi/), and the Institute of Human Genetics, University of Bonn, for array processing.	Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hagenkord JM, 2010, J MOL DIAGN, V12, P184, DOI 10.2353/jmoldx.2010.090118; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kulkarni A, 2010, MOL CELL BIOL, V30, P578, DOI 10.1128/MCB.01137-09; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Maimets T, 2008, ONCOGENE, V27, P5277, DOI 10.1038/onc.2008.166; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mikkola M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-40; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Riethman H, 2005, CHROMOSOME RES, V13, P505, DOI 10.1007/s10577-005-0998-1; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zschenker O, 2009, DNA REPAIR, V8, P886, DOI 10.1016/j.dnarep.2009.05.004	49	692	734	2	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					58	U67		10.1038/nature09871	http://dx.doi.org/10.1038/nature09871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368824				2022-12-24	WOS:000287924100033
J	Arumugam, M; Raes, J; Pelletier, E; Le Paslier, D; Yamada, T; Mende, DR; Fernandes, GR; Tap, J; Bruls, T; Batto, JM; Bertalan, M; Borruel, N; Casellas, F; Fernandez, L; Gautier, L; Hansen, T; Hattori, M; Hayashi, T; Kleerebezem, M; Kurokawa, K; Leclerc, M; Levenez, F; Manichanh, C; Nielsen, HB; Nielsen, T; Pons, N; Poulain, J; Qin, JJ; Sicheritz-Ponten, T; Tims, S; Torrents, D; Ugarte, E; Zoetendal, EG; Wang, J; Guarner, F; Pedersen, O; de Vos, WM; Brunak, S; Dore, J; Weissenbach, J; Ehrlich, SD; Bork, P				Arumugam, Manimozhiyan; Raes, Jeroen; Pelletier, Eric; Le Paslier, Denis; Yamada, Takuji; Mende, Daniel R.; Fernandes, Gabriel R.; Tap, Julien; Bruls, Thomas; Batto, Jean-Michel; Bertalan, Marcelo; Borruel, Natalia; Casellas, Francesc; Fernandez, Leyden; Gautier, Laurent; Hansen, Torben; Hattori, Masahira; Hayashi, Tetsuya; Kleerebezem, Michiel; Kurokawa, Ken; Leclerc, Marion; Levenez, Florence; Manichanh, Chaysavanh; Nielsen, H. Bjorn; Nielsen, Trine; Pons, Nicolas; Poulain, Julie; Qin, Junjie; Sicheritz-Ponten, Thomas; Tims, Sebastian; Torrents, David; Ugarte, Edgardo; Zoetendal, Erwin G.; Wang, Jun; Guarner, Francisco; Pedersen, Oluf; de Vos, Willem M.; Brunak, Soren; Dore, Joel; Weissenbach, Jean; Ehrlich, S. Dusko; Bork, Peer		MetaHIT Consortium	Enterotypes of the human gut microbiome	NATURE			English	Article							BACTERIAL; DIVERSITY; PATHWAYS; CATALOG; GENES; MUCIN	Our knowledge of species and functional composition of the human gut microbiome is rapidly increasing, but it is still based on very few cohorts and little is known about variation across the world. By combining 22 newly sequenced faecal metagenomes of individuals from four countries with previously published data sets, here we identify three robust clusters (referred to as enterotypes hereafter) that are not nation or continent specific. We also confirmed the enterotypes in two published, larger cohorts, indicating that intestinal microbiota variation is generally stratified, not continuous. This indicates further the existence of a limited number of well-balanced host-microbial symbiotic states that might respond differently to diet and drug intake. The enterotypes are mostly driven by species composition, but abundant molecular functions are not necessarily provided by abundant species, highlighting the importance of a functional analysis to understand microbial communities. Although individual host properties such as body mass index, age, or gender cannot explain the observed enterotypes, data-driven marker genes or functional modules can be identified for each of these host properties. For example, twelve genes significantly correlate with age and three functional modules with the body mass index, hinting at a diagnostic potential of microbial markers.	[Arumugam, Manimozhiyan; Raes, Jeroen; Yamada, Takuji; Mende, Daniel R.; Fernandes, Gabriel R.; Tap, Julien; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Raes, Jeroen] Vrije Univ Brussel VIB, B-1050 Brussels, Belgium; [Pelletier, Eric; Le Paslier, Denis; Bruls, Thomas; Poulain, Julie; Ugarte, Edgardo; Weissenbach, Jean] CEA, F-91000 Evry, France; [Pelletier, Eric; Le Paslier, Denis; Bruls, Thomas; Weissenbach, Jean] CNRS, UMR8030, F-91000 Evry, France; [Pelletier, Eric; Le Paslier, Denis; Bruls, Thomas; Weissenbach, Jean] Univ Evry Val dEssone, F-91000 Evry, France; [Fernandes, Gabriel R.] Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil; [Tap, Julien; Batto, Jean-Michel; Leclerc, Marion; Levenez, Florence; Pons, Nicolas; Dore, Joel; Ehrlich, S. Dusko] INRA, F-78350 Jouy En Josas, France; [Bertalan, Marcelo; Gautier, Laurent; Nielsen, H. Bjorn; Sicheritz-Ponten, Thomas; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Borruel, Natalia; Casellas, Francesc; Manichanh, Chaysavanh; Guarner, Francisco] Univ Hosp Vall Hebron, Digest Syst Res Unit, Barcelona 08035, Spain; [Fernandez, Leyden; Torrents, David] Barcelona Supercomp Ctr, Barcelona 08034, Spain; [Hansen, Torben; Nielsen, Trine; Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Sect Metab Genet, Marie Krogh Ctr Metab Res, DK-2100 Copenhagen, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, DK-5000 Odense, Denmark; [Hattori, Masahira] Univ Tokyo, Computat Biol Lab Bld, Chiba 2778561, Japan; [Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Div Bioenvironm Sci, Miyazaki 8891692, Japan; [Kleerebezem, Michiel; Tims, Sebastian; Zoetendal, Erwin G.; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6710 BA Ede, Netherlands; [Kurokawa, Ken] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Qin, Junjie; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Sicheritz-Ponten, Thomas] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark; [Torrents, David] Pg Lluis Co 23, ICREA, Barcelona 08010, Spain; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Inst Biomed Sci, DK-2200 Copenhagen, Denmark; [Pedersen, Oluf] Hagedom Res Inst, DK-2820 Gentofte, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [de Vos, Willem M.] Univ Helsinki, FI-00014 Helsinki, Finland; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal de Minas Gerais; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Technical University of Denmark; Hospital Universitari Vall d'Hebron; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); University of Copenhagen; University of Southern Denmark; University of Tokyo; University of Miyazaki; Wageningen University & Research; Tokyo Institute of Technology; Beijing Genomics Institute (BGI); Technical University of Denmark; ICREA; University of Copenhagen; University of Copenhagen; Aarhus University; University of Helsinki; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	dusko.ehrlich@jouy.inra.fr; bork@embl.de	Muller, Jean/L-7412-2018; Hattori, Masahira/AAD-3785-2019; Duarte, Graziela Biude Silva/Q-7728-2016; Guedon, Eric/S-5635-2016; Dore, Joel/ABA-8921-2020; BLOTTIERE, Hervé M/C-6120-2011; da Rocha Fernandes, Gabriel/A-5383-2010; Guédon, Eric/AAP-4143-2021; Borruel, Natalia/AFO-6891-2022; GUEDON, Eric/N-8624-2019; Arumugam, Manimozhiyan/AAJ-2394-2020; van Hylckama Vlieg, Johan/F-7887-2014; Hattori, Masahira/C-6958-2016; Gautier, Laurent/F-9849-2012; Guarner, Francisco/ABF-1192-2020; Tap, Julien/E-5760-2010; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Kleerebezem, Michiel/AAT-2078-2021; Wang, Jun/A-7261-2013; Bork, Peer/F-1813-2013; Knol, Jan/A-2178-2010; Knol, Jan/AAL-6487-2020; Nielsen, Henrik/B-8961-2019; Leclerc, Marion/AAZ-3950-2021; Förstner, Konrad U./B-1531-2010; Chervaux, Christian/N-1972-2014; Hayashi, Tetsuya/ABA-1074-2020; InWeb, Inct/J-9839-2013; Sunagawa, Shinichi/Q-5950-2019; Ehrlich, S./Y-2423-2019; Rescigno, Maria/J-9704-2012; Casellas, Francesc/AAT-1018-2021; Mende, Daniel R/I-3662-2019; raes, jeroen/D-7835-2018; Arumugam, Manimozhiyan/E-1211-2011; Shingakujyutsu, Kurokawaken/G-1378-2011; Zeller, Georg/M-6484-2013; de Melo-Minardi, Raquel C./AAG-6540-2021; Parkhill, Julian/G-4703-2011; Wang, Jun/B-9503-2016; Brunak, Soren/O-6621-2016; Wang, Jun/C-8434-2016; Torrents, David/G-5785-2015; Sicheritz-Ponten, Thomas/A-4325-2017	Muller, Jean/0000-0002-7682-559X; Guedon, Eric/0000-0002-0901-4447; BLOTTIERE, Hervé M/0000-0002-8390-0607; da Rocha Fernandes, Gabriel/0000-0002-4897-8521; Borruel, Natalia/0000-0002-4449-2292; GUEDON, Eric/0000-0002-0901-4447; Arumugam, Manimozhiyan/0000-0002-0886-9101; van Hylckama Vlieg, Johan/0000-0001-6656-8668; Hattori, Masahira/0000-0001-9467-0344; Guarner, Francisco/0000-0002-4051-0836; Tap, Julien/0000-0001-8998-5413; Pedersen, Oluf/0000-0002-3321-3972; Bork, Peer/0000-0002-2627-833X; Knol, Jan/0000-0002-2103-5961; Knol, Jan/0000-0002-2103-5961; Nielsen, Henrik/0000-0003-2281-5713; Leclerc, Marion/0000-0001-8684-2847; Förstner, Konrad U./0000-0002-1481-2996; Chervaux, Christian/0000-0001-6812-0912; Sunagawa, Shinichi/0000-0003-3065-0314; Ehrlich, S./0000-0002-7563-4046; Rescigno, Maria/0000-0002-6464-509X; Casellas, Francesc/0000-0003-3196-039X; Mende, Daniel R/0000-0001-6831-4557; raes, jeroen/0000-0002-1337-041X; Arumugam, Manimozhiyan/0000-0002-0886-9101; Zeller, Georg/0000-0003-1429-7485; Pelletier, Eric/0000-0003-4228-1712; Parkhill, Julian/0000-0002-7069-5958; Wang, Jun/0000-0002-2113-5874; Brunak, Soren/0000-0003-0316-5866; Nielsen, Trine/0000-0002-2066-7895; Varela Castro, Encarna/0000-0001-6334-9320; Wang, Jun/0000-0002-8540-8931; Chaysavanh, Manichanh/0000-0002-2287-4003; Kleerebezem, Michiel/0000-0001-8552-2235; Le Paslier, Denis/0000-0003-4335-9956; C. de Melo-Minardi, Raquel/0000-0001-5190-100X; Poulain, Julie/0000-0002-8744-3116; TORREJON, ANTONIO/0000-0002-3126-1532; Delorme, Christine/0000-0002-5208-7238; Huber, Wolfgang/0000-0002-0474-2218; Torrents, David/0000-0002-6086-9037; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Hansen, Torben/0000-0001-8748-3831	European Community [HEALTH-F4-2007-201052]; Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCAMP); Novo Nordisk Foundation; International Science and Technology Cooperation Project in China [0806]; Agence Nationale de la Recherche (ANR); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Fund for Scientific Research Flanders (FWO); ICREA Funding Source: Custom; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002800] Funding Source: NIH RePORTER	European Community(European Commission); Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCAMP); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); International Science and Technology Cooperation Project in China; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Fund for Scientific Research Flanders (FWO)(FWO); ICREA(ICREA); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to C. Creevey, G. Falony and members of the Bork group at EMBL for discussions and assistance. We thank the EMBL IT core facility and Y. Yuan for managing the high-performance computing resources. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013): MetaHIT, grant agreement HEALTH-F4-2007-201052, EMBL, the Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCAMP), Novo Nordisk Foundation and the International Science and Technology Cooperation Project in China (0806). Obese/non-obese volunteers for the MicroObes study were recruited from the SU.VI.MAX cohort study coordinated by P. Galan and S. Hercberg, and metagenome sequencing was funded by Agence Nationale de la Recherche (ANR); volunteers for MicroAge study were recruited from the CROWNALIFE cohort study coordinated by S. Silvi and A. Cresci, and metagenome sequencing was funded by GenoScope. Ciberehd is funded by the Instituto de Salud Carlos III (Spain). J.R. is supported by the Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB) and the Odysseus programme of the Fund for Scientific Research Flanders (FWO). We are thankful to the Human Microbiome Project for generating the reference genomes from human gut microbes and the International Human Microbiome Consortium for discussions and exchange of data.	Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fujihashi K, 2009, TRENDS IMMUNOL, V30, P334, DOI 10.1016/j.it.2009.04.004; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; GIBSON GR, 1990, GUT, V31, P679, DOI 10.1136/gut.31.6.679; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kovacikova G, 2002, INFECT IMMUN, V70, P5355, DOI 10.1128/IAI.70.10.5355-5362.2002; KROGFELT KA, 1991, REV INFECT DIS, V13, P721; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; MetaHITConsortium, 2010, METAHIT DRAFT BACT G; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Walker A, 2007, NAT REV MICROBIOL, V5, P572, DOI 10.1038/nrmicro1720; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Wright DP, 2000, FEMS MICROBIOL LETT, V190, P73, DOI 10.1016/S0378-1097(00)00324-4; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	40	4079	4389	64	1666	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					174	180		10.1038/nature09944	http://dx.doi.org/10.1038/nature09944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21508958	Green Submitted, Green Accepted			2022-12-24	WOS:000290487200030
J	Castro, H; Judd, A; Gibb, DM; Butler, K; Lodwick, RK; van Sighem, A; Ramos, JT; Warsawski, J; Thorne, C; Noguera-Julian, A; Obel, N; Costagliola, D; Tookey, PA; Colin, C; Kjaer, J; Grarup, J; Chene, G; Phillips, A				Castro, Hannah; Judd, Ali; Gibb, Diana M.; Butler, Karina; Lodwick, Rebecca K.; van Sighem, Ard; Ramos, Jose T.; Warsawski, Josiane; Thorne, Claire; Noguera-Julian, Antoni; Obel, Niels; Costagliola, Dominique; Tookey, Pat A.; Colin, Celine; Kjaer, Jesper; Grarup, Jesper; Chene, Genevieve; Phillips, Andrew		COHERE	Risk of triple-class virological failure in children with HIV: a retrospective cohort study	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED CHILDREN; ADHERENCE; MORTALITY; GUIDELINES; IRELAND; UK	Background In adults with HIV treated with antiretroviral drug regimens from within the three original drug classes (nucleoside or nucleotide reverse transcriptase inhibitors [NRTIs], non-NRTIs [NNRTIs], and protease inhibitors), virological failure occurs slowly, suggesting that long-term virological suppression can be achieved in most people, even in areas where access is restricted to drugs from these classes. It is unclear whether this is the case for children, the group who will need to maintain viral suppression for longest. We aimed to determine the rate and predictors of triple-class virological failure to the three original drugs classes in children. Methods In the Collaboration of Observational HIV Epidemiological Research Europe, the rate of triple-class virological failure was studied in children infected perinatally with HIV who were aged less than 16 years, starting antiretroviral therapy (ART) with three or more drugs, between 1998 and 2008. We used Kaplan-Meier and Cox regression methods to investigate the risk and predictors of triple-class virological failure after ART initiation. Findings Of 1007 children followed up for a median of 4.2 (IQR 2.4-6.5) years, 237 (24%) were triple-class exposed and 105 (10%) had triple-class virological failure, of whom 29 never had a viral-load measurement less than 500 copies per mL. Incidence of triple-class virological failure after ART initiation increased with time, and risk by 5 years after ART initiation was 12.0% (95% CI 9.4-14.6). In multivariate analysis, older age at ART initiation was associated with increased risk of failure (p=0.02). Of 686 children starting ART with NRTIs and either a NNRTI or ritonavir-boosted protease inhibitor, the rate of failure was higher than in adults with heterosexually transmitted HIV (hazard ratio 2.2 [95% CI 1.6-3.0, p<0.0001]). Interpretation Findings highlight the challenges of attaining long-term viral suppression in children who will be taking life-long ART Early identification of children not responding to ART, adherence support, particularly for children and adolescents aged 13 years or older starting ART, and ART simplification strategies are all needed to attain and sustain virological suppression.			Judd, A (corresponding author), MRC, Clin Trials Unit, 222 Euston Rd, London NW1 2DA, England.	a.judd@ctu.mrc.ac.uk	Phillips, Andrew N/B-4427-2008; Thorne, Claire/C-5943-2008; DEL AMO VALERO, JULIA/M-7020-2015; Costagliola, Dominique/H-5849-2011; Lodwick, Rebecca/B-7578-2015; Judd, Ali/B-5132-2009; Tookey, Pat A/G-2732-2010; Mocroft, Amanda/G-8748-2011; chene, genevieve/H-8665-2014; Matheron, Sophie/D-7420-2017	Phillips, Andrew N/0000-0003-2384-4807; Thorne, Claire/0000-0003-0389-1956; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Costagliola, Dominique/0000-0003-0765-0869; Lodwick, Rebecca/0000-0003-2558-4762; Judd, Ali/0000-0003-3176-5295; Tookey, Pat A/0000-0001-6258-0387; Mocroft, Amanda/0000-0001-8316-1122; chene, genevieve/0000-0002-8368-6460; Noguera-Julian, Antoni/0000-0001-7485-0583; Casabona-Barbara, Jordi/0000-0003-4816-5536; Gibb, Diana/0000-0002-9738-5490; Matheron, Sophie/0000-0001-7879-6553; Obel, Niels/0000-0002-5031-0045; Castro, Hannah/0000-0001-9086-8687; Paraskevis, Dimitrios/0000-0001-6167-7152; Lo Caputo, Sergio/0000-0002-4729-7548	UK Medical Research Council [G0700832]; European Union [260694]; Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France; HIV Monitoring Foundation, Netherlands; Augustinus Foundation, Denmark; Swiss Bridge Foundation; MRC [G0700832, G0900274, MC_U122886353, G9620552] Funding Source: UKRI; Medical Research Council [MC_U122886353, G0900274, G9620552, G0700832] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France(ANRS); HIV Monitoring Foundation, Netherlands(Netherlands Government); Augustinus Foundation, Denmark; Swiss Bridge Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The PLATO II project is funded by UK Medical Research Council award G0700832. The COHERE study group has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement number 260694; Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France; HIV Monitoring Foundation, Netherlands; and the Augustinus Foundation, Denmark. The group has also received project specific funding from the UK Medical Research Council and the Swiss Bridge Foundation. A list of the funding sources of participating cohorts can be found on the regional coordinating centre websites.	Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Bangsberg David R, 2007, Curr HIV/AIDS Rep, V4, P65, DOI 10.1007/s11904-007-0010-0; Boyd K, 2010, PREVALENCE DARUNAVIR, P851; Brady MT, 2010, JAIDS-J ACQ IMM DEF, V53, P86, DOI 10.1097/QAI.0b013e3181b9869f; Butler L, 2010, 18 INT AIDS C VIENN; de Martino M, 2000, JAMA-J AM MED ASSOC, V284, P190, DOI 10.1001/jama.284.2.190; Deeks SG, 2000, CLIN INFECT DIS, V30, pS177, DOI 10.1086/313855; Giaquinto C, 2008, CLIN DRUG INVEST, V28, P375, DOI 10.2165/00044011-200828060-00005; Goetghebuer T, 2009, AIDS, V23, P597, DOI 10.1097/QAD.0b013e328326ca37; HIV-1 viral load CD4cellcountinuntreatedchildrenwithverticallyacquiredasymptomaticormilddisease, 1998, AIDS, V12, P1; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Kekitiinwa A, 2008, JAIDS-J ACQ IMM DEF, V49, P384, DOI 10.1097/QAI.0b013e31818cdef5; Kjaer J, 2004, ANTIVIR THER, V9, P631; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Lee KJ, 2006, 8 INT C DRUG THER HI; Lodwick R, 2010, ARCH INTERN MED, V170, P410, DOI 10.1001/archinternmed.2009.472; Martin S, 2007, PEDIATR INFECT DIS J, V26, P61, DOI 10.1097/01.inf.0000250625.80340.48; Melvin A, 2010, 18 INT AIDS C VIENN; Menson EN, 2006, BMJ-BRIT MED J, V332, P1183, DOI 10.1136/bmj.332.7551.1183; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Murphy DA, 2005, ARCH PEDIAT ADOL MED, V159, P764, DOI 10.1001/archpedi.159.8.764; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Reddington C, 2000, PEDIATR INFECT DIS J, V19, P1148, DOI 10.1097/00006454-200012000-00005; Sabin CA, 2008, AIDS, V22, P1463; Sharland M, 2004, HIV MED, V5, P61, DOI 10.1111/j.1468-1293.2004.00227.x; Swan J, 2007, PEDIATRICS, V119, P838, DOI 10.1542/peds.2007-0273; The PLATO II Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group, 2009, EUR AIDS CLIN SOC C; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Walker AS, 2004, AIDS, V18, P1915, DOI 10.1097/00002030-200409240-00007; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; *WORK GROUP ANT TH, 2009, GUID US ANT AG PED H, P1; World Health Organization, 2010, ANT THER HIV INF INF	34	86	87	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1580	1587		10.1016/S0140-6736(11)60208-0	http://dx.doi.org/10.1016/S0140-6736(11)60208-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21511330	Green Published			2022-12-24	WOS:000290549700031
J	Huh, JR; Leung, MWL; Huang, PX; Ryan, DA; Krout, MR; Malapaka, RRV; Chow, J; Manel, N; Ciofani, M; Kim, SV; Cuesta, A; Santori, FR; Lafaille, JJ; Xu, HE; Gin, DY; Rastinejad, F; Littman, DR				Huh, Jun R.; Leung, Monica W. L.; Huang, Pengxiang; Ryan, Daniel A.; Krout, Michael R.; Malapaka, Raghu R. V.; Chow, Jonathan; Manel, Nicolas; Ciofani, Maria; Kim, Sangwon V.; Cuesta, Adolfo; Santori, Fabio R.; Lafaille, Juan J.; Xu, H. Eric; Gin, David Y.; Rastinejad, Fraydoon; Littman, Dan R.			Digoxin and its derivatives suppress T(H)17 cell differentiation by antagonizing ROR gamma t activity	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CARDIAC-GLYCOSIDES; THERAPEUTIC APPLICATIONS; AUTOIMMUNE INFLAMMATION; SODIUM/POTASSIUM-ATPASE; LIGAND-BINDING; BETA; IL-23; ALPHA; POPULATIONS	CD4(+) T helper lymphocytes that express interleukin-17 (T(H)17 cells) have critical roles in mouse models of autoimmunity, and there is mounting evidence that they also influence inflammatory processes in humans. Genome-wide association studies in humans have linked genes involved in T(H)17 cell differentiation and function with susceptibility to Crohn's disease, rheumatoid arthritis and psoriasis(1-3). Thus, the pathway towards differentiation of T(H)17 cells and, perhaps, of related innate lymphoid cells with similar effector functions(4,5), is an attractive target for therapeutic applications. Mouse and human T(H)17 cells are distinguished by expression of the retinoic acid receptor-related orphan nuclear receptor ROR gamma t, which is required for induction of IL-17 transcription and for the manifestation of T(H)17-dependent autoimmune disease in mice(6). By performing a chemical screen with an insect cell-based reporter system, we identified the cardiac glycoside digoxin as a specific inhibitor of ROR gamma t transcriptional activity. Digoxin inhibited murine T(H)17 cell differentiation without affecting differentiation of other T cell lineages and was effective in delaying the onset and reducing the severity of autoimmune disease in mice. At high concentrations, digoxin is toxic for human cells, but non-toxic synthetic derivatives 20,22-dihydrodigoxin-21,23-diol and digoxin-21-salicylidene specifically inhibited induction of IL-17 in human CD4(+) T cells. Using these small-molecule compounds, we demonstrate that ROR gamma t is important for the maintenance of IL-17 expression in mouse and human effector T cells. These data indicate that derivatives of digoxin can be used as chemical templates for the development of ROR gamma t-targeted therapeutic agents that attenuate inflammatory lymphocyte function and autoimmune disease.	[Huh, Jun R.; Leung, Monica W. L.; Chow, Jonathan; Manel, Nicolas; Ciofani, Maria; Kim, Sangwon V.; Cuesta, Adolfo; Santori, Fabio R.; Lafaille, Juan J.; Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Huang, Pengxiang; Rastinejad, Fraydoon] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL 32827 USA; [Ryan, Daniel A.; Krout, Michael R.; Gin, David Y.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Malapaka, Raghu R. V.; Xu, H. Eric] Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Chow, Jonathan; Cuesta, Adolfo; Littman, Dan R.] NYU, Howard Hughes Med Inst, Sch Med, New York, NY 10016 USA	New York University; Sanford Burnham Prebys Medical Discovery Institute; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; New York University	Littman, DR (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA.	Dan.Littman@med.nyu.edu	Malapaka, Raghu/B-6185-2012; Manel, Nicolas/E-2128-2011; Xu, H. Eric/ABD-7487-2021; Santori, Fabio/GRF-1002-2022; Kim, Sangwon V./S-1166-2016	Manel, Nicolas/0000-0002-1481-4430; Santori, Fabio/0000-0002-0220-8935; Kim, Sangwon V./0000-0001-8453-7080; Krout, Michael/0000-0002-0539-6986; Chow, Jonathan/0000-0002-4321-2420; Xu, H. Eric/0000-0002-6829-8144; Ciofani, Maria/0000-0001-6472-5260	Jane Coffin Childs Memorial Funds; Howard Hughes Medical Institute; National Institutes of Health [F32GM0860552, RO1GM058833, RO1GM067659, 2RO1GM55217, RO1AI080885]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058833, R01GM055217, R01GM067659] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Funds; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Shamu at ICCB-Longwood for screening small-compound libraries. We also thank the New York Cord Blood Center for providing samples, the Developmental Studies Hybridoma Bank for beta-tubulin antibody, the NYU Cancer Institute Genomics Facility for expert assistance with microarray experiments, V. Kuchroo and M. Oukka for the IL-23R GFP reporter mice, T. Iwaki, C. Thummel and R. Dasgupta for plasmids, M. Garabedian for R1881 and plasmids, D. Mangelsdorf for dafachronic acid and plasmids, G. Diehl and M. Sellars for reading the manuscript, M. Menager and J. Johnson for sharing peripheral blood mononuclear cells, and members of the D. R. L. laboratory for their suggestions. Supported by the Jane Coffin Childs Memorial Funds (J. R. H.), the Howard Hughes Medical Institute (D. R. L.) and National Institutes of Health grants F32GM0860552 (M. R. K.), RO1GM058833 (D.Y.G.), RO1GM067659 (D.Y.G), 2RO1GM55217 (F. R.) and RO1AI080885 (D.R.L.).	Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bagrov AY, 2008, NAT CLIN PRACT NEPHR, V4, P378, DOI 10.1038/ncpneph0848; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Johansson S, 2001, ANTI-CANCER DRUG, V12, P475, DOI 10.1097/00001813-200106000-00009; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LINDENBAUM J, 1981, NEW ENGL J MED, V305, P789, DOI 10.1056/NEJM198110013051403; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; ROBERTSON LW, 1986, APPL ENVIRON MICROB, V51, P1300, DOI 10.1128/AEM.51.6.1300-1303.1986; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stehlin C, 2001, EMBO J, V20, P5822, DOI 10.1093/emboj/20.21.5822; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zavareh RB, 2008, CANCER RES, V68, P6688, DOI 10.1158/0008-5472.CAN-07-6833; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	30	396	430	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					486	490		10.1038/nature09978	http://dx.doi.org/10.1038/nature09978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21441909	Green Accepted			2022-12-24	WOS:000289949600037
J	Uytterhoeven, V; Kuenen, S; Kasprowicz, J; Miskiewicz, K; Verstreken, P				Uytterhoeven, Valerie; Kuenen, Sabine; Kasprowicz, Jaroslaw; Miskiewicz, Katarzyna; Verstreken, Patrik			Loss of Skywalker Reveals Synaptic Endosomes as Sorting Stations for Synaptic Vesicle Proteins	CELL			English	Article							FROG NEUROMUSCULAR JUNCTION; NEUROTRANSMITTER RELEASE; BULK ENDOCYTOSIS; RAB PROTEINS; MEMBRANE; TRANSMITTER; EXOCYTOSIS; TRANSPORT; MACHINERY; ELEGANS	Exchange of proteins at sorting endosomes is not only critical to numerous signaling pathways but also to receptor-mediated signaling and to pathogen entry into cells; however, how this process is regulated in synaptic vesicle cycling remains unexplored. In this work, we present evidence that loss of function of a single neuronally expressed GTPase activating protein (GAP), Skywalker (Sky) facilitates endosomal trafficking of synaptic vesicles at Drosophila neuromuscular junction boutons, chiefly by controlling Rab35 GTPase activity. Analyses of genetic interactions with the ESCRT machinery as well as chimeric ubiquitinated synaptic vesicle proteins indicate that endosomal trafficking facilitates the replacement of dysfunctional synaptic vesicle components. Consequently, sky mutants harbor a larger readily releasable pool of synaptic vesicles and show a dramatic increase in basal neurotransmitter release. Thus, the trafficking of vesicles via endosomes uncovered using sky mutants provides an elegant mechanism by which neurons may regulate synaptic vesicle rejuvenation and neurotransmitter release.	[Uytterhoeven, Valerie; Kuenen, Sabine; Kasprowicz, Jaroslaw; Miskiewicz, Katarzyna; Verstreken, Patrik] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Uytterhoeven, Valerie; Kuenen, Sabine; Kasprowicz, Jaroslaw; Miskiewicz, Katarzyna; Verstreken, Patrik] Katholieke Univ Leuven, Ctr Human Genet, Program Mol & Dev Genet, Program Cognit & Mol Neurosci,Lab Neuronal Commun, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Verstreken, P (corresponding author), VIB, Dept Mol & Dev Genet, Herestr 49, B-3000 Louvain, Belgium.	patrik.verstreken@med.kuleuven.be	Uytterhoeven, Valerie/ABB-6274-2021; Verstreken, Patrik/AAC-7591-2022	Verstreken, Patrik/0000-0002-5073-5393	Marie Curie Excellence grant [MEXT-CT-2006-042267]; ERC [260678]; FWO [G074709, G094011]; Research Fund; Flemish Government; Francqui Foundation; VIB; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)	Marie Curie Excellence grant(European Commission); ERC(European Research Council (ERC)European Commission); FWO(FWO); Research Fund; Flemish Government(European Commission); Francqui Foundation; VIB; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	We thank H. Bellen for reagents and access to screen mutants and A. Di Antonio, M. Scott, K. Suyama, M. Gonzalez-Gaitan, G. Davis, Harvard University, the Bloomington and Harvard Drosophila stock centers, and the Developmental Studies Hybridoma bank for reagents. We thank S. Munck (LiMoNe), P. Baatsen (EM-facility of the CME, VIB-KULeuven), V. Morais, W. Annaert, B. Hassan and members of the Verstreken lab for help and comments. Support was provided by a Marie Curie Excellence grant (MEXT-CT-2006-042267); and ERC Starting Grant (260678), FWO grants G074709 and G094011; the Research Fund KU Leuven; a Methusalem grant of the Flemish Government; the Francqui Foundation; VIB and an Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen), fellowship to VU.	Akbergenova Y, 2009, MOL CELL NEUROSCI, V40, P199, DOI 10.1016/j.mcn.2008.10.005; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Clayton EL, 2008, NEUROCHEM INT, V53, P51, DOI 10.1016/j.neuint.2008.06.002; Clayton EL, 2009, J NEUROSCI METH, V185, P76, DOI 10.1016/j.jneumeth.2009.09.016; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Dyer N, 2007, DEVELOPMENT, V134, P4437, DOI 10.1242/dev.010983; Falace A, 2010, AM J HUM GENET, V87, P365, DOI 10.1016/j.ajhg.2010.07.020; Glyvuk N, 2010, EMBO J, V29, P1318, DOI 10.1038/emboj.2010.15; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HOOPMANN P, 2010, P NATL ACAD SCI US; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Khuong TM, 2010, P NATL ACAD SCI USA, V107, P17379, DOI 10.1073/pnas.1001794107; Kim S, 2010, J CELL BIOL, V188, P717, DOI 10.1083/jcb.200911126; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Meunier FA, 2010, J CELL SCI, V123, P1131, DOI 10.1242/jcs.049296; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Opazo F, 2010, TRAFFIC, V11, P800, DOI 10.1111/j.1600-0854.2010.01058.x; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Rizzoli SO, 2006, TRAFFIC, V7, P1163, DOI 10.1111/j.1600-0854.2006.00466.x; Rosenmund C, 1997, J NEUROSCI METH, V76, P1, DOI 10.1016/S0165-0270(97)00061-7; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; Shimizu H, 2003, J CELL SCI, V116, P3583, DOI 10.1242/jcs.00676; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Verstreken Patrik, 2008, V440, P349, DOI 10.1007/978-1-59745-178-9_26; Verstreken P, 2009, NEURON, V63, P203, DOI 10.1016/j.neuron.2009.06.017; Vijayakrishnan N, 2009, J CELL SCI, V122, P114, DOI 10.1242/jcs.036673; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yao CK, 2009, CELL, V138, P947, DOI 10.1016/j.cell.2009.06.033; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	49	137	144	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					117	132		10.1016/j.cell.2011.02.039	http://dx.doi.org/10.1016/j.cell.2011.02.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458671	Bronze			2022-12-24	WOS:000289053900014
J	Zettl, M; Adrain, C; Strisovsky, K; Lastun, V; Freeman, M				Zettl, Markus; Adrain, Colin; Strisovsky, Kvido; Lastun, Viorica; Freeman, Matthew			Rhomboid Family Pseudoproteases Use the ER Quality Control Machinery to Regulate Intercellular Signaling	CELL			English	Article							INTRAMEMBRANE PROTEOLYSIS; SUBSTRATE-SPECIFICITY; DROSOPHILA RHOMBOID-1; SLEEP; PROTEASES; PATHWAY; IDENTIFICATION; ACTIVATION; PEPTIDASE; RESIDUES	Intramembrane proteolysis governs many cellular control processes, but little is known about how intramembrane proteases are regulated. iRhoms are a conserved subfamily of proteins related to rhomboid intramembrane serine proteases that lack key catalytic residues. We have used a combination of genetics and cell biology to determine that these "pseudoproteases'' inhibit rhomboid-dependent signaling by the epidermal growth factor receptor pathway in Drosophila, thereby regulating sleep. iRhoms prevent the cleavage of potential rhomboid substrates by promoting their destabilization by endoplasmic reticulum (ER)-associated degradation; this mechanism has been conserved in mammalian cells. The exploitation of the intrinsic quality control machinery of the ER represents a new mode of regulation of intercellular signaling. Inactive cognates of enzymes are common, but their functions are mostly unclear; our data indicate that pseudoenzymes can readily evolve into regulatory proteins, suggesting that this may be a significant evolutionary mechanism.	[Zettl, Markus; Adrain, Colin; Strisovsky, Kvido; Lastun, Viorica; Freeman, Matthew] MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Freeman, M (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	mf1@mrc-lmb.cam.ac.uk	Strisovsky, Kvido/H-6284-2014; Adrain, Colin/I-6259-2013	Strisovsky, Kvido/0000-0003-3677-0907; Adrain, Colin/0000-0001-7597-4393; Freeman, Matthew/0000-0003-0410-5451	Austrian FWF; Austrian Academy of Science; International Human Frontier Science Program Organization; EMBO Long-Term Fellowship; Marie Curie Intraeuropean Fellowship; MRC [MC_U105178780] Funding Source: UKRI; Medical Research Council [MC_U105178780] Funding Source: researchfish	Austrian FWF(Austrian Science Fund (FWF)); Austrian Academy of Science; International Human Frontier Science Program Organization(Human Frontier Science Program); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Intraeuropean Fellowship(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Yonka Christova, Marius Lemberg, Marc de la Roche, Amita Sehgal, Sean Munro, Don Ryoo, and Simon Bullock for reagents, discussion, and unpublished data. M.Z. was supported by an Erwin-Schrodinger fellowship from the Austrian FWF and an APART fellowship from the Austrian Academy of Science. C. A. was supported by a long-term fellowship from The International Human Frontier Science Program Organization and was the recipient of an EMBO Long-Term Fellowship. K. S. acknowledges support from Marie Curie Intraeuropean Fellowship and an EMBO Long-Term Fellowship.	Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Bartlett GJ, 2003, J MOL BIOL, V331, P829, DOI 10.1016/S0022-2836(03)00734-4; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cirelli C, 2008, ANN NY ACAD SCI, V1129, P323, DOI 10.1196/annals.1417.017; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Makinoshima H, 2006, MICROBES INFECT, V8, P1882, DOI 10.1016/j.micinf.2006.02.021; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Nakagawa T, 2005, DEV DYNAM, V233, P1315, DOI 10.1002/dvdy.20450; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sakai J, 2001, CURR OPIN LIPIDOL, V12, P261, DOI 10.1097/00041433-200106000-00004; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urban S, 2002, CURR BIOL, V12, P1507, DOI 10.1016/S0960-9822(02)01092-8; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wasserman JD, 2000, GENE DEV, V14, P1651; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Yan ZW, 2008, MOL CANCER THER, V7, P1355, DOI 10.1158/1535-7163.MCT-08-0104; Yogev S, 2008, EMBO J, V27, P1219, DOI 10.1038/emboj.2008.58; Zou HF, 2009, FASEB J, V23, P425, DOI 10.1096/fj.08-112771	42	123	133	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					79	91		10.1016/j.cell.2011.02.047	http://dx.doi.org/10.1016/j.cell.2011.02.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21439629	Green Published, hybrid			2022-12-24	WOS:000289053900011
J	Arnaud-Haond, S; Arrieta, JM; Duarte, CM				Arnaud-Haond, Sophie; Arrieta, Jesus M.; Duarte, Carlos M.			Marine Biodiversity and Gene Patents	SCIENCE			English	Editorial Material							DISTRIBUTIONS; RESOURCES; LAW		[Arnaud-Haond, Sophie] Ifremer French Res Inst Explorat Sea, Ctr Brest, Dept DEEP LEP, F-29280 Plouzane, France; [Arrieta, Jesus M.; Duarte, Carlos M.] CSIC UIB, Dept Global Change Resarch, Mediterranean Inst Adv Studies, IMEDEA, Esporles 07190, Mallorca, Spain; [Duarte, Carlos M.] Univ Western Australia, Oceans Inst, Crawley, WA 6009, Australia	Ifremer; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; University of Western Australia	Arnaud-Haond, S (corresponding author), Ifremer French Res Inst Explorat Sea, Ctr Brest, Dept DEEP LEP, F-29280 Plouzane, France.	sophie.arnaud@ifremer.fr	Duarte Quesada, Carlos Manuel/ABD-6208-2021; Arnaud-Haond, Sophie/B-2479-2008; Duarte, Carlos M/A-7670-2013; Arrieta, Jesus M/B-1226-2008	Arnaud-Haond, Sophie/0000-0001-5814-8452; Duarte, Carlos M/0000-0002-1213-1361; Arrieta, Jesus M/0000-0002-0190-6950				[Anonymous], 2007, REP WORK UN OP END I; Arico S., 2005, REP WORK UN OP END I; Arico S., 2005, BIOPROSPECTING GENET; Arrieta JM, 2010, P NATL ACAD SCI USA, V107, P18318, DOI 10.1073/pnas.0911897107; Bermudez Jorge, 2010, Open AIDS J, V4, P37, DOI 10.2174/1874613601004020037; Blaustein RJ, 2010, BIOSCIENCE, V60, P408, DOI 10.1525/bio.2010.60.6.3; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1352, DOI 10.1038/nbt1106-1352; Clark J., 2000, PATENT POOLS SOLUTIO; Douglas-Westwood Limited, 2005, MAR FOR SER, V1; Dragulescu A, 2001, PHYSICA A, V299, P213, DOI 10.1016/S0378-4371(01)00298-9; Francisco M., 2010, BIOTECHNIQUES, V28, P300; FRANCISCO M, 2010, NAT BIOTECHNOL, V28, P300; GARRISON C, 2007, KESTUDIES, V1, P1, DOI DOI 10.1038/NRD2487; GROSSMAN GM, 1994, J ECON PERSPECT, V8, P23, DOI 10.1257/jep.8.1.23; Hu MB, 2006, EUR PHYS J B, V53, P273, DOI 10.1140/epjb/e2006-00365-8; Leary D, 2009, MAR POLICY, V33, P183, DOI 10.1016/j.marpol.2008.05.010; Martinez SI, 2010, CURR OPIN ENV SUST, V2, P27, DOI 10.1016/j.cosust.2010.03.004; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Ossorio PN, 2007, J LAW MED ETHICS, V35, P425, DOI 10.1111/j.1748-720X.2007.00165.x; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; ZEWERS K, 2007, LOYOLA U CHICAGO INT, V5, P151	22	50	50	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1521	1522		10.1126/science.1200783	http://dx.doi.org/10.1126/science.1200783			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739XH	21436424				2022-12-24	WOS:000288754500027
J	Fan, J; Crooks, C; Creissen, G; Hill, L; Fairhurst, S; Doerner, P; Lamb, C				Fan, Jun; Crooks, Casey; Creissen, Gary; Hill, Lionel; Fairhurst, Shirley; Doerner, Peter; Lamb, Chris			Pseudomonas sax Genes Overcome Aliphatic Isothiocyanate-Mediated Non-Host Resistance in Arabidopsis	SCIENCE			English	Article							PV. TOMATO DC3000; GENOME SEQUENCE; PLANT DEFENSE; PATHOGENS; ACCUMULATION; METABOLITES; THALIANA; INSIGHTS; FAMILY	Most plant-microbe interactions do not result in disease; natural products restrict non-host pathogens. We found that sulforaphane (4-methylsulfinylbutyl isothiocyanate), a natural product derived from aliphatic glucosinolates, inhibits growth in Arabidopsis of non-host Pseudomonas bacteria in planta. Multiple sax genes (saxCAB/F/D/G) were identified in Pseudomonas species virulent on Arabidopsis. These sax genes are required to overwhelm isothiocyanate-based defenses and facilitate a disease outcome, especially in the young leaves critical for plant survival. Introduction of saxCAB genes into non-host strains enabled them to overcome these Arabidopsis defenses. Our study shows that aliphatic isothiocyanates, previously shown to limit damage by herbivores, are also crucial, robust, and developmentally regulated defenses that underpin non-host resistance in the Arabidopsis-Pseudomonas pathosystem.	[Fan, Jun; Crooks, Casey; Creissen, Gary; Hill, Lionel; Fairhurst, Shirley; Lamb, Chris] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Crooks, Casey] USDA, Forest Prod Lab, Madison, WI 53726 USA; [Doerner, Peter] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Doerner, Peter] INRA, CNRS, CEA, Physiol Cellulaire Vegetale Lab, F-38000 Grenoble, France; [Doerner, Peter] Univ Grenoble 1, F-38000 Grenoble, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; United States Department of Agriculture (USDA); United States Forest Service; University of Edinburgh; INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fan, J (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	jun.fan@bbsrc.ac.uk; peter.doerner@ed.ac.uk	Creissen, Gary P/C-7481-2009	Creissen, Gary P/0000-0003-4992-8056; Fan, Jun/0000-0003-0591-0372; Doerner, Peter/0000-0001-7218-8469	UK Biotechnology and Biological Sciences Research Council	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Haas, C. Zipfel, K. Sohn, and D. J. Kliebenstein for providing the pME vectors, bacterial strains, and Arabidopsis myb mutants used in this study; B. Lee and S. Kopriva for help with the glucosinolate assay; and C. Zipfel, C. Dean, A. Maule, and V. Vitart for critical reading of earlier versions of the manuscript. Supported by a grant from the UK Biotechnology and Biological Sciences Research Council (C.L.). J.F., C.C., G.C., L.H., S.F., and P.D. dedicate this paper to the memory of Chris Lamb.	Agrawal AA, 2003, J CHEM ECOL, V29, P1403, DOI 10.1023/A:1024265420375; Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661; Beekwilder J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002068; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Ellis J, 2006, PLANT CELL, V18, P523, DOI 10.1105/tpc.105.040584; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Hipskind JD, 2000, MOL PLANT MICROBE IN, V13, P551, DOI 10.1094/MPMI.2000.13.5.551; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Sandrock RW, 2001, PHYSIOL MOL PLANT P, V58, P159, DOI 10.1006/pmpp.2001.0324; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2	26	136	137	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1185	1188		10.1126/science.1199707	http://dx.doi.org/10.1126/science.1199707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385714				2022-12-24	WOS:000287971200040
J	Zhao, YF; Terry, DS; Shi, L; Quick, M; Weinstein, H; Blanchard, SC; Javitch, JA				Zhao, Yongfang; Terry, Daniel S.; Shi, Lei; Quick, Matthias; Weinstein, Harel; Blanchard, Scott C.; Javitch, Jonathan A.			Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue	NATURE			English	Article							BACTERIAL HOMOLOG; DOPAMINE TRANSPORTER; MOLECULAR-MECHANISM; SODIUM SYMPORTER; BINDING-SITE; LEUT; ION; CONFORMATION; STATE; IDENTIFICATION	Neurotransmitter/Na+ symporters (NSSs) terminate neuronal signalling by recapturing neurotransmitter released into the synapse in a co-transport (symport) mechanism driven by the Na+ electrochemical gradient(1-6). NSSs for dopamine, noradrenaline and serotonin are targeted by the psychostimulants cocaine and amphetamine(1), as well as by antidepressants(7). The crystal structure of LeuT, a prokaryotic NSS homologue, revealed an occluded conformation in which a leucine (Leu) and two Na+ are bound deep within the protein(8). This structure has been the basis for extensive structural and computational exploration of the functional mechanisms of proteins with a LeuT-like fold(9-22). Subsequently, an 'outward-open' conformation was determined in the presence of the inhibitor tryptophan(23), and the Na+-dependent formation of a dynamic outward-facing intermediate was identified using electron paramagnetic resonance spectroscopy(24). In addition, single-molecule fluorescence resonance energy transfer imaging has been used to reveal reversible transitions to an inward-open LeuT conformation, which involve the movement of transmembrane helix TM1a away from the transmembrane helical bundle(22). We investigated how substrate binding is coupled to structural transitions in LeuT during Na+-coupled transport. Here we report a process whereby substrate binding from the extracellular side of LeuT facilitates intracellular gate opening and substrate release at the intracellular face of the protein. In the presence of alanine, a substrate that is transported 10-fold faster than leucine(15,25), we observed alanine-induced dynamics in the intracellular gate region of LeuT that directly correlate with transport efficiency. Collectively, our data reveal functionally relevant and previously hidden aspects of the NSS transport mechanism that emphasize the functional importance of a second substrate (S2) binding site within the extracellular vestibule(15,20). Substrate binding in this S2 site appears to act cooperatively with the primary substrate (S1) binding site to control intracellular gating more than 30 angstrom away, in a manner that allows the Na+ gradient to power the transport mechanism.	[Zhao, Yongfang; Quick, Matthias; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Zhao, Yongfang; Quick, Matthias; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Zhao, Yongfang; Quick, Matthias; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Terry, Daniel S.; Shi, Lei; Weinstein, Harel; Blanchard, Scott C.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Cornell University; Cornell University	Javitch, JA (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, 630 W 168th St, New York, NY 10032 USA.	scb2005@med.cornell.edu; jaj2@columbia.edu	Blanchard, Scott C./A-5804-2009; WEINSTEIN, HAREL/O-8245-2019; Zhao, Yongfang/B-5437-2010; Shi, Lei/AAV-1321-2020	Blanchard, Scott C./0000-0003-2717-9365; WEINSTEIN, HAREL/0000-0003-3473-9818; Shi, Lei/0000-0002-4137-096X; Javitch, Jonathan/0000-0001-7395-2967; Terry, Daniel/0000-0001-9021-0084	National Institutes of Health [DA17293, DA022413, DA12408, DA023694]; Irma T. Hirschl/Monique Weill-Caulier trusts; Lieber Center for Schizophrenia Research and Treatment; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, R00DA023694, R01DA017293, P01DA012408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl/Monique Weill-Caulier trusts; Lieber Center for Schizophrenia Research and Treatment; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Altman for assistance in preparing reagents for single-molecule experiments and F. Carvalho for the preparation of membranes. Molecular graphics were prepared with PyMOL. Computations were performed on Ranger at the Texas Advanced Computing Center (TG-MCB090022) and the David A. Cofrin computational infrastructure of the Institute for Computational Biomedicine at Weill Cornell Medical College. This work was supported in part by National Institutes of Health grants DA17293 and DA022413 (J.A.J.), DA12408 (H.W.), DA023694 (L.S.), the Irma T. Hirschl/Monique Weill-Caulier trusts (S.C.B.) and the Lieber Center for Schizophrenia Research and Treatment. D.S.T. is supported by the Tri-Institutional Training Program in Computational Biology and Medicine.	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; GU H, 1994, J BIOL CHEM, V269, P7124; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krause S, 2005, MOL PHARMACOL, V68, P1728, DOI 10.1124/mol.105.013870; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Noskov SY, 2008, PROTEINS, V73, P851, DOI 10.1002/prot.22108; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rudnick G., 2002, MECH BIOGENIC AMINE; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, CHANNELS, V2, P380, DOI 10.4161/chan.2.5.6904; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sonders MS, 2005, CURR OPIN NEUROBIOL, V15, P296, DOI 10.1016/j.conb.2005.05.009; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	33	188	192	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					109	U11		10.1038/nature09971	http://dx.doi.org/10.1038/nature09971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21516104	Green Accepted			2022-12-24	WOS:000291156700048
J	Ernst, J; Kheradpour, P; Mikkelsen, TS; Shoresh, N; Ward, LD; Epstein, CB; Zhang, XL; Wang, L; Issner, R; Coyne, M; Ku, MC; Durham, T; Kellis, M; Bernstein, BE				Ernst, Jason; Kheradpour, Pouya; Mikkelsen, Tarjei S.; Shoresh, Noam; Ward, Lucas D.; Epstein, Charles B.; Zhang, Xiaolan; Wang, Li; Issner, Robbyn; Coyne, Michael; Ku, Manching; Durham, Timothy; Kellis, Manolis; Bernstein, Bradley E.			Mapping and analysis of chromatin state dynamics in nine human cell types	NATURE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION-FACTOR-BINDING; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; HISTONE MODIFICATIONS; SUSCEPTIBILITY LOCI; ENHANCERS; POPULATION; METAANALYSIS; PROMOTERS	Chromatin profiling has emerged as a powerful means of genome annotation and detection of regulatory activity. The approach is especially well suited to the characterization of non-coding portions of the genome, which critically contribute to cellular phenotypes yet remain largely uncharted. Here we map nine chromatin marks across nine cell types to systematically characterize regulatory elements, their cell-type specificities and their functional interactions. Focusing on cell-type-specific patterns of promoters and enhancers, we define multicell activity profiles for chromatin state, gene expression, regulatory motif enrichment and regulator expression. We use correlations between these profiles to link enhancers to putative target genes, and predict the cell-type-specific activators and repressors that modulate them. The resulting annotations and regulatory predictions have implications for the interpretation of genome-wide association studies. Top-scoring disease single nucleotide polymorphisms are frequently positioned within enhancer elements specifically active in relevant cell types, and in some cases affect a motif instance for a predicted regulator, thus suggesting a mechanism for the association. Our study presents a general framework for deciphering cis-regulatory connections and their roles in disease.	[Ernst, Jason; Kheradpour, Pouya; Mikkelsen, Tarjei S.; Shoresh, Noam; Ward, Lucas D.; Epstein, Charles B.; Zhang, Xiaolan; Wang, Li; Issner, Robbyn; Coyne, Michael; Ku, Manching; Durham, Timothy; Kellis, Manolis; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ernst, Jason; Kheradpour, Pouya; Ward, Lucas D.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Howard Hughes Med Inst, Boston, MA 02114 USA; [Ku, Manching; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Kellis, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	manoli@mit.edu	Kellis, Manolis/ABE-7385-2020; Mikkelsen, Tarjei S/A-1306-2007	Kellis, Manolis/0000-0001-7113-9630; Mikkelsen, Tarjei S/0000-0002-8133-3135; Issner, Robbyn/0000-0003-4132-9219; Epstein, Charles B./0000-0001-8358-8345; Ward, Lucas/0000-0002-8017-809X	National Human Genome Research Institute [U54 HG004570, R01 HG004037, RC1 HG005334]; Howard Hughes Medical Institute; National Science Foundation [0644282, 0905968]; Sloan Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005334, U54HG004570, R01HG004037] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the epigenomics community at the Broad Institute and the Bernstein and Kellis laboratories, and M. Daly, D. Altshuler and E. Lander for discussions and criticisms. We also thank M. Suva, E. Mendenhall and S. Gillespie for assistance with experiments, and L. Goff and A. Chess for critical reading of the manuscript. We acknowledge the Broad Institute Genome Sequencing Platform for their expertise and assistance with data production. This research was supported by the National Human Genome Research Institute under an ENCODE grant (U54 HG004570; B.E.B.), R01 HG004037 (M. Kellis), RC1 HG005334 (M. Kellis), the Howard Hughes Medical Institute (B.E.B.), the National Science Foundation (awards 0644282 (M. Kellis) and 0905968 (J.E.)) and the Sloan Foundation (M. Kellis).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Forte E, 2009, J VIROL, V83, P2491, DOI 10.1128/JVI.01681-08; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hoshino H, 2007, J BIOCHEM, V141, P719, DOI 10.1093/jb/mvm073; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Naumova N, 2010, J CELL SCI, V123, P1979, DOI 10.1242/jcs.051631; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Solozobova V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-46; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Touzet H, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-15; Vassen L, 2006, EMBO J, V25, P2409, DOI 10.1038/sj.emboj.7601124; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	65	1994	2045	6	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					43	U52		10.1038/nature09906	http://dx.doi.org/10.1038/nature09906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21441907	Green Submitted, Green Accepted			2022-12-24	WOS:000290218300027
J	Carlson, BA; Hasan, SM; Hollmann, M; Miller, DB; Harmon, LJ; Arnegard, ME				Carlson, Bruce A.; Hasan, Saad M.; Hollmann, Michael; Miller, Derek B.; Harmon, Luke J.; Arnegard, Matthew E.			Brain Evolution Triggers Increased Diversification of Electric Fishes	SCIENCE			English	Article							DIVERGENCE; MORMYRIDAE; SPECIATION; TELEOSTEI; RATES; MORMYROIDEA; RADIATION; DIVERSITY; DISCHARGE; SIGNALS	Communication can contribute to the evolution of biodiversity by promoting speciation and reinforcing reproductive isolation between existing species. The evolution of species-specific signals depends on the ability of individuals to detect signal variation, which in turn relies on the capability of the brain to process signal information. Here, we show that evolutionary change in a region of the brain devoted to the analysis of communication signals in mormyrid electric fishes improved detection of subtle signal variation and resulted in enhanced rates of signal evolution and species diversification. These results show that neural innovations can drive the diversification of signals and promote speciation.	[Carlson, Bruce A.; Hasan, Saad M.; Hollmann, Michael; Miller, Derek B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; [Arnegard, Matthew E.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA	Washington University (WUSTL); Idaho; University of Idaho; Fred Hutchinson Cancer Center	Carlson, BA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	carlson.bruce@wustl.edu	Hollmann, Michael/AAW-5574-2021; Harmon, Luke/A-8225-2012	Harmon, Luke/0000-0002-4985-5750; Hollmann, Michael/0000-0002-2209-2773	NSF [IOS-0818390, DEB-0919499]; Division Of Integrative Organismal Systems [0818390] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. D. Hopkins and J. R. Gallant for help with field work, J. P. Friel (Cornell University Museum of Vertebrates) for providing specimens, and S. Lavoue and J. P. Sullivan for providing cytb sequences (GenBank accession numbers provided in table S1). Supported by NSF IOS-0818390 (B.A.C.); L.J.H. was supported by NSF DEB-0919499.	Arnegard ME, 2006, J EXP BIOL, V209, P2182, DOI 10.1242/jeb.02239; Arnegard ME, 2010, AM NAT, V176, P335, DOI 10.1086/655221; Bass A.H., 1986, P13; BASS AH, 1982, J MORPHOL, V174, P313, DOI 10.1002/jmor.1051740306; Bell C.C., 1986, P375; Carlson Bruce, 2006, P805; Eschmeyer WN, 2010, CATALOG FISHES ELECT; Feulner PGD, 2007, J EVOLUTION BIOL, V20, P403, DOI 10.1111/j.1420-9101.2006.01181.x; Feulner PGD, 2009, BIOL LETTERS, V5, P225, DOI 10.1098/rsbl.2008.0566; HARDER W, 1968, Z VERGL PHYSIOL, V59, P272; HOPKINS CD, 1981, SCIENCE, V212, P85, DOI 10.1126/science.7209524; HOPKINS CD, 1981, AM ZOOL, V21, P211; Hoskin CJ, 2010, ECOL LETT, V13, P409, DOI 10.1111/j.1461-0248.2010.01448.x; Lavoue S, 2004, ZOOSYSTEMA, V26, P511; Lavoue S, 2003, BIOL J LINN SOC, V78, P273, DOI 10.1046/j.1095-8312.2003.00170.x; Lavoue S, 2010, ZOOTAXA, P1; Lavoue S, 2008, J PHYSIOL-PARIS, V102, P322, DOI 10.1016/j.jphysparis.2008.10.003; Machnik P, 2008, J EXP BIOL, V211, P1969, DOI 10.1242/jeb.016949; MOLLER P, 1989, ETHOLOGY, V82, P177; O'Meara BC, 2006, EVOLUTION, V60, P922; Post N, 1999, PHYSIOL BEHAV, V68, P115, DOI 10.1016/S0031-9384(99)00153-5; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; RYAN MJ, 1986, P NATL ACAD SCI USA, V83, P1379, DOI 10.1073/pnas.83.5.1379; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shumway CA, 2008, BRAIN BEHAV EVOLUT, V72, P123, DOI 10.1159/000151472; Sullivan JP, 2000, J EXP BIOL, V203, P665; Sylvester JB, 2010, P NATL ACAD SCI USA, V107, P9718, DOI 10.1073/pnas.1000395107; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; Xu-Friedman MA, 1999, J EXP BIOL, V202, P1311; Zakon H.H., 1986, P103	30	71	71	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					583	586		10.1126/science.1201524	http://dx.doi.org/10.1126/science.1201524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527711				2022-12-24	WOS:000289991100047
J	Schoggins, JW; Wilson, SJ; Panis, M; Murphy, MY; Jones, CT; Bieniasz, P; Rice, CM				Schoggins, John W.; Wilson, Sam J.; Panis, Maryline; Murphy, Mary Y.; Jones, Christopher T.; Bieniasz, Paul; Rice, Charles M.			A diverse range of gene products are effectors of the type I interferon antiviral response	NATURE			English	Article							HEPATITIS-C VIRUS; IDENTIFICATION; PROTEINS; REVEALS; RNA; CLASSIFICATION; REPLICATION; EXPRESSION; RESISTANCE; DISEASE	The type I interferon response protects cells against invading viral pathogens. The cellular factors that mediate this defence are the products of interferon-stimulated genes (ISGs). Although hundreds of ISGs have been identified since their discovery more than 25 years ago(1-3), only a few have been characterized with respect to antiviral activity. For most ISG products, little is known about their antiviral potential, their target specificity and their mechanisms of action. Using an overexpression screening approach, here we show that different viruses are targeted by unique sets of ISGs. We find that each viral species is susceptible to multiple antiviral genes, which together encompass a range of inhibitory activities. To conduct the screen, more than 380 human ISGs were tested for their ability to inhibit the replication of several important human and animal viruses, including hepatitis C virus, yellow fever virus, West Nile virus, chikungunya virus, Venezuelan equine encephalitis virus and human immunodeficiency virus type-1. Broadly acting effectors included IRF1, C6orf150 (also known as MB21D1), HPSE, RIG-I (also known as DDX58), MDA5 (also known as IFIH1) and IFITM3, whereas more targeted antiviral specificity was observed with DDX60, IFI44L, IFI6, IFITM2, MAP3K14, MOV10, NAMPT (also known as PBEF1), OASL, RTP4, TREX1 and UNC84B (also known as SUN2). Combined expression of pairs of ISGs showed additive antiviral effects similar to those of moderate type I interferon doses. Mechanistic studies uncovered a common theme of translational inhibition for numerous effectors. Several ISGs, including ADAR, FAM46C, LY6E and MCOLN2, enhanced the replication of certain viruses, highlighting another layer of complexity in the highly pleiotropic type I interferon system.	[Schoggins, John W.; Panis, Maryline; Murphy, Mary Y.; Jones, Christopher T.; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10065 USA; [Wilson, Sam J.; Bieniasz, Paul] Rockefeller Univ, Howard Hughes Med Inst, Aaron Diamond AIDS Res Ctr, Lab Retrovirol, New York, NY 10016 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10065 USA.	ricec@mail.rockefeller.edu		Wilson, Sam/0000-0002-6065-0895	New York State Department of Health (NYSDOH) [C023046]; National Institutes of Health [AI057158, AI064003]; Greenberg Medical Research Institute; Starr Foundation; Ronald A. Shellow, M. D. Memorial Fund; National Institute of Diabetes and Digestive and Kidney Diseases [DK082155, DK081193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R37AI064003, R01AI064003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK082155, F32DK081193] Funding Source: NIH RePORTER	New York State Department of Health (NYSDOH); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenberg Medical Research Institute; Starr Foundation; Ronald A. Shellow, M. D. Memorial Fund; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the following investigators for contributing viral molecular clones: C. Stoyanov (YFV), S. Higgs (CHIKV), I. Frolov (WNV and VEEV), M. MacDonald and J. Law (SINV(ts6) and SINV-Fluc), M. Heise (SINV and SINV-GFP). We thank E. Jouanguy and J.-L. Casanova for STAT1<SUP>-/-</SUP> fibroblasts. We acknowledge the support of C. Zhao, X. Wang and W. Zhang at The Rockefeller University Genomics Resource Center. For technical advice, we thank S. Mazel and C. Bare at The Rockefeller University Flow Cytometry Resource Center, supported by the Empire State Stem Cell Fund through the New York State Department of Health (NYSDOH) contract no. C023046; the opinions expressed here are solely those of the authors and do not necessarily reflect those of the Empire State Stem Cell Fund, the NYSDOH or the State of New York. We thank M. Holz, E. Castillo and A. Webson for laboratory support; C. Murray for critical reading and editing of the manuscript; and A. Ploss, M. Scull, M. T. Catanese and S. You for discussions. This work was supported in part by National Institutes of Health grants AI057158 (Northeast Biodefense Center-Lipkin) to C. M. R. and AI064003 to P. B. Additional funding was provided by the Greenberg Medical Research Institute, the Starr Foundation and the Ronald A. Shellow, M. D. Memorial Fund (C. M. R.). J. W. S. and C. T. J. were supported by National Research Service Awards DK082155 and DK081193, respectively, from the National Institute of Diabetes and Digestive and Kidney Diseases.	Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brodsky LI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000584; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Doria M, 2009, NUCLEIC ACIDS RES, V37, P5848, DOI 10.1093/nar/gkp604; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Frontini M, 2009, NUCLEIC ACIDS RES, V37, P1073, DOI 10.1093/nar/gkn1051; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Hilkens CMU, 2003, J IMMUNOL, V171, P5255, DOI 10.4049/jimmunol.171.10.5255; Hultcrantz M, 2007, VIROLOGY, V367, P92, DOI 10.1016/j.virol.2007.05.010; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; KNIGHT E, 1979, P NATL ACAD SCI USA, V76, P1824, DOI 10.1073/pnas.76.4.1824; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167; LARNER AC, 1984, P NATL ACAD SCI-BIOL, V81, P6733, DOI 10.1073/pnas.81.21.6733; Leaman DW, 2003, J INTERF CYTOK RES, V23, P745, DOI 10.1089/107999003772084860; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu HC, 2003, CYTOGENET GENOME RES, V102, P304, DOI 10.1159/000075767; McGee CE, 2010, VECTOR-BORNE ZOONOT, V10, P267, DOI 10.1089/vbz.2009.0067; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005; Rani MRS, 2007, J LEUKOCYTE BIOL, V82, P1353, DOI 10.1189/jlb.0507273; ROY S, 1990, SCIENCE, V247, P1216, DOI 10.1126/science.2180064; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Spindler KR, 2010, J IMMUNOL, V184, P3055, DOI 10.4049/jimmunol.0903363; Suthar MS, 2005, J VIROL, V79, P4219, DOI 10.1128/JVI.79.7.4219-4228.2005; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	42	1595	1643	4	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					481	U545		10.1038/nature09907	http://dx.doi.org/10.1038/nature09907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21478870	Green Accepted			2022-12-24	WOS:000289949600036
J	Edery, P; Marcaillou, C; Sahbatou, M; Labalme, A; Chastang, J; Touraine, R; Tubacher, E; Senni, F; Bober, MB; Nampoothiri, S; Jouk, PS; Steichen, E; Berland, S; Toutain, A; Wise, CA; Sanlaville, D; Rousseau, F; Clerget-Darpoux, F; Leutenegger, AL				Edery, Patrick; Marcaillou, Charles; Sahbatou, Mourad; Labalme, Audrey; Chastang, Joelle; Touraine, Renaud; Tubacher, Emmanuel; Senni, Faiza; Bober, Michael B.; Nampoothiri, Sheela; Jouk, Pierre-Simon; Steichen, Elisabeth; Berland, Siren; Toutain, Annick; Wise, Carol A.; Sanlaville, Damien; Rousseau, Francis; Clerget-Darpoux, Francoise; Leutenegger, Anne-Louise			Association of TALS Developmental Disorder with Defect in Minor Splicing Component U4atac snRNA	SCIENCE			English	Article							NONSENSE-MEDIATED DECAY; INBREEDING COEFFICIENT; RNA SURVEILLANCE; U4 SNRNA; PROTEIN; INTRONS; U12-TYPE; SPLICEOSOME; DWARFISM	The spliceosome, a ribonucleoprotein complex that includes proteins and small nuclear RNAs (snRNAs), catalyzes RNA splicing through intron excision and exon ligation to produce mature messenger RNAs, which, in turn serve as templates for protein translation. We identified four point mutations in the U4atac snRNA component of the minor spliceosome in patients with brain and bone malformations and unexplained postnatal death [microcephalic osteodysplastic primordial dwarfism type 1 (MOPD 1) or Taybi-Linder syndrome (TALS); Mendelian Inheritance in Man ID no. 210710]. Expression of a subgroup of genes, possibly linked to the disease phenotype, and minor intron splicing were affected in cell lines derived from TALS patients. Our findings demonstrate a crucial role of the minor spliceosome component U4atac snRNA in early human development and postnatal survival.	[Edery, Patrick; Labalme, Audrey; Chastang, Joelle; Senni, Faiza; Sanlaville, Damien] Hosp Civils Lyon, Serv Cytogenet Constitut, F-69677 Bron, France; [Edery, Patrick; Sanlaville, Damien] INSERM, U1028, F-69000 Lyon, France; [Edery, Patrick; Sanlaville, Damien] CNRS, UMR5292, F-69000 Lyon, France; [Edery, Patrick; Sanlaville, Damien] Univ Lyon 1, F-69000 Lyon, France; [Edery, Patrick; Sanlaville, Damien] Ctr Rech Neurosci Lyon, Translat & Integrat Grp Epilepsy Res, F-69000 Lyon, France; [Marcaillou, Charles; Rousseau, Francis] IntegraGen, F-91030 Evry, France; [Sahbatou, Mourad; Tubacher, Emmanuel] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France; [Touraine, Renaud] Hop Nord St Etienne, CHU, Serv Genet, F-42055 St Etienne, France; [Bober, Michael B.] Alfred I DuPont Hosp Children, Dept Pediat, Div Med Genet, Wilmington, DE 19803 USA; [Nampoothiri, Sheela] Amrita Inst Med Sci & Res Ctr, Dept Pediat Genet, Cochin 682041, Kerala, India; [Jouk, Pierre-Simon] CHU Grenoble, Dept Genet & Procreat, F-38043 Grenoble 9, France; [Jouk, Pierre-Simon] Univ Grenoble 1, CNRS, UMR 5525, F-38041 Grenoble, France; [Steichen, Elisabeth] Univ Innsbruck Hosp, Dept Pediat, A-6020 Innsbruck, Austria; [Berland, Siren] St Olavs Hosp, Dept Pathol, Clin Genet Sect, N-7006 Trondheim, Norway; [Berland, Siren] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Toutain, Annick] Hop Bretonneau, CHRU, Serv Genet, F-37044 Tours, France; [Toutain, Annick] Univ Tours, INSERM, U930, Tours, France; [Wise, Carol A.] Texas Scottish Rite Hosp Children, Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Clerget-Darpoux, Francoise] INSERM, U669, F-94804 Villejuif, France; [Clerget-Darpoux, Francoise] Univ Paris 11, UMR S669, F-94804 Villejuif, France; [Leutenegger, Anne-Louise] INSERM, U946, F-75010 Paris, France; [Leutenegger, Anne-Louise] Univ Paris Diderot, Inst Univ Hematol, UMR S946, F-75010 Paris, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Foundation Jean Dausset-CEPH; CHU de St Etienne; Nemours Alfred I. duPont Hospital for Children; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Medical University of Innsbruck; Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Texas Scottish Rite Hospital for Children; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Edery, P (corresponding author), Hosp Civils Lyon, Serv Cytogenet Constitut, F-69677 Bron, France.	patrick.edery@chu-lyon.fr	Nampoothiri, Sheela/AAQ-4854-2021; Bober, Michael/AAH-4553-2021; Edery, Patrick/B-6407-2012; Sanlaville, Damien/M-4716-2014; Jouk, Pierre-Simon/M-7367-2014; Jouk, Pierre-Simon/AAB-5262-2022; Leutenegger, Anne-Louise/B-5597-2009; Touraine, Renaud/AAV-1605-2020; Clerget-Darpoux, Francoise/I-4825-2017	Nampoothiri, Sheela/0000-0002-9575-0722; Sanlaville, Damien/0000-0001-9939-2849; Jouk, Pierre-Simon/0000-0001-8301-320X; Leutenegger, Anne-Louise/0000-0002-1302-4357; Clerget-Darpoux, Francoise/0000-0003-4816-6619; Wise, Carol/0000-0002-6790-2194; Berland, Siren/0000-0002-8048-6682; Bober, Michael/0000-0002-6178-1264; Toutain, Annick/0000-0002-5999-5300	Fondation Yves Cotrel-Institut de France; Hospices Civils de Lyon; French Ministry of Health; Lyon 1 University; INSERM; Association GEN'HOM; Texas Scottish Rite Hospital for Children	Fondation Yves Cotrel-Institut de France; Hospices Civils de Lyon; French Ministry of Health; Lyon 1 University; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association GEN'HOM; Texas Scottish Rite Hospital for Children	We express our heartfelt thanks to the patients and families who participated in this study. We thank M. Gallagher-Gambarelli for her editorial assistance and R. Hennekam for his assistance during the project; M. Letexier for her assistance in analyzing high-throughput sequencing data; T. Rio Frio for helpful discussions on splicing analyses; M. de Tayrac and C. Depienne for helpful discussions on expression data analysis; I. Rouvet and M.-T. Zabot for fibroblast banking; and R. Padgett for providing us with the hand-built U4atac/U6atac bimolecular structure reflecting mfold software predictions. This work was supported by the Fondation Yves Cotrel-Institut de France, the Hospices Civils de Lyon, the French Ministry of Health (Direction de l'Hospitalisation et de l'Organisation des Soins, Plan Maladies Rares 2004), Lyon 1 University, the INSERM, the Association GEN'HOM, and the Texas Scottish Rite Hospital for Children Research Fund.	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Leutenegger AL, 2006, AM J HUM GENET, V79, P62, DOI 10.1086/504640; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Padgett RA, 2002, RNA, V8, P125, DOI 10.1017/S1355838202017156; Pessa HKJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013215; Schultz A, 2006, J BIOL CHEM, V281, P28278, DOI 10.1074/jbc.M603350200; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; Shukla GC, 2002, NUCLEIC ACIDS RES, V30, P4650, DOI 10.1093/nar/gkf609; Sigaudy S, 1998, AM J MED GENET, V80, P16, DOI 10.1002/(SICI)1096-8628(19981102)80:1<16::AID-AJMG4>3.3.CO;2-X; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; TAYBI H, 1967, RADIOLOGY, V89, P275, DOI 10.1148/89.2.275; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3	20	140	142	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					240	243		10.1126/science.1202205	http://dx.doi.org/10.1126/science.1202205			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474761				2022-12-24	WOS:000289251100053
J	Fischer, MG; Suttle, CA				Fischer, Matthias G.; Suttle, Curtis A.			A Virophage at the Origin of Large DNA Transposons	SCIENCE			English	Article							EUKARYOTES; EVOLUTION; ELEMENTS; INTEGRASES; MIMIVIRUS; VIRUSES; PRD1	DNA transposons are mobile genetic elements that have shaped the genomes of eukaryotes for millions of years, yet their origins remain obscure. We discovered a virophage that, on the basis of genetic homology, likely represents an evolutionary link between double-stranded DNA viruses and Maverick/Polinton eukaryotic DNA transposons. The Mavirus virophage parasitizes the giant Cafeteria roenbergensis virus and encodes 20 predicted proteins, including a retroviral integrase and a protein-primed DNA polymerase B. On the basis of our data, we conclude that Maverick/Polinton transposons may have originated from ancient relatives of Mavirus, and thereby influenced the evolution of eukaryotic genomes, although we cannot rule out alternative evolutionary scenarios.	[Fischer, Matthias G.; Suttle, Curtis A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Suttle, CA (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 1365-2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	csuttle@eos.ubc.ca	Fischer, Matthias G/Q-2738-2017; Suttle, Curtis A/C-3150-2008; suttle, c/N-1144-2019	Fischer, Matthias G/0000-0002-4014-3626; Suttle, Curtis A/0000-0002-0372-0033; suttle, c/0000-0002-0372-0033	Natural Science and Engineering Research Council of Canada (NSERC); Tula Foundation through the Centre for Microbial Diversity and Evolution; Gottlieb Daimler- and Karl Benz-Foundation, Germany; University of British Columbia	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tula Foundation through the Centre for Microbial Diversity and Evolution; Gottlieb Daimler- and Karl Benz-Foundation, Germany; University of British Columbia	We thank B.N. Ross and G. D. Martens of the UBC Bioimaging Facility and A. M. Chan for assistance with electron microscopy; E. Zaikova for qPCR assistance; and E. J. Pritham, J. Davies, and E. Nomis for constructive comments. Supported by the Natural Science and Engineering Research Council of Canada (NSERC) Discovery Grants Program, the Tula Foundation through the Centre for Microbial Diversity and Evolution, and fellowships awarded to M. G. F. by the Gottlieb Daimler- and Karl Benz-Foundation, Germany, and the University of British Columbia. The genome sequence of Mavirus has been deposited in GenBank under the accession number HQ712116.	Bao WD, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-3; Benson SD, 1999, CELL, V98, P825, DOI 10.1016/S0092-8674(00)81516-0; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Claverie JM, 2009, ANNU REV GENET, V43, P49, DOI 10.1146/annurev-genet-102108-134255; Feschotte C, 2005, TRENDS GENET, V21, P551, DOI 10.1016/j.tig.2005.07.007; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Filee J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-320; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Gao X, 2005, TRENDS GENET, V21, P133, DOI 10.1016/j.tig.2005.01.006; Johnson WE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001210; Kapitonov VV, 2006, P NATL ACAD SCI USA, V103, P4540, DOI 10.1073/pnas.0600833103; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; Krupovic M, 2008, NAT REV MICROBIOL, V6, P941, DOI 10.1038/nrmicro2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Pritham EJ, 2009, J HERED, V100, P648, DOI 10.1093/jhered/esp065; Stromsten NJ, 2005, J MOL BIOL, V348, P617, DOI 10.1016/j.jmb.2005.03.002	18	184	194	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					231	234		10.1126/science.1199412	http://dx.doi.org/10.1126/science.1199412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21385722				2022-12-24	WOS:000289251100050
J	Tye, KM; Prakash, R; Kim, SY; Fenno, LE; Grosenick, L; Zarabi, H; Thompson, KR; Gradinaru, V; Ramakrishnan, C; Deisseroth, K				Tye, Kay M.; Prakash, Rohit; Kim, Sung-Yon; Fenno, Lief E.; Grosenick, Logan; Zarabi, Hosniya; Thompson, Kimberly R.; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl			Amygdala circuitry mediating reversible and bidirectional control of anxiety	NATURE			English	Article							CONDITIONED FEAR; CENTRAL NUCLEUS; RAT; DISORDERS; BEHAVIOR; BRAIN; CAT; PROJECTIONS; COMPLEX; MICE	Anxiety-a sustained state of heightened apprehension in the absence of immediate threat-becomes severely debilitating in disease states(1). Anxiety disorders represent the most common of psychiatric diseases (28% lifetime prevalence) 2 and contribute to the aetiology of major depression and substance abuse(3,4). Although it has been proposed that the amygdala, a brain region important for emotional processing(5-8), has a role in anxiety(9-13), the neural mechanisms that control anxiety remain unclear. Here we explore the neural circuits underlying anxiety-related behaviours by using optogenetics with two-photon microscopy, anxiety assays in freely moving mice, and electrophysiology. With the capability of optogenetics(14-16) to control not only cell types but also specific connections between cells, we observed that temporally precise optogenetic stimulation of basolateral amygdala (BLA) terminals in the central nucleus of the amygdala (CeA)-achieved by viral transduction of the BLA with a codon-optimized channelrhodopsin followed by restricted illumination in the downstream CeA-exerted an acute, reversible anxiolytic effect. Conversely, selective optogenetic inhibition of the same projection with a third-generation halorhodopsin(15) (eNpHR3.0) increased anxiety-related behaviours. Importantly, these effects were not observed with direct optogenetic control of BLA somata, possibly owing to recruitment of antagonistic downstream structures. Together, these results implicate specific BLACeA projections as critical circuit elements for acute anxiety control in the mammalian brain, and demonstrate the importance of optogenetically targeting defined projections, beyond simply targeting cell types, in the study of circuit function relevant to neuropsychiatric disease.	[Tye, Kay M.; Prakash, Rohit; Kim, Sung-Yon; Fenno, Lief E.; Grosenick, Logan; Zarabi, Hosniya; Thompson, Kimberly R.; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Prakash, Rohit; Kim, Sung-Yon; Fenno, Lief E.; Grosenick, Logan; Gradinaru, Viviana; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Core, Vector/CAF-4832-2022; Tye, Kay/J-6158-2013; Fenno, Lief/AAF-9638-2019; Fenno, Lief/AAK-2924-2020; Kim, Sung-Yon/AAO-8405-2020	Tye, Kay/0000-0002-2435-0182; Kim, Sung-Yon/0000-0003-0791-7308; Ramakrishnan, Charu/0000-0002-3474-6332	NIMH [1F32MH088010-01]; NARSAD; Samsung; NSF [0801700]; Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery [N66001-10-C-2010]; Alice Woo Foundation; Albert Yu Foundation; Snyder Foundation; McKnight Foundation; NIDA; NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH088010, R01MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD(NARSAD); Samsung(Samsung); NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery; Alice Woo Foundation; Albert Yu Foundation; Snyder Foundation; McKnight Foundation; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank P. Janak, H. Fields, G. Stuber, E. Thomas, F. Zhang, I. Witten, V. Sohal, T. Davidson and M. Warden as well as J. Mattis, R. Durand, M. Mogri, J. Mirzabekov and E. Steinberg for discussions, and the entire K. D. laboratory for their support. All viruses were packaged at University of North Carolina (UNC) Vector Core. Supported by NIMH (1F32MH088010-01, K. M. T.), NARSAD (K. R. T.), Samsung Scholarship (S.-Y.K.), NSF IGERT Award 0801700 (L. G.) and the Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery (N66001-10-C-2010), the Alice Woo, Albert Yu, Snyder, and McKnight Foundations, as well as NIDA, NIMH and the NIH Pioneer Award (K. D.)	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CARLSEN J, 1988, J COMP NEUROL, V273, P513, DOI 10.1002/cne.902730407; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Davis M., 2000, AMYGDALA, P213; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Deisseroth K, 2010, SCI AM, V303, P48, DOI 10.1038/scientificamerican1110-48; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gray J A, 1996, Nebr Symp Motiv, V43, P61; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koob GF, 2009, BRAIN RES, V1293, P61, DOI 10.1016/j.brainres.2009.03.038; KRETTEK JE, 1978, J COMP NEUROL, V178, P255, DOI 10.1002/cne.901780205; KRETTEK JE, 1978, J COMP NEUROL, V178, P225, DOI 10.1002/cne.901780204; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lesscher HMB, 2008, GENES BRAIN BEHAV, V7, P323, DOI 10.1111/j.1601-183X.2007.00356.x; Lieb R, 2005, HANDB EXP PHARM, V169, P405; Lyons AM, 2010, PEPTIDES, V31, P2193, DOI 10.1016/j.peptides.2010.09.009; MCDONALD AJ, 1982, J COMP NEUROL, V208, P401, DOI 10.1002/cne.902080409; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pitkanen A., 2000, AMYGDALA FUNCTIONAL, V2; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; SMITH Y, 1994, J COMP NEUROL, V342, P232, DOI 10.1002/cne.903420207; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; WEISKRANTZ L, 1956, J COMP PHYSIOL PSYCH, V49, P381, DOI 10.1037/h0088009; WOODS JH, 1992, PHARMACOL REV, V44, P151	30	786	845	5	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					358	362		10.1038/nature09820	http://dx.doi.org/10.1038/nature09820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21389985	Green Accepted			2022-12-24	WOS:000288444000041
J	Attwood, BK; Bourgognon, JM; Patel, S; Mucha, M; Schiavon, E; Skrzypiec, AE; Young, KW; Shiosaka, S; Korostynski, M; Piechota, M; Przewlocki, R; Pawlak, R				Attwood, Benjamin K.; Bourgognon, Julie-Myrtille; Patel, Satyam; Mucha, Mariusz; Schiavon, Emanuele; Skrzypiec, Anna E.; Young, Kenneth W.; Shiosaka, Sadao; Korostynski, Michal; Piechota, Marcin; Przewlocki, Ryszard; Pawlak, Robert			Neuropsin cleaves EphB2 in the amygdala to control anxiety	NATURE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; NMDA RECEPTORS; STRESS; BRAIN; GENE; POLYMORPHISMS; HIPPOCAMPAL; MODULATION; EXPRESSION; BEHAVIOR	A minority of individuals experiencing traumatic events develop anxiety disorders. The reason for the lack of correspondence between the prevalence of exposure to psychological trauma and the development of anxiety is unknown. Extracellular proteolysis contributes to fear-associated responses by facilitating neuronal plasticity at the neuron-matrix interface(1-4). Here we show in mice that the serine protease neuropsin is critical for stress-related plasticity in the amygdala by regulating the dynamics of the EphB2-NMDA-receptor interaction, the expression of Fkbp5 and anxiety-like behaviour. Stress results in neuropsin-dependent cleavage of EphB2 in the amygdala causing dissociation of EphB2 from the NR1 subunit of the NMDA receptor and promoting membrane turnover of EphB2 receptors. Dynamic EphB2-NR1 interaction enhances NMDA receptor current, induces Fkbp5 gene expression and enhances behavioural signatures of anxiety. On stress, neuropsin-deficient mice do not show EphB2 cleavage and its dissociation from NR1 resulting in a static EphB2-NR1 interaction, attenuated induction of the Fkbp5 gene and low anxiety. The behavioural response to stress can be restored by intra-amygdala injection of neuropsin into neuropsin-deficient mice and disrupted by the injection of either anti-EphB2 antibodies or silencing the Fkbp5 gene in the amygdala of wild-type mice. Our findings establish a novel neuronal pathway linking stress-induced proteolysis of EphB2 in the amygdala to anxiety.	[Attwood, Benjamin K.; Bourgognon, Julie-Myrtille; Patel, Satyam; Mucha, Mariusz; Schiavon, Emanuele; Skrzypiec, Anna E.; Pawlak, Robert] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Young, Kenneth W.] MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Shiosaka, Sadao] Nara Inst Sci & Technol, Div Struct Cell Biol, Nara 6300192, Japan; [Korostynski, Michal; Piechota, Marcin; Przewlocki, Ryszard] Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, PL-31343 Krakow, Poland	University of Leicester; University of Leicester; Nara Institute of Science & Technology; Polish Academy of Sciences	Pawlak, R (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Univ Rd, Leicester LE1 9HN, Leics, England.	rp135@le.ac.uk	Korostynski, Michal/AAS-2626-2021; Shiosaka, Sadao/B-1142-2008; Piechota, Marcin/G-9464-2011	Korostynski, Michal/0000-0002-4273-7401; Piechota, Marcin/0000-0003-2468-151X; Schiavon, Emanuele/0000-0002-4592-6961	Medical Research Council [G0500231/73852]; European Commission [MEXT-CT-2006-042265, LSHM-CT-2004-005166]; Medisearch Fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan [20300128]; Japan Science and Technology Agency; Ministry of Science and Higher Education of Poland [NN405 274137]; MRC [G0500231] Funding Source: UKRI; Medical Research Council [G0500231] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medisearch Fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council Project Grant (G0500231/73852), and a Marie Curie Excellence Grant (MEXT-CT-2006-042265 from the European Commission) to R. Pawlak, a Medisearch Fellowship to B.K.A., the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid, # 20300128) and Japan Science and Technology Agency (CREST program) to S.S., GENADDICT (LSHM-CT-2004-005166 from the European Commission) to R. Przewlocki, and NN405 274137 from the Ministry of Science and Higher Education of Poland to M.K. We are obliged to A. Kania, H. Castro and R. Fern for reagents. We are grateful to B. McEwen and A. Tobin for their comments on the manuscript and T. Gerdjikov, G. Mallucci and her laboratory members for advice.	Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Calo L, 2005, J NEUROSCI, V25, P2245, DOI 10.1523/JNEUROSCI.4956-04.2005; CHEN ZL, 1995, J NEUROSCI, V15, P5088; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Hirata A, 2001, MOL CELL NEUROSCI, V17, P600, DOI 10.1006/mcne.2000.0945; Horii Y, 2008, BEHAV NEUROSCI, V122, P498, DOI 10.1037/0735-7044.122.3.498; Huang YY, 2007, J NEUROSCI, V27, P3111, DOI 10.1523/JNEUROSCI.3908-06.2007; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Lin KT, 2008, J BIOL CHEM, V283, P28969, DOI 10.1074/jbc.M804401200; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; Matys T, 2004, P NATL ACAD SCI USA, V101, P16345, DOI 10.1073/pnas.0407355101; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Segman RH, 2005, MOL PSYCHIATR, V10, P500, DOI 10.1038/sj.mp.4001636; Shimizu C, 1998, J BIOL CHEM, V273, P11189, DOI 10.1074/jbc.273.18.11189; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Vyas A, 2002, J NEUROSCI, V22, P6810; WASHBURN MS, 1992, J NEUROSCI, V12, P4066	30	142	147	1	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					372	U553		10.1038/nature09938	http://dx.doi.org/10.1038/nature09938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21508957	Green Accepted			2022-12-24	WOS:000290722400048
J	Phillips, RJ; Davis, BJ; Tanaka, KL; Byrne, S; Mellon, MT; Putzig, NE; Haberle, RM; Kahre, MA; Campbell, BA; Carter, LM; Smith, IB; Holt, JW; Smrekar, SE; Nunes, DC; Plaut, JJ; Egan, AF; Titus, TN; Seu, R				Phillips, Roger J.; Davis, Brian J.; Tanaka, Kenneth L.; Byrne, Shane; Mellon, Michael T.; Putzig, Nathaniel E.; Haberle, Robert M.; Kahre, Melinda A.; Campbell, Bruce A.; Carter, Lynn M.; Smith, Isaac B.; Holt, John W.; Smrekar, Suzanne E.; Nunes, Daniel C.; Plaut, Jeffrey J.; Egan, Anthony F.; Titus, Timothy N.; Seu, Roberto			Massive CO2 Ice Deposits Sequestered in the South Polar Layered Deposits of Mars	SCIENCE			English	Article							SOLID CO2; CIRCULATION; MODEL	Shallow Radar soundings from the Mars Reconnaissance Orbiter reveal a buried deposit of carbon dioxide (CO2) ice within the south polar layered deposits of Mars with a volume of 9500 to 12,500 cubic kilometers, about 30 times that previously estimated for the south pole residual cap. The deposit occurs within a stratigraphic unit that is uniquely marked by collapse features and other evidence of interior CO2 volatile release. If released into the atmosphere at times of high obliquity, the CO2 reservoir would increase the atmospheric mass by up to 80%, leading to more frequent and intense dust storms and to more regions where liquid water could persist without boiling.	[Phillips, Roger J.] SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA; [Phillips, Roger J.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Davis, Brian J.; Putzig, Nathaniel E.] SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; [Tanaka, Kenneth L.; Titus, Timothy N.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Byrne, Shane] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Mellon, Michael T.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Haberle, Robert M.] NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA; [Kahre, Melinda A.] NASA, Ames Res Ctr, Bay Area Environm Res Inst, Moffett Field, CA 94035 USA; [Campbell, Bruce A.] Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20013 USA; [Carter, Lynn M.] NASA, Goddard Space Flight Ctr, Sci & Explorat Directorate, Greenbelt, MD 20771 USA; [Smith, Isaac B.; Holt, John W.] Univ Texas Austin, Jackson Sch Geosci, Inst Geophys, Austin, TX 78758 USA; [Smrekar, Suzanne E.; Nunes, Daniel C.; Plaut, Jeffrey J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Egan, Anthony F.] SW Res Inst, Dept Space Operat, Boulder, CO 80302 USA; [Seu, Roberto] Univ Roma La Sapienza, Dept Informat Engn Elect & Telecommun, I-00184 Rome, Italy	Washington University (WUSTL); United States Department of the Interior; United States Geological Survey; University of Arizona; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Smithsonian Institution; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Texas System; University of Texas Austin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Sapienza University Rome	Phillips, RJ (corresponding author), SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA.	roger@boulder.swri.edu	Smrekar, Suzanne/AAH-8074-2020; Byrne, Shane/B-8104-2012; Nunes, Daniel C/G-1279-2018; Holt, John/C-4896-2009; Mellon, Michael/C-3456-2016; Carter, Lynn/D-2937-2012	Smrekar, Suzanne/0000-0001-8775-075X; Carter, Lynn/0000-0002-6245-4142; Putzig, Nathaniel/0000-0003-4485-6321; Smith, Isaac/0000-0002-4331-913X; Nunes, Daniel/0000-0002-0937-7176	NASA	NASA(National Aeronautics & Space Administration (NASA))	K. Herkenhoff and C. Fortezzo provided useful comments on an earlier version of the paper. Remarks by three anonymous referees were exceedingly helpful. Funding for this work was provided by the NASA MRO project. The radar and imaging data are available through NASA's Planetary Data System.	Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Haberle RM, 2001, J GEOPHYS RES-PLANET, V106, P23317, DOI 10.1029/2000JE001360; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; Kolb E. J., 2006, 37 LUN PLAN SCI C LE; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Newman CE, 2005, ICARUS, V174, P135, DOI 10.1016/j.icarus.2004.10.023; Nunes DC, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002609; Pettinelli E, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001869; Phillips RJ, 2008, SCIENCE, V320, P1182, DOI 10.1126/science.1157546; Putzig NE, 2009, ICARUS, V204, P443, DOI 10.1016/j.icarus.2009.07.034; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Seu R, 2007, SCIENCE, V317, P1715, DOI 10.1126/science.1144120; SIMPSON RA, 1980, J GEOPHYS RES, V85, P5481, DOI 10.1029/JB085iB10p05481; Tanaka K. L., 2007, 7 INT C MARS PAS CA; Thomas PC, 2009, ICARUS, V203, P352, DOI 10.1016/j.icarus.2009.05.014; Weast R. C., 1974, CRC HDB CHEM PHYS	19	136	138	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2011	332	6031					838	841		10.1126/science.1203091	http://dx.doi.org/10.1126/science.1203091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21512003	Green Published			2022-12-24	WOS:000290529900045
J	Qureshi, OS; Zheng, Y; Nakamura, K; Attridge, K; Manzotti, C; Schmidt, EM; Baker, J; Jeffery, LE; Kaur, S; Briggs, Z; Hou, TZ; Futter, CE; Anderson, G; Walker, LSK; Sansom, DM				Qureshi, Omar S.; Zheng, Yong; Nakamura, Kyoko; Attridge, Kesley; Manzotti, Claire; Schmidt, Emily M.; Baker, Jennifer; Jeffery, Louisa E.; Kaur, Satdip; Briggs, Zoe; Hou, Tie Z.; Futter, Clare E.; Anderson, Graham; Walker, Lucy S. K.; Sansom, David M.			Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4	SCIENCE			English	Article							T-CELL; DENDRITIC CELLS; SURFACE EXPRESSION; TARGET-CELLS; B-CELLS; ACTIVATION; PROTEINS; LYMPHOPROLIFERATION; TROGOCYTOSIS; SECRETION	Cytotoxic T lymphocyte antigen 4 (CTLA-4) is an essential negative regulator of T cell immune responses whose mechanism of action is the subject of debate. CTLA-4 shares two ligands (CD80 and CD86) with a stimulatory receptor, CD28. Here, we show that CTLA-4 can capture its ligands from opposing cells by a process of trans-endocytosis. After removal, these costimulatory ligands are degraded inside CTLA-4-expressing cells, resulting in impaired costimulation via CD28. Acquisition of CD86 from antigen-presenting cells is stimulated by T cell receptor engagement and observed in vitro and in vivo. These data reveal a mechanism of immune regulation in which CTLA-4 acts as an effector molecule to inhibit CD28 costimulation by the cell-extrinsic depletion of ligands, accounting for many of the known features of the CD28-CTLA-4 system.	[Qureshi, Omar S.; Zheng, Yong; Nakamura, Kyoko; Attridge, Kesley; Manzotti, Claire; Schmidt, Emily M.; Baker, Jennifer; Jeffery, Louisa E.; Kaur, Satdip; Briggs, Zoe; Hou, Tie Z.; Anderson, Graham; Walker, Lucy S. K.; Sansom, David M.] Univ Birmingham, Sch Med, Inst Biomed Res, Sch Immun & Infect,MRC,Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England; [Futter, Clare E.] UCL, Dept Cell Biol, Inst Ophthalmol, London EC1V 9EL, England	University of Birmingham; University of London; University College London	Sansom, DM (corresponding author), Univ Birmingham, Sch Med, Inst Biomed Res, Sch Immun & Infect,MRC,Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England.	d.m.sansom@bham.ac.uk	Qureshi, Omar/CAF-4545-2022; HOU, TIEZHENG/B-4848-2015; Nakamura, Kyoko/B-4184-2013	Futter, Clare/0000-0001-5559-9389; anderson, graham/0000-0002-2917-4085; Walker, Lucy/0000-0001-5986-5015; Attridge, Kesley/0000-0003-4521-9009; Kaur, Satdip/0000-0002-0901-9141; Sansom, David/0000-0001-6506-3115; Manzotti, Claire/0000-0001-5894-5435	UK Biotechnology and Biological Sciences Research Council; MRC; Wellcome Trust; Arthritis Research UK; BBSRC [BB/H013598/1, BB/D011000/1] Funding Source: UKRI; MRC [G9818340, G0802382, G1000213, G0401620, G0400931] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011000/1, BB/H013598/1] Funding Source: researchfish; Medical Research Council [G0401620, G0802382, G0400931, G9818340B, G9818340, G1000213] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research UK(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank A. Sharpe for the generous gift of Ctla4<SUP>-/-</SUP> mice, W. Heath for the rip-mOVA mice, and G. Freeman for the I-A<SUP>d</SUP>-expressing CHO cells. This work was supported by the UK Biotechnology and Biological Sciences Research Council (O.Q.), MRC (L. S. K. W., Y.Z., K. A., E. S., and K.N.), Wellcome Trust (C. M., T. H., and Z.B.), and Arthritis Research UK (L.J.). L. S. K. W. is an MRC Senior Fellow. Cell lines expressing CD80, CD86, and CTLA-4 are available under a material transfer agreement for noncommercial use.	Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Catalfamo M, 2008, IMMUNOLOGY, V125, P70, DOI 10.1111/j.1365-2567.2008.02822.x; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Choi JM, 2006, NAT MED, V12, P574, DOI 10.1038/nm1385; Chuang E, 1997, J IMMUNOL, V159, P144; Daubeuf S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008716; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Homann D, 2006, J VIROL, V80, P270, DOI 10.1128/JVI.80.1.270-280.2006; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Iida T, 2000, J IMMUNOL, V165, P5062, DOI 10.4049/jimmunol.165.9.5062; Kusakari S, 2008, J CELL SCI, V121, P1213, DOI 10.1242/jcs.025015; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Oderup C, 2006, IMMUNOLOGY, V118, P240, DOI 10.1111/j.1365-2567.2006.02362.x; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Williams GS, 2007, TRAFFIC, V8, P1190, DOI 10.1111/j.1600-0854.2007.00603.x; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng Y, 2008, J IMMUNOL, V181, P1683, DOI 10.4049/jimmunol.181.3.1683	31	1010	1059	2	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					600	603		10.1126/science.1202947	http://dx.doi.org/10.1126/science.1202947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21474713	Green Accepted			2022-12-24	WOS:000289991100052
J	Chapman, MA; Lawrence, MS; Keats, JJ; Cibulskis, K; Sougnez, C; Schinzel, AC; Harview, CL; Brunet, JP; Ahmann, GJ; Adli, M; Anderson, KC; Ardlie, KG; Auclair, D; Baker, A; Bergsagel, PL; Bernstein, BE; Drier, Y; Fonseca, R; Gabriel, SB; Hofmeister, CC; Jagannath, S; Jakubowiak, AJ; Krishnan, A; Levy, J; Liefeld, T; Lonial, S; Mahan, S; Mfuko, B; Monti, S; Perkins, LM; Onofrio, R; Pugh, TJ; Rajkumar, SV; Ramos, AH; Siegel, DS; Sivachenko, A; Stewart, AK; Trudel, S; Vij, R; Voet, D; Winckler, W; Zimmerman, T; Carpten, J; Trent, J; Hahn, WC; Garraway, LA; Meyerson, M; Lander, ES; Getz, G; Golub, TR				Chapman, Michael A.; Lawrence, Michael S.; Keats, Jonathan J.; Cibulskis, Kristian; Sougnez, Carrie; Schinzel, Anna C.; Harview, Christina L.; Brunet, Jean-Philippe; Ahmann, Gregory J.; Adli, Mazhar; Anderson, Kenneth C.; Ardlie, Kristin G.; Auclair, Daniel; Baker, Angela; Bergsagel, P. Leif; Bernstein, Bradley E.; Drier, Yotam; Fonseca, Rafael; Gabriel, Stacey B.; Hofmeister, Craig C.; Jagannath, Sundar; Jakubowiak, Andrzej J.; Krishnan, Amrita; Levy, Joan; Liefeld, Ted; Lonial, Sagar; Mahan, Scott; Mfuko, Bunmi; Monti, Stefano; Perkins, Louise M.; Onofrio, Robb; Pugh, Trevor J.; Rajkumar, S. Vincent; Ramos, Alex H.; Siegel, David S.; Sivachenko, Andrey; Stewart, A. Keith; Trudel, Suzanne; Vij, Ravi; Voet, Douglas; Winckler, Wendy; Zimmerman, Todd; Carpten, John; Trent, Jeff; Hahn, William C.; Garraway, Levi A.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Golub, Todd R.			Initial genome sequencing and analysis of multiple myeloma	NATURE			English	Article							B-CELL LYMPHOMA; HUMAN CANCER; SOMATIC MUTATIONS; STRESS-RESPONSE; GENE; PATHOGENESIS; BLIMP-1; EXOSOME; DIFFERENTIATION; CLASSIFICATION	Multiple myeloma is an incurable malignancy of plasma cells, and its pathogenesis is poorly understood. Here we report the massively parallel sequencing of 38 tumour genomes and their comparison to matched normal DNAs. Several new and unexpected oncogenic mechanisms were suggested by the pattern of somatic mutation across the data set. These include the mutation of genes involved in protein translation (seen in nearly half of the patients), genes involved in histone methylation, and genes involved in blood coagulation. In addition, a broader than anticipated role of NF-kappa B signalling was indicated by mutations in 11 members of the NF-kappa B pathway. Of potential immediate clinical relevance, activating mutations of the kinase BRAF were observed in 4% of patients, suggesting the evaluation of BRAF inhibitors in multiple myeloma clinical trials. These results indicate that cancer genome sequencing of large collections of samples will yield new insights into cancer not anticipated by existing knowledge.	[Chapman, Michael A.; Lawrence, Michael S.; Cibulskis, Kristian; Sougnez, Carrie; Harview, Christina L.; Brunet, Jean-Philippe; Adli, Mazhar; Ardlie, Kristin G.; Bernstein, Bradley E.; Drier, Yotam; Gabriel, Stacey B.; Liefeld, Ted; Mahan, Scott; Monti, Stefano; Onofrio, Robb; Pugh, Trevor J.; Ramos, Alex H.; Sivachenko, Andrey; Voet, Douglas; Winckler, Wendy; Hahn, William C.; Garraway, Levi A.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Golub, Todd R.] Eli & Edythe L Broad Inst, Cambridge Ctr 7, Cambridge, MA 02412 USA; [Keats, Jonathan J.; Ahmann, Gregory J.; Bergsagel, P. Leif; Fonseca, Rafael; Stewart, A. Keith] Mayo Clin Arizona, Scottsdale, AZ 85259 USA; [Keats, Jonathan J.; Ahmann, Gregory J.; Anderson, Kenneth C.; Auclair, Daniel; Bergsagel, P. Leif; Fonseca, Rafael; Hofmeister, Craig C.; Jagannath, Sundar; Jakubowiak, Andrzej J.; Krishnan, Amrita; Levy, Joan; Lonial, Sagar; Mfuko, Bunmi; Perkins, Louise M.; Rajkumar, S. Vincent; Siegel, David S.; Stewart, A. Keith; Trudel, Suzanne; Vij, Ravi; Zimmerman, Todd] Multiple Myeloma Res Consortium, Norwalk, CT 06581 USA; [Schinzel, Anna C.; Anderson, Kenneth C.; Hahn, William C.; Garraway, Levi A.; Meyerson, Matthew; Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Adli, Mazhar; Bernstein, Bradley E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Auclair, Daniel; Levy, Joan; Mfuko, Bunmi; Perkins, Louise M.] Multiple Myeloma Res Fdn, Norwalk, CT 06581 USA; [Baker, Angela; Carpten, John; Trent, Jeff] Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Bernstein, Bradley E.; Hahn, William C.; Meyerson, Matthew; Lander, Eric S.; Golub, Todd R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bernstein, Bradley E.; Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Drier, Yotam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Hofmeister, Craig C.] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Jagannath, Sundar] St Vincents Comprehens Canc Ctr, New York, NY 11001 USA; [Jakubowiak, Andrzej J.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Krishnan, Amrita] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA; [Lonial, Sagar] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Rajkumar, S. Vincent] Mayo Clin Rochester, Rochester, MN 55905 USA; [Siegel, David S.] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ 07601 USA; [Trudel, Suzanne] Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada; [Vij, Ravi] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Zimmerman, Todd] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Lander, Eric S.] MIT, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Mayo Clinic; Mayo Clinic Phoenix; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Translational Genomics Research Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Weizmann Institute of Science; University System of Ohio; Ohio State University; Saint Vincents Hospital Manhattan; University of Michigan System; University of Michigan; City of Hope; Emory University; Mayo Clinic; Hackensack University Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Washington University (WUSTL); University of Chicago; University of Chicago Medical Center; Massachusetts Institute of Technology (MIT)	Golub, TR (corresponding author), Eli & Edythe L Broad Inst, Cambridge Ctr 7, Cambridge, MA 02412 USA.	gadgetz@broadinstitute.org; golub@broadinstitute.org	Hofmeister, Craig/E-3256-2011; Pugh, Trevor/Y-2535-2019; Meyerson, Matthew L/E-7123-2012; Lawrence, Michael/AAC-8202-2020; Drier, Yotam/K-5208-2012; Rajkumar, S. Vincent/AAV-1834-2021; Cibulskis, Kristian/AAC-7380-2019; Hofmeister, Craig/O-4988-2019; Bergsagel, Peter Leif/A-7842-2011	Hofmeister, Craig/0000-0003-4816-1607; Pugh, Trevor/0000-0002-8073-5888; Drier, Yotam/0000-0003-1725-2995; Rajkumar, S. Vincent/0000-0002-5862-1833; Hofmeister, Craig/0000-0003-4816-1607; Bergsagel, Peter Leif/0000-0003-1523-7388; Fonseca, Rafael/0000-0002-5938-3769; Cibulskis, Kristian/0000-0003-1343-1582; Monti, Stefano/0000-0002-9376-0660; Harview, Christina/0000-0002-5003-8539; Meyerson, Matthew/0000-0002-9133-8108; Keats, Jonathan/0000-0003-4375-7399; Perkins, Louise/0000-0003-3945-8927	Multiple Myeloma Research Foundation; Leukaemia and Lymphoma Research (UK); NATIONAL CANCER INSTITUTE [R01CA133966, K12CA133250, R01CA133115] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020686] Funding Source: NIH RePORTER	Multiple Myeloma Research Foundation; Leukaemia and Lymphoma Research (UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by a grant from the Multiple Myeloma Research Foundation. M.A.C. was supported by a Clinician Scientist Fellowship from Leukaemia and Lymphoma Research (UK). We are grateful to all members of the Broad Institute's Biological Samples Platform, Genetic Analysis Platform, and Genome Sequencing Platform, without whom this work would not have been possible.	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Barbas A, 2009, J BIOL CHEM, V284, P20486, DOI 10.1074/jbc.M109.020693; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carbone A, 2008, GENE CHROMOSOME CANC, V47, P1067, DOI 10.1002/gcc.20601; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Cenci S, 2007, FEBS LETT, V581, P3652, DOI 10.1016/j.febslet.2007.04.031; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; ESUMI N, 1991, CANCER RES, V51, P4549; Flaherty K., 2009, 2009 ASCO M AM SOC C; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Ibrahim H, 2008, BBA-GENE REGUL MECH, V1779, P256, DOI 10.1016/j.bbagrm.2007.11.004; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kim K, 2010, BRIT J HAEMATOL, V149, P537, DOI 10.1111/j.1365-2141.2010.08127.x; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lessard J, 2003, EXP HEMATOL, V31, P567, DOI 10.1016/S0301-472X(03)00081-X; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Masciarelli S, 2010, MOL IMMUNOL, V47, P1356, DOI 10.1016/j.molimm.2009.12.003; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Zani VJ, 1996, BLOOD, V87, P3124, DOI 10.1182/blood.V87.8.3124.bloodjournal8783124; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhang W, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-332; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	47	1092	1135	0	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					467	472		10.1038/nature09837	http://dx.doi.org/10.1038/nature09837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430775	Green Accepted, hybrid, Green Submitted			2022-12-24	WOS:000288702200053
J	Avinoam, O; Fridman, K; Valansi, C; Abutbul, I; Zeev-Ben-Mordehai, T; Maurer, UE; Sapir, A; Danino, D; Grunewald, K; White, JM; Podbilewicz, B				Avinoam, Ori; Fridman, Karen; Valansi, Clari; Abutbul, Inbal; Zeev-Ben-Mordehai, Tzviya; Maurer, Ulrike E.; Sapir, Amir; Danino, Dganit; Gruenewald, Kay; White, Judith M.; Podbilewicz, Benjamin			Conserved Eukaryotic Fusogens Can Fuse Viral Envelopes to Cells	SCIENCE			English	Article							VESICULAR STOMATITIS-VIRUS; MEMBRANE-FUSION; C-ELEGANS; GLYCOPROTEIN; MECHANISMS; EFF-1; PROTEINS	Caenorhabditis elegans proteins AFF-1 and EFF-1 [C. elegans fusion family (CeFF) proteins] are essential for developmental cell-to-cell fusion and can merge insect cells. To study the structure and function of AFF-1, we constructed vesicular stomatitis virus (VSV) displaying AFF-1 on the viral envelope, substituting the native fusogen VSV glycoprotein. Electron microscopy and tomography revealed that AFF-1 formed distinct supercomplexes resembling pentameric and hexameric "flowers" on pseudoviruses. Viruses carrying AFF-1 infected mammalian cells only when CeFFs were on the target cell surface. Furthermore, we identified fusion family (FF) proteins within and beyond nematodes, and divergent members from the human parasitic nematode Trichinella spiralis and the chordate Branchiostoma floridae could also fuse mammalian cells. Thus, FF proteins are part of an ancient family of cellular fusogens that can promote fusion when expressed on a viral particle.	[Avinoam, Ori; Fridman, Karen; Valansi, Clari; Sapir, Amir; Podbilewicz, Benjamin] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Abutbul, Inbal; Danino, Dganit] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel; [Abutbul, Inbal; Danino, Dganit] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel; [Zeev-Ben-Mordehai, Tzviya; Gruenewald, Kay] Univ Oxford, Oxford Particle Imaging Ctr, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Maurer, Ulrike E.; Gruenewald, Kay] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [White, Judith M.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Oxford; Wellcome Centre for Human Genetics; Max Planck Society; University of Virginia	Podbilewicz, B (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	podbilew@technion.ac.il	Zeev-Ben-Mordehai, Tzviya/D-7112-2014; Podbilewicz, Benjamin/N-4825-2014; Sapir, Amir/C-5758-2015; Danino, Dganit/D-6832-2016; Avinoam, Ori/AAX-7382-2020; Grünewald, Kay/AAW-3652-2020; Zeev-Ben-Mordehai, Tzviya/AAD-3270-2021	Zeev-Ben-Mordehai, Tzviya/0000-0002-2571-550X; Sapir, Amir/0000-0001-9888-1800; Danino, Dganit/0000-0002-9782-4940; Avinoam, Ori/0000-0003-3543-168X; Grünewald, Kay/0000-0002-4788-2691; Zeev-Ben-Mordehai, Tzviya/0000-0002-2571-550X; Podbilewicz, Benjamin/0000-0002-0411-4182	Israel Science Foundation [ISF 1542/07]; Human Frontier Science Program [RG0079/2009-C]; NIH [AI22470]; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022470] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank I. Nagano, M. Whitt, A. Fire, C. Giraudo, and J. Rothman for reagents; F. Glaser, M. Glickman, A. Harel, O. Kleifeld, T. Schwartz, I. Sharon, E. Spooner, R. Sommer, and members of the White and Podbilewicz labs for discussions; the Smoler Proteomics Center at the Technion and the Whitehead Institute for Biomedical Research for mass spectrometry; T. Ziv for proteomics analysis; the Caenorhabditis Genetics Center for nematode strains; and I. Yanai and A. de Silva for critically reading the manuscript. This work was supported by grants from the FIRST Program of the Israel Science Foundation (ISF 1542/07 to B.P.), the Human Frontier Science Program (RG0079/2009-C to K.G.), and the NIH (AI22470 to J.M.W.), as well as a Wellcome Trust Senior Research Fellowship to K. G. The Technion Research and Development Foundation has filed a patent relating to methods and compositions useful in cell-cell fusion using FF proteins of nematode origin and to antinematodal methods and compositions, using proteins of the nematode fusion family.	Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Libersou S, 2010, J CELL BIOL, V191, P199, DOI 10.1083/jcb.201006116; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Matsuura Y, 2001, VIROLOGY, V286, P263, DOI 10.1006/viro.2001.0971; Mohler WA, 2002, DEV CELL, V2, P355, DOI 10.1016/S1534-5807(02)00129-6; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Sapir A, 2008, DEV CELL, V14, P11, DOI 10.1016/j.devcel.2007.12.008; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Shemer G, 2004, CURR BIOL, V14, P1587, DOI 10.1016/j.cub.2004.07.059; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; ZAVADA J, 1972, J GEN VIROL, V15, P183, DOI 10.1099/0022-1317-15-3-183	17	51	55	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					589	592		10.1126/science.1202333	http://dx.doi.org/10.1126/science.1202333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21436398	Green Accepted			2022-12-24	WOS:000289991100049
J	Merritt, DJ; Dixon, KW				Merritt, David J.; Dixon, Kingsley W.			Restoration Seed Banks-A Matter of Scale	SCIENCE			English	Editorial Material							ECOLOGICAL RESTORATION		[Merritt, David J.; Dixon, Kingsley W.] Kings Pk & Bot Gardens, Perth, WA 6005, Australia; [Merritt, David J.; Dixon, Kingsley W.] Univ Western Australia, Fac Nat & Agr Sci, Sch Plant Biol, Crawley, WA 6009, Australia	University of Western Australia	Merritt, DJ (corresponding author), Kings Pk & Bot Gardens, Perth, WA 6005, Australia.	david.merritt@bgpa.wa.gov.au	Dixon, Kingsley W/A-8133-2016; Merritt, David J/G-9376-2011; Dixon, Kingsley W/B-1042-2011	Dixon, Kingsley W/0000-0001-5989-2929; Merritt, David J/0000-0002-3250-6861; 				*BHP BILL IR OR, 2006, JIMB WHEEL HILL MIN; BOWERS K, RHIZOME; Broadhurst LM, 2008, EVOL APPL, V1, P587, DOI 10.1111/j.1752-4571.2008.00045.x; Crane PR, 2009, TRENDS PLANT SCI, V14, P575, DOI 10.1016/j.tplants.2009.09.007; CUNNINGHAM S, 2008, REWEALTHL; DELANGE JH, 1990, S AFR J BOT, V59, P145; Dixon KW, 2009, ACTA HORTIC, V813, P155; *GREAT BAS RES CTR, SEED WAR; Hardwick KA, 2011, CONSERV BIOL, V25, P265, DOI 10.1111/j.1523-1739.2010.01632.x; Higgs E, 2005, RESTOR ECOL, V13, P159, DOI 10.1111/j.1526-100X.2005.00020.x; *KEW, BREATH PLAN PROGR; Koch JM, 2007, RESTOR ECOL, V15, pS26, DOI 10.1111/j.1526-100X.2007.00290.x; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Li DZ, 2009, TRENDS PLANT SCI, V14, P614, DOI 10.1016/j.tplants.2009.09.005; MERRITT DJ, 2005, P 5 AUSTR WORKSH NAT, P69; Mortlock BW., 2000, ECOLOGICAL MANAGEMEN, V1, P93, DOI [10.1046/j.1442-8903.2000.00029.x, DOI 10.1046/J.1442-8903.2000.00029.X]; Nelleman C, 2010, DEAD PLANET LIVING P; OMAR SAS, 2009, HDB ENV CHEM, V3, P141; Rokich DP, 2007, AUST J BOT, V55, P375, DOI 10.1071/BT06108; *SECR CONV BIOL DI, 2010, CBD PUBL; Smith P, 2011, SEED SCI RES, V21, P1, DOI 10.1017/S0960258510000309; SMITH RD, 2003, SEED CONSERVATION TU, pCH56; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Wehi PM, 2009, ECOL APPL, V19, P267, DOI 10.1890/07-1693.1; Wijdeven SMJ, 2000, RESTOR ECOL, V8, P414, DOI 10.1046/j.1526-100x.2000.80056.x; Williams MI, 2002, RESTOR ECOL, V10, P385, DOI 10.1046/j.1526-100X.2002.01025.x	26	222	230	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					424	425		10.1126/science.1203083	http://dx.doi.org/10.1126/science.1203083			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512021				2022-12-24	WOS:000289784900028
J	Beardmore, RE; Gudelj, I; Lipson, DA; Hurst, LD				Beardmore, Robert E.; Gudelj, Ivana; Lipson, David A.; Hurst, Laurence D.			Metabolic trade-offs and the maintenance of the fittest and the flattest	NATURE			English	Article							LETHAL MUTAGENESIS; ESCHERICHIA-COLI; PERIODIC SELECTION; GROWTH-RATE; EVOLUTION; YIELD; POPULATIONS; MECHANISMS; TRANSPORT; DIVERSITY	How is diversity maintained? Environmental heterogeneity is considered to be important(1), yet diversity in seemingly homogeneous environments is nonetheless observed(2). This, it is assumed, must either be owing to weak selection, mutational input or a fitness advantage to genotypes when rare(1). Here we demonstrate the possibility of a new general mechanism of stable diversity maintenance, one that stems from metabolic and physiological trade-offs(3). The model requires that such trade-offs translate into a fitness landscape in which the most fit has unfit near-mutational neighbours, and a lower fitness peak also exists that is more mutationally robust. The 'survival of the fittest' applies at low mutation rates, giving way to 'survival of the flattest'(4-6) at high mutation rates. However, as a consequence of quasispecies-level negative frequency-dependent selection and differences in mutational robustness we observe a transition zone in which both fittest and flattest coexist. Although diversity maintenance is possible for simple organisms in simple environments, the more trade-offs there are, the wider the maintenance zone becomes. The principle may be applied to lineages within a species or species within a community, potentially explaining why competitive exclusion need not be observed in homogeneous environments. This principle predicts the enigmatic richness of metabolic strategies in clonal bacteria(7) and questions the safety of lethal mutagenesis(8,9) as an antimicrobial treatment.	[Hurst, Laurence D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Beardmore, Robert E.; Gudelj, Ivana] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2A7, England; [Lipson, David A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	University of Bath; Imperial College London; California State University System; San Diego State University	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	l.d.hurst@bath.ac.uk	Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054	Royal Society; EPSRC; NERC; EPSRC [EP/F037856/1, EP/I018263/1] Funding Source: UKRI; MRC [G0802611] Funding Source: UKRI; NERC [NE/E013007/2, NE/E013007/1, NE/E013007/3] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I018263/1, EP/F037856/1] Funding Source: researchfish; Medical Research Council [G0802611] Funding Source: researchfish; Natural Environment Research Council [NE/E013007/3, NE/E013007/1, NE/E013007/2] Funding Source: researchfish	Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank C. Burch, M. Doebeli and T. Ferenci for discussions. L. D. H. is a Royal Society Wolfson Research Merit Award Holder, R. E. B. holds an EPSRC Leadership Fellowship, and I. G. holds a NERC Advanced Research Fellowship.	Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Bull JJ, 2008, GENETICS, V180, P1061, DOI 10.1534/genetics.108.091413; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Codoner FM, 2006, PLOS PATHOG, V2, P1187, DOI 10.1371/journal.ppat.0020136; Gillies RJ, 2007, J BIOENERG BIOMEMBR, V39, P251, DOI 10.1007/s10863-007-9085-y; Gudelj I, 2007, J EVOLUTION BIOL, V20, P1882, DOI 10.1111/j.1420-9101.2007.01376.x; Keller H.B., 1977, APPL BIFURCATION THE; KOCH AL, 1974, GENETICS, V77, P127; Krak N, 2008, MOL IMAGING BIOL, V10, P356, DOI 10.1007/s11307-008-0163-2; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; LEVIN BR, 1981, GENETICS, V99, P1; Lipson DA, 2009, BIOGEOCHEMISTRY, V95, P23, DOI 10.1007/s10533-008-9252-1; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Maharjan R, 2006, SCIENCE, V313, P514, DOI 10.1126/science.1129865; Maharjan RP, 2007, J BACTERIOL, V189, P2350, DOI 10.1128/JB.01414-06; Martin G, 2010, PHILOS T R SOC B, V365, P1953, DOI 10.1098/rstb.2010.0058; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; Novak M, 2006, AM NAT, V168, P242, DOI 10.1086/506527; Pfeiffer T, 2004, AM NAT, V163, pE126, DOI 10.1086/383593; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Sanjuan R, 2007, PLOS GENET, V3, P939, DOI 10.1371/journal.pgen.0030093; Turner PE, 1996, ECOLOGY, V77, P2119, DOI 10.2307/2265706; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEUSTHUIS RA, 1994, MICROBIOL REV, V58, P616, DOI 10.1128/MMBR.58.4.616-630.1994; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569	27	72	75	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					342	346		10.1038/nature09905	http://dx.doi.org/10.1038/nature09905			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21441905	Green Submitted			2022-12-24	WOS:000289724600038
J	Cain, LE; Logan, R; Robins, JM; Sterne, JAC; Sabin, C; Bansi, L; Justice, A; Goulet, J; van Sighem, A; de Wolf, F; Bucher, HC; von Wyl, V; Esteve, A; Casabona, J; del Amo, J; Moreno, S; Seng, R; Meyer, L; Perez-Hoyos, S; Muga, R; Lodi, S; Lanoy, E; Costagliola, D; Hernan, MA				Cain, Lauren E.; Logan, Roger; Robins, James M.; Sterne, Jonathan A. C.; Sabin, Caroline; Bansi, Loveleen; Justice, Amy; Goulet, Joseph; van Sighem, Ard; de Wolf, Frank; Bucher, Heiner C.; von Wyl, Viktor; Esteve, Anna; Casabona, Jordi; del Amo, Julia; Moreno, Santiago; Seng, Remonie; Meyer, Laurence; Perez-Hoyos, Santiago; Muga, Roberto; Lodi, Sara; Lanoy, Emilie; Costagliola, Dominique; Hernan, Miguel A.		HIV-CAUSAL Collaboration	When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; CONTROLLED-TRIAL; BASE-LINE; DEATH; INDIVIDUALS; PROGNOSIS; SURVIVAL; DISEASE	Background: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell counts below 0.350 x 10(9) cells/L initiate combined antiretroviral therapy (cART), but the optimal CD4 cell count at which cART should be initiated remains a matter of debate. Objective: To identify the optimal CD4 cell count at which cART should be initiated. Design: Prospective observational data from the HIV-CAUSAL Collaboration and dynamic marginal structural models were used to compare cART initiation strategies for CD4 thresholds between 0.200 and 0.500 x 10(9) cells/L. Setting: HIV clinics in Europe and the Veterans Health Administration system in the United States. Patients: 20 971 HIV-infected, therapy-naive persons with baseline CD4 cell counts at or above 0.500 x 10(9) cells/L and no previous AIDS-defining illnesses, of whom 8392 had a CD4 cell count that decreased into the range of 0.200 to 0.499 x 10(9) cells/L and were included in the analysis. Measurements: Hazard ratios and survival proportions for all-cause mortality and a combined end point of AIDS-defining illness or death. Results: Compared with initiating cART at the CD4 cell count threshold of 0.500 x 10(9) cells/L, the mortality hazard ratio was 1.01 (95% CI, 0.84 to 1.22) for the 0.350 threshold and 1.20 (CI, 0.97 to 1.48) for the 0.200 threshold. The corresponding hazard ratios were 1.38 (CI, 1.23 to 1.56) and 1.90 (CI, 1.67 to 2.15), respectively, for the combined end point of AIDS-defining illness or death. Limitations: CD4 cell count at cART initiation was not randomized. Residual confounding may exist. Conclusion: Initiation of cART at a threshold CD4 count of 0.500 x 10(9) cells/L increases AIDS-free survival. However, mortality did not vary substantially with the use of CD4 thresholds between 0.300 and 0.500 x 10(9) cells/L.	[Cain, Lauren E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Bristol, Bristol, Avon, England; UCL, Sch Med, London W1N 8AA, England; MRC, London, England; Yale Univ, Sch Med, New Haven, CT USA; Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; Univ Amsterdam, Amsterdam, Netherlands; Univ Spital Basel, Basel, Switzerland; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Univ Zurich, Zurich, Switzerland; Hosp Badalona Germans Trias & Pujol, Badalona, Spain; Inst Salud Carlos III, Madrid, Spain; Hosp Ramon & Cajal, Madrid, Spain; Hop Bicetre, Le Kremlin Bicetre, France; Barcelona Ctr Int Hlth Res, Barcelona, Spain; Hosp Clin Barcelona, Barcelona, Spain; Univ Paris 06, INSERM, U943, Paris, France; Hop La Pitie Salpetriere, Paris, France	Harvard University; Harvard T.H. Chan School of Public Health; University of Bristol; University of London; University College London; UCL Medical School; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Amsterdam; University of Basel; University of Zurich; University Zurich Hospital; University of Zurich; Hospital Germans Trias i Pujol; Instituto de Salud Carlos III; Hospital Universitario Ramon y Cajal; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Cain, LE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	lcain@hsph.harvard.edu	Perez-Hoyos, Santiago/E-2370-2012; van der Ven, A.J.A.M./H-8102-2014; Costagliola, Dominique/H-5849-2011; Guevara, Marcela/B-4473-2015; Sabin, Caroline/C-2464-2008; Oteo, Jose A./AAB-3134-2020; Guiguet, Marguerite/L-8480-2018; Muga, Roberto/AAY-8655-2021; Cuellar, Sandra/I-3069-2015; Boucherit, Soraya/I-1704-2017; Mahamat, Aba/V-7888-2019; , Felipe/F-4242-2014; Sobrino-Vegas, Paz/E-1741-2015; Sterne, Jonathan/Z-3106-2019; Cepeda, Concepción/D-7728-2016; Lanoy, Emilie/A-8541-2011; Victor, Moreno-Cuerda/G-3851-2016; TISSOT-DUPONT, Hervé/P-5808-2016; Perez Hoyos, Santiago/O-1075-2019; Pantaleo, Giuseppe/K-6163-2016; Pulido, Federico/B-8417-2009; DEL AMO VALERO, JULIA/M-7020-2015; Bergmann, Jean-Francois/L-6044-2017; Soriano, Vicente/O-5730-2018; Matheron, Sophie/D-7420-2017; Lopez.Cortes, Luis Fernando/S-5625-2018	Perez-Hoyos, Santiago/0000-0001-9797-4917; van der Ven, A.J.A.M./0000-0003-1833-3391; Costagliola, Dominique/0000-0003-0765-0869; Guevara, Marcela/0000-0001-9242-6364; Sabin, Caroline/0000-0001-5173-2760; Oteo, Jose A./0000-0001-7080-6542; Muga, Roberto/0000-0001-6301-431X; Boucherit, Soraya/0000-0002-8819-7594; Mahamat, Aba/0000-0001-8755-0424; , Felipe/0000-0001-7658-5832; Sobrino-Vegas, Paz/0000-0002-0775-1558; Sterne, Jonathan/0000-0001-8496-6053; Cepeda, Concepción/0000-0002-9197-9589; Lanoy, Emilie/0000-0002-4789-7770; Victor, Moreno-Cuerda/0000-0003-0262-8216; Perez Hoyos, Santiago/0000-0001-9797-4917; Pulido, Federico/0000-0002-7414-8812; DEL AMO VALERO, JULIA/0000-0002-3104-540X; delpech, valerie/0000-0002-9952-8109; De Lazzari, Elisa/0000-0003-2614-6545; Montoliu, Alexandra/0000-0002-4251-7062; Hervas Gomez, Rafael/0000-0002-2840-8839; Bergmann, Jean-Francois/0000-0001-6861-9748; Rijnders, Bart/0000-0003-3343-9610; Cabie, Andre/0000-0003-0117-3061; Arvieux, Cedric/0000-0003-2332-2507; Sanchez-Hellin, Victoria/0000-0002-4101-0120; ABEL, Sylvie/0000-0002-3351-0547; Cabellos, Carmen/0000-0001-7392-7382; /0000-0001-7808-5479; Goulet, Joseph Lucien/0000-0002-0842-804X; Vargas Laguna, Montserrat/0000-0001-7650-0587; von Wyl, Viktor/0000-0002-8754-9797; Leen, Clifford/0000-0001-8439-7719; Gayet-Ageron, Angele/0000-0002-6164-9693; Soriano, Vicente/0000-0002-4624-5199; Casabona-Barbara, Jordi/0000-0003-4816-5536; Matheron, Sophie/0000-0001-7879-6553; Bernal, Enrique/0000-0002-4041-0579; JARRIN, INMA/0000-0002-7485-2252; Easterbrook, Philippa/0000-0002-2603-5418; Hernan, Miguel/0000-0003-1619-8456; Negredo, Eugenia/0000-0001-5298-1734; Gerschenson, Mariana/0000-0002-8615-5964; Gnatiuc Friedrichs, Louisa/0000-0002-0641-2220; Kozal, Michael/0000-0002-3100-8254; Taffe, Patrick/0000-0002-2049-6651; Fidler, Sarah/0000-0003-1676-7583; Galinier, Anne/0000-0003-2454-5681; Vilades, Consuelo/0000-0002-2991-9593; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458	National Institutes of Health [R01-AI073127, U10-AA013566]; Medical Research Council [G0700820]; MRC [G0100221, G0900274, G0700820, MC_U122886351] Funding Source: UKRI; Medical Research Council [MC_U122886351, G0100221, G0900274] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032475, R01AI073127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020794, U10AA013566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Grant Support: By the National Institutes of Health (grants R01-AI073127 and U10-AA013566) and the Medical Research Council (grant G0700820).	ANGLARET X, EARLY ANTIRETROVIRAL; [Anonymous], [No title captured]; BERAL V, 1996, EPIDEMIOL INFECT, V117, P305; Cain LE, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1212; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Desquilbet L, 2004, AIDS, V18, P2361; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; European AIDS Clinical Society, 2009, GUID CLIN MAN TREATM; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hernan MA, 2006, BASIC CLIN PHARMACOL, V98, P237, DOI 10.1111/j.1742-7843.2006.pto_329.x; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2009, NEW ENGL J MED, V361, P822; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Orellana L, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1200; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Perez-Hoyos S, 2003, AIDS, V17, P353, DOI 10.1097/00002030-200302140-00009; Phillips AN, 2007, AIDS, V21, P1717; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Robins J, 2008, STAT MED, V27, P4678, DOI 10.1002/sim.3301; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; van der Laan Mark J, 2007, Int J Biostat, V3, P3, DOI 10.2202/1557-4679.1022; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; World Health Organization, 2009, RAP ADV ANT THER HIV; 2009, STRATEGIC TIMING ANT	44	171	176	0	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8					509	515		10.7326/0003-4819-154-8-201104190-00001	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-00001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502648				2022-12-24	WOS:000289622000013
J	Weiss, J; Pyrski, M; Jacobi, E; Bufe, B; Willnecker, V; Schick, B; Zizzari, P; Gossage, SJ; Greer, CA; Leinders-Zufall, T; Woods, CG; Wood, JN; Zufall, F				Weiss, Jan; Pyrski, Martina; Jacobi, Eric; Bufe, Bernd; Willnecker, Vivienne; Schick, Bernhard; Zizzari, Philippe; Gossage, Samuel J.; Greer, Charles A.; Leinders-Zufall, Trese; Woods, C. Geoffrey; Wood, John N.; Zufall, Frank			Loss-of-function mutations in sodium channel Na(v)1.7 cause anosmia	NATURE			English	Article							MOUSE OLFACTORY-BULB; PAIN; EXPRESSION; SYSTEM; RAT; RECEPTOR; ORGANIZATION; DELETION; SUBUNIT; REVEALS	Loss of function of the gene SCN9A, encoding the voltage-gated sodium channel Na(v)1.7, causes a congenital inability to experience pain in humans. Here we show that Na(v)1.7 is not only necessary for pain sensation but is also an essential requirement for odour perception in both mice and humans. We examined human patients with loss-of-function mutations in SCN9A and show that they are unable to sense odours. To establish the essential role of Na(v)1.7 in odour perception, we generated conditional null mice in which Na(v)1.7 was removed from all olfactory sensory neurons. In the absence of Na(v)1.7, these neurons still produce odour-evoked action potentials but fail to initiate synaptic signalling from their axon terminals at the first synapse in the olfactory system. The mutant mice no longer display vital, odour-guided behaviours such as innate odour recognition and avoidance, short-term odour learning, and maternal pup retrieval. Our study creates a mouse model of congenital general anosmia and provides new strategies to explore the genetic basis of the human sense of smell.	[Weiss, Jan; Pyrski, Martina; Jacobi, Eric; Bufe, Bernd; Leinders-Zufall, Trese; Zufall, Frank] Univ Saarland, Dept Physiol, Sch Med, D-66421 Homburg, Germany; [Willnecker, Vivienne; Schick, Bernhard] Univ Saarland, Dept Otolaryngol, Sch Med, D-66421 Homburg, Germany; [Zizzari, Philippe] Univ Paris 05, Fac Med, INSERM, Ctr Psychiat & Neurosci,UMR 894, F-75014 Paris, France; [Gossage, Samuel J.; Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, London WC1E 6BT, England; [Greer, Charles A.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Woods, C. Geoffrey] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Wood, John N.] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea	Saarland University; Saarland University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Yale University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Seoul National University (SNU)	Zufall, F (corresponding author), Univ Saarland, Dept Physiol, Sch Med, D-66421 Homburg, Germany.	frank.zufall@uks.eu	Leinders-Zufall, Trese/S-3664-2019; Zufall, Frank/AAE-5290-2021; Leinders-Zufall, Trese/B-4103-2009; Bufe, Bernd/N-6685-2018	Leinders-Zufall, Trese/0000-0002-0678-362X; Zufall, Frank/0000-0002-4383-8618; Leinders-Zufall, Trese/0000-0002-0678-362X; Jacobi, Eric/0000-0003-0055-3476; Bufe, Bernd/0000-0003-1610-0658; Zizzari, Philippe/0000-0001-8838-0762; Pyrski, Martina/0000-0002-5751-178X	Deutsche Forschungsgemeinschaft (DFG) [SFB 530, SFB 894, GK 1326]; Biotechnology and Biological Sciences Research Council; Medical Research Council; Wellcome Trust; Korean Ministry of Education, Science and Technology [R31-2008-000-10103-0]; National Research Foundation of Korea; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [G0901905] Funding Source: researchfish; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000210] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the individuals who participated in this study, P. Mombaerts for supplying OMP-Cre and OMP-GFP mice, F. Margolis for anti-OMP antibodies, J. Epelbaum for supporting the IGF-1 measurements, P. Hammes for assistance with the immunohistochemistry and C. Kaliszewski for assistance with the electron microscopy. This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) to F.Z. (SFB 530 and SFB 894) and T.L.-Z. (SFB 894). E.J. was supportedby the DFG-funded International Graduate School GK 1326. T.L.-Z. is a Lichtenberg Professor of the Volkswagen Foundation. J.N.W. was supported by the Biotechnology and Biological Sciences Research Council, Medical Research Council, Wellcome Trust and grant number R31-2008-000-10103-0 from the World Class University project of the Korean Ministry of Education, Science and Technology and the National Research Foundation of Korea.	Ahmad S, 2007, HUM MOL GENET, V16, P2114, DOI 10.1093/hmg/ddm160; Au WW, 2002, J COMP NEUROL, V446, P68, DOI 10.1002/cne.10182; BAKER H, 1989, J COMP NEUROL, V285, P246, DOI 10.1002/cne.902850207; Baker H, 1999, J NEUROSCI, V19, P9313; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cho JY, 1996, J COMP NEUROL, V369, P264; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Feldmesser E, 2007, CHEM SENSES, V32, P21, DOI 10.1093/chemse/bjl032; Gabellec MM, 2007, EUR J NEUROSCI, V25, P1373, DOI 10.1111/j.1460-9568.2007.05400.x; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; Keller A, 2008, CURR OPIN NEUROBIOL, V18, P364, DOI 10.1016/j.conb.2008.09.020; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Leinders-Zufall T, 2007, P NATL ACAD SCI USA, V104, P14507, DOI 10.1073/pnas.0704965104; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Morinville A, 2007, J COMP NEUROL, V504, P680, DOI 10.1002/cne.21484; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nickell WT, 1996, BRAIN RES BULL, V39, P57, DOI 10.1016/0361-9230(95)02042-X; Nilsen KB, 2009, PAIN, V145, P264, DOI 10.1016/j.pain.2009.06.025; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Puche AC, 1999, J NEUROSCI, V19, P1359; Pyrski M, 2007, J COMP NEUROL, V501, P944, DOI 10.1002/cne.21290; Richard MB, 2010, P NATL ACAD SCI USA, V107, P15613, DOI 10.1073/pnas.1007931107; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Ukhanov K, 2007, J NEUROPHYSIOL, V98, P2357, DOI 10.1152/jn.00642.2007; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	37	209	217	4	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					186	190		10.1038/nature09975	http://dx.doi.org/10.1038/nature09975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21441906	Green Accepted			2022-12-24	WOS:000289469100035
J	Conde, DA; Flesness, N; Colchero, F; Jones, OR; Scheuerlein, A				Conde, D. A.; Flesness, N.; Colchero, F.; Jones, O. R.; Scheuerlein, A.			An Emerging Role of Zoos to Conserve Biodiversity	SCIENCE			English	Editorial Material							POPULATION VIABILITY ANALYSIS; VERTEBRATES		[Conde, D. A.; Colchero, F.; Jones, O. R.; Scheuerlein, A.] Max Planck Inst Demog Res, D-18057 Rostock, Germany; [Flesness, N.] Int Species Informat Syst, Eagan, MN 55121 USA	Max Planck Society	Conde, DA (corresponding author), Max Planck Inst Demog Res, D-18057 Rostock, Germany.	conde@demogr.mpg.de	Colchero, Fernando/A-9368-2015; Scheuerlein, Alexander/AAK-1111-2021; Jones, Owen/B-8439-2008	Colchero, Fernando/0000-0001-8613-4568; Jones, Owen/0000-0001-5720-4686; Conde, Dalia A./0000-0002-7923-8163				Barnett R, 2006, CONSERV GENET, V7, P507, DOI 10.1007/s10592-005-9062-0; BELANT J, 2010, IUCN RED LIST THREAT; BISBY FA, ISIS IUCN INFORM WER; Conway WG, 2011, ZOO BIOL, V30, P1, DOI 10.1002/zoo.20352; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; GUSSET M, 2010, ZOO BIOL        1206; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; *IUCN, 2002, IUCN TECHN GUID MAN, P4; IUCN, 2014, IUCN RED LIST THREAT; Meretsky VJ, 2000, CONSERV BIOL, V14, P957, DOI 10.1046/j.1523-1739.2000.99113.x; Morell V, 2008, SCIENCE, V320, P742, DOI 10.1126/science.320.5877.742; NORMILE D, 2010, SCI INSIDER     1029; Reed JM, 2002, CONSERV BIOL, V16, P7, DOI 10.1046/j.1523-1739.2002.99419.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Spalton JA, 1999, ORYX, V33, P168, DOI 10.1046/j.1365-3008.1999.00062.x; Thibault JC, 2001, ORYX, V35, P73, DOI 10.1017/S0030605300031550; VanDierendonck MC, 1996, CONSERV BIOL, V10, P728, DOI 10.1046/j.1523-1739.1996.10030728.x; WAZA (World Association of Zoos and Aquariums), 2005, BUILD FUT WILDL WORL; White TH, 2005, CONDOR, V107, P424, DOI 10.1650/7672	20	187	195	8	286	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1390	1391		10.1126/science.1200674	http://dx.doi.org/10.1126/science.1200674			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736OM	21415339				2022-12-24	WOS:000288504000023
J	Deriano, L; Chaumeil, J; Coussens, M; Multani, A; Chou, YF; Alekseyenko, AV; Chang, S; Skok, JA; Roth, DB				Deriano, Ludovic; Chaumeil, Julie; Coussens, Marc; Multani, Asha; Chou, Yifan; Alekseyenko, Alexander V.; Chang, Sandy; Skok, Jane A.; Roth, David B.			The RAG2 C terminus suppresses genomic instability and lymphomagenesis	NATURE			English	Article							DOUBLE-STRAND BREAKS; ATM-DEFICIENT MICE; V(D)J RECOMBINATION; LYMPHOCYTE DEVELOPMENT; GENE AMPLIFICATION; THYMIC LYMPHOMA; B-CELL; REPAIR; ROLES; TRANSLOCATIONS	Misrepair of DNA double-strand breaks produced by the V(D)J recombinase (the RAG1/RAG2 proteins) at immunoglobulin (Ig) and T cell receptor (Tcr) loci has been implicated in pathogenesis of lymphoid malignancies in humans(1) and in mice(2-7). Defects in DNA damage response factors such as ataxia telangiectasia mutated (ATM) protein and combined deficiencies in classical non-homologous end joining and p53 predispose to RAG-initiated genomic rearrangements and lymphomagenesis(2-11). Although we showed previously that RAG1/RAG2 shepherd the broken DNA ends to classical non-homologous end joining for proper repair(12,13), roles for the RAG proteins in preserving genomic stability remain poorly defined. Here we show that the RAG2 carboxy (C) terminus, although dispensable for recombination(14,15), is critical for maintaining genomic stability. Thymocytes from 'core' Rag2 homozygotes (Rag2(c/c) mice) show dramatic disruption of Tcr alpha/delta locus integrity. Furthermore, all Rag2(c/c) p53(-/-) mice, unlike Rag1(c/c) p53(-/-) and p53(-/-) animals, rapidly develop thymic lymphomas bearing complex chromosomal translocations, amplifications and deletions involving the Tcra/delta and Igh loci. We also find these features in lymphomas from Atm(-/-) mice. We show that, like ATM-deficiency(3), core RAG2 severely destabilizes the RAG post-cleavage complex. These results reveal a novel genome guardian role for RAG2 and suggest that similar 'end release/end persistence' mechanisms underlie genomic instability and lymphomagenesis in Rag2(c/c) p53(-/-) and Atm(-/-) mice.	[Deriano, Ludovic; Chaumeil, Julie; Coussens, Marc; Chou, Yifan; Skok, Jane A.; Roth, David B.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Multani, Asha] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Alekseyenko, Alexander V.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, Div Clin Pharmacol,Dept Med, New York, NY 10016 USA; [Chang, Sandy] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Skok, Jane A.] UCL, Div Infect & Immun, Dept Immunol & Mol Pathol, London W1T 4JF, England	New York University; University of Texas System; UTMD Anderson Cancer Center; New York University; Yale University; University of London; University College London	Roth, DB (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	david.roth@nyumc.org	Skok, Jane/ABF-7249-2020; Deriano, Ludovic/D-2048-2019	Skok, Jane/0000-0002-4145-1516; Deriano, Ludovic/0000-0002-9673-9525; Alekseyenko, Alexander/0000-0002-5748-2085; CHAUMEIL, Julie/0000-0002-8976-2890	National Institutes of Health Roadmap Initiative in Nanomedicine through a Nanomedicine Development Center [1PN2EY018244]; National Institutes of Health [CA104588, R01GM086852]; Irene Diamond Fund; National Center for Research Resources, National Institutes of Health [1UL1RR029893]; NCI [R01CA145746-01]; Leukemia and Lymphoma Scholar Award; Wellcome trust [085096]; NATIONAL CANCER INSTITUTE [R01CA104588, RC1CA145746] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086852] Funding Source: NIH RePORTER	National Institutes of Health Roadmap Initiative in Nanomedicine through a Nanomedicine Development Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irene Diamond Fund; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Scholar Award(Leukemia and Lymphoma Society); Wellcome trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Schlissel for the gift of core Rag2 mice, F. Alt for the gift of core Rag1 mice and S. Hewitt for the Igh BAC probes. D.B.R. was supported by National Institutes of Health Roadmap Initiative in Nanomedicine through a Nanomedicine Development Center award (1PN2EY018244), a National Institutes of Health grant CA104588 and the Irene Diamond Fund. L.D. is a Fellow of The Leukemia and Lymphoma Society. A.V.A. was supported in part by grant 1UL1RR029893 from the National Center for Research Resources, National Institutes of Health. J.A.S. was supported by a National Institutes of Health grant R01GM086852, a National Institutes of Health Challenge grant NCI R01CA145746-01, a Leukemia and Lymphoma Scholar Award and a Wellcome trust project grant 085096.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Arnal SM, 2010, NUCLEIC ACIDS RES, V38, P2944, DOI 10.1093/nar/gkp1252; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Callen E, 2009, CELL CYCLE, V8, P2408, DOI 10.4161/cc.8.15.9085; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Curry JD, 2008, NUCLEIC ACIDS RES, V36, P5750, DOI 10.1093/nar/gkn553; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dudley DD, 2003, J EXP MED, V198, P1439, DOI 10.1084/jem.20030627; FORSTER A, 1980, NATURE, V286, P897, DOI 10.1038/286897a0; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jones JM, 2009, ARCH IMMUNOL THER EX, V57, P105, DOI 10.1007/s00005-009-0011-3; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Matei IR, 2007, BLOOD, V109, P1887, DOI 10.1182/blood-2006-05-020917; Multani AS, 2000, NEOPLASIA, V2, P339, DOI 10.1038/sj.neo.7900105; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; PATHAK S, 1976, J REPROD MED, V17, P25; Qiu JX, 2001, MOL CELL, V7, P77, DOI 10.1016/S1097-2765(01)00156-3; R Development Core Team, 2006, R LANG ENV STAT COMP; Ryu CJ, 2006, CANCER CELL, V9, P109, DOI 10.1016/j.ccr.2006.01.004; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Steen SB, 1999, MOL CELL BIOL, V19, P3010; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Theunissen JWF, 2006, METHOD ENZYMOL, V409, P251, DOI 10.1016/S0076-6879(05)09015-4; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zha S, 2010, J EXP MED, V207, P1369, DOI 10.1084/jem.20100285; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	39	78	80	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					119	U145		10.1038/nature09755	http://dx.doi.org/10.1038/nature09755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368836	Green Accepted			2022-12-24	WOS:000287924100046
J	Magklara, A; Yen, A; Colquitt, BM; Clowney, EJ; Allen, W; Markenscoff-Papadimitriou, E; Evans, ZA; Kheradpour, P; Mountoufaris, G; Carey, C; Barnea, G; Kellis, M; Lomvardas, S				Magklara, Angeliki; Yen, Angela; Colquitt, Bradley M.; Clowney, E. Josephine; Allen, William; Markenscoff-Papadimitriou, Eirene; Evans, Zoe A.; Kheradpour, Pouya; Mountoufaris, George; Carey, Catriona; Barnea, Gilad; Kellis, Manolis; Lomvardas, Stavros			An Epigenetic Signature for Monoallelic Olfactory Receptor Expression	CELL			English	Article							ODORANT RECEPTORS; GENE-EXPRESSION; BASAL-CELLS; STEM-CELLS; CHROMATIN; FAMILY; ONTOGENY; DOMAINS; NEURONS; PROTEIN	Constitutive heterochromatin is traditionally viewed as the static form of heterochromatin that silences pericentromeric and telomeric repeats in a cell cycle-and differentiation-independent manner. Here, we show that, in the mouse olfactory epithelium, olfactory receptor (OR) genes are marked in a highly dynamic fashion with the molecular hallmarks of constitutive heterochromatin, H3K9me3 and H4K20me3. The cell type and developmentally dependent deposition of these marks along the OR clusters are, most likely, reversed during the process of OR choice to allow for monogenic and monoallelic OR expression. In contrast to the current view of OR choice, our data suggest that OR silencing takes place before OR expression, indicating that it is not the product of an OR-elicited feedback signal. Our findings suggest that chromatin-mediated silencing lays a molecular foundation upon which singular and stochastic selection for gene expression can be applied.	[Magklara, Angeliki; Evans, Zoe A.; Mountoufaris, George; Carey, Catriona; Lomvardas, Stavros] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Colquitt, Bradley M.; Markenscoff-Papadimitriou, Eirene; Lomvardas, Stavros] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [Clowney, E. Josephine; Lomvardas, Stavros] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [Yen, Angela; Kheradpour, Pouya; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Yen, Angela; Kheradpour, Pouya; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Allen, William; Barnea, Gilad] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Brown University	Lomvardas, S (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	stavros.lomvardas@ucsf.edu	Colquitt, Bradley/AAR-7838-2021; Magklara, Angeliki/AAK-8347-2020; Kellis, Manolis/ABE-7385-2020	Colquitt, Bradley/0000-0001-5819-7924; Magklara, Angeliki/0000-0003-3408-6722; Kellis, Manolis/0000-0001-7113-9630; Lomvardas, Stavros/0000-0002-7668-3026; Clowney, Eleanor/0000-0002-9150-9464	National Science Foundation; Royce Fellowship; McKnight Endowment Fund for Neuroscience; Rett Syndrome Research Trust; Hellman Family Foundation; NIDCD [R03 DC010273]; Director's New Innovator Award Program [1DP2 OD006667]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030320] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006667] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Royce Fellowship; McKnight Endowment Fund for Neuroscience; Rett Syndrome Research Trust; Hellman Family Foundation; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Director's New Innovator Award Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Dr. Frank Margolis for the OMP-LacZ mouse strain, Dr. John Rubenstein for the Emx2 knockout mouse, Dr. James E. Schwob for the SUS4 antibody, Drs. Andrew Feinberg and Bo Wen for the primer sequences for the positive controls for the H3K9me2 ChIPs, and Dr. Richard Axel for the P2-IRES-GFP and OMP-IRES-GFP mice as well as for the helpful discussions and support. We would also like to thank Drs. Hiten Madhani, Barbara Panning, Nirao Shah, Dimitris Thanos, Tim Mcclintock, Kevin Monahan, and Keith Yamamoto for critical reading of the manuscript. B. M. C., E.J.C., and E. M.-P. are supported by fellowships from the National Science Foundation. W. A. is supported by a Royce Fellowship, G. B. is a Pew Scholar in the Biomedical Sciences, and S. L. is funded by the McKnight Endowment Fund for Neuroscience, Rett Syndrome Research Trust, Hellman Family Foundation, NIDCD (R03 DC010273), and Director's New Innovator Award Program (1DP2 OD006667).	Axel R, 2005, ANGEW CHEM INT EDIT, V44, P6110, DOI 10.1002/anie.200501726; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Cau E, 2002, DEVELOPMENT, V129, P1871; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Duggan CD, 2007, NAT NEUROSCI, V10, P673, DOI 10.1038/nn0607-673; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Ghirlando R, 2004, J MOL BIOL, V336, P597, DOI 10.1016/j.jmb.2003.12.049; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Goldmit M, 2004, IMMUNOL REV, V200, P197, DOI 10.1111/j.0105-2896.2004.00158.x; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Jang WC, 2007, J COMP NEUROL, V502, P367, DOI 10.1002/cne.21328; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Larson JL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-557; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; McIntyre JC, 2008, CHEM SENSES, V33, P825, DOI 10.1093/chemse/bjn061; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Pyrski M, 2001, J NEUROSCI, V21, P4637, DOI 10.1523/JNEUROSCI.21-13-04637.2001; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; ROTHMAN A, 2008, CURR BIOL, V18, pR255; Sammeta N, 2007, J COMP NEUROL, V502, P1138, DOI 10.1002/cne.21365; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Walters E, 1996, INT J DEV NEUROSCI, V14, P813, DOI 10.1016/S0736-5748(96)00063-9; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297	48	199	200	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2011	145	4					555	570		10.1016/j.cell.2011.03.040	http://dx.doi.org/10.1016/j.cell.2011.03.040			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21529909	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-24	WOS:000290560800009
J	Peca, J; Feliciano, C; Ting, JT; Wang, WT; Wells, MF; Venkatraman, TN; Lascola, CD; Fu, ZY; Feng, GP				Peca, Joao; Feliciano, Catia; Ting, Jonathan T.; Wang, Wenting; Wells, Michael F.; Venkatraman, Talaignair N.; Lascola, Christopher D.; Fu, Zhanyan; Feng, Guoping			Shank3 mutant mice display autistic-like behaviours and striatal dysfunction	NATURE			English	Article							22Q13 DELETION SYNDROME; SPECTRUM DISORDERS; SYNAPTIC-TRANSMISSION; MUTATIONS; PROTEIN; BRAIN; GENE; NEUROLIGINS; SAPAPS; FAMILY	Autismspectrum disorders (ASDs) comprise a range of disorders that share a core of neurobehavioural deficits characterized by widespread abnormalities in social interactions, deficits in communication as well as restricted interests and repetitive behaviours. The neurological basis and circuitry mechanisms underlying these abnormal behaviours are poorly understood. SHANK3 is a postsynaptic protein, whose disruption at the genetic level is thought to be responsible for the development of 22q13 deletion syndrome (Phelan-McDermid syndrome) and other non-syndromic ASDs. Here we show that mice with Shank3 gene deletions exhibit self-injurious repetitive grooming and deficits in social interaction. Cellular, electrophysiological and biochemical analyses uncovered defects at striatal synapses and cortico-striatal circuits in Shank3 mutant mice. Our findings demonstrate a critical role for SHANK3 in the normal development of neuronal connectivity and establish causality between a disruption in the Shank3 gene and the genesis of autistic-like behaviours in mice.	[Peca, Joao; Feliciano, Catia; Ting, Jonathan T.; Wang, Wenting; Wells, Michael F.; Lascola, Christopher D.; Fu, Zhanyan; Feng, Guoping] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Peca, Joao] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Programme Biomed & Expt Biol, Coimbra, Portugal; [Feliciano, Catia] Gulbenkian Inst Sci, Gulbenkian PhD Programme Biomed, P-2781901 Oeiras, Portugal; [Venkatraman, Talaignair N.; Lascola, Christopher D.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Venkatraman, Talaignair N.; Lascola, Christopher D.] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27710 USA; [Fu, Zhanyan] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Fu, Zhanyan; Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Feng, Guoping] Stanley Ctr Psychiat Res, Broad Inst, Cambridge, MA 02142 USA	Duke University; Universidade de Coimbra; Duke University; Duke University; Duke University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Feng, GP (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	fengg@mit.edu	Feng, Guoping/Y-2827-2019; Peça, João/K-7900-2013; Lascola, Christopher D/B-9126-2017	Peça, João/0000-0003-4989-2129; Lascola, Christopher D/0000-0002-8031-782X; Wells, Michael/0000-0002-1367-2565; Wang, Wenting/0000-0002-8344-0102; Ting, Jonathan/0000-0001-8266-0392; Feliciano, Catia/0000-0001-7545-6924	NIMH/NIH [R01MH081201]; Hartwell Foundation; Simons Foundation Autism Research Initiative (SFARI); NARSAD; NIH [F32MH084460, R03MH085224]; Portuguese Foundation for Science and Technology [SFRH/BD/15231/2004, SFRH/BD/15855/2005]; "Programa Gulbenkian de Doutoramento em Biomedicina'' (PGDB, Oeiras, Portugal); "Programa Doutoral em Biologia Experimental e Biomedicina'' (CNC, Coimbra, Portugal); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081201, F32MH084460, R03MH085224] Funding Source: NIH RePORTER	NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hartwell Foundation; Simons Foundation Autism Research Initiative (SFARI); NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); "Programa Gulbenkian de Doutoramento em Biomedicina'' (PGDB, Oeiras, Portugal); "Programa Doutoral em Biologia Experimental e Biomedicina'' (CNC, Coimbra, Portugal); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Duarte, S. Chaterjee and A. Oliveira-Maia for discussions; L. Kruger and Q. Liu for technical assistance; A. Hadiono for assistance in behavioural annotation; D. Bredt for the PSD-93 antibody; T. Boeckers for the anti-SHANK3 antibody; S. Miller and P. Christopher for advice and assistance with electron microscopy techniques; J. Crawley for the demonstration of social behaviour tests; N. Calakos and Y. Wan for advice on electrophysiology studies; A. Graybiel for critical comments of the manuscript; D. Wang and the other members of the G. F. laboratory for their support. We thank The Poitras Center for Affective Disorders Research. This work was funded by a grant from NIMH/NIH (R01MH081201), a Hartwell Individual Biomedical Research Award from The Hartwell Foundation, and a Simons Foundation Autism Research Initiative (SFARI) grant Award to G. F.; a NARSAD Young Investigator Award and NIH Ruth L. Kirschstein National Research Service Award (F32MH084460) to J. T. T.; a NIH (R03MH085224) grant to Z.F.; and doctoral fellowships from the Portuguese Foundation for Science and Technology to J. P. (SFRH/BD/15231/2004) and C. F. (SFRH/BD/15855/2005). C. F. would like to acknowledge the support from the "Programa Gulbenkian de Doutoramento em Biomedicina'' (PGDB, Oeiras, Portugal) and J. P. the "Programa Doutoral em Biologia Experimental e Biomedicina'' (CNC, Coimbra, Portugal).	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bonaglia MC, 2006, J MED GENET, V43, P822, DOI 10.1136/jmg.2005.038604; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; HORWITZ B, 1988, ARCH NEUROL-CHICAGO, V45, P749, DOI 10.1001/archneur.1988.00520310055018; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; MALENKA RC, 1988, J NEUROSCI, V8, P3750; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Myme CIO, 2003, J NEUROPHYSIOL, V90, P771, DOI 10.1152/jn.00070.2003; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prasad C, 2000, CLIN GENET, V57, P103, DOI 10.1034/j.1399-0004.2000.570203.x; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Rosenberg RE, 2009, ARCH PEDIAT ADOL MED, V163, P907, DOI 10.1001/archpediatrics.2009.98; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Silk TJ, 2006, AM J PSYCHIAT, V163, P1440, DOI 10.1176/appi.ajp.163.8.1440; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Welch JM, 2004, J COMP NEUROL, V472, P24, DOI 10.1002/cne.20060; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Yin HH, 2006, J NEUROSCI, V26, P11811, DOI 10.1523/JNEUROSCI.3196-06.2006; Zoghbi HY, 2010, NEURON, V68, P165, DOI 10.1016/j.neuron.2010.10.015; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	42	907	950	5	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					437	U534		10.1038/nature09965	http://dx.doi.org/10.1038/nature09965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21423165	Green Accepted, Green Submitted			2022-12-24	WOS:000289949600027
J	Bonnin, A; Goeden, N; Chen, K; Wilson, ML; King, J; Shih, JC; Blakely, RD; Deneris, ES; Levitt, P				Bonnin, Alexandre; Goeden, Nick; Chen, Kevin; Wilson, Melissa L.; King, Jennifer; Shih, Jean C.; Blakely, Randy D.; Deneris, Evan S.; Levitt, Pat			A transient placental source of serotonin for the fetal forebrain	NATURE			English	Article							NORMAL ANXIETY-LIKE; TRYPTOPHAN 2,3-DIOXYGENASE; AGGRESSIVE-BEHAVIOR; MONOAMINE-OXIDASE; BRAIN-SEROTONIN; EXPRESSION; MICE; TRANSPORTER; NEURONS; PREGNANCY	Serotonin (5-hydroxytryptamine or 5-HT) is thought to regulate neurodevelopmental processes through maternal-fetal interactions that have long-term mental health implications. It is thought that beyond fetal 5-HT neurons there are significant maternal contributions to fetal 5-HT during pregnancy(1,2) but this has not been tested empirically. To examine putative central and peripheral sources of embryonic brain 5-HT, we used Pet1(-/-) (also called Fev) mice in which most dorsal raphe neurons lack 5-HT3. We detected previously unknown differences in accumulation of 5-HT between the forebrain and hindbrain during early and late fetal stages, through an exogenous source of 5-HT which is not of maternal origin. Using additional genetic strategies, a new technology for studying placental biology ex vivo and direct manipulation of placental neosynthesis, we investigated the nature of this exogenous source. We uncovered a placental 5-HT synthetic pathway from a maternal tryptophan precursor in both mice and humans. This study reveals a new, direct role for placental metabolic pathways in modulating fetal brain development and indicates that maternal-placental-fetal interactions could underlie the pronounced impact of 5-HT on long-lasting mental health outcomes.	[Bonnin, Alexandre; Goeden, Nick; Levitt, Pat] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Bonnin, Alexandre; Levitt, Pat] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [Chen, Kevin; Shih, Jean C.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Wilson, Melissa L.; King, Jennifer] Univ So Calif, Keck Sch Med, Dept OB GYN, Los Angeles, CA 90089 USA; [Wilson, Melissa L.; King, Jennifer] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Blakely, Randy D.] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37221 USA; [Blakely, Randy D.] Vanderbilt Univ, Ctr Mol Neurosci, Med Ctr, Nashville, TN 37221 USA; [Deneris, Evan S.] Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Vanderbilt University; Vanderbilt University; Case Western Reserve University	Bonnin, A (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.	bonnin@usc.edu; plevitt@usc.edu	Chen, Kevin/GYU-8963-2022; Wilson, Melissa/P-3100-2017	Wilson, Melissa/0000-0001-7785-4221	NICHD [5R21HD065287]; NARSAD; NIMH [R01MH39085, 1P50MH078280A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH078028, R01MH039085] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NARSAD(NARSAD); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank H. H. Wu and K. Eagleson for discussions and comments on the manuscript. We thank R. Johnson (Vanderbilt HPLC core facility), L. Zhang for technical help and E. Meng for discussions. This work was supported by the NICHD (grant 5R21HD065287 to A. B.), NARSAD (A. B.) and the NIMH (grant R01MH39085 to J.C.S. and 1P50MH078280A1 to R. D. B. and P.L.).	AITKEN AR, 1988, J COMP NEUROL, V274, P32, DOI 10.1002/cne.902740105; Anderson GM, 2002, MOL PSYCHIATR, V7, P831, DOI 10.1038/sj.mp.4001099; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; BALKOVETZ DF, 1989, J BIOL CHEM, V264, P2195; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; BRANCHEK TA, 1989, J COMP NEUROL, V285, P262, DOI 10.1002/cne.902850208; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Buznikov GA, 2001, CELL TISSUE RES, V305, P177, DOI 10.1007/s004410100408; Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; Chen K, 2007, J BIOL CHEM, V282, P115, DOI 10.1074/jbc.M609830200; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; HOWD RA, 1975, LIFE SCI, V17, P803, DOI 10.1016/0024-3205(75)90538-X; Jawerbaum A, 2010, ENDOCR REV, V31, P680, DOI 10.1210/er.2009-0038; JOHANSEN PA, 1995, J NEUROCHEM, V65, P882; Kanai M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-8; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; KOE BK, 1966, J PHARMACOL EXP THER, V154, P499; KUHN DM, 1980, J BIOL CHEM, V255, P4137; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Lebrand C, 1998, J COMP NEUROL, V401, P506; LIDOV HGW, 1982, BRAIN RES BULL, V9, P559, DOI 10.1016/0361-9230(82)90164-2; Lynn-Bullock CP, 2004, J CHEM NEUROANAT, V27, P129, DOI 10.1016/j.jchemneu.2004.02.003; Miller CL, 2009, SCHIZOPHR RES, V113, P259, DOI 10.1016/j.schres.2009.05.014; Nabi R, 2004, AM J MED GENET B, V125B, P63, DOI 10.1002/ajmg.b.20147; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; ROBSON JM, 1964, BRIT J PHARM CHEMOTH, V22, P380, DOI 10.1111/j.1476-5381.1964.tb02043.x; Scott AL, 2008, NEUROREPORT, V19, P739, DOI 10.1097/WNR.0b013e3282fd6e88; Suzuki S, 2001, BIOCHEM J, V355, P425, DOI 10.1042/0264-6021:3550425; Taylor SE, 2006, BIOL PSYCHIAT, V60, P671, DOI 10.1016/j.biopsych.2006.04.019; YAVARONE MS, 1993, PLACENTA, V14, P149, DOI 10.1016/S0143-4004(05)80257-7	35	362	370	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					347	U246		10.1038/nature09972	http://dx.doi.org/10.1038/nature09972			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21512572	Green Published, Green Accepted			2022-12-24	WOS:000289724600039
J	Aubin-Tam, ME; Olivares, AO; Sauer, RT; Baker, TA; Lang, MJ				Aubin-Tam, Marie-Eve; Olivares, Adrian O.; Sauer, Robert T.; Baker, Tania A.; Lang, Matthew J.			Single-Molecule Protein Unfolding and Translocation by an ATP-Fueled Proteolytic Machine	CELL			English	Article							PLUS CLPXP PROTEASE; OPERATING PRINCIPLES; DEPENDENT PROTEASES; DEGRADATION MACHINE; FORCE SPECTROSCOPY; RNA-POLYMERASE; PORE LOOPS; DENATURATION; RECOGNITION; BINDING	All cells employ ATP-powered proteases for protein-quality control and regulation. In the ClpXP protease, ClpX is a AAA+ machine that recognizes specific protein substrates, unfolds these molecules, and then translocates the denatured polypeptide through a central pore and into ClpP for degradation. Here, we use optical-trapping nanometry to probe the mechanics of enzymatic unfolding and translocation of single molecules of a multidomain substrate. Our experiments demonstrate the capacity of ClpXP and ClpX to perform mechanical work under load, reveal very fast and highly cooperative unfolding of individual substrate domains, suggest a translocation step size of 5-8 amino acids, and support a power-stroke model of denaturation in which successful enzyme-mediated unfolding of stable domains requires coincidence between mechanical pulling by the enzyme and a transient stochastic reduction in protein stability. We anticipate that single-molecule studies of the mechanical properties of other AAA+ proteolytic machines will reveal many shared features with ClpXP.	[Aubin-Tam, Marie-Eve; Olivares, Adrian O.; Sauer, Robert T.; Baker, Tania A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Aubin-Tam, Marie-Eve; Lang, Matthew J.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Lang, Matthew J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tabaker@mit.edu; matt.lang@vanderbilt.edu	Aubin-Tam, Marie-Eve/J-3337-2013; Olivares, Adrian/D-7717-2012; Aubin-Tam, Marie-Eve/F-5253-2012	Aubin-Tam, Marie-Eve/0000-0001-9995-2623; Olivares, Adrian/0000-0002-0895-7988; Sauer, Robert/0000-0002-1719-5399	National Science Foundation [0643745]; Howard Hughes Medical Institute; National Institutes of Health [AI-15706, AI-82929]; Direct For Biological Sciences [1118490] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015706, F32AI082929, R37AI015706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101988] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Nakamura for filamin-A plasmids and S. Glynn, J. Kardon, A. Nager, B. Stinson, Y. Shin, and other members of our labs for advice and discussions. This study was supported by National Science Foundation Career Award 0643745 (M.J.L.), the Howard Hughes Medical Institute, and National Institutes of Health grants AI-15706 and AI-82929 (A.O.O.). T.A.B. is an employee of the Howard Hughes Medical Institute.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Aubin-Tam ME, 2011, J PHYS CHEM A, V115, P3657, DOI 10.1021/jp1031493; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Burton BM, 2001, MOL CELL, V8, P449, DOI 10.1016/S1097-2765(01)00307-0; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Ferrer JM, 2008, P NATL ACAD SCI USA, V105, P9221, DOI 10.1073/pnas.0706124105; Fucini P, 1997, NAT STRUCT BIOL, V4, P223, DOI 10.1038/nsb0397-223; Furuike S, 2001, FEBS LETT, V498, P72, DOI 10.1016/S0014-5793(01)02497-8; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Greenleaf WJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208102; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Hollien J, 1999, P NATL ACAD SCI USA, V96, P13674, DOI 10.1073/pnas.96.24.13674; Hwang W, 2009, CELL BIOCHEM BIOPHYS, V54, P11, DOI 10.1007/s12013-009-9049-4; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Los GV, 2007, METH MOL B, V356, P195; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlierf M, 2007, BIOPHYS J, V93, P3989, DOI 10.1529/biophysj.107.114397; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shin Y, 2009, P NATL ACAD SCI USA, V106, P19340, DOI 10.1073/pnas.0910484106; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Taniguchi Y, 2010, LANGMUIR, V26, P10433, DOI 10.1021/la101658a; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200	49	189	191	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					257	267		10.1016/j.cell.2011.03.036	http://dx.doi.org/10.1016/j.cell.2011.03.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496645	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000289549900014
J	Xiao, B; Sanders, MJ; Underwood, E; Heath, R; Mayer, FV; Carmena, D; Jing, C; Walker, PA; Eccleston, JF; Haire, LF; Saiu, P; Howell, SA; Aasland, R; Martin, SR; Carling, D; Gamblin, SJ				Xiao, Bing; Sanders, Matthew J.; Underwood, Elizabeth; Heath, Richard; Mayer, Faith V.; Carmena, David; Jing, Chun; Walker, Philip A.; Eccleston, John F.; Haire, Lesley F.; Saiu, Peter; Howell, Steven A.; Aasland, Rein; Martin, Stephen R.; Carling, David; Gamblin, Steven J.			Structure of mammalian AMPK and its regulation by ADP	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; LKB1-AMPK PATHWAY; SKELETAL-MUSCLE; PHOSPHORYLATION; BINDING	The heterotrimeric AMP-activated protein kinase (AMPK) has a key role in regulating cellular energy metabolism; in response to a fall in intracellular ATP levels it activates energy-producing pathways and inhibits energy-consuming processes(1). AMPK has been implicated in a number of diseases related to energy metabolism including type 2 diabetes, obesity and, most recently, cancer(2-6). AMPK is converted from an inactive form to a catalytically competent form by phosphorylation of the activation loop within the kinase domain(7): AMP binding to the c-regulatory domain promotes phosphorylation by the upstream kinase(8), protects the enzyme against dephosphorylation, as well as causing allosteric activation(9). Here we show that ADP binding to just one of the two exchangeable AXP (AMP/ADP/ATP) binding sites on the regulatory domain protects the enzyme from dephosphorylation, although it does not lead to allosteric activation. Our studies show that active mammalian AMPK displays significantly tighter binding to ADP than to MgATP, explaining how the enzyme is regulated under physiological conditions where the concentration of Mg-ATP is higher than that of ADP and much higher than that of AMP. We have determined the crystal structure of an active AMPK complex. The structure shows how the activation loop of the kinase domain is stabilized by the regulatory domain and how the kinase linker region interacts with the regulatory nucleotide-binding site that mediates protection against dephosphorylation. From our biochemical and structural data we develop a model for how the energy status of a cell regulates AMPK activity.	[Sanders, Matthew J.; Mayer, Faith V.; Carmena, David; Carling, David] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England; [Xiao, Bing; Underwood, Elizabeth; Heath, Richard; Jing, Chun; Walker, Philip A.; Eccleston, John F.; Haire, Lesley F.; Saiu, Peter; Howell, Steven A.; Aasland, Rein; Martin, Stephen R.; Gamblin, Steven J.] Natl Inst Med Res, MRC, London NW7 1AA, England	Imperial College London; MRC National Institute for Medical Research	Carling, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Hammersmith Hosp Campus,DuCane Rd, London W12 0NN, England.	david.carling@csc.mrc.ac.uk; sgambli@nimr.mrc.ac.uk	Sanders, Matthew J/B-4077-2009; Carling, David/F-1943-2014; Carmena, David/S-4049-2019	Carling, David/0000-0002-2316-1830; Carmena, David/0000-0002-4015-8553; Sanders, Matthew James/0000-0001-6185-6337; Gamblin, Steve/0000-0001-5331-639X	MRC; Medical Research Council [MC_U120027537, MC_U117584222] Funding Source: researchfish; MRC [MC_U117584222] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Webb for gift of coumarin nucleotides, J. Skehel for comments on the manuscript and S. Smerdon for discussion and assistance. Work in both laboratories is supported by the MRC and we gratefully acknowledge Diamond Light Source for synchrotron access.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; Hellsten Y, 1999, J PHYSIOL-LONDON, V520, P909, DOI 10.1111/j.1469-7793.1999.00909.x; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2007, STRUCTURE, V15, P1161, DOI 10.1016/j.str.2007.09.006; Littler DR, 2010, ACTA CRYSTALLOGR F, V66, P143, DOI 10.1107/S1744309109052543; McConell GK, 2005, J PHYSIOL-LONDON, V568, P665, DOI 10.1113/jphysiol.2005.089839; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Otwinowski Z., 1993, P CCP4 STUDY WEEKEND, P556; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	30	625	662	5	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					230	233		10.1038/nature09932	http://dx.doi.org/10.1038/nature09932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21399626	Green Accepted			2022-12-24	WOS:000289469100045
J	Kondrashov, N; Pusic, A; Stumpf, CR; Shimizu, K; Hsieh, AC; Xue, SF; Ishijima, J; Shiroishi, T; Barna, M				Kondrashov, Nadya; Pusic, Aya; Stumpf, Craig R.; Shimizu, Kunihiko; Hsieh, Andrew C.; Xue, Shifeng; Ishijima, Junko; Shiroishi, Toshihiko; Barna, Maria			Ribosome-Mediated Specificity in Hox mRNA Translation and Vertebrate Tissue Patterning	CELL			English	Article							AXIAL SKELETON; HOMEOBOX GENES; RETINOIC ACID; MOUSE; INITIATION; ACTIVATION; MUTATION; PROTEINS; IDENTITY; SUBUNIT	Historically, the ribosome has been viewed as a complex ribozyme with constitutive rather than regulatory capacity in mRNA translation. Here we identify mutations of the Ribosomal Protein L38 (Rpl38) gene in mice exhibiting surprising tissue-specific patterning defects, including pronounced homeotic transformations of the axial skeleton. In Rpl38 mutant embryos, global protein synthesis is unchanged; however the translation of a select subset of Homeobox mRNAs is perturbed. Our data reveal that RPL38 facilitates 80S complex formation on these mRNAs as a regulatory component of the ribosome to confer transcript-specific translational control. We further show that Rpl38 expression is markedly enriched in regions of the embryo where loss-of-function phenotypes occur. Unexpectedly, a ribosomal protein (RP) expression screen reveals dynamic regulation of individual RPs within the vertebrate embryo. Collectively, these findings suggest that RP activity may be highly regulated to impart a new layer of specificity in the control of gene expression and mammalian development.	[Kondrashov, Nadya; Pusic, Aya; Stumpf, Craig R.; Hsieh, Andrew C.; Xue, Shifeng; Barna, Maria] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Hsieh, Andrew C.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94158 USA; [Shimizu, Kunihiko] Nihon Univ, Dept Pediat Dent, Sch Dent Matsudo, Chiba 2718587, Japan; [Shimizu, Kunihiko; Ishijima, Junko; Shiroishi, Toshihiko] Natl Inst Genet, Mammalian Genet Lab, Mishima, Shizuoka 4118540, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Nihon University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Barna, M (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	maria.barna@ucsf.edu	Stumpf, Craig/B-8703-2014	Stumpf, Craig/0000-0002-9946-8986; Xue, Shifeng/0000-0002-4668-5952	NICHD; UCSF; March of Dimes Basil O'Connor Scholar Research Award; MEXT, Japan; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008509] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UCSF; March of Dimes Basil O'Connor Scholar Research Award(March of Dimes); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are very grateful to Dr. Davide Ruggero for helpful discussions and CMV-HCV-IRES transgenic mice. We thank Katrina Cabaltera for technical assistance; Dr. Gail Martin and members of her lab, Drs. Davide Ruggero, Tom Kornberg, and Ross Metzger for critical reading of the manuscript; Drs. Rudi Balling and Toshio Uchiumi for discussion and comments; Dr. Lee Niswander for helpful discussions on neural tube patterning; Drs. Jens Schuster and Cristina Al-Khalili Szigyarto for the RPL38 antibody; and Dr. Lucie Jeannotte for the Hoxa5 antibody. We are grateful to Dr. Jean-Louis Guenet for providing Rbt and Dr. Tsutomu Hirasawa for providing Tss; Dr. Catherine Kirn-Safran for Rpl29<SUP>+/-</SUP> mice; Dr. Greg Barsh for Rps19<SUP>DSK3/+</SUP> and Rps20<SUP>DSK4/+</SUP> mice. The monoclonal antibodies against Shh, Nkx2.2, Isl1, Pax6, and Pax7 were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA, USA. This work was supported by the Program for Breakthrough Biomedical Research, UCSF (M.B.), the March of Dimes Basil O'Connor Scholar Research Award (M.B.), and Special coordination funds for promoting Science and Technology from the MEXT, Japan (T.S.).	Agmon I, 2009, INT J MOL SCI, V10, P2921, DOI 10.3390/ijms10072921; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; BURKE AC, 1995, DEVELOPMENT, V121, P333; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carpenter EM, 1997, DEVELOPMENT, V124, P4505; Chow CS, 2007, ACS CHEM BIOL, V2, P610, DOI 10.1021/cb7001494; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; DEOL MS, 1961, PROC R SOC SER B-BIO, V155, P78, DOI 10.1098/rspb.1961.0058; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; HORAN GSB, 1994, P NATL ACAD SCI USA, V91, P12644, DOI 10.1073/pnas.91.26.12644; Hustert E, 1996, MAMM GENOME, V7, P881, DOI 10.1007/s003359900261; Iimura T, 2009, CURR TOP DEV BIOL, V88, P201, DOI 10.1016/S0070-2153(09)88007-1; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Juan AH, 2003, DEVELOPMENT, V130, P4823, DOI 10.1242/dev.00672; Kirn-Safran CB, 2007, DEV DYNAM, V236, P447, DOI 10.1002/dvdy.21046; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; LABORATORY CSH, 2002, RIBOSOME, V66; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; Lipton JM, 2010, CURR OPIN PEDIATR, V22, P12, DOI 10.1097/MOP.0b013e328334573b; Mauro VP, 2007, CELL CYCLE, V6, P2246, DOI 10.4161/cc.6.18.4739; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; MORGAN WC, 1950, J HERED, V41, P208, DOI 10.1093/oxfordjournals.jhered.a106131; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nishiyama T, 2007, NUCLEIC ACIDS RES, V35, P1514, DOI 10.1093/nar/gkl1121; OH SK, 1992, GENE DEV, V6, P1643, DOI 10.1101/gad.6.9.1643; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Oristian DS, 2009, J ORTHOP RES, V27, P28, DOI 10.1002/jor.20706; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; RAMAGOPAL S, 1992, BIOCHEM CELL BIOL, V70, P738, DOI 10.1139/o92-113; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Sagliocco F A, 1996, Methods Mol Biol, V53, P297; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SIMEONE A, 1991, MECH DEVELOP, V33, P215, DOI 10.1016/0925-4773(91)90029-6; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thompson B, 2007, TRANSLATIONAL CONTRO, V48, P507; Tsukahara K, 2000, EXP ANIM TOKYO, V49, P131, DOI 10.1538/expanim.49.131; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wellik DM, 2009, CURR TOP DEV BIOL, V88, P257, DOI 10.1016/S0070-2153(09)88009-5; Ye X, 1997, MOL CELL BIOL, V17, P1714, DOI 10.1128/MCB.17.3.1714; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; ZAPPAVIGNA V, 1991, EMBO J, V10, P4177, DOI 10.1002/j.1460-2075.1991.tb04996.x; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200	65	372	378	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					383	397		10.1016/j.cell.2011.03.028	http://dx.doi.org/10.1016/j.cell.2011.03.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529712	Bronze, Green Accepted			2022-12-24	WOS:000290022900008
J	Tronstein, E; Johnston, C; Huang, ML; Selke, S; Magaret, A; Warren, T; Corey, L; Wald, A				Tronstein, Elizabeth; Johnston, Christine; Huang, Meei-Li; Selke, Stacy; Magaret, Amalia; Warren, Terri; Corey, Lawrence; Wald, Anna			Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons With HSV-2 Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-2 INFECTION; UNITED-STATES; TRANSMISSION; REACTIVATION; DNA; ACYCLOVIR; WOMEN; PREVALENCE; PREVENTION; DIAGNOSIS	Context Since herpes simplex virus type 2 (HSV-2) antibody tests have become commercially available, an increasing number of persons have learned that they have genital herpes through serologic testing. The course of natural history of HSV-2 in asymptomatic, seropositive persons is uncertain. Objective To evaluate the virologic and clinical course of HSV genital shedding among individuals with symptomatic and asymptomatic HSV-2 infection. Design, Setting, and Participants Cohort of 498 immunocompetent HSV-2-seropositive persons enrolled in prospective studies of genital HSV shedding at the University of Washington Virology Research Clinic, Seattle, and Westover Heights Clinic, Portland, Oregon, between March 1992 and April 2008. Each participant obtained daily self-collected swabs of genital secretions for at least 30 days. Main Outcome Measure The rate of viral shedding measured by quantitative realtime fluorescence polymerase chain reaction for HSV DNA from genital swabs. Results Herpes simplex virus type 2 was detected on 4753 of 23 683 days (20.1%; 95% confidence interval [CI], 18.3%-22.0%) in 410 persons with symptomatic genital HSV-2 infection compared with 519 of 5070 days (10.2%; 95% CI, 7.7%-13.6%) in 88 persons with asymptomatic infection (P < .001). Subclinical shedding rates were higher in persons with symptomatic infection compared with asymptomatic infection (2708 of 20 735 days [13.1%; 95% CI, 11.5%-14.6%) vs 434 of 4929 days [8.8%; 95% CI, 6.3%-11.5%]) (P < .001). However, the amount of HSV detected during subclinical shedding episodes was similar (median, 4.3 [interquartile range, 3.1-5.6] log(10) copies in the symptomatic infection group vs 4.2 [interquartile range, 2.9-5.5] in the asymptomatic infection group, P=.27). Days with lesions accounted for 2045 of 4753 days (43.0%; 95% CI, 39.8%-46.5%) with genital viral shedding among persons with symptomatic genital HSV-2 infection compared with 85 of 519 days (16.4%; 95% CI, 11.2%-23.9%) among persons with asymptomatic infection (P < .001). Conclusion Persons with asymptomatic HSV-2 infection shed virus in the genital tract less frequently than persons with symptomatic infection, but much of the difference is attributable to less frequent genital lesions because lesions are accompanied by frequent viral shedding. JAMA. 2011;305(14):1441-1449 www.jama.com	[Wald, Anna] Univ Washington, Virol Res Clin, Dept Med, Seattle, WA 98104 USA; [Huang, Meei-Li; Selke, Stacy; Magaret, Amalia; Corey, Lawrence; Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Johnston, Christine; Huang, Meei-Li; Magaret, Amalia; Corey, Lawrence; Wald, Anna] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Magaret, Amalia] Fred Hutchinson Canc Res Ctr, Program Biostat, Seattle, WA 98104 USA; [Warren, Terri] Westover Hts Clin, Portland, OR USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Wald, A (corresponding author), Univ Washington, Virol Res Clin, Dept Med, Box 359928,325 9th Ave, Seattle, WA 98104 USA.	annawald@u.washington.edu	Warren, Terri/AAJ-1650-2021; Wald, Anna/B-6272-2012; Corey, Lawrence/AAE-1796-2020	Wald, Anna/0000-0003-3486-6438; Corey, Lawrence/0000-0002-2179-2436; Johnston, Christine/0000-0002-3073-0843	National Institutes of Health (NIH) [P01AI030731, K23AI079394, K24AI071113, R37AI042528, PO1A1030731]; GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731, K24AI071113, K23AI079394, R37AI042528] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Ms Tronstein, Ms Selke, and Dr Huang all reported receiving research support from National Institutes of Health (NIH) P01AI030731. Dr Johnston reported receiving research support from NIH K23AI079394 and having received funding from GlaxoSmithKline and AiCuris. Dr Magaret reported receiving funding from NIH (P01AI030731 and K24AI071113) and consulting for Immune Design. Ms Warren reported having received research support from AiCuris and having served on the GlaxoSmithKline speakers' bureau. Dr Corey reported receiving research support from NIH (P01AI030731, R37AI042528) and consulting for AiCuris; he reports being listed as a coinventor on several patents describing antigens and epitopes to which T-cell responses to HSV-2 are directed (these proteins have the potential to be used in candidate vaccines against HSV), and he has received fees for serving as the head of the scientific advisory board of Immune Design, including equity shares that are less than 1% ownership. Dr Wald reported receiving research support from NIH (K24AI071113, P01AI030731) and GlaxoSmithKline and consulting for AiCuris.; This work was supported by NIH grants PO1A1030731 and K24 AI 071113.	ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Bochud PY, 2007, J INFECT DIS, V196, P505, DOI 10.1086/519693; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; CONE RW, 1994, JAMA-J AM MED ASSOC, V272, P792, DOI 10.1001/jama.272.10.792; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; COREY L, 1983, ANN INTERN MED, V98, P973, DOI 10.7326/0003-4819-98-6-973; COWAN FM, 1994, BRIT MED J, V309, P1325, DOI 10.1136/bmj.309.6965.1325; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Guerry SL, 2005, CLIN INFECT DIS, V40, P38, DOI 10.1086/426438; Leone P, 2010, CURR MED RES OPIN, V26, P653, DOI 10.1185/03007990903554471; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Magaret AS, 2009, SEX TRANSM INFECT, V85, P270, DOI 10.1136/sti.2008.034751; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Melville J, 2003, SEX TRANSM INFECT, V79, P280, DOI 10.1136/sti.79.4.280; MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197; Mertz GJ, 2008, J INFECT DIS, V198, P1098, DOI 10.1086/591914; Mertz KJ, 1998, J INFECT DIS, V178, P1795, DOI 10.1086/314502; Phipps W, 2011, J INFECT DIS, V203, P180, DOI 10.1093/infdis/jiq035; Ryncarz AJ, 1999, J CLIN MICROBIOL, V37, P1941, DOI 10.1128/JCM.37.6.1941-1947.1999; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; Sucato G, 1998, J INFECT DIS, V177, P1069, DOI 10.1086/515261; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 2006, J INFECT DIS, V194, P42, DOI 10.1086/504717; Wald A, 1996, ANN INTERN MED, V124, P8, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00002; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	34	182	190	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1441	1449		10.1001/jama.2011.420	http://dx.doi.org/10.1001/jama.2011.420			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486977	Green Accepted, Bronze			2022-12-24	WOS:000289424100021
J	Arkin, AP; Schaffer, DV				Arkin, Adam P.; Schaffer, David V.			Network News: Innovations in 21st Century Systems Biology	CELL			English	Article							STOCHASTIC GENE-EXPRESSION; MOTIFS; GENOME; CELLS; STRATEGIES; DIVERSITY; PATHWAY; MODULE; MODEL; YEAST	A decade ago, seminal perspectives and papers set a strong vision for the field of systems biology, and a number of these themes have flourished. Here, we describe key technologies and insights that have elucidated the evolution, architecture, and function of cellular networks, ultimately leading to the first predictive genome-scale regulatory and metabolic models of organisms. Can systems approaches bridge the gap between correlative analysis and mechanistic insights?	[Arkin, Adam P.; Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Arkin, Adam P.; Schaffer, David V.] EO Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Arkin, AP (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aparkin@lbl.gov	Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008	Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931	National Institutes of Health [R01 GM073010-01]; Office of Science, Office of Biological and Environmental Research of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Biological and Environmental Research of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank our colleagues for suggesting a number of the papers that we reference in this work, and we apologize for not being able to include all of them. The authors would like to acknowledge the National Institutes of Health (R01 GM073010-01), and work conducted by ENIGMA was supported by the Office of Science, Office of Biological and Environmental Research of the US Department of Energy under contract number DE-AC02-05CH11231.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Arkin A, 1997, SCIENCE, V277, P1275, DOI 10.1126/science.277.5330.1275; Arkin A, 1998, GENETICS, V149, P1633; BEKEY GA, 1978, AUTOMATICA, V14, P41, DOI 10.1016/0005-1098(78)90075-4; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; CANON W, 1939, WISDOM BODY; Carlson Robert, 2003, Biosecur Bioterror, V1, P203, DOI 10.1089/153871303769201851; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Cheng Y., 2000, P 8 INT C INT SYST M, P93; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; El Samad H, 2005, P 16 IFAC WORLD C; El-Samad H, 2005, P NATL ACAD SCI USA, V102, P2736, DOI 10.1073/pnas.0403510102; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Hartemink A J, 2001, Pac Symp Biocomput, P422; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moore G., 1965, ELECTRONICS, V38, P114, DOI [DOI 10.1109/N-SSC.2006.4785860, DOI 10.1109/JPROC.1998.658762]; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rao CV, 2001, ANNU REV BIOMED ENG, V3, P391, DOI 10.1146/annurev.bioeng.3.1.391; Rosenblueth A., 1943, PHILOS SCI, V10, P18, DOI 10.1086/286788; Rzhetsky A, 2001, BIOINFORMATICS, V17, P988, DOI 10.1093/bioinformatics/17.10.988; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Singh AH, 2008, P NATL ACAD SCI USA, V105, P7500, DOI 10.1073/pnas.0709764105; Voigt CA, 2005, GENETICS, V169, P1187, DOI 10.1534/genetics.104.031955; WADDINGTON CH, 1954, P 9 INT C GEN, V9, P232; Waddington CH, 1977, TOOLS THOUGHT UNDERS; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhou JZ, 2010, MBIO, V1, DOI 10.1128/mBio.00169-10	54	35	38	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					844	849		10.1016/j.cell.2011.03.008	http://dx.doi.org/10.1016/j.cell.2011.03.008			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414475	Bronze			2022-12-24	WOS:000288543500002
J	Hoskins, AA; Friedman, LJ; Gallagher, SS; Crawford, DJ; Anderson, EG; Wombacher, R; Ramirez, N; Cornish, VW; Gelles, J; Moore, MJ				Hoskins, Aaron A.; Friedman, Larry J.; Gallagher, Sarah S.; Crawford, Daniel J.; Anderson, Eric G.; Wombacher, Richard; Ramirez, Nicholas; Cornish, Virginia W.; Gelles, Jeff; Moore, Melissa J.			Ordered and Dynamic Assembly of Single Spliceosomes	SCIENCE			English	Article							PRE-MESSENGER-RNA; MOLECULE FLUORESCENCE; YEAST SPLICEOSOME; CATALYTIC STEPS; EXON DEFINITION; IN-VIVO; COMPLEX; SNRNP; U1; MACHINE	The spliceosome is the complex macromolecular machine responsible for removing introns from precursors to messenger RNAs (pre-mRNAs). We combined yeast genetic engineering, chemical biology, and multiwavelength fluorescence microscopy to follow assembly of single spliceosomes in real time in whole-cell extracts. We find that individual spliceosomal subcomplexes associate with pre-mRNA sequentially via an ordered pathway to yield functional spliceosomes and that association of every subcomplex is reversible. Further, early subcomplex binding events do not fully commit a pre-mRNA to splicing; rather, commitment increases as assembly proceeds. These findings have important implications for the regulation of alternative splicing. This experimental strategy should prove widely useful for mechanistic analysis of other macromolecular machines in environments approaching the complexity of living cells.	[Hoskins, Aaron A.; Friedman, Larry J.; Crawford, Daniel J.; Gelles, Jeff] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Gallagher, Sarah S.; Wombacher, Richard; Cornish, Virginia W.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Hoskins, Aaron A.; Crawford, Daniel J.; Anderson, Eric G.; Ramirez, Nicholas; Moore, Melissa J.] Univ Massachusetts, Howard Hughes Med Inst, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01605 USA	Brandeis University; Columbia University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Gelles, J (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	gelles@brandeis.edu; melissa.moore@umassmed.edu	Wombacher, Richard/M-7117-2016; Wombacher, Richard/AAP-7591-2021	Wombacher, Richard/0000-0002-3027-7778; Wombacher, Richard/0000-0002-3027-7778; Friedman, Larry/0000-0003-4946-8731	NIH [RO1s GM043369, GM81648, GM053007, GM54469, RC1 GM091804, GM759628]; National Research Service Award fellowship [GM079971, K99/R00 GM086471]; National Defense Science and Engineering Graduate fellowship; Deutscher Akademischer Austausch Dienst fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081648, T32GM007596, R01GM054469, R01GM053007, F32GM079971, RC1GM091804, K99GM086471, R01GM043369, R37GM043369] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate fellowship; Deutscher Akademischer Austausch Dienst fellowship(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Chung, A. Okonechnikov, J. Yan, J. Haber, S. Lovett, I. Correa, M.-Q. Xu, Z. Chen, and B. Smith for helpful discussions and assistance. This work was supported by NIH RO1s GM043369 (J. G.), GM81648 (J. G.), GM053007 (M. J. M), GM54469 (V. W. C.), RC1 GM091804 (V. W. C), National Research Service Award fellowship GM079971 (A. A. H.), and K99/R00 GM086471 (A. A. H.). D. J. C., S. S. G., and R. W were supported by NIH training grant GM759628, a National Defense Science and Engineering Graduate fellowship, and a Deutscher Akademischer Austausch Dienst fellowship, respectively. M. J. M. is a Howard Hughes Medical Institute investigator. V. W. C. holds patents on the TMP-tag technology, and the technology is licensed and commercialized by Active Motif.	Abelson J, 2010, NAT STRUCT MOL BIOL, V17, P504, DOI 10.1038/nsmb.1767; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Crawford DJ, 2008, RNA, V14, P170, DOI 10.1261/rna.794808; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; DUNN SMJ, 1980, BIOCHEMISTRY-US, V19, P766, DOI 10.1021/bi00545a024; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Friedman LJ, 2006, BIOPHYS J, V91, P1023, DOI 10.1529/biophysj.106.084004; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; LEGRAIN P, 1988, MOL CELL BIOL, V8, P3755, DOI 10.1128/MCB.8.9.3755; Liu L, 2007, NAT STRUCT MOL BIOL, V14, P519, DOI 10.1038/nsmb1240; Miller LW, 2005, NAT METHODS, V2, P255, DOI 10.1038/NMETH749; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Ruby SW, 1997, J BIOL CHEM, V272, P17333, DOI 10.1074/jbc.272.28.17333; Schneider M, 2010, MOL CELL, V38, P223, DOI 10.1016/j.molcel.2010.02.027; SERAPHIN B, 1991, EMBO J, V10, P1209, DOI 10.1002/j.1460-2075.1991.tb08062.x; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Tseng CK, 2008, SCIENCE, V320, P1782, DOI 10.1126/science.1158993; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Xu YZ, 2004, EMBO J, V23, P376, DOI 10.1038/sj.emboj.7600050	23	200	204	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1289	1295		10.1126/science.1198830	http://dx.doi.org/10.1126/science.1198830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393538	Green Accepted			2022-12-24	WOS:000288215200037
J	Wartlick, O; Mumcu, P; Kicheva, A; Bittig, T; Seum, C; Julicher, F; Gonzalez-Gaitan, M				Wartlick, O.; Mumcu, P.; Kicheva, A.; Bittig, T.; Seum, C.; Juelicher, F.; Gonzalez-Gaitan, M.			Dynamics of Dpp Signaling and Proliferation Control	SCIENCE			English	Article							WING IMAGINAL DISC; CELL-PROLIFERATION; MORPHOGEN GRADIENT; DROSOPHILA; SIZE; GROWTH; HEDGEHOG; ROBUSTNESS; EXPRESSION; DIFFUSION	Morphogens, such as Decapentaplegic (Dpp) in the fly imaginal discs, form graded concentration profiles that control patterning and growth of developing organs. In the imaginal discs, proliferative growth is homogeneous in space, posing the conundrum of how morphogen concentration gradients could control position-independent growth. To understand the mechanism of proliferation control by the Dpp gradient, we quantified Dpp concentration and signaling levels during wing disc growth. Both Dpp concentration and signaling gradients scale with tissue size during development. On average, cells divide when Dpp signaling levels have increased by 50%. Our observations are consistent with a growth control mechanism based on temporal changes of cellular morphogen signaling levels. For a scaling gradient, this mechanism generates position-independent growth rates.	[Mumcu, P.; Bittig, T.; Juelicher, F.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Wartlick, O.; Kicheva, A.; Seum, C.; Gonzalez-Gaitan, M.] Univ Geneva, Fac Sci, Dept Biochem, CH-1211 Geneva, Switzerland; [Wartlick, O.; Kicheva, A.; Seum, C.; Gonzalez-Gaitan, M.] Univ Geneva, Fac Sci, Dept Mol Biol, CH-1211 Geneva, Switzerland	Max Planck Society; University of Geneva; University of Geneva	Julicher, F (corresponding author), Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany.	julicher@pks.mpg.de; marcos.gonzalez@unige.ch	Julicher, Frank/B-1828-2009	Julicher, Frank/0000-0003-4731-9185; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; Kicheva, Anna/0000-0003-4509-4998	Max-Planck-Gesellschaft; Geneva University; European Research Council; SystemsX (LipidX); Swiss National Science Foundation (SNF); National Centre of Competence in Research (NCCR)	Max-Planck-Gesellschaft(Max Planck Society); Geneva University; European Research Council(European Research Council (ERC)European Commission); SystemsX (LipidX); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); National Centre of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	We thank E. Sanchez-Herrero, S. Cohen, G. Campbell, and K. Irvine for reagents, and M. Milinkovitch, A. Martinez-Arias, T. Ferraro, and F. Naef for discussions. A.K. developed and performed the FRAP and P-Mad assays. O.W. generated all other experimental data and had a leading role to develop the quantitative methods to analyze it. P.M. had a leading role to develop the theoretical description of growth control, and he performed computer simulations. P.M. and T.B. developed a continuum theory of the Dpp gradient during growth and studied possible growth rules. C.S. generated reagents. O.W., P.M., A.K., T.B., F.J., and M.G.-G. developed the whole project synergistically and equally and wrote the paper together. P.M., T.B., and F.J. were supported by the Max-Planck-Gesellschaft. O.W., A.K., C.S., and M.G.-G. were supported by Geneva University and by European Research Council advanced investigator grant (SARA), SystemsX (LipidX), Swiss National Science Foundation (SNF), National Centre of Competence in Research (NCCR) chemical biology and Frontiers in Genetics and R'equip grants.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barkai N, 2009, FEBS J, V276, P1196, DOI 10.1111/j.1742-4658.2008.06854.x; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Burke R, 1996, DEVELOPMENT, V122, P2261; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; Day SJ, 2000, DEVELOPMENT, V127, P2977; de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; FAIN MJ, 1982, DEV BIOL, V92, P247, DOI 10.1016/0012-1606(82)90169-5; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Friedrich BM, 2007, P NATL ACAD SCI USA, V104, P13256, DOI 10.1073/pnas.0703530104; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GONZALEZGAITAN M, 1994, MECH DEVELOP, V46, P183, DOI 10.1016/0925-4773(94)90070-1; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; OTHMER HG, 1980, P NATL ACAD SCI-BIOL, V77, P4180, DOI 10.1073/pnas.77.7.4180; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Schwank G, 2008, DEVELOPMENT, V135, P4003, DOI 10.1242/dev.025635; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; Strigini M, 1997, DEVELOPMENT, V124, P4697; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; Weiss A, 2010, NAT STRUCT MOL BIOL, V17, P69, DOI 10.1038/nsmb.1715; Yao LC, 2008, DEVELOPMENT, V135, P2183, DOI 10.1242/dev.015826; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004307	39	233	236	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1154	1159		10.1126/science.1200037	http://dx.doi.org/10.1126/science.1200037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385708				2022-12-24	WOS:000287971200032
J	Porrello, ER; Mahmoud, AI; Simpson, E; Hill, JA; Richardson, JA; Olson, EN; Sadek, HA				Porrello, Enzo R.; Mahmoud, Ahmed I.; Simpson, Emma; Hill, Joseph A.; Richardson, James A.; Olson, Eric N.; Sadek, Hesham A.			Transient Regenerative Potential of the Neonatal Mouse Heart	SCIENCE			English	Article							CELL-CYCLE CONTROL; MAMMALIAN CARDIOMYOCYTES; ZEBRAFISH; INJURY; PROLIFERATION; GROWTH	Certain fish and amphibians retain a robust capacity for cardiac regeneration throughout life, but the same is not true of the adult mammalian heart. Whether the capacity for cardiac regeneration is absent in mammals or whether it exists and is switched off early after birth has been unclear. We found that the hearts of 1-day-old neonatal mice can regenerate after partial surgical resection, but this capacity is lost by 7 days of age. This regenerative response in 1-day-old mice was characterized by cardiomyocyte proliferation with minimal hypertrophy or fibrosis, thereby distinguishing it from repair processes. Genetic fate mapping indicated that the majority of cardiomyocytes within the regenerated tissue originated from preexisting cardiomyocytes. Echocardiography performed 2 months after surgery revealed that the regenerated ventricular apex had normal systolic function. Thus, for a brief period after birth, the mammalian heart appears to have the capacity to regenerate.	[Porrello, Enzo R.; Hill, Joseph A.; Richardson, James A.; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Mahmoud, Ahmed I.; Hill, Joseph A.; Sadek, Hesham A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Simpson, Emma; Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu; hesham.sadek@utsouthwestern.edu	Porrello, Enzo/G-9934-2012	Porrello, Enzo/0000-0001-6105-7463; Mahmoud, Ahmed/0000-0003-1528-7393	National Health and Medical Research Council; National Heart Foundation of Australia; American Heart Association; NIH [HL100401-01]; Donald W. Reynolds Center for Clinical Cardiovascular Research; Jon Holden DeHaan Foundation; Leducq Foundation; Robert A. Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115275, R01HL093039, R01HL077439, U01HL100401, R37HL053351] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; Jon Holden DeHaan Foundation; Leducq Foundation(Leducq Foundation); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Simsek, J. Shelton, and the UT Southwestern Histology Core for help with histology and immunostaining, and J. Cabrera for graphical assistance. Supported by an overseas postdoctoral fellowship from the National Health and Medical Research Council and National Heart Foundation of Australia (E.R.P.), a cardiovascular research scholar award from Gilead Sciences and a fellow-to-faculty award from the American Heart Association (H.A.S.), and NIH grant HL100401-01, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the American Heart Association, the Jon Holden DeHaan Foundation, the Leducq Foundation, and the Robert A. Welch Foundation (E.N.O.).	Ahuja P, 2004, J CELL SCI, V117, P3295, DOI 10.1242/jcs.01159; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Drenckhahn JD, 2008, DEV CELL, V15, P521, DOI 10.1016/j.devcel.2008.09.005; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005	15	1557	1628	10	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1078	1080		10.1126/science.1200708	http://dx.doi.org/10.1126/science.1200708			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350179	Green Accepted			2022-12-24	WOS:000287699000067
J	Merrikh, H; Machon, C; Grainger, WH; Grossman, AD; Soultanas, P				Merrikh, Houra; Machon, Cristina; Grainger, William H.; Grossman, Alan D.; Soultanas, Panos			Co-directional replication-transcription conflicts lead to replication restart	NATURE			English	Article							BACILLUS-SUBTILIS; DNA-REPLICATION; PROTEINS; PRIA; LOCALIZATION; INITIATION; REPLISOME; REP; RNA; RECOMBINATION	Head-on encounters between the replication and transcription machineries on the lagging DNA strand can lead to replication fork arrest and genomic instability(1,2). To avoid head-on encounters, most genes, especially essential and highly transcribed genes, are encoded on the leading strand such that transcription and replication are co-directional. Virtually all bacteria have the highly expressed ribosomal RNA genes co-directional with replication(3). In bacteria, co-directional encounters seem inevitable because the rate of replication is about 10-20-fold greater than the rate of transcription. However, these encounters are generally thought to be benign(2,4-9). Biochemical analyses indicate that head-on encounters(10) are more deleterious than co-directional encounters(8) and that in both situations, replication resumes without the need for any auxiliary restart proteins, at least in vitro. Here we show that in vivo, co-directional transcription can disrupt replication, leading to the involvement of replication restart proteins. We found that highly transcribed rRNA genes are hotspots for co-directional conflicts between replication and transcription in rapidly growing Bacillus subtilis cells. We observed a transcription-dependent increase in association of the replicative helicase and replication restart proteins where head-on and co-directional conflicts occur. Our results indicate that there are co-directional conflicts between replication and transcription in vivo. Furthermore, in contrast to the findings in vitro, the replication restart machinery is involved in vivo in resolving potentially deleterious encounters due to head-on and co-directional conflicts. These conflicts probably occur in many organisms and at many chromosomal locations and help to explain the presence of important auxiliary proteins involved in replication restart and in helping to clear a path along the DNA for the replisome.	[Merrikh, Houra; Grossman, Alan D.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Machon, Cristina; Grainger, William H.; Soultanas, Panos] Univ Nottingham, Sch Chem, Ctr Biomol Sci, Nottingham NG7 2RD, England	Massachusetts Institute of Technology (MIT); University of Nottingham	Grossman, AD (corresponding author), MIT, Dept Biol, Bldg 68-530, Cambridge, MA 02139 USA.	adg@mit.edu; Panos.Soultanas@nottingham.ac.uk	Sobrado, Cristina Machón/K-1634-2014	Sobrado, Cristina Machón/0000-0001-5363-2958; Soultanas, Panos/0000-0003-3578-5699	Biotechnology and Biological Sciences Research Council [BB/E006450/1]; Wellcome Trust [091968/Z/10/Z]; NIH [GM41934, GM093408]; Royal Society; BBSRC [BB/E006450/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041934, R01GM041934, F32GM093408] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Grainger, C. Lee, T. Baker, and W. K. Smits for discussions, W. K. Smits for constructing the priA-ssrA* mutant, and C. Lee, C. Bonilla, S. P. Bell, and J. D. Wang for comments on the manuscript. Work in the P. S. laboratory was supported by Biotechnology and Biological Sciences Research Council grant BB/E006450/1 and a Wellcome Trust grant 091968/Z/10/Z. Work in the A. D. G. laboratory was supported by NIH grant GM41934 and H. M. was supported in part by NIH postdoctoral fellowship GM093408. The Biotechnology and Biological Sciences Research Council and the Royal Society provided funds for a sabbatical visit of P. S. in the A. D. G. laboratory.	Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Bruand C, 2005, MOL MICROBIOL, V55, P1138, DOI 10.1111/j.1365-2958.2004.04451.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Grainger WH, 2010, NUCLEIC ACIDS RES, V38, P2851, DOI 10.1093/nar/gkp1236; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Harwood C.R., 1990, MOL BIOL METHODS BAC; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Imai Y, 2000, MOL MICROBIOL, V36, P1037, DOI 10.1046/j.1365-2958.2000.01928.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Mahdi AA, 2006, GENE DEV, V20, P2135, DOI 10.1101/gad.382306; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; Meile JC, 2006, PROTEOMICS, V6, P2135, DOI 10.1002/pmic.200500512; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mirkin EV, 2006, P NATL ACAD SCI USA, V103, P7276, DOI 10.1073/pnas.0601127103; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; Olavarrieta L, 2002, J MOL BIOL, V322, P1, DOI 10.1016/S0022-2836(02)00740-4; Polard P, 2002, NUCLEIC ACIDS RES, V30, P1593, DOI 10.1093/nar/30.7.1593; Pomerantz RT, 2010, CELL CYCLE, V9, P2537, DOI 10.4161/cc.9.13.12122; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rokop ME, 2004, MOL MICROBIOL, V52, P1757, DOI 10.1111/j.1365-2958.2004.04091.x; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Smits WK, 2010, MOL MICROBIOL, V75, P452, DOI 10.1111/j.1365-2958.2009.06999.x; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Wang JD, 2007, P NATL ACAD SCI USA, V104, P5608, DOI 10.1073/pnas.0608999104	34	123	124	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					554	U147		10.1038/nature09758	http://dx.doi.org/10.1038/nature09758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350489	Green Accepted, Green Submitted			2022-12-24	WOS:000287652900046
J	Montpetit, B; Thomsen, ND; Helmke, KJ; Seeliger, MA; Berger, JM; Weis, K				Montpetit, Ben; Thomsen, Nathan D.; Helmke, Kara J.; Seeliger, Markus A.; Berger, James M.; Weis, Karsten			A conserved mechanism of DEAD-box ATPase activation by nucleoporins and InsP(6) in mRNA export	NATURE			English	Article							PROTEIN DBP5; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HELICASE; COMPLEX; DOMAIN; EIF4A; CRYSTALLOGRAPHY; REVEALS; NUP214	Superfamily 1 and superfamily 2 RNA helicases are ubiquitous messenger-RNA-protein complex (mRNP) remodelling enzymes that have critical roles in all aspects of RNA metabolism(1,2). The superfamily 2 DEAD-box ATPase Dbp5 (human DDX19) functions in mRNA export and is thought to remodel mRNPs at the nuclear pore complex (NPC)(3-8). Dbp5 is localized to the NPC via an interaction with Nup159 (NUP214 in vertebrates)(3-5,8,9) and is locally activated there by Gle1 together with the small-molecule inositol hexakisphosphate (InsP(6))(10,11). Local activation of Dbp5 at the NPC by Gle1 is essential for mRNA export in vivo(10,12); however, the mechanistic role of Dbp5 in mRNP export is poorly understood and it is not known how Gle1(InsP6) and Nup159 regulate the activity of Dbp5. Here we report, from yeast, structures of Dbp5 in complex with Gle1(InsP6), Nup159/Gle1(InsP6) and RNA. These structures reveal that InsP6 functions as a small-molecule tether for the Gle1-Dbp5 interaction. Surprisingly, the Gle1(InsP6)-Dbp5 complex is structurally similar to another DEAD-box ATPase complex essential for translation initiation, eIF4G-eIF4A, and we demonstrate that Gle1(InsP6) and eIF4G both activate their DEAD-box partner by stimulating RNA release. Furthermore, Gle1(InsP6) relieves Dbp5 autoregulation and cooperates with Nup159 in stabilizing an open Dbp5 intermediate that precludes RNA binding. These findings explain how Gle1(InsP6), Nup159 and Dbp5 collaborate in mRNA export and provide a general mechanism for DEAD-box ATPase regulation by Gle1/eIF4G-like activators.	[Montpetit, Ben; Helmke, Kara J.; Weis, Karsten] Univ Calif Berkeley, Div Cell & Dev Biol, Berkeley, CA 94720 USA; [Montpetit, Ben; Thomsen, Nathan D.; Helmke, Kara J.; Seeliger, Markus A.; Berger, James M.; Weis, Karsten] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Montpetit, Ben; Thomsen, Nathan D.; Helmke, Kara J.; Seeliger, Markus A.; Berger, James M.; Weis, Karsten] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA; [Thomsen, Nathan D.; Seeliger, Markus A.; Berger, James M.] Univ Calif Berkeley, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Weis, K (corresponding author), Univ Calif Berkeley, Div Cell & Dev Biol, Berkeley, CA 94720 USA.	jmberger@berkeley.edu; kweis@berkeley.edu	Weis, Karsten/F-5719-2011; Seeliger, Markus A/D-6409-2013; Montpetit, Ben/L-6456-2019	Weis, Karsten/0000-0001-7224-925X; Montpetit, Ben/0000-0002-8317-983X; Seeliger, Markus/0000-0003-0990-1756	G Harold and Leila Y Mathers foundation; NIH [R01GM58065, RC1GM91533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232, R01GM058065, RC1GM091533, R00GM080097] Funding Source: NIH RePORTER	G Harold and Leila Y Mathers foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kirsch, J. Thorner, M. Welch, D. Wemmer, B. Krantz, J. Zorn and all J.M.B. and K.W. laboratory members for discussions and advice. We also thank J. Kuriyan, M. Welch and S. Marqusee for access to equipment and workspace; J. Tanamachi, G. Meigs and J. Holton at ALS beamline 8.3.1; and N. Echols for assistance with programs from the Yale Morph Server. Research was supported by the G Harold and Leila Y Mathers foundation (J.M.B.) and the NIH (K.W., R01GM58065 and RC1GM91533).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dossani ZY, 2009, P NATL ACAD SCI USA, V106, P16251, DOI 10.1073/pnas.0902251106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan JS, 2009, J MOL BIOL, V388, P1, DOI 10.1016/j.jmb.2009.03.004; Flores S, 2006, NUCLEIC ACIDS RES, V34, pD296, DOI 10.1093/nar/gkj046; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Kadlec J, 2006, RNA, V12, P1817, DOI 10.1261/rna.177606; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032	40	178	184	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					238	242		10.1038/nature09862	http://dx.doi.org/10.1038/nature09862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21441902	Green Accepted			2022-12-24	WOS:000289469100047
J	Sutton, MA; Oenema, O; Erisman, JW; Leip, A; van Grinsven, H; Winiwarter, W				Sutton, Mark A.; Oenema, Oene; Erisman, Jan Willem; Leip, Adrian; van Grinsven, Hans; Winiwarter, Wilfried			Too much of a good thing	NATURE			English	Editorial Material									[Sutton, Mark A.] Ctr Ecol & Hydrol, Edinburgh EH26 0QB, Midlothian, Scotland; [Oenema, Oene] Alterra, NL-6700 AA Wageningen, Netherlands; [Sutton, Mark A.; Oenema, Oene; Erisman, Jan Willem] Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Leip, Adrian] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21027 Ispra, Italy; [van Grinsven, Hans] PBL Netherlands Environm Assessment Agcy, NL-3720 AH Bilthoven, Netherlands; [Winiwarter, Wilfried] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	UK Centre for Ecology & Hydrology (UKCEH); Wageningen University & Research; Vrije Universiteit Amsterdam; European Commission Joint Research Centre; EC JRC ISPRA Site; International Institute for Applied Systems Analysis (IIASA)	Sutton, MA (corresponding author), Ctr Ecol & Hydrol, Edinburgh EH26 0QB, Midlothian, Scotland.	ms@ceh.ac.uk	Winiwarter, Wilfried/F-5073-2017	Winiwarter, Wilfried/0000-0001-7131-1496; Erisman, Jan Willem/0000-0001-5058-7012; Leip, Adrian/0000-0001-7616-5029	Natural Environment Research Council [ceh010023] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Amann M., 2011, 12011 CIAM IIASA; [Anonymous], 2010, DELHI DECLARATION; [Anonymous], 2009, BARSAC DECLARATION E; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Magid J, 2006, ECOL ENG, V28, P44, DOI 10.1016/j.ecoleng.2006.03.009; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Sutton M.A, 2011, EUROPEAN NITROGEN AS, DOI DOI 10.1017/CBO9780511976988	7	588	614	13	415	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					159	161		10.1038/472159a	http://dx.doi.org/10.1038/472159a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21478874	Green Accepted			2022-12-24	WOS:000289469100016
J	Wochner, A; Attwater, J; Coulson, A; Holliger, P				Wochner, Aniela; Attwater, James; Coulson, Alan; Holliger, Philipp			Ribozyme-Catalyzed Transcription of an Active Ribozyme	SCIENCE			English	Article							RNA-POLYMERASE RIBOZYME; MOLECULAR EVOLUTION; POLYMERIZATION; EXTENSION; SELECTION; SEQUENCES; LIGANDS	A critical event in the origin of life is thought to have been the emergence of an RNA molecule capable of replicating a primordial RNA "genome." Here we describe the evolution and engineering of an RNA polymerase ribozyme capable of synthesizing RNAs of up to 95 nucleotides in length. To overcome its sequence dependence, we recombined traits evolved separately in different ribozyme lineages. This yielded a more general polymerase ribozyme that was able to synthesize a wider spectrum of RNA sequences, as we demonstrate by the accurate synthesis of an enzymatically active RNA, a hammerhead endonuclease ribozyme. This recapitulates a central aspect of an RNA-based genetic system: the RNA-catalyzed synthesis of an active ribozyme from an RNA template.	[Wochner, Aniela; Attwater, James; Coulson, Alan; Holliger, Philipp] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Holliger, P (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ph1@mrc-lmb.cam.ac.uk	daehun, lee/H-2435-2013	Attwater, James/0000-0002-7244-9910	Medical Research Council (MRC) [MC_US_A024_0014]; MRC [MC_U105178804] Funding Source: UKRI; Medical Research Council [MC_U105178804] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to M. Daly for assistance with FACS and to our colleagues V. B. Pinheiro, C. Cozens, A. Taylor, and J. Sutherland for helpful discussions. This work was supported by the Medical Research Council (MRC) program grant MC_US_A024_0014.	Attwater J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1076; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; GESTELAND R, 2005, RNA WORLD NATURE MOD; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Joyce GF, 2007, SCIENCE, V315, P1507, DOI 10.1126/science.1140736; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; Lawrence MS, 2003, BIOCHEMISTRY-US, V42, P8748, DOI 10.1021/bi034228l; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; McCall MJ, 2000, MOL BIOTECHNOL, V14, P5, DOI 10.1385/MB:14:1:5; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Shechner DM, 2009, SCIENCE, V326, P1271, DOI 10.1126/science.1174676; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Wang QS, 2011, RNA, V17, P469, DOI 10.1261/rna.2495011; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	26	236	248	5	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					209	212		10.1126/science.1200752	http://dx.doi.org/10.1126/science.1200752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474753				2022-12-24	WOS:000289251100043
J	Premsrirut, PK; Dow, LE; Kim, SY; Camiolo, M; Malone, CD; Miething, C; Scuoppo, C; Zuber, J; Dickins, RA; Kogan, SC; Shroyer, KR; Sordella, R; Hannon, GJ; Lowe, SW				Premsrirut, Prem K.; Dow, Lukas E.; Kim, Sang Yong; Camiolo, Matthew; Malone, Colin D.; Miething, Cornelius; Scuoppo, Claudio; Zuber, Johannes; Dickins, Ross A.; Kogan, Scott C.; Shroyer, Kenneth R.; Sordella, Raffaella; Hannon, Gregory J.; Lowe, Scott W.			A Rapid and Scalable System for Studying Gene Function in Mice Using Conditional RNA Interference	CELL			English	Article							TRANSGENIC MICE; STEM-CELLS; MOUSE; EXPRESSION; DIFFERENTIATION; APC; DISRUPTION; ACTIVATION; RAS	RNA interference is a powerful tool for studying gene function, however, the reproducible generation of RNAi transgenic mice remains a significant limitation. By combining optimized fluorescence-coupled miR30-based shRNAs with high efficiency ES cell targeting, we developed a fast, scalable pipeline for the production of shRNA transgenic mice. Using this system, we generated eight tet-regulated shRNA transgenic lines targeting Firefly and Renilla luciferases, Oct4 and tumor suppressors p53, p16(INK4a), p19(ARF) and APC and demonstrate potent gene silencing and GFP-tracked knockdown in a broad range of tissues in vivo. Further, using an shRNA targeting APC, we illustrate how this approach can identify predicted phenotypes and also unknown functions for a well-studied gene. In addition, through regulated gene silencing we validate APC/Wnt and p19(ARF) as potential therapeutic targets in T cell acute lymphoblastic leukemia/lymphoma and lung adenocarcinoma, respectively. This system provides a cost-effective and scalable platform for the production of RNAi transgenic mice targeting any mammalian gene.	[Premsrirut, Prem K.; Dow, Lukas E.; Kim, Sang Yong; Camiolo, Matthew; Malone, Colin D.; Miething, Cornelius; Scuoppo, Claudio; Zuber, Johannes; Dickins, Ross A.; Sordella, Raffaella; Hannon, Gregory J.; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Malone, Colin D.; Scuoppo, Claudio] Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Hannon, Gregory J.; Lowe, Scott W.] Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Premsrirut, Prem K.; Camiolo, Matthew] SUNY Stony Brook, Med Ctr, Med Scientist Training Program, Stony Brook, NY 11794 USA; [Shroyer, Kenneth R.] SUNY Stony Brook, Med Ctr, Dept Pathol, Stony Brook, NY 11794 USA; [Dickins, Ross A.] Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3052, Australia; [Kogan, Scott C.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Kogan, Scott C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Walter & Eliza Hall Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Zuber, Johannes/E-7517-2011; Hannon, Gregory/AAB-3568-2019; Miething, Cornelius/F-9498-2014; Dickins, Ross A/K-2852-2012	Zuber, Johannes/0000-0001-8810-6835; Miething, Cornelius/0000-0003-4699-3805; Dickins, Ross A/0000-0003-4112-5304; Dow, Lukas/0000-0001-7048-1418; Kogan, Scott/0000-0002-2395-8479; Kim, Sang Yong/0000-0001-7326-7505	National Cancer Institute; National Health & Medical Research Council of Australia; Deutsche Forschungsgemeinschaft; AACR-Astellas USA Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444, R01GM062534] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); AACR-Astellas USA Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Beard and R. Jaenisch (Whitehead Institute) for pBS31 flp-in and pCAGs-FLPe-Puro vectors, ColA1 3' probe and KH2 ES cells; X. Guo, Y. Park, and P.W.J. Russell for discussions and assistance in procedures; and E. McGlinn and C. Tabin (Harvard Medical School) for advice with the skeletal preparations of embryos. Thanks to L. Bianco, J. Coblentz, E. Earl, and the Cold Spring Harbor Laboratory animal house staff. We gratefully acknowledge Janelle Simon, Danielle Grace, and Jacqueline Cappellani for technical assistance, and members of the Lowe laboratory for advice and discussions. This study was supported by a Mouse Models of Human Cancer Consortium grant, a program project grant from the National Cancer Institute, and philanthropic support from the Don Monti Research Foundation. P. K. P is MSTP Fellow of Stony Brook University, L. E. D. is supported by a National Health & Medical Research Council of Australia overseas Biomedical Training Fellowship, C. M. was supported by a fellowship from the Deutsche Forschungsgemeinschaft and a AACR-Astellas USA Foundation Fellowship in Basic Cancer Research, J.Z. is the Andrew Seligson Memorial Fellow, R. A. D is a VESKI Fellow, and G. J. H and S. W. L. are Howard Hughes Medical Institute investigators. P. K. P, G. J. H, and S. W. L. are founders on the scientific advisory board of Mirimus, Inc., a company that has licensed technology related to this work.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kado M, 2008, BIOCHEM BIOPH RES CO, V377, P413, DOI 10.1016/j.bbrc.2008.09.160; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Miclea RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-26; MOSER AR, 1995, DEV DYNAM, V203, P422, DOI 10.1002/aja.1002030405; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Yang Y, 2005, LEUKEMIA RES, V29, P47, DOI 10.1016/j.leukres.2004.05.004; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	43	222	231	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					145	158		10.1016/j.cell.2011.03.012	http://dx.doi.org/10.1016/j.cell.2011.03.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458673	Green Accepted, Bronze			2022-12-24	WOS:000289053900016
J	Seo, JY; Yaneva, R; Hinson, ER; Cresswell, P				Seo, Jun-Young; Yaneva, Rakina; Hinson, Ella R.; Cresswell, Peter			Human Cytomegalovirus Directly Induces the Antiviral Protein Viperin to Enhance Infectivity	SCIENCE			English	Article							AMPHIPATHIC ALPHA-HELIX; ENDOPLASMIC-RETICULUM; ATP DEPLETION; ACTIN CYTOSKELETON; GENE-EXPRESSION; BETA-OXIDATION; MITOCHONDRIA; VIRUS; CELLS; REPLICATION	Viperin is an interferon-inducible protein that is directly induced in cells by human cytomegalovirus (HCMV) infection. Why HCMV would induce viperin, which has antiviral activity, is unknown. We show that HCMV-induced viperin disrupts cellular metabolism to enhance the infectious process. Viperin interaction with the viral protein vMIA resulted in viperin relocalization from the endoplasmic reticulum to the mitochondria. There, viperin interacted with the mitochondrial trifunctional protein that mediates beta-oxidation of fatty acids to generate adenosine triphosphate (ATP). This interaction with viperin, but not with a mutant lacking the viperin iron-sulfur cluster-binding motif, reduced cellular ATP generation, which resulted in actin cytoskeleton disruption and enhancement of infection. This function of viperin, which was previously attributed to vMIA, suggests that HCMV has coopted viperin to facilitate the infectious process.	[Seo, Jun-Young; Yaneva, Rakina; Hinson, Ella R.; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, 300 Cedar St, New Haven, CT 06520 USA.	peter.cresswell@yale.edu			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank C. Rahner in the Yale Center for Cell and Molecular Imaging for EM and the Keck Biotechnology Resource Laboratory for protein identification. The work was supported by the Howard Hughes Medical Institute. J.-Y.S. and P. C. conceived the study and designed experiments. J.-Y.S. performed experiments. R.Y. and E. R. H. performed assays and produced reagents. J.-Y.S. and P. C. analyzed and interpreted the data, and wrote the manuscript. All authors contributed to the final version of the manuscript.	AlBarazi HO, 1996, J VIROL, V70, P7198, DOI 10.1128/JVI.70.10.7198-7208.1996; BACALLAO R, 1994, J CELL SCI, V107, P3301; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Boudinot P, 2000, J GEN VIROL, V81, P2675, DOI 10.1099/0022-1317-81-11-2675; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Bresnahan WA, 2000, J VIROL, V74, P10816, DOI 10.1128/JVI.74.22.10816-10818.2000; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Colberg-Poley AM, 2000, J GEN VIROL, V81, P1779, DOI 10.1099/0022-1317-81-7-1779; Cudmore S, 1997, TRENDS MICROBIOL, V5, P142, DOI 10.1016/S0966-842X(97)01011-1; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Goldmacher VS, 2002, BIOCHIMIE, V84, P177, DOI 10.1016/S0300-9084(02)01367-6; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; GOLENHOFEN N, 1995, KIDNEY INT, V48, P1837, DOI 10.1038/ki.1995.482; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; JONES NL, 1986, EUR J CELL BIOL, V41, P304; Poncet D, 2006, J CELL BIOL, V174, P985, DOI 10.1083/jcb.200604069; Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Sharon-Friling R, 2006, P NATL ACAD SCI USA, V103, P19117, DOI 10.1073/pnas.0609353103; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Shelden EA, 2002, J AM SOC NEPHROL, V13, P2667, DOI 10.1097/01.ASN.0000033353.21502.31; Suh HS, 2007, J VIROL, V81, P9838, DOI 10.1128/JVI.00792-07; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Zhu H, 1997, P NATL ACAD SCI USA, V94, P13985, DOI 10.1073/pnas.94.25.13985	30	147	157	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1093	1097		10.1126/science.1202007	http://dx.doi.org/10.1126/science.1202007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21527675				2022-12-24	WOS:000290996700047
J	Deltcheva, E; Chylinski, K; Sharma, CM; Gonzales, K; Chao, YJ; Pirzada, ZA; Eckert, MR; Vogel, J; Charpentier, E				Deltcheva, Elitza; Chylinski, Krzysztof; Sharma, Cynthia M.; Gonzales, Karine; Chao, Yanjie; Pirzada, Zaid A.; Eckert, Maria R.; Vogel, Joerg; Charpentier, Emmanuelle			CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III	NATURE			English	Article							PROVIDES ACQUIRED-RESISTANCE; IMMUNE-SYSTEM; BACTERIA; REPEATS; GENE; ENDORIBONUCLEASE; MECHANISMS; VIRULENCE; PHAGES; DNA	CRISPR/Cas systems constitute a widespread class of immunity systems that protect bacteria and archaea against phages and plasmids, and commonly use repeat/spacer-derived short crRNAs to silence foreign nucleic acids in a sequence-specific manner. Although the maturation of crRNAs represents a key event in CRISPR activation, the responsible endoribonucleases (CasE, Cas6, Csy4) are missing in many CRISPR/Cas subtypes. Here, differential RNA sequencing of the human pathogen Streptococcus pyogenes uncovered tracrRNA, a trans-encoded small RNA with 24-nucleotide complementarity to the repeat regions of crRNA precursor transcripts. We show that tracrRNA directs the maturation of crRNAs by the activities of the widely conserved endogenous RNase III and the CRISPR-associated Csn1 protein; all these components are essential to protect S. pyogenes against prophage-derived DNA. Our study reveals a novel pathway of small guide RNA maturation and the first example of a host factor (RNase III) required for bacterial RNA-mediated immunity against invaders.	[Deltcheva, Elitza; Chylinski, Krzysztof; Charpentier, Emmanuelle] Umea Univ, Dept Mol Biol, UCMR, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Deltcheva, Elitza; Chylinski, Krzysztof; Gonzales, Karine; Pirzada, Zaid A.; Eckert, Maria R.; Charpentier, Emmanuelle] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Sharma, Cynthia M.; Chao, Yanjie; Vogel, Joerg] Univ Wurzburg, ZINF Res Ctr Infect Dis, D-97080 Wurzburg, Germany; [Chao, Yanjie; Vogel, Joerg] Univ Wurzburg, RNA Biol Grp, Inst Mol Infect Biol, D-97080 Wurzburg, Germany	Umea University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Wurzburg; University of Wurzburg	Charpentier, E (corresponding author), Umea Univ, Dept Mol Biol, UCMR, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.	emmanuelle.charpentier@mims.umu.se	Vogel, Jörg/D-5574-2011; Chao, Yanjie/J-1931-2014; Sharma, Cynthia/D-2869-2013	Vogel, Jörg/0000-0003-2220-1404; Chao, Yanjie/0000-0002-5735-7954; Sharma, Cynthia Mira/0000-0002-2321-9705; Kohrer, Karine Anne/0000-0001-6713-2540; Chylinski, Krzysztof/0000-0001-7029-8090	European Community [BACRNAs-018618]; Austrian Science Fund (FWF) [P17238-B09, W1207-B09]; Austrian Agency for Research Promotion (FFG) [812138-SCK/KUG]; Theodor Korner Fonds; Umea University; Swedish Research Council; IMPRS-IDI; German Research Council (DFG) [SPP1258, Vo875/4]; German Ministry of Education and Research (BMBF) [01GS0806/JV-BMBF-01, 0315836]	European Community(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Agency for Research Promotion (FFG); Theodor Korner Fonds; Umea University; Swedish Research Council(Swedish Research CouncilEuropean Commission); IMPRS-IDI; German Research Council (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank D. Veit for technical help. This work was funded by the European Community (FP6, BACRNAs-018618; E.C.), the Austrian Science Fund (FWF, P17238-B09 (E.C.) and W1207-B09 (E.C., K.C.)), the Austrian Agency for Research Promotion (FFG, 812138-SCK/KUG; E.C.), the Theodor Korner Fonds (E.C.), Umea University (E.C.), the Swedish Research Council (E.C.), IMPRS-IDI (Y.C.), the German Research Council (DFG Priority Program "Sensory and Regulatory RNAs in Prokaryotes'' SPP1258, Vo875/4; J.V.), and the German Ministry of Education and Research (BMBF, 01GS0806/JV-BMBF-01 and 0315836; J.V.).	Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Britton RA, 2007, MOL MICROBIOL, V63, P127, DOI 10.1111/j.1365-2958.2006.05499.x; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Condon C, 2007, CURR OPIN MICROBIOL, V10, P271, DOI 10.1016/j.mib.2007.05.008; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Drider D, 2004, J MOL MICROB BIOTECH, V8, P195, DOI 10.1159/000086700; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fischetti VA, 2007, TRENDS MICROBIOL, V15, P297, DOI 10.1016/j.tim.2007.05.003; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Herbert S, 2001, INFECT IMMUN, V69, P2996, DOI 10.1128/IAI.69.5.2996-3003.2001; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Koonin Eugene V, 2009, F1000 Biol Rep, V1, P95; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mangold M, 2004, MOL MICROBIOL, V53, P1515, DOI 10.1111/j.1365-2958.2004.04222.x; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; NAKATA A, 1989, J BACTERIOL, V171, P3553, DOI 10.1128/jb.171.6.3553-3556.1989; Nicholson AW, 1999, FEMS MICROBIOL REV, V23, P371, DOI 10.1016/S0168-6445(99)00013-3; Opdyke JA, 2011, J MOL BIOL, V406, P29, DOI 10.1016/j.jmb.2010.12.009; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Roberts C, 2006, J BACTERIOL, V188, P2593, DOI 10.1128/JB.188.7.2593-2603.2006; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Siller M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-188; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; van der Oost J, 2009, CELL, V139, P863, DOI 10.1016/j.cell.2009.11.018; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Vogel J, 2004, CURR BIOL, V14, P2271, DOI 10.1016/j.cub.2004.12.003; Vojtek I, 2008, J INFECT DIS, V197, P225, DOI 10.1086/524687; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	66	1488	1966	38	802	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					602	+		10.1038/nature09886	http://dx.doi.org/10.1038/nature09886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455174	Green Accepted			2022-12-24	WOS:000288951200035
J	Turtle, EP; Perry, JE; Hayes, AG; Lorenz, RD; Barnes, JW; McEwen, AS; West, RA; Del Genio, AD; Barbara, JM; Lunine, JI; Schaller, EL; Ray, TL; Lopes, RMC; Stofan, ER				Turtle, E. P.; Perry, J. E.; Hayes, A. G.; Lorenz, R. D.; Barnes, J. W.; McEwen, A. S.; West, R. A.; Del Genio, A. D.; Barbara, J. M.; Lunine, J. I.; Schaller, E. L.; Ray, T. L.; Lopes, R. M. C.; Stofan, E. R.			Rapid and Extensive Surface Changes Near Titan's Equator: Evidence of April Showers	SCIENCE			English	Article							REFLECTANCE; CONSTRAINTS; ATMOSPHERE; STORMS; RAIN; WET; DRY	Although there is evidence that liquids have flowed on the surface at Titan's equator in the past, to date, liquids have only been confirmed on the surface at polar latitudes, and the vast expanses of dunes that dominate Titan's equatorial regions require a predominantly arid climate. We report the detection by Cassini's Imaging Science Subsystem of a large low-latitude cloud system early in Titan's northern spring and extensive surface changes (spanning more than 500,000 square kilometers) in the wake of this storm. The changes are most consistent with widespread methane rainfall reaching the surface, which suggests that the dry channels observed at Titan's low latitudes are carved by seasonal precipitation.	[Turtle, E. P.; Lorenz, R. D.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Perry, J. E.; McEwen, A. S.; Schaller, E. L.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Hayes, A. G.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Barnes, J. W.] Univ Idaho, Dept Phys, Moscow, ID 83844 USA; [West, R. A.; Ray, T. L.; Lopes, R. M. C.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Del Genio, A. D.; Barbara, J. M.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Lunine, J. I.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Stofan, E. R.] Proxemy Res, Rectortown, VA 20140 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Arizona; California Institute of Technology; Idaho; University of Idaho; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Rome Tor Vergata	Turtle, EP (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	elizabeth.turtle@jhuapl.edu	Turtle, Elizabeth/K-8673-2012; Lorenz, Ralph D/B-8759-2016; Hayes, Alexander G/P-2024-2014; Barnes, Jason W/B-1284-2009; Lopes, Rosaly M.C./D-1608-2016; Del Genio, Anthony/D-4663-2012	Turtle, Elizabeth/0000-0003-1423-5751; Lorenz, Ralph D/0000-0001-8528-4644; Hayes, Alexander G/0000-0001-6397-2630; Barnes, Jason W/0000-0002-7755-3530; Lopes, Rosaly M.C./0000-0002-7928-3167; Del Genio, Anthony/0000-0001-7450-1359; Lunine, Jonathan/0000-0003-2279-4131; Barbara, John/0000-0002-2190-4290; Schaller, Emily/0000-0001-8967-5423	Cassini-Huygens mission; NASA; ESA; ASI; Hubble Postdoctoral Fellowship	Cassini-Huygens mission; NASA(National Aeronautics & Space Administration (NASA)); ESA(European Space Agency); ASI(Agenzia Spaziale Italiana (ASI)); Hubble Postdoctoral Fellowship	We are grateful to all who developed and operate the Cassini-Huygens mission and to two very helpful anonymous reviewers. Research was supported by the Cassini-Huygens mission, a cooperative project of NASA, ESA, and ASI, managed by JPL, a division of the California Institute of Technology, under a contract with NASA. Supported by a Hubble Postdoctoral Fellowship (E.L.S.).	Almeida MP, 2008, P NATL ACAD SCI USA, V105, P6222, DOI 10.1073/pnas.0800202105; Brown ME, 2009, ASTROPHYS J LETT, V706, pL110, DOI 10.1088/0004-637X/706/1/L110; Clark RN, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003369; Collins GC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024551; Griffith CA, 2009, ASTROPHYS J LETT, V702, pL105, DOI 10.1088/0004-637X/702/2/L105; Griffith CA, 2008, ASTROPHYS J LETT, V687, pL41, DOI 10.1086/593117; Hayes A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033409; Hayes AG, 2011, ICARUS, V211, P655, DOI 10.1016/j.icarus.2010.08.017; Jaumann R, 2008, ICARUS, V197, P526, DOI 10.1016/j.icarus.2008.06.002; Karkoschka E, 2009, ICARUS, V199, P442, DOI 10.1016/j.icarus.2008.09.020; Lopes RMC, 2010, ICARUS, V205, P540, DOI 10.1016/j.icarus.2009.08.010; Lorenz RD, 2008, PLANET SPACE SCI, V56, P1132, DOI 10.1016/j.pss.2008.02.009; Lorenz RD, 2006, METEORIT PLANET SCI, V41, P1705, DOI 10.1111/j.1945-5100.2006.tb00446.x; Lorenz RD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036850; Lorenz RD, 1995, J GEOPHYS RES-PLANET, V100, P26377, DOI 10.1029/95JE02708; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; Lorenz RD, 1996, PLANET SPACE SCI, V44, P1021, DOI 10.1016/0032-0633(95)00139-5; Mitchell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003017; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Roe HG, 2005, SCIENCE, V310, P477, DOI 10.1126/science.1116760; Schaller EL, 2009, NATURE, V460, P873, DOI 10.1038/nature08193; Schaller EL, 2006, ICARUS, V182, P224, DOI 10.1016/j.icarus.2005.12.021; Self S., 1997, GEOPH MONOG SERIES, V100, P381; Soderblom LA, 2007, PLANET SPACE SCI, V55, P2025, DOI 10.1016/j.pss.2007.04.014; Soderblom LA, 2007, PLANET SPACE SCI, V55, P2015, DOI 10.1016/j.pss.2007.04.015; Stofan ER, 2007, NATURE, V445, P61, DOI 10.1038/nature05438; Tokano T, 2006, NATURE, V442, P432, DOI 10.1038/nature04948; Tokano T, 2010, AEOLIAN RES, V2, P113, DOI 10.1016/j.aeolia.2010.04.003; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; Turtle EP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046266; Turtle EP, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036186; TWOMEY SA, 1986, APPL OPTICS, V25, P431, DOI 10.1364/AO.25.000431; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; Zhang H, 2006, APPL OPTICS, V45, P8753, DOI 10.1364/AO.45.008753	34	147	149	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1414	1417		10.1126/science.1201063	http://dx.doi.org/10.1126/science.1201063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415347				2022-12-24	WOS:000288504000034
J	Burden, SJ				Burden, Steven J.			SnapShot: Neuromuscular Junction	CELL			English	Editorial Material							MUSCLE; DOK-7; MUSK		[Burden, Steven J.] New York Univ Med Sch, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University				Burden, Steven/0000-0002-3550-6891				Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Farrugia ME, 2010, CURR OPIN NEUROL, V23, P489, DOI 10.1097/WCO.0b013e32833cc968; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711	10	37	37	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					826	827		10.1016/j.cell.2011.02.037	http://dx.doi.org/10.1016/j.cell.2011.02.037			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376240	Bronze			2022-12-24	WOS:000288007100022
J	Kasturi, SP; Skountzou, I; Albrecht, RA; Koutsonanos, D; Hua, T; Nakaya, HI; Ravindran, R; Stewart, S; Alam, M; Kwissa, M; Villinger, F; Murthy, N; Steel, J; Jacob, J; Hogan, RJ; Garcia-Sastre, A; Compans, R; Pulendran, B				Kasturi, Sudhir Pai; Skountzou, Ioanna; Albrecht, Randy A.; Koutsonanos, Dimitrios; Hua, Tang; Nakaya, Helder I.; Ravindran, Rajesh; Stewart, Shelley; Alam, Munir; Kwissa, Marcin; Villinger, Francois; Murthy, Niren; Steel, John; Jacob, Joshy; Hogan, Robert J.; Garcia-Sastre, Adolfo; Compans, Richard; Pulendran, Bali			Programming the magnitude and persistence of antibody responses with innate immunity	NATURE			English	Article							MEMORY B-CELLS; YELLOW-FEVER VACCINE; DERMAL DENDRITIC CELLS; TOLL-LIKE RECEPTORS; GERMINAL CENTER; IN-VIVO; T-CELLS; LANGERHANS CELLS; EXPRESSION; ANTIGEN	Many successful vaccines induce persistent antibody responses that can last a lifetime. The mechanisms by which they do so remain unclear, but emerging evidence indicates that they activate dendritic cells via Toll-like receptors (TLRs)(1,2). For example, the yellow fever vaccine YF-17D, one of the most successful empiric vaccines ever developed(3), activates dendritic cells via multiple TLRs to stimulate proinflammatory cytokines(4,5). Triggering specific combinations of TLRs in dendritic cells can induce synergistic production of cytokines(6), which results in enhanced T-cell responses, but its impact on antibody responses remain unknown. Learning the critical parameters of innate immunity that program such antibody responses remains a major challenge in vaccinology. Here we demonstrate that immunization of mice with synthetic nanoparticles containing antigens plus ligands that signal through TLR4 and TLR7 induces synergistic increases in antigen-specific, neutralizing antibodies compared to immunization with nanoparticles containing antigens plus a single TLR ligand. Consistent with this there was enhanced persistence of germinal centres and of plasma-cell responses, which persisted in the lymph nodes for >1.5 years. Surprisingly, there was no enhancement of the early short-lived plasma-cell response relative to that observed with single TLR ligands. Molecular profiling of activated B cells, isolated 7 days after immunization, indicated that there was early programming towards B-cell memory. Antibody responses were dependent on direct triggering of both TLRs on B cells and dendritic cells, as well as on T-cell help. Immunization protected completely against lethal avian and swine influenza virus strains in mice, and induced robust immunity against pandemic H1N1 influenza in rhesus macaques.	[Kasturi, Sudhir Pai; Skountzou, Ioanna; Hua, Tang; Nakaya, Helder I.; Ravindran, Rajesh; Kwissa, Marcin; Villinger, Francois; Jacob, Joshy; Compans, Richard; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Kasturi, Sudhir Pai; Hua, Tang; Nakaya, Helder I.; Ravindran, Rajesh; Kwissa, Marcin; Villinger, Francois; Jacob, Joshy; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Skountzou, Ioanna; Koutsonanos, Dimitrios; Jacob, Joshy; Compans, Richard] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Albrecht, Randy A.; Steel, John; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Stewart, Shelley; Alam, Munir] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Villinger, Francois; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Murthy, Niren] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Hogan, Robert J.] Univ Georgia, Dept Anat & Radiol, Coll Vet Med, Athens, GA 30602 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA	Emory University; Emory University; Emory University; Icahn School of Medicine at Mount Sinai; Duke University; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; University of Georgia; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.	bpulend@emory.edu	Alam, S. Munir/AAC-6711-2019; Skountzou, Ioanna/A-4454-2010; Albrecht, Randy A./H-5119-2019; Compans, Richard W/I-4087-2013; Nakaya, Helder I/A-1397-2010; Pulendran, Bali/AAW-9550-2021; Nakaya, Helder/AAF-1738-2020	Skountzou, Ioanna/0000-0002-6429-244X; Albrecht, Randy A./0000-0003-4008-503X; Compans, Richard W/0000-0003-2360-335X; Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Pulendran, Bali/0000-0001-6517-4333; Garcia-Sastre, Adolfo/0000-0002-6551-1827	National Institutes of Health [U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266200700006C, NO1 AI50025, U19AI090023, HHSN266200700010C, U54AI57158, U01AI070469]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R37AI048638, U54AI057157, R56AI048638, U01AI070469, R01AI048638, U19AI057266, N01AI050025, U19AI090023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Ahmed and B. Rouse for discussion and comments on the manuscript. We thank B. Norris for assistance with FACS analysis, and H. Oluoch for assistance with cryostat sectioning. The work in the laboratory of B. P. was supported by grants U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266200700006C, NO1 AI50025 and U19AI090023 from the National Institutes of Health and a grant from the Bill & Melinda Gates Foundation. Work in A.G.-S. laboratories was partly funded by grants HHSN266200700010C, U54AI57158) and U01AI070469 from the National Institutes of Health.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Airoldi I, 2004, CLIN CANCER RES, V10, P144, DOI 10.1158/1078-0432.CCR-1026-3; Airoldi I, 2000, J IMMUNOL, V165, P6880, DOI 10.4049/jimmunol.165.12.6880; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Badr G, 2010, CELL IMMUNOL, V263, P31, DOI 10.1016/j.cellimm.2010.02.012; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Chen GL, 2009, CURR TOP MICROBIOL, V333, P109, DOI 10.1007/978-3-540-92165-3_5; Chin AID, 1999, MOL CELL BIOL, V19, P6665; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; COMPANS RW, 1974, J VIROL, V14, P1307, DOI 10.1128/JVI.14.5.1307-1309.1974; den Haan JMM, 2007, J IMMUNOL, V178, P5429, DOI 10.4049/jimmunol.178.9.5429; Dorner M, 2009, IMMUNOLOGY, V128, P573, DOI 10.1111/j.1365-2567.2009.03143.x; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hikida M, 2009, J EXP MED, V206, P681, DOI 10.1084/jem.20082100; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kano G, 2008, LEUKEMIA LYMPHOMA, V49, P965, DOI 10.1080/10428190801993462; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kazzaz J, 2006, J CONTROL RELEASE, V110, P566, DOI 10.1016/j.jconrel.2005.10.010; Ke N, 2001, J BIOL CHEM, V276, P12481, DOI 10.1074/jbc.C000871200; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nera KP, 2006, SCAND J IMMUNOL, V64, P190, DOI 10.1111/j.1365-3083.2006.01809.x; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sah HK, 1997, J PHARM SCI, V86, P1315, DOI 10.1021/js960363q; Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Staats HF, 2007, INFECT IMMUN, V75, P5443, DOI 10.1128/IAI.00529-07; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Thibault DL, 2008, J CLIN INVEST, V118, P1417, DOI 10.1172/JCI30065; Tovey MG, 2008, BIOL CHEM, V389, P541, DOI 10.1515/BC.2008.051; van Essen D, 2000, J IMMUNOL, V165, P3640; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Young JAT, 2002, SCI AM, V286, P48, DOI 10.1038/scientificamerican0302-48; Zhou G, 2005, EXP MOL PATHOL, V78, P25, DOI 10.1016/j.yexmp.2004.08.008; Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106	56	688	717	4	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					543	U136		10.1038/nature09737	http://dx.doi.org/10.1038/nature09737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350488	Green Accepted			2022-12-24	WOS:000287652900044
J	Sergeev, AG; Hartwig, JF				Sergeev, Alexey G.; Hartwig, John F.			Selective, Nickel-Catalyzed Hydrogenolysis of Aryl Ethers	SCIENCE			English	Article							N-HETEROCYCLIC CARBENES; CARBON-CARBON BONDS; MODEL COMPOUNDS; HYDROGENATION; OXYGEN; ACTIVATION; CHEMISTRY; CHEMICALS; CLEAVAGE; BIARYLS	Selective hydrogenolysis of the aromatic carbon-oxygen (C-O) bonds in aryl ethers is an unsolved synthetic problem important for the generation of fuels and chemical feedstocks from biomass and for the liquefaction of coal. Currently, the hydrogenolysis of aromatic C-O bonds requires heterogeneous catalysts that operate at high temperature and pressure and lead to a mixture of products from competing hydrogenolysis of aliphatic C-O bonds and hydrogenation of the arene. Here, we report hydrogenolyses of aromatic C-O bonds in alkyl aryl and diaryl ethers that form exclusively arenes and alcohols. This process is catalyzed by a soluble nickel carbene complex under just 1 bar of hydrogen at temperatures of 80 to 120 C; the relative reactivity of ether substrates scale as Ar-OAr>>Ar-OMe>ArCH(2)-OMe (Ar, Aryl; Me, Methyl). Hydrogenolysis of lignin model compounds highlights the potential of this approach for the conversion of refractory aryl ether biopolymers to hydrocarbons.	[Sergeev, Alexey G.; Hartwig, John F.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Hartwig, JF (corresponding author), Univ Illinois, Dept Chem, 600 S Matthews Ave, Urbana, IL 61801 USA.	jhartwig@illinois.edu	Sergeev, Alexey/H-4105-2013	Sergeev, Alexey/0000-0003-1587-2517	BP	BP	We thank the BP for financial support of this project through the Energy Biosciences Program and T. Rauchfuss for helpful discussions. A provisional patent has been filed on the methods presented herein.	Alvarez-Bercedo P, 2010, J AM CHEM SOC, V132, P17352, DOI 10.1021/ja106943q; Dabo P, 1999, CAN J CHEM, V77, P1225, DOI 10.1139/cjc-77-7-1225; Dankwardt JW, 2004, ANGEW CHEM INT EDIT, V43, P2428, DOI 10.1002/anie.200453765; Diez-Gonzalez S, 2009, CHEM REV, V109, P3612, DOI 10.1021/cr900074m; Dyson PJ, 2003, DALTON T, P2964, DOI 10.1039/b303250g; Ellsworth BA, 2008, BIOORG MED CHEM LETT, V18, P4770, DOI 10.1016/j.bmcl.2008.07.109; Furimsky E, 2000, APPL CATAL A-GEN, V199, P147, DOI 10.1016/S0926-860X(99)00555-4; Glorius F, 2007, TOP ORGANOMETAL CHEM, V21, P1, DOI 10.1007/3418_2006_059; Guan BT, 2008, CHEM COMMUN, P1437, DOI 10.1039/b718998b; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; HUUSKA MK, 1986, POLYHEDRON, V5, P233, DOI 10.1016/S0277-5387(00)84915-3; LEVINE DG, 1982, P NATL ACAD SCI USA, V79, P3365, DOI 10.1073/pnas.79.10.3365; MAERCKER A, 1987, ANGEW CHEM INT EDIT, V26, P972, DOI 10.1002/anie.198709721; Marshall AL, 2010, CHEM-EUR J, V16, P4970, DOI 10.1002/chem.200903028; POPPIUS K, 1984, ACTA CHEM SCAND B, V38, P611, DOI 10.3891/acta.chem.scand.38b-0611; Pu YQ, 2008, BIOFUEL BIOPROD BIOR, V2, P58, DOI 10.1002/bbb.48; Rylander P.N, 1985, HYDROGENATION METHOD, P157; SNIECKUS V, 1990, CHEM REV, V90, P879, DOI 10.1021/cr00104a001; STORK G, 1947, J AM CHEM SOC, V69, P576, DOI 10.1021/ja01195a034; Tobisu M, 2008, ANGEW CHEM INT EDIT, V47, P4866, DOI 10.1002/anie.200801447; Tobisu M, 2011, CHEM COMMUN, V47, P2946, DOI 10.1039/c0cc05169a; UTOH S, 1986, FUEL PROCESS TECHNOL, V14, P221, DOI 10.1016/0378-3820(86)90024-X; van der Boom ME, 1998, J AM CHEM SOC, V120, P6531, DOI 10.1021/ja9738889; Van Duzee EM, 1935, J AM CHEM SOC, V57, P147, DOI 10.1021/ja01304a040; WENKERT E, 1979, J AM CHEM SOC, V101, P2246, DOI 10.1021/ja00502a074; WENKERT E, 1984, J ORG CHEM, V49, P4894, DOI 10.1021/jo00199a030; Widegren JA, 2003, J MOL CATAL A-CHEM, V198, P317, DOI 10.1016/S1381-1169(02)00728-8; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u	28	628	644	13	707	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					439	443		10.1126/science.1200437	http://dx.doi.org/10.1126/science.1200437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512027				2022-12-24	WOS:000289784900036
J	Wu, D; Molofsky, AB; Liang, HE; Ricardo-Gonzalez, RR; Jouihan, HA; Bando, JK; Chawla, A; Locksley, RM				Wu, Davina; Molofsky, Ari B.; Liang, Hong-Erh; Ricardo-Gonzalez, Roberto R.; Jouihan, Hani A.; Bando, Jennifer K.; Chawla, Ajay; Locksley, Richard M.			Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis	SCIENCE			English	Article							T-CELLS; IN-VIVO; INSULIN-RESISTANCE; TISSUE; INFLAMMATION; OBESITY; POLARIZATION; EXPRESSION; CYTOKINES; DISEASE	Eosinophils are associated with helminth immunity and allergy, often in conjunction with alternatively activated macrophages (AAMs). Adipose tissue AAMs are necessary to maintain glucose homeostasis and are induced by the cytokine interleukin-4 (IL-4). Here, we show that eosinophils are the major IL-4-expressing cells in white adipose tissues of mice, and, in their absence, AAMs are greatly attenuated. Eosinophils migrate into adipose tissue by an integrin-dependent process and reconstitute AAMs through an IL-4- or IL-13-dependent process. Mice fed a high-fat diet develop increased body fat, impaired glucose tolerance, and insulin resistance in the absence of eosinophils, and helminth-induced adipose tissue eosinophilia enhances glucose tolerance. Our results suggest that eosinophils play an unexpected role in metabolic homeostasis through maintenance of adipose AAMs.	[Wu, Davina; Liang, Hong-Erh; Bando, Jennifer K.; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Ricardo-Gonzalez, Roberto R.; Jouihan, Hani A.] Stanford Univ, Sch Med, Dept Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA; [Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94107 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94107 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94107 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu		Bando, Jennifer/0000-0002-1331-7424; Molofsky, Ari/0000-0003-0764-3175; Ricardo-Gonzalez, Roberto/0000-0002-6135-4035	Howard Hughes Medical Institute; NIH [AI026918, 5F30DK083194-02]; Juvenile Diabetes Research Foundation; Larry L. Hillblom Foundation; Sandler Asthma Basic Research Center; Diabetes Endocrinology Research Center [DK063720]; UCSF; UCSF Department of Laboratory Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, R37AI026918, R01AI030663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, F30DK083194, R01DK081405, R01DK076760] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006415] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Larry L. Hillblom Foundation; Sandler Asthma Basic Research Center; Diabetes Endocrinology Research Center; UCSF; UCSF Department of Laboratory Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Cyster, D. Erle, C. Gerard, J. Lee, and A. McKenzie for reagents and mice; N. Flores for animal husbandry; Z. Wang for technical assistance; and M. Anderson and C. Lowell for constructive review of the manuscript. This work was supported by the Howard Hughes Medical Institute and grants from the NIH (AI026918), Juvenile Diabetes Research Foundation Innovative Grant, Larry L. Hillblom Foundation Network Grant and the Sandler Asthma Basic Research Center. Support was provided by the Diabetes Endocrinology Research Center grant DK063720, UCSF Medical Scientist Training Program (D. W.), UCSF Department of Laboratory Medicine (A. B. M.), and 5F30DK083194-02 from the National Institutes of Health (D. W.). Animal care was in accordance with UCSF Laboratory Animal Resource Center committee guidelines. Mouse strains described are available upon completion of standard institutional Material Transfer Agreements.	Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Jeninga EH, 2009, TRENDS ENDOCRIN MET, V20, P380, DOI 10.1016/j.tem.2009.04.005; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Lee NA, 1997, J IMMUNOL, V158, P1332; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	25	923	943	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					243	247		10.1126/science.1201475	http://dx.doi.org/10.1126/science.1201475			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21436399	Green Accepted			2022-12-24	WOS:000289251100054
J	Macheboeuf, P; Buffalo, C; Fu, CY; Zinkernagel, AS; Cole, JN; Johnson, JE; Nizet, V; Ghosh, P				Macheboeuf, Pauline; Buffalo, Cosmo; Fu, Chi-yu; Zinkernagel, Annelies S.; Cole, Jason N.; Johnson, John E.; Nizet, Victor; Ghosh, Partho			Streptococcal M1 protein constructs a pathological host fibrinogen network	NATURE			English	Article							HEPARIN-BINDING PROTEIN; GROUP-A STREPTOCOCCI; OLIGOMERIZATION STATE; CRYSTAL-STRUCTURE; SURFACE-PROTEINS; COILED COILS; FRAGMENT-D; CRYSTALLOGRAPHY; PHAGOCYTOSIS; STABILITY	M1 protein, a major virulence factor of the leading invasive strain of group A Streptococcus, is sufficient to induce toxic-shock-like vascular leakage and tissue injury. These events are triggered by the formation of a complex between M1 and fibrinogen that, unlike M1 or fibrinogen alone, leads to neutrophil activation. Here we provide a structural explanation for the pathological properties of the complex formed between streptococcal M1 and human fibrinogen. A conformationally dynamic coiled-coil dimer of M1 was found to organize four fibrinogen molecules into a specific cross-like pattern. This pattern supported the construction of a supramolecular network that was required for neutrophil activation but was distinct from a fibrin clot. Disruption of this network into other supramolecular assemblies was not tolerated. These results have bearing on the pathophysiology of streptococcal toxic shock.	[Macheboeuf, Pauline; Buffalo, Cosmo; Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Fu, Chi-yu; Johnson, John E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Zinkernagel, Annelies S.; Cole, Jason N.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Cole, Jason N.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Nizet, Victor] Univ Calif San Diego, Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego; University of Queensland; University of California System; University of California San Diego	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pghosh@ucsd.edu	Zinkernagel, Annelies S/F-1780-2017; Johnson, Johnson/HDL-9124-2022; Nizet, Victor/AAF-3190-2019	Zinkernagel, Annelies S/0000-0003-4700-1118; Macheboeuf, Pauline/0000-0003-4523-9923; Nizet, Victor/0000-0003-3847-0422; Buffalo, Cosmo/0000-0002-8187-4660	NIH [R21 AI071167, T32 GM007240, R01 AI077780, R01 GM54076]; National Health and Medical Research Council of Australia [514639]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780, R01AI052453, R37AI052453, R21AI071167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240, R01GM054076] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Argonne Photon Source Laboratory GM/CA CAT staff for help with data collection, R. Doolittle and A. Royant for advice, and S. Mel and G. Ghosh for comments on the manuscript. This work was supported by NIH R21 AI071167 (P.G.), T32 GM007240 (C.B.), R01 AI077780 (V.N.), R01 GM54076 (J.E.J.), and a fellowship (J.N.C.) from the National Health and Medical Research Council of Australia (514639).	AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bowley SR, 2009, BLOOD, V113, P4425, DOI 10.1182/blood-2008-09-178178; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVERSE SJ, 1995, PROTEIN SCI, V4, P1013; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gautam N, 2000, J EXP MED, V191, P1829, DOI 10.1084/jem.191.11.1829; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Kahn F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000149; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Linder A, 2009, CLIN INFECT DIS, V49, P1044, DOI 10.1086/605563; Lishko VK, 2002, BIOCHEMISTRY-US, V41, P12942, DOI 10.1021/bi026324c; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; Medved L, 1997, BIOCHEMISTRY-US, V36, P4685, DOI 10.1021/bi962795l; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Shannon O, 2007, MOL MICROBIOL, V65, P1147, DOI 10.1111/j.1365-2958.2007.05841.x; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Wagschal K, 1999, PROTEIN SCI, V8, P2312; WHITNACK E, 1985, J EXP MED, V162, P1983, DOI 10.1084/jem.162.6.1983; Yang Z, 2001, BIOCHEMISTRY-US, V40, P12515, DOI 10.1021/bi011394p	41	72	73	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					64	68		10.1038/nature09967	http://dx.doi.org/10.1038/nature09967			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475196	Green Accepted			2022-12-24	WOS:000289199400037
J	Navin, N; Kendall, J; Troge, J; Andrews, P; Rodgers, L; McIndoo, J; Cook, K; Stepansky, A; Levy, D; Esposito, D; Muthuswamy, L; Krasnitz, A; McCombie, WR; Hicks, J; Wigler, M				Navin, Nicholas; Kendall, Jude; Troge, Jennifer; Andrews, Peter; Rodgers, Linda; McIndoo, Jeanne; Cook, Kerry; Stepansky, Asya; Levy, Dan; Esposito, Diane; Muthuswamy, Lakshmi; Krasnitz, Alex; McCombie, W. Richard; Hicks, James; Wigler, Michael			Tumour evolution inferred by single-cell sequencing	NATURE			English	Article							WHOLE GENOME AMPLIFICATION; COPY-NUMBER ALTERATIONS; BREAST-CANCER; CARCINOMAS; HETEROGENEITY; PROGRESSION; METASTASIS; PHENOTYPE; VARIANTS	Genomic analysis provides insights into the role of copy number variation in disease, but most methods are not designed to resolve mixed populations of cells. In tumours, where genetic heterogeneity is common(1-3), very important information may be lost that would be useful for reconstructing evolutionary history. Here we show that with flow-sorted nuclei, whole genome amplification and next generation sequencing we can accurately quantify genomic copy number within an individual nucleus. We apply single-nucleus sequencing to investigate tumour population structure and evolution in two human breast cancer cases. Analysis of 100 single cells from a polygenomic tumour revealed three distinct clonal subpopulations that probably represent sequential clonal expansions. Additional analysis of 100 single cells from a monogenomic primary tumour and its liver metastasis indicated that a single clonal expansion formed the primary tumour and seeded the metastasis. In both primary tumours, we also identified an unexpectedly abundant subpopulation of genetically diverse 'pseudodiploid' cells that do not travel to the metastatic site. In contrast to gradual models of tumour progression, our data indicate that tumours grow by punctuated clonal expansions with few persistent intermediates.	[Navin, Nicholas; Kendall, Jude; Troge, Jennifer; Andrews, Peter; Rodgers, Linda; McIndoo, Jeanne; Cook, Kerry; Stepansky, Asya; Levy, Dan; Esposito, Diane; Krasnitz, Alex; McCombie, W. Richard; Hicks, James; Wigler, Michael] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Navin, Nicholas] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Muthuswamy, Lakshmi] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada	Cold Spring Harbor Laboratory; University of Texas System; UTMD Anderson Cancer Center; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Wigler, M (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	wigler@cshl.edu	Yang, Chen/G-1379-2010	Wigler, Michael/0000-0003-4396-1971; McCombie, W. Richard/0000-0003-1899-0682	NCI; Department of the Army [W81XWH04-1-0477]; Breast Cancer Research Foundation; Simons Foundation; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA009176] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of the Army; Breast Cancer Research Foundation; Simons Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Ronemus, T. Spencer, A. Leotta, J. Meth, M. Kramer, L. Gelley, E. Ghiban. We also thank P. Blake and N. Navin at Sophic Systems Alliance. This work was supported by the NCI T32 Fellowship to N.N., and grants to M.W. and J.H. from the Department of the Army (W81XWH04-1-0477), the Breast Cancer Research Foundation, and the Simons Foundation. M.W. is an American Cancer Society Research Professor.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Farabegoli F, 2001, CYTOMETRY, V46, P50, DOI 10.1002/1097-0320(20010215)46:1<50::AID-CYTO1037>3.0.CO;2-T; Fuhrmann C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn101; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Heng HHQ, 2006, J CELL PHYSIOL, V208, P461, DOI 10.1002/jcp.20685; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Huang J, 2009, J MOL DIAGN, V11, P109, DOI 10.2353/jmoldx.2009.080143; Hughes S, 2004, CYTOGENET GENOME RES, V105, P18, DOI 10.1159/000078004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; LOEB LA, 1974, CANCER RES, V34, P2311; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Pugh TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn378; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Talseth-Palmer Bente A, 2008, BMC Res Notes, V1, P56, DOI 10.1186/1756-0500-1-56; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	25	1714	1801	10	486	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					90	U119		10.1038/nature09807	http://dx.doi.org/10.1038/nature09807			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21399628	Green Accepted			2022-12-24	WOS:000289199400043
J	Flynn, RL; Centore, RC; O'Sullivan, RJ; Rai, R; Tse, A; Zhou, SY; Chang, S; Karlseder, J; Zou, L				Flynn, Rachel Litman; Centore, Richard C.; O'Sullivan, Roderick J.; Rai, Rekha; Tse, Alice; Zhou Songyang; Chang, Sandy; Karlseder, Jan; Zou, Lee			TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA	NATURE			English	Article							REPLICATION PROTEIN-A; REPEAT-CONTAINING RNA; FISSION YEAST; CHROMOSOME ENDS; BINDING PROTEIN; ATR; DAMAGE; POT1; RPA; ELONGATION	Maintenance of telomeres requires both DNA replication and telomere 'capping' by shelterin. These two processes use two single-stranded DNA (ssDNA)-binding proteins, replication protein A (RPA) and protection of telomeres 1 (POT1). Although RPA and POT1 each have a critical role at telomeres, how they function in concert is not clear. POT1 ablation leads to activation of the ataxia telangiectasia and Rad3-related (ATR) checkpoint kinase at telomeres(1,2), suggesting that POT1 antagonizes RPA binding to telomeric ssDNA. Unexpectedly, we found that purified POT1 and its functional partner TPP1 are unable to prevent RPA binding to telomeric ssDNA efficiently. In cell extracts, we identified a novel activity that specifically displaces RPA, but not POT1, from telomeric ssDNA. Using purified protein, here we show that the heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) recapitulates the RPA displacing activity. The RPA displacing activity is inhibited by the telomeric repeat-containing RNA (TERRA) in early S phase, but is then unleashed in late S phase when TERRA levels decline at telomeres(3). Interestingly, TERRA also promotes POT1 binding to telomeric ssDNA by removing hnRNPA1, suggesting that the reaccumulation of TERRA after S phase helps to complete the RPA-to-POT1 switch on telomeric ssDNA. Together, our data suggest that hnRNPA1, TERRA and POT1 act in concert to displace RPA from telomeric ssDNA after DNA replication, and promote telomere capping to preserve genomic integrity.	[Flynn, Rachel Litman; Centore, Richard C.; Tse, Alice; Zou, Lee] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA; [Zou, Lee] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [O'Sullivan, Roderick J.; Karlseder, Jan] Salk Inst Biol Studies, Mol & Cellular Lab, La Jolla, CA 92037 USA; [Rai, Rekha; Chang, Sandy] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Zhou Songyang] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Salk Institute; Yale University; Baylor College of Medicine	Zou, L (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA.	zou.lee@mgh.harvard.edu	rai, rekha/A-3680-2012		National Institutes of Health (NIH) [5T32CA009216-28, F32-GM089150, CA133249, CA129037, GM06525, AG025837, GM076388]; American Cancer Society [0902501]; George E. Hewitt Foundation for Medical Research; Welch Foundation [Q-1673]; ACS [RSG-08-297]; NATIONAL CANCER INSTITUTE [T32CA009216, R01CA129037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089150, R01GM076388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025837] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); George E. Hewitt Foundation for Medical Research; Welch Foundation(The Welch Foundation); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. de Lange, A. Krainer, B. Chabot and M. Wold for reagents, and members of the Zou laboratory for discussion. L.Z. is an Ellison New Scholar on Aging. R.L.F. is supported by National Institutes of Health (NIH) fellowship 5T32CA009216-28 and American Cancer Society fellowship 0902501. R.C.C. is supported by NIH fellowship F32-GM089150. R.J.O. is supported by the George E. Hewitt Foundation for Medical Research. This work is supported by a Welch Foundation grant (Q-1673) to Z.S., an ACS grant (RSG-08-297) to L.Z., and NIH grants CA133249 to Z.S., CA129037 to S.C., GM06525 and AG025837 to J.K. and GM076388 to L.Z.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; Kibe T, 2007, MOL BIOL CELL, V18, P2378, DOI 10.1091/mbc.E06-12-1084; LaBranche H, 1998, NAT GENET, V19, P199, DOI 10.1038/575; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; de Silanes IL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1032; McGee JS, 2010, NAT STRUCT MOL BIOL, V17, P1438, DOI 10.1038/nsmb.1947; MCKAY SJ, 1992, NUCLEIC ACIDS RES, V20, P6461, DOI 10.1093/nar/20.24.6461; McNees CJ, 2010, J CELL BIOL, V188, P639, DOI 10.1083/jcb.200908136; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Redon S, 2010, NUCLEIC ACIDS RES, V38, P5797, DOI 10.1093/nar/gkq296; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	30	240	247	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					532	+		10.1038/nature09772	http://dx.doi.org/10.1038/nature09772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21399625	Green Accepted			2022-12-24	WOS:000288702200066
J	Baxter, J; Sen, N; Martinez, VL; De Carandini, MEM; Schvartzman, JB; Diffley, JFX; Aragon, L				Baxter, J.; Sen, N.; Lopez Martinez, V.; Monturus De Carandini, M. E.; Schvartzman, J. B.; Diffley, J. F. X.; Aragon, L.			Positive Supercoiling of Mitotic DNA Drives Decatenation by Topoisomerase II in Eukaryotes	SCIENCE			English	Article							INTERTWINED CATENATED DIMERS; CHROMOSOME CONDENSATION; REPLICATION; YEAST; SEGREGATION; SEPARATION; CLEAVAGE; COHESIN	DNA topoisomerase II completely removes DNA intertwining, or catenation, between sister chromatids before they are segregated during cell division. How this occurs throughout the genome is poorly understood. We demonstrate that in yeast, centromeric plasmids undergo a dramatic change in their topology as the cells pass through mitosis. This change is characterized by positive supercoiling of the DNA and requires mitotic spindles and the condensin factor Smc2. When mitotic positive supercoiling occurs on decatenated DNA, it is rapidly relaxed by topoisomerase II. However, when positive supercoiling takes place in catenated plasmid, topoisomerase II activity is directed toward decatenation of the molecules before relaxation. Thus, a topological change on DNA drives topoisomerase II to decatenate molecules during mitosis, potentially driving the full decatenation of the genome.	[Baxter, J.; Sen, N.; Aragon, L.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Cell Cycle Grp, Med Res Council MRC Clin Sci Ctr, London W12 0NN, England; [Lopez Martinez, V.; Monturus De Carandini, M. E.; Schvartzman, J. B.] CSIC, Ctr Invest Biol, Dept Cell Proliferat & Dev, E-28040 Madrid, Spain; [Baxter, J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Diffley, J. F. X.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Sussex; Cancer Research UK	Baxter, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Cell Cycle Grp, Med Res Council MRC Clin Sci Ctr, Du Cane Rd, London W12 0NN, England.	Jon.Baxter@sussex.ac.uk; luis.aragon@csc.mrc.ac.uk	Lopez, Virginia/AAC-1321-2021; Schvartzman, Jorge B/J-9171-2014	Lopez, Virginia/0000-0002-0065-7999; Baxter, Jonathan/0000-0002-4455-9717; Diffley, John/0000-0001-5184-7680	European Research Council [202337]; Royal Society; Spanish government [BFU2008-00408/BMC]; Cancer Research UK; MRC UK; MRC [MC_U120074328] Funding Source: UKRI; Medical Research Council [MC_U120074328, G0801130B] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Spanish government(Spanish GovernmentEuropean Commission); Cancer Research UK(Cancer Research UK); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the Aragon laboratory, M. Merkenschlager, A. Carr, and J. Murray for discussions and critical reading of the manuscript. We also thank K. Nasmyth and S. Henikoff for helpful discussions, as well as anonymous referees for useful suggestions. This work was funded by European Research Council starting grant 202337 (L. A. and J. B.), the Royal Society (J. B.), the Spanish government grant BFU2008-00408/BMC (J. B. S.), Cancer Research UK (J. F. X. D.), and the MRC UK (L. A.). Extended figure legends are available in the supporting online material.	Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Hardy CD, 2004, PHILOS T R SOC B, V359, P39, DOI 10.1098/rstb.2003.1363; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Martinez-Robles ML, 2009, NUCLEIC ACIDS RES, V37, P5126, DOI 10.1093/nar/gkp530; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Zechiedrich EL, 1997, GENE DEV, V11, P2580, DOI 10.1101/gad.11.19.2580	15	106	106	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2011	331	6022					1328	1332		10.1126/science.1201538	http://dx.doi.org/10.1126/science.1201538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393545				2022-12-24	WOS:000288215200048
J	Selvin, E; Steffes, MW; Ballantyne, CM; Hoogeveen, RC; Coresh, J; Brancati, FL				Selvin, Elizabeth; Steffes, Michael W.; Ballantyne, Christie M.; Hoogeveen, Ron C.; Coresh, Josef; Brancati, Frederick L.			Racial Differences in Glycemic Markers: A Cross-sectional Analysis of Community-Based Data	ANNALS OF INTERNAL MEDICINE			English	Article							3RD NATIONAL-HEALTH; HISPANIC WHITE ADULTS; HEMOGLOBIN A(1C); ATHEROSCLEROSIS RISK; CARDIOVASCULAR RISK; AFRICAN-AMERICAN; HBA(1C) LEVELS; BLOOD-GLUCOSE; A1C; 1,5-ANHYDROGLUCITOL	Background: Although differences between black and white persons in hemoglobin A(1c) (HbA(1c)) values are well established, recent studies suggest that this might not reflect differences in glycemia. Objective: To investigate racial disparities in glycemic markers, including those that reflect biological processes independent of hemoglobin glycation and erythrocyte turnover. Design: Cross-sectional. Setting: Community-based. Participants: 1376 nondiabetic and 343 diabetic adults in a sub-study of the Atherosclerosis Risk in Communities Study. Measurements: Hemoglobin A1c, fasting glucose, glycated albumin, fructosamine, and 1,5-anhydroglucitol levels. Results: Among persons with and without diabetes, black persons had significantly higher HbA1c, glycated albumin, and fructosamine levels than white persons before and after adjustment for covariates and fasting glucose concentration. Serum 1,5-anhydroglucitol levels, which are reduced in the setting of hyperglycemia-induced glycosuria, were lower in black persons than in white persons, although this difference was statistically significant only in nondiabetic adults. Limitation: The design was cross-sectional, a limited number of participants with a history of diabetes was included, and the study did not include integrated measures of circulating nonfasting glycemia. Conclusion: Differences between black and white persons in glycated albumin, fructosamine, and 1,5-anhydroglucitol levels parallel differences between these groups in HbA(1c) values. Racial differences in hemoglobin glycation and erythrocyte turnover cannot explain racial disparities in these serum markers. The possibility that black persons have systematically higher levels of nonfasting glycemia warrants further study.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Minnesota, Minneapolis, MN USA; Baylor Coll Med, Houston, TX 77030 USA; Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Brancati, FL (corresponding author), Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-600, Baltimore, MD 21287 USA.	lselvin@jhsph.edu	Ballantyne, Christie/A-6599-2008	Hoogeveen, Ron/0000-0003-2399-4653; Ballantyne, Christie/0000-0002-6432-1730	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) [R21 DK080294, K01 DK076595, K24 DK62222]; Johns Hopkins Diabetes Research and Training Center (NIDDK) [P60 DK079637]; National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055022, N01HC055016, N01HC055019, N01HC055020, N01HC055021, N01HC055018] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055019, R42HL055018, R41HL055018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK062222, R21DK080294, R01DK089174, P60DK079637, K01DK076595] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Johns Hopkins Diabetes Research and Training Center (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support: By the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) (grants R21 DK080294 and K01 DK076595 [Dr. Selvin] and K24 DK62222 [Dr. Brancati]) and by the Johns Hopkins Diabetes Research and Training Center (NIDDK grant P60 DK079637 [Dr. Brancati]). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bloomgarden Zachary T, 2009, Diabetes Care, V32, pe141, DOI 10.2337/dc09-zb12; Borg R, 2010, DIABETES, V59, P1585, DOI [10.2337/db09-1774, 10.2337/db10-0777]; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839; Cohen RM, 2007, DIABETES CARE, V30, P2756, DOI 10.2337/dc07-1301; Dagogo-Jack S, 2010, NAT REV ENDOCRINOL, V6, P589, DOI 10.1038/nrendo.2010.126; Eldeirawi K, 2003, AM J EPIDEMIOL, V157, P624, DOI 10.1093/aje/kwg023; Fagot-Campagna A, 2001, DIABETES CARE, V24, P834, DOI 10.2337/diacare.24.5.834; Gama R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5648; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2010, ANN INTERN MED, V152, P815, DOI 10.7326/0003-4819-152-12-201006150-00011; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Hu YQ, 2009, J AM COLL NUTR, V28, P636, DOI 10.1080/07315724.2009.10719796; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Kamps JL, 2010, DIABETES CARE, V33, P1025, DOI 10.2337/dc09-1440; Kirk JK, 2005, ANN PHARMACOTHER, V39, P1489, DOI 10.1345/aph.1E685; Kirk JK, 2008, DIABETES CARE, V31, P240, DOI 10.2337/dc07-0382; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nguyen QM, 2008, METABOLISM, V57, P1487, DOI 10.1016/j.metabol.2008.04.011; Olabi B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4354; Pal A, 2010, DIABETES CARE, V33, P252, DOI 10.2337/dc09-1246; Saaddine JB, 2002, DIABETES CARE, V25, P1326, DOI 10.2337/diacare.25.8.1326; Selvin E, 2011, DIABETES, V60, P298, DOI 10.2337/db10-1198; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Selvin E, 2009, DIABETES CARE, V32, P828, DOI 10.2337/dc08-1699; SIMON D, 1989, DIABETOLOGIA, V32, P864, DOI 10.1007/BF00297451; Stettler C, 2008, DIABETES CARE, V31, P1534, DOI 10.2337/dc08-0385; Steven J, 2002, DIABETES CARE, V25, P1715, DOI 10.2337/diacare.25.10.1715; Suwa T, 2010, ENDOCR J, V57, P135, DOI 10.1507/endocrj.K09E-234; True Mark W, 2009, J Diabetes Sci Technol, V3, P743; Viberti G, 2006, DIABETIC MED, V23, P1289, DOI 10.1111/j.1464-5491.2006.02022.x; Wagenknecht L, 2009, CIRC-CARDIOVASC IMAG, V2, P314, DOI 10.1161/CIRCIMAGING.108.823922; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Won JC, 2009, DIABETES RES CLIN PR, V84, P51, DOI 10.1016/j.diabres.2009.01.002; YAMANOUCHI T, 1989, DIABETES, V38, P723, DOI 10.2337/diabetes.38.6.723; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	39	140	142	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5								10.7326/0003-4819-154-5-201103010-00004	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21357907	Green Accepted			2022-12-24	WOS:000287799900002
J	Kamakura, M				Kamakura, Masaki			Royalactin induces queen differentiation in honeybees	NATURE			English	Article							CULTURED RAT HEPATOCYTES; APIS-MELLIFERA; ENHANCES PROLIFERATION; CASTE DIFFERENTIATION; PROTHORACIC GLAND; REGULATES GROWTH; BODY-SIZE; DROSOPHILA; PROTEINS; FAMILY	The honeybee (Apis mellifera) forms two female castes: the queen and the worker. This dimorphism depends not on genetic differences, but on ingestion of royal jelly, although the mechanism through which royal jelly regulates caste differentiation has long remained unknown. Here I show that a 57-kDa protein in royal jelly, previously designated as royalactin, induces the differentiation of honeybee larvae into queens. Royalactin increased body size and ovary development and shortened developmental time in honeybees. Surprisingly, it also showed similar effects in the fruitfly (Drosophila melanogaster). Mechanistic studies revealed that royalactin activated p70 S6 kinase, which was responsible for the increase of body size, increased the activity of mitogen-activated protein kinase, which was involved in the decreased developmental time, and increased the titre of juvenile hormone, an essential hormone for ovary development. Knockdown of epidermal growth factor receptor (Egfr) expression in the fat body of honeybees and fruitflies resulted in a defect of all phenotypes induced by royalactin, showing that Egfr mediates these actions. These findings indicate that a specific factor in royal jelly, royalactin, drives queen development through an Egfr-mediated signalling pathway.	Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan	Toyama Prefectural University	Kamakura, M (corresponding author), Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan.	kamakura@pu-toyama.ac.jp	Kamakura, Masaki/E-7954-2011					BEETSMA J, 1979, BEE WORLD, V60, P24, DOI 10.1080/0005772X.1979.11097727; Belgacem YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000187; Bilikova K, 2002, FEBS LETT, V528, P125, DOI 10.1016/S0014-5793(02)03272-6; Bloch Guy, 2002, P195; BOWNES M, 1994, BIOESSAYS, V16, P745, DOI 10.1002/bies.950161009; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; EBERT R, 1980, J COMP PHYSIOL, V137, P7, DOI 10.1007/BF00656912; Gilboa L, 2006, NATURE, V443, P97, DOI 10.1038/nature05068; GOEWIE EA, 1976, P K NED AKAD C BIOL, V79, P466; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Kamakura M, 2006, PROTEIN EXPRES PURIF, V45, P307, DOI 10.1016/j.pep.2005.08.004; Kamakura M, 2002, J BIOCHEM, V132, P911, DOI 10.1093/oxfordjournals.jbchem.a003304; Kamakura M, 2001, J NUTR SCI VITAMINOL, V47, P394, DOI 10.3177/jnsv.47.394; Kamakura M, 2001, BIOCHEM BIOPH RES CO, V282, P865, DOI 10.1006/bbrc.2001.4656; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; LeVea CM, 2004, EXP CELL RES, V297, P272, DOI 10.1016/j.yexcr.2004.03.026; McManus EJ, 2002, NAT CELL BIOL, V4, pE214, DOI 10.1038/ncb0902-e214; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Navolanic PM, 2003, INT J ONCOL, V22, P237; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; PATEL NG, 1960, NATURE, V186, P633, DOI 10.1038/186633a0; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; SHUEL R. W., 1960, INSECTES SOCIAUX, V7, P265, DOI 10.1007/BF02224497; Szathmary E, 1995, MAJOR TRANSITIONS EV; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; WEAVER NEVIN, 1957, ANN ENT SOC AMER, V50, P283; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; WIRTZ P, 1972, ENTOMOL EXP APPL, V15, P517, DOI 10.1007/BF00293616; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zinke I, 1999, DEVELOPMENT, V126, P5275	37	391	449	18	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					478	483		10.1038/nature10093	http://dx.doi.org/10.1038/nature10093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21516106	Green Submitted			2022-12-24	WOS:000290951300033
J	Ruediger, S; Vittori, C; Bednarek, E; Genoud, C; Strata, P; Sacchetti, B; Caroni, P				Ruediger, Sarah; Vittori, Claudia; Bednarek, Ewa; Genoud, Christel; Strata, Piergiorgio; Sacchetti, Benedetto; Caroni, Pico			Learning-related feedforward inhibitory connectivity growth required for memory precision	NATURE			English	Article							STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; CORTICAL CIRCUITS; HIPPOCAMPUS; CA3; CONSOLIDATION; CONTEXT; BRAIN; CELLS	In the adult brain, new synapses are formed and pre-existing ones are lost, but the function of this structural plasticity has remained unclear(1-5). Learning of new skills is correlated with formation of new synapses(6-8). These may directly encode new memories, but they may also have more general roles in memory encoding and retrieval processes(2). Here we investigated how mossy fibre terminal complexes at the entry of hippocampal and cerebellar circuits rearrange upon learning in mice, and what is the functional role of the rearrangements. We show that one-trial and incremental learning lead to robust, circuit-specific, long-lasting and reversible increases in the numbers of filopodial synapses onto fast-spiking interneurons that trigger feedforward inhibition. The increase in feedforward inhibition connectivity involved a majority of the presynaptic terminals, restricted the numbers of c-Fos-expressing postsynaptic neurons at memory retrieval, and correlated temporally with the quality of the memory. We then show that for contextual fear conditioning and Morris water maze learning, increased feedforward inhibition connectivity by hippocampal mossy fibres has a critical role for the precision of the memory and the learned behaviour. In the absence of mossy fibre long-term potentiation in Rab3a(-/-) mice(9), c-Fos ensemble reorganization and feedforward inhibition growth were both absent in CA3 upon learning, and the memory was imprecise. By contrast, in the absence of adducin 2 (Add2; also known as beta-adducin)(10) c-Fos reorganization was normal, but feedforward inhibition growth was abolished. In parallel, c-Fos ensembles in CA3 were greatly enlarged, and the memory was imprecise. Feedforward inhibition growth and memory precision were both rescued by re-expression of Add2 specifically in hippocampal mossy fibres. These results establish a causal relationship between learning-related increases in the numbers of defined synapses and the precision of learning and memory in the adult. The results further relate plasticity and feedforward inhibition growth at hippocampal mossy fibres to the precision of hippocampus-dependent memories.	[Ruediger, Sarah; Vittori, Claudia; Bednarek, Ewa; Genoud, Christel; Caroni, Pico] Friedrich Miescher Inst, CH-4058 Basel, Switzerland; [Vittori, Claudia; Strata, Piergiorgio; Sacchetti, Benedetto] Dept Neurosci, I-10125 Turin, Italy; [Vittori, Claudia; Strata, Piergiorgio; Sacchetti, Benedetto] Natl Inst Neurosci Italy, I-10125 Turin, Italy	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch	Ruediger Lee, Sarah/ABG-6969-2021; Sacchetti, Benedetto/AAG-2916-2022; Sacchetti, Benedetto/AFK-4141-2022	Sacchetti, Benedetto/0000-0002-8695-8310; Ruediger, Sarah/0000-0001-6684-4693; Vittori, Claudia/0000-0002-3467-5984; Ruediger, Sarah/0000-0001-9140-872X; genoud, christel/0000-0002-0933-9911				Acsady L, 1998, J NEUROSCI, V18, P3386; BEDNAREK E, NEURON IN PRESS; Biedenkapp JC, 2007, LEARN MEMORY, V14, P200, DOI 10.1101/lm.499407; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Galimberti I, 2010, NEURON, V65, P627, DOI 10.1016/j.neuron.2010.02.016; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Knott GW, 2009, NAT PROTOC, V4, P1145, DOI 10.1038/nprot.2009.114; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; Sacchetti B, 2004, NEURON, V42, P973, DOI 10.1016/j.neuron.2004.05.012; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	30	186	187	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2011	473	7348					514	U258		10.1038/nature09946	http://dx.doi.org/10.1038/nature09946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	768QM	21532590	Green Submitted			2022-12-24	WOS:000290951300041
J	Sahay, A; Scobie, KN; Hill, AS; O'Carroll, CM; Kheirbek, MA; Burghardt, NS; Fenton, AA; Dranovsky, A; Hen, R				Sahay, Amar; Scobie, Kimberly N.; Hill, Alexis S.; O'Carroll, Colin M.; Kheirbek, Mazen A.; Burghardt, Nesha S.; Fenton, Andre A.; Dranovsky, Alex; Hen, Rene			Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation	NATURE			English	Article							DENTATE GYRUS; SYNAPTIC PLASTICITY; FLUOXETINE; MATURATION; NEURONS; BRAIN; DEPRESSION; DISORDER; MODELS; MEMORY	Adult hippocampal neurogenesis is a unique form of neural circuit plasticity that results in the generation of new neurons in the dentate gyrus throughout life(1,2). Neurons that arise in adults (adult-born neurons) show heightened synaptic plasticity during their maturation(3) and can account for up to ten per cent of the entire granule cell population(4). Moreover, levels of adult hippocampal neurogenesis are increased by interventions that are associated with beneficial effects on cognition and mood, such as learning(5), environmental enrichment(6), exercise(6) and chronic treatment with antidepressants(7-10). Together, these properties of adult neurogenesis indicate that this process could be harnessed to improve hippocampal functions. However, despite a substantial number of studies demonstrating that adult-born neurons are necessary for mediating specific cognitive functions(11), as well as some of the behavioural effects of antidepressants(8-10,12,13), it is unknown whether an increase in adult hippocampal neurogenesis is sufficient to improve cognition and mood. Here we show that inducible genetic expansion of the population of adult-born neurons through enhancing their survival improves performance in a specific cognitive task in which two similar contexts need to be distinguished. Mice with increased adult hippocampal neurogenesis show normal object recognition, spatial learning, contextual fear conditioning and extinction learning but are more efficient in differentiating between overlapping contextual representations, which is indicative of enhanced pattern separation. Furthermore, stimulation of adult hippocampal neurogenesis, when combined with an intervention such as voluntary exercise, produces a robust increase in exploratory behaviour. However, increasing adult hippocampal neurogenesis alone does not produce a behavioural response like that induced by anxiolytic agents or antidepressants. Together, our findings suggest that strategies that are designed to increase adult hippocampal neurogenesis specifically, by targeting the cell death of adult-born neurons or by other mechanisms, may have therapeutic potential for reversing impairments in pattern separation and dentate gyrus dysfunction such as those seen during normal ageing(14,15).	[Sahay, Amar; Scobie, Kimberly N.; Hill, Alexis S.; O'Carroll, Colin M.; Kheirbek, Mazen A.; Burghardt, Nesha S.; Dranovsky, Alex; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Sahay, Amar; Scobie, Kimberly N.; Hill, Alexis S.; O'Carroll, Colin M.; Kheirbek, Mazen A.; Burghardt, Nesha S.; Dranovsky, Alex; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Sahay, Amar; Scobie, Kimberly N.; Hill, Alexis S.; O'Carroll, Colin M.; Kheirbek, Mazen A.; Burghardt, Nesha S.; Dranovsky, Alex; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Fenton, Andre A.] SUNY, Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Physiol, Brooklyn, NY 11203 USA; [Fenton, Andre A.] SUNY, Downstate Med Ctr, Dept Pharmacol & Neurol, Brooklyn, NY 11203 USA; [Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College; Columbia University	Sahay, A (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	as2619@columbia.edu; rh95@columbia.edu	Dranovsky, Alex/P-4357-2018; Kheirbek, Mazen A/J-3656-2015; Sahay, Amar/J-3696-2014	Dranovsky, Alex/0000-0001-7896-3243; Kheirbek, Mazen A/0000-0001-9157-7363; Fenton, Andre/0000-0002-5063-1156	National Institute of Mental Health [1K99MH86615-01]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Sackler Institute of Columbia University; Ruth L. Kirschstein National Research Service Award [F31]; New York Stem Cell Initiative (NYSTEM); National Institutes of Health [R01 MH068542]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH079088, R01MH091844, R01MH068542, K99MH086615] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Sackler Institute of Columbia University; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Initiative (NYSTEM); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Gordon, S. Fusi, C. Kellendonk, H. Scharfman and members of the Hen laboratory for comments on the manuscript and discussions about the project. We thank E. Pavlopoulos for consultation on spatial learning, and M. Drew and C. A. Denny for input on the novel object recognition test. A. S. was supported by a 2009 National Institute of Mental Health Grant (1K99MH86615-01), 2006 and 2008 National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Awards, and a 2008 Sackler Institute of Columbia University Award. K.N.S. was supported by a Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows (F31). R. H. was supported by grants from NARSAD, the New York Stem Cell Initiative (NYSTEM) and the National Institutes of Health (R01 MH068542).	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Chen ACH, 2001, BIOL PSYCHIAT, V49, P753, DOI 10.1016/S0006-3223(00)01114-8; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Lever C, 2006, REV NEUROSCIENCE, V17, P111; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; TRONEL S, 2010, HIPPOCAMPUS     1103, DOI DOI 10.1002/HIPO.20895; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; YASSA M, 2010, HIPPOCAMPUS     0520, DOI DOI 10.1002/HIPO.20808; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	36	1029	1061	12	253	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					466	U539		10.1038/nature09817	http://dx.doi.org/10.1038/nature09817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21460835	Green Accepted, Green Submitted			2022-12-24	WOS:000289949600033
J	Baldwin, DR; White, B; Schmidt-Hansen, M; Champion, AR; Melder, AM				Baldwin, D. R.; White, B.; Schmidt-Hansen, M.; Champion, A. R.; Melder, A. M.			Diagnosis and treatment of lung cancer: summary of updated NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Baldwin, D. R.; White, B.] Nottingham Univ Hosp NHS Trust, Nottingham NG5 1PB, England; [Schmidt-Hansen, M.; Champion, A. R.] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales; [Melder, A. M.] Ctr Clin Effectiveness, Clayton, Vic 3168, Australia	Nottingham University Hospital NHS Trust	Baldwin, DR (corresponding author), Univ Nottingham Hosp, David Evans Res Ctr, Resp Med Unit, City Campus,Hucknall Rd, Nottingham NG5 1PB, England.	david.baldwin@nuh.nhs.uk						[Anonymous], 2008, ERL TREATM NONSM CEL; Cancer Research UK, 2009, CANC MORT UK STAT; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Falcoz PE, 2007, J THORAC CARDIOV SUR, V133, P325, DOI 10.1016/j.jtcvs.2006.09.020; *NAT I HLTH CLIN, 2011, DIAGN TREATM LUNG CA; *NAT I HLTH CLIN E, 2009, TOP TREATM REL SMALL; *NAT I HLTH CLIN E, 2010, GEF 1 LIN TREATM LOC; National Institute for Health and Clinical Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2009, PEM 1 LIN TREATM NON; *NHS INF CTR, 2009, IC23090809 NHS INF C	10	53	54	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 27	2011	342								d2110	10.1136/bmj.d2110	http://dx.doi.org/10.1136/bmj.d2110			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759BT	21525094				2022-12-24	WOS:000290215600002
J	Wang, KC; Yang, YW; Liu, B; Sanyal, A; Corces-Zimmerman, R; Chen, Y; Lajoie, BR; Protacio, A; Flynn, RA; Gupta, RA; Wysocka, J; Lei, M; Dekker, J; Helms, JA; Chang, HY				Wang, Kevin C.; Yang, Yul W.; Liu, Bo; Sanyal, Amartya; Corces-Zimmerman, Ryan; Chen, Yong; Lajoie, Bryan R.; Protacio, Angeline; Flynn, Ryan A.; Gupta, Rajnish A.; Wysocka, Joanna; Lei, Ming; Dekker, Job; Helms, Jill A.; Chang, Howard Y.			A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression	NATURE			English	Article							ANATOMIC DEMARCATION; HISTONE H3; TRANSCRIPTION; ELEMENTS; METHYLATION; DIVERSITY; GENOME; 5C	The genome is extensively transcribed into long intergenic noncoding RNAs (lincRNAs), many of which are implicated in gene silencing(1,2). Potential roles of lincRNAs in gene activation are much less understood(3-5). Development and homeostasis require coordinate regulation of neighbouring genes through a process termed locus control(6). Some locus control elements and enhancers transcribe lincRNAs(7-10), hinting at possible roles in long-range control. In vertebrates, 39 Hox genes, encoding homeodomain transcription factors critical for positional identity, are clustered in four chromosomal loci; the Hox genes are expressed in nested anterior-posterior and proximal-distal patterns colinear with their genomic position from 3' to 5' of the cluster(11). Here we identify HOTTIP, a lincRNA transcribed from the 5' tip of the HOXA locus that coordinates the activation of several 5' HOXA genes in vivo. Chromosomal looping brings HOTTIP into close proximity to its target genes. HOTTIP RNA binds the adaptor protein WDR5 directly and targets WDR5/MLL complexes across HOXA, driving histone H3 lysine 4 trimethylation and gene transcription. Induced proximity is necessary and sufficient for HOTTIP RNA activation of its target genes. Thus, by serving as key intermediates that transmit information from higher order chromosomal looping into chromatin modifications, lincRNAs may organize chromatin domains to coordinate long-range gene activation.	[Wang, Kevin C.; Yang, Yul W.; Corces-Zimmerman, Ryan; Protacio, Angeline; Flynn, Ryan A.; Gupta, Rajnish A.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Program Epithelial Biol, Stanford, CA 94305 USA; [Wang, Kevin C.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA; [Liu, Bo; Helms, Jill A.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Sanyal, Amartya; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Gene Funct & Express, Worcester, MA 01605 USA; [Chen, Yong; Lei, Ming] Univ Michigan, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; University of California System; University of California San Francisco; Stanford University; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Stanford University	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu	SANYAL, AMARTYA/D-7240-2015; Jha, Rajneesh/L-5606-2017; Chen, Yong/AAF-9915-2020; Corces, M. Ryan/ABG-6947-2020	SANYAL, AMARTYA/0000-0002-2109-4478; Chen, Yong/0000-0001-5857-6086; Corces, M. Ryan/0000-0001-7465-7652; Helms, Jill/0000-0002-0463-396X; Wang, Kevin/0000-0002-5305-6791; Flynn, Ryan/0000-0001-5013-0442	California Institute for Regenerative Medicine; National Institutes of Health [HG003143]; Scleroderma Research Foundation; Dermatology Foundation; W. M. Keck Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; Dermatology Foundation; W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank C. Tabin for chick Hox gene probes, M. Scott and members of our labs for input, and M. Lin for use of the confocal microscope and imaging expertise. Supported by grants from the California Institute for Regenerative Medicine (H.Y.C., J.W.), the National Institutes of Health (HG003143 to J.D.), and the Scleroderma Research Foundation (H.Y.C.). K.C.W. is a recipient of a Dermatology Foundation Career Development Award. J.D. is a recipient of the W. M. Keck Foundation Distinguished Young Scholar Award. H.Y.C. and M.L. are Early Career Scientists of the Howard Hughes Medical Institute.	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chang HY, 2009, SCIENCE, V326, P1206, DOI 10.1126/science.1175686; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Harpavat S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-2; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Michlewski G, 2010, RNA, V16, P1673, DOI 10.1261/rna.2136010; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rinn JL, 2008, J INVEST DERMATOL, V128, P776, DOI 10.1038/sj.jid.5700986; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Sasaki YTF, 2007, BIOCHEM BIOPH RES CO, V357, P724, DOI 10.1016/j.bbrc.2007.03.200; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	45	1462	1541	3	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					120	U158		10.1038/nature09819	http://dx.doi.org/10.1038/nature09819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21423168	Green Accepted			2022-12-24	WOS:000289199400049
J	Wang, ZN; Klipfell, E; Bennett, BJ; Koeth, R; Levison, BS; Dugar, B; Feldstein, AE; Britt, EB; Fu, XM; Chung, YM; Wu, YP; Schauer, P; Smith, JD; Allayee, H; Tang, WHW; DiDonato, JA; Lusis, AJ; Hazen, SL				Wang, Zeneng; Klipfell, Elizabeth; Bennett, Brian J.; Koeth, Robert; Levison, Bruce S.; Dugar, Brandon; Feldstein, Ariel E.; Britt, Earl B.; Fu, Xiaoming; Chung, Yoon-Mi; Wu, Yuping; Schauer, Phil; Smith, Jonathan D.; Allayee, Hooman; Tang, W. H. Wilson; DiDonato, Joseph A.; Lusis, Aldons J.; Hazen, Stanley L.			Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease	NATURE			English	Article							TRIMETHYLAMINE-N-OXIDE; CORONARY-HEART-DISEASE; GENE-EXPRESSION; CHLAMYDIA-PNEUMONIAE; MURINE MACROPHAGES; MASS-SPECTROMETRY; DNA METHYLATION; ATHEROSCLEROSIS; MOUSE; MICE	Metabolomics studies hold promise for the discovery of pathways linked to disease processes. Cardiovascular disease (CVD) represents the leading cause of death and morbidity worldwide. Here we used a metabolomics approach to generate unbiased small-molecule metabolic profiles in plasma that predict risk for CVD. Three metabolites of the dietary lipid phosphatidylcholine-choline, trimethylamine N-oxide (TMAO) and betaine-were identified and then shown to predict risk for CVD in an independent large clinical cohort. Dietary supplementation of mice with choline, TMAO or betaine promoted upregulation of multiple macrophage scavenger receptors linked to atherosclerosis, and supplementation with choline or TMAO promoted atherosclerosis. Studies using germ-free mice confirmed a critical role for dietary choline and gut flora in TMAO production, augmented macrophage cholesterol accumulation and foam cell formation. Suppression of intestinal microflora in atherosclerosis-prone mice inhibited dietary-choline-enhanced atherosclerosis. Genetic variations controlling expression of flavin monooxygenases, an enzymatic source of TMAO, segregated with atherosclerosis in hyperlipidaemic mice. Discovery of a relationship between gut-flora-dependent metabolism of dietary phosphatidylcholine and CVD pathogenesis provides opportunities for the development of new diagnostic tests and therapeutic approaches for atherosclerotic heart disease.	[Wang, Zeneng; Klipfell, Elizabeth; Koeth, Robert; Levison, Bruce S.; Dugar, Brandon; Feldstein, Ariel E.; Britt, Earl B.; Fu, Xiaoming; Chung, Yoon-Mi; Smith, Jonathan D.; Tang, W. H. Wilson; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Wang, Zeneng; Klipfell, Elizabeth; Levison, Bruce S.; Feldstein, Ariel E.; Britt, Earl B.; Fu, Xiaoming; Chung, Yoon-Mi; Tang, W. H. Wilson; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Bennett, Brian J.; Lusis, Aldons J.] Univ Calif Los Angeles, Ctr Hlth Sci BH 307, Div Cardiol, Dept Med, Los Angeles, CA 90095 USA; [Wu, Yuping] Cleveland State Univ, Dept Math, Cleveland, OH 44115 USA; [Schauer, Phil] Cleveland Clin, Bariatr & Metab Inst, Cleveland, OH 44195 USA; [Smith, Jonathan D.; Tang, W. H. Wilson; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Allayee, Hooman] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Allayee, Hooman] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90089 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Southern California; University of Southern California	Hazen, SL (corresponding author), Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA.	hazens@ccf.org	Wang, Zeneng/AAK-6119-2021; Tang, Wai Hong Wilson/I-1238-2013; Lorkiewicz, Pawel/A-2126-2011; Hazen, Stanley L/ABD-5845-2021; Smith, Jonathan D./H-9723-2013	Lorkiewicz, Pawel/0000-0002-1755-9826; Schauer, Philip/0000-0002-4029-7537; bennett, brian/0000-0002-0766-3195; Levison, Bruce/0000-0002-1816-368X; Tang, W. H. Wilson/0000-0002-8335-735X; Smith, Jonathan D./0000-0002-0415-386X	National Institutes of Health [R01 HL103866, P01 HL098055, P01HL087018-020001, P01 HL28481, P01 HL30568, T32-DK07789]; Cleveland Clinic Foundation General Clinical Research Center of the Cleveland Clinic/Case Western Reserve University CTSA [1UL1RR024989]; Abbott Diagnostics;  [P01 HL076491-055328];  [R01 HL103931];  [R01 DK080732]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, P01HL098055, R01HL103931, P01HL076491, R01HL103866, P01HL030568, P01HL087018, R01HL098193, K99HL102223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007789, R01DK080732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Clinic Foundation General Clinical Research Center of the Cleveland Clinic/Case Western Reserve University CTSA; Abbott Diagnostics(Abbott Laboratories); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We wish to thank E. Sehayek for discussions, L. W. Castellani for help with lipoprotein profile analysis, and F. McNally, M. Berk and M. Pepoy for technical assistance. This research was supported by National Institutes of Health grants R01 HL103866, P01 HL098055, P01HL087018-020001, P01 HL28481 and P01 HL30568. B.J.B. was supported by NIH training grant T32-DK07789. The clinical study GeneBank was supported in part by P01 HL076491-055328, R01 HL103931 and the Cleveland Clinic Foundation General Clinical Research Center of the Cleveland Clinic/Case Western Reserve University CTSA (1UL1RR024989). Some of the laboratory studies (haemaglobin A1C, fasting glucose) in GeneBank were supported by R01 DK080732 and Abbott Diagnostics provided supplies for performance of some of the fasting lipid profile, glucose, creatinine, troponin I and hsCRP measured in GeneBank.	Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6; Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baglione Julie, 2006, V129, P83; Bain MA, 2006, NEPHROL DIAL TRANSPL, V21, P1300, DOI 10.1093/ndt/gfk056; Barham Ann Hiott, 2009, Prev Cardiol, V12, P95, DOI 10.1111/j.1751-7141.2008.00019.x; Bidulescu Aurelian, 2007, BMC Cardiovasc Disord, V7, P20, DOI 10.1186/1471-2261-7-20; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; Cashman JR, 2003, CURR DRUG METAB, V4, P151, DOI 10.2174/1389200033489505; CHEN FCM, 1976, CAN J CHEM, V54, P3310, DOI 10.1139/v76-475; DACOSTA KA, 1990, ANAL BIOCHEM, V187, P234, DOI 10.1016/0003-2697(90)90449-J; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danne O, 2007, CLIN CHIM ACTA, V383, P103, DOI 10.1016/j.cca.2007.05.001; de Vries TJ, 2009, J LEUKOCYTE BIOL, V85, P919, DOI 10.1189/jlb.0708402; Deichmann M, 1999, J CLIN ONCOL, V17, P1891, DOI 10.1200/JCO.1999.17.6.1891; Devlin GL, 2001, AM J RESP CELL MOL, V24, P727, DOI 10.1165/ajrcmb.24.6.4407; Dolphin CT, 1997, NAT GENET, V17, P491, DOI 10.1038/ng1297-491; Dong CM, 2002, J NUTR, V132, p2406S, DOI 10.1093/jn/132.8.2406S; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Epstein SE, 1996, LANCET, V348, pS13, DOI 10.1016/S0140-6736(96)98005-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; GADDIS ML, 1990, ANN EMERG MED, V19, P1462, DOI 10.1016/S0196-0644(05)82622-8; Gautam S, 1997, BIOMETRICS, V53, P1163, DOI 10.2307/2533575; GAUVREAU K, 1993, NUTRITION, V9, P386; GOODALL CM, 1986, J APPL TOXICOL, V6, P95, DOI 10.1002/jat.2550060206; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; LeLeiko RM, 2009, AM J CARDIOL, V104, P638, DOI 10.1016/j.amjcard.2009.04.047; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; Miles EA, 2000, ATHEROSCLEROSIS, V152, P43, DOI 10.1016/S0021-9150(99)00446-3; Millward CA, 2009, MAMM GENOME, V20, P71, DOI 10.1007/s00335-008-9165-2; Mitchell SC, 2001, DRUG METAB DISPOS, V29, P517; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Nicholls SJ, 2010, J LIPID RES, V51, P3055, DOI 10.1194/jlr.M008961; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rasooly R, 2007, BRIT J NUTR, V97, P58, DOI 10.1017/S0007114507257745; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Rizzo ML, 2008, STAT COMPUTING R; Robinet P, 2010, J LIPID RES, V51, P3364, DOI 10.1194/jlr.D007336; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; SALMON WD, 1962, ARCH PATHOL, V73, P190; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Song JL, 2001, J BIOL CHEM, V276, P40241, DOI 10.1074/jbc.M107242200; Stoves J, 2002, NEPHROL DIAL TRANSPL, V17, P2036, DOI 10.1093/ndt/17.11.2036; Traissac P, 1999, REV EPIDEMIOL SANTE, V47, P593; Treberg JR, 2002, J EXP BIOL, V205, P1419; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Westendorf T, 2005, MOL CELL BIOCHEM, V277, P143, DOI 10.1007/s11010-005-5873-z; Wijnand HP, 2000, COMPUT METH PROG BIO, V63, P21, DOI 10.1016/S0169-2607(00)00058-4; Wright SD, 2000, J EXP MED, V191, P1437, DOI 10.1084/jem.191.8.1437; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zaina S, 2005, J NUTR, V135, P5, DOI 10.1093/jn/135.1.5; Zeisel SH, 2003, J NUTR, V133, P1302; Zhang AQ, 1999, FOOD CHEM TOXICOL, V37, P515, DOI 10.1016/S0278-6915(99)00028-9; Zhang J, 2006, DRUG METAB DISPOS, V34, P19, DOI 10.1124/dmd.105.006171; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	68	3220	3446	50	1323	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					57	U82		10.1038/nature09922	http://dx.doi.org/10.1038/nature09922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475195	Green Accepted, Green Submitted			2022-12-24	WOS:000289199400036
J	Edlich, F; Banerjee, S; Suzuki, M; Cleland, MM; Arnoult, D; Wang, CX; Neutzner, A; Tjandra, N; Youle, RJ				Edlich, Frank; Banerjee, Soojay; Suzuki, Motoshi; Cleland, Megan M.; Arnoult, Damien; Wang, Chunxin; Neutzner, Albert; Tjandra, Nico; Youle, Richard J.			Bcl-x(L) Retrotranslocates Bax from the Mitochondria into the Cytosol	CELL			English	Article							PROSURVIVAL BCL-2 PROTEINS; CELL-DEATH; MEMBRANE PERMEABILIZATION; CYTOCHROME-C; APOPTOTIC FUNCTION; BH3-ONLY PROTEINS; PROAPOPTOTIC BAX; DISULFIDE BONDS; BH3 DOMAINS; FAMILY	The Bcl-2 family member Bax translocates from the cytosol to mitochondria, where it oligomerizes and permeabilizes the mitochondrial outer membrane to promote apoptosis. Bax activity is counteracted by prosurvival Bcl-2 proteins, but how they inhibit Bax remains controversial because they neither colocalize nor form stable complexes with Bax. We constrained Bax in its native cytosolic conformation within cells using intramolecular disulfide tethers. Bax tethers disrupt interaction with Bcl-x(L) in detergents and cell-free MOMP activity but unexpectedly induce Bax accumulation on mitochondria. Fluorescence loss in photobleaching (FLIP) reveals constant retrotranslocation of WT Bax, but not tethered Bax, from the mitochondria into the cytoplasm of healthy cells. Bax retrotranslocation depends on prosurvival Bcl-2 family proteins, and inhibition of retrotranslocation correlates with Bax accumulation on the mitochondria. We propose that Bcl-x(L) inhibits and maintains Bax in the cytosol by constant retrotranslocation of mitochondrial Bax.	[Edlich, Frank; Banerjee, Soojay; Cleland, Megan M.; Wang, Chunxin; Youle, Richard J.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Suzuki, Motoshi; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Neutzner, Albert] Univ Spital Basel, Augenklin, CH-4031 Basel, Switzerland; [Arnoult, Damien] Hop Paul Brousse, INSERM, U1014, F-94807 Villejuif, France	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Basel; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Youle, RJ (corresponding author), NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.	youle@helix.nih.gov	Arnoult, Damien/R-2032-2018; Wang, Chunxin/B-9312-2016; Neutzner, Albert/ABC-4368-2020	Wang, Chunxin/0000-0001-6015-6806; Neutzner, Albert/0000-0001-9254-5558; Suzuki, Motoshi/0000-0002-4346-7677; Harwig, Megan/0000-0003-2140-5739	Leopoldina, National Academy of Sciences, Germany; La Ligue contre le Cancer; NHLBI; NINDS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002859] Funding Source: NIH RePORTER	Leopoldina, National Academy of Sciences, Germany; La Ligue contre le Cancer(Ligue nationale contre le cancer); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. D. W. Andrews and Dr. J.-C. Martinou for helpful discussions and comments. We also thank Dr. D. R. Green for the Omi-mCherry construct. This work is supported by the Leopoldina, National Academy of Sciences, Germany (F. E.); La Ligue contre le Cancer (D. A.); the NHLBI (M. S. and N.T.); and the NINDS intramural programs.	Arnoult D, 2004, P NATL ACAD SCI USA, V101, P7988, DOI 10.1073/pnas.0401897101; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Gilmore AP, 2000, J CELL BIOL, V149, P431, DOI 10.1083/jcb.149.2.431; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Locker JK, 1999, J CELL BIOL, V144, P267, DOI 10.1083/jcb.144.2.267; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schouten A, 2002, J BIOL CHEM, V277, P19339, DOI 10.1074/jbc.M201245200; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang GQ, 2001, J BIOL CHEM, V276, P3610, DOI 10.1074/jbc.M006222200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	41	414	433	5	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					104	116		10.1016/j.cell.2011.02.034	http://dx.doi.org/10.1016/j.cell.2011.02.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458670	Green Accepted, Bronze			2022-12-24	WOS:000289053900013
J	Lachke, SA; Alkuraya, FS; Kneeland, SC; Ohn, T; Aboukhalil, A; Howell, GR; Saadi, I; Cavallesco, R; Yue, YZ; Tsai, ACH; Nair, KS; Cosma, MI; Smith, RS; Hodges, E; AlFadhli, SM; Al-Hajeri, A; Shamseldin, HE; Behbehani, A; Hannon, GJ; Bulyk, ML; Drack, AV; Anderson, PJ; John, SWM; Maas, RL				Lachke, Salil A.; Alkuraya, Fowzan S.; Kneeland, Stephen C.; Ohn, Takbum; Aboukhalil, Anton; Howell, Gareth R.; Saadi, Irfan; Cavallesco, Resy; Yue, Yingzi; Tsai, Anne C-H.; Nair, K. Saidas; Cosma, Mihai I.; Smith, Richard S.; Hodges, Emily; AlFadhli, Suad M.; Al-Hajeri, Amal; Shamseldin, Hanan E.; Behbehani, AbdulMutalib; Hannon, Gregory J.; Bulyk, Martha L.; Drack, Arlene V.; Anderson, Paul J.; John, Simon W. M.; Maas, Richard L.			Mutations in the RNA Granule Component TDRD7 Cause Cataract and Glaucoma	SCIENCE			English	Article							CYTOPLASMIC PROCESSING BODIES; MAMMALIAN STRESS GRANULES; EUKARYOTIC MESSENGER-RNAS; MALE GERM-CELLS; P-BODIES; CHROMATOID BODY; TRANSLATION; PROTEINS; DECAY; LOCALIZATION	The precise transcriptional regulation of gene expression is essential for vertebrate development, but the role of posttranscriptional regulatory mechanisms is less clear. Cytoplasmic RNA granules (RGs) function in the posttranscriptional control of gene expression, but the extent of RG involvement in organogenesis is unknown. We describe two human cases of pediatric cataract with loss-of-function mutations in TDRD7 and demonstrate that Tdrd7 nullizygosity in mouse causes cataracts, as well as glaucoma and an arrest in spermatogenesis. TDRD7 is a Tudor domain RNA binding protein that is expressed in lens fiber cells in distinct TDRD7-RGs that interact with STAU1-ribonucleoproteins (RNPs). TDRD7 coimmunoprecipitates with specific lens messenger RNAs (mRNAs) and is required for the posttranscriptional control of mRNAs that are critical to normal lens development and to RG function. These findings demonstrate a role for RGs in vertebrate organogenesis.	[Kneeland, Stephen C.; Howell, Gareth R.; Nair, K. Saidas; Cosma, Mihai I.; Smith, Richard S.; John, Simon W. M.] Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; [Kneeland, Stephen C.; Howell, Gareth R.; Nair, K. Saidas; Cosma, Mihai I.; Smith, Richard S.; John, Simon W. M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Lachke, Salil A.; Alkuraya, Fowzan S.; Aboukhalil, Anton; Saadi, Irfan; Cavallesco, Resy; Yue, Yingzi; Bulyk, Martha L.; Maas, Richard L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard Massachusetts Inst Technol Div Hlth Sci &, Boston, MA 02115 USA; [Alkuraya, Fowzan S.; Shamseldin, Hanan E.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Riyadh 11461, Saudi Arabia; [Ohn, Takbum; Anderson, Paul J.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Aboukhalil, Anton] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Tsai, Anne C-H.] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA; [Cosma, Mihai I.] Maine Med Ctr, Dept Med, Portland, ME 04102 USA; [Hodges, Emily; Hannon, Gregory J.] Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hodges, Emily; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [AlFadhli, Suad M.; Al-Hajeri, Amal] Kuwait Univ, Fac Allied Hlth Sci, Kuwait 13060, Kuwait; [Behbehani, AbdulMutalib] Kuwait Univ, Fac Med, Dept Surg, Alsafat 13110, Kuwait; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Drack, Arlene V.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [John, Simon W. M.] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Jackson Laboratory; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; King Faisal Specialist Hospital & Research Center; Alfaisal University; King Saud University; King Saud University; King Khalid University Hospital; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Maine Medical Center; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Kuwait University; Kuwait University; Harvard University; Brigham & Women's Hospital; University of Iowa; Tufts University	John, SWM (corresponding author), Howard Hughes Med Inst, 600 Main St, Bar Harbor, ME 04609 USA.	simon.john@jax.org; maas@genetics.med.harvard.edu	Hannon, Gregory/AAB-3568-2019; Alkuraya, Fowzan S./A-1542-2009; Saadi, Irfan/I-5989-2019	Alkuraya, Fowzan S./0000-0003-4158-341X; Saadi, Irfan/0000-0002-6250-6651; Lachke, Salil/0000-0001-8845-010X; Hodges, Emily/0000-0001-6513-610X; Drack, Arlene/0000-0002-8195-8426	Barbara and Joseph Cohen Foundation; Peace by Pieces Fund; Dubai Harvard Foundation for Medical Research; Kuwait University [YM01/09]; Foundation Fighting Blindness; American Heart Association;  [R01 EY10123];  [R01 HD060050];  [P01 GM061354];  [KACST 08-MED497-20];  [R01 EY11721]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060050] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010123, R01EY011721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	Barbara and Joseph Cohen Foundation; Peace by Pieces Fund; Dubai Harvard Foundation for Medical Research; Kuwait University; Foundation Fighting Blindness(European Commission); American Heart Association(American Heart Association); ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 EY10123, R01 HD060050, P01 GM061354, KACST 08-MED497-20, R01 EY11721, The Barbara and Joseph Cohen Foundation, The Peace by Pieces Fund, and the Dubai Harvard Foundation for Medical Research. S.M.A. is supported by a grant from Kuwait University (YM01/09). A.V.D. was supported by a Marjorie Carr Adams Career Development Award from the Foundation Fighting Blindness. A.A. is supported by an American Heart Association Predoctoral Fellowship. S.W.M.J. and G.J.H. are Investigators of the Howard Hughes Medical Institute. We thank C. Cepko for advice on the chick experiments, L. Reinholdt for assistance in assessing male sterility, A. Bell for technical assistance, J. Reddan and V. Reddy for their gifts of lens cell lines, and the patients and their families for participating in this research. All microarray data are deposited in the Gene Expression Omnibus database (www.ncbi.nih.gov/geo), and the accession number for the SuperSeries for all data files is GSE25812.	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Alkuraya FS, 2010, GENET MED, V12, P236, DOI 10.1097/GIM.0b013e3181ceb95d; Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-13; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fu L, 2003, BIOCHEM BIOPH RES CO, V302, P710, DOI 10.1016/S0006-291X(03)00257-2; Fu L, 2002, J BIOL CHEM, V277, P4255, DOI 10.1074/jbc.M110027200; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Haque MSR, 1999, MOL VIS, V5, pU1; Harpavat S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-2; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Hosokawa M, 2007, DEV BIOL, V301, P38, DOI 10.1016/j.ydbio.2006.10.046; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Roegiers F, 2000, TRENDS CELL BIOL, V10, P220, DOI 10.1016/S0962-8924(00)01767-0; Sacca SC, 2008, PROG BRAIN RES, V173, P385, DOI 10.1016/S0079-6123(08)01127-8; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sinsimer KS, 2008, MOL CELL BIOL, V28, P5223, DOI 10.1128/MCB.00431-08; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI 10.1073/pnas.0804583105; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008	37	132	138	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1571	1576		10.1126/science.1195970	http://dx.doi.org/10.1126/science.1195970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436445	Green Accepted			2022-12-24	WOS:000288754500046
J	Larschan, E; Bishop, EP; Kharchenko, PV; Core, LJ; Lis, JT; Park, PJ; Kuroda, MI				Larschan, Erica; Bishop, Eric P.; Kharchenko, Peter V.; Core, Leighton J.; Lis, John T.; Park, Peter J.; Kuroda, Mitzi I.			X chromosome dosage compensation via enhanced transcriptional elongation in Drosophila	NATURE			English	Article							MSL COMPLEX; H4-K16 ACETYLATION; ANALYSIS REVEALS; RNA-POLYMERASE; GENES; GENOME; MELANOGASTER; INITIATION; YEAST; MOF	The evolution of sex chromosomes has resulted innumerous species in which females inherit two X chromosomes but males have a single X, thus requiring dosage compensation. MSL (Male-specific lethal) complex increases transcription on the single X chromosome of Drosophila males to equalize expression of X-linked genes between the sexes(1). The biochemical mechanisms used for dosage compensation must function over a wide dynamic range of transcription levels and differential expression patterns. It has been proposed(2) that the MSL complex regulates transcriptional elongation to control dosage compensation, a model subsequently supported by mapping of the MSL complex and MSL-dependent histone 4 lysine 16 acetylation to the bodies of X-linked genes in males, with a bias towards 39 ends(3-7). However, experimental analysis of MSL function at the mechanistic level has been challenging owing to the small magnitude of the chromosome-wide effect and the lack of an in vitro system for biochemical analysis. Here we use global run-on sequencing (GRO-seq) 8 to examine the specific effect of the MSL complex on RNA Polymerase II (RNAP II) on a genome-wide level. Results indicate that the MSL complex enhances transcription by facilitating the progression of RNAP II across the bodies of active X-linked genes. Improving transcriptional output downstream of typical gene-specific controls may explain how dosage compensation can be imposed on the diverse set of genes along an entire chromosome.	[Larschan, Erica; Kuroda, Mitzi I.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Larschan, Erica; Kuroda, Mitzi I.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Larschan, Erica] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Bishop, Eric P.; Kharchenko, Peter V.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Bishop, Eric P.; Kharchenko, Peter V.; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Bishop, Eric P.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Core, Leighton J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Boston University; Cornell University	Kuroda, MI (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	peter_park@harvard.edu; mkuroda@genetics.med.harvard.edu		Park, Peter/0000-0001-9378-960X	NIH [GM45744, GM082798, HG4845]; Medical Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045744, R01GM082798, R01GM045744] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. M. Winston, S. Buratowski, A. Alekseyenko, M. Gelbart, C. Wang and A. Gortchakov for comments on the manuscript, and are grateful to N. Gehlenborg for graphic design expertise. This work was supported by the following NIH grants: GM45744 (M.I.K.), GM082798 (P.J.P.) and HG4845 (J.T.L.). E.L. was supported by a Charles A. King Trust fellowship from the Medical Foundation.	Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Bai XY, 2004, EMBO J, V23, P2853, DOI 10.1038/sj.emboj.7600299; BELOTE JM, 1980, GENETICS, V96, P165; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Oh K, 2003, GENE DEV, V17, P1334, DOI 10.1101/gad.1082003; Park Y, 2002, SCIENCE, V298, P1620, DOI 10.1126/science.1076686; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	28	136	135	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					115	U139		10.1038/nature09757	http://dx.doi.org/10.1038/nature09757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368835	Green Accepted			2022-12-24	WOS:000287924100045
J	Ressler, KJ; Mercer, KB; Bradley, B; Jovanovic, T; Mahan, A; Kerley, K; Norrholm, SD; Kilaru, V; Smith, AK; Myers, AJ; Ramirez, M; Engel, A; Hammack, SE; Toufexis, D; Braas, KM; Binder, EB; May, V				Ressler, Kerry J.; Mercer, Kristina B.; Bradley, Bekh; Jovanovic, Tanja; Mahan, Amy; Kerley, Kimberly; Norrholm, Seth D.; Kilaru, Varun; Smith, Alicia K.; Myers, Amanda J.; Ramirez, Manuel; Engel, Anzhelika; Hammack, Sayamwong E.; Toufexis, Donna; Braas, Karen M.; Binder, Elisabeth B.; May, Victor			Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor	NATURE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; ADENYLATE-CYCLASE; SIGNAL-TRANSDUCTION; BRAIN-DEVELOPMENT; STRIA TERMINALIS; GENE-EXPRESSION; FEAR INHIBITION; BED NUCLEUS; AMYGDALA; PTSD	Pituitary adenylate cyclase-activating polypeptide (PACAP) is known to broadly regulate the cellular stress response. In contrast, it is unclear if the PACAP-PAC1 receptor pathway has a role in human psychological stress responses, such as post-traumatic stress disorder (PTSD). Here we find, in heavily traumatized subjects, a sex-specific association of PACAP blood levels with fear physiology, PTSD diagnosis and symptoms in females. We examined 44 single nucleotide polymorphisms (SNPs) spanning the PACAP (encoded by ADCYAP1) and PAC1 (encoded by ADCYAP1R1) genes, demonstrating a sex-specific association with PTSD. A single SNP in a putative oestrogen response element within ADCYAP1R1, rs2267735, predicts PTSD diagnosis and symptoms in females only. This SNP also associates with fear discrimination and with ADCYAP1R1 messenger RNA expression in human brain. Methylation of ADCYAP1R1 in peripheral blood is also associated with PTSD. Complementing these human data, ADCYAP1R1 mRNA is induced with fear conditioning or oestrogen replacement in rodent models. These data suggest that perturbations in the PACAP-PAC1 pathway are involved in abnormal stress responses underlying PTSD. These sex-specific effects may occur via oestrogen regulation of ADCYAP1R1. PACAP levels and ADCYAP1R1 SNPs may serve as useful biomarkers to further our mechanistic understanding of PTSD.	[Ressler, Kerry J.; Mercer, Kristina B.; Kerley, Kimberly] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ressler, Kerry J.; Bradley, Bekh; Jovanovic, Tanja; Norrholm, Seth D.; Kilaru, Varun; Smith, Alicia K.; Binder, Elisabeth B.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Bradley, Bekh; Norrholm, Seth D.] Atlanta VA Med Ctr, Atlanta, GA 30033 USA; [Ressler, Kerry J.; Mahan, Amy; Toufexis, Donna] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Myers, Amanda J.; Ramirez, Manuel; Engel, Anzhelika] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Hammack, Sayamwong E.; Toufexis, Donna] Univ Vermont, Dept Psychol, Burlington, VT 05401 USA; [Braas, Karen M.; May, Victor] Univ Vermont, Coll Med, Dept Anat & Neurobiol, Burlington, VT 05401 USA; [Braas, Karen M.; May, Victor] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05401 USA; [Binder, Elisabeth B.] Max Planck Inst Psychiat, D-80804 Munich, Germany	Howard Hughes Medical Institute; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; University of Miami; University of Vermont; University of Vermont; University of Vermont; Max Planck Society	Ressler, KJ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	kressle@emory.edu	Binder, Elisabeth B/K-8905-2014; Norrholm, Seth/AAC-2464-2022; Bradley, Bekh/H-8399-2012; Ressler, Kerry J/N-8741-2018; Smith, Alicia/W-6809-2019; Myers, Amanda J/B-1796-2010	Ressler, Kerry J/0000-0002-5158-1103; Smith, Alicia/0000-0002-8537-5156; Myers, Amanda J/0000-0002-3100-9396	NIH [MH071537, DA019624, HD27468]; Emory and Grady Memorial Hospital General Clinical Research Center; NIH National Centers for Research Resources [M01RR00039, P20RR16435]; American Foundation for Suicide Prevention; Burroughs Wellcome Fund; National Institute on Aging [AG034504]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027468] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435, M01RR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH071537, R01MH071537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019624] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory and Grady Memorial Hospital General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Centers for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Foundation for Suicide Prevention; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was primarily supported by NIH grant MH071537 (K.J.R.), as well as DA019624 (K.J.R.) and HD27468 (V. M.). Support was also received from Emory and Grady Memorial Hospital General Clinical Research Center, NIH National Centers for Research Resources (M01RR00039 and P20RR16435), the American Foundation for Suicide Prevention (B. B.) and the Burroughs Wellcome Fund (K.J.R.). RNA samples were run using the Oncogenomics Core Facility at University of Miami. A.J.M. is supported by The National Institute on Aging (AG034504). We thank J.F. Cubells, Y. Tang and K. Conneely for discussions. We thank the Grady Trauma Project, including C. F. Gillespie, A. Schwartz, A. Wingo, D. A. Gutman and T. Weiss for medical support; A. Graham, A. Brown, J. Phifer, D. Crain, A. Kamkwalala, J. Poole, D. Cross, N. Fani and A. Smith for clinical research support; and K. Schutz, E. Reiser and C. Fitzgerald for molecular/genetics technical support. Methylation chip assays were performed by the Emory University Biomarkers Service Center.	Aenlle KK, 2009, NEUROBIOL AGING, V30, P932, DOI 10.1016/j.neurobiolaging.2007.09.004; Bangasser DA, 2010, MOL PSYCHIATR, V15, P896, DOI 10.1038/mp.2010.66; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dejda A, 2008, J MOL NEUROSCI, V36, P26, DOI 10.1007/s12031-008-9087-1; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Ghzili H, 2008, FRONT NEUROENDOCRIN, V29, P128, DOI 10.1016/j.yfrne.2007.10.001; Gillespie CF, 2009, GEN HOSP PSYCHIAT, V31, P505, DOI 10.1016/j.genhosppsych.2009.05.003; Gillespie CF, 2009, DEPRESS ANXIETY, V26, P984, DOI 10.1002/da.20605; Girard BA, 2006, J NEUROCHEM, V99, P499, DOI 10.1111/j.1471-4159.2006.04112.x; Grillon C, 1998, AM J PSYCHIAT, V155, P812; Hamelink C, 2002, P NATL ACAD SCI USA, V99, P461, DOI 10.1073/pnas.012608999; Hammack SE, 2009, PSYCHONEUROENDOCRINO, V34, P833, DOI 10.1016/j.psyneuen.2008.12.013; Hashimoto H, 2006, ANN NY ACAD SCI, V1070, P75, DOI 10.1196/annals.1317.038; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Jovanovic T, 2010, DEPRESS ANXIETY, V27, P244, DOI 10.1002/da.20663; LEDOUX JE, 1993, ANN NY ACAD SCI, V702, P149, DOI 10.1111/j.1749-6632.1993.tb17246.x; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MCEWEN BS, 1992, HORM RES, V37, P1, DOI 10.1159/000182393; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Shansky RM, 2010, CEREB CORTEX, V20, P2560, DOI 10.1093/cercor/bhq003; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Walker DL, 1997, J NEUROSCI, V17, P9375; Walker DL, 2002, PSYCHOPHARMACOLOGY, V159, P304, DOI 10.1007/s002130100913; Watanabe J, 2007, PEPTIDES, V28, P1713, DOI 10.1016/j.peptides.2007.06.029; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0	41	534	545	8	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					492	497		10.1038/nature09856	http://dx.doi.org/10.1038/nature09856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350482	Green Accepted			2022-12-24	WOS:000287652900033
J	Round, JL; Lee, SM; Li, J; Tran, G; Jabri, B; Chatila, TA; Mazmanian, SK				Round, June L.; Lee, S. Melanie; Li, Jennifer; Tran, Gloria; Jabri, Bana; Chatila, Talal A.; Mazmanian, Sarkis K.			The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human Microbiota	SCIENCE			English	Article							REGULATORY T-CELLS; BACTERIA; DIFFERENTIATION; MATURATION; DIVERSITY	Mucosal surfaces constantly encounter microbes. Toll-like receptors (TLRs) mediate recognition of microbial patterns to eliminate pathogens. By contrast, we demonstrate that the prominent gut commensal Bacteroides fragilis activates the TLR pathway to establish host-microbial symbiosis. TLR2 on CD4(+) T cells is required for B. fragilis colonization of a unique mucosal niche in mice during homeostasis. A symbiosis factor (PSA, polysaccharide A) of B. fragilis signals through TLR2 directly on Foxp3(+) regulatory T cells to promote immunologic tolerance. B. fragilis lacking PSA is unable to restrain T helper 17 cell responses and is defective in niche-specific mucosal colonization. Therefore, commensal bacteria exploit the TLR pathway to actively suppress immunity. We propose that the immune system can discriminate between pathogens and the microbiota through recognition of symbiotic bacterial molecules in a process that engenders commensal colonization.	[Round, June L.; Lee, S. Melanie; Li, Jennifer; Tran, Gloria; Mazmanian, Sarkis K.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jabri, Bana] Univ Chicago, Dept Med, Dept Pediat, Dept Pathol, Chicago, IL 60637 USA; [Chatila, Talal A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Immunol Allergy & Rheumatol, Los Angeles, CA 90095 USA	California Institute of Technology; University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Round, JL (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	jround@caltech.edu; sarkis@caltech.edu	Mazmanian, Sarkis/ABD-7729-2021	Mazmanian, Sarkis/0000-0003-2713-1513; Chatila, Talal/0000-0001-7439-2762	Crohn's and Colitis Foundation of America (CCFA) [2831, 2405]; NIH [AI 080002, DK 078938, DK 083633, AI 088626]; Damon Runyon Cancer Research Foundation; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080002, R21AI088626, R01AI085090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078938, R21DK083633, R56DK078938] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America (CCFA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. W. McBride and Y. Shen (California Institute for Technology) for help with bacterial colonization and germ-free studies. We are grateful to A. Rudensky [Memorial Sloan-Kettering Cancer Center and Howard Hughes Medical Institute (HHMI)] for the gift of Foxp3-DTR mice and L. Hooper (University of Texas Southwestern and HHMI) for germ-free Rag1<SUP>-/-</SUP> mice. We thank members of the Mazmanian laboratory for their critical review of the manuscript. B.J. acknowledges support from the Crohn's and Colitis Foundation of America (CCFA) (award 2831) and T.A.C acknowledges support from the NIH (grant AI 080002). J.L.R. is a Merck Fellow of the Jane Coffin Childs Memorial Fund. S.K.M. is a Searle Scholar. This work was supported by funding from the NIH (grants DK 078938, DK 083633, AI 088626), the Damon Runyon Cancer Research Foundation, and the CCFA (award 2405) to S.K.M. J.L.R. and S.K.M. have a patent application (PCT/US2008/082928) on the use of PSA as a therapy for inflammatory bowel disease. The authors have no competing financial interests related to this publication.	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Babu S, 2006, J IMMUNOL, V176, P3885, DOI 10.4049/jimmunol.176.7.3885; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fukata M, 2008, J IMMUNOL, V180, P1886, DOI 10.4049/jimmunol.180.3.1886; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439	24	1027	1127	11	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2011	332	6032					974	977		10.1126/science.1206095	http://dx.doi.org/10.1126/science.1206095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21512004	Green Accepted			2022-12-24	WOS:000290766600046
J	Sun, JR; Singh, V; Kajino-Sakamoto, R; Aballay, A				Sun, Jingru; Singh, Varsha; Kajino-Sakamoto, Rie; Aballay, Alejandro			Neuronal GPCR Controls Innate Immunity by Regulating Noncanonical Unfolded Protein Response Genes	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TOLL-LIKE RECEPTOR; CAENORHABDITIS-ELEGANS; ACTIVATION; DISEASE	The unfolded protein response (UPR), which is activated when unfolded or misfolded proteins accumulate in the endoplasmic reticulum, has been implicated in the normal physiology of immune defense and in several human diseases, including diabetes, cancer, neurodegenerative disease, and inflammatory disease. In this study, we found that the nervous system controlled the activity of a noncanonical UPR pathway required for innate immunity in Caenorhabditis elegans. OCTR-1, a putative octopamine G protein-coupled catecholamine receptor (GPCR, G protein-coupled receptor), functioned in sensory neurons designated ASH and ASI to actively suppress innate immune responses by down-regulating the expression of noncanonical UPR genes pqn/abu in nonneuronal tissues. Our findings suggest a molecular mechanism by which the nervous system may sense inflammatory responses and respond by controlling stress-response pathways at the organismal level.	[Sun, Jingru; Singh, Varsha; Kajino-Sakamoto, Rie; Aballay, Alejandro] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27705 USA	Duke University	Aballay, A (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27705 USA.	a.aballay@duke.edu			Dana Foundation; NIH [GM070977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM070977, R01GM070977] Funding Source: NIH RePORTER	Dana Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Caenorhabditis Genetics Center (Univ. of Minnesota) for strains used in this study, R. Komuniecki (Univ. of Toledo) for providing FY745 and FY746, and D. Ron for providing the abu-1 transgenic strain. A.A. is funded by the Dana Foundation and the NIH (grant GM070977).	Aballay A, 2009, CELL CYCLE, V8, P966, DOI 10.4161/cc.8.7.8074; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Faber PW, 2002, P NATL ACAD SCI USA, V99, P17131, DOI 10.1073/pnas.262544899; Fuhrman LE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000657; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007	18	161	180	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					729	732		10.1126/science.1203411	http://dx.doi.org/10.1126/science.1203411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21474712	Green Accepted			2022-12-24	WOS:000290265800046
J	Jiao, YN; Wickett, NJ; Ayyampalayam, S; Chanderbali, AS; Landherr, L; Ralph, PE; Tomsho, LP; Hu, Y; Liang, HY; Soltis, PS; Soltis, DE; Clifton, SW; Schlarbaum, SE; Schuster, SC; Ma, H; Leebens-Mack, J; dePamphilis, CW				Jiao, Yuannian; Wickett, Norman J.; Ayyampalayam, Saravanaraj; Chanderbali, Andre S.; Landherr, Lena; Ralph, Paula E.; Tomsho, Lynn P.; Hu, Yi; Liang, Haiying; Soltis, Pamela S.; Soltis, Douglas E.; Clifton, Sandra W.; Schlarbaum, Scott E.; Schuster, Stephan C.; Ma, Hong; Leebens-Mack, Jim; dePamphilis, Claude W.			Ancestral polyploidy in seed plants and angiosperms	NATURE			English	Article							PHYLOGENETIC ANALYSIS; GENOME DUPLICATIONS; MAXIMUM-LIKELIHOOD; EVOLUTIONARY TREES; WHOLE-GENOME; GENE; ARABIDOPSIS; ORIGIN; LAND; PALEOPOLYPLOIDY	Whole-genome duplication (WGD), or polyploidy, followed by gene loss and diploidization has long been recognized as an important evolutionary force in animals, fungi and other organisms(1-3), especially plants. The success of angiosperms has been attributed, in part, to innovations associated with gene or whole-genome duplications(4-6), but evidence for proposed ancient genome duplications pre-dating the divergence of monocots and eudicots remains equivocal in analyses of conserved gene order. Here we use comprehensive phylogenomic analyses of sequenced plant genomes and more than 12.6 million new expressed-sequence-tag sequences from phylogenetically pivotal lineages to elucidate two groups of ancient gene duplications-one in the common ancestor of extant seed plants and the other in the common ancestor of extant angiosperms. Gene duplication events were intensely concentrated around 319 and 192 million years ago, implicating two WGDs in ancestral lineages shortly before the diversification of extant seed plants and extant angiosperms, respectively. Significantly, these ancestral WGDs resulted in the diversification of regulatory genes important to seed and flower development, suggesting that they were involved in major innovations that ultimately contributed to the rise and eventual dominance of seed plants and angiosperms.	[Jiao, Yuannian; Ma, Hong; dePamphilis, Claude W.] Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA; [Jiao, Yuannian; Wickett, Norman J.; Landherr, Lena; Ralph, Paula E.; Hu, Yi; Ma, Hong; dePamphilis, Claude W.] Penn State Univ, Inst Mol Evolutionary Genet, Dept Biol, University Pk, PA 16802 USA; [Jiao, Yuannian; Wickett, Norman J.; Landherr, Lena; Ralph, Paula E.; Hu, Yi; Ma, Hong; dePamphilis, Claude W.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Ayyampalayam, Saravanaraj; Leebens-Mack, Jim] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Chanderbali, Andre S.; Soltis, Douglas E.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Tomsho, Lynn P.; Schuster, Stephan C.] Penn State Univ, Ctr Infect Dis Dynam, Ctr Comparat Genom, University Pk, PA 16802 USA; [Liang, Haiying] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; [Soltis, Pamela S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Clifton, Sandra W.] Washington Univ, Genome Ctr, St Louis, MO 63108 USA; [Schlarbaum, Scott E.] Univ Tennessee, Inst Agr, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA; [Ma, Hong] Fudan Univ, Ctr Evolutionary Biol, Inst Plant Biol, Sch Life Sci,State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Ma, Hong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; University of Georgia; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Clemson University; State University System of Florida; University of Florida; Washington University (WUSTL); University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Fudan University; Fudan University	dePamphilis, CW (corresponding author), Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA.	cwd3@psu.edu	Wickett, Norman/AAV-8136-2021; Soltis, Pamela S/GNH-5557-2022; Jiao, Yuannian/H-8668-2012; Soltis, Pamela S/L-5184-2015; Jiao, Yuannian/AAZ-7054-2021; dePamphilis, Claude W/P-6652-2016; Leebens-Mack, James/AAF-6770-2019; Ma, Hong/W-5251-2018; Soltis, Douglas/L-5957-2015	Wickett, Norman/0000-0003-0944-1956; Soltis, Pamela S/0000-0001-9310-8659; Jiao, Yuannian/0000-0002-8987-2782; Leebens-Mack, James/0000-0003-4811-2231; Ma, Hong/0000-0001-8717-4422; Chanderbali, Andre/0000-0002-8728-6739	NSF [DEB 0638595]; Department of Biology; Huck Institutes of Life Sciences of the Pennsylvania State University; Fudan University; Direct For Biological Sciences [0830009] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0922742] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Department of Biology; Huck Institutes of Life Sciences of the Pennsylvania State University; Fudan University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported primarily by NSF Plant Genome Research Program (DEB 0638595, The Ancestral Angiosperm Genome Project) and in part by the Department of Biology and by the Huck Institutes of Life Sciences of the Pennsylvania State University. H. M. was also supported by funds from Fudan University. We thank J. Carlson, M. Frohlich, S. DiLoretto, L. Warg, S. Crutchfield, C. Johnson, N. Naznin, X. Zhou, J. Duarte, B. J. Bliss, J. Der and E. Wafula for help and discussion, D. Stevenson and C. Schultz for Zamia samples, J. McNeal, S. Kim and M. Axtell for photographs, and all the members of The Genome Center at Washington University production team, especially L. Fulton, K. Delehaunty and C. Fronick.	[Anonymous], 1991, POLLEN SPORES PATTER; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Buggs RJA, 2009, HEREDITY, V103, P73, DOI 10.1038/hdy.2009.24; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Dechaine JM, 2009, PLANT CELL ENVIRON, V32, P1297, DOI 10.1111/j.1365-3040.2009.01998.x; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Hu W, 2008, J INTEGR PLANT BIOL, V50, P1031, DOI 10.1111/j.1744-7909.2008.00681.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lynch M, 2007, ORIGINS GENOME ARCHI; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Mathews S, 2003, MOL BIOL EVOL, V20, P1087, DOI 10.1093/molbev/msg123; McLachlan G.J., 1999, J STAT SOFTW, V4, DOI DOI 10.18637/JSS.V004.I02; Miller CN, 1999, BOT REV, V65, P239, DOI 10.1007/BF02857631; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Ohno S., 1970, EVOLUTION GENE DUPLI; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Prigge MJ, 2006, EVOL DEV, V8, P350, DOI 10.1111/j.1525-142X.2006.00107.x; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Vandepoele K, 2002, TRENDS GENET, V18, P606, DOI 10.1016/S0168-9525(02)02796-8; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	54	1353	1406	24	632	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					97	U113		10.1038/nature09916	http://dx.doi.org/10.1038/nature09916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21478875				2022-12-24	WOS:000290218300038
J	Paul, P; van den Hoorn, T; Jongsma, MLM; Bakker, MJ; Hengeveld, R; Janssen, L; Cresswell, P; Egan, DA; van Ham, M; ten Brinke, A; Ovaa, H; Beijersbergen, RL; Kuijl, C; Neefjes, J				Paul, Petra; van den Hoorn, Tineke; Jongsma, Marlieke L. M.; Bakker, Mark J.; Hengeveld, Rutger; Janssen, Lennert; Cresswell, Peter; Egan, David A.; van Ham, Marieke; ten Brinke, Anja; Ovaa, Huib; Beijersbergen, Roderick L.; Kuijl, Coenraad; Neefjes, Jacques			A Genome-wide Multidimensional RNAi Screen Reveals Pathways Controlling MHC Class II Antigen Presentation	CELL			English	Article							HLA-DR MOLECULES; DENDRITIC CELLS; MYOSIN 1E; TRANSPORT; PROTEIN; EXPRESSION; MEMBRANE; INHIBITION; MATURATION; COMPLEXES	MHC class II molecules (MHC-II) present peptides to T helper cells to facilitate immune responses and are strongly linked to autoimmune diseases. To unravel processes controlling MHC-II antigen presentation, we performed a genome-wide flow cytometry-based RNAi screen detecting MHC-II expression and peptide loading followed by additional high-throughput assays. All data sets were integrated to answer two fundamental questions: what regulates tissue-specific MHC-II transcription, and what controls MHC-II transport in dendritic cells? MHC-II transcription was controlled by nine regulators acting in feedback networks with higher-order control by signaling pathways, including TGF beta. MHC-II transport was controlled by the GTPase ARL14/ARF7, which recruits the motor myosin 1E via an effector protein ARF7EP. This complex controls movement of MHC-II vesicles along the actin cytoskeleton in human dendritic cells (DCs). These genome-wide systems analyses have thus identified factors and pathways controlling MHC-II transcription and transport, defining targets for manipulation of MHC-II antigen presentation in infection and autoimmunity.	[Paul, Petra; van den Hoorn, Tineke; Jongsma, Marlieke L. M.; Bakker, Mark J.; Hengeveld, Rutger; Janssen, Lennert; Ovaa, Huib; Kuijl, Coenraad; Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Paul, Petra; van den Hoorn, Tineke; Jongsma, Marlieke L. M.; Bakker, Mark J.; Hengeveld, Rutger; Janssen, Lennert; Ovaa, Huib; Kuijl, Coenraad; Neefjes, Jacques] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Egan, David A.; Beijersbergen, Roderick L.] Netherlands Canc Inst, Robot & Screening Ctr, NL-1066 CX Amsterdam, Netherlands; [Cresswell, Peter] Yale Univ, Howard Hughes Med Inst, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [van Ham, Marieke; ten Brinke, Anja] Univ Amsterdam, Acad Med Ctr, Dept Immunopathol, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Howard Hughes Medical Institute; Yale University; University of Amsterdam; Academic Medical Center Amsterdam	Kuijl, C (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	kuijl.coenraad@gene.com; j.neefjes@nki.nl	Yang, Chen/G-1379-2010; Neefjes, Jacques J.C./H-8780-2017; ovaa, huib/M-2334-2016	Neefjes, Jacques J.C./0000-0001-6763-2211; Paul, Petra/0000-0003-1187-7994; Kuijl, Coen/0000-0003-4378-1428; Janssen, Lennert/0000-0001-9705-0204; ovaa, huib/0000-0002-0068-054X; Beijersbergen, Roderick/0000-0003-0116-4130; ten Brinke, Anja/0000-0002-0135-7496	NWO ALW and CW; Dutch Cancer Society; Centre for Biomedical Genetics (CBG); EEC MC RTN; ERC; Organon/Merck	NWO ALW and CW; Dutch Cancer Society(KWF Kankerbestrijding); Centre for Biomedical Genetics (CBG); EEC MC RTN; ERC(European Research Council (ERC)European Commission); Organon/Merck(Merck & Company)	We thank the NKI Central Microarray and Protein Production Facility and the NKI Robotics and Screening Center, as well as A. Pfauth and F. van Diepen for help with the flow cytometry; L. Oomen and L. Brocks for support with the confocal microscope; D. Logan (Broad Institute, Cambridge, MA) for support in operating CellProfiler; P. van Veelen for mass spec analyses; I. Lee (Network Biotechnology Lab, Seoul, Korea) and E. Marcotte (University of Texas, Austin, TX) for access to the Humannet v. 1 software; and Y. Souwer for samples of human primary B cells. This work was supported by grants from NWO ALW and CW, the Dutch Cancer Society, the Centre for Biomedical Genetics (CBG), EEC MC RTN, and an ERC program grant. The NKI Robotics and Screening Center is supported by Organon/Merck.	Agrawal S, 2004, NAT BIOTECHNOL, V22, P1533, DOI 10.1038/nbt1042; Anderson HA, 1998, J IMMUNOL, V160, P4850; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Breton G, 2009, J CLIN IMMUNOL, V29, P637, DOI 10.1007/s10875-009-9313-9; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cerf ME, 2006, EUR J ENDOCRINOL, V155, P671, DOI 10.1530/eje.1.02277; Chaplin D D, 1988, Year Immunol, V3, P179; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; Derrien V, 2002, J CELL SCI, V115, P2867; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dong YS, 2001, J IMMUNOL, V167, P311, DOI 10.4049/jimmunol.167.1.311; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Imai A, 2007, EUR J IMMUNOL, V37, P1730, DOI 10.1002/eji.200636392; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Krendel M, 2007, FEBS LETT, V581, P644, DOI 10.1016/j.febslet.2007.01.021; Kuipers HF, 2005, HUM IMMUNOL, V66, P653, DOI 10.1016/j.humimm.2005.04.004; LAMPSON LA, 1980, J IMMUNOL, V125, P293; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Ribet D, 2010, NATURE, V464, P1192, DOI 10.1038/nature08963; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; Schietroma C, 2007, J BIOL CHEM, V282, P29504, DOI 10.1074/jbc.M705825200; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Souwer Y, 2009, J IMMUNOL, V182, P7473, DOI 10.4049/jimmunol.0802831; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Tang BL, 1997, MOL CELL BIOL, V17, P256, DOI 10.1128/MCB.17.1.256; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; ten Brinke A, 2007, VACCINE, V25, P7145, DOI 10.1016/j.vaccine.2007.07.031; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Vascotto F, 2007, J CELL BIOL, V176, P1007, DOI 10.1083/jcb.200611147; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Voong LN, 2008, J BIOL CHEM, V283, P9031, DOI 10.1074/jbc.M706487200; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	58	97	102	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					268	283		10.1016/j.cell.2011.03.023	http://dx.doi.org/10.1016/j.cell.2011.03.023			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21458045	Bronze			2022-12-24	WOS:000289549900015
J	Shiels, MS; Pfeiffer, RM; Hall, HI; Li, JM; Goedert, JJ; Morton, LM; Hartge, P; Engels, EA				Shiels, Meredith S.; Pfeiffer, Ruth M.; Hall, H. Irene; Li, Jianmin; Goedert, James J.; Morton, Lindsay M.; Hartge, Patricia; Engels, Eric A.			Proportions of Kaposi Sarcoma, Selected Non-Hodgkin Lymphomas, and Cervical Cancer in the United States Occurring in Persons With AIDS, 1980-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INCIDENCE PATTERNS; SURVEILLANCE DATA; HIV; TRENDS; RISK; RECOMMENDATIONS; ADOLESCENTS; ADULTS; ASSOCIATION; SOCIETY	Context Given the higher risk of AIDS-defining malignancies that include Kaposi sarcoma (KS), certain non-Hodgkin lymphomas (NHLs), and cervical cancer in persons with human immunodeficiency virus (HIV) infection, the HIV epidemic has likely contributed to the overall numbers of these cancers in the United States. Objective To quantify the proportions of KS, AIDS-defining NHLs, and cervical cancer in the United States that occurred among persons with AIDS from 1980 to 2007. Design, Setting, and Participants The HIV/AIDS Cancer Match Study (19802007) linked data from 16 US HIV/AIDS and cancer registries to identify cases with and without AIDS for KS, AIDS-defining NHLs (ie, diffuse large B-cell lymphoma [DLBCL], Burkitt lymphoma [BL], and central nervous system [CNS] lymphoma), and cervical cancer. Using linked data, we derived cancer rates for persons with and without AIDS. To estimate national counts, the rates were applied to national AIDS surveillance and US Census data. Main Outcome Measure Proportion of AIDS-defining malignancies in the United States occurring in persons with AIDS. Results In the United States, an estimated 81.6% (95% confidence interval [CI], 81.2%-81.9%) of 83 252 KS cases, 6.0% (95% CI, 5.8%-6.1%) of 351 618 DLBCL cases, 19.9% (95% CI, 18.1%-21.7%) of 17 307 BL cases, 27.1% (95% CI, 26.1%-28.1%) of 27 265 CNS lymphoma cases, and 0.42% (95% CI, 0.37%-0.47%) of 375 452 cervical cancer cases occurred among persons with AIDS during 1980-2007. The proportion of KS and AIDS-defining NHLs in persons with AIDS peaked in the early 1990s (1990-1995: KS, 90.5% [95% CI, 90.2%-90.8%]; DLBCL, 10.2% [95% CI, 9.9%-10.5%]; BL, 27.8% [95% CI, 25.0%-30.5%]; and CNS lymphoma, 48.3% [95% CI, 46.7%-49.8%]; all P < .001 [compared with 1980-1989]) and then declined (2001-2007: KS, 70.5% [95% CI, 68.1%-73.0%]; DLBCL, 4.7% [95% CI, 4.3%-5.2%]; BL, 21.5% [95% CI, 17.7%-25.4%]; and CNS lymphoma, 12.9% [95% CI, 10.5%-15.3%]; all P < .001 [compared with 1990-1995]). The proportion of cervical cancers in persons with AIDS increased over time (1980-1989: 0.11% [95% CI, 0.09%-0.13%]; 2001-2007: 0.71% [95% CI, 0.51%-0.91%]; P < .001). Conclusions In the United States, the estimated proportions of AIDS-defining malignancies that occurred among persons with AIDS were substantial, particularly for KS and some NHLs. Except for cervical cancer, the proportions of AIDS-defining malignancies occurring among persons with AIDS peaked in the mid-1990s and then declined. JAMA. 2011;305(14):1450-1459 www.jama.com	[Shiels, Meredith S.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA; [Hall, H. Irene; Li, Jianmin] Ctr Dis Control & Prevent, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA	Shiels, MS (corresponding author), NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, 6120 Execut Blvd,EPS 7059, Rockville, MD 20892 USA.	shielsms@mail.nih.gov	Morton, Lindsay M/B-5234-2015; Morton, Lindsay/AAE-7495-2022	Morton, Lindsay M/0000-0001-9767-2310; Morton, Lindsay/0000-0001-9767-2310	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010150] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Intramural Research Program of the National Cancer Institute.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2011, GUID US ANT AG HIV 1; [Anonymous], HIV AIDS STAT SURV; [Anonymous], 2007, HIV AIDS SURV REP US, V17; [Anonymous], 2011, SEER STAT DAT POP TO; BASHIR R, 1994, J NEURO-ONCOL, V20, P47, DOI 10.1007/BF01057960; Bedimo R, 2004, CLIN INFECT DIS, V39, P1380, DOI 10.1086/424883; Bellan C, 2003, ONCOGENE, V22, P6639, DOI 10.1038/sj.onc.1206815; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; Chiao EY, 2010, JAMA-J AM MED ASSOC, V304, P334, DOI 10.1001/jama.2010.752; Dunleavy K, 2010, BLOOD, V115, P3017, DOI 10.1182/blood-2009-11-253039; Eltom MA, 2002, J NATL CANCER I, V94, P1204, DOI 10.1093/jnci/94.16.1204; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Gatter KC, 2001, PATHOLOGY GENETICS T, P171; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Green TA, 1998, STAT MED, V17, P143, DOI 10.1002/(SICI)1097-0258(19980130)17:2&lt;143::AID-SIM757&gt;3.0.CO;2-Y; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harrison KM, 2008, PUBLIC HEALTH REP, V123, P618, DOI 10.1177/003335490812300512; Iscovich J, 2000, CANCER-AM CANCER SOC, V88, P500, DOI 10.1002/(SICI)1097-0142(20000201)88:3<500::AID-CNCR3>3.3.CO;2-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kadan-Lottick NS, 2002, CANCER, V95, P193, DOI 10.1002/cncr.10643; Larocca LM, 1998, BLOOD, V92, P1011; Levine AM, 2010, BLOOD, V115, P2986, DOI 10.1182/blood-2010-01-262717; Mbulaiteye SM, 2010, INT J CANCER, V126, P1732, DOI 10.1002/ijc.24934; National Cancer Institute, 2019, HIV AIDS CANC MATCH; National Cancer Institute, 2018, SEER STAT DAT INC SE; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Rouhani P, 2008, CANCER-AM CANCER SOC, V113, P616, DOI 10.1002/cncr.23571; Shiels M, 2010, 18 ANN INT AIDS C VI; Shiels MS, 2008, JAIDS-J ACQ IMM DEF, V48, P485, DOI 10.1097/QAI.0b013e31817dc42b; Sparano JA, 2010, BLOOD, V115, P3008, DOI 10.1182/blood-2009-08-231613; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004	37	104	107	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1450	1459		10.1001/jama.2011.396	http://dx.doi.org/10.1001/jama.2011.396			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486978	Green Accepted, Bronze			2022-12-24	WOS:000289424100022
J	Schrijvers, EMC; Koudstaal, PJ; Hofman, A; Breteler, MMB				Schrijvers, Elisabeth M. C.; Koudstaal, Peter J.; Hofman, Albert; Breteler, Monique M. B.			Plasma Clusterin and the Risk of Alzheimer Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; APOLIPOPROTEIN-J; MENTAL STATE; DIAGNOSIS; DEMENTIA; CLU	Context Variants in the clusterin gene are associated with the risk of Alzheimer disease (AD) and clusterin levels have been found to be increased in brain and cerebrospinal fluid of patients with AD. Plasma clusterin was reported to be associated with brain atrophy, baseline disease severity, and rapid clinical progression in patients with AD. Objective To evaluate the potential of plasma clusterin as a biomarker of the presence, severity, and risk of AD. Design, Setting, and Participants A case-cohort study nested within the Rotterdam Study, a prospective population-based cohort study conducted in Rotterdam, the Netherlands. Plasma levels of clusterin were measured at baseline (1997-1999) in 60 individuals with prevalent AD, a random subcohort of 926 participants, and an additional 156 participants diagnosed with AD during follow-up until January 1, 2007 (mean [SD], 7.2 [2.3] years). Main Outcome Measures Prevalent AD, severity of AD measured by the Mini-Mental State Examination (MMSE) score, and the risk of developing AD during follow-up. Results The likelihood of prevalent AD increased with increasing plasma levels of clusterin (odds ratio [OR] per SD increase of plasma clusterin level, 1.63; 95% confidence interval [CI], 1.21-2.20; adjusted for age, sex, education level, apolipoprotein E status, diabetes, smoking, coronary heart disease, and hypertension). Among patients with AD, higher clusterin levels were associated with more severe disease (adjusted difference in MMSE score per SD increase in clusterin levels, -1.36; 95% CI, -2.70 to -0.02; P=.047). Plasma clusterin levels were not related to the risk of incident AD during total follow-up (adjusted HR, 1.00; 95% CI, 0.85-1.17; P for trend=.77) or within 3 years of baseline (adjusted HR, 1.09; 95% CI, 0.84-1.42; P for trend=.65). Conclusion Plasma clusterin levels were significantly associated with baseline prevalence and severity of AD, but not with incidence of AD. JAMA. 2011;305(13):1322-1326 www.jama.com	[Schrijvers, Elisabeth M. C.; Hofman, Albert; Breteler, Monique M. B.] Univ Med Ctr, Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Schrijvers, Elisabeth M. C.; Koudstaal, Peter J.] Univ Med Ctr, Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Breteler, Monique M. B.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Breteler, MMB (corresponding author), Univ Med Ctr, Erasmus MC, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.breteler@erasmusmc.nl	Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305	Erasmus MC University Medical Center; Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture, and Science; Ministry of Health, Welfare, and Sports; European Commission; Municipality of Rotterdam; Alzheimer's Association [IIRG-06-27261]; Pfizer	Erasmus MC University Medical Center; Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Alzheimer's Association(Alzheimer's Association); Pfizer(Pfizer)	The Rotterdam Study is supported by the Erasmus MC University Medical Center and Erasmus University Rotterdam; the Netherlands Organization for Scientific Research (NWO); the Netherlands Organization for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture, and Science; the Ministry of Health, Welfare, and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. This study was financially supported by grant IIRG-06-27261 from the Alzheimer's Association and by an unrestricted research grant from Pfizer (Dr Breteler).	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lidstrom AM, 1998, EXP NEUROL, V154, P511, DOI 10.1006/exnr.1998.6892; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Ott A, 1998, AM J EPIDEMIOL, V147, P574; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sihlbom C, 2008, NEUROCHEM RES, V33, P1332, DOI 10.1007/s11064-008-9588-x; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com	22	158	167	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1322	1326		10.1001/jama.2011.381	http://dx.doi.org/10.1001/jama.2011.381			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467285	Bronze			2022-12-24	WOS:000289162400021
J	Tuite, AR; Tien, J; Eisenberg, M; Earn, DJD; Ma, JL; Fisman, DN				Tuite, Ashleigh R.; Tien, Joseph; Eisenberg, Marisa; Earn, David J. D.; Ma, Junling; Fisman, David N.			Cholera Epidemic in Haiti, 2010: Using a Transmission Model to Explain Spatial Spread of Disease and Identify Optimal Control Interventions	ANNALS OF INTERNAL MEDICINE			English	Article							INFECTIOUS-DISEASE; UNITED-STATES; INFLUENZA; DYNAMICS; TIME	Background: Haiti is in the midst of a cholera epidemic. Surveillance data for formulating models of the epidemic are limited, but such models can aid understanding of epidemic processes and help define control strategies. Objective: To predict, by using a mathematical model, the sequence and timing of regional cholera epidemics in Haiti and explore the potential effects of disease-control strategies. Design: Compartmental mathematical model allowing person-to-person and waterborne transmission of cholera. Within-and between-region epidemic spread was modeled, with the latter dependent on population sizes and distance between regional centroids (a "gravity" model). Setting: Haiti, 2010 to 2011. Data Sources: Haitian hospitalization data, 2009 census data, literature-derived parameter values, and model calibration. Measurements: Dates of epidemic onset and hospitalizations. Results: The plausible range for cholera's basic reproductive number (R-o, defined as the number of secondary cases per primary case in a susceptible population without intervention) was 2.06 to 2.78. The order and timing of regional cholera outbreaks predicted by the gravity model were closely correlated with empirical observations. Analysis of changes in disease dynamics over time suggests that public health interventions have substantially affected this epidemic. A limited vaccine supply provided late in the epidemic was projected to have a modest effect. Limitations: Assumptions were simplified, which was necessary for modeling. Projections are based on the initial dynamics of the epidemic, which may change. Conclusion: Despite limited surveillance data from the cholera epidemic in Haiti, a model simulating between-region disease transmission according to population and distance closely reproduces reported disease patterns. This model is a tool that planners, policy-makers, and medical personnel seeking to manage the epidemic could use immediately.	[Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; Ohio State Univ, Columbus, OH 43210 USA; McMaster Univ, Hamilton, ON, Canada; Univ Victoria, Victoria, BC, Canada	University of Toronto; University System of Ohio; Ohio State University; McMaster University; University of Victoria	Fisman, DN (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St,Room 678, Toronto, ON M5T 3M7, Canada.	david.fisman@utoronto.ca	Ma, Junling/I-7349-2012	Ma, Junling/0000-0002-0197-2317; Earn, David/0000-0002-7562-1341	Institute of Population and Public Health of the Canadian Institutes of Health Research [22228]; National Science Foundation [0635561]; Natural Sciences and Engineering Research Council of Canada; James S. McDonnell Foundation	Institute of Population and Public Health of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); James S. McDonnell Foundation	Ms. Tuite and Dr. Fisman are supported by a grant from the Institute of Population and Public Health of the Canadian Institutes of Health Research (PH2-#22228). Dr. Eisenberg is supported by the National Science Foundation (agreement 0635561). Dr. Earn receives support from the Natural Sciences and Engineering Research Council of Canada and the James S. McDonnell Foundation.	Albert M. John, 1997, World Health Statistics Quarterly, V50, P111; ANDERSON RM, 1991, CMAJ; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1586; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1473; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; BHARTI N, 2008, NEW ENGL J MED, V3; BROWNSTEIN JS, 2008, MMWR-MORBID MORTAL W, V5, pE151; CAMPBELLMCINTYRE R, 1979, LANCET, V1, P311; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1411; CHIN CS, 2011, WKLY EPIDEMIOL REC, V364, P33; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Crepey P, 2007, AM J EPIDEMIOL, V166, P1244, DOI 10.1093/aje/kwm266; Eggo RM, 2011, J R SOC INTERFACE, V8, P233, DOI 10.1098/rsif.2010.0216; Graves PM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000974.pub2; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; Guthmann JP, 1995, J TROP MED HYG, V98, P419; HOOD MA, 1981, APPL ENVIRON MICROB, V41, P559, DOI 10.1128/AEM.41.2.559-560.1981; Institut Haitien de Statistique et d'Informatique, 2009, POP TOT POP 18 ANS P; *INT MON FUND, 2009, HAIT ENH IN HEAV IND; IVERS LC, 2010, J R SOC INTERFACE, V376, P2048; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; JOHANNESSON M, 1994, MED DECIS MAKING, V14, P188, DOI 10.1177/0272989X9401400212; KEELING MJ, 2009, PLOS MED, P233; KNOX R, 2010, DOCTORS URGE CHOLERA; *MIN SANT PUBL POP, 2010, DOC HAIT CHOL EP; Misch A, 1991, World Watch, V4, P37; Mishra S, 2011, J EPIDEMIOL COMMUN H, V65, P87, DOI 10.1136/jech.2009.097113; Moghadas S, 2009, CAN MED ASSOC J, V181, P171, DOI 10.1503/cmaj.090885; NEILAN RLM, 2010, J R SOC INTERFACE, V72, P2004; PASCUAL M, 2006, CMAJ, V3, pE280; *PUBL HLTH AG CAN, 2006, CAN IMM GUID, P158; RABBANI GH, 1999, LANCET, V17, P1; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Sontag Deborah, 2010, NY TIMES, pA1; TAUXE RV, 1998, BACTERIAL INFECT HUM, P223; TIEN JH, 2010, PLOS MED; Tien JH, 2010, B MATH BIOL, V72, P1506, DOI 10.1007/s11538-010-9507-6; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; 2008, WKLY EPIDEMIOL REC, V83, P269; 2007, WKLY EPIDEMIOL REC, V82, P273	41	172	175	1	71	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					593	601		10.7326/0003-4819-154-9-201105030-00334	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00334			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21383314				2022-12-24	WOS:000290112300003
J	Adams, KN; Takaki, K; Connolly, LE; Wiedenhoft, H; Winglee, K; Humbert, O; Edelstein, PH; Cosma, CL; Ramakrishnan, L				Adams, Kristin N.; Takaki, Kevin; Connolly, Lynn E.; Wiedenhoft, Heather; Winglee, Kathryn; Humbert, Olivier; Edelstein, Paul H.; Cosma, Christine L.; Ramakrishnan, Lalita			Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism	CELL			English	Article							ANTITUBERCULOSIS DRUGS; ANTIBIOTIC-RESISTANCE; MARINUM INFECTION; INITIAL TREATMENT; TUBERCULOSIS; PUMP; EXPRESSION; STRESS; GENES; SUSCEPTIBILITY	Treatment of tuberculosis, a complex granulomatous disease, requires long-term multidrug therapy to overcome tolerance, an epigenetic drug resistance that is widely attributed to nonreplicating bacterial subpopulations. Here, we deploy Mycobacterium marinum-infected zebrafish larvae for in vivo characterization of antitubercular drug activity and tolerance. We describe the existence of multidrug-tolerant organisms that arise within days of infection, are enriched in the replicating intracellular population, and are amplified and disseminated by the tuberculous granuloma. Bacterial efflux pumps that are required for intracellular growth mediate this macrophage-induced tolerance. This tolerant population also develops when Mycobacterium tuberculosis infects cultured macrophages, suggesting that it contributes to the burden of drug tolerance in human tuberculosis. Efflux pump inhibitors like verapamil reduce this tolerance. Thus, the addition of this currently approved drug or more specific efflux pump inhibitors to standard antitubercular therapy should shorten the duration of curative treatment.	[Adams, Kristin N.; Takaki, Kevin; Wiedenhoft, Heather; Winglee, Kathryn; Humbert, Olivier; Cosma, Christine L.; Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Connolly, Lynn E.; Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Edelstein, Paul H.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	lalitar@uw.edu	Edelstein, Paul/I-5527-2019	Edelstein, Paul/0000-0002-4069-5279; Winglee, Kathryn/0000-0002-3623-0700; Takaki, Kevin/0000-0002-4790-4598; Ramakrishnan, Lalita/0000-0003-0692-5533	Gates Foundation; University of Washington; Burroughs Wellcome Foundation; NIH [RO1 AI036396, RO1 AI54503, U54AI057141, T32 AI55396, K08 AI076620, 5R21 AI073328-02, 5R21 AI078189-02]; Levinson Emerging Scholars Program; Mary Gates Endowment Grant; Washington NASA; Pfizer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076620, R01AI036396, T32AI055396, R21AI078189, R21AI073328, U54AI057141, R01AI054503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099901] Funding Source: NIH RePORTER	Gates Foundation(Bill & Melinda Gates Foundation); University of Washington(University of Washington); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Levinson Emerging Scholars Program; Mary Gates Endowment Grant; Washington NASA; Pfizer(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. R. Sherman for the gift of pBP10, advice, and the use of the BSL-3 facilities at Seattle BioMed; the members of his laboratory, especially R. Liao and J. Pang, for help in using the BSL-3 facilities; M. Nixon for advice in analyzing the unstable plasmid data; W. R. Bishai and G. Lamichhane for providing the Mtb Rv1258c mutants through the Tuberculosis Animal Research and Gene Evaluation Taskforce (NIH/NIAID N01 AI30036); E. Nuermberger and P. Donald for sharing knowledge and insights about TB drugs; B. Cormack and M. Troll for discussion; J. M. Davis and C. T. Yang for technical advice; J. Ray and H. Volkman for figure design and preparation; and S. Phillips and T. Pecor for technical assistance. This work was supported by a Gates Foundation TB drug accelerator grant; a University of Washington Royalty Research Fund Grant; a Burroughs Wellcome Foundation Pathogenesis of Infectious Diseases award; NIH grants RO1 AI036396, RO1 AI54503, and U54AI057141 to L. R.; NIH grant T32 AI55396 to K.N.A.; a Levinson Emerging Scholars Program Grant, a Mary Gates Endowment Grant, and a Washington NASA Space Grant to K. W.; a Pfizer Fellowship in Infectious Diseases and NIH grant K08 AI076620 to L. E. C.; and NIH grants 5R21 AI073328-02 and 5R21 AI078189-02 to P. H. E. L. R. is a recipient of the NIH Director's Pioneer Award and a consultant for Sanofi Aventis.	Akira M, 2000, J COMPUT ASSIST TOMO, V24, P426, DOI 10.1097/00004728-200005000-00014; Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; Aubry A, 2002, ARCH INTERN MED, V162, P1746, DOI 10.1001/archinte.162.15.1746; BARKER J, 1995, ANTIMICROB AGENTS CH, V39, P2684, DOI 10.1128/AAC.39.12.2684; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; BOBROWITZ ID, 1980, AM REV RESPIR DIS, V121, P735; Canetti G., 1955, TUBERCLE BACILLUS PU; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; Cosma C. L., 2006, CURRENT PROTOCOLS MI, DOI 10.1002/; Cosma CL, 2006, INFECT IMMUN, V74, P3125, DOI 10.1128/IAI.02061-05; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; Dannenberg AM, 2003, TUBERCULOSIS, V83, P251, DOI 10.1016/S1472-9792(03)00048-9; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Decostere A, 2004, VET MICROBIOL, V99, P159, DOI 10.1016/j.vetmic.2003.07.011; Donald PR, 2008, TUBERCULOSIS, V88, pS75, DOI 10.1016/S1472-9792(08)70038-6; Duits LA, 2001, BIOCHEM BIOPH RES CO, V280, P522, DOI 10.1006/bbrc.2000.4157; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Fontan PA, 2008, J INFECT DIS, V198, P877, DOI 10.1086/591098; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Grange, 2009, TUBERCULOSIS COMPREH, P608, DOI [10.1016/B978-1-4160-3988-4.00059-7, DOI 10.1016/B978-1-4160-3988-4.00059-7]; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Ibrahim M, 2009, AM J RESP CRIT CARE, V180, P553, DOI 10.1164/rccm.200807-1152OC; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Nguyen L, 2006, TRENDS MICROBIOL, V14, P304, DOI 10.1016/j.tim.2006.05.005; Paramasivan CN, 2005, ANTIMICROB AGENTS CH, V49, P627, DOI 10.1128/AAC.49.2.627-631.2005; Ramon-Garcia S, 2009, ANTIMICROB AGENTS CH, V53, P3675, DOI 10.1128/AAC.00550-09; Rich AR, 1946, PATHOGENESIS TUBERCU; Rivas-Santiago B, 2008, INFECT IMMUN, V76, P935, DOI 10.1128/IAI.01218-07; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; ROOK GAW, 1987, EUR J RESPIR DIS, V71, P286; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sharma S, 2010, J ANTIMICROB CHEMOTH, V65, P1694, DOI 10.1093/jac/dkq186; Siddiqi N, 2004, INFECTION, V32, P109, DOI 10.1007/s15010-004-3097-x; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Viveiros M, 2002, ANTIMICROB AGENTS CH, V46, P2804, DOI 10.1128/AAC.46.9.2804-2810.2002; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Zahner D, 2010, ANTIMICROB AGENTS CH, V54, P3516, DOI 10.1128/AAC.01756-09	58	362	371	6	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					39	53		10.1016/j.cell.2011.02.022	http://dx.doi.org/10.1016/j.cell.2011.02.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21376383	Bronze, Green Accepted			2022-12-24	WOS:000289053900008
J	Tokunaga, F; Nakagawa, T; Nakahara, M; Saeki, Y; Taniguchi, M; Sakata, S; Tanaka, K; Nakano, H; Iwai, K				Tokunaga, Fuminori; Nakagawa, Tomoko; Nakahara, Masaki; Saeki, Yasushi; Taniguchi, Masami; Sakata, Shin-ichi; Tanaka, Keiji; Nakano, Hiroyasu; Iwai, Kazuhiro			SHARPIN is a component of the NF-kappa B-activating linear ubiquitin chain assembly complex	NATURE			English	Article							CHRONIC PROLIFERATIVE DERMATITIS; INCONTINENTIA PIGMENTI; IMMUNE-DEFICIENCY; SIGNALING PATHWAY; MUTATIONS; NEMO; PROTEIN; LIGASE; IDENTIFICATION; ALPHA	Cpdm (chronic proliferative dermatitis) mice develop chronic dermatitis and an immunodeficiency with increased serum IgM(1-3), symptoms that resemble those of patients with X-linked hyper-IgM syndrome and hypohydrotic ectodermal dysplasia (XHM-ED), which is caused by mutations in NEMO (NF-kappa B essential modulator; also known as IKBKG)(4-6). Spontaneous null mutations in the Sharpin (SHANK-associated RH domain interacting protein in postsynaptic density)(7) gene are responsible for the cpdm phenotype in mice(8). SHARPIN shows significant similarity to HOIL-1L (also known as RBCK1)(8,9), a component of linear ubiquitin chain assembly complex (LUBAC), which induces NF-kappa B activation through conjugation of linear polyubiquitin chains to NEMO10-13. Here, we identify SHARPIN as an additional component of LUBAC. SHARPIN-containing complexes can linearly ubiquitinate NEMO and activated NF-kappa B. Thus, we re-define LUBAC as a complex containing SHARPIN, HOIL-1L, and HOIP (also known as RNF31). Deletion of SHARPIN drastically reduced the amount of LUBAC, which resulted in attenuated TNF-alpha- and CD40-mediated activation of NF-kappa B in mouse embryonic fibroblasts (MEFs) or B cells from cpdm mice. Considering the pleomorphic phenotype of cpdm mice, these results confirm the predicted role of LUBAC-mediated linear polyubiquitination in NF-kappa B activation induced by various stimuli, and strongly suggest the involvement of LUBAC-induced NF-kappa B activation in various disorders.	[Tokunaga, Fuminori; Nakagawa, Tomoko; Nakahara, Masaki; Taniguchi, Masami; Sakata, Shin-ichi; Iwai, Kazuhiro] Osaka Univ, Grad Sch Med, Dept Biophys & Biochem, Suita, Osaka 5650871, Japan; [Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Nakano, Hiroyasu] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Iwai, Kazuhiro] Osaka Univ, Grad Sch Frontier Biosci, Cell Biol & Metab Grp, Suita, Osaka 5650871, Japan	Osaka University; Tokyo Metropolitan Institute of Medical Science; Juntendo University; Osaka University	Iwai, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Biophys & Biochem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kiwai@cellbio.med.osaka-u.ac.jp	Saeki, Yasushi/AAR-8198-2021; IWAI, KAZUHIRO/GSN-7385-2022	Saeki, Yasushi/0000-0002-9202-5453; Tokunaga, Fuminori/0000-0003-3626-9119; Iwai, Kazuhiro/0000-0001-5620-5951; Nakano, Hiroyasu/0000-0003-4843-1427	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23659404, 22117006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Kitamura, S. Sugano, P. Rennert and J. Browning for reagents; O. Takeuchi for comments; and K. Kamei and K. Fukunaga for technical assistance. This work was partly supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (F.T. and K.I.).	Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HogenEsch H, 1999, J IMMUNOL, V162, P3890; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jain A, 2004, J CLIN INVEST, V114, P1593, DOI 10.1172/JCI200421345; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Jung J, 2010, MOL CELL BIOCHEM, V340, P161, DOI 10.1007/s11010-010-0413-x; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Piao JH, 2007, J IMMUNOL, V178, P2272, DOI 10.4049/jimmunol.178.4.2272; Renninger ML, 2010, EXP DERMATOL, V19, P252, DOI 10.1111/j.1600-0625.2009.00944.x; Seymour R, 2006, VET PATHOL, V43, P401, DOI 10.1354/vp.43-4-401; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Smahi A, 2002, HUM MOL GENET, V11, P2371, DOI 10.1093/hmg/11.20.2371; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Torres HIG, 1995, PATHOBIOLOGY, V63, P341; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	26	462	481	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					633	U113		10.1038/nature09815	http://dx.doi.org/10.1038/nature09815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455180				2022-12-24	WOS:000288951200042
J	Chiolo, I; Minoda, A; Colmenares, SU; Polyzos, A; Costes, SV; Karpen, GH				Chiolo, Irene; Minoda, Aki; Colmenares, Serafin U.; Polyzos, Aris; Costes, Sylvain V.; Karpen, Gary H.			Double-Strand Breaks in Heterochromatin Move Outside of a Dynamic HP1a Domain to Complete Recombinational Repair	CELL			English	Article							DNA-DAMAGE; PROTEIN-1; GENE; STABILITY; TELOMERES; MEIOSIS; FAMILY; YEAST; SUMO; RPA	Double-strand breaks (DSBs) in heterochromatic repetitive DNAs pose significant threats to genome integrity, but information about how such lesions are processed and repaired is sparse. We observe dramatic expansion and dynamic protrusions of the heterochromatin domain in response to ionizing radiation (IR) in Drosophila cells. We also find that heterochromatic DSBs are repaired by homologous recombination (HR) but with striking differences from euchromatin. Proteins involved in early HR events (resection) are rapidly recruited to DSBs within heterochromatin. In contrast, Rad51, which mediates strand invasion, only associates with DSBs that relocalize outside of the domain. Heterochromatin expansion and relocalization of foci require checkpoint and resection proteins. Finally, the Smc5/6 complex is enriched in heterochromatin and is required to exclude Rad51 from the domain and prevent abnormal recombination. We propose that the spatial and temporal control of DSB repair in heterochromatin safeguards genome stability by preventing aberrant exchanges between repeats.	[Chiolo, Irene; Minoda, Aki; Colmenares, Serafin U.; Polyzos, Aris; Costes, Sylvain V.; Karpen, Gary H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Karpen, Gary H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chiolo, I (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Dynam, Berkeley, CA 94720 USA.	iechiolo@lbl.gov; karpen@fruitfly.org	Minoda, Aki/Q-4454-2019; Minoda, Aki/D-5335-2017; Costes, Sylvain V/D-2522-2013	Minoda, Aki/0000-0002-2927-5791; Minoda, Aki/0000-0002-2927-5791; Costes, Sylvain V/0000-0002-8542-2389; Chiolo, Irene/0000-0002-3080-550X; Polyzos, Aris/0000-0002-9542-5807	FIRC; Unesco; Ruth Kirchstein NIH [1F32GM086111]; U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086613, F32GM086111] Funding Source: NIH RePORTER	FIRC(Fondazione AIRC per la ricerca sul cancro); Unesco; Ruth Kirchstein NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by postdoctoral fellowships from FIRC and Unesco to I. C., by Ruth Kirchstein NIH Postdoctoral Fellowship to S. U. C. (1F32GM086111), and by the Low Dose Radiation Research Program U.S. Department of Energy (DOE) (DE-AC02-05CH11231) to S. V. C. and G. H. K. We are grateful to P.-O. Mari for assistance with the NIR experiments and to S. Elgin, J. Kadonaga, B. Mellone, and D. Rio for reagents. We thank H. V. Le, R. Kunitake, and C. Pham for their help; A. Dernburg, E. Dunleavy, J. Swenson, and W. Zhang for comments on the manuscript; S. Langley for advice on ChIP-array data analysis; C-Y. Chen for software development; and the Karpen lab for sharing reagents and helpful discussions.	Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; COSTES SV, 2009, MUTAT RES, V704, P78; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; Digilio FA, 1996, DEV BIOL, V178, P90, DOI 10.1006/dbio.1996.0200; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Dronamraju R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000473; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Hughes SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000348; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; KELLUM R, 1995, J CELL SCI, V108, P1407; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Kusano K, 1999, GENETICS, V151, P1027; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Royou A, 2010, CELL, V140, P235, DOI 10.1016/j.cell.2009.12.043; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sato A, 2009, CELL, V139, P907, DOI 10.1016/j.cell.2009.10.039; Shin DM, 2011, GERONTOLOGY, V57, P76, DOI 10.1159/000281882; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Soutoglou Evi, 2008, J Natl Cancer Inst Monogr, P16, DOI 10.1093/jncimonographs/lgn017; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Westphal T, 2002, GENETICS, V160, P609; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	47	371	376	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					732	744		10.1016/j.cell.2011.02.012	http://dx.doi.org/10.1016/j.cell.2011.02.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21353298	Bronze, Green Accepted			2022-12-24	WOS:000288007100012
J	Vyazovskiy, VV; Olcese, U; Hanlon, EC; Nir, Y; Cirelli, C; Tononi, G				Vyazovskiy, Vladyslav V.; Olcese, Umberto; Hanlon, Erin C.; Nir, Yuval; Cirelli, Chiara; Tononi, Giulio			Local sleep in awake rats	NATURE			English	Article							SLOW-WAVE ACTIVITY; CORTICAL SYNCHRONIZATION; VISUAL-STIMULATION; THETA ACTIVITY; HOMEOSTASIS; EEG; NEURONS; WAKING; STATES; BRAIN	In an awake state, neurons in the cerebral cortex fire irregularly and electroencephalogram (EEG) recordings display low-amplitude, high-frequency fluctuations. During sleep, neurons oscillate between 'on' periods, when they fire as in an awake brain, and 'off' periods, when they stop firing altogether and the EEG displays high-amplitude slowwaves. However, what happens to neuronal firing after a long period of being awake is not known. Here we show that in freely behaving rats after a long period in an awake state, cortical neurons can go briefly 'offline' as in sleep, accompanied by slow waves in the local EEG. Neurons often go offline in one cortical area but not in another, and during these periods of 'local sleep', the incidence of which increases with the duration of the awake state, rats are active and display an 'awake' EEG. However, they are progressively impaired in a sugar pellet reaching task. Thus, although both the EEG and behaviour indicate wakefulness, local populations of neurons in the cortex may be falling asleep, with negative consequences for performance.	[Vyazovskiy, Vladyslav V.; Olcese, Umberto; Hanlon, Erin C.; Nir, Yuval; Cirelli, Chiara; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; [Olcese, Umberto] Scuola Super Sant Anna, PERCRO Lab, I-56217 Pisa, Italy	University of Wisconsin System; University of Wisconsin Madison; Scuola Superiore Sant'Anna	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	gtononi@wisc.edu		Olcese, Umberto/0000-0001-6968-2503; Vyazovskiy, Vladyslav/0000-0002-4336-6681; Nir, Yuval/0000-0002-5433-6349	NIMH [P20 MH077967]; NIH; AFOSR [FA9550-08-1-0244]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH077967] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIMH P20 MH077967 (C. C.), NIH Director's Pioneer award (G. T.) and AFOSR FA9550-08-1-0244 (G. T.). We thank A. Nelson, M. Dash and U. Faraguna for help with the experiments, L. Krugner-Higby for advice about surgical procedures and P. Frumento for advice on statistical procedures.	Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Blaivas AJ, 2007, SLEEP MED, V8, P156, DOI 10.1016/j.sleep.2006.06.011; Borbely A. A., 2005, PRINCIPLES PRACTICE, P405; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Dang-Vu TT, 2010, SLEEP, V33, P1589, DOI 10.1093/sleep/33.12.1589; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Ferrillo F, 2000, CLIN NEUROPHYSIOL, V111, P916, DOI 10.1016/S1388-2457(00)00246-7; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Hanlon EC, 2009, SLEEP, V32, P719, DOI 10.1093/sleep/32.6.719; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Laplante F, 2005, NEUROSCIENCE, V132, P501, DOI 10.1016/j.neuroscience.2004.11.059; Leemburg S, 2010, P NATL ACAD SCI USA, V107, P15939, DOI 10.1073/pnas.1002570107; Mahowald MW, 2005, NATURE, V437, P1279, DOI 10.1038/nature04287; Maquet P, 2000, J SLEEP RES, V9, P207; MARROCCO RT, 1987, J NEUROSCI, V7, P2756; MORUZZI G, 1966, FUNCTIONAL SIGNIFICA; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Nunez A, 1996, NEUROSCIENCE, V72, P757, DOI 10.1016/0306-4522(95)00582-X; Pigarev IN, 1997, NEUROREPORT, V8, P2557, DOI 10.1097/00001756-199707280-00027; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Terzaghi M, 2009, SLEEP, V32, P409, DOI 10.1093/sleep/32.3.409; Tirunahari VL, 2003, SLEEP MED, V4, P63, DOI 10.1016/S1389-9457(02)00250-2; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vyazovskiy VV, 2008, J NEUROPHYSIOL, V99, P969, DOI 10.1152/jn.01154.2007; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Vyazovskiy VV, 2009, J NEUROPHYSIOL, V101, P1921, DOI 10.1152/jn.91157.2008; Vyazovskiy VV, 2005, BRAIN RES, V1050, P64, DOI 10.1016/j.brainres.2005.05.022; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9	40	491	496	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					443	447		10.1038/nature10009	http://dx.doi.org/10.1038/nature10009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525926	Green Accepted			2022-12-24	WOS:000289949600028
J	Zhu, HL; Hu, FQ; Wang, RH; Zhou, X; Sze, SH; Liou, LW; Barefoot, A; Dickman, M; Zhang, XR				Zhu, Hongliang; Hu, Fuqu; Wang, Ronghui; Zhou, Xin; Sze, Sing-Hoi; Liou, Lisa Wen; Barefoot, Ashley; Dickman, Martin; Zhang, Xiuren			Arabidopsis Argonaute10 Specifically Sequesters miR166/165 to Regulate Shoot Apical Meristem Development	CELL			English	Article							LEAF POLARITY; SMALL RNAS; GENE; EXPRESSION; PATHWAY; ESTABLISHMENT; MICRORNAS; COMPLEXES; ROLES; SIRNA	The shoot apical meristem (SAM) comprises a group of undifferentiated cells that divide to maintain the plant meristem and also give rise to all shoot organs. SAM fate is specified by class III HOMEODOMAIN-LEUCINE ZIPPER (HD-ZIP III) transcription factors, which are targets of miR166/165. In Arabidopsis, AGO10 is a critical regulator of SAM maintenance, and here we demonstrate that AGO10 specifically interacts with miR166/165. The association is determined by a distinct structure of the miR166/165 duplex. Deficient loading of miR166 into AGO10 results in a defective SAM. Notably, the miRNA-binding ability of AGO10, but not its catalytic activity, is required for SAM development, and AGO10 has a higher binding affinity for miR166 than does AGO1, a principal contributor to miRNA-mediated silencing. We propose that AGO10 functions as a decoy for miR166/165 to maintain the SAM, preventing their incorporation into AGO1 complexes and the subsequent repression of HD-ZIP III gene expression.	[Zhu, Hongliang; Hu, Fuqu; Wang, Ronghui; Sze, Sing-Hoi; Liou, Lisa Wen; Barefoot, Ashley; Zhang, Xiuren] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Zhu, Hongliang; Hu, Fuqu; Wang, Ronghui; Zhou, Xin; Dickman, Martin; Zhang, Xiuren] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; [Sze, Sing-Hoi] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA; [Zhou, Xin] Washington Univ, Dept Genet, St Louis, MO 63108 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Washington University (WUSTL)	Zhang, XR (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	xiuren.zhang@tamu.edu	Zhu, Hongliang/I-7035-2019	Zhu, Hongliang/0000-0002-1484-2212	NSF [MCB-0951120]; Texas AM University; NSF-REU [MCB-1037884]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097570] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0951120] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Texas AM University; NSF-REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We are grateful to K. Barton for the ago10<SUP>pnh-2</SUP> mutant, T. Laux for the YFP-AGO10 lines, H. Vaucheret for the ago1-27 mutant, and D. Baulcombe for providing an anti-AGO1 antibody. We thank Drs. D. Shippen, G. Kapler, F. Qiao, T. Devarenne, and C. Kaplan for stimulating discussions and critical review of the manuscript. The work was supported by a grant from NSF (MCB-0951120) and a startup from Texas A&M University to X.Z. L.W.L. and A.B. were supported by NSF-REU (MCB-1037884).	Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Liu QL, 2009, PLANT J, V58, P27, DOI 10.1111/j.1365-313X.2008.03757.x; Lynn K, 1999, DEVELOPMENT, V126, P469; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Mallory AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000646; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Tucker MR, 2008, DEVELOPMENT, V135, P2839, DOI 10.1242/dev.023648; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Zhang XY, 2006, FASEB J, V20, pA122; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P391, DOI 10.1093/pcp/pcm008; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	35	311	349	8	125	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					242	256		10.1016/j.cell.2011.03.024	http://dx.doi.org/10.1016/j.cell.2011.03.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496644	Green Accepted, Bronze			2022-12-24	WOS:000289549900013
J	Negre, N; Brown, CD; Ma, LJ; Bristow, CA; Miller, SW; Wagner, U; Kheradpour, P; Eaton, ML; Loriaux, P; Sealfon, R; Li, ZR; Ishii, H; Spokony, RF; Chen, J; Hwang, L; Cheng, C; Auburn, RP; Davis, MB; Domanus, M; Shah, PK; Morrison, CA; Zieba, J; Suchy, S; Senderowicz, L; Victorsen, A; Bild, NA; Grundstad, AJ; Hanley, D; MacAlpine, DM; Mannervik, M; Venken, K; Bellen, H; White, R; Gerstein, M; Russell, S; Grossman, RL; Ren, B; Posakony, JW; Kellis, M; White, KP				Negre, Nicolas; Brown, Christopher D.; Ma, Lijia; Bristow, Christopher Aaron; Miller, Steven W.; Wagner, Ulrich; Kheradpour, Pouya; Eaton, Matthew L.; Loriaux, Paul; Sealfon, Rachel; Li, Zirong; Ishii, Haruhiko; Spokony, Rebecca F.; Chen, Jia; Hwang, Lindsay; Cheng, Chao; Auburn, Richard P.; Davis, Melissa B.; Domanus, Marc; Shah, Parantu K.; Morrison, Carolyn A.; Zieba, Jennifer; Suchy, Sarah; Senderowicz, Lionel; Victorsen, Alec; Bild, Nicholas A.; Grundstad, A. Jason; Hanley, David; MacAlpine, David M.; Mannervik, Mattias; Venken, Koen; Bellen, Hugo; White, Robert; Gerstein, Mark; Russell, Steven; Grossman, Robert L.; Ren, Bing; Posakony, James W.; Kellis, Manolis; White, Kevin P.			A cis-regulatory map of the Drosophila genome	NATURE			English	Article							TRANSCRIPTION FACTOR; ENHANCERS; MELANOGASTER; EXPRESSION; BLASTODERM; PROTEINS	Systematic annotation of gene regulatory elements is a major challenge in genome science. Direct mapping of chromatin modification marks and transcriptional factor binding sites genome-wide(1,2) has successfully identified specific subtypes of regulatory elements(3). In Drosophila several pioneering studies have provided genome-wide identification of Polycomb response elements(4), chromatin states(5), transcription factor binding sites(6-9), RNA polymerase II regulation(8) and insulator elements(10); however, comprehensive annotation of the regulatory genome remains a significant challenge. Here we describe results from the modENCODE cis-regulatory annotation project. We produced a map of the Drosophila melanogaster regulatory genome on the basis of more than 300 chromatin immunoprecipitation data sets for eight chromatin features, five histone deacetylases and thirty-eight site-specific transcription factors at different stages of development. Using these data we inferred more than 20,000 candidate regulatory elements and validated a subset of predictions for promoters, enhancers and insulators in vivo. We identified also nearly 2,000 genomic regions of dense transcription factor binding associated with chromatin activity and accessibility. We discovered hundreds of new transcription factor co-binding relationships and defined a transcription factor network with over 800 potential regulatory relationships.	[Negre, Nicolas; Brown, Christopher D.; Ma, Lijia; Spokony, Rebecca F.; Davis, Melissa B.; Domanus, Marc; Morrison, Carolyn A.; Zieba, Jennifer; Suchy, Sarah; Senderowicz, Lionel; Victorsen, Alec; Bild, Nicholas A.; Grundstad, A. Jason; Grossman, Robert L.; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Dept Human Genet, Chicago, IL 60637 USA; [Bristow, Christopher Aaron; Kheradpour, Pouya; Sealfon, Rachel; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Miller, Steven W.; Ishii, Haruhiko; Posakony, James W.] Univ Calif San Diego, Div Biol Sci CDB, La Jolla, CA 92093 USA; [Wagner, Ulrich; Li, Zirong; Hwang, Lindsay; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Eaton, Matthew L.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27710 USA; [Loriaux, Paul] Univ Calif San Diego, Signaling Syst Lab, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Chen, Jia; Hanley, David; Grossman, Robert L.] Univ Illinois, Natl Ctr Data Min, Chicago, IL 60607 USA; [Cheng, Chao; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Cheng, Chao; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Cheng, Chao] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Auburn, Richard P.; Russell, Steven] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Auburn, Richard P.; Russell, Steven] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 3EH, England; [Shah, Parantu K.] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Mannervik, Mattias] Stockholm Univ, Dept Dev Biol, Wenner Gren Inst, Arrhenius Labs E3, S-10691 Stockholm, Sweden; [Venken, Koen; Bellen, Hugo] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [White, Robert] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Grossman, Robert L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ren, Bing] Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Moores Canc Ctr, La Jolla, CA 92093 USA	University of Chicago; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; Duke University; University of California System; University of California San Diego; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yale University; Yale University; Yale University; University of Cambridge; University of Cambridge; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Stockholm University; Baylor College of Medicine; University of Cambridge; University of Chicago	White, KP (corresponding author), Univ Chicago, Inst Genom & Syst Biol, Dept Human Genet, 900 E 57th St, Chicago, IL 60637 USA.	kpwhite@uchicago.edu	Eaton, Matthew/C-4408-2011; Spokony, Rebecca/AAD-3014-2020; Venken, Koen/B-9909-2013; Zieba, Jennifer/ABE-1077-2020; Russell, Steve/A-4072-2011; Kellis, Manolis/ABE-7385-2020; White, Rob A H/G-4835-2012; Grossman, Robert/B-1865-2009	Venken, Koen/0000-0003-0741-4698; Zieba, Jennifer/0000-0003-1650-1830; Russell, Steve/0000-0003-0546-3031; Kellis, Manolis/0000-0001-7113-9630; Ishii, Haruhiko/0000-0002-1593-096X; Mannervik, Mattias/0000-0003-4999-9655; Grossman, Robert/0000-0003-3741-5739; Miller, Steven/0000-0001-7610-6336; Bellen, Hugo/0000-0001-5992-5989; Negre, Nicolas/0000-0001-9727-3416; Brown, Christopher/0000-0002-3785-5008; Davis, Melissa/0000-0002-6124-6923	National Human Genome Research Institute [U01HG004264]; Chicago Biomedical Consortium; Chicago Community Trust; Lilly-Life Sciences Research Foundation; NIH NRSA; Isaac Newton Trust; Department of Energy; NHGRI [U01 HG004279]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004264, RC2HG005639, U01HG004279, R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074364, P50GM081892] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Chicago Biomedical Consortium; Chicago Community Trust; Lilly-Life Sciences Research Foundation; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Isaac Newton Trust; Department of Energy(United States Department of Energy (DOE)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U01HG004264 from the National Human Genome Research Institute to K.P.W. and also funded by the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Human Genome Research Institute (NHGRI) or the National Institutes of Health (NIH). C.D.B. is supported by a Lilly-Life Sciences Research Foundation fellowship. C.A.B. is supported by a NIH NRSA postdoctoral fellowship. R.P.A. is in part supported by an Isaac Newton Trust award to R.W.P.L. was supported by a grant from the Department of Energy Computational Sciences Graduate Fellowship (DOE CSGF). M.E.L. and D.M.M. work was supported by NHGRI grant U01 HG004279. We thank the Functional Genomics Facility at the University of Chicago and the High-Throughput Genome Analysis Core at Argonne National Laboratory for processing of microarrays and of Illumina sequence. We thank T.-R. Li, J.D. Lambert, S. Rifkin, T. Herreman, C. Mason, L. Sun and Z. Gauhar for producing the developmental expression microarray data. We also thank the many members of the Drosophila community who contributed to this work by providing reagents. A complete list of community participants is included in the Supplementary Methods.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Haecker A, 2007, PLOS BIOL, V5, P1298, DOI 10.1371/journal.pbio.0050145; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531; Zraly CB, 2003, DEV BIOL, V253, P291, DOI 10.1016/S0012-1606(02)00011-8	27	371	379	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					527	531		10.1038/nature09990	http://dx.doi.org/10.1038/nature09990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430782	Green Accepted, Green Submitted			2022-12-24	WOS:000288702200065
J	Nurse, P; Hayles, J				Nurse, Paul; Hayles, Jacqueline			The Cell in an Era of Systems Biology	CELL			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; PROTEIN INTERACTION NETWORK; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; GLOBAL ANALYSIS; BUDDING YEAST; SIZE CONTROL; GENOME; CYCLE	The increasing use of high-throughput technologies and computational modeling is revealing new levels of biological function and organization. How are these features of systems biology influencing our view of the cell?	[Nurse, Paul; Hayles, Jacqueline] Cancer Res UK, London Res Inst, London WC2A 3LY, England; [Nurse, Paul] Rockefeller Univ, New York, NY 10021 USA	Cancer Research UK; Rockefeller University	Nurse, P (corresponding author), Cancer Res UK, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.	janet.bonner@royalsociety.org			Wellcome Trust [093917] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bray, 2009, WETWARE COMPUTER EVE; BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; Choi JK, 2009, NAT GENET, V41, P498, DOI 10.1038/ng.319; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; DICKSON RC, 1975, SCIENCE, V187, P27, DOI 10.1126/science.1088926; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; Guo YB, 2010, GENOME RES, V20, P239, DOI 10.1101/gr.099648.109; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Monod J., 1972, CHANCE NECESSITY ESS; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; OHKI M, 1975, NATURE, V253, P654, DOI 10.1038/253654a0; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; SAUNDERS PT, 1976, J THEOR BIOL, V63, P375, DOI 10.1016/0022-5193(76)90040-0; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sioud M, 2011, METHODS MOL BIOL, V703, P173, DOI 10.1007/978-1-59745-248-9_12; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Towers M, 2009, INT J DEV BIOL, V53, P805, DOI 10.1387/ijdb.072499mt; TYSON JJ, 1983, J THEOR BIOL, V104, P617, DOI 10.1016/0022-5193(83)90250-3; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wang Y, 2010, J PROTEOME RES, V9, P6665, DOI 10.1021/pr100808n; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	54	52	56	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 18	2011	144	6					850	854		10.1016/j.cell.2011.02.045	http://dx.doi.org/10.1016/j.cell.2011.02.045			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414476	Bronze			2022-12-24	WOS:000288543500003
J	Feng, D; Liu, T; Sun, Z; Bugge, A; Mullican, SE; Alenghat, T; Liu, XS; Lazar, MA				Feng, Dan; Liu, Tao; Sun, Zheng; Bugge, Anne; Mullican, Shannon E.; Alenghat, Theresa; Liu, X. Shirley; Lazar, Mitchell A.			A Circadian Rhythm Orchestrated by Histone Deacetylase 3 Controls Hepatic Lipid Metabolism	SCIENCE			English	Article							RECEPTOR COREPRESSOR; TRANSCRIPTION; LIVER; CLOCK; MICE; TISSUE	Disruption of the circadian clock exacerbates metabolic diseases, including obesity and diabetes. We show that histone deacetylase 3 ( HDAC3) recruitment to the genome displays a circadian rhythm in mouse liver. Histone acetylation is inversely related to HDAC3 binding, and this rhythm is lost when HDAC3 is absent. Although amounts of HDAC3 are constant, its genomic recruitment in liver corresponds to the expression pattern of the circadian nuclear receptor Rev-erb alpha. Rev-erb alpha colocalizes with HDAC3 near genes regulating lipid metabolism, and deletion of HDAC3 or Rev-erb alpha in mouse liver causes hepatic steatosis. Thus, genomic recruitment of HDAC3 by Rev-erb alpha directs a circadian rhythm of histone acetylation and gene expression required for normal hepatic lipid homeostasis.	[Feng, Dan; Sun, Zheng; Bugge, Anne; Mullican, Shannon E.; Alenghat, Theresa; Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA; [Feng, Dan; Sun, Zheng; Bugge, Anne; Mullican, Shannon E.; Alenghat, Theresa; Lazar, Mitchell A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab IDOM, Philadelphia, PA 19104 USA; [Liu, Tao; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, Tao; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Pennsylvania; University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Lazar, MA (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Liu, Tao/G-3585-2010; Liu, Tao/AAO-6310-2021; Feng, Dan/F-7205-2013; Lazar, Mitchell A/AAF-3738-2019; Sun, Zheng/C-1146-2012	Liu, Tao/0000-0002-8818-8313; Liu, Tao/0000-0002-8818-8313; Sun, Zheng/0000-0002-6858-0633; Feng, Dan/0000-0001-5926-8894; Liu, Tao/0000-0003-0446-9001; Bugge, Anne/0000-0001-5885-4541	NIH [DK19525, DK49210, DK45586, DK43806, RC1DK08623, HG4069]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086239, P01DK049210, R37DK043806, P30DK019525, R01DK043806, R01DK045586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ChIP-seq and microarray data have been deposited in the Gene Expression Omnibus (GSE25937 and GSE26345) database. We thank B. Vennstrom for providing Rev-erba KO mice; M. Brown, D. Steger, and members of the Lazar lab for helpful discussions; D. Zhuo for technical assistance; the Penn IDOM Metabolism Resource (J. Millar) for help with de novo lipogenesis experiments; the Functional Genomics Core (J. Schug and K. Kaestner) and the Viral Vector Core (J. Johnston) of the Penn Diabetes Endocrinology Research Center (NIH DK19525) for deep sequencing and virus preparation; the Morphology Core (J. Katz and G. Swain) (NIH DK49210) for tissue preparation and staining; and the Penn Bioinformatics Core (J. Tobias) and Microarray Core (D. Baldwin) for gene expression analysis. Supported by the Cox Institute, NIH DK45586, DK43806, and RC1DK08623 (to M. A. L.) and NIH HG4069 (to X. S. L.).	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Chomez P, 2000, DEVELOPMENT, V127, P1489; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Goodson Michael, 2005, Nucl Recept Signal, V3, pe003; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; HEMS DA, 1975, BIOCHEM J, V150, P167, DOI 10.1042/bj1500167; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pietroiusti A, 2010, OCCUP ENVIRON MED, V67, P54, DOI 10.1136/oem.2009.046797; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Sookoian S, 2007, WORLD J GASTROENTERO, V13, P4242, DOI 10.3748/wjg.v13.i31.4242; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Zamir I, 1996, MOL CELL BIOL, V16, P5458	30	478	493	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1315	1319		10.1126/science.1198125	http://dx.doi.org/10.1126/science.1198125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393543	Green Accepted			2022-12-24	WOS:000288215200044
J	Briggman, KL; Helmstaedter, M; Denk, W				Briggman, Kevin L.; Helmstaedter, Moritz; Denk, Winfried			Wiring specificity in the direction-selectivity circuit of the retina	NATURE			English	Article							STARBURST AMACRINE CELLS; GANGLION-CELLS; RABBIT RETINA; ACETYLCHOLINE-RECEPTORS; DENDRITIC STRUCTURE; CALCIUM SIGNALS; IMAGE MOTION; MECHANISMS; GABA; CONNECTIONS	The proper connectivity between neurons is essential for the implementation of the algorithms used in neural computations, such as the detection of directed motion by the retina. The analysis of neuronal connectivity is possible with electron microscopy, but technological limitations have impeded the acquisition of high-resolution data on a large enough scale. Here we show, using serial block-face electron microscopy and two-photon calcium imaging, that the dendrites of mouse starburst amacrine cells make highly specific synapses with direction-selective ganglion cells depending on the ganglion cell's preferred direction. Our findings indicate that a structural (wiring) asymmetry contributes to the computation of direction selectivity. The nature of this asymmetry supports some models of direction selectivity and rules out others. It also puts constraints on the developmental mechanisms behind the formation of synaptic connections. Our study demonstrates how otherwise intractable neurobiological questions can be addressed by combining functional imaging with the analysis of neuronal connectivity using large-scale electron microscopy.	[Briggman, Kevin L.; Helmstaedter, Moritz; Denk, Winfried] Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany	Max Planck Society	Briggman, KL (corresponding author), Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany.	briggman@mpimf-heidelberg.mpg.de	denk, winfried/I-6627-2012					BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Blankenship AG, 2009, NEURON, V62, P230, DOI 10.1016/j.neuron.2009.03.015; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; BRIGGMAN KL, J NEUROPHYS IN PRESS; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Chen YC, 2008, J COMP NEUROL, V508, P175, DOI 10.1002/cne.21677; Chiao CC, 2002, J NEUROSCI, V22, P10509; Dacheux RF, 2003, J COMP NEUROL, V456, P267, DOI 10.1002/cne.10521; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Denk W, 1999, P NATL ACAD SCI USA, V96, P7035, DOI 10.1073/pnas.96.12.7035; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dmitrieva NA, 2003, J COMP NEUROL, V456, P167, DOI 10.1002/cne.10520; Dmitrieva NA, 2007, J HISTOCHEM CYTOCHEM, V55, P461, DOI 10.1369/jhc.6A7116.2006; Dong W, 2004, J PHYSIOL-LONDON, V556, P11, DOI 10.1113/jphysiol.2004.060715; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; Fahmy A., 1967, P ELECTRON MICROSCOP, P148; Famiglietti EV, 2002, VISUAL NEUROSCI, V19, P145, DOI 10.1017/S0952523802191139; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; GLAUERT AM, 1998, PRACTICAL METHODS EL, V21; Granstedt AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006923; Grzywacz NM, 1997, VISUAL NEUROSCI, V14, P39, DOI 10.1017/S0952523800008749; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; He SG, 1999, J NEUROSCI, V19, P8049; Karnovsky M.J., 1971, P 11 M AM SOC CELL B, P146; Keeley PW, 2007, J COMP NEUROL, V505, P539, DOI 10.1002/cne.21518; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031; Mumm JS, 2005, PROG BRAIN RES, V147, P155, DOI 10.1016/S0079-6123(04)47012-5; Oesch NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012447; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; OYSTER CW, 1993, VISION RES, V33, P579, DOI 10.1016/0042-6989(93)90181-U; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Schachter MJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000899; Schlichtenbrede FC, 2009, INVEST OPHTH VIS SCI, V50, P5880, DOI 10.1167/iovs.08-3078; SELIGMAN AM, 1966, J CELL BIOL, V30, P424, DOI 10.1083/jcb.30.2.424; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Taylor WR, 2002, J NEUROSCI, V22, P7712; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; WALTON J, 1979, J HISTOCHEM CYTOCHEM, V27, P1337, DOI 10.1177/27.10.512319; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Yamada ES, 2003, J COMP NEUROL, V461, P76, DOI 10.1002/cne.10672; YANG G, 1994, J NEUROSCI, V14, P5267; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	55	537	542	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					183	U67		10.1038/nature09818	http://dx.doi.org/10.1038/nature09818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390125				2022-12-24	WOS:000288170200030
J	Pan, J; Sasaki, M; Kniewel, R; Murakami, H; Blitzblau, HG; Tischfield, SE; Zhu, X; Neale, MJ; Jasin, M; Socci, ND; Hochwagen, A; Keeney, S				Pan, Jing; Sasaki, Mariko; Kniewel, Ryan; Murakami, Hajime; Blitzblau, Hannah G.; Tischfield, Sam E.; Zhu, Xuan; Neale, Matthew J.; Jasin, Maria; Socci, Nicholas D.; Hochwagen, Andreas; Keeney, Scott			A Hierarchical Combination of Factors Shapes the Genome-wide Topography of Yeast Meiotic Recombination Initiation	CELL			English	Article							DOUBLE-STRAND BREAKS; TRANSCRIPTION FACTOR; CHROMATIN-STRUCTURE; GENE CONVERSION; GLOBAL ANALYSIS; CHROMOSOME-III; DNA REVEALS; IN-VIVO; SITES; CROSSOVERS	The nonrandom distribution of meiotic recombination influences patterns of inheritance and genome evolution, but chromosomal features governing this distribution are poorly understood. Formation of the DNA double-strand breaks (DSBs) that initiate recombination results in the accumulation of Spo11 protein covalently bound to small DNA fragments. By sequencing these fragments, we uncover a genome-wide DSB map of unprecedented resolution and sensitivity. We use this map to explore how DSB distribution is influenced by large-scale chromosome structures, chromatin, transcription factors, and local sequence composition. Our analysis offers mechanistic insight into DSB formation and early processing steps, supporting the view that the recombination terrain is molded by combinatorial and hierarchical interaction of factors that work on widely different size scales. This map illuminates the occurrence of DSBs in repetitive DNA elements, repair of which can lead to chromosomal rearrangements. We also discuss implications for evolutionary dynamics of recombination hot spots.	[Pan, Jing; Sasaki, Mariko; Kniewel, Ryan; Murakami, Hajime; Tischfield, Sam E.; Zhu, Xuan; Neale, Matthew J.; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Sasaki, Mariko; Kniewel, Ryan; Zhu, Xuan] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Blitzblau, Hannah G.; Hochwagen, Andreas] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tischfield, Sam E.] Cornell Univ, Triinst Training Program Computat Biol & Med, New York, NY 10065 USA; [Neale, Matthew J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Cornell University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Cornell University; University of Sussex	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA.	s-keeney@ski.mskcc.org	Murakami, Hajime/AAX-9411-2021; Keeney, Scott/GVR-8515-2022; Sasaki, Mariko/AAF-3414-2019; Sasaki, Mariko/AAT-6090-2020; Sasaki, Mariko/K-6217-2017	Keeney, Scott/0000-0002-1283-6417; Sasaki, Mariko/0000-0003-4208-1251; Kniewel, Ryan/0000-0003-3462-6450; Zhu, Xuan/0000-0002-8422-2828; Neale, Matthew/0000-0002-6453-1877; Hochwagen, Andreas/0000-0002-6184-443X; Murakami, Hajime/0000-0002-7022-6887	NIH [GM58673, HD53855, T32 GM008539]; Royal Society; MRC; HFSP; Leukemia and Lymphoma Society; Medical Research Council [G0800005] Funding Source: researchfish; MRC [G0800005] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673, T32GM008539] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HFSP(Human Frontier Science Program); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Viale (MSKCC Genomics Core Laboratory) for sequencing; S. Shuman and J. Nandakumar (MSKCC) for generous gifts of RNA ligase; and M. Lichten (NCI), I. Whitehouse (MSKCC), and G. Smith (Fred Hutchinson Cancer Research Center) for comments on the manuscript. This work was supported in part by NIH grants GM58673 (S. K.) and HD53855 (S. K. and M. J.). M. J. N. is supported by a Royal Society University Research Fellowship, an MRC New Investigator Grant, and an HFSP Career Development Award. J. P. was supported by a Leukemia and Lymphoma Society Fellowship. R. K. was supported by NIH training grant T32 GM008539. S. K. is an Investigator of the Howard Hughes Medical Institute.	Ahmed NT, 2009, MOL CELL BIOL, V29, P4352, DOI 10.1128/MCB.00305-09; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Barton AB, 2008, GENETICS, V179, P1221, DOI 10.1534/genetics.107.083493; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Ben-Aroya S, 2004, MOL CELL, V15, P221, DOI 10.1016/j.molcel.2004.06.002; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Borde V, 1999, MOL CELL BIOL, V19, P4832; Borde V, 2004, MOL CELL, V13, P389, DOI 10.1016/S1097-2765(04)00034-6; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Gabriel A, 2006, PLOS GENET, V2, P2026, DOI 10.1371/journal.pgen.0020212; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HOROWITZ H, 1984, MOL CELL BIOL, V4, P2509, DOI 10.1128/MCB.4.11.2509; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mieczkowski PA, 2006, MOL CELL BIOL, V26, P1014, DOI 10.1128/MCB.26.3.1014-1027.2006; Murakami H, 2009, MOL CELL BIOL, V29, P3500, DOI 10.1128/MCB.00088-09; Neale MJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-104; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; OHTA K, 1994, EMBO J, V13, P5754, DOI 10.1002/j.1460-2075.1994.tb06913.x; PETES TD, 1977, P NATL ACAD SCI USA, V74, P5091, DOI 10.1073/pnas.74.11.5091; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Schlecht U, 2008, MOL BIOL CELL, V19, P2193, DOI 10.1091/mbc.E07-12-1242; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Xu F, 1996, GENETICS, V143, P1115	50	350	352	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					719	731		10.1016/j.cell.2011.02.009	http://dx.doi.org/10.1016/j.cell.2011.02.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376234	Green Accepted, Bronze			2022-12-24	WOS:000288007100011
J	van't Hof, AE; Edmonds, N; Dalikova, M; Marec, F; Saccheri, IJ				van't Hof, Arjen E.; Edmonds, Nicola; Dalikova, Martina; Marec, Frantisek; Saccheri, Ilik J.			Industrial Melanism in British Peppered Moths Has a Singular and Recent Mutational Origin	SCIENCE			English	Article							BLACK-AND-WHITE; LINKAGE DISEQUILIBRIUM; HELICONIUS BUTTERFLIES; SELECTION	The rapid spread of a novel black form (known as carbonaria) of the peppered moth Biston betularia in 19th-century Britain is a textbook example of how an altered environment may produce morphological adaptation through genetic change. However, the underlying genetic basis of the difference between the wild-type (light-colored) and carbonaria forms has remained unknown. We have genetically mapped the carbonaria morph to a 200-kilobase region orthologous to a segment of silkworm chromosome 17 and show that there is only one core sequence variant associated with the carbonaria morph, carrying a signature of recent strong selection. The carbonaria region coincides with major wing-patterning loci in other lepidopteran systems, suggesting the existence of basal color-patterning regulators in this region.	[van't Hof, Arjen E.; Edmonds, Nicola; Saccheri, Ilik J.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Dalikova, Martina; Marec, Frantisek] Acad Sci Czech Republic, Inst Entomol, CR-37005 Ceske Budejovice, Czech Republic; [Dalikova, Martina; Marec, Frantisek] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	University of Liverpool; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Saccheri, IJ (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	saccheri@liv.ac.uk	Van 't Hof, Arjen/AAE-8044-2022; Dalikova, Martina/J-5722-2015; Marec, Frantisek/G-7943-2014	Dalikova, Martina/0000-0002-0266-8894; Marec, Frantisek/0000-0002-6745-5603	Natural Environment Research Council [NE/C003101/1]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA600960925]; Entomology Institute [Z50070508]; Grant Agency of the Czech Republic [521/08/H042]; NERC [NE/H024352/1] Funding Source: UKRI; Natural Environment Research Council [NE/H024352/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Entomology Institute; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by Natural Environment Research Council grant NE/C003101/1 to I.J.S. Cytogenetic experiments were financed by Grant Agency of the Academy of Sciences of the Czech Republic grant IAA600960925, Entomology Institute project Z50070508, and Grant Agency of the Czech Republic 521/08/H042 grants to F.M. and M.D. Specimens for the UK-wide survey were made available by several museums and private collectors, listed in table S4. J. Delf produced fig. S3. GenBank accession numbers are listed in table S1.	Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Cook Laurence M., 2003, Entomologist's Gazette, V54, P211; Cook LM, 2005, J HERED, V96, P522, DOI 10.1093/jhered/esi082; Cook LM, 2003, Q REV BIOL, V78, P399, DOI 10.1086/378925; GOLDSMITH MR, 1995, MOL MODEL SYSTEMS LE; Hedrick P, 2001, EUR J HUM GENET, V9, P969, DOI 10.1038/sj.ejhg.5200735; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; Kronforst MR, 2006, GENETICS, V174, P535, DOI 10.1534/genetics.106.059527; Lees D. R., 1981, GENETIC CONSEQUENCES, P129; Majerus M, 1998, MELANISM EVOLUTION A; Majerus MEN, 2003, TRENDS GENET, V19, P585, DOI 10.1016/j.tig.2003.09.003; Papa R, 2008, CURR OPIN GENET DEV, V18, P559, DOI 10.1016/j.gde.2008.11.007; Pfaffelhuber P, 2008, GENETICS, V179, P527, DOI 10.1534/genetics.107.081497; Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105; Stern D. L., 2010, EVOLUTION DEV PREDIC; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; van't Hof AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010889; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X	18	101	104	4	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					958	960		10.1126/science.1203043	http://dx.doi.org/10.1126/science.1203043			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21493823				2022-12-24	WOS:000290766600041
J	Flenady, V; Middleton, P; Smith, GC; Duke, W; Erwich, JJ; Khong, TY; Neilson, J; Ezzati, M; Koopmans, L; Ellwood, D; Fretts, R; Froen, JF				Flenady, Vicki; Middleton, Philippa; Smith, Gordon C.; Duke, Wes; Erwich, Jan Jaap; Khong, T. Yee; Neilson, Jim; Ezzati, Majid; Koopmans, Laura; Ellwood, David; Fretts, Ruth; Froen, J. Frederik		Lancet's Stillbirths Series Steeri	Stillbirths 5 Stillbirths: the way forward in high-income countries	LANCET			English	Article							PERINATAL-MORTALITY; GESTATIONAL-AGE; FETAL-DEATH; PERIODONTAL-DISEASE; AVOIDABLE MORTALITY; ALCOHOL-CONSUMPTION; NEONATAL DEATHS; AUTOPSY RATES; PRENATAL-CARE; BIRTH-WEIGHT	Stillbirth rates in high-income countries declined dramatically from about 1940, but this decline has slowed or stalled over recent times. The present variation in stillbirth rates across and within high-income countries indicates that further reduction in stillbirth is possible. Large disparities (linked to disadvantage such as poverty) in stillbirth rates need to be addressed by providing more educational opportunities and improving living conditions for women. Placental pathologies and infection associated with preterm birth are linked to a substantial proportion of stillbirths. The proportion of unexplained stillbirths associated with under investigation continues to impede efforts in stillbirth prevention. Overweight, obesity, and smoking are important modifiable risk factors for stillbirth, and advanced maternal age is also an increasingly prevalent risk factor. Intensified efforts are needed to ameliorate the effects of these factors on stillbirth rates. Culturally appropriate preconception care and quality antenatal care that is accessible to all women has the potential to reduce stillbirth rates in high-income countries. Implementation of national perinatal mortality audit programmes aimed at improving the quality of care could substantially reduce stillbirths. Better data on numbers and causes of stillbirth are needed, and international consensus on definition and classification related to stillbirth is a priority. All parents should be offered a thorough investigation including a high-quality autopsy and placental histopathology. Parent organisations are powerful change agents and could have an important role in raising awareness to prevent stillbirth. Future research must focus on screening and interventions to reduce antepartum stillbirth as a result of placental dysfunction. Identification of ways to reduce maternal overweight and obesity is a high priority for high-income countries.	[Flenady, Vicki] Mater Med Res Inst, Mater Hlth Serv, Brisbane, Qld 4101, Australia; [Flenady, Vicki] Univ Queensland, Brisbane, Qld, Australia; [Flenady, Vicki] Int Stillbirth Alliance, Baltimore, MD USA; [Middleton, Philippa] Univ Adelaide, Adelaide, SA, Australia; [Smith, Gordon C.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Duke, Wes] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [Erwich, Jan Jaap] Univ Groningen, Dept Obstet, Utrecht, Netherlands; [Erwich, Jan Jaap] Fdn Perinatal Audit Netherlands, Utrecht, Netherlands; [Khong, T. Yee] Womens & Childrens Hosp, SA Pathol, Adelaide, SA, Australia; [Neilson, Jim] Univ Liverpool, Cochrane Pregnancy & Childbirth Grp, Liverpool L69 3BX, Merseyside, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Ellwood, David] Canberra Hosp, Canberra, ACT, Australia; [Ellwood, David] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Fretts, Ruth] Harvard Vanguard Med Associates, Wellesley, MA USA; [Froen, J. Frederik] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway	Mater Health Services; Mater Research; University of Queensland; University of Adelaide; University of Cambridge; Centers for Disease Control & Prevention - USA; University of Groningen; SA Pathology; Womens & Childrens Hospital Australia; University of Liverpool; Imperial College London; Australian National University; Canberra Hospital; Australian National University; Harvard Vanguard Medical Associates; Norwegian Institute of Public Health (NIPH)	Flenady, V (corresponding author), Mater Med Res Inst, Mater Hlth Serv, Brisbane, Qld 4101, Australia.	Vicki.Flenady@mmri.mater.org.au	Frøen, J. Frederik/C-3271-2009; Ellwood, David Alan/GNW-4485-2022; Smith, Gordon/A-8070-2008; Lawn, Joy/ABE-6382-2020; Flenady, Vicki Jane/O-9609-2014	Ellwood, David Alan/0000-0003-4512-6443; Smith, Gordon/0000-0003-2124-0997; Lawn, Joy/0000-0002-4573-1443; Flenady, Vicki Jane/0000-0001-8114-7677; Froen Froen, Jahn Frederik/0000-0001-9390-8509	Bill & Melinda Gates Foundation; International Stillbirth Alliance; Norwegian Institute of Public Health; Medical Research Council [G0801056B] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); International Stillbirth Alliance; Norwegian Institute of Public Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Bill & Melinda Gates Foundation for a grant to support this work to the International Stillbirth Alliance administered by the Mater Medical Research Institute, Brisbane, QLD, Australia. Additionally, we thank the International Stillbirth Alliance and the Norwegian Institute of Public Health for seed funding to support meetings of the steering committee. We thank the following for technical support: Dominique Rossouw, Madeleine Elder, and, Elizabeth Flenady for literature searching and reference management, Kristen Gibbons for statistical advice, and Glenda Hawley, Teresa Walsh, Shelley Wilkinson, and Ann Kingsbury for providing feedback on the report. We thank Janet Scott of Sands UK, Sue Hale of Sands UK and ISA Parent Advisory Committee, and Liz Conway Sands Australia and the ISA Parent Advisory Committee for their comments and contributions to the report. We thank the following for their contributions to the research priority component: Justus Hofmeyr for his assistance with the development of the research priority questions, review of interventions, and comment of drafts of the report; Eckhart Buchmann for development of the initial drafts of all the research questions; Igor Rudan for guidance and support; and Ibinabo Ibiebele for data analysis. We thank all those who scored the stillbirth research priorities: Adrian Charles, Paul Colditz, Linda Dodds, Lelia Duley, Jason Gardosi, Sanne Gordijn, Grace Guyon, Justus Hofmeyr, Alex Heazell, Robyn Kennare, Russell Kirby, Wolfgang Kuenzel, Kassam Mahomed, Luigi Matturri, Elizabeth M McClure, Lesley McCowan, Giorgio Mello, Ayman el Mohandes, Halit Pinar, Ingela Radestad, Uma M Reddy, Birgit Reime, Bob Silver, and Bert Timmer, and members of the GAPPS Basic Biology Working Group: Craig Rubens, Michael Gravett, Gordon Smith, Leslie Myatt, Oslem Equils, Roger Smith, and Sarah England.	Acolet D, 2005, PEDIATRICS, V116, P1457, DOI 10.1542/peds.2004-2691; Alderliesten ME, 2008, EUR J OBSTET GYN R B, V137, P141, DOI 10.1016/j.ejogrb.2007.06.002; Alfirevic Z, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007529.pub2; Aliyu MH, 2008, ALCOHOL, V42, P369, DOI 10.1016/j.alcohol.2008.04.003; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2007, DIAB PREGN AR WE PRO; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Bateman BT, 2006, AM J OBSTET GYNECOL, V194, P840, DOI 10.1016/j.ajog.2005.08.038; Bergsjo P, 2003, ACTA OBSTET GYN SCAN, V82, P780, DOI 10.1034/j.1600-0412.2003.00224.x; BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Bolling K, 2007, INFANT FEEDING SURVE; Breeze ACG, 2008, ULTRASOUND OBST GYN, V31, P187, DOI 10.1002/uog.5199; Brookes JS, 2006, J MAGN RESON IMAGING, V24, P1221, DOI 10.1002/jmri.20770; Bryant AS, 2010, AM J OBSTET GYNECOL, V202, P335, DOI 10.1016/j.ajog.2009.10.864; Burnley H, 2005, J CLIN PATHOL, V58, P93, DOI 10.1136/jcp.2004.020636; *CCOPMM, 2007, ANN REP YEAR 2007 IN; *CESDI, 2001, 8 CESDI; Chan A, 2004, J PAEDIATR CHILD H, V40, P340, DOI 10.1111/j.1440-1754.2004.00398.x; *CMACE, 2010, CTR MAT CHILD ENQ PE; Cnattingius S, 1998, BRIT MED J, V316, P1483, DOI 10.1136/bmj.316.7143.1483; Cogswell ME, 1999, OBSTET GYNECOL, V94, P616, DOI 10.1016/S0029-7844(99)00375-0; Cohen MC, 2008, PEDIATR DEVEL PATHOL, V11, P1, DOI 10.2350/07-01-0213.1; Corabian P, 2007, J OBSTET GYNAECOL CA, V29, P560, DOI 10.1016/S1701-2163(16)32500-2; Crowther CA, 1999, AUST NZ J OBSTET GYN, V39, P12, DOI 10.1111/j.1479-828X.1999.tb03434.x; d'Espaignet ET, 2008, FORENSIC SCI MED PAT, V4, P83, DOI 10.1007/s12024-007-9011-y; Darmstadt GL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S6; De Lange TE, 2008, AUST NZ J OBSTET GYN, V48, P50, DOI 10.1111/j.1479-828X.2007.00801.x; De Reu PAOM, 2000, EUR J OBSTET GYN R B, V88, P65, DOI 10.1016/S0301-2115(99)00135-9; De Reu P, 2009, ACTA OBSTET GYN SCAN, V88, P1201, DOI 10.3109/00016340903280990; De Reu PAOM, 2010, J PERINAT MED, V38, P311, DOI [10.1515/JPM.2010.027, 10.1515/jpm.2010.027]; Dodd JM, 2010, BJOG-INT J OBSTET GY, V117, P1316, DOI 10.1111/j.1471-0528.2010.02540.x; Doumit G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000125.pub3; Doyle LW, 2000, LANCET, V355, P2093, DOI 10.1016/S0140-6736(00)02373-4; Dudley DJ, 2010, OBSTET GYNECOL, V116, P254, DOI 10.1097/AOG.0b013e3181e7d975; Duke W, 2010, WOMEN HEALTH ISS, V20, P366, DOI 10.1016/j.whi.2010.06.004; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Essen B, 2002, BJOG-INT J OBSTET GY, V109, P677, DOI 10.1016/S1470-0328(02)01077-7; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flenady V, 2010, AUST NZ J OBSTET GYN, V50, P138, DOI 10.1111/j.1479-828X.2009.01125.x; Flenady V, 2010, STILLBIRTH UNDERSTAN; FLENADY V, 2010, J PAEDIATR CHILD H, V46, P46; Flenady V., 2009, CLIN PRACTICE GUIDEL; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Floyd RL, 2007, AM J PREV MED, V32, P1, DOI 10.1016/j.amepre.2006.08.028; Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-22; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Froen JF, 2004, J PERINAT MED, V32, P13, DOI 10.1515/JPM.2004.003; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Getahun D, 2005, OBSTET GYNECOL, V106, P81, DOI 10.1097/01.AOG.0000165274.06811.86; Gissler M, 2010, INFORM HEALTH SOC CA, V35, P64, DOI 10.3109/17538157.2010.492923; Goldenberg R L, 2004, J Matern Fetal Neonatal Med, V16, P79; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Gordijn SJ, 2007, EUR J OBSTET GYN R B, V132, P3, DOI 10.1016/j.ejogrb.2006.10.031; Gordijn SJ, 2002, PEDIATR DEVEL PATHOL, V5, P480, DOI 10.1007/s10024-002-0008-y; Gulmezoglu AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945; Haavaldsen C, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.014; Hagmann CF, 2007, ARCH DIS CHILD-FETAL, V92, pF215, DOI 10.1136/fnn.2005.092387; HALL MH, 1980, LANCET, V2, P78; HARVEY SM, 1993, FAM PLANN PERSPECT, V25, P32, DOI 10.2307/2135990; Haws RA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S5; Hawthorne G, 1997, BRIT MED J, V315, P279, DOI 10.1136/bmj.315.7103.279; Henderson-Smart DJ, 2003, CLIN PERINATOL, V30, P333, DOI 10.1016/S0095-5108(03)00026-5; Herring Sharon J, 2008, BMC Pregnancy Childbirth, V8, P54, DOI 10.1186/1471-2393-8-54; Hofmeyr GJ, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001059.pub2, 10.1002/14651858.CD001059.pub4, 10.1002/14651858.CD001059.pub5]; Holt J, 2002, ACTA OBSTET GYN SCAN, V81, P899, DOI 10.1034/j.1600-0412.2002.811001.x; Huisman Thierry A G M, 2004, Semin Neonatol, V9, P347, DOI 10.1016/j.siny.2003.09.004; Hutcheon JA, 2011, PAEDIATR PERINAT EP, V25, P11, DOI 10.1111/j.1365-3016.2010.01155.x; *I MED NAT RES COU, 2009, WEIGHT GAIN PREGN RE; *INT STILLB ALL, 2009, ISA POS STAT FET MOV; Jack BW, 2008, AM J OBSTET GYNECOL, V199, pS266, DOI 10.1016/j.ajog.2008.07.067; Jorgensen T, 2008, SCAND J PUBLIC HEALT, V36, P635, DOI 10.1177/1403494808089653; Kenyon S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001058.pub2; Khong TY, 2006, J PAEDIATR CHILD H, V42, P366, DOI 10.1111/j.1440-1754.2006.00874.x; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Khong TY, 2003, PEDIATR DEVEL PATHOL, V6, P54, DOI 10.1007/s10024-001-0263-3; Khong TY, 1996, PAEDIATR PERINAT EP, V10, P97, DOI 10.1111/j.1365-3016.1996.tb00030.x; Khong TY., 2006, CURR DIAG PATHOL, V12, P61, DOI 10.1016/j.cdip.2006.03.001; KHONG TY, 2009, STILLBIRTH UNDERSTAN, P91; Korteweg FJ, 2008, PLACENTA, V29, P71, DOI 10.1016/j.placenta.2007.07.003; Korteweg FJ, 2006, BJOG-INT J OBSTET GY, V113, P393, DOI 10.1111/j.1471-0528.2006.00881.x; Korteweg FJ, 2010, OBSTET GYNECOL, V116, P355, DOI 10.1097/AOG.0b013e3181e66d58; Krebs L, 2002, J PERINAT MED, V30, P220, DOI 10.1515/JPM.2002.030; Laing Ian A, 2004, Semin Neonatol, V9, P247, DOI 10.1016/j.siny.2003.11.004; Lauenborg J, 2003, DIABETES CARE, V26, P1385, DOI 10.2337/diacare.26.5.1385; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Laws P, 2009, PERINATAL STAT SERIE; Loftin Ryan W, 2010, Rev Obstet Gynecol, V3, P10; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Luo ZC, 2010, CAN MED ASSOC J, V182, P235, DOI 10.1503/cmaj.082042; Macdorman Marian F, 2009, NCHS Data Brief, P1; Macones GA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.892; MANGESI L, 2007, COCHRANE DB SYST REV, V1; McDonnell KA, 2004, MATERN CHILD HLTH J, V8, P231, DOI 10.1023/B:MACI.0000047421.93207.51; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Menezes EV, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S4; Michalowicz BS, 2006, NEW ENGL J MED, V355, P1885, DOI 10.1056/NEJMoa062249; *NAT I HLTH CLIN E, 2010, NICE CLIN GUID, V107; *NAT I HLTH CLIN E, 2010, QUITT SMOK PREGN FOL, V26; National Collaborating Centre for Women's and Children's Health (UK), 2008, DIAB PREGN MAN DIAB; National Institute for Health and Clinical Excellence, 2010, WEIGHT MAN PREGN, V27; NEILSON JP, 2000, COCHRANE DB SYST REV, V2; Newnham JP, 2009, OBSTET GYNECOL, V114, P1239, DOI 10.1097/AOG.0b013e3181c15b40; Orentlicher D, 2010, HASTINGS CENT REP, V40, P12; Pattinson RC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002961.pub2; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Pinar H, 2010, CLIN OBSTET GYNECOL, V53, P656, DOI 10.1097/GRF.0b013e3181eb68fe; *PMMRC, 2010, 4 PMMRC MIN HLTH; PRESTON P, 2010, J PAEDIAT CHILD H S3, V46, P45; Ravelli ACJ, 2011, J EPIDEMIOL COMMUN H, V65, P696, DOI 10.1136/jech.2009.095406; Richardus J H, 2003, J Matern Fetal Neonatal Med, V14, P267, DOI 10.1080/713606659; Roberts CL, 2000, AUST NZ J PUBL HEAL, V24, P291, DOI 10.1111/j.1467-842X.2000.tb01571.x; Robson S, 2006, AUST NZ J OBSTET GYN, V46, P305, DOI 10.1111/j.1479-828X.2006.00597.x; Rotter T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006632.pub2; *ROYAL COLL PAED C, 2002, FUT PAED PATH SERV F; Saastad E, 2007, ACTA OBSTET GYN SCAN, V86, P444, DOI 10.1080/00016340701207724; Salihu H, 2004, OBSTET GYNECOL, V104, P734, DOI 10.1097/01.AOG.0000139944.15133.e3; Salihu HM, 2003, OBSTET GYNECOL, V102, P1006, DOI 10.1016/S0029-7844(03)00739-7; Silver RM, 2007, OBSTET GYNECOL, V109, P153, DOI 10.1097/01.AOG.0000248537.89739.96; Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Smith GCS, 2010, JAMA-J AM MED ASSOC, V303, P561, DOI 10.1001/jama.2010.102; Stade BC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004228.pub2; Stock SJ, 2010, EUR J OBSTET GYN R B, V153, P148, DOI 10.1016/j.ejogrb.2010.07.022; Streuling I, 2010, AM J CLIN NUTR, V92, P678, DOI 10.3945/ajcn.2010.29363; Sun CCJ, 2002, ARCH PATHOL LAB MED, V126, P706; Tan K. H., 1999, SMJ, V40, P251; Thomas LH, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000349, DOI 10.1002/14651858.CD000349]; Thornton CM, 1998, BRIT J OBSTET GYNAEC, V105, P18, DOI 10.1111/j.1471-0528.1998.tb09344.x; Tieu J, 2010, COCHRANE DB SYST REV, V12; TUGWELL P, 1985, J CHRON DIS, V38, P339, DOI 10.1016/0021-9681(85)90080-3; Tveit JVH, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-32; Van Diem M, 2010, ACTA OBSTET GYN SCAN, V89, P1168, DOI 10.3109/00016349.2010.500468; VERKERK PH, 1993, EARLY HUM DEV, V32, P121, DOI 10.1016/0378-3782(93)90006-G; Vintzileos AM, 2002, OBSTET GYNECOL, V99, P483, DOI 10.1016/S0029-7844(01)01758-6; Vredevoogd C B, 2001, Ned Tijdschr Geneeskd, V145, P482; VUJANIC GM, 1995, J CLIN PATHOL, V48, P998, DOI 10.1136/jcp.48.11.998; *W MIDL PER I, 2009, W MIDL KEY HLTH DAT, pCH13; Whitworth M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007058.pub2; Whitworth M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007536.pub2; WIGGLESWORTH JS, 1987, ARCH DIS CHILD, V62, P1207, DOI 10.1136/adc.62.12.1207; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057; Wolleswinkel-van den Bosch JH, 2002, ACTA OBSTET GYN SCAN, V81, P17, DOI 10.1034/j.1600-0412.2002.810104.x; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471; Wright C, 1998, BRIT J OBSTET GYNAEC, V105, P24, DOI 10.1111/j.1471-0528.1998.tb09345.x; Wylie BJ, 2010, OBSTET GYNECOL, V115, P1039, DOI 10.1097/AOG.0b013e3181da7929; Yakoob MY, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S3; YUDKIN PL, 1987, LANCET, V1, P1192; [No title captured]	155	300	308	3	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2011	377	9778					1703	1717		10.1016/S0140-6736(11)60064-0	http://dx.doi.org/10.1016/S0140-6736(11)60064-0			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	766JF	21496907				2022-12-24	WOS:000290777700035
J	Soutourina, J; Wydau, S; Ambroise, Y; Boschiero, C; Werner, M				Soutourina, Julie; Wydau, Sandra; Ambroise, Yves; Boschiero, Claire; Werner, Michel			Direct Interaction of RNA Polymerase II and Mediator Required for Transcription in Vivo	SCIENCE			English	Article							REPEAT DOMAIN; ACTIVATION; PROTEIN; YEAST; COMPLEX; RESOLUTION; GENOME; HOLOENZYME; INITIATION; MECHANISM	Gene transcription is highly regulated. Altered transcription can lead to cancer or developmental diseases. Mediator, a multisubunit complex conserved among eukaryotes, is generally required for RNA polymerase II (Pol II) transcription. An interaction between the two complexes is known, but its molecular nature and physiological role are unclear. We identify a direct physical interaction between the Rpb3 Pol II subunit of Saccharomyces cerevisiae and the essential Mediator subunit, Med17. Furthermore, we demonstrate a functional element in the Mediator-Pol II interface that is important for genome-wide Pol II recruitment in vivo. Our findings suggest that a direct interaction between Mediator and Pol II is generally required for transcription of class II genes in eukaryotes.	[Soutourina, Julie; Wydau, Sandra; Boschiero, Claire; Werner, Michel] Commissariat Energie Atom & Energies Alternat CEA, IBiTec S, Serv Biol Integrat & Genet Mol, F-91191 Gif Sur Yvette, France; [Ambroise, Yves] CEA, IBiTec S, Serv Chim Bioorgan & Marquage, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Soutourina, J (corresponding author), Commissariat Energie Atom & Energies Alternat CEA, IBiTec S, Serv Biol Integrat & Genet Mol, F-91191 Gif Sur Yvette, France.	julie.soutourina@cea.fr; michel.werner@cea.fr	Soutourina, Julie/F-8305-2014; Werner, Michel/B-7316-2009	Soutourina, Julie/0000-0001-5218-2350; Werner, Michel/0000-0002-2965-5858; Ambroise, Yves/0000-0001-7174-9914; Wydau-Dematteis, Sandra/0000-0003-2023-3656	Agence Nationale de la Recherche [ANR-08-BLAN-0229]; Association pour la Recherche sur le Cancer [5118]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank N. Woychik, P. Thuriaux, O. Gadal, and B. Guglielmi for strains or plasmids; S. Hahn and M. Ptashne for antibodies; the Service de Pharmacologie et d'Immuno Analyse (CEA/Saclay) for monoclonal antibodies; A. Sentenac, A. W. Rutherford, and P. Thuriaux for discussions and critical reading of the manuscript; P. Thuriaux for help with crystal-structures visualization; Y. Ghavi-Helm and M. Pinskaya for help with ChIP-chip data analyses; and B. Guglielmi for initial interest in Mediator-Pol II interaction. This work was supported by the Agence Nationale de la Recherche (ANR-08-BLAN-0229) and Association pour la Recherche sur le Cancer (subvention fixe 5118). J.S. and S. W. performed the experimental work and analyzed the results, Y. A. participated in photo-cross-linking experiments and C. B. in yeast-strain constructions, and J.S. and M. W. designed the research and wrote the manuscript. Raw ChIP-chip data are available at Array Express under accession number E-MEXP-3043 (www.ebi.ac.uk/arrayexpress).	Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Mehta S, 2009, FEBS LETT, V583, P3115, DOI 10.1016/j.febslet.2009.08.036; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; NONET ML, 1989, GENETICS, V123, P715; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Tan Q, 2000, GENE DEV, V14, P339; Tardiff DF, 2007, P NATL ACAD SCI USA, V104, P19948, DOI 10.1073/pnas.0710179104; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	24	105	108	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1451	1454		10.1126/science.1200188	http://dx.doi.org/10.1126/science.1200188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415355				2022-12-24	WOS:000288504000045
J	Mihlbachler, MC; Rivals, F; Solounias, N; Semprebon, GM				Mihlbachler, Matthew C.; Rivals, Florent; Solounias, Nikos; Semprebon, Gina M.			Dietary Change and Evolution of Horses in North America	SCIENCE			English	Article							FOSSIL HORSES; STABLE-ISOTOPES; GREAT-PLAINS; OPEN-HABITAT; HYPSODONTY; MAMMALS; CARBON; COEVOLUTION; ADAPTATION; GRASSES	The evolution of high-crowned molars among horses (Family Equidae) is thought to be an adaptation for abrasive diets associated with the spread of grasslands. The sharpness and relief of the worn cusp apices of teeth (mesowear) are a measure of dietary abrasion. We collected mesowear data for North American Equidae for the past 55.5 million years to test the association of molar height and dietary abrasion. Mesowear trends in horses are reflective of global cooling and associated vegetation changes. There is a strong correlation between mesowear and crown height in horses; however, most horse paleopopulations had highly variable amounts of dietary abrasion, suggesting that selective pressures for crown height may have been weak much of the time. However, instances of higher abrasion were observed in some paleopopulations, suggesting intervals of stronger selection for the evolution of dentitions, including the early Miocene shortly before the first appearance of Equinae, the horse subfamily in which high-crowned dentitions evolved.	[Mihlbachler, Matthew C.; Solounias, Nikos] New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Mihlbachler, Matthew C.; Solounias, Nikos] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Rivals, Florent] Univ Rovira & Virgili, ICREA, Inst Catala Paleoecol Humana & Evolucio Social, Tarragona 43002, Spain; [Semprebon, Gina M.] Bay Path Coll, Dept Biol, Longmeadow, MA 01106 USA	New York Institute Technology; American Museum of Natural History (AMNH); ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES)	Mihlbachler, MC (corresponding author), New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA.	mmihlbac@nyit.edu	Rivals, Florent/B-7962-2014	Rivals, Florent/0000-0001-8074-9254	NSF [EAR-0824657]; ICREA Funding Source: Custom	NSF(National Science Foundation (NSF)); ICREA(ICREA)	We thank B. Beatty, C. Norris, R. O'Leary, and H. Galiano for assistance. We thank NSF (grant EAR-0824657) for support to M.C.M. and N.S.	DeMiguel D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-13; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Eronen JT, 2010, EVOL ECOL RES, V12, P217; Eronen JT, 2010, EVOLUTION, V64, P398, DOI 10.1111/j.1558-5646.2009.00830.x; Feranec RS, 2003, PALEOBIOLOGY, V29, P230, DOI 10.1666/0094-8373(2003)029<0230:SIHATP>2.0.CO;2; Fortelius Mikael, 2000, American Museum Novitates, V3301, P1, DOI 10.1206/0003-0082(2000)301<0001:FCOUMU>2.0.CO;2; Fox DL, 2004, PALAEOGEOGR PALAEOCL, V207, P305, DOI 10.1016/j.palaeo.2003.09.030; Janis Christine, 2008, V195, P21, DOI 10.1007/978-3-540-72422-3_2; Jernvall J, 2002, NATURE, V417, P538, DOI 10.1038/417538a; MacFadden BJ, 2005, SCIENCE, V307, P1728, DOI 10.1126/science.1105458; Matthew WD, 1926, Q REV BIOL, V1, P139, DOI 10.1086/394242; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; Mihlbachler Matthew C., 2006, Journal of Mammalian Evolution, V13, P11, DOI 10.1007/s10914-005-9001-3; Passey BH, 2002, J GEOL, V110, P123, DOI 10.1086/338280; Retallack GJ, 1992, EOCENE OLIGOCENE CLI, P382; Rivals F, 2007, QUATERNARY RES, V68, P338, DOI 10.1016/j.yqres.2007.07.012; Secord R, 2008, PALEOBIOLOGY, V34, P282, DOI 10.1666/0094-8373(2008)034[0282:SIIEEM]2.0.CO;2; Simpson, 1951, HORSES STORY HORSE F; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; STEBBINS GL, 1981, ANN MO BOT GARD, V68, P75, DOI 10.2307/2398811; STIRTON RA, 1947, EVOLUTION, V1, P32, DOI 10.2307/2405401; Stromberg CAE, 2006, PALEOBIOLOGY, V32, P236, DOI 10.1666/0094-8373(2006)32[236:EOHIET]2.0.CO;2; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; WANG Y, 1994, PALAEOGEOGR PALAEOCL, V107, P269, DOI 10.1016/0031-0182(94)90099-X; Williams Susan H., 2001, Journal of Mammalian Evolution, V8, P207, DOI 10.1023/A:1012231829141; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551	28	197	203	4	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1178	1181		10.1126/science.1196166	http://dx.doi.org/10.1126/science.1196166			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385712				2022-12-24	WOS:000287971200038
J	Shin, JH; Ko, HS; Kang, H; Lee, Y; Lee, YI; Pletinkova, O; Troconso, JC; Dawson, VL; Dawson, TM				Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul; Lee, Yunjong; Lee, Yun-Il; Pletinkova, Olga; Troconso, Juan C.; Dawson, Valina L.; Dawson, Ted M.			PARIS (ZNF746) Repression of PGC-1 alpha Contributes to Neurodegeneration in Parkinson's Disease	CELL			English	Article							ZINC-FINGER PROTEINS; MITOCHONDRIAL BIOGENESIS; UBIQUITIN; BINDING; IDENTIFICATION; SUBSTRATE; INTERACTS; INSULIN; LIGASE; DOMAIN	A hallmark of Parkinson's disease (PD) is the preferential loss of substantia nigra dopamine neurons. Here, we identify a new parkin interacting substrate, PARIS (ZNF746), whose levels are regulated by the ubiquitin proteasome system via binding to and ubiquitination by the E3 ubiquitin ligase, parkin. PARIS is a KRAB and zinc finger protein that accumulates in models of parkin inactivation and in human PD brain. PARIS represses the expression of the transcriptional coactivator, PGC-1 alpha and the PGC-1 alpha target gene, NRF-1 by binding to insulin response sequences in the PGC-1 alpha promoter. Conditional knockout of parkin in adult animals leads to progressive loss of dopamine (DA) neurons in a PARIS-dependent manner. Moreover, overexpression of PARIS leads to the selective loss of DA neurons in the substantia nigra, and this is reversed by either parkin or PGC-1 alpha coexpression. The identification of PARIS provides a molecular mechanism for neurodegeneration due to parkin inactivation.	[Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul; Lee, Yunjong; Lee, Yun-Il; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, NeuroRegenerat Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul; Lee, Yunjong; Lee, Yun-Il; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul; Lee, Yun-Il; Troconso, Juan C.; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Lee, Yunjong; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Pletinkova, Olga; Troconso, Juan C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, NeuroRegenerat Program, Inst Cell Engn, Baltimore, MD 21205 USA.	tdawson@jhmi.edu	Shin, Joo-Ho/P-1417-2018; Dawson, Valina/Y-9757-2019	Lee, Yunjong/0000-0003-0182-2279; Dawson, Valina/0000-0002-2915-3970	Bachmann Strauss Dystonia and Parkinson's Disease Foundation; Samsung Scholarship Foundation;  [NS38377];  [NS048206];  [NS051764]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051764, P50NS038377, R01NS048206] Funding Source: NIH RePORTER	Bachmann Strauss Dystonia and Parkinson's Disease Foundation; Samsung Scholarship Foundation(Samsung); ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NS38377, NS048206, NS051764, and the Bachmann Strauss Dystonia and Parkinson's Disease Foundation. Y. L. is supported by Samsung Scholarship Foundation. T. M. D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. The authors thank Drs. Xin Guo, Sathya Siram, and members of the Dawson laboratory for assistance and contributions to the manuscript. We also thank Drs. Alex Kolodkin, David Ginty, and Solomon H. Snyder for helpful suggestions.	Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; FUNK WD, 1992, P NATL ACAD SCI USA, V89, P9484, DOI 10.1073/pnas.89.20.9484; Gasser T, 2007, MOVEMENT DISORD, V22, pS343, DOI 10.1002/mds.21676; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Vives-Bauza C, 2010, AUTOPHAGY, V6, P315, DOI 10.4161/auto.6.2.11199; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Voz ML, 2000, CANCER RES, V60, P106; Winklhofer KF, 2003, J BIOL CHEM, V278, P47199, DOI 10.1074/jbc.M306769200; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	38	668	691	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					689	702		10.1016/j.cell.2011.02.010	http://dx.doi.org/10.1016/j.cell.2011.02.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376232	Bronze, Green Accepted			2022-12-24	WOS:000288007100009
J	Larson, DR; Zenklusen, D; Wu, B; Chao, JA; Singer, RH				Larson, Daniel R.; Zenklusen, Daniel; Wu, Bin; Chao, Jeffrey A.; Singer, Robert H.			Real-Time Observation of Transcription Initiation and Elongation on an Endogenous Yeast Gene	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; SINGLE CELLS; LIVING YEAST; LIVE CELLS; DYNAMICS; ASSOCIATION; RECRUITMENT; ACTIVATION; EXPRESSION; BINDING	Cellular messenger RNA levels are achieved by the combinatorial complexity of factors controlling transcription, yet the small number of molecules involved in these pathways fluctuates stochastically. It has not yet been experimentally possible to observe the activity of single polymerases on an endogenous gene to elucidate how these events occur in vivo. Here, we describe a method of fluctuation analysis of fluorescently labeled RNA to measure dynamics of nascent RNA-including initiation, elongation, and termination-at an active yeast locus. We find no transcriptional memory between initiation events, and elongation speed can vary by threefold throughout the cell cycle. By measuring the abundance and intranuclear mobility of an upstream transcription factor, we observe that the gene firing rate is directly determined by trans-activating factor search times.	[Larson, Daniel R.; Zenklusen, Daniel; Wu, Bin; Chao, Jeffrey A.; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Larson, Daniel R.; Wu, Bin; Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Larson, Daniel R.; Singer, Robert H.] Howard Hughes Med Inst, Transcript Imaging Consortium, Ashburn, VA 20147 USA; [Zenklusen, Daniel] Univ Montreal, Dept Biochim, Montreal, PQ H3T 1J4, Canada	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Universite de Montreal	Singer, RH (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	robert.singer@einstein.yu.edu	Larson, Daniel R/B-9829-2008; Zenklusen, Daniel/C-4503-2008	Larson, Daniel R/0000-0001-9253-3055; Zenklusen, Daniel/0000-0002-0067-0093; Chao, Jeffrey/0000-0002-5895-9156	NIH National Institute of General Medical Sciences [57071, 86217]; NATIONAL CANCER INSTITUTE [ZIABC011383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086217, R01GM057071] Funding Source: NIH RePORTER	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the following for critical reading of the manuscript: D. Grunwald, T. Lionnet, T. Trcek, J. Yao, X. Darzacq, R. Tjian, and M. Larson. D. R. L. thanks W. Zipfel, S. Hess, J. Atilgan, and M. Nicholas for discussions about fluctuation analysis. S. Silverman provided the fkh1fkh2 deletion strain. B. Slaughter provided the NLS-GFP strain and J. Vogel the Mbp-GFP strain. We thank E. Gruss Lipper for her gift founding the Gruss Lipper Biophotonics Center that provided the equipment used in this study. Supported by NIH National Institute of General Medical Sciences grants 57071 and 86217 to R. H. S. There is a patent (no. 6,586,240) associated with the methods for visualization of RNA in living cells as presented in this manuscript.	BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Boireau S, 2007, J CELL BIOL, V179, P291, DOI 10.1083/jcb.200706018; Chao JA, 2008, NAT STRUCT MOL BIOL, V15, P103, DOI 10.1038/nsmb1327; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Keaveney M, 1998, MOL CELL, V1, P917, DOI 10.1016/S1097-2765(00)80091-X; Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102; Michelman-Ribeiro A, 2009, BIOPHYS J, V97, P337, DOI 10.1016/j.bpj.2009.04.027; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; PIZZAGALLI A, 1992, CURR GENET, V21, P183, DOI 10.1007/BF00336839; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	27	412	420	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					475	478		10.1126/science.1202142	http://dx.doi.org/10.1126/science.1202142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512033	Green Accepted			2022-12-24	WOS:000289784900046
J	Tirosh, A; Shai, I; Afek, A; Dubnov-Raz, G; Ayalon, N; Gordon, B; Derazne, E; Tzur, D; Shamis, A; Vinker, S; Rudich, A				Tirosh, Amir; Shai, Iris; Afek, Arnon; Dubnov-Raz, Gal; Ayalon, Nir; Gordon, Barak; Derazne, Estela; Tzur, Dorit; Shamis, Ari; Vinker, Shlomo; Rudich, Assaf			Adolescent BMI Trajectory and Risk of Diabetes versus Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE SYNDROME; HEART-DISEASE; YOUNG ADULTHOOD; FOLLOW-UP; CARDIOVASCULAR-DISEASE; TRIGLYCERIDE LEVELS; METABOLIC SYNDROME; CHILDHOOD; CHILDREN	BACKGROUND The association of body-mass index (BMI) from adolescence to adulthood with obesity-related diseases in young adults has not been completely delineated. METHODS We conducted a prospective study in which we followed 37,674 apparently healthy young men for incident angiography-proven coronary heart disease and diabetes through the Staff Periodic Examination Center of the Israeli Army Medical Corps. The height and weight of participants were measured at regular intervals, with the first measurements taken when they were 17 years of age. RESULTS During approximately 650,000 person-years of follow-up (mean follow-up, 17.4 years), we documented 1173 incident cases of type 2 diabetes and 327 of coronary heart disease. In multivariate models adjusted for age, family history, blood pressure, lifestyle factors, and biomarkers in blood, elevated adolescent BMI (the weight in kilograms divided by the square of the height in meters; mean range for the first through last deciles, 17.3 to 27.6) was a significant predictor of both diabetes (hazard ratio for the highest vs. the lowest decile, 2.76; 95% confidence interval [CI], 2.11 to 3.58) and angiography-proven coronary heart disease (hazard ratio, 5.43; 95% CI, 2.77 to 10.62). Further adjustment for BMI at adulthood completely ablated the association of adolescent BMI with diabetes (hazard ratio, 1.01; 95% CI, 0.75 to 1.37) but not the association with coronary heart disease (hazard ratio, 6.85; 95% CI, 3.30 to 14.21). After adjustment of the BMI values as continuous variables in multivariate models, only elevated BMI in adulthood was significantly associated with diabetes (beta = 1.115, P = 0.003; P = 0.89 for interaction). In contrast, elevated BMI in both adolescence (beta = 1.355, P = 0.004) and adulthood (beta = 1.207, P = 0.03) were independently associated with angiography-proven coronary heart disease (P = 0.048 for interaction). CONCLUSIONS An elevated BMI in adolescence - one that is well within the range currently considered to be normal - constitutes a substantial risk factor for obesity-related disorders in midlife. Although the risk of diabetes is mainly associated with increased BMI close to the time of diagnosis, the risk of coronary heart disease is associated with an elevated BMI both in adolescence and in adulthood, supporting the hypothesis that the processes causing incident coronary heart disease, particularly atherosclerosis, are more gradual than those resulting in incident diabetes.	[Tirosh, Amir] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Tirosh, Amir] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Afek, Arnon] Boston Univ, Med Ctr, Cardiovasc Med Sect, Boston, MA USA; [Tirosh, Amir] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel; [Afek, Arnon; Shamis, Ari] Chaim Sheba Med Ctr, Chaim Sheba Med Ctr Management, IL-52621 Tel Hashomer, Israel; [Dubnov-Raz, Gal] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Exercise Nutr & Lifestyle Clin, Tel Hashomer, Israel; [Shai, Iris; Rudich, Assaf] Ben Gurion Univ Negev, S Daniel Abraham Ctr Hlth & Nutr, IL-84105 Beer Sheva, Israel; [Shai, Iris] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel; [Rudich, Assaf] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Beer Sheva, Israel; [Rudich, Assaf] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Afek, Arnon; Shamis, Ari] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Gordon, Barak; Derazne, Estela; Tzur, Dorit; Vinker, Shlomo] Israel Def Forces Med Corps, Jerusalem, Israel	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Tel Aviv University; Sackler Faculty of Medicine	Tirosh, A (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.	atirosh@partners.org	Dubnov-Raz, Gal/L-3297-2016; Gordon, Barak/L-6139-2018	Dubnov-Raz, Gal/0000-0003-1469-8043; Gordon, Barak/0000-0002-5283-722X; Shai, Iris/0000-0001-9050-4605; Ayalon, Nir/0000-0002-0480-1249; Tirosh, Amir/0000-0003-2210-5906; Rudich, Assaf/0000-0002-1366-1444	Chaim Sheba Medical Center, Tel-Hashomer, Israel; Israel Defense Forces Medical Corps; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER	Chaim Sheba Medical Center, Tel-Hashomer, Israel; Israel Defense Forces Medical Corps; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant from the Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel (to Dr. Tirosh), and by the Israel Defense Forces Medical Corps.	ABRAHAM S, 1971, HSMHA HEALTH REP, V86, P273, DOI 10.2307/4594149; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Deshmukh-Taskar P, 2006, EUR J CLIN NUTR, V60, P48, DOI 10.1038/sj.ejcn.1602266; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Field AE, 2005, OBES RES, V13, P163, DOI 10.1038/oby.2005.21; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Lawlor DA, 2005, CIRCULATION, V111, P1891, DOI 10.1161/01.CIR.0000161798.45728.4D; Lawlor DA, 2006, AM J CLIN NUTR, V83, P767, DOI 10.1093/ajcn/83.4.767; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; MOSSBERG HO, 1989, LANCET, V2, P491; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Oren A, 2003, INT J OBESITY, V27, P1383, DOI 10.1038/sj.ijo.0802404; Osler M, 2009, EUR J EPIDEMIOL, V24, P57, DOI 10.1007/s10654-008-9301-z; POPKIN BM, 2006, OBESITY SILVER SPRIN, V14, P846; Rodriguez G, 2004, INT J OBESITY, V28, pS54, DOI 10.1038/sj.ijo.0802805; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; Shai I, 2010, CIRCULATION, V121, P1200, DOI 10.1161/CIRCULATIONAHA.109.879254; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Srinivasan SR, 2002, DIABETES, V51, P204, DOI 10.2337/diabetes.51.1.204; Srinivasan SR, 1996, METABOLISM, V45, P235, DOI 10.1016/S0026-0495(96)90060-8; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Thompson DR, 2007, J PEDIATR-US, V150, P18, DOI 10.1016/j.jpeds.2006.09.039; Tirosh A, 2006, NEW ENGL J MED, V354, P2401; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Tirosh A, 2007, ANN INTERN MED, V147, P377, DOI 10.7326/0003-4819-147-6-200709180-00007; Tirosh A, 2010, HYPERTENSION, V56, P203, DOI 10.1161/HYPERTENSIONAHA.109.146415; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Viner RM, 2005, ARCH DIS CHILD, V90, P10, DOI 10.1136/adc.2003.036467; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049	31	437	446	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1315	1325		10.1056/NEJMoa1006992	http://dx.doi.org/10.1056/NEJMoa1006992			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WS	21470009	Green Accepted, Bronze			2022-12-24	WOS:000289202800007
J	Gerlach, B; Cordier, SM; Schmukle, AC; Emmerich, CH; Rieser, E; Haas, TL; Webb, AI; Rickard, JA; Anderton, H; Wong, WWL; Nachbur, U; Gangoda, L; Warnken, U; Purcell, AW; Silke, J; Walczak, H				Gerlach, Bjoern; Cordier, Stefanie M.; Schmukle, Anna C.; Emmerich, Christoph H.; Rieser, Eva; Haas, Tobias L.; Webb, Andrew I.; Rickard, James A.; Anderton, Holly; Wong, Wendy W-L.; Nachbur, Ueli; Gangoda, Lahiru; Warnken, Uwe; Purcell, Anthony W.; Silke, John; Walczak, Henning			Linear ubiquitination prevents inflammation and regulates immune signalling	NATURE			English	Article							CHRONIC PROLIFERATIVE DERMATITIS; K11-LINKED POLYUBIQUITINATION; MEDIATED REGULATION; STRUCTURAL BASIS; TNF; ACTIVATION; NEMO; RECOGNITION; MECHANISMS; CHAINS	Members of the tumour necrosis factor (TNF) receptor superfamily have important functions in immunity and inflammation. Recently linear ubiquitin chains assembled by a complex containing HOIL-1 and HOIP (also known as RBCK1 and RNF31, respectively) were implicated in TNF signalling, yet their relevance in vivo remained uncertain. Here we identify SHARPIN as a third component of the linear ubiquitin chain assembly complex, recruited to the CD40 and TNF receptor signalling complexes together with its other constituents, HOIL-1 and HOIP. Mass spectrometry of TNF signalling complexes revealed RIP1 (also known as RIPK1) and NEMO (also known as IKK gamma or IKBKG) to be linearly ubiquitinated. Mutation of the Sharpin gene (Sharpin(cpdm/cpdm)) causes chronic proliferative dermatitis (cpdm) characterized by inflammatory skin lesions and defective lymphoid organogenesis. Gene induction by TNF, CD40 ligand and interleukin-1 beta was attenuated in cpdm-derived cells which were rendered sensitive to TNF-induced death. Importantly, Tnf gene deficiency prevented skin lesions in cpdm mice. We conclude that by enabling linear ubiquitination in the TNF receptor signalling complex, SHARPIN interferes with TNF-induced cell death and, thereby, prevents inflammation. Our results provide evidence for the relevance of linear ubiquitination in vivo in preventing inflammation and regulating immune signalling.	[Gerlach, Bjoern; Cordier, Stefanie M.; Schmukle, Anna C.; Emmerich, Christoph H.; Rieser, Eva; Walczak, Henning] Univ London Imperial Coll Sci Technol & Med, Dept Med, Tumour Immunol Unit, London W12 0NN, England; [Gerlach, Bjoern; Emmerich, Christoph H.; Haas, Tobias L.; Walczak, Henning] German Canc Res Ctr, Div Apoptosis Regulat, D-69120 Heidelberg, Germany; [Haas, Tobias L.] Mediterranean Inst Oncol, Dept Expt Oncol, I-95029 Viagrande, Italy; [Webb, Andrew I.; Purcell, Anthony W.] Bio21 Melbourne Univ, Dept Biochem, Melbourne, Vic 3010, Australia; [Rickard, James A.; Anderton, Holly; Wong, Wendy W-L.; Nachbur, Ueli; Gangoda, Lahiru; Silke, John] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Warnken, Uwe] German Canc Res Ctr, Prot Anal Core Facil, D-69120 Heidelberg, Germany	Imperial College London; Helmholtz Association; German Cancer Research Center (DKFZ); Mediterranean Institute of Oncology; University of Melbourne; La Trobe University; Helmholtz Association; German Cancer Research Center (DKFZ)	Walczak, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Tumour Immunol Unit, London W12 0NN, England.	h.walczak@imperial.ac.uk	Walczak, Henning/AAV-2214-2020; Purcell, Anthony/AAH-1942-2019; Silke, John/B-7622-2008; Wong, W. Wei-Lynn/A-6851-2015	Walczak, Henning/0000-0002-6312-4591; Purcell, Anthony/0000-0003-0532-8331; Silke, John/0000-0002-7611-5774; Wong, W. Wei-Lynn/0000-0003-3155-1211; Gerlach, Bjorn/0000-0002-4900-6302; Gangoda, Lahiru/0000-0003-1931-6809; Haas, Tobias/0000-0003-2336-0263; Nachbur, Ueli/0000-0001-5968-2235; Anderton, Holly/0000-0003-3913-9686	Cancer Research UK; AICR; BBSRC (ERASysBio PLUS); Ovarian Cancer Action; EU; NHMRC [541901, 541902, 602516]; HGF/SBCancer; Schweizer Nationalfonds (SNF); BBSRC [BB/I004580/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004580/1] Funding Source: researchfish; Cancer Research UK [10950] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); AICR; BBSRC (ERASysBio PLUS)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ovarian Cancer Action(Ovarian Cancer Action); EU(European Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); HGF/SBCancer; Schweizer Nationalfonds (SNF); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank M. Miasari for developing the cIAP2 antibody, M. Leverkus for advice on skin histology, J. Lokan for advice on liver histology, C. Rappl, N. Barboza, S. Kupka, D. Heinze, J. Zipprich, J. Corbin, S. Wiegelmann and A. Bankovacki for excellent technical assistance, M. Bolognesi and P. Seneci for SM-164, H. Koerner for Tnf<SUP>-/-</SUP> mice, and all past and present members of the Walczak and Silke laboratories for continuous stimulating scientific discussions and support. Research in the Walczak lab is supported by grants from Cancer Research UK, AICR, BBSRC (ERASysBio PLUS), Ovarian Cancer Action and the EU Marie Curie Research Training Network ApopTRAIN. Work in the Silke lab is supported by NHMRC grants 541901, 541902 and 602516. Work in the Purcell lab is supported by the NHMRC (Senior Research Fellowships for A.W.P. and a C.J. Martin Overseas Biomedical Fellowship to A.I.W.), and by grants from the NHMRC and ARC. U.W. is funded by HGF/SBCancer. E.R. and T.L.H. are ApopTRAIN fellows and U.N. is supported by the Schweizer Nationalfonds (SNF).	Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Cossu F, 2009, J MOL BIOL, V392, P630, DOI 10.1016/j.jmb.2009.04.033; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; GIJBELS MJJ, 1995, J INVEST DERMATOL, V105, P769, DOI 10.1111/1523-1747.ep12325599; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; HOGENESCH H, 1993, AM J PATHOL, V143, P972; HogenEsch H, 1999, J IMMUNOL, V162, P3890; HogenEsch H, 2001, EUR J IMMUNOL, V31, P734, DOI 10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9; Huang HN, 2010, IMMUNITY, V33, P60, DOI 10.1016/j.immuni.2010.07.002; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Sacre Sandra M., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009488; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Ware CF, 2003, CYTOKINE GROWTH F R, V14, P181, DOI 10.1016/S1359-6101(03)00032-7; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002	37	656	672	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					591	+		10.1038/nature09816	http://dx.doi.org/10.1038/nature09816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455173				2022-12-24	WOS:000288951200033
J	Wakim, LM; Bevan, MJ				Wakim, Linda M.; Bevan, Michael J.			Cross-dressed dendritic cells drive memory CD8(+) T-cell activation after viral infection	NATURE			English	Article							IMMUNE-RESPONSES; LIVE CELLS; IN-VIVO; COMPLEXES; ANTIGENS	After an infection, cytotoxic T lymphocyte precursors proliferate and become effector cells by recognizing foreign peptides in the groove of major histocompatibility complex (MHC) class I molecules expressed by antigen-presenting cells (APCs)(1). Professional APCs specialized for T-cell activation acquire viral antigen either by becoming infected themselves (direct presentation) or by phagocytosis of infected cells, followed by transfer of antigen to the cytosol, processing and MHC class I loading in a process referred to as cross-presentation(2). An alternative way, referred to as 'cross-dressing', by which an uninfected APC could present antigen was postulated to be by the transfer of preformed peptide-MHC complexes from the surface of an infected cell to the APC without the need of further processing(3). Here we show that this mechanism exists and boosts the antiviral response of mouse memory CD8(+) T cells. A number of publications have demonstrated sharing of peptide-loaded MHC molecules in vitro(4-7). Our in vitro experiments demonstrate that cross-dressing APCs do not acquire peptide-MHC complexes in the form of exosomes released by donor cells. Rather, the APCs and donor cells have to contact each other for the transfer to occur. After a viral infection, we could isolate cross-dressed APCs able to present viral antigen in vitro. Furthermore, using the diphtheria toxin system to selectively eliminate APCs that could only acquire viral peptide-MHC complexes by cross-dressing, we show that such presentation can promote the expansion of resting memory T cells. Notably, naive T cells were excluded from taking part in the response. Cross-dressing is a mechanism of antigen presentation used by dendritic cells that may have a significant role in activating previously primed CD8(+) T cells.	[Wakim, Linda M.; Bevan, Michael J.] Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Immunol, Box 357370, Seattle, WA 98195 USA.	mbevan@u.washington.edu		Wakim, Linda/0000-0003-1752-9579	Howard Hughes Medical Institute; National Institutes of Health; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute and National Institutes of Health. L.M.W is supported by an Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia.	Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Dolan BP, 2006, J IMMUNOL, V176, P1447, DOI 10.4049/jimmunol.176.3.1447; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Matheoud D, 2010, BLOOD, V115, P4412, DOI 10.1182/blood-2009-11-255935; Qu CF, 2009, J IMMUNOL, V182, P3650, DOI 10.4049/jimmunol.0801532; Smyth LA, 2008, J IMMUNOL, V181, P3212, DOI 10.4049/jimmunol.181.5.3212; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Turner MJ, 2008, J EXP MED, V205, P1859, DOI 10.1084/jem.20072390; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702	18	197	199	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					629	632		10.1038/nature09863	http://dx.doi.org/10.1038/nature09863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455179	Green Accepted			2022-12-24	WOS:000288951200041
J	Harrop, T; Aird, J; Thwaites, G				Harrop, Tara; Aird, James; Thwaites, Guy			Practice Pointer How to minimise risk of acquiring tuberculosis when working in a high prevalence setting: a guide for healthcare workers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESISTANT TUBERCULOSIS; N95 RESPIRATORS; TRANSMISSION; TB		[Harrop, Tara] Sandground Cottage, Bristol BS39 4BZ, Avon, England		Harrop, T (corresponding author), Sandground Cottage, Bristol BS39 4BZ, Avon, England.	taraharrop@hotmail.com	Thwaites, Guy E/R-4993-2019	Thwaites, Guy E/0000-0002-2858-2087				Al-Orainey IO, 2009, ANN THORAC MED, V4, P5, DOI 10.4103/1817-1737.44778; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; [Anonymous], 2009, GLOB TUB CONTR; [Anonymous], 2007, GUIDELINE ISOLATION; Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1; Balazy A, 2006, AM J INFECT CONTROL, V34, P51, DOI 10.1016/j.ajic.2005.08.018; Basu S, 2008, EPIDEMIOL INFECT, V136, P1585, DOI 10.1017/S0950268808000964; Bonifacio N, 2002, EMERG INFECT DIS, P8; Centers for Disease Control and Prevention, 2010, BCG VACC FACTSH; Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; European Centre for Disease Prevention and Control, 2008, ECDC SUMM GUID XDR T; Fraser A, 2006, INT J TUBERC LUNG D, V10, P19; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Grant A, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1110; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; National Institute of Health and Clinical Excellence, 2006, CG33 NAT I HLTH CLIN; Qian YG, 1998, AM IND HYG ASSOC J, V59, P128, DOI 10.1080/15428119891010389; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; Smieja M J, 2000, Cochrane Database Syst Rev, pCD001363; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; WOLDEHANNA S, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000171.PUB2; Yassi A, 2004, PROTECTING FACES HLT	25	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2011	342								d1544	10.1136/bmj.d1544	http://dx.doi.org/10.1136/bmj.d1544			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FK	21411488				2022-12-24	WOS:000288699200003
J	Ko, H; Hofer, SB; Pichler, B; Buchanan, KA; Sjostrom, PJ; Mrsic-Flogel, TD				Ko, Ho; Hofer, Sonja B.; Pichler, Bruno; Buchanan, Katherine A.; Sjoestroem, P. Jesper; Mrsic-Flogel, Thomas D.			Functional specificity of local synaptic connections in neocortical networks	NATURE			English	Article							PRIMARY VISUAL-CORTEX; IN-VIVO; HORIZONTAL CONNECTIONS; INTRACORTICAL CIRCUITS; NEURONAL NETWORKS; CORTICAL NETWORKS; STRIATE CORTEX; SIMPLE CELLS; CAT; INHIBITION	Neuronal connectivity is fundamental to information processing in the brain. Therefore, understanding the mechanisms of sensory processing requires uncovering how connection patterns between neurons relate to their function. On a coarse scale, long-range projections can preferentially link cortical regions with similar responses to sensory stimuli(1-4). But on the local scale, where dendrites and axons overlap substantially, the functional specificity of connections remains unknown. Here we determine synaptic connectivity between nearby layer 2/3 pyramidal neurons in vitro, the response properties of which were first characterized in mouse visual cortex in vivo. We found that connection probability was related to the similarity of visually driven neuronal activity. Neurons with the same preference for oriented stimuli connected at twice the rate of neurons with orthogonal orientation preferences. Neurons responding similarly to naturalistic stimuli formed connections at much higher rates than those with uncorrelated responses. Bidirectional synaptic connections were found more frequently between neuronal pairs with strongly correlated visual responses. Our results reveal the degree of functional specificity of local synaptic connections in the visual cortex, and point to the existence of fine-scale subnetworks dedicated to processing related sensory information.	[Ko, Ho; Hofer, Sonja B.; Pichler, Bruno; Buchanan, Katherine A.; Sjoestroem, P. Jesper; Mrsic-Flogel, Thomas D.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England	University of London; University College London	Mrsic-Flogel, TD (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, 21 Univ St, London WC1E 6DE, England.	t.mrsic-flogel@ucl.ac.uk	Ko, Ho/I-7513-2016; Ko, Ho/AAH-2755-2020; Sjöström, Per Jesper/B-9696-2019	Ko, Ho/0000-0002-0254-3274; Ko, Ho/0000-0002-0254-3274; Sjöström, Per Jesper/0000-0001-7085-2223; Hofer, Sonja/0000-0003-4921-8521; Mrsic-Flogel, Tom/0000-0002-8947-408X	Wellcome Trust; European Research Council; European Molecular Biology Organisation; Medical Research Council [243914]; Overseas Research Students Award; UCL; MRC [G0700188] Funding Source: UKRI; Medical Research Council [G0700188] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organisation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Overseas Research Students Award; UCL; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Margrie for discussions about the project and the manuscript, and J. Vogelstein for the spike inference algorithm. This work was supported by the Wellcome Trust (T.D.M.-F.), the European Research Council (T.D.M.-F.), the European Molecular Biology Organisation (S.B.H.), the Medical Research Council and FP7 grant #243914 (K.A.B., P.J.S.), the Overseas Research Students Award Scheme and UCL studentship (H.K.).	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Alitto HJ, 2010, CURR OPIN NEUROBIOL, V20, P340, DOI 10.1016/j.conb.2010.02.012; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Debanne D, 2008, NAT PROTOC, V3, P1559, DOI 10.1038/nprot.2008.147; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Roerig B, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0002.1999; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Thomson AM, 2002, PHILOS T R SOC B, V357, P1781, DOI 10.1098/rstb.2002.1163; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; VOGELSTEIN JT, 2010, J NEUROPHYSIOL; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	38	502	505	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					87	U100		10.1038/nature09880	http://dx.doi.org/10.1038/nature09880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21478872	Green Accepted			2022-12-24	WOS:000290218300036
J	Zhang, JM; Wang, Y; Chi, ZK; Keuss, MJ; Pai, YME; Kang, HC; Shin, JH; Bugayenko, A; Wang, H; Xiong, YL; Pletnikov, MV; Mattson, MP; Dawson, TM; Dawson, VL				Zhang, Jianmin; Wang, Yue; Chi, Zhikai; Keuss, Matthew J.; Pai, Ying-Min Emily; Kang, Ho Chul; Shin, Joo-Ho; Bugayenko, Artem; Wang, Hong; Xiong, Yulan; Pletnikov, Mikhail V.; Mattson, Mark P.; Dawson, Ted M.; Dawson, Valina L.			The AAA(+) ATPase Thorase Regulates AMPA Receptor-Dependent Synaptic Plasticity and Behavior	CELL			English	Article							TRANSGENIC MICE; GLUR2; SYNAPSES; MEMORY; NMDA; TRAFFICKING; SUBUNIT; COMPLEX; BINDING; PROTEIN	The synaptic insertion or removal of AMPA receptors (AMPAR) plays critical roles in the regulation of synaptic activity reflected in the expression of long-term potentiation (LTP) and long-term depression (LTD). The cellular events underlying this important process in learning and memory are still being revealed. Here we describe and characterize the AAA(+) ATPase Thorase, which regulates the expression of surface AMPAR. In an ATPase-dependent manner Thorase mediates the internalization of AMPAR by disassembling the AMPAR-GRIP1 complex. Following genetic deletion of Thorase, the internalization of AMPAR is substantially reduced, leading to increased amplitudes of miniature excitatory postsynaptic currents, enhancement of LTP, and elimination of LTD. These molecular events are expressed as deficits in learning and memory in Thorase null mice. This study identifies an AAA(+) ATPase that plays a critical role in regulating the surface expression of AMPAR and thereby regulates synaptic plasticity and learning and memory.	[Zhang, Jianmin; Keuss, Matthew J.; Pai, Ying-Min Emily; Kang, Ho Chul; Shin, Joo-Ho; Bugayenko, Artem; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21205 USA; [Zhang, Jianmin; Chi, Zhikai; Pai, Ying-Min Emily; Kang, Ho Chul; Shin, Joo-Ho; Bugayenko, Artem; Xiong, Yulan; Pletnikov, Mikhail V.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Chi, Zhikai; Wang, Hong; Mattson, Mark P.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Pletnikov, Mikhail V.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Keuss, Matthew J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21205 USA; [Wang, Yue; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21205 USA.	tdawson@jhmi.edu; vdawson@jhmi.edu	Pletnikov, Mikhail V/G-8709-2012; Dawson, Valina/Y-9757-2019; Mattson, Mark P/F-6038-2012; Shin, Joo-Ho/P-1417-2018	Pletnikov, Mikhail V/0000-0002-8819-6559; Dawson, Valina/0000-0002-2915-3970	National Institute on Aging, USPHS [AG029368, DA00266]; Simon's Foundation Autism Research Initiative; McKnight Endowment for the Neuroscience; American Heart Association [0725470U]; NATIONAL INSTITUTE ON AGING [ZIAAG000312, ZIAAG000317, R01AG029368, ZIAAG000330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	National Institute on Aging, USPHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)United States Public Health Service); Simon's Foundation Autism Research Initiative; McKnight Endowment for the Neuroscience; American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We apologize that, due to space limitations, we were not able to cite all the primary papers on AMPAR trafficking, LTD, and LTP. We thank all of our colleagues who generously contributed reagents as noted in the Supplemental Information and Dr. Richard Huganir for the generous gift of monoclonal anti-GluR1 N-terminal antibody. Research was supported by the Intramural Research Program of the National Institute on Aging, USPHS grants AG029368 and DA00266, the Simon's Foundation Autism Research Initiative, McKnight Endowment for the Neuroscience, and an American Heart Association Postdoctoral Fellowship to J.Z. (0725470U). We thank the Comparative Medicine Section of NIA for technical support. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases.	Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Biou V, 2008, P NATL ACAD SCI USA, V105, P1038, DOI 10.1073/pnas.0711412105; Dai C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015008; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Singer HS, 2009, J NEUROIMMUNOL, V211, P39, DOI 10.1016/j.jneuroim.2009.03.011; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wang Y, 2009, NEUROBIOL AGING, V30, P1061, DOI 10.1016/j.neurobiolaging.2007.10.009; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x	32	68	75	3	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					284	299		10.1016/j.cell.2011.03.016	http://dx.doi.org/10.1016/j.cell.2011.03.016			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496646	Green Accepted, Bronze			2022-12-24	WOS:000289549900016
J	Eiraku, M; Takata, N; Ishibashi, H; Kawada, M; Sakakura, E; Okuda, S; Sekiguchi, K; Adachi, T; Sasai, Y				Eiraku, Mototsugu; Takata, Nozomu; Ishibashi, Hiroki; Kawada, Masako; Sakakura, Eriko; Okuda, Satoru; Sekiguchi, Kiyotoshi; Adachi, Taiji; Sasai, Yoshiki			Self-organizing optic-cup morphogenesis in three-dimensional culture	NATURE			English	Article							RETINAL-PIGMENT EPITHELIUM; EMBRYONIC STEM-CELLS; EYE DEVELOPMENT; APICAL CONSTRICTION; MOUSE EMBRYOS; NEURAL PLATE; SHAPE CHANGE; VESICLE; DIFFERENTIATION; RHO	Balanced organogenesis requires the orchestration of multiple cellular interactions to create the collective cell behaviours that progressively shape developing tissues. It is currently unclear how individual, localized parts are able to coordinate with each other to develop a whole organ shape. Here we report the dynamic, autonomous formation of the optic cup (retinal primordium) structure from a three-dimensional culture of mouse embryonic stem cell aggregates. Embryonic-stem-cell-derived retinal epithelium spontaneously formed hemispherical epithelial vesicles that became patterned along their proximal-distal axis. Whereas the proximal portion differentiated into mechanically rigid pigment epithelium, the flexible distal portion progressively folded inward to form a shape reminiscent of the embryonic optic cup, exhibited interkinetic nuclear migration and generated stratified neural retinal tissue, as seen in vivo. We demonstrate that optic-cup morphogenesis in this simple cell culture depends on an intrinsic self-organizing program involving stepwise and domain-specific regulation of local epithelial properties.	[Eiraku, Mototsugu; Takata, Nozomu; Kawada, Masako; Sakakura, Eriko; Sasai, Yoshiki] RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Eiraku, Mototsugu; Sakakura, Eriko; Sasai, Yoshiki] RIKEN Ctr Dev Biol, Dimens Tissue Anal Unit 4, Kobe, Hyogo 6500047, Japan; [Ishibashi, Hiroki; Okuda, Satoru; Adachi, Taiji] Kyoto Univ, Inst Frontier Med Sci, Dept Biomech, Kyoto 6068507, Japan; [Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan; [Adachi, Taiji] RIKEN, VCAD Syst Res Program, Computat Cell Biomech Team, Wako, Saitama 3510198, Japan	RIKEN; RIKEN; Kyoto University; Osaka University; RIKEN	Eiraku, M (corresponding author), RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	eiraku@cdb.riken.jp; yoshikisasai@cdb.riken.jp	Adachi, Taiji/P-8981-2016; Takata, Nozomu/AAI-9801-2020	Adachi, Taiji/0000-0001-5280-4156; Eiraku, Mototsugu/0000-0002-9433-9085; Takata, Nozomu/0000-0003-0171-6994	MEXT; Knowledge Cluster Initiative at Kobe; S-Innovation Project; Leading Project for Realization of Regenerative Medicine	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Knowledge Cluster Initiative at Kobe; S-Innovation Project; Leading Project for Realization of Regenerative Medicine	We are grateful to S. Nakanishi, S. Yonemura, R. Ladher, K. Muguruma, H. Inomata and M. Ohgushi for comments and to members of the Sasai laboratory for discussion. We also thank Olympus, particularly Y. Saito, M. Suzuki and Y. Imai, for their help and discussion regarding the design, assembly and optimized utility of the incubator-combined multi-photon and confocal optic systems, and T. Sugitate and N. Saito at JPK Instruments for technical advice on the AFM assay. This work was supported by grants-in-aid from MEXT (Y.S., M.E., T.A.), the Knowledge Cluster Initiative at Kobe and the S-Innovation Project (Y.S., K.S.), and the Leading Project for Realization of Regenerative Medicine (Y.S).	Adler R, 2007, DEV BIOL, V305, P1, DOI 10.1016/j.ydbio.2007.01.045; Agius E, 2004, DEV BIOL, V270, P308, DOI 10.1016/j.ydbio.2004.02.015; Allegra Mascaro AL, 2010, FRONT NEUROENERGETIC, P2; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Au E, 2008, CELL STEM CELL, V3, P472, DOI 10.1016/j.stem.2008.10.013; Bailey TJ, 2004, INT J DEV BIOL, V48, P761, DOI 10.1387/ijdb.041878tb; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Diep DB, 2004, DEV BRAIN RES, V153, P261, DOI 10.1016/j.devbrainres.2004.09.008; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Fujiwara H, 2007, J BIOL CHEM, V282, P29701, DOI 10.1074/jbc.M611452200; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; HILFER SR, 1980, ANAT REC, V197, P423; Honda H, 2004, J THEOR BIOL, V226, P439, DOI 10.1016/j.jtbi.2003.10.001; Hyer J, 2003, DEV BIOL, V259, P351, DOI 10.1016/S0012-1606(03)00205-7; Hyer J, 1998, DEVELOPMENT, V125, P869; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Inoue Y, 2011, BIOMECH MODEL MECHAN, V10, P495, DOI 10.1007/s10237-010-0250-6; Kinoshita N, 2008, MOL BIOL CELL, V19, P2289, DOI 10.1091/mbc.E07-12-1286; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lagutin O, 2001, DEV DYNAM, V221, P342, DOI 10.1002/dvdy.1148; Lewis WH, 1904, AM J ANAT, V3, P505, DOI 10.1002/aja.1000030405; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lopashov GV, 1963, DEV MECH VERTEBRATE; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Nagai T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061903; Nakagawa S, 2003, DEV BIOL, V260, P414, DOI 10.1016/S0012-1606(03)00320-8; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Picker A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000214; Pinzon-Duarte G, 2000, VISION RES, V40, P3455, DOI 10.1016/S0042-6989(00)00185-1; Martinez-Morales JR, 2009, CURR OPIN GENET DEV, V19, P511, DOI 10.1016/j.gde.2009.08.003; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; SCHOENWOLF GC, 1990, DEVELOPMENT, V109, P243; Seiler MJ, 2010, EUR J NEUROSCI, V31, P508, DOI 10.1111/j.1460-9568.2010.07085.x; Smith AN, 2009, DEVELOPMENT, V136, P2977, DOI 10.1242/dev.037341; Spemann H, 1901, VERH ANAT GESELLSCH, V15, P61; Stella SL, 2008, BRAIN RES, V1215, P20, DOI 10.1016/j.brainres.2008.03.038; Tang K, 2010, DEVELOPMENT, V137, P725, DOI 10.1242/dev.040568; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Yang XH, 2004, SEMIN CELL DEV BIOL, V15, P91, DOI 10.1016/j.semcdb.2003.09.004	53	1246	1313	6	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					51	U73		10.1038/nature09941	http://dx.doi.org/10.1038/nature09941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475194				2022-12-24	WOS:000289199400035
J	Ikeda, F; Deribe, YL; Skanland, SS; Stieglitz, B; Grabbe, C; Franz-Wachtel, M; van Wijk, SJL; Goswami, P; Nagy, V; Terzic, J; Tokunaga, F; Androulidaki, A; Nakagawa, T; Pasparakis, M; Iwai, K; Sundberg, JP; Schaefer, L; Rittinger, K; Macek, B; Dikic, I				Ikeda, Fumiyo; Deribe, Yonathan Lissanu; Skanland, Sigrid S.; Stieglitz, Benjamin; Grabbe, Caroline; Franz-Wachtel, Mirita; van Wijk, Sjoerd J. L.; Goswami, Panchali; Nagy, Vanja; Terzic, Janos; Tokunaga, Fuminori; Androulidaki, Ariadne; Nakagawa, Tomoko; Pasparakis, Manolis; Iwai, Kazuhiro; Sundberg, John P.; Schaefer, Liliana; Rittinger, Katrin; Macek, Boris; Dikic, Ivan			SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappa B activity and apoptosis	NATURE			English	Article							POLYUBIQUITIN CHAINS; IMMUNE-SYSTEM; PROTEINS; ACTIVATION; FRACTIONATION; DERMATITIS; PROTEOMICS; INDUCTION; NEMO	SHARPIN is a ubiquitin-binding and ubiquitin-like-domain-containing protein which, when mutated in mice, results in immune system disorders and multi-organ inflammation(1,2). Here we report that SHARPIN functions as a novel component of the linear ubiquitin chain assembly complex (LUBAC) and that the absence of SHARPIN causes dysregulation of NF-kappa B and apoptotic signalling pathways, explaining the severe phenotypes displayed by chronic proliferative dermatitis (cpdm) in SHARPIN-deficient mice. Upon binding to the LUBAC subunit HOIP (also known as RNF31), SHARPIN stimulates the formation of linear ubiquitin chains in vitro and in vivo. Coexpression of SHARPIN and HOIP promotes linear ubiquitination of NEMO (also known as IKBKG), an adaptor of the I kappa B kinases (IKKs) and subsequent activation of NF-kappa B signalling, whereas SHARPIN deficiency in mice causes an impaired activation of the IKK complex and NF-kappa B in B cells, macrophages and mouse embryonic fibroblasts (MEFs). This effect is further enhanced upon concurrent downregulation of HOIL-1L (also known as RBCK1), another HOIP-binding component of LUBAC. In addition, SHARPIN deficiency leads to rapid cell death upon tumour-necrosis factor alpha (TNF-alpha) stimulation via FADD- and caspase-8-dependent pathways. SHARPIN thus activates NF kappa B and inhibits apoptosis via distinct pathways in vivo.	[Ikeda, Fumiyo; Deribe, Yonathan Lissanu; Skanland, Sigrid S.; Grabbe, Caroline; van Wijk, Sjoerd J. L.; Goswami, Panchali; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Ikeda, Fumiyo; Deribe, Yonathan Lissanu; Skanland, Sigrid S.; Grabbe, Caroline; van Wijk, Sjoerd J. L.; Goswami, Panchali; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; [Stieglitz, Benjamin; Rittinger, Katrin] Natl Inst Med Res, MRC, London NW7 1AA, England; [Grabbe, Caroline] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Franz-Wachtel, Mirita; Macek, Boris] Univ Tubingen, Interfac Inst Cell Biol, Proteome Ctr Tubingen, D-72076 Tubingen, Germany; [Nagy, Vanja] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Terzic, Janos; Dikic, Ivan] Univ Split, Sch Med, HR-21000 Split, Croatia; [Tokunaga, Fuminori; Nakagawa, Tomoko; Iwai, Kazuhiro] Osaka Univ, Grad Sch Med, Dept Biophys & Biochem, Suita, Osaka 5650871, Japan; [Androulidaki, Ariadne; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50674 Cologne, Germany; [Androulidaki, Ariadne; Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Iwai, Kazuhiro] Osaka Univ, Grad Sch Frontier Biosci, Cell Biol & Metab Grp, Suita, Osaka 5650871, Japan; [Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA; [Schaefer, Liliana] Klinikum Goethe Univ, Div Nephropharmakol, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; MRC National Institute for Medical Research; Umea University; Eberhard Karls University of Tubingen; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Split; Osaka University; University of Cologne; University of Cologne; Osaka University; Jackson Laboratory; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Ivan.Dikic@biochem2.de	Stieglitz, Benjamin/AAY-4140-2020; van Wijk, Sjoerd/AAL-6680-2021; Rittinger, Katrin/N-3344-2019; Rittinger, Katrin/D-2586-2014; Pasparakis, Manolis/H-9292-2017; Skånland, Sigrid S/AAW-4817-2021; Macek, Boris/N-1442-2015; Ikeda, Fumiyo/AAD-3770-2020; IWAI, KAZUHIRO/GSN-7385-2022; Pasparakis, Manolis/N-4350-2019; Dikic, Ivan/O-4650-2015	Stieglitz, Benjamin/0000-0003-3634-6997; van Wijk, Sjoerd/0000-0001-6532-7651; Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435; Pasparakis, Manolis/0000-0002-9870-0966; Macek, Boris/0000-0002-1206-2458; Ikeda, Fumiyo/0000-0003-0407-2768; Pasparakis, Manolis/0000-0002-9870-0966; Dikic, Ivan/0000-0001-8156-9511; Tokunaga, Fuminori/0000-0003-3626-9119; Iwai, Kazuhiro/0000-0001-5620-5951; Nagy, Vanja/0000-0002-9521-4794; Schaefer, Liliana/0000-0002-3318-3005; Skanland, Sigrid S./0000-0003-1630-356X; Terzic, Janos/0000-0003-3228-2076	Deutsche Forschungsgemeinschaft [DI 931/3-1]; Goethe University Frankfurt [EXC115]; Landesstiftung Baden-Wurttemberg; Medical Research Council UK; JSPS; EMBO; National Institutes of Health [AR049288]; Unity Through Knowledge Fund; International Human Frontier Science Program Organization; Medical Research Council [MC_U117565398] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22117006] Funding Source: KAKEN; MRC [MC_U117565398] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Goethe University Frankfurt; Landesstiftung Baden-Wurttemberg; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Unity Through Knowledge Fund; International Human Frontier Science Program Organization(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank E. Kim, K. Rajalingham and H.-J. Kreienkampfor reagents used in this study, I. Matic for initial MS analysis of HOIP/HOIL-1L samples, S. Wahl for sample preparation, and V. Dotsch and members of the Dikic lab for discussions and comments. This work was supported by grants from the Deutsche Forschungsgemeinschaft (DI 931/3-1), the Cluster of Excellence "Macromolecular Complexes'' of the Goethe University Frankfurt (EXC115) to I.D., Landesstiftung Baden-Wurttemberg to B.M., the Medical Research Council UK to K.R. and B.S., JSPS Postdoctoral Fellowships for Research Abroad to F.I., EMBO long-term fellowship to S.S.S. and The National Institutes of Health (AR049288 to J.P.S.). V.N. was supported by the Unity Through Knowledge Fund, 3B Grant. C.G. acknowledges support from The International Human Frontier Science Program Organization.	Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; GIJBELS MJJ, 1995, ULTRASTRUCT PATHOL, V19, P107, DOI 10.3109/01913129509014610; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	27	536	553	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					637	U120		10.1038/nature09814	http://dx.doi.org/10.1038/nature09814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455181	Green Accepted			2022-12-24	WOS:000288951200043
J	Bock, DD; Lee, WCA; Kerlin, AM; Andermann, ML; Hood, G; Wetzel, AW; Yurgenson, S; Soucy, ER; Kim, HS; Reid, RC				Bock, Davi D.; Lee, Wei-Chung Allen; Kerlin, Aaron M.; Andermann, Mark L.; Hood, Greg; Wetzel, Arthur W.; Yurgenson, Sergey; Soucy, Edward R.; Kim, Hyon Suk; Reid, R. Clay			Network anatomy and in vivo physiology of visual cortical neurons	NATURE			English	Article							INHIBITORY NEURONS; SYNAPTIC CONNECTIONS; ELECTRON-MICROSCOPY; PYRAMIDAL NEURONS; TRANSGENIC MICE; RAT NEOCORTEX; CORTEX; CAT; CELLS; MAP	In the cerebral cortex, local circuits consist of tens of thousands of neurons, each of which makes thousands of synaptic connections. Perhaps the biggest impediment to understanding these networks is that we have no wiring diagrams of their interconnections. Even if we had a partial or complete wiring diagram, however, understanding the network would also require information about each neuron's function. Here we show that the relationship between structure and function can be studied in the cortex with a combination of in vivo physiology and network anatomy. We used two-photon calcium imaging to characterize a functional property-the preferred stimulus orientation-of a group of neurons in the mouse primary visual cortex. Large-scale electron microscopy of serial thin sections was then used to trace a portion of these neurons' local network. Consistent with a prediction from recent physiological experiments, inhibitory interneurons received convergent anatomical input from nearby excitatory neurons with a broad range of preferred orientations, although weak biases could not be rejected.	[Bock, Davi D.; Lee, Wei-Chung Allen; Kerlin, Aaron M.; Andermann, Mark L.; Yurgenson, Sergey; Kim, Hyon Suk; Reid, R. Clay] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Bock, Davi D.; Lee, Wei-Chung Allen; Soucy, Edward R.; Kim, Hyon Suk; Reid, R. Clay] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Hood, Greg; Wetzel, Arthur W.] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA	Harvard University; Harvard Medical School; Harvard University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	clay_reid@hms.harvard.edu		Lee, Wei-Chung/0000-0002-4618-295X	Center for Brain Science; Center for Brain Science at Harvard University; Microsoft Research; NIH though the NEI [EY10115, EY18742]; NIH though NRBSC [P41 RR06009]; Harvard Center of Neurodegeneration and Repair; NEI [EY18532]; Pittsburgh Supercomputing Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010115, R01EY018742, F32EY018532] Funding Source: NIH RePORTER	Center for Brain Science; Center for Brain Science at Harvard University; Microsoft Research(Microsoft); NIH though the NEI; NIH though NRBSC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Center of Neurodegeneration and Repair; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Pittsburgh Supercomputing Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Raviola for discussions and technical advice on all aspects of EM; J. Stiles for support and advice concerning the alignment and stitching effort at The Pittsburgh Supercomputing Center; J. Lichtman for discussions and, along with K. Blum and J. Sanes, support from the Center for Brain Science; A. Cardona for help with TrakeEM2, and many modifications of it; and H. Pfister and S. Warfield for discussions and help with computational issues. We also thank S. Butterfield for programming, and L. Benecchi and Harvard Medical School EM Core Facility for technical support. For technical help with EM and its interpretation, we thank K. Harris, M. Bickford, M. Ellisman, K. Martin and T. Reese. We thank J. Assad, R. Born, J. Maunsell, J. Stiles, E. Raviola, and members of the Reid laboratory for critical reading of the manuscript. This work was supported by the Center for Brain Science at Harvard University, Microsoft Research, and the NIH though the NEI to R.C.R. (EY10115 and EY18742) and through resources provided by the NRBSC (P41 RR06009), which is part of The Pittsburgh Supercomputing Center; and by fellowships from Harvard Center of Neurodegeneration and Repair to D.D.B. and the NEI to W.-C.A.L. (EY18532).	Ahmed B, 1997, J COMP NEUROL, V380, P230; Alitto HJ, 2010, CURR OPIN NEUROBIOL, V20, P340, DOI 10.1016/j.conb.2010.02.012; Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; ANDERSON JC, 1994, J COMP NEUROL, V341, P25, DOI 10.1002/cne.903410104; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Cajal S. R., 1904, TEXTURA SISTEMA NERV, V2; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; DACHEUX RF, 1986, J NEUROSCI, V6, P331; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Ellisman M, 2005, MICROSC MICROANAL, V11, P610; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2001, J MICROSC-OXFORD, V202, P468, DOI 10.1046/j.1365-2818.2001.00926.x; Grewe BF, 2009, CURR OPIN NEUROBIOL, V19, P520, DOI 10.1016/j.conb.2009.09.003; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; KISVARDAY ZF, 1986, EXP BRAIN RES, V64, P541, DOI 10.1007/BF00340492; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Martone ME, 2002, J STRUCT BIOL, V138, P145, DOI 10.1016/S1047-8477(02)00006-0; MASON A, 1991, J NEUROSCI, V11, P72; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; PETERS A, 1985, J COMP NEUROL, V234, P242, DOI 10.1002/cne.902340209; Peters A., 1991, FINE STRUCTURE NERVO; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Ringach DL, 2002, J NEUROSCI, V22, P5639; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sorra KE, 1998, J NEUROSCI, V18, P658; Stepanyants A, 2008, CEREB CORTEX, V18, P13, DOI 10.1093/cercor/bhm027; STERLING P, 1983, ANNU REV NEUROSCI, V6, P149, DOI 10.1146/annurev.ne.06.030183.001053; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tamas G, 1998, J NEUROSCI, V18, P4255; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; White E.L., 1989, CORTICAL CIRCUITS SY; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	57	552	558	0	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					177	U59		10.1038/nature09802	http://dx.doi.org/10.1038/nature09802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390124	Green Accepted			2022-12-24	WOS:000288170200029
J	Brennand, KJ; Simone, A; Jou, J; Gelboin-Burkhart, C; Tran, N; Sangar, S; Li, Y; Mu, YL; Chen, G; Yu, D; McCarthy, S; Sebat, J; Gage, FH				Brennand, Kristen J.; Simone, Anthony; Jou, Jessica; Gelboin-Burkhart, Chelsea; Tran, Ngoc; Sangar, Sarah; Li, Yan; Mu, Yangling; Chen, Gong; Yu, Diana; McCarthy, Shane; Sebat, Jonathan; Gage, Fred H.			Modelling schizophrenia using human induced pluripotent stem cells	NATURE			English	Article							RABIES VIRUS; RECEPTORS; PATHOGENESIS; PATHWAYS; PATIENT	Schizophrenia (SCZD) is a debilitating neurological disorder with a world-wide prevalence of 1%; there is a strong genetic component, with an estimated heritability of 80-85%(1). Although post-mortem studies have revealed reduced brain volume, cell size, spine density and abnormal neural distribution in the prefrontal cortex and hippocampus of SCZD brain tissue(2) and neuropharmacological studies have implicated dopaminergic, glutamatergic and GABAergic activity in SCZD(3), the cell types affected in SCZD and the molecular mechanisms underlying the disease state remain unclear. To elucidate the cellular and molecular defects of SCZD, we directly reprogrammed fibroblasts from SCZD patients into human induced pluripotent stem cells (hiPSCs) and subsequently differentiated these disorder-specific hiPSCs into neurons (Supplementary Fig. 1). SCZD hiPSC neurons showed diminished neuronal connectivity in conjunction with decreased neurite number, PSD95-protein levels and glutamate receptor expression. Gene expression profiles of SCZD hiPSC neurons identified altered expression of many components of the cyclic AMP and WNT signalling pathways. Key cellular and molecular elements of the SCZD phenotype were ameliorated following treatment of SCZD hiPSC neurons with the antipsychotic loxapine. To date, hiPSC neuronal pathology has only been demonstrated in diseases characterized by both the loss of function of a single gene product and rapid disease progression in early childhood(4-6). We now report hiPSC neuronal phenotypes and gene expression changes associated with SCZD, a complex genetic psychiatric disorder.	[Brennand, Kristen J.; Simone, Anthony; Jou, Jessica; Gelboin-Burkhart, Chelsea; Tran, Ngoc; Sangar, Sarah; Li, Yan; Mu, Yangling; Yu, Diana; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Chen, Gong] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [McCarthy, Shane] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Salk Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cold Spring Harbor Laboratory; University of California System; University of California San Diego; University of California System; University of California San Diego	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Brennand, Kristen J/U-5470-2019; Brennand, Kristen J/J-8704-2012	Brennand, Kristen J/0000-0003-0993-5956; Chen JNU, Gong/0000-0002-1857-3670; Sebat, Jonathan/0000-0002-9087-526X	California Institute for Regenerative Medicine; CIRM [RL1-00649-1]; Lookout and Mathers Foundation; Helmsley Foundation; Sanofi-Aventis; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS028121, P30NS072031] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); CIRM(California Institute for Regenerative Medicine); Lookout and Mathers Foundation; Helmsley Foundation; Sanofi-Aventis(Sanofi-Aventis); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	L. Moore, B. Miller, K. Stecker, J. Jepsen, D. Sepp, S. Larkin and L. Johnson provided technical assistance. T. Berggren directs, and M. Lutz manages, the Salk Stem Cell facility. D. Gibbs directs the Salk Viral Vector Core. J. Nguyen and L. Ouyang provided gene expression support. D. Chambers and J. Barrie provided FACS support. E. Callaway and I. Wickersham provided rabies trans-neuronal tracing viruses and invaluable advice and scientific feedback. M. Lawson provided assistance with statistical analysis. Thanks to G. Yeo, M. McConnell, S. Aigner, C. Marchetto and L. Boyer for advice and conversation. K.J.B. is supported by a training grant from the California Institute for Regenerative Medicine. The Gage Laboratory, and this project, is partially funded by CIRM Grant RL1-00649-1, The Lookout and Mathers Foundation, the Helmsley Foundation as well as Sanofi-Aventis.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Cannon TD, 2006, ANNU REV CLIN PSYCHO, V2, P267, DOI 10.1146/annurev.clinpsy.2.022305.095232; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; Jaaro-Peled H, 2010, SCHIZOPHRENIA BULL, V36, P301, DOI 10.1093/schbul/sbp133; Javitt DC, 2008, NAT REV DRUG DISCOV, V7, P68, DOI 10.1038/nrd2463; Kapur S, 1997, AM J PSYCHIAT, V154, P1525, DOI 10.1176/ajp.154.11.1525; Karayiorgou M, 2004, MOL BRAIN RES, V132, P95, DOI 10.1016/j.molbrainres.2004.09.029; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Ugolini G, 2008, DEV BIOLOGICALS, V131, P493; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang XD, 2008, INT J NEUROPSYCHOPH, V11, P553, DOI 10.1017/S1461145707008371; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wong AHC, 2003, NEUROSCI BIOBEHAV R, V27, P269, DOI 10.1016/S0149-7634(03)00035-6	25	950	983	3	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					221	+		10.1038/nature09915	http://dx.doi.org/10.1038/nature09915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21490598	Green Accepted			2022-12-24	WOS:000290487200040
J	Ezard, THG; Aze, T; Pearson, PN; Purvis, A				Ezard, Thomas H. G.; Aze, Tracy; Pearson, Paul N.; Purvis, Andy			Interplay Between Changing Climate and Species' Ecology Drives Macroevolutionary Dynamics	SCIENCE			English	Article							RED QUEEN; FOSSIL RECORD; COURT JESTER; EXTINCTION; DIVERSITY; TIME; FORAMINIFERA; ORIGINATION; EVOLUTION; MODELS	Ecological change provokes speciation and extinction, but our knowledge of the interplay among the biotic and abiotic drivers of macroevolution remains limited. Using the unparalleled fossil record of Cenozoic macroperforate planktonic foraminifera, we demonstrate that macroevolutionary dynamics depend on the interaction between species' ecology and the changing climate. This interplay drives diversification but differs between speciation probability and extinction risk: Speciation was more strongly shaped by diversity dependence than by climate change, whereas the reverse was true for extinction. Crucially, no single ecology was optimal in all environments, and species with distinct ecologies had significantly different probabilities of speciation and extinction. The ensuing macroevolutionary dynamics depend fundamentally on the ecological structure of species' assemblages.	[Ezard, Thomas H. G.; Purvis, Andy] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Ezard, Thomas H. G.] Univ Surrey, Dept Math, Fac Engn & Phys Sci, Surrey GU2 7XH, England; [Aze, Tracy; Pearson, Paul N.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, S Glam, Wales	Imperial College London; University of Surrey; Cardiff University	Ezard, THG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	t.ezard@surrey.ac.uk	Pearson, Paul N/B-2276-2009; Purvis, Andy/A-7529-2008	Pearson, Paul N/0000-0003-4628-9818; Purvis, Andy/0000-0002-8609-6204; Ezard, Thomas/0000-0001-8305-6605; Aze, Tracy/0000-0002-4201-7105	Natural Environment Research Council (UK) [NE/E015956/1]; NERC [NE/E015956/1, NE/E018165/1] Funding Source: UKRI; Natural Environment Research Council [NE/E018165/1, NE/E015956/1] Funding Source: researchfish	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Natural Environment Research Council (UK) for funding (grant NE/E015956/1 to A. P. and P.N.P.) and G. Mace, T. Barraclough, N. Bunnefeld, L.-M. Chevin, T. Coulson, L. McInnes, I. Owens, A. Phillimore, G. Thomas, and two anonymous reviewers for insightful comments that improved our work. The data we analyzed are deposited as online appendices to (13).	Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; BERGGREN WA, 1995, SEPM SPEC P, pR5; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; De Roos AM, 2008, ECOL LETT, V11, P1, DOI 10.1111/j.1461-0248.2007.01121.x; Doran NA, 2006, PALAIOS, V21, P571, DOI 10.2110/palo.2006.p06-055r; Foote M, 1999, NATURE, V398, P415, DOI 10.1038/18872; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; Hemleben C., 1991, Geologisches Jahrbuch Reihe A, V128, P117; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; NORRIS RD, 1992, PALAEOGEOGR PALAEOCL, V95, P1, DOI 10.1016/0031-0182(92)90161-W; Norris RD, 1996, PALEOBIOLOGY, V22, P461, DOI 10.1017/S0094837300016468; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; Sharpe FR, 1911, PHILOS MAG, V21, P435, DOI 10.1080/14786440408637050; Simpson G.G., 1961, PRINCIPLES ANIMAL TA; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; VALENTINE JW, 1980, PALEOBIOLOGY, V6, P444, DOI 10.1017/S0094837300003614; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	28	220	221	6	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					349	351		10.1126/science.1203060	http://dx.doi.org/10.1126/science.1203060			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493859	Green Submitted			2022-12-24	WOS:000289516600044
J	Gomez, P; Buckling, A				Gomez, Pedro; Buckling, Angus			Bacteria-Phage Antagonistic Coevolution in Soil	SCIENCE			English	Article							LOCAL ADAPTATION; POPULATION; EVOLUTION; DYNAMICS; COST	Bacteria and their viruses (phages) undergo rapid coevolution in test tubes, but the relevance to natural environments is unclear. By using a "mark-recapture" approach, we showed rapid coevolution of bacteria and phages in a soil community. Unlike coevolution in vitro, which is characterized by increases in infectivity and resistance through time (arms race dynamics), coevolution in soil resulted in hosts more resistant to their contemporary than past and future parasites (fluctuating selection dynamics). Fluctuating selection dynamics, which can potentially continue indefinitely, can be explained by fitness costs constraining the evolution of high levels of resistance in soil. These results suggest that rapid coevolution between bacteria and phage is likely to play a key role in structuring natural microbial communities.	[Gomez, Pedro; Buckling, Angus] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Gomez, Pedro] CSIC, CEBAS, Murcia 30100, Espinardo, Spain; [Buckling, Angus] Univ Exeter, Penryn TR10 9EZ, England	University of Oxford; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Exeter	Gomez, P (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	pedro.gomezlopez@zoo.ox.ac.uk	Gómez López, Pedro/H-2230-2012; López, Pedro Gómez/M-4712-2019	Gómez López, Pedro/0000-0003-2830-4105; López, Pedro Gómez/0000-0003-2830-4105; Buckling, Angus/0000-0003-1170-4604	Ministerio de Ciencia e Innovacion (MICINN, Spain)	Ministerio de Ciencia e Innovacion (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank T. Bell and A. Hall for comments on the manuscript. The work was supported by the European Research Council. P. G. was supported from Ministerio de Ciencia e Innovacion (MICINN, Spain) by National Mobility Program of Human Resources "Jose Castillejo." Partial 16S ribosomal RNA sequences have been assigned to the European Nucleotide Archive, European Molecular Biology Laboratory-European Bioinformatics Institute, under accession numbers FR746065 to FR746094.	Adams MH, 1959, BACTERIOPHAGES; Agrawal A, 2002, EVOL ECOL RES, V4, P79; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Brockhurst MA, 2007, INFECT GENET EVOL, V7, P547, DOI 10.1016/j.meegid.2007.01.005; Buckling A, 2006, P ROY SOC B-BIOL SCI, V273, P45, DOI 10.1098/rspb.2005.3279; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Gandon S, 2008, J EVOLUTION BIOL, V21, P1861, DOI 10.1111/j.1420-9101.2008.01598.x; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Lennon JT, 2007, ISME J, V1, P300, DOI 10.1038/ismej.2007.37; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; Lopez-Pascua LDC, 2008, J EVOLUTION BIOL, V21, P853, DOI 10.1111/j.1420-9101.2008.01501.x; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; PARKER MA, 1985, EVOLUTION, V39, P713, DOI 10.1111/j.1558-5646.1985.tb00414.x; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; Thompson J. N., 2005, INTERSPEC INTERACT; Thrall PH, 2002, EVOLUTION, V56, P1340; Vos M, 2009, SCIENCE, V325, P833, DOI 10.1126/science.1174173	27	291	295	7	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					106	109		10.1126/science.1198767	http://dx.doi.org/10.1126/science.1198767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454789				2022-12-24	WOS:000289000000048
J	Sato, T; Katagiri, K; Gohbara, A; Inoue, K; Ogonuki, N; Ogura, A; Kubota, Y; Ogawa, T				Sato, Takuya; Katagiri, Kumiko; Gohbara, Ayako; Inoue, Kimiko; Ogonuki, Narumi; Ogura, Atsuo; Kubota, Yoshinobu; Ogawa, Takehiko			In vitro production of functional sperm in cultured neonatal mouse testes	NATURE			English	Article							RAT SPERMATOGENIC CELLS; TRANSMEIOTIC DIFFERENTIATION; ORGAN-CULTURE; GERM-CELLS; PROTEIN; NUCLEI; MARKER	Spermatogenesis is one of the most complex and longest processes of sequential cell proliferation and differentiation in the body, taking more than a month from spermatogonial stem cells, through meiosis, to sperm formation(1,2). The whole process, therefore, has never been reproduced in vitro in mammals(3-5), nor in any other species with a very few exceptions in some particular types of fish(6,7). Here we show that neonatal mouse testes which contain only gonocytes or primitive spermatogonia as germ cells can produce spermatids and sperm in vitro with serum-free culture media. Spermatogenesis was maintained over 2 months in tissue fragments positioned at the gas-liquid interphase. The obtained spermatids and sperm resulted in healthy and reproductively competent offspring through microinsemination. In addition, neonatal testis tissues were cryopreserved and, after thawing, showed complete spermatogenesis in vitro. Our organ culture method could be applicable through further refinements to a variety of mammalian species, which will serve as a platform for future clinical application as well as mechanistic understanding of spermatogenesis.	[Sato, Takuya; Katagiri, Kumiko; Gohbara, Ayako; Kubota, Yoshinobu; Ogawa, Takehiko] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan; [Inoue, Kimiko; Ogonuki, Narumi; Ogura, Atsuo] RIKEN, Bioresource Ctr, Ibaraki 3050074, Japan; [Ogawa, Takehiko] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan	Yokohama City University; RIKEN; Yokohama City University	Ogawa, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan.	ogawa@med.yokohama-cu.ac.jp	Ogura, Atsuo/J-3916-2014; Jeong, Wonjun/AAM-5937-2020; Sato, Takuya/F-8251-2017; Sato, Takuya/X-9143-2019	Ogura, Atsuo/0000-0003-0447-1988; Sato, Takuya/0000-0002-6198-2234; Sato, Takuya/0000-0002-6198-2234	Ministry of Education, Culture, Sports, Science, and Technology, Japan [20116005, 21592080]; Yokohama Foundation for Advancement of Medical Science; Yokohama City University, Japan [S2116]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Foundation for Advancement of Medical Science; Yokohama City University, Japan	We thank S. Yoshida and G. Yoshizaki for comments and pre-submission review. We thank A. Tanaka and Y. W. Zheng for their technical help in flow cytometric analysis. T.O. is grateful to his mentor R. L. Brinster for his advice on devising the experimental strategies and for his encouragements. We would like to thank A. Steinberger and the late E. Steinberger whose work in the study of in vitro spermatogenesis became the ground work for our present study. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, "Regulatory Mechanism of Gamete Stem Cells'' (#20116005); a Grant-in-Aid for Scientific Research (C) (#21592080) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a grant from the Yokohama Foundation for Advancement of Medical Science; and a grant for Research and Development Project II (No.S2116) of Yokohama City University, Japan (to T.O.).	Champy C., 1920, Archives de Zoologie Experimentale Paris, V60; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; GOETZ P, 1984, J CELL SCI, V65, P249; Gohbara A, 2010, BIOL REPROD, V83, P261, DOI 10.1095/biolreprod.110.083899; Goldsborough M.D, 1998, FOCUS, V20, P8; La Salle S, 2009, METHODS MOL BIOL, V558, P279, DOI 10.1007/978-1-60761-103-5_17; Martinovitch P. N., 1937, Nature London, V139, P413, DOI 10.1038/139413a0; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Ogonuki N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011062; Ogura A, 1999, HUM REPROD, V14, P1294, DOI 10.1093/humrep/14.5.1294; Parks JE, 2003, THERIOGENOLOGY, V59, P73, DOI 10.1016/S0093-691X(02)01275-X; PRICE PJ, 1998, Patent No. 9830679; Price PJ, 1998, Patent No. [PCT/US98/00467, 9800467]; RASSOULZADEGAN M, 1993, CELL, V75, P997, DOI 10.1016/0092-8674(93)90543-Y; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Sakai N, 2002, DEVELOPMENT, V129, P3359; SHARPE RM, 2006, SERTOLI CELL BIOL, P199; Staub C, 2000, EXP CELL RES, V260, P85, DOI 10.1006/excr.2000.4998; Staub C, 2001, J ANDROL, V22, P911; STEINBERGER A, 1964, EXP CELL RES, V36, P19, DOI 10.1016/0014-4827(64)90156-9; Steinberger A., 1967, J REPROD FERTIL S, V2, P117; Tanaka H, 1999, J BIOL CHEM, V274, P17049, DOI 10.1074/jbc.274.24.17049; TRES LL, 1983, P NATL ACAD SCI-BIOL, V80, P3377, DOI 10.1073/pnas.80.11.3377; TROWELL OA, 1959, EXP CELL RES, V16, P118, DOI 10.1016/0014-4827(59)90201-0; Ventela S, 2000, TISSUE CELL, V32, P501, DOI [10.1016/S0040-8166(00)80006-3, 10.1054/tice.2000.0140]; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5	28	457	486	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					504	+		10.1038/nature09850	http://dx.doi.org/10.1038/nature09850			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430778				2022-12-24	WOS:000288702200060
J	Zhang, HB; Zhou, XH; McQuade, T; Li, JH; Chan, FKM; Zhang, JK				Zhang, Haibing; Zhou, Xiaohui; McQuade, Thomas; Li, Jinghe; Chan, Francis Ka-Ming; Zhang, Jianke			Functional complementation between FADD and RIP1 in embryos and lymphocytes	NATURE			English	Article							RECEPTOR-INTERACTING PROTEIN; DEATH DOMAIN PROTEIN; CELL-DEATH; KINASE RIP; PROGRAMMED NECROSIS; FAS; APOPTOSIS; REGULATOR; FAS/APO1	FADD is a common adaptor shared by several death receptors for signalling apoptosis through recruitment and activation of caspase 8 (refs 1-3). Death receptors are essential for immune homeostasis, but dispensable during embryogenesis. Surprisingly, Fadd(-/-) mice die in utero(4,5) and conditional deletion of FADD leads to impaired lymphocyte proliferation(6,7). How FADD regulates embryogenesis and lymphocyte responses has been a long-standing enigma. FADD could directly bind to RIP1 (also known as RIPK1), a serine/threonine kinase that mediates both necrosis and NF-kappa B activation. Here we show that Fadd(-/-) embryos contain raised levels of RIP1 and exhibit massive necrosis. To investigate a potential in vivo functional interaction between RIP1 and FADD, null alleles of RIP1 were crossed into Fadd(-/-) mice. Notably, RIP1 deficiency allowed normal embryogenesis of Fadd(-/-) mice. Conversely, the developmental defect of Rip1(-/-) lymphocytes was partially corrected by FADD deletion. Furthermore, RIP1 deficiency fully restored normal proliferation in Fadd(-/-) T cells but not in Fadd(-/-) B cells. Fadd(-/-)Rip1(-/-) double-knockout T cells are resistant to death induced by Fas or TNF-alpha and show reduced NF-kappa B activity. Therefore, our data demonstrate an unexpected cell-type-specific interplay between FADD and RIP1, which is critical for the regulation of apoptosis and necrosis during embryogenesis and lymphocyte function.	[Zhang, Haibing; Zhou, Xiaohui; Li, Jinghe; Zhang, Jianke] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [McQuade, Thomas; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	Jefferson University; University of Massachusetts System; University of Massachusetts Worcester	Zhang, JK (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	francis.chan@umassmed.edu; jzhang@mail.jci.tju.edu	Chan, Francis/ABB-1895-2021; Chan, Francis Ka-Ming/E-9647-2014	Chan, Francis Ka-Ming/0000-0002-4803-8353; Zhang, Haibing/0000-0002-8814-7378; Zhang, Jianke/0000-0002-5822-2226	NIH [CA95454, AI083915, AI076788, AI083497, AI017672]; W. W. Smith Charitable Trust grant; TJU Enhancement grant; CONCERN Foundation; NATIONAL CANCER INSTITUTE [R01CA095454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI076788, R37AI017672, R01AI083497, R21AI083915, R01AI017672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. W. Smith Charitable Trust grant; TJU Enhancement grant; CONCERN Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Kelliher for providing Rip1<SUP>-/-</SUP> mice, S. Rosenberg, S. Waggoner, R. Welsh, V. Vanguri and Y. Liu for advice and technical assistance, X. Lin for discussions and suggestions, C. E. Calkins and K. Reinersmann for critical reading of the manuscript, and Z. Zhong for help with histology analysis. This study was supported in part by NIH grants CA95454, AI083915 and AI076788 awarded to J.Z. and AI083497 awarded to F. K.-M. C.; a W. W. Smith Charitable Trust grant, a TJU Enhancement grant, and a CONCERN Foundation grant awarded to J.Z. F. K.-M. C. is a member of the UMass DERC (DK32520) and is also supported in part by an NIH grant (AI017672).	BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Rosenberg S, 2011, J IMMUNOL, V186, P203, DOI 10.4049/jimmunol.1000648; Shen HM, 2004, MOL CELL BIOL, V24, P5914, DOI 10.1128/MCB.24.13.5914-5922.2004; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033	23	334	336	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					373	+		10.1038/nature09878	http://dx.doi.org/10.1038/nature09878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368761	Green Accepted			2022-12-24	WOS:000288444000044
J	Gore, A; Li, Z; Fung, HL; Young, JE; Agarwal, S; Antosiewicz-Bourget, J; Canto, I; Giorgetti, A; Israel, MA; Kiskinis, E; Lee, JH; Loh, YH; Manos, PD; Montserrat, N; Panopoulos, AD; Ruiz, S; Wilbert, ML; Yu, JY; Kirkness, EF; Belmonte, JCI; Rossi, DJ; Thomson, JA; Eggan, K; Daley, GQ; Goldstein, LSB; Zhang, K				Gore, Athurva; Li, Zhe; Fung, Ho-Lim; Young, Jessica E.; Agarwal, Suneet; Antosiewicz-Bourget, Jessica; Canto, Isabel; Giorgetti, Alessandra; Israel, Mason A.; Kiskinis, Evangelos; Lee, Je-Hyuk; Loh, Yuin-Han; Manos, Philip D.; Montserrat, Nuria; Panopoulos, Athanasia D.; Ruiz, Sergio; Wilbert, Melissa L.; Yu, Junying; Kirkness, Ewen F.; Izpisua Belmonte, Juan Carlos; Rossi, Derrick J.; Thomson, James A.; Eggan, Kevin; Daley, George Q.; Goldstein, Lawrence S. B.; Zhang, Kun			Somatic coding mutations in human induced pluripotent stem cells	NATURE			English	Article							FIBROBLASTS; GENERATION; EFFICIENT; VARIANTS	Defined transcription factors can induce epigenetic reprogramming of adult mammalian cells into induced pluripotent stem cells. Although DNA factors are integrated during some reprogramming methods, it is unknown whether the genome remains unchanged at the single nucleotide level. Here we show that 22 human induced pluripotent stem (hiPS) cell lines reprogrammed using five different methods each contained an average of five protein-coding point mutations in the regions sampled (an estimated six protein-coding point mutations per exome). The majority of these mutations were non-synonymous, nonsense or splice variants, and were enriched in genes mutated or having causative effects in cancers. At least half of these reprogramming-associated mutations pre-existed in fibroblast progenitors at low frequencies, whereas the rest occurred during or after reprogramming. Thus, hiPS cells acquire genetic modifications in addition to epigenetic modifications. Extensive genetic screening should become a standard procedure to ensure hiPS cell safety before clinical use.	[Young, Jessica E.; Canto, Isabel; Israel, Mason A.; Wilbert, Melissa L.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Young, Jessica E.; Canto, Isabel; Israel, Mason A.; Wilbert, Melissa L.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Gore, Athurva; Li, Zhe; Fung, Ho-Lim; Zhang, Kun] Univ Calif San Diego, Inst Genom Med, Dept Bioengn, La Jolla, CA 92093 USA; [Gore, Athurva; Li, Zhe; Fung, Ho-Lim; Zhang, Kun] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Agarwal, Suneet; Loh, Yuin-Han; Manos, Philip D.; Daley, George Q.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; Manos, Philip D.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Antosiewicz-Bourget, Jessica; Yu, Junying; Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53705 USA; [Giorgetti, Alessandra; Montserrat, Nuria; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med, Barcelona 08003, Spain; [Kiskinis, Evangelos; Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Lee, Je-Hyuk] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02135 USA; [Panopoulos, Athanasia D.; Ruiz, Sergio; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Kirkness, Ewen F.] J Craig Venter Inst, Rockville, MD 20850 USA; [Rossi, Derrick J.] Childrens Hosp Boston, Immune Dis Inst, Boston, MA 02115 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Wisconsin System; University of Wisconsin Madison; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Salk Institute; J. Craig Venter Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Goldstein, LSB (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu; kzhang@bioeng.ucsd.edu	Zhang, Kun/ABE-6349-2020; Eggan, Kevin/P-7119-2018; Montserrat, Nuria/F-3136-2016; Giorgetti, Alessandra/D-3784-2016; Loh, Yuin-Han/E-1096-2014; Ruiz, Sergio/G-1561-2016; Giorgetti, Alessandra/AAB-5870-2019	Zhang, Kun/0000-0002-7596-5224; Montserrat, Nuria/0000-0002-1603-1755; Giorgetti, Alessandra/0000-0002-2747-6514; Loh, Yuin-Han/0000-0002-4715-6454; Ruiz, Sergio/0000-0002-0177-6965; Giorgetti, Alessandra/0000-0001-5803-3567; Panopoulos, Athanasia/0000-0002-9610-2604; Israel, Mason/0000-0003-0867-0626	NIH [R01 HL094963]; UCSD; California Institute for Regenerative Medicine [TG2-01154]; CIRM [RC1-00116]; Focht-Powell Fellowship; National Institute of General Medical Sciences [T32 GM008666]; A*Star Institute of Medical Biology; Singapore Stem Cell Consortium; MICINN; Sanofi-Aventis; G. Harold and Leila Y. Mathers Foundation; Cellex Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, R01HL094963, K08HL089150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); CIRM(California Institute for Regenerative Medicine); Focht-Powell Fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); A*Star Institute of Medical Biology(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Sanofi-Aventis(Sanofi-Aventis); G. Harold and Leila Y. Mathers Foundation; Cellex Foundation(Foundation CELLEX); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. M. Akey, G. M. Church, S. Ding, J. B. Li and J. Shendure for discussions and suggestions, S. Vassallo for assistance with DNA shearing, and G. L. Boulting and S. Ratansirintrawoot for assistance with hiPS cell culture. This study is supported by NIH R01 HL094963 and a UCSD new faculty start-up fund (to K.Z.), a training grant from the California Institute for Regenerative Medicine (TG2-01154) and a CIRM grant (RC1-00116) (to L.S.B.G.). L.S.B.G. is an Investigator of the Howard Hughes Medical Institute. A. Gore is supported by the Focht-Powell Fellowship and a CIRM predoctoral fellowship. M.L.W. is supported by an institutional training grant from the National Institute of General Medical Sciences (T32 GM008666). Y.-H.L. is supported by the A*Star Institute of Medical Biology and the Singapore Stem Cell Consortium. Work in the laboratory of J.C.I.B. was supported by grants from MICINN, Sanofi-Aventis, the G. Harold and Leila Y. Mathers Foundation and the Cellex Foundation. G.Q.D. is an investigator of the Howard Hughes Medical Institute and supported by grants from the NIH.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	41	916	968	3	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					63	U76		10.1038/nature09805	http://dx.doi.org/10.1038/nature09805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368825	Green Accepted, Green Submitted			2022-12-24	WOS:000287924100034
J	Ascunce, MS; Yang, CC; Oakey, J; Calcaterra, L; Wu, WJ; Shih, CJ; Goudet, J; Ross, KG; Shoemaker, D				Ascunce, Marina S.; Yang, Chin-Cheng; Oakey, Jane; Calcaterra, Luis; Wu, Wen-Jer; Shih, Cheng-Jen; Goudet, Jerome; Ross, Kenneth G.; Shoemaker, DeWayne			Global Invasion History of the Fire Ant Solenopsis invicta	SCIENCE			English	Article							POPULATION-GENETICS; UNITED-STATES; HYMENOPTERA; FORMICIDAE; TRANSPORT; PATHWAYS; ROUTES; TRADE	The fire ant Solenopsis invicta is a significant pest that was inadvertently introduced into the southern United States almost a century ago and more recently into California and other regions of the world. An assessment of genetic variation at a diverse set of molecular markers in 2144 fire ant colonies from 75 geographic sites worldwide revealed that at least nine separate introductions of S. invicta have occurred into newly invaded areas and that the main southern U.S. population is probably the source of all but one of these introductions. The sole exception involves a putative serial invasion from the southern United States to California to Taiwan. These results illustrate in stark fashion a severe negative consequence of an increasingly massive and interconnected global trade and travel system.	[Ascunce, Marina S.; Yang, Chin-Cheng; Shoemaker, DeWayne] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Ascunce, Marina S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Yang, Chin-Cheng; Wu, Wen-Jer; Shih, Cheng-Jen] Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan; [Oakey, Jane] Biosecur Queensland, Brisbane, Qld, Australia; [Calcaterra, Luis] USDA ARS S Amer Biol Control Lab, Buenos Aires, DF, Argentina; [Goudet, Jerome] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Ross, Kenneth G.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida; National Taiwan University; Queensland Department of Agriculture & Fisheries; University of Lausanne; University System of Georgia; University of Georgia	Shoemaker, D (corresponding author), ARS, USDA, Ctr Med Agr & Vet Entomol, 1600-1700 SW 23rd Dr, Gainesville, FL USA.	dewayne.shoemaker@ars.usda.gov	Ascunce, Marina/AAW-2139-2020; Goudet, Jerome/A-9730-2012; Calcaterra, Luis/AAM-7370-2020	Goudet, Jerome/0000-0002-5318-7601; Shoemaker, DeWayne/0000-0003-3659-8393; Ascunce, Marina/0000-0002-5239-3585	National Research Initiative of the USDA National Institute of Food and Agriculture [2006-35302-16561, 58-6615-7-137]; Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan [98AS-9.1.2-BQ-B1(1)]; National Science Council Executive Yuan, Taiwan [NSC97-2917-I-002-103]	National Research Initiative of the USDA National Institute of Food and Agriculture; Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan; National Science Council Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	We thank numerous individuals responsible for fire ant collections (see table S1) and the University of Florida Interdisciplinary Center for Biotechnology Research and Genetics Institute Fisher Bioinformatics Cluster for technical and computer support. We are grateful to S. Porter and D. Gotzek for reviewing an earlier draft of the manuscript. This work was supported by the National Research Initiative of the USDA National Institute of Food and Agriculture (grant no. 2006-35302-16561: Agreement No. 58-6615-7-137); the Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan [grant no. 98AS-9.1.2-BQ-B1(1)]; and the National Science Council Executive Yuan, Taiwan (grant no. NSC97-2917-I-002-103). Sequence data have been deposited in GenBank (accession nos. HM231195-96, HM231200, and HM241155-65).	Caldera EJ, 2008, BIOL INVASIONS, V10, P1457, DOI 10.1007/s10530-008-9219-0; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; Henshaw MT, 2005, AUST J ENTOMOL, V44, P37, DOI 10.1111/j.1440-6055.2005.00421.x; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lard CF., 2006, EC IMPACT IMPORTED F; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; MARKIN G P, 1971, Journal of the Georgia Entomological Society, V6, P145; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Morrison LW, 2004, BIOL INVASIONS, V6, P183, DOI 10.1023/B:BINV.0000022135.96042.90; Perrings C, 2010, BIOINVASIONS AND GLOBALIZATION: ECOLOGY, ECONOMICS, MANAGEMENT, AND POLICY, P1; Sax D. F., 2005, SPECIES INVASIONS IN; Shoemaker DD, 2006, ANN ENTOMOL SOC AM, V99, P1213, DOI 10.1603/0013-8746(2006)99[1213:PGOTIF]2.0.CO;2; Tschinkel WR., 2006, FIRE ANTS; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Yang CC, 2008, INSECT SOC, V55, P54, DOI 10.1007/s00040-007-0969-y	21	304	339	17	233	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1066	1068		10.1126/science.1198734	http://dx.doi.org/10.1126/science.1198734			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350177				2022-12-24	WOS:000287699000063
J	Carpenter, SR; Cole, JJ; Pace, ML; Batt, R; Brock, WA; Cline, T; Coloso, J; Hodgson, JR; Kitchell, JF; Seekell, DA; Smith, L; Weidel, B				Carpenter, S. R.; Cole, J. J.; Pace, M. L.; Batt, R.; Brock, W. A.; Cline, T.; Coloso, J.; Hodgson, J. R.; Kitchell, J. F.; Seekell, D. A.; Smith, L.; Weidel, B.			Early Warnings of Regime Shifts: A Whole-Ecosystem Experiment	SCIENCE			English	Article							TROPHIC CASCADES; ECOLOGICAL-SYSTEMS; PLANKTON; PHYTOPLANKTON; INDICATORS; PATTERNS; SIGNALS; CHAOS; FISH	Catastrophic ecological regime shifts may be announced in advance by statistical early warning signals such as slowing return rates from perturbation and rising variance. The theoretical background for these indicators is rich, but real-world tests are rare, especially for whole ecosystems. We tested the hypothesis that these statistics would be early warning signals for an experimentally induced regime shift in an aquatic food web. We gradually added top predators to a lake over 3 years to destabilize its food web. An adjacent lake was monitored simultaneously as a reference ecosystem. Warning signals of a regime shift were evident in the manipulated lake during reorganization of the food web more than a year before the food web transition was complete, corroborating theory for leading indicators of ecological regime shifts.	[Carpenter, S. R.; Batt, R.; Cline, T.; Kitchell, J. F.; Smith, L.; Weidel, B.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Cole, J. J.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Pace, M. L.; Coloso, J.; Seekell, D. A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Brock, W. A.] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Hodgson, J. R.] St Norbert Coll, Dept Biol, De Pere, WI 54115 USA	University of Wisconsin System; University of Wisconsin Madison; Cary Institute of Ecosystem Studies; University of Virginia; University of Wisconsin System; University of Wisconsin Madison	Carpenter, SR (corresponding author), Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA.	srcarpen@wisc.edu	Batt, Ryan/D-7690-2013; Carpenter, Stephen/AAQ-6404-2020; Cole, Jonathan Jay/G-4566-2011	Cole, Jonathan Jay/0000-0003-4633-7402; Pace, Michael/0000-0001-5945-6131; Carpenter, Stephen/0000-0001-8097-8700; Batt, Ryan/0000-0002-7267-5395	NSF	NSF(National Science Foundation (NSF))	This research was supported by the NSF. C. Brousseau, M. Dougherty, A. Farrell, R. Johnson, S. Klobucar, J. Kurtzweil, K. Lee, T. Matthys, K. McDonnell, H. Pack, T. Walsworth, and L. Zinn provided technical help. We thank the staff of the University of Notre Dame Environmental Research Center for assistance.	[Anonymous], 2005, EC HUM WELL BEING OU; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Brock WA, 2010, ECOL MONOGR, V80, P353, DOI 10.1890/09-1824.1; Brock WA, 1996, ECONOMET REV, V15, P197, DOI [10.1080/07474939608800353, DOI 10.1080/07474939608800353]; Carpenter SR, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00016.1; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Carpenter S. R., 1993, TROPHIC CASCADES LAK; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Carpenter SR, 2001, ECOL MONOGR, V71, P163, DOI 10.1890/0012-9615(2001)071[0163:TCNALP]2.0.CO;2; Contamin R, 2009, ECOL APPL, V19, P799, DOI 10.1890/08-0109.1; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; DOVERI F, 1993, THEOR POPUL BIOL, V43, P159, DOI 10.1006/tpbi.1993.1008; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Estes J.A., 2010, TROPHIC CASCADES; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kleinen T, 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; Kuwahara VS, 2008, J OCEANOGR, V64, P691, DOI 10.1007/s10872-008-0058-5; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, HYDROBIOLOGIA, V491, P9, DOI 10.1023/A:1024404804748; Scheffer M, 2000, CAN J FISH AQUAT SCI, V57, P1208, DOI 10.1139/cjfas-57-6-1208; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Weston K, 2008, J SEA RES, V60, P262, DOI 10.1016/j.seares.2008.09.003	30	583	604	13	598	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2011	332	6033					1079	1082		10.1126/science.1203672	http://dx.doi.org/10.1126/science.1203672			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21527677				2022-12-24	WOS:000290996700043
J	Guarani, V; Deflorian, G; Franco, CA; Kruger, M; Phng, LK; Bentley, K; Toussaint, L; Dequiedt, F; Mostoslavsky, R; Schmidt, MHH; Zimmermann, B; Brandes, RP; Mione, M; Westphal, CH; Braun, T; Zeiher, AM; Gerhardt, H; Dimmeler, S; Potente, M				Guarani, Virginia; Deflorian, Gianluca; Franco, Claudio A.; Krueger, Marcus; Phng, Li-Kun; Bentley, Katie; Toussaint, Louise; Dequiedt, Franck; Mostoslavsky, Raul; Schmidt, Mirko H. H.; Zimmermann, Barbara; Brandes, Ralf P.; Mione, Marina; Westphal, Christoph H.; Braun, Thomas; Zeiher, Andreas M.; Gerhardt, Holger; Dimmeler, Stefanie; Potente, Michael			Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase	NATURE			English	Article							NEGATIVE REGULATOR; ANGIOGENESIS; CELLS; DLL4; DIFFERENTIATION; ZEBRAFISH; GROWTH; ACTS	Notch signalling is a key intercellular communication mechanism that is essential for cell specification and tissue patterning, and which coordinates critical steps of blood vessel growth(1-3). Although subtle alterations in Notch activity suffice to elicit profound differences in endothelial behaviour and blood vessel formation(2,3), little is known about the regulation and adaptation of endothelial Notch responses. Here we report that the NAD1-dependent deacetylase SIRT1 acts as an intrinsic negative modulator of Notch signalling in endothelial cells. We show that acetylation of the Notch1 intracellular domain (NICD) on conserved lysines controls the amplitude and duration of Notch responses by altering NICD protein turnover. SIRT1 associates with NICD and functions as a NICD deacetylase, which opposes the acetylation-induced NICD stabilization. Consequently, endothelial cells lacking SIRT1 activity are sensitized to Notch signalling, resulting in impaired growth, sprout elongation and enhanced Notch target gene expression in response to DLL4 stimulation, thereby promoting a non-sprouting, stalk-cell-like phenotype. In vivo, inactivation of Sirt1 in zebrafish and mice causes reduced vascular branching and density as a consequence of enhanced Notch signalling. Our findings identify reversible acetylation of the NICD as a molecular mechanism to adapt the dynamics of Notch signalling, and indicate that SIRT1 acts as rheostat to fine-tune endothelial Notch responses.	[Guarani, Virginia; Zimmermann, Barbara; Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany; [Deflorian, Gianluca; Mione, Marina] FIRC Inst Mol Oncol, IFOM, I-20139 Milan, Italy; [Franco, Claudio A.; Phng, Li-Kun; Bentley, Katie; Gerhardt, Holger] London Res Inst Canc Res UK, Vasc Biol Lab, London WC2A 3LY, England; [Krueger, Marcus; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Toussaint, Louise; Dequiedt, Franck] GxABT, Lab Prot Signaling & Interact, B-5030 Gembloux, Belgium; [Toussaint, Louise; Dequiedt, Franck] Univ Liege, Interdisciplinary Cluster Appl Genoprote GIGA R, B-4000 Sart Tilman Par Liege, Belgium; [Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Schmidt, Mirko H. H.] Goethe Univ Frankfurt, Edinger Inst, Inst Neurol, D-60590 Frankfurt, Germany; [Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, Vasc Res Ctr, D-60590 Frankfurt, Germany; [Westphal, Christoph H.] Sirtris, Cambridge, MA 02139 USA; [Zeiher, Andreas M.; Potente, Michael] Goethe Univ Frankfurt, Dept Cardiol, D-60590 Frankfurt, Germany; [Gerhardt, Holger] VIB, Vesalius Res Ctr, Vasc Patterning Lab, Consultant Grp, B-3000 Louvain, Belgium	Goethe University Frankfurt; IFOM - FIRC Institute of Molecular Oncology; University of London; Institute of Cancer Research - UK; Max Planck Society; University of Liege; Harvard University; Harvard Medical School; Massachusetts General Hospital; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Flanders Institute for Biotechnology (VIB)	Potente, M (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany.	potente@em.uni-frankfurt.de	Mione, Maria Caterina/I-3073-2013; Gerhardt, Holger/G-4610-2011; Phng, Li-Kun/L-7346-2013; Braun, Thomas/B-2310-2008; Mione, Maria Caterina/ABG-9926-2021; Franco, Claudio A/D-8117-2015; Brandes, Ralf P/L-3058-2017; Schmidt, Mirko H. H./ABI-6650-2020; Franco, Claudio A/B-1060-2013; Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Franco, Claudio A/0000-0002-2861-3883; Brandes, Ralf P/0000-0002-8035-0048; Schmidt, Mirko H. H./0000-0001-7411-8835; Franco, Claudio A/0000-0002-2861-3883; Mione, Maria Caterina/0000-0002-9040-3705; Potente, Michael/0000-0002-5689-0036; Dimmeler, Stefanie/0000-0002-1045-2436; Dequiedt, Franck/0000-0003-1234-7477; Bentley, Katie/0000-0002-9391-659X; Braun, Thomas/0000-0002-6165-4804; Gerhardt, Holger/0000-0001-9228-7472	DFG [PO1306/1-1, SFB 834/A6, Exc 147/1]; Interuniversity Attraction Poles Program-Belgian Science Policy [IUAP-BELSPO PVI/28]; Sidney Kimmel Cancer Research Foundation; Massachusetts Life Sciences Center; NIH [R01DK088190-01A1, R01GM093072-01]; Cancer Research UK; European Molecular Biology Organisation; Lister Institute of Preventive Medicine; Fondation Leducq Transatlantic Network of Excellence ARTEMIS; Marie Curie FP7 People initiative; AIRC (Associazione Italiana per la Ricerca sul Cancro); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Interuniversity Attraction Poles Program-Belgian Science Policy(Belgian Federal Science Policy Office); Sidney Kimmel Cancer Research Foundation; Massachusetts Life Sciences Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); European Molecular Biology Organisation; Lister Institute of Preventive Medicine; Fondation Leducq Transatlantic Network of Excellence ARTEMIS; Marie Curie FP7 People initiative; AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are thankful to F. W. Alt, R. Kopan, Z. Lou, E. Seto, S. L. Berger, S. Diane Hayward, S. McMahon, G. Thurston and N. D. Lawson for reagents and to I. Dikic for comments. This work was supported by grants from the DFG (PO1306/1-1, SFB 834/A6 and Exc 147/1). F.D. was supported by the Interuniversity Attraction Poles Program-Belgian Science Policy (IUAP-BELSPO PVI/28). R.M. is supported by the Sidney Kimmel Cancer Research Foundation, a New Investigator Grant from the Massachusetts Life Sciences Center, an AFAR Research Grant and NIH grants (R01DK088190-01A1 and R01GM093072-01). H.G. is supported by Cancer Research UK, the European Molecular Biology Organisation Young Investigator Programme, and The Lister Institute of Preventive Medicine. H.G. and K.B. are supported by the Fondation Leducq Transatlantic Network of Excellence ARTEMIS. C.A.F. is supported by the Marie Curie FP7 People initiative. G.D. and M.M. thank F. Pezzimenti for fish care and technical help, and AIRC (Associazione Italiana per la Ricerca sul Cancro) for financial support.	Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim MY, 2007, MOL CELL BIOL, V27, P6506, DOI 10.1128/MCB.01515-06; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095	36	273	285	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					234	+		10.1038/nature09917	http://dx.doi.org/10.1038/nature09917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21499261	Green Accepted			2022-12-24	WOS:000290487200043
J	Brandon, MP; Bogaard, AR; Libby, CP; Connerney, MA; Gupta, K; Hasselmo, ME				Brandon, Mark P.; Bogaard, Andrew R.; Libby, Christopher P.; Connerney, Michael A.; Gupta, Kishan; Hasselmo, Michael E.			Reduction of Theta Rhythm Dissociates Grid Cell Spatial Periodicity from Directional Tuning	SCIENCE			English	Article							FREELY MOVING RATS; ENTORHINAL CORTEX; PHASE PRECESSION; REPRESENTATION; MEMORY; HIPPOCAMPUS; MODULATION; WORKING	Grid cells recorded in the medial entorhinal cortex of freely moving rats exhibit firing at regular spatial locations and temporal modulation with theta rhythm oscillations (4 to 11 hertz). We analyzed grid cell spatial coding during reduction of network theta rhythm oscillations caused by medial septum (MS) inactivation with muscimol. During MS inactivation, grid cells lost their spatial periodicity, whereas head-direction cells maintained their selectivity. Conjunctive grid-by-head-direction cells lost grid cell spatial periodicity but retained head-direction specificity. All cells showed reduced rhythmicity in autocorrelations and cross-correlations. This supports the hypothesis that spatial coding by grid cells requires theta oscillations, and dissociates the mechanisms underlying the generation of entorhinal grid cell periodicity and head-direction selectivity.	[Brandon, Mark P.; Bogaard, Andrew R.; Libby, Christopher P.; Connerney, Michael A.; Gupta, Kishan; Hasselmo, Michael E.] Boston Univ, Dept Psychol, Ctr Memory & Brain, Grad Program Neurosci, Boston, MA 02215 USA	Boston University	Brandon, MP (corresponding author), Boston Univ, Dept Psychol, Ctr Memory & Brain, Grad Program Neurosci, 2 Cummington St, Boston, MA 02215 USA.	markpb68@bu.edu; hasselmo@bu.edu		Hasselmo, Michael/0000-0002-9925-6377	National Institute of Mental Health [R01 MH60013, MH61492]; Office of Naval Research Multidisciplinary University Research Initiative [N00014-10-1-0936]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061492, R01MH060013] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of Naval Research Multidisciplinary University Research Initiative(MURIOffice of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Thanks to C. Stern, S. Leutgeb, H. Eichenbaum, N. Schultheiss, E. Newman, C. Monaghan, J. Climer, and E. Zilli for advice and comments and to T. Ware for technical assistance. The research was supported by National Institute of Mental Health grants R01 MH60013 and MH61492 and Office of Naval Research Multidisciplinary University Research Initiative grant N00014-10-1-0936.	Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CHROBAK JJ, 1989, BEHAV NEURAL BIOL, V52, P357, DOI 10.1016/S0163-1047(89)90472-X; Deshmukh SS, 2010, J NEUROPHYSIOL, V104, P994, DOI 10.1152/jn.01141.2009; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; GIVENS B, 1994, J NEUROSCI, V14, P3578; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; JEFFERY KJ, 1995, NEUROREPORT, V6, P2166, DOI 10.1097/00001756-199511000-00017; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Martin MM, 2007, PHYSIOL BEHAV, V90, P412, DOI 10.1016/j.physbeh.2006.10.007; MITCHELL SJ, 1982, J NEUROSCI, V2, P292; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Moser EI, 2008, HIPPOCAMPUS, V18, P1142, DOI 10.1002/hipo.20483; Navratilova Z., 2011, HIPPOCAMPUS, DOI 10.1002/hipo.20939; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pang KCH, 1999, BEHAV NEUROSCI, V113, P265, DOI 10.1037/0735-7044.113.2.265; RAWLINS JNP, 1979, EXP BRAIN RES, V37, P49, DOI 10.1007/BF01474253; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646	28	285	285	4	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					595	599		10.1126/science.1201652	http://dx.doi.org/10.1126/science.1201652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527714	Green Accepted			2022-12-24	WOS:000289991100051
J	Guo, JU; Su, YJ; Zhong, C; Ming, GL; Song, HJ				Guo, Junjie U.; Su, Yijing; Zhong, Chun; Ming, Guo-li; Song, Hongjun			Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain	CELL			English	Article							SINGLE-STRANDED-DNA; METHYLATION; GLYCOSYLASE; GENOME; 5-HYDROXYMETHYLCYTOSINE; INHIBITOR; DEAMINASE; QUANTIFICATION; MECHANISMS; CONVERSION	Cytosine methylation is the major covalent modification of mammalian genomic DNA and plays important roles in transcriptional regulation. The molecular mechanism underlying the enzymatic removal of this epigenetic mark, however, remains elusive. Here, we show that 5-methylcytosine (5mC) hydroxylase TET1, by converting 5mCs to 5-hydroxymethylcytosines (5hmCs), promotes DNA demethylation in mammalian cells through a process that requires the base excision repair pathway. Though expression of the 12 known human DNA glycosylases individually did not enhance removal of 5hmCs in mammalian cells, demethylation of both exogenously introduced and endogenous 5hmCs is promoted by the AID (activation-induced deaminase)/APOBEC (apolipoprotein B mRNA-editing enzyme complex) family of cytidine deaminases. Furthermore, Tet1 and Apobec1 are involved in neuronal activity-induced, region-specific, active DNA demethylation and subsequent gene expression in the dentate gyrus of the adult mouse brain in vivo. Our study suggests a TET1-induced oxidation-deamination mechanism for active DNA demethylation in mammals.	[Guo, Junjie U.; Su, Yijing; Zhong, Chun; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Guo, Junjie U.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Su, Yijing; Zhong, Chun; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	shongju1@jhmi.edu	liyue, shi/G-4890-2011; Erlitzki, Noa/AHC-5346-2022; Ming, Guo-li/J-7880-2013	Ming, Guo-li/0000-0002-2517-6075	AMRF; NIH [HD069184, NS048271, NS047344, AG024984, MH087874]; FARMS; MSCRF; NARSAD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087874, R33MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS047344, R01NS047344, R37NS047344, R01NS048271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	AMRF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FARMS; MSCRF; NARSAD(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D.K.Ma and K. Christian for comments; members of Song and Ming laboratories for discussion; Y. Gao for RNA-seq; H.C. Kang, J.S. Jeong, N.Y. Jung and J. Shin for help with molecular cloning; and Q. Hussaini, Y. Cai, and L. Liu for technical support. This work was supported by AMRF and NIH (HD069184 and NS048271) to G.-I.M., by NIH (NS047344, AG024984, and MH087874) and NARSAD to H.J.S., and by fellowships from FARMS to J.U.G, AMRF to Y.S., and MSCRF to C.Z.	Baker D, 2002, CHEM RES TOXICOL, V15, P33, DOI 10.1021/tx010113b; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Feng J, 2009, INT REV NEUROBIOL, V89, P67, DOI 10.1016/S0074-7742(09)89004-1; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zhang QM, 2005, DNA REPAIR, V4, P71, DOI 10.1016/j.dnarep.2004.08.002; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	55	998	1065	0	159	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					423	434		10.1016/j.cell.2011.03.022	http://dx.doi.org/10.1016/j.cell.2011.03.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21496894	Green Accepted, Bronze			2022-12-24	WOS:000290022900011
J	Goodridge, HS; Reyes, CN; Becker, CA; Katsumoto, TR; Ma, J; Wolf, AJ; Bose, N; Chan, ASH; Magee, AS; Danielson, ME; Weiss, A; Vasilakos, JP; Underhill, DM				Goodridge, Helen S.; Reyes, Christopher N.; Becker, Courtney A.; Katsumoto, Tamiko R.; Ma, Jun; Wolf, Andrea J.; Bose, Nandita; Chan, Anissa S. H.; Magee, Andrew S.; Danielson, Michael E.; Weiss, Arthur; Vasilakos, John P.; Underhill, David M.			Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'	NATURE			English	Article							BETA-GLUCAN RECOGNITION; CANDIDA-ALBICANS; LECTIN RECEPTORS; DENDRITIC CELLS; MACROPHAGES; KINASE; CD148; CLEC-2; CD45	Innate immune cells must be able to distinguish between direct binding to microbes and detection of components shed from the surface of microbes located at a distance. Dectin-1 (also known as CLEC7A) is a pattern-recognition receptor expressed by myeloid phagocytes (macrophages, dendritic cells and neutrophils) that detects beta-glucans in fungal cell walls and triggers direct cellular antimicrobial activity, including phagocytosis and production of reactive oxygen species (ROS)(1,2). In contrast to inflammatory responses stimulated upon detection of soluble ligands by other pattern-recognition receptors, such as Toll-like receptors (TLRs), these responses are only useful when a cell comes into direct contact with a microbe and must not be spuriously activated by soluble stimuli. In this study we show that, despite its ability to bind both soluble and particulate beta-glucan polymers, Dectin-1 signalling is only activated by particulate beta-glucans, which cluster the receptor in synapse-like structures from which regulatory tyrosine phosphatases CD45 and CD148 (also known as PTPRC and PTPRJ, respectively) are excluded (Supplementary Fig. 1). The 'phagocytic synapse' now provides a model mechanism by which innate immune receptors can distinguish direct microbial contact from detection of microbes at a distance, thereby initiating direct cellular antimicrobial responses only when they are required.	[Goodridge, Helen S.; Reyes, Christopher N.; Becker, Courtney A.; Ma, Jun; Wolf, Andrea J.; Underhill, David M.] Cedars Sinai Med Ctr, IBD & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Goodridge, Helen S.] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [Goodridge, Helen S.; Underhill, David M.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Katsumoto, Tamiko R.; Weiss, Arthur] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Bose, Nandita; Chan, Anissa S. H.; Magee, Andrew S.; Danielson, Michael E.; Vasilakos, John P.] Biothera, Eagan, MN 55121 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Underhill, DM (corresponding author), Cedars Sinai Med Ctr, IBD & Immunobiol Res Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	david.underhill@csmc.edu	Katsumoto, Tamiko/V-4086-2019; UNDERHILL, DAVID/ABE-2185-2021	Katsumoto, Tamiko/0000-0002-7978-0315; Underhill, David/0000-0002-2989-658X	NIH [AI071116, AI066120]; American Heart Association; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071116, R01AI066120] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Wawrowsky for help with confocal microscopy, and G. D. Brown for Dectin-1-deficient mice. This study was funded by grants from the NIH (AI071116 and AI066120 to D. M. U. and A. W., respectively) and the American Heart Association (D. M. U.). H. S. G. held a Research Fellowship Award from the Crohn's and Colitis Foundation of America. D. M. U. holds the Janis and William Wetsman Family Chair in Inflammatory Bowel Disease at Cedars-Sinai Medical Center.	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; CZOP JK, 1985, J IMMUNOL, V134, P2588; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Feng D, 2007, J NEUROSCI, V27, P12757, DOI 10.1523/JNEUROSCI.2846-07.2007; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Lavigne LM, 2006, J IMMUNOL, V177, P8667, DOI 10.4049/jimmunol.177.12.8667; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	24	531	552	2	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					471	U541		10.1038/nature10071	http://dx.doi.org/10.1038/nature10071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525931	Green Submitted, Green Accepted			2022-12-24	WOS:000289949600034
J	Burguillos, MA; Deierborg, T; Kavanagh, E; Persson, A; Hajji, N; Garcia-Quintanilla, A; Cano, J; Brundin, P; Englund, E; Venero, JL; Joseph, B				Burguillos, Miguel A.; Deierborg, Tomas; Kavanagh, Edel; Persson, Annette; Hajji, Nabil; Garcia-Quintanilla, Albert; Cano, Josefina; Brundin, Patrik; Englund, Elisabet; Venero, Jose L.; Joseph, Bertrand			Caspase signalling controls microglia activation and neurotoxicity	NATURE			English	Article							KINASE-C-DELTA; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; BLOOD-BRAIN-BARRIER; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; ENDOTOXIC-SHOCK; NITRIC-OXIDE; CELL-DEATH	Activation of microglia and inflammation-mediated neurotoxicity are suggested to play a decisive role in the pathogenesis of several neurodegenerative disorders. Activated microglia release pro-inflammatory factors that may be neurotoxic. Here we show that the orderly activation of caspase-8 and caspase-3/7, known executioners of apoptotic cell death, regulate microglia activation through a protein kinase C (PKC)-delta-dependent pathway. We find that stimulation of microglia with various inflammogens activates caspase-8 and caspase-3/7 in microglia without triggering cell death in vitro and in vivo. Knockdown or chemical inhibition of each of these caspases hindered microglia activation and consequently reduced neurotoxicity. We observe that these caspases are activated in microglia in the ventral mesencephalon of Parkinson's disease (PD) and the frontal cortex of individuals with Alzheimer's disease (AD). Taken together, we show that caspase-8 and caspase-3/7 are involved in regulating microglia activation. We conclude that inhibition of these caspases could be neuroprotective by targeting the microglia rather than the neurons themselves.	[Burguillos, Miguel A.; Kavanagh, Edel; Hajji, Nabil; Joseph, Bertrand] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden; [Burguillos, Miguel A.; Cano, Josefina; Venero, Jose L.] Univ Seville, Dept Bioquim & Biol Mol, Fac Farm, E-41012 Seville, Spain; [Burguillos, Miguel A.; Cano, Josefina; Venero, Jose L.] Inst Biomed Sevilla, Seville 41012, Spain; [Burguillos, Miguel A.; Deierborg, Tomas; Brundin, Patrik] Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, S-22184 Lund, Sweden; [Persson, Annette; Englund, Elisabet] Univ Lund Hosp, Div Neuropathol, Dept Pathol, S-22185 Lund, Sweden; [Garcia-Quintanilla, Albert] Univ Seville, Serv Biol, CITIUS, Ctr Invest Tecnol & Innovac, E-41012 Seville, Spain	Karolinska Institutet; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Lund University; Skane University Hospital; University of Sevilla	Joseph, B (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden.	jlvenero@us.es; bertrand.joseph@ki.se	Venero, Jose/E-9979-2015; Burguillos, Miguel/N-4806-2019; IBIS, ENVEJECIMIENTO/O-9381-2015; hajji, nabil/AAV-1435-2020; Garcia-Quintanilla, Albert/AAE-3247-2020; Deierborg, Tomas/P-6345-2015; Garcia-Quintanilla, Albert/F-1463-2015	Venero, Jose/0000-0003-1137-8706; Burguillos, Miguel/0000-0002-3165-9997; Deierborg, Tomas/0000-0002-3651-3444; Garcia-Quintanilla, Albert/0000-0001-9617-1354; Joseph, Bertrand/0000-0001-5655-9979; Englund, Elisabet/0000-0002-2708-2443	Spanish Ministerio de Ciencia y Tecnologia [SAF2006-04119, 2009-13778]; Swedish Research Council; Parkinson Foundation of Sweden; Swedish Alzheimer Foundation; Swedish Cancer Society; Medical Research Council [G0801056B] Funding Source: researchfish	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinson Foundation of Sweden; Swedish Alzheimer Foundation; Swedish Cancer Society(Swedish Cancer Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Gorman, O. Hermanson, M. Malewicz, S. Orrenius, T. Panaretakis and B. Zhivotovsky for discussion, and L. Hjortsberg, M. Reyland and S. Ceccatelli for providing us with reagents. M. Carballo, JL. Ribas, A. Fernandez and B. Haraldsson provided qualified technical support. This work has been supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (SAF2006-04119 and 2009-13778), the Swedish Research Council, the Parkinson Foundation of Sweden, the Swedish Alzheimer Foundation and the Swedish Cancer Society. M. A. B., T. D. and P. B. are members of Neurofortis and Bagadilico, both of which are research environments sponsored by the Swedish Research Council.	Aarli JA, 2003, CURR MED CHEM, V10, P1931, DOI 10.2174/0929867033456918; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Balistreri CR, 2008, CURR PHARM DESIGN, V14, P2672, DOI 10.2174/138161208786264089; Bilsland James, 2002, Curr Opin Investig Drugs, V3, P1745; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; CAR BD, 1994, J EXP MED, V179, P1437, DOI 10.1084/jem.179.5.1437; Castano A, 1998, J NEUROCHEM, V70, P1584; CHAO CC, 1992, J IMMUNOL, V149, P2736; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cutillas B, 1999, NEUROREPORT, V10, P2605, DOI 10.1097/00001756-199908200-00030; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Jordan J, 2008, CURR PHARM DESIGN, V14, P3549, DOI 10.2174/138161208786848766; Joseph B, 2003, P NATL ACAD SCI USA, V100, P15619, DOI 10.1073/pnas.2635658100; Joseph B, 2002, ONCOGENE, V21, P65, DOI 10.1038/sj/onc/1205018; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Karatas H, 2009, J NEUROSCI, V29, P13761, DOI 10.1523/JNEUROSCI.4246-09.2009; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kuno R, 2005, J NEUROIMMUNOL, V162, P89, DOI 10.1016/j.jneuroim.2005.01.015; Le DA, 2002, P NATL ACAD SCI USA, V99, P15188, DOI 10.1073/pnas.232473399; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Schulz JB, 1998, CELL DEATH DIFFER, V5, P847, DOI 10.1038/sj.cdd.4400420; Schumann RR, 1998, BLOOD, V91, P577, DOI 10.1182/blood.V91.2.577.577_577_584; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Vancurova I, 2001, J BIOL CHEM, V276, P19746, DOI 10.1074/jbc.M100234200; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	47	412	438	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					319	U214		10.1038/nature09788	http://dx.doi.org/10.1038/nature09788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21389984				2022-12-24	WOS:000289724600033
J	Bohnert, ASB; Valenstein, M; Bair, MJ; Ganoczy, D; McCarthy, JF; Ilgen, MA; Blow, FC				Bohnert, Amy S. B.; Valenstein, Marcia; Bair, Matthew J.; Ganoczy, Dara; McCarthy, John F.; Ilgen, Mark A.; Blow, Frederic C.			Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAKTHROUGH PAIN; CANCER PAIN; CASE-COHORT; MORTALITY; TIME	Context The rate of prescription opioid-related overdose death increased substantially in the United States over the past decade. Patterns of opioid prescribing may be related to risk of overdose mortality. Objective To examine the association of maximum prescribed daily opioid dose and dosing schedule ("as needed," regularly scheduled, or both) with risk of opioid overdose death among patients with cancer, chronic pain, acute pain, and substance use disorders. Design Case-cohort study. Setting Veterans Health Administration (VHA), 2004 through 2008. Participants All unintentional prescription opioid overdose decedents (n=750) and a random sample of patients (n=154 684) among those individuals who used medical services in 2004 or 2005 and received opioid therapy for pain. Main Outcome Measure Associations of opioid regimens (dose and schedule) with death by unintentional prescription opioid overdose in subgroups defined by clinical diagnoses, adjusting for age group, sex, race, ethnicity, and comorbid conditions. Results The frequency of fatal overdose over the study period among individuals treated with opioids was estimated to be 0.04%. The risk of overdose death was directly related to the maximum prescribed daily dose of opioid medication. The adjusted hazard ratios (HRs) associated with a maximum prescribed dose of 100 mg/d or more, compared with the dose category 1 mg/d to less than 20 mg/d, were as follows: among those with substance use disorders, adjusted HR=4.54 (95% confidence interval [CI], 2.46-8.37; absolute risk difference approximation [ARDA]=0.14%); among those with chronic pain, adjusted HR=7.18 (95% CI, 4.85-10.65; ARDA=0.25%); among those with acute pain, adjusted HR=6.64 (95% CI, 3.31-13.31; ARDA=0.23%); and among those with cancer, adjusted HR=11.99 (95% CI, 4.42-32.56; ARDA=0.45%). Receiving both as-needed and regularly scheduled doses was not associated with overdose risk after adjustment. Conclusion Among patients receiving opioid prescriptions for pain, higher opioid doses were associated with increased risk of opioid overdose death. JAMA. 2011;305(13):1315-1321 www.jama.com	[Bohnert, Amy S. B.; Valenstein, Marcia; Ganoczy, Dara; McCarthy, John F.; Ilgen, Mark A.; Blow, Frederic C.] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA; [Bohnert, Amy S. B.; Valenstein, Marcia; Ganoczy, Dara; McCarthy, John F.; Ilgen, Mark A.; Blow, Frederic C.] Ctr Excellence, Dept Vet Affairs Hlth Serv Res & Dev HSR&D, Ann Arbor, MI USA; [Bohnert, Amy S. B.; Valenstein, Marcia; Ganoczy, Dara; McCarthy, John F.; Ilgen, Mark A.; Blow, Frederic C.] Serious Mental Illness Treatment Resource & Evalu, Ann Arbor, MI USA; [Bair, Matthew J.] Ctr Excellence, Dept Vet Affairs HSR&D, Indianapolis, IN USA; [Bair, Matthew J.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA	University of Michigan System; University of Michigan; Indiana University System; Indiana University Bloomington	Bohnert, ASB (corresponding author), Univ Michigan, Sch Med, Dept Psychiat, 4250 Plymouth Rd,Box 5765, Ann Arbor, MI 48109 USA.	amybohne@med.umich.edu	Bohnert, Amy SB/C-7313-2015		Health Services Research and Development Service (HSRD) [CDA-09-204]; Department of Veterans Affairs Office of Mental Health Services, Patient Care Services	Health Services Research and Development Service (HSRD)(US Department of Veterans Affairs); Department of Veterans Affairs Office of Mental Health Services, Patient Care Services(US Department of Veterans Affairs)	This work was financially supported by the Department of Veterans Affairs Office of Mental Health Services, Patient Care Services, and a Health Services Research and Development Service (HSR&D) Career Development Award (CDA-09-204; A.S.B.B.).	[Anonymous], NAT DEATH IND; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Donaldson AE, 2006, INJURY PREV, V12, P338, DOI 10.1136/ip.2005.011171; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Gammaitoni AR, 2003, CLIN J PAIN, V19, P286, DOI 10.1097/00002508-200309000-00002; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Langholz B, 2007, COMPUT STAT DATA AN, V51, P3737, DOI 10.1016/j.csda.2006.12.028; Lash TL, 2009, J CLIN ONCOL, V27, pE55, DOI 10.1200/JCO.2009.24.1877; Lawlor PG, 1998, CANCER, V82, P1167, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1167::AID-CNCR23>3.0.CO;2-3; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; McCarthy JF, 2009, AM J EPIDEMIOL, V169, P1033, DOI 10.1093/aje/kwp010; McLellan AT, 2008, JAMA-J AM MED ASSOC, V300, P2672, DOI 10.1001/jama.2008.793; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Portenoy RK, 1999, PAIN, V81, P129, DOI 10.1016/S0304-3959(99)00006-8; Portenoy RK, 2007, CURR MED RES OPIN, V23, P222, DOI 10.1185/030079906X162818; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Prommer E, 2006, SUPPORT CARE CANCER, V14, P109, DOI 10.1007/s00520-005-0917-1; Schumann H, 2008, CLIN TOXICOL, V46, P501, DOI 10.1080/15563650701877374; Simpson DM, 2007, CLIN THER, V29, P588, DOI 10.1016/j.clinthera.2007.04.007; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; The Management of Posttraumatic Stress Disorder Work Group, 2017, VA DOD CLIN PRACT GU; Valenstein M, 2004, AM J PSYCHIAT, V161, P654, DOI 10.1176/appi.ajp.161.4.654; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007	27	1046	1055	2	73	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1315	1321		10.1001/jama.2011.370	http://dx.doi.org/10.1001/jama.2011.370			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467284				2022-12-24	WOS:000289162400020
J	Strunker, T; Goodwin, N; Brenker, C; Kashikar, ND; Weyand, I; Seifert, R; Kaupp, UB				Struenker, Timo; Goodwin, Normann; Brenker, Christoph; Kashikar, Nachiket D.; Weyand, Ingo; Seifert, Reinhard; Kaupp, U. Benjamin			The CatSper channel mediates progesterone-induced Ca2+ influx in human sperm	NATURE			English	Article							HUMAN SPERMATOZOA; CALCIUM INFLUX; CHEMOTAXIS; ACTIVATION; RECEPTORS; MECHANISM; CELLS	In the oviduct, cumulus cells that surround the oocyte release progesterone. In human sperm, progesterone stimulates a Ca2+ increase by a non-genomic mechanism(1-3). The Ca2+ signal has been proposed to control chemotaxis, hyperactivation and acrosomal exocytosis of sperm(4-8). However, the underlying signalling mechanism has remained mysterious. Here we show that progesterone activates the sperm-specific, pH-sensitive CatSper Ca2+ channel(9-11). We found that both progesterone and alkaline pH stimulate a rapid Ca2+ influx with almost no latency, incompatible with a signalling pathway involving metabotropic receptors and second messengers. The Ca2+ signals evoked by alkaline pH and progesterone are inhibited by the Ca-v channel blockers NNC 55-0396 and mibefradil. Patch-clamp recordings from sperm reveal an alkaline-activated current carried by mono-and divalent ions that exhibits all the hallmarks of sperm-specific CatSper Ca2+ channels(10,11). Progesterone substantially enhances the CatSper current. The alkaline- and progesterone-activated CatSper current is inhibited by both drugs. Our results resolve a long-standing controversy over the non-genomic progesterone signalling. In human sperm, either the CatSper channel itself or an associated protein serves as the non-genomic progesterone receptor. The identification of CatSper channel blockers will greatly facilitate the study of Ca2+ signalling in sperm and help to define further the physiological role of progesterone and CatSper.	[Struenker, Timo; Goodwin, Normann; Brenker, Christoph; Kashikar, Nachiket D.; Seifert, Reinhard; Kaupp, U. Benjamin] Ctr Adv European Studies & Res, Abt Mol Neurosensor, D-53175 Bonn, Germany; [Weyand, Ingo] Forschungszentrum Julich, Inst Complex Syst Cellular Biophys ICS 4, D-52425 Julich, Germany	Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; Research Center Julich	Kaupp, UB (corresponding author), Ctr Adv European Studies & Res, Abt Mol Neurosensor, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	timo.struenker@caesar.de; u.b.kaupp@caesar.de	Strünker, Timo/AAE-4722-2020	Kashikar, Nachiket/0000-0002-4466-7486	German Research Foundation [SFB 645]; International Helmholtz Research School on Biophysics and Soft Matter	German Research Foundation(German Research Foundation (DFG)); International Helmholtz Research School on Biophysics and Soft Matter	This work was supported by the German Research Foundation (SFB 645) and the International Helmholtz Research School on Biophysics and Soft Matter. We thank S. Stark for technical assistance, H. Krause and B. Kayser for preparing the manuscript, and C. Bernsdorff for preparing the figures. The caged compounds were kindly provided by V. Hagen.	Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; Bedu-Addo K, 2008, INT J DEV BIOL, V52, P615, DOI 10.1387/ijdb.072535kb; BLACKMORE PF, 1990, J BIOL CHEM, V265, P1376; BLACKMORE PF, 1991, J BIOL CHEM, V266, P18655; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044; Harper CV, 2003, BIOCHEM J, V372, P407, DOI 10.1042/BJ20021560; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; Kilic F, 2009, J AM CHEM SOC, V131, P4027, DOI 10.1021/ja808334f; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Kirkman-Brown JC, 2000, DEV BIOL, V222, P326, DOI 10.1006/dbio.2000.9729; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Oren-Benaroya R, 2008, HUM REPROD, V23, P2339, DOI 10.1093/humrep/den265; Parinaud J, 1996, J CLIN ENDOCR METAB, V81, P1357, DOI 10.1210/jc.81.4.1357; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schaefer M, 1998, P NATL ACAD SCI USA, V95, P3008, DOI 10.1073/pnas.95.6.3008; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Strunker T, 2006, NAT CELL BIOL, V8, P1149, DOI 10.1038/ncb1473; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Sun F, 2003, DEV BIOL, V255, P423, DOI 10.1016/S0012-1606(02)00090-8; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; THOMAS P, 1989, BIOCHEM J, V264, P539, DOI 10.1042/bj2640539; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861	30	389	413	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					382	+		10.1038/nature09769	http://dx.doi.org/10.1038/nature09769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412338				2022-12-24	WOS:000288444000046
J	Mullighan, CG; Zhang, JH; Kasper, LH; Lerach, S; Payne-Turner, D; Phillips, LA; Heatley, SL; Holmfeldt, L; Collins-Underwood, JR; Ma, J; Buetow, KH; Pui, CH; Baker, SD; Brindle, PK; Downing, JR				Mullighan, Charles G.; Zhang, Jinghui; Kasper, Lawryn H.; Lerach, Stephanie; Payne-Turner, Debbie; Phillips, Letha A.; Heatley, Sue L.; Holmfeldt, Linda; Collins-Underwood, J. Racquel; Ma, Jing; Buetow, Kenneth H.; Pui, Ching-Hon; Baker, Sharyn D.; Brindle, Paul K.; Downing, James R.			CREBBP mutations in relapsed acute lymphoblastic leukaemia	NATURE			English	Article							RUBINSTEIN-TAYBI SYNDROME; GENETIC ALTERATIONS; BINDING PROTEIN; GENOMIC ANALYSIS; P300; CBP; CANCER; REVEALS; CELLS; COACTIVATOR	Relapsed acute lymphoblastic leukaemia (ALL) is a leading cause of death due to disease in young people, but the biological determinants of treatment failure remain poorly understood. Recent genome-wide profiling of structural DNA alterations in ALL have identified multiple submicroscopic somatic mutations targeting key cellular pathways(1,2), and have demonstrated substantial evolution in genetic alterations from diagnosis to relapse(3). However, DNA sequence mutations in ALL have not been analysed in detail. To identify novel mutations in relapsed ALL, we resequenced 300 genes in matched diagnosis and relapse samples from 23 patients with ALL. This identified 52 somatic non-synonymous mutations in 32 genes, many of which were novel, including the transcriptional coactivators CREBBP and NCOR1, the transcription factors ERG, SPI1, TCF4 and TCF7L2, components of the Ras signalling pathway, histone genes, genes involved in histone modification (CREBBP and CTCF), and genes previously shown(1,2) to be targets of recurring DNA copy number alteration in ALL. Analysis of an extended cohort of 71 diagnosis-relapse cases and 270 acute leukaemia cases that did not relapse found that 18.3% of relapse cases had sequence or deletion mutations of CREBBP, which encodes the transcriptional coactivator and histone acetyltransferase CREB-binding protein (CREBBP, also known as CBP)(4). The mutations were either present at diagnosis or acquired at relapse, and resulted in truncated alleles or deleterious substitutions in conserved residues of the histone acetyltransferase domain. Functionally, the mutations impaired histone acetylation and transcriptional regulation of CREBBP targets, including glucocorticoid responsive genes. Several mutations acquired at relapse were detected in subclones at diagnosis, suggesting that the mutations may confer resistance to therapy. These results extend the landscape of genetic alterations in leukaemia, and identify mutations targeting transcriptional and epigenetic regulation as a mechanism of resistance in ALL.	[Mullighan, Charles G.; Payne-Turner, Debbie; Phillips, Letha A.; Heatley, Sue L.; Holmfeldt, Linda; Collins-Underwood, J. Racquel; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Zhang, Jinghui] St Jude Childrens Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Kasper, Lawryn H.; Lerach, Stephanie; Brindle, Paul K.] St Jude Childrens Hosp, Dept Biochem, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Buetow, Kenneth H.] NCI, Ctr Bioinformat, Rockville, MD 20892 USA; [Buetow, Kenneth H.] NCI, Lab Populat Genet, NIH, Bethesda, MD 20892 USA; [Pui, Ching-Hon] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Baker, Sharyn D.] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Mullighan, CG (corresponding author), St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA.	charles.mullighan@stjude.org	Downing, James R./N-8102-2018; Kasper, Lawryn/GWV-5700-2022; Pui, Ching-Hon/N-8076-2018; Mullighan, Charles/H-3253-2011; Zhang, Jing/GWZ-7332-2022; Zhang, Jing/HII-4294-2022; Heatley, Susan/AGP-2179-2022	Pui, Ching-Hon/0000-0003-0303-5658; Mullighan, Charles/0000-0002-1871-1850; Baker, Sharyn/0000-0003-3062-3252; Heatley, Susan/0000-0001-7497-6477; Holmfeldt, Linda/0000-0003-4140-3423; Brindle, Paul/0000-0001-7172-8478	ALSAC of St Jude and Cancer Center [P30 CA021765, DE018183]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018183] Funding Source: NIH RePORTER	ALSAC of St Jude and Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank T. Jeevan, S. Orwick and A. Gibson for technical assistance, B. Schulman for assistance with structural modelling, and B. Woolf and J. Hartigan of Beckman Coulter Genomics for assistance with sequencing. We thank the Tissue Resources Facility of St Jude Children's Research Hospital for providing samples, and the following St Jude core facilities: Vector Development and Production, Flow Cytometry and Cell Sorting, Cell and Tissue Imaging, the Animal Resource Center, and the DNA sequencing and Macromolecular Synthesis laboratories of the Hartwell Center for Bioinformatics and Biotechnology. This study was supported by ALSAC of St Jude and Cancer Center support grant P30 CA021765, and grant number DE018183 (P.K.B.). C.G.M. is a Pew Scholar in the Biomedical Sciences.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bordoli L, 2001, NUCLEIC ACIDS RES, V29, P4462, DOI 10.1093/nar/29.21.4462; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dordelmann M, 1999, BLOOD, V94, P1209, DOI 10.1182/blood.V94.4.1209.416k05_1209_1217; Drexler HG., 2001, LEUKEMIA LYMPHOMA CE, P2, DOI [10.1016/B978-012221970-2/50002-4, DOI 10.1016/B978-012221970-2/50002-4]; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Goodman RH, 2000, GENE DEV, V14, P1553; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Harrison CJ, 2009, BRIT J HAEMATOL, V144, P147, DOI 10.1111/j.1365-2141.2008.07417.x; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kishimoto M, 2005, CLIN CANCER RES, V11, P512; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Kuiper RP, 2010, LEUKEMIA, V24, P1258, DOI 10.1038/leu.2010.87; Kung AL, 2000, GENE DEV, V14, P272; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; MANABE A, 1994, BLOOD, V83, P1731, DOI 10.1182/blood.V83.7.1731.bloodjournal8371731; MILLER RW, 1995, AM J MED GENET, V56, P112, DOI 10.1002/ajmg.1320560125; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Radtke I, 2009, P NATL ACAD SCI USA, V106, P12944, DOI 10.1073/pnas.0903142106; Schorry EK, 2008, AM J MED GENET A, V146A, P2512, DOI 10.1002/ajmg.a.32424; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shigeno K, 2004, CANCER LETT, V213, P11, DOI 10.1016/S0304-3835(03)00442-7; Tsapis M, 2007, INT J BIOCHEM CELL B, V39, P1500, DOI 10.1016/j.biocel.2007.03.009; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053; Zhang JH, 2002, NUCLEIC ACIDS RES, V30, P5213, DOI 10.1093/nar/gkf654; Zhang J, 2007, GENOME RES, V17, P1111, DOI 10.1101/gr.5963407	42	426	444	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					235	U127		10.1038/nature09727	http://dx.doi.org/10.1038/nature09727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390130	Green Accepted			2022-12-24	WOS:000288170200041
J	West, AP; Brodsky, IE; Rahner, C; Woo, DK; Erdjument-Bromage, H; Tempst, P; Walsh, MC; Choi, Y; Shadel, GS; Ghosh, S				West, A. Phillip; Brodsky, Igor E.; Rahner, Christoph; Woo, Dong Kyun; Erdjument-Bromage, Hediye; Tempst, Paul; Walsh, Matthew C.; Choi, Yongwon; Shadel, Gerald S.; Ghosh, Sankar			TLR signalling augments macrophage bactericidal activity through mitochondrial ROS	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; REACTIVE OXYGEN; PHAGOSOME MATURATION; ECSIT; ASSOCIATION; HOMEOSTASIS; UBIQUITIN; MEMBRANE; COMPLEX; PROTEIN	Reactive oxygen species (ROS) are essential components of the innate immune response against intracellular bacteria and it is thought that professional phagocytes generate ROS primarily via the phagosomal NADPH oxidase machinery(1). However, recent studies have suggested that mitochondrial ROS (mROS) also contribute to mouse macrophage bactericidal activity, although the mechanisms linking innate immune signalling to mitochondria for mROS generation remain unclear(2-4). Here we demonstrate that engagement of a subset of Toll-like receptors (TLR1, TLR2 and TLR4) results in the recruitment of mitochondria to macrophage phagosomes and augments mROS production. This response involves translocation of a TLR signalling adaptor, tumour necrosis factor receptor-associated factor 6 (TRAF6), to mitochondria, where it engages the protein ECSIT (evolutionarily conserved signalling intermediate in Toll pathways), which is implicated in mitochondrial respiratory chain assembly(5). Interaction with TRAF6 leads to ECSIT ubiquitination and enrichment at the mitochondrial periphery, resulting in increased mitochondrial and cellular ROS generation. ECSIT-and TRAF6-depleted macrophages have decreased levels of TLR-induced ROS and are significantly impaired in their ability to kill intracellular bacteria. Additionally, reducing macrophage mROS levels by expressing catalase in mitochondria results in defective bacterial killing, confirming the role of mROS in bactericidal activity. These results reveal a novel pathway linking innate immune signalling to mitochondria, implicate mROS as an important component of antibacterial responses and further establish mitochondria as hubs for innate immune signalling.	[Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [West, A. Phillip; Brodsky, Igor E.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Rahner, Christoph] Yale Univ, Dept Cell Biol, Sch Med, New Haven, CT 06520 USA; [Woo, Dong Kyun; Shadel, Gerald S.] Yale Univ, Dept Pathol, Sch Med, New Haven, CT 06520 USA; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Walsh, Matthew C.; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Columbia University; Yale University; Yale University; Yale University; Memorial Sloan Kettering Cancer Center; University of Pennsylvania	Ghosh, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA.	sg2715@columbia.edu	West, A. Phillip/W-8171-2019; West, A. Phillip/A-7867-2009	West, A. Phillip/0000-0003-2884-6895; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NIH [R37-AI33443, NS-056206]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033443, R37AI033443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank C. Schindler, B. Reizis and L. Ciaccia for comments on the manuscript. We also thank P. Rabinovitch for MCAT mice, J. Cotney for technical assistance, Z. Zhang for animal maintenance and M. Graham and K. Zichichi for assistance with immuno-electron microscopy. This work was supported by NIH grants to S. G. (R37-AI33443) and G. S. S. (NS-056206).	Adachi Y, 2006, J IMMUNOL, V176, P5033, DOI 10.4049/jimmunol.176.8.5033; Arnoult D, 2009, SEMIN IMMUNOL, V21, P223, DOI 10.1016/j.smim.2009.05.009; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brodsky IE, 2005, MOL MICROBIOL, V55, P954, DOI 10.1111/j.1365-2958.2004.04444.x; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chong A, 2009, INFECT IMMUN, V77, P4724, DOI 10.1128/IAI.00150-09; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; MATSUMOTO A, 1991, J ELECTRON MICROSC, V40, P356; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Remer KA, 2005, CLIN EXP IMMUNOL, V140, P73, DOI 10.1111/j.1365-2249.2005.02740.x; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Sinai AP, 1997, J CELL SCI, V110, P2117; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; Vazquez-Torres A, 2001, MICROBES INFECT, V3, P1313, DOI 10.1016/S1286-4579(01)01492-7; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Werling D, 2004, IMMUNOLOGY, V111, P41, DOI 10.1111/j.1365-2567.2004.01781.x; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Xiao CC, 2003, GENE DEV, V17, P2933, DOI 10.1101/gad.1145603	36	992	1025	9	261	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					476	U543		10.1038/nature09973	http://dx.doi.org/10.1038/nature09973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525932	Green Accepted			2022-12-24	WOS:000289949600035
J	Cousens, S; Blencowe, H; Stanton, C; Chou, D; Ahmed, S; Steinhardt, L; Creanga, AA; Tuncalp, O; Balsara, ZP; Gupta, S; Say, L; Lawn, JE				Cousens, Simon; Blencowe, Hannah; Stanton, Cynthia; Chou, Doris; Ahmed, Saifuddin; Steinhardt, Laura; Creanga, Andreea A.; Tuncalp, Oezge; Balsara, Zohra Patel; Gupta, Shivam; Say, Lale; Lawn, Joy E.			National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis	LANCET			English	Article							COUNTRIES; MORTALITY	Background Stillbirths do not count in routine worldwide data-collating systems or for the Millennium Development Goals. Two sets of national stillbirth estimates for 2000 produced similar worldwide totals of 3.2 million and 3.3 million, but rates differed substantially for some countries. We aimed to develop more reliable estimates and a time series from 1995 for 193 countries, by increasing input data, using recent data, and applying improved modelling approaches. Methods For international comparison, stillbirth is defined as fetal death in the third trimester (>= 1000 g birthweight or >= 28 completed weeks of gestation). Several sources of stillbirth data were identified and assessed against prespecified inclusion criteria: vital registration data; nationally representative surveys; and published studies identified through systematic literature searches, unpublished studies, and national data identified through a WHO country consultation process. For 2009, reported rates were used for 33 countries and model-based estimates for 160 countries. A regression model of log stillbirth rate was developed and used to predict national stillbirth rates from 1995 to 2009. Uncertainty ranges were obtained with a bootstrap approach. The final model included log(neonatal mortality rate) (cubic spline), log(low birthweight rate) (cubic spline), log(gross national income purchasing power parity) (cubic spline), region, type of data source, and definition of stillbirth. Findings Vital registration data from 79 countries, 69 nationally representative surveys from 39 countries, and 113 studies from 42 countries met inclusion criteria. The estimated number of global stillbirths was 2.64 million (uncertainty range 2.14 million to 3.82 million) in 2009 compared with 3.03 million (uncertainty range 2.37 million to 4.19 million) in 1995. Worldwide stillbirth rate has declined by 14.5%, from 22.1 stillbirths per 1000 births in 1995 to 18.9 stillbirths per 1000 births in 2009. In 2009,76.2% of stillbirths occurred in south Asia and sub-Saharan Africa. Interpretation This study draws attention to the dearth of reliable data in regions where most stillbirths occur. The estimated trend in stillbirth rate reduction is slower than that for maternal mortality and lags behind the increasing progress in reducing deaths in children younger than 5 years. Improved data and improved use of data are crucial to ensure that stillbirths count in global and national policy.	[Cousens, Simon; Blencowe, Hannah] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Stanton, Cynthia; Ahmed, Saifuddin; Steinhardt, Laura; Creanga, Andreea A.; Tuncalp, Oezge; Balsara, Zohra Patel; Gupta, Shivam] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Chou, Doris; Say, Lale] WHO, CH-1211 Geneva, Switzerland; [Lawn, Joy E.] Saving Newborn Lives Save Children, Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; Save the Children	Cousens, S (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	simon.cousens@lshtm.ac.uk	Blencowe, Hannah/K-7415-2012; , lalesay/AAG-1912-2021; Tunçalp, Ӧzge/Y-2724-2018; Lawn, Joy/ABE-6382-2020	Tunçalp, Ӧzge/0000-0002-5370-682X; Lawn, Joy/0000-0002-4573-1443; Blencowe, Hannah/0000-0003-1556-3159	Bill & Melinda Gates Foundation through the Global Alliance to Prevent Prematurity and Stillbirth, Saving Newborn Lives/Save the Children; International Stillbirth Alliance; Department of Reproductive Health and Research, WHO; WHO; World Bank; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation through the Global Alliance to Prevent Prematurity and Stillbirth, Saving Newborn Lives/Save the Children; International Stillbirth Alliance; Department of Reproductive Health and Research, WHO(World Health Organization); WHO(World Health Organization); World Bank(The World Bank India); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Bill & Melinda Gates Foundation through the Global Alliance to Prevent Prematurity and Stillbirth, Saving Newborn Lives/Save the Children, and the International Stillbirth Alliance. The Department of Reproductive Health and Research, WHO, through the UN Development Programme, UN Population Fund, WHO, and World Bank Special Programme of Research, Development and Research Training in Human Reproduction.	*AUSTR I HLTH WELF, NAT PER STAT UN; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001006; Efron B., 1994, INTRO BOOTSTRAP; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; *I NAT STAT ET EC, 1994, NES VIV ENF SANS VIE; *INF GES BUND, FED HLTH MON; Joint United Nations Programme on HIV/AIDS, UNAIDS REP GLOB AIDS; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; OESTERGAARD MZ, WORLD HLTH IN PRESS; *ORC MACR, DEM HLTH SURV; *ORC MACR, 2001, MOD A QUEST HIGH CON; *PLOS COLL, GLOB HLTH EST; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Scott J, 2011, LANCET, V377, P1386, DOI 10.1016/S0140-6736(11)60107-4; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; UNICEF, 2009, STAT WORLDS CHILDR; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV; WHO, 1993, INT STAT CLASS DIS R, V2; WHO, COUNTD 2015 MAT NEWB; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471; World Bank, WORLD DEV IND 2008; World Health Organization, 2010, TRENDS MAT MORT 1990, P18; World Health Organization, 2006, NEON PER MORT YEAR 2	32	413	424	1	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1319	1330		10.1016/S0140-6736(10)62310-0	http://dx.doi.org/10.1016/S0140-6736(10)62310-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UE	21496917	Green Accepted			2022-12-24	WOS:000289962900033
J	Andrews, JR; Basu, S				Andrews, Jason R.; Basu, Sanjay			Transmission dynamics and control of cholera in Haiti: an epidemic model	LANCET			English	Article							ENDEMIC CHOLERA; BANGLADESH; OUTBREAK; EXPERTS; SCALE	Background Official projections of the cholera epidemic in Haiti have not incorporated existing disease trends or patterns of transmission, and proposed interventions have been debated without comparative estimates of their effect. We used a mathematical model of the epidemic to provide projections of future morbidity and mortality, and to Produce comparative estimates of the effects of proposed interventions. Methods We designed mathematical models of cholera transmission based on existing models and fitted them to incidence data reported in Haiti for each province from Oct 31, 2010, to Jan 24, 2011. We then simulated future epidemic trajectories from March 1 to Nov 30, 2011, to estimate the effect of clean water, vaccination, and enhanced antibiotic distribution programmes. Findings We project 779 000 cases of cholera in Haiti (95% CI 599 000-914 000) and 11 100 deaths (7300-17 400) between March 1 and Nov 30, 2011. We expect that a 1% per week reduction in consumption of contaminated water would avert 105 000 cases (88 000-116 000) and 1500 deaths (1100-2300). We predict that the vaccination of 10% of the population, from March 1, will avert 63 000 cases (48 000-78 000) and 900 deaths (600-1500). The proposed extension of the use of antibiotics to all patients with severe dehydration and half of patients with moderate dehydration is expected to avert 9000 cases (8000-10 000) and 1300 deaths (900-2000). Interpretation A decline in cholera prevalence in early 2011 is part of the natural course of the epidemic, and should not be interpreted as indicative of successful intervention. Substantially more cases of cholera are expected than official estimates used for resource allocation. Combined, clean water provision, vaccination, and expanded access to antibiotics might avert thousands of deaths.	[Andrews, Jason R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Andrews, Jason R.] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02114 USA; [Basu, Sanjay] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Basu, Sanjay] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Andrews, JR (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Infect Dis, Cox 5, Boston, MA 02114 USA.	jandrews6@partners.org		Andrews, Jason/0000-0002-5967-251X	National Institutes of Health (NIGMS) [U54 GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JRA is supported by the National Institutes of Health (NIGMS grant number U54 GM088558). This report is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank Marc Lipsitch for his helpful comments.	Alam A, 2005, INFECT IMMUN, V73, P6674, DOI 10.1128/IAI.73.10.6674-6679.2005; Anh Dang Duc, 2011, PLoS Negl Trop Dis, V5, pe1006, DOI 10.1371/journal.pntd.0001006; CLAYTON E, 2011, HAITI PROGR REPORT 2; Codeco CT, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-1; Cyranoski D, 2011, NATURE, V469, P273, DOI 10.1038/469273a; Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118; FOX B, 2011, CHOLERA TAKES BREATH; Hartley DM, 2006, PLOS MED, V3, P63, DOI 10.1371/journal.pmed.0030007; International Federation of Red Cross and Red Crescent Societies, 2011, HAIT DOM REP CHOL OU; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Lawoyin TO, 1999, EUR J EPIDEMIOL, V15, P367, DOI 10.1023/A:1007547117763; Longini IM, 2002, J INFECT DIS, V186, P246, DOI 10.1086/341206; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Luby SP, 2008, AM J TROP MED HYG, V78, P382, DOI 10.4269/ajtmh.2008.78.382; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Neilan RLM, 2010, B MATH BIOL, V72, P2004, DOI 10.1007/s11538-010-9521-8; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; RAHAMAN MM, 1976, ANTIMICROB AGENTS CH, V10, P610, DOI 10.1128/AAC.10.4.610; Reyburn R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000952; Ryan ET, 2000, AM J TROP MED HYG, V63, P12, DOI 10.4269/ajtmh.2000.63.12; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Sullivan CA, 2003, NAT RESOUR FORUM, V27, P189, DOI 10.1111/1477-8947.00054; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Thiem VD, 2006, VACCINE, V24, P4297, DOI 10.1016/j.vaccine.2006.03.008; United Nations Office for the Coordination of Humanitarian Affairs, 2010, CHOL INT RESP STRAT; Walton DA, 2011, NEW ENGL J MED, V364, P3, DOI 10.1056/NEJMp1012997; WHO/UNICEF-Joint Monitoring Program, 2010, PROGR SAN DRINK WAT; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P117; World Health Organization, 2010, 107 WHO; Zarocostas J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d23	34	131	137	3	49	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1248	1255		10.1016/S0140-6736(11)60273-0	http://dx.doi.org/10.1016/S0140-6736(11)60273-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751DI	21414658	Green Accepted			2022-12-24	WOS:000289597300031
J	Kaiser, WJ; Upton, JW; Long, AB; Livingston-Rosanoff, D; Daley-Bauer, LP; Hakem, R; Caspary, T; Mocarski, ES				Kaiser, William J.; Upton, Jason W.; Long, Alyssa B.; Livingston-Rosanoff, Devon; Daley-Bauer, Lisa P.; Hakem, Razqallah; Caspary, Tamara; Mocarski, Edward S.			RIP3 mediates the embryonic lethality of caspase-8-deficient mice	NATURE			English	Article							RECEPTOR-INTERACTING PROTEIN; HOMOTYPIC INTERACTION MOTIF; CELL-DEATH; PROGRAMMED NECROSIS; IMMUNE-SYSTEM; TNF-ALPHA; T-CELLS; IN-VIVO; CASPASE-8; EXPRESSION	Apoptosis and necroptosis are complementary pathways controlled by common signalling adaptors, kinases and proteases; among these, caspase-8 (Casp8) is critical for death receptor-induced apoptosis. This caspase has also been implicated in non-apoptotic pathways that regulate Fas-associated via death domain (FADD)dependent signalling and other less defined biological processes as diverse as innate immune signalling and myeloid or lymphoid differentiation patterns(1). Casp8 suppresses RIP3-RIP1 (also known as RIPK3-RIPK1) kinase complex-dependent(2-4) necroptosis(5) that follows death receptor activation as well as a RIP3-dependent, RIP(1)-independent necrotic pathway that has emerged as a host defence mechanism against murine cytomegalovirus(6). Disruption of Casp8 expression leads to embryonic lethality in mice between embryonic days 10.5 and 11.5 (ref. 7). Thus, Casp8 may naturally hold alternative RIP3-dependent death pathways in check in addition to promoting apoptosis. We find that RIP3 is responsible for the mid-gestational death of Casp8-deficient embryos. Remarkably, Casp8(-/-)Rip3(-/-) double mutant mice are viable and mature into fertile adults with a full immune complement of myeloid and lymphoid cell types. These mice seem immunocompetent but develop lymphadenopathy by four months of age marked by accumulation of abnormal T cells in the periphery, a phenotype reminiscent of mice with Fas-deficiency (lpr/lpr; also known as Fas). Thus, Casp8 contributes to homeostatic control in the adult immune system; however, RIP3 and Casp8 are together completely dispensable for mammalian development.	[Kaiser, William J.; Upton, Jason W.; Livingston-Rosanoff, Devon; Daley-Bauer, Lisa P.; Mocarski, Edward S.] Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Long, Alyssa B.; Caspary, Tamara] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Hakem, Razqallah] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Hakem, Razqallah] Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	Emory University; Emory University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kaiser, WJ (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	wkaiser@emory.edu	Kaiser, William/A-3079-2012; Long, Alyssa/AAN-8497-2020; Mocarski, Edward/ABC-2893-2020; Caspary, Tamara/AAH-5625-2020	Long, Alyssa/0000-0002-4467-4213; Caspary, Tamara/0000-0002-6579-7589; Daley-Bauer, Lisa/0000-0002-3377-7989; Hakem, Razqallah/0000-0001-5948-7931; Upton, Jason/0000-0002-4218-4026	Georgia Cancer Coalition; NIH [R01 AI20211, AI30363]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI030363, R01AI030363, R01AI020211, R21AI030363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012198] Funding Source: NIH RePORTER	Georgia Cancer Coalition; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge D. Green, A. Oberst and C. Dillon for their discussions and material support. We thank V. Dixit and K. Newton for RIP32/2 mice, A. Kowalczyk, R. Oas, S. Speck and R. Ahmed for providing reagents, T. Kaufmann for technical advice, C. Strauss for editing, and A. L. McCormick for discussion and comments on the manuscript. Additionally, we appreciate M. Dowdy and J. Perry for mouse colony maintenance. This work was supported by the Georgia Cancer Coalition and the NIH (PHS grants R01 AI20211 and AI30363 to E. S. M.).	Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; LAOUAR Y, 1994, J IMMUNOL, V153, P3948; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; McCormick AL, 2003, VIROLOGY, V316, P221, DOI 10.1016/j.virol.2003.07.003; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	30	741	764	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2011	471	7338					368	+		10.1038/nature09857	http://dx.doi.org/10.1038/nature09857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368762	Green Accepted			2022-12-24	WOS:000288444000043
J	Wang, F; Mei, ZQ; Qi, YT; Yan, CY; Hu, Q; Wang, JW; Shi, YG				Wang, Feng; Mei, Ziqing; Qi, Yutao; Yan, Chuangye; Hu, Qi; Wang, Jiawei; Shi, Yigong			Structure and mechanism of the hexameric MecA-ClpC molecular machine	NATURE			English	Article							RAY-DIFFRACTION DATA; CRYSTAL-STRUCTURE; HSP100 CHAPERONE; PROTEIN; ADAPTER; DOMAIN; RECOGNITION; COMPETENCE; COMPLEX; DISAGGREGATION	Regulated proteolysis by ATP-dependent proteases is universal in all living cells. Bacterial ClpC, a member of the Clp/Hsp100 family of AAA1 proteins (ATPases associated with diverse cellular activities) with two nucleotide-binding domains (D1 and D2), requires the adaptor protein MecA for activation and substrate targeting. The activated, hexameric MecA-ClpC molecular machine harnesses the energy of ATP binding and hydrolysis to unfold specific substrate proteins and translocate the unfolded polypeptide to the ClpP protease for degradation. Here we report three relatedcrystal structures: a heterodimer between MecA and the amino domain of ClpC, a heterododecamer between MecA and D2-deleted ClpC, and a hexameric complex between MecA and full-length ClpC. In conjunction with biochemical analyses, these structures reveal the organizational principles behind the hexameric MecA-ClpC complex, explain the molecular mechanisms for MecA-mediated ClpC activation and provide mechanistic insights into the function of the MecA-ClpC molecular machine. These findings have implications for related Clp/Hsp100 molecular machines.	[Wang, Feng; Mei, Ziqing; Qi, Yutao; Yan, Chuangye; Hu, Qi; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China; [Wang, Feng; Mei, Ziqing; Qi, Yutao; Yan, Chuangye; Hu, Qi; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Wang, JW (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China.	jwwang@tsinghua.edu.cn; shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021; Wang, Feng/AAC-6221-2022; Mei, Ziqing/AHD-6788-2022; Wang, Jiawei/D-1144-2010	Wang, Feng/0000-0002-9403-4337; Mei, Ziqing/0000-0001-8554-6309; Wang, Jiawei/0000-0001-9893-8539; Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X	National Natural Science Foundation of China [30888001]; China Postdoctoral Science Foundation [023201058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank J. He and S. Huang at Shanghai Synchrotron Radiation Source and staff at the SPring-8 beamline BL41XU for help. This work was supported by Project 30888001 of the National Natural Science Foundation of China (Y.S.) and Postdoctoral Fellowship # 023201058 from the China Postdoctoral Science Foundation (Z.M.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Barends TRM, 2010, CURR OPIN STRUC BIOL, V20, P46, DOI 10.1016/j.sbi.2009.12.014; Bruker, 2003, SAINT SADABS XPREP S; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLano W.L., 2002, PYMOL MOL VIEWER; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Inobe T, 2008, CURR OPIN STRUC BIOL, V18, P43, DOI 10.1016/j.sbi.2007.12.014; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Lee S, 2004, J STRUCT BIOL, V146, P99, DOI 10.1016/j.jsb.2003.11.016; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Li JZ, 2003, STRUCTURE, V11, P323, DOI 10.1016/S0969-2126(03)00030-3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mei ZQ, 2009, J BIOL CHEM, V284, P34366, DOI 10.1074/jbc.M109.053017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 1998, EMBO J, V17, P6730; Wang F, 2009, J BIOL CHEM, V284, P34376, DOI 10.1074/jbc.M109.053033; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2010, BIOCHEM CELL BIOL, V88, P89, DOI [10.1139/O09-164, 10.1139/o09-164]; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	49	103	106	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					331	+		10.1038/nature09780	http://dx.doi.org/10.1038/nature09780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368759				2022-12-24	WOS:000288444000035
J	Zinzalla, V; Stracka, D; Oppliger, W; Hall, MN				Zinzalla, Vittoria; Stracka, Daniele; Oppliger, Wolfgang; Hall, Michael N.			Activation of mTORC2 by Association with the Ribosome	CELL			English	Article							ENDOPLASMIC-RETICULUM; MAMMALIAN TARGET; CELL-GROWTH; COMPLEX 2; TRANSLATION INITIATION; MOTIF PHOSPHORYLATION; AKT PHOSPHORYLATION; BINDING PARTNER; KINASE-B; RAPAMYCIN	The target of rapamycin (TOR) is a highly conserved protein kinase and a central controller of growth. Mammalian TOR complex 2 (mTORC2) regulates AGC kinase family members and is implicated in various disorders, including cancer and diabetes. Here, we investigated the upstream regulation of mTORC2. A genetic screen in yeast and subsequent studies in mammalian cells revealed that ribosomes, but not protein synthesis, are required for mTORC2 signaling. Active mTORC2 was physically associated with the ribosome, and insulin-stimulated PI3K signaling promoted mTORC2-ribosome binding, suggesting that ribosomes activate mTORC2 directly. Findings with melanoma and colon cancer cells suggest that mTORC2-ribosome association is important in oncogenic PI3K signaling. Thus, TORC2-ribosome interaction is a likely conserved mechanism of TORC2 activation that is physiologically relevant in both normal and cancer cells. As ribosome content determines growth capacity of a cell, this mechanism of TORC2 regulation ensures that TORC2 is active only in growing cells.	[Zinzalla, Vittoria; Stracka, Daniele; Oppliger, Wolfgang; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	m.hall@unibas.ch		Hall, Michael N/0000-0002-2998-0757	Swiss National Science Foundation, SystemsX.ch; Swiss Cancer League; Louis Jeantet Foundation; Canton of Basel	Swiss National Science Foundation, SystemsX.ch(Swiss National Science Foundation (SNSF)); Swiss Cancer League; Louis Jeantet Foundation; Canton of Basel	We thank Rachel Idol and Stefano Grosso for valuable discussions and technical assistance and Giulio Spagnoli for the melanoma cell lines. We acknowledge support from the Swiss National Science Foundation, SystemsX.ch, the Swiss Cancer League, the Louis Jeantet Foundation, and the Canton of Basel. We declare that no competing interests exist.	Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Certa U, 2001, BRIT J CANCER, V85, P107, DOI 10.1054/bjoc.2001.1865; Chiocchetti A, 2005, HAEMATOLOGICA, V90, P1453; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DESCHODTLANCKMAN M, 1990, INT J CANCER, V46, P1124, DOI 10.1002/ijc.2910460629; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gervois N, 1996, J EXP MED, V183, P2403, DOI 10.1084/jem.183.5.2403; Grosso S, 2008, BIOCHEM J, V415, P77, DOI 10.1042/BJ20080463; Grossso S, 2008, BIOCHEM BIOPH RES CO, V376, P65, DOI 10.1016/j.bbrc.2008.08.118; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He HN, 2010, CANCER LETT, V295, P38, DOI 10.1016/j.canlet.2010.02.011; Helliwell SB, 1998, GENETICS, V148, P99; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Idol RA, 2007, BLOOD CELL MOL DIS, V39, P35, DOI 10.1016/j.bcmd.2007.02.001; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Madhunapantula SV, 2009, PIGM CELL MELANOMA R, V22, P400, DOI 10.1111/j.1755-148X.2009.00585.x; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Mulet JM, 2006, J BIOL CHEM, V281, P33000, DOI 10.1074/jbc.M604244200; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Robertson GP, 2005, CANCER METAST REV, V24, P273, DOI 10.1007/s10555-005-1577-9; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stahl JM, 2003, CANCER RES, V63, P2881; Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001	71	482	509	0	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					757	768		10.1016/j.cell.2011.02.014	http://dx.doi.org/10.1016/j.cell.2011.02.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376236	Bronze			2022-12-24	WOS:000288007100014
J	Scepaniak, JJ; Vogel, CS; Khusniyarov, MM; Heinemann, FW; Meyer, K; Smith, JM				Scepaniak, Jeremiah J.; Vogel, Carola S.; Khusniyarov, Marat M.; Heinemann, Frank W.; Meyer, Karsten; Smith, Jeremy M.			Synthesis, Structure, and Reactivity of an Iron(V) Nitride	SCIENCE			English	Article							SPECTROSCOPIC CHARACTERIZATION; INTERSTITIAL ATOM; FEMO-COFACTOR; COMPLEX; NITROGENASE; MOSSBAUER; CATALYSIS; FIXATION; LIGAND; ENDOR	Despite being implicated as important intermediates, iron(V) compounds have proven very challenging to isolate and characterize. Here, we report the preparation of the iron(V) nitrido complex, [PhB((t)BuIm)(3)Fe-V N]BArF24 (PhB((t)BuIm)(3)(-) = phenyltris(3-tert-butylimidazol-2-ylidene)borato, BArF24 = B(3,5-(CF3)(2)C6H3)(4)(-)), by one electron oxidation of the iron(IV) nitrido precursor. Single-crystal x-ray diffraction of the iron(V) complex reveals a four-coordinate metal ion with a terminal nitrido ligand. Mossbauer and electron paramagnetic resonance spectroscopic characterization, supported by electronic structure calculations, provide evidence for a d(3) iron(V) metal center in a low spin (S = 1/2) electron configuration. Low-temperature reaction of the iron(V) nitrido complex with water under reducing conditions leads to high yields of ammonia with concomitant formation of an iron(II) species.	[Vogel, Carola S.; Khusniyarov, Marat M.; Heinemann, Frank W.; Meyer, Karsten] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91058 Erlangen, Germany; [Scepaniak, Jeremiah J.; Smith, Jeremy M.] New Mexico State Univ, Dept Chem & Biochem, MSC 3C, Las Cruces, NM 88003 USA	University of Erlangen Nuremberg; New Mexico State University	Meyer, K (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Egerlandstr 1, D-91058 Erlangen, Germany.	KMeyer@chemie.uni-erlangen.de; jesmith@nmsu.edu	Meyer, Karsten/G-2570-2012; Heinemann, Frank Wilhelm/AAC-3062-2022; Smith, Jeremy M/H-5043-2012; Khusniyarov, Marat/O-7723-2016; Scepaniak, Jeremiah/I-5920-2015	Meyer, Karsten/0000-0002-7844-2998; Heinemann, Frank Wilhelm/0000-0002-9007-8404; Smith, Jeremy M/0000-0002-3206-4725; Khusniyarov, Marat/0000-0002-2034-421X; Scepaniak, Jeremiah/0000-0002-0135-3954	Friedrich-Alexander-University Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie; Department of Energy Office of Basic Energy Sciences [DE-FG02-08ER15996]; Camille and Henry Dreyfus Foundation	Friedrich-Alexander-University Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Camille and Henry Dreyfus Foundation	We acknowledge funding from Friedrich-Alexander-University Erlangen-Nuremberg and the Deutsche Forschungsgemeinschaft (K.M.); Fonds der Chemischen Industrie (M.M.K.); and the Department of Energy Office of Basic Energy Sciences (DE-FG02-08ER15996) and the Camille and Henry Dreyfus Foundation (J.M.S.). J. Sutter is gratefully acknowledged for collecting the spectroscopic data, and K. Wieghardt and E. Bill (Max-Planck-Institut for Bioinorganic Chemistry, Mulheim/Ruhr, Germany) for helpful discussions. The crystallographic data CCDC-786059 (2 at 35 K) and CCDC-786060 (2 at 100 K) can be obtained free at www.ccdc.cam.ac.uk/data_request/cif (or from Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, CB2 1EZ, UK; fax: ++44-1223-336-033; e-mail: deposit@ccdc.cam.ac.uk).	Aliaga-Alcalde N, 2005, ANGEW CHEM INT EDIT, V44, P2908, DOI 10.1002/anie.200462368; Berry JF, 2006, SCIENCE, V312, P1937, DOI 10.1126/science.1128506; BERTHELOT MPE, 1959, REP CHEM APPL, V1, P284, DOI DOI 10.1056/NEJMOA1708131; Betley TA, 2004, J AM CHEM SOC, V126, P6252, DOI 10.1021/ja048713v; Chen K, 2002, J AM CHEM SOC, V124, P3026, DOI 10.1021/ja0120025; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Ertl G, 2001, CHEM REC, V1, P33; ERTL G, 1990, ANGEW CHEM INT EDIT, V29, P1219, DOI 10.1002/anie.199012191; Hendrich MP, 2006, P NATL ACAD SCI USA, V103, P17107, DOI 10.1073/pnas.0604402103; Herber R. H., 1984, CHEM MOSSBAUER SPECT; Hoffman BM, 2009, ACCOUNTS CHEM RES, V42, P609, DOI 10.1021/ar8002128; Jackson TA, 2008, J AM CHEM SOC, V130, P12394, DOI 10.1021/ja8022576; Lukoyanov D, 2007, INORG CHEM, V46, P11437, DOI 10.1021/ic7018814; Meyer K, 1999, J AM CHEM SOC, V121, P4859, DOI 10.1021/ja983454t; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Scepaniak JJ, 2008, J AM CHEM SOC, V130, P10515, DOI 10.1021/ja8027372; SCHULZ CE, 1987, J CHEM PHYS, V87, P5077, DOI 10.1063/1.453675; de Oliveira FT, 2007, SCIENCE, V315, P835, DOI 10.1126/science.1133417; Vogel C, 2008, ANGEW CHEM INT EDIT, V47, P2681, DOI 10.1002/anie.200800600; Yang TC, 2005, J AM CHEM SOC, V127, P12804, DOI 10.1021/ja0552489; YOUSIF AA, 1989, J PHYS-CONDENS MAT, V1, P7103, DOI 10.1088/0953-8984/1/39/022	22	227	229	6	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1049	1052		10.1126/science.1198315	http://dx.doi.org/10.1126/science.1198315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350172				2022-12-24	WOS:000287699000058
J	Wenzel, DM; Lissounov, A; Brzovic, PS; Klevit, RE				Wenzel, Dawn M.; Lissounov, Alexei; Brzovic, Peter S.; Klevit, Rachel E.			UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids	NATURE			English	Article							UBIQUITIN-CONJUGATING ENZYME; CRYSTAL-STRUCTURE; PROTEIN; LIGASE; RING; EXPRESSION; ACTIVATION; RESIDUES; INSIGHTS; COMPLEX	Although the functional interaction between ubiquitin-conjugating enzymes (E2s) and ubiquitin ligases (E3s) is essential in ubiquitin (Ub) signalling, the criteria that define an active E2-E3 pair are not well established. The human E2 UBCH7 (also known as UBE2L3) shows broad specificity for HECT-type E3s(1), but often fails to function with RING E3s in vitro despite forming specific complexes(2-4). Structural comparisons of inactive UBCH7-RING complexes with active UBCH5-RING complexes reveal no defining differences(3,4), highlighting a gap in our understanding of Ub transfer. Here we show that, unlike many E2s that transfer Ub with RINGs, UBCH7 lacks intrinsic, E3-independent reactivity with lysine, explaining its preference for HECTs. Despite lacking lysine reactivity, UBCH7 exhibits activity with the RING-inbetween-RING (RBR) family of E3s that includes parkin (also known as PARK2) and human homologue of ariadne (HHARI; also known as ARIH1)(5,6). Found in all eukaryotes(7), RBRs regulate processes such as translation(8) and immune signalling(9). RBRs contain a canonical C3HC4-type RING, followed by two conserved Cys/His-rich Zn2+-binding domains, in-between-RING (IBR) and RING2 domains, which together define this E3 family(7). We show that RBRs function like RING/HECT hybrids: they bind E2s via a RING domain, but transfer Ub through an obligate thioester-linked Ub (denoted Ub), requiring a conserved cysteine residue in RING2. Our results define the functional cadre of E3s for UBCH7, an E2 involved in cell proliferation(10) and immune function(11), and indicate a novel mechanism for an entire class of E3s.	[Wenzel, Dawn M.; Lissounov, Alexei; Brzovic, Peter S.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	klevit@u.washington.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X	National Institute of General Medical Sciences [5R01 GM088055, T32 GM07270]; National Science Foundation [MCB0615632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM088055] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Stoll, M. Schwartz and N. Zheng for critical reading of the manuscript and discussions and V. Vittal, K. Stoll and P. Littlefield for technical help. We thank K. Borden, E. Fon, B. Schulman, L. Boyd, J. Chen and A. Merz for expression vectors for HHARI, parkin, E6-AP, Ubc18, human E1 and GST pull-down reagents, respectively. We acknowledge support from the National Institute of General Medical Sciences in the form of 5R01 GM088055 (R.E.K.) and T32 GM07270 (D.M.W.), and the National Science Foundation in the form of MCB0615632 (R.E.K.)	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Ardley HC, 2001, J BIOL CHEM, V276, P19640, DOI 10.1074/jbc.M011028200; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diao J, 2008, NAT STRUCT MOL BIOL, V15, P65, DOI 10.1038/nsmb1346; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones D, 2002, GENOME BIOL, V3; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Maruyama M, 2000, ANN NEUROL, V48, P245, DOI 10.1002/1531-8249(200008)48:2<245::AID-ANA15>3.0.CO;2-2; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tan NGS, 2003, FEBS LETT, V554, P501, DOI 10.1016/S0014-5793(03)01235-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Whitcomb EA, 2009, MOL BIOL CELL, V20, P1, DOI 10.1091/mbc.E08-01-0036; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	35	370	386	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					105	U136		10.1038/nature09966	http://dx.doi.org/10.1038/nature09966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21532592	Green Accepted			2022-12-24	WOS:000291156700047
J	Winslow, MM; Dayton, TL; Verhaak, RGW; Kim-Kiselak, C; Snyder, EL; Feldser, DM; Hubbard, DD; DuPage, MJ; Whittaker, CA; Hoersch, S; Yoon, S; Crowley, D; Bronson, RT; Chiang, DY; Meyerson, M; Jacks, T				Winslow, Monte M.; Dayton, Talya L.; Verhaak, Roel G. W.; Kim-Kiselak, Caroline; Snyder, Eric L.; Feldser, David M.; Hubbard, Diana D.; DuPage, Michel J.; Whittaker, Charles A.; Hoersch, Sebastian; Yoon, Stephanie; Crowley, Denise; Bronson, Roderick T.; Chiang, Derek Y.; Meyerson, Matthew; Jacks, Tyler			Suppression of lung adenocarcinoma progression by Nkx2-1	NATURE			English	Article							EMBRYONIC STEM-CELLS; CLINICAL-SIGNIFICANCE; PROTEIN EXPRESSION; BREAST-CANCER; SELF-RENEWAL; HMGI-C; K-RAS; METASTASIS; P53; ONCOGENE	Despite the high prevalence and poor outcome of patients with metastatic lung cancer the mechanisms of tumour progression and metastasis remain largely uncharacterized. Here we modelled human lung adenocarcinoma, which frequently harbours activating point mutations in KRAS(1) and inactivation of the p53 pathway(2), using conditional alleles in mice(3-5). Lentiviral-mediated somatic activation of oncogenic Kras and deletion of p53 in the lung epithelial cells of Kras(LSL-G12D/+); p53(flox/flox) mice initiates lung adenocarcinoma development(4). Although tumours are initiated synchronously by defined genetic alterations, only a subset becomes malignant, indicating that disease progression requires additional alterations. Identification of the lentiviral integration sites allowed us to distinguish metastatic from non-metastatic tumours and determine the gene expression alterations that distinguish these tumour types. Cross-species analysis identified the NK2-related homeobox transcription factor Nkx2-1 (also called Ttf-1 or Titf1) as a candidate suppressor of malignant progression. In this mouse model, Nkx2-1 negativity is pathognomonic of high-grade poorly differentiated tumours. Gain-and loss-of-function experiments in cells derived from metastatic and non-metastatic tumours demonstrated that Nkx2-1 controls tumour differentiation and limits metastatic potential in vivo. Interrogation of Nkx2-1-regulated genes, analysis of tumours at defined developmental stages, and functional complementation experiments indicate that Nkx2-1 constrains tumours in part by repressing the embryonically restricted chromatin regulator Hmga(2). Whereas focal amplification of NKX2-1 in a fraction of human lung adenocarcinomas has focused attention on its oncogenic function(6-9), our data specifically link Nkx2-1 downregulation to loss of differentiation, enhanced tumour seeding ability and increased metastatic proclivity. Thus, the oncogenic and suppressive functions of Nkx2-1 in the same tumour type substantiate its role as a dual function lineage factor.	[Winslow, Monte M.; Dayton, Talya L.; Kim-Kiselak, Caroline; Snyder, Eric L.; Feldser, David M.; DuPage, Michel J.; Whittaker, Charles A.; Hoersch, Sebastian; Yoon, Stephanie; Crowley, Denise; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Winslow, Monte M.; Kim-Kiselak, Caroline; Jacks, Tyler] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA; [Verhaak, Roel G. W.; Hubbard, Diana D.; Chiang, Derek Y.; Meyerson, Matthew] Harvard Univ, Dana Farber Canc Inst, Cambridge, MA 02115 USA; [Verhaak, Roel G. W.; Hubbard, Diana D.; Chiang, Derek Y.; Meyerson, Matthew] Broad Inst, Cambridge, MA 02142 USA; [Bronson, Roderick T.] Tufts Univ, Sch Vet, Dept Biomed Sci, North Grafton, MA 01536 USA; [Chiang, Derek Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tufts University; University of North Carolina; University of North Carolina Chapel Hill; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu	Chiang, Derek/L-6452-2019; Verhaak, Roel/ABE-7058-2020; Meyerson, Matthew L/E-7123-2012	Chiang, Derek/0000-0002-1131-6065; Whittaker, Charles/0000-0002-2400-0094; Dayton, Talya/0000-0002-7994-7963; Meyerson, Matthew/0000-0002-9133-8108	Genentech; Dutch Cancer Society KWF; Alfred P. Sloan Foundation; National Institutes of Health [U01-CA84306, K99-CA151968]; Howard Hughes Medical Institute; Ludwig Center for Molecular Oncology at MIT; National Cancer Institute [P30-CA14051];  [T32-HL007627]; NATIONAL CANCER INSTITUTE [K08CA154784, R00CA151968, U01CA084306, P30CA014051, K99CA151968, R01CA109038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); Dutch Cancer Society KWF(KWF Kankerbestrijding); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ludwig Center for Molecular Oncology at MIT; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Dooley, N. Dimitrova, T. Oliver and M. Ebert for providing reagents; M. Luo (Biology/Koch Institute BioMicro Core) for array processing; M. Kumar for experimental assistance; T. Staton, D. McFadden, A. Shaw and the entire T.J. laboratory for comments. M.M.W. was a Merck Fellow of the Damon Runyon Cancer Research Foundation and was funded by a Genentech Postdoctoral Fellowship. R. G. W. V. is supported by a Fellowship from the Dutch Cancer Society KWF. E.L.S. is supported by a training grant (T32-HL007627). D.Y.C. is supported by an Alfred P. Sloan Foundation Research Fellowship. D.M.F. is a Leukemia and Lymphoma Postdoctoral Fellow. This work was supported by National Institutes of Health grants U01-CA84306 (to T.J.) and K99-CA151968 (to M.M.W.), the Howard Hughes Medical Institute, the Ludwig Center for Molecular Oncology at MIT, and in part by the Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. T.J. is the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar.	Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barletta JA, 2009, J CELL MOL MED, V13, P1977, DOI 10.1111/j.1582-4934.2008.00594.x; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bengtsson H, 2009, BIOINFORMATICS, V25, P861, DOI 10.1093/bioinformatics/btp074; Berghmans T, 2006, ANN ONCOL, V17, P1673, DOI 10.1093/annonc/mdl287; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Di Cello F, 2008, MOL CANCER RES, V6, P743, DOI 10.1158/1541-7786.MCR-07-0095; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hristov AC, 2009, MODERN PATHOL, V22, P43, DOI 10.1038/modpathol.2008.140; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Krude H, 2002, J CLIN INVEST, V109, P475, DOI 10.1172/JC1200214341; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Li O, 2006, GENESIS, V44, P523, DOI 10.1002/dvg.20242; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Meyer B, 2007, MOL CARCINOGEN, V46, P503, DOI 10.1002/mc.20235; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; R Development Core Team, 2005, R LANG ENV STAT COMP; RODENHUIS S, 1988, CANCER RES, V48, P5738; Rogalla P, 1997, MOL CARCINOGEN, V19, P153, DOI 10.1002/(SICI)1098-2744(199707)19:3<153::AID-MC2>3.0.CO;2-F; Rommel B, 1997, LEUKEMIA LYMPHOMA, V26, P603, DOI 10.3109/10428199709050896; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	49	303	322	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					101	U120		10.1038/nature09881	http://dx.doi.org/10.1038/nature09881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21471965	Green Accepted, Green Submitted			2022-12-24	WOS:000290218300039
J	Cardinale, BJ				Cardinale, Bradley J.			Biodiversity improves water quality through niche partitioning	NATURE			English	Article							PLANT DIVERSITY; STREAM PERIPHYTON; PATCH DYNAMICS; NITROGEN; EUTROPHICATION; PRODUCTIVITY; DISTURBANCE; ECOLOGY; NITRATE; RESPONSES	Excessive nutrient loading of water bodies is a leading cause of water pollution worldwide(1,2), and controlling nutrient levels in watersheds is a primary objective of most environmental policy(3). Over the past two decades, much research has shown that ecosystems with more species are more efficient at removing nutrients from soil and water than are ecosystems with fewer species(4-7). This has led some to suggest that conservation of biodiversity might be a useful tool for managing nutrient uptake and storage(7-10), but this suggestion has been controversial, in part because the specific biological mechanisms by which species diversity influences nutrient uptake have not been identified(10-12). Here I use a model system of stream biofilms to show that niche partitioning among species of algae can increase the uptake and storage of nitrate, a nutrient pollutant of global concern. I manipulated the number of species of algae growing in the biofilms of 150 stream mesocosms that had been set up to mimic the variety of flow habitats and disturbance regimes that are typical of natural streams. Nitrogen uptake rates, as measured by using N-15-labelled nitrate, increased linearly with species richness and were driven by niche differences among species. As different forms of algae came to dominate each unique habitat in a stream, the more diverse communities achieved a higher biomass and greater N-15 uptake. When these niche opportunities were experimentally removed by making all of the habitats in a stream uniform, diversity did not influence nitrogen uptake, and biofilms collapsed to a single dominant species. These results provide direct evidence that communities with more species take greater advantage of the niche opportunities in an environment, and this allows diverse systems to capture a greater proportion of biologically available resources such as nitrogen. One implication is that biodiversity may help to buffer natural ecosystems against the ecological impacts of nutrient pollution.	Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Cardinale, BJ (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	bradcard@umich.edu	Cardinale, Bradley J/I-7076-2013		US National Science Foundation [DEB 0614428, DEB 1046121]; Division Of Environmental Biology [1046121] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Byrnes, W. Dodds, J. Levine and A. Steinman for comments that improved the manuscript. D. Bennett, K. Matulich, L. Power and J. Weis helped to set up and run the experiment. M. Potapova provided images of the algae in Fig. 2. This work was funded by grants from the US National Science Foundation (DEB 0614428 and DEB 1046121).	Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Andersen R. A., 2005, ALGAL CULTURING TECH; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Biggs BJF, 1998, ARCH HYDROBIOL, V143, P21; BIGGS BJF, 1995, J PHYCOL, V31, P233, DOI 10.1111/j.0022-3646.1995.00233.x; Biggs BJF, 1998, J PHYCOL, V34, P598, DOI 10.1046/j.1529-8817.1998.340598.x; Bracken MES, 2006, ECOLOGY, V87, P2397, DOI 10.1890/0012-9658(2006)87[2397:SDENUV]2.0.CO;2; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Carroll I. T., ECOLOGY IN PRESS; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cooper SD, 1997, J N AM BENTHOL SOC, V16, P174, DOI 10.2307/1468250; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dodds WK, 2006, LIMNOL OCEANOGR, V51, P671, DOI 10.4319/lo.2006.51.1_part_2.0671; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Fry B., 2006, STABLE ISOTOPE ECOLO; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hubbell SP, 2008, P NATL ACAD SCI USA, V105, P11498, DOI 10.1073/pnas.0801915105; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Legendre L, 1997, J PLANKTON RES, V19, P263, DOI 10.1093/plankt/19.2.263; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Nusch E.A., 1980, ARCH HYDROBIOLOGIE B, V14, P14; Passy SI, 2001, J PHYCOL, V37, P370, DOI 10.1046/j.1529-8817.2001.037003370.x; PETERSON CG, 1992, ECOLOGY, V73, P1445, DOI 10.2307/1940689; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; PRINGLE CM, 1988, J N AM BENTHOL SOC, V7, P503, DOI 10.2307/1467303; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Scherer-Lorenzen M, 2003, ECOLOGY, V84, P1539, DOI 10.1890/0012-9658(2003)084[1539:TROPDA]2.0.CO;2; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; STEINMAN AD, 1986, J PHYCOL, V22, P352, DOI 10.1111/j.1529-8817.1986.tb00035.x; Steinman Alan D., 1996, P295; Stevenson R. Jan, 1996, P321; STEVENSON RJ, 1983, ECOLOGY, V64, P1514, DOI 10.2307/1937506; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Townsend CR, 1998, ECOL LETT, V1, P200; TOWNSEND CR, 1989, J N AM BENTHOL SOC, V8, P36, DOI 10.2307/1467400; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VOGEL S, 1978, BIOSCIENCE, V28, P638, DOI 10.2307/1307394	49	456	481	22	931	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					86	U113		10.1038/nature09904	http://dx.doi.org/10.1038/nature09904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475199				2022-12-24	WOS:000289199400042
J	Ito, H; Gaubert, H; Bucher, E; Mirouze, M; Vaillant, I; Paszkowski, J				Ito, Hidetaka; Gaubert, Herve; Bucher, Etienne; Mirouze, Marie; Vaillant, Isabelle; Paszkowski, Jerzy			An siRNA pathway prevents transgenerational retrotransposition in plants subjected to stress	NATURE			English	Article							DNA-METHYLATION; TRANSPOSABLE ELEMENTS; EPIGENETIC REGULATION; REPETITIVE ELEMENTS; GENOME SIZE; ARABIDOPSIS; DEMETHYLATION; EXPRESSION; DYNAMICS	Eukaryotic genomes consist to a significant extent of retrotransposons that are suppressed by host epigenetic mechanisms, preventing their uncontrolled propagation(1,2). However, it is not clear how this is achieved. Here we show that in Arabidopsis seedlings subjected to heat stress, a copia-type retrotransposon named ONSEN (Japanese 'hot spring') not only became transcriptionally active but also synthesized extrachromosomal DNA copies. Heat-induced ONSEN accumulation was stimulated in mutants impaired in the biogenesis of small interfering RNAs (siRNAs); however, there was no evidence of transposition occurring in vegetative tissues. After stress, both ONSEN transcripts and extrachromosomal DNA gradually decayed and were no longer detected after 20-30 days. Surprisingly, a high frequency of new ONSEN insertions was observed in the progeny of stressed plants deficient in siRNAs. Insertion patterns revealed that this transgenerational retrotransposition occurred during flower development and before gametogenesis. Therefore in plants with compromised siRNA biogenesis, memory of stress was maintained throughout development, priming ONSEN to transpose during differentiation of generative organs. Retrotransposition was not observed in the progeny of wild-type plants subjected to stress or in non-stressed mutant controls, pointing to a crucial role of the siRNA pathway in restricting retrotransposition triggered by environmental stress. Finally, we found that natural and experimentally induced variants in ONSEN insertions confer heat responsiveness to nearby genes, and therefore mobility bursts may generate novel, stress-responsive regulatory gene networks.	[Ito, Hidetaka; Gaubert, Herve; Bucher, Etienne; Mirouze, Marie; Vaillant, Isabelle; Paszkowski, Jerzy] Univ Geneva, Dept Plant Biol, CH-1211 Geneva 4, Switzerland	University of Geneva	Paszkowski, J (corresponding author), Univ Geneva, Dept Plant Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jerzy.paszkowski@unige.ch	Mirouze, Marie/AAG-8128-2022; Mirouze, Marie/AFL-9387-2022; Mirouze, Marie/AFL-8165-2022; Bucher, Etienne/E-7681-2013; Ito, Hidetaka/Y-2865-2018	Mirouze, Marie/0000-0002-0514-1270; Mirouze, Marie/0000-0002-0514-1270; Bucher, Etienne/0000-0002-3114-3763; 	Swiss National Science Foundation [31003A-125005]; European Commission [FP7 226477]; RECBREED consortium [FP7 227190]; Epigenome Network of Excellence [FP6 503433]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); RECBREED consortium; Epigenome Network of Excellence	We thank all members of the J.P. laboratory and R. L. Fisher for discussions, L. Broger, M. Freyre, J. Nicolet, C. Megies for technical assistance and P. King and J. Reinders for editing of the manuscript. This work was supported by grants from the Swiss National Science Foundation (31003A-125005) and the European Commission through the AENEAS collaborative project (FP7 226477), the RECBREED consortium (FP7 227190) and The Epigenome Network of Excellence (FP6 503433).	Ammiraju JSS, 2007, PLANT J, V52, P342, DOI 10.1111/j.1365-313X.2007.03242.x; Feuerbach F, 1997, J VIROL, V71, P4005, DOI 10.1128/JVI.71.5.4005-4015.1997; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; HIROCHIKA H, 1995, GENE, V165, P229, DOI 10.1016/0378-1119(95)00581-P; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Johnson LM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000280; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lim CJ, 2006, J PLANT RES, V119, P373, DOI 10.1007/s10265-006-0285-z; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pecinka A, 2010, PLANT CELL, V22, P3118, DOI 10.1105/tpc.110.078493; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tittel-Elmer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001175; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	30	392	404	1	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					115	U151		10.1038/nature09861	http://dx.doi.org/10.1038/nature09861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21399627				2022-12-24	WOS:000289199400048
J	Umena, Y; Kawakami, K; Shen, JR; Kamiya, N				Umena, Yasufumi; Kawakami, Keisuke; Shen, Jian-Ren; Kamiya, Nobuo			Crystal structure of oxygen-evolving photosystem II at a resolution of 1.9 angstrom	NATURE			English	Article							DIFFRACTION DATA; WATER; BINDING; PROTEIN; MECHANISM; OXIDATION; MANGANESE; CHANNELS; CLUSTER; CRYSTALLOGRAPHY	Photosystem II is the site of photosynthetic water oxidation and contains 20 subunits with a total molecular mass of 350 kDa. The structure of photosystem II has been reported at resolutions from 3.8 to 2.9 angstrom. These resolutions have provided much information on the arrangement of protein subunits and cofactors but are insufficient to reveal the detailed structure of the catalytic centre of water splitting. Here we report the crystal structure of photosystem II at a resolution of 1.9 angstrom. From our electron density map, we located all of the metal atoms of the Mn4CaO5 cluster, together with all of their ligands. We found that five oxygen atoms served as oxo bridges linking the five metal atoms, and that four water molecules were bound to the Mn4CaO5 cluster; some of them may therefore serve as substrates for dioxygen formation. We identified more than 1,300 water molecules in each photosystem II monomer. Some of them formed extensive hydrogen-bonding networks that may serve as channels for protons, water or oxygen molecules. The determination of the high-resolution structure of photosystem II will allow us to analyse and understand its functions in great detail.	[Kawakami, Keisuke; Shen, Jian-Ren] Okayama Univ, Fac Sci, Grad Sch Nat Sci & Technol, Div Biosci, Okayama 7008530, Japan; [Umena, Yasufumi; Kamiya, Nobuo] Osaka City Univ, Grad Sch Sci, Dept Chem, Osaka 5588585, Japan	Okayama University; Osaka Metropolitan University	Shen, JR (corresponding author), Okayama Univ, Fac Sci, Grad Sch Nat Sci & Technol, Div Biosci, Okayama 7008530, Japan.	shen@cc.okayama-u.ac.jp; nkamiya@sci.osaka-cu.ac.jp	Shen, Jian-Ren/B-2558-2011; Umena, Yasufumi/AAD-5472-2019	Kamiya, Nobuo/0000-0002-9056-7558	Ministry of Education, Culture, Sports, Science and Technology of Japan; Yamada Science foundation; Grants-in-Aid for Scientific Research [10J02491] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The X-ray diffraction data was taken at beamlines BL44XU, BL41XU and BL38B1 at SPring-8. We thank E. Yamashita, N. Shimizu, S. Baba and N. Mizuno for their help in using the beamlines. J.-R.S. thanks Y. Inoue for his support in the initiation of this work. This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (Structures of Biological Macromolecular Assemblies), a Grant-in-Aid for Creative Scientific Research, a GCOE programme on Pico-biology at the University of Hyogo, a Grant-in-Aid for Scientific Research (C), from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a research grant from the Yamada Science foundation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Broser M, 2010, J BIOL CHEM, V285, P26255, DOI 10.1074/jbc.M110.127589; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURRELL JWK, 1959, P CHEM SOC LONDON, P263; Carrell TG, 2002, J BIOL INORG CHEM, V7, P2, DOI 10.1007/s00775-001-0305-3; CHU HA, 1995, BIOCHEMISTRY-US, V34, P5839, DOI 10.1021/bi00017a016; CRABBE P, 1959, P CHEM SOC LONDON, P264; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; DAOPIN S, 1994, ACTA CRYSTALLOGR D, V50, P85, DOI 10.1107/S090744499300808X; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; DEPAULA JC, 1986, J AM CHEM SOC, V108, P4002, DOI 10.1021/ja00274a025; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hays AMA, 1999, BIOCHEMISTRY-US, V38, P11851, DOI 10.1021/bi990716a; Ho FM, 2008, BBA-BIOENERGETICS, V1777, P140, DOI 10.1016/j.bbabio.2007.08.009; Hoganson CW, 1997, SCIENCE, V277, P1953, DOI 10.1126/science.277.5334.1953; Hwang HJ, 2007, BIOCHEMISTRY-US, V46, P11987, DOI 10.1021/bi701387b; Joliot P, 2003, PHOTOSYNTH RES, V76, P65, DOI 10.1023/A:1024946610564; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kawakami K, 2007, FEBS LETT, V581, P4983, DOI 10.1016/j.febslet.2007.09.036; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Murray JW, 2007, J STRUCT BIOL, V159, P228, DOI 10.1016/j.jsb.2007.01.016; Murray JW, 2008, ENERG ENVIRON SCI, V1, P161, DOI 10.1039/b810067p; NIXON PJ, 1994, BIOCHEM SOC T, V22, P338, DOI 10.1042/bst0220338; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Robblee JH, 2001, BBA-BIOENERGETICS, V1503, P7, DOI 10.1016/S0005-2728(00)00217-6; Service RJ, 2010, BIOCHEMISTRY-US, V49, P6655, DOI 10.1021/bi100730d; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Tommos C, 2000, BBA-BIOENERGETICS, V1458, P199, DOI 10.1016/S0005-2728(00)00069-4; Vasil'ev S, 2001, P NATL ACAD SCI USA, V98, P8602, DOI 10.1073/pnas.141239598; VINCENT JB, 1987, INORG CHIM A-BIOINOR, V136, pL41, DOI 10.1016/S0020-1693(00)81142-1; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zein S, 2008, PHILOS T R SOC B, V363, P1167, DOI 10.1098/rstb.2007.2212; Zhang CX, 2007, BBA-BIOENERGETICS, V1767, P493, DOI 10.1016/j.bbabio.2006.12.008; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	40	2871	2950	30	1243	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					55	U65		10.1038/nature09913	http://dx.doi.org/10.1038/nature09913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21499260	Green Submitted			2022-12-24	WOS:000290218300029
J	Ferreira, A; Marguti, I; Bechmann, I; Jeney, V; Chora, A; Palha, NR; Rebelo, S; Henri, A; Beuzard, Y; Soares, MP				Ferreira, Ana; Marguti, Ivo; Bechmann, Ingo; Jeney, Viktoria; Chora, Angelo; Palha, Nuno R.; Rebelo, Sofia; Henri, Annie; Beuzard, Yves; Soares, Miguel P.			Sickle Hemoglobin Confers Tolerance to Plasmodium Infection	CELL			English	Article							HEME OXYGENASE-1; CELL-DISEASE; FALCIPARUM-MALARIA; MOUSE MODEL; PROTECTION; TRAIT; INDUCTION; PATHOGENESIS; RESISTANCE; MECHANISM	Sickle human hemoglobin (Hb) confers a survival advantage to individuals living in endemic areas of malaria, the disease caused by Plasmodium infection. As demonstrated hereby, mice expressing sickle Hb do not succumb to experimental cerebral malaria (ECM). This protective effect is exerted irrespectively of parasite load, revealing that sickle Hb confers host tolerance to Plasmodium infection. Sickle Hb induces the expression of heme oxygenase-1 (HO-1) in hematopoietic cells, via a mechanism involving the transcription factor NF-E2-related factor 2 (Nrf2). Carbon monoxide (CO), a byproduct of heme catabolism by HO-1, prevents further accumulation of circulating free heme after Plasmodium infection, suppressing the pathogenesis of ECM. Moreover, sickle Hb inhibits activation and/or expansion of pathogenic CD8(+) T cells recognizing antigens expressed by Plasmodium, an immunoregulatory effect that does not involve Nrf2 and/or HO-1. Our findings provide insight into molecular mechanisms via which sickle Hb confers host tolerance to severe forms of malaria.	[Ferreira, Ana; Marguti, Ivo; Jeney, Viktoria; Chora, Angelo; Palha, Nuno R.; Rebelo, Sofia; Soares, Miguel P.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04103 Leipzig, Germany; [Bechmann, Ingo] Goethe Univ Frankfurt, Inst Clin Neuroanat, D-60596 Frankfurt, Germany; [Henri, Annie; Beuzard, Yves] Univ Paris 07, Inst Univ Hematol, F-75221 Paris 05, France; [Henri, Annie; Beuzard, Yves] CEA, Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France; [Henri, Annie; Beuzard, Yves] INSERM, F-75654 Paris 13, France; [Henri, Annie; Beuzard, Yves] Univ Paris 11, Paris, France	Instituto Gulbenkian de Ciencia; Leipzig University; Goethe University Frankfurt; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Soares, MP (corresponding author), Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal.	mpsoares@igc.gulbenkian.pt	Soares, Miguel P/G-4188-2011; Ferreira Chora, Angelo/AAZ-6503-2021; Jeney, Viktória/AAF-5355-2019; Jeney, Viktoria/A-6779-2011	Ferreira Chora, Angelo/0000-0002-7941-7196; Soares, Miguel/0000-0002-9314-4833; Rebelo, Sofia/0000-0001-8399-0262; Jeney, Viktoria/0000-0003-4942-7091; Ferreira, Ana/0000-0002-9171-6068	"Fundacao para a Ciencia e a Tecnologia'', Portugal [PTDC/SAU-MII/71140/2006, SFRH/BPD/21707/2005, SFHR/BD/33218/2007, PTDC/BIA-BCM/101311/2008, PTDC/SAU-FCF/100762/2008]; GEMI Fund Linde Healthcare; European Community; DFG; BMBF; Dr. Senckenberg-Stiftung; Kassel-Stiftung; Messer-Stiftung, Germany; Paris VII University; Commissariat a l'Energie Atomique; Agence Nationale de la Recherche Scientifique, France;  [LSH-2005-1.2.5-1];  [FP7-PEOPLE-2007-2-1-IEF]	"Fundacao para a Ciencia e a Tecnologia'', Portugal(Portuguese Foundation for Science and Technology); GEMI Fund Linde Healthcare; European Community(European Commission); DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Dr. Senckenberg-Stiftung; Kassel-Stiftung; Messer-Stiftung, Germany; Paris VII University; Commissariat a l'Energie Atomique(French Atomic Energy Commission); Agence Nationale de la Recherche Scientifique, France(French National Research Agency (ANR)); ; 	We thank Ruslan Medzhitov for intellectual support and encouragement by means of many insightful discussions, Thiago Carvalho (Instituto Gulbenkian de Cie ncia) and Rui Costa Fundacao Champalimaud as well as Marcelo Bozza (Universidade Federal do Rio De Janeiro), Robert P. Hebbel and Gregory Vercellotti (University of Minnesota, USA) for critical review of the manuscript, Nuno Sepulveda for support in statistical analysis, Tim M. Townes and Tom M. Ryan (University of Alabama at Birmingham) for providing the HbA/A mice. Silvia Cardoso and Matteo Villa for mouse breeding and genotyping. This work was supported by "Fundacao para a Ciencia e a Tecnologia'', Portugal grants PTDC/SAU-MII/71140/2006 and SFRH/BPD/21707/2005 (AF), SFHR/BD/33218/2007 (IM), PTDC/SAU-MII/71140/2006, PTDC/BIA-BCM/101311/2008, PTDC/SAU-FCF/100762/2008, GEMI Fund Linde Healthcare, European Community and LSH-2005-1.2.5-1 (MPS), FP7-PEOPLE-2007-2-1-IEF (VJ). I. B. is supported by the DFG, BMBF, Dr. Senckenberg-Stiftung, Kassel-Stiftung and Messer-Stiftung, Germany. Annie Henri is supported by INSERM and Yves Beuzard by Paris VII University, Commissariat a l'Energie Atomique and Agence Nationale de la Recherche Scientifique, France.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Bains SK, 2010, ARTERIOSCL THROM VAS, V30, P305, DOI 10.1161/ATVBAHA.109.196360; BALLA G, 1992, J BIOL CHEM, V267, P18148; BEET E A, 1947, East Afr Med J, V24, P212; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Berberat PO, 2003, FASEB J, V17, P1724, DOI 10.1096/fj.03-0229fje; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Clark IA, 2004, CLIN MICROBIOL REV, V17, P509, DOI 10.1128/CMR.17.3.509-539.2004; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; EISENSTEIN RS, 1991, P NATL ACAD SCI USA, V88, P688, DOI 10.1073/pnas.88.3.688; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; Hood AT, 1996, BLOOD, V87, P1600, DOI 10.1182/blood.V87.4.1600.bloodjournal8741600; Hutagalung R, 1999, J INFECT DIS, V179, P283, DOI 10.1086/314561; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JALLOW M, 2009, GENOME WIDE FINE RES; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; LIVINGSTONE FB, 1971, ANNU REV GENET, V5, P33, DOI 10.1146/annurev.ge.05.120171.000341; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; MOTULSKY AG, 1966, AM J HUM GENET, V18, P514; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nath KA, 2001, AM J PATHOL, V158, P893, DOI 10.1016/S0002-9440(10)64037-0; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sabaa N, 2008, J CLIN INVEST, V118, P1924, DOI 10.1172/JCI33308; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Sears DA, 2001, AM J MED SCI, V322, P345, DOI 10.1097/00000441-200112000-00007; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; SHEAR HL, 1993, BLOOD, V81, P222; Soares MP, 2009, TRENDS MOL MED, V15, P50, DOI 10.1016/j.molmed.2008.12.004; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; TRUDEL M, 1994, BLOOD, V84, P3189; TRUDEL M, 1991, EMBO J, V10, P3157, DOI 10.1002/j.1460-2075.1991.tb04877.x; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163	55	213	217	2	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					398	409		10.1016/j.cell.2011.03.049	http://dx.doi.org/10.1016/j.cell.2011.03.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529713	Bronze			2022-12-24	WOS:000290022900009
J	Marshall, BDL; Milloy, MJ; Wood, E; Montaner, JSG; Kerr, T				Marshall, Brandon D. L.; Milloy, M-J; Wood, Evan; Montaner, Julio S. G.; Kerr, Thomas			Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study	LANCET			English	Article							NEW-YORK-CITY; DRUG-USERS; COHORT; VANCOUVER; RISK; ATTENDANCE; PATTERNS; TRENDS; IMPACT; DEATH	Background Overdose from illicit drugs is a leading cause of premature mortality in North America. Internationally, more than 65 supervised injecting facilities (SIFs), where drug users can inject pre-obtained illicit drugs, have been opened as part of various strategies to reduce the harms associated with drug use. We sought to determine whether the opening of an SIF in Vancouver, BC, Canada, was associated with a reduction in overdose mortality. Methods We examined population-based overdose mortality rates for the period before (Jan 1, 2001, to Sept 20, 2003) and after (Sept 21, 2003, to Dec 31, 2005) the opening of the Vancouver SIF. The location of death was determined from provincial coroner records. We compared overdose fatality rates within an a priori specified 500 m radius of the SIF and for the rest of the city. Findings Of 290 decedents, 229 (79.0%) were male, and the median age at death was 40 years (IQR 32-48 years). A third (89, 30.7%) of deaths occurred in city blocks within 500 m of the SIF. The fatal overdose rate in this area decreased by 35.0% after the opening of the SIF, from 253.8 to 165.1 deaths per 100000 person-years (p=0.048). By contrast, during the same period, the fatal overdose rate in the rest of the city decreased by only 9.3%, from 7.6 to 6.9 deaths per 100 000 person-years (p=0.490). There was a significant interaction of rate differences across strata (p=0.049). Interpretation SIFs should be considered where injection drug use is prevalent, particularly in areas with high densities of overdose.	[Marshall, Brandon D. L.; Milloy, M-J; Wood, Evan; Montaner, Julio S. G.; Kerr, Thomas] Univ British Columbia, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V5Z 1M9, Canada; [Wood, Evan; Montaner, Julio S. G.; Kerr, Thomas] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Milloy, M-J] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Marshall, Brandon D. L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; University of British Columbia; Columbia University	Kerr, T (corresponding author), St Pauls Hosp, BC Ctr Excellence HIV AIDS, Urban Hlth Res Initiat, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	uhri-tk@cfenet.ubc.ca	Marshall, Brandon/B-4895-2010; Milloy, M-J/AAY-3618-2020; Montaner, Julio/K-7621-2012	Marshall, Brandon/0000-0002-0134-7052; 	Abbott Laboratories; Agouron Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Borean Pharma AS; Bristol-Myers Squibb; DuPont Pharma; Gilead Sciences; GlaxoSmithKline; Hoffmann-La Roche; Immune Response Corporation; Incyte; Janssen-Ortho Inc; Kucera Pharmaceutical Company; Merck Frosst Laboratories; Pfizer Canada; Sanofi Pasteur; Shire Biochem; Tibotec Pharmaceuticals; Trimeris; Health Canada; Canadian Institutes of Health Research (CIHR); Vancouver Coastal Health; Michael Smith Foundation for Health Research (MSFHR)	Abbott Laboratories(Abbott Laboratories); Agouron Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); Borean Pharma AS; Bristol-Myers Squibb(Bristol-Myers Squibb); DuPont Pharma; Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Hoffmann-La Roche(Hoffmann-La Roche); Immune Response Corporation; Incyte; Janssen-Ortho Inc; Kucera Pharmaceutical Company; Merck Frosst Laboratories; Pfizer Canada(Pfizer); Sanofi Pasteur; Shire Biochem; Tibotec Pharmaceuticals; Trimeris; Health Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Vancouver Coastal Health; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	JSGM has received educational grants from, serves as an ad hoc adviser to, or speaks at various events sponsored by Abbott Laboratories, Agouron Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Borean Pharma AS, Bristol-Myers Squibb, DuPont Pharma, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Immune Response Corporation, Incyte, Janssen-Ortho Inc, Kucera Pharmaceutical Company, Merck Frosst Laboratories, Pfizer Canada, Sanofi Pasteur, Shire Biochem, Tibotec Pharmaceuticals, and Trimeris. No other authors declared any conflicts of interest.; We gratefully acknowledge the invaluable assistance of the Chief Coroner and other officials of the British Columbia Coroners Service, in particular Sara Weinstein and Tej Sidhu. We thank Daniel Kane, Deborah Graham, and Tricia Collingham of the British Columbia Centre for Excellence in HIV/AIDS for their research and administrative assistance. The SIF assessment was originally funded by a contribution from Health Canada, although the views expressed in this analysis do not represent the official policies of Health Canada. The study is now supported by the Canadian Institutes of Health Research (CIHR) and Vancouver Coastal Health. TK is supported by a CIHR New Investigator Award and a Michael Smith Foundation for Health Research (MSFHR) Scholar Award. BDLM and MJM are supported by Canada Graduate Scholarships from CIHR; BDLM is supported by a Senior Graduate Trainee Award from Michael Smith Foundation for Health Research.	*ANG REID, CAN AR SUPP INS OPP; Apparicio P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-7; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Bohnert ASB, 2010, ADDICTION, V105, P1049, DOI 10.1111/j.1360-0443.2009.02887.x; Bohnert ASB, 2009, ANN EMERG MED, V54, P618, DOI 10.1016/j.annemergmed.2009.05.004; Bow C Jennifer D, 2004, Int J Health Geogr, V3, P5, DOI 10.1186/1476-072X-3-5; Brugal MT, 2005, ADDICTION, V100, P981, DOI 10.1111/j.1360-0443.2005.01089.x; BUXTON JA, VANCOUVER DRUG USE E; Cameron AC, 1997, J ECONOMETRICS, V77, P329; *CDCP, UN DRUG POIS US; Crandall CG, 2002, ANN INTERN MED, V136, P785, DOI 10.7326/0003-4819-136-11-200206040-00006; Darke S, 2003, J URBAN HEALTH, V80, P189, DOI 10.1093/jurban/jtg022; DeBeck K, 2008, SUBST ABUSE TREAT PR, V3, DOI 10.1186/1747-597X-3-11; Fairbairn N, 2008, SOC SCI MED, V67, P817, DOI 10.1016/j.socscimed.2008.05.012; Fielden Sarah J, 2007, Harm Reduct J, V4, P10, DOI 10.1186/1477-7517-4-10; Fischer B, 2006, CAN J PUBLIC HEALTH, V97, P384, DOI 10.1007/BF03405347; Galai N, 2003, AM J EPIDEMIOL, V158, P695, DOI 10.1093/aje/kwg209; Galea S, 2003, J URBAN HEALTH, V80, P201, DOI 10.1093/jurban/jtg023; Hall W, 2005, LANCET, V366, P271, DOI 10.1016/S0140-6736(05)66476-8; HEDRICH D, EUROPEAN REPORT DRUG; Hulse GK, 1999, ADDICTION, V94, P221, DOI 10.1046/j.1360-0443.1999.9422216.x; Kaye S, 2004, ADDICTION, V99, P1315, DOI 10.1111/j.1360-0443.2004.00875.x; Kerr T, 2006, BRIT MED J, V332, P220, DOI 10.1136/bmj.332.7535.220; Kerr T, 2005, LANCET, V366, P316, DOI 10.1016/S0140-6736(05)66475-6; Kerr T, 2008, LANCET, V372, P354, DOI 10.1016/S0140-6736(08)61138-1; Kerr T, 2007, AM J PUBLIC HEALTH, V97, P1228, DOI 10.2105/AJPH.2006.086256; Kerr T, 2006, INT J DRUG POLICY, V17, P436, DOI 10.1016/j.drugpo.2006.05.008; Kimber J, 2003, DRUG ALCOHOL REV, V22, P227, DOI 10.1080/095952301000116951; Lloyd-Smith E, 2009, DRUG ALCOHOL DEPEN, V99, P176, DOI 10.1016/j.drugalcdep.2008.07.003; Milloy MJ, 2010, ADDICTION, V105, P1962, DOI 10.1111/j.1360-0443.2010.03077.x; *MSIC EV COMM, FIN REP EV SYDN MED; Petrar S, 2007, ADDICT BEHAV, V32, P1088, DOI 10.1016/j.addbeh.2006.07.013; Rachlis BS, 2008, HEALTH PLACE, V14, P536, DOI 10.1016/j.healthplace.2007.10.006; ROTHMAN KJ, 2008, MODERN EPIDEMIOLOGY; Small W, 2008, DRUG ALCOHOL DEPEN, V98, P159, DOI 10.1016/j.drugalcdep.2008.05.014; Small W, 2007, INT J DRUG POLICY, V18, P27, DOI 10.1016/j.drugpo.2006.11.019; Spittal PM, 2006, AIDS CARE, V18, P101, DOI 10.1080/09540120500159292; *STAT CAN, 2003, POP FAM EST METH STA; Statistics Canada, 2007, POST COD CONV FIL PC; Stoove MA, 2008, DRUG ALCOHOL DEPEN, V96, P281, DOI 10.1016/j.drugalcdep.2008.03.006; Strathdee SA, 1997, AIDS, V11, pF59, DOI 10.1097/00002030-199708000-00001; Tyndall MW, 2006, DRUG ALCOHOL DEPEN, V83, P193, DOI 10.1016/j.drugalcdep.2005.11.011; *VANC COAST HLTH, INJ DRUG US DTES; Werb D, 2010, DRUG ALCOHOL REV, V29, P271, DOI 10.1111/j.1465-3362.2009.00145.x; White JM, 1999, ADDICTION, V94, P961, DOI 10.1046/j.1360-0443.1999.9479612.x; Wood E, 2006, NEW ENGL J MED, V354, P2512, DOI 10.1056/NEJMc052939; Wood E, 2006, AM J PUBLIC HEALTH, V96, P770, DOI 10.2105/AJPH.2004.057828; Wood E, 2006, ADDICTION, V101, P689, DOI 10.1111/j.1360-0443.2006.01385.x; Wood E, 2005, AM J PREV MED, V29, P126, DOI 10.1016/j.amepre.2005.04.011; Wood E, 2004, LANCET INFECT DIS, V4, P301, DOI 10.1016/S1473-3099(04)01006-0; Wood E, 2008, INT J DRUG POLICY, V19, P220, DOI 10.1016/j.drugpo.2007.11.001; Wood E, 2008, AM J PUBLIC HEALTH, V98, P515, DOI 10.2105/AJPH.2007.114595; Wood E, 2006, CAN MED ASSOC J, V175, P1399, DOI 10.1503/cmaj.060863; Wood Evan, 2004, Harm Reduct J, V1, P9, DOI 10.1186/1477-7517-1-9; DOWNTOWN EASTSIDE CO	55	275	275	3	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2011	377	9775					1429	1437		10.1016/S0140-6736(10)62353-7	http://dx.doi.org/10.1016/S0140-6736(10)62353-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	21497898				2022-12-24	WOS:000289963000032
J	Root, CM; Ko, KI; Jafari, A; Wang, JW				Root, Cory M.; Ko, Kang I.; Jafari, Amir; Wang, Jing W.			Presynaptic Facilitation by Neuropeptide Signaling Mediates Odor-Driven Food Search	CELL			English	Article							ANTENNAL LOBE; PHOSPHOINOSITIDE 3-KINASE; GENE-EXPRESSION; SOCIAL-BEHAVIOR; GAIN-CONTROL; Y-LIKE; CIRCUIT; NEURONS; INHIBITION; RECEPTOR	Internal physiological states influence behavioral decisions. We have investigated the underlying cellular and molecular mechanisms at the first olfactory synapse for starvation modulation of food-search behavior in Drosophila. We found that a local signal by short neuropeptide F (sNPF) and a global metabolic cue by insulin are integrated at specific odorant receptor neurons (ORNs) to modulate olfactory sensitivity. Results from two-photon calcium imaging show that starvation increases presynaptic activity via intraglomerular sNPF signaling. Expression of sNPF and its receptor (sNPFR1) in Or42b neurons is necessary for starvation-induced food-search behavior. Presynaptic facilitation in Or42b neurons is sufficient to mimic starvation-like behavior in fed flies. Furthermore, starvation elevates the transcription level of sNPFR1 but not that of sNPF, and insulin signaling suppresses sNPFR1 expression. Thus, starvation increases expression of sNPFR1 to change the odor map, resulting in more robust food-search behavior.	[Root, Cory M.; Ko, Kang I.; Jafari, Amir; Wang, Jing W.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wang, JW (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	jw800@ucsd.edu	Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802	National Institute of Deafness and other Communication Disorders [R01DC009597, R21DC010458, 1F31DC009511]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009597, R21DC010458, F31DC009511] Funding Source: NIH RePORTER	National Institute of Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank R. Axel, M. Gallio, A. Gelperin, S. Kim, and M. Ramaswami for comments on the manuscript. We thank D. Green for assistance with the fly tracking software, E. Troemel for assistance with quantitative RT-PCR, and Jun Hee Lee for helpful discussion of insulin signaling. This work was supported by research grants from the National Institute of Deafness and other Communication Disorders to J.W.W. (R01DC009597, R21DC010458) and fellowship to C. M. R. (1F31DC009511). C. M. R. and J.W.W. designed experiments, analyzed data, and wrote the manuscript. C. M. R, K. I. K., and A.J. carried out experiments.	ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; Distler PG, 1997, J COMP NEUROL, V383, P529, DOI 10.1002/(SICI)1096-9861(19970714)383:4&lt;529::AID-CNE9&gt;3.0.CO;2-4; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; GELPERIN A, 1971, ANNU REV ENTOMOL, V16, P365, DOI 10.1146/annurev.en.16.010171.002053; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kyriaki G, 2003, CELL MOL NEUROBIOL, V23, P1, DOI 10.1023/A:1022598900246; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Mathieu M, 2002, DEV BRAIN RES, V139, P255, DOI 10.1016/S0165-3806(02)00577-1; Mayer CM, 2009, MOL CELL ENDOCRINOL, V307, P99, DOI 10.1016/j.mce.2009.02.031; Mousley A, 2006, J NEUROSCI, V26, P7707, DOI 10.1523/JNEUROSCI.1977-06.2006; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9	51	313	316	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					133	144		10.1016/j.cell.2011.02.008	http://dx.doi.org/10.1016/j.cell.2011.02.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458672	Bronze, Green Accepted			2022-12-24	WOS:000289053900015
J	Ceol, CJ; Houvras, Y; Jane-Valbuena, J; Bilodeau, S; Orlando, DA; Battisti, V; Fritsch, L; Lin, WM; Hollmann, TJ; Ferre, F; Bourque, C; Burke, CJ; Turner, L; Uong, A; Johnson, LA; Beroukhim, R; Mermel, CH; Loda, M; Ait-Si-Ali, S; Garraway, LA; Young, RA; Zon, LI				Ceol, Craig J.; Houvras, Yariv; Jane-Valbuena, Judit; Bilodeau, Steve; Orlando, David A.; Battisti, Valentine; Fritsch, Lauriane; Lin, William M.; Hollmann, Travis J.; Ferre, Fabrizio; Bourque, Caitlin; Burke, Christopher J.; Turner, Laura; Uong, Audrey; Johnson, Laura A.; Beroukhim, Rameen; Mermel, Craig H.; Loda, Massimo; Ait-Si-Ali, Slimane; Garraway, Levi A.; Young, Richard A.; Zon, Leonard I.			The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset	NATURE			English	Article							MALIGNANT-MELANOMA; BRAF MUTATIONS; HUMAN CANCER; GENES; NEVI; SENESCENCE; EXPRESSION; REPRESSION; LYSINE-9; CELLS	The most common mutation in human melanoma, BRAF(V600E), activates the serine/threonine kinase BRAF and causes excessive activity in the mitogen-activated protein kinase pathway(1,2). BRAF(V600E) mutations are also present in benign melanocytic naevi(3), highlighting the importance of additional genetic alterations in the genesis of malignant tumours. Such changes include recurrent copy number variations that result in the amplification of oncogenes(4,5). For certain amplifications, the large number of genes in the interval has precluded an understanding of the cooperating oncogenic events. Here we have used a zebrafish melanoma model to test genes in a recurrently amplified region of chromosome 1 for the ability to cooperate with BRAF(V600E) and accelerate melanoma. SETDB1, an enzyme that methylates histone H3 on lysine 9 (H3K9), was found to accelerate melanoma formation significantly in zebrafish. Chromatin immunoprecipitation coupled with massively parallel DNA sequencing and gene expression analyses uncovered genes, including HOX genes, that are transcriptionally dysregulated in response to increased levels of SETDB1. Our studies establish SETDB1 as an oncogene in melanoma and underscore the role of chromatin factors in regulating tumorigenesis.	[Ceol, Craig J.; Houvras, Yariv; Bourque, Caitlin; Burke, Christopher J.; Turner, Laura; Uong, Audrey; Zon, Leonard I.] Harvard Univ, Stem Cell Program & Hematol Oncol, Childrens Hosp Boston,Med Sch, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Houvras, Yariv] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA; [Jane-Valbuena, Judit; Lin, William M.; Johnson, Laura A.; Beroukhim, Rameen; Mermel, Craig H.; Garraway, Levi A.] Harvard Univ, Dept Med Oncol, Dana Farber Canc Inst, Sch Med, Boston, MA 02115 USA; [Jane-Valbuena, Judit; Lin, William M.; Johnson, Laura A.; Beroukhim, Rameen; Mermel, Craig H.; Garraway, Levi A.] Harvard Univ, Ctr Canc Genome Discovery, Dana Farber Canc Inst, Sch Med, Boston, MA 02115 USA; [Jane-Valbuena, Judit; Lin, William M.; Johnson, Laura A.; Beroukhim, Rameen; Mermel, Craig H.; Garraway, Levi A.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Bilodeau, Steve; Orlando, David A.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Battisti, Valentine; Fritsch, Lauriane; Ait-Si-Ali, Slimane] Univ Paris Diderot, Epigenet & Destin Cellulaire UMR7216, CNRS, F-75013 Paris, France; [Hollmann, Travis J.; Loda, Massimo] Harvard Univ, Ctr Mol Oncol Pathol, Brigham & Womens Hosp, Dana Farber Canc Inst,Med Sch, Boston, MA 02115 USA; [Ferre, Fabrizio] Univ Roma La Sapienza, A Rossi Fanelli Biochem Sci Dept, I-00185 Rome, Italy	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Sapienza University Rome	Zon, LI (corresponding author), Harvard Univ, Stem Cell Program & Hematol Oncol, Childrens Hosp Boston,Med Sch, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Young, Richard A/F-6495-2012; Mermel, Craig/AAZ-7322-2020	Young, Richard A/0000-0001-8855-8647; Mermel, Craig/0000-0002-0816-3395; Bilodeau, Steve/0000-0002-9799-3832; FERRE', FABRIZIO/0000-0003-2768-5305; Houvras, Yariv/0000-0003-0751-3215; Burke, Christopher/0000-0001-7609-1146	Damon Runyon Cancer Research Foundation [DRG-1855-05]; Charles A. King Trust Foundation; American Society of Clinical Oncology; Canadian Institutes of Health Research; National Institutes of Health [K99AR056899-02, K08DK075432-04, CA146455, HG002668, CA103846, DK055381]; NATIONAL CANCER INSTITUTE [R01CA103846, R01CA146445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR056899, K99AR056899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK055381, R01DK053298, R01DK055381, K08DK075432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Charles A. King Trust Foundation; American Society of Clinical Oncology; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Harrington, R. White and Y. Zhou for discussions; C. Lawrence, I. Adatto and L.-K. Zhang for expert fish care; G. Frampton for bioinformatics assistance; and K. Kwan, C.-B. Chien, and J. Boehm for reagents. This work was supported by grants from the Damon Runyon Cancer Research Foundation (C.J.C., DRG-1855-05), the Charles A. King Trust Foundation (C.J.C.), a Young Investigator Award from the American Society of Clinical Oncology (Y.H.), the Canadian Institutes of Health Research (S.B.) and the National Institutes of Health (C.J.C., K99AR056899-02; Y.H., K08DK075432-04; R.A.Y., CA146455, HG002668; and L.I.Z., CA103846 and DK055381).	Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nisolle M, 1999, HUM REPROD, V14, P2844, DOI 10.1093/humrep/14.11.2844; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Santoriello C, 2009, DIS MODEL MECH, V2, P56, DOI 10.1242/dmm.001016; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007	23	383	392	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					513	+		10.1038/nature09806	http://dx.doi.org/10.1038/nature09806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430779	Green Accepted, Green Submitted			2022-12-24	WOS:000288702200062
J	Schlegelmilch, K; Mohseni, M; Kirak, O; Pruszak, J; Rodriguez, JR; Zhou, DW; Kreger, BT; Vasioukhin, V; Avruch, J; Brummelkamp, TR; Camargo, FD				Schlegelmilch, Karin; Mohseni, Morvarid; Kirak, Oktay; Pruszak, Jan; Rodriguez, J. Renato; Zhou, Dawang; Kreger, Bridget T.; Vasioukhin, Valera; Avruch, Joseph; Brummelkamp, Thijn R.; Camargo, Fernando D.			Yap1 Acts Downstream of alpha-Catenin to Control Epidermal Proliferation	CELL			English	Article							ORGAN SIZE CONTROL; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; PROMOTES APOPTOSIS; SIGNALING PATHWAY; HIPPO PATHWAY; PROGENITOR CELLS; TEAD/TEF FAMILY; PROTEIN-KINASE; GROWTH-CONTROL	During development and regeneration, proliferation of tissue-specific stem cells is tightly controlled to produce organs of a predetermined size. The molecular determinants of this process remain poorly understood. Here, we investigate the function of Yap1, the transcriptional effector of the Hippo signaling pathway, in skin biology. Using gain- and loss-of-function studies, we show that Yap1 is a critical modulator of epidermal stem cell proliferation and tissue expansion. Yap1 mediates this effect through interaction with TEAD transcription factors. Additionally, our studies reveal that alpha-catenin, a molecule previously implicated in tumor suppression and cell density sensing in the skin, is an upstream negative regulator of Yap1. alpha-catenin controls Yap1 activity and phosphorylation by modulating its interaction with 14-3-3 and the PP2A phosphatase. Together, these data identify Yap1 as a determinant of the proliferative capacity of epidermal stem cells and as an important effector of a "crowd control" molecular circuitry in mammalian skin.	[Schlegelmilch, Karin; Mohseni, Morvarid; Camargo, Fernando D.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Schlegelmilch, Karin; Mohseni, Morvarid; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Schlegelmilch, Karin; Mohseni, Morvarid; Pruszak, Jan; Camargo, Fernando D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Schlegelmilch, Karin] FU Berlin, Inst Chem Biochem, D-14195 Berlin, Germany; [Kirak, Oktay; Pruszak, Jan; Rodriguez, J. Renato; Brummelkamp, Thijn R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Zhou, Dawang; Avruch, Joseph] Massachusetts Gen Hosp, Dept Mol & Cellular Biol, Boston, MA 02114 USA; [Kreger, Bridget T.; Vasioukhin, Valera] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Free University of Berlin; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Fred Hutchinson Cancer Center	Camargo, FD (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	fernando.camargo@childrens.harvard.edu	Pruszak, Jan/G-6972-2015; Kirak, Oktay/H-6347-2013	Pruszak, Jan/0000-0003-4297-4009; Kirak, Oktay/0000-0002-6524-4685; Vasioukhin, Valeri/0000-0002-6730-0281; Schlegelmilch, Karin/0000-0003-3173-0914; Zhou, Dawang/0000-0002-9053-5249	Stand Up to Cancer-AACR initiative, NIH [R01 CA131426]; Whitehead Institute; NATIONAL CANCER INSTITUTE [R01CA131426] Funding Source: NIH RePORTER	Stand Up to Cancer-AACR initiative, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehead Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Shrestha and S. Zaghlul for their technical assistance; L. Zon and A. von Giese and members of the Camargo lab for critical discussion; and members of the Gregory laboratory for advice on mass spectrometry experiments. This work was supported by grants from the Stand Up to Cancer-AACR initiative, NIH grant R01 CA131426, and funds from the Whitehead Institute Fellows Program. F. D. C. is a V Foundation Scholar and Pew Scholar in the Biomedical Sciences.	Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dellambra E, 2000, J CELL BIOL, V149, P1117, DOI 10.1083/jcb.149.5.1117; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hariharan IK, 2006, CURR BIOL, V16, pR1037, DOI 10.1016/j.cub.2006.11.012; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Herron BJ, 2005, NAT GENET, V37, P1210, DOI 10.1038/ng1652; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Li QT, 2005, P NATL ACAD SCI USA, V102, P15977, DOI 10.1073/pnas.0508310102; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lien WH, 2006, CURR OPIN CELL BIOL, V18, P499, DOI 10.1016/j.ceb.2006.07.001; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Tinkle CL, 2008, P NATL ACAD SCI USA, V105, P15405, DOI 10.1073/pnas.0807374105; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	58	749	780	0	97	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					782	795		10.1016/j.cell.2011.02.031	http://dx.doi.org/10.1016/j.cell.2011.02.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376238	Green Accepted, Bronze			2022-12-24	WOS:000288007100016
J	Manceau, M; Domingues, VS; Mallarino, R; Hoekstra, HE				Manceau, Marie; Domingues, Vera S.; Mallarino, Ricardo; Hoekstra, Hopi E.			The Developmental Role of Agouti in Color Pattern Evolution	SCIENCE			English	Article							SIGNAL PROTEIN; COAT COLOR; MOUSE COAT; PIGMENTATION; MELANOCYTES; MUTATIONS; GENETICS; STRIPES; GENES; LOCUS	Animal color patterns can affect fitness in the wild; however, little is known about the mechanisms that control their formation and subsequent evolution. We took advantage of two locally camouflaged populations of Peromyscus mice to show that the negative regulator of adult pigmentation, Agouti, also plays a key developmental role in color pattern evolution. Genetic and functional analyses showed that ventral-specific embryonic expression of Agouti establishes a prepattern by delaying the terminal differentiation of ventral melanocytes. Moreover, a skin-specific increase in both the level and spatial domain of Agouti expression prevents melanocyte maturation in a regionalized manner, resulting in a novel and adaptive color pattern. Thus, natural selection favors late-acting, tissue-specific changes in embryonic Agouti expression to produce large changes in adult color pattern.	[Manceau, Marie; Domingues, Vera S.; Mallarino, Ricardo; Hoekstra, Hopi E.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Manceau, Marie; Domingues, Vera S.; Hoekstra, Hopi E.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Harvard University; Harvard University	Hoekstra, HE (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	hoekstra@oeb.harvard.edu	Hoekstra, Hopi E/I-6690-2012	Hoekstra, Hopi E/0000-0003-1431-1769	Portuguese Foundation for Science and Technology; NSF [DEB-0919190]; Direct For Biological Sciences [0919190] Funding Source: National Science Foundation	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Kanadia, C. Punzo, E. McGlinn, J. Gros, A. Abzhanov, and C. Tabin for technical assistance; G. Barsh for helpful discussions; V. Hearing for antibodies to Trp1/Trp2; and C. Desplan, C. Tabin, A. Abzhanov, C. Linnen, and J. Gros for comments on the manuscript. In situ hybridizations on sections and in utero injections were conducted in the Abzhanov and Tabin/Cepko laboratories, respectively. Supported by the Portuguese Foundation for Science and Technology (V.S.D.) and by NSF grant DEB-0919190 (H.E.H.).	Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Botchkareva NV, 2003, J INVEST DERM SYMP P, V8, P76, DOI 10.1046/j.1523-1747.2003.12176.x; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen YR, 1996, GENETICS, V144, P265; Cott H.B., 1940, ADAPTIVE COLORATION; Hirobe T, 1998, EUR J CELL BIOL, V75, P184, DOI 10.1016/S0171-9335(98)80060-5; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; Kopp A, 2009, EVOLUTION, V63, P2771, DOI 10.1111/j.1558-5646.2009.00761.x; Le Pape E, 2009, P NATL ACAD SCI USA, V106, P1802, DOI 10.1073/pnas.0806753106; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Mills MG, 2009, SEMIN CELL DEV BIOL, V20, P72, DOI 10.1016/j.semcdb.2008.11.012; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Parichy DM, 2003, CURR BIOL, V13, pR947, DOI 10.1016/j.cub.2003.11.038; Punzo C, 2008, DEV DYNAM, V237, P1034, DOI 10.1002/dvdy.21500; Rawls JF, 2001, DEV BIOL, V240, P301, DOI 10.1006/dbio.2001.0418; Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544; SIRACUSA LD, 1994, TRENDS GENET, V10, P423, DOI 10.1016/0168-9525(94)90112-0; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x	24	150	155	0	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1062	1065		10.1126/science.1200684	http://dx.doi.org/10.1126/science.1200684			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350176	Green Submitted			2022-12-24	WOS:000287699000062
